PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adam, K; Iuga, A; Tocheva, AS; Mor, A				Adam, Kieran; Iuga, Alina; Tocheva, Anna S.; Mor, Adam			A novel mouse model for checkpoint inhibitor-induced adverse events	PLOS ONE			English	Article								Immune checkpoint inhibitors have demonstrated significant efficacy in the treatment of a variety of cancers, however their therapeutic potential is limited by abstruse immune related adverse events. Currently, no robust animal model exists of checkpoint inhibitor-induced adverse events. Establishing such a model will improve our mechanistic understanding of this process, which in turn will inform design of improved therapies. We developed a mouse model to determine inflammatory toxicities in response to dual checkpoint blockade in the presence of syngeneic tumors. Mice from susceptible genetic backgrounds received intraperitoneal injections of anti-mouse PD-1 and CTLA-4 antibodies. The mice were monitored for weight loss and histologic evidence of inflammation. Blood was collected for basic metabolic panels and titers of anti-nuclear antibodies. In parallel, mice were also treated with prednisolone, which is commonly used to treat immune related adverse events among cancer patients. Among all the genetic backgrounds, B6/lpr mice treated with anti-CTLA-4 and anti-PD-1 antibodies developed more substantial hepatitis, pancreatitis, colitis, and pneumonitis characterized by organ infiltration of immune cells. Mice that developed tissue infiltration demonstrated high serum levels of glucose and high titers of anti-nuclear antibodies. Finally, while administration of prednisolone prevented the development of the inflammatory adverse events, it also abrogated the protective anti-tumor effect of the checkout inhibitors. Genetic background and treatment modalities jointly modified the inflammatory adverse events in tumor bearing mice, suggesting a complex mechanism for checkpoint inhibitor-related inflammation. Future studies will assess additional genetic susceptibility factors and will examine possible contributions from the administration of other anti-inflammatory drugs.	[Adam, Kieran; Tocheva, Anna S.; Mor, Adam] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Iuga, Alina] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA	Columbia University; Columbia University	Mor, A (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA.	am5121@cumc.columbia.edu	Iuga, Alina/ABA-5825-2021	Adam, Kieran/0000-0003-0787-6868	National Institute of Allergy and Infectious Diseases [AI25640]; Dr. Adam Mor National Cancer Institute [CA231277]; Dr. Adam Mor National Institute of Allergy and Infectious Diseases [AI013696]; Dr. Adam Mor Cancer Research Institute; Dr. Adam Mor Lisa M. Baker autoimmunity innovation fund	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dr. Adam Mor National Cancer Institute; Dr. Adam Mor National Institute of Allergy and Infectious Diseases; Dr. Adam Mor Cancer Research Institute; Dr. Adam Mor Lisa M. Baker autoimmunity innovation fund	National Institute of Allergy and Infectious Diseases, AI25640, Dr. Adam Mor National Cancer Institute, CA231277, Dr. Adam Mor National Institute of Allergy and Infectious Diseases, AI013696, Dr. Adam Mor Cancer Research Institute, Dr. Adam Mor Lisa M. Baker autoimmunity innovation fund, Dr. Adam Mor.	Ali OH, 2020, J AM ACAD DERMATOL, V82, P854, DOI 10.1016/j.jaad.2019.08.045; Ali OH, 2019, EUR J CANCER, V107, P8, DOI 10.1016/j.ejca.2018.11.009; Ali OH, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1231292; Alvarez M, 2019, CELL STRESS, V3, P236, DOI 10.15698/cst2019.07.193; Baroudjian B, 2019, EXPERT REV ANTICANC, V19, P209, DOI 10.1080/14737140.2019.1562342; Berner F, 2019, JAMA ONCOL, V5, P1043, DOI 10.1001/jamaoncol.2019.0402; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Cathcart-Rake EJ, 2020, CLIN LUNG CANCER, V21, P421, DOI 10.1016/j.cllc.2020.04.003; Chang CY, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1611; Cohen BE, 2020, AM J CLIN DERMATOL, V21, P669, DOI 10.1007/s40257-020-00524-0; Corneth OBJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39483-w; Das S, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0805-8; Du XX, 2018, CELL RES, V28, P433, DOI 10.1038/s41422-018-0012-z; Efremova M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02424-0; Hoefsmit EP, 2019, ESMO OPEN, V4, DOI 10.1136/esmoopen-2018-000472; Ibraheim H, 2019, RHEUMATOLOGY, V58, P17, DOI 10.1093/rheumatology/kez465; Jeltsch-David H, 2014, AUTOIMMUN REV, V13, P963, DOI 10.1016/j.autrev.2014.08.015; Kochupurakkal NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089561; Lerrer S., 2019, TRANSLATION CANC RES, V10, P21037; Lin ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160485; Liu J, 2016, CANCER RES, V76, P5288, DOI 10.1158/0008-5472.CAN-16-0194; Liu J, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.18; Matsuya T, 2020, J DERMATOL, V47, P629, DOI 10.1111/1346-8138.15345; Myers G, 2018, CURR ONCOL, V25, P342, DOI 10.3747/co.25.4235; Park R, 2021, CLIN TRANSL ONCOL, V23, P100, DOI 10.1007/s12094-020-02397-5; Pedoeem A, 2014, CLIN IMMUNOL, V153, P145, DOI 10.1016/j.clim.2014.04.010; Perez-Ruiz E, 2019, NATURE, V569, P428, DOI 10.1038/s41586-019-1162-y; Postow MA, 2012, CANCER J, V18, P153, DOI 10.1097/PPO.0b013e318250c001; Quandt Z, 2020, CLIN EXP IMMUNOL, V200, P131, DOI 10.1111/cei.13424; Raval RR, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-14; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Sakic B, 2018, METHODS MOL BIOL, V1781, P259, DOI 10.1007/978-1-4939-7828-1_14; Sandigursky S, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0770-0; Schachter J, 2017, LANCET, V390, P1853, DOI 10.1016/S0140-6736(17)31601-X; Selby MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161779; Tison A, 2019, ARTHRITIS RHEUMATOL, V71, P2100, DOI 10.1002/art.41068; Wu KJ, 2019, EXP HEMATOL ONCOL, V8, DOI 10.1186/s40164-019-0150-0; Young A, 2018, CANCER IMMUNOL RES, V6, P1445, DOI 10.1158/2326-6066.CIR-18-0487	38	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246168	10.1371/journal.pone.0246168	http://dx.doi.org/10.1371/journal.pone.0246168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571254	Green Published, gold			2022-12-26	WOS:000620071100009
J	Banerdt, JK; Mateyo, K; Wang, L; Lindsell, CJ; Riviello, ED; Saylor, D; Heimburger, DC; Ely, EW				Banerdt, Justin K.; Mateyo, Kondwelani; Wang, Li; Lindsell, Christopher J.; Riviello, Elisabeth D.; Saylor, Deanna; Heimburger, Douglas C.; Ely, E. Wesley			Delirium as a predictor of mortality and disability among hospitalized patients in Zambia	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; EARLY WARNING SCORE; PROGNOSTIC ACCURACY; CRITICAL ILLNESS; GLOBAL BURDEN; CRITICAL-CARE; CRITERIA; SEPSIS; SURVIVORS; ADULTS	Objective To study the epidemiology and outcomes of delirium among hospitalized patients in Zambia. Methods We conducted a prospective cohort study at the University Teaching Hospital in Lusaka, Zambia, from October 2017 to April 2018. The primary exposure was delirium duration over the initial 3 days of hospitalization, assessed daily using the Brief Confusion Assessment Method. The primary outcome was 6-month mortality. Secondary outcomes included 6-month disability, evaluated using the World Health Organization Disability Assessment Schedule 2.0. Findings 711 adults were included (median age, 39 years; 461 men; 459 medical, 252 surgical; 323 with HIV). Delirium prevalence was 48.5% (95% CI, 44.8%-52.3%). 6-month mortality was higher for delirious participants (44.6% [39.3%-50.1%]) versus non-delirious participants (20.0% [15.4%-25.2%]; P < .001). After adjusting for covariates, delirium duration independently predicted 6-month mortality and disability with a significant dose-response association between number of days with delirium and odds of worse clinical outcome. Compared to no delirium, presence of 1, 2 or 3 days of delirium resulted in odds ratios for 6-month mortality of 1.43 (95% CI, 0.73-2.80), 2.20 (1.07-4.51), and 3.92 (2.24-6.87), respectively (P < .001). Odds of 6-month disability were 1.20 (0.70-2.05), 1.73 (0.95-3.17), and 2.80 (1.78-4.43), respectively (P < .001). Conclusion Among hospitalized medical and surgical patients in Zambia, delirium prevalence was high and delirium duration independently predicted mortality and disability at 6 months. This work lays the foundation for prevention, detection, and management of delirium in low-income countries. Long-term follow up of outcomes of critical illness in resource-limited settings appears feasible using the WHO Disability Assessment Schedule.	[Banerdt, Justin K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Banerdt, Justin K.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Banerdt, Justin K.; Ely, E. Wesley] Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN 37235 USA; [Mateyo, Kondwelani; Saylor, Deanna; Heimburger, Douglas C.] Univ Zambia, Sch Med, Lusaka, Zambia; [Mateyo, Kondwelani; Saylor, Deanna] Univ Teaching Hosp, Lusaka, Zambia; [Wang, Li; Lindsell, Christopher J.] Vanderbilt Univ, Dept Biostat, Med Ctr, Nashville, TN USA; [Riviello, Elisabeth D.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Riviello, Elisabeth D.] Harvard Med Sch, Boston, MA 02115 USA; [Saylor, Deanna] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Heimburger, Douglas C.; Ely, E. Wesley] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Heimburger, Douglas C.] Vanderbilt Inst Global Hlth, Nashville, TN USA; [Ely, E. Wesley] Tennessee Valley Vet Affairs Geriatr Res Educ Cli, Nashville, TN USA	Yale University; Vanderbilt University; Vanderbilt University; University of Zambia; University of Zambia; Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Johns Hopkins University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center	Banerdt, JK (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Banerdt, JK (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.; Banerdt, JK (corresponding author), Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN 37235 USA.	justin.banerdt@yale.edu		Saylor, Deanna/0000-0002-9297-0244; Heimburger, Douglas/0000-0003-3551-9710; Riviello, Elisabeth/0000-0002-9443-3928	Fogarty International Center of the US National Institutes of Health [D43 TW009337]; Vanderbilt Institute for Clinical and Translational Research grant from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002243]; School of Medicine, Vanderbilt University	Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Vanderbilt Institute for Clinical and Translational Research grant from the National Center for Advancing Translational Sciences of the National Institutes of Health; School of Medicine, Vanderbilt University	JKB was supported by the Fogarty International Center of the US National Institutes of Health under award D43 TW009337 (https://www.vumc.org/vecd/home), Vanderbilt Institute for Clinical and Translational Research grant UL1TR002243 from the National Center for Advancing Translational Sciences of the National Institutes of Health (https://victr.vumc.org), and the School of Medicine, Vanderbilt University (https://medschool.vanderbilt.edu/curriculum/medicalscholars-program).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Andrews B, 2017, JAMA-J AM MED ASSOC, V318, P1233, DOI 10.1001/jama.2017.10913; Dart PJ, 2017, ANAESTHESIA, V72, P172, DOI 10.1111/anae.13709; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Gardner-Thorpe J, 2006, ANN ROY COLL SURG, V88, P571, DOI 10.1308/003588406X130615; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Han JH, 2016, AM J EMERG MED, V34, P1031, DOI 10.1016/j.ajem.2016.02.069; Han JH, 2013, ANN EMERG MED, V62, P457, DOI 10.1016/j.annemergmed.2013.05.003; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hshieh TT, 2017, ANN SURG, V265, P647, DOI 10.1097/SLA.0000000000001952; Hsieh S Jean, 2013, Ann Am Thorac Soc, V10, P648, DOI 10.1513/AnnalsATS.201307-232FR; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Kiely DK, 2009, J AM GERIATR SOC, V57, P55, DOI 10.1111/j.1532-5415.2008.02092.x; Kwizera A, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/491780; Leslie DL, 2005, ARCH INTERN MED, V165, P1657, DOI 10.1001/archinte.165.14.1657; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Moore CC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000344; Murthy Srinivas, 2013, Ann Am Thorac Soc, V10, P509, DOI 10.1513/AnnalsATS.201307-246OT; Paddick SM, 2015, J NEUROL SCI, V348, P6, DOI 10.1016/j.jns.2014.10.034; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Riviello ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155858; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Rudolph JL, 2010, J AM GERIATR SOC, V58, P643, DOI 10.1111/j.1532-5415.2010.02762.x; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Samanamalee S, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-017-0463-7; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shi ZY, 2019, ANESTHESIOLOGY, V131, P492, DOI 10.1097/ALN.0000000000002849; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Uldall KK, 2000, AIDS PATIENT CARE ST, V14, P95, DOI 10.1089/108729100318037; Uldall KK, 2000, COMPR PSYCHIAT, V41, P88, DOI 10.1016/S0010-440X(00)90138-X; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Vasilevskis EE, 2012, BEST PRACT RES-CLIN, V26, P277, DOI 10.1016/j.bpa.2012.07.003; Vukoja M, 2018, CURR OPIN CRIT CARE, V24, P421, DOI 10.1097/MCC.0000000000000528; World Health Organization, 2018, REG OFF WHO COUNTR C	40	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246330	10.1371/journal.pone.0246330	http://dx.doi.org/10.1371/journal.pone.0246330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571227	Green Published, gold			2022-12-26	WOS:000618274000062
J	Liao, TY; Lu, PL; Yu, YH; Huang, WC; Shiao, JC; Lin, HD; Jhuang, WC; Chou, TK; Li, F				Liao, Te-Yu; Lu, Pei-Luen; Yu, Yuan-Huan; Huang, Wen-Chien; Shiao, Jen-Chieh; Lin, Hung-Du; Jhuang, Wei-Cheng; Chou, Tak-Kei; Li, Fan			Amphidromous but endemic: Population connectivity of Rhinogobius gigas (Teleostei: Gobioidei)	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; LIFE-HISTORY; PHYLOGEOGRAPHY; GOBY; GOBIES; GOBIIDAE; FISH; METAMORPHOSIS; VARIABILITY; SICYDIINAE	Rhinogobius gigas is an amphidromous fish endemic to eastern Taiwan. Fishes with the diadromous behavior are expected to have a broader distribution range and higher genetic homogeneity despite that some amphidromous fishes with limited distribution are observed and R. gigas is an additional exception with a limited distribution range. Rhinogobius gigas has been documented to be retained inshore near the river plume with a short pelagic larval duration of 30-40 days, which may account for the endemism of this species. The short marine larval stage of R. gigas may imply a population genetic structure and the aim of the present study is to test whether the population genetic structure is present in R. gigas. To test the population genetic structure, fragments of mitochondrial displacement loop and cytochrome c oxidase subunit I were sequenced to provide molecular inference for genetic structure among populations. Sixty-nine haplotypes were identified among 191 R. gigas from 10 populations of eastern Taiwan and the mean haplotype and nucleotide diversities for all samples were 0.956 and 0.0024, respectively, implying a bottleneck followed by a recent population expansion further supported by Fu's Fs (-26.6; p < 0.001) and Tajima's D (-1.5; p = 0.037) values. The phylogenetic analysis revealed lack of genetic structure and the bush-like median joining network without commonly shared haplotypes supports the same scenario. The genetic homogeneity is probably due to the amphidromous life history providing the opportunity for passive larval transportation among the rivers through coastal currents in eastern Taiwan. The endemism to eastern Taiwan may be a consequence of complicated interactions among short pelagic larval duration, interspecific competition and coastal currents.	[Liao, Te-Yu; Yu, Yuan-Huan; Chou, Tak-Kei; Li, Fan] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan; [Lu, Pei-Luen] Natl Taitung Univ, Dept Life Sci, Taitung, Taiwan; [Huang, Wen-Chien; Jhuang, Wei-Cheng] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Huang, Wen-Chien; Jhuang, Wei-Cheng] Acad Sinica, Doctoral Degree Program Marine Biotechnol, Taipei, Taiwan; [Shiao, Jen-Chieh] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Lin, Hung-Du] Natl Tainan First Senior High Sch, Affiliated Sch, Tainan, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University; Academia Sinica - Taiwan; National Taiwan University	Liao, TY (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan.	swp0117@gmail.com		Huang, Wen Chien/0000-0002-9482-8188; SHIAO, JEN-CHIEH/0000-0002-3824-5738; Liao, Te-Yu/0000-0001-7588-200X	Ministry of Science and Technology [106-2923-B-110 -002 -MY3, 107-2311-B-143-001]; NSYSU-NTTU 2019 academic cooperation project	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSYSU-NTTU 2019 academic cooperation project	This study was supported by grants from the NSYSU-NTTU 2019 academic cooperation project and Ministry of Science and Technology to T.Y.L. (106-2923-B-110 -002 -MY3) and P.L.L. (107-2311-B-143-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIBONE RM, 1993, BIOL J LINN SOC, V50, P19, DOI 10.1006/bijl.1993.1045; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; BELL KNI, 1995, MAR BIOL, V121, P409, DOI 10.1007/BF00349450; Benoit HP, 1999, MAR ECOL PROG SER, V184, P231, DOI 10.3354/meps184231; Chen I.S., 1999, FRESHWATER ESTUARINE; Cheng HL, 2005, ZOOL STUD, V44, P329; Cheng YH, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2020JC016123; Chiang TY, 2017, BIOCHEM SYST ECOL, V70, P283, DOI 10.1016/j.bse.2016.12.010; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feutry P, 2013, MOL ECOL, V22, P1518, DOI 10.1111/mec.12192; Feutry P, 2012, MAR FRESHWATER RES, V63, P397, DOI 10.1071/MF11243; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; He LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15645; Hoareau TB, 2007, MAR ECOL PROG SER, V333, P303, DOI 10.3354/meps333303; Hohenlohe PA, 2004, BIOL J LINN SOC, V82, P169, DOI 10.1111/j.1095-8312.2004.00318.x; Ju YM, 2013, GENET MOL RES, V12, P4046, DOI 10.4238/2013.September.27.6; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Liao TY, 2020, ZOOKEYS, P91, DOI 10.3897/zookeys.951.50429; Lin HD, 2008, J FISH BIOL, V72, P2011, DOI 10.1111/j.1095-8649.2008.01836.x; Lord C, 2015, VIE MILIEU, V65, P63; Lord C, 2012, MAR ECOL PROG SER, V455, P269, DOI 10.3354/meps09617; Lord C, 2010, ECOL FRESHW FISH, V19, P26, DOI 10.1111/j.1600-0633.2009.00386.x; McDowall RM, 2007, FISH FISH, V8, P1, DOI 10.1111/j.1467-2979.2007.00232.x; Montgomery JC, 2001, FISH FISH, V2, P261, DOI 10.1046/j.1467-2960.2001.00053.x; Muhs DR, 2002, QUATERNARY RES, V58, P36, DOI 10.1006/qres.2002.2339; Ohara K, 2005, ICHTHYOL RES, V52, P306, DOI 10.1007/s10228-005-0284-4; Qiu F, 2016, MOL PHYLOGENET EVOL, V96, P112, DOI 10.1016/j.ympev.2015.11.020; Radtke RL, 2001, J FISH BIOL, V59, P928, DOI 10.1006/jfbi.2001.1705; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rudnick DL, 2011, OCEANOGRAPHY, V24, P52, DOI 10.5670/oceanog.2011.94; Shen KN, 2002, MAR ECOL PROG SER, V228, P205, DOI 10.3354/meps228205; Shiao JC, 2015, ENVIRON BIOL FISH, V98, P933, DOI 10.1007/s10641-014-0329-5; Suzuki T, 2011, J MAR SCI TECH-TAIW, V19, P693; Taillebois L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075465; Tsunagawa T, 2008, J FISH BIOL, V73, P2421, DOI 10.1111/j.1095-8649.2008.02089.x; Wang TY, 2007, ZOOL STUD, V46, P547; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watanabe Shun, 2006, Coastal Marine Science, V30, P473; Wu CR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004697; Yamasaki YY, 2015, MOL PHYLOGENET EVOL, V90, P20, DOI 10.1016/j.ympev.2015.04.012; Yang Y, 2001, GEOPHYS RES LETT, V28, P2461, DOI 10.1029/2000GL011709	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246406	10.1371/journal.pone.0246406	http://dx.doi.org/10.1371/journal.pone.0246406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571236	Green Published, gold			2022-12-26	WOS:000618274000045
J	Thierry, M; Pardikes, NA; Lue, CH; Lewis, OT; Hrcek, J				Thierry, Melanie; Pardikes, Nicholas A.; Lue, Chia-Hua; Lewis, Owen T.; Hrcek, Jan			Experimental warming influences species abundances in a Drosophila host community through direct effects on species performance rather than altered competition and parasitism	PLOS ONE			English	Article							CLIMATE-CHANGE; TROPHIC INTERACTIONS; NATURAL-POPULATIONS; FOOD-WEB; TEMPERATURE; RESPONSES; MELANOGASTER; DIVERSITY; PREDATION; IMPACTS	Global warming is expected to have direct effects on species through their sensitivity to temperature, and also via their biotic interactions, with cascading indirect effects on species, communities, and entire ecosystems. To predict the community-level consequences of global climate change we need to understand the relative roles of both the direct and indirect effects of warming. We used a laboratory experiment to investigate how warming affects a tropical community of three species of Drosophila hosts interacting with two species of parasitoids over a single generation. Our experimental design allowed us to distinguish between the direct effects of temperature on host species performance, and indirect effects through altered biotic interactions (competition among hosts and parasitism by parasitoid wasps). Although experimental warming significantly decreased parasitism for all host-parasitoid pairs, the effects of parasitism and competition on host abundances and host frequencies did not vary across temperatures. Instead, effects on host relative abundances were species-specific, with one host species dominating the community at warmer temperatures, irrespective of parasitism and competition treatments. Our results show that temperature shaped a Drosophila host community directly through differences in species' thermal performance, and not via its influences on biotic interactions.	[Thierry, Melanie; Hrcek, Jan] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Thierry, Melanie; Pardikes, Nicholas A.; Lue, Chia-Hua; Hrcek, Jan] Czech Acad Sci, Biol Ctr, Inst Entomol, Dept Ecol, Ceske Budejovice, Czech Republic; [Lewis, Owen T.] Univ Oxford, Dept Zool, Oxford, England	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Oxford	Thierry, M (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Thierry, M (corresponding author), Czech Acad Sci, Biol Ctr, Inst Entomol, Dept Ecol, Ceske Budejovice, Czech Republic.	m.thierry@entu.cas.cz	Hrček, Jan/D-7335-2015; Thierry, Melanie J./AAB-3589-2019	Hrček, Jan/0000-0003-0711-6447; Thierry, Melanie J./0000-0003-4169-2413	Grantova Agentura Ceske Republiky [17-27184Y]; Jihoceska Univerzita v Ceskych Budejovicich [038/2019/P]; OTL by the UK Natural Environment Research Council [NE/N010221/1]; NERC [NE/N010221/1] Funding Source: UKRI	Grantova Agentura Ceske Republiky(Grant Agency of the Czech Republic); Jihoceska Univerzita v Ceskych Budejovicich; OTL by the UK Natural Environment Research Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge funding support of JH from the Grantova Agentura Ceske Republiky no. 17-27184Y. MT was further supported by Jihoceska Univerzita v Cesky ' ch Budejovicich (GA JU no. 038/2019/P), and OTL by the UK Natural Environment Research Council (NE/N010221/1).	Alexander JM, 2015, NATURE, V525, P515, DOI 10.1038/nature14952; Babasaheb B. F., 2018, ADV CROP ENV INTERAC, P389, DOI DOI 10.1007/978-981-13-1861-0_15; Bartley TJ, 2019, NAT ECOL EVOL, V3, P345, DOI 10.1038/s41559-018-0772-3; Benard MF, 2015, GLOBAL CHANGE BIOL, V21, P1058, DOI 10.1111/gcb.12720; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bideault A, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00045; BOULETREAU M, 1986, ENTOMOL EXP APPL, V41, P107, DOI 10.1007/BF00195565; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; CARTON Y, 1981, BIOL J LINN SOC, V16, P227, DOI 10.1111/j.1095-8312.1981.tb01849.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Dancau T, 2017, BIOCONTROL SCI TECHN, V27, P3, DOI 10.1080/09583157.2016.1241982; Daufresne M, 2007, GLOBAL CHANGE BIOL, V13, P2467, DOI 10.1111/j.1365-2486.2007.01449.x; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Derocles SAP, 2018, MOL ECOL, V27, P4931, DOI 10.1111/mec.14903; Dyer LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062528; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Flores-Mejia S., 2017, FOOD WEBS, V11, P1; Forbes RW, 1944, P ROY SOC LOND B BIO, V132, P258, DOI [10.1098/rspb.1944.0017, DOI 10.1098/RSPB.1944.0017]; Fox J., 2018, R COMPANION APPL REG, VThird; Fox JW, 2001, J ANIM ECOL, V70, P80; Freeman BG, 2018, GLOBAL ECOL BIOGEOGR, V27, P1268, DOI 10.1111/geb.12774; Garcia-Robledo C, 2016, P NATL ACAD SCI USA, V113, P680, DOI 10.1073/pnas.1507681113; Gardmark A, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0449; Gilbert B, 2014, ECOL LETT, V17, P902, DOI 10.1111/ele.12307; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Godoy O, 2018, TRENDS ECOL EVOL, V33, P287, DOI 10.1016/j.tree.2018.01.007; GRIMALDI D, 1984, ECOLOGY, V65, P1113, DOI 10.2307/1938319; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Han P, 2019, CURR OPIN INSECT SCI, V35, P27, DOI 10.1016/j.cois.2019.05.005; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hartig F., 2022, DHARMA RESIDUAL DIAG; Higgie M., 2018, INTERACTING EFFECTS, DOI [10.1101/395624, DOI 10.1101/395624]; IUCN, 2012, IUCN RED LIST THREAT, DOI [10.5860/choice.49-6872, DOI 10.5860/CHOICE.49-6872]; Jeffs CT, 2021, ECOGRAPHY, V44, P403, DOI 10.1111/ecog.05390; Jeffs CT, 2013, ECOL ENTOMOL, V38, P209, DOI 10.1111/een.12026; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Kefi S, 2015, ECOLOGY, V96, P291, DOI 10.1890/13-1424.1; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lavandero B, 2013, MOL ECOL, V22, P229, DOI 10.1111/mec.12100; Le Lann C, 2014, OECOLOGIA, V174, P967, DOI 10.1007/s00442-013-2810-9; Lenth RV., 2021, EMMEANS ESTIMATED MA; Linder JE, 2008, J INSECT PHYSIOL, V54, P297, DOI 10.1016/j.jinsphys.2007.10.001; MacLean HJ, 2019, J THERM BIOL, V86, DOI 10.1016/j.jtherbio.2019.102428; MacLean HJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0548; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; Ockendon N, 2014, GLOBAL CHANGE BIOL, V20, P2221, DOI 10.1111/gcb.12559; Ohlberger J, 2013, FUNCT ECOL, V27, P991, DOI 10.1111/1365-2435.12098; Overgaard J, 2014, GLOBAL CHANGE BIOL, V20, P1738, DOI 10.1111/gcb.12521; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Pilosof S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0101; Roman-Palacios C, 2020, P NATL ACAD SCI USA, V117, P4211, DOI 10.1073/pnas.1913007117; Sage RF, 2020, GLOBAL CHANGE BIOL, V26, P3, DOI 10.1111/gcb.14893; Seibold S, 2018, TRENDS ECOL EVOL, V33, P754, DOI 10.1016/j.tree.2018.07.001; Sentis A, 2017, GLOBAL CHANGE BIOL, V23, P2629, DOI 10.1111/gcb.13560; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Team RC, 2017, R R PROJ STAT COMP; Terry JCD, 2020, EFFECT NATURAL ENEMI, DOI [10.1101/2020.08.27.270389, DOI 10.1101/2020.08.27.270389]; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thierry M, 2019, ECOL ENTOMOL, V44, P581, DOI 10.1111/een.12750; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Tougeron K, 2020, ECOL ENTOMOL, V45, P167, DOI 10.1111/een.12792; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Venables WN., 2002, MODERN APPL STAT S, V4; Vesely L, 2019, FRESHWATER BIOL, V64, P1984, DOI 10.1111/fwb.13387; Villalpando SN, 2009, GLOBAL CHANGE BIOL, V15, P930, DOI 10.1111/j.1365-2486.2008.01721.x; Wagner DL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2002549117; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WOODMAN RL, 1992, ECOLOGY, V73, P1028, DOI 10.2307/1940177	77	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245029	10.1371/journal.pone.0245029	http://dx.doi.org/10.1371/journal.pone.0245029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571220	gold, Green Submitted, Green Published			2022-12-26	WOS:000618274000031
J	Gebreegziabiher, G; Belachew, T; Mehari, K; Tamiru, D				Gebreegziabiher, Gebremedhin; Belachew, Tefera; Mehari, Kibrti; Tamiru, Dessalegn			Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia	PLOS ONE			English	Article							HEART-DISEASE; POPULATION; CHINA	Introduction Dyslipidemia is a major risk factor for cardiovascular diseases (CVD). The prevalence of dyslipidemia is not known among Ethiopian adults. The prevalence is expected to rise due to the socio-economic development accompanied by lifestyle changes. This study was conducted to estimate the prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City. Methods A community-based cross-sectional study was conducted among 321 randomly selected subjects. Data were collected on sociodemographic, anthropometric, lifestyle, and clinical characteristics of the participants using the WHO STEPS survey instrument. Data were analyzed using SPSS software version 24.0. Student's t-test and Pearson's Chi-square test were used to assessing the interrelationship between each factor and outcome variables. Bivariate and multivariable logistic regression analysis were used to identify risk factors associated with dyslipidemia. All statistical significance was considered at p <= 0.05. Results The prevalence of dyslipidemia in this study was 66.7%. The prevalence of high low-density lipoprotein cholesterol (LDL-C), elevated triglyceride, elevated total cholesterol, and low high-density lipoprotein cholesterol (HDL-C) was 49.5%, 40.2%, 30.8%, and 16.5%, respectively. Being above 64 years (aOR: 2.196, 95% CI: 1.183-4.078) and 40-64 years old (aOR: 2.196, 95% CI: 1.183-4.078), overweight (aOR: 2.50, 95% CI: 1.314-4.756) and obesity (aOR: 15.489, 95% CI: 3.525-68.070), walking <150 minutes per week (aOR: 1.722, 95% CI: 1.004-2.953), raised fasting blood glucose (FBG) (aOR: 4.804, 95% CI: 1.925-11.988), and medium socio-economic status (aOR: 2.017, 95% CI: 1.044-3.899) were identified as significant predictors of dyslipidemia. Conclusions The finding of this study indicated that the prevalence of dyslipidemia is unacceptably high among adult residents of Mekelle City, which underlines an urgent need for early detection and public health interventions through the integrated involvement of public, governmental, and non-governmental organizations.	[Gebreegziabiher, Gebremedhin] Adigrat Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Human Nutr, Adigrat, Tigray, Ethiopia; [Belachew, Tefera; Tamiru, Dessalegn] Jimma Univ, Fac Publ Hlth, Dept Nutr & Dietet, Jimma, Oromia, Ethiopia; [Mehari, Kibrti] Tigray Hlth Res Inst, Mekelle, Tigray, Ethiopia	Jimma University	Gebreegziabiher, G (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Human Nutr, Adigrat, Tigray, Ethiopia.	ghingherg@gmail.com						Abujbara M, 2018, J LIPIDS, V2018, DOI 10.1155/2018/6298739; Agongo G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206326; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Ali I, 2019, J LIPIDS, V2019, DOI 10.1155/2019/3473042; Amberbir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197728; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P89; [Anonymous], 2012, J CLIN GASTROENTEROL, V46, pS64; [Anonymous], 2014, EUROMET EMPIR CALL T, P1; [Anonymous], 2019, JURISTEN ZEITUNG; Anyabolu EN, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.204.13505; Asiki G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126166; Association of Paediatric Anaesthetists of Great Britain and Ireland, 2012, PAEDIAT ANAESTH S1, V22, pS1; Azizi F, 2003, EUR J EPIDEMIOL, V18, P311, DOI 10.1023/A:1023606524944; Bakesiima R, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022338; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooney MT, 2009, ATHEROSCLEROSIS, V206, P611, DOI 10.1016/j.atherosclerosis.2009.02.041; Cziraky Mark J, 2004, J Am Pharm Assoc (2003), V44, P478, DOI 10.1331/1544345041475643; Dave JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151911; Del Bono E., 2016, EC J, V126, pF96; Douglas G, 2013, MACLEODS CLIN EXAMIN; Doupa D, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.181.4872; Doupa D, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.75.3577; Eaton CB, 2005, PRIMARY CARE, V32, P1027, DOI 10.1016/j.pop.2005.09.002; Feng W, 2019, INT J CLIN EXP MED, V12, P2729; Gebreyes YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194819; Gonzalez-Rivas JP, 2018, ARQ BRAS CARDIOL, V110, P30, DOI 10.5935/abc.20170180; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Li YR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205709; Lin HQ, 2019, CLIN INTERV AGING, V14, P1119, DOI 10.2147/CIA.S207665; Lumu William, 2017, BMC Res Notes, V10, P587, DOI 10.1186/s13104-017-2916-y; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Najafipour H, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0268-0; Narindrarangkura P, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1034-3; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; Noubiap JJ, 2018, LANCET GLOB HEALTH, V6, pE998, DOI 10.1016/S2214-109X(18)30275-4; Olamoyegun Michael Adeyemi, 2016, Pan Afr Med J, V25, P72, DOI 10.11604/pamj.2016.25.72.6496; Pagidipati NJ, 2016, JAMA CARDIOL, V1, P145, DOI 10.1001/jamacardio.2016.0183; Pan JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22167-2; Pedhambkar R, 2018, INT J COMMUN MED PUB, V5, P1458, DOI 10.18203/2394-6040.ijcmph20181217; Qi L, 2015, INT J ENV RES PUB HE, V12, P13455, DOI 10.3390/ijerph121013455; Reiger S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187347; Rinkuniene E, 2015, CLIN LIPIDOL, V10, P219, DOI 10.2217/CLP.15.16; Feitosa ACR, 2017, ARQ BRAS CARDIOL, V109, P30, DOI 10.5935/abc.20170070; Sang VK, 2017, J ENDOCRINOL DIAB, V4, P1, DOI [DOI 10.15226/2374-6890/4/5/00190, 10.15226/2374-6890/4/5/00190]; Smith S, 2008, TURK J BIOCHEM, V33, P138; Stewart A, 2011, INT SOC ADVANCEMENT, P3; Sufa B, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4148-9; Wang SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017326; Wang Y, 2016, INT J CLIN EXP PATHO, V9, P10603; WHO, WHO STEPWISE APPROAC; WHO, 2002, RED RISKS PROM HLTH; World Health Organization, 2019, GLOBAL HLTH OBSERVAT; World Health Organization, 2004, ATLAS HEART DIS STRO; Zhang FL, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0453-2	55	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0243103	10.1371/journal.pone.0243103	http://dx.doi.org/10.1371/journal.pone.0243103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561153	Green Published, gold			2022-12-26	WOS:000617533000002
J	Ke, XY; Chen, Y; Tham, VYY; Lin, RYT; Dakle, P; Nacro, K; Puhaindran, ME; Houghton, P; Pang, A; Lee, VK; Ding, LW; Gery, S; Hill, J; Chen, LL; Xu, L; Koeffler, HP				Ke, Xin-Yu; Chen, Ye; Tham, Valarie Yu-Yan; Lin, Ruby Yu-Tong; Dakle, Pushkar; Nacro, Kassoum; Puhaindran, Mark Edward; Houghton, Peter; Pang, Angela; Lee, Victor Kwanmin; Ding, Ling-Wen; Gery, Sigal; Hill, Jeffrey; Chen, Leilei; Xu, Liang; Koeffler, H. Phillip			MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma	ONCOGENE			English	Article								Soft tissue sarcoma (STS) is a heterogeneous disease that arises from connective tissues. Clinical outcome of patients with advanced tumors especially de-differentiated liposarcoma and uterine leiomyosarcoma remains unsatisfactory, despite intensive treatment regimens including maximal surgical resection, radiation, and chemotherapy. MAP kinase-interacting serine/threonine-protein kinase 1 and 2 (MNK1/2) have been shown to contribute to oncogenic translation via phosphorylation of eukaryotic translation initiation factor 4E (eIF4E). However, little is known about the role of MNK1/2 and their downstream targets in STS. In this study, we show that depletion of either MNK1 or MNK2 suppresses cell viability, anchorage-independent growth, and tumorigenicity of STS cells. We also identify a compelling antiproliferative efficacy of a novel, selective MNK inhibitor ETC-168. Cellular responsiveness of STS cells to ETC-168 correlates positively with that of phosphorylated ribosomal protein S6 (RPS6). Mirroring MNK1/2 silencing, ETC-168 treatment strongly blocks eIF4E phosphorylation and represses expression of sarcoma-driving onco-proteins including E2F1, FOXM1, and WEE1. Moreover, combination of ETC-168 and MCL1 inhibitor S63845 exerts a synergistic antiproliferative activity against STS cells. In summary, our study reveals crucial roles of MNK1/2 and their downstream targets in STS tumorigenesis. Our data encourage further clinical translation of MNK inhibitors for STS treatment.	[Ke, Xin-Yu; Chen, Ye; Tham, Valarie Yu-Yan; Lin, Ruby Yu-Tong; Dakle, Pushkar; Chen, Leilei; Xu, Liang; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Ke, Xin-Yu; Chen, Leilei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore; [Nacro, Kassoum] Agcy Sci Technol & Res, Expt Drug Dev Ctr, Singapore, Singapore; [Puhaindran, Mark Edward; Pang, Angela; Koeffler, H. Phillip] Natl Univ, Natl Univ Hosp, Canc Inst, Singapore, Singapore; [Puhaindran, Mark Edward] Natl Univ Singapore Hosp, Div Musculoskeletal Oncol, Univ Orthopaed Hand & Reconstruct Microsurg Clust, Singapore, Singapore; [Puhaindran, Mark Edward] Natl Univ Singapore Hosp, Dept Hand & Reconstruct Microsurg, Singapore, Singapore; [Houghton, Peter] UT Hlth San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Lee, Victor Kwanmin] Natl Univ Singapore Hosp, Dept Pathol, Singapore, Singapore; [Ding, Ling-Wen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore, Singapore; [Gery, Sigal; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Hill, Jeffrey] Univ Sussex, Sch Life Sci, Sussex Drug Discovery Ctr, Brighton, E Sussex, England	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); National University of Singapore; National University of Singapore; National University of Singapore; University of Texas System; University of Texas Health San Antonio; National University of Singapore; National University of Singapore; Cedars Sinai Medical Center; University of Sussex	Chen, Y; Xu, L (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.	zjuchenye@gmail.com; xuliang.zju@gmail.com	Xu, Liang/I-9877-2014; Ding, Ling-Wen/H-6916-2019	Xu, Liang/0000-0002-2700-4840; Ding, Ling-Wen/0000-0003-0022-1551; Lin, Ruby/0000-0003-3229-4659; Lee, Victor Kwan Min/0000-0001-7803-0005	Biomedical Sciences Institutes; Joint Council Office (JCO), Agency for Science, Technology and Research, Singapore [11 03 FG 07 05]; National Institutes of Health [R01-CA200992-04]; Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award [NMRC/STaR/0021/2014]; Singapore Ministry of Education [MOE2017-T21-033]; RNA Biology Center at the Cancer Science Institute of Singapore of NUS as part of Singapore Ministry of Education's AcRF [MOE2014-T3-1-006]; NMRC Centre Grant Programme [NMRC/CG/012/2013, CGAug16M005, NMRC/CG/M005/2017_NCIS]; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centres of Excellence initiatives; NUS Center for Cancer Research (N2CR), Cancer Programme under Translational Research Programmes; Yong Loo Lin School of Medicine, NUS [NUHSRO/2020/122/MSC/07/Cancer]; NCIS Centre Grant; NCIS Yong Siew Yoon Research grant; NMRC Open Fund Young Individual Research Grants [MOH-OFYIRG19Nov-0016, MOH-OFYIRG18May-0001]; Walk Foundation	Biomedical Sciences Institutes; Joint Council Office (JCO), Agency for Science, Technology and Research, Singapore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); RNA Biology Center at the Cancer Science Institute of Singapore of NUS as part of Singapore Ministry of Education's AcRF; NMRC Centre Grant Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centres of Excellence initiatives(Ministry of Education, Singapore); NUS Center for Cancer Research (N2CR), Cancer Programme under Translational Research Programmes; Yong Loo Lin School of Medicine, NUS; NCIS Centre Grant; NCIS Yong Siew Yoon Research grant; NMRC Open Fund Young Individual Research Grants; Walk Foundation	We thank Drs Pierre Aman, Christopher DM Fletcher, Florence Pedeutour, Eugenio Erba, Jun Nishio, Peter Moller, Dominique Broccoli, Raphael Pollock, Peter Houghton, Stefan Frohling, Karen Sisley, Abdulazeez Salawu, Matthew Ho, Omid Khorram, Rebecca Lock, and Alex Matter for generous sharing of cell lines and reagents. We also thank kind helps from Dr Motomi Osato, Dr Yangyang Song, Mr. Haoqing Shen, and Dr Jian Han in experiments and discussion. The discovery of ETC-168 (also known as AUM168 in AUM Biosciences) was financially supported by Biomedical Sciences Institutes and Joint Council Office (JCO Project 11 03 FG 07 05), Agency for Science, Technology and Research, Singapore. This work is funded by the National Institutes of Health (R01-CA200992-04 to HPK), Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award to HPK. (NMRC/STaR/0021/2014), the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2017-T21-033), the RNA Biology Center at the Cancer Science Institute of Singapore of NUS as part of funding under the Singapore Ministry of Education's AcRF Tier 3 grants (MOE2014-T3-1-006), the NMRC Centre Grant Programme awarded to National University Cancer Institute of Singapore (NMRC/CG/012/2013, CGAug16M005 and NMRC/CG/M005/2017_NCIS) and the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiatives. It is additionally supported by NUS Center for Cancer Research (N2CR), Cancer Programme under Translational Research Programmes, Yong Loo Lin School of Medicine, NUS (NUHSRO/2020/122/MSC/07/Cancer), a Seed Funding Program within the NCIS Centre Grant, a NCIS Yong Siew Yoon Research grant through donations from the Yong Loo Lin Trust, and philanthropic donations from the Wendy Walk Foundation, Ms. Tricia West and Ms. Linda Abrams. YC and LX are supported by the NMRC Open Fund Young Individual Research Grants (MOH-OFYIRG19Nov-0016 and MOH-OFYIRG18May-0001).	AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Brown MC, 2017, CELL REP, V18, P1444, DOI 10.1016/j.celrep.2017.01.023; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09257-z; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Diab S, 2014, CHEM BIOL, V21, P441, DOI 10.1016/j.chembiol.2014.01.011; Dreas A, 2017, CURR MED CHEM, V24, P3025, DOI 10.2174/0929867324666170203123427; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Fletcher CDM, 2013, WHO CLASSIFICATION T; George S, 2018, J CLIN ONCOL, V36, P144, DOI 10.1200/JCO.2017.75.9845; Grzmil M, 2014, J CLIN INVEST, V124, P742, DOI 10.1172/JCI70198; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Guo QY, 2019, CANCER RES, V79, P1646, DOI 10.1158/0008-5472.CAN-18-1602; Guo ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10397-9; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Hazawa M, 2020, ONCOGENE, V39, P2212, DOI 10.1038/s41388-019-1137-3; Hazawa M, 2018, EMBO REP, V19, P73, DOI 10.15252/embr.201744523; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Hou S, 2017, CLIN TRANSL ONCOL, V19, P1107, DOI 10.1007/s12094-017-1646-x; Hu SI, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002466; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; Lim S, 2013, P NATL ACAD SCI USA, V110, pE2298, DOI 10.1073/pnas.1301838110; Lock R, 2016, J CLIN INVEST, V126, P2181, DOI 10.1172/JCI85183; Lopez G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188859; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Nishio J, 2003, INT J ONCOL, V22, P535; Pang A, 2016, JAMA ONCOL, V2, P941, DOI 10.1001/jamaoncol.2016.0241; Persson F, 2008, CANCER LETT, V260, P37, DOI 10.1016/j.canlet.2007.10.032; Salawu A, 2016, BRIT J CANCER, V115, P1058, DOI 10.1038/bjc.2016.259; Santag S, 2017, CANCER LETT, V390, P21, DOI 10.1016/j.canlet.2016.12.029; Sekiyama N, 2015, P NATL ACAD SCI USA, V112, pE4036, DOI 10.1073/pnas.1512118112; Sharma B, 2012, J BIOL CHEM, V287, P42352, DOI 10.1074/jbc.M112.400721; Snyder EL, 2009, J PATHOL, V218, P292, DOI 10.1002/path.2564; Thelin-Jarnum S, 1999, INT J CANCER, V83, P30, DOI 10.1002/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4; Uboldi S, 2012, INT J CANCER, V131, P59, DOI 10.1002/ijc.26340; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Vitale G, 2012, BIOTECHNOL ADV, V30, P169, DOI 10.1016/j.biotechadv.2011.08.001; Wabitsch M, 2000, INT J CANCER, V88, P889, DOI 10.1002/1097-0215(20001215)88:6<889::AID-IJC8>3.0.CO;2-N; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Webster KR, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.1554.1554; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wilson C, 2014, CANCER RES, V74, P5878, DOI 10.1158/0008-5472.CAN-14-1009; Xu L, 2018, P NATL ACAD SCI USA, V115, pE5086, DOI 10.1073/pnas.1712363115; Xu YC, 2019, NAT MED, V25, P301, DOI 10.1038/s41591-018-0321-2; Yang H, 2018, J MED CHEM, V61, P4348, DOI 10.1021/acs.jmedchem.7b01714; Yang W, 2020, ONCOGENE, V39, P3650, DOI 10.1038/s41388-020-1240-5; Yao S, 2018, SEMIN CANCER BIOL, V50, P77, DOI 10.1016/j.semcancer.2017.11.018; Zhan Y, 2017, J CLIN INVEST, V127, P4179, DOI 10.1172/JCI91258	56	6	6	6	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1851	1867		10.1038/s41388-021-01661-4	http://dx.doi.org/10.1038/s41388-021-01661-4		FEB 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564073	Green Published, hybrid			2022-12-26	WOS:000616489100006
J	Chu, S; Skidmore, ZL; Kunisaki, J; Walker, JR; Griffith, M; Griffith, OL; Bryan, JN				Chu, Shirley; Skidmore, Zachary L.; Kunisaki, Jason; Walker, Jason R.; Griffith, Malachi; Griffith, Obi L.; Bryan, Jeffrey N.			Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches	PLOS ONE			English	Article							TELOMERASE ACTIVITY; FAS EXPRESSION; GENE-MUTATIONS; TP53 GENE; CANCER; P53; DELETIONS; BREAST; DOGS; CARCINOMA	Osteosarcoma is a rare disease in children but is one of the most common cancers in adult large breed dogs. The mutational landscape of both the primary and pulmonary metastatic tumor in two dogs with appendicular osteosarcoma (OSA) was comprehensively evaluated using an automated whole genome sequencing, exome and RNA-seq pipeline that was adapted for this study for use in dogs. Chromosomal lesions were the most common type of mutation. The mutational landscape varied substantially between dogs but the lesions within the same patient were similar. Copy number neutral loss of heterozygosity in mutant TP53 was the most significant driver mutation and involved a large region in the middle of chromosome 5. Canine and human OSA is characterized by loss of cell cycle checkpoint integrity and DNA damage response pathways. Mutational profiling of individual patients with canine OSA would be recommended prior to targeted therapy, given the heterogeneity seen in our study and previous studies.	[Chu, Shirley; Bryan, Jeffrey N.] Univ Missouri, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Skidmore, Zachary L.; Kunisaki, Jason; Walker, Jason R.; Griffith, Malachi; Griffith, Obi L.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63110 USA; [Griffith, Malachi; Griffith, Obi L.] Washington Univ, Dept Med, St Louis, MO USA	University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); Washington University (WUSTL)	Chu, S (corresponding author), Univ Missouri, Dept Vet Med & Surg, Columbia, MO 65211 USA.	chus@missouri.edu		Bryan, Jeffrey/0000-0002-6820-9850; Skidmore, Zachary/0000-0003-1928-7139; Chu, Shirley/0000-0001-8164-7268	Clinician Scientist Grant from the American Kennel Club's Canine Health Foundation; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [R00HG007940]; National Cancer Institute (NCI) of the NIH [K22CA188163]; Siteman Cancer Center; Foundation for Barnes-Jewish Hospital	Clinician Scientist Grant from the American Kennel Club's Canine Health Foundation; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute (NCI) of the NIH; Siteman Cancer Center; Foundation for Barnes-Jewish Hospital	This work was funded in part by a Clinician Scientist Grant from the American Kennel Club's Canine Health Foundation (to SC), https://www.akcchf.org/.MG was supported by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) under Award Number R00HG007940, https://www.genome.gov/. OLG was supported by the National Cancer Institute (NCI) of the NIH under Award Number K22CA188163, https://www.cancer.gov/, and by the Siteman Cancer Center, https://siteman.wustl.edu/, and The Foundation for Barnes-Jewish Hospital, https://www.foundationbarnesjewish.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Hernandez J, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-27; Al-Hebshi NN, 2016, INT J CANCER, V139, P363, DOI 10.1002/ijc.30068; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Bai B, 2015, NUCLEIC ACIDS RES, V43, pD777, DOI 10.1093/nar/gku1174; Barnell EK, 2019, GENET MED, V21, P972, DOI 10.1038/s41436-018-0278-z; Barthel FP, 2017, NAT GENET, V49, P349, DOI 10.1038/ng.3781; Baugh EH, 2018, CELL DEATH DIFFER, V25, P154, DOI 10.1038/cdd.2017.180; Bendris N, 2017, TRENDS CELL BIOL, V27, P189, DOI 10.1016/j.tcb.2016.11.001; Benetos A, 2011, AGING CELL, V10, P991, DOI 10.1111/j.1474-9726.2011.00744.x; Broeckx BJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12810; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; de Gonzalez AB, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-18; Demetri GD, 2013, J CLIN ONCOL, V31, P2485, DOI 10.1200/JCO.2012.45.5766; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Egenvall A, 2007, CAN J VET RES, V71, P292; Evans DGR, 2017, CLIN CANCER RES, V23, pE54, DOI 10.1158/1078-0432.CCR-17-0590; Fenger JM, 2014, ILAR J, V55, P69, DOI 10.1093/ilar/ilu009; Gao G, 2014, CELL MOL LIFE SCI, V71, P4601, DOI 10.1007/s00018-014-1753-6; Gardner HL, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0487-2; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GILLETTE SM, 1990, CANCER RES, V50, P54; Griffith M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004274; Haase M, 2016, GENE, V575, P171, DOI 10.1016/j.gene.2015.08.063; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He YL, 2015, STEM CELLS, V33, P1304, DOI 10.1002/stem.1925; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Johnson AS, 1998, CARCINOGENESIS, V19, P213, DOI 10.1093/carcin/19.1.213; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kim E, 2019, CANCER RES, V79, P2649, DOI 10.1158/0008-5472.CAN-18-2331; Kim M, 2016, CELL DEATH DIFFER, V23, P1638, DOI 10.1038/cdd.2016.54; Kirpensteijn J, 2008, VET SURG, V37, P454, DOI 10.1111/j.1532-950X.2008.00407.x; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9940; Kow K, 2008, J VET INTERN MED, V22, P1366, DOI 10.1111/j.1939-1676.2008.0175.x; Krishnamurthy N, 2018, CANCER TREAT REV, V62, P50, DOI 10.1016/j.ctrv.2017.11.002; Lafleur EA, 2004, CLIN CANCER RES, V10, P8114, DOI 10.1158/1078-0432.CCR-04-0353; Lafleur EA, 2001, CANCER RES, V61, P4066; London CA, 2018, CLIN CANCER RES, V24, P6396, DOI 10.1158/1078-0432.CCR-18-0703; London CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027018; Makielski KM, 2019, VET SCI, V6, DOI 10.3390/vetsci6020048; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melsted P., 2017, BIORXIV; Mendoza S, 1998, ANTICANCER RES, V18, P4449; Miller CW, 2002, GENE CHROMOSOME CANC, V33, P17, DOI 10.1002/gcc.1207; Mirabello L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv101; Mirabello L, 2011, CANCER CAUSE CONTROL, V22, P899, DOI 10.1007/s10552-011-9763-2; MISDORP W, 1979, JNCI-J NATL CANCER I, V62, P537, DOI 10.1093/jnci/62.3.537; Mohseny AB, 2010, GENE CHROMOSOME CANC, V49, P1095, DOI 10.1002/gcc.20817; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Morello E, 2011, VET J, V189, P268, DOI 10.1016/j.tvjl.2010.08.014; Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Mueller F, 2007, ANTICANCER RES, V27, P155; Nakajima Go, 2008, Cancer Genomics & Proteomics, V5, P37; Nasir L, 2001, NEOPLASIA, V3, P351, DOI 10.1038/sj.neo.7900173; Nielsen GP, 1998, AM J PATHOL, V153, P159, DOI 10.1016/S0002-9440(10)65556-3; Oshima J, 2002, CANCER RES, V62, P547; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Palermo V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12880; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Petrilli AM, 2016, ONCOGENE, V35, P537, DOI 10.1038/onc.2015.125; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Poulain S, 2017, CLIN CANCER RES, V23, P6325, DOI 10.1158/1078-0432.CCR-17-0007; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Reble E, 2017, PSYCHIAT GENET, V27, P62, DOI 10.1097/YPG.0000000000000162; Ribi S, 2015, ONCOTARGET, V6, P7727, DOI 10.18632/oncotarget.3115; Rusch M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06485-7; Sakthikumar S, 2018, CANCER RES, V78, P3421, DOI 10.1158/0008-5472.CAN-17-3558; Saldivar JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003077; Satriyo PB, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020148; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sayles LC, 2019, CANCER DISCOV, V9, P46, DOI 10.1158/2159-8290.CD-17-1152; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Sens-Abuazar C, 2012, TRANSL ONCOL, V5, P113, DOI 10.1593/tlo.11280; Shao YW, 2019, ONCOGENE, V38, P291, DOI 10.1038/s41388-018-0444-4; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shearin AL, 2012, CANCER EPIDEM BIOMAR, V21, P1019, DOI 10.1158/1055-9965.EPI-12-0190-T; Simpson S, 2020, CANCERS, V12, DOI 10.3390/cancers12092405; Simpson S, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0341-9; Sotillo-Pineiro E, 2004, PEDIATR RES, V55, P231, DOI 10.1203/01.PDR.0000102455.36737.3C; Spies N, 2015, BIOINFORMATICS, V31, P3994, DOI 10.1093/bioinformatics/btv478; Stein TJ, 2011, VET COMP ONCOL, V9, P65, DOI 10.1111/j.1476-5829.2010.00236.x; Stemmer-Rachamimov AO, 1998, NEUROGENETICS, V2, P73, DOI 10.1007/s100480050054; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; STONE DM, 1991, AM J MED GENET, V40, P214, DOI 10.1002/ajmg.1320400219; STONE DM, 1993, AM J MED GENET, V46, P198, DOI 10.1002/ajmg.1320460220; Thomas R, 2011, LEUKEMIA LYMPHOMA, V52, P1321, DOI 10.3109/10428194.2011.559802; Ticha I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53636-x; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; vanLeeuwen IS, 1997, CANCER LETT, V111, P173, DOI 10.1016/S0304-3835(96)04529-6; Worth LL, 2002, ONCOL REP, V9, P823; Yazawa M, 1999, J VET MED SCI, V61, P1125, DOI 10.1292/jvms.61.1125; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zhou C, 2017, ONCOTARGET, V8, P74276, DOI 10.18632/oncotarget.19395	102	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246443	10.1371/journal.pone.0246443	http://dx.doi.org/10.1371/journal.pone.0246443			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556121	Green Published, gold			2022-12-26	WOS:000617379900062
J	Kreissig, KJ; Hansen, LT; Jensen, PE; Wegeberg, S; Geertz-Hansen, O; Sloth, JJ				Kreissig, Katharina J.; Hansen, Lisbeth Truelstrup; Jensen, Pernille Erland; Wegeberg, Susse; Geertz-Hansen, Ole; Sloth, Jens J.			Characterisation and chemometric evaluation of 17 elements in ten seaweed species from Greenland	PLOS ONE			English	Article							KELP SACCHARINA-LATISSIMA; LAMINARIA-DIGITATA; SEASONAL-VARIATION; ALARIA-ESCULENTA; EDIBLE SEAWEED; IODINE CONTENT; FOOD; ABSORPTION; SPECIATION; ALGINATE	Several Greenland seaweed species have potential as foods or food ingredients, both for local consumption and export. However, knowledge regarding their content of beneficial and deleterious elements on a species specific and geographical basis is lacking. This study investigated the content of 17 elements (As, Ca, Cd, Cr, Cu, Fe, Hg, I, K, Mg, Mn, Na, Ni, P, Pb, Se and Zn) in 77 samples of ten species (Agarum clathratum, Alaria esculenta, Ascophyllum nodosum, Fucus distichus, Fucus vesiculosus, Hedophyllum nigripes, Laminaria solidungula, Palmaria palmata, Saccharina latissima and Saccharina longicruris). Element profiles differed between species but showed similar patterns within the same family. For five species, different thallus parts were investigated separately, and showed different element profiles. A geographic origin comparison of Fucus species indicated regional differences. The seaweeds investigated were especially good sources of macrominerals (K > Na > Ca > Mg) and trace minerals, such as Fe. Iodine contents were high, especially in macroalgae of the family Laminariaceae. None of the samples exceeded the EU maximum levels for Cd, Hg or Pb, but some exceeded the stricter French regulations, especially for Cd and I. In conclusion, these ten species are promising food items.	[Kreissig, Katharina J.; Hansen, Lisbeth Truelstrup; Sloth, Jens J.] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Jensen, Pernille Erland] Tech Univ Denmark, Dept Civil Engn, Lyngby, Denmark; [Wegeberg, Susse] Aarhus Univ, DCE Danish Ctr Environm & Energy, Dept Biosci, Roskilde, Denmark; [Geertz-Hansen, Ole] Greenland Inst Nat Resources, Nuuk, Greenland	Technical University of Denmark; Technical University of Denmark; Aarhus University; Greenland Institute of Natural Resources	Sloth, JJ (corresponding author), Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark.	jjsl@food.dtu.dk	Sloth, Jens J/H-6283-2017; Jensen, Pernille Erland Erland/A-1560-2011	Sloth, Jens J/0000-0002-3636-8769; Jensen, Pernille Erland Erland/0000-0003-4718-1630; Hansen, Lisbeth Truelstrup/0000-0003-0485-5252	 [80.24]		KJK was funded by Pinngortitaleriffik case number 80.24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3845; Al Mamun MA, 2019, J APPL PHYCOL, V31, P2669, DOI 10.1007/s10811-018-1721-x; Andersen S, 2019, J MED FOOD, V22, P421, DOI 10.1089/jmf.2018.0187; [Anonymous], 2013, NAT REV MICROBIOL, V11, P1, DOI 10.1038/nrmicro2948; [Anonymous], [No title captured]; [Anonymous], 2016, POTENTIAL RISKS POSE; [Anonymous], 2008, OFF J EUR UNION, V173, P6; [Anonymous], 2018, OFF J, V78, P16; [Anonymous], [No title captured]; [Anonymous], 2014, OFF J EUR UNION L, V138, P75; [Anonymous], [No title captured]; ANSES, 2018, OPINION FRENCH AGENC; Banach JL, 2020, COMPR REV FOOD SCI F, V19, P332, DOI 10.1111/1541-4337.12523; Baumann HA, 2009, ECOTOX ENVIRON SAFE, V72, P1063, DOI 10.1016/j.ecoenv.2008.10.010; Benford D, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4002; Brinza L, 2020, CHEMOSPHERE, V238, DOI 10.1016/j.chemosphere.2019.124652; BUGGELN RG, 1974, J PHYCOL, V10, P283; Cupisti A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030261; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; de Bonneval L, 1979, ETUDESINUITSTUDIES, V3, P103; Desideri D, 2016, J TOXICOL ENV HEAL A, V79, P112, DOI 10.1080/15287394.2015.1113598; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.243r; European Commission, 2002, OPINION SCI COMMITTE; European Committee for Standardization, 2014, EN13805; European Committee for Standardization, 2009, EN15763 FOODSTUFFS; European Committee for Standardization, 2007, EN15111 FOODSTUFFS; European Council, 2015, OFF J EUR UNION, V327, P1; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; Garcia-Seoane R, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113349; HAUG A, 1965, ACTA CHEM SCAND, V19, P341, DOI 10.3891/acta.chem.scand.19-0341; Heleniak T., 2020, POLAR PEOPLES FUTURE; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; Kreissig KJ, 2020, DATASET ELEMENTAL AN, DOI [10.11583/DTU.13251575, DOI 10.11583/DTU.13251575]; Kruse K., 2015, SERMITSIAQ; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Luning K, 2015, BOT MAR, V58, P449, DOI 10.1515/bot-2015-0036; Maehre HK, 2014, J SCI FOOD AGR, V94, P3281, DOI 10.1002/jsfa.6681; Miedico O, 2017, J FOOD COMPOS ANAL, V64, P188, DOI 10.1016/j.jfca.2017.09.004; Mitra A, 2017, I CONF SENS TECHNOL, P145; Monteiro MS, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.e170915; Mouritsen O.G., 2012, FLAVOUR, V1, DOI [10.1186/2044-7248-1-4, DOI 10.1186/2044-7248-1-4]; Mouritsen OG, 2013, J APPL PHYCOL, V25, P1777, DOI 10.1007/s10811-013-0014-7; Nayak D, 2007, J RADIOANAL NUCL CH, V274, P219, DOI 10.1007/s10967-007-1101-5; Nielsen CW, 2020, FOODS, V9, DOI 10.3390/foods9050569; Noahsen P, 2020, J ENDOCRINOL INVEST, V43, P431, DOI 10.1007/s40618-019-01122-6; Nordic Council of Ministers, 2014, NORD NUTR REC 2012 I; Northern Periphery and Arctic Programme Secretariat, 2019, NO PERIPHERY ARCTIC; Petursdottir AH, 2019, ANAL BIOANAL CHEM, V411, P4973, DOI 10.1007/s00216-019-01907-x; R Core Team, 2020, R LANG ENV STAT COMP; RIGET F, 1995, MAR POLLUT BULL, V30, P409, DOI 10.1016/0025-326X(95)99847-W; Riget F, 1997, MAR POLLUT BULL, V34, P171, DOI 10.1016/S0025-326X(96)00084-7; Roest-Madsen L., 2017, MESTERKOKKEN GRONLAN; Roleda MY, 2018, FOOD CHEM, V254, P333, DOI [10.1016/j.foodchem.2018.02.024, 10.1016/j.foodchem.]; Ronan JM, 2017, CHEMOSPHERE, V186, P17, DOI 10.1016/j.chemosphere.2017.07.076; Schiener P, 2015, J APPL PHYCOL, V27, P363, DOI 10.1007/s10811-014-0327-1; Sondergaard J, 2013, ENVIRON MONIT ASSESS, V185, P7025, DOI 10.1007/s10661-013-3082-x; Stevant P, 2018, J APPL PHYCOL, V30, P2047, DOI 10.1007/s10811-017-1343-8; Suckow MA, 1995, SEAWATER ITS COMPOSI, V2nd, P85; Suckow MA, 1995, SEAWATER ITS COMPOSI, V2nd, P29; Taylor VF, 2016, CHEMOSPHERE, V163, P6, DOI 10.1016/j.chemosphere.2016.08.004; WHO, 2011, WHO TECH REP SER, V960, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Ye NH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7986	63	4	4	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0243672	10.1371/journal.pone.0243672	http://dx.doi.org/10.1371/journal.pone.0243672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556100	Green Published, gold, Green Submitted			2022-12-26	WOS:000617379900029
J	Lee, N; Kim, SM; Lee, Y; Jeong, D; Yun, J; Ryu, S; Yoon, SS; Ahn, YO; Hwang, SM; Lee, DS				Lee, Nuri; Kim, Sung-Min; Lee, Youngeun; Jeong, Dajeong; Yun, Jiwon; Ryu, Sohee; Yoon, Sung-Soo; Ahn, Yong-Oon; Hwang, Sang Mee; Lee, Dong Soon			Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma	PLOS ONE			English	Article							CONSENSUS; VARIANTS; IDENTIFICATION; ABNORMALITIES; GUIDELINES; FRAMEWORK; GENOMICS; PROGRESS; 1Q	Background To investigate the prognostic value of gene variants and copy number variations (CNVs) in patients with newly diagnosed multiple myeloma (NDMM), an integrative genomic analysis was performed. Methods Sixty-seven patients with NDMM exhibiting more than 60% plasma cells in the bone marrow aspirate were enrolled in the study. Whole-exome sequencing was conducted on bone marrow nucleated cells. Mutation and CNV analyses were performed using the CNVkit and Nexus Copy Number software. In addition, karyotype and fluorescent in situ hybridization were utilized for the integrated analysis. Results Eighty-three driver gene mutations were detected in 63 patients with NDMM. The median number of mutations per patient was 2.0 (95% confidence interval [CI] = 2.0-3.0, range = 0-8). MAML2 and BHLHE41 mutations were associated with decreased survival. CNVs were detected in 56 patients (72.7%; 56/67). The median number of CNVs per patient was 6.0 (95% CI = 5.7-7.0; range = 0-16). Among the CNVs, 1q gain, 6p gain, 6q loss, 8p loss, and 13q loss were associated with decreased survival. Additionally, 1q gain and 6p gain were independent adverse prognostic factors. Increased numbers of CNVs and driver gene mutations were associated with poor clinical outcomes. Cluster analysis revealed that patients with the highest number of driver mutations along with 1q gain, 6p gain, and 13q loss exhibited the poorest prognosis. Conclusions In addition to the known prognostic factors, the integrated analysis of genetic variations and CNVs could contribute to prognostic stratification of patients with NDMM.	[Lee, Nuri] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Lab Med, Coll Med, Seoul, South Korea; [Kim, Sung-Min; Ahn, Yong-Oon; Lee, Dong Soon] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea; [Lee, Youngeun; Jeong, Dajeong; Yun, Jiwon; Ryu, Sohee; Lee, Dong Soon] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea; [Yoon, Sung-Soo] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Clin Res Inst,Coll Med, Seoul, South Korea; [Hwang, Sang Mee] Seoul Natl Univ, Dept Lab Med, Bundang Hosp, Seongnam, South Korea	Hallym University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, DS (corresponding author), Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea.	soonlee@snu.ac.kr	Yun, Jiwon/GPC-6815-2022; Yun, Jiwon/HII-9361-2022; Lee, Nuri/AAE-7551-2022	Yoon, Sung-Soo/0000-0003-2591-7459	National Research Foundation of Korea(NRF) - Korea government(MSIT) [NRF-2017R1A2A1A17069780]	National Research Foundation of Korea(NRF) - Korea government(MSIT)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (NRF-2017R1A2A1A17069780).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anzick SL, 2010, GENE CHROMOSOME CANC, V49, P59, DOI 10.1002/gcc.20719; Avet-Loiseau H, 2013, LEUKEMIA, V27, P711, DOI 10.1038/leu.2012.282; Avet-Loiseau H, 2009, J CLIN ONCOL, V27, P4585, DOI 10.1200/JCO.2008.20.6136; Barila G, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0285-6; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Binder M, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.83; Bolli N, 2018, LEUKEMIA, V32, P2604, DOI 10.1038/s41375-018-0037-9; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Chretien ML, 2015, BLOOD, V126, P2713, DOI 10.1182/blood-2015-06-650242; Cifola I, 2015, ONCOTARGET, V6, P17543, DOI 10.18632/oncotarget.4028; du Pont SR, 2017, J CLIN ONCOL, V35, P963, DOI 10.1200/JCO.2016.70.6705; Hong J, 2016, KOREAN J INTERN MED, V31, P820, DOI 10.3904/kjim.2015.408; Hu Y, 2019, ONCOTARGETS THER, V12, P4075, DOI 10.2147/OTT.S205922; Kim M, 2016, ANN LAB MED, V36, P573, DOI 10.3343/alm.2016.36.6.573; Kim M, 2015, GENE CHROMOSOME CANC, V54, P20, DOI 10.1002/gcc.22213; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lee DS, 2002, CANCER GENET CYTOGEN, V132, P97, DOI 10.1016/S0165-4608(01)00533-7; Leich E, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2012.47; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manier S, 2017, NAT REV CLIN ONCOL, V14, P100, DOI 10.1038/nrclinonc.2016.122; Marchuk DS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209185; Maura F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11680-1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikhael JR, 2013, MAYO CLIN PROC, V88, P360, DOI 10.1016/j.mayocp.2013.01.019; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Prideaux Steven M, 2014, Adv Hematol, V2014, P864058, DOI 10.1155/2014/864058; Pugh TJ, 2018, CANCER GENET-NY, V228, P184, DOI 10.1016/j.cancergen.2018.07.002; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Shah V, 2018, LEUKEMIA, V32, P102, DOI 10.1038/leu.2017.179; Shen ZJ, 2019, ONCOL REP, V41, P2137, DOI 10.3892/or.2019.7004; Sonneveld P, 2016, BLOOD, V127, P2955, DOI 10.1182/blood-2016-01-631200; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Trojani A, 2013, CL LYMPH MYELOM LEUK, V13, P208, DOI 10.1016/j.clml.2013.02.012; Walker BA, 2006, BLOOD, V108, P1733, DOI 10.1182/blood-2006-02-005496; Walker BA, 2018, BLOOD, V132, P587, DOI 10.1182/blood-2018-03-840132; Walker BA, 2018, METHODS MOL BIOL, V1792, P71, DOI 10.1007/978-1-4939-7865-6_6; Walker BA, 2015, J CLIN ONCOL, V33, P3911, DOI 10.1200/JCO.2014.59.1503; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; White BS, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0062-y	49	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246322	10.1371/journal.pone.0246322	http://dx.doi.org/10.1371/journal.pone.0246322			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544757	gold, Green Published			2022-12-26	WOS:000617991900050
J	Yang, S; Bai, MD; Hao, GW; Zhang, XW; Guo, HP; Fu, BC				Yang, Sheng; Bai, Mudan; Hao, Guowei; Zhang, Xiaowei; Guo, Huangping; Fu, Baochun			Transcriptome survey and expression analysis reveals the adaptive mechanism of 'Yulu Xiang' Pear in response to long-term drought stress	PLOS ONE			English	Article							PHOTOSYNTHESIS; INHIBITION; RESISTANCE; SEEDLINGS; LIFE; L.	Pear is one of the most important economic fruits worldwide. The productivity is often negatively affected by drought disaster, but the effects and adaptive mechanism of pear in response to drought stress has not been well understood at the gene transcription levels. Using Illumina HiSeq 2500, the transcriptome from 'Yulu Xiang' Pear leaves were sequenced and analyzed to evaluate the effects of long-term drought stress on the expression of genes in different biosynthetic pathways. Results showed that long-term drought stress weakened antioxidant systematization and impaired the synthesis of photosynthetic pigment in 'Yulu Xiang' Pear leaves. The reduced light utilization and photosynthetic productivity finally resulted in the inhibited fruit development. The transcriptome survey and expression analysis identified 2,207 differentially expressed genes (DEGs) which were summarized into the 30 main functional categories. DEGs analysis showed that the enzyme genes involved in phenylpropanoid biosynthesis under drought stress were up-regulated, and the promoted process of phenylpropanoid synthesis may be beneficial to reduce the transpiration rate and increase water use efficiency of 'Yulu Xiang' Pear leaves. Up-regulated malate dehydrogenase expression were also observed in drought stress groups, and the activated soluble sugar biosynthesis could be helpful to promote osmotic regulation and increase antioxidant capacity to enhance drought resistance of leaves. The mRNA expression of enzyme genes associated with hormones including ethylene, abscisic acid, and gibberellin were higher in drought stress groups than that in control, indicating a promoted cell proliferation under drought stress. Long-term drought stress significantly decreased photosynthetic productivity, and negatively affected development of 'Yulu Xiang' Pear. Transcriptome survey and expression analysis reveals that the inhibited photosynthesis could be closely related with drought-induced lignification and hormones synthesis, and the present dataset can provide more valuable information to analyze the function of drought stress-related genes improving plant drought tolerance.	[Yang, Sheng; Bai, Mudan; Hao, Guowei; Zhang, Xiaowei; Guo, Huangping; Fu, Baochun] Shanxi Agr Univ, Pomol Inst, Shanxi Key Lab Germplasm Improvement & Utilizat P, Taiyuan, Shanxi, Peoples R China	Shanxi Agricultural University	Guo, HP; Fu, BC (corresponding author), Shanxi Agr Univ, Pomol Inst, Shanxi Key Lab Germplasm Improvement & Utilizat P, Taiyuan, Shanxi, Peoples R China.	ghping1959@163.com; 397999001@qq.com	zhang, xiaowei/GQH-5387-2022		China Agriculture Research System [CARS-28-28]; Research Subject of Agricultural Science and Technology Innovation of Shanxi Academy of Agricultural Sciences [YCX2018D2YS14]; Shanxi Province Natural Science Foundation [201801D121255]; Project of Scientific and Technological Innovation research of Shanxi Academy of Agricultural Sciences [YCX2020SJ10]	China Agriculture Research System; Research Subject of Agricultural Science and Technology Innovation of Shanxi Academy of Agricultural Sciences; Shanxi Province Natural Science Foundation(Natural Science Foundation of Shanxi Province); Project of Scientific and Technological Innovation research of Shanxi Academy of Agricultural Sciences	This work was partially supported by the China Agriculture Research System (CARS-28-28), The Research Subject of Agricultural Science and Technology Innovation of Shanxi Academy of Agricultural Sciences (YCX2018D2YS14), Shanxi Province Natural Science Foundation (201801D121255), The Project of Scientific and Technological Innovation research of Shanxi Academy of Agricultural Sciences (YCX2020SJ10).	Ahmed IM, 2013, PLANT PHYSIOL BIOCH, V63, P49, DOI 10.1016/j.plaphy.2012.11.004; Alam A, 2021, SILICON-NETH, V13, P3153, DOI 10.1007/s12633-020-00673-1; Bogunovic I, 2015, HORTIC SCI, V42, P132, DOI 10.17221/161/2014-HORTSCI; Bunce J, 2012, HORTSCIENCE, V47, P687, DOI 10.21273/HORTSCI.47.6.687; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cui GB, 2019, PLANT MOL BIOL, V100, P391, DOI 10.1007/s11103-019-00866-2; Du BW, 2015, CHEMOSPHERE, V119, P927, DOI 10.1016/j.chemosphere.2014.08.044; Fang YJ, 2015, CELL MOL LIFE SCI, V72, P673, DOI 10.1007/s00018-014-1767-0; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Fu SH, 2011, PLOS NEGL TROP DIS, V5, pe1231; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YY, 2018, PHOTOSYNTHETICA, V56, P861, DOI 10.1007/s11099-017-0741-0; Hakeem A, 2017, SEED SCI TECHNOL, V45, P485, DOI 10.15258/sst.2017.45.2.12; Hu Y, 2009, J APPL GENET, V50, P213, DOI 10.1007/BF03195675; Jain R, 2010, ACTA PHYSIOL PLANT, V32, P979, DOI 10.1007/s11738-010-0487-9; Johnson EJ, 2017, J PUBLIC HEALTH-HEID, V25, P69, DOI 10.1007/s10389-016-0759-y; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kitajima K, 2003, PLANT CELL ENVIRON, V26, P857, DOI 10.1046/j.1365-3040.2003.01017.x; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Li H., 2000, PRINCIPLE TECHNOLOGY, P184; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2014, J HUNAN AGR U SOCIAL, V4, P35; Maes WH, 2009, J ARID ENVIRON, V73, P877, DOI 10.1016/j.jaridenv.2009.04.013; Arraes FBM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0597-z; Munzbergova Z, 2019, PHOTOSYNTH RES, V140, P289, DOI 10.1007/s11120-018-0604-y; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Perin EC, 2019, FOOD CHEM, V271, P516, DOI 10.1016/j.foodchem.2018.07.213; Pozzi W, 2013, B AM METEOROL SOC, V94, P776, DOI 10.1175/BAMS-D-11-00176.1; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Zobiole LHS, 2012, J PLANT NUTR SOIL SC, V175, P319, DOI 10.1002/jpln.201000434; Schuback N, 2016, BIOGEOSCIENCES, V13, P1019, DOI 10.5194/bg-13-1019-2016; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xi ZM, 2013, PLANT GROWTH REGUL, V71, P57, DOI 10.1007/s10725-013-9809-4; Zargar S.M., 2017, PLANT GENE, V11, P154, DOI [10.1016/j.plgene.2017.04.003, DOI 10.1016/J.PLGENE.2017.04.003]	35	4	4	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246070	10.1371/journal.pone.0246070	http://dx.doi.org/10.1371/journal.pone.0246070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0UN	33545712	Green Published, gold			2022-12-26	WOS:000617993300007
J	Fukuyama, K; Asagiri, M; Sugimoto, M; Tsushima, H; Seo, S; Taura, K; Uemoto, S; Iwaisako, K				Fukuyama, Keita; Asagiri, Masataka; Sugimoto, Masahiro; Tsushima, Hiraki; Seo, Satoru; Taura, Kojiro; Uemoto, Shinji; Iwaisako, Keiko			Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ESTABLISHMENT; GROWTH; METASTASIS; PROTEINS	Cancer cell lines are widely used in basic research to study cancer development, growth, invasion, or metastasis. They are also used for the development and screening of anticancer drugs. However, there are no clear criteria for choosing the most suitable cell lines among the wide variety of cancer cell lines commercially available for research, and the choice is often based on previously published reports. Here, we investigated the characteristics of liver cancer cell lines by analyzing the gene expression data available in the Cancer Cell Line Encyclopedia. Unsupervised clustering analysis of 28 liver cancer cell lines yielded two main clusters. One cluster showed a gene expression pattern similar to that of hepatocytes, and the other showed a pattern similar to that of fibroblasts. Analysis of hepatocellular carcinoma gene expression profiles available in The Cancer Genome Atlas showed that the gene expression patterns in most hepatoma tissues were similar to those in the hepatocyte-like cluster. With respect to liver cancer research, our findings may be useful for selecting an appropriate cell line for a specific study objective. Furthermore, our approach of utilizing a public database for comparing the properties of cell lines could be an attractive cell line selection strategy that can be applied to other fields of research.	[Fukuyama, Keita; Seo, Satoru; Taura, Kojiro; Uemoto, Shinji; Iwaisako, Keiko] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat & Transplant Surg, Kyoto, Japan; [Asagiri, Masataka] Yamaguchi Univ, Dept Pharmacol, Grad Sch Med, Ube, Yamaguchi, Japan; [Asagiri, Masataka; Iwaisako, Keiko] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka, Japan; [Sugimoto, Masahiro] Tokyo Med Univ, Res & Dev Ctr Minimally Invas Therapies Hlth Prom, Shinjuku Ku, Tokyo, Japan; [Tsushima, Hiraki; Iwaisako, Keiko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Kyotanabe, Japan	Kyoto University; Yamaguchi University; Osaka University; Tokyo Medical University; Doshisha University	Iwaisako, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat & Transplant Surg, Kyoto, Japan.; Iwaisako, K (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka, Japan.; Iwaisako, K (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Kyotanabe, Japan.	iwaisako@kuhp.kyoto-u.ac.jp		Sugimoto, Masahiro/0000-0003-3316-2543; Tsushima, Hiraki/0000-0003-0720-7664; Iwaisako, Keiko/0000-0003-1977-8456	Project for Cancer Research and Therapeutic Evolution (PCREATE) from the Japan Agency for Medical Research and Development (AMED) [19cm0106303h0004]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20K08996, 17K10510]	Project for Cancer Research and Therapeutic Evolution (PCREATE) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by The Project for Cancer Research and Therapeutic Evolution (PCREATE) from the Japan Agency for Medical Research and Development (AMED) in the form of a grant (grant number 19cm0106303h0004) awarded to KI, Grants-in-Aid for Scientific Research (KAKENHI) funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan in the form of a grant (grant number 17K10510) awarded to KI, and Grants-inAid for Scientific Research (KAKENHI) funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan in the form of a grant (grant number 20K08996) awarded to KI.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ALEXANDER JJ, 1976, S AFR MED J, V50, P2124; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Caruso S, 2019, GASTROENTEROLOGY, V157, P760, DOI 10.1053/j.gastro.2019.05.001; Chen B, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S2-S5; Dhanasekaran R, 2019, GASTROENTEROLOGY, V156, P492, DOI 10.1053/j.gastro.2018.11.001; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; DiMasi JA, 2013, CLIN PHARMACOL THER, V94, P329, DOI 10.1038/clpt.2013.117; DOI I, 1976, GANN, V67, P1; DOI I, 1975, GANN, V66, P385; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Giannelli G, 2016, J HEPATOL, V65, P798, DOI 10.1016/j.jhep.2016.05.007; HIROHASHI S, 1979, CANCER RES, V39, P1819; Homma S., 1985, JIKEIKAI MED J, V32, P289; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; HUH N, 1981, GANN, V72, P178; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lee JH, 1999, WORLD J GASTROENTERO, V5, P289; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; MASON A, 1993, HEPATOLOGY, V18, P781, DOI 10.1002/hep.1840180406; McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001; Mizutani A, 2011, J BIOL CHEM, V286, P29848, DOI 10.1074/jbc.M110.217745; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; PARK JG, 1987, CANCER RES, V47, P6710; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Peng JM, 2018, HEPATOLOGY, V67, P2226, DOI 10.1002/hep.29678; Qiu ZX, 2019, CANCER CELL, V36, P179, DOI 10.1016/j.ccell.2019.07.001; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Samonakis DN, 2017, WORLD J HEPATOL, V9, P80, DOI 10.4254/wjh.v9.i2.80; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Wan S, 2018, HEPATOLOGY, V67, P1842, DOI 10.1002/hep.29669; Wilding JL, 2014, CANCER RES, V74, P2377, DOI 10.1158/0008-5472.CAN-13-2971; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Xiang QF, 2014, CLIN CANCER RES, V20, P2959, DOI 10.1158/1078-0432.CCR-13-2620	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245939	10.1371/journal.pone.0245939	http://dx.doi.org/10.1371/journal.pone.0245939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539378	Green Published, gold			2022-12-26	WOS:000616960200046
J	Kim, TO; Lee, JK; Kwon, YS; Kim, YI; Lim, SC; Kim, MS; Kho, BG; Park, CK; Oh, IJ; Kim, YC; Park, HY; Shin, HJ				Kim, Tae-Ok; Lee, Jae-Kyeong; Kwon, Yong-Soo; Kim, Yu-Il; Lim, Sung-Chul; Kim, Min-Seok; Kho, Bo Gun; Park, Cheol-Kyu; Oh, In-Jae; Kim, Young-Chul; Park, Ha Young; Shin, Hong-Joon			Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness	PLOS ONE			English	Article							CARINII-PNEUMONIA; QUANTITATIVE PCR; INFECTION; DIAGNOSIS; MANAGEMENT; OUTCOMES; THERAPY	Objective Pneumocystis jirovecii pneumonia (PCP) is a fatal respiratory infection, mostly associated with immunocompromised conditions. Several reports have described PCP development in patients who were not immunocompromised, but the clinical course and prognosis of PCP are not well understood. We compared the clinical characteristics and prognoses between patients with and without immunocompromised conditions who developed PCP. Methods We retrospectively analyzed patients who had been treated for PCP from three hospitals. We defined immunocompromised (IC) status as following: human immunodeficiency virus (HIV) infection; hematological malignancy; solid organ tumor under chemotherapy; rheumatic disease; medication with immunosuppressive agents. Patients without immunocompromised status were defined as being non-immunocompromised (non-IC). Results The IC and non-IC groups comprised 173 and 14 patients. The median ages were 62.0 and 74.0 years in the IC and the non-IC group, respectively. The median interval between admission and anti-PCP treatment was significantly longer for patients in the non-IC group than that for patients in the IC group (7 vs. 2 days). The in-hospital mortality rates were significantly higher for patients in the non-IC group than that for patients in the IC group (71.4% vs. 43.9%; P = 0.047). A longer interval between admission and anti-PCP therapy was associated with increased 90-day mortality rate in patients with PCP (hazard ratio, 1.082; 95% confidence interval, 1.015-1.153; P = 0.016). Conclusions Patients with PCP with no predisposing illnesses were older and had higher mortality rates than IC patients with PCP. Delayed anti-PCP treatment was associated with increased 90-day mortality.	[Kim, Tae-Ok; Lee, Jae-Kyeong; Kwon, Yong-Soo; Kim, Yu-Il; Lim, Sung-Chul; Shin, Hong-Joon] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea; [Kim, Tae-Ok; Lee, Jae-Kyeong; Kwon, Yong-Soo; Kim, Yu-Il; Lim, Sung-Chul; Kim, Min-Seok; Kho, Bo Gun; Park, Cheol-Kyu; Oh, In-Jae; Kim, Young-Chul; Park, Ha Young; Shin, Hong-Joon] Chonnam Natl Univ, Med Sch, Gwangju, South Korea; [Kim, Min-Seok; Kho, Bo Gun; Park, Cheol-Kyu; Oh, In-Jae; Kim, Young-Chul] Chonnam Natl Univ, Hwasun Hosp, Lung & Esophageal Canc Clin, Joennam, South Korea; [Park, Ha Young] Chonnam Natl Univ, Dept Internal Med, Bitgoeul Hosp, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University; Chonnam National University	Shin, HJ (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea.; Shin, HJ (corresponding author), Chonnam Natl Univ, Med Sch, Gwangju, South Korea.	99naussica@naver.com	Oh, In-Jae/AAG-5919-2020	Oh, In-Jae/0000-0003-4837-1321; Kwon, Yong-Soo/0000-0001-5121-4488; Kim, Young-Chul/0000-0001-7019-7687	National Research Foundation of Korea - Korean Government [2019R1F1A1060899]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea funded by the Korean Government (grant 2019R1F1A1060899).	[Anonymous], 2019, CIRCULATION, V2019; CANO S, 1993, CHEST, V104, P376, DOI 10.1378/chest.104.2.376; Damiani C, 2013, J CLIN MICROBIOL, V51, P3380, DOI 10.1128/JCM.01554-13; Delclaux A, 1999, CLIN INFECT DIS, V29, P670, DOI 10.1086/598651; Fan LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073099; Fauchier T, 2016, J CLIN MICROBIOL, V54, P1487, DOI 10.1128/JCM.03174-15; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; Festic E, 2005, CHEST, V128, P573, DOI 10.1378/chest.128.2.573; Fillatre P, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.07.010; Gupta R, 2007, SCAND J INFECT DIS, V39, P571, DOI 10.1080/00365540601131976; Harris K, 2012, HEART LUNG CIRC, V21, P221, DOI 10.1016/j.hlc.2011.10.006; HUGHES W, 1993, NEW ENGL J MED, V328, P1521, DOI 10.1056/NEJM199305273282103; JACOBS JL, 1991, NEW ENGL J MED, V324, P246, DOI 10.1056/NEJM199101243240407; Kato H, 2019, J INFECT CHEMOTHER, V25, P920, DOI 10.1016/j.jiac.2019.06.007; Krajicek BJ, 2009, CLIN CHEST MED, V30, P265, DOI 10.1016/j.ccm.2009.02.005; Li MC, 2014, J MICROBIOL IMMUNOL, V47, P42, DOI 10.1016/j.jmii.2012.08.024; Liu Y, 2017, ONCOTARGET, V8, P59729, DOI 10.18632/oncotarget.19927; Maggi G, 2012, SURG INFECT, V13, P183, DOI 10.1089/sur.2011.099; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; MASUR H, 1990, NEW ENGL J MED, V323, P1500, DOI 10.1056/NEJM199011223232131; MASUR H, 1992, NEW ENGL J MED, V327, P1853, DOI 10.1056/NEJM199212243272606; Matsumura Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-76; Monnet X, 2008, CRIT CARE, V12, DOI 10.1186/cc6806; Moon SM, 2011, ANTIMICROB AGENTS CH, V55, P4613, DOI 10.1128/AAC.00669-11; Muhlethaler K, 2012, EUR RESPIR J, V39, P971, DOI 10.1183/09031936.00095811; Nejmi H, 2010, MED MALADIES INFECT, V40, P241, DOI 10.1016/j.medmal.2009.08.006; Nuesch R, 1999, CLIN INFECT DIS, V29, P1519, DOI 10.1086/313534; Pagano L, 2002, BRIT J HAEMATOL, V117, P379, DOI 10.1046/j.1365-2141.2002.03419.x; Roblot F, 2004, SCAND J INFECT DIS, V36, P848, DOI 10.1080/00365540410021180; Salzer HJF, 2018, RESPIRATION, V96, P52, DOI 10.1159/000487713; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; SEPKOWITZ KA, 1992, JAMA-J AM MED ASSOC, V267, P832, DOI 10.1001/jama.267.6.832; Tasaka S, 2020, TUBERC RESPIR DIS, V83, P132, DOI 10.4046/trd.2020.0015	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246296	10.1371/journal.pone.0246296	http://dx.doi.org/10.1371/journal.pone.0246296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539407	Green Published, gold			2022-12-26	WOS:000616960200065
J	Carim, KJ; Relyea, S; Barfoot, C; Eby, LA; Kronenberger, JA; Whiteley, AR; Larkin, B				Carim, Kellie J.; Relyea, Scott; Barfoot, Craig; Eby, Lisa A.; Kronenberger, John A.; Whiteley, Andrew R.; Larkin, Beau			Ultrasound imaging identifies life history variation in resident Cutthroat Trout	PLOS ONE			English	Article							BROWN TROUT; REPRODUCTIVE CHARACTERISTICS; SEXUAL-MATURITY; SIZE; AGE; FECUNDITY; FISH; CONSERVATION; POPULATION; MATURATION	Human activities that fragment fish habitat have isolated inland salmonid populations. This isolation is associated with loss of migratory life histories and declines in population density and abundance. Isolated populations exhibiting only resident life histories may be more likely to persist if individuals can increase lifetime reproductive success by maturing at smaller sizes or earlier ages. Therefore, accurate estimates of age and size at maturity across resident salmonid populations would improve estimates of population viability. Commonly used methods for assessing maturity such as dissection, endoscopy and hormone analysis are invasive and may disturb vulnerable populations. Ultrasound imaging is a non-invasive method that has been used to measure reproductive status across fish taxa. However, little research has assessed the accuracy of ultrasound for determining maturation status of small-bodied fish, or reproductive potential early in a species' reproductive cycle. To address these knowledge gaps, we tested whether ultrasound imaging could be used to identify maturing female Westslope Cutthroat Trout (Oncorhynchus clarkii lewisi). Our methods were accurate at identifying maturing females reared in a hatchery setting up to eight months prior to spawning, with error rates <= 4.0%; accuracy was greater for larger fish. We also imaged fish in a field setting to examine variation in the size of maturing females among six wild, resident populations of Westslope Cutthroat Trout in western Montana. The median size of maturing females varied significantly across populations. We observed oocyte development in females as small as 109 mm, which is smaller than previously documented for this species. Methods tested in this study will allow researchers and managers to collect information on reproductive status of small-bodied salmonids without disrupting fish during the breeding season. This information can help elucidate life history traits that promote persistence of isolated salmonid populations.	[Carim, Kellie J.; Kronenberger, John A.] US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59804 USA; [Carim, Kellie J.; Eby, Lisa A.; Whiteley, Andrew R.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Relyea, Scott] Montana Fish Wildlife & Pk, Sekokini Springs Hatchery, Great Falls, MT USA; [Barfoot, Craig] Confederated Salish & Kootenai Tribes, Pablo, MT USA; [Larkin, Beau] MPG Ranch, Condon, MT USA	United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Carim, KJ (corresponding author), US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59804 USA.; Carim, KJ (corresponding author), Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA.	kellie.carim@usda.gov		Carim, Kellie/0000-0002-9622-9146	MPG Ranch	MPG Ranch	Funding for this research was provided by MPG Ranch to KJC and BL. Employees of MPG Ranch assisted in data collection on MPG Ranch property.	Awruch CA, 2008, MAR ECOL PROG SER, V355, P277, DOI 10.3354/meps07227; Bangs PD, 2014, J FISH WILDL MANAG, V5, P183, DOI 10.3996/022013-JFWM-009; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Bryan JL, 2005, N AM J AQUACULT, V67, P221, DOI 10.1577/A04-020.1; Carim KJ, 2017, GLOB ECOL CONSERV, V10, P93, DOI 10.1016/j.gecco.2017.02.001; Crozier LG, 2014, EVOL APPL, V7, P68, DOI 10.1111/eva.12135; Day CC, 2018, BIOL CONSERV, V221, P10, DOI 10.1016/j.biocon.2018.01.017; Downs Christopher C., 1997, North American Journal of Fisheries Management, V17, P85, DOI 10.1577/1548-8675(1997)017<0085:AASMSR>2.3.CO;2; Dunham Jason B., 1997, North American Journal of Fisheries Management, V17, P1126, DOI 10.1577/1548-8675(1997)017<1126:HFAERO>2.3.CO;2; Evans AF, 2004, T AM FISH SOC, V133, P1089, DOI 10.1577/T03-121.1; Evans AF, 2004, N AM J FISH MANAGE, V24, P967, DOI 10.1577/M03-112.1; Falahatkar B, 2014, ANAT HISTOL EMBRYOL, V43, P81, DOI 10.1111/ahe.12049; Foster MB, 2003, THESIS; Frost DA, 2014, N AM J AQUACULT, V76, P153, DOI 10.1080/15222055.2014.886647; Gallagher CP, 2019, HYDROBIOLOGIA, V840, P189, DOI 10.1007/s10750-019-3927-6; Hastings K., 2005, THESIS; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Hirsch CL, 2006, RANGE WIDE STATUS CO; Hliwa P, 2014, AQUACULT INT, V22, P89, DOI 10.1007/s10499-013-9646-5; Hodge BW, 2016, T AM FISH SOC, V145, P227, DOI 10.1080/00028487.2015.1111257; Janowicz ME, 2018, J FISH BIOL, V93, P874, DOI 10.1111/jfb.13792; Jonsson B, 2001, FUNCT ECOL, V15, P310, DOI 10.1046/j.1365-2435.2001.00528.x; Jonsson B, 2013, J ANIM ECOL, V82, P201, DOI 10.1111/j.1365-2656.2012.02022.x; Kikko T, 2011, ICHTHYOL RES, V58, P370, DOI 10.1007/s10228-011-0229-z; Letcher BH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001139; Martin R.W., 1983, North American Journal of Fisheries Management, V3, P258, DOI 10.1577/1548-8659(1983)3&lt;258:UIAPTF&gt;2.0.CO;2; Meyer KA, 2003, T AM FISH SOC, V132, P183, DOI 10.1577/1548-8659(2003)132&lt;0183:RDAFTI&gt;2.0.CO;2; Meyer KA, 2006, T AM FISH SOC, V135, P1329, DOI 10.1577/T05-161.1; Mims MC, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2589; Morita K, 1998, J FISH BIOL, V53, P1140, DOI 10.1111/j.1095-8649.1998.tb00471.x; Morita K, 2000, CAN J FISH AQUAT SCI, V57, P1300, DOI 10.1139/cjfas-57-6-1300; Morita K, 2005, CAN J FISH AQUAT SCI, V62, P2752, DOI 10.1139/F05-182; Morita K, 2002, J FISH BIOL, V61, P1230, DOI [10.1006/jfbi.2002.2138, 10.1111/j.1095-8649.2002.tb02467.x]; Morita K, 2010, CAN J FISH AQUAT SCI, V67, P955, DOI 10.1139/F10-028; Murphy BP, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3023; Naeve I, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13640; Novelo ND, 2012, N AM J AQUACULT, V74, P169, DOI 10.1080/15222055.2012.672370; O'Neal SL, 2011, T AM FISH SOC, V140, P623, DOI 10.1080/00028487.2011.585577; Olofsson H, 1999, ECOL FRESHW FISH, V8, P59, DOI 10.1111/j.1600-0633.1999.tb00054.x; Olsen EM, 2005, ECOL FRESHW FISH, V14, P202, DOI 10.1111/j.1600-0633.2005.00094.x; Perkin JS, 2012, ECOL APPL, V22, P2176, DOI 10.1890/12-0318.1; Radinger J, 2017, GLOBAL CHANGE BIOL, V23, P4970, DOI 10.1111/gcb.13760; SADOVY Y, 1994, ENVIRON BIOL FISH, V41, P269, DOI 10.1007/BF02197849; Schill DJ, 2010, N AM J FISH MANAGE, V30, P1352, DOI 10.1577/M10-021.1; Shepard BB, 2005, N AM J FISH MANAGE, V25, P1426, DOI 10.1577/M05-004.1; Stahl MT, 2009, J APPL ICHTHYOL, V25, P75, DOI 10.1111/j.1439-0426.2009.01334.x; Stearns S.C., 1992, pi; Swenson EA, 2007, T AM FISH SOC, V136, P994, DOI 10.1577/T06-193.1; Whiteman EA, 2005, J FISH BIOL, V66, P983, DOI 10.1111/j.0022-1112.2005.00653.x; Whitlock M. C., 2009, ANAL BIOL DATA	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246365	10.1371/journal.pone.0246365	http://dx.doi.org/10.1371/journal.pone.0246365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534856	Green Published, gold			2022-12-26	WOS:000616739700062
J	Yang, CW; Shi, ZL				Yang, Chu-Wen; Shi, Zhi-Ling			Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans	PLOS ONE			English	Article							RESPIRATORY SYNDROME-CORONAVIRUS; HEDGEHOG PATHWAY; NUCLEOCAPSID PROTEIN; CELL-CYCLE; CANNABINOIDS; PROGRESSION; ACTIVATION; HEPATITIS; COMPLEX; PHASE	A coronavirus pandemic caused by a novel coronavirus (SARS-CoV-2) has spread rapidly worldwide since December 2019. Improved understanding and new strategies to cope with novel coronaviruses are urgently needed. Viruses (especially RNA viruses) encode a limited number and size (length of polypeptide chain) of viral proteins and must interact with the host cell components to control (hijack) the host cell machinery. To achieve this goal, the extensive mimicry of SLiMs in host proteins provides an effective strategy. However, little is known regarding SLiMs in coronavirus proteins and their potential targets in host cells. The objective of this study is to uncover SLiMs in coronavirus proteins that are present within host cells. These SLiMs have a high possibility of interacting with host intracellular proteins and hijacking the host cell machinery for virus replication and dissemination. In total, 1,479 SLiM hits were identified in the 16 proteins of 590 coronaviruses infecting humans. Overall, 106 host proteins were identified that may interact with SLiMs in 16 coronavirus proteins. These SLiM-interacting proteins are composed of many intracellular key regulators, such as receptors, transcription factors and kinases, and may have important contributions to virus replication, immune evasion and viral pathogenesis. A total of 209 pathways containing proteins that may interact with SLiMs in coronavirus proteins were identified. This study uncovers potential mechanisms by which coronaviruses hijack the host cell machinery. These results provide potential therapeutic targets for viral infections.	[Yang, Chu-Wen] Soochow Univ, Ctr Appl Artificial Intelligence Res, Dept Microbiol, Taipei, Taiwan; [Shi, Zhi-Ling] Fuzhou Univ, Ocean Sch, Fuzhou, Peoples R China	Soochow University; Fuzhou University	Yang, CW (corresponding author), Soochow Univ, Ctr Appl Artificial Intelligence Res, Dept Microbiol, Taipei, Taiwan.	ycw6861@scu.edu.tw						Abdoli A, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1973; Becerra A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1570-7; Boorman E, 2016, PSYCHOPHARMACOLOGY, V233, P1591, DOI 10.1007/s00213-015-4105-9; Ceron JJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051491; Chen CJ, 2004, J VIROL, V78, P10410, DOI 10.1128/JVI.78.19.10410-10419.2004; Chen CJ, 2004, J VIROL, V78, P5658, DOI 10.1128/JVI.78.11.5658-5669.2004; Choi SS, 2011, HEPATOLOGY, V54, P1580, DOI 10.1002/hep.24576; Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001; Cornillez-Ty CT, 2009, J VIROL, V83, P10314, DOI 10.1128/JVI.00842-09; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Fan Y, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00396; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Hagai T, 2014, CELL REP, V7, P1729, DOI 10.1016/j.celrep.2014.04.052; Khan S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00187-20; Kumar M, 2020, NUCLEIC ACIDS RES, V48, pD296, DOI 10.1093/nar/gkz1030; Lai FW, 2014, J VIROL, V88, P54, DOI 10.1128/JVI.02678-13; Lan XQ, 2017, EXP CELL RES, V352, P193, DOI 10.1016/j.yexcr.2017.01.019; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li QS, 2006, ADV EXP MED BIOL, V581, P121; Liu L, 2011, J VIROL, V85, P4025, DOI 10.1128/JVI.02292-10; Olah A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01487; Pal AD, 2015, VIROLOGY, V484, P22, DOI 10.1016/j.virol.2015.05.007; Pereira TD, 2010, LAB INVEST, V90, P1690, DOI 10.1038/labinvest.2010.147; Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209; Reiss CS, 2010, PHARMACEUTICALS, V3, P1873, DOI 10.3390/ph3061873; Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002; Smelkinson MG, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040014; Smelkinson MG, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006588; Sobhy H, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4010003; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Tahamtan A, 2016, J MED VIROL, V88, P1, DOI 10.1002/jmv.24292; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; van Zuylen WJ, 2016, REV MED VIROL, V26, P340, DOI 10.1002/rmv.1892; Vidalain PO, 2010, MICROBES INFECT, V12, P1134, DOI 10.1016/j.micinf.2010.09.001; Wang CX, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109789; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Xu RS, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0080-z; Yang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038637; Ying WT, 2004, PROTEOMICS, V4, P492, DOI 10.1002/pmic.200300676; Yuan XL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-66; Yuan XL, 2006, VIROLOGY, V346, P74, DOI 10.1016/j.virol.2005.10.015	44	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246150	10.1371/journal.pone.0246150	http://dx.doi.org/10.1371/journal.pone.0246150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534852	Green Published, gold			2022-12-26	WOS:000616739700046
J	Liberato, MV; Prates, ET; Goncalves, TA; Bernardes, A; Vilela, N; Fattori, J; Ematsu, GC; Chinaglia, M; Gomes, ERM; Figueira, ACM; Damasio, A; Polikarpov, I; Skaf, MS; Squina, FM				Liberato, Marcelo Vizona; Prates, Erica Teixeira; Goncalves, Thiago Augusto; Bernardes, Amanda; Vilela, Nathalia; Fattori, Juliana; Ematsu, Gabriela Cristina; Chinaglia, Mariana; Machi Gomes, Emerson Rodrigo; Migliorini Figueira, Ana Carolina; Damasio, Andre; Polikarpov, Igor; Skaf, Munir S.; Squina, Fabio Marcio			Insights into the dual cleavage activity of the GH16 laminarinase enzyme class on beta-1,3 and beta-1,4 glycosidic bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; TRANSGLYCOSYLATION; GLYCOSYNTHESIS; RECOGNITION; VALIDATION; MECHANISMS; DYNAMICS; BINDING; BIOMASS; MUTANT	Glycoside hydrolases (GHs) are involved in the degradation of a wide diversity of carbohydrates and present several biotechnological applications. Many GH families are composed of enzymes with a single well-defined specificity. In contrast, enzymes from the GH16 family can act on a range of different polysaccharides, including beta-glucans and galactans. SCLam, a GH16 member derived from a soil metagenome, an endo-beta 1,3(4)-glucanase (EC 3.2.1.6), can cleave both beta-1,3 and beta-1,4 glycosidic bonds in glucans, such as laminarin, barley beta-glucan, and cello-oligosaccharides. A similar cleavage pattern was previously reported for other GH16 family members. However, the molecular mechanisms for this dual cleavage activity on (1,3)- and (1,4)-beta-D-glycosidic bonds by laminarinases have not been elucidated. In this sense, we determined the X-ray structure of a presumably inactive form of SCLam cocrystallized with different oligosaccharides. The solved structures revealed general bound products that are formed owing to residual activities of hydrolysis and transglycosylation. Biochemical and biophysical analyses and molecular dynamics simulations help to rationalize differences in activity toward different substrates. Our results depicted a bulky aromatic residue near the catalytic site critical to select the preferable configuration of glycosidic bonds in the binding cleft. Altogether, these data contribute to understanding the structural basis of recognition and hydrolysis of beta-1,3 and beta-1,4 glycosidic linkages of the laminarinase enzyme class, which is valuable for future studies on the GH16 family members and applications related to biomass conversion into feedstocks and bioproducts.	[Liberato, Marcelo Vizona; Ematsu, Gabriela Cristina; Chinaglia, Mariana; Machi Gomes, Emerson Rodrigo] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Liberato, Marcelo Vizona; Goncalves, Thiago Augusto; Vilela, Nathalia; Squina, Fabio Marcio] Univ Sorocaba, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Prates, Erica Teixeira; Skaf, Munir S.] Univ Estadual Campinas, Inst Quim, Campinas, SP, Brazil; [Prates, Erica Teixeira; Skaf, Munir S.] Univ Estadual Campinas, Ctr Pesquisa Engn & Ciencias Computacionais, Campinas, SP, Brazil; [Goncalves, Thiago Augusto; Vilela, Nathalia; Damasio, Andre] Univ Estadual Campinas, Inst Biol, Dept Bioquim & Biol Tecidual, Campinas, SP, Brazil; [Bernardes, Amanda; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Fattori, Juliana; Migliorini Figueira, Ana Carolina] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Prates, Erica Teixeira] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Universidade de Sorocaba; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; United States Department of Energy (DOE); Oak Ridge National Laboratory	Squina, FM (corresponding author), Univ Sorocaba, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil.	fabio.squina@prof.uniso.br	Teixeira Prates, Erica/GLU-6833-2022; Squina, Fabio/J-8130-2012; Liberato, Marcelo V/J-3606-2014	Squina, Fabio/0000-0002-8154-7459; Liberato, Marcelo V/0000-0002-7609-7844; Vilela, Nathalia/0000-0002-1072-0568; Polikarpov, Igor/0000-0001-9496-4174	FAPESP [2013/15582-5, 2014/04105-4, 2015/50612-8, 2017/22669-0, 2013/08293-7, 17/16089-1, 17/08166-6, 2015/505904]; CNPq [428527/2018-3, 306279/2020-7, 404654/2018-5, 304816/2017-5, 158882/20148]; Center for Bioenergy Innovation, a DOE Bioenergy Research Center - Office of Biological and Environmental Research in the DOE Office of Science	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Center for Bioenergy Innovation, a DOE Bioenergy Research Center - Office of Biological and Environmental Research in the DOE Office of Science	The authors would like to acknowledge FAPESP for financial support to F. M. S. (2015/505904), E. T. P. (2013/15582-5), M. V. L. (2014/04105-4), A. D. (2015/50612-8; 2017/22669-0), M. S. S. (2013/08293-7), T. A. G. (17/16089-1), and N. V. (17/08166-6). We also acknowledge CNPq for financial support to F. M. S. (428527/2018-3 and 306279/2020-7), A. D. (404654/2018-5; 304816/2017-5), and M. V. L. (158882/20148) and the LEC and Robolab facilities from LNBio/CNPEM, Beamline MX-2 from LNLS/CNPEM and CTBE/CNPEM for structural support. E. T. P. also acknowledges funding from the Center for Bioenergy Innovation, a DOE Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science	Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Alvarez TM, 2015, APPL BIOCHEM BIOTECH, V177, P304, DOI 10.1007/s12010-015-1743-7; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YS, 2014, BBA-PROTEINS PROTEOM, V1844, P366, DOI 10.1016/j.bbapap.2013.11.005; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; Ducros VMA, 2003, CHEM BIOL, V10, P619, DOI 10.1016/S1074-5521(03)00143-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANGELISTA RA, 1995, ANAL CHEM, V67, P2239, DOI 10.1021/ac00109a051; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEITEL T, 1994, EUR J BIOCHEM, V222, P203, DOI 10.1111/j.1432-1033.1994.tb18858.x; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krah M, 1998, EUR J BIOCHEM, V257, P101, DOI 10.1046/j.1432-1327.1998.2570101.x; Labourel A, 2015, ACTA CRYSTALLOGR D, V71, P173, DOI 10.1107/S139900471402450X; Lee Sang Hoon, 2015, Prev Nutr Food Sci, V20, P110, DOI 10.3746/pnf.2015.20.2.110; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malet C, 1998, FEBS LETT, V440, P208, DOI 10.1016/S0014-5793(98)01448-3; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; PARRISH FW, 1960, CAN J CHEM, V38, P2094, DOI 10.1139/v60-284; Qin HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11542-0; Qin Z, 2017, J BIOL CHEM, V292, P1666, DOI 10.1074/jbc.M116.762419; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Strohmeier M, 2004, PROTEIN SCI, V13, P3200, DOI 10.1110/ps.04828404; Tosh SM, 2004, CARBOHYD POLYM, V55, P425, DOI 10.1016/j.carbpol.2003.11.004; Vasur J, 2010, J AM CHEM SOC, V132, P1724, DOI 10.1021/ja909129b; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Viborg AH, 2019, J BIOL CHEM, V294, P15973, DOI 10.1074/jbc.RA119.010619	42	3	3	5	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100385	10.1016/j.jbc.2021.100385	http://dx.doi.org/10.1016/j.jbc.2021.100385			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556371	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400359
J	Chiu, LY; Wu, NL; Hung, CF; Bai, P; Dai, YS; Lin, WW				Chiu, Ling-Ya; Wu, Nan-Lin; Hung, Chi-Feng; Bai, Peter; Dai, Yang-Shia; Lin, Wan-Wan			PARP-1 involves in UVB-induced inflammatory response in keratinocytes and skin injury via regulation of ROS-dependent EGFR transactivation and p38 signaling	FASEB JOURNAL			English	Article						EGFR; inflammation; keratinocyte; PARP&#8208; 1; UVB	GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; KINASE ACTIVATION; OXIDATIVE STRESS; I INTERFERON; EXPRESSION; IRRADIATION; INHIBITION; APOPTOSIS	UV irradiation can injure the epidermis, resulting in sunburn, inflammation, and cutaneous tissue disorders. Previous studies demonstrate that EGFR in keratinocytes can be activated by UVB and contributes to inflammation. Poly (ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme and plays an essential role in DNA repair under moderate stress. In this study, we set out to understand how PARP-1 regulates UVB irradiation-induced skin injury and interplays with EGFR to mediate the inflammation response. We found that PARP-1 deficiency exacerbated the UVB-induced inflammation, water loss, and back skin damage in mice. In human primary keratinocytes, UVB can activate PARP-1 and enhance DNA damage upon PARP-1 gene silencing. Moreover, PARP-1 silencing and PARP inhibitor olaparib can suppress UVB-induced COX-2 and MMP-1 expression, but enhance TNF-alpha and IL-8 expression. In addition, EGFR silencing or EGFR inhibition by gefitinib can decrease UVB-induced COX-2, TNF-alpha, and IL-8 expression, suggesting EGFR activation via paracrine action can mediate UVB-induced inflammation responses. Immunoblotting data revealed that PARP-1 inhibition decreases UVB-induced EGFR and p38 activation. Pharmacological inhibition of p38 also dramatically led to the attenuation of UVB-induced inflammatory gene expression. Of note, genetic ablation of PARP-1 or EGFR can attenuate UVB-induced ROS production, and antioxidant NAC can attenuate UVB-induced EGFR-p38 signaling axis and PARP-1 activation. These data suggest the regulatory loops among EGFR, PARP-1, and ROS upon UVB stress. PARP-1 not only serves DNA repair function but also orchestrates interactions to EGFR transactivation and ROS production, leading to p38 signaling for inflammatory gene expression in keratinocytes.	[Chiu, Ling-Ya; Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Rm 1119,11F,1,Sec 1,Renai Rd, Taipei 100, Taiwan; [Chiu, Ling-Ya] MacKay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wu, Nan-Lin] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Wu, Nan-Lin] MacKay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Bai, Peter] Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary; [Bai, Peter] MTA DE Lendulet Lab Cellular Metab, Debrecen, Hungary; [Bai, Peter] Univ Debrecen, Res Ctr Mol Med, Debrecen, Hungary; [Dai, Yang-Shia] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Lin, Wan-Wan] Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan; [Lin, Wan-Wan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; Fu Jen Catholic University; University of Debrecen; University of Debrecen; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Taipei Medical University	Lin, WW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Rm 1119,11F,1,Sec 1,Renai Rd, Taipei 100, Taiwan.	wwllaura1119@ntu.edu.tw	Hung, Chi-Feng/AAL-4977-2021	Hung, Chi-Feng/0000-0003-3478-5451; Lin, Wan Wan/0000-0002-3207-734X	Ministry of Science and Technology, Taiwan (MOST) [MOST 108-2911-I-002-513, MOST 107-2911-I-002-544]; Hungarian Academy of Sciences [NKM-26/2019]; Academia Sinica [AS-TP-106-L11]; NTU | College of Medicine, National Taiwan University (NTUCM) [NSCCMOH-94-51, NSCCMOH-131-21]; National Taiwan University Hospital (NTUH) [109-M4754]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Academia Sinica(Academia Sinica - Taiwan); NTU | College of Medicine, National Taiwan University (NTUCM); National Taiwan University Hospital (NTUH)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 107-2911-I-002-544; Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 108-2911-I-002-513; Hungarian Academy of Sciences, Grant/Award Number: NKM-26/2019; Academia Sinica, Grant/Award Number: AS-TP-106-L11; NTU | College of Medicine, National Taiwan University (NTUCM), Grant/Award Number: NSCCMOH-94-51; NTU | College of Medicine, National Taiwan University (NTUCM), Grant/Award Number: NSCCMOH-131-21; National Taiwan University Hospital (NTUH), Grant/Award Number: 109-M4754	Brand RM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00920; Burian M, 2018, J INVEST DERMATOL, V138, P2507, DOI 10.1016/j.jid.2018.08.004; Byun S, 2013, CARCINOGENESIS, V34, P397, DOI 10.1093/carcin/bgs358; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Cimino F, 2006, J AGR FOOD CHEM, V54, P4041, DOI 10.1021/jf060253x; El-Abaseri Taghrid Bahig, 2013, ISRN Dermatol, V2013, P848705, DOI 10.1155/2013/848705; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Ghodgaonkar MM, 2008, DNA REPAIR, V7, P617, DOI 10.1016/j.dnarep.2008.01.001; Gruber JV, 2019, J INFLAMM RES, V12, P219, DOI 10.2147/JIR.S215776; Gu YP, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101036; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Han WN, 2009, PHOTOCHEM PHOTOBIOL, V85, P997, DOI 10.1111/j.1751-1097.2008.00531.x; He Y, 2017, J PHOTOCH PHOTOBIO B, V177, P24, DOI 10.1016/j.jphotobiol.2017.10.006; Hegedus C, 2020, CANCERS, V12, DOI 10.3390/cancers12010005; Hegedus C, 2014, REDOX BIOL, V2, P978, DOI 10.1016/j.redox.2014.08.003; Hocsak E, 2017, FREE RADICAL BIO MED, V108, P770, DOI 10.1016/j.freeradbiomed.2017.04.018; Huang CC, 2010, INT J MOL SCI, V11, P4782, DOI 10.3390/ijms11124782; Jiao J, 2014, CARCINOGENESIS, V35, P1310, DOI 10.1093/carcin/bgu020; Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001; Kang JS, 2007, J INVEST DERMATOL, V127, P698, DOI 10.1038/sj.jid.5700572; Kim I, 2014, GENES DIS, V1, P188, DOI 10.1016/j.gendis.2014.08.005; Kim KM, 2019, BIOL PHARM BULL, V42, P1524, DOI 10.1248/bpb.b19-00222; Kiss B, 2020, EXP DERMATOL, V29, P79, DOI 10.1111/exd.14061; Langelier MF, 2018, CURR OPIN STRUC BIOL, V53, P187, DOI 10.1016/j.sbi.2018.11.002; Lee JW, 2020, PHOTOCHEM PHOTOBIOL, V96, P478, DOI 10.1111/php.13245; Li N, 2016, CELL REP, V15, P843, DOI 10.1016/j.celrep.2016.03.070; Li YL, 2018, CARCINOGENESIS, V39, P700, DOI 10.1093/carcin/bgy039; Lin P, 2019, CYTOTECHNOLOGY, V71, P1003, DOI 10.1007/s10616-019-00342-1; Liu Q, 2018, ONCOGENE, V37, P2793, DOI 10.1038/s41388-018-0130-6; MILLER CC, 1994, J BIOL CHEM, V269, P3529; Mohania D, 2017, ADV EXP MED BIOL, V996, P71, DOI 10.1007/978-3-319-56017-5_7; Mortadza SAS, 2018, GLIA, V66, P562, DOI 10.1002/glia.23265; Nanba D, 2013, J DERMATOL SCI, V72, P81, DOI 10.1016/j.jdermsci.2013.05.009; Park M, 2013, EXP DERMATOL, V22, P336, DOI 10.1111/exd.12138; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pastore S, 2014, ARCH TOXICOL, V88, P1189, DOI 10.1007/s00204-014-1244-4; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Peus D, 2001, CURR PROBL DERMATOL, V29, P114; Pines A, 2013, TRENDS BIOCHEM SCI, V38, P321, DOI 10.1016/j.tibs.2013.03.002; Piskunova T S, 2007, Adv Gerontol, V20, P82; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Prasad R, 2017, PHOTOCHEM PHOTOBIOL, V93, P930, DOI 10.1111/php.12687; Raad H, 2017, J INVEST DERMATOL, V137, P1311, DOI 10.1016/j.jid.2016.12.027; Robaszkiewicz A, 2014, FREE RADICAL BIO MED, V76, P69, DOI 10.1016/j.freeradbiomed.2014.07.027; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Seo M, 2010, BIOCHEM BIOPH RES CO, V393, P190, DOI 10.1016/j.bbrc.2010.01.085; Sontheimer C, 2017, ARTHRITIS RHEUMATOL, V69, P826, DOI 10.1002/art.39987; Tan TC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00703; Van Laethem A, 2006, FREE RADICAL BIO MED, V41, P1361, DOI 10.1016/j.freeradbiomed.2006.07.007; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Wan YS, 2001, INT J MOL MED, V7, P329; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Wang JY, 2020, J DERMATOL SCI, V98, P119, DOI 10.1016/j.jdermsci.2020.03.007; Wang Q, 2005, INT J MOL MED, V15, P633; Wu NL, 2016, J INVEST DERMATOL, V136, P192, DOI 10.1038/JID.2015.381; Wu SL, 2008, MOL IMMUNOL, V45, P2288, DOI 10.1016/j.molimm.2007.11.019; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yin ZX, 2018, ONCOTARGET, V9, P1885, DOI 10.18632/oncotarget.21277; Zhuang LH, 1999, J IMMUNOL, V162, P1440	62	10	11	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21393	10.1096/fj.202002285RR	http://dx.doi.org/10.1096/fj.202002285RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570794	Bronze			2022-12-26	WOS:000629576700042
J	Koch, L; Kespohl, B; Agthe, M; Schumertl, T; Dusterhoft, S; Lemberg, MK; Lokau, J; Garbers, C				Koch, Lydia; Kespohl, Birte; Agthe, Maria; Schumertl, Tim; Dusterhoft, Stefan; Lemberg, Marius K.; Lokau, Juliane; Garbers, Christoph			Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling	FASEB JOURNAL			English	Article						cytokine; interleukin&#8208; 11; protease; RHBDL2; rhomboid		Interleukin-11 (IL-11) is a pleiotropic cytokine with both pro- and anti-inflammatory properties. It activates its target cells via binding to the membrane-bound IL-11 receptor (IL-11R), which then recruits a homodimer of the ubiquitously expressed, signal-transducing receptor gp130. Besides this classic signaling pathway, IL-11 can also bind to soluble forms of the IL-11R (sIL-11R), and IL-11/sIL-11R complexes activate cells via the induction of gp130 homodimerization (trans-signaling). We have previously reported that the metalloprotease ADAM10 cleaves the membrane-bound IL-11R and thereby generates sIL-11R. In this study, we identify the rhomboid intramembrane protease RHBDL2 as a so far unrecognized alternative sheddase that can efficiently trigger IL-11R secretion. We determine the cleavage site used by RHBDL2, which is located in the extracellular part of the receptor in close proximity to the plasma membrane, between Ala-370 and Ser-371. Furthermore, we identify critical amino acid residues within the transmembrane helix that are required for IL-11R proteolysis. We also show that ectopically expressed RHBDL2 is able to cleave the IL-11R within the early secretory pathway and not only at the plasma membrane, indicating that its subcellular localization plays a central role in controlling its activity. Moreover, RHBDL2-derived sIL-11R is biologically active and able to perform IL-11 trans-signaling. Finally, we show that the human mutation IL-11R-A370V does not impede IL-11 classic signaling, but prevents RHBDL2-mediated IL-11R cleavage.	[Koch, Lydia; Agthe, Maria] Univ Kiel, Inst Biochem, Kiel, Germany; [Kespohl, Birte; Schumertl, Tim; Lokau, Juliane; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Dusterhoft, Stefan] Rhein Westfal TH Aachen, Inst Mol Pharmacol, Aachen, Germany; [Lemberg, Marius K.] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany	University of Kiel; Otto von Guericke University; RWTH Aachen University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Garbers, C (corresponding author), Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany.	christoph.garbers@med.ovgu.de	Garbers, Christoph/D-9932-2015; Lemberg, Marius K/B-8881-2016	Garbers, Christoph/0000-0003-4939-6950; Lemberg, Marius K/0000-0002-0996-1268; Dusterhoft, Stefan/0000-0002-6926-136X	Deutsche Forschungsgemeinschaft (DFG) [125440785 -A10]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 125440785 -A10	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Agthe M, 2018, CELL REP, V25, P10, DOI 10.1016/j.celrep.2018.09.005; Agthe M, 2017, PLACENTA, V57, P13, DOI 10.1016/j.placenta.2017.05.015; Balic JJ, 2017, CYTOKINE, V92, P118, DOI 10.1016/j.cyto.2017.01.015; Battistini C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235958; Bilinski P, 1998, GENE DEV, V12, P2234, DOI 10.1101/gad.12.14.2234; Brischoux-Boucher E, 2018, CLIN GENET, V94, P373, DOI 10.1111/cge.13409; Clarke CM, 2018, AM J MED GENET A, V176, P290, DOI 10.1002/ajmg.a.38540; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Johnstone CN, 2015, CYTOKINE GROWTH F R, V26, P489, DOI 10.1016/j.cytogfr.2015.07.015; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Keupp K, 2013, MOL GENET GENOM MED, V1, P223, DOI 10.1002/mgg3.28; Korakavi N, 2019, AM J MED GENET A, V179, P668, DOI 10.1002/ajmg.a.61070; Lastun VL, 2016, SEMIN CELL DEV BIOL, V60, P10, DOI 10.1016/j.semcdb.2016.07.033; Lei XJ, 2009, J MOL BIOL, V394, P815, DOI 10.1016/j.jmb.2009.10.025; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Liao HJ, 2012, TRAFFIC, V13, P1106, DOI 10.1111/j.1600-0854.2012.01371.x; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Lokau J, 2018, J BIOL CHEM, V293, P6398, DOI 10.1074/jbc.RA118.001879; Lokau J, 2017, BBA-MOL CELL RES, V1864, P2105, DOI 10.1016/j.bbamcr.2017.06.008; Lokau J, 2017, BIOCHEM BIOPH RES CO, V491, P296, DOI 10.1016/j.bbrc.2017.07.106; Lokau J, 2017, INT J BIOCHEM CELL B, V85, P6, DOI 10.1016/j.biocel.2017.01.014; Lokau J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1785021; Lokau J, 2016, CELL REP, V14, P1761, DOI 10.1016/j.celrep.2016.01.053; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Nitz R, 2015, BIOCHIMIE, V119, P175, DOI 10.1016/j.biochi.2015.11.005; Noy PJ, 2016, FASEB J, V30, P2311, DOI 10.1096/fj.201500122R; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Putoczki TL, 2015, IMMUNOTHERAPY-UK, V7, P441, DOI [10.2217/IMT.15.17, 10.2217/imt.15.17]; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Riethmueller S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000080; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sammel M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153677; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schumacher N, 2015, J BIOL CHEM, V290, P26059, DOI 10.1074/jbc.M115.649509; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; SUEN Y, 1994, BLOOD, V84, P4125, DOI 10.1182/blood.V84.12.4125.bloodjournal84124125; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wilde MI, 1998, BIODRUGS, V10, P159, DOI 10.2165/00063030-199810020-00006; Winship AL, 2016, MOL CANCER THER, V15, P720, DOI 10.1158/1535-7163.MCT-15-0677; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342	55	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21380	10.1096/fj.202002087R	http://dx.doi.org/10.1096/fj.202002087R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566379	Green Published			2022-12-26	WOS:000629576700001
J	Armadans-Tremolosa, I; Guilera, G; Heras, ML; Castrechini, A; Selva-O'Callaghan, A				Armadans-Tremolosa, I; Guilera, G.; Las Heras, M.; Castrechini, A.; Selva-O'Callaghan, A.			Functioning in adult patients with idiopathic inflammatory myopathy: Exploring the role of environmental factors using focus groups	PLOS ONE			English	Article							QUALITY-OF-LIFE; ICF LINKING RULES; CLASSIFICATION; POLYMYOSITIS; DISABILITY; AGREEMENT	Objective Health-related quality of life is impaired in idiopathic inflammatory myopathies. This study aimed to identify the main areas of the health-related quality of life environment domain that are affected in patients with myositis. Methods A qualitative study was performed using focus groups and applying the International Classification of Functioning, Disability, and Health. Participants were recruited from a cohort of 323 adult inflammatory myopathy patients consulting at a reference center for idiopathic inflammatory myopathy in Spain, selected by the maximum variation strategy, and placed in focus groups with 5 to 7 patients per group. The number of focus groups required was determined by data saturation. Results Twenty-five patients distributed in 4 focus groups were interviewed. The verbatim provided 54 categories directly related with environmental factors. Those associated with products or substances for personal consumption (e110), health professionals (e355), health services, systems and policies (e580), products and technology for personal use in daily living (e115), and immediate family (e310) were the ones most frequently reported. Conclusion The results of this study led to identification of several environmental factors that affect the health-related quality of life of patients with myositis. Remedial interventions should be designed to address some of these factors.	[Armadans-Tremolosa, I; Las Heras, M.; Castrechini, A.] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, PsicoSAO Res Grp Social Environm & Org Psychol, Barcelona, Spain; [Guilera, G.] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Barcelona, Spain; [Guilera, G.] Univ Barcelona, Inst Neurosci, Barcelona, Spain; [Selva-O'Callaghan, A.] Univ Autonoma Barcelona, Vall dHebron Gen Hosp, Dept Med, Syst Autoimmune Dis Unit, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Selva-O'Callaghan, A (corresponding author), Univ Autonoma Barcelona, Vall dHebron Gen Hosp, Dept Med, Syst Autoimmune Dis Unit, Barcelona, Spain.	aselva@vhebron.net	Armadans, Immaculada/AAA-1268-2022; Castrechini, Angela/H-3650-2015	Armadans, Immaculada/0000-0003-2690-0544; Castrechini, Angela/0000-0003-3241-5254; Selva-O'Callaghan, Albert/0000-0003-2823-9761	Instituto de Salud Carlos III; European Regional Development Fund (ERDF) [PI15/02100]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission)	This work was supported in part by the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF) (grant number PI15/02100).	Aiachini B, 2016, DISABIL REHABIL, V38, P337, DOI 10.3109/09638288.2015.1041611; Armadans-Tremolosa I, 2014, CLIN RHEUMATOL, V33, P1119, DOI 10.1007/s10067-014-2685-0; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cieza A, 2019, DISABIL REHABIL, V41, P574, DOI 10.3109/09638288.2016.1145258; Cleary LC, 2015, ARTHRIT CARE RES, V67, P1031, DOI 10.1002/acr.22557; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dany A, 2017, DISABIL REHABIL, V39, P1262, DOI 10.1080/09638288.2016.1191552; Feldon M, 2017, ARTHRIT CARE RES, V69, P1743, DOI 10.1002/acr.23198; Goreshi R, 2011, J AM ACAD DERMATOL, V65, P1107, DOI 10.1016/j.jaad.2010.10.016; Greenfield J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189840; Hachulla E, 2017, INT J NEUROSCI, V127, P516, DOI 10.1080/00207454.2016.1204544; Hieblinger R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2696; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landon-Cardinal O, 2018, NEUROLOGY, V91, P760, DOI 10.1212/WNL.0000000000006365; Leclair V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160753; Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468; McDaid C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015927; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Opinc AH, 2019, RHEUMATOL INT, V39, P1213, DOI 10.1007/s00296-019-04302-y; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Patton M. Q., 1990, QUALITATIVE EVALUATI; Robinson ES, 2015, BRIT J DERMATOL, V172, P169, DOI 10.1111/bjd.13167; Selva-O'Callaghan A, 2018, LANCET NEUROL, V17, P816, DOI 10.1016/S1474-4422(18)30254-0; STRUTZEL E, 1968, NURS RES, V17, P364; Suri H, 2011, QUAL RES J, V11, P63, DOI 10.3316/QRJ1102063; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2001, WHO INT CLASS FUNCT	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0244959	10.1371/journal.pone.0244959	http://dx.doi.org/10.1371/journal.pone.0244959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571213	gold, Green Published			2022-12-26	WOS:000618274000084
J	Zhang, GP; Liu, XD				Zhang, Gengpei; Liu, Xiongding			Prediction and control of COVID-19 spreading based on a hybrid intelligent model	PLOS ONE			English	Article							EPIDEMIC MODEL; DYNAMICS; STABILITY	The coronavirus (COVID-19) is a highly infectious disease that emerged in the late December 2019 in Wuhan, China. It caused a worldwide outbreak and a major threat to global health. It is important to design prediction and control strategies to restrain its exploding. In this study, a hybrid intelligent model is proposed to simulate the spreading of COVID-19. First, considering the effect of control measures, such as government investment, media publicity, medical treatment, and law enforcement in epidemic spreading. Then, the infection rates are optimized by genetic algorithm (GA) and a modified susceptible-infected-quarantined-recovered (SIQR) epidemic spreading model is proposed. In addition, the long short-term memory (LSTM) is imbedded into the SIQR model to design the hybrid intelligent model to further optimize other parameters of the system model, which can obtain the optimal predictive model and control measures. Simulation results show that the proposed hybrid intelligence algorithm has good predictive ability. This study provide a reliable model to predict cases of infection and death, and reasonable suggestion to control COVID-19.	[Zhang, Gengpei] China Three Gorges Univ, Yichang, Hubei, Peoples R China; [Liu, Xiongding] South China Univ Technol, Sch Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China	China Three Gorges University; South China University of Technology	Liu, XD (corresponding author), South China Univ Technol, Sch Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China.	201771338@yangtzeu.edu.cn						Alkahtani BST, 2020, CHAOS SOLITON FRACT, V138, DOI [10.1016/j.chaos.2020.11006, 10.1016/j.chaos.2020.110006]; [Anonymous], 2020, ALEXANDRIA ENG J; Ardabili, ALGORITHMS, DOI [10.20944/preprints202004.0311.v1, DOI 10.20944/PREPRINTS202004.0311.V1]; Arora P, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110017; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Car Z, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/5714714; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chimmula VKR, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109864; Crokidakis N, 2020, INT J MOD PHYS C, V31, DOI 10.1142/S0129183120501351; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Elsheikh AH, 2021, PROCESS SAF ENVIRON, V149, P223, DOI 10.1016/j.psep.2020.10.048; Haghshenas SS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103730; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012; Lalmuanawma S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110059; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li T, 2016, PHYSICA A, V450, P649, DOI 10.1016/j.physa.2016.01.045; Li T, 2014, COMMUN NONLINEAR SCI, V19, P686, DOI 10.1016/j.cnsns.2013.07.010; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu XD, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-019-2221-2; Liu XD, 2019, PHYSICA A, V514, P497, DOI 10.1016/j.physa.2018.09.085; Liu XD, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1852-z; Mandal M, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109889; Miralles-Pechuan L., 2020, ARXIV200507656; Mishra BK, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109928; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Pinter G, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8060890; Wong ZSY, 2019, INFECT DIS HEALTH, V24, P44, DOI 10.1016/j.idh.2018.10.002; Wu XJ, 2020, EUR J RADIOL, V128, DOI 10.1016/j.ejrad.2020.109041; Yang M, 2011, PHYSICA A, V390, P2408, DOI 10.1016/j.physa.2011.02.007; Ye F, 2020, INT J INFECT DIS, V94, P133, DOI 10.1016/j.ijid.2020.03.042; Zhang JC, 2014, PHYSICA A, V394, P24, DOI 10.1016/j.physa.2013.09.058; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114; Zhang Y, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109959; Zhou YC, 2004, MATH COMPUT MODEL, V40, P1491, DOI 10.1016/j.mcm.2005.01.007; Zhu GH, 2012, APPL MATH MODEL, V36, P5808, DOI 10.1016/j.apm.2012.01.023	38	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246360	10.1371/journal.pone.0246360	http://dx.doi.org/10.1371/journal.pone.0246360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571234	gold, Green Published			2022-12-26	WOS:000618274000052
J	Beule, L; Karlovsky, P				Beule, Lukas; Karlovsky, Petr			Tree rows in temperate agroforestry croplands alter the composition of soil bacterial communities	PLOS ONE			English	Article								Background Tree-based intercropping (agroforestry) has been advocated to reduce adverse environmental impacts of conventional arable cropping. Modern agroforestry systems in the temperate zone are alley-cropping systems that combine rows of fast-growing trees with rows of arable crops. Soil microbial communities in these systems have been investigated intensively; however, molecular studies with high taxonomical resolution are scarce. Methods Here, we assessed the effect of temperate agroforestry on the abundance, diversity and composition of soil bacterial communities at three paired poplar-based alley cropping and conventional monoculture cropland systems using real-time PCR and Illumina sequencing of bacterial 16S rRNA genes. Two of the three systems grew summer barley (Hordeum vulgare); one system grew maize (Zea mays) in the sampling year. To capture the spatial heterogeneity induced by the tree rows, soil samples in the agroforestry systems were collected along transects spanning from the centre of the tree rows to the centre of the agroforestry crop rows. Results Tree rows of temperate agroforestry systems increased the abundance of soil bacteria while their alpha diversity remained largely unaffected. The composition of the bacterial communities in tree rows differed from those in arable land (crop rows of the agroforestry systems and conventional monoculture croplands). Several bacterial groups in soil showed strong association with either tree rows or arable land, revealing that the introduction of trees into arable land through agroforestry is accompanied by the introduction of a tree row-associated microbiome. Conclusion The presence of tree row-associated bacteria in agroforestry increases the overall microbial diversity of the system. We speculate that the increase in biodiversity is accompanied by functional diversification. Differences in plant-derived nutrients (root exudates and tree litter) and management practices (fertilization and tillage) likely account for the differences between bacterial communities of tree rows and arable land in agroforestry systems.	[Beule, Lukas; Karlovsky, Petr] Univ Goettingen, Fac Agr Sci, Mol Phytopathol & Mycotoxin Res, Gottingen, Germany	University of Gottingen	Beule, L (corresponding author), Univ Goettingen, Fac Agr Sci, Mol Phytopathol & Mycotoxin Res, Gottingen, Germany.	lukas.beule@agr.uni-goettingen.de	Beule, Lukas/AAY-5667-2020	Beule, Lukas/0000-0003-1107-7540; Karlovsky, Petr/0000-0002-6532-5856	German Federal Ministry of Education and Research (BMBF), in the framework of the Bonares-SIGNAL project [031A562A, 031B0510A]; Open Access Publication Funds of the Gottingen University	German Federal Ministry of Education and Research (BMBF), in the framework of the Bonares-SIGNAL project(Federal Ministry of Education & Research (BMBF)); Open Access Publication Funds of the Gottingen University	This study was financed by the German Federal Ministry of Education and Research (BMBF), in the framework of the Bonares-SIGNAL project (funding codes: 031A562A and 031B0510A). We acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Allen SC, 2004, FOREST ECOL MANAG, V192, P395, DOI 10.1016/j.foreco.2004.02.009; Banerjee S, 2016, ENVIRON MICROBIOL, V18, P1805, DOI 10.1111/1462-2920.12986; Bardhan S, 2013, AGROFOREST SYST, V87, P1031, DOI 10.1007/s10457-013-9617-x; Beule L, 2020, PEERJ, V8, DOI 10.7717/peerj.9593; Beule L, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03108; Beule L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218779; Beule L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102925; Beuschel R, 2019, BIOL FERT SOILS, V55, P1, DOI 10.1007/s00374-018-1324-3; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brandfass C, 2008, INT J MOL SCI, V9, P2306, DOI 10.3390/ijms9112306; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cannell MGR, 1996, AGROFOREST SYST, V34, P27, DOI 10.1007/BF00129630; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Edgar RC, 2018, BIOINFORMATICS, V34, P2371, DOI 10.1093/bioinformatics/bty113; Fanin N, 2014, PLANT SOIL, V379, P79, DOI 10.1007/s11104-014-2051-7; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gaby JC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau001; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gomez E, 2000, APPL SOIL ECOL, V15, P273, DOI 10.1016/S0929-1393(00)00078-0; Guerra V, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040532; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; HILL RL, 1990, SOIL SCI SOC AM J, V54, P161, DOI 10.2136/sssaj1990.03615995005400010025x; Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1; Jose S, 2004, AGROFOREST SYST, V61-2, P237, DOI 10.1023/B:AGFO.0000029002.85273.9b; Kay S, 2018, AGROFOREST SYST, V92, P1075, DOI 10.1007/s10457-017-0132-3; Krehenwinkel H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17333-x; Lange M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7707; Laranjo M, 2014, MICROBIOL RES, V169, P2, DOI 10.1016/j.micres.2013.09.012; Lee KH, 2003, AGROFOREST SYST, V58, P45, DOI 10.1023/A:1025404019211; Liu S, 2017, APPL SOIL ECOL, V120, P121, DOI 10.1016/j.apsoil.2017.07.034; Mao R, 2012, ENVIRON MONIT ASSESS, V184, P6845, DOI 10.1007/s10661-011-2462-3; Mathew R. P., 2012, Applied and Environmental Soil Science, V2012, P548620; Mungai NW, 2005, BIOL FERT SOILS, V42, P129, DOI 10.1007/s00374-005-0005-1; Oelbermann M, 2004, AGR ECOSYST ENVIRON, V104, P359, DOI 10.1016/j.agee.2004.04.001; Oksanen J, 2019, THE VEGAN PACKAGE; Pardon P, 2020, RENEW AGR FOOD SYST, V35, P533, DOI 10.1017/S1742170519000176; Pardon P, 2018, AGR SYST, V166, P135, DOI 10.1016/j.agsy.2018.08.008; Pardon P, 2017, AGR ECOSYST ENVIRON, V247, P98, DOI 10.1016/j.agee.2017.06.018; PHILLIPS DA, 1980, ANNU REV PLANT PHYS, V31, P29, DOI 10.1146/annurev.pp.31.060180.000333; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2018, R LANG ENV STAT COMP; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rivest D, 2013, SCI TOTAL ENVIRON, V463, P51, DOI 10.1016/j.scitotenv.2013.05.071; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schlatter DC, 2015, ECOLOGY, V96, P134, DOI 10.1890/13-1648.1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seiter S, 1999, APPL SOIL ECOL, V12, P139, DOI 10.1016/S0929-1393(98)00163-2; Smith CR, 2016, ECOL EVOL, V6, P8075, DOI 10.1002/ece3.2553; Smith J, 2013, RENEW AGR FOOD SYST, V28, P80, DOI 10.1017/S1742170511000585; Smith J, 2012, RENEW AGR FOOD SYST, V27, P323, DOI 10.1017/S1742170511000597; Swieter A, 2019, AGROFOREST SYST, V93, P1853, DOI 10.1007/s10457-018-0288-5; Torralba M, 2016, AGR ECOSYST ENVIRON, V230, P150, DOI 10.1016/j.agee.2016.06.002; Tsonkova P, 2012, AGROFOREST SYST, V85, P133, DOI 10.1007/s10457-012-9494-8; Udawatta RP, 2008, APPL SOIL ECOL, V39, P153, DOI 10.1016/j.apsoil.2007.12.002; Udawatta RP, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102879; Udawatta RP, 2009, AGR ECOSYST ENVIRON, V131, P98, DOI 10.1016/j.agee.2008.06.001; Unger IM, 2013, AGROFOREST SYST, V87, P395, DOI 10.1007/s10457-012-9559-8; Veach AM, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0668-8; Voges MJEEE, 2019, P NATL ACAD SCI USA, V116, P12558, DOI 10.1073/pnas.1820691116; Wang Y, 2011, AGR ECOSYST ENVIRON, V140, P441, DOI 10.1016/j.agee.2011.01.007; Weerasekara C, 2016, AGROFOREST SYST, V90, P829, DOI 10.1007/s10457-016-9903-5; Yin CT, 2017, PHYTOBIOMES J, V1, P83, DOI 10.1094/PBIOMES-09-16-0008-R; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zeng QC, 2017, PEERJ, V5, DOI 10.7717/peerj.3777; Zhalnina K, 2018, NAT MICROBIOL, V3, P470, DOI 10.1038/s41564-018-0129-3	69	14	14	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246919	10.1371/journal.pone.0246919	http://dx.doi.org/10.1371/journal.pone.0246919			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566862	gold, Green Published			2022-12-26	WOS:000618271700055
J	Houle, B; Kabudula, CW; Stein, A; Gareta, D; Herbst, K; Clark, SJ				Houle, Brian; Kabudula, Chodziwadziwa W.; Stein, Alan; Gareta, Dickman; Herbst, Kobus; Clark, Samuel J.			Linking the timing of a mother's and child's death: Comparative evidence from two rural South African population-based surveillance studies, 2000-2015	PLOS ONE			English	Article							MORTALITY; HIV; SURVIVAL; PREVALENCE; PROFILE; BURDEN; COHORT; UGANDA; IMPACT	Background The effect of the period before a mother's death on child survival has been assessed in only a few studies. We conducted a comparative investigation of the effect of the timing of a mother's death on child survival up to age five years in rural South Africa. Methods We used discrete time survival analysis on data from two HIV-endemic population surveillance sites (2000-2015) to estimate a child's risk of dying before and after their mother's death. We tested if this relationship varied between sites and by availability of antiretroviral therapy (ART). We assessed if related adults in the household altered the effect of a mother's death on child survival. Findings 3,618 children died from 2000-2015. The probability of a child dying began to increase in the 7-11 months prior to the mother's death and increased markedly in the 3 months before (2000-2003 relative risk = 22.2, 95% CI = 14.2-34.6) and 3 months following her death (2000-2003 RR = 20.1; CI = 10.3-39.4). This increased risk pattern was evident at both sites. The pattern attenuated with ART availability but remained even with availability at both sites. The father and maternal grandmother in the household lowered children's mortality risk independent of the association between timing of mother and child mortality. Conclusions The persistence of elevated mortality risk both before and after the mother's death for children of different ages suggests that absence of maternal care and abrupt breastfeeding cessation might be crucial risk factors. Formative research is needed to understand the circumstances for children when a mother is very ill or dies, and behavioral and other risk factors that increase both the mother and child's risk of dying. Identifying families when a mother is very ill and implementing training and support strategies for other members of the household are urgently needed to reduce preventable child mortality.	[Houle, Brian] Australian Natl Univ, Sch Demog, Canberra, ACT, Australia; [Houle, Brian; Kabudula, Chodziwadziwa W.; Stein, Alan; Clark, Samuel J.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Houle, Brian; Clark, Samuel J.] Univ Colorado, Inst Behav Sci, CU Populat Ctr, Boulder, CO 80309 USA; [Stein, Alan] Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford, England; [Gareta, Dickman; Herbst, Kobus] Africa Hlth Res Inst, Kwa Zulu, South Africa; [Clark, Samuel J.] Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA	Australian National University; University of Witwatersrand; University of Colorado System; University of Colorado Boulder; University of Oxford; Africa Health Research Institute; University System of Ohio; Ohio State University	Houle, B (corresponding author), Australian Natl Univ, Sch Demog, Canberra, ACT, Australia.; Houle, B (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa.; Houle, B (corresponding author), Univ Colorado, Inst Behav Sci, CU Populat Ctr, Boulder, CO 80309 USA.	brian.houle@anu.edu.au	Clark, Samuel J/A-8419-2009; Kabudula, Chodziwadziwa/AAV-6704-2021	Clark, Samuel J/0000-0002-4929-6231; Houle, Brian/0000-0003-2157-3118; Kabudula, Chodziwadziwa/0000-0002-5867-0336; Stein, Alan/0000-0001-8207-2822	Department of Science and Innovation; University of the Witwatersrand; Medical Research Council, South Africa; Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; Wellcome Trust [201433/Z/16/Z]; Howard Hughes Medical Institute	Department of Science and Innovation; University of the Witwatersrand; Medical Research Council, South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The MRC/Wits Rural Public Health and Health Transitions Research Unit and Agincourt Health and Socio-Demographic Surveillance System, a node of the South African Population Research Infrastructure Network (SAPRIN), is supported by the Department of Science and Innovation, the University of the Witwatersrand, and the Medical Research Council, South Africa, and previously the Wellcome Trust, UK (grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z). The Africa Health Research Institute is supported largely by Wellcome Trust (grant 201433/Z/16/Z) and Howard Hughes Medical Institute. The population surveillance, a node of the South African Population Research Infrastructure Network (SAPRIN), is funded by the Department of Science and Innovation and hosted by the South African Medical Research Council. The authors received no specific funding for this work.	Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; [Anonymous], 2018, LEV TRENDS CHILD MOR; Arikawa S, 2018, CLIN INFECT DIS, V66, P1668, DOI 10.1093/cid/cix1102; Atrash Hani K, 2011, Rev Bras Crescimento Desenvolv Hum, V21, P759; Bennett R, 2015, POPUL SPACE PLACE, V21, P322, DOI 10.1002/psp.1843; Blacklock C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145206; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Byass P, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1333-6; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000325; Chikhungu LC, 2017, B WORLD HEALTH ORGAN, V95, P281, DOI [10.2471/blt.15.157149, 10.2471/BLT.15.157149]; Clark SJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001409; Collinson MA, 2009, THESIS; Nguyen DTN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7316-x; Fraser BA, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2017.010090; Garenne M, 2013, INT J WOMENS HEALTH, V5, P457, DOI 10.2147/IJWH.S45983; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Grant L, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-8; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Horton R, 2010, LANCET, V375, P1941, DOI 10.1016/S0140-6736(10)60902-6; Hosegood V., 2012, FATHERING, V10, P257, DOI [DOI 10.3149/FTH.1003.257, 10.3149/fth.1003.257]; Houle B, 2013, INT J EPIDEMIOL, V42, P1444, DOI 10.1093/ije/dyt149; Kabudula CW, 2017, SOC INDIC RES, V133, P1047, DOI 10.1007/s11205-016-1397-z; Kabudula CW, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4312-x; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kautzky KJM, 2009, THESIS; Kravdal O, 2018, POP STUD-J DEMOG, V72, P139, DOI 10.1080/00324728.2018.1439180; Lumley T., 2006, RELATIVE RISK REGRES, V293; Madhavan S, 2008, J S AFR STUD, V34, P647, DOI 10.1080/03057070802259902; Masmas TN, 2004, ACTA PAEDIATR, V93, P99, DOI 10.1080/08035250310007970; Molitoris J, 2019, DEMOGRAPHY, V56, P1349, DOI 10.1007/s13524-019-00798-y; MUHWAVA W, 2007, OPERATIONAL METHODOL; Nannan NN, 2019, SAMJ S AFR MED J, V109, P480, DOI [10.7196/samj.2019.v109i7.13717, 10.7196/SAMJ.2019.v109i7.13717]; Ndirangu J, 2012, ANTIVIR THER, V17, P81, DOI 10.3851/IMP1991; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; Ng'weshemi J, 2003, JAIDS-J ACQ IMM DEF, V33, P393, DOI 10.1097/00126334-200307010-00015; Richter L., 2006, IMPORTANCE FATHERING, P53; Richter Linda, 2010, Child Educ, V86, P360; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Scott S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172286; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Selman LE, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-21; StataCorp, 2017, STATA STAT SOFTWARE; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tlou B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207294; Tlou B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4463-9; Tlou B, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6152-8; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Volinsky CT, 2000, BIOMETRICS, V56, P256, DOI 10.1111/j.0006-341X.2000.00256.x; WHO, 2019, WORLD HLTH STAT 2019; Wilford A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5056-y; Willcox ML, 2018, LANCET GLOB HEALTH, V6, pE691, DOI 10.1016/S2214-109X(18)30215-8; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	54	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246671	10.1371/journal.pone.0246671	http://dx.doi.org/10.1371/journal.pone.0246671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556118	Green Published, gold			2022-12-26	WOS:000617379900043
J	Ulivieri, FM; Rinaudo, L; Piodi, LP; Messina, C; Sconfienza, LM; Sardanelli, F; Guglielmi, G; Grossi, E				Ulivieri, Fabio Massimo; Rinaudo, Luca; Piodi, Luca Petruccio; Messina, Carmelo; Sconfienza, Luca Maria; Sardanelli, Francesco; Guglielmi, Giuseppe; Grossi, Enzo			Bone strain index as a predictor of further vertebral fracture in osteoporotic women: An artificial intelligence-based analysis	PLOS ONE			English	Article							NEURAL-NETWORKS; MINERAL DENSITY; HIP FRACTURE; DIAGNOSIS; METHYLATION; STRENGTH; SCORE; RISK	Background Osteoporosis is an asymptomatic disease of high prevalence and incidence, leading to bone fractures burdened by high mortality and disability, mainly when several subsequent fractures occur. A fragility fracture predictive model, Artificial Intelligence-based, to identify dual X-ray absorptiometry (DXA) variables able to characterise those patients who are prone to further fractures called Bone Strain Index, was evaluated in this study. Methods In a prospective, longitudinal, multicentric study 172 female outpatients with at least one vertebral fracture at the first observation were enrolled. They performed a spine X-ray to calculate spine deformity index (SDI) and a lumbar and femoral DXA scan to assess bone mineral density (BMD) and bone strain index (BSI) at baseline and after a follow-up period of 3 years in average. At the end of the follow-up, 93 women developed a further vertebral fracture. The further vertebral fracture was considered as one unit increase of SDI. We assessed the predictive capacity of supervised Artificial Neural Networks (ANNs) to distinguish women who developed a further fracture from those without it, and to detect those variables providing the maximal amount of relevant information to discriminate the two groups. ANNs choose appropriate input data automatically (TWIST-system, Training With Input Selection and Testing). Moreover, we built a semantic connectivity map usingthe Auto Contractive Map to provide further insights about the convoluted connections between the osteoporotic variables under consideration and the two scenarios (further fracture vs no further fracture). Results TWIST system selected 5 out of 13 available variables: age, menopause age, BMI, FTot BMC, FTot BSI. With training testing procedure, ANNs reached predictive accuracy of 79.36%, with a sensitivity of 75% and a specificity of 83.72%. The semantic connectivity map highlighted the role of BSI in predicting the risk of a further fracture. Conclusions Artificial Intelligence is a useful method to analyse a complex system like that regarding osteoporosis, able to identify patients prone to a further fragility fracture. BSI appears to be a useful DXA index in identifying those patients who are at risk of further vertebral fractures.	[Ulivieri, Fabio Massimo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Med Nucl, Milan, Italy; [Rinaudo, Luca] TECHNOLOGIC Srl, Turin, Italy; [Messina, Carmelo; Sconfienza, Luca Maria] IRCCS Ist Ortoped Galeazzi, UO Radiol Diagnost & Interventist, Milan, Italy; [Messina, Carmelo; Sconfienza, Luca Maria; Sardanelli, Francesco] Univ Milan, Dipartimento Sci Biomed Salute, Diagnost Immagini & Radioterapia, Milan, Italy; [Sardanelli, Francesco] IRCCS Policlin San Donato, Radiol & Diagnost Immagini, Piazza Edmondo Malan, San Donato Milanese, MI, Italy; [Guglielmi, Giuseppe] Univ Foggia, Dipartimento Med Clin & Sperimentale, Viale Luigi Pinto, Foggia, Italy; [Grossi, Enzo] Villa Santa Maria Fdn, Tavernerio, CO, Italy; [Ulivieri, Fabio Massimo] Univ Vita Salute San Raffaele, UO Endocrinol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Ortopedico Galeazzi; University of Milan; IRCCS Policlinico San Donato; University of Foggia; Vita-Salute San Raffaele University	Messina, C (corresponding author), IRCCS Ist Ortoped Galeazzi, UO Radiol Diagnost & Interventist, Milan, Italy.; Messina, C (corresponding author), Univ Milan, Dipartimento Sci Biomed Salute, Diagnost Immagini & Radioterapia, Milan, Italy.	carmelo.messina@unimi.it	Messina, Carmelo/B-5604-2018	Messina, Carmelo/0000-0001-7518-5773; Rinaudo, Luca/0000-0003-1221-8552				Buscema M, 2005, ARTIF INTELL MED, V34, P279, DOI 10.1016/j.artmed.2004.12.001; Buscema M, 2004, EXPERT SYST, V21, P63, DOI 10.1111/j.1468-0394.2004.00264.x; Buscema M, 2008, CURR ALZHEIMER RES, V5, P481, DOI 10.2174/156720508785908928; Buscema Massimo, 2007, Comput Intell Neurosci, P35021, DOI 10.1155/2007/35021; Buscema M, 2008, INT J DATA MIN BIOIN, V2, P362, DOI 10.1504/IJDMB.2008.022159; Colombo C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225905; Coppede F, 2015, EPIGENOMICS-UK, V7, P175, DOI [10.2217/EPI.14.77, 10.2217/epi.14.77]; Crans GG, 2005, BONE, V37, P175, DOI 10.1016/j.bone.2005.04.003; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; Diacinti D, 2019, QUANT IMAG MED SURG, V9, P1485, DOI 10.21037/qims.2019.09.10; Drago L, 2017, ISME J, V11, P875, DOI 10.1038/ismej.2016.183; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Grossi E, 2016, J ALZHEIMERS DIS, V53, P1517, DOI 10.3233/JAD-160210; Grossi E, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-15; Guglielmi G, 2011, RADIOGRAPHICS, V31, P1343, DOI 10.1148/rg.315105712; Han KS, 2013, MED ENG PHYS, V35, P969, DOI 10.1016/j.medengphy.2012.09.009; Hans D, 2011, J CLIN DENSITOM, V14, P302, DOI 10.1016/j.jocd.2011.05.005; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Kanis JA, 2000, BONE, V27, P585, DOI 10.1016/S8756-3282(00)00381-1; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lewiecki EM, 2008, SOUTH MED J, V101, P735, DOI 10.1097/SMJ.0b013e31817a8b02; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; Messina C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229820; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; PECK WA, 1993, AM J MED, V94, P646; Penco S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-254; Pothuaud L, 2009, J CLIN DENSITOM, V12, P170, DOI 10.1016/j.jocd.2008.11.006; Rodari G, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0507-8; Roux JP, 2010, J BONE MINER RES, V25, P356, DOI 10.1359/jbmr.090803; Rumelhart DE, 1986, PARALLEL DISTRIBUTED; Street ME, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-24; Tabaton M, 2010, J ALZHEIMERS DIS, V19, P1035, DOI 10.3233/JAD-2010-1300; Terzini M, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00220; Ulivieri FM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190477; Ulivieri FM, 2020, EUR RADIOL EXP, V4, DOI 10.1186/s41747-020-00151-8; Ulivieri FM, 2018, HAEMOPHILIA, V24, P980, DOI 10.1111/hae.13611; Xu M, 2017, COMPUT METHOD BIOMEC, V20, P1, DOI 10.1080/10255842.2016.1193596; Yang L, 2014, J BONE MINER RES, V29, P2594, DOI 10.1002/jbmr.2291; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	40	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245967	10.1371/journal.pone.0245967	http://dx.doi.org/10.1371/journal.pone.0245967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556061	gold, Green Published			2022-12-26	WOS:000617379900005
J	Carr, JJ; Lalara, J; Lalara, G; Lalara, G; Daniels, B; Clough, AR; Lowell, A; Barker, RN				Carr, Jennifer J.; Lalara, Joyce; Lalara, Gayangwa; Lalara, Gwen; Daniels, Bronwyn; Clough, Alan R.; Lowell, Anne; Barker, Ruth N.			Staying Strong Toolbox: Co-design of a physical activity and lifestyle program for Aboriginal families with Machado-Joseph disease in the Top End of Australia	PLOS ONE			English	Article							PARKINSONS-DISEASE; HEALTH-CARE; EXERCISE; PEOPLE; REHABILITATION; PHYSIOTHERAPY; SERVICE; ATAXIA	Physical activity has positive health implications for individuals living with neurodegenerative diseases. The success of physical activity programs, particularly in culturally and linguistically diverse populations, is typically dependent on their alignment with the culture, lifestyle and environmental context of those involved. Aboriginal families living in remote communities in the Top End of Australia invited researchers to collaborate with them to co-design a physical activity and lifestyle program to keep individuals with Machado-Joseph disease (MJD) walking and moving around. The knowledge of Aboriginal families living with MJD, combined with findings from worldwide MJD research, formed the foundation for the co-design. An experience-based co-design (EBCD) approach, drawing from Indigenous and Participatory methodologies, was used. An expert panel of individuals with lived experience of MJD participated in a series of co-design phases. Prearranged and spontaneous co-design meetings were led by local community researchers within each phase. Data was collected using a culturally responsive ethnographic approach and analysed thematically. Sixteen panel members worked to develop the 'Staying Strong Toolbox' to cater for individuals with MJD who are 'walking strong'; or 'wobbly'; or 'in a wheelchair'. Based on the 'Staying Strong Framework', the Toolbox was developed as a spiral bound A3 book designed to guide the user to select from a range of activities to keep them walking and moving around and to identify those activities most important to them to work on. The 'Staying Strong Toolbox' is a community driven, evidence based resource for a physical activity and lifestyle program for Aboriginal families with MJD. The Toolbox provides a guide for health professionals and support workers to deliver person-centred support to Aboriginal families with MJD, and that can be modified for use by other families with MJD or people with other forms of ataxia around the world.	[Carr, Jennifer J.; Barker, Ruth N.] James Cook Univ, Coll Healthcare Sci, Cairns, Qld, Australia; [Lalara, Joyce; Lalara, Gayangwa; Lalara, Gwen; Daniels, Bronwyn] MJD Fdn, Darwin, NT, Australia; [Clough, Alan R.] James Cook Univ, Coll Publ Hlth, Med & Vet Sci & Australian Inst Trop Hlth & Med, Community Based Hlth Promot & Prevent Studies Grp, Cairns, Qld, Australia; [Lowell, Anne] Charles Darwin Univ, Northern Inst, Darwin, NT, Australia	James Cook University; James Cook University; Charles Darwin University	Carr, JJ (corresponding author), James Cook Univ, Coll Healthcare Sci, Cairns, Qld, Australia.	jennifer.carr2@my.jcu.edu.au	; Lowell, Anne/H-9307-2013	Carr, Jennifer/0000-0002-9612-0722; Lowell, Anne/0000-0001-9540-1939; Barker, Ruth/0000-0002-2546-2581	Lowitja Institute Aboriginal and Torres Strait Islander Health CRC (Lowitja Institute CRC) [017-SF-005]	Lowitja Institute Aboriginal and Torres Strait Islander Health CRC (Lowitja Institute CRC)	This study received in-kind support from the MJD Foundation Ltd (http://mjd.org.au) and Anindilyakwa Land Council (https://www.anindilyakwa.com.au) (flights and accommodation (JC)). GL received salary from MJD Foundation. This study received funding support from the Lowitja Institute Aboriginal and Torres Strait Islander Health CRC (Lowitja Institute CRC) (Grant ID: 017-SF-005) (https://www.lowitja.org.au).JL received salary from the Lowitja Institute CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amery R, 2017, MED J AUSTRALIA, V207, P13, DOI 10.5694/mja17.00042; Ang ET, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00025; [Anonymous], 2013, PANCREATOLOGY, V13, pe1; Barker RN, 2017, DISABIL REHABIL, V39, P1136, DOI 10.1080/09638288.2016.1185803; Bettencourt C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-35; Boyd H, 2012, NEW ZEAL MED J, V125, P76; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Carr JJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032092; Carr JJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212953; Cassidy E, 2018, DISABIL REHABIL, V40, P894, DOI 10.1080/09638288.2016.1277400; Chamberlain C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028397; Cruickshank TM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000411; Dahlberg EE, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071492; Daker-White G, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113505560; de Ara?jo M., 2016, JSM BRAIN SCI, V1, P1001; Donetto S, 2015, DES J, V18, P227, DOI 10.2752/175630615X14212498964312; El Masri A, 2022, ETHNIC HEALTH, V27, P40, DOI 10.1080/13557858.2019.1658183; Garzo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207136; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Goodyear-Smith F, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0072-2; Green T, 2020, BMJ QUAL SAF, V29, P64, DOI 10.1136/bmjqs-2019-009570; Guo LY, 2020, J NEUROSCI RES, V98, P509, DOI 10.1002/jnr.24524; Hale LA, 2012, DISABIL REHABIL, V34, P1887, DOI 10.3109/09638288.2012.670037; Hjelmfors L, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0340-2; Horn KK, 2012, J ORTHOP SPORT PHYS, V42, P30, DOI 10.2519/jospt.2012.3727; Keller JL, 2014, NEUROREHAB NEURAL RE, V28, P770, DOI 10.1177/1545968314522350; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Kite E, 2015, HEALTH PROMOT J AUST, V26, P191, DOI 10.1071/HE15064; Kuhn T, 2014, COMPUT LINGUIST, V40, P121, DOI 10.1162/COLI_a_00168; Larkin M, 2015, QUAL HEALTH RES, V25, P1463, DOI 10.1177/1049732315576494; Liu Y, 2019, LAB INVEST, V99, P943, DOI 10.1038/s41374-019-0232-y; Milne SC, 2017, NEUROREHAB NEURAL RE, V31, P609, DOI 10.1177/1545968317712469; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; MJD Foundation, 2015, MED PROT MOB BAL DET; Morenga LT, 2018, ALTERNATIVE, V14, P90, DOI 10.1177/1177180117753169; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Peters D, 2018, PROCEEDINGS OF THE 30TH AUSTRALIAN COMPUTER-HUMAN INTERACTION CONFERENCE (OZCHI 2018), P97, DOI 10.1145/3292147.3292204; Phillips C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00170; Pressick EL, 2016, J SCI MED SPORT, V19, P726, DOI 10.1016/j.jsams.2015.11.005; Quinn L, 2012, NEURODEGENER DIS MAN, V2, P21, DOI 10.2217/NMT.11.86; Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801; Sacristan Jose A, 2016, Patient Prefer Adherence, V10, P631, DOI 10.2147/PPA.S104259; Smith G, 2019, AUST HEALTH REV, V43, P486, DOI 10.1071/AH18107; Smith M, 2020, PHYSIOTHERAPY, V106, P174, DOI 10.1016/j.physio.2019.04.003; Steen M, 2011, INT J DES, V5, P53; SUDARSKY L, 1992, MOVEMENT DISORD, V7, P204, DOI 10.1002/mds.870070303; Thomson, 2013, AUSTR INDIGENOUS HLT, V13, P1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Praag H, 2009, TRENDS NEUROSCI, V32, P283, DOI 10.1016/j.tins.2008.12.007; Verbiest MEA, 2019, TRANSL BEHAV MED, V9, P720, DOI 10.1093/tbm/iby093; Wheeler AJ, 2018, HEALTH SOC CARE COMM, V26, P860, DOI 10.1111/hsc.12597; Wolstenholme D., 2017, DESIGN HLTH, V1, P42, DOI [10.1080/24735132.2017.1295531, DOI 10.1080/24735132.2017.1295531]; Zhou WB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190160	74	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244311	10.1371/journal.pone.0244311	http://dx.doi.org/10.1371/journal.pone.0244311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544709	Green Accepted, gold, Green Published			2022-12-26	WOS:000617991900012
J	Dewau, R; Muche, A; Fentaw, Z; Yalew, M; Bitew, G; Amsalu, ET; Arefaynie, M; Mekonen, AM				Dewau, Reta; Muche, Amare; Fentaw, Zinabu; Yalew, Melaku; Bitew, Gedamnesh; Amsalu, Erkihun Tadesse; Arefaynie, Mastewal; Mekonen, Asnakew Molla			Time to initiation of antenatal care and its predictors among pregnant women in Ethiopia: Cox-gamma shared frailty model	PLOS ONE			English	Article								Background Timely initiating antenatal care (ANC) is crucial in the countries that have high maternal morbidity and mortality. However, in developing countries including Ethiopia, pregnant mother's time to initiate antenatal care was not well-studied. Therefore, this study aimed to assess time to first ANC and its predictors among pregnant women in Ethiopia. Methods A community-based cross-sectional study was conducted among 7,543 pregnant women in Ethiopia using the Ethiopian Demographic Health Survey (EDHS), 2016 data. A two-stage stratified cluster sampling was employed. The Kaplan-Meier (KM) method was used to estimate time to first antenatal care visit. Cox-gamma shared frailty model was applied to determine predictors. Adjusted Hazard Ratio (AHR) with 95% confidence interval was reported as the effect size. Model adequacy was assessed by using the Cox-Snell residual plot. Statistical significance was considered at p value Results The median time to first ANC was 5 months with IQR (3,-). The independent predictors of time to first ANC visit were primary education [AHR: 1.24 (95%CI, 1.13-1.35)], secondary education [AHR: 1.28(95% CI, 1.11-1.47)], higher education [AHR: 1.43 (1.19-1.72)] as compared to women with no formal education. Having media exposure [AHR: 1.13 (95% CI, 1.03-1.24)], early initiation of ANC increases by 25% [AHR: 1.25 (95% CI, 1.12-1.40)] in poorer, 32% [AHR: 1.32 (95% CI, 1.17-1.49)] in middle, 37% [AHR: 1.37 (95% CI, 1.20-1.56)] in richer and 41% [AHR: 1.41 (95%CI, 1.1.19-1.67)] in richest households as compared to poorest household wealth index. Living in city administration, media exposure and community women literacy were also enabler factors, while, long distance from health facility and nomadic region residency were hindering factors of early ANC visit. Conclusions The current study revealed that women's time to first antenatal care visit was by far late in Ethiopia as compared to the world health organization recommendation (WHO). The predictors of time to first ANC visit were education status of women, having media exposure, level of household wealth index, community women literacy ad distance to health facility. It is vital that maternal and child health policies and strategies better to be directed at women development and also designing and applying interventions that intended to increase timely initiation ANC among pregnant-women. Researchers also recommended conducting studies using a stronger design like a cohort to establish temporality and reduce biases.	[Dewau, Reta; Muche, Amare; Fentaw, Zinabu; Bitew, Gedamnesh; Amsalu, Erkihun Tadesse] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia; [Yalew, Melaku; Arefaynie, Mastewal] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod & Family Hlth, Dessie, Ethiopia; [Mekonen, Asnakew Molla] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Serv Management, Dessie, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Dewau, R (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia.	retadewau30@gmail.com	muche, amare/GNW-4693-2022; Mekonen, Asnakew Molla/ABA-7257-2020; Dewau, Reta/AAA-4202-2022; Fentaw, Zinabu/ABB-7298-2021; Arefaynie, Mastewal/AAZ-8374-2021; Tadesse, Erkihun/AAS-1819-2021	Mekonen, Asnakew Molla/0000-0001-7573-1594; Dewau, Reta/0000-0001-6531-2468; Arefaynie, Mastewal/0000-0001-9525-0552; Fentaw, Zinabu/0000-0002-4577-868X				Abejirinde IOO, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1853-7; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1; [Anonymous], 2017, NCCN PRACT GUIDEL, V2017, P1, DOI DOI 10.1155/2017/2683789; [Anonymous], 2017, EXPERT OPIN THER PAT, V27, P1, DOI DOI 10.1017/S0959270917000065; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; [Anonymous], 2016, BIOMED RES INT, V3, P1; Atuhaire S., 2020, OBSTET GYNECOL INT J, V11, P77, DOI [DOI 10.15406/OGIJ.2020.11.00492, 10.15406/ogij.2020.11.00492]; Central Statistical Agency (CSA), 2016, ETH 2016 ICF ETH DEM; David Collett, 2015, FRANCESCA DOMINICI H, VThird; Dulla D., 2017, NURS HLTH CARE DIVER, V14, P76; Ejeta E, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.184.10926; Ewunetie AA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1748-7; Fatema K, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100614; Fisseha G, 2017, INT J WOMENS HEALTH, V9, P749, DOI 10.2147/IJWH.S140366; Gebremeskel F, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/971506; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Jordan RG, PRENATAL CARE POSTNA, V2nd, P1036; Lincetto O, ANTENATAL CARE; Makate M, 2017, J EPIDEMIOL GLOB HEA, V7, P255, DOI 10.1016/j.jegh.2017.08.005; Mezmur M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2298-9; Ministry of Health, 2019, ETHIOPIA NATL GUIDEL; Muniro Z, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2377-5; Nguyen KTQ, 2016, ELECTRON J STRUCT EN, V16, P69; Obiyan MO, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015614070; Ogbo FA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173152; Paudel YR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00242; Ponna Satyendra Nath, 2017, J Family Med Prim Care, V6, P231, DOI 10.4103/2249-4863.220024; Roy R., 2017, INT J REPROD CONTRAC, V6, P2846, DOI [10.18203/2320-1770.ijrcog20172562, DOI 10.18203/2320-1770.IJRCOG20172562]; SDGH Targets, 2016, ENSURE HLTH LIVES PR, DOI [10.18356/bd21ed60-en, DOI 10.18356/BD21ED60-EN]; Stacey T, 2012, AUST NZ J OBSTET GYN, V52, P242, DOI 10.1111/j.1479-828X.2011.01406.x; Tanou M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7150-1; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214848; The World Health Organization, 2019, WHO CONSOLIDATED GUI; Tripathi V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013408; Turyasiima M, 2015, E AFR MED J, V91, P317; Utuk N, 2017, INT J REPROD CONTRAC, V6, P3731, DOI 10.18203/2320-1770.ijrcog20174016; Wado YD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209602; Who/MSM/, 2015, ANT CAR MAT HLTH EFF	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246349	10.1371/journal.pone.0246349	http://dx.doi.org/10.1371/journal.pone.0246349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0UN	33544714	gold, Green Published			2022-12-26	WOS:000617993300002
J	Hashimoto, S; Shirasaki, T; Yamashita, T; Iwabuchi, S; Suzuki, Y; Takamura, Y; Ukita, Y; Deshimaru, S; Okayama, T; Ikeo, K; Kuroki, K; Kawaguchi, K; Mizukoshi, E; Matsushima, K; Honda, M; Kaneko, S				Hashimoto, Shinichi; Shirasaki, Takayoshi; Yamashita, Taro; Iwabuchi, Sadahiro; Suzuki, Yutaka; Takamura, Yuzuru; Ukita, Yoshiaki; Deshimaru, Shungo; Okayama, Toshitugu; Ikeo, Kazuho; Kuroki, Kazuyuki; Kawaguchi, Kazunori; Mizukoshi, Eishiro; Matsushima, Kouji; Honda, Masao; Kaneko, Shuichi			DOCK11 and DENND2A play pivotal roles in the maintenance of hepatitis B virus in host cells	PLOS ONE			English	Article							REPLICATION; BIOGENESIS; GTPASE	Human hepatitis B virus (HBV) infection remains a serious health problem worldwide. However, the mechanism for the maintenance of HBV in a latent state within host cells remains unclear. Here, using single-cell RNA sequencing analysis, we identified four genes linked to the maintenance of HBV in a liver cell line expressing HBV RNA at a low frequency. These genes included DOCK11 and DENND2A, which encode small GTPase regulators. In primary human hepatocytes infected with HBV, knockdown of these two genes decreased the amount of both HBV DNA and covalently closed circular DNA to below the limit of detection. Our findings reveal a role for DOCK11 and DENND2A in the maintenance of HBV.	[Hashimoto, Shinichi; Iwabuchi, Sadahiro] Wakayama Med Univ, Inst Adv Med, Dept Mol Pathophysiol, Wakayama, Japan; [Hashimoto, Shinichi; Iwabuchi, Sadahiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Shirasaki, Takayoshi; Yamashita, Taro; Kuroki, Kazuyuki; Kawaguchi, Kazunori; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba, Japan; [Takamura, Yuzuru] Japan Adv Inst Sci & Technol, Dept Biosci & Biotechnol, Nomi, Ishikawa, Japan; [Ukita, Yoshiaki] Univ Yamanashi, Fac Engn, Grad Fac Interdisciplinary Res, Kofu, Yamanashi, Japan; [Deshimaru, Shungo; Matsushima, Kouji] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Regulat Inflammatory & Immune Dis, Noda, Chiba, Japan; [Okayama, Toshitugu; Ikeo, Kazuho] Natl Inst Genet, Lab DNA Data Anal, Shizuoka, Japan	Wakayama Medical University; Japan Science & Technology Agency (JST); Kanazawa University; University of Tokyo; Japan Advanced Institute of Science & Technology (JAIST); University of Yamanashi; Tokyo University of Science; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Hashimoto, S (corresponding author), Wakayama Med Univ, Inst Adv Med, Dept Mol Pathophysiol, Wakayama, Japan.; Hashimoto, S (corresponding author), Japan Sci & Technol Agcy, CREST, Tokyo, Japan.	hashimot@wakayama-med.ac.jp	Iwabuchi, Sadahiro/AAD-4455-2022; Yamashita, Taro/ABA-5910-2021; Takamura, Yuzuru/A-3450-2009	Takamura, Yuzuru/0000-0001-5329-7387; Kawaguchi, Kazunori/0000-0002-4927-1704; Iwabuchi, Sadahiro/0000-0003-0434-3054	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Program on the Innovative Development and the Application of New Drugs for Hepatitis B from AMED [20fk0310110]	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Program on the Innovative Development and the Application of New Drugs for Hepatitis B from AMED	The author(s) received specific funding for this work. This research was supported in part by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and by the Japan Agency for Medical Research and Development (AMED). In addition, this research was partially supported by the Program on the Innovative Development and the Application of New Drugs for Hepatitis B from AMED under Grant Number 20fk0310110.	Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Gadea G, 2014, EUR J CELL BIOL, V93, P466, DOI 10.1016/j.ejcb.2014.06.003; Hashimoto S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14676-3; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Matsuda T, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0028-x; SHAUL Y, 1984, J VIROL, V51, P776, DOI 10.1128/JVI.51.3.776-787.1984; Shirasaki T, 2010, J INFECT DIS, V202, P75, DOI 10.1086/653081; Swaine T, 2015, VIRUSES-BASEL, V7, P6526, DOI 10.3390/v7122955; Tan TL, 2008, BBA-MOL CELL RES, V1783, P360, DOI 10.1016/j.bbamcr.2007.10.024; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Wu MJ, 2014, BIOCHEM BIOPH RES CO, V454, P19, DOI 10.1016/j.bbrc.2014.10.008; Yamasaki C, 2006, J HEPATOL, V44, P749, DOI 10.1016/j.jhep.2005.10.028; Yang HC, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.64; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051	19	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246313	10.1371/journal.pone.0246313	http://dx.doi.org/10.1371/journal.pone.0246313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539396	gold, Green Published			2022-12-26	WOS:000616960200101
J	Nara, T; Nakagawa, Y; Tsuganezawa, K; Yuki, H; Sekimata, K; Koyama, H; Ogawa, N; Honma, T; Shirouzu, M; Fukami, T; Matsuo, Y; Inaoka, DK; Kita, K; Tanaka, A				Nara, Takeshi; Nakagawa, Yukari; Tsuganezawa, Keiko; Yuki, Hitomi; Sekimata, Katsuhiko; Koyama, Hiroo; Ogawa, Naoko; Honma, Teruki; Shirouzu, Mikako; Fukami, Takehiro; Matsuo, Yuichi; Inaoka, Daniel Ken; Kita, Kiyoshi; Tanaka, Akiko			The ubiquinone synthesis pathway is a promising drug target for Chagas disease	PLOS ONE			English	Article							SOLANESYL-DIPHOSPHATE SYNTHASE; COENZYME-Q BIOSYNTHESIS; TRYPANOSOMA-CRUZI; FATTY-ACIDS; IN-VITRO; BIOLOGICAL EVALUATION; GROWTH; PROTEIN; CLK-1; INHIBITORS	Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi (T. cruzi). It was originally a Latin American endemic health problem, but now is expanding worldwide as a result of increasing migration. The currently available drugs for Chagas disease, benznidazole and nifurtimox, provoke severe adverse effects, and thus the development of new drugs is urgently required. Ubiquinone (UQ) is essential for respiratory chain and redox balance in trypanosomatid protozoans, therefore we aimed to provide evidence that inhibitors of the UQ biosynthesis have trypanocidal activities. In this study, inhibitors of the human COQ7, a key enzyme of the UQ synthesis, were tested for their trypanocidal activities because they were expected to cross-react and inhibit trypanosomal COQ7 due to their genetic homology. We show the trypanocidal activity of a newly found human COQ7 inhibitor, an oxazinoquinoline derivative. The structurally similar compounds were selected from the commercially available compounds by 2D and 3D ligand-based similarity searches. Among 38 compounds selected, 12 compounds with the oxazinoquinoline structure inhibited significantly the growth of epimastigotes of T. cruzi. The most effective 3 compounds also showed the significant antitrypanosomal activity against the mammalian stage of T. cruzi at lower concentrations than benznidazole, a commonly used drug today. We found that epimastigotes treated with the inhibitor contained reduced levels of UQ(9). Further, the growth of epimastigotes treated with the inhibitors was partially rescued by UQ(10) supplementation to the culture medium. These results suggest that the antitrypanosomal mechanism of the oxazinoquinoline derivatives results from inhibition of the trypanosomal UQ synthesis leading to a shortage of the UQ pool. Our data indicate that the UQ synthesis pathway of T. cruzi is a promising drug target for Chagas disease.	[Nara, Takeshi] Iryo Sosei Univ, Fac Pharm, Iwaki, Fukushima, Japan; [Nakagawa, Yukari; Tsuganezawa, Keiko; Yuki, Hitomi; Ogawa, Naoko; Honma, Teruki; Shirouzu, Mikako; Tanaka, Akiko] RIKEN Ctr Biosyst Dynam Res, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Sekimata, Katsuhiko; Koyama, Hiroo] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Fukami, Takehiro] RIKEN Program Drug Discovery & Med Technol Platfo, Wako, Saitama, Japan; [Matsuo, Yuichi; Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan	RIKEN; RIKEN; RIKEN; Nagasaki University	Tanaka, A (corresponding author), RIKEN Ctr Biosyst Dynam Res, Tsurumi Ku, Yokohama, Kanagawa, Japan.	aktanaka@riken.jp	YUKI, Hitomi/C-5044-2012; Inaoka, Daniel Ken/GMX-4344-2022	YUKI, Hitomi/0000-0002-8778-8261; Inaoka, Daniel Ken/0000-0002-9791-927X; Matsuo, Yuichi/0000-0001-6942-3202; Koyama, Hiroo/0000-0002-4134-4286				Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; Alcazar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107; Anderson CM, 2015, CELL REP, V10, P505, DOI 10.1016/j.celrep.2014.12.048; [Anonymous], 2019, CHAGAS DIS; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Barison MJ, 2017, J BIOL CHEM, V292, P8964, DOI 10.1074/jbc.M117.778522; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Branicky R, 2006, MOL CELL BIOL, V26, P3976, DOI 10.1128/MCB.26.10.3976-3985.2006; Brea-Calvo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005301; Cal M, 2016, INT J PARASITOL-DRUG, V6, P165, DOI 10.1016/j.ijpddr.2016.08.003; Cascajo MV, 2016, RNA BIOL, V13, P622, DOI 10.1080/15476286.2015.1119366; Cristovao-Silva AC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00873; Desoti VC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144033; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ferella M, 2006, J BIOL CHEM, V281, P39339, DOI 10.1074/jbc.M607451200; Gonzalez-Mariscal I, 2018, BBA-BIOENERGETICS, V1859, P1235, DOI 10.1016/j.bbabio.2018.09.369; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; Jonassen T, 2003, J BIOL CHEM, V278, P51735, DOI 10.1074/jbc.M308760200; Jonassen T, 1996, ARCH BIOCHEM BIOPHYS, V330, P285, DOI 10.1006/abbi.1996.0255; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; KANEDA Y, 1986, COMP BIOCHEM PHYS B, V83, P533, DOI 10.1016/0305-0491(86)90292-0; Kratz JM, 2019, ACTA TROP, V198, DOI 10.1016/j.actatropica.2019.105107; Lai DH, 2014, EUKARYOT CELL, V13, P320, DOI 10.1128/EC.00271-13; Mesias AC, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00435; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; NAKAJIMASHIMADA J, 1994, J PROTOZOOL RES, V4, P10; Nara T, 2005, PARASITOL INT, V54, P59, DOI 10.1016/j.parint.2004.11.001; Perez DR, 2019, PHARMACOL THERAPEUT, V199, P155, DOI 10.1016/j.pharmthera.2019.03.009; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Pinto AV, 2009, MOLECULES, V14, P4570, DOI 10.3390/molecules14114570; Rea S, 2001, FEBS LETT, V509, P389, DOI 10.1016/S0014-5793(01)03099-X; Rosso VS, 2011, BIOORGAN MED CHEM, V19, P2211, DOI 10.1016/j.bmc.2011.02.037; Menna-Barreto RFS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/614014; Sales PA, 2017, AM J TROP MED HYG, V97, P1289, DOI 10.4269/ajtmh.16-0761; Shiba T, 2019, BBA-BIOENERGETICS, V1860, P375, DOI 10.1016/j.bbabio.2019.03.008; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Szajnman SH, 2008, BIOORGAN MED CHEM, V16, P3283, DOI 10.1016/j.bmc.2007.12.010; Szajnman SH, 2003, BIOORG MED CHEM LETT, V13, P3231, DOI 10.1016/S0960-894X(03)00663-2; Szajnman SH, 2005, BIOORG MED CHEM LETT, V15, P4685, DOI 10.1016/j.bmcl.2005.07.060; Szajnman SH, 2001, BIOORG MED CHEM LETT, V11, P789, DOI 10.1016/S0960-894X(01)00057-9; Tajiri H, 2017, CELL REP, V19, P969, DOI 10.1016/j.celrep.2017.04.016; TALIAFERRO WH, 1955, J INFECT DIS, V96, P199, DOI 10.1093/infdis/96.3.199; THELIN A, 1992, FEBS LETT, V313, P118, DOI 10.1016/0014-5793(92)81425-L; Tsuganezawa K, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2019.115182; Urbina JA, 1999, J BIOL CHEM, V274, P33609, DOI 10.1074/jbc.274.47.33609; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Villalta F, 2019, EXPERT OPIN DRUG DIS, V14, P1161, DOI 10.1080/17460441.2019.1652593; Wang Y, 2016, TRENDS CELL BIOL, V26, P367, DOI 10.1016/j.tcb.2015.12.007; Wang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7393; Wang Y, 2009, J BIOL CHEM, V284, P314, DOI 10.1074/jbc.M807579200; Zhao RZ, 2019, INT J MOL MED, V44, P3, DOI 10.3892/ijmm.2019.4188; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	53	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0243855	10.1371/journal.pone.0243855	http://dx.doi.org/10.1371/journal.pone.0243855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539347	gold, Green Published			2022-12-26	WOS:000616960200112
J	Thaler, C; Kyselyova, AA; Faizy, TD; Nawka, MT; Jespersen, S; Hansen, B; Stellmann, JP; Heesen, C; Sturner, KH; Stark, M; Fiehler, J; Bester, M; Gellissen, S				Thaler, Christian; Kyselyova, Anna A.; Faizy, Tobias D.; Nawka, Marie T.; Jespersen, Sune; Hansen, Brian; Stellmann, Jan-Patrick; Heesen, Christoph; Stuerner, Klarissa H.; Stark, Maria; Fiehler, Jens; Bester, Maxim; Gellissen, Susanne			Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging	PLOS ONE			English	Article							WHITE-MATTER; COGNITIVE IMPAIRMENT; MRI; QUANTIFICATION; MICROSTRUCTURE	Background Mean kurtosis (MK), one of the parameters derived from diffusion kurtosis imaging (DKI), has shown increased sensitivity to tissue microstructure damage in several neurological disorders. Methods Thirty-seven patients with relapsing-remitting MS and eleven healthy controls (HC) received brain imaging on a 3T MR scanner, including a fast DKI sequence. MK and mean diffusivity (MD) were measured in the white matter of HC, normal-appearing white matter (NAWM) of MS patients, contrast-enhancing lesions (CE-L), FLAIR lesions (FLAIR-L) and black holes (BH). Results Overall 1529 lesions were analyzed, including 30 CE-L, 832 FLAIR-L and 667 BH. Highest MK values were obtained in the white matter of HC (0.814 +/- 0.129), followed by NAWM (0.724 +/- 0.137), CE-L (0.619 +/- 0.096), FLAIR-L (0.565 +/- 0.123) and BH (0.549 +/- 0.12). Lowest MD values were obtained in the white matter of HC (0.747 +/- 0.068 10(-3)mm(2)/sec), followed by NAWM (0.808 +/- 0.163 10(-3)mm(2)/sec), CE-L (0.853 +/- 0.211 10(-3)mm(2)/sec), BH (0.957 +/- 0.304 10(-3)mm(2)/sec) and FLAIR-L (0.976 +/- 0.35 10(-3)mm(2)/sec). While MK differed significantly between CE-L and non-enhancing lesions, MD did not. Conclusion MK adds predictive value to differentiate between MS lesions and might provide further information about diffuse white matter injury and lesion microstructure.	[Thaler, Christian; Kyselyova, Anna A.; Faizy, Tobias D.; Nawka, Marie T.; Fiehler, Jens; Bester, Maxim; Gellissen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Jespersen, Sune; Hansen, Brian] Aarhus Univ, Ctr Funct Integrat Neurosci, Dept Clin Med, Aarhus, Denmark; [Stellmann, Jan-Patrick; Heesen, Christoph; Stuerner, Klarissa H.] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Stellmann, Jan-Patrick; Heesen, Christoph; Stuerner, Klarissa H.] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Hamburg, Germany; [Stellmann, Jan-Patrick] Hosp la Timone, AP HM, CEMEREM, Marseille, France; [Stellmann, Jan-Patrick] Aix Marseille Univ, CNRS, CRMBM, UMR 7339, Marseille, France; [Stuerner, Klarissa H.] Univ Hosp Schleswig Holstein, Dept Neurol, Kiel, Germany; [Stark, Maria] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Aarhus University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Thaler, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	c.thaler@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Norhoj Jespersen, Sune/0000-0003-3146-4329; Sturner, Klarissa Hanja/0000-0003-2199-3315				Bay V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196161; Bellanger G, 2020, CLIN NEURORADIOL, V30, P553, DOI 10.1007/s00062-019-00794-0; Belli G, 2016, J MAGN RESON IMAGING, V43, P213, DOI 10.1002/jmri.24956; Bester M, 2015, MULT SCLER J, V21, P935, DOI 10.1177/1352458514556295; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; Blystad I, 2016, AM J NEURORADIOL, V37, P94, DOI 10.3174/ajnr.A4501; Buyukturkoglu K, 2018, J NEUROIMAGING, V28, P320, DOI 10.1111/jon.12497; Chuhutin A, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116406; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; de Kouchkovsky I, 2016, J NEUROL, V263, P1146, DOI 10.1007/s00415-016-8118-z; De Santis S, 2019, NEUROSCIENCE, V403, P17, DOI 10.1016/j.neuroscience.2018.03.048; Deh K, 2018, J MAGN RESON IMAGING, V48, P1281, DOI 10.1002/jmri.25997; Eichinger P, 2019, RADIOLOGY, V291, P428, DOI 10.1148/radiol.2019181568; Faizy TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151496; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Fedeli L, 2018, PHYS MEDICA, V55, P135, DOI 10.1016/j.ejmp.2018.09.007; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Forslin Y, 2019, AM J NEURORADIOL, V40, P1265, DOI 10.3174/ajnr.A6112; Garza-Villarreal EA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.92; Giannelli M, 2013, NEURORADIOLOGY, V55, P1423, DOI 10.1007/s00234-013-1271-5; Gooijers J, 2014, BRAIN STRUCT FUNCT, V219, P1627, DOI 10.1007/s00429-013-0590-y; Gupta A, 2017, AM J NEURORADIOL, V38, P1317, DOI 10.3174/ajnr.A5209; Hansen B, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00040; Hansen B, 2016, MAGN RESON MED, V76, P1455, DOI 10.1002/mrm.26055; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y; Li HQ, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1108-2; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; Naess-Schmidt ET, 2018, BRAIN INJURY, V32, P91, DOI 10.1080/02699052.2017.1377352; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Novikov DS, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3998; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qian WS, 2016, NMR BIOMED, V29, P1536, DOI 10.1002/nbm.3607; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sexton CE, 2016, NEUROIMAGE, V131, P81, DOI 10.1016/j.neuroimage.2015.09.071; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Thaler C, 2018, J NEUROL, V265, P127, DOI 10.1007/s00415-017-8683-9; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Wang Y, 2015, BRAIN, V138, P1223, DOI 10.1093/brain/awv046; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yu F, 2019, AM J NEURORADIOL, V40, P1871, DOI 10.3174/ajnr.A6283; Zhang S, 2018, NEUROIMAGE-CLIN, V18, P143, DOI 10.1016/j.nicl.2018.01.013; Zhang Y, 2016, AM J NEURORADIOL, V37, P1794, DOI 10.3174/ajnr.A4856	58	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245844	10.1371/journal.pone.0245844	http://dx.doi.org/10.1371/journal.pone.0245844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539364	gold, Green Published			2022-12-26	WOS:000616960200002
J	Walsh, ML; Meason-Smith, C; Arnold, C; Suchodolski, JS; Scott, EM				Walsh, Mary L.; Meason-Smith, Courtney; Arnold, Carolyn; Suchodolski, Jan S.; Scott, Erin M.			Evaluation of the ocular surface mycobiota in clinically normal horses	PLOS ONE			English	Article							CONJUNCTIVAL FUNGAL FLORA; HEALTHY HORSES; SUSCEPTIBILITY PATTERNS; BACTERIAL; MICROBIOME; DIVERSITY; KERATITIS; IMPACT	The eye is host to myriad bacterial, fungal, and viral organisms that likely influence ocular surface physiology in normal and diseased states. The ocular surface mycobiota of horses has not yet been described using NGS techniques. This study aimed to characterize the ocular surface fungal microbiota (mycobiota) in healthy horses in 2 environmental conditions (stalled versus pasture). Conjunctival swabs of both eyes were obtained from 7 adult stallions stabled in an open-air pavilion and 5 adult mares living on pasture. Genomic DNA was extracted from ocular surface swabs and sequenced using primers that target the Internal Transcribed Spacer 1 (ITS1) region of the fungal genome on an Illumina platform. Sequences were processed using Quantitative Insights Into Molecular Ecology (QIIME 2.0) and taxonomy assigned with the Findley et al. 2013 ITS1 database. The most abundant genera identified were Leptosphaerulina (22.7%), unclassified Pleosporaceae (17.3%), Cladosporium (16.2%), Alternaria (9.8%), unclassified Pleosporales (4.4%), unclassified Montagnulaceae (2.9%), Fusarium (2.5%), and Pestalotiopsis (1.4%). Fungal community composition (Jaccard, R = 0.460, p = 0.001) and structure (Bray-Curtis, R = 0.811, p = 0.001) were significantly different between pastured mares and stabled stallions. The ocular surface of pastured mares had significantly increased fungal species richness and diversity compared to stabled stallions (Shannon p = 0.0224, Chao1 p = 0.0118, Observed OTUs p = 0.0241). Relative abundances of Aspergillus (p = 0.005) and Alternaria spp. (p = 0.002) were significantly increased in the mycobiota of pastured mares. This is the first report to describe the mycobiota of the equine ocular surface. Environmental factors such as housing influence the composition, structure, and richness of the equine ocular surface mycobiota.	[Walsh, Mary L.; Meason-Smith, Courtney; Suchodolski, Jan S.; Scott, Erin M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77834 USA; [Arnold, Carolyn] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Scott, EM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77834 USA.	escott@cvm.tamu.edu		Scott, Erin/0000-0002-9702-7298; Smith, Courtney/0000-0002-5189-2702				Andrew SE, 2003, VET OPHTHALMOL, V6, P45, DOI 10.1046/j.1463-5224.2003.00265.x; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; Bharathi M. Jayahar, 2003, Indian Journal of Ophthalmology, V51, P315; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bradley CW, 2020, VET DERMATOL, V31, P225, DOI 10.1111/vde.12826; Brooks DE, 2013, VET OPHTHALMOL, V16, P93, DOI 10.1111/j.1463-5224.2012.01031.x; Cullen M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214214; Darden JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223859; Sousa Maria Evódia de, 2011, Braz. J. Microbiol., V42, P1151, DOI [10.1590/S1517-83822011000300038, 10.1590/S1517-838220110003000038]; Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Ge C, 2019, INT J OPHTHALMOL-CHI, V12, P194, DOI 10.18240/ijo.2019.02.02; Gemensky-Metzler AJ, 2005, AM J VET RES, V66, P800, DOI 10.2460/ajvr.2005.66.800; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Hampson ECGM, 2019, VET OPHTHALMOL, V22, P265, DOI 10.1111/vop.12587; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.04.008; Johns IC, 2011, VET OPHTHALMOL, V14, P195, DOI 10.1111/j.1463-5224.2010.00867.x; Khosravi AR, 2014, J MYCOL MED, V24, P29, DOI 10.1016/j.mycmed.2013.10.006; Korbelik J, 2018, VET DERMATOL, V29, P417, DOI 10.1111/vde.12665; Kumari Namrata, 2002, Indian J Pathol Microbiol, V45, P299; Leis ML, 2019, VET OPHTHALMOL, V22, P337, DOI 10.1111/vop.12599; Lu Louise J., 2016, Yale Journal of Biology and Medicine, V89, P325; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Meason-Smith C, 2017, VET DERMATOL, V28, P71, DOI 10.1111/vde.12373; Meason-Smith C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv139; MOORE CP, 1983, J AM VET MED ASSOC, V182, P600; MOORE CP, 1995, J AM VET MED ASSOC, V207, P928; Moore CP, 1988, AM EQUINE PRACT, V8, P537; Older CE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220463; Ozkan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10494-9; Pearce JW, 2009, VET OPHTHALMOL, V12, P318, DOI 10.1111/j.1463-5224.2009.00721.x; Raja HA, 2017, J NAT PROD, V80, P756, DOI 10.1021/acs.jnatprod.6b01085; Rogers CM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234313; Prashanthi GS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090309; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SAMUELSON DA, 1984, J AM VET MED ASSOC, V184, P1240; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scott EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214877; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Sherman AB, 2017, VET OPHTHALMOL, V20, P140, DOI 10.1111/vop.12381; Shivaji S, 2019, INVEST OPHTH VIS SCI, V60, P451, DOI 10.1167/iovs.18-26076; Usyk M, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00488-17; Voelter-Ratson K, 2014, VET OPHTHALMOL, V17, P31, DOI 10.1111/vop.12088; Wang Y, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2019.05.011; Whitley R. D., 1983, Equine Veterinary Journal, P138; WHITLEY RD, 1984, VET CLIN N AM-LARGE, V6, P451; Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003	51	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246537	10.1371/journal.pone.0246537	http://dx.doi.org/10.1371/journal.pone.0246537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539431	Green Published, gold			2022-12-26	WOS:000616960200003
J	Graham, TGW; Dugast-Darzacq, C; Dailey, GM; Nguyenla, XH; Van Dis, E; Esbin, MN; Abidi, A; Stanley, SA; Darzacq, X; Tjian, R				Graham, Thomas G. W.; Dugast-Darzacq, Claire; Dailey, Gina M.; Nguyenla, Xammy H.; Van Dis, Erik; Esbin, Meagan N.; Abidi, Abrar; Stanley, Sarah A.; Darzacq, Xavier; Tjian, Robert			Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection	PLOS ONE			English	Article								Re-opening of communities in the midst of the ongoing COVID-19 pandemic has ignited new waves of infections in many places around the world. Mitigating the risk of reopening will require widespread SARS-CoV-2 testing, which would be greatly facilitated by simple, rapid, and inexpensive testing methods. This study evaluates several protocols for RNA extraction and RT-qPCR that are simpler and less expensive than prevailing methods. First, isopropanol precipitation is shown to provide an effective means of RNA extraction from nasopharyngeal (NP) swab samples. Second, direct addition of NP swab samples to RT-qPCRs is evaluated without an RNA extraction step. A simple, inexpensive swab collection solution suitable for direct addition is validated using contrived swab samples. Third, an open-source master mix for RT-qPCR is described that permits detection of viral RNA in NP swab samples with a limit of detection of approximately 50 RNA copies per reaction. Quantification cycle (Cq) values for purified RNA from 30 known positive clinical samples showed a strong correlation (r(2) = 0.98) between this homemade master mix and commercial TaqPath master mix. Lastly, end-point fluorescence imaging is found to provide an accurate diagnostic readout without requiring a qPCR thermocycler. Adoption of these simple, open-source methods has the potential to reduce the time and expense of COVID-19 testing.	[Graham, Thomas G. W.; Dugast-Darzacq, Claire; Dailey, Gina M.; Van Dis, Erik; Esbin, Meagan N.; Abidi, Abrar; Stanley, Sarah A.; Darzacq, Xavier; Tjian, Robert] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Nguyenla, Xammy H.; Stanley, Sarah A.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Tjian, Robert] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Graham, TGW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	tgwgraham@gmail.com		Esbin, Meagan/0000-0002-2157-3831; Nguyenla, Xammy/0000-0002-7532-8356; Van Dis, Erik S/0000-0003-4773-379X; Dugast-Darzacq, Claire/0000-0001-8602-3534	Howard Hughes Medical Institute [CC34430]; Jane Coffin Childs Memorial Fund for Medical Research	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Memorial Fund for Medical Research	The authors gratefully acknowledge funding from the Howard Hughes Medical Institute (Grant CC34430 to R.T.) This work was largely funded by Xavier Darzacq and Robert Tjian's discretionary funds. T.G. is supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akst J., 2020, SCI; Alcoba-Florez J, 2020, FAST SARS COV 2 DETE, DOI [10.1101/2020.04.08.20058495v132492531, DOI 10.1101/2020.04.08.20058495V132492531]; Amen AM, 2020, NAT BIOTECHNOL, V38, P791, DOI 10.1038/s41587-020-0583-3; Arumugam A, 2020, BIORXIV, DOI [10.1101/2020.04.06.028811v1, DOI 10.1101/2020.04.06.028811V1]; Beltran-Pavez C, 2020, BIORXIV, DOI [10.1101/2020.03.28.013508v1.full, DOI 10.1101/2020.03.28.013508V1.FULL]; Bruce EA, 2020, BIORXIV, DOI [10.1101/, 10.1101/2020.03.20.001008 32511328]; Bueno AM, 2020, BIORXIV; Byrnes SA, 2020, MULTIPLEXED EXTRACTI; Carlos Ponce-Rojas Jose, 2020, BIORXIV, DOI [10.1101/2020.06.29.178384v3, DOI 10.1101/2020.06.29.178384V3]; Centers for Disease Control and Prevention, 2020, CDC 2019 NOV COR 201; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; Dang C, 1996, J MOL BIOL, V264, P268, DOI 10.1006/jmbi.1996.0640; Doudna JA, 2020, BLUEPRINT POP UP SAR, DOI [10.1101/2020.04.11.20061424v2, DOI 10.1101/2020.04.11.20061424V2]; Ellington AD, 2020, ONE ENZYME RTQPCR AS, DOI DOI 10.1101/2020.03.29.013342; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Fomsgaard AS, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.14.2000398; Gonzalez-Gonzalez E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237418; Grant PR, 2020, BIORXIV, DOI [10.1101/2020.04.06.028316v2, DOI 10.1101/2020.04.06.028316V2]; Hasan MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236564; Ivanov I, 1998, United States, Patent No. [US6183998B1, 6183998B1]; Joung Julia, 2020, medRxiv, DOI 10.1101/2020.05.04.20091231; Kalikiri MKR, 2020, HIGH THROUGHPUT EXTR; KELLOGG DE, 1994, BIOTECHNIQUES, V16, P1134; Lakhotia S, 2020, BIORXIV; Larremore D.B., 2020, MEDRXIV, DOI [10.1101/2020.06.22.20136309, DOI 10.1126/SCIADV.ABD5393]; Long David, COMMUNICATION; Mallmann L, 2020, BIORXIV, DOI [10.1101/2020.05.07.083139v1, DOI 10.1101/2020.05.07.083139V1]; Marzinotto S, 2020, STREAMLINED APPROACH, DOI [10.1155/2020/886942433343767, DOI 10.1155/2020/886942433343767]; Mascuch SJ, 2020, J BIOL CHEM, V295, P15438, DOI 10.1074/jbc.RA120.015434; Matsumura Y, 2020, BIORXIV; Merindol N, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104423; Ranoa DRE, 2020, BIORXIV, DOI [10.1101/2020.06.26.174698, DOI 10.1101/2020.06.26.174698]; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Sentmanat M, 2020, BIORXIV; Smyrlaki I, 2020, MASSIVE RAPID COVID, DOI [10.1101/2020.04.17.20067348v432968075, DOI 10.1101/2020.04.17.20067348V432968075]; Srivatsan Sanjay, 2021, bioRxiv, DOI 10.1101/2020.04.22.056283; TELESNITSKY A, 1993, P NATL ACAD SCI USA, V90, P1276, DOI 10.1073/pnas.90.4.1276; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Vogels CBF, 2020, SALIVADIRECT SIMPLE, DOI [10.1101/2020.08.03.20167791v1, DOI 10.1101/2020.08.03.20167791V1]; Wee SK, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060664; Won J, 2020, EXP NEUROBIOL, V29, P107, DOI [10.5607/en2009, 10.5607/en20009]; Wozniak A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73616-w; Xabier Guruceaga, 2020, FAST SARS COV 2 DETE, DOI [10.1101/2020.04.26.20081307v1, DOI 10.1101/2020.04.26.20081307V1]; Xu JS, 2020, CLIN BIOCHEM, V84, P73, DOI 10.1016/j.clinbiochem.2020.06.013; Zhao Z, 2020, BIORXIV	45	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246647	10.1371/journal.pone.0246647	http://dx.doi.org/10.1371/journal.pone.0246647			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534838	gold, Green Published			2022-12-26	WOS:000616739700050
J	Meyer, M; Bacha, N; Tesfaye, T; Alemayehu, Y; Abera, E; Hundie, B; Woldeab, G; Girma, B; Gemechu, A; Negash, T; Mideksa, T; Smith, J; Jaleta, M; Hodson, D; Gilligan, CA				Meyer, M.; Bacha, N.; Tesfaye, T.; Alemayehu, Y.; Abera, E.; Hundie, B.; Woldeab, G.; Girma, B.; Gemechu, A.; Negash, T.; Mideksa, T.; Smith, J.; Jaleta, M.; Hodson, D.; Gilligan, C. A.			Wheat rust epidemics damage Ethiopian wheat production: A decade of field disease surveillance reveals national-scale trends in past outbreaks	PLOS ONE			English	Article							STEM RUST	Wheat rusts are the key biological constraint to wheat production in Ethiopia-one of Africa's largest wheat producing countries. The fungal diseases cause economic losses and threaten livelihoods of smallholder farmers. While it is known that wheat rust epidemics have occurred in Ethiopia, to date no systematic long-term analysis of past outbreaks has been available. We present results from one of the most comprehensive surveillance campaigns of wheat rusts in Africa. More than 13,000 fields have been surveyed during the last 13 years. Using a combination of spatial data-analysis and visualization, statistical tools, and empirical modelling, we identify trends in the distribution of wheat stem rust (Sr), stripe rust (Yr) and leaf rust (Lr). Results show very high infection levels (mean incidence for Yr: 44%; Sr: 34%; Lr: 18%). These recurrent rust outbreaks lead to substantial economic losses, which we estimate to be of the order of 10s of millions of US-D annually. On the widely adopted wheat variety, Digalu, there is a marked increase in disease prevalence following the incursion of new rust races into Ethiopia, which indicates a pronounced boom-and-bust cycle of major gene resistance. Using spatial analyses, we identify hotspots of disease risk for all three rusts, show a linear correlation between altitude and disease prevalence, and find a pronounced north-south trend in stem rust prevalence. Temporal analyses show a sigmoidal increase in disease levels during the wheat season and strong inter-annual variations. While a simple logistic curve performs satisfactorily in predicting stem rust in some years, it cannot account for the complex outbreak patterns in other years and fails to predict the occurrence of stripe and leaf rust. The empirical insights into wheat rust epidemiology in Ethiopia presented here provide a basis for improving future surveillance and to inform the development of mechanistic models to predict disease spread.	[Meyer, M.] Univ Hamburg, Ctr Earth Syst Res & Sustainabil, Reg Comp Ctr, Visual Data Anal, Hamburg, Germany; [Meyer, M.; Smith, J.; Gilligan, C. A.] Univ Cambridge, Dept Plant Sci, Epidemiol & Modelling Grp, Cambridge, England; [Bacha, N.; Tesfaye, T.; Abera, E.; Hundie, B.; Woldeab, G.; Girma, B.; Gemechu, A.; Negash, T.] Ethiopian Inst Agr Res EIAR, Addis Ababa, Ethiopia; [Alemayehu, Y.; Jaleta, M.] Int Maize & Wheat Improvement Ctr CIMMYT, Addis Ababa, Ethiopia; [Abera, E.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Mideksa, T.] Oromia Agr Res Inst, Sinana, Ethiopia; [Hodson, D.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico	University of Hamburg; University of Cambridge; Ethiopian Institute of Agricultural Research (EIAR); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Minnesota System; University of Minnesota Twin Cities; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Meyer, M (corresponding author), Univ Hamburg, Ctr Earth Syst Res & Sustainabil, Reg Comp Ctr, Visual Data Anal, Hamburg, Germany.; Meyer, M; Gilligan, CA (corresponding author), Univ Cambridge, Dept Plant Sci, Epidemiol & Modelling Grp, Cambridge, England.; Hodson, D (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico.	marcel.meyer@uni-hamburg.de; D.Hodson@cgiar.org; cag1@cam.ac.uk	Alemayehu, Yadeta/CAF-9010-2022	Alemayehu, Yadeta/0000-0002-2461-1987; Smith, Jacob Willock/0000-0002-0079-4045; Meyer, Marcel/0000-0002-8457-9608	Durable Rust Resistance in Wheat (DRRW) project; Delivering Genetic Gains in Wheat (DGGW) project; Bill & Melinda Gates Foundation; UK Foreign, Commonwealth and Development Office (FCDO); Deutsche Forschungsgemeinschaft (DFG, Germany Research Foundation) [EXC 2037, 390683824]; BBSRC [BB/P023193/1] Funding Source: UKRI	Durable Rust Resistance in Wheat (DRRW) project; Delivering Genetic Gains in Wheat (DGGW) project; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK Foreign, Commonwealth and Development Office (FCDO); Deutsche Forschungsgemeinschaft (DFG, Germany Research Foundation)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Field surveillance efforts were funded by the Durable Rust Resistance in Wheat (DRRW) and Delivering Genetic Gains in Wheat (DGGW) projects managed by Cornell University and funded by the Bill & Melinda Gates Foundation and the UK Foreign, Commonwealth and Development Office (FCDO). Additional support was provided to the Cambridge University from the Bill and Melinda Gates Foundation, the UK Biotechnology and Biological Sciences Council and FCDO for initiating the data review, cleaning and analysis. The final stages of this study were completed afterMM started at the University of Hamburg, funded by the Deutsche Forschungsgemeinschaft (DFG, Germany Research Foundation) under Germany's Excellence Strategy -EXC 2037 `CLICCS -Climate, Climatic Change, and Society' -Project Number: 390683824, contribution to the Center for Earth System Research and Sustainability (CEN).	Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01057; Allen-Sader C, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab4034; FAOSTAT. Food and Agriculture Organization of the United Nations, 2020, CORP STAT DAT; Gebre-Mariam H, 1991, TECHNICAL REPORT; Hodson DP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75181-8; Jaleta M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219327; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Kolmer JA, 2016, PHYTOPATHOLOGY, V106, P380, DOI 10.1094/PHYTO-10-15-0247-R; Meyer M, 2017, NAT PLANTS, V3, P780, DOI 10.1038/s41477-017-0017-5; Meyer M, 2017, PHYTOPATHOLOGY, V107, P1175, DOI [10.1094/PHYTO-01-17-0035-F1, 10.1094/PHYTO-01-17-0035-FI, 10.1094/phyto-01-17-0035-fi]; Minda TT, 2018, AGR FOREST METEOROL, V262, P166, DOI 10.1016/j.agrformet.2018.07.009; Olivera P, 2015, PHYTOPATHOLOGY, V105, P917, DOI 10.1094/PHYTO-11-14-0302-FI; Park R, 2011, EUPHYTICA, V179, P109, DOI 10.1007/s10681-011-0375-4; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Radhakrishnan GV, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0684-y; Taffesse AS, 2018, TECHNICAL REPORT; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06	17	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245697	10.1371/journal.pone.0245697	http://dx.doi.org/10.1371/journal.pone.0245697			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534869	Green Published, gold			2022-12-26	WOS:000616739700025
J	Meng, CJ; Zhan, J; Chen, DL; Shao, GZ; Zhang, HQ; Gu, W; Luo, JY				Meng, Chunjie; Zhan, Jun; Chen, Delin; Shao, Genze; Zhang, Hongquan; Gu, Wei; Luo, Jianyuan			The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2	ONCOGENE			English	Article								The transcription factor nuclear factor (erythroid-derived 2)-like 2 (NRF2) plays a key role in cancer progression and is tightly regulated by the proteasome pathway. E3 ligases that mediate NRF2 ubiquitination have been widely reported, but the mechanism of NRF2 deubiquitination remains largely unclear. Here, we identified ubiquitin-specific-processing protease 11 (USP11) in NRF2 complexes and confirmed an interaction between these two proteins. We further found that USP11 deubiquitinates NRF2; this modification stabilizes NRF2. Functionally, USP11 depletion contributes to the suppression of cell proliferation and induction of ferroptotic cell death due to ROS-mediated stress, which can be largely abrogated by overexpression of NRF2. Finally, immunohistochemical staining of USP11 and NRF2 was performed using a lung tissue microarray, which revealed that USP11 is highly expressed in patients with NSCLC and positively correlated with NRF2 expression. Together, USP11 stabilizes NRF2 and is thus an important player in cell proliferation and ferroptosis.	[Meng, Chunjie; Luo, Jianyuan] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Biophys, Dept Med Genet,Ctr Med Genet,Hlth Sci Ctr, Beijing, Peoples R China; [Zhan, Jun; Zhang, Hongquan] Peking Univ, Dept Human Anat Histol & Embryol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Hlth Sci Ctr, Beijing, Peoples R China; [Zhan, Jun; Zhang, Hongquan] Peking Univ, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing, Peoples R China; [Chen, Delin; Gu, Wei] Columbia Univ, Dept Pathol & Cell Biol, Inst Canc Genet, New York, NY USA; [Shao, Genze] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Peking University; Peking University; Columbia University; Peking University	Luo, JY (corresponding author), Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Biophys, Dept Med Genet,Ctr Med Genet,Hlth Sci Ctr, Beijing, Peoples R China.	luojianyuan@bjmu.edu.cn		Shao, Genze/0000-0002-4374-3969; Gu, Wei/0000-0002-1480-2368	National Natural Science Foundation of China [81874147, 81671389, 81621063, 81773199]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (81874147, 81671389, 81621063, 81773199). We thank core facility at Peking University Health Science Center for experiment help. We thank members in Wei Gu's Lab (Columbia University Medical school) for helps to finish the project.	Bai XP, 2016, DRUG METAB REV, V48, P541, DOI 10.1080/03602532.2016.1197239; Chen DL, 2017, MOL CELL, V68, P224, DOI 10.1016/j.molcel.2017.09.009; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Fan Z, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.65; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Hammad A, 2019, CANCER LETT, V467, P40, DOI 10.1016/j.canlet.2019.09.016; Hanpude P, 2015, IUBMB LIFE, V67, P544, DOI 10.1002/iub.1402; Harris IS, 2019, CELL METAB, V29, P1166, DOI 10.1016/j.cmet.2019.01.020; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Jayakumar S, 2015, MUTAT RES-FUND MOL M, V779, P33, DOI 10.1016/j.mrfmmm.2015.06.007; Jeong Y, 2017, CANCER DISCOV, V7, P86, DOI 10.1158/2159-8290.CD-16-0127; Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014; Kapadia B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03028-y; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lignitto L, 2019, CELL, V178, P316, DOI 10.1016/j.cell.2019.06.003; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Liu BY, 2019, ONCOGENE, V38, P2501, DOI 10.1038/s41388-018-0605-5; Liu PF, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101702; Liu T, 2019, CANCER RES, V79, P1913, DOI 10.1158/0008-5472.CAN-18-3037; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ou Y, 2016, P NATL ACAD SCI USA, V113, pE6806, DOI 10.1073/pnas.1607152113; Park MK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08481-x; Roh JL, 2017, REDOX BIOL, V11, P254, DOI 10.1016/j.redox.2016.12.010; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Ting X, 2019, NUCLEIC ACIDS RES, V47, P9721, DOI 10.1093/nar/gkz726; Villeneuve NF, 2013, MOL CELL, V51, P68, DOI 10.1016/j.molcel.2013.04.022; Wang D, 2018, J MOL CELL BIOL, V10, P60, DOI 10.1093/jmcb/mjx034; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wiel C, 2019, CELL, V178, P330, DOI 10.1016/j.cell.2019.06.005; Wu HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4214; Xia XJ, 2019, CURR GENE THER, V19, P117, DOI 10.2174/1566523219666190628152137; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yu M, 2016, J BIOL CHEM, V291, P959, DOI 10.1074/jbc.M114.624478; Zhan J, 2019, THERANOSTICS, V9, P2084, DOI 10.7150/thno.29463; Zhang YL, 2019, CELL CYCLE, V18, P773, DOI 10.1080/15384101.2019.1597506	52	18	18	1	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1706	1720		10.1038/s41388-021-01660-5	http://dx.doi.org/10.1038/s41388-021-01660-5		FEB 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33531626				2022-12-26	WOS:000613991700002
J	Li, S; Liu, J; Zhang, H; Sun, ZP; Ying, Z; Wu, YH; Xu, JH; Liu, Q				Li, Shuang; Liu, Jing; Zhang, Heng; Sun, Zhepeng; Ying, Zhu; Wu, Yihan; Xu, Jianhai; Liu, Qun			Toxoplasma gondii glutathione S-transferase 2 plays an important role in partial secretory protein transport	FASEB JOURNAL			English	Article						GSTs; protein trafficking; Toxoplasma gondii; vesicle	ORGANELLE BIOGENESIS; TRAFFICKING; MECHANISMS; COMPLEXES; PATHWAYS; INVASION; BINDING; TGSUB1	Toxoplasma gondii is an apicomplexan parasite, which has three unique secretory organelles: micronemes, rhoptries, and dense granules. Almost all the secreted proteins are transported through the endoplasmic reticulum (ER) and Golgi system to function in their respective destination by accurate targeting and packaging. Glutathione S-transferase (GST) is a supergene family enzyme that has multiple functions, which include regulation of cell proliferation and death signaling pathways, and participation in transportation and metabolism in mammal cells. However, the role of GST in Toxoplasma gondii has not been explained. In this study, we identified three GST proteins in T gondii, of which GST2 acts as a membrane protein that localizes to the Golgi-endosomal system and colocalizes with proteins involved in vesicle transport as well, including synaptobrevin, putative sortilin (VPS10), Rab5 and Rab6, which function as vesicle transport factors. Moreover, the loss of TgGST2 leads to Rab5 and Rab6 distribution of discrete puncta, and incorrect localization and decreased expression of several secretory proteins, and to significantly reduced invasion capacity and virulence to mice. Consistent with its relation to vesicle transport proteins, the distribution of TgGST2 relies on post-Golgi trafficking. Overall, our findings demonstrated that TgGST2 contributes to vesicle trafficking and plays a critical role in parasite lytic cycle.	[Li, Shuang; Liu, Jing; Zhang, Heng; Sun, Zhepeng; Ying, Zhu; Wu, Yihan; Xu, Jianhai; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Beijing, Peoples R China; [Li, Shuang; Liu, Jing; Zhang, Heng; Sun, Zhepeng; Ying, Zhu; Wu, Yihan; Xu, Jianhai; Liu, Qun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, Q (corresponding author), China Agr Univ, Acad Vet Med, Lab Natl Anim Protozoa, Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qunliu@cau.edu.cn	ZHU, YING/HHC-8921-2022					Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Aksoy M, 2016, J ENZYM INHIB MED CH, V31, P546, DOI 10.3109/14756366.2015.1046063; [Anonymous], 2009, TOXOPLASMOSIS ANIMAL; Biddau M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006836; Binder EM, 2008, TRAFFIC, V9, P1485, DOI 10.1111/j.1600-0854.2008.00774.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; Dixon DP, 2010, J BIOL CHEM, V285, P36322, DOI 10.1074/jbc.M110.164806; Dybas JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003899; Gomez C, 2011, PLANT J, V67, P960, DOI 10.1111/j.1365-313X.2011.04648.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; Kemp LE, 2013, FEMS MICROBIOL REV, V37, P607, DOI 10.1111/1574-6976.12013; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Langsley G, 2008, MICROBES INFECT, V10, P462, DOI 10.1016/j.micinf.2008.01.017; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; McGovern OL, 2018, TRAFFIC, V19, P336, DOI 10.1111/tra.12556; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Morlon-Guyot J, 2015, CELL MICROBIOL, V17, P1157, DOI 10.1111/cmi.12426; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Ngo HM, 2000, TRENDS CELL BIOL, V10, P67, DOI 10.1016/S0962-8924(99)01698-0; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Remoue F, 2002, INFECT IMMUN, V70, P601, DOI 10.1128/IAI.70.2.601-605.2002; Roiko MS, 2009, CELL MICROBIOL, V11, P1444, DOI 10.1111/j.1462-5822.2009.01357.x; Saadatnia G, 2012, SCAND J INFECT DIS, V44, P805, DOI 10.3109/00365548.2012.693197; Sakura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38842; Sheiner L, 2008, TRAFFIC, V9, P636, DOI 10.1111/j.1600-0854.2008.00713.x; Shitan N, 2013, INT REV CEL MOL BIO, V305, P383, DOI 10.1016/B978-0-12-407695-2.00009-3; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Sreenath AS, 2005, CLIN BIOCHEM, V38, P436, DOI 10.1016/j.clinbiochem.2005.01.009; Stedman TT, 2003, J BIOL CHEM, V278, P5433, DOI 10.1074/jbc.M209390200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tomavo S, 2014, INT J PARASITOL, V44, P133, DOI 10.1016/j.ijpara.2013.10.003; Tomavo S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003629; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Venugopal K, 2018, INT J MED MICROBIOL, V308, P751, DOI 10.1016/j.ijmm.2018.07.007; Wang SA, 2015, RES VET SCI, V99, P157, DOI 10.1016/j.rvsc.2014.12.006; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Zhang Y, 2019, MICROBIOL RES, V227, DOI 10.1016/j.micres.2019.06.003; Zhao J, 2015, TRENDS PLANT SCI, V20, P576, DOI 10.1016/j.tplants.2015.06.007; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006	47	1	1	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21352	10.1096/fj.202001987RR	http://dx.doi.org/10.1096/fj.202001987RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33543805				2022-12-26	WOS:000647789600096
J	Borrello, MT; Emma, MR; Listi, A; Rubis, M; Coslet, S; Augello, G; Cusimano, A; Cabibi, D; Porcasi, R; Giannitrapani, L; Soresi, M; Pantuso, G; Blyth, K; Montalto, G; Pin, C; Cervello, M; Iovanna, J				Borrello, Maria Teresa; Emma, Maria Rita; Listi, Angela; Rubis, Marion; Coslet, Sergiu; Augello, Giuseppa; Cusimano, Antonella; Cabibi, Daniela; Porcasi, Rossana; Giannitrapani, Lydia; Soresi, Maurizio; Pantuso, Gianni; Blyth, Karen; Montalto, Giuseppe; Pin, Christopher; Cervello, Melchiorre; Iovanna, Juan			NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response	FASEB JOURNAL			English	Article						lipotoxicity; NAFL; NASH; NUPR1; PPAR&#8208; a signalling; UPR	ER-STRESS; HEPATIC STEATOSIS; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; NUCLEAR-PROTEIN; CELL-DEATH; P8; MICE; DYSFUNCTION	Non-alcoholic fatty liver (NAFL) and related syndromes affect one-third of the adult population in industrialized and developing countries. Lifestyle and caloric oversupply are the main causes of such array of disorders, but the molecular mechanisms underlying their etiology remain elusive. Nuclear Protein 1 (NUPR1) expression increases upon cell injury in all organs including liver. Recently, we reported NUPR1 actively participates in the activation of the Unfolded Protein Response (UPR). The UPR typically maintains protein homeostasis, but downstream mediators of the pathway regulate metabolic functions including lipid metabolism. As increases in UPR and NUPR1 in obesity and liver disease have been well documented, the goal of this study was to investigate the roles of NUPR1 in this context. To establish whether NUPR1 is involved in these liver conditions we used patient-derived liver biopsies and in vitro and in vivo NUPR1 loss of functions models. First, we analyzed NUPR1 expression in a cohort of morbidly obese patients (MOPs), with simple fatty liver (NAFL) or more severe steatohepatitis (NASH). Next, we explored the metabolic roles of NUPR1 in wild-type (Nupr1(+/+)) or Nupr1 knockout mice (Nupr1(-/-)) fed with a high-fat diet (HFD) for 15 weeks. Immunohistochemical and mRNA analysis revealed NUPR1 expression is inversely correlated to hepatic steatosis progression. Mechanistically, we found NUPR1 participates in the activation of PPAR-alpha signaling via UPR. As PPAR-alpha signaling is controlled by UPR, collectively, these findings suggest a novel function for NUPR1 in protecting liver from metabolic distress by controlling lipid homeostasis, possibly through the UPR.	[Borrello, Maria Teresa; Listi, Angela; Rubis, Marion; Iovanna, Juan] Aix Marseille Univ, Ctr Rech Cancerol Marseille, INSERM, CNRS,UMR 7258,U1068, Parc Sci & Technol Luminy, Marseille, France; [Borrello, Maria Teresa; Listi, Angela; Rubis, Marion; Iovanna, Juan] Inst Paoli Calmettes, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France; [Emma, Maria Rita; Augello, Giuseppa; Cusimano, Antonella; Cervello, Melchiorre] CNR, Ist Ric & Innovaz Biomed IRIB, Via Ugo La Malfa 153, I-90144 Palermo, Italy; [Coslet, Sergiu] Aix Marseille Univ, MI mAbs, Parc Sci & Technol Luminy, Marseille, France; [Cabibi, Daniela; Porcasi, Rossana; Giannitrapani, Lydia; Soresi, Maurizio; Montalto, Giuseppe] Univ Palermo, Dipartimento Promoz Salute Maternoinfantile Med I, Palermo, Italy; [Pantuso, Gianni] Univ Palermo, Dept Surg Oncol & Oral Sci, Div Gen & Oncol Surg, Palermo, Italy; [Blyth, Karen] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Pin, Christopher] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Consiglio Nazionale delle Ricerche (CNR); Istituto Ricerca l'Innovazione Biomedica (IRIB-CNR); UDICE-French Research Universities; Aix-Marseille Universite; University of Palermo; University of Palermo; Beatson Institute; Western University (University of Western Ontario)	Iovanna, J (corresponding author), Inst Paoli Calmettes, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France.; Cervello, M (corresponding author), CNR, Ist Ric & Innovaz Biomed IRIB, Via Ugo La Malfa 153, I-90144 Palermo, Italy.; Iovanna, J (corresponding author), Aix Marseille Univ, Ctr Rech Cancerol Marseille CRCM, INSERM, CNRS,UMR 7258,U1068, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France.	melchiorre.cervello@irib.cnr.it; juan.iovanna@inserm.fr	Borrello, Maria Teresa/AAD-6227-2021; cabibi, daniela/D-7438-2013	Borrello, Maria Teresa/0000-0003-1365-1358; cabibi, daniela/0000-0001-6571-6577; Giannitrapani, Lydia/0000-0003-2845-5296	La Ligue Contre le Cancer; Canceropole PACA; INSERM; Associazione Italiana per la Ricerca sul Cancro (AIRC) [18394]; Associazione Italiana per la Ricerca sul Cancro (AIRC)	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Canceropole PACA(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by La Ligue Contre le Cancer, to MTB INCa, Canceropole PACA and INSERM to JI; MC was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC project number 18394). MRE was supported by a post-doctoral fellowship from Associazione Italiana per la Ricerca sul Cancro (AIRC)	Allen-Jennings AE, 2002, J BIOL CHEM, V277, P20020, DOI 10.1074/jbc.M200727200; Arora S, 2016, CLIN CHIM ACTA, V452, P66, DOI 10.1016/j.cca.2015.10.021; Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Chen XQ, 2016, DIABETES, V65, P1904, DOI 10.2337/db15-1637; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Garcia-Montero A, 2001, EUR J CELL BIOL, V80, P720, DOI 10.1078/0171-9335-00209; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949; Huang C, 2019, CANCERS, V11, DOI 10.3390/cancers11121869; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KRAMER R, 1995, BRIT J CANCER, V71, P670, DOI 10.1038/bjc.1995.133; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mueller Fabrice A., 2019, Current Opinion in Toxicology, V16, P9, DOI 10.1016/j.cotox.2019.03.001; Nagahara R, 2019, YONAGO ACTA MED, V62, P36, DOI 10.33160/yam.2019.03.006; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Path G, 2020, AM J PHYSIOL-ENDOC M, V319, pE338, DOI 10.1152/ajpendo.00088.2020; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Santofimia-Castano P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35020-3; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Zhu XH, 2018, FOOD CHEM TOXICOL, V114, P52, DOI 10.1016/j.fct.2018.02.019	46	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21395	10.1096/fj.202002413RR	http://dx.doi.org/10.1096/fj.202002413RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566371	Bronze, Green Submitted			2022-12-26	WOS:000629576700045
J	Ceynowa, M; Zerdzicki, K; Klosowski, P; Zrodowski, M; Pankowski, R; Roclawski, M; Mazurek, T				Ceynowa, Marcin; Zerdzicki, Krzysztof; Klosowski, Pawel; Zrodowski, Maciej; Pankowski, Rafal; Roclawski, Marek; Mazurek, Tomasz			The cement-bone bond is weaker than cement-cement bond in cement-in-cement revision arthroplasty. A comparative biomechanical study	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; FEMORAL COMPONENT REVISION; FOLLOW-UP; STEM; FRACTURES; FIXATION; REPLACEMENT; STRENGTH; MANTLE; NAIL	This study compares the strength of the native bone-cement bond and the old-new cement bond under cyclic loading, using third generation cementing technique, rasping and contamination of the surface of the old cement with biological tissue. The possible advantages of additional drilling of the cement surface is also taken into account. Femoral heads from 21 patients who underwent a total hip arthroplasty performed for hip arthritis were used to prepare bone-cement samples. The following groups of samples were prepared. A bone-cement sample and a composite sample of a 6 weeks old cement part attached to new cement were tested 24 hours after preparation to avoid bone decay. Additionally, a uniform cement sample was prepared as control (6 weeks polymerization time) and 2 groups of cement-cement samples with and without anchoring drill hole on its surface, where the old cement polymerized for 6 weeks before preparing composite samples and then another 6 weeks after preparation. The uniaxial cyclic tension-compression tests were carried out using the Zwick-Roell Z020 testing machine. The uniform cement sample had the highest ultimate force of all specimens (n = 15; R-m = 3149 N). The composite cement sample (n = 15; R-m = 902 N) had higher ultimate force as the bone-cement sample (n = 31; R-m = 284 N; p <0.001). There were no significant differences between composite samples with 24 hours (n = 15; R-m = 902 N) and 6 weeks polymerization periods (n = 22; R-m = 890 N; p = 0.93). The composite cement samples with drill hole (n = 16; R-m = 607 N) were weaker than those without it (n = 22; R-m = 890 N; p < 0.001). This study shows that the bond between the old and new cement was stronger than the bond between cement and bone. This suggests that it is better to leave the cement that is not loosened from the bone and perform cement in cement revision, than compromising bone stock by removal of the old cement with the resulting weaker cement-bone interface. The results support performing cement-in-cement revision arthroplasty The drill holes in the old cement mantle decrease cement binding strength and are not recommended in this type of surgery.	[Ceynowa, Marcin; Zrodowski, Maciej; Pankowski, Rafal; Roclawski, Marek; Mazurek, Tomasz] Med Univ Gdansk, Dept Orthoped Surg, Gdansk, Poland; [Zerdzicki, Krzysztof; Klosowski, Pawel] Gdansk Univ Technol, Fac Civil & Environm Engn, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology	Ceynowa, M (corresponding author), Med Univ Gdansk, Dept Orthoped Surg, Gdansk, Poland.	mceynowa@gumed.edu.pl		Klosowski, Pawel/0000-0002-4329-2678	Department of Orthopedic Surgery, Medical University of Gdansk; Faculty of Civil and Environmental Engineering, Gdansk University of Technology	Department of Orthopedic Surgery, Medical University of Gdansk; Faculty of Civil and Environmental Engineering, Gdansk University of Technology	The study was financed from Department of Orthopedic Surgery, Medical University of Gdansk, and Faculty of Civil and Environmental Engineering, Gdansk University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminian A, 2007, J ORTHOP TRAUMA, V21, P544, DOI 10.1097/BOT.0b013e31814b822e; Briant-Evans TW, 2007, J BONE JOINT SURG BR, V89B, P393, DOI 10.1302/0301-620X.89B3.18200; Briant-Evans TW, 2009, ACTA ORTHOP, V80, P548, DOI 10.3109/17453670903316827; Brogan K, 2012, J BONE JOINT SURG BR, V94B, P1482, DOI 10.1302/0301-620X.94B11.29415; Ceynowa M, 2020, CLIN BIOMECH, V71, P201, DOI 10.1016/j.clinbiomech.2019.11.006; Cnudde PHJ, 2017, BONE JOINT J, V99B, P27, DOI 10.1302/0301-620X.99B4.BJJ-2016-1222.R1; Cox JL, 2019, J SHOULDER ELB SURG, V28, P900, DOI 10.1016/j.jse.2018.10.023; DOHMAE Y, 1988, CLIN ORTHOP RELAT R, P214; Duncan WW, 2009, J BONE JOINT SURG BR, V91B, P577, DOI 10.1302/0301-620X.91B5.21621; Gorman RA, 2020, J SHOULDER ELB SURG, V29, pS9, DOI 10.1016/j.jse.2020.01.094; GREENWALD AS, 1978, J BONE JOINT SURG BR, V60, P107, DOI 10.1302/0301-620X.60B1.627570; Guerin SR, 2007, BIO-MED MATER ENG, V17, P379; Holsgrove TP, 2015, HIP INT, V25, P67, DOI 10.5301/hipint.5000178; Kaiser W, 1997, LANGENBECK ARCH CHIR, V382, P100; Keeling P, 2008, ARCH ORTHOP TRAUM SU, V128, P1193, DOI 10.1007/s00402-007-0470-0; Keeling P, 2012, CLIN BIOMECH, V27, P673, DOI 10.1016/j.clinbiomech.2012.02.009; Kukla C, 2001, J BIOMECH, V34, P1519, DOI 10.1016/S0021-9290(01)00157-9; Kwak DK, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7618079; Leijtens B, 2016, HIP INT, V26, P67, DOI 10.5301/hipint.5000310; Li PLS, 1996, J BONE JOINT SURG BR, V78B, P809, DOI 10.1302/0301-620X.78B5.0780809; LIEBERMAN JR, 1993, J BONE JOINT SURG BR, V75, P869; Lieberman JR, 2005, J ARTHROPLASTY, V20, P72, DOI 10.1016/j.arth.2005.03.005; Marcos L, 2009, INT ORTHOP, V33, P633, DOI 10.1007/s00264-008-0516-0; Mounsey EJ, 2015, BONE JOINT J, V97B, P1623, DOI 10.1302/0301-620X.97B12.35814; Okuzu Y, 2016, J ORTHOP SCI, V21, P810, DOI 10.1016/j.jos.2016.03.013; Quinlan JF, 2006, J BONE JOINT SURG BR, V88B, P730, DOI 10.1302/0301-620X.88B6; Rosenstein A, 1992, Proc Inst Mech Eng H, V206, P47, DOI 10.1243/PIME_PROC_1992_206_261_02; Sandiford NA, 2017, BONE JOINT J, V99B, P199, DOI 10.1302/0301-620X.99B2.BJJ-2016-0076.R1; Scheele C, 2018, CLIN BIOMECH, V51, P34, DOI 10.1016/j.clinbiomech.2017.11.006; te Stroet MAJ, 2014, HIP INT, V24, P428, DOI 10.5301/hipint.5000145; Wagner ER, 2017, J SHOULDER ELB SURG, V26, P1448, DOI 10.1016/j.jse.2017.01.013; Weinrauch PC, 2007, J ARTHROPLASTY, V22, P394, DOI 10.1016/j.arth.2006.04.010; Wilson LJ, 2009, J ARTHROPLASTY, V24, P789, DOI 10.1016/j.arth.2008.02.014; Woodbridge AB, 2019, J ARTHROPLASTY, V34, pS297, DOI 10.1016/j.arth.2019.03.035	34	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246740	10.1371/journal.pone.0246740	http://dx.doi.org/10.1371/journal.pone.0246740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571251	gold, Green Published			2022-12-26	WOS:000618274000077
J	Tayal, B; Malahfji, M; Buergler, JM; Shah, DJ; Nagueh, SF				Tayal, Bhupendar; Malahfji, Maan; Buergler, John M.; Shah, Dipan J.; Nagueh, Sherif F.			Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study	PLOS ONE			English	Article								Background Left atrial (LA) strain is associated with symptomatic status and atrial fibrillation in patients with hypertrophic cardiomyopathy (HCM). However, hemodynamic determinants of LA reservoir (LARS), conduit, and pump strains have not been examined and data are needed on the relation of LA strain with exercise tolerance in HCM. Methods Fifty HCM patients with echocardiographic and CMR imaging within 30 days were included. Left ventricular (LV) volumes, mass, EF, scar extent, extracellular volume fraction (ECV), and LA maximum volume were measured by CMR. Echo studies were analyzed for mitral inflow, pulmonary vein flow, mitral annulus tissue Doppler velocities, LV global longitudinal strain, and LA strain. Twenty six patients able and willing to exercise underwent cardiopulmonary stress testing for peak oxygen consumption (MVO2), and V-E/V-CO2 slope. Patients were followed for clinical events. Findings LARS was significantly associated with indices of LA systolic function, LV GLS, and LV filling pressures (P<0.05). Conduit strain was significantly associated with mitral annulus early diastolic velocity and ECV, whereas LA pump strain was determined by LA systolic function and indices of LV end diastolic pressure (all P< 0.05). LARS and conduit strain were significantly higher in patients who achieved >= 80% of MVO2. LARS, conduit, and pump strains were significantly associated with atrial fibrillation (P<0.05). Conclusions LV structure, systolic and diastolic function, and LA systolic function determine the 3 components of LA strain. LA strain is associated with exercise tolerance and clinical events in patients with HCM.	[Tayal, Bhupendar; Malahfji, Maan; Buergler, John M.; Shah, Dipan J.; Nagueh, Sherif F.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Tayal, Bhupendar] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark	The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Aalborg University; Aalborg University Hospital	Nagueh, SF (corresponding author), Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA.	snagueh@houstonmethodist.org						Appleton CP, 1997, J AM COLL CARDIOL, V30, P1562, DOI 10.1016/S0735-1097(97)00354-9; Avenatti E, 2018, AM J CARDIOL, V122, P1204, DOI 10.1016/j.amjcard.2018.06.031; Badano LP, 2018, EUR HEART J-CARD IMG, V19, P591, DOI 10.1093/ehjci/jey042; Biagini E, 2009, AM J CARDIOL, V104, P1727, DOI 10.1016/j.amjcard.2009.07.057; Brennan EG, 1997, J AM SOC ECHOCARDIOG, V10, P293, DOI 10.1016/S0894-7317(97)70065-8; Debonnaire P, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004052; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Haaf P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0308-4; Hiemstra YL, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005706; Khan MA, 2019, J CARDIOVASC MAGN R, V21, DOI 10.1186/s12968-018-0517-0; Kusunose K, 2012, HEART, V98, P1311, DOI 10.1136/heartjnl-2012-302007; MANNING WJ, 1993, J AM COLL CARDIOL, V22, P221, DOI 10.1016/0735-1097(93)90838-R; Maragiannis D, 2018, INT J CARDIOVAS IMAG, V34, P121, DOI 10.1007/s10554-017-1214-z; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; Nagueh SF, 1999, CIRCULATION, V99, P254, DOI 10.1161/01.CIR.99.2.254; Nagueh SF, 1999, J AM COLL CARDIOL, V34, P1123, DOI 10.1016/S0735-1097(99)00341-1; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Opdahl A, 2009, CIRCULATION, V119, P2578, DOI 10.1161/CIRCULATIONAHA.108.791681; PAI RG, 1994, CIRCULATION, V89, P553, DOI 10.1161/01.CIR.89.2.553; Pathan F, 2017, J AM SOC ECHOCARDIOG, V30, P59, DOI 10.1016/j.echo.2016.09.007; Ramkumar S, 2017, J AM SOC ECHOCARDIOG, V30, P659, DOI 10.1016/j.echo.2017.03.014; ROKEY R, 1986, J AM COLL CARDIOL, V7, P1273, DOI 10.1016/S0735-1097(86)80146-2; Rosca M, 2010, J AM SOC ECHOCARDIOG, V23, P1090, DOI 10.1016/j.echo.2010.07.016; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SASSON Z, 1988, J AM COLL CARDIOL, V11, P752, DOI 10.1016/0735-1097(88)90207-0; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Vasquez N, 2019, J AM SOC ECHOCARDIOG, V32, P593, DOI 10.1016/j.echo.2019.01.007; Wakami K, 2009, J AM SOC ECHOCARDIOG, V22, P847, DOI 10.1016/j.echo.2009.04.026; Woo A, 2005, CIRCULATION, V111, P2033, DOI 10.1161/01.CIR.0000162460.36735.71	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245934	10.1371/journal.pone.0245934	http://dx.doi.org/10.1371/journal.pone.0245934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566865	gold, Green Published			2022-12-26	WOS:000618271700020
J	Chasco, B; Burke, B; Crozier, L; Zabel, R				Chasco, Brandon; Burke, Brian; Crozier, Lisa; Zabel, Rich			Differential impacts of freshwater and marine covariates on wild and hatchery Chinook salmon marine survival	PLOS ONE			English	Article							ONCORHYNCHUS-TSHAWYTSCHA; COHO SALMON; LIFE-STAGE; CLIMATE; OCEAN; MANAGEMENT; MIGRATION; GROWTH; SIZE; TEMPERATURE	Large-scale atmospheric conditions in the Northeast Pacific Ocean affect both the freshwater environment in the Columbia River Basin and marine conditions along the coasts of Oregon, Washington, and British Columbia, resulting in correlated conditions in the two environments. For migrating species, such as salmonids that move through multiple habitats, these correlations can amplify the impact of good or poor physical conditions on growth and survival, as movements among habitats may not alleviate effects of anomalous conditions. Unfortunately, identifying the mechanistic drivers of salmon survival in space and time is hindered by these cross-habitat correlations. To address this issue, we modeled the marine survival of Snake River spring/summer Chinook salmon with multiple indices of the marine environment and an explicit treatment of the effect of arrival timing from freshwater to the ocean, and found that both habitats contribute to marine survival rates. We show how this particular carryover effect of freshwater conditions on marine survival varies by year and rearing type (hatchery or wild), with a larger effect for wild fish. As environmental conditions change, incorporating effects from both freshwater and marine habitats into salmon survival models will become more important, and has the additional benefit of highlighting how management actions that affect arrival timing may improve marine survival.	[Chasco, Brandon] NOAA, Fish Ecol Div, Natl Marine Fisheries Serv, Newport, OR 97365 USA; [Burke, Brian; Crozier, Lisa; Zabel, Rich] NOAA, Fish Ecol Div, Natl Marine Fisheries Serv, Seattle, WA USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Chasco, B (corresponding author), NOAA, Fish Ecol Div, Natl Marine Fisheries Serv, Newport, OR 97365 USA.	Brandon.Chasco@noaa.gov		Crozier, Lisa/0000-0001-7744-9525	NOAA government salaries	NOAA government salaries	There were no grants or funders associated with this work. All authors were paid from their NOAA government salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We did not receive any funding or salary from an outside agency or institution.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2012, WORLD PUMPS, V9, P34, DOI DOI 10.1016/S0262-1762(12)70220-1; [Anonymous], [No title captured]; BEAMISH RJ, 1992, T AM FISH SOC, V121, P444, DOI 10.1577/1548-8659(1992)121<0444:SDPOCA>2.3.CO;2; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Burke BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054134; Chasco BE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14984-8; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Crozier LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217711; Du XN, 2014, ESTUAR COAST, V37, P299, DOI 10.1007/s12237-013-9679-z; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; Faulkner JR, 2019, T AM FISH SOC, V148, P1069, DOI 10.1002/tafs.10200; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gosselin JL, 2018, ECOL EVOL, V8, P319, DOI 10.1002/ece3.3663; Greven S, 2010, BIOMETRIKA, V97, P773, DOI 10.1093/biomet/asq042; Griffiths JR, 2014, J APPL ECOL, V51, P1554, DOI 10.1111/1365-2664.12341; Haeseker SL, 2012, T AM FISH SOC, V141, P121, DOI 10.1080/00028487.2011.652009; Halsing DL, 2009, CONSERV BIOL, V23, P479, DOI 10.1111/j.1523-1739.2009.01171.x; HENDERSON MA, 1991, CAN J FISH AQUAT SCI, V48, P988, DOI 10.1139/f91-115; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Holsman KK, 2012, CONSERV BIOL, V26, P912, DOI 10.1111/j.1523-1739.2012.01895.x; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Keefer ML, 2008, T AM FISH SOC, V137, P1120, DOI 10.1577/T07-008.1; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Kilduff DP, 2014, ICES J MAR SCI, V71, P1671, DOI 10.1093/icesjms/fsu031; Kristensen K, 2015, ARXIV150900660; Litzow MA, 2020, P NATL ACAD SCI USA, V117, P7665, DOI 10.1073/pnas.1921266117; Litzow MA, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1855; Mantua N., 2002, J OCEANOGR, V1, P592; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Miller JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099814; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Peterson WT, 2014, OCEANOGRAPHY, V27, P80, DOI 10.5670/oceanog.2014.88; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Quinn TP, 2018, BEHAV ECOLOGY PACIFI; RCore Team, 2020, R LANG ENV STAT COMP; Roby DD, 2003, CAN J ZOOL, V81, P250, DOI 10.1139/Z02-242; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; Scheuerell MD, 2005, FISH OCEANOGR, V14, P448, DOI 10.1111/j.1365-2419.2005.00346.x; Scheuerell MD, 2019, INTEGRATED POPULATIO, P734996; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Spence BC, 2014, CAN J FISH AQUAT SCI, V71, P56, DOI 10.1139/cjfas-2012-0479; Thorson JT, 2015, ICES J MAR SCI, V72, P1245, DOI 10.1093/icesjms/fsu213; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Wells BK, 2007, FISH OCEANOGR, V16, P363, DOI 10.1111/j.1365-2419.2007.00437.x; Wells BK, 2016, MAR ECOL PROG SER, V552, P271, DOI 10.3354/meps11757; Wells PM, 2017, BIOCONTROL, V62, P373, DOI 10.1007/s10526-016-9775-7; Woodson CB, 2015, P NATL ACAD SCI USA, V112, P1710, DOI 10.1073/pnas.1417143112; Woodson LE, 2013, MAR ECOL PROG SER, V487, P163, DOI 10.3354/meps10353; Zabel RW, 2006, CONSERV BIOL, V20, P190, DOI 10.1111/j.1523-1739.2005.00300.x; Zuur Alain F., 2009, P1	53	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246659	10.1371/journal.pone.0246659	http://dx.doi.org/10.1371/journal.pone.0246659			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561177	gold, Green Published			2022-12-26	WOS:000617533000007
J	Hirose, N; Kagaya, Y; Tsuruike, M				Hirose, Norikazu; Kagaya, Yoshinori; Tsuruike, Masaaki			The task dependent differences in electromyography activity of hamstring muscles during leg curls and hip extensions	PLOS ONE			English	Article							NONUNIFORM CHANGES; INJURIES; ARCHITECTURE; EXERCISES; FOOTBALL; RISK; EMG; SEMITENDINOSUS; ACTIVATION; MANAGEMENT	This study aimed to investigate the influence of the task type on the relative electromyography (EMG) activity of biceps femoris long head (BFlh) to semitendinosus (ST) muscles, and of proximal to distal regions during isometric leg-curl (LC) and hip-extension (HE). Twenty male volunteers performed isometric LC with the knee flexed to 30 degrees (LC30) and 90 degrees (LC90), as well as isometric HE with the knee extended (HE0) and flexed to 90 degrees (HE90), at 40% and 100% maximal voluntary contraction (MVIC). Hip position was neutral in all conditions. EMG activity was recorded from the proximal and distal region of the BFlh and ST muscles. BFlh/ST was calculated from the raw root-mean-square (RMS) amplitudes. The RMS of 40% MVIC was normalized using MVIC data and the proximal/distal (P/D) ratio of normalized EMG (NEMG) was calculated. The BFlh/ST ratio was higher in HE0 than in LC90 during MVIC and 40% MVIC (p<0.05), and was higher in HE90 than in LC90 (p<0.05) during 40% MVIC at the proximal region, whereas no difference was observed between HE0 and LC30. There was no inter-task difference in BFlh/ST ratio in the distal region. Furthermore, the P/D ratio was higher in LC90 than in LC30 and HE0 (p<0.05) in BFlh and ST muscles, and was higher in HE90 than in LC30 and HE0 (p<0.05) in BFlh during 40% MVIC. However, there was no difference in P/D ratio between LC30 and LC90, and HE0 and HE90. This showed that there was no task-dependent difference in the EMG activity of the BFlh muscle relative to the ST muscle between prone hip extension and prone knee flexion when the knee joint was set at an equivalent angle. Similarly, there was no task-dependent difference in the NEMG of the proximal region relative to the distal region in BFlh and ST muscles during 40% MVIC.	[Hirose, Norikazu] Waseda Univ, Fac Sport Sci, Nishitokyo, Tokyo, Japan; [Kagaya, Yoshinori] Showa Univ, Dept Phys Therapy, Yokohama, Kanagawa, Japan; [Tsuruike, Masaaki] San Jose State Univ, Dept Kinesiol, San Jose, CA USA	Waseda University; Showa University; California State University System; San Jose State University	Hirose, N (corresponding author), Waseda Univ, Fac Sport Sci, Nishitokyo, Tokyo, Japan.	toitsu_hirose@waseda.jp		Hirose, Norikazu/0000-0001-7212-6057; Tsuruike, Masaaki/0000-0002-5604-8738	Grant Program for Promotion of International Joint Research of Waseda University	Grant Program for Promotion of International Joint Research of Waseda University	The corresponding author (NH) received grant from Grant Program for Promotion of International Joint Research of Waseda University. However, this grant has no ID. The funder has no role in this research.	Bourne MN, 2018, SPORTS MED, V48, P251, DOI 10.1007/s40279-017-0796-x; Bourne MN, 2017, BRIT J SPORT MED, V51, P1021, DOI 10.1136/bjsports-2015-095739; Bourne MN, 2017, BRIT J SPORT MED, V51, P469, DOI 10.1136/bjsports-2016-096130; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Chumanov ES, 2011, MED SCI SPORT EXER, V43, P525, DOI 10.1249/MSS.0b013e3181f23fe8; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2016, BRIT J SPORT MED, V50, P738, DOI 10.1136/bjsports-2016-095974; Farina D, 2001, IEEE ENG MED BIOL, V20, P62, DOI 10.1109/51.982277; Garner JC, 2008, J ELECTROMYOGR KINES, V18, P466, DOI 10.1016/j.jelekin.2006.11.006; Hegyi A, 2018, SCAND J MED SCI SPOR, V28, P992, DOI 10.1111/sms.13016; Hegyi A, 2019, J ORTHOP SPORT PHYS, V49, P584, DOI 10.2519/jospt.2019.8801; Hegyi A, 2019, SCAND J MED SCI SPOR, V29, P34, DOI 10.1111/sms.13303; HEISER TM, 1984, AM J SPORT MED, V12, P368, DOI 10.1177/036354658401200506; Hirose N, 2018, J STRENGTH COND RES, V32, P3357, DOI 10.1519/JSC.0000000000002747; Jeon IC, 2016, PHYS THER SPORT, V22, P35, DOI 10.1016/j.ptsp.2016.03.004; Kellis E, 2012, J ELECTROMYOGR KINES, V22, P520, DOI 10.1016/j.jelekin.2012.03.012; Kellis E, 2010, J ELECTROMYOGR KINES, V20, P1237, DOI 10.1016/j.jelekin.2010.07.012; Koulouris G, 2003, SKELETAL RADIOL, V32, P582, DOI 10.1007/s00256-003-0674-5; Kubota J, 2007, EUR J APPL PHYSIOL, V101, P713, DOI 10.1007/s00421-007-0549-x; Kumazaki T, 2012, INT J SPORTS MED, V33, P950, DOI 10.1055/s-0032-1311593; Mendiguchia J, 2013, J STRENGTH COND RES, V27, P574, DOI 10.1519/JSC.0b013e31825c2f38; Onishi H, 2002, J ELECTROMYOGR KINES, V12, P399, DOI 10.1016/S1050-6411(02)00033-0; Ono T, 2011, RES SPORTS MED, V19, P42, DOI 10.1080/15438627.2011.535769; Ono T, 2010, RES SPORTS MED, V18, P188, DOI 10.1080/15438627.2010.490185; Orchard J, 2002, CLIN J SPORT MED, V12, P3, DOI 10.1097/00042752-200201000-00004; Rab M, 1997, SURG RADIOL ANAT, V19, P287, DOI 10.1007/BF01637592; Rainoldi A, 2000, J ELECTROMYOGR KINES, V10, P327, DOI 10.1016/S1050-6411(00)00024-9; Reina N, 2013, KNEE, V20, P90, DOI 10.1016/j.knee.2012.06.003; Schache AG, 2012, MED SCI SPORT EXER, V44, P647, DOI 10.1249/MSS.0b013e318236a3d2; Schaefer LV, 2017, BMC SPORTS SCI MED R, V9, DOI 10.1186/s13102-017-0075-z; Schoenfeld BJ, 2015, J STRENGTH COND RES, V29, P159, DOI 10.1519/JSC.0000000000000598; Seidel PMP, 1996, ARCH PHYS MED REHAB, V77, P1157, DOI 10.1016/S0003-9993(96)90140-9; Watanabe K, 2016, J APPL BIOMECH, V32, P97, DOI 10.1123/jab.2015-0017; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275, DOI 10.1097/00003086-198310000-00042; Woodley SJ, 2005, CELLS TISSUES ORGANS, V179, P125, DOI 10.1159/000085004; Yeung SS, 2009, BRIT J SPORT MED, V43, P589, DOI 10.1136/bjsm.2008.056283	36	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0245838	10.1371/journal.pone.0245838	http://dx.doi.org/10.1371/journal.pone.0245838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561137	Green Published, gold			2022-12-26	WOS:000617533000016
J	Jeong, H; Johnson, AW; Feland, JB; Petersen, SR; Staten, JM; Bruening, DA				Jeong, Hwigeum; Johnson, A. Wayne; Feland, J. Brent; Petersen, Spencer R.; Staten, Jared M.; Bruening, Dustin A.			Added body mass alters plantar shear stresses, postural control, and gait kinetics: Implications for obesity	PLOS ONE			English	Article							GROUND REACTION FORCES; PRESSURE DISTRIBUTION; YOUNG-ADULTS; LOAD; BIOMECHANICS; VARIABILITY; PARAMETERS; BACKPACK; WALKING	Context Obesity is a growing global health concern. The increased body mass and altered mass distribution associated with obesity may be related to increases in plantar shear that putatively leads to physical functional deficits. Therefore, measurement of plantar shear may provide unique insights on the effects of body mass and body distribution on physical function or performance. Purpose 1) To investigate the effects of body mass and distribution on plantar shear. 2) To examine how altered plantar shear influences postural control and gait kinetics. Hypothesis 1) a weighted vest forward distributed (FV) would shift the center of pressure (CoP) location forward during standing compared with a weighted vest evenly distributed (EV), 2) FV would increase plantar shear spreading forces more than EV during standing, 3) FV would increase postural sway during standing while EV would not, and 4) FV would elicit greater compensatory changes during walking than EV. Methods Twenty healthy young males participated in four different tests: 1) static test (for measuring plantar shear and CoP location without acceleration, 2) bilateral-foot standing postural control test, 3) single-foot standing postural test, and 4) walking test. All tests were executed in three different weight conditions: 1) unweighted (NV), 2) EV with 20% added body mass, and 3) FV, also with 20% added body mass. Plantar shear stresses were measured using a pressure/shear device, and several shear and postural control metrics were extracted. Repeated measures ANOVAs with Holms post hoc test were used to compare each metric among the three conditions (alpha = 0.05). Results FV and EV increased both AP and ML plantar shear forces compared to NV. FV shifted CoP forward in single-foot trials. FV and EV showed decreased CoP range and velocity and increased Time-to-Boundary (TTB) during postural control compared to NV. EV and FV showed increased breaking impulse and propulsive impulse compared to NV. In addition, EV showed even greater impulses than FV. While EV increased ML plantar shear spreading force, FV increased AP plantar shear spreading force during walking. Conclusion Added body mass increases plantar shear spreading forces. Body mass distribution had greater effects during dynamic tasks. In addition, healthy young individuals seem to quickly adapt to external stimuli to control postural stability. However, as this is a first step study, follow-up studies are necessary to further support the clinical role of plantar shear in other populations such as elderly and individuals with obesity or diabetes.	[Jeong, Hwigeum; Johnson, A. Wayne; Feland, J. Brent; Petersen, Spencer R.; Staten, Jared M.; Bruening, Dustin A.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA	Brigham Young University	Jeong, H (corresponding author), Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA.	hwiguem@gmail.com	Feland, Jeffrey Brent/AFO-2411-2022	Bruening, Dustin/0000-0003-3815-6089				Arnold JB, 2010, DIABET FOOT ANKLE, V1, DOI 10.3402/dfa.v1i0.5518; Binkley JM, 1999, PHYS THER, V79, P371; Birrell SA, 2009, ERGONOMICS, V52, P1298, DOI 10.1080/00140130903003115; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Bruening DA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237449; Butler RJ, 2008, J AM PODIAT MED ASSN, V98, P102, DOI 10.7547/0980102; Butterworth PA, 2015, GAIT POSTURE, V41, P465, DOI 10.1016/j.gaitpost.2014.11.010; Castro M, 2013, APPL ERGON, V44, P503, DOI 10.1016/j.apergo.2012.10.016; Castro MP, 2012, APPL ERGON; Chang E, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1031-3; Dahl KD, 2016, GAIT POSTURE, V45, P90, DOI 10.1016/j.gaitpost.2016.01.012; Davis B, 2017, J BIOMECH, V52, P176, DOI 10.1016/j.jbiomech.2016.12.024; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Finkelstein EA, 2007, AM J HEALTH PROMOT, V21, P460, DOI 10.4278/0890-1171-21.5.460; Fjeldstad Cecilie, 2008, Dyn Med, V7, P4, DOI 10.1186/1476-5918-7-4; Frimenko R, 2015, PHYSIOTHERAPY, V101, P266, DOI 10.1016/j.physio.2015.01.003; Garcia-Hidalgo L, 1999, OBES RES, V7, P299, DOI 10.1002/j.1550-8528.1999.tb00410.x; Goss LP, 2020, MEAS SCI TECHNOL, V31, DOI 10.1088/1361-6501/ab4453; Gravante G, 2003, CLIN BIOMECH, V18, P780, DOI 10.1016/S0268-0033(03)00123-2; Harbo T, 2012, EUR J APPL PHYSIOL, V112, P267, DOI 10.1007/s00421-011-1975-3; Hills AP, 2001, INT J OBESITY, V25, P1674, DOI 10.1038/sj.ijo.0801785; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Jammes Y, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0175-4; Kern AM, 2019, PEERJ, V7, DOI 10.7717/peerj.7487; KINOSHITA H, 1985, ERGONOMICS, V28, P1347, DOI 10.1080/00140138508963251; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; LANZARA RG, 1994, MATH BIOSCI, V122, P89, DOI 10.1016/0025-5564(94)90083-3; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Li SSW, 2019, ERGONOMICS, V62, P537, DOI 10.1080/00140139.2018.1552764; Maktouf W, 2018, J BIOMECH, V79, P198, DOI 10.1016/j.jbiomech.2018.08.017; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; Otten E, 1999, PHILOS T ROY SOC B, V354, P869, DOI 10.1098/rstb.1999.0439; Park H, 2014, GAIT POSTURE, V39, P430, DOI 10.1016/j.gaitpost.2013.08.018; Patel S, 2007, AM J CLIN DERMATOL, V8, P1, DOI 10.2165/00128071-200708010-00001; Neri SGR, 2017, J APPL BIOMECH, V33, P323, DOI 10.1123/jab.2016-0357; Ritzmann R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128400; Roberts M, 2018, GAIT POSTURE, V66, P139, DOI 10.1016/j.gaitpost.2018.08.039; Rugelj D, 2011, APPL ERGON, V42, P860, DOI 10.1016/j.apergo.2011.02.002; Sabharwal S, 2012, J BONE JOINT SURG AM, V94A, P1045, DOI 10.2106/JBJS.K.00330; Scaglioni G, 2003, J PHYSIOL-LONDON, V548, P649, DOI 10.1113/jphysiol.2002.032763; Son Sung Min, 2016, Osong Public Health Res Perspect, V7, P378, DOI 10.1016/j.phrp.2016.10.001; Song K, 2016, MED SCI SPORT EXER, V48, P2046, DOI 10.1249/MSS.0000000000000992; Strzalkowski NDJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12425; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011; Wu XF, 2014, NEUROSCI LETT, V583, P49, DOI 10.1016/j.neulet.2014.09.029; Xiong SP, 2009, ANTHROPOL SCI, V117, P77, DOI 10.1537/ase.070915; Yumin Eylem Tutun, 2016, J Phys Ther Sci, V28, P2587	52	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246605	10.1371/journal.pone.0246605	http://dx.doi.org/10.1371/journal.pone.0246605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0UN	33544773	gold, Green Published			2022-12-26	WOS:000617993300008
J	Williams, ET; Lepczyk, CA; Morse, W; Smith, M				Williams, Ellary Tucker; Lepczyk, Christopher A.; Morse, Wayde; Smith, Mark			Stakeholder perspectives towards the use of toxicants for managing wild pigs	PLOS ONE			English	Article							FERAL PIGS; SUS-SCROFA; BIOLOGICAL INVASIONS; ATTITUDES; MANAGEMENT; HOGS; ERADICATION; WARFARIN; RANGE; CONSEQUENCES	Wild pigs (Sus scrofa) are one of the most detrimental invasive mammals in the US. Lack of adequate population control has allowed pigs to become established across the landscape, causing significant ecological and economic damage. Given the need for additional tools for reducing wild pig populations, two toxicants, warfarin and sodium nitrite, are at the forefront of the discussion regarding future wild pig management. However, no research has examined stakeholders' perspectives towards the use of toxicants in wild pig management. Given the lack of knowledge, our goal was to determine stakeholders' perspectives towards the legal use of toxicants for managing wild pigs. We surveyed 1822 individuals from three stakeholder groups (hunters, farmers, and forestland owners) across Alabama during February 2018 using an online survey following the Tailored Design Method. All three stakeholder groups were generally supportive of toxicant use, though their views differed slightly by group. Furthermore, all stakeholder groups were supportive of toxicant purchasing and use regulations, while accidental water contamination, human health impact, and incorrect usage of a toxicant were stakeholders' greatest concerns. These results indicate that these groups would likely be in support of using toxicants for wild pig management in Alabama and could be a model for other states or locations. Consequently, these results have direct implications for shaping policy and possible use of toxicants as a future wild pig management tool.	[Williams, Ellary Tucker; Lepczyk, Christopher A.; Morse, Wayde; Smith, Mark] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Lepczyk, CA (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	lepczyk@auburn.edu		Lepczyk, Christopher/0000-0002-5316-3159	United States Department of Agriculture, National Institute of Food and Agriculture Hatch [ALA031-1-15025]	United States Department of Agriculture, National Institute of Food and Agriculture Hatch	CAL, WM, MS #ALA031-1-15025 United States Department of Agriculture, National Institute of Food and Agriculture Hatch The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2005, WILDLIFE SOC B, V33, P1312, DOI 10.2193/0091-7648(2005)33[1312:RPAOFF]2.0.CO;2; Anderson A, 2016, CROP PROT, V89, P89, DOI 10.1016/j.cropro.2016.06.023; ANDERSON SJ, 1993, BIOL CONSERV, V63, P195, DOI 10.1016/0006-3207(93)90712-A; [Anonymous], 2015, J OPER OCEANOGR, V8, ps80, DOI 10.1080/1755876X.2015.1022329; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bengsen AJ, 2014, MAMMAL REV, V44, P135, DOI 10.1111/mam.12011; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; Caplenor CA, 2017, J ENVIRON MANAGE, V201, P45, DOI 10.1016/j.jenvman.2017.06.022; CHOQUENOT D, 1990, J WILDLIFE MANAGE, V54, P353, DOI 10.2307/3809054; Cowled BD, 2008, WILDLIFE RES, V35, P651, DOI 10.1071/WR07072; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; DECK E, 1975, ANNU REV ENTOMOL, V20, P119, DOI 10.1146/annurev.en.20.010175.001003; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; EPA, 1991, PEST TOX SUBST 738 F; Estevez RA, 2015, CONSERV BIOL, V29, P19, DOI 10.1111/cobi.12359; Etter D.R., 2020, INVASIVE WILD PIGS N, P319; Farnworth MJ, 2014, J APPL ANIM WELF SCI, V17, P1, DOI 10.1080/10888705.2013.799414; Fisher N. I., 2011, Australian Zoologist, V35, P576; Fleming PJS, 2017, RANGELAND J, V39, P523, DOI [10.1071/rj17046, 10.1071/RJ17046]; Fraser A., 2006, LIT REV; Harper EE, 2014, HR1405 HUM DIM RES P; Harper EE, 2016, WILDLIFE SOC B, V40, P269, DOI 10.1002/wsb.653; Hartsell AJ, 2015, RESOURCE B USDA FOR, VSRS-220; Hess S.C., 2020, INVASIVE WILD PIGS N, P403; Higginbotham B, 2008, NAT C FER HOGS, P9; Holderieath J., 2016, PARTIAL EQUILIBRIUM, DOI [10.22004/ag.econ.235867, DOI 10.22004/AG.ECON.235867]; HOROWITZ J, 1994, AM J AGR ECON, V76, P396, DOI 10.2307/1243652; Hulme PE, 2003, ORYX, V37, P178, DOI 10.1017/S003060530300036X; IBM Corp, IBM SPSS STAT WIND V; Jack Sherman W., 2012, Human-Wildlife Interactions, V6, P89; Jerrolds W. R., 2014, J SE ASS FISH WILDLI, V1, P167; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Jolley DB, 2010, J MAMMAL, V91, P519, DOI 10.1644/09-MAMM-A-129.1; Koichi Kana, 2013, Human Dimensions of Wildlife, V18, P97, DOI 10.1080/10871209.2013.727523; Lapidge S, 2012, 1158 USDA NAT WILDL; Larson DL, 2011, J ENVIRON MANAGE, V92, P14, DOI 10.1016/j.jenvman.2010.08.025; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lowe S., 2000, ENCY BIOL INVASIONS; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Massei Giovanna, 2011, Human-Wildlife Interactions, V5, P79; Mayer J.J., 2008, WILD PIGS US THEIR H; Mayer J. J., 2009, WILD PIGS BIOL DAMAG, P5; Mayer J.J., 2009, WILD PIGS BIOL DAMAG, P1; Mayer JJ, 2009, WILD PIGS BIOL DAMAG, P227; Mccann BE, 2008, J WILDLIFE MANAGE, V72, P1287, DOI 10.2193/2007-164; MCILROY JC, 1989, AUST WILDLIFE RES, V16, P195; McIlroy JC, 1997, WILDLIFE RES, V24, P483, DOI 10.1071/WR96109; Means DB, 2007, SOUTHEAST NAT, V6, P83, DOI 10.1656/1528-7092(2007)6[83:DIRDSO]2.0.CO;2; Mengak MT., 2016, WSFNR1623 U GEOGRG S; Mengak MT., 2012, WILDLIFE MANAGEMENT, VWMS-12-16; Mihulka S, 2001, J BIOGEOGR, V28, P597, DOI 10.1046/j.1365-2699.2001.00574.x; Morzillo AT, 2011, URBAN ECOSYST, V14, P243, DOI 10.1007/s11252-010-0152-5; Niemiec RM, 2017, ENVIRON MANAGE, V59, P477, DOI 10.1007/s00267-016-0807-y; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P1, DOI 10.1201/b10938; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel David, 2007, P2; Poudyal NC, 2017, HUM DIMENS WILDL, V22, P538, DOI 10.1080/10871209.2017.1368103; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Raedeke AH, 2001, WILDLIFE SOC B, V29, P195; Reidy MM, 2008, J WILDLIFE MANAGE, V72, P1012, DOI 10.2193/2007-158; Rollins Dale, 2007, Human-Wildlife Conflicts, V1, P192; SAUNDERS G, 1990, AUST WILDLIFE RES, V17, P525; SAUNDERS G, 1993, WILDLIFE RES, V20, P771, DOI 10.1071/WR9930771; Seward N. W., 2004, Sheep & Goat Research Journal, V19, P34; Shapiro L, 2016, J PEST SCI, V89, P489, DOI 10.1007/s10340-015-0706-7; Shih JG, 2008, WETLANDS, V28, P1, DOI 10.1672/07-40.1; Siemann E, 2009, FOREST ECOL MANAG, V258, P546, DOI 10.1016/j.foreco.2009.03.056; SINGER FJ, 1984, J WILDLIFE MANAGE, V48, P464, DOI 10.2307/3801179; Snow NP, 2017, WILDLIFE SOC B, V41, P256, DOI 10.1002/wsb.775; SPECTOR PL, 1976, ECOL LAW QUART, V5, P233; Summers J, 2017, KENTUCKY J UNDERGRAD, V1, P52; Tait J, 2001, J ENVIRON MONITOR, V3, p64N; Tolleson DR, 1995, GREAT PLAINS WILDL D, P454; United States Department of Agriculture National Agriculture Statistical Service, 2018, FARMS LAND FARMS 201; USDA APHIS, 2020, APHIS WILDL SERV CON; Vaske J., 2008, SURVEY RES ANAL APPL; Vaske JV, 2020, BELIEFS PERCEIVED RI, DOI [10.1007/s10344-020-01379-w32647501, DOI 10.1007/S10344-020-01379-W32647501]; Veitch C.R., 2001, P63; Vilardell A, 2008, EUR J WILDLIFE RES, V54, P745, DOI 10.1007/s10344-008-0176-9; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilkinson IS., 2011, ISLAND INVASIVES ERA, P508; WOOD G W, 1977, Southern Journal of Applied Forestry, V1, P12	84	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246457	10.1371/journal.pone.0246457	http://dx.doi.org/10.1371/journal.pone.0246457			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544753	gold, Green Published			2022-12-26	WOS:000617991900002
J	Agathao, BT; Cunha, DB; Sichieri, R; Lopes, CS				Agathao, Beatriz Tose; Cunha, Diana Barbosa; Sichieri, Rosely; Lopes, Claudia Souza			The role of family meal frequency in common mental disorders in children and adolescents over eight months of follow-up	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; HEALTH; ASSOCIATIONS; DEPRESSION; PREVALENCE; OUTCOMES; QUALITY	Objective This study evaluated the influence of family meal frequency on the occurrence of common mental disorders (CMD) in children and adolescents over eight months of follow-up. Design Data from this longitudinal study were derived from the PAAPAS-Parents, Students, Community Health Agents, and Teachers for Healthy Eating-community trial. CMD were evaluated using the General Health Questionnaire. Frequency of family meals (breakfast and dinner) was categorized as "breakfast and dinner regularly with the family", "at least breakfast or dinner regularly with the family", and "does not have any meal regularly with the family." The effect of family meal frequency on CMD was analyzed using generalized estimation equations with log-binomial models for repeated measures. Setting This study was conducted in public schools (N = 18) of Duque de Caxias, Rio de Janeiro, Brazil, in 2016. Participants Children (aged 9-11 years) and adolescents (aged 12-17 years) from the fifth and sixth grades (N = 2,743). Results These findings suggested that regular family meals were a protective factor for mental health. The adjusted relative risk of CMD was 0.75 (95% confidence interval = 0.69-0.83) for those who had two family meals regularly and 0.87 (95% confidence interval = 0.77-0.97) for those who had only one regular family meal, compared to students who had no regular family meals. Conclusions Potential strategies that educate and encourage families about the mental health benefits of eating regular meals together must be explored and implemented.	[Agathao, Beatriz Tose; Cunha, Diana Barbosa; Sichieri, Rosely; Lopes, Claudia Souza] State Univ Rio de Janeiro UERJ, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Agathao, BT (corresponding author), State Univ Rio de Janeiro UERJ, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil.	beatrizagathao1705@gmail.com		Agathao, Beatriz/0000-0003-3288-5504				ABEP. Codigos e guias, 2016, CCEB CRIT CLASS EC B; Agathao BT, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8260-5; Ahadi Z, 2015, PUBLIC HEALTH, V129, P740, DOI 10.1016/j.puhe.2015.03.019; Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002; Burgess-Champoux TL, 2009, J NUTR EDUC BEHAV, V41, P79, DOI 10.1016/j.jneb.2008.03.113; de Moraes CL, 2018, CHILD ABUSE NEGLECT, V83, P74, DOI 10.1016/j.chiabu.2018.07.008; Eisenberg ME, 2008, J ADOLESCENT HEALTH, V43, P151, DOI 10.1016/j.jadohealth.2008.01.019; Eisenberg ME, 2004, ARCH PEDIAT ADOL MED, V158, P792, DOI 10.1001/archpedi.158.8.792; Elgar FJ, 2004, CLIN PSYCHOL REV, V24, P441, DOI 10.1016/j.cpr.2004.02.002; Fortes S, 2008, REV BRAS PSIQUIATR, V30, P32, DOI 10.1590/S1516-44462006005000066; Fulkerson JA, 2006, J ADOLESCENT HEALTH, V39, P337, DOI 10.1016/j.jadohealth.2005.12.026; Fulkerson JA, 2009, J ADOLESCENT HEALTH, V45, P389, DOI 10.1016/j.jadohealth.2009.02.011; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goodyer IM., 2005, ORIGINS COURSE COMMO; Harbec MJ, 2018, J DEV BEHAV PEDIATR, V39, P136, DOI 10.1097/DBP.0000000000000520; HARRINGTON R, 1990, ARCH GEN PSYCHIAT, V47, P465; Harrison ME, 2015, CAN FAM PHYSICIAN, V61, pE96; Hassan BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200587; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2000, CENS DEM; Jones BL, 2018, PHYSIOL BEHAV, V193, P248, DOI 10.1016/j.physbeh.2018.03.035; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Lopes CS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006690, 10.1590/s01518-8787.2016050006690]; Maragno Luciana, 2006, Cad. Saúde Pública, V22, P1639, DOI 10.1590/S0102-311X2006000800012; MARI JD, 1985, PSYCHOL MED, V15, P651; MARI JD, 1987, REV SAUDE PUBL, V21, P501; MARI JD, 1987, SOC PSYCH PSYCH EPID, V22, P129, DOI 10.1007/BF00583847; Mestdag I, 2005, APPETITE, V45, P62, DOI 10.1016/j.appet.2005.03.003; Musick K, 2012, J MARRIAGE FAM, V74, P476, DOI 10.1111/j.1741-3737.2012.00973.x; Olinto MTA, 2007, PADROES ALIMENTARES; Pereira JCR., 1999, ANALISE DADOS QUALIT; Sgambato MR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3473-3; Silva SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232007; Smith SL, 2020, OTJR-OCCUP PART HEAL, V40, P138, DOI 10.1177/1539449219876878; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Pinheiro KAT, 2007, REV BRAS PSIQUIATR, V29, P241, DOI 10.1590/S1516-44462006005000040; Tessier S, 2005, APPETITE, V45, P121, DOI 10.1016/j.appet.2005.03.015; Utter J, 2017, J NUTR EDUC BEHAV, V49, P67, DOI 10.1016/j.jneb.2016.09.002; White J, 2010, J HEALTH PSYCHOL, V15, P526, DOI 10.1177/1359105309355337; Woodruff SJ, 2009, J ADOLESCENT HEALTH, V44, P431, DOI 10.1016/j.jadohealth.2008.10.141; World Health Organization, 2002, COMMON LANGUAGE FUNC	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0243793	10.1371/journal.pone.0243793	http://dx.doi.org/10.1371/journal.pone.0243793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539371	Green Published, gold			2022-12-26	WOS:000616960200025
J	Christoff, AP; Cruz, GNF; Sereia, AFR; Boberg, DR; de Bastiani, DC; Yamanaka, LE; Fongaro, G; Stoco, PH; Bazzo, ML; Grisard, EC; Hernandes, C; de Oliveira, LFV				Christoff, Ana Paula; Flores Cruz, Giuliano Netto; Rodrigues Sereia, Aline Fernanda; Boberg, Dellyana Rodrigues; de Bastiani, Daniela Carolina; Yamanaka, Lais Eiko; Fongaro, Gislaine; Stoco, Patricia Hermes; Bazzo, Maria Luiza; Grisard, Edmundo Carlos; Hernandes, Camila; Valter de Oliveira, Luiz Felipe			Swab pooling: A new method for large-scale RT-qPCR screening of SARS-CoV-2 avoiding sample dilution	PLOS ONE			English	Article							PCR	To minimize sample dilution effect on SARS-CoV-2 pool testing, we assessed analytical and diagnostic performance of a new methodology, namely swab pooling. In this method, swabs are pooled at the time of collection, as opposed to pooling of equal volumes from individually collected samples. Paired analysis of pooled and individual samples from 613 patients revealed 94 positive individuals. Having individual testing as reference, no false-positives or false-negatives were observed for swab pooling. In additional 18,922 patients screened with swab pooling (1,344 pools), mean Cq differences between individual and pool samples ranged from 0.1 (Cr.I. -0.98 to 1.17) to 2.09 (Cr.I. 1.24 to 2.94). Overall, 19,535 asymptomatic patients were screened using 4,400 RT-qPCR assays. This corresponds to an increase of 4.4 times in laboratory capacity and a reduction of 77% in required tests. Therefore, swab pooling represents a major alternative for reliable and large-scale screening of SARS-CoV-2 in low prevalence populations.	[Christoff, Ana Paula; Flores Cruz, Giuliano Netto; Rodrigues Sereia, Aline Fernanda; Boberg, Dellyana Rodrigues; de Bastiani, Daniela Carolina; Yamanaka, Lais Eiko; Valter de Oliveira, Luiz Felipe] BiomeHub Biotechnol, Florianopolis, SC, Brazil; [Fongaro, Gislaine] Univ Fed Santa Catarina UFSC, Dept Microbiol Imunol & Parasitol, Lab Virol Aplicada, Florianopolis, SC, Brazil; [Stoco, Patricia Hermes; Grisard, Edmundo Carlos] Univ Fed Santa Catarina UFSC, Dept Microbiol Imunol & Parasitol, Lab Protozool, Florianopolis, SC, Brazil; [Bazzo, Maria Luiza] Univ Fed Santa Catarina UFSC, Lab Biol Mol Microbiol & Sorol LBMMS, Florianopolis, SC, Brazil; [Hernandes, Camila] Hosp Israelita Albert Einstein HIAE, Sao Paulo, SP, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Hospital Israelita Albert Einstein	de Oliveira, LFV (corresponding author), BiomeHub Biotechnol, Florianopolis, SC, Brazil.	felipe@lfelipedeoliveira.com	BAZZO, MARIA L/W-5436-2018; Grisard, Edmundo C/A-7338-2015; Christoff, Ana Paula/L-3887-2013	BAZZO, MARIA L/0000-0003-1292-0974; Grisard, Edmundo C/0000-0001-8916-8296; Netto Flores Cruz, Giuliano/0000-0001-9122-8286; Christoff, Ana Paula/0000-0002-0264-6177; Fongaro, Gislaine/0000-0001-5596-3320	BiomeHub Biotechnologies	BiomeHub Biotechnologies	This work was supported by BiomeHub Biotechnologies. The funder provided support in the form of salaries for authors [APC, GNFC, AFR, DRB, DCB, LEY and LFVO], and also helped in the sample collection process, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	[Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; Ben-Ami R, 2020, CLIN MICROBIOL INFEC, V26, P1248, DOI 10.1016/j.cmi.2020.06.009; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Caruana G, 2020, CLIN MICROBIOL INFEC, V26, P1178, DOI 10.1016/j.cmi.2020.06.019; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Cherif A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13075; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dorai-Raj S, 2014, BINOM BINOMIAL CONDE; Eberhardt JN, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104382; Gupta E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236859; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Perchetti GA, 2020, J CLIN VIROL, V131, DOI 10.1016/j.jcv.2020.104570; R Core Team, 2019, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Torres I, 2020, J MED VIROL, V92, P2306, DOI 10.1002/jmv.25971; Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; World Health Organization, 2020, LAB TEST COR DIS COV; Yang PH, 2020, CELL MOL IMMUNOL, V17, P555, DOI 10.1038/s41423-020-0407-x; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531	30	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246544	10.1371/journal.pone.0246544	http://dx.doi.org/10.1371/journal.pone.0246544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0ZY	33539474	Green Published, gold			2022-12-26	WOS:000617317500002
J	Fontes, SG; Morato, RG; Stanzani, SL; Correa, PLP				Fontes, Suelane Garcia; Morato, Ronaldo Goncalves; Stanzani, Silvio Luiz; Pizzigatti Correa, Pedro Luiz			Jaguar movement behavior: using trajectories and association rule mining algorithms to unveil behavioral states and social interactions	PLOS ONE			English	Article							PANTHERA-ONCA; APEX PREDATOR; HABITAT; POPULATION; SELECTION; LIVESTOCK; SPACE	Animal movement data are widely collected with devices such as sensors and collars, increasing the ability of researchers to monitor animal movement and providing information about animal behavioral patterns. Animal behavior is used as a basis for understanding the relationship between animals and the environment and for guiding decision-making by researchers and public agencies about environmental preservation and conservation actions. Animal movement and behavior are widely studied with a focus on identifying behavioral patterns, such as, animal group formation, the distance between animals and their home range. However, we observed a lack of research proposing a unified solution that aggregates resources for analyses of individual animal behavior and of social interactions between animals. The primary scientific contribution of this work is to present a framework that uses trajectory analysis and association rule mining [Jaiswal and Agarwal, 2012] to provide statistical measures of correlation and dependence to determine the relationship level between animals, their social interactions, and their interactions with other environmental factors based on their individual behavior and movement data. We demonstrate the usefulness of the framework by applying it to movement data from jaguars in the Pantanal, Brazil. This allowed us to describe jaguar behavior, social interactions among jaguars and their behavior in different landscapes, thus providing a highly detailed investigation of jaguar movement decisions at the fine scale.	[Fontes, Suelane Garcia; Pizzigatti Correa, Pedro Luiz] Univ Sao Paulo, Escola Politecn, Comp Engn & Digital Syst Dept, Sao Paulo, SP, Brazil; [Morato, Ronaldo Goncalves] ICMBIO, Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Atibaia, SP, Brazil; [Stanzani, Silvio Luiz] Univ Estadual Paulista, UNESP, Ctr Comp Cient, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Fontes, SG (corresponding author), Univ Sao Paulo, Escola Politecn, Comp Engn & Digital Syst Dept, Sao Paulo, SP, Brazil.	suelane@uol.com.br	Corrêa, Pedro Luiz Pizzigatti/G-8519-2012; Garcia Fontes, Suelane/N-5263-2015	Corrêa, Pedro Luiz Pizzigatti/0000-0002-8743-4244; Morato, Ronaldo/0000-0002-8304-9779; Garcia Fontes, Suelane/0000-0003-2753-7310	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SGF, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) - Financial Code 001; We acknowledge the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)-Financial Code 001, the University of Sao Paulo (EPUSP) and the ICMBio-Taiama Ecological Station, with special attention to the environmental analysts of the ICMBIO, Daniel Kantek, Selma Onuma and Thadeu Pereira. We also acknowledge ICMBIO-CENAP for the provision of the Taiama data.	Agrawal R., 1994, P 20 INT C VER LARG, P487; [Anonymous], [No title captured]; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Brin S., 1997, SIGMOD Record, V26, P255, DOI [10.1145/253262.253327, 10.1145/253262.253325]; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Cheraghi F, 2019, ZOOL MIDDLE EAST, V65, P283, DOI 10.1080/09397140.2019.1632538; Concone H.V.B, 2012, COALIZAO MACHOS ONCA; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Cullen L, 2013, ZOOLOGIA-CURITIBA, V30, P379, DOI 10.1590/S1984-46702013000400003; de Azevedo FCC, 2007, J WILDLIFE MANAGE, V71, P2379, DOI 10.2193/2006-520; Dekhtyar A, 2016, DATA 301 INTRO DATA; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fayyad U, 1996, AI MAG, V17, P37; French JT, 2019, MOV ECOL, V7, DOI 10.1186/s40462-019-0183-3; Gaynor KM, 2018, SCIENCE, V360, P1232, DOI 10.1126/science.aar7121; Graw B, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.182160; Gurarie E, 2016, J ANIM ECOL, V85, P69, DOI 10.1111/1365-2656.12379; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hahsler M, 2005, J STAT SOFTW, V14; Hai PN, 2012, ADV INTELLIGENT DATA, P276, DOI [10.1007/978-3-642-34156-4_26, DOI 10.1007/978-3-642-34156-4_26]; Jacob G. M., 2012, Proceedings of the 2012 International Conference on Data Science & Engineering (ICDSE 2012), P69, DOI 10.1109/ICDSE.2012.6282312; Jitendra A., 2012, INT J MODELING OPTIM, V2, P726, DOI [10.7763/IJMO.2012.V2.220, DOI 10.7763/IJMO.2012.V2.220]; Kanda CZ, 2019, J ZOOL, V308, P66, DOI 10.1111/jzo.12655; Li Z., 2010, P 16 ACM SIGKDD INT, P1099, DOI DOI 10.1145/1835804.1835942; Li ZH, 2010, PROC VLDB ENDOW, V3, P723, DOI 10.14778/1920841.1920934; Martinez-Garcia R, 2020, J THEOR BIOL, V498, DOI 10.1016/j.jtbi.2020.110267; Morato RG, 2018, BIOL CONSERV, V228, P233, DOI 10.1016/j.biocon.2018.10.022; Morato RG, 2018, ECOLOGY, V99, P1691, DOI 10.1002/ecy.2379; Morato RG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168176; Quigley H, 2014, 18 C SOC MES BIOL CO; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Souza CM, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12172735; Torres LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168513; Tortato FR, 2017, GLOB ECOL CONSERV, V11, P106, DOI 10.1016/j.gecco.2017.05.003; Tortato FR, 2017, ACTA ETHOL, V20, P69, DOI 10.1007/s10211-016-0241-4; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; Vincenty T., 1975, SURV REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Wang YW, 2013, P IEEE INT C E-SCI, P17, DOI 10.1109/eScience.2013.11; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wu F, 2014, PROC VLDB ENDOW, V7, P1613, DOI 10.14778/2733004.2733043	43	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246233	10.1371/journal.pone.0246233	http://dx.doi.org/10.1371/journal.pone.0246233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539384	gold, Green Published			2022-12-26	WOS:000616960200041
J	Sullens, DG; Gilley, K; Jensen, K; Vichaya, E; Dolan, SL; Sekeres, MJ				Sullens, D. Gregory; Gilley, Kayla; Jensen, Kendall; Vichaya, Elisabeth; Dolan, Sara L.; Sekeres, Melanie J.			Social isolation induces hyperactivity and exploration in aged female mice	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; LONELINESS; ANXIETY; BEHAVIOR; HEALTH; DEPRESSION; PREDICTOR; SYMPTOMS; DEFICITS; STRESS	Prolonged social isolation is associated with poor physical and mental health outcomes, findings observed in both humans, and rodent models of isolation. Humans, like mice, may engage in enhanced exploratory and social behaviour following isolation, which may protect against subsequent cognitive decline and psychological distress. Understanding how these effects may impact behaviour in older adults is particularly relevant, as this population is likely to experience periods of late-life social isolation. We report that late-life social isolation in female mice did not lead to robust depressive-like symptomology, altered social interaction behaviour, sensitivity to context fear acquisition and memory, or alterations in inflammatory cytokines (IL-6, IL-1 beta, Tnf-alpha) or microglial activation (Itgam) within the hippocampus. Rather, isolation increased hyperactivity and exploration behaviours. These findings have translational value as the first female mouse model of late-life social isolation, and provide evidence to inform the development of interventions aimed at promoting functional recovery following isolation in late-life.	[Sullens, D. Gregory; Gilley, Kayla; Jensen, Kendall; Vichaya, Elisabeth; Dolan, Sara L.; Sekeres, Melanie J.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Sekeres, Melanie J.] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada	Baylor University; University of Ottawa	Sekeres, MJ (corresponding author), Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA.; Sekeres, MJ (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON, Canada.	msekeres@uottawa.ca	; Vichaya, Elisabeth/G-3437-2013	Sekeres, Melanie/0000-0002-7952-3175; Vichaya, Elisabeth/0000-0001-9421-7419	Baylor University Undergraduate Research and Scholarly Achievement (URSA) Grant; University Research Committee (URC)	Baylor University Undergraduate Research and Scholarly Achievement (URSA) Grant; University Research Committee (URC)	Funding for the study was provided by a Baylor University Undergraduate Research and Scholarly Achievement (URSA) Grant, and a University Research Committee (URC) Grant to M. J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2016, NEUROPSYCHOPHARMACOL, V41, P1929, DOI 10.1038/npp.2015.364; An D, 2017, ANIM SCI J, V88, P798, DOI 10.1111/asj.12688; Arakawa H, 2018, BEHAV BRAIN RES, V341, P98, DOI 10.1016/j.bbr.2017.12.022; Ashby DM, 2010, BEHAV BRAIN RES, V212, P64, DOI 10.1016/j.bbr.2010.03.041; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Berry A, 2012, PSYCHONEUROENDOCRINO, V37, P762, DOI 10.1016/j.psyneuen.2011.09.007; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cooke BM, 2000, BEHAV BRAIN RES, V117, P107, DOI 10.1016/S0166-4328(00)00301-6; Donnelly EA, 2010, GERONTOLOGIST, V50, P158, DOI 10.1093/geront/gnp103; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Ekwall AK, 2005, J ADV NURS, V49, P23, DOI 10.1111/j.1365-2648.2004.03260.x; Evans IEM, 2019, J ALZHEIMERS DIS, V70, pS119, DOI 10.3233/JAD-180501; Fei XY, 2019, FRONT ZOOL, V16, DOI 10.1186/s12983-019-0339-4; Flanigan TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019058; Guo M, 2004, PROG NEURO-PSYCHOPH, V28, P115, DOI 10.1016/j.pnpbp.2003.09.027; HILAKIVI LA, 1989, PHARMACOL BIOCHEM BE, V33, P371, DOI 10.1016/0091-3057(89)90516-9; Ieraci A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6212983; Inagaki TK, 2016, SOC COGN AFFECT NEUR, V11, P1096, DOI 10.1093/scan/nsv076; Kulesskaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024755; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Liu N, 2020, EUR J NEUROSCI, V52, P2694, DOI 10.1111/ejn.14565; Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; Malatynska E, 2012, EXP GERONTOL, V47, P552, DOI 10.1016/j.exger.2012.04.010; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Newman MG, 2020, LANCET PUBLIC HEALTH, V5, pE12, DOI 10.1016/S2468-2667(19)30253-1; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; Pinna G, 2006, P NATL ACAD SCI USA, V103, P4275, DOI 10.1073/pnas.0600329103; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0; Sekeres MJ, 2018, NEUROSCI LETT, V680, P39, DOI 10.1016/j.neulet.2018.05.006; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Shoji H, 2011, PHYSIOL BEHAV, V102, P58, DOI 10.1016/j.physbeh.2010.10.001; Stephens C, 2011, J AGING HEALTH, V23, P887, DOI 10.1177/0898264311400189; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Takatsu-Coleman AL, 2013, J PSYCHIATR NEUROSCI, V38, P259, DOI 10.1503/jpn.120050; Vogel RW, 2002, LEARN MEMORY, V9, P321, DOI 10.1101/lm.50902; Wang LM, 2018, INT J NEUROPSYCHOPH, V21, P1114, DOI 10.1093/ijnp/pyy084	41	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245355	10.1371/journal.pone.0245355	http://dx.doi.org/10.1371/journal.pone.0245355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534853	Green Published, Green Submitted, gold			2022-12-26	WOS:000616739700066
J	Heuvel, JO; de Wit-van der Veen, BJ; Sinaasappel, M; Slump, CH; Stokkel, MPM				Heuvel, J. olde; de Wit-van der Veen, B. J.; Sinaasappel, M.; Slump, C. H.; Stokkel, M. P. M.			Early differences in dynamic uptake of Ga-68-PSMA-11 in primary prostate cancer: A test-retest study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GA-68-LABELED PSMA LIGAND; HBED-CC; PET/CT; IMPACT; DIAGNOSIS; DISCRIMINATION; RECURRENCE	Introduction Dynamic PET/CT allows visualization of pharmacokinetics over the time, in contrast to static whole body PET/CT. The objective of this study was to assess Ga-68-PSMA-11 uptake in pathological lesions and benign tissue, within 30 minutes after injection in primary prostate cancer (PCa) patients in test-retest setting. Materials and methods Five patients, with biopsy proven PCa, were scanned dynamically in list mode for 30 minutes on a digital PET/CT-scanner directly after an intravenous bolus injection of 100 MBq Ga-68-PSMA-11. Approximately 45 minutes after injection a static whole body scan was acquired, followed by a one bed position scan of the pelvic region. The scans were repeated approximately four weeks later, without any intervention in between. Semi-quantitative assessment was performed using regions-of-interest in the prostate tumor, bladder, gluteal muscle and iliac artery. Time-activity curves were extracted from the counts in these regions and the intra-patient variability between both scans was assessed. Results The uptake of the iliac artery and gluteal muscle reached a plateau after 5 and 3 minutes, respectively. The population fell apart in two groups with respect to tumor uptake: in some patients the tumor uptake reached a plateau after 5 minutes, whereas in other patients the uptake kept increasing, which correlated with larger tumor volumes on PET/CT scan. Median intra-patient variation between both scans was 12.2% for artery, 9.7% for tumor, 32.7% for the bladder and 14.1% for the gluteal muscle. Conclusion Dynamic Ga-68-PSMA-11 PET/CT scans, with a time interval of four weeks, are reproducible with a 10% variation in uptake in the primary prostate tumor. An uptake plateau was reached for the iliac artery and gluteal muscle within 5 minutes post-injection. A larger tumor volume seems to be related to continued tumor uptake. This information might be relevant for both response monitoring and PSMA-based radionuclide therapies.	[Heuvel, J. olde; de Wit-van der Veen, B. J.; Stokkel, M. P. M.] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Nucl Med, Amsterdam, Netherlands; [Heuvel, J. olde; Slump, C. H.] Univ Twente, Tech Med Ctr, Robot & Mechatron, Enschede, Netherlands; [Sinaasappel, M.] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Med Phys, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Twente; Netherlands Cancer Institute	de Wit-van der Veen, BJ (corresponding author), Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Nucl Med, Amsterdam, Netherlands.	l.vd.veen@nki.nl		olde Heuvel, Judith/0000-0003-3219-8608; de Wit - van der Veen, Berlinda (Linda) J./0000-0002-7860-2904	KWF Kankerbestrijding; Technology Foundation STW, as part of their joint strategic research programme `Technology for Oncology' [15175]	KWF Kankerbestrijding(KWF Kankerbestrijding); Technology Foundation STW, as part of their joint strategic research programme `Technology for Oncology'	This research is supported by KWF Kankerbestrijding and Technology Foundation STW, as part of their joint strategic research programme `Technology for Oncology' (Grant number 15175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalbersberg EA, 2019, JOVE-J VIS EXP, DOI 10.3791/59358; Afshar-Oromieh A, 2017, J NUCL MED, V58, P750, DOI 10.2967/jnumed.116.183483; Afshar-Oromieh A, 2016, EUR J NUCL MED MOL I, V43, P1611, DOI 10.1007/s00259-016-3419-0; Afshar-Oromieh A, 2015, EUR J NUCL MED MOL I, V42, P197, DOI 10.1007/s00259-014-2949-6; Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P11, DOI 10.1007/s00259-013-2525-5; Beichel RR, 2016, MED PHYS, V43, P2948, DOI 10.1118/1.4948679; BIGLER SA, 1993, HUM PATHOL, V24, P220, DOI 10.1016/0046-8177(93)90304-Y; Cysouw MCF, 2017, EUR J NUCL MED MOL I, V44, P2105, DOI 10.1007/s00259-017-3775-4; Demirci E, 2016, NUCL MED COMMUN, V37, P1169, DOI 10.1097/MNM.0000000000000566; Demirkol MO, 2015, PROSTATE, V75, P748, DOI 10.1002/pros.22956; Eder M, 2014, PHARMACEUTICALS, V7, P779, DOI 10.3390/ph7070779; Eiber M, 2015, J NUCL MED, V56, P668, DOI 10.2967/jnumed.115.154153; Evans JD, 2018, PRACT RADIAT ONCOL, V8, P28, DOI 10.1016/j.prro.2017.07.011; Heuvel JO, 2020, EUR J NUCL MED MOL I, V47, P2624, DOI 10.1007/s00259-020-04783-1; Hofman MS, 2020, LANCET, V395, P1208, DOI 10.1016/S0140-6736(20)30314-7; Huizing DMV, 2019, EJNMMI PHYS, V6, DOI 10.1186/s40658-019-0253-z; Jansen BHE, 2020, J NUCL MED, V61, P1320, DOI 10.2967/jnumed.119.236075; Jansen BHE, 2019, J NUCL MED, V60, P1730, DOI 10.2967/jnumed.119.227520; Kabasakal L, 2015, NUCL MED COMMUN, V36, P582, DOI 10.1097/MNM.0000000000000290; Lutje S, 2015, THERANOSTICS, V5, P1388, DOI 10.7150/thno.13348; Mafeld S, 2015, BJU INT, V116, P538, DOI 10.1111/bju.12988; Nicholson B, 2001, CANCER METAST REV, V20, P297, DOI 10.1023/A:1015543713485; Perera M, 2016, EUR UROL, V70, P926, DOI 10.1016/j.eururo.2016.06.021; Pollard JH, 2020, J NUCL MED, V61, P1145, DOI 10.2967/jnumed.119.236083; Rauscher I, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0072-6; Sachpekidis C, 2016, EUR J NUCL MED MOL I, V43, P1288, DOI 10.1007/s00259-015-3302-4; Sachpekidis C, 2018, AM J NUCL MED MOLEC, V8, P351; Sachpekidis C, 2016, CLIN NUCL MED, V41, pE473, DOI 10.1097/RLU.0000000000001349; Schmuck S, 2017, CLIN NUCL MED, V42, pe286, DOI 10.1097/RLU.0000000000001589; Uprimny C, 2017, EUR J NUCL MED MOL I, V44, P765, DOI 10.1007/s00259-016-3578-z; Verma S., 2016, CANC DIAGNOSIS MANAG, V118, P6072; Woythal N, 2018, J NUCL MED, V59, P238, DOI 10.2967/jnumed.117.195172; Zamboglou C, 2019, THERANOSTICS, V9, P2595, DOI 10.7150/thno.32376	33	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246394	10.1371/journal.pone.0246394	http://dx.doi.org/10.1371/journal.pone.0246394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529259	Green Published, gold			2022-12-26	WOS:000616736200037
J	Russell, MC; Qureshi, A; Wilson, CG; Cator, LJ				Russell, Marie C.; Qureshi, Alima; Wilson, Christopher G.; Cator, Lauren J.			Size, not temperature, drives cyclopoid copepod predation of invasive mosquito larvae	PLOS ONE			English	Article							MACROCYCLOPS-ALBIDUS COPEPODA; AEDES-ALBOPICTUS; DIPTERA-CULICIDAE; MESOCYCLOPS-ASPERICORNIS; FUNCTIONAL-RESPONSES; BIOLOGICAL-CONTROL; AQUATIC PREDATORS; CULEX-PIPIENS; LIFE-HISTORY; BODY-MASS	During range expansion, invasive species can experience new thermal regimes. Differences between the thermal performance of local and invasive species can alter species interactions, including predator-prey interactions. The Asian tiger mosquito, Aedes albopictus, is a known vector of several viral diseases of public health importance. It has successfully invaded many regions across the globe and currently threatens to invade regions of the UK where conditions would support seasonal activity. We assessed the functional response and predation efficiency (percentage of prey consumed) of the cyclopoid copepods Macrocyclops albidus and Megacyclops viridis from South East England, UK against newly-hatched French Ae. albopictus larvae across a relevant temperature range (15, 20, and 25 degrees C). Predator-absent controls were included in all experiments to account for background prey mortality. We found that both M. albidus and M. viridis display type II functional response curves, and that both would therefore be suitable biocontrol agents in the event of an Ae. albopictus invasion in the UK. No significant effect of temperature on the predation interaction was detected by either type of analysis. However, the predation efficiency analysis did show differences due to predator species. The results suggest that M. viridis would be a superior predator against invasive Ae. albopictus larvae due to the larger size of this copepod species, relative to M. albidus. Our work highlights the importance of size relationships in predicting interactions between invading prey and local predators.	[Russell, Marie C.; Qureshi, Alima; Wilson, Christopher G.; Cator, Lauren J.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	Imperial College London	Russell, MC (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.	m.russell17@imperial.ac.uk		Russell, Marie/0000-0001-6907-6159	European Union [731060]; Imperial College London	European Union(European Commission); Imperial College London(General Electric)	This project has received resources funded by the European Union's Horizon 2020 research and innovation program under grant agreement No 731060 (Infravec2). The work was primarily funded by a President's PhD Scholarship from Imperial College London awarded to MCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; ABDULLAHI BA, 1985, OECOLOGIA, V67, P295, DOI 10.1007/BF00384303; ALCARAZ M, 1988, HYDROBIOLOGIA, V167, P409, DOI 10.1007/BF00026333; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Awasthi AK, 2012, ZOOL STUD, V51, P927; Baldacchino F, 2017, EUR ZOOL J, V84, P43, DOI 10.1080/11250003.2016.1271028; Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BLAUSTEIN L, 1994, ISR J ZOOL, V40, P55; Bolker B, 2008, ECOLOGICAL MODELS DA; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham KP, 2002, MODEL SELECTION MULT, P149, DOI [10.1007/978-0-387-22456-5_4, DOI 10.1007/978-0-387-22456-5_4]; Centers for Disease Control and Prevention, 2017, SURV CONTR AED AEG A; Charnov EL., 1973, OPTIMAL FORAGING SOM; Coelho P, 2017, COPEPODS AEDES MOSQU; Coker R. E., 1933, Internationale Revue der Hydrobiologie Leipzig, V29, P406, DOI 10.1002/iroh.19330290504; Cuthbert RN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51705-9; Cuthbert RN, 2018, J VECTOR ECOL, V43, P334, DOI 10.1111/jvec.12318; Cuthbert RN, 2019, J MED ENTOMOL, V56, P276, DOI 10.1093/jme/tjy155; Cuthbert RN, 2018, BIOL CONTROL, V121, P50, DOI 10.1016/j.biocontrol.2018.02.008; Daane KM, 1996, ENVIRON ENTOMOL, V25, P1224, DOI 10.1093/ee/25.5.1224; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Dhanker R, 2013, HYDROBIOLOGIA, V716, P147, DOI 10.1007/s10750-013-1559-9; Dieng H, 2003, J AM MOSQUITO CONTR, V19, P67; Dussart BH, 1969, COPEPODES EAUX CONTI; Dussart BH, 2001, INTRO COPEPODA; Einsle U, 1993, CRUSTACEA COPEPODA C, P208; EINSLE UK, 1988, HYDROBIOLOGIA, V167, P387, DOI 10.1007/BF00026330; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; European Centre for Disease P Control cartographers, AED ALB CURR KNOWN D; Fruh L, 2019, J VECTOR ECOL, V44, P241, DOI 10.1111/jvec.12355; FRYER G, 1957, J ANIM ECOL, V26, P263, DOI 10.2307/1747; FRYER G., 1957, PROC ZOOL SOC LONDON, V129, P1; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178, DOI DOI 10.1201/9781003059813; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kalinoski RM, 2016, OECOLOGIA, V180, P543, DOI 10.1007/s00442-015-3487-z; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; Kiefer F., 1960, RUDERFU KREBSE COPEP; Klekowski RZ, 1966, ERNAHRUNG ATMUNG WAC, P399; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Kumar R, 2008, MAR FRESHWATER RES, V59, P817, DOI 10.1071/MF07143; Kumar R, 2006, ZOOL STUD, V45, P447; Kumar RM, 2003, INT REV HYDROBIOL, V88, P570, DOI 10.1002/iroh.200310631; LAYBOURNPARRY J, 1988, CAN J ZOOL, V66, P2709, DOI 10.1139/z88-397; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; MAIER G, 1994, FRESHWATER BIOL, V31, P77, DOI 10.1111/j.1365-2427.1994.tb00840.x; Marten G. G., 1990, ARBOVIRUS RES AUST, V5, P159; Marten GG, 2007, J AM MOSQUITO CONTR, V23, P65, DOI 10.2987/8756-971X(2007)23[65:CC]2.0.CO;2; MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491, DOI 10.1007/BF00229976; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P689; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5; Metelmann S, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0761; Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640; Paradis AR, 1996, CAN J FISH AQUAT SCI, V53, P1226, DOI 10.1139/cjfas-53-6-1226; Peters RH, 1983, ECOLOGICAL IMPLICATI, P100; Pritchard DW, 2017, METHODS ECOL EVOL, V8, P1528, DOI 10.1111/2041-210X.12784; Rall BC, 2012, PHILOS T R SOC B, V367, P2923, DOI 10.1098/rstb.2012.0242; Rao T. Ramakrishna, 2002, Aquatic Ecology, V36, P411; Rosenbaum B, 2018, METHODS ECOL EVOL, V9, P2076, DOI 10.1111/2041-210X.13039; Russell BM, 1996, MED VET ENTOMOL, V10, P155, DOI 10.1111/j.1365-2915.1996.tb00722.x; Schreiber ET, 1996, J AM MOSQUITO CONTR, V12, P688; SUAREZ MF, 1992, J AM MOSQUITO CONTR, V8, P409; Twardochleb LA, 2012, ECOL APPL, V22, P1162, DOI 10.1890/11-0871.1; Uiterwaal SF, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2975; Veronesi R, 2015, J AM MOSQUITO CONTR, V31, P32, DOI 10.2987/13-6381.1; Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035; Wojnacki Jose, 2014, Small GTPases, V5, pe28430; Zidon R, 2016, ECOL APPL, V26, P1198, DOI 10.1890/15-1045	73	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246178	10.1371/journal.pone.0246178	http://dx.doi.org/10.1371/journal.pone.0246178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529245	Green Submitted, Green Published, gold			2022-12-26	WOS:000616736200011
J	Dizhoor, AM; Olshevskaya, EV; Peshenko, IV				Dizhoor, Alexander M.; Olshevskaya, Elena, V; Peshenko, Igor, V			Retinal degeneration-3 protein promotes photoreceptor survival by suppressing activation of guanylyl cyclase rather than accelerating GMP recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RD3 PROTEIN; ROD; CALCIUM; BINDING; GCAPS; PHOTOTRANSDUCTION; SENSITIVITY; CLONING; RETGC; EXPRESSION	Retinal degeneration-3 protein (RD3) deficiency causes photoreceptor dysfunction and rapid degeneration in the rd3 mouse strain and in human Leber's congenital amaurosis, a congenital retinal dystrophy that results in early vision loss. However, the mechanisms responsible for photoreceptor death remain unclear. Here, we tested two hypothesized biochemical events that may underlie photoreceptor death: (i) the failure to prevent aberrant activation of retinal guanylyl cyclase (RetGC) by calcium-sensor proteins (GCAPs) versus (ii) the reduction of GMP phosphorylation rate, preventing its recycling to GDP/GTP. We found that GMP converts to GDP/GTP in the photoreceptor fraction of the retina similar to 24-fold faster in WT mice and similar to 400-fold faster in rd3 mice than GTP conversion to cGMP by RetGC. Adding purified RD3 to the retinal extracts inhibited RetGC 4-fold but did not affect GMP phosphorylation in wildtype or rd3 retinas. RD3-deficient photoreceptors rapidly degenerated in rd3 mice that were reared in constant darkness to prevent light-activated GTP consumption via RetGC and phosphodiesterase 6. In contrast, rd3 degeneration was alleviated by deletion of GCAPs. After 2.5 months, only similar to 40% of photoreceptors remained in rd3/rd3 retinas. Deletion of GCAP1 or GCAP2 alone preserved 68% and 57% of photoreceptors, respectively, whereas deletion of GCAP1 and GCAP2 together preserved 86%. Taken together, our in vitro and in vivo results support the hypothesis that RD3 prevents photoreceptor death primarily by suppressing activation of RetGC by both GCAP1 and GCAP2 but do not support the hypothesis that RD3 plays a significant role in GMP recycling.	[Dizhoor, Alexander M.; Olshevskaya, Elena, V; Peshenko, Igor, V] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM; Peshenko, IV (corresponding author), Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA.	dizhoor@salus.edu; ipenshenko@salus.edu			National Institutes of Health from NEI [EY11522]; Pennsylvania Department of Health	National Institutes of Health from NEI; Pennsylvania Department of Health	We thank Dr Nikolai Artemyev for a generous gift of purified PDE6. This work was supported by National Institutes of Health grant EY11522 from NEI and by a CURE Formula grant from Pennsylvania Department of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Berg J. M., 2015, BIOCHEMISTRY-US, V8th; BERGER SJ, 1980, J BIOL CHEM, V255, P3128; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dizhoor AM, 2019, J BIOL CHEM, V294, P13729, DOI 10.1074/jbc.RA119.009948; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; HALL SW, 1986, EUR J BIOCHEM, V161, P551, DOI 10.1111/j.1432-1033.1986.tb10477.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Olshevskaya E. V., 2004, J NEUROSCI; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Perrault I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051622; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2020, J BIOL CHEM, V295, P10781, DOI 10.1074/jbc.RA120.013789; Peshenko IV, 2019, J BIOL CHEM, V294, P2318, DOI 10.1074/jbc.RA118.006106; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Plana-Bonamaiso A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2255-0; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	43	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100362	10.1016/j.jbc.2021.100362	http://dx.doi.org/10.1016/j.jbc.2021.100362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539922	gold, Green Published			2022-12-26	WOS:000672866400336
J	Yu, H; Zhong, HM; Li, N; Chen, KZ; Chen, JJ; Sun, J; Xu, LL; Wang, J; Zhang, MG; Liu, XH; Deng, LF; Huang, P; Huang, SY; Shen, X; Zhong, YS				Yu, Huan; Zhong, Huimin; Li, Na; Chen, Kaizhe; Chen, Junjue; Sun, Jun; Xu, Lili; Wang, Jing; Zhang, Mingui; Liu, Xiaohong; Deng, Lianfu; Huang, Ping; Huang, Shouyue; Shen, Xi; Zhong, Yisheng			Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma	FASEB JOURNAL			English	Article						glaucoma; microglia; osteopontin; p38 MAPK signaling pathway; rat	OPTIC-NERVE HEAD; CYTOKINE EXPRESSION; IMMUNE-MECHANISMS; MOUSE MODEL; RAT MODEL; RECEPTOR; COMPRESSION; INHIBITION; APOPTOSIS; AUTOPHAGY	Microglia activation and release of pro-inflammatory cytokines have been closely linked to glaucoma. However, the mechanisms that initiate these pathways remain unclear. Here, we investigated the role of a pro-inflammatory cytokine--osteopontin (OPN), in retinal microglia activation process along with the underlying mechanisms in glaucoma. A rat chronic ocular hypertension (COH) model was established presenting an increase in retinal OPN level and activation of microglia. Primary microglia cells were isolated and cultured under a pressure culture system showing heightened expressions of microglia-derived OPN with changes in inflammatory factors (TNF-alpha, IL-1 beta, and IL-6). OPN and OPN neutralizing antibody (Anti-OPN) interventions were both applied systems for comparison, and cross-referenced with OPN knockdown in vitro. JAK/STAT, NF-kappa B, ERK1/2, and p38 MAPK, recognized as the primary signaling pathways related to microglia activation, were then screened on whether they can facilitate OPN to act on microglia and their impact on specific inhibitors. Thereafter, retrograde labeling of retinal ganglion cells (RGCs) and flash visual evoked potentials (F-VEP) were used to investigate neuron protection in context of each blockade. Results suggest that OPN is able to enhance the proliferation and activation of retinal microglia in experimental glaucoma which may play a role in the glaucomatous optic neuropathy, and contribute to the eventual RGCs loss and vision function impairment. Such effect may be mediated through the regulation of p38 MAPK signaling pathway.	[Yu, Huan; Zhong, Huimin; Li, Na; Chen, Junjue; Sun, Jun; Wang, Jing; Zhang, Mingui; Liu, Xiaohong; Huang, Shouyue; Shen, Xi; Zhong, Yisheng] Shanghai Jiao Tong Univ, Affiliated Med Sch, Dept Ophthalmol, Ruijin Hosp, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China; [Chen, Kaizhe; Deng, Lianfu; Huang, Ping] Shanghai Jiao Tong Univ, Affiliated Med Sch, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Bone & Joint Dis,Ruijin Hosp, Shanghai, Peoples R China; [Xu, Lili] Shanghai Jiao Tong Univ, Affiliated Med Sch, Ruijin Hosp, Dept Emergency, Shanghai, Peoples R China; [Zhong, Yisheng] Shanghai Jiao Tong Univ, Affiliated Med Sch, Ruijin Hosp, Dept Ophthalmol,Zhoushan Branch, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, X; Zhong, YS (corresponding author), Shanghai Jiao Tong Univ, Affiliated Med Sch, Dept Ophthalmol, Ruijin Hosp, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	carl_shen2005@126.com; yszhong68@126.com			National Natural Science Foundation of China (NSFC) [81870652, 82070953, 82000885]; Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation) [2020LP034, 2018JP008]; Ruijin Youth NSFC Cultivation Foundation [2019QNPY01026]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation); Ruijin Youth NSFC Cultivation Foundation	National Natural Science Foundation of China (NSFC), Grant/Award Number: NO. 81870652, NO. 82070953 and NO. 82000885; Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation), Grant/Award Number: NO. 2020LP034 and NO. 2018JP008; Ruijin Youth NSFC Cultivation Foundation, Grant/Award Number: NO. 2019QNPY01026	Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Birke MT, 2010, INVEST OPHTH VIS SCI, V51, P5759, DOI 10.1167/iovs.10-5558; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Broom L, 2015, EXP NEUROL, V263, P1, DOI 10.1016/j.expneurol.2014.09.005; Chan KC, 2019, ACTA BIOMATER, V94, P219, DOI 10.1016/j.actbio.2019.06.005; Chang SW, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00058; Chen X, 2017, MOL MED REP, V15, P2890, DOI 10.3892/mmr.2017.6327; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6443, DOI 10.1167/iovs.11-7409; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Dong LD, 2015, J NEUROSCI, V35, P5409, DOI 10.1523/JNEUROSCI.4376-14.2015; Dong N, 2014, MOL VIS, V20, P616; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Esposito E, 2018, J NEUROCHEM, V146, P160, DOI 10.1111/jnc.14337; Gramlich OW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0542-6; Hazenbiller O, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0148-6; Huang RH, 2017, CELL PHYSIOL BIOCHEM, V41, P1851, DOI 10.1159/000471933; Huang SY, 2017, NEUROSCIENCE, V341, P27, DOI 10.1016/j.neuroscience.2016.11.019; Jo AO, 2017, J PHYSIOL-LONDON, V595, P6499, DOI 10.1113/JP274562; Kamat SS, 2016, SEMIN OPHTHALMOL, V31, P147, DOI 10.3109/08820538.2015.1114858; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kong YXG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.026; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Kupenova P, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000128; Kurtenbach S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00263; Lavery WJ, 2012, INVEST OPHTH VIS SCI, V53, P560, DOI 10.1167/iovs.11-8429; Liu XH, 2016, INVEST OPHTH VIS SCI, V57, P776, DOI 10.1167/iovs.15-18024; Lo JY, 2015, FOOD FUNCT, V6, P3550, DOI 10.1039/c5fo00607d; Lozano DC, 2019, INVEST OPHTH VIS SCI, V60, P921, DOI 10.1167/iovs.18-25700; Mac Nair CE, 2015, PROG MOL BIOL TRANSL, V134, P343, DOI 10.1016/bs.pmbts.2015.06.010; Moreno M, 2014, Arch Soc Esp Oftalmol, V89, P471, DOI 10.1016/j.oftal.2014.05.011; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Nettelhoff L, 2016, CLIN ORAL INVEST, V20, P621, DOI 10.1007/s00784-015-1542-0; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Rabenstein M, 2016, J NEUROIMMUNOL, V299, P130, DOI 10.1016/j.jneuroim.2016.09.009; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Song FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149991; Swiatkowski P, 2016, NEUROSCIENCE, V318, P22, DOI 10.1016/j.neuroscience.2016.01.008; Tambuyzer BR, 2012, CELL BIOL INT, V36, P1233, DOI 10.1042/CBI20120172; Tan HB, 2012, EXP THER MED, V4, P401, DOI 10.3892/etm.2012.619; Vargas JLC, 2015, J NEUROSCI, V35, P12088, DOI 10.1523/JNEUROSCI.1273-15.2015; Wang AYM, 2020, CLIN EXP OPTOM, V103, P562, DOI 10.1111/cxo.13031; Wang JW, 2016, J GLAUCOMA, V25, P459, DOI 10.1097/IJG.0000000000000200; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Wen XY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00162; Wu JH, 2015, NEUROBIOL DIS, V74, P167, DOI 10.1016/j.nbd.2014.11.014; Xu YF, 2012, J INT MED RES, V40, P1438, DOI 10.1177/147323001204000422; Yang WL, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00008; Yu H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925852; Yu H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1879437; Zhen PY, 2017, EXP EYE RES, V162, P97, DOI 10.1016/j.exer.2017.06.014; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhu SH, 2017, INFLAMMATION, V40, P1475, DOI 10.1007/s10753-017-0571-z; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	58	12	12	8	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21405	10.1096/fj.202002218R	http://dx.doi.org/10.1096/fj.202002218R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559950				2022-12-26	WOS:000629576700029
J	Jie, J; Chu, X; Li, D; Luo, ZQ				Jie, Jing; Chu, Xiao; Li, Dan; Luo, Zhaoqing			A set of shuttle plasmids for gene expression in Acinetobacter baumannii	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; COPY NUMBER; REPLICATION; SEQUENCE; IDENTIFICATION; PURIFICATION; PATHOGENS; COMPLEX	Infections caused by the emerging opportunistic bacterial pathogen Acinetobacter baumannii are occurring at increasingly alarming rates, and such increase in incidence is further compounded by the development of wide spread multidrug-resistant strains. Yet, our understanding of its pathogenesis and biology remains limited which can be attributed in part to the scarce of tools for molecular genetic analysis of this bacterium. Plasmids based on pWH1277 originally isolated from Acinetobacter calcoaceticus are the only vehicles currently available for ectopic gene expression in Acinetobacter species, which restricts experiments that require simultaneous analysis of multiple genes. Here, we found that plasmids of the IncQ group are able to replicate in A. baumannii and can stably co-reside with derivatives of pWH1277. Furthermore, we have constructed a series of four plasmids that allow inducible expression of Flag-tagged proteins in A. baumannii by arabinose or isopropyl beta-d-1-thiogalactopyranoside. Together with constructs previously developed, these plasmids will accommodate the need in genetic analysis of this increasingly important pathogen.	[Jie, Jing; Chu, Xiao; Li, Dan; Luo, Zhaoqing] First Hosp Jilin Univ, Dept Resp Med, Key Lab Organ Regenerat & Transplantat, Minist Educ, Changchun, Jilin, Peoples R China; [Jie, Jing; Chu, Xiao; Li, Dan; Luo, Zhaoqing] First Hosp Jilin Univ, Ctr Infect & Immun, Key Lab Organ Regenerat & Transplantat, Minist Educ, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Li, D; Luo, ZQ (corresponding author), First Hosp Jilin Univ, Dept Resp Med, Key Lab Organ Regenerat & Transplantat, Minist Educ, Changchun, Jilin, Peoples R China.	lisa05@yeah.net; luoz@jlu.edu.cn		Luo, Zhao-Qing/0000-0001-8890-6621	National Major Science and Technology Projects of China [2017ZX10302301-002]; First Hospital of Jilin University	National Major Science and Technology Projects of China; First Hospital of Jilin University	This study was supported in the form of funding by the National Major Science and Technology Projects of China (Grant number: 2017ZX10302301-002) awarded to DL. The First Hospital of Jilin University provided funding in the form of salaries to JJ, XC, and DL.	Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; COOK DM, 1992, J BACTERIOL, V174, P6238, DOI 10.1128/JB.174.19.6238-6246.1992; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; FREY J, 1992, GENE, V113, P101, DOI 10.1016/0378-1119(92)90675-F; Geisinger E, 2019, ANNU REV MICROBIOL, V73, P481, DOI 10.1146/annurev-micro-020518-115714; Geisinger E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007030; Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691; GUERRY P, 1974, J BACTERIOL, V117, P619, DOI 10.1128/JB.117.2.619-630.1974; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; HERSHFIE.V, 1974, P NATL ACAD SCI USA, V71, P3455, DOI 10.1073/pnas.71.9.3455; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Juttukonda LJ, 2016, MBIO, V7, DOI 10.1128/mBio.01475-16; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lucidi M, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02480-17, 10.1128/aac.02480-17]; MARRA A, 1989, J BACTERIOL, V171, P2238, DOI 10.1128/jb.171.4.2238-2240.1989; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; MILLER J H, 1972, P466; Moynie L, 2018, ELIFE, V7, DOI 10.7554/eLife.42270; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Nairn BL, 2016, CELL HOST MICROBE, V19, P826, DOI 10.1016/j.chom.2016.05.007; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Rawlings DE, 2001, MICROBIOL MOL BIOL R, V65, P481, DOI 10.1128/MMBR.65.4.481-496.2001; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; SCHERZINGER E, 1984, P NATL ACAD SCI-BIOL, V81, P654, DOI 10.1073/pnas.81.3.654; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skariyachan S, 2019, CRIT REV MICROBIOL, V45, P315, DOI 10.1080/1040841X.2019.1600472; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wang ND, 2014, MBIO, V5, DOI 10.1128/mBio.01163-14; Weber BS, 2017, TRENDS MICROBIOL, V25, P533, DOI 10.1016/j.tim.2017.01.005; Wong D, 2017, CLIN MICROBIOL REV, V30, P409, DOI 10.1128/CMR.00058-16; Yildirim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22110	50	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246918	10.1371/journal.pone.0246918	http://dx.doi.org/10.1371/journal.pone.0246918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566854	Green Published, gold			2022-12-26	WOS:000618271700056
J	Lapidaire, W; Urrila, AS; Artiges, E; Miranda, R; Vulser, H; Bezivin-Frere, P; Lemaitre, H; Penttila, J; Banaschewski, T; Bokde, ALW; Bromberg, U; Buchel, C; Conrod, PJ; Desrivieres, S; Frouin, V; Gallinat, J; Garavan, H; Gowland, P; Heinz, A; Ittermann, B; Papadopoulos-Orfanos, D; Paus, T; Smolka, MN; Schumann, G; Martinot, MLP; Martinot, JL				Lapidaire, Winok; Urrila, Anna S.; Artiges, Eric; Miranda, Ruben; Vulser, Helene; Bezivin-Frere, Pauline; Lemaitre, Herve; Penttila, Jani; Banaschewski, Tobias; Bokde, Arun L. W.; Bromberg, Uli; Buchel, Christian; Conrod, Patricia J.; Desrivieres, Sylvane; Frouin, Vincent; Gallinat, Jurgen; Garavan, Hugh; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Papadopoulos-Orfanos, Dimitri; Paus, Tomas; Smolka, Michael N.; Schumann, Gunter; Martinot, Marie-Laure Paillere; Martinot, Jean-Luc		IMAGEN Consortium	Irregular sleep habits, regional grey matter volumes, and psychological functioning in adolescents	PLOS ONE			English	Article							TYPICALLY DEVELOPING-CHILDREN; NEUROIMAGING FINDINGS; BRAIN; CONNECTIVITY; IMPULSIVITY; PERFORMANCE; DISORDER; HEALTH; ADULTS	Changing sleep rhythms in adolescents often lead to sleep deficits and a delay in sleep timing between weekdays and weekends. The adolescent brain, and in particular the rapidly developing structures involved in emotional control, are vulnerable to external and internal factors. In our previous study in adolescents at age 14, we observed a strong relationship between weekend sleep schedules and regional medial prefrontal cortex grey matter volumes. Here, we aimed to assess whether this relationship remained in this group of adolescents of the general population at the age of 16 (n = 101; mean age 16.8 years; 55% girls). We further examined grey matter volumes in the hippocampi and the amygdalae, calculated with voxel-based morphometry. In addition, we investigated the relationships between sleep habits, assessed with self-reports, and regional grey matter volumes, and psychological functioning, assessed with the Strengths and Difficulties Questionnaire and tests on working memory and impulsivity. Later weekend wake-up times were associated with smaller grey matter volumes in the medial prefrontal cortex and the amygdalae, and greater weekend delays in wake-up time were associated with smaller grey matter volumes in the right hippocampus and amygdala. The medial prefrontal cortex region mediated the correlation between weekend wake up time and externalising symptoms. Paying attention to regular sleep habits during adolescence could act as a protective factor against the emergence of psychopathology via enabling favourable brain development.	[Lapidaire, Winok; Urrila, Anna S.; Artiges, Eric; Miranda, Ruben; Vulser, Helene; Bezivin-Frere, Pauline; Lemaitre, Herve; Penttila, Jani; Martinot, Marie-Laure Paillere; Martinot, Jean-Luc] Univ Paris Saclay, Ecole Normale Super Paris Saclay, CNRS,Natl Inst Hlth & Med Res, Ctr Borelli,INSERM UA10 Trajectoires Dev & Psychi, Gif Sur Yvette, France; [Urrila, Anna S.] Natl Inst Hlth & Welf, Dept Hlth, Unit Mental Hlth, Helsinki, Finland; [Urrila, Anna S.] Univ Helsinki, Dept Psychiat Adolescent Psychiat, Helsinki, Finland; [Urrila, Anna S.] Univ Cent Hosp, Helsinki, Finland; [Artiges, Eric] EPS Barthelemy Durand, Psychiat Dept, Etampes, France; [Penttila, Jani] Tampere Univ, Med Sch, Adolescent Psychiat Dept, Tampere, Finland; [Banaschewski, Tobias] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Bokde, Arun L. W.; Garavan, Hugh; Schumann, Gunter] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Bromberg, Uli; Buchel, Christian] Univ Hosp Hamburg Eppendorf, Hamburg, Germany; [Conrod, Patricia J.; Desrivieres, Sylvane] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Conrod, Patricia J.] Univ Montreal, CHU Ste Justine Hosp, Dept Psychiat, Montreal, PQ, Canada; [Desrivieres, Sylvane; Schumann, Gunter] Genet & Dev Psychiat SGDP Ctr, MRC Social, London, England; [Frouin, Vincent; Papadopoulos-Orfanos, Dimitri] Commiss Atom & Alternat Energy, Neurospin, Saclay, France; [Gallinat, Jurgen; Heinz, Andreas; Ittermann, Bernd] Charite Univ Med Ctr Berlin, Dept Psychiat & Psychotherapy, Campus Charite Mitte, Berlin, Germany; [Garavan, Hugh] Univ Vermont, Dept Psychiat, 6436 UHC, Burlington, VT USA; [Garavan, Hugh] Univ Vermont, Dept Psychol, 6436 UHC, Burlington, VT 05405 USA; [Gowland, Penny] Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham, England; [Paus, Tomas] Univ Toronto, Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Bloorview Res Inst, Dept Psychol, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Bloorview Res Inst, Dept Psychiat, Toronto, ON, Canada; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany; [Martinot, Marie-Laure Paillere] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Child & Adolescent Psychiat, Paris, France; [Martinot, Jean-Luc] ICM Inst, Ctr Neuroimaging Res, CENIR, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Trinity College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; King's College London; Universite de Montreal; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Vermont; University of Vermont; University of Nottingham; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University of Toronto; Technische Universitat Dresden; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Martinot, JL (corresponding author), Univ Paris Saclay, Ecole Normale Super Paris Saclay, CNRS,Natl Inst Hlth & Med Res, Ctr Borelli,INSERM UA10 Trajectoires Dev & Psychi, Gif Sur Yvette, France.; Martinot, JL (corresponding author), ICM Inst, Ctr Neuroimaging Res, CENIR, Paris, France.	jean-luc.martinot@inserm.fr	Gowland, Penny A./I-9016-2012; Desrivières, Sylvane/ABC-4336-2021; Artiges, Eric/AAT-7219-2021; Heinz, Andreas/ABB-7736-2020	Gowland, Penny A./0000-0002-4900-4817; Desrivières, Sylvane/0000-0002-9120-7060; Artiges, Eric/0000-0003-4461-7646; Heinz, Andreas/0000-0001-5405-9065; Lapidaire, Winok/0000-0002-3703-0735; Schumann, Gunter/0000-0003-4905-5523; Sarvasmaa (Urrila), Anna Sofia/0000-0002-2807-0954; MIRANDA, RUBEN/0000-0002-9445-7348	European Union-funded FP6 Integrated Project IMAGEN [LSHM-CT-2007-037286]; agence nationale de la recherche [ANR-12-SAMA-0004, ANR-19CE37-0017-03]; Eranet [ANR-18-NEUR00002-01ADORe, AF12-NEUR0008-01 -WM2NA]; Fondation pour la Recherche Medicale [DPA20140629802]; Mission Interministerielle de Lutte Contre les Drogues et les Conduites Addictives; Fondation de France [00081242]; Federation pour la Recherche sur le Cerveau; Academy of Finland [276612]; Emil Aaltosen Saatio Foundation; Jalmari ja Rauha Ahokkaan Saatio Foundation; IDEX Paris Saclay; INSERM -APHP 2010 interface grant	European Union-funded FP6 Integrated Project IMAGEN; agence nationale de la recherche(French National Research Agency (ANR)); Eranet; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Mission Interministerielle de Lutte Contre les Drogues et les Conduites Addictives; Fondation de France(Fondation de France); Federation pour la Recherche sur le Cerveau; Academy of Finland(Academy of Finland); Emil Aaltosen Saatio Foundation; Jalmari ja Rauha Ahokkaan Saatio Foundation; IDEX Paris Saclay; INSERM -APHP 2010 interface grant	This study was funded by the European Union-funded FP6 Integrated Project IMAGEN (LSHM-CT-2007-037286), agence nationale de la recherche (ANR-12-SAMA-0004 and ANR-19CE37-0017-03), Eranet (ANR-18-NEUR00002-01ADORe and AF12-NEUR0008-01 -WM2NA), Fondation pour la Recherche Medicale (DPA20140629802), Mission Interministerielle de Lutte Contre les Drogues et les Conduites Addictives, and Fondation de France (00081242) in the form of grants awarded to JLM. This study was also funded by the Federation pour la Recherche sur le Cerveau in the form of a grant awarded to MLP and JLM. This study was also funded by the Academy of Finland (276612), Emil Aaltosen Saatio Foundation, and Jalmari ja Rauha Ahokkaan Saatio Foundation in the form of grants awarded to ASU and in the form of grants from IDEX Paris Saclay and INSERM -APHP 2010 interface grant awarded to HV.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bootzin RR, 2011, ANNU REV CLIN PSYCHO, V7, P435, DOI 10.1146/annurev.clinpsy.3.022806.091516; Cambridge Cognition Ltd, 2013, CANTAB NORM DAT; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Cho SS, 2013, BRAIN TOPOGR, V26, P479, DOI 10.1007/s10548-012-0270-x; Colman I, 2007, AM J PSYCHIAT, V164, P126, DOI 10.1176/appi.ajp.164.1.126; Colman I, 2009, BMJ-BRIT MED J, V338, DOI [10.1136/bmj.a2981, 10.1136/bmj.b777]; Coutinho JF, 2015, CHRONOBIOL INT, V32, P143, DOI 10.3109/07420528.2014.955187; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; Faridi N, 2015, NEUROPSYCHOLOGY, V29, P82, DOI 10.1037/neu0000079; Forbes EE, 2010, J AM ACAD CHILD PSY, V49, P162, DOI 10.1016/j.jaac.2009.11.006; Galvan A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.006.2010; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hagenauer MH, 2009, DEV NEUROSCI-BASEL, V31, P276, DOI 10.1159/000216538; Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Imai K., 2010, CAUSAL MEDIATION ANA, P129, DOI DOI 10.1007/978-1-4419-1764-5_8; Kaplan B. A., 2014, CTR APPL NEUROECONOM; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Merikanto I, 2017, CHRONOBIOL INT, V34, P225, DOI 10.1080/07420528.2016.1267739; Motomura Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00306; O'Byrne JN, 2014, PATHOL BIOL, V62, P262, DOI 10.1016/j.patbio.2014.05.013; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Robinson JL, 2018, DEV COGN NEUROS-NETH, V31, P1, DOI 10.1016/j.dcn.2018.03.012; Rosenberg J, 2018, BRAIN STRUCT FUNCT, V223, P3411, DOI 10.1007/s00429-018-1697-y; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Suleiman AB, 2017, J ADOLESCENT HEALTH, V60, P240, DOI 10.1016/j.jadohealth.2016.12.010; Taki Y, 2012, NEUROIMAGE, V60, P471, DOI 10.1016/j.neuroimage.2011.11.072; Tashjian SM, 2017, DEV COGN NEUROS-NETH, V27, P35, DOI 10.1016/j.dcn.2017.07.006; Taylor A, 2008, SLEEP BIOL RHYTHMS, V6, P172, DOI 10.1111/j.1479-8425.2008.00356.x; Teicher MH, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2018.1450594; Tesler N, 2013, CURR OPIN PSYCHIATR, V26, P572, DOI 10.1097/YCO.0b013e328365a335; Urrila AS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41678; Wileyto EP, 2004, BEHAV RES METH INS C, V36, P41, DOI 10.3758/BF03195548; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	42	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0243720	10.1371/journal.pone.0243720	http://dx.doi.org/10.1371/journal.pone.0243720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566829	Green Published, gold			2022-12-26	WOS:000618271700035
J	De Armond, CC; Kim, SE; Lewis, DD; Biedryzcki, AH; Banks, SA; Cook, JL; Keister, JD				De Armond, Christina C.; Kim, Stanley E.; Lewis, Daniel D.; Biedryzcki, Adam H.; Banks, Scott A.; Cook, James L.; Keister, Justin D.			Three-dimensional-printed custom guides for bipolar coxofemoral osteochondral allograft in dogs	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; KNEE; INSTRUMENTATION; PRESERVATION; DISSECANS; VIABILITY; ACCURACY; INJURIES; SYSTEM	The objective of this experimental study was to develop and evaluate a three-dimensionally printed custom surgical guide system for performing bipolar coxofemoral osteochondral allograft transplantation in dogs. Five cadaver dogs, weighing 20-38 kg were used in the study. Custom surgical guides were designed and three-dimensionally printed to facilitate accurate execution of a surgical plan for bipolar coxofemoral osteochondral allograft transplantation. Guide-assisted technique was compared to freehand technique in each cadaver. Surgical time was recorded and postoperative computed tomography and three-dimensional segmentation was performed. Femoral version and inclination angles, femoral neck length, and gap present at the femoral and acetabular donor-recipient interface was compared between the virtual surgical plan and postoperative outcome for both techniques. One-tailed paired t-test (P < .05) was used for statistical analysis. When compared to free-hand preparation, mean donor femoral preparation time was 10 minutes longer and mean recipient preparation time was 2 minutes longer when using guides (p = 0.011 and p = 0.001, respectively). No difference in acetabular preparation time was noted between groups. Gap volume at the acetabular and femoral donor-recipient interface was not different between groups. Mean difference between the planned and postoperative version angle was 6.2 degrees lower for the guide group when compared to the freehand group (p = 0.025). Mean femoral neck length was 2 mm closer to the plan when using guides than when performing surgery freehand (p = 0.037). Accuracy for femoral angle of inclination was not different between groups. Custom surgical guides warrants consideration in developing bipolar coxofemoral osteochondral allograft transplantation as an alternative surgical technique for managing hip disorders in dogs.	[De Armond, Christina C.; Kim, Stanley E.; Lewis, Daniel D.] Univ Florida, Coll Vet Med, Small Anim Clin Sci, Gainesville, FL 32611 USA; [Biedryzcki, Adam H.] Univ Florida, Coll Vet Med, Large Anim Clin Sci, Gainesville, FL USA; [Banks, Scott A.; Keister, Justin D.] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL USA; [Cook, James L.] Univ Missouri, Dept Orthopaed Surg, Thompson Lab Regenerat Orthopaed, Columbia, MO USA; [Cook, James L.] Univ Missouri, Mizzou BioJoint Ctr, Columbia, MO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kim, SE (corresponding author), Univ Florida, Coll Vet Med, Small Anim Clin Sci, Gainesville, FL 32611 USA.	stankim@ufl.edu	Banks, Scott Arthur/B-6345-2008	Banks, Scott Arthur/0000-0003-0404-6826; De Armond, Christina/0000-0001-8302-2798	University of Florida College of Veterinary Medicine	University of Florida College of Veterinary Medicine(University of Florida)	Authors: SK, AB, SB. University of Florida College of Veterinary Medicine Fall Faculty Research Development Award Grant, 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAVER RJ, 1992, J BONE JOINT SURG BR, V74, P105, DOI 10.1302/0301-620X.74B1.1732235; BioMedtrix Inc, 2008, CAN MOD TOT HIP REPL; Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192; Bugbee WD, 1999, CLIN SPORT MED, V18, P67, DOI 10.1016/S0278-5919(05)70130-7; Cook JL, 2016, AM J SPORT MED, V44, P1260, DOI 10.1177/0363546516629434; Cook JL, 2014, CLIN ORTHOP RELAT R, V472, P3404, DOI 10.1007/s11999-014-3773-9; Cypher T J, 1996, J Foot Ankle Surg, V35, P413; CZITROM AA, 1990, J BONE JOINT SURG AM, V72A, P574, DOI 10.2106/00004623-199072040-00016; Demange M, 2012, CURR REV MUSCULOSKE, V5, P229, DOI 10.1007/s12178-012-9132-0; Donnez M, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0872-4; Familiari F, 2018, AM J SPORT MED, V46, P3541, DOI 10.1177/0363546517732531; Fitzpatrick N, 2012, VET COMP ORTHOPAED, V25, P135, DOI 10.3415/VCOT-10-09-0134; Giannini S, 2010, FOOT ANKLE INT, V31, P38, DOI 10.3113/FAI.2010.0038; Hall EL, 2019, VET SURG, V48, P584, DOI 10.1111/vsu.13126; Hamilton WG, 2013, J ARTHROPLASTY, V28, P96, DOI 10.1016/j.arth.2013.04.049; Hamilton-Bennett SE, 2018, VET SURG, V47, P236, DOI 10.1111/vsu.12734; Hunter WVI, 1743, PHILOS T R SOC LOND, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Johnson KA, 2014, PIERMATTEIS ATLAS SU, P322; King MD, 2017, VET CLIN N AM-SMALL, V47, P753, DOI 10.1016/j.cvsm.2017.03.001; Kuroki K, 2017, TOXICOL PATHOL, V45, P931, DOI 10.1177/0192623317735786; LANGER F, 1974, J BONE JOINT SURG AM, VA 56, P297, DOI 10.2106/00004623-197456020-00007; Liau JJ, 2002, CLIN BIOMECH, V17, P140, DOI 10.1016/S0268-0033(01)00109-7; Lynch AC, 2019, VET COMP ORTHOPAED, V32, P139, DOI 10.1055/s-0039-1677751; Mahaisavariya B, 2002, MED ENG PHYS, V24, P617, DOI 10.1016/S1350-4533(02)00113-3; Mccoy AM, 2013, OSTEOARTHR CARTILAGE, V21, P1638, DOI 10.1016/j.joca.2013.08.011; MCGRORY BJ, 1995, J BONE JOINT SURG BR, V77B, P865, DOI 10.1302/0301-620X.77B6.7593096; Meric G, 2015, AM J SPORT MED, V43, P709, DOI 10.1177/0363546514562549; Miyake Junichi, 2012, J Bone Joint Surg Am, V94, pe150, DOI 10.2106/JBJS.K.00829; Nelson LL, 2007, VET SURG, V36, P644, DOI 10.1111/j.1532-950X.2007.00316.x; Ng VY, 2012, CLIN ORTHOP RELAT R, V470, P99, DOI 10.1007/s11999-011-1996-6; Nunley RM, 2012, CLIN ORTHOP RELAT R, V470, P889, DOI 10.1007/s11999-011-2221-3; Oladeji LO, 2017, AM J SPORT MED, V45, P2797, DOI 10.1177/0363546517715725; Rucinski K, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119884291; Schiller TD, 2017, VET CLIN N AM-SMALL, V47, P899, DOI 10.1016/j.cvsm.2017.03.005; Shi JH, 2019, INT ORTHOP, V43, P619, DOI 10.1007/s00264-018-4043-3; Stannard JP, 2020, AM J SPORT MED, V48, P1356, DOI 10.1177/0363546520907101; Stoker AM, 2018, AM J SPORT MED, V46, P58, DOI 10.1177/0363546517727516; Tetteh ES, 2012, J ORTHOP SPORT PHYS, V42, P243, DOI 10.2519/jospt.2012.3673; TWYMAN RS, 1991, J BONE JOINT SURG BR, V73, P461, DOI 10.1302/0301-620X.73B3.1670450; Worth AJ, 2019, VET COMP ORTHOPAED, V32, P241, DOI 10.1055/s-0039-1678701	40	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0244208	10.1371/journal.pone.0244208	http://dx.doi.org/10.1371/journal.pone.0244208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561146	Green Published, gold			2022-12-26	WOS:000617533000020
J	Ali, S; Borin, TF; Piranlioglu, R; Ara, R; Lebedyeva, I; Angara, K; Achyut, BR; Arbab, AS; Rashid, MH				Ali, Sehar; Borin, Thaiz F.; Piranlioglu, Raziye; Ara, Roxan; Lebedyeva, Iryna; Angara, Kartik; Achyut, Bhagelu R.; Arbab, Ali Syed; Rashid, Mohammad H.			Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study	PLOS ONE			English	Article							STIMULATING FACTOR-1 RECEPTOR; INFILTRATING MYELOID CELLS; MARROW-DERIVED CELLS; RECURRENT GLIOBLASTOMA; SELECTIVE INHIBITOR; MDSC INFILTRATION; SUPPRESSOR-CELLS; VASCULAR MIMICRY; ANIMAL-MODEL; CANCER	Glioblastoma (GBM) is a hypervascular and aggressive primary malignant tumor of the central nervous system. Recent investigations showed that traditional therapies along with antiangiogenic therapies failed due to the development of post-therapy resistance and recurrence. Previous investigations showed that there were changes in the cellular and metabolic compositions in the tumor microenvironment (TME). It can be said that tumor cell-directed therapies are ineffective and rethinking is needed how to treat GBM. It is hypothesized that the composition of TME-associated cells will be different based on the therapy and therapeutic agents, and TME-targeting therapy will be better to decrease recurrence and improve survival. Therefore, the purpose of this study is to determine the changes in the TME in respect of T-cell population, M1 and M2 macrophage polarization status, and MDSC population following different treatments in a syngeneic model of GBM. In addition to these parameters, tumor growth and survival were also studied following different treatments. The results showed that changes in the TME-associated cells were dependent on the therapeutic agents, and the TME-targeting therapy improved the survival of the GBM bearing animals. The current GBM therapies should be revisited to add agents to prevent the accumulation of bone marrow-derived cells in the TME or to prevent the effect of immune-suppressive myeloid cells in causing alternative neovascularization, the revival of glioma stem cells, and recurrence. Instead of concurrent therapy, a sequential strategy would be better to target TME-associated cells.	[Ali, Sehar; Borin, Thaiz F.; Piranlioglu, Raziye; Ara, Roxan; Arbab, Ali Syed; Rashid, Mohammad H.] Augusta Univ, Georgia Canc Ctr, Lab Tumor Angiogenesis Initiat, Augusta, GA 30912 USA; [Lebedyeva, Iryna] Augusta Univ, Dept Chem & Phys, Augusta, GA USA; [Angara, Kartik] Michigan State Univ, Dept Pediat & Human Dev, Grand Rapids, MI USA; [Achyut, Bhagelu R.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Rashid, Mohammad H.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Michigan State University; Emory University; Cedars Sinai Medical Center	Arbab, AS; Rashid, MH (corresponding author), Augusta Univ, Georgia Canc Ctr, Lab Tumor Angiogenesis Initiat, Augusta, GA 30912 USA.; Rashid, MH (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA.	aarbab@augusta.edu; MohammadHarun.Rashid@cshs.org	Rashid, Mohammad Harun/E-3985-2019	Rashid, Mohammad Harun/0000-0003-1056-4910; Arbab, Ali/0000-0003-2902-3671	Georgia Cancer Center startup fund; Augusta University	Georgia Cancer Center startup fund; Augusta University	This study was supported by the Georgia Cancer Center startup fund and intramural grant program at Augusta University to Ali S. Arbab (ASA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14079-4; Achyut BR, 2016, CANCER BIOL THER, V17, P280, DOI 10.1080/15384047.2016.1139243; Achyut BR, 2015, CANCER LETT, V369, P416, DOI 10.1016/j.canlet.2015.09.004; Achyut BR, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-252; Achyut BR, 2016, ONCOTARGETS THER, V9, P1047, DOI 10.2147/OTT.S102907; Acker G, 2020, EUR J CANCER, V126, P106, DOI 10.1016/j.ejca.2019.12.005; Ali MM, 2013, TRANSL ONCOL, V6, P660, DOI 10.1593/tlo.13559; Angara K, 2018, NEOPLASIA, V20, P1070, DOI 10.1016/j.neo.2018.08.011; Angara Kartik, 2017, Histol Histopathol, V32, P917, DOI 10.14670/HH-11-856; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Arbab AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122732; Arbab AS, 2012, HISTOL HISTOPATHOL, V27, P549, DOI 10.14670/HH-27.549; Borin TF, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-1043; Borin TF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178830; Borin TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116247; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Carter TC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6204676; Caudill JS, 2011, AM J CLIN ONCOL-CANC, V34, P385, DOI 10.1097/COC.0b013e3181e8461a; Chen L, 2019, AM J PHYSIOL-HEART C, V316, pH1468, DOI 10.1152/ajpheart.00690.2018; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Cheng Y, 2019, BBA-REV CANCER, V1871, P289, DOI 10.1016/j.bbcan.2019.01.005; Choi J, 2018, HISTOL HISTOPATHOL, V33, P133, DOI 10.14670/HH-11-916; Dhermain F, 2005, B CANCER, V92, P333; Di Mitri D, 2019, CELL REP, V28, P2156, DOI 10.1016/j.celrep.2019.07.068; Diaz RJ, 2017, J NEURO-ONCOL, V133, P455, DOI 10.1007/s11060-017-2477-x; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Ding ZC, 2014, CANCER RES, V74, P3441, DOI 10.1158/0008-5472.CAN-13-3596; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Endo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21991; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Gerstner ER, 2011, J NEURO-ONCOL, V103, P325, DOI 10.1007/s11060-010-0390-7; Ghose A, 2010, CURR ONCOL, V17, P52; Guo AM, 2007, J PHARMACOL EXP THER, V321, P18, DOI 10.1124/jpet.106.115360; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Gupta K, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00503; Gupta SK, 2014, CLIN CANCER RES, V20, P3730, DOI 10.1158/1078-0432.CCR-13-3446; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han YX, 2020, ADV EXP MED BIOL, V1248, P547, DOI 10.1007/978-981-15-3266-5_22; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jain M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41809; Janic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037577; Johnson BW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092565; Kim MM, 2018, CANCER J, V24, P180, DOI 10.1097/PPO.0000000000000326; Kumar Sanath, 2013, Zhong Liu Za Zhi, V1, P16; Kumar S, 2012, J NEURO-ONCOL, V108, P411, DOI 10.1007/s11060-012-0846-z; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Labelle M, 2014, P NATL ACAD SCI USA, V111, pE3053, DOI 10.1073/pnas.1411082111; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Lesueur P, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5413-y; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu KH, 2015, ONCOTARGET, V6, P5088, DOI 10.18632/oncotarget.3243; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Mann J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00748; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani Alberto, 2004, Novartis Found Symp, V256, P137; Mazaris P, 2014, CLIN NEUROL NEUROSUR, V120, P103, DOI 10.1016/j.clineuro.2014.03.001; Mehta M, 2014, SEMIN ONCOL, V41, pS1, DOI 10.1053/j.seminoncol.2014.09.007; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Noch EK, 2018, WORLD NEUROSURG, V116, P505, DOI 10.1016/j.wneu.2018.04.022; Ouzounova M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14979; Pasqualetti F, 2018, AM J CLIN ONCOL-CANC, V41, P1272, DOI 10.1097/COC.0000000000000464; Pawelek JM, 2008, FUTURE ONCOL, V4, P449, DOI 10.2217/14796694.4.4.449; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Huong PT, 2019, CANCERS, V11, DOI 10.3390/cancers11020240; Piranlioglu R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09015-1; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Qiu SQ, 2018, CANCER TREAT REV, V70, P178, DOI 10.1016/j.ctrv.2018.08.010; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Remer Sandra, 2004, Clin J Oncol Nurs, V8, P368, DOI 10.1188/04.CJON.368-376; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2; Richardsen E, 2015, ANTICANCER RES, V35, P865; Rivera LB, 2015, CELL REP, V11, P577, DOI 10.1016/j.celrep.2015.03.055; Runa F, 2017, Curr Mol Biol Rep, V3, P218, DOI 10.1007/s40610-017-0073-7; Salminen A, 2018, AGEING RES REV, V48, P1, DOI 10.1016/j.arr.2018.09.001; Salminen A, 2018, BIOGERONTOLOGY, V19, P325, DOI 10.1007/s10522-018-9762-8; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Schlesinger M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0669-2; Seki T, 2005, BIOL PHARM BULL, V28, P1651, DOI 10.1248/bpb.28.1651; Shaaban S, 2016, Int J Cancer Res, V12, P69; Shankar A, 2016, ONCOTARGETS THER, V9, P1205, DOI 10.2147/OTT.S93790; Shankar A, 2014, CHIN J CANCER, V33, P148, DOI 10.5732/cjc.013.10095; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soda Y, 2013, J MOL MED, V91, P439, DOI 10.1007/s00109-013-1019-z; Stafford JH, 2016, NEURO-ONCOLOGY, V18, P797, DOI 10.1093/neuonc/nov272; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Tamura R, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.11; Tan SK, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00218; Tesi RJ, 2019, TRENDS PHARMACOL SCI, V40, P4, DOI 10.1016/j.tips.2018.10.008; Tipping M, 2017, J CLIN NEUROSCI, V44, P101, DOI 10.1016/j.jocn.2017.06.070; Tripathi C, 2014, ONCOTARGET, V5, P5350, DOI 10.18632/oncotarget.2110; Tsang DS, 2015, CLIN ONCOL-UK, V27, P176, DOI 10.1016/j.clon.2014.11.026; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Umansky V, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040036; Uzuka T, 2014, J NEURO-ONCOL, V116, P299, DOI 10.1007/s11060-013-1291-3; van Linde ME, 2017, J NEURO-ONCOL, V135, P183, DOI 10.1007/s11060-017-2564-z; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; Wang SL, 2019, AM J CANCER RES, V9, P1161; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Yan MJ, 2016, BBA-MOL CELL RES, V1863, P392, DOI 10.1016/j.bbamcr.2015.07.008; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946; Zhou YD, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00100; Zhu P, 2017, ONCOTARGET, V8, P44015, DOI 10.18632/oncotarget.17054; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	118	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246646	10.1371/journal.pone.0246646	http://dx.doi.org/10.1371/journal.pone.0246646			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544755	gold, Green Published			2022-12-26	WOS:000617991900042
J	Figueiredo, CVB; Santiago, RP; Guarda, CC; Oliveira, RM; Fiuza, LM; Yahouedehou, SCMA; Carvalho, SP; Neres, JSD; Oliveira, AMD; Fonseca, CA; Nascimento, VML; Lyra, IM; Aleluia, MM; Goncalves, MS				Boas Figueiredo, Camylla Vilas; Santiago, Rayra Pereira; Guarda, Caroline Conceicao; Oliveira, Rodrigo Mota; Fiuza, Luciana Magalhaes; Alexandre Yahouedehou, Setondji Cocou Modeste; Carvalho, Suellen Pinheiro; dos Santos Neres, Joelma Santana; de Jesus Oliveira, Antonio Mateus; Fonseca, Cleverson Alves; Lopes Nascimento, Valma Maria; Lyra, Isa Menezes; Aleluia, Milena Magalhaes; Goncalves, Marilda Souza			Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers	PLOS ONE			English	Article							OXIDE SYNTHASE GENE; NITRIC-OXIDE; PLASMA ENDOTHELIN-1; RISK-FACTORS; ENOS GENE; HEMOLYSIS; ANEMIA; COMPLICATIONS; DYSFUNCTION; CHILDREN	Priapism is a urologic emergency characterized by an uncontrolled, persistent and painful erection in the absence of sexual stimulation, which can lead to penile fibrosis and impotence. It is highly frequent in sickle cell disease (SCD) associated with hemolytic episodes. Our aim was to investigate molecules that may participate in the regulation of vascular tone. Eighty eight individuals with SCD were included, of whom thirty-seven reported a history of priapism. Priapism was found to be associated with alterations in laboratory biomarkers, as well as lower levels of HbF. Patients with sickle cell anemia using hydroxyurea and those who received blood products seemed to be less affected by priapism. Multivariate analysis suggested that low HbF and NOm were independently associated with priapism. The frequency of polymorphisms in genes NOS3 and EDN1 was not statistically significant between the studied groups, and the presence of the variant allele was not associated with alterations in NOm and ET-1 levels in patients with SCD. The presence of the variant allele in the polymorphisms investigated did not reveal any influence on the occurrence priapism. Future studies involving larger samples, as well as investigations including patients in priapism crisis, could contribute to an enhanced understanding of the development of priapism in SCD.	[Boas Figueiredo, Camylla Vilas; Santiago, Rayra Pereira; Guarda, Caroline Conceicao; Oliveira, Rodrigo Mota; Fiuza, Luciana Magalhaes; Alexandre Yahouedehou, Setondji Cocou Modeste; Carvalho, Suellen Pinheiro; dos Santos Neres, Joelma Santana; de Jesus Oliveira, Antonio Mateus; Goncalves, Marilda Souza] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Boas Figueiredo, Camylla Vilas; Santiago, Rayra Pereira; Guarda, Caroline Conceicao; Oliveira, Rodrigo Mota; Fiuza, Luciana Magalhaes; Alexandre Yahouedehou, Setondji Cocou Modeste; Carvalho, Suellen Pinheiro; dos Santos Neres, Joelma Santana; de Jesus Oliveira, Antonio Mateus; Fonseca, Cleverson Alves; Goncalves, Marilda Souza] Univ Fed Bahia, Salvador, BA, Brazil; [Lopes Nascimento, Valma Maria] Fundacao Hematol & Hemoterapia Bahia HEMOBA, Salvador, BA, Brazil; [Lyra, Isa Menezes] Complexo Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil; [Aleluia, Milena Magalhaes] Univ Estadual Santa Cruz, Ilheus, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Estadual de Santa Cruz	Goncalves, MS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Goncalves, MS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.	mari@bahia.fiocruz.br	Yahouedehou, Modeste/AAA-4406-2022; Aleluia, Milena M/F-2517-2019; Gonçalves, Marilda/AAO-4559-2021; Aleluia, Milena/AAI-7971-2021	Aleluia, Milena M/0000-0001-6928-824X; Gonçalves, Marilda/0000-0003-3000-1437; Yahouedehou, Setondji Cocou Modeste Alexandre/0000-0003-4219-1311; Fonseca, Cleverson/0000-0002-8251-988X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 470959/2014-2, 405595/2016-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work from MSG was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 470959/2014-2 and 405595/2016-6). SCMAY, RPS, and SPC received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES), Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Adeyoju AB, 2002, BJU INT, V90, P898, DOI 10.1046/j.1464-410X.2002.03022.x; Aggarwal PK, 2009, J HYPERTENS, V27, P2044, DOI 10.1097/HJH.0b013e32832f7f3f; Ahmed SG, 2006, ANN SAUDI MED, V26, P439, DOI 10.5144/0256-4947.2006.439; Alagbe AE, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.017; Aleluia MM, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0454-1; Almeida LEF, 2020, NITRIC OXIDE-BIOL CH, V94, P79, DOI 10.1016/j.niox.2019.10.011; Ballas SK, 2016, J CLIN APHERESIS, V31, P5, DOI 10.1002/jca.21394; Barden AE, 2001, J HYPERTENS, V19, P1775, DOI 10.1097/00004872-200110000-00011; Bivalacqua TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068028; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Burnett AL, 2002, J ANDROL, V23, P92, DOI 10.1002/j.1939-4640.2002.tb02601.x; Chester Adrian H, 2017, Glob Cardiol Sci Pract, V2017, P14, DOI 10.21542/gcsp.2017.14; Chong SS, 2000, BLOOD, V95, P360; Cita KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154866; da Guarda CC, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8842362; Donaldson JF, 2014, J PEDIATR UROL, V10, P11, DOI 10.1016/j.jpurol.2013.07.024; Dubert M, 2017, BLOOD, V130, P2215, DOI 10.1182/blood-2016-12-755777; Elliott L, 2007, BRIT J HAEMATOL, V137, P262, DOI 10.1111/j.1365-2141.2007.06560.x; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Glueck CJ, 2010, AM J CARDIOL, V105, P792, DOI 10.1016/j.amjcard.2009.10.062; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; Granger JP, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0828-4; Hendrix P, 2017, NITRIC OXIDE-BIOL CH, V71, P52, DOI 10.1016/j.niox.2017.10.008; Houde M, 2016, ADV PHARMACOL, V77, P143, DOI 10.1016/bs.apha.2016.05.002; Jaja S I, 2016, Pathophysiology, V23, P81, DOI 10.1016/j.pathophys.2016.04.004; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10; Kato GJ, 2012, J SEX MED, V9, P70, DOI 10.1111/j.1743-6109.2011.02287.x; Khorshied MM, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22264; Madu AJ, 2014, MED PRIN PRACT, V23, P259, DOI 10.1159/000360608; Makis AC, 2000, ANN HEMATOL, V79, P407, DOI 10.1007/s002770000173; Montague DK, 2003, J UROLOGY, V170, P1318, DOI 10.1097/01.ju.0000087608.07371.ca; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Nishank SS, 2013, J HUM GENET, V58, P775, DOI 10.1038/jhg.2013.99; Nishank SS, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.036; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; POILLON WN, 1993, P NATL ACAD SCI USA, V90, P5039, DOI 10.1073/pnas.90.11.5039; Rogers ZR, 2005, HEMATOL ONCOL CLIN N, V19, P917, DOI 10.1016/j.hoc.2005.08.003; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Saad STO, 2004, AM J HEMATOL, V77, P45, DOI 10.1002/ajh.20142; Salonia A, 2014, EUR UROL, V65, P480, DOI 10.1016/j.eururo.2013.11.008; Sandoval YHG, 2014, CURR VASC PHARMACOL, V12, P202, DOI 10.2174/1570161112666140226122054; Seixas MO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-91; Sharan K, 2004, BRIT J HAEMATOL, V124, P240, DOI 10.1046/j.1365-2141.2003.04762.x; Sinici I, 2010, UROLOGY, V75, P955, DOI 10.1016/j.urology.2009.06.063; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Sundd P, 2019, ANNU REV PATHOL-MECH, V14, P263, DOI 10.1146/annurev-pathmechdis-012418-012838; Thakur TJ, 2014, GENE REGUL SYST BIO, V8, P119, DOI 10.4137/GRSB.S14836; Vargas AE, 2005, TISSUE ANTIGENS, V66, P683, DOI 10.1111/j.1399-0039.2005.00506.x; Vilas-Boas W, 2016, GENE REGUL SYST BIO, V10, P67, DOI 10.4137/GRSB.S38276; Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z; Wang XL, 2000, MOL GENET METAB, V70, P241, DOI 10.1006/mgme.2000.3033	57	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246067	10.1371/journal.pone.0246067	http://dx.doi.org/10.1371/journal.pone.0246067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539452	Green Published, gold			2022-12-26	WOS:000616960200087
J	Rathod, YD; Di Fulvio, M				Rathod, Yakshkumar Dilipbhai; Di Fulvio, Mauricio			The feeding microstructure of male and female mice	PLOS ONE			English	Article							PORTION SIZE LEADS; FOOD-INTAKE; ENERGY-INTAKE; BODY-WEIGHT; MEAL FREQUENCY; SOCIAL-ISOLATION; PHYSIOLOGICAL ROLES; SUSTAINED INCREASE; LABORATORY MICE; EATING PATTERNS	The feeding pattern and control of energy intake in mice housed in groups are poorly understood. Here, we determined and quantified the normal feeding microstructure of social male and female mice of the C57BL/6J genetic background fed a chow diet. Mice at 10w, 20w and 30w of age showed the expected increase in lean and fat mass, being the latter more pronounced and variable in males than in females. Under ad libitum conditions, 20w and 30w old females housed in groups showed significantly increased daily energy intake when adjusted to body weight relative to age-matched males. This was the combined result of small increases in energy intake during the nocturnal and diurnal photoperiods of the day without major changes in the circadian pattern of energy intake or spontaneous ambulatory activity. The analysis of the feeding microstructure suggests sex- and age-related contributions of meal size, meal frequency and intermeal interval to the control of energy intake under stable energy balance, but not under negative energy balance imposed by prolonged fasting. During the night, 10-20w old females ate less frequently bigger meals and spent more time eating them resulting in reduced net energy intake relative to age-matched males. In addition, male and female mice at all ages tested significantly shortened the intermeal interval during the first hours of re-feeding in response to fasting without affecting meal size. Further, 20-30w old males lengthened their intermeal interval as re-feeding time increased to reach fed-levels faster than age-matched females. Collectively, our results suggest that the physiological mechanisms controlling meal size (satiation) and the non-eating time spent between meals (satiety) during stable or negative energy balance are regulated in a sex- and age-dependent manner in social mice.	[Rathod, Yakshkumar Dilipbhai; Di Fulvio, Mauricio] Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Di Fulvio, M (corresponding author), Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	Mauricio.DiFulvio@wright.edu			American Diabetes Association; National Institutes of Health [1-17-IBS-258, R21DK113446-01]	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research has been supported in part by funds from the American Diabetes Association and National Institutes of Health Grants #1-17-IBS-258 and R21DK113446-01 to MDiF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov U, 2004, BEHAV BRAIN RES, V155, P1, DOI 10.1016/j.bbr.2004.03.027; Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Atalayer D, 2010, AM J PHYSIOL-REG I, V298, pR1667, DOI 10.1152/ajpregu.00562.2009; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Bake T, 2014, APPETITE, V77, P60, DOI 10.1016/j.appet.2014.02.020; Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104; Ben Menachem-Zidon O, 2008, NEUROPSYCHOPHARMACOL, V33, P2251, DOI 10.1038/sj.npp.1301606; Benelam B, 2009, NUTR BULL, V34, P126, DOI 10.1111/j.1467-3010.2009.01753.x; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; BLAUSTEIN JD, 1976, PHYSIOL BEHAV, V17, P201, DOI 10.1016/0031-9384(76)90064-0; Butera PC, 2010, PHYSIOL BEHAV, V99, P142, DOI 10.1016/j.physbeh.2009.10.009; CASTONGUAY TW, 1986, BRAIN RES BULL, V17, P439, DOI 10.1016/0361-9230(86)90252-2; CHVEDOFF M, 1980, FOOD COSMET TOXICOL, V18, P517, DOI 10.1016/0015-6264(80)90167-4; Cintron-Colon Rigo, 2019, Temperature (Austin), V6, P158, DOI 10.1080/23328940.2019.1607653; Cintron-Colon R, 2017, P NATL ACAD SCI USA, V114, P9731, DOI 10.1073/pnas.1617876114; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Clinthorne JF, 2010, J NUTR, V140, P1495, DOI 10.3945/jn.110.122408; Corrigan JK, 2020, ELIFE, V9, DOI 10.7554/eLife.53560; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; Demaria-Pesce VH, 1998, PHYSIOL BEHAV, V65, P157, DOI 10.1016/S0031-9384(98)00159-0; Diliberti N, 2004, OBES RES, V12, P562, DOI 10.1038/oby.2004.64; Eckel LA, 2004, PHYSIOL BEHAV, V82, P35, DOI 10.1016/j.physbeh.2004.04.023; Espinosa-Carrasco J, 2018, ADDICT BIOL, V23, P531, DOI 10.1111/adb.12595; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Furnes MW, 2009, OBES SURG, V19, P1430, DOI 10.1007/s11695-009-9863-1; Geary N, 2005, AM J PHYSIOL-REG I, V288, pR1444, DOI 10.1152/ajpregu.00066.2005; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Goebel M, 2011, PEPTIDES, V32, P36, DOI 10.1016/j.peptides.2010.09.027; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Gotthardt JD, 2017, PHYSIOL BEHAV, V174, P49, DOI 10.1016/j.physbeh.2017.02.046; Gruda MC, 2010, J AM ASSOC LAB ANIM, V49, P826; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; Halm ST, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13137; Hart RA, 2017, ENDOCR CONNECT, V6, P20, DOI 10.1530/EC-16-0089; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Jeffery RW, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-27; JENKINS DJA, 1989, NEW ENGL J MED, V321, P929, DOI 10.1056/NEJM198910053211403; JENNINGS G, 1986, COMP BIOCHEM PHYS A, V85, P583, DOI 10.1016/0300-9629(86)90451-2; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kamakura R, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12703; Kappel S, 2017, ANIMALS, V7, DOI 10.3390/ani7120088; Kelly MT, 2009, BRIT J NUTR, V102, P470, DOI 10.1017/S0007114508201960; Kless C, 2017, EUR J CLIN NUTR, V71, P306, DOI 10.1038/ejcn.2016.243; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kral TVE, 2004, AM J CLIN NUTR, V79, P962; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Landsberg L, 2012, OBES REV, V13, P97, DOI 10.1111/j.1467-789X.2012.01040.x; LANGHANS W, 1987, BEHAV NEURAL BIOL, V47, P7, DOI 10.1016/S0163-1047(87)90112-9; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Leidy HJ, 2011, J NUTR, V141, P154, DOI 10.3945/jn.109.114389; Levitsky DA, 2004, J NUTR, V134, P2546, DOI 10.1093/jn/134.10.2546; Lin LG, 2014, J NUTR, V144, P1349, DOI 10.3945/jn.114.191171; Livingstone MBE, 2014, ADV NUTR, V5, P829, DOI 10.3945/an.114.007104; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Maher RL, 2015, AM J PHYSIOL-REG I, V308, pR1070, DOI 10.1152/ajpregu.00407.2014; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; Mattson MP, 2005, LANCET, V365, P1978, DOI 10.1016/S0140-6736(05)66667-6; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; MCLAREN A, 1961, Q J EXP PHYSIOL CMS, V46, P38, DOI 10.1113/expphysiol.1961.sp001513; Mesas AE, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00936.x; Molcan L, 2019, ONLINE APPL, P805960, DOI [10.1101/805960%JbioRxiv, DOI 10.1101/805960%JBIORXIV]; Mousel MR, 2001, J ANIM SCI, V79, P861; Nagy TR, 2002, OBES RES, V10, P412, DOI 10.1038/oby.2002.57; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Palmer MA, 2009, NUTR REV, V67, P379, DOI 10.1111/j.1753-4887.2009.00204.x; Pearcey SM, 2002, AM J CLIN NUTR, V76, P107, DOI 10.1093/ajcn/76.1.107; Pedroso JAB, 2016, ENDOCRINOLOGY, V157, P3901, DOI 10.1210/en.2016-1038; Pernold K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211063; Peters SM, 2015, EUR J PHARMACOL, V759, P42, DOI 10.1016/j.ejphar.2015.03.043; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Richard CD, 2011, EUR J PHARMACOL, V660, P131, DOI 10.1016/j.ejphar.2010.12.022; Rivera HM, 2018, STEROIDS, V133, P44, DOI 10.1016/j.steroids.2017.11.011; Rolls BJ, 2006, J AM DIET ASSOC, V106, P543, DOI 10.1016/j.jada.2006.01.014; Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207, DOI 10.1093/ajcn/76.6.1207; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Sakakibara H, 2012, J TOXICOL SCI, V37, P1071, DOI 10.2131/jts.37.1071; Sanchez-Alavez M, 2011, AGE, V33, P89, DOI 10.1007/s11357-010-9164-6; Schipper L, 2018, OBES REV, V19, P614, DOI 10.1111/obr.12663; Schipper L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225488; Shemesh Y, 2013, ELIFE, V2, DOI [10.7554/eLife.00759, 10.7554/eLife.03602]; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; So NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134509; Steinert RE, 2017, PHYSIOL REV, V97, P411, DOI 10.1152/physrev.00031.2014; STROHMAYER AJ, 1987, APPETITE, V8, P111, DOI 10.1016/S0195-6663(87)80004-1; Strubbe JH, 2004, PSYCHOL REV, V111, P128, DOI 10.1037/0033-295X.111.1.128; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Tabarin A, 2007, EUR J NEUROSCI, V26, P2303, DOI 10.1111/j.1460-9568.2007.05856.x; Theil JH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73620-0; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; VANDERWEELE DA, 1982, APPETITE, V3, P99, DOI 10.1016/S0195-6663(82)80003-2; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Wang LX, 2011, PEPTIDES, V32, P51, DOI 10.1016/j.peptides.2010.10.017; Williamson CM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00152; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Yamada C, 2017, AGING-US, V9, P2269, DOI 10.18632/aging.101320; Yamada K, 2000, PHYSIOL BEHAV, V68, P555, DOI 10.1016/S0031-9384(99)00214-0; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yeates MP, 2001, J THEOR BIOL, V213, P413, DOI 10.1006/jtbi.2001.2425; Zorrilla EP, 2005, PSYCHOPHARMACOLOGY, V177, P324, DOI 10.1007/s00213-004-1952-1; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	108	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246569	10.1371/journal.pone.0246569	http://dx.doi.org/10.1371/journal.pone.0246569			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539467	gold, Green Published			2022-12-26	WOS:000616960200108
J	Amann, J; Sleigh, J; Vayena, E				Amann, Julia; Sleigh, Joanna; Vayena, Effy			Digital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland	PLOS ONE			English	Article							TRUST; UK	Governments around the globe have started to develop and deploy digital contact tracing apps to gain control over the spread of the novel coronavirus (Covid-19). The appropriateness and usefulness of these technologies as a containment measure have since sparked political and academic discussions globally. The present paper contributes to this debate through an exploration of how the national daily newspapers in Germany, Austria, and Switzerland reported on the development and adoption of digital contact-tracing apps during early and after stages of the lockdown. These countries were among the first in Europe to develop apps and were critical voices in the debate of decentralized vs. centralized data processing. We conducted thematic analysis on news coverage published between January and May 2020 in high-circulation national daily newspapers from Germany, Austria, and Switzerland. A total of 148 articles from nine newspaper companies were included in the final analysis. From our analysis emerged six core themes of the development and adoption of digital contact tracing apps: 1) data governance; 2) role of IT giants; 3) scientific rigor; 4) voluntariness; 5) functional efficacy; 6) role of the app. These results shed light on the different facets of discussion regarding digital contact tracing as portrayed in German-speaking media. This study complements emerging survey data on public perceptions of digital contact tracing apps by providing a better understanding of the ideas circulating in the media ecosystem.	[Amann, Julia; Sleigh, Joanna; Vayena, Effy] Swiss Fed Inst Technol, Hlth Eth & Policy Lab, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Amann, J (corresponding author), Swiss Fed Inst Technol, Hlth Eth & Policy Lab, Dept Hlth Sci & Technol, Zurich, Switzerland.	julia.amann@hest.ethz.ch	Vayena, Effy/ABD-8272-2021	Vayena, Effy/0000-0003-1303-5467; Amann, Julia/0000-0003-2155-5286				[Anonymous], 2020, STUDIE STOPP CORONA; BAG BfG, 2020, SWISSCOVID APP POSIT; Bally G., 2020, NEUE ZURCHER ZEITUNG; Becker S, AKZEPTANZ CORONA APP; Bf Statistik, 2020, SWISSCOVID APP MONIT; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bridgman A, 2020, CAUSES CONSEQUENCES; Calvo R.A, 2020, HLTH SURVEILLANCE CO; Camerer C.F., 2011, BEHAV GAME THEORY EX; Cappelen A, 2010, FORUM DEV STUDIES; Cross AR, 2020, DATENSCHUTZINFORMATI; Di Domenico L, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01698-4; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Gasser U, 2020, LANCET DIGIT HEALTH, V2, pE425, DOI 10.1016/S2589-7500(20)30137-0; Hargittai E, 2020, NEUE ZURICHER ZEITUN; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Horstmann KT, 2021, EUR J PUBLIC HEALTH, V31, P49, DOI 10.1093/eurpub/ckaa239; Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5; Institut F, 2020, STOPP CORONA APP AUS; Institute RK, 2020, KENNZAHLEN CORONAWAR; Kaptchuk Gabriel, 2020, ARXIV200504343; Kelion L., 2020, BBC; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Lee JJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/22205; Markon MPL, 2013, HUM ECOL RISK ASSESS, V19, P1102, DOI 10.1080/10807039.2012.702015; Munnichs G, 2004, J AGR ENVIRON ETHIC, V17, P113, DOI 10.1023/B:JAGE.0000017391.41994.d2; Pagliari C, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020103; Pleitgen F., 2020, CNN; Radiker S, 2019, ANAL QUALITATIVE DAT; Renner A, 2020, NEUE ZURCHER ZEITUNG; Rodrigues UM, 2020, MEDIA INT AUST, V177, P125, DOI 10.1177/1329878X20948202; Rooke C, 2014, TOB CONTROL, V23, P507, DOI 10.1136/tobaccocontrol-2013-051043; Roques L, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00274; Rowe F, 2020, EUR J INFORM SYST, V29, P545, DOI 10.1080/0960085X.2020.1803155; Rowe F, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102178; Ruktanonchai NW, 2020, SCIENCE, V369, P1465, DOI 10.1126/science.abc5096; Sanche S, 2020, ARXIV200203268; Sharon T, 2021, ETHICS INF TECHNOL, V23, P45, DOI 10.1007/s10676-020-09547-x; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; Siegrist M, 2003, RISK ANAL, V23, P705, DOI 10.1111/1539-6924.00349; Thier J., 2020, NEUE ZURCHER ZEITUNG; Thorneloe R, 2020, SCOPING REV MOBILE P; Troncoso C., 2020, ARXIV PREPRINT ARXIV; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; von Wyl Viktor, 2020, Swiss Med Wkly, V150, pw20324, DOI 10.4414/smw.2020.20324; Walrave M, 2020, JMIR PUBLIC HLTH SUR, V6, P488, DOI 10.2196/20572; Wood K, 2014, ADDICTION, V109, P578, DOI 10.1111/add.12427; Zhao E, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003323	49	26	26	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246524	10.1371/journal.pone.0246524	http://dx.doi.org/10.1371/journal.pone.0246524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534839	Green Published, Green Submitted, gold			2022-12-26	WOS:000616739700048
J	Chen, TC; Kuo, TY; Dandan, M; Lee, RA; Chang, M; Villivalam, SD; Liao, SC; Costello, D; Shankaran, M; Mohammed, H; Kang, S; Hellerstein, MK; Wang, JC				Chen, Tzu-Chieh; Kuo, Taiyi; Dandan, Mohamad; Lee, Rebecca A.; Chang, Maggie; Villivalam, Sneha D.; Liao, Szu-Chi; Costello, Damian; Shankaran, Mahalakshmi; Mohammed, Hussein; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan			The role of striated muscle Pik3r1 in glucose and protein metabolism following chronic glucocorticoid exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; P85-ALPHA SUBUNIT; TRANSLATION INITIATION; REGULATORY SUBUNIT; RECEPTOR; PHOSPHORYLATION; EXPRESSION; GROWTH; P85; MECHANISMS	Chronic glucocorticoid exposure causes insulin resistance and muscle atrophy in skeletal muscle. We previously identified phosphoinositide-3-kinase regulatory subunit 1 (Pik3r1) as a primary target gene of skeletal muscle glucocorticoid receptors involved in the glucocorticoid-mediated suppression of insulin action. However, the in vivo functions of Pik3r1 remain unclear. Here, we generated striated muscle-specific Pik3r1 knockout (MKO) mice and treated them with a dexamethasone (DEX), a synthetic glucocorticoid. Treating wildtype (WT) mice with DEX attenuated insulin activated Akt activity in liver, epididymal white adipose tissue, and gastrocnemius (GA) muscle. This DEX effect was diminished in GA muscle of MKO mice, therefore, resulting in improved glucose and insulin tolerance in DEX-treated MKO mice. Stable isotope labeling techniques revealed that in WT mice, DEX treatment decreased protein fractional synthesis rates in GA muscle. Furthermore, histology showed that in WT mice, DEX treatment reduced GA myotube diameters. In MKO mice, myotube diameters were smaller than in WT mice, and there were more fast oxidative fibers. Importantly, DEX failed to further reduce myotube diameters. Pik3r1 knockout also decreased basal protein synthesis rate (likely caused by lower 4E-BP1 phosphorylation at Thr37/Thr46) and curbed the ability of DEX to attenuate protein synthesis rate. Finally, the ability of DEX to inhibit eIF2 alpha phosphorylation and insulin-induced 4E-BP1 phosphorylation was reduced in MKO mice. Taken together, these results demonstrate the role of Pik3r1 in glucocorticoid-mediated effects on glucose and protein metabolism in skeletal muscle.	[Chen, Tzu-Chieh; Dandan, Mohamad; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA; [Chen, Tzu-Chieh; Kuo, Taiyi; Dandan, Mohamad; Lee, Rebecca A.; Chang, Maggie; Villivalam, Sneha D.; Liao, Szu-Chi; Costello, Damian; Shankaran, Mahalakshmi; Mohammed, Hussein; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kuo, Taiyi; Lee, Rebecca A.; Chang, Maggie; Villivalam, Sneha D.; Liao, Szu-Chi; Costello, Damian; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Endocrinol Grad Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, JC (corresponding author), Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA.; Wang, JC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.; Wang, JC (corresponding author), Univ Calif Berkeley, Endocrinol Grad Program, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886; Liao, Szu-Chi/0000-0003-2744-363X; Chang, Maggie/0000-0002-4618-5958; Dandan, Mohamad/0000-0002-3751-8968	National Institutes of Health [DK08359, DK113019]; Muscular Dystrophy Association [186068]; NIH [DK116008]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health DK08359 and DK113019, and Muscular Dystrophy Association (Research Grant 186068) to J. C. W. This work was also supported by the NIH DK116008 to S. K. The content is solely the responsibility of the authors and does not necessarily represent the office views of the National Institutes of Health or the Muscular Dystrophy Association.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Bergmeister K. D., 2017, J VIS EXP, V55441; Bodine SC, 2015, ADV EXP MED BIOL, V872, P145, DOI 10.1007/978-1-4939-2895-8_7; Bolster DR, 2003, EXERC SPORT SCI REV, V31, P111, DOI 10.1097/00003677-200307000-00002; Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, pE983, DOI 10.1152/ajpendo.00234.2014; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bulut GB, 2013, BLOOD, V122, P3964, DOI 10.1182/blood-2013-05-506212; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang-Doran I, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88766; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Kalvisa A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006249; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kuo TY, 2017, DIABETES, V66, P1601, DOI 10.2337/db16-0831; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Magomedova L, 2016, HANDB EXP PHARMACOL, V233, P73, DOI 10.1007/164_2015_1; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; McCurdy CE, 2012, DIABETES, V61, P2495, DOI 10.2337/db11-1433; Musa J, 2016, ONCOGENE, V35, P4675, DOI 10.1038/onc.2015.515; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Papageorgopoulos C, 1999, ANAL BIOCHEM, V267, P1, DOI 10.1006/abio.1998.2958; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Ringseis R, 2020, METABOLITES, V10, DOI 10.3390/metabo10040138; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762; Schiaffino S, 2018, FEBS J, V285, P3688, DOI 10.1111/febs.14502; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Waterlow J. C., 1978, PROTEIN TURNOVER MAM; Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	61	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100395	10.1016/j.jbc.2021.100395	http://dx.doi.org/10.1016/j.jbc.2021.100395			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567340	Green Published, gold			2022-12-26	WOS:000672866400369
J	Chen, ZF; Dong, D; Zhu, YJ; Pang, NN; Ding, JB				Chen, Zhifang; Dong, Di; Zhu, Yuejie; Pang, Nannan; Ding, Jianbing			The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma	FASEB JOURNAL			English	Article						cervical cancer; human papilloma virus; prognosis; Tim-3/Galectin-9	IMMUNOGLOBULIN MUCIN-3; TIM-3 EXPRESSION; POOR-PROGNOSIS; CANCER; PHENOTYPE; CD4; HPV	The interaction between Tim-3 on T cell and its ligand, Galectin-9, negatively regulates cellular immune responses. However, the role of Tim-3/Galectin-9 pathway in the immune evasion of cervical cancer remains unknown. This study is to investigate the expression, function, and regulation of Tim-3/Galectin-9 signaling pathway in human papilloma virus (HPV) positive cervical cancer. Flow cytometry showed that Tim-3 expression on T cell and Galectin-9 expression on monocytes in HPV positive cervical cancer patients were significantly higher compared to cervical intraepithelial neoplasia and benign uterine fibroids Tim-3 + CD4+ Th1 cells and Tim-3 + CD8+ T cells in HPV positive cervical cancer patients were significantly reduced after surgery. Serum TGF-beta and IL-10 levels were positively correlated with Tim-3 + Treg cells, while IFN-gamma and IL-2 were negatively correlated with Tim-3 + Th1 cells. Additionally, Tim-3 + CD4+ T cells were positively correlated with Galectin-9 + monocytes. Survival curve analysis showed that Tim-3 + CD4+ T cells were negatively correlated with patient survival, and closely related to FIGO stage, degree of differentiation, and lymph node metastasis of HPV positive cervical cancer. In vitro experiments showed that by blocking the Tim-3/Galectin-9 pathway, the proliferation of T cells and their ability to express IFN-gamma, IL-2, perforin, and granzyme B was significantly restored. In conclusion, high levels of Tim-3 and Galectin-9 in HPV positive cervical cancer patients play roles in the progression of disease by promoting Treg cells to inhibit the cytotoxic function of Th1 and CD8+ T cells. Tim-3/Galectin-9 may serve as a new immunotherapy target for patients with HPV positive cervical cancer.	[Chen, Zhifang; Dong, Di; Pang, Nannan; Ding, Jianbing] Affiliated Hosp 1, State Key Lab Pathogenesis Prevent Treatment Cent, Xinjiang Med Univ, 393 Xinyi Rd, Urumqi 830011, Peoples R China; [Chen, Zhifang; Zhu, Yuejie] Xinjiang Med Univ, Dept Gynecol, Affiliated Hosp 1, Urumqi, Peoples R China; [Ding, Jianbing] Xinjiang Med Univ, Dept Immunol, Coll Basic Med, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Ding, JB (corresponding author), Affiliated Hosp 1, State Key Lab Pathogenesis Prevent Treatment Cent, Xinjiang Med Univ, 393 Xinyi Rd, Urumqi 830011, Peoples R China.	1601379937@qq.com		Ding, Jianbing/0000-0001-5506-7665	State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian [SKL-HIDCA-2019-8]; National Natural Science Foundation of China (NSFC) [81660475]	State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian, Grant/Award Number: SKL--HIDCA--2019--8; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81660475	Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; Chen ZF, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/6519427; Chen ZF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6891482; Chen ZF, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-61; Chibwesha CJ, 2019, JAMA-J AM MED ASSOC, V322, P1558, DOI 10.1001/jama.2019.16176; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; Dutta A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7374; Golden-Mason L, 2015, CLIN IMMUNOL, V158, P114, DOI 10.1016/j.clim.2015.03.008; Han JF, 2020, CANCER IMMUNOL RES, V8, P146, DOI 10.1158/2326-6066.CIR-19-0398; Ji J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0528-7; Ji XJ, 2013, EUR J IMMUNOL, V43, P458, DOI 10.1002/eji.201242768; Ju Y, 2014, MOL IMMUNOL, V58, P85, DOI 10.1016/j.molimm.2013.11.001; Kang CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15659; Kim BH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49928-x; Laheurte C, 2019, BRIT J CANCER, V121, P405, DOI 10.1038/s41416-019-0531-5; Lan Y, 2017, J BUON, V22, P1017; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Li L, 2018, INT IMMUNOPHARMACOL, V57, P139, DOI 10.1016/j.intimp.2018.02.016; Liu YX, 2015, J HEPATOL, V62, P563, DOI 10.1016/j.jhep.2014.10.034; Lu X, 2017, CELL IMMUNOL, V313, P43, DOI 10.1016/j.cellimm.2017.01.001; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Markwick LJL, 2015, GASTROENTEROLOGY, V148, P590, DOI 10.1053/j.gastro.2014.11.041; Maskey N, 2019, CANCER MANAG RES, V11, P7647, DOI 10.2147/CMAR.S217264; Ostroumov D, 2018, CELL MOL LIFE SCI, V75, P689, DOI 10.1007/s00018-017-2686-7; Piao YR, 2013, ASIAN PAC J CANCER P, V14, P3897, DOI 10.7314/APJCP.2013.14.6.3897; Sada-Ovalle I, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20078; Saresella M, 2014, FASEB J, V28, P5000, DOI 10.1096/fj.14-258194; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Su H, 2018, LUNG CANCER, V121, P18, DOI 10.1016/j.lungcan.2018.04.009; Telli TA, 2020, CANCER LETT, V469, P142, DOI 10.1016/j.canlet.2019.10.036; Wang XX, 2018, INT IMMUNOPHARMACOL, V56, P249, DOI 10.1016/j.intimp.2018.01.037; Wu JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09484-8; Yang M, 2015, J SURG ONCOL, V112, P430, DOI 10.1002/jso.24012; Yang SF, 2017, INFLAMMATION, V40, P1062, DOI 10.1007/s10753-017-0549-x; Yasinska IM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01594; Yuan J, 2014, NEOPLASMA, V61, P35, DOI 10.4149/neo_2014_006; Zhang R, 2019, SMALL, V15, DOI 10.1002/smll.201903881; Zhao FH, 2019, LANCET, V393, P969, DOI 10.1016/S0140-6736(18)32849-6; Zhou EC, 2015, INT J CLIN EXP PATHO, V8, P8018	39	8	8	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21401	10.1096/fj.202000528RR	http://dx.doi.org/10.1096/fj.202000528RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559190	hybrid			2022-12-26	WOS:000629576700036
J	Souza, LAF; Pereira, LV; de Moura, LA; Diaz, LJR; da Cruz, DDLM; Da Silva, JA				Ferreira Souza, Layz Alves; Pereira, Lilian Varanda; de Moura, Louise Amalia; Rueda Diaz, Leidy-Johanna; Lopes Monteiro da Cruz, Dina de Almeida; Da Silva, Jose Aparecido			Structural validity of the Chronic Pain Coping Inventory-Brazilian version	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; 2-ITEM MEASURES; BELIEFS; RELIABILITY; STRATEGIES; HYPNOSIS; SAMPLE	Background The Chronic Pain Coping Inventory (CPCI) has been widely used to measure coping with pain, however, the psychometric properties of the Brazilian CPCI are unknown. Aim To verify the validity and reliability of the CPCI-Brazilian version. Materials and methods A sample of 705 outpatients with chronic pain participated in the study. Cronbach's alpha, corrected item-total correlations, and confirmatory factor analysis were performed, using the method of Diagonally Weighted Least Squares. Results Construct validity was supported with a factor loading range of 0.36-0.90 (9 factors) corroborating original loads. The final model had adequate fit with items 42 and 54 excluded, D.F = 2174, TLI = 0.96; CFI = 0.96 and RMSEA = 0.051(p = 0.067). Eight of the nine CPCI scales showed satisfactory reliability (Cronbach's alpha ranged from 0.70 to 0.92). The Relaxation scale obtained a low alpha value (0.53). Conclusion The CPCI-Brazilian version, after exclusion of items 42 and 54, is valid to measure chronic pain coping in Brazilian adults.	[Ferreira Souza, Layz Alves; Pereira, Lilian Varanda; de Moura, Louise Amalia] Univ Fed Goias, Coll Nursing, Goiania, Go, Brazil; [Rueda Diaz, Leidy-Johanna] Univ Ind Santander, Coll Nursing, Bucaramanga, Santander, Colombia; [Lopes Monteiro da Cruz, Dina de Almeida] Univ Sao Paulo, Coll Nursing, Sao Paulo, SP, Brazil; [Da Silva, Jose Aparecido] Univ Fed Juiz de Fora, Dept Psychol, Juiz De Fora, MG, Brazil	Universidade Federal de Goias; Universidad Industrial de Santander; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora	Souza, LAF (corresponding author), Univ Fed Goias, Coll Nursing, Goiania, Go, Brazil.	layzent@gmail.com	VARANDA PEREIRA, LILIAN/GQB-0875-2022	VARANDA PEREIRA, LILIAN/0000-0003-4604-0238; Souza, Layz/0000-0002-5563-7928; Cruz, Dina/0000-0003-1373-409X	Research Support Foundation of the State of Goias (Fundacao de Amparo a Pesquisa do Estado de Goias -FAPEG) [2014.102.670.005.06]; National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico -CNPq) [552408/2011-5]	Research Support Foundation of the State of Goias (Fundacao de Amparo a Pesquisa do Estado de Goias -FAPEG); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico -CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The main researcher of this study was supported by the Research Support Foundation of the State of Goias (Fundacao de Amparo a Pesquisa do Estado de Goias -FAPEG) [grant number: 2014.102.670.005.06]; and the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico -CNPq) [grant number: 552408/2011-5]. The funding sources had no involvement in any study decisions.	Alschuler KN, 2013, PAIN, V154, P2775, DOI 10.1016/j.pain.2013.08.012; Arafat SY., 2016, J BEHAV HLTH, V5, P129, DOI [10.5455/jbh.20160615121755, DOI 10.5455/JBH.20160615121755]; Baird A, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030058; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Broderick JE, 2014, PAIN, V155, P1743, DOI 10.1016/j.pain.2014.05.024; Chang HY, 2011, PAIN MED, V12, P846, DOI 10.1111/j.1526-4637.2011.01151.x; Cheng S.H., 2014, J MATER CHEM, V10, P1; Ektor-Andersen J, 2002, J REHABIL MED, V34, P33, DOI 10.1080/165019702317242686; Ersek M, 2006, J PAIN, V7, P833, DOI 10.1016/j.jpain.2006.04.002; Ferreira-Valente MA, 2011, PAIN MED, V12, P1470, DOI 10.1111/j.1526-4637.2011.01208.x; Forero CG, 2009, STRUCT EQU MODELING, V16, P625, DOI 10.1080/10705510903203573; Garcia-Campayo J, 2007, PAIN, V132, pS68, DOI 10.1016/j.pain.2007.02.013; Hadjistavropoulos HD, 1999, PAIN, V80, P471, DOI 10.1016/S0304-3959(98)00224-3; Hair J.F., 2010, MULTIVARIATE DATA AN, V7; Higgins NC, 2015, J PSYCHOL, V149, P737, DOI 10.1080/00223980.2014.977759; Instituto Paulo Montenegro, 2016, FUNCTIONAL ILLITERAC; Ismail Ayah, 2017, J Phys Ther Sci, V29, P2228, DOI 10.1589/jpts.29.2228; Jafarizadeh H, 2018, BURNS, V44, P108, DOI 10.1016/j.burns.2017.06.001; Jensen M, 2008, CHRONIC PAIN COPING, V1st; JENSEN MP, 1991, J CONSULT CLIN PSYCH, V59, P431, DOI 10.1037/0022-006X.59.3.431; Jensen MP, 2003, PAIN, V104, P453, DOI 10.1016/S0304-3959(03)00076-9; JENSEN MP, 1991, PAIN, V47, P249, DOI 10.1016/0304-3959(91)90216-K; JENSEN MP, 1995, PAIN, V60, P203, DOI 10.1016/0304-3959(94)00118-X; Karsdorp PA, 2009, PAIN, V147, P29, DOI 10.1016/j.pain.2009.07.019; Kato T, 2015, STRESS HEALTH, V31, P315, DOI 10.1002/smi.2557; Kline P., 1986, HDB TEST CONSTRUCTIO; Ko YM, 2010, SPINE, V35, P666, DOI 10.1097/BRS.0b013e3181ba7a78; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Meints SM, 2018, PROG NEURO-PSYCHOPH, V87, P168, DOI 10.1016/j.pnpbp.2018.01.017; Merskey H, 1994, CLASSIFICATION CHRON, P1; Misterska E, 2014, MED SCI MONITOR, V20, P789, DOI 10.12659/MSM.889728; Monticone M, 2013, QUAL LIFE RES, V22, P1459, DOI 10.1007/s11136-012-0271-y; Mueller R.O., 2001, INT ENCY SOCIAL BEHA, P5239, DOI DOI 10.1016/B0-08-043076-7/00426-5; Mvududu N.H., 2013, COUNSELING OUTCOME R, V4, P75, DOI [10.1177/2150137813494766, DOI 10.1177/2150137813494766]; Nicholas MK, 2015, PAIN CLIN UPDATES, VXXIII, P1; Nielson WR, 2001, PAIN, V89, P111, DOI 10.1016/S0304-3959(00)00351-1; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Polit DF, 2019, ESSENTIALS NURSING R, V9th; Richardson C, 2001, J ADV NURS, V34, P659, DOI 10.1046/j.1365-2648.2001.01795.x; Riddle DL, 2011, ARCH PHYS MED REHAB, V92, P859, DOI 10.1016/j.apmr.2011.01.003; Romano JM, 2003, PAIN, V104, P65, DOI 10.1016/S0304-3959(02)00466-9; Schrubbe LA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1217-2; Souza Layz Alves Ferreira, 2018, BrJP, V1, P94, DOI 10.5935/2595-0118.20180020; STEIGER JH, 1985, PSYCHOMETRIKA, V50, P253, DOI 10.1007/BF02294104; Tan G, 2006, J PAIN, V7, P252, DOI 10.1016/j.jpain.2005.11.007; Tan G, 2005, J PAIN, V6, P29, DOI 10.1016/j.jpain.2004.09.006; Thompson T, 2019, NEUROSCI BIOBEHAV R, V99, P298, DOI 10.1016/j.neubiorev.2019.02.013; Truchon M, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-13; Truchon M, 2005, PAIN, V116, P205, DOI 10.1016/j.pain.2005.04.003; Turk DC, 2016, J PAIN, V17, pT21, DOI 10.1016/j.jpain.2016.02.006; Van Damme S, 2008, PAIN, V139, P1, DOI 10.1016/j.pain.2008.07.022; Wong WS, 2010, J PAIN, V11, P672, DOI 10.1016/j.jpain.2009.10.008; Yazdi-Ravandi S, 2013, BASIC CLIN NEUROSCI, V4, P117	56	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246294	10.1371/journal.pone.0246294	http://dx.doi.org/10.1371/journal.pone.0246294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4AY	33556089	Green Published, gold			2022-12-26	WOS:000617531400002
J	Wang, H				Wang, Hui			Regional assessment of human-caused ecological risk in the Poyang Lake Eco-economic Zone using production-living-ecology analysis	PLOS ONE			English	Article							DEGAZETTEMENT PADDD; ECOSYSTEM SERVICES; LAND; BASIN; WETLAND; AREA; CHINA; TRENDS; CITY	In this study, based on the regional land-use risk space division (regional ecological risk source/receptor space identification) using production-living-ecology analysis, three spatial function indexes, i.e., production, living, and ecology function indexes, were proposed for regional ecological risk assessment (RERA) with respect to human disturbance. The first two indexes can be regarded as regional ecological risk source indexes, whereas the final index can be regarded as a regional ecological risk receptor index. Using an artificial assignment method based on the land-use types and Defense Meteorological Program Operational Line-Scan System (DMSP/OLS) nighttime light intensity data, these three spatial function indexes were effectively manifested. By incorporating these indexes with eco-environmental vulnerability proxies, an RERA framework was established and applied in the Poyang Lake Eco-economic Zone (PLEZ), which is an ecological-protection and economic-development coordination-oriented region in China. The results suggest that (1) the DMSP/OLS nighttime light intensity data correlated well with the spatial distribution of regional urban/town areas; consequently, it was reasonable to use this dataset for representing regional production-living function space (urban/town area). (2) Overall, the forestlands and winter waterbodies of Poyang Lake were in the high-risk grade, and so did the Nanchang City construction land area; in contrast, the final risk levels of winter wetlands and croplands were relatively low. (3) Owing to the highest human disturbance (including both production and consumption human activities) and eco-environmental vulnerability level, urban/town areas such as Nanchang City had the highest final risk grade. (4) The low, medium, high, and very high-risk grades accounted for 21.22%, 39.53%, 36.31%, and 2.94% of the region, respectively. I believe that the proposed land use function indexes will be helpful in conducting human-caused RERA research in the future. Furthermore, the assessment results can provide a scientific basis for regional ecological risk management within the PLEZ.	[Wang, Hui] Jiujiang Univ, Coll Tourism & Geog, Jiujiang, Peoples R China; [Wang, Hui] Nanning Normal Univ, Coll Geog & Planning, Nanning, Peoples R China	Jiujiang University; Nanning Normal University	Wang, H (corresponding author), Jiujiang Univ, Coll Tourism & Geog, Jiujiang, Peoples R China.; Wang, H (corresponding author), Nanning Normal Univ, Coll Geog & Planning, Nanning, Peoples R China.	wanghuipku110@163.com		wang, hui/0000-0001-8376-0731	Jiujiang University [8691409]	Jiujiang University	This research was financially supported by the launching funds of Jiujiang University for doctors (8691409) and the author kindly acknowledged the support. Moreover, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Cai EX, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010066; Cai S, 2017, WATER-SUI, V9, DOI 10.3390/w9100745; Cao SX, 2009, LAND USE POLICY, V26, P1182, DOI 10.1016/j.landusepol.2009.02.006; Chen Ping, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; [崔家兴 Cui Jiaxing], 2018, [中国土地科学, China Land Science], V32, P67; Cui XH, 2000, J FRESHWATER ECOL, V15, P537, DOI 10.1080/02705060.2000.9663776; [戴文远 Dai Wenyuan], 2018, [自然资源学报, Journal of Natural Resources], V33, P2098; Han Y, 2020, CATENA, V187, DOI 10.1016/j.catena.2019.104357; Hu QW, 2015, ATMOS ENVIRON, V100, P124, DOI 10.1016/j.atmosenv.2014.10.047; Huang L, 2012, ECOL ENG, V44, P53, DOI 10.1016/j.ecoleng.2012.03.007; Huang N, 2010, ENVIRON MANAGE, V46, P790, DOI 10.1007/s00267-010-9547-6; Huang SL, 2017, BIOL CONSERV, V210, P40, DOI 10.1016/j.biocon.2016.05.021; [黄心怡 Huang Xinyi], 2020, [生态学报, Acta Ecologica Sinica], V40, P1065; Jiang WG, 2017, ECOL INDIC, V82, P316, DOI 10.1016/j.ecolind.2017.06.059; Jiangxi Statistical Bureau, 2020, JJIANGX STAT YB 2020; Kanai Y, 2002, BIOL CONSERV, V106, P339, DOI 10.1016/S0006-3207(01)00259-2; Kang P, 2018, SCI TOTAL ENVIRON, V636, P1442, DOI 10.1016/j.scitotenv.2018.04.427; Khadka D, 2010, ENVIRON MANAGE, V45, P351, DOI 10.1007/s00267-009-9405-6; Landis WG, 1997, HUM ECOL RISK ASSESS, V3, P287, DOI 10.1080/10807039709383685; Li B, 2020, ENVIRON POLLUT, V260, DOI 10.1016/j.envpol.2020.114033; [李广东 Li Guangdong], 2016, [地理学报, Acta Geographica Sinica], V71, P49; Li YK, 2019, J GREAT LAKES RES, V45, P976, DOI 10.1016/j.jglr.2019.08.002; Liao GT, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11061600; Liu C, 2018, HABITAT INT, V76, P48, DOI 10.1016/j.habitatint.2018.05.010; [刘海 Liu Hai], 2017, [生态学报, Acta Ecologica Sinica], V37, P2575; Liu JT, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6678-6; Liu YC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081691; Malekmohammadi B, 2014, ECOL INDIC, V41, P133, DOI 10.1016/j.ecolind.2014.01.038; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; Moraes R, 2004, HUM ECOL RISK ASSESS, V10, P349, DOI 10.1080/10807030490438427; Mulligan GF, 2012, ANN REGIONAL SCI, V48, P405, DOI 10.1007/s00168-011-0496-7; Pack SM, 2016, BIOL CONSERV, V197, P32, DOI 10.1016/j.biocon.2016.02.004; Peng J, 2015, SUSTAINABILITY-BASEL, V7, P8312, DOI 10.3390/su7078312; Qi Shu-hua, 2011, China Environmental Science, V31, P1197; Su B, 2013, J CLEAN PROD, V42, P215, DOI 10.1016/j.jclepro.2012.11.020; Tao H, 2014, STOCH ENV RES RISK A, V28, P1543, DOI 10.1007/s00477-014-0863-x; Taylor MFJ, 2011, BIODIVERS CONSERV, V20, P767, DOI 10.1007/s10531-010-9977-8; Tian P, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102817; [涂小松 Tu Xiaosong], 2015, [资源科学, Resources Science], V37, P2451; United States Environmental Protection Agency, 1998, GUID EC RISK ASS, P4; Wang H, 2021, J INDIAN SOC REMOTE, V49, P449, DOI 10.1007/s12524-020-01254-w; Wang H, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051974; Wang J., 2012, EC GEOGR, V32, P101; Wang WJ, 2019, WETLANDS, V39, pS125, DOI 10.1007/s13157-017-0981-6; Ward C, 2018, J ENVIRON MANAGE, V228, P1, DOI 10.1016/j.jenvman.2018.09.018; [吴健生 Wu Jiansheng], 2014, [地理学报, Acta Geographica Sinica], V69, P759; [谢高地 Xie Gaodi], 2003, [自然资源学报, Journal of Natural Resources], V18, P189; Xie HL, 2014, INT J ENV RES PUB HE, V11, P583, DOI 10.3390/ijerph110100583; Xie HL, 2013, INT J ENV RES PUB HE, V10, P328, DOI 10.3390/ijerph10010328; Xu XG, 2004, J ENVIRON MANAGE, V70, P253, DOI 10.1016/j.jenvman.2003.12.001; Xu XB, 2016, SCI TOTAL ENVIRON, V554, P7, DOI 10.1016/j.scitotenv.2016.02.120; Xu XG, 2015, ENVIRON EARTH SCI, V74, P747, DOI 10.1007/s12665-015-4079-2; [徐羽 Xu Yu], 2016, [生态学报, Acta Ecologica Sinica], V36, P7850; [杨柳 Yang Liu], 2017, [中国土地科学, China Land Science], V31, P44; Yu ZJ, 2019, J FUJIAN NORMAL U NA, V35, P90; Yue TX, 2015, ECOL MODEL, V306, P16, DOI 10.1016/j.ecolmodel.2014.09.015; Zagas TD, 2011, ECOL ENG, V37, P286, DOI 10.1016/j.ecoleng.2010.11.004; Zhang CL, 2011, ENVIRON MANAGE, V47, P107, DOI 10.1007/s00267-010-9586-z; Zhang YN, 2019, ECOL INDIC, V107, DOI 10.1016/j.ecolind.2019.105550; [赵志刚 Zhao Zhigang], 2017, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V26, P198; Zhong Y, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010117; Zhou D, 2017, SCI TOTAL ENVIRON, V577, P136, DOI 10.1016/j.scitotenv.2016.10.143; Zhuang D., 1997, J NAT RESOUR, V12, P105, DOI DOI 10.11849/ZRZYXB.1997.02.002	66	3	3	20	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246749	10.1371/journal.pone.0246749	http://dx.doi.org/10.1371/journal.pone.0246749			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556111	Green Published, gold			2022-12-26	WOS:000617379900023
J	Che, F; Yin, C; Zhao, XK; Hu, ZN; Sheng, L; Liu, D				Che, Fa; Yin, Chao; Zhao, Xingkui; Hu, Zhinan; Sheng, Lu; Liu, Dong			Embankment seismic fragility assessment: A case study on Xi'an-Baoji expressway (China)	PLOS ONE			English	Article							RISK-ASSESSMENT; ROCKFILL DAM; CURVES; DISPLACEMENT; VULNERABILITY; PERFORMANCE; BEHAVIOR; BRIDGES; SURFACE	Although embankment seismic damages are very complex, there has been little seismic fragility research yet. Researches on seismic fragility of bridges, dams and reinforced concrete (RC) structures have achieved fruitful results, which can provide references for embankment seismic fragility assessment. Meanwhile, the influencing degrees of retaining structures, such as retaining walls on the embankment seismic performances are still unclear. The K1025+470 embankment of the Xi'an-Baoji expressway was selected as the research object, and the finite difference models of the embankment fill-soil foundation system and embankment fill-soil foundation-retaining wall system were established. The ground-motion records for Incremental Dynamic Analysis (IDA) were selected and the dynamic response analysis were conducted. Probabilistic Seismic Demand Analysis (PSDA) was used to deal with the IDA results and the seismic fragility curves were generated. Based on the assessment results, the influences of the retaining wall on the embankment seismic fragility were further verified. The research results show that regardless of which seismic damage parameter is considered or the presence or absence of the retaining wall, larger PGAs always correspond to higher probabilities of each seismic damage grade. Seismic damages to the embankment fill-soil foundation-retaining wall system are always lower than those of the embankment fill-soil foundation system under the same PGA actions, thus, the retaining wall can decrease the embankment seismic fragility significantly.	[Che, Fa] Zibo Transportat Serv Ctr, Zibo, Peoples R China; [Yin, Chao] Shandong Univ Technol, Sch Civil & Architecture Engn, Zibo, Peoples R China; [Yin, Chao] Shijiazhuang Tiedao Univ, Minist Educ, Key Lab Rd & Railway Engn Safety Control, Shijiazhuang, Hebei, Peoples R China; [Yin, Chao; Hu, Zhinan] Shijiazhuang Tiedao Univ, State Key Lab Mech Behav & Syst Safety Traff Engn, Shijiazhuang, Hebei, Peoples R China; [Zhao, Xingkui; Sheng, Lu] Shandong Dongtai Engineer Consulting Co LTD, Zibo, Peoples R China; [Liu, Dong] Dezhou Highway Dev Ctr, Laoling Branch, Dezhou, Peoples R China	Shandong University of Technology; Shijiazhuang Tiedao University; Shijiazhuang Tiedao University	Yin, C (corresponding author), Shandong Univ Technol, Sch Civil & Architecture Engn, Zibo, Peoples R China.; Yin, C (corresponding author), Shijiazhuang Tiedao Univ, Minist Educ, Key Lab Rd & Railway Engn Safety Control, Shijiazhuang, Hebei, Peoples R China.; Yin, C (corresponding author), Shijiazhuang Tiedao Univ, State Key Lab Mech Behav & Syst Safety Traff Engn, Shijiazhuang, Hebei, Peoples R China.	yinchao1987611@163.com			National Natural Science Foundation of China [51808327]; Natural Science Foundation of Shandong Province [ZR2019PEE016]; Shandong Dongtai Engineer Consulting Co., LTD.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Dongtai Engineer Consulting Co., LTD.	This work was supported by the National Natural Science Foundation of China (Grant NO. 51808327) and Natural Science Foundation of Shandong Province (Grant NO. ZR2019PEE016), awarded to author CY. Zibo Transportation Service Center is a commercial organization and provided support in the form of salary for FC. Shandong Dongtai Engineer Consulting Co., LTD. is also a commercial organization and provided support in the form of salary for XZ and LS. Laoling Branch of Dezhou Highway Development Center is not a commercial organization, but provided funding to author DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors were articulated in the "author contributions" section.	Abyani M, 2019, OCEAN ENG, V189, DOI 10.1016/j.oceaneng.2019.106326; Adafer S, 2017, ENRGY PROCED, V139, P624, DOI 10.1016/j.egypro.2017.11.263; Alielahi H, 2017, J EARTHQ ENG, V21, P1, DOI 10.1080/13632469.2016.1142487; Andreotti G, 2019, TUNN UNDERGR SP TECH, V91, DOI 10.1016/j.tust.2019.103008; Bao X, 2019, ENG STRUCT, V198, DOI 10.1016/j.engstruct.2019.109511; Billah AHMM, 2019, SOIL DYN EARTHQ ENG, V126, DOI 10.1016/j.soildyn.2019.105814; Cai Z, 2018, NUCL ENG DES, V335, P195, DOI 10.1016/j.nucengdes.2018.05.013; Castaldo P, 2014, SOIL DYN EARTHQ ENG, V64, P102, DOI 10.1016/j.soildyn.2014.05.005; Castaldo P, 2019, ENG STRUCT, V193, P136, DOI 10.1016/j.engstruct.2019.05.029; Chen ZX, 2019, SOIL DYN EARTHQ ENG, V126, DOI 10.1016/j.soildyn.2019.105761; Ciano M, 2020, PROBABILIST ENG MECH, V60, DOI 10.1016/j.probengmech.2020.103041; Dang CT, 2017, CR MECANIQUE, V345, P678, DOI 10.1016/j.crme.2017.06.011; Di Sarno L, 2020, SOIL DYN EARTHQ ENG, V134, DOI 10.1016/j.soildyn.2020.106169; Dimova SL, 2000, EARTHQUAKE ENG STRUC, V29, P1153, DOI 10.1002/1096-9845(200008)29:8<1153::AID-EQE961>3.0.CO;2-Y; Ding XM, 2020, SOIL DYN EARTHQ ENG, V133, DOI 10.1016/j.soildyn.2020.106133; Ebrahimi E, 2020, APPL SOFT COMPUT, V91, DOI 10.1016/j.asoc.2020.106190; Enomoto T, 2018, SOILS FOUND, V58, P212, DOI 10.1016/j.sandf.2017.12.005; Foytong P, 2020, INT J DISAST RISK RE, V42, DOI 10.1016/j.ijdrr.2019.101344; Guo X, 2020, STRUCTURES, V24, P464, DOI 10.1016/j.istruc.2020.01.012; Han B, 2016, SOIL DYN EARTHQ ENG, V88, P124, DOI 10.1016/j.soildyn.2016.06.002; Hashemi A, 2020, STRUCTURES, V27, P274, DOI 10.1016/j.istruc.2020.05.050; Hofer L, 2018, SOIL DYN EARTHQ ENG, V111, P98, DOI 10.1016/j.soildyn.2018.02.013; Hu HQ, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8696-z; Ko YY, 2019, SOIL DYN EARTHQ ENG, V123, P265, DOI 10.1016/j.soildyn.2019.05.014; Kumar P, 2020, STRUCTURES, V27, P54, DOI 10.1016/j.istruc.2020.05.036; Liang H, 2020, SOIL DYN EARTHQ ENG, V130, DOI 10.1016/j.soildyn.2019.105981; Lin CG, 2020, TUNN UNDERGR SP TECH, V96, DOI 10.1016/j.tust.2019.103230; Lin P, 2015, ENG GEOL, V194, P86, DOI 10.1016/j.enggeo.2014.05.011; Liu KH, 2019, ENG STRUCT, V187, P1, DOI 10.1016/j.engstruct.2019.01.134; Melani A, 2016, STRUCTURES, V5, P13, DOI 10.1016/j.istruc.2015.07.003; Mercer B, 2016, INT J SOLIDS STRUCT, V96, P162, DOI 10.1016/j.ijsolstr.2016.06.011; Modoni G, 2018, SOIL DYN EARTHQ ENG, V106, P231, DOI 10.1016/j.soildyn.2018.01.005; Morfidis K, 2019, ENG STRUCT, V197, DOI 10.1016/j.engstruct.2019.109436; Oishi CM, 2016, INT J ENG SCI, V109, P165, DOI 10.1016/j.ijengsci.2016.08.004; Pan HY, 2020, J CONSTR STEEL RES, V167, DOI 10.1016/j.jcsr.2020.105941; Pang R, 2020, ENG STRUCT, V206, DOI 10.1016/j.engstruct.2019.110152; Pang R, 2019, SCI CHINA TECHNOL SC, V62, P635, DOI 10.1007/s11431-017-9220-8; Pang R, 2018, SOIL DYN EARTHQ ENG, V104, P432, DOI 10.1016/j.soildyn.2017.11.017; Ramanathan K, 2015, ENG STRUCT, V97, P29, DOI 10.1016/j.engstruct.2015.03.069; Sainct R, 2020, STRUCT SAF, V86, DOI 10.1016/j.strusafe.2020.101972; Sengupta P, 2016, J EARTHQ ENG, V20, P809, DOI 10.1080/13632469.2015.1104755; Shimbo T, 2017, SOILS FOUND, V57, P357, DOI 10.1016/j.sandf.2017.05.004; Silva V, 2015, B EARTHQ ENG, V13, P429, DOI 10.1007/s10518-014-9630-0; Stefanidou SP, 2017, ENG STRUCT, V151, P366, DOI 10.1016/j.engstruct.2017.08.033; Straub D, 2008, STRUCT SAF, V30, P320, DOI 10.1016/j.strusafe.2007.05.004; Su L, 2019, ENG STRUCT, V186, P270, DOI 10.1016/j.engstruct.2019.02.022; Tsompanakis Y, 2009, ADV ENG SOFTW, V40, P640, DOI 10.1016/j.advengsoft.2008.11.005; Wang JT, 2018, SOIL DYN EARTHQ ENG, V109, P58, DOI 10.1016/j.soildyn.2018.01.018; Wang ZY, 2018, ENG STRUCT, V162, P213, DOI 10.1016/j.engstruct.2018.02.024; Xiang NL, 2020, ENG STRUCT, V207, DOI 10.1016/j.engstruct.2020.110229; Xie YZ, 2019, ENG STRUCT, V189, P605, DOI 10.1016/j.engstruct.2019.03.115; Xu B, 2020, ENG GEOL, V264, DOI 10.1016/j.enggeo.2019.105412; Xu CX, 2020, J BUILD ENG, V28, DOI 10.1016/j.jobe.2019.101057; Xu CX, 2018, J BUILD ENG, V20, P736, DOI 10.1016/j.jobe.2018.09.019; Xu JG, 2020, SOIL DYN EARTHQ ENG, V134, DOI 10.1016/j.soildyn.2020.106165; Yang SC, 2020, GEOTEXT GEOMEMBRANES, V48, P221, DOI 10.1016/j.geotexmem.2019.11.001; Yang XL, 2007, INT J ROCK MECH MIN, V44, P948, DOI 10.1016/j.ijrmms.2007.01.002; Yazgan U, 2015, ENG STRUCT, V100, P479, DOI 10.1016/j.engstruct.2015.06.027; Yilmaz I, 2020, INT J MECH SCI, V166, DOI 10.1016/j.ijmecsci.2019.105237; Yin C, 2020, NAT HAZARDS, V100, P535, DOI 10.1007/s11069-019-03824-9; [尹超 Yin Chao], 2017, [地震工程与工程振动, Journal of Earthquake Engineering and Engineering Vibration], V37, P181; Yoon S, 2019, INT J PRES VES PIP, V175, DOI 10.1016/j.ijpvp.2019.103932; Yoshikawa T, 2016, SOIL DYN EARTHQ ENG, V85, P217, DOI 10.1016/j.soildyn.2016.02.008; Zhang JM, 2015, SOIL DYN EARTHQ ENG, V76, P145, DOI 10.1016/j.soildyn.2015.03.014; Zhang LW, 2020, SOIL DYN EARTHQ ENG, V134, DOI 10.1016/j.soildyn.2020.106150; Zhang WG, 2020, SOIL DYN EARTHQ ENG, V136, DOI 10.1016/j.soildyn.2020.106118; [张小娟 Zhang Xiaojuan], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P157; Zhao LH, 2017, SOIL DYN EARTHQ ENG, V99, P74, DOI 10.1016/j.soildyn.2017.04.019; Zhao XQ, 2020, GEOMORPHOLOGY, V358, DOI 10.1016/j.geomorph.2020.107130; Zheng Z, 2020, AGR WATER MANAGE, V239, DOI 10.1016/j.agwat.2020.106233; Zhong ZL, 2020, SOIL DYN EARTHQ ENG, V132, DOI 10.1016/j.soildyn.2020.106044	71	1	1	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246407	10.1371/journal.pone.0246407	http://dx.doi.org/10.1371/journal.pone.0246407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544728	gold, Green Published			2022-12-26	WOS:000617991900044
J	Hofmann, A; Putz, F; Buttner-Herold, M; Hecht, M; Fietkau, R; Distel, LV				Hofmann, Alexander; Putz, Florian; Buttner-Herold, Maike; Hecht, Markus; Fietkau, Rainer; Distel, Luitpold, V			Increase in non-professional phagocytosis during the progression of cell cycle	PLOS ONE			English	Article							CANNIBALISM; ENTOSIS; TRANSFORMATION; DEATH	Homotypic or heterotypic internalization of another, either living or necrotic cell is currently in the center of research interest. The active invasion of a living cell called entosis and cannibalism of cells by rapidly proliferating cancers are prominent examples. Additionally, normal healthy tissue cells are capable of non-professional phagocytosis. This project studied the relationship between non-professional phagocytosis, individual proliferation and cell cycle progression. Three mesenchymal and two epithelial normal tissue cell lines were studied for homotypic non-professional phagocytosis. Homotypic dead cells were co-incubated with adherent growing living cell layers. Living cells were synchronized by mitotic shake-off as well as Aphidicolin-treatment and phagocytotic activity was analyzed by immunostaining. Cell cycle phases were evaluated by flow cytometry. Mesenchymal and epithelial normal tissue cells were capable of internalizing dead cells. Epithelial cells had much higher non-professional phagocytotic rates than mesenchymal cells. Cells throughout the entire cell cycle were able to phagocytose. The phagocytotic rate significantly increased with progressing cell cycle phases. Mitotic cells regularly phagocytosed dead cells, this was verified by Nocodazole and Colcemid treatment. Taken together, our findings indicate the ability of human tissue cells to phagocytose necrotic neighboring cells in confluent cell layers. The origin of the cell line influences the rate of cell-in-cell structure formation. The higher cell-in-cell structure rates during cell cycle progression might be influenced by cytoskeletal reorganization during this period or indicate an evolutionary anchorage of the process. Recycling of nutrients during cell growth might also be an explanation.	[Hofmann, Alexander; Putz, Florian; Hecht, Markus; Fietkau, Rainer; Distel, Luitpold, V] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, Erlangen, Germany; [Buttner-Herold, Maike] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Inst Pathol, Dept Nephropathol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Distel, LV (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, Erlangen, Germany.	Luitpold.Distel@uk-erlangen.de	Putz, Florian/GLT-8227-2022; Hecht, Markus/AAX-1792-2020	Putz, Florian/0000-0003-3966-2872; Hecht, Markus/0000-0003-2082-216X; Distel, Luitpold/0000-0002-8040-3226				Abodief WT, 2006, CYTOPATHOLOGY, V17, P304, DOI 10.1111/j.1365-2303.2006.00326.x; Chircop Megan, 2014, Small GTPases, V5, DOI 10.4161/sgtp.29770; Cini N, 2020, STRAHLENTHER ONKOL, V196, P85, DOI 10.1007/s00066-019-01532-8; Cunin P, 2020, PLATELETS, V31, P700, DOI 10.1080/09537104.2019.1693035; Durgan J, 2018, BBA-MOL CELL RES, V1865, P831, DOI 10.1016/j.bbamcr.2018.03.004; Durgan J, 2017, ELIFE, V6, DOI 10.7554/eLife.27134; Fais S, 2007, CANCER LETT, V258, P155, DOI 10.1016/j.canlet.2007.09.014; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gottwald D, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00326-6; Gupta K, 2003, DIAGN CYTOPATHOL, V28, P86, DOI 10.1002/dc.10234; Hamann JC, 2017, CELL REP, V20, P201, DOI 10.1016/j.celrep.2017.06.037; Hattori M, 2007, ACTA CYTOL, V51, P547, DOI 10.1159/000325792; Kim Y, 2019, HUM PATHOL, V85, P174, DOI 10.1016/j.humpath.2018.10.029; Kojima SI, 1998, ACTA CYTOL, V42, P1365, DOI 10.1159/000332169; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Mackay HL, 2019, BIOCHEM SOC T, V47, P725, DOI 10.1042/BST20180618; Nandy SK, 2007, FEBS LETT, V581, P151, DOI 10.1016/j.febslet.2006.12.011; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; REDDEL RR, 1988, CANCER RES, V48, P1904; Schwegler M, 2015, BIOL CELL, V107, P372, DOI 10.1111/boc.201400090; Seeberg JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48370-3; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Timmons AK, 2016, P NATL ACAD SCI USA, V113, pE1246, DOI 10.1073/pnas.1522830113; Uhlig S, 2020, STRAHLENTHER ONKOL, V196, P398, DOI 10.1007/s00066-020-01586-z; WADDELL DR, 1986, J CELL BIOL, V102, P298, DOI 10.1083/jcb.102.1.298; Wang S, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.05.028; Wang XL, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00311; White E, 2007, CELL, V131, P840, DOI 10.1016/j.cell.2007.11.015; Yue WX, 2019, VIROL SIN, V34, P253, DOI 10.1007/s12250-019-00097-1; Zhang X, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00895	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246402	10.1371/journal.pone.0246402	http://dx.doi.org/10.1371/journal.pone.0246402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544774	gold, Green Published			2022-12-26	WOS:000617991900038
J	Kazi, AK; Rowther, AA; Atif, N; Nazir, H; Atiq, M; Zulfiqar, S; Malik, A; Surkan, PJ				Kazi, Asiya K.; Rowther, Armaan A.; Atif, Najia; Nazir, Huma; Atiq, Maria; Zulfiqar, Shaffaq; Malik, Abid; Surkan, Pamela J.			Intersections between patient-provider communication and antenatal anxiety in a public healthcare setting in Pakistan	PLOS ONE			English	Article							PHYSICIAN EMPATHY; CANCER; SATISFACTION; ASSOCIATIONS; PREVALENCE; OUTCOMES; QUALITY; WOMEN; TRUST	This study explores pregnant women's and healthcare providers' perspectives on the role of patient-provider communication in experiences of antenatal anxiety within a low-resource setting. In 2017-18, we consecutively sampled pregnant women (n = 19) with at least mild anxiety and purposively sampled antenatal care providers (n = 10) from a public hospital in Punjab Province, Pakistan. We then conducted in-depth interviews and thematically coded them with a combination of inductive and deductive coding methodologies. We found that patients expressed a desire for warm, empathetic communication from providers who demonstrate respect, attentiveness, and a shared lived experience. Providers revealed an awareness that their heavy caseloads, high stress levels, and discourteous tones adversely influenced communication with pregnant women and may exacerbate their anxieties, but also reported that compassionately addressing women's concerns, providing financial problem-solving and/or assistance, and moderating conflicting healthcare desires between patients and their families could alleviate anxiety in pregnant women. Patients reported feelings of anxiety stemming from a belief that they received lower quality communication from antenatal providers at public hospitals than patients received from antenatal providers at private hospitals, an experience that they partially attributed to their low socioeconomic status. Meanwhile, some providers disclosed potentially stigmatizing views of women from particular sociocultural backgrounds or low socioeconomic status, including perceptions that appeared to shape communication with these patients in antenatal care encounters. Our findings provide preliminary evidence that communication between pregnant women and antenatal providers that is warm, normalizes patient fears, and integrates patients' interpersonal and financial considerations can mitigate pregnant women's experiences of anxiety and reduce barriers to accessing antenatal care in Pakistan's public healthcare facilities.	[Kazi, Asiya K.; Rowther, Armaan A.; Surkan, Pamela J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Atif, Najia; Nazir, Huma; Atiq, Maria; Zulfiqar, Shaffaq; Malik, Abid] Human Dev Res Fdn, Islamabad, Pakistan; [Malik, Abid] Rawalpindi Med Univ, Rawalpindi, Pakistan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kazi, AK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	akazi5@alumin.jh.edu	Nazir, Huma/AAU-8995-2021	Kazi, Asiya K./0000-0001-9259-6726	National Institute of Mental Health (NIMH) at the United States National Institutes of Health (NIH) [RO1 MH111859-01]	National Institute of Mental Health (NIMH) at the United States National Institutes of Health (NIH)	This research was funded by the National Institute of Mental Health (NIMH) at the United States National Institutes of Health (NIH), grant number RO1 MH111859-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, DED VERS 8 2 14 WEB; Atif N, 2020, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00927; Bernstein M, 2004, CAN J NEUROL SCI, V31, P208, DOI 10.1017/S0317167100053841; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; Butow PN, 2002, SUPPORT CARE CANCER, V10, P161, DOI 10.1007/s005200100290; Chaitoff A, 2017, ACAD MED, V92, P1464, DOI 10.1097/ACM.0000000000001671; Dennis CL, 2017, BRIT J PSYCHIAT, V210, P315, DOI 10.1192/bjp.bp.116.187179; Dodani S, 2000, J Pak Med Assoc, V50, P138; Epstein RM, 2017, JAMA ONCOL, V3, P92, DOI 10.1001/jamaoncol.2016.4373; Fawcett EJ, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.18r12527; Feldman-Stewart D, 2005, PSYCHO-ONCOLOGY, V14, P801, DOI 10.1002/pon.950; Figueiredo B, 2011, ARCH WOMEN MENT HLTH, V14, P247, DOI 10.1007/s00737-011-0217-3; First M, 2016, AM PSYCHIATR ASSOC; Fogarty LA, 1999, J CLIN ONCOL, V17, P371, DOI 10.1200/JCO.1999.17.1.371; Girgis A, 2009, PATIENT EDUC COUNS, V77, P456, DOI 10.1016/j.pec.2009.09.018; Guba E., 1989, 4 GENERATION EVALUAT; Hassan R, 2011, PAK J MED RES; Hillen MA, 2011, PSYCHO-ONCOLOGY, V20, P227, DOI 10.1002/pon.1745; Jalil A, 2017, BMC HEALTH SERV RES, V17, P1, DOI 10.1186/s12913-017-2094-6; Kang YT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050468; Knight Kelly, 2015, ADDICTED PREGNANT PO; Knight Kelly R, 2017, Contemp Drug Probl, V44, P301, DOI 10.1177/0091450917740359; Knight KR., 2020, WOMENS REPROD HLTH, V7, P164, DOI [10.1080/23293691.2020.1780400, DOI 10.1080/23293691.2020.1780400]; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; LEVINSON W, 1995, J GEN INTERN MED, V10, P375, DOI 10.1007/BF02599834; Liang WC, 2006, PATIENT EDUC COUNS, V64, P387, DOI 10.1016/j.pec.2006.04.004; Matusitz J, 2015, J HUM BEHAV SOC ENVI, V25, P871, DOI 10.1080/10911359.2015.1035148; Mechanic D, 2000, SOC SCI MED, V51, P657, DOI 10.1016/S0277-9536(00)00014-9; Miles M., 1994, QUALITATIVE ANAL EXP; Mills J., 2006, INT J QUAL METHODS, V5, P25, DOI [DOI 10.1177/160940690600500103, 10.1177/160940690600500103]; Misri S, 2015, J WOMENS HEALTH, V24, P762, DOI 10.1089/jwh.2014.5150; Moazam F, 2000, HASTINGS CENT REP, V30, P28, DOI 10.2307/3528451; Nadir M, 2018, INDIAN J PSYCHIAT, V60, P103, DOI 10.4103/psychiatry.IndianJPsychiatry_153_17; Nasreen HE, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1781-0; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; National Institute of Population Studies (NIPS) ICF International, PAK DEM HLTH SURV 20; Nicoloro-SantaBarbara J, 2017, SOC SCI MED, V190, P133, DOI 10.1016/j.socscimed.2017.08.011; O'Connor TG, 2013, BRAIN BEHAV IMMUN, V32, P21, DOI 10.1016/j.bbi.2013.02.002; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P1255, DOI 10.1017/S095457941400100X; O'Donnell KJ, 2013, PSYCHONEUROENDOCRINO, V38, P1630, DOI 10.1016/j.psyneuen.2013.01.008; Oliffe J, 2007, QUAL HEALTH RES, V17, P149, DOI 10.1177/1049732306297695; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Onyeajam DJ, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5285-0; Patel I, 2011, PATIENT-RELAT OUTCOM, V2, P21, DOI 10.2147/PROM.S15747; Qadir F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1150; Raine R, 2010, MATERN CHILD HLTH J, V14, P590, DOI 10.1007/s10995-009-0489-7; Riedl D, 2017, Z PSYCHOSOM MED PSYC, V63, P131, DOI 10.13109/zptm.2017.63.2.131; Rowe Rachel E, 2002, Health Expect, V5, P63, DOI 10.1046/j.1369-6513.2002.00159.x; Saldana J., 2021, CODING MANUAL QUALIT, P1; Schetter CD, 2016, PAEDIATR PERINAT EP, V30, P421, DOI 10.1111/ppe.12300; Singh P., 2013, PARADIGM, V17, P37, DOI DOI 10.1177/0971890720130105; Stortenbeker IA, 2018, PATIENT EDUC COUNS, V101, P1577, DOI 10.1016/j.pec.2018.05.002; Sufrin C., 2017, JAILCARE JAILCARE, DOI [10.1525/california/9780520288669.001.0001, DOI 10.1525/CALIFORNIA/9780520288669.001.0001]; Surkan PJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037590; Travaline JM, 2005, J AM OSTEOPATH ASSOC, V105, P13; UNICEF, PAK DEM HLTH INF MOR; van Osch M, 2017, PATIENT EDUC COUNS, V100, P1482, DOI 10.1016/j.pec.2017.03.009; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Verheul W, 2010, PATIENT EDUC COUNS, V80, P300, DOI 10.1016/j.pec.2010.06.017; Waqas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116510; Weiss R, 2017, J HOSP MED, V12, P805, DOI 10.12788/jhm.2828; WHO UNICEF UNFPA World Bank, 2019, TRENDS MAT MORT 2000; Wong ST, 2004, WOMEN HEALTH ISS, V14, P118, DOI 10.1016/j.whi.2004.04.003; World Health Organization, 2019, MAT MORT; Wright EB, 2004, BMJ-BRIT MED J, V328, P864, DOI 10.1136/bmj.38046.771308.7C; Young GJ, 2000, MED CARE, V38, P325, DOI 10.1097/00005650-200003000-00009; Zhang Shaoling, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P1070, DOI 10.3969/j.issn.1672-7347.2013.10.015; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	68	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244671	10.1371/journal.pone.0244671	http://dx.doi.org/10.1371/journal.pone.0244671			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544747	gold, Green Published			2022-12-26	WOS:000617991900010
J	Patil, P; Lalwani, P; Vidwans, H; Kulkarni, S; Bais, D; Diwekar-Joshi, M; Rasal, M; Bhasme, N; Naik, M; Batwal, S; Watve, M				Patil, Pramod; Lalwani, Poortata; Vidwans, Harshada; Kulkarni, Shubhankar; Bais, Deepika; Diwekar-Joshi, Manawa; Rasal, Mayur; Bhasme, Nikhila; Naik, Mrinmayee; Batwal, Shweta; Watve, Milind			A multidimensional functional fitness score has a stronger association with type 2 diabetes than obesity parameters in cross sectional data	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; ADIPOSE-TISSUE; GRIP STRENGTH; GROWTH-FACTOR; HYPERINSULINEMIA; BRAIN; SENSITIVITY; PREDICTOR; REVERSAL; PROVIDES	Objectives We examine here the association of multidimensional functional fitness with type 2 diabetes mellitus (T2DM) as compared to anthropometric indices of obesity such as body mass index (BMI) and waist to hip ratio (WHR) in a sample of Indian population. Research design and method We analysed retrospective data of 663 volunteer participants (285 males and 378 females between age 28 and 84), from an exercise clinic in which every participant was required to undergo a health related physical fitness (HRPF) assessment consisting of 15 different tasks examining 8 different aspects of functional fitness. Results The odds of being diabetic in the highest quartile of BMI were not significantly higher than that in the lowest quartile in either of the sexes. The odds of being a diabetic in the highest WHR quartile were significantly greater than the lowest quartile in females (OR = 4.54 (1.95, 10.61) as well as in males (OR = 3.81 (1.75, 8.3). In both sexes the odds of being a diabetic were significantly greater in the lowest quartile of HRPF score than the highest (males OR = 10.52 (4.21, 26.13); females OR = 10.50 (3.53, 31.35)). After removing confounding, the predictive power of HRPF was significantly greater than that of WHR. HRPF was negatively correlated with WHR, however for individuals that had contradicting HRPF and WHR based predictions, HRPF was the stronger predictor of T2DM. Conclusion The association of multidimensional functional fitness score with type 2 diabetes was significantly stronger than obesity parameters in a cross sectional self-selected sample from an Indian city.	[Patil, Pramod; Kulkarni, Shubhankar; Rasal, Mayur; Bhasme, Nikhila; Naik, Mrinmayee; Batwal, Shweta; Watve, Milind] Deenanath Mangeshkar Hosp, BILD Clin, Pune, Maharashtra, India; [Lalwani, Poortata] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Vidwans, Harshada; Bais, Deepika; Diwekar-Joshi, Manawa] Indian Inst Sci Educ & Res Pune IISER P, Dept Biol, Pune, Maharashtra, India	University of Michigan System; University of Michigan; Indian Institute of Science Education & Research (IISER) Pune	Watve, M (corresponding author), Deenanath Mangeshkar Hosp, BILD Clin, Pune, Maharashtra, India.	milind.watve@gmail.com	Patil, Pramod/GMW-7263-2022	Bais, Deepika/0000-0003-3051-4742; Lalwani, Poortata/0000-0003-3022-3152				[Anonymous], 2018, REGEN RECONSTR RESTO, V3, pX, DOI [10.22037/rrr.v3i4.24267., DOI 10.22037/RRR.V3I4.24267]; de Brito LBB, 2014, EUR J PREV CARDIOL, V21, P892, DOI 10.1177/2047487312471759; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Bluher M, 2020, ENDOCR REV, V41, P405, DOI 10.1210/endrev/bnaa004; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Chakravarthy MV, 2008, DIABETES, V57, P2698, DOI 10.2337/db08-0404; Cleasby ME, 2016, J ENDOCRINOL, V229, pR67, DOI 10.1530/JOE-15-0533; Corbett SJ, 2009, AM J HUM BIOL, V21, P587, DOI 10.1002/ajhb.20937; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Deem JD, 2017, DIABETES, V66, P1758, DOI 10.2337/dbi16-0067; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Flowers E, 2019, DIABETES CARE, V42, P946, DOI 10.2337/dc18-1510; Gamas L, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/359159; Gill SV, 2017, OSTEOARTHR CARTILAGE, V25, P60, DOI 10.1016/j.joca.2016.07.011; Gogg S, 2002, J BIOL CHEM, V277, P36045, DOI 10.1074/jbc.M200575200; Greater Mekong Subregion Secretariat, 2020, EL MAL GREAT MEK SUB; Greisen J, 2001, ANESTHESIOLOGY, V95, P578, DOI 10.1097/00000542-200109000-00007; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Kennedy AB, 2018, JAMA-J AM MED ASSOC, V319, P231, DOI 10.1001/jama.2017.21649; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; King LK, 2013, INDIAN J MED RES, V138, P185; LANG CH, 1992, AM J PHYSIOL, V263, pE703, DOI 10.1152/ajpendo.1992.263.4.E703; Lee CC, 2005, J GERONTOL A-BIOL, V60, P872, DOI 10.1093/gerona/60.7.872; Lee HY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209575; Lustig RH, 2003, J CLIN ENDOCR METAB, V88, P2586, DOI 10.1210/jc.2002-030003; Mainous AG, 2015, AM J PREV MED, V49, P850, DOI 10.1016/j.amepre.2015.05.025; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Meek TH, 2013, DIABETES, V62, P1512, DOI 10.2337/db12-0837; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Raud B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60587-1; Reyes C, 2016, ARTHRITIS RHEUMATOL, V68, P1869, DOI 10.1002/art.39707; Rogers C, 2012, J CLIN ENDOCR METAB, V97, pE329, DOI 10.1210/jc.2011-1033; S BE, 2018, J CROHNS COLITIS, V12, pS049; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shpakov AO, 2015, FUTUR SCI OA, V1, DOI [10.4155/FSO.15.23, 10.4155/fso.15.23]; Sierra-Johnson J, 2004, OBES RES, V12, P2070, DOI 10.1038/oby.2004.258; Smith GI, 2019, J CLIN INVEST, V129, P3978, DOI 10.1172/JCI129186; So B, 2014, INTEGR MED RES, V3, P172, DOI 10.1016/j.imr.2014.09.007; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157968; Watve MG, 2013, DOVES DIPLOMATS DIAB, DOI [10.1016/j.mehy.2013.11.00224321738, DOI 10.1016/J.MEHY.2013.11.00224321738]; Watve M, 2008, CURR SCI INDIA, V95, P171; Watve M, 2017, EVOL MED PUBLIC HLTH, P178, DOI 10.1093/emph/eox020; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Wells JCK, 2016, EVOL MED PUBLIC HLTH, P133, DOI 10.1093/emph/eow011; YKIJARVINEN H, 1989, J CLIN ENDOCR METAB, V69, P317, DOI 10.1210/jcem-69-2-317; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	54	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245093	10.1371/journal.pone.0245093	http://dx.doi.org/10.1371/journal.pone.0245093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0UN	33544739	gold, Green Published			2022-12-26	WOS:000617993300004
J	Eybpoosh, S; Mostaan, S; Gouya, MM; Masoumi-Asl, H; Owlia, P; Eshrati, B; Khorasan, MRMR; Bouzari, S				Eybpoosh, Sana; Mostaan, Saeid; Gouya, Mohammad Mehdi; Masoumi-Asl, Hossein; Owlia, Parviz; Eshrati, Babak; Khorasan, Mohammad Reza Montazer Razavi; Bouzari, Saeid			Frequency of five Escherichia Coli pathotypes in Iranian adults and children with acute diarrhea	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE PATTERNS; ANTIMICROBIAL RESISTANCE; VTEC INFECTION; PREVALENCE; COUNTRIES; IDENTIFICATION; EPIDEMIOLOGY; POPULATION; VIRULENCE; OUTBREAK	Background Knowledge about the distribution of Escherichia Coli (E. coli) pathotypes in Iran is limited. This nation-wide survey aims to provide a comprehensive description of the distribution of five pathogenic E. coli in Iran. Methods Stool samples were collected from 1,306 acute diarrhea cases from 15 provinces (2013-2014). E. coli-positive cultures underwent PCR testing for the detection of STEC, ETEC, EPEC, EAEC, and EIEC pathotypes. Pathotype frequency by province, age-group, and season was estimated. Results 979 diarrhea samples (75.0%) were culture-positive for E. coli (95% CI: 72.6, 77.3%), and 659 (50.5%) were pathogenic E. coli (95% CI: 47.8, 53.2%). STEC was the most frequent pathotype (35.4%). ETEC (14.0%) and EPEC (13.1%) were the second and the third most frequent pathotypes, respectively. EAEC (4.3%) and EIEC (0.3%) were not highly prevalent. Fars (88.7%) and Khorasan-e-Razavi (34.8%) provinces had the highest and lowest frequencies, respectively. E. coli pathotypes were more frequent in warmer than cooler seasons, showed the highest frequency among children under five years of age (73%), and had no significant association with participants' gender. Conclusions Diarrheagenic E. coli may be an important cause of acute diarrhea in adults and children in Iran. STEC and ETEC seem to be widespread in the country with a peak in warmer seasons, impacting the recommended use of seasonal STEC and ETEC vaccines, especially in high-risk groups. Monitoring the incidence of E. coli pathotypes, serotypes, and antibiotic resistance over time is highly recommended for evaluation of interventions.	[Eybpoosh, Sana] Pasteur Inst Iran, Dept Epidemiol & Biostat, Res Ctr Emerging & Reemerging Infect Dis, Tehran, Iran; [Mostaan, Saeid; Bouzari, Saeid] Pasteur Inst Iran, Dept Mol Biol, Tehran, Iran; [Gouya, Mohammad Mehdi; Masoumi-Asl, Hossein; Khorasan, Mohammad Reza Montazer Razavi] Minist Hlth & Med Educ, Ctr Communicable Dis Control, Tehran, Iran; [Owlia, Parviz] Shahed Univ, Mol Microbiol Res Ctr, Tehran, Iran; [Eshrati, Babak] Iran Univ Med Sci, Ctr Prevent Med, Dept Social Med, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Ministry of Health & Medical Education (MOHME); Shahed University; Iran University of Medical Sciences	Bouzari, S (corresponding author), Pasteur Inst Iran, Dept Mol Biol, Tehran, Iran.	bouzari@pasteur.ac.ir		Mostaan, Saied/0000-0003-1892-0019	 [IR.PII.1394.672]		Initials of the authors who received each award: MMG; HMA; SB. Grant numbers awarded to each author: IR.PII.1394.672 (Awarded to SB). The full name of each funder: Pasteur Institute of Iran and office for food-and water-borne diseases and deputy of research and technology in the ministry of health. URL of each funder website: http://www.pasteur.ac.ir/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahangarzadeh Rezaee, 2015, J ANAL RES CLIN MED, V3, P183; Al-Gallas N, 2007, AM J TROP MED HYG, V77, P571, DOI 10.4269/ajtmh.2007.77.571; Alikhani MV, 2013, IRAN J MICROBIOL, V5, P42; Alizade H, 2014, ASIAN PAC J TROP DIS, V4, pS813; Alizade H, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_256_18; Alizade Hesam, 2017, J Int Assoc Provid AIDS Care, V16, P353, DOI 10.1177/2325957415617831; Alizadeh A, 2007, ESCHERICHIA COLI SHI; Anderson JD, 2019, LANCET GLOB HEALTH, V7, pE321, DOI 10.1016/S2214-109X(18)30483-2; [Anonymous], 2013, MOL THER, V21, pe1; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2014, J MED INTERNET RES; Aslani MM, 1998, SCAND J INFECT DIS, V30, P473, DOI 10.1080/00365549850161467; Aslani MM, 2003, EUR J EPIDEMIOL, V18, P345, DOI 10.1023/A:1023602416726; Bafandeh S, 2015, J MED MICROBIOL, V64, P519, DOI 10.1099/jmm.0.000055; Bouzari S., 2007, Eastern Mediterranean Health Journal, V13, P287; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Cohen MB, 2005, J PEDIATR-US, V146, P54, DOI 10.1016/j.jpeds.2004.08.059; Dallal MS, 2006, OCCURRENCE ENTEROPAT; Vasconcelos MJDB, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052016094, 10.11606/s1518-8787.2018052016094]; Eybpoosh S, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007081; Gonzalez-Escalona N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214620; Gupta SK, 2008, EPIDEMIOL INFECT, V136, P721, DOI 10.1017/S095026880700934X; Haghi F, 2014, J MED MICROBIOL, V63, P427, DOI 10.1099/jmm.0.064600-0; Heidary M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.12329; Huang WC, 2016, ECOTOX ENVIRON SAFE, V124, P37, DOI 10.1016/j.ecoenv.2015.09.040; Ihekweazu C, 2012, EPIDEMIOL INFECT, V140, P1400, DOI 10.1017/S0950268811002111; Jafari A, 2012, IRAN J MICROBIOL, V4, P102; Jafari F, 2009, J INFECTION, V58, P21, DOI 10.1016/j.jinf.2008.10.013; Jafari F, 2008, JPN J INFECT DIS, V61, P269; Jafari Fereshteh, 2009, Can J Infect Dis Med Microbiol, V20, pe56; Kalantar E, 2009, ASIAN PAC J TROP MED, V2, P64; Kalantar E, 2011, FREQUENCY ANTIMICROB; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keskimaki M, 2000, J CLIN MICROBIOL, V38, P4425; Khoshvaght Hakimeh, 2014, Gastroenterol Hepatol Bed Bench, V7, P131; Miri ST, 2017, IRAN J MICROBIOL, V9, P33; Mitra M, 2011, AFR J MICROBIOL RES, V5, P3305; Nazarian S, 2014, JPN J INFECT DIS, V67, P78, DOI 10.7883/yoken.67.78; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; PAYNE SM, 1977, INFECT IMMUN, V18, P94, DOI 10.1128/IAI.18.1.94-98.1977; Philipsborn R, 2016, J INFECT DIS, V214, P6, DOI 10.1093/infdis/jiw081; Pourakbari B, 2013, DIARRHOEAGENIC COLI; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Shah Mohammad, 2016, Trop Med Health, V44, P39, DOI 10.1186/s41182-016-0038-1; SOLTAN DMM, 2001, DIARRHEA CAUSED ENTE; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; Willshaw GA, 2001, J MED MICROBIOL, V50, P135, DOI 10.1099/0022-1317-50-2-135; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001; Zeighami H, 2015, J CHEMOTHERAPY, V27, P152, DOI 10.1179/1973947813Y.0000000161; Zhang H, 2015, EPIDEMIOL INFECT, V143, P2512, DOI 10.1017/S0950268814003756	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245470	10.1371/journal.pone.0245470	http://dx.doi.org/10.1371/journal.pone.0245470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539359	Green Submitted, Green Published, gold			2022-12-26	WOS:000616960200113
J	Khan, MA; Khan, N; Rahman, O; Mustagir, G; Hossain, K; Islam, R; Khan, HTA				Khan, Mostaured Ali; Khan, Nuruzzaman; Rahman, Obaidur; Mustagir, Golam; Hossain, Kamal; Islam, Rafiqul; Khan, Hafiz T. A.			Trends and projections of under-5 mortality in Bangladesh including the effects of maternal high-risk fertility behaviours and use of healthcare services	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHILD-MORTALITY; ASSOCIATION; INFANT	Objective This study examines trends and puts forward projections of under-5 mortality (U5M) in Bangladesh and identifies the effects of maternal high-risk fertility behaviours and use of healthcare services. Methods Data from seven waves of the Bangladesh Demographic and Health Survey (1994-2014) were analyzed for trends and projections of U5M and a Chi-square (chi(2)) test was used to identify if there was any association with maternal high-risk fertility behaviours and use of healthcare services. A multivariate logistic regression model was used to determine the effects of fertility behaviors and healthcare usage on the occurrence of U5M adjusting with confounders. Results U5M declined from 82.5 to 41.0 per 1000 livebirths during 1994-2014 and is projected to further reduce to 17.6 per 1000 livebirths by 2030. The study identified a noticeable regional variation in U5M with maternal high-risk fertility behaviours including age at birth <18 years (aOR: 1.84, 95% CI: 1.23-2.76) and birth interval <24 months (aOR: 1.56, 95% CI: 1.02-2.37) found to be significant determinants. There was a 39-53% decline in this rate of mortality among women that had used antenatal care services at least four times (aOR, 0.51, 95% CI: 0.27-0.97), delivery care (aOR, 0.47, 95% CI: 0.24-0.95), and had received postnatal care (aOR, 0.61, 95% CI: 0.41-0.91) in their last birth. Cesarean section was found to be associated with a 51% reduction in U5M (aOR, 0.49, 95% CI: 0.29-0.82) compared to its non-use. Conclusion The Sustainable Development Goals require a U5M rate of 25 per 1000 livebirths to be achieved by 2030. This study suggests that with the current trend of reduction, Bangladesh will achieve this target before the deadline. This study also found that maternal high-risk fertility behaviours and non-use of maternal healthcare services are very prevalent in some regions of Bangladesh and have increased the occurrence of U5M in those areas. This suggests therefore, that policies and programmes designed to reduce the pregnancy rates of women that are at risk and to encourage an increase in the use of maternal healthcare services are needed.	[Khan, Mostaured Ali; Mustagir, Golam; Hossain, Kamal; Islam, Rafiqul] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh; [Khan, Mostaured Ali] Pract Act, MEL & Res, Dhaka, Bangladesh; [Khan, Nuruzzaman] Univ Newcastle, Fac Hlth & Med, Sch Publ Hlth & Med, Callaghan, NSW, Australia; [Khan, Nuruzzaman] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Rahman, Obaidur] St Lukes Int Univ, Dept Global Hlth Nursing, Grad Sch Nursing Sci, Tokyo, Japan; [Rahman, Obaidur] Univ Tokyo, Sch Int Hlth, Dept Global Hlth Policy, Tokyo, Japan; [Khan, Hafiz T. A.] Univ West London, Coll Nursing Midwifery & Healthcare, Publ Hlth & Stat, Brentford, England	University of Rajshahi; University of Newcastle; St. Luke's International Hospital; University of Tokyo	Islam, R (corresponding author), Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh.	rafique_pops@yahoo.com	Rahman, Dr. Md. Obaidur/AAK-5762-2020; Khan, Md. Mostaured Ali/HII-9959-2022	Rahman, Dr. Md. Obaidur/0000-0002-2219-3013; Khan, Md. Mostaured Ali/0000-0001-7837-3251; Islam, Md. Rafiqul/0000-0001-6959-4554; Khan, Md Nuruzzaman/0000-0002-4550-4363				Abir T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187090; Abir T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006722; Adekanmbi VT, 2015, J EPIDEMIOL COMMUN H, V69, P1102, DOI 10.1136/jech-2015-205457; Agho K.E., 2020, FACTORS ASS UNDER 5; Aheto JMK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6390-4; Amouzou A, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020504; [Anonymous], 2001, BANGLADESH DEMOGRAPH; Bado A.R., 2018, J PUBLIC HLTH; Bhutta ZA, 2016, LANCET GLOB HEALTH, V4, pE877, DOI 10.1016/S2214-109X(16)30264-9; Bills CB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019937; Chadoka-Mutanda N, 2017, J BIOSOC SCI, V49, P408, DOI 10.1017/S0021932016000298; Chao FQ, 2018, LANCET GLOB HEALTH, V6, pE535, DOI 10.1016/S2214-109X(18)30059-7; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Doku DT, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001558; Dwyer-Lindgren L, 2018, POPUL HEALTH METR, V16, DOI 10.1186/s12963-018-0171-7; Ezeh OK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006779; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; Ghimire PR, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071241; Gruebner O, 2017, HEALTH PLACE, V47, P156, DOI 10.1016/j.healthplace.2017.08.012; Hossain MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003616; IGME, 2018, UN INT GROUP CHILD M; Khan JR, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0224-6; Khan MN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177579; Kikuchi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164965; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Makate M, 2017, HEALTH POLICY PLANN, V32, P395, DOI 10.1093/heapol/czw154; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Molitoris J, 2017, POPUL DEV REV, V43, P61, DOI 10.1111/padr.12050; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Neal S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195731; NIPORT, 2009, NAT I POP RES TRAIN; NIPORT, 1995, BANGL DEM HLTH SURV; NIPORT, 1998, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; Nuamah GB, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-018-2159-5; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Rahman MS, 2018, LANCET GLOB HEALTH, V6, pE84, DOI 10.1016/s2214-109x(17)30413-8; Rahman M, 2019, AM J TROP MED HYG, V101, P929, DOI 10.4269/ajtmh.19-0221; Rahman M, 2017, PUBLIC HEALTH NUTR, V20, P305, DOI [10.1017/S136898001600224X, 10.1017/s136898001600224x]; Rajia S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211875; Roy S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2129-y; Silveira MF, 2020, INT J STD AIDS, V31, P432, DOI 10.1177/0956462419898982; Sobhy S, 2019, LANCET, V393, P1973, DOI 10.1016/S0140-6736(18)32386-9; UN, 2015, MILLENNIUM DEV GOALS; UNICEF, 2018, 2018 2021 PROGR REP; UNICEF, 2007, CALC AV ANN RAT RED; Van Malderen C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7111-8; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; Victora CG, 2020, LANCET GLOB HEALTH, V8, pE352, DOI 10.1016/S2214-109X(20)30025-5; WHO, 2018, WHO UND 5 MORT; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246210	10.1371/journal.pone.0246210	http://dx.doi.org/10.1371/journal.pone.0246210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539476	Green Accepted, gold, Green Published			2022-12-26	WOS:000616960200068
J	Rasker, JJ; Wolfe, F; Klaver-Krol, EG; Zwarts, MJ; ten Klooster, PM				Rasker, Johannes J.; Wolfe, Frederick; Klaver-Krol, Ewa G.; Zwarts, Machiel J.; ten Klooster, Peter M.			The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures	PLOS ONE			English	Article							PSYCHOGENIC NONEPILEPTIC SEIZURES; NATIONAL DATA-BANK; POLYSYMPTOMATIC DISTRESS; PSYCHOLOGICAL DISTRESS; SOMATIC COMORBIDITY; EPILEPSY; PAIN; CRITERIA; QUESTIONNAIRE; POPULATION	Objective Several epidemiological and clinical reports associate fibromyalgia (FM) with seizure disorders, and clinical studies associate FM diagnosis with psychogenic non-epileptic seizures. However, these associations rely on self-reports of being diagnosed with FM or unstandardized clinical diagnosis in combination with small samples. We investigated the association of FM and self-reported seizures using a large rheumatic disease databank and the current established self-reported, symptom-based FM diagnostic criteria. Methods We selected a random observation from 11,378 subjects with rheumatoid arthritis (RA), 2,390 (21.0%) of whom satisfied 2016 revised criteria for FM. Patients were inquired about the presence of any kind of seizures in the previous 6 months, anti-epileptic medications, and patient-reported symptoms and outcomes. Results Seizures were reported by 89 RA patients who met FM criteria (FM+) and by 97 patients who did not (FM-), resulting in an age- and sex-adjusted seizure prevalence of 3.74 (95% CI 2.95 to 4.53) per 100 FM+ subjects and 1.08 (95% CI 0.87 to 1.30) in FM- subjects. The seizure odds ratio of FM+ to FM- cases was 3.54 (95% CI 2.65 to 4.74). Seizures were associated to a very similar degree with symptom reporting (somatic symptom count and comorbidity index) as to FM diagnosis variables. RA patients reporting seizures also reported worse pain, quality of life, and functional status. Seizure patients treated with anti-seizure medication had worse outcomes and more comorbidities than seizure patients with no seizure drugs. Conclusions We found a significant and similar association of both FM diagnostic variables and FM-related symptom variables, including the number of symptoms and comorbidities, with self-reported seizures in people with RA. The observed association was similar to those found in previous studies of symptoms variables and seizures and does not suggest a unique role for fibromyalgia diagnosis. Rather, it suggests that multi-symptom comorbidity is linked to seizures in a complex and not yet clearly understood way. As the current study relied on self-reported seizures and was not able to distinguish between epileptic and psychogenic nonepileptic seizures, future studies are needed to replicate the findings using both validated FM criteria assessments and clinically verified diagnoses of epileptic and psychogenic seizures.	[Rasker, Johannes J.; ten Klooster, Peter M.] Univ Twente, Fac Behav Management & Social Sci, Dept Psychol Hlth & Technol, Enschede, Netherlands; [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS USA; [Wolfe, Frederick] Univ Kansas, Sch Med, Wichita, KS 67214 USA; [Klaver-Krol, Ewa G.] Roessingh Res & Dev, Enschede, Netherlands; [Zwarts, Machiel J.] Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands	University of Twente; National Data Bank for Rheumatic Diseases; University of Kansas; University of Kansas Medical Center	ten Klooster, PM (corresponding author), Univ Twente, Fac Behav Management & Social Sci, Dept Psychol Hlth & Technol, Enschede, Netherlands.	p.m.tenklooster@utwente.nl	Klooster, Peter M. ten/D-2905-2009	Klooster, Peter M. ten/0000-0002-2565-5439; Wolfe, Frederick/0000-0002-2801-6413				Ablin JN, 2017, J RHEUMATOL, V44, P1271, DOI 10.3899/jrheum.170095; Amanat M, 2019, SEIZURE-EUR J EPILEP, V64, P59, DOI 10.1016/j.seizure.2018.11.012; Asadi-Pooya AA, 2016, J CLIN NEUROSCI, V34, P105, DOI 10.1016/j.jocn.2016.05.037; Benbadis SR, 2005, EPILEPSY BEHAV, V6, P264, DOI 10.1016/j.yebeh.2004.12.007; Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ehrlich GE, 2003, J RHEUMATOL, V30, P1666; FRIES JF, 1982, J RHEUMATOL, V9, P789; Frucht MM, 2000, EPILEPSIA, V41, P1534; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Green B, 2017, EPILEPSY BEHAV, V66, P120, DOI 10.1016/j.yebeh.2016.10.015; Haut SR, 2003, EPILEPSY BEHAV, V4, P511, DOI 10.1016/S1525-5050(03)00182-3; Hazemeijer I, 2003, RHEUMATOLOGY, V42, P507, DOI 10.1093/rheumatology/keg129; Hernandez MA, 2012, RELATIONSHIP EQ 5D H; Huang F, 2019, ANN RHEUM DIS, V78, P1171, DOI 10.1136/annrheumdis-2019-eular.6665; Keezer MR, 2016, LANCET NEUROL, V15, P106, DOI 10.1016/S1474-4422(15)00225-2; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Michaud K, 2016, CLIN EXP RHEUMATOL, V34, pS100; Nakamura I, 2014, ARTHRIT CARE RES, V66, P1093, DOI 10.1002/acr.22277; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Sleurs D, 2020, EUR J PAIN, V24, P1471, DOI 10.1002/ejp.1585; Smith R, 2002, BRIT MED J, V324, P883, DOI 10.1136/bmj.324.7342.883; *STAT CORP, 2017, STAT STAT SOFTW REL; Strine TW, 2005, EPILEPSIA, V46, P1133, DOI 10.1111/j.1528-1167.2005.01605.x; Tatum WO, 2016, EPILEPTIC DISORD, V18, P148, DOI 10.1684/epd.2016.0823; Tellez-Zenteno JF, 2005, EPILEPSIA, V46, P1955, DOI 10.1111/j.1528-1167.2005.00344.x; Tojek TM, 2000, PSYCHOSOMATICS, V41, P221, DOI 10.1176/appi.psy.41.3.221; Walitt B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157235; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; Wilner AN, 2016, EPILEPSY BEHAV, V57, P126, DOI 10.1016/j.yebeh.2016.01.033; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2003, J RHEUMATOL, V30, P369; Wolfe F, 2020, J RHEUMATOL, V47, P624, DOI 10.3899/jrheum.190149; Wolfe F, 2019, ARTHRIT CARE RES, V71, P343, DOI 10.1002/acr.23731; Wolfe F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203755; Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012; Wolfe F, 2014, ARTHRIT CARE RES, V66, P1465, DOI 10.1002/acr.22300; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155; Wolfe F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2944; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zhao HW, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622319899300; Zhao SS, 2019, BEST PRACT RES CL RH, V33, DOI 10.1016/j.berh.2019.06.005	45	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246051	10.1371/journal.pone.0246051	http://dx.doi.org/10.1371/journal.pone.0246051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539459	Green Published, gold			2022-12-26	WOS:000616960200077
J	Antonescu, ON; Rasmussen, A; Damm, NAM; Heidemann, DF; Popov, R; Nesterov-Mueller, A; Johansson, KE; Winther, JR				Antonescu, Oana N.; Rasmussen, Andreas; Damm, Nicole A. M.; Heidemann, Ditte F.; Popov, Roman; Nesterov-Mueller, Alexander; Johansson, Kristoffer E.; Winther, Jakob R.			Substitutional landscape of a split fluorescent protein fragment using high-density peptide microarrays	PLOS ONE			English	Article							COMPLEMENTATION; RECONSTITUTION	Split fluorescent proteins have wide applicability as biosensors for protein-protein interactions, genetically encoded tags for protein detection and localization, as well as fusion partners in super-resolution microscopy. We have here established and validated a novel platform for functional analysis of leave-one-out split fluorescent proteins (LOO-FPs) in high throughput and with rapid turnover. We have screened more than 12,000 variants of the beta-strand split fragment using high-density peptide microarrays for binding and functional complementation in Green Fluorescent Protein. We studied the effect of peptide length and the effect of different linkers to the solid support. We further mapped the effect of all possible amino acid substitutions on each position as well as in the context of some single and double amino acid substitutions. As all peptides were tested in 12 duplicates, the analysis rests on a firm statistical basis allowing for confirmation of the robustness and precision of the method. Based on experiments in solution, we conclude that under the given conditions, the signal intensity on the peptide microarray faithfully reflects the binding affinity between the split fragments. With this, we are able to identify a peptide with 9-fold higher affinity than the starting peptide.	[Antonescu, Oana N.; Rasmussen, Andreas; Damm, Nicole A. M.; Heidemann, Ditte F.; Johansson, Kristoffer E.; Winther, Jakob R.] Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Dept Biol, Sect Biomol Sci, Copenhagen, Denmark; [Popov, Roman; Nesterov-Mueller, Alexander] Karlsruhe Inst Technol, Inst Microstruct Technol, Eggenstein Leopoldshafen, Germany	University of Copenhagen; Helmholtz Association; Karlsruhe Institute of Technology	Winther, JR (corresponding author), Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Dept Biol, Sect Biomol Sci, Copenhagen, Denmark.	jrwinther@bio.ku.dk	; Winther, Jakob/K-4451-2014	Antonescu, Oana/0000-0003-1161-0835; Heidemann, Ditte/0000-0003-4315-5793; Johansson, Kristoffer Enoe/0000-0001-6054-0461; Winther, Jakob/0000-0001-6995-9154	Independent Research Fund Denmark	Independent Research Fund Denmark	This work was supported by Independent Research Fund Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco C, 2019, ANNU REV BIOPHYS, V48, P1, DOI 10.1146/annurev-biophys-052118-115333; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Do K, 2011, J AM CHEM SOC, V133, P18078, DOI 10.1021/ja207985w; Feng SY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00494-8; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Huang YM, 2015, BIOCHEMISTRY-US, V54, P6263, DOI 10.1021/acs.biochem.5b00786; Huang YM, 2011, PROTEIN SCI, V20, P1775, DOI 10.1002/pro.735; Huang YM, 2009, BIOCHEMISTRY-US, V48, P929, DOI 10.1021/bi802027g; Jung G, 2005, BIOPHYS J, V88, P1932, DOI 10.1529/biophysj.104.044412; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Lars Behrendt AS, 2018, BIORXIV; Layton CJ, 2019, MOL CELL, V73, P1075, DOI 10.1016/j.molcel.2019.02.019; Lundqvist M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36559-x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pedelacq JD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143479; Poreba M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43135; Romei MG, 2019, ANNU REV BIOPHYS, V48, P19, DOI 10.1146/annurev-biophys-051013-022846; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; Szymczak LC, 2018, ANAL CHEM, V90, P266, DOI 10.1021/acs.analchem.7b04380; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang W, 2015, ACTA BIOMATER, V11, P88, DOI 10.1016/j.actbio.2014.09.039; Wang W, 2014, ACTA BIOMATER, V10, P761, DOI 10.1016/j.actbio.2013.10.025	28	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0241461	10.1371/journal.pone.0241461	http://dx.doi.org/10.1371/journal.pone.0241461			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534832	Green Submitted, Green Published, gold			2022-12-26	WOS:000616739700031
J	Dahal, K; Yadav, DK; Baral, D; Yadav, BK				Dahal, Kajol; Yadav, Deepak Kumar; Baral, Dharanidhar; Yadav, Birendra Kumar			Determinants of severe acute malnutrition among under 5 children in Satar community of Jhapa, Nepal	PLOS ONE			English	Article							RISK-FACTORS; UNDERNUTRITION; DISTRICT	Background Severe acute malnutrition (SAM) is the most extreme and visible form of undernutrition plagued by chronic poverty, household food insecurity, lack of education. One of the indigenous and marginalized community of Nepal, Satar/Santhal has often been neglected and is devoid of good education and are economically deprived. This predisposes under 5 children of Satar into malnutrition. The study aims to assess determinants of SAM among children under 5 years of age in Satar community of Jhapa district, Nepal. Material & methods A community based matched case control study was carried from September 2019 to February 2020 among under five children of Satar community residing in Jhapa district. Multistage random sampling technique was used to select 50 cases and 100 controls in the ratio of 1:2. Information was collected through personal interview with the parents and anthropometric measurement of the children was measured. Bivariate and multivariate conditional logistic regression analysis was used to explore the determinants of severe acute malnutrition. Results A total of 664 children between the age group of 6-59 months were screened for SAM. The prevalence of SAM was found 7.53%. Factors like, low economic status, birth interval less than 2 years, frequency of breast feeding <8 times/day and household food insecurity were found to be significant determinants of SAM. Multivariate logistic regression documented low economic status (AOR: 11.14, 95% CI 1.42 to 87.46); and frequency of breast feeding <8 times/day (AOR: 2.09, 95% CI 1.00 to 4.37) as determinants of SAM. Conclusion Low economic status and frequency of breast feeding less than 8times/day were major determinants of SAM among children under 5yrs of age. Ending malnutrition will require greater efforts and integrated approaches to eradicate extreme poverty. Multi-sector approaches have been conducting for SAM in Nepal but there are no specific approaches for marginalized community.	[Dahal, Kajol] BP Koirala Inst Hlth Sci, Sch Publ Hlth & Community Med, Dharan, Nepal; [Yadav, Deepak Kumar; Baral, Dharanidhar; Yadav, Birendra Kumar] BP Koirala Inst Hlth Sci, Fac Sch Publ Hlth & Community Med, Dharan, Nepal	B.P. Koirala Institute of Health Sciences; B.P. Koirala Institute of Health Sciences	Dahal, K (corresponding author), BP Koirala Inst Hlth Sci, Sch Publ Hlth & Community Med, Dharan, Nepal.	kajol.dahal09@gmail.com	Dahal, Kajol/AAO-4879-2021	Dahal, Kajol/0000-0002-1930-8246	Nepal Health Research Council	Nepal Health Research Council	KD received the award. Grant number of the award is 90/2020 MT. The full name of the funder is Nepal Health Research Council with URL: http://nhrc.gov.np/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya BA, 2011, MATERN CHILD HLTH J, V15, P1389, DOI 10.1007/s10995-010-0670-z; Ahmed T, 2014, FOOD NUTR BULL, V35, pS14, DOI 10.1177/15648265140352S103; Ambadekar NN, 2017, PUBLIC HEALTH, V142, P136, DOI 10.1016/j.puhe.2016.07.018; [Anonymous], 2017, RHEUMATOLOGY, V56, pe22; [Anonymous], 2012, REHABILITATION ST S1, V51, pS28; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2013, LANCET GLOB HLTH; [Anonymous], 2011, BANDUE REV SOC ESPAN, V5, P5; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2007, STAND COMM NUTR UN C; [Anonymous], 2016, SENSORS, V16, pC1, DOI 10.1109/JSEN.2016.2517933; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; [Anonymous], 2011, BANDUE REV SOC ESPAN, V5, P5; Awoke A, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0211-5; Bisai S, 2014, INT J PEDIATR-MASSHA, V2, P347; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Chowdhury MRK, 2016, J PEDIATR-US, V172, P194, DOI 10.1016/j.jpeds.2016.01.023; Gebre A, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9187609; Ghimire U, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02154-1; Ghosh J.R., 2013, SRI LANKA J CHILD HL, V42, P147, DOI 10.4038/sljch.v42i3.6019; Government of Nepal, 2017, NEP INT MAN AC MALN; Kamal S. M. M., 2011, Malaysian Journal of Nutrition, V17, P105; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B., 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Mahapatra B, 2019, HUMAN BIOL REV, V8, P179; Ministry of Health Nepal; New ERA; ICF, 2017, NEP DEM HLTH SURV 20; Mishra K, 2014, INDIAN J PEDIATR, V81, P762, DOI 10.1007/s12098-013-1127-3; Nzefa LD, 2019, S AFR J CLIN NUTR, V32, P46, DOI 10.1080/16070658.2018.1448503; Pravana NK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017084; Sand A, 2018, PAK J MED SCI, V34, P260, DOI 10.12669/pjms.342.14977; Singh A, 2014, FOOD NUTR BULL, V35, P3, DOI 10.1177/156482651403500101; Tette EMA, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0496-3; United Nations Children's Fund, 2015, SEV AC MALN; von Grebmer K., 2019, 2019 GLOBAL HUNGER I; World Bank Group, 2018, LEV TRENDS CHILD MAL; World Health Organization, 2018, MALN FACTSH	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245151	10.1371/journal.pone.0245151	http://dx.doi.org/10.1371/journal.pone.0245151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534789	Green Submitted, gold, Green Published			2022-12-26	WOS:000616739700057
J	Pentikainen, E; Pitkaniemi, A; Siponkoski, ST; Jansson, M; Louhivuori, J; Johnson, JK; Paajanen, T; Sarkamo, T				Pentikainen, Emmi; Pitkaniemi, Anni; Siponkoski, Sini-Tuuli; Jansson, Maarit; Louhivuori, Jukka; Johnson, Julene K.; Paajanen, Teemu; Sarkamo, Teppo			Beneficial effects of choir singing on cognition and well-being of older adults: Evidence from a cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; WORKING-MEMORY; MENTAL-HEALTH; MUSIC; IMPACT; PLASTICITY	Background and objectives Choir singing has been associated with better mood and quality of life (QOL) in healthy older adults, but little is known about its potential cognitive benefits in aging. In this study, our aim was to compare the subjective (self-reported) and objective (test-based) cognitive functioning of senior choir singers and matched control subjects, coupled with assessment of mood, QOL, and social functioning. Research design and methods We performed a cross-sectional questionnaire study in 162 healthy older (age >= 60 years) adults (106 choir singers, 56 controls), including measures of cognition, mood, social engagement, QOL, and role of music in daily life. The choir singers were divided to low (1-10 years, N = 58) and high (>10 years, N = 48) activity groups based on years of choir singing experience throughout their life span. A subcohort of 74 participants (39 choir singers, 35 controls) were assessed also with a neuropsychological testing battery. Results In the neuropsychological testing, choir singers performed better than controls on the verbal flexibility domain of executive function, but not on other cognitive domains. In questionnaires, high activity choir singers showed better social integration than controls and low activity choir singers. In contrast, low activity choir singers had better general health than controls and high activity choir singers. Discussion and implications In healthy older adults, regular choir singing is associated with better verbal flexibility. Long-standing choir activity is linked to better social engagement and more recently commenced choir activity to better general health.	[Pentikainen, Emmi; Pitkaniemi, Anni; Siponkoski, Sini-Tuuli; Jansson, Maarit; Sarkamo, Teppo] Univ Helsinki, Fac Med, Dept Psychol & Logoped, Cognit Brain Res Unit, Helsinki, Finland; [Louhivuori, Jukka] Univ Jyvaskyla, Dept Mus Art & Culture Studies, Jyvaskyla, Finland; [Johnson, Julene K.] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA USA; [Paajanen, Teemu] Finnish Inst Occupat Hlth, Helsinki, Finland	University of Helsinki; University of Jyvaskyla; University of California System; University of California San Francisco; Finnish Institute of Occupational Health	Pentikainen, E (corresponding author), Univ Helsinki, Fac Med, Dept Psychol & Logoped, Cognit Brain Res Unit, Helsinki, Finland.	emmi.pentikainen@helsinki.fi		Pentikainen, Emmi/0000-0001-6700-0062; Siponkoski, Sini-Tuuli/0000-0001-8078-3620; Pitkaniemi, Anni/0000-0002-3458-074X	TS Academy of Finland [299044, 305264, 306625, 803466]	TS Academy of Finland	TS Academy of Finland: grants 299044, 305264, 306625 https://www.aka.fi/en/European Research Council: grant 803466 https://erc.europa.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri V, 2013, NEUROIMAGE, V83, P627, DOI 10.1016/j.neuroimage.2013.06.064; Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Bakkour A, 2013, NEUROIMAGE, V76, P332, DOI 10.1016/j.neuroimage.2013.02.059; Benz S, 2016, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.02023, 10.3389/fpsyg.2075.02023]; Bernardi NF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07171-2; Berry AS, 2016, J NEUROSCI, V36, P12559, DOI 10.1523/JNEUROSCI.0626-16.2016; Boss L, 2015, INT PSYCHOGERIATR, V27, P541, DOI 10.1017/S1041610214002749; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Cohen GD, 2006, GERONTOLOGIST, V46, P726, DOI 10.1093/geront/46.6.726; Coulton S, 2015, BRIT J PSYCHIAT, V207, P250, DOI 10.1192/bjp.bp.113.129908; Cutrona C.E., 1987, ADV PERSONAL RELATIO, V1, P37; European Choral Association, 2015, SING EUR REP 2015; Fancourt D., 2019, WHO HLTH EVIDENCE NE; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fu MC, 2018, ARCH GERONTOL GERIAT, V76, P138, DOI 10.1016/j.archger.2018.02.012; Hanna-Pladdy B, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00198; Hanna-Pladdy B, 2011, NEUROPSYCHOLOGY, V25, P378, DOI 10.1037/a0021895; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; James CE, 2014, BRAIN STRUCT FUNCT, V219, P353, DOI 10.1007/s00429-013-0504-z; Johnson JK, 2020, J GERONTOL B-PSYCHOL, V75, P549, DOI 10.1093/geronb/gby132; Johnson JK, 2013, INT PSYCHOGERIATR, V25, P1055, DOI 10.1017/S1041610213000422; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Kubo Y, 2019, PSYCHOGERIATRICS, V19, P181, DOI 10.1111/psyg.12371; Nguyen L, 2019, AGEING RES REV, V53, DOI 10.1016/j.arr.2019.100912; Liu-Ambrose T, 2019, INT REV NEUROBIOL, V147, P95, DOI 10.1016/bs.irn.2019.07.004; Mansens D, 2018, AGING MENT HEALTH, V22, P964, DOI 10.1080/13607863.2017.1328481; Martin N, 2012, APHASIOLOGY, V26, P462, DOI 10.1080/02687038.2011.619516; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Rourke HM, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0897-x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reuter-Lorenz PA, 2014, NEUROPSYCHOL REV, V24, P355, DOI 10.1007/s11065-014-9270-9; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Ripolles P, 2018, ELIFE, V7, DOI 10.7554/eLife.38113; Rogenmoser L, 2018, BRAIN STRUCT FUNCT, V223, P297, DOI 10.1007/s00429-017-1491-2; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Sarkamo T, 2018, CORTEX, V109, P104, DOI 10.1016/j.cortex.2018.08.034; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Stone NL, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00269; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valtorta NK, 2018, EUR J PREV CARDIOL, V25, P1387, DOI 10.1177/2047487318792696; Vanstone AD, 2016, AGING MENT HEALTH, V20, P474, DOI 10.1080/13607863.2015.1021750; Wang WD, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00815; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Whitehead JC, 2018, HUM BRAIN MAPP, V39, P4913, DOI 10.1002/hbm.24333; Williams E, 2018, EUR J PUBLIC HEALTH, V28, P1035, DOI 10.1093/eurpub/cky115; Zarate JM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00237; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110	54	13	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245666	10.1371/journal.pone.0245666	http://dx.doi.org/10.1371/journal.pone.0245666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534842	Green Published, gold			2022-12-26	WOS:000616739700030
J	Duffy, J; Loch-Temzelides, T				Duffy, John; Loch-Temzelides, Ted			A double-slit experiment with human subjects	PLOS ONE			English	Article							QUANTUM-MECHANICS	We study a sequence of "double-slit" experiments designed to perform repeated measurements of an attribute in a large pool of subjects using Amazon's Mechanical Turk. Our findings contrast the prescriptions of decision theory in novel and interesting ways. The response to an identical sequel measurement of the same attribute can be at significant variance with the initial measurement. Furthermore, the response to the sequel measurement depends on whether the initial measurement has taken place. In the absence of the initial measurement, the sequel measurement reveals additional variability, leading to a multimodal frequency distribution which is largely absent if the first measurement has taken place.	[Duffy, John] Univ Calif Irvine, Dept Econ, Irvine, CA 92717 USA; [Loch-Temzelides, Ted] Rice Univ, Dept Econ, Houston, TX USA	University of California System; University of California Irvine; Rice University	Duffy, J (corresponding author), Univ Calif Irvine, Dept Econ, Irvine, CA 92717 USA.	duffy@uci.edu		Loch-Temzelides, Ted/0000-0001-8339-6722	UC Irvine School of Social Sciences	UC Irvine School of Social Sciences	Our experiment was funded by the UC Irvine School of Social Sciences.	Busemeyer Jerome R., 2012, QUANTUM MODELS COGNI; de Barros JA, 2009, J MATH PSYCHOL, V53, P306, DOI 10.1016/j.jmp.2009.03.005; Debreu G, 1959, THEORY VALUE AXIOMAT; Feynman R, 1965, FEYNMAN LECT PHYS, VIII, DOI [10.1126/science.150.3696.588, DOI 10.1126/SCIENCE.150.3696.588]; Koch C, 2006, NATURE, V440, P611, DOI 10.1038/440611a; KROSNICK JA, 1987, PUBLIC OPIN QUART, V51, P201, DOI 10.1086/269029; Mogiliansky AL, 2009, J MATH PSYCHOL, V53, P349, DOI 10.1016/j.jmp.2009.01.001; Rashkovskiy S, 2020, BIOSYSTEMS, V195, DOI 10.1016/j.biosystems.2020.104171; Savage L.J., 1954, FDN STAT; Schwinger J. S., 2001, QUANTUM MECH SYMBOLI; Temzelides T, 2010, J MATH EC, V46; TVERSKY A, 1992, PSYCHOL SCI, V3, P305, DOI 10.1111/j.1467-9280.1992.tb00678.x; TVERSKY A, 1990, J ECON PERSPECT, V4, P201, DOI 10.1257/jep.4.2.201; Van Orden GC, 2010, ECOL PSYCHOL, V22, P24, DOI 10.1080/10407410903493145; von Neumann J., 1953, THEORY GAMES EC BEHA; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	16	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246526	10.1371/journal.pone.0246526	http://dx.doi.org/10.1371/journal.pone.0246526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571250	gold, Green Published			2022-12-26	WOS:000618274000041
J	Gouglas, D; Marsh, K				Gouglas, Dimitrios; Marsh, Kevin			Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis	PLOS ONE			English	Article							RESOURCE-ALLOCATION; EPIDEMIC PREPAREDNESS; PRODUCT DEVELOPMENT; MANAGEMENT; FRAMEWORK; SELECTION; OPTIMIZATION; RISK; DRUG; STANDARD	This study reports on the application of a Portfolio Decision Analysis (PDA) to support investment decisions of a non-profit funder of vaccine technology platform development for rapid response to emerging infections. A value framework was constructed via document reviews and stakeholder consultations. Probability of Success (PoS) data was obtained for 16 platform projects through expert assessments and stakeholder portfolio preferences via a Discrete Choice Experiment (DCE). The structure of preferences and the uncertainties in project PoS suggested a non-linear, stochastic value maximization problem. A simulation-optimization algorithm was employed, identifying optimal portfolios under different budget constraints. Stochastic dominance of the optimization solution was tested via mean-variance and mean-Gini statistics, and its robustness via rank probability analysis in a Monte Carlo simulation. Project PoS estimates were low and substantially overlapping. The DCE identified decreasing rates of return to investing in single platform types. Optimal portfolio solutions reflected this non-linearity of platform preferences along an efficiency frontier and diverged from a model simply ranking projects by PoS-to-Cost, despite significant revisions to project PoS estimates during the review process in relation to the conduct of the DCE. Large confidence intervals associated with optimization solutions suggested significant uncertainty in portfolio valuations. Mean-variance and Mean-Gini tests suggested optimal portfolios with higher expected values were also accompanied by higher risks of not achieving those values despite stochastic dominance of the optimal portfolio solution under the decision maker's budget constraint. This portfolio was also the highest ranked portfolio in the simulation; though having only a 54% probability of being preferred to the second-ranked portfolio. The analysis illustrates how optimization modelling can help health R&D decision makers identify optimal portfolios in the face of significant decision uncertainty involving portfolio trade-offs. However, in light of such extreme uncertainty, further due diligence and ongoing updating of performance is needed on highly risky projects as well as data on decision makers' portfolio risk attitude before PDA can conclude about optimal and robust solutions.	[Gouglas, Dimitrios] Coalit Epidem Preparedness Innovat, Oslo, Norway; [Marsh, Kevin] Evidera, Patient Ctr Res, London, England	Evidera	Gouglas, D (corresponding author), Coalit Epidem Preparedness Innovat, Oslo, Norway.	dimitrios.gouglas@cepi.net			Research Council of Norway [234608]	Research Council of Norway(Research Council of Norway)	DG reports grants from the Research Council of Norway, during the conduct of this study (ref. 234608). DG also reports paid employment by CEPI, during the conduct of the study. The funders provided support in the form of salaries for DG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KM is employed by a commercial company. The commercial affiliation of KM played no role in the study. KM reports personal fees from CEPI, during the conduct of the study. The funder provided support in the form of personal fees and research materials for KM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Barbati M, 2018, OMEGA-INT J MANAGE S, V78, P192, DOI 10.1016/j.omega.2017.06.013; Blau GE, 2004, J PROD INNOVAT MANAG, V21, P227, DOI 10.1111/j.0737-6782.2004.00075.x; Burk RC, 2011, INT SER OPER RES MAN, V162, P333, DOI 10.1007/978-1-4419-9943-6_14; CEPI, 2016, COAL EP PREP INN PRE; CEPI, PLATF TECHN EN RAP V; Challener C, 2017, PHARM TECHNOLOGY BIO, P11; Chien CF, 2002, R&D MANAGE, V32, P359, DOI 10.1111/1467-9310.00266; Christian B, 2015, COMPUT CHEM ENG, V74, P34, DOI 10.1016/j.compchemeng.2014.12.014; Colvin M, 2011, EUR J OPER RES, V215, P616, DOI 10.1016/j.ejor.2011.06.023; Coulson KE, 2010, PHARM BIOMEDICAL PRO; Cox LA, 2012, RISK ANAL, V32, P1607, DOI 10.1111/j.1539-6924.2012.01792.x; Ding Y, 2014, INT CON DISTR COMP S, P83, DOI 10.1109/ICDCS.2014.17; Evans R, 2009, NAT REV DRUG DISCOV, V8, P189, DOI 10.1038/nrd2744; Figueira J, 2005, INT SER OPER RES MAN, V78, P1, DOI 10.1007/b100605; George ED, 2008, IND ENG CHEM RES, V47, P8762, DOI 10.1021/ie8003144; George ED, 2008, BIOTECHNOL PROGR, V24, P698, DOI 10.1021/bp070410s; Gilbert SC, 2017, VACCINE, V35, P4461, DOI 10.1016/j.vaccine.2017.04.085; Gouglas D, 2019, EPIDEMIOL REV, V41, P28, DOI 10.1093/epirev/mxz012; Gouglas D, 2019, INFORMS J APPL ANAL, V49, P430, DOI 10.1287/inte.2019.1011; Gouglas D, 2019, J MULTI-CRITERIA DEC, V26, P153, DOI 10.1002/mcda.1683; Gouglas D, 2018, LANCET GLOB HEALTH, V6, pE1386, DOI 10.1016/S2214-109X(18)30346-2; Graham BS, 2018, JAMA-J AM MED ASSOC, V319, P1431, DOI 10.1001/jama.2018.0345; IJzerman, 2017, MULTICRITERIA DECISI, P89, DOI DOI 10.1007/978-3-319-47540-0_6; IJzerman MJ, 2017, PHARMACOECONOMICS, V35, P727, DOI 10.1007/s40273-017-0509-1; ISLEI G, 1991, INTERFACES, V21, P4, DOI 10.1287/inte.21.6.4; Jekunen A, 2014, DRUG DES DEV THER, V8, P2009, DOI 10.2147/DDDT.S68579; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Kleinmuntz DN, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P400, DOI 10.1017/CBO9780511611308.021; Kloeber J, 2011, INT SER OPER RES MAN, V162, P283, DOI 10.1007/978-1-4419-9943-6_13; Lahtinen TJ, 2017, ENVIRON MODELL SOFTW, V94, P73, DOI 10.1016/j.envsoft.2017.04.001; Liesio J, 2007, EUR J OPER RES, V181, P1488, DOI 10.1016/j.ejor.2005.12.041; Lo Nigro G, 2016, MANAG DECIS ECON, V37, P392, DOI 10.1002/mde.2727; Loch CH, 2002, MANAGE SCI, V48, P1227, DOI 10.1287/mnsc.48.10.1227.275; Loch CH, 2001, R&D MANAGE, V31, P231, DOI 10.1111/1467-9310.00212; Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872; Montajabiha M, 2017, INT J MANAG PROJ BUS, V10, P386, DOI 10.1108/IJMPB-12-2015-0114; Montibeller G, 2009, EUR J OPER RES, V199, P846, DOI 10.1016/j.ejor.2009.01.054; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Oyston P, 2012, J MED MICROBIOL, V61, P889, DOI 10.1099/jmm.0.039180-0; Patel NR, 2013, STAT MED, V32, P1763, DOI 10.1002/sim.5731; Peakman T, 2000, DRUG DISCOV TODAY, V5, P337, DOI 10.1016/S1359-6446(00)01514-2; Perez-Escobedo JL, 2012, COMPUT CHEM ENG, V37, P278, DOI 10.1016/j.compchemeng.2011.10.004; Phillips LD, 2007, ANN OPER RES, V154, P51, DOI 10.1007/s10479-007-0183-3; Plotkin S, 2017, VACCINE, V35, P4064, DOI 10.1016/j.vaccine.2017.06.003; Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051; Rajao DS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00123; Rajapakse A, 2006, J CHEM TECHNOL BIOT, V81, P1705, DOI 10.1002/jctb.1595; Rauch S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01963; Ringuest JL, 2004, EUR J OPER RES, V154, P157, DOI 10.1016/S0377-2217(02)00708-7; Rogers MJ, 2002, IND ENG CHEM RES, V41, P6607, DOI 10.1021/ie020385p; Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577; Russell PK, 2012, BIOSECUR BIOTERROR, V10, P66, DOI 10.1089/bsp.2012.0305; Salo A, 2011, INT SERIES OPERATION, V162; Shalit H, 1989, INT J FINANC, V1, P16; Sharpe P, 1998, HARVARD BUS REV, V76, P45; STEWART TJ, 1984, MANAGE SCI, V30, P1067, DOI 10.1287/mnsc.30.9.1067; Stonebraker JS, 2011, INT SER OPER RES MAN, V162, P131, DOI 10.1007/978-1-4419-9943-6_6; Subramanian D, 2003, AICHE J, V49, P96, DOI 10.1002/aic.690490110; Talias MA, 2007, EUR J OPER RES, V177, P1105, DOI 10.1016/j.ejor.2006.01.011; Taylor KA, 2007, DRUG DEVELOP RES, V68, P183, DOI 10.1002/ddr.20180; Tiggemann RF, 1998, DRUG INF J, V32, P813, DOI 10.1177/009286159803200321; Varma VA, 2008, COMPUT CHEM ENG, V32, P1000, DOI 10.1016/j.compchemeng.2007.05.006; Vilkkumaa E, 2014, GROUP DECIS NEGOT, V23, P49, DOI 10.1007/s10726-012-9328-0; Wang JT, 2007, OMEGA-INT J MANAGE S, V35, P247, DOI 10.1016/j.omega.2005.06.002; Way R, 2019, J ECON DYN CONTROL, V101, P211, DOI 10.1016/j.jedc.2018.10.006; WHITTLE P, 1981, ANN PROBAB, V9, P284, DOI 10.1214/aop/1176994469; Zapata JC, 2010, EUR J OPER RES, V206, P653, DOI 10.1016/j.ejor.2010.03.015; Zapata JC, 2008, COMPUT CHEM ENG, V32, P307, DOI 10.1016/j.compchemeng.2007.03.024	68	2	2	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246235	10.1371/journal.pone.0246235	http://dx.doi.org/10.1371/journal.pone.0246235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571206	Green Submitted, Green Published, gold			2022-12-26	WOS:000618274000037
J	Chomczynski, P; Chomczynski, PW; Kennedy, A; Rymaszewski, M; Wilfinger, WW; Heiny, JA; Mackey, K				Chomczynski, Piotr; Chomczynski, Peter W.; Kennedy, Amy; Rymaszewski, Michal; Wilfinger, William W.; Heiny, Judith A.; Mackey, Karol			Rapid processing of SARS-CoV-2 containing specimens for direct RT-PCR	PLOS ONE			English	Article								Widespread diagnostic testing is needed to reduce transmission of COVID-19 and manage the pandemic. Effective mass screening requires robust and sensitive tests that reliably detect the SARS-CoV-2 virus, including asymptomatic and pre-symptomatic infections with a low viral count. Currently, the most accurate tests are based on detection of viral RNA by RT-PCR. We developed a method to process COVID-19 specimens that simplifies and increases the sensitivity of viral RNA detection by direct RT-qPCR, performed without RNA purification. In the method, termed Alkaline-Glycol Processing (AG Processing), a SARS-CoV-2-containing biological specimen, such as saliva or a swab-collected suspension, is processed at pH 12.2 to 12.8 for 5 min at room temperature. An aliquot of the AG-processed specimen is used for detection of SARS-CoV-2 RNA by direct RT-qPCR. AG processing effectively lyses viruses and reduces the effect of inhibitors of RT-PCR that are present in biological specimens. The sensitivity of detecting viral RNA using AG processing is on par with methods that include a viral RNA purification step. One copy of SARS-CoV-2 virus per reaction, equivalent to 300 copies per ml of saliva, is detectable in the AG-processed saliva. The LOD is 300 viral copies per ml of initial saliva specimen. AG processing works with saliva specimens or swab specimens collected into Universal Transport Medium, is compatible with heat treatment of saliva, and was confirmed to work with a range of CDC-approved RT-qPCR products and kits. Detection of SARS-CoV-2 RNA using AG processing with direct RT-qPCR provides a reliable and scalable diagnostic test for COVID-19 that can be integrated into a range of workflows, including automated settings.	[Chomczynski, Piotr; Chomczynski, Peter W.; Kennedy, Amy; Rymaszewski, Michal; Wilfinger, William W.; Mackey, Karol] Mol Res Ctr Inc, Cincinnati, OH 45212 USA; [Heiny, Judith A.] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	Chomczynski, P (corresponding author), Mol Res Ctr Inc, Cincinnati, OH 45212 USA.	piotr@mrcgene.com		Chomczynski, Piotr/0000-0001-9375-1353	Molecular Research Center, Inc.	Molecular Research Center, Inc.	This study was funded by Molecular Research Center, Inc., https://www.mrcgene.com/.The funder provided support in the form of financial compensation for authors (PCh, PWC, AK, MR, WWW, JH and KM) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2020, FDA SARS COV 2 REFER; Bruce EA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000896; CDC, 2019, NOVEL CORONAVIRUS 20; Chomczynski P, 2006, BIOTECHNIQUES, V40, P454, DOI 10.2144/000112149; Chomczynski P, 2010, US Patent, Patent No. [7,727,718, 7727718]; Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029; Hasan MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236564; Li Y, 2020, EMER MICROB INFECT, DOI [10.1080/22221751.2020.1782774PMID:, DOI 10.1080/22221751.2020.1782774PMID]; Mandala VS, 2020, RES SQ, DOI [10.1038/s41594- 020-00536-8, DOI 10.1038/S41594-020-00536-8]; Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022; Park GS, 2020, J MOL DIAGN, V22, P729, DOI 10.1016/j.jmoldx.2020.03.006; Pastorino B, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070735; Ranoa DRE, 2020, SALIVA BASED MOL TES, DOI [10.1101/2020.06.18.159434, DOI 10.1101/2020.06.18.159434]; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Van Wesenbeeck Liesbeth, 2014, Virol J, V11, P233, DOI 10.1186/s12985-014-0233-9; Vogels CBF, 2021, MED-CAMBRIDGE, V2, P263, DOI 10.1016/j.medj.2020.12.010; Wee SK, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060664; Wyllie AL, 2020, SALIVA IS MORE SENSI, DOI [10.1101/2020.04, DOI 10.1101/2020.04]	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246867	10.1371/journal.pone.0246867	http://dx.doi.org/10.1371/journal.pone.0246867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566873	Green Published, gold, Green Submitted			2022-12-26	WOS:000618271700018
J	Landry, B; Whitton, J; Bazzicalupo, AL; Ceska, O; Berbee, ML				Landry, Brandon; Whitton, Jeannette; Bazzicalupo, Anna L.; Ceska, Oldriska; Berbee, Mary L.			Phylogenetic analysis of the distribution of deadly amatoxins among the little brown mushrooms of the genus Galerina	PLOS ONE			English	Article							SPECIES CONCEPTS; AMANITIN; IDENTIFICATION; PHALLOTOXINS; FASCICULATA; MARGINATA	Some but not all of the species of 'little brown mushrooms' in the genus Galerina contain deadly amatoxins at concentrations equaling those in the death cap, Amanita phalloides. However, Galerina's similar to 300 species are notoriously difficult to identify by morphology, and the identity of toxin-containing specimens has not been verified with DNA barcode sequencing. This left open the question of which Galerina species contain toxins and which do not. We selected specimens for toxin analysis using a preliminary phylogeny of the fungal DNA barcode region, the ribosomal internal transcribed spacer (ITS) region. Using liquid chromatography/mass spectrometry, we analyzed amatoxins from 70 samples of Galerina and close relatives, collected in western British Columbia, Canada. To put the presence of toxins into a phylogenetic context, we included the 70 samples in maximum likelihood analyses of 438 taxa, using ITS, RNA polymerase II second largest subunit gene (RPB2), and nuclear large subunit ribosomal RNA (LSU) gene sequences. We sequenced barcode DNA from types where possible to aid with applications of names. We detected amatoxins only in the 24 samples of the G. marginata s.l. complex in the Naucoriopsis clade. We delimited 56 putative Galerina species using Automatic Barcode Gap Detection software. Phylogenetic analysis showed moderate to strong support for Galerina infrageneric clades Naucoriopsis, Galerina, Tubariopsis, and Sideroides. Mycenopsis appeared paraphyletic and included Gymnopilus. Amatoxins were not detected in 46 samples from Galerina clades outside of Naucoriopsis or from outgroups. Our data show significant quantities of toxin in all mushrooms tested from the G. marginata s.l. complex. DNA barcoding revealed consistent accuracy in morphology-based identification of specimens to G. marginata s.l. complex. Prompt and careful morphological identification of ingested G. marginata s.l. has the potential to improve patient outcomes by leading to fast and appropriate treatment.	[Landry, Brandon; Whitton, Jeannette; Bazzicalupo, Anna L.; Berbee, Mary L.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Ceska, Oldriska] 1809 Penshurst Rd, Victoria, BC, Canada	University of British Columbia	Berbee, ML (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	mary.berbee@gmail.com	Whitton, Jeannette/AAK-7843-2021	Whitton, Jeannette/0000-0003-1609-5203; Ceska, Oldriska/0000-0003-1762-1279	Natural Sciences and Engineering Research Council of Canada; Canada Graduate Scholarship-Master's Program; Michael Smith Foreign Travel Supplement [RGPIN-2016-03746]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Graduate Scholarship-Master's Program; Michael Smith Foreign Travel Supplement	This research was funded by grants from the Natural Sciences and Engineering Research Council of Canada (https://www.nserc-crsng.gc.ca/index_eng.asp) including a Canada Graduate Scholarship-Master's Program and a Michael Smith Foreign Travel Supplement to BL, and a Discovery Grant RGPIN-2016-03746 to MLB.	Bazzicalupo AL, 2019, J BIOGEOGR, V46, P1547, DOI 10.1111/jbi.13617; Bazzicalupo AL, 2017, TAXON, V66, P791, DOI 10.12705/664.1; Berger KJ, 2005, J EMERG MED, V28, P53, DOI 10.1016/j.jemermed.2004.08.013; BESL H, 1981, Zeitschrift fuer Mykologie, V47, P253; Beug MW, 2017, MCILVAINEA, V21; Bresinsky A., 1966, J SCHAEFF ANDERE AGA, V32, P8; Cai Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-143; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Enjalbert F, 2004, MYCOLOGIA, V96, P720, DOI 10.2307/3762106; GROSSMAN CM, 1954, ANN INTERN MED, V40, P249, DOI 10.7326/0003-4819-40-2-249; Gulden G, 2005, MYCOLOGIA, V97, P823, DOI 10.3852/mycologia.97.4.823; Gulden G, 2001, MYCOL RES, V105, P432, DOI 10.1017/S0953756201003707; GULDEN G., 2012, FUNGA NORDICA AGARIC, P886; Gulden G, 2000, ACTA BOT ISL, V13, P3; Hallen HE, 2002, S AFR J BOT, V68, P322, DOI 10.1016/S0254-6299(15)30393-8; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; HONGO T, 1974, Journal of Japanese Botany, V49, P294; Horak E, 1994, MYKOLOGIE, V60, P85; HULTING J, 1985, J TOXICOL-CLIN TOXIC, V23, P428; Hyde KD, 2017, FUNGAL DIVERS, V87, P1, DOI 10.1007/s13225-017-0391-3; Kaneko H, 2001, J TOXICOL-CLIN TOXIC, V39, P413, DOI 10.1081/CLT-100105164; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kume K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25895; Luo H, 2012, FUNGAL GENET BIOL, V49, P123, DOI 10.1016/j.fgb.2011.12.005; Maddison W.P., 2018, MESQUITE; Matheny PB, 2015, SYST BIODIVERS, V13, P28, DOI 10.1080/14772000.2014.967823; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; MILLER CE, 1963, MYCOLOGIA, V55, P358, DOI 10.2307/3756526; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Moldenhauer G, 2012, JNCI-J NATL CANCER I, V104, P622, DOI 10.1093/jnci/djs140; Moshnikova A, 2013, BIOCHEMISTRY-US, V52, P1171, DOI 10.1021/bi301647y; Muraoka S, 2000, J BIOSCI BIOENG, V89, P73, DOI 10.1016/S1389-1723(00)88053-6; Muraoka S, 1999, APPL ENVIRON MICROB, V65, P4207; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Pulman JA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3378-7; Rees BJ, 1999, MYCOL RES, V103, P427, DOI 10.1017/S095375629800745X; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Sgambelluri RM, 2018, ACS SYNTH BIOL, V7, P145, DOI 10.1021/acssynbio.7b00264; Sgambelluri RM, 2014, TOXINS, V6, P2336, DOI 10.3390/toxins6082336; Smith A., 1964, MONOGRAPH GENUS GALE; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Walton J., 2018, CYCLIC PEPTIDE TOXIN; Ward J, 2013, J EMERG MED, V44, P116, DOI 10.1016/j.jemermed.2012.02.020	46	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246575	10.1371/journal.pone.0246575	http://dx.doi.org/10.1371/journal.pone.0246575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566818	Green Published, gold			2022-12-26	WOS:000618271700007
J	Bish, DR; Bish, EK; El-Hajj, H; Aprahamian, H				Bish, Douglas R.; Bish, Ebru K.; El-Hajj, Hussein; Aprahamian, Hrayer			A robust pooled testing approach to expand COVID-19 screening capacity	PLOS ONE			English	Article								Limited testing capacity for COVID-19 has hampered the pandemic response. Pooling is a testing method wherein samples from specimens (e.g., swabs) from multiple subjects are combined into a pool and screened with a single test. If the pool tests positive, then new samples from the collected specimens are individually tested, while if the pool tests negative, the subjects are classified as negative for the disease. Pooling can substantially expand COVID-19 testing capacity and throughput, without requiring additional resources. We develop a mathematical model to determine the best pool size for different risk groups, based on each group's estimated COVID-19 prevalence. Our approach takes into consideration the sensitivity and specificity of the test, and a dynamic and uncertain prevalence, and provides a robust pool size for each group. For practical relevance, we also develop a companion COVID-19 pooling design tool (through a spread sheet). To demonstrate the potential value of pooling, we study COVID-19 screening using testing data from Iceland for the period, February-28-2020 to June-14-2020, for subjects stratified into high- and low-risk groups. We implement the robust pooling strategy within a sequential framework, which updates pool sizes each week, for each risk group, based on prior week's testing data. Robust pooling reduces the number of tests, over individual testing, by 88.5% to 90.2%, and 54.2% to 61.9%, respectively, for the low-risk and high-risk groups (based on test sensitivity values in the range [0.71, 0.98] as reported in the literature). This results in much shorter times, on average, to get the test results compared to individual testing (due to the higher testing throughput), and also allows for expanded screening to cover more individuals. Thus, robust pooling can potentially be a valuable strategy for COVID-19 screening.	[Bish, Douglas R.; Bish, Ebru K.] Univ Alabama, Informat Syst Stat & Management Sci, Blacksburg, VA 24061 USA; [El-Hajj, Hussein] Virginia Tech, Ind & Syst Engn, Blacksburg, VA USA; [Aprahamian, Hrayer] Texas A&M Univ, Ind & Syst Engn, College Stn, TX USA	Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University College Station	Bish, DR (corresponding author), Univ Alabama, Informat Syst Stat & Management Sci, Blacksburg, VA 24061 USA.	drbish@cba.ua.edu		Bish, Douglas/0000-0002-1376-8268; Bish, Ebru/0000-0002-2653-7135; El Hajj, Hussein/0000-0002-8364-4586	National Science Foundation [1761842]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation Grant #1761842 DRB, EKB (sponsor did not play a role in study design).	Adalja AA, 2020, JAMA-J AM MED ASSOC, V323, P1343, DOI 10.1001/jama.2020.3413; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], 2020, GLOB CAS CTR SYST SC; [Anonymous], 2020, COVID 19 ICELAND STA; Aprahamian H, 2020, INFORMS J COMPUT, V32, P895, DOI 10.1287/ijoc.2019.0942; Aprahamian H, 2019, MANAGE SCI, V65, P4365, DOI 10.1287/mnsc.2018.3138; Aragon-Caqueo D, 2020, J MED VIROL, V92, P1988, DOI 10.1002/jmv.25929; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bamforth E., 2020, ICELAND TESTS ANYONE; Becker MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241959; Bilder CR, 2020, CLIN INFECT DIS; Carter LJ, 2020, ACS CENTRAL SCI, V6, P591, DOI 10.1021/acscentsci.0c00501; Cherif A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13075; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Furstenau TN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236849; Hanel R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240652; He JL, 2020, RESP MED, V168, DOI 10.1016/j.rmed.2020.105980; Lim KL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238417; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; McMahan CS, 2012, BIOMETRICS, V68, P287, DOI 10.1111/j.1541-0420.2011.01644.x; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nguyen NT, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1992-2; Nguyen NT, 2018, STAT MED, V37, P2391, DOI 10.1002/sim.7657; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Pilcher CD, 2020, J INFECT DIS; Singh AK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239492; Stock J.H., 2020, ESTIMATES UNDETECTED; Wacharapluesadee S, 2020, J MED VIROL, V92, P2193, DOI 10.1002/jmv.26005; Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808; Wein LM, 1996, OPER RES, V44, P543, DOI 10.1287/opre.44.4.543; WHO, 2020, DIR GEN OP REM MED B; Won J, 2020, EXP NEUROBIOL, V29, P107, DOI [10.5607/en2009, 10.5607/en20009]; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531; Zastrow Mark, 2020, Nature, DOI 10.1038/d41586-020-00740-y	35	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246285	10.1371/journal.pone.0246285	http://dx.doi.org/10.1371/journal.pone.0246285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556129	gold, Green Published			2022-12-26	WOS:000617379900058
J	Hur, MS; Lee, S; Oh, CS; Choe, YH				Hur, Mi-Sun; Lee, Seunggyu; Oh, Chang-Seok; Choe, Yeon Hyeon			Newly-found channels in the interatrial septum of the heart by dissection, histologic evaluation, and three-dimensional microcomputed tomography	PLOS ONE			English	Article							PATENT FORAMEN OVALE; PERCUTANEOUS CLOSURE; CRYPTOGENIC STROKE; RISK-FACTOR; POUCH; ANATOMY; SIZE	A minute thrombus can pass through a small type of interatrial communication, which can result in a stroke or transient ischemic attack and several associated symptoms. This study sought to investigate a new type of interatrial communication. Thirty-one hearts from embalmed adult cadavers were investigated. Each interatrial channels (IACs) was classified as either an open or obstructed channel according to the connection of each hole on the right and left surfaces of the interatrial septum. Open channels were found in two specimens (6.5%). Both open and obstructed IACs followed tortuous courses through the interatrial septum. On the right surface of the interatrial septum, the hole was usually found adjacent to the left border of the interatrial septum between the opening of the superior vena cava into the right atrium and the superior margin of the fossa ovalis. Conversely, holes on the left surface of the interatrial septum were usually found in the upper and middle parts adjacent to the left border of the interatrial septum. This novel finding is expected to support our understanding of the onset of possible symptoms such as stroke in the absence of classical atrial septal defects.	[Hur, Mi-Sun] Catholic Kwandong Univ, Coll Med, Dept Anat, Kangnung, South Korea; [Lee, Seunggyu] Korea Univ, Div Appl Math Sci, Sejong, South Korea; [Oh, Chang-Seok] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Suwon, South Korea; [Choe, Yeon Hyeon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea	Catholic Kwandong University; Korea University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, CS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Suwon, South Korea.; Choe, YH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea.	changoh@skku.edu; yhchoe@skku.edu	Choe, Yeon Hyeon/F-1422-2010	Choe, Yeon Hyeon/0000-0002-9983-048X; Lee, Seunggyu/0000-0003-3141-6968	National Research Foundation of Korea [2020R1A2C1A01100114, 2020R1C1C1003237]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was funded by grants from the National Research Foundation of Korea to SL (No. 2020R1A2C1A01100114) and MSH (No.2020R1C1C1003237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi A, 2010, CIRC-CARDIOVASC INTE, V3, P506, DOI 10.1161/CIRCINTERVENTIONS.109.908533; Bechis Mary Z, 2017, Interv Cardiol Clin, V6, P505, DOI 10.1016/j.iccl.2017.05.004; Collado Fareed Moses S, 2018, J Am Heart Assoc, V7, DOI 10.1161/JAHA.117.007146; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Ho SY, 2001, HEART, V86, pII3; Holda MK, 2018, CEREBROVASC DIS, V46, P223, DOI 10.1159/000495573; Holda MK, 2018, J AM SOC ECHOCARDIOG, V31, P771, DOI 10.1016/j.echo.2018.01.023; Holda MK, 2016, INT J CARDIOL, V220, P337, DOI 10.1016/j.ijcard.2016.06.141; Ioannidis SG, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00567; Jusufovic Mirza, 2014, Tidsskr Nor Laegeforen, V134, P180, DOI 10.4045/tidsskr.13.0038; Klimek-Piotrowska W, 2016, ANN ANAT, V205, P60, DOI 10.1016/j.aanat.2016.01.009; Krishnan SC, 2010, JACC-CARDIOVASC INTE, V3, P98, DOI 10.1016/j.jcin.2009.07.017; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Martin SS, 2014, CLIN MED INSIGHTS-CA, V8, P93, DOI 10.4137/CMC.S15715; Mazur M, 2018, TRANSL RES ANAT, V13, P7, DOI DOI 10.1016/J.TRIA.2018.11.002; Naqvi N, 2018, J THORAC DIS, V10, pS2837, DOI 10.21037/jtd.2018.02.18; Raviprasanna KH, 2016, SCH J MED CASE REP, V4, P632; Rigatelli G, 2011, AM J CARDIOVASC DIS, V1, P227; Strachinaru M, 2017, ARCH CARDIOVASC DIS, V110, P250, DOI 10.1016/j.acvd.2017.01.001; Tobis J, 2012, J AM COLL CARDIOL, V60, P1722, DOI 10.1016/j.jacc.2012.01.086; Van de Bruaene A, 2015, ACTA CARDIOL, V70, P133, DOI 10.1080/AC.70.2.3073503; Windecker S, 2000, CIRCULATION, V101, P893, DOI 10.1161/01.CIR.101.8.893; Yaghi Shadi, 2014, Neurol Clin Pract, V4, P386; Yasunag D, 2015, DIAGN INTERV IMAG, V96, P891, DOI 10.1016/j.diii.2015.02.011	25	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246585	10.1371/journal.pone.0246585	http://dx.doi.org/10.1371/journal.pone.0246585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556133	gold, Green Published			2022-12-26	WOS:000617379900028
J	Kiwuka, C; Goudsmit, E; Tournebize, R; de Aquino, SO; Douma, JC; Bellanger, L; Crouzillat, D; Stoffelen, P; Sumirat, U; Legnate, H; Marraccini, P; de Kochko, A; Andrade, AC; Mulumba, JW; Musoli, P; Anten, NPR; Poncet, V				Kiwuka, Catherine; Goudsmit, Eva; Tournebize, Remi; de Aquino, Sinara Oliveira; Douma, Jacob C.; Bellanger, Laurence; Crouzillat, Dominique; Stoffelen, Piet; Sumirat, Ucu; Legnate, Hyacinthe; Marraccini, Pierre; de Kochko, Alexandre; Andrade, Alan Carvalho; Mulumba, John Wasswa; Musoli, Pascal; Anten, Niels P. R.; Poncet, Valerie			Genetic diversity of native and cultivated Ugandan Robusta coffee (Coffea canephora Pierre ex A. Froehner): Climate influences, breeding potential and diversity conservation	PLOS ONE			English	Article							KIBALE-NATIONAL-PARK; POPULATION-STRUCTURE; LOCAL ADAPTATION; WILD RELATIVES; HYBRIDIZATION; PLANT; RUBIACEAE; SOFTWARE; IMPACTS; ARABICA	Wild genetic resources and their ability to adapt to environmental change are critically important in light of the projected climate change, while constituting the foundation of agricultural sustainability. To address the expected negative effects of climate change on Robusta coffee trees (Coffea canephora), collecting missions were conducted to explore its current native distribution in Uganda over a broad climatic range. Wild material from seven forests could thus be collected. We used 19 microsatellite (SSR) markers to assess genetic diversity and structure of this material as well as material from two ex-situ collections and a feral population. The Ugandan C. canephora diversity was then positioned relative to the species' global diversity structure. Twenty-two climatic variables were used to explore variations in climatic zones across the sampled forests. Overall, Uganda's native C. canephora diversity differs from other known genetic groups of this species. In northwestern (NW) Uganda, four distinct genetic clusters were distinguished being from Zoka, Budongo, Itwara and Kibale forests A large southern-central (SC) cluster included Malabigambo, Mabira, and Kalangala forest accessions, as well as feral and cultivated accessions, suggesting similarity in genetic origin and strong gene flow between wild and cultivated compartments. We also confirmed the introduction of Congolese varieties into the SC region where most Robusta coffee production takes place. Identified populations occurred in divergent environmental conditions and 12 environmental variables significantly explained 16.3% of the total allelic variation across populations. The substantial genetic variation within and between Ugandan populations with different climatic envelopes might contain adaptive diversity to cope with climate change. The accessions that we collected have substantially enriched the diversity hosted in the Ugandan collections and thus contribute to ex situ conservation of this vital genetic resource. However, there is an urgent need to develop strategies to enhance complementary in-situ conservation of Coffea canephora in native forests in northwestern Uganda.	[Kiwuka, Catherine; Goudsmit, Eva; Douma, Jacob C.; Anten, Niels P. R.] Wageningen Univ & Res WUR, Ctr Crop Syst Anal, Dept Plant Sci, Wageningen, Netherlands; [Kiwuka, Catherine; Mulumba, John Wasswa; Musoli, Pascal] Natl Agr Res Org NARO, Entebbe, Uganda; [Tournebize, Remi; de Aquino, Sinara Oliveira; de Kochko, Alexandre; Poncet, Valerie] Univ Montpellier, CIRAD, UMR DIADE, IRD, Montpellier, France; [de Aquino, Sinara Oliveira; Andrade, Alan Carvalho] EMBRAPA Coffee INOVACAFE, Lavras, Brazil; [Bellanger, Laurence; Crouzillat, Dominique] Nestle Res, Tours, France; [Stoffelen, Piet] Meise Bot Garden, Meise, Belgium; [Sumirat, Ucu] ICCRI, Jember, Indonesia; [Legnate, Hyacinthe] CNRA, Divo, Cote Ivoire; [Marraccini, Pierre] Univ Montpellier, Inst Agr Genet AGI LMI RICE2, UMR IPME, CIRAD,IRD, Hanoi, Vietnam	Wageningen University & Research; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Riset Perkebunan Nusantara; Indonesian Coffee & Cocoa Research Institute (ICCRI); CIRAD; Institut de Recherche pour le Developpement (IRD)	Poncet, V (corresponding author), Univ Montpellier, CIRAD, UMR DIADE, IRD, Montpellier, France.	valerie.poncet@ird.fr	Poncet, Valérie/AGG-5592-2022; de Kochko, Alexandre/C-7512-2009; Andrade, Alan Carvalho/C-7722-2012; Douma, Bob/C-9721-2014; Marraccini, Pierre/C-1211-2015	Poncet, Valérie/0000-0002-1099-2846; de Kochko, Alexandre/0000-0001-9212-3195; Andrade, Alan Carvalho/0000-0001-7128-3472; Douma, Bob/0000-0002-8779-838X; Aquino, Sinara/0000-0002-6443-2107; Marraccini, Pierre/0000-0001-7637-6811	Agropolis Foundation - CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [1002-009, 1402-003]; Investissements d'avenir program [ANR-10-LABX-0001-01]; I-SITE MUSE [ANR-16-IDEX-0006]; World Bank through NARO ATAAS project; Rinny Huizinga Stichting; Alberta Mennega Stichting; CAPES	Agropolis Foundation - CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Investissements d'avenir program(French National Research Agency (ANR)); I-SITE MUSE; World Bank through NARO ATAAS project; Rinny Huizinga Stichting; Alberta Mennega Stichting; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partially supported by two Agropolis Foundation - CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) projects, i.e. ID 1002-009 and ID 1402-003 (CLIMCOFFEA), through the Investissements d'avenir program (Labex Agro:ANR-10-LABX-0001-01), in the framework of I-SITE MUSE (ANR-16-IDEX-0006). CK was funded by a PhD grant from the World Bank through NARO ATAAS project. EG master was funded by the Rinny Huizinga Stichting and the Alberta Mennega Stichting. SOdA was funded by a PhD grant from CAPES. DC and LB are employed by Nestle ' Centre Tours. Nestle ' Centre Tours provided support in the form of salary for authors DC and LB. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **DATA OBJECT**; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; [Anonymous], 2017, J DEMOCRACY, V28, P63; Aquino de, 2019, CANEPHORA POPULATION; BASALIRWA CPK, 1995, INT J CLIMATOL, V15, P1161, DOI 10.1002/joc.3370151008; Berthaud J., 1986, RESSOURCES GENETIQUE; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; CHARRIER A, 1985, P13; Craparo ACW, 2015, AGR FOREST METEOROL, V207, P1, DOI 10.1016/j.agrformet.2015.03.005; Cubry P, 2013, GENET RESOUR CROP EV, V60, P483, DOI 10.1007/s10722-012-9851-5; DaMatta FM, 2018, J AGR FOOD CHEM, V66, P5264, DOI 10.1021/acs.jafc.7b04537; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; Davis AP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3473; Davis AP, 2011, BOT J LINN SOC, V167, P357, DOI 10.1111/j.1095-8339.2011.01177.x; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Dereeper A, 2015, NUCLEIC ACIDS RES, V43, pD1028, DOI 10.1093/nar/gku1108; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Gomez C, 2016, ECOL EVOL, V6, P3240, DOI 10.1002/ece3.2055; Gomez C, 2010, J APPL ECOL, V47, P85, DOI 10.1111/j.1365-2664.2009.01762.x; Gomez C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-167; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hamon P, 2017, MOL PHYLOGENET EVOL, V109, P351, DOI 10.1016/j.ympev.2017.02.009; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hendre PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113661; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Klein AM, 2003, AM J BOT, V90, P153, DOI 10.3732/ajb.90.1.153; Merot-L'anthoene V, 2019, PLANT BIOTECHNOL J, V17, P1418, DOI 10.1111/pbi.13066; Moat J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.81; Moncada P, 2004, GENOME, V47, P501, DOI 10.1139/G03-129; Montagnon C., 1998, Plantations Recherche Developpement, V5, P89; Musoli P, 2009, GENOME, V52, P634, DOI 10.1139/G09-037; NEMA, 2009, UGANDA ATLAS OUR CHA; Nyakaana S, 2007, AFR J ECOL, V45, P71, DOI 10.1111/j.1365-2028.2007.00741.x; Oryem-Origa H, 1999, AFR J ECOL, V37, P439, DOI 10.1046/j.1365-2028.1999.00200.x; Ovalle-Rivera O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124155; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Piacenza C., 2012, INT C GLOBAL LAND GR; Plechakova O, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-123; Poncet V, 2004, GENOME, V47, P1071, DOI 10.1139/G04-064; Poncet V, 2007, GENOME, V50, P1156, DOI 10.1139/G07-073; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Samper LF, 2017, POWERFUL ROLE INTANG; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Thomas A. S., 1944, EMPIRE JOUR EXP AGRIC, V12, P1; THOMAS A. S., 1935, East African Agricultural Journal, V1, P193; UCDA, 2017, 25 YEARS EMPOWERING; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	61	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245965	10.1371/journal.pone.0245965	http://dx.doi.org/10.1371/journal.pone.0245965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556074	Green Published, gold			2022-12-26	WOS:000617379900002
J	Bakshi, B; Doucette, EM; Kyser, SJ				Bakshi, Baishali; Doucette, Elise M.; Kyser, Scott J.			Centralized softening as a solution to chloride pollution: An empirical analysis based on Minnesota cities	PLOS ONE			English	Article							SULFATE MASS-RATIO; TOXICITY; FRESH; SALT	Chloride is a key component of salt, used in many activities such as alkali production, water treatment, and de-icing. Chloride entering surface and groundwater is a concern due to its toxicity to aquatic life and potential to degrade drinking water sources. Minnesota being a hard-water state, has a high demand for water softening. Recent research has found that home-based water softeners contribute significantly to chloride loading at municipal wastewater treatment plants (WWTPs). Because of this, many WWTPs would now require water quality based effluent limits (WQBELs) to comply with the state's chloride water quality standards (WQS), unless they install chloride treatment technologies, which are limited and cost-prohibitive to most communities. A potential solution to this problem, is shifting from home-based water softening to a system where water is softened at drinking water plants, before reaching homes, i.e. centralized softening, analyzed in this paper based on its ability to address both chloride pollution and water softening needs, at reasonable cost. We estimate lifetime costs of three alternative solutions: centralized softening, home-based softening, and a Business as Usual (BAU) or baseline alternative, using annualized 20-year loan payments and Net Present Value (NPV), applied to 84 Minnesota cities with matching data on drinking water plants and WWTPs. We find that centralized softening using either Reverse Osmosis (RO) or lime-softening technologies is the more cost-effective solution, compared to the alternative of home-based softening with end-of-pipe chloride treatment, with a cost ratio in the range 1:3-1:4. Between the two centralized softening options, we find RO-softening to be the lower cost option, only slightly more costly (1.1 cost ratio) than the BAU option. Considering additional environmental and public health benefits, and cost savings associated with removal of home-based softeners, our results provide helpful information to multiple stakeholders interested in an effective solution to chloride pollution.	[Bakshi, Baishali] Minnesota Pollut Control Agcy, Water Qual Stand Unit, Water Assessment Sect, Environm Anal & Outcomes Div, St Paul, MN 55155 USA; [Doucette, Elise M.; Kyser, Scott J.] Minnesota Pollut Control Agcy, Effluent Limits Unit, Water Assessment Sect, Environm Anal & Outcomes Div, St Paul, MN USA		Bakshi, B (corresponding author), Minnesota Pollut Control Agcy, Water Qual Stand Unit, Water Assessment Sect, Environm Anal & Outcomes Div, St Paul, MN 55155 USA.	Baishali.Bakshi@state.mn.us		Bakshi, Baishali/0000-0003-2584-4798				Akrivos J, 2000, WATER SCI TECHNOL, V42, P203, DOI 10.2166/wst.2000.0207; American Community Survey US Census Bureau, 2018, INC 12 MONTHS; [Anonymous], 2003, STAT MAND CHLOR SALT; [Anonymous], 2020, MAD WAT UT ROAD SALT; [Anonymous], PUBL WORKS MINN WAT; Assessment M.E., 2005, EC HUM WELL BEING SY, P534, DOI [10.1119/1.2344558, DOI 10.1119/1.2344558]; Beeftink M, 2020, J CLEANER PRODUCTION, V278; Bolton & Menk and Barr Engineering Company, 2018, AN ALT SULF TREATM M; California Legislative Information, HLTH SAF COD DIV 12; California Public Utilities Commision,, 2016, WHAT WILL BE COST FU; Castro AJ, 2016, J WATER RES PLAN MAN, V142, DOI 10.1061/(ASCE)WR.1943-5452.0000671; Christensen P, 2019, EC EFFECTS ENV CRISE; Corsi SR, 2010, ENVIRON SCI TECHNOL, V44, P7376, DOI 10.1021/es101333u; Crook J, 2016, ENVIRON FORENSICS, V17, P211, DOI 10.1080/15275922.2016.1177755; Daugherty EN, 2010, ACS SYM SER, V1048, P497; Edwards M, 2007, J AM WATER WORKS ASS, V99, P96; Environment Agency England (EAE), 2019, DRINK WAT PROT AR PR; Fishbeck Thompson, 2019, WAT SYST STUD; Jason's Water Systems, POINT OF US VS POINT; Kefford BJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0021; Kelly W., 2012, B ILLINOIS STATE WAT, V74; Krishna KCB, 2017, J ENVIRON MANAGE, V200, P359, DOI 10.1016/j.jenvman.2017.06.003; Lake Geneva Utility Commission, 2017, WAST UT; Lake K, 2015, REDUCTION INFLUENT C; Metropolitan Water Reclamation District of Greater Chicago, 2018, ISS IN; Minnesota Department of Employment and Economic Development, 2020, PUBL FAC AUTH INFR F; Minnesota Department of Employment and Economic Development, PUBL FAC AUTH INFR F; Minnesota Department of Health, 2019, MINN DRINK WAT ANN R; Minnesota Department of Health, HOM WAT SOFT; Minnesota Office of the State Auditor, 2018, 2018 CIT FIN REP DAT; Minnesota Pollution Control Agency, WAT QUAL STAND BEN U; Minnesota Pollution Control Agency, 2017, FEAT STOR SALT ISS W; Minnesota Pollution Control Agency, WAT SUBS SEW TREATM; Minnesota Pollution Control Agency, 2013, COND MINN GROUNDW 20; Minnesota Pollution Control Agency, CHLOR SALTS; Minnesota Pollution Control Agency, 2017, WAST DAT BROWS; Minnesota Pollution Control Agency, 2012, CHLOR OUR WAT MON MI; Minnesota Pollution Control Agency, 2018, ALT ADDR CHLOR WAST; Minnesota Pollution Control Agency, 2019, GUID DEV LOC WAT SOF; Minnesota Pollution Control Agency, 2016, TWIN CIT METR AR CHL; Minnesota Pollution Control Agency, 2019, STAT CHLOR MAN PLAN; Minnesota Pollution Control Agency, CLEAN WAT PARTN LOAN; Minnesota Public Facilities Authority, 2020, US PUBL FAC AUTH; Minnesota State Demographic Center, 2019, CIT TOWNSH DAT; Mukherjee M, 2014, AGR WATER MANAGE, V145, P110, DOI 10.1016/j.agwat.2014.01.013; Mullaney J. R., 2009, US GEOLOGICAL SURVEY; Natural Resources Defense Council, 2020, FLINT WAT CRIS; Nguyen CK, 2011, J AM WATER WORKS ASS, V103, P81; Novotny EV, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008141; Novotny EV, 2008, SCI TOTAL ENVIRON, V406, P131, DOI 10.1016/j.scitotenv.2008.07.037; Nowasell QC, 2017, ADV CIV ENG MATER, V6, P372, DOI 10.1520/ACEM20160051; Oram B., 2020, HARD WATER HARDNESS; Overbo A, 2020, SCI TOTAL ENV; Prosser RS, 2017, ENVIRON POLLUT, V230, P589, DOI 10.1016/j.envpol.2017.07.001; Rochester Public Utilities, WAT QUAL WAT SOURC; Rohm, 2008, ION EXCH DUMM; SCHWARTZ ES, 1994, J FINANC, V49, P1924, DOI 10.2307/2329279; Shea Bill, 2017, MESSENGER 0425; Soucek DJ, 2015, ENVIRON TOXICOL CHEM, V34, P2126, DOI 10.1002/etc.3038; Soucek DJ, 2011, ENVIRON TOXICOL CHEM, V30, P930, DOI 10.1002/etc.454; Soucek DJ, 2007, ENVIRON TOXICOL CHEM, V26, P773, DOI 10.1897/06-229R.1; Stark J.R., 2000, WATER QUALITY UPPER; Stets EG, 2018, SCI TOTAL ENVIRON, V613, P1498, DOI 10.1016/j.scitotenv.2017.07.119; U.S. Department of the Interior U.S. Fish and Wildlife Service and U.S. Department of Commerce U.S. Census Bureau, 2013, 2011 NAT SURV FISH H; U.S. Environmental Protection Agency, SEC DRINK WAT STAND; U.S. Fish and Wildlife Service, 2018, 2016 NAT SURV FISH H; United States Geological Survey, 2005, SALT END US STAT; US Environmental Protection Agency, 2006, POINT OF US POINT OF; US Environmental Protection Agency, 1995, INT EC GUID WAT QUAL; US Environmental Protection Agency, RAD DRINK WAT LIM SO; US Environmental Protection Agency, DRINK WAT DISTR SYST; US Environmental Protection Agency, 1988, 440588001 US EPA; US Environmental Protection Agency, RAD DRINK WAT REV OS; US Environmental Protection Agency, 2016, LEAD DC DRINK WAT CO; US Geological Survey, HARDN WAT; van Leeuwen J, 2011, REUSE WATER TREATM 1; Vasquez WF, 2019, ECOHYDROL HYDROBIOL, V19, P610, DOI 10.1016/j.ecohyd.2018.01.001; Vaughn CC, 2018, HYDROBIOLOGIA, V810, P15, DOI 10.1007/s10750-017-3139-x; Vaughn CC, 2015, ECOL EVOL, V5, P1291, DOI 10.1002/ece3.1442; Wang N, 2018, ENVIRON TOXICOL CHEM, V37, P3050, DOI 10.1002/etc.4258; Well Owner.org, 2020, GROUNDW QUAL BAS HAR; Wiest M, 2011, P 84 ANN WAT ENV FED, P10	82	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246688	10.1371/journal.pone.0246688	http://dx.doi.org/10.1371/journal.pone.0246688			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544771	gold, Green Published			2022-12-26	WOS:000617991900039
J	Erickson, LD; Brown, BL; Gale, SD; Hedges, DW				Erickson, Lance D.; Brown, Bruce L.; Gale, Shawn D.; Hedges, Dawson W.			Association between Toxoplasma gondii seropositivity and serointensity and brain volume in adults: A cross-sectional study	PLOS ONE			English	Article							INFECTION LEADS; MEMORY; BEHAVIOR; DEFICITS	The intracellular protozoal parasite Toxoplasma gondii has been associated with worsened cognitive function in animal models and in humans. Despite these associations, the mechanisms by which Toxoplasma gondii might affect cognitive function remain unknown, although Toxoplasma gondii does produce physiologically active intraneuronal cysts and appears to affect dopamine synthesis. Using data from the UK Biobank, we sought to determine whether Toxoplasma gondii is associated with decreased prefrontal, hippocampal, and thalamic gray-matter volumes and with decreased total gray-matter and total white-matter volumes in an adult community-based sample. The results from adjusted multivariable regression modelling showed no associations between Toxoplasma gondii and prefrontal, hippocampal, and thalamic brain gray-matter volumes. In contrast, natural-log transformed antibody levels against the Toxoplasma gondii p22 (b = -3960, 95-percent confidence interval, -6536 to -1383, p < .01) and sag1 (b = -4863, 95-percent confidence interval, -8301 to -1425, p < .01) antigens were associated with smaller total gray-matter volume, as was the mean of natural-log transformed p22 and sag1 titers (b = -6141, 95-percent confidence interval, -9886 to -2397, p < .01). There were no associations between any of the measures of Toxoplasma gondii and total white-matter volume. These findings suggest that Toxoplasma gondii might be associated with decreased total gray-matter in middle-aged and older middle-aged adults in a community-based sample from the United Kingdom.	[Erickson, Lance D.] Brigham Young Univ, Dept Sociol, Provo, UT USA; [Brown, Bruce L.; Gale, Shawn D.; Hedges, Dawson W.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Gale, Shawn D.; Hedges, Dawson W.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Gale, SD (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.; Gale, SD (corresponding author), Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA.	shawn_gale@byu.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964				Alfaro-Almagro F, 2018, NEUROIMAGE, V166, P400, DOI 10.1016/j.neuroimage.2017.10.034; Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Bayani M, 2019, ACTA TROP, V196, P165, DOI 10.1016/j.actatropica.2019.05.015; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Beste C, 2014, NEUROBIOL AGING, V35, P1037, DOI 10.1016/j.neurobiolaging.2013.11.012; Brenner N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210407; Darde ML, 2008, PARASITE, V15, P366, DOI 10.1051/parasite/2008153366; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Gajewski PD, 2016, BIOL PSYCHOL, V120, P35, DOI 10.1016/j.biopsycho.2016.08.002; Gajewski PD, 2014, BRAIN BEHAV IMMUN, V36, P193, DOI 10.1016/j.bbi.2013.11.019; Gale SD, 2015, PARASITOLOGY, V142, P557, DOI 10.1017/S0031182014001577; Gale SD, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008733; Guenter W, 2012, FOLIA PARASIT, V59, P93, DOI 10.14411/fp.2012.014; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; Marden JR, 2017, AM J EPIDEMIOL, V186, P805, DOI 10.1093/aje/kwx155; Mendy A, 2015, BRAIN BEHAV IMMUN, V45, P36, DOI 10.1016/j.bbi.2014.12.006; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Mize TD, 2019, SOCIOL METHODOL, V49, P152, DOI 10.1177/0081175019852763; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Ngoungou EB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003525; Nimgaonkar VL, 2016, ALZ DIS ASSOC DIS, V30, P216, DOI 10.1097/WAD.0000000000000133; Pearce BD, 2014, SOC PSYCH PSYCH EPID, V49, P1001, DOI 10.1007/s00127-014-0820-5; Pietschnig J, 2015, NEUROSCI BIOBEHAV R, V57, P411, DOI 10.1016/j.neubiorev.2015.09.017; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; RENCHER AC, 1990, COMMUN STAT SIMULAT, V19, P535, DOI 10.1080/03610919008812874; Rossini J.C., 2019, PSYCHOL NEUROSCI, V12, P485; Royle NA, 2013, NEUROBIOL AGING, V34, P2726, DOI 10.1016/j.neurobiolaging.2013.05.015; Severance EG, 2016, INT REV NEUROBIOL, V131, P143, DOI 10.1016/bs.irn.2016.08.008; Stock AK, 2014, BRAIN BEHAV IMMUN, V37, P103, DOI 10.1016/j.bbi.2013.11.004; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sugden K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148435; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Torniainen-Holm M, 2019, BRAIN BEHAV IMMUN, V76, P159, DOI 10.1016/j.bbi.2018.11.016; Xiao J, 2015, ACTA PHYSIOL, V213, P828, DOI 10.1111/apha.12458; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051	37	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245994	10.1371/journal.pone.0245994	http://dx.doi.org/10.1371/journal.pone.0245994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544748	gold, Green Published			2022-12-26	WOS:000617991900054
J	Silva, T; Jeewandara, C; Gomes, L; Gangani, C; Mahapatuna, SD; Pathmanathan, T; Wijewickrama, A; Ogg, GS; Malavige, GN				Silva, Tehani; Jeewandara, Chandima; Gomes, Laksiri; Gangani, Chathurika; Mahapatuna, Sameera D.; Pathmanathan, Thilagaraj; Wijewickrama, Ananda; Ogg, Graham S.; Malavige, Gathsaurie Neelika			Urinary leukotrienes and histamine in patients with varying severity of acute dengue	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; ASTHMA; MONTELUKAST; ANTAGONIST; BURDEN; E(4)	Background Vascular leak is a hallmark of severe dengue, and high leukotriene levels have been observed in dengue mouse models, suggesting a role in disease pathogenesis. We sought to explore their role in acute dengue, by assessing levels of urinary LTE4 and urinary histamine in patients with varying severity of acute dengue. Methods Urinary LTE4(,) histamine and creatinine were measured by a quantitative ELISA, in healthy individuals (n = 19), patients with dengue fever (DF = 72) and dengue haemorrhagic fever DHF (n = 48). The kinetics of LTE4 and histamine and diurnal variations were assessed in a subset of patients. Results Urinary LTE4 levels were significantly higher (p = 0.004) in patients who proceed to develop DHF when compared to patients with DF during early illness (<= 4 days) and during the critical phase (p = 0.02), which continued to rise in patients who developed DHF during the course of illness. However, LTE4 is unlikely to be a good biomarker as ROCs gave an AUC value of 0.67 (95% CI 0.57 and 0.76), which was nevertheless significant (p = 0.002). Urinary LTE4 levels did not associate with the degree of viraemia, infecting virus serotype and was not different in those with primary vs secondary dengue. Urinary histamine levels were significantly high in patients with acute dengue although no difference was observed between patients with DF and DHF and again did not associate with the viraemia. Interestingly, LTE4, histamine and the viral loads showed a marked diurnal variation in both patients with DF and DHF. Conclusions Our data suggest that LTE4 could play a role in disease pathogenesis and since there are safe and effective cysteinyl leukotriene receptor blockers, it would be important to assess their efficacy in reducing dengue disease severity.	[Silva, Tehani; Jeewandara, Chandima; Gomes, Laksiri; Gangani, Chathurika; Mahapatuna, Sameera D.; Pathmanathan, Thilagaraj; Malavige, Gathsaurie Neelika] Univ Sri Jayewardenepura, Ctr Dengue Res, Nugegoda, Sri Lanka; [Silva, Tehani] Gen Sir John Kotelawala Def Univ, Rathmalana, Sri Lanka; [Wijewickrama, Ananda] Natl Inst Infect Dis, Angoda, Sri Lanka; [Ogg, Graham S.; Malavige, Gathsaurie Neelika] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England	University Sri Jayewardenepura; General Sir John Kotelawala Defence University; University of Oxford	Malavige, GN (corresponding author), Univ Sri Jayewardenepura, Ctr Dengue Res, Nugegoda, Sri Lanka.; Malavige, GN (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.	gathsaurie.malavige@ndm.ox.ac.uk	Malavige, Gathsaurie/J-5483-2015	Malavige, Gathsaurie/0000-0001-9201-0449; Ogg, Graham/0000-0002-3097-045X	Centre for Dengue Research, University of Sri YJayewardenepura (GNM), National Science Foundation, Sri Lanka [RPHS/2016/D-06]	Centre for Dengue Research, University of Sri YJayewardenepura (GNM), National Science Foundation, Sri Lanka	The funding was provided by the Centre for Dengue Research, University of Sri YJayewardenepura (GNM), National Science Foundation, Sri Lanka (RPHS/2016/D-06, GNM), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007389; ASANO K, 1995, J ALLERGY CLIN IMMUN, V96, P643, DOI 10.1016/S0091-6749(95)70263-6; Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Chiu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115216; Ciebiada M, 2006, ANN ALLERG ASTHMA IM, V97, P664, DOI 10.1016/S1081-1206(10)61098-8; Cui L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004607; Divekar R, 2016, J ALLER CL IMM-PRACT, V4, P665, DOI 10.1016/j.jaip.2016.03.004; Fernando S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1656-2; Furuta T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001505; Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Huang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01392; Jeewandara C, 2017, IMMUN INFLAMM DIS, V5, P7, DOI 10.1002/iid3.135; Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003459; JORIS I, 1987, AM J PATHOL, V126, P19; Krakowiak Karolina, 2018, Pulm Ther, V4, P29, DOI 10.1007/s41030-018-0058-6; KUMLIN M, 1995, CLIN EXP ALLERGY, V25, P467, DOI 10.1111/j.1365-2222.1995.tb01079.x; Loke WM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-322; Malavige GN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22285-x; Malavige GN, 2017, IMMUNOLOGY, V151, P261, DOI 10.1111/imm.12748; Merlos M, 1997, J PHARMACOL EXP THER, V280, P114; Murhekar MV, 2019, LANCET GLOB HEALTH, V7, pE1065, DOI 10.1016/S2214-109X(19)30250-5; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Ogawa Y, 2006, J ALLERGY CLIN IMMUN, V118, P789, DOI 10.1016/j.jaci.2006.08.009; Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738; Rathore APS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68844-z; Rathore APS, 2019, J CLIN INVEST, V129, P4180, DOI 10.1172/JCI128426; Reicin A, 2000, ARCH INTERN MED, V160, P2481, DOI 10.1001/archinte.160.16.2481; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481; Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Thangam EB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01873; Tissera H, 2017, J INFECT DIS, V216, P1112, DOI 10.1093/infdis/jix447; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; TUCHINDA M, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P80; Velasquez CV, 2015, HUM IMMUNOL, V76, P318, DOI 10.1016/j.humimm.2015.03.009; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245926	10.1371/journal.pone.0245926	http://dx.doi.org/10.1371/journal.pone.0245926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544746	gold, Green Submitted, Green Published			2022-12-26	WOS:000617991900027
J	Arguni, E; Karyanti, MR; Satari, HI; Hadinegoro, SR				Arguni, Eggi; Karyanti, Mulya Rahma; Satari, Hindra Irawan; Hadinegoro, Sri Rezeki			Diphtheria outbreak in Jakarta and Tangerang, Indonesia: Epidemiological and clinical predictor factors for death	PLOS ONE			English	Article							RISK-FACTORS; GEORGIA	Background In 2017, a diphtheria outbreak occurred in several provinces in Indonesia. The aim of this study was to identify predictors of mortality outcome of pediatric patients with clinical diphtheria. Methods A retrospective cohort study was conducted using patient medical records at five referral hospitals in the Province of Jakarta and one in Tangerang District, Banten Province during January 2017 to 31 August 2018. All children in the age group of 1-18 years old discharged with diagnosis of clinical diphtheria formed the study group. All anonymized patient data were evaluated for demographic issues, clinical features, immunization status, complication, laboratory profiles and outcome. Results A total of 283 patients with clinical diphtheria were included in the study group with case fatality rate of 3.5%. All mortal patients had the complication of myocarditis. Regression analyses revealed factors for predicting mortality. Incomplete primary diphtheria toxoid immunization, stridor, bull neck, leukocytosis >= 15 x10(9) cells/L and thrombocytopenia <= 150 x10(9) cells/L in each combination for 2 predictors modeling were correlated with death. Conclusions We report key predictors of mortality in pediatric patients with clinical diphtheria. The presence of these features when admitted to the hospital must be taken into account, because they can lead to fatal outcome.	[Arguni, Eggi] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Child Hlth, Yogyakarta, Indonesia; [Karyanti, Mulya Rahma; Satari, Hindra Irawan; Hadinegoro, Sri Rezeki] Univ Indonesia, Fac Med, Dept Pediat, Jakarta, Indonesia	Gadjah Mada University; University of Indonesia	Arguni, E (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Child Hlth, Yogyakarta, Indonesia.	eggiarguni@ugm.ac.id	Arguni, Eggi/AFO-5492-2022	Arguni, Eggi/0000-0001-7462-7904				[Anonymous], REV EPIDEMIOLOGY DIP; Dravid MN, 2008, INDIAN J MED RES, V127, P616; Galazka A, 2000, J INFECT DIS, V181, pS2, DOI 10.1086/315533; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P107, DOI 10.1007/BF01719955; Glinyenko VM, 2000, J INFECT DIS, V181, pS98, DOI 10.1086/315547; Hadfield TL, 2000, J INFECT DIS, V181, pS116, DOI 10.1086/315551; Harapan H, 2019, CLIN EPIDEMIOL GLOB, V7, P261, DOI 10.1016/j.cegh.2018.03.007; Havaldar PV, 2000, ANN TROP PAEDIATR, V20, P209, DOI 10.1080/02724936.2000.11748136; Jayashree A, 2006, INDIAN PEDIATR, V43, P155; Kementrian Kesehatan Republik Indonesia, 2017, PROFIL KESEHATAN IND; Khetsuriani N, 2000, J INFECT DIS, V181, pS80, DOI 10.1086/315544; Kneen R, 2004, CLIN INFECT DIS, V39, P1591, DOI 10.1086/425305; Kolybo DV, 2013, BIOTECHNOLOGIA ACTA, V6, P43; Krumina A, 2005, J NEUROL NEUROSUR PS, V76, P1555, DOI 10.1136/jnnp.2004.056523; Macgregor PR, 2005, PRINCIPLES PRACTICE, P2457; Meera M, 2014, INT J INFECT DIS, V19, P74, DOI 10.1016/j.ijid.2013.10.017; Muhamad Ramdan Iwan, 2018, F1000Res, V7, P1625, DOI 10.12688/f1000research.16433.1; Murhekar M, 2017, AM J TROP MED HYG, V97, P313, DOI 10.4269/ajtmh.17-0047; Ohuabunwo C, 2005, SCAND J INFECT DIS, V37, P813, DOI 10.1080/00365540500262658; Phalkey RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-317; Quick ML, 2000, J INFECT DIS, V181, pS130, DOI 10.1086/315550; Quick ML, 2000, J INFECT DIS, V181, pS121, DOI 10.1086/315563; Rakhmanova AG, 1996, SCAND J INFECT DIS, V28, P37, DOI 10.3109/00365549609027147; Sadoh AE, 2012, VACCINE, V30, P7221, DOI 10.1016/j.vaccine.2012.10.014; Scheifele DW, 2009, DIPHTHERIA UPDATE; Wagner KS, 2012, EMERG INFECT DIS, V18, P217, DOI 10.3201/eid1802.110987; *WHO, 2006, WHO VACC PREV DIS MO	27	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246301	10.1371/journal.pone.0246301	http://dx.doi.org/10.1371/journal.pone.0246301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539453	Green Published, gold			2022-12-26	WOS:000616960200027
J	Burrows, H; Talbot, B; McKay, R; Slatculescu, A; Logan, J; Thickstun, C; Lindsay, LR; Dibernardo, A; Koffi, JK; Ogden, NH; Kulkarni, MA				Burrows, Holly; Talbot, Benoit; McKay, Roman; Slatculescu, Andreea; Logan, James; Thickstun, Charles; Lindsay, L. Robbin; Dibernardo, Antonia; Koffi, Jules K.; Ogden, Nicholas H.; Kulkarni, Manisha A.			A multi-year assessment of blacklegged tick (Ixodes scapularis) population establishment and Lyme disease risk areas in Ottawa, Canada, 2017-2019	PLOS ONE			English	Article							INVASION; EMERGENCE	Canadians face an emerging threat of Lyme disease due to the northward expansion of the tick vector, Ixodes scapularis. We evaluated the degree of I. scapularis population establishment and Borrelia burgdorferi occurrence in the city of Ottawa, Ontario, Canada from 2017-2019 using active surveillance at 28 sites. We used a field indicator tool developed by Clow et al. to determine the risk of I. scapularis establishment for each tick cohort at each site using the results of drag sampling. Based on results obtained with the field indicator tool, we assigned each site an ecological classification describing the pattern of tick colonization over two successive cohorts (cohort 1 was comprised of ticks collected in fall 2017 and spring 2018, and cohort 2 was collected in fall 2018 and spring 2019). Total annual site-specific I. scapularis density ranged from 0 to 16.3 ticks per person-hour. Sites with the highest density were located within the Greenbelt zone, in the suburban/rural areas in the western portion of the city of Ottawa, and along the Ottawa River; the lowest densities occurred at sites in the suburban/urban core. B. burgdorferi infection rates exhibited a similar spatial distribution pattern. Of the 23 sites for which data for two tick cohorts were available, 11 sites were classified as "high-stable", 4 were classified as "emerging", 2 were classified as "low-stable", and 6 were classified as "non-zero". B. burgdorferi-infected ticks were found at all high-stable sites, and at one emerging site. These findings suggest that high-stable sites pose a risk of Lyme disease exposure to the community as they have reproducing tick populations with consistent levels of B. burgdorferi infection. Continued surveillance for I. scapularis, B. burgdorferi, and range expansion of other tick species and emerging tick-borne pathogens is important to identify areas posing a high risk for human exposure to tick-borne pathogens in the face of ongoing climate change and urban expansion.	[Burrows, Holly] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA; [Burrows, Holly; Talbot, Benoit; McKay, Roman; Slatculescu, Andreea; Logan, James; Thickstun, Charles; Kulkarni, Manisha A.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Lindsay, L. Robbin; Dibernardo, Antonia] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens Div, Winnipeg, MB, Canada; [Koffi, Jules K.] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, St Hyacinthe, PQ, Canada; [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, St Hyacinthe, PQ, Canada	Yale University; University of Ottawa; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada	Kulkarni, MA (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	Manisha.kulkarni@uottawa.ca		Burrows, Holly/0000-0002-6895-0526	Public Health Agency of Canada [1000183915]; Canadian Institutes of Health Research [148714]; Natural Sciences and Engineering Research Council [04730]	Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study is funded by grants to MAK from the Public Health Agency of Canada (https://www.canada.ca/en/public-health.html; no.1000183915), Canadian Institutes of Health Research (https://cihr-irsc.gc.ca; no.148714) and the Natural Sciences and Engineering Research Council (https://www.nserc-crsng.gc.ca; no.04730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Clifford C.M., 1961, LARVAL IXODID TICKS; Clow KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193524; Clow KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189393; Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Egizi AM, 2019, ZOOKEYS, P117, DOI 10.3897/zookeys.818.30448; Government of Canada, 2017, LYM DIS 2016 CAS DEF; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1996, J MED ENTOMOL, V33, P297, DOI 10.1093/jmedent/33.3.297; Kulkarni M, 2018, Can Commun Dis Rep, V44, P237, DOI 10.14745/ccdr.v44i10a02; Kulkarni MA, 2019, EMERG INFECT DIS, V25, P328, DOI 10.3201/eid2502.180771; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindquist EE., 2016, HDB TICKS CANADA IXO, DOI DOI 10.3752/9780968932186; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; McKay R, 2020, TICKS TICK-BORNE DIS, V11, DOI 10.1016/j.ttbdis.2019.101361; McPherson M, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP57, 10.1289/ehp57]; Meyer DZA., 2020, VCD VISUALIZING CATE; National Capital Comission, CAN CAP GREENB; Nelder MP, 2019, TICKS TICK-BORNE DIS, V10, P146, DOI 10.1016/j.ttbdis.2018.10.001; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden N H, 2015, Can Commun Dis Rep, V41, P132; Ogden N H, 2014, Can Commun Dis Rep, V40, P83; Ogden NH, 2009, EPIDEMICS-NETH, V1, P196, DOI 10.1016/j.epidem.2009.06.002; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ontario Agency for Health Protection and Promotion, 2015, TICK DRAGG STAND OP; Ottawa, 2017, OTTAWA CV CENSUS SUB; Ottawa Public Health, 2018, CAS INF DIS PUBL HLT; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Schulze T.L., 2006, ASSESSMENT MANAGEMEN; Slatculescu AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238126; Soucy JPR, 2018, VECTOR-BORNE ZOONOT, V18, P235, DOI 10.1089/vbz.2017.2234; Talbot B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50858-x	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246484	10.1371/journal.pone.0246484	http://dx.doi.org/10.1371/journal.pone.0246484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539458	gold, Green Published			2022-12-26	WOS:000616960200054
J	Duo, H; Hossain, F; Muthusamy, V; Zunjare, RU; Goswami, R; Chand, G; Mishra, SJ; Chhabra, R; Gowda, MM; Pal, S; Baveja, A; Bhat, JS; Kamboj, MC; Kumar, B; Amalraj, JJ; Khulbe, R; Prakash, B; Neeraja, CN; Rakshit, S; Yadav, OP				Duo, Hriipulou; Hossain, Firoz; Muthusamy, Vignesh; Zunjare, Rajkumar U.; Goswami, Rajat; Chand, Gulab; Mishra, Subhra J.; Chhabra, Rashmi; Gowda, Munegowda M.; Pal, Saikat; Baveja, Aanchal; Bhat, Jayant S.; Kamboj, Mehar C.; Kumar, Bhupender; Amalraj, John J.; Khulbe, Rajesh; Prakash, Bhukya; Neeraja, C. N.; Rakshit, Sujay; Yadav, Om P.			Development of sub-tropically adapted diverse provitamin-A rich maize inbreds through marker-assisted pedigree selection, their characterization and utilization in hybrid breeding	PLOS ONE			English	Article							BETA-CAROTENE-HYDROXYLASE; LYCOPENE-EPSILON-CYCLASE; POSSESSING RARE ALLELE; QUALITY PROTEIN MAIZE; GENETIC-VARIABILITY; KERNEL CAROTENOIDS; COMBINING ABILITY; BIOFORTIFICATION; INTROGRESSION; ACCUMULATION	Malnutrition has emerged as one of the major health problems worldwide. Traditional yellow maize has low provitamin-A (proA) content and its genetic base in proA biofortification breeding program of subtropics is extremely narrow. To diversify the proA rich germplasm, 10 elite low proA inbreds were crossed with a proA rich donor (HP702-22) having mutant crtRB1 gene. The F-2 populations derived from these crosses were genotyped using InDel marker specific to crtRB1. Severe marker segregation distortion was observed. Seventeen crtRB1 inbreds developed through marker-assisted pedigree breeding and seven inbreds generated using marker-assisted backcross breeding were characterized using 77 SSRs. Wide variation in gene diversity (0.08 to 0.79) and dissimilarity coefficient (0.28 to 0.84) was observed. The inbreds were grouped into three major clusters depicting the existing genetic diversity. The crtRB1-based inbreds possessed high beta-carotene (BC: 8.72 mu g/g), beta-cryptoxanthin (BCX: 4.58 mu g/g) and proA (11.01 mu g/g), while it was 2.35 mu g/g, 1.24 mu g/g and 2.97 mu g/g in checks, respectively. Based on their genetic relationships, 15 newly developed crtRB1-based inbreds were crossed with five testers (having crtRB1 gene) using line x tester mating design. 75 experimental hybrids with crtRB1 gene were evaluated over three locations. These experimental hybrids possessed higher BC (8.02 mu g/g), BCX (4.69 mu g/g), proA (10.37 mu g/g) compared to traditional hybrids used as check (BC: 2.36 mu g/g, BCX: 1.53 mu g/g, proA: 3.13 mu g/g). Environment and genotypes x environment interaction had minor effects on proA content. Both additive and dominance gene action were significant for proA. The mean proportion of proA to total carotenoids (TC) was 44% among crtRB1-based hybrids, while 11% in traditional hybrids. BC was found to be positively correlated with BCX (r = 0.68) and proA (r = 0.98). However, no correlation was observed between proA and grain yield. Several hybrids with >10.0 t/ha grain yield with proA content >10.0 mu g/g were identified. This is the first comprehensive study on development of diverse proA rich maize hybrids through marker-assisted pedigree breeding approach. The findings provides sustainable and cost-effective solution to alleviate vitamin-A deficiency.	[Duo, Hriipulou; Hossain, Firoz; Muthusamy, Vignesh; Zunjare, Rajkumar U.; Goswami, Rajat; Chand, Gulab; Mishra, Subhra J.; Chhabra, Rashmi; Gowda, Munegowda M.; Pal, Saikat; Baveja, Aanchal; Bhat, Jayant S.] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Kamboj, Mehar C.] CCS Haryana Agr Univ, Reg Res Stn, Uchani, Haryana, India; [Kumar, Bhupender; Rakshit, Sujay; Yadav, Om P.] ICAR Indian Inst Maize Res, Ludhiana, Punjab, India; [Amalraj, John J.] Tamil Nadu Agr Univ, Coimbatore, Tamil Nadu, India; [Khulbe, Rajesh] ICAR Vivekananda Parvatiya Krishi Anusandhan Sans, Almora, India; [Prakash, Bhukya] ICAR Directorate Poultry Res, Hyderabad, Telangana, India; [Neeraja, C. N.] ICAR Indian Inst Rice Res, Hyderabad, Telangana, India; [Yadav, Om P.] ICAR Cent Arid Zone Res Inst, Jodhpur, Rajasthan, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CCS Haryana Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Maize Research; Tamil Nadu Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan; Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Poultry Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; Indian Council of Agricultural Research (ICAR); ICAR - Central Arid Zone Research Institute	Hossain, F (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.	fh_gpb@yahoo.com	Muthusamy, Vignesh/AAU-5785-2020; Zunjare, Rajkumar/AAI-6417-2021	Zunjare, Rajkumar/0000-0001-5001-2681; Chand, Gulab/0000-0002-5359-5373	Indian Council of Agricultural Research (ICAR) - `Consortia Research Platform on Biofortification in Selected Crops for Nutritional Security-Maize'; ICAR	Indian Council of Agricultural Research (ICAR) - `Consortia Research Platform on Biofortification in Selected Crops for Nutritional Security-Maize'; ICAR(Indian Council of Agricultural Research (ICAR))	This study was funded by the Indian Council of Agricultural Research (ICAR) sponsored `Consortia Research Platform on Biofortification in Selected Crops for Nutritional Security-Maize' to FH and by a Junior Research Fellowship from ICAR to HD. The authors thankfully acknowledge ICAR for their financial support of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M. S., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P11905, DOI 10.18697/ajfand.78.harvestplus05; [Anonymous], 2018, GLOBAL NUTR REPORT; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; Babu R, 2013, THEOR APPL GENET, V126, P389, DOI 10.1007/s00122-012-1987-3; Bouis H, 2018, WORLD REV NUTR DIET, V118, P112, DOI 10.1159/000484342; BUCKNER B, 1990, PLANT CELL, V2, P867, DOI 10.1105/tpc.2.9.867; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Choudhary M, 2016, J PLANT BIOCHEM BIOT, V25, P12, DOI 10.1007/s13562-015-0300-3; CROSSA J, 1990, MAYDICA, V35, P273; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Egesel CO, 2003, CROP SCI, V43, P818, DOI 10.2135/cropsci2003.0818; Goswami R, 2019, CEREAL RES COMMUN, V47, P205, DOI 10.1556/0806.47.2019.12; Goswami R, 2019, PLANT BREEDING, V138, P174, DOI 10.1111/pbr.12676; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gupta HS, 2015, INDIAN J GENET PL BR, V75, P1, DOI 10.5958/0975-6906.2015.00001.2; Gupta HS, 2019, MARKER ASSISTED BREE, P139; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hossain F, 2019, CONC STRAT PLANT SCI, P115, DOI 10.1007/978-3-319-95354-0_5; Hossain F, 2018, J GENET, V97, P287, DOI 10.1007/s12041-018-0914-z; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Kempthorne O, 1957, INTRO GENETIC STAT; Kumar B, 2008, J PLANT BIOCHEM BIOT, V17, P133, DOI 10.1007/BF03263274; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu L, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0349-7; Liu YQ, 2012, POULTRY SCI, V91, P432, DOI 10.3382/ps.2011-01719; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Menkir A, 2008, FOOD CHEM, V109, P521, DOI 10.1016/j.foodchem.2008.01.002; Menkir A, 2015, EUPHYTICA, V205, P203, DOI 10.1007/s10681-015-1426-z; Muthusamy V, 2016, CEREAL RES COMMUN, V44, P669, DOI 10.1556/0806.44.2016.035; Muthusamy V, 2015, CEREAL RES COMMUN, V43, P567, DOI 10.1556/0806.43.2015.012; Muthusamy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113583; Neeraja CN, 2017, CURR SCI INDIA, V113, P1050, DOI 10.18520/cs/v113/i06/1050-1057; Neuffer MG, 1968, MUTANTS MAIZE FOLLET; Pandey N, 2016, PLANT BREEDING, V135, P47, DOI 10.1111/pbr.12328; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Pixley K, 2013, BIOFORTIFICATION MAI, P271; Prasanna BM, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01392; Rakshit S, 2011, J PLANT BIOCHEM BIOT, V20, P173, DOI 10.1007/s13562-011-0043-8; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Senete CT, 2011, EUPHYTICA, V182, P395, DOI 10.1007/s10681-011-0513-z; Singh RK., 1977, BIOMETRICAL METHODS; Sizer FS, NUTR CONCEPTS CONTRO, V4th, P244; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; Suwarno WB, 2014, CROP SCI, V54, P14, DOI 10.2135/cropsci2013.02.0096; Tanumihardjo SA, 2010, INT J VITAM NUTR RES, V80, P336, DOI 10.1024/0300-9831/a000042; Vignesh M, 2012, INDIAN J GENET PL BR, V72, P189; WHO, 2019, WORLD HLTH STAT 2019; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Yadav OP, 2015, AGR RES, V4, P325, DOI 10.1007/s40003-015-0180-8; Yadava DK, 2018, INDIAN J MED RES, V148, P621, DOI [10.4103/ijmr.IJMR_1893_18, 10.4103/ijmr.ijmr_1893_18]; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Zunjare RU, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00178; Zunjare RU, 2017, PLANT BREED, DOI [10.1111/pbr.1246428781399, DOI 10.1111/PBR.1246428781399]	55	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245497	10.1371/journal.pone.0245497	http://dx.doi.org/10.1371/journal.pone.0245497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539427	Green Published, gold			2022-12-26	WOS:000616960200088
J	Kim, YA; Kang, D; Moon, H; Sinn, D; Kang, M; Woo, SM; Chang, YJ; Park, B; Kong, SY; Guallar, E; Shin, SY; Gwak, G; Back, JH; Lee, ES; Cho, J				Kim, Young Ae; Kang, Danbee; Moon, Hyeyoung; Sinn, Donghyun; Kang, Minwoong; Woo, Sang Myung; Chang, Yoon Jung; Park, Boram; Kong, Sun-Young; Guallar, Eliseo; Shin, Soo-Yong; Gwak, Geunyeon; Back, Joung Hwan; Lee, Eun Sook; Cho, Juhee			Survival in untreated hepatocellular carcinoma: A national cohort study	PLOS ONE			English	Article							METAANALYSIS; MANAGEMENT; PROGNOSIS; HEALTH	This study aimed to analyze the proportion, characteristics and prognosis of untreated hepatocellular carcinoma (HCC) patients in a large representative nationwide study. A cohort study was conducted using the National Health Insurance Service (NHIS) database in Korea. A total of 63,668 newly-diagnosed HCC patients between January 2008 and December 2013 were analyzed. Patients were categorized into treatment group and no treatment group using claim codes after HCC diagnosis. The proportion of untreated HCC patients was 27.6%, decreasing from 33.4% in 2008 to 24.8% in 2013. Compared to treated patients, untreated patients were more likely to be older (P < 0.001), female (P < 0.01), to have a distant SEER stage (P < 0.001), severe liver disease (P < 0.001), and lower income (P < 0.001). The fully-adjusted hazard ratio for all-cause mortality comparing untreated to treated patients was 3.11 (95% CI, 3.04-3.18). The risk of mortality was higher for untreated patients in all pre-defined subgroups, including those with distant SEER stage and those with severe liver disease. About one fourth of newly diagnosed HCC patients did not receive any HCC-specific treatment. Untreated patients showed higher risk of mortality compared to treated patients in all subgroups. Further studies are needed to identify obstacles for HCC treatment and to improve treatment rates.	[Kim, Young Ae; Chang, Yoon Jung] Natl Canc Ctr, Natl Canc Control Inst, Div Canc Control & Policy, Goyang, South Korea; [Kang, Danbee; Moon, Hyeyoung; Cho, Juhee] Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul, South Korea; [Kang, Danbee; Kang, Minwoong; Cho, Juhee] Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Sinn, Donghyun; Gwak, Geunyeon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea; [Kang, Minwoong; Shin, Soo-Yong; Cho, Juhee] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea; [Woo, Sang Myung] Natl Canc Ctr, Ctr Liver & Pancreatobiliary Canc, Res Inst, Goyang, South Korea; [Park, Boram] Natl Canc Ctr, Res Core Ctr, Res Inst, Biostat Collaborat Team, Goyang, South Korea; [Kong, Sun-Young] Natl Canc Ctr, Res Inst, Div Translat Sci, Goyang, South Korea; [Guallar, Eliseo; Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Guallar, Eliseo; Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Epidemiol Prevent & Clin Res, Baltimore, MD 21205 USA; [Back, Joung Hwan] Natl Hlth Insurance Serv, Hlth Insurance Policy Res Inst, Gangwon Do, South Korea; [Lee, Eun Sook] Natl Canc Ctr, Res Inst & Hosp, Dept Surg, Goyang, South Korea	National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Health Insurance Service; National Cancer Center - Korea (NCC)	Cho, J (corresponding author), Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul, South Korea.; Cho, J (corresponding author), Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Sch Med, Seoul, South Korea.; Cho, J (corresponding author), Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea.; Cho, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Cho, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Epidemiol Prevent & Clin Res, Baltimore, MD 21205 USA.; Lee, ES (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Dept Surg, Goyang, South Korea.	eslee@ncc.re.kr; jcho@skku.edu	Cho, Juhee/ABD-2280-2021; Kang, Danbee/AAN-5933-2020; Kong, Sun-Young/ABB-7914-2021	Kang, Danbee/0000-0003-0244-7714; 	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1520240]; National Cancer Center Grant [NCC-1911275]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Cancer Center Grant	This work was supported by National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1520240) and National Cancer Center Grant (NCC-1911275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costentin CE, 2018, GASTROENTEROLOGY, V155, P431, DOI 10.1053/j.gastro.2018.04.027; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Devaki P, 2014, CANCER-AM CANCER SOC, V120, P1725, DOI 10.1002/cncr.28639; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giannini EG, 2015, HEPATOLOGY, V61, P184, DOI 10.1002/hep.27443; Hanouneh IA, 2019, CLIN MOL HEPATOL, V25, P264, DOI 10.3350/cmh.2019.1001; Khalaf N, 2017, CLIN GASTROENTEROL H, V15, P273, DOI 10.1016/j.cgh.2016.07.033; Kim BH, 2018, CLIN MOL HEPATOL, V24, P1, DOI 10.3350/cmh.2017.0112; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kim JH, 2016, GUT LIVER, V10, P939, DOI 10.5009/gnl15527; Kim KM, 2018, SCAND J GASTROENTERO, V53, P727, DOI 10.1080/00365521.2018.1458895; Kim KM, 2016, LIVER INT, V36, P1490, DOI 10.1111/liv.13107; Kim YJ, 2012, J KOREAN MED SCI, V27, P1147, DOI 10.3346/jkms.2012.27.10.1147; Korean-Liver-Canc-Study-Grp-KLCSG, 2015, GUT LIVER, V9, P267, DOI 10.5009/gnl14460; Lee HS, 2011, DIGEST DIS, V29, P333, DOI 10.1159/000327572; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001; Nouso K, 2014, ONCOLOGY-BASEL, V87, P99, DOI 10.1159/000368152; Serper M, 2017, GASTROENTEROLOGY, V152, P1954, DOI 10.1053/j.gastro.2017.02.040; Shaya FT, 2014, PHARMACOECONOMICS, V32, P63, DOI 10.1007/s40273-013-0109-7; Shin DW, 2016, JAMA INTERN MED, V176, P138, DOI 10.1001/jamainternmed.2015.7110; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Sinn DH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210730; Sinn DH, 2016, GASTROENTEROLOGY, V151, P481, DOI 10.1053/j.gastro.2016.06.001; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Tan D, 2013, ALIMENT PHARM THER, V38, P703, DOI 10.1111/apt.12450; Tran SA, 2018, BMJ OPEN GASTROENTER, V5, DOI 10.1136/bmjgast-2017-000192; Yang H, 2017, CLIN MOL HEPATOL, V23, P128, DOI 10.3350/cmh.2016.0071; Yeon JE, 2018, CLIN MOL HEPATOL, V24, P169, DOI 10.3350/cmh.2018.1004; Yim SY, 2016, LIVER INT, V36, P445, DOI 10.1111/liv.12960; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Zhao CQ, 2018, LIVER INT, V38, P503, DOI 10.1111/liv.13555	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246143	10.1371/journal.pone.0246143	http://dx.doi.org/10.1371/journal.pone.0246143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539397	gold, Green Published			2022-12-26	WOS:000616960200021
J	Molnar, R; Szabo, L; Tomesz, A; Deutsch, A; Darago, R; Ghodratollah, N; Varjas, T; Nemeth, B; Budan, F; Kiss, I				Molnar, Richard; Szabo, Laszlo; Tomesz, Andras; Deutsch, Arpad; Darago, Richard; Ghodratollah, Nowrasteh; Varjas, Timea; Nemeth, Balazs; Budan, Ferenc; Kiss, Istvan			In vivo effects of olive oil and trans-fatty acids on miR-134, miR-132, miR-124-1, miR-9-3 and mTORC1 gene expression in a DMBA-treated mouse model	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; HUMAN CANCER; INFLAMMATION; INVASION; PROLIFERATION; ACTIVATION; BIOMARKERS	Both the intake of beneficial olive oil and of harmful trans-fatty acids (TFAs) in consumed foods are of great significance in tumor biology. In our present study we examined the effects they exert on the expression patterns of miR-134, miR-132, miR-124-1, miR-9-3 and mTOR in the liver, spleen and kidney of mice treated with 7,12-dimethylbenz [a] anthracene (DMBA). Feeding of TFA-containing diet significantly increased the expression of all studied miRs and mTORC1 in all organs examined, except the expression of mTORC1 in the spleen and kidney. Diet containing olive oil significantly reduced the expression of miR-124-1, miR-9-3 and mTORC1 in the liver and spleen. In the kidney, apart from the mTORC1 gene, the expression of all miRs examined significantly decreased compared to the DMBA control. According to our results, the cell membrane protective, antioxidant, and anti-inflammatory effects of olive oil and the cell membrane damaging, inflammatory, and carcinogenic properties of TFA suggest negative feedback regulatory mechanisms. In contrast to our expectations, mTORC1 gene expression in the kidney has not been shown to be an appropriate biomarker-presumably, because the many complex effects that regulate mTOR expression may quench each other.	[Molnar, Richard; Szabo, Laszlo; Tomesz, Andras; Deutsch, Arpad; Darago, Richard; Ghodratollah, Nowrasteh; Varjas, Timea; Nemeth, Balazs; Budan, Ferenc; Kiss, Istvan] Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary; [Budan, Ferenc] Univ Pecs, Med Sch, Inst Physiol, Pecs, Hungary; [Budan, Ferenc] Univ Pannonia, Fac Engn, Inst Environm Engn, Veszprem, Hungary; [Budan, Ferenc] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; University of Pannonia; University of Pecs	Molnar, R (corresponding author), Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary.	richard.molnar.pte@gmail.com	Budán, Ferenc/AAW-1481-2020; Nemeth, Balazs/AAP-1660-2021	Nemeth, Balazs/0000-0002-4914-9872; Kiss, Istvan/0000-0002-7558-1300; Molnar, Richard/0000-0001-8600-0842; Budan, Ferenc/0000-0003-1562-9496				Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Anjom-Shoae J, 2020, CLIN NUTR, V39, P755, DOI 10.1016/j.clnu.2019.03.024; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bartsch H, 2000, EUR J CANCER, V36, P1229, DOI 10.1016/S0959-8049(00)00095-2; Bermudez B, 2004, GRASAS ACEITES, V55, P1; Bosetti C, 2002, INT J CANCER, V100, P355, DOI 10.1002/ijc.10485; Brinkman MT, 2011, EUR J CANCER, V47, P436, DOI 10.1016/j.ejca.2010.09.027; Bryk D, 2011, J PHYSIOL PHARMACOL, V62, P229; Cao J, 2018, J CANCER, V9, P3006, DOI 10.7150/jca.25956; Cao YH, 2001, J SURG RES, V100, P135, DOI 10.1006/jsre.2001.6229; De Souza VRC, 2009, INT J CANCER, V124, P1478, DOI 10.1002/ijc.24066; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Ferenc B, 2009, IN VIVO, V23, P591; Ferreri C, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7010001; Fortes C, 2003, NUTR CANCER, V46, P30, DOI 10.1207/S15327914NC4601_04; Giusti L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082329; Gu W, 2017, ONCOTARGET, V8, P111882, DOI 10.18632/oncotarget.22948; Hemminki K., 1990, HDB EXPT PHARM, V94, DOI [10.1007/978-3-642-74775-5_2, DOI 10.1007/978-3-642-74775-5_2]; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hornedo-Ortega R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00373; Khanfar MA, 2015, PHYTOTHER RES, V29, P1776, DOI 10.1002/ptr.5434; Kouka P, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1870965; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lipworth L, 1997, PREV MED, V26, P181, DOI 10.1006/pmed.1996.9977; Liu K, 2015, INT J ONCOL, V47, P1585, DOI 10.3892/ijo.2015.3112; Liu YY, 2015, DNA CELL BIOL, V34, P429, DOI 10.1089/dna.2014.2629; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Md S, 2011, EXPERT OPIN DRUG DEL, V8, P359, DOI 10.1517/17425247.2011.556616; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Nakbi A, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-89; Notarnicola M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030485; Owen RW, 2000, EUR J CANCER, V36, P1235, DOI 10.1016/S0959-8049(00)00103-9; Pan JY, 2017, MOL THER-NUCL ACIDS, V6, P140, DOI 10.1016/j.omtn.2016.11.003; Pantuck AJ, 2007, CANCER-AM CANCER SOC, V109, P2257, DOI 10.1002/cncr.22677; Park J, 2017, J NEUROIMMUNOL, V306, P46, DOI 10.1016/j.jneuroim.2017.02.019; Pelucchi C, 2011, CURR PHARM DESIGN, V17, P805, DOI 10.2174/138161211795428920; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schooley AM, 2012, CANCER LETT, V316, P157, DOI 10.1016/j.canlet.2011.10.032; Seiquer I, 2015, FOOD CHEM, V188, P496, DOI 10.1016/j.foodchem.2015.05.006; Shor B, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-28; Shuang T, 2017, ONCOTARGET, V8, P24853, DOI 10.18632/oncotarget.15267; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Szpechcinski A, 2019, CELL MOL LIFE SCI, V76, P3641, DOI 10.1007/s00018-019-03089-2; Tomesz A, 2020, IN VIVO, V34, P2337, DOI 10.21873/invivo.12046; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Vannini I, 2013, CLIN BIOCHEM, V46, P918, DOI 10.1016/j.clinbiochem.2013.01.024; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055; Yin C, 2013, HEPATOLOGY, V58, P1964, DOI 10.1002/hep.26573; Zha RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087665; Zhang JB, 2015, ONCOTARGET, V6, P42040, DOI 10.18632/oncotarget.5969; Zhuang P, 2019, CIRC RES, V124, P757, DOI 10.1161/CIRCRESAHA.118.314038	59	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246022	10.1371/journal.pone.0246022	http://dx.doi.org/10.1371/journal.pone.0246022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539381	gold, Green Published			2022-12-26	WOS:000616960200022
J	Tyagi, S; Kumar, A; Gautam, T; Pandey, R; Rustgi, S; Mir, RR				Tyagi, Sandhya; Kumar, Anuj; Gautam, Tinku; Pandey, Renu; Rustgi, Sachin; Mir, Reyazul Rouf			Development and use of miRNA-derived SSR markers for the study of genetic diversity, population structure, and characterization of genotypes for breeding heat tolerant wheat varieties	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; RESPONSIVE MICRORNAS; ABIOTIC STRESS; DROUGHT; IDENTIFICATION; BARLEY; QTL; MICROSATELLITES; METAANALYSIS; SOFTWARE	Heat stress is an important abiotic factor that limits wheat production globally, including south-east Asia. The importance of micro (mi) RNAs in gene expression under various biotic and abiotic stresses is well documented. Molecular markers, specifically simple sequence repeats (SSRs), play an important role in the wheat improvement breeding programs. Given the role of miRNAs in heat stress-induced transcriptional regulation and acclimatization, the development of miRNA-derived SSRs would prove useful in studying the allelic diversity at the heat-responsive miRNA-genes in wheat. In the present study, efforts have been made to identify SSRs from 96 wheat heat-responsive miRNA-genes and their characterization using a panel of wheat genotypes with contrasting reactions (tolerance/susceptible) to heat stress. A set of 13 miRNA-derived SSR markers were successfully developed as an outcome. These miRNA-SSRs are located on 11 different common wheat chromosomes (2A, 3A, 3B, 3D, 4D, 5A, 5B, 5D, 6A, 6D, and 7A). Among 13 miRNA-SSRs, seven were polymorphic on a set of 37 selected wheat genotypes. Within these polymorphic SSRs, three makers, namely HT-169j, HT-160a, and HT-160b, were found promising as they could discriminate heat-tolerant and heat-susceptible genotypes. This is the first report of miRNA-SSR development in wheat and their deployment in genetic diversity and population structure studies and characterization of trait-specific germplasm. The study suggests that this new class of molecular makers has great potential in the marker-assisted breeding (MAB) programs targeted at improving heat tolerance and other adaptability or developmental traits in wheat and other crops.	[Tyagi, Sandhya; Mir, Reyazul Rouf] SKUAST Kashmir, Div Genet & Plant Breeding, Fac Agr FoA, Sopore, Kashmir, India; [Tyagi, Sandhya; Pandey, Renu] ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India; [Kumar, Anuj] Uttarakhand Council Biotechnol UCB, Adv Ctr Computat & Appl Biotechnol, Dehra Dun, Uttarakhand, India; [Gautam, Tinku] CCS Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Rustgi, Sachin] Clemson Univ, Pee Dee Res & Educ Ctr, Dept Plant & Environm Sci, Florence, SC 29506 USA	Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Chaudhary Charan Singh University; Clemson University	Mir, RR (corresponding author), SKUAST Kashmir, Div Genet & Plant Breeding, Fac Agr FoA, Sopore, Kashmir, India.	imrouf2006@gmail.com	Kumar, Anuj/AAE-8773-2021; Pandey, Renu/AES-7797-2022; Mir, Reyazul rouf/H-4232-2019	Kumar, Anuj/0000-0002-5023-7618; Pandey, Renu/0000-0002-9244-8579; Mir, Reyazul rouf/0000-0002-3196-211X; TYAGI, SANDHYA/0000-0002-8168-017X	Science and Engineering Research Board (SERB), New Delhi, India [PDF/2016/002667]; NIFA Hatch/Multi-state grant [S009]	Science and Engineering Research Board (SERB), New Delhi, India; NIFA Hatch/Multi-state grant	The funding for the study was received from Science and Engineering Research Board (SERB), New Delhi, India with Award Number/grant number of PDF/2016/002667 and NIFA Hatch/Multi-state grant (S009)	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; [Anonymous], 2013, CEREAL GENOMICS; [Anonymous], 2013, MOL MARKERS PLANTS; Bhandawat A, 2020, MOL BIOL REP, V47, P6111, DOI 10.1007/s11033-020-05687-x; Bolser DM, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu183; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; Cheong WH, 2015, BIOINFORMATICS, V31, P3685, DOI 10.1093/bioinformatics/btv433; Dhyani K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24564; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fahad S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01147; Ganie SA, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0207-7; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gautam, 2019, PLANT BREED, V189, P28; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Kamthan A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00208; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kumar A., 2017, BIORXIV, P203851, DOI [10.1101/203851, DOI 10.1101/203851]; Kumar A, 2019, INT J BIOL MACROMOL, V140, P17, DOI 10.1016/j.ijbiomac.2019.08.105; Kumar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208409; Kumar D, 2014, J NUCLEIC ACIDS, V2014, DOI 10.1155/2014/570176; Kumar RR, 2015, FUNCT INTEGR GENOMIC, V15, P323, DOI 10.1007/s10142-014-0421-0; Kumar S., 2016, INT J BIOL SCI BIOTE, V6, P90, DOI [10.5958/2322-0996.2016.00014.4, DOI 10.5958/2322-0996.2016.00014.4]; Lamaoui M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00026; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu XD, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01277; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Luan MD, 2015, GENE, V555, P178, DOI 10.1016/j.gene.2014.11.001; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Min XY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112440; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Mir RR., 2013, DIAGNOSTICS PLANT BR, P229, DOI [DOI 10.1007/978-94-007-5687-8_11, 10.1007/978-94-007-5687-8_11]; Mondal TK, 2014, GENE, V535, P204, DOI 10.1016/j.gene.2013.11.033; Munusamy P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43861; NEI M, 1978, GENETICS, V89, P583; Ni ZF, 2018, CROP J, V6, P32, DOI 10.1016/j.cj.2017.09.005; Nizampatnam NR, 2015, PLANT J, V84, P140, DOI 10.1111/tpj.12965; Paliwal R, 2012, THEOR APPL GENET, V125, P561, DOI 10.1007/s00122-012-1853-3; Pandey G. C., 2019, Wheat and Barley Research, V11, P1, DOI 10.25174/2249-4065/2019/79252; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pegler JL, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8030058; Perrier Xavier, 2003, P31; Pritchard JK, 2010, DOCUMENTATION STRUCT; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Santosh Jaiswal JP, 2019, INT J CHEM STUD, V7, P297; Singh I, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01943; Suneha Goswami, 2014, Australian Journal of Crop Science, V8, P697; Tegelstrom Hakan, 1992, P89; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tyagi S, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1942-y; Vitsios DM, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx836; Wei LY, 2009, INT J PLANT SCI, V170, P979, DOI 10.1086/605122; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yan J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006416; Yang TX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39397-7; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang XC, 2017, PLANTA, V245, P283, DOI 10.1007/s00425-016-2605-4; Zhao JG, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01213, 10.3339/fpls.2016.01213]; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zoric M, 2012, GENETICA, V140, P259, DOI 10.1007/s10709-012-9677-2	68	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0231063	10.1371/journal.pone.0231063	http://dx.doi.org/10.1371/journal.pone.0231063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539339	Green Published, Green Submitted, gold			2022-12-26	WOS:000616960200102
J	Hidalgo-Tenorio, C; Garcia-Martinez, CM; Pasquau, J; Omar-Mohamed-Balgahata, M; Lopez-Ruz, M; Lopez-Hidalgo, J; Gil-Anguita, C				Hidalgo-Tenorio, Carmen; Maria Garcia-Martinez, Carmen; Pasquau, Juan; Omar-Mohamed-Balgahata, Mohamed; Lopez-Ruz, Miguel; Lopez-Hidalgo, Javier; Gil-Anguita, Concepcion			Risk factors for >= high-grade anal intraepithelial lesions in MSM living with HIV and the response to topical and surgical treatments	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED MEN; SEX; CANCER; TERMINOLOGY; DYSPLASIA; NEOPLASIA; ABLATION	Background The objective of this study in MSM living with HIV was to determine the incidence of HSIL and ASCC, related factors, and the response to treatment. Patients and methods Data were gathered in 405 consecutive HIV-infected MSM (May 2010-December 2018) at baseline and annually on: sexual behavior, anal cytology, and HPV PCR and/or high-resolution anoscopy results. They could choose mucosectomy with electric scalpel (from May 2010) or self-administration of 5% imiquimod 3 times weekly for 16 weeks (from November 2013). A multivariate logistic regression model was developed for >= HSIL-related factors using a step-wise approach to select variables, with a significance level of 0.05 for entry and 0.10 for exit, applying the Hosmer-Lemeshow test to assess the goodness of fit. Results The study included 405 patients with a mean age of 36.2 years; 56.7% had bachelor ' s degree, and 52.8% were smokers. They had a mean of 1 (IQR 1-7) sexual partner in the previous 12 months, median time since HIV diagnosis of 2 years, and mean CD4 nadir of 367.9 cells/uL; 86.7% were receiving ART, the mean CD4 level was 689.6 cells/uL, mean CD4/CD8 ratio was 0.77, and 85.9% of patients were undetectable. Incidence rates were 30.86/1,000 patient-years for >= high squamous intraepithelial lesion (HSIL) and 81.22/100,000 for anal squamous cell carcinoma (ASCC). The >= HSIL incidence significantly decreased from 42.9% (9/21) in 2010 to 4.1% (10/254) in 2018 (p = 0.034). >= HSIL risk factors were infection with HPV 11 (OR 3.81; 95%CI 1.76-8.24), HPV 16 (OR 2.69, 95%CI 1.22-5.99), HPV 18 (OR 2.73, 95%CI 1.01-7.36), HPV 53 (OR 2.97, 95%CI 1.002-8.79); HPV 61 (OR 11.88, 95%CI 3.67-38.53); HPV 68 (OR 2.44, CI 95% 1.03-5.8); low CD4 nadir (OR1.002; 95%CI 1-1.004) and history of AIDS (OR 2.373, CI 95% 1.009-5.577). Among HSIL-positive patients, the response rate was higher after imiquimod than after surgical excision (96.7% vs 73.3%, p = 0.009) and there were fewer re-treatments (2.7% vs 23.4%, p = 0.02) and adverse events (2.7% vs 100%, p = 0.046); none developed ASCC. Conclusions HSIL screening and treatment programs reduce the incidence of HSIL, which is related to chronic HPV infection and poor immunological status. Self-administration of 5% imiquimod as first-line treatment of HSIL is more effective than surgery in HIV+ MSM.	[Hidalgo-Tenorio, Carmen; Maria Garcia-Martinez, Carmen; Pasquau, Juan; Lopez-Ruz, Miguel] Virgen Nieves Univ Hosp, Infect Dis Dept, Granada, Spain; [Omar-Mohamed-Balgahata, Mohamed] Hosp Complex Jaen, Infect Dis Dept, Jaen, Spain; [Lopez-Hidalgo, Javier] Virgen Nieves Univ Hosp, Pathol Dept, Granada, Spain; [Gil-Anguita, Concepcion] Marina Baixa Hosp, Internal Med Dept, Alicante, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves	Hidalgo-Tenorio, C (corresponding author), Virgen Nieves Univ Hosp, Infect Dis Dept, Granada, Spain.	chidalgo72@gmail.com		Hidalgo Tenorio, Carmen/0000-0002-6394-5728; Lopez-Hidalgo, Javier Luis/0000-0001-9106-2028				[Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Arens Y, 2019, DIS COLON RECTUM, V62, P934, DOI 10.1097/DCR.0000000000001384; Blaser N, 2017, AIDS, V31, P1859, DOI 10.1097/QAD.0000000000001546; Burgos J, 2016, HIV MED, V17, P524, DOI 10.1111/hiv.12352; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Dindo D, 2011, COLORECTAL DIS, V13, P796, DOI 10.1111/j.1463-1318.2010.02258.x; Direccion general de Salud Publica Calidad e Innovacion, 2019, SIST INF NUEV DIAGN; Fox PA, 2010, AIDS, V24, P2331, DOI 10.1097/QAD.0b013e32833d466c; Freeman D, 1987, APPL CATEGORICAL DAT; Goldstone RN, 2011, DIS COLON RECTUM, V54, P1284, DOI 10.1097/DCR.0b013e318227833e; Hidalgo-Tenorio C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224183; Hildebrand JA, 2020, J EUR ACAD DERMATOL, V34, P377, DOI 10.1111/jdv.15932; Jin FY, 2019, AIDS, V33, P1361, DOI [10.1097/QAD.0000000000002218, 10.1097/qad.0000000000002218]; Libois A, 2017, SEX TRANSM INFECT, V93, P15, DOI 10.1136/sextrans-2015-052444; Machalek DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-946; Piroth L, 2019, J INFECT DIS, V22; Salas-Marquez C, 2018, J EUR ACAD DERMATOL, V32, pE334, DOI 10.1111/jdv.14895; Siddharthan RV, 2019, ANN GASTROENTEROL, V32, P257, DOI 10.20524/aog.2019.0364; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; van der Snoek EM, 2015, SEX TRANSM INFECT, V91, P245, DOI 10.1136/sextrans-2014-051810; van Heukelom MLS, 2017, AIDS, V31, P2295, DOI [10.1097/QAD.0000000000001639, 10.1097/qad.0000000000001639]; Wexler A, 2008, DIS COLON RECTUM, V51, P73, DOI 10.1007/s10350-007-9154-7; Willeford WG, 2016, SEX TRANSM DIS, V43, P479, DOI 10.1097/OLQ.0000000000000475; Yuan TW, 2019, LANCET GLOB HEALTH, V7, pE436, DOI 10.1016/S2214-109X(18)30567-9; Zucchetto A, 2016, JAIDS-J ACQ IMM DEF, V73, P190, DOI 10.1097/QAI.0000000000001033	28	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245870	10.1371/journal.pone.0245870	http://dx.doi.org/10.1371/journal.pone.0245870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534790	gold, Green Published			2022-12-26	WOS:000616739700063
J	Mizuno, M; Aoyama, H; Fujiwara, Y				Mizuno, Makoto; Aoyama, Hideaki; Fujiwara, Yoshi			Untangling the complexity of market competition in consumer goods-A complex Hilbert PCA analysis	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; DYNAMICS	Today's consumer goods markets are rapidly evolving with significant growth in the number of information media as well as the number of competitive products. In this environment, obtaining a quantitative grasp of heterogeneous interactions of firms and customers, which have attracted interest of management scientists and economists, requires the analysis of extremely high-dimensional data. Existing approaches in quantitative research could not handle such data without any reliable prior knowledge nor strong assumptions. Alternatively, we propose a novel method called complex Hilbert principal component analysis (CHPCA) and construct a synchronization network using Hodge decomposition. CHPCA enables us to extract significant comovements with a time lead/delay in the data, and Hodge decomposition is useful for identifying the time-structure of correlations. We apply this method to the Japanese beer market data and reveal comovement of variables related to the consumer choice process across multiple products. Furthermore, we find remarkable customer heterogeneity by calculating the coordinates of each customer in the space derived from the results of CHPCA. Lastly, we discuss the policy and managerial implications, limitations, and further development of the proposed method.	[Mizuno, Makoto] Meiji Univ, Sch Commerce, Tokyo, Japan; [Aoyama, Hideaki] Res Inst Econ Trade & Ind, Tokyo, Japan; [Aoyama, Hideaki] RIKEN iTHEMS, Wako, Saitama, Japan; [Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan	Meiji University; University of Hyogo	Mizuno, M (corresponding author), Meiji Univ, Sch Commerce, Tokyo, Japan.	makmizuno@gmail.com			JSPS [17H02041, 20H02391]; MEXT as Exploratory Challenges on Post-K Computer (Studies of Multilevel Spatiotemporal Simulation of Socioeconomic Phenomena)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT as Exploratory Challenges on Post-K Computer (Studies of Multilevel Spatiotemporal Simulation of Socioeconomic Phenomena)	YF was awarded by Grant-in-Aid for Scientific Research (KAKENHI) of JSPS Grant Numbers 17H02041, 20H02391. YF and HA were awarded by MEXT as Exploratory Challenges on Post-K Computer (Studies of Multilevel Spatiotemporal Simulation of Socioeconomic Phenomena: Macroeconomic Simulations), https://www.jsps.go.jp/english/e-grants/index.html.	Anderl E, 2016, INT J RES MARK, V33, P457, DOI 10.1016/j.ijresmar.2016.03.001; [Anonymous], 1964, SPECTRAL ANAL EC TIM; Aoyama H., 2010, ECONOPHYSICS COMPANI; Aoyama H., 2017, MACROECONOPHYSICS NE; Arai Y, 2013, FRONT ARTIF INTEL AP, V255, P111, DOI 10.3233/978-1-61499-264-6-111; Ataman MB, 2010, J MARKETING RES, V47, P866, DOI 10.1509/jmkr.47.5.866; BARNETT TP, 1983, MON WEATHER REV, V111, P756, DOI 10.1175/1520-0493(1983)111<0756:IOTMAP>2.0.CO;2; Bendat JS, 2011, RANDOM DATA ANAL MEA, V729; De Haan E, 2015, ROLE MOBILE DEVICES; Edelman DC, 2015, HARVARD BUS REV, V93, P90; Feldman M, 2011, MECH SYST SIGNAL PR, V25, P735, DOI 10.1016/j.ymssp.2010.07.018; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Guadagni PM, 2008, MARKET SCI, V27, P29, DOI 10.1287/mksc.1070.0331; Hannachi A, 2007, INT J CLIMATOL, V27, P1119, DOI 10.1002/joc.1499; Hartmann W, 2011, MARKET SCI, V30, P1079, DOI 10.1287/mksc.1110.0670; Hilbert D., 1912, GRUNDZG ALLGEMEINEN; HOREL JD, 1984, J CLIM APPL METEOROL, V23, P1660, DOI 10.1175/1520-0450(1984)023<1660:CPCATA>2.0.CO;2; Ikeda Y, 201313E086 RIETI; Ikeda Y, 2013, EVOL INST ECON REV, V10, P315, DOI 10.14441/eier.A2013016; Iyetomi H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65002-3; Iyetomi H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016103; Kichikawa Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228026; Kolsarici C, 2015, MANAGE SCI, V61, P2495, DOI 10.1287/mnsc.2014.2027; Kwon M, 2018, COUNTER CYCLICAL PRI; Lemon KN, 2016, J MARKETING, V80, P69, DOI 10.1509/jm.15.0420; Li HL, 2016, NEUROCOMPUTING, V171, P744, DOI 10.1016/j.neucom.2015.07.010; Mizuno M, 2006, ASSESSING SHORT TERM; NERLOVE M, 1962, ECONOMICA, V29, P129, DOI 10.2307/2551549; Pauwels K, 2007, J RETAILING, V83, P297, DOI 10.1016/j.jretai.2006.03.001; RASMUSSON EM, 1981, MON WEATHER REV, V109, P587, DOI 10.1175/1520-0493(1981)109<0587:BVISTO>2.0.CO;2; Sriram S, 2007, J MARKETING, V71, P61, DOI 10.1509/jmkg.71.2.61; Steenkamp JBEM, 2005, MARKET SCI, V24, P35, DOI 10.1287/mksc.1040.0069; Stein K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128501; Vodenska I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150994	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245531	10.1371/journal.pone.0245531	http://dx.doi.org/10.1371/journal.pone.0245531			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534817	gold, Green Published, Green Submitted			2022-12-26	WOS:000616739700027
J	Gbeasor-Komlanvi, FA; Zida-Compaore, WIC; Sadio, A; Tchankoni, MK; Kadangha, BM; Salou, M; Dagnra, AC; Ekouevi, DK				Gbeasor-Komlanvi, Fifonsi Adjidossi; Zida-Compaore, Wendpouire Ida Carine; Junior Sadio, Arnold, Jr.; Tchankoni, Martin Kouame; Kadangha, Balakiyem Magnim; Salou, Mounerou; Dagnra, Anoumou Claver; Ekouevi, Didier Koumavi			HIV testing uptake and prevalence among hospitalized older adults in Togo: A cross-sectional study	PLOS ONE			English	Article							HEALTH; INFECTION; COMMUNITY; TANZANIA; BEHAVIOR; RISK; CARE; AGE	Objectives This study aimed to describe HIV testing uptake, as well as HIV prevalence and its associated factors among older adults aged >= 50 years in health facilities in Togo. Methods A cross-sectional study was carried out from February 2018 to June 2019 among hospitalized older adults aged >= 50 years in tertiary and secondary hospitals in Togo. HIV testing was performed according to the national algorithm. Socio-demographic data and HIV testing history were collected using a standardized questionnaire. Results A total of 619 patients (43.9% female) of median age 61 years, (IQR: 55-70) were recruited and offered HIV testing. Among them, 25.7% had never previously tested for HIV. In total, 91.6% (567/619) accepted HIV testing while 8.4% (52/619) refused to be tested. Of those who tested, forty patients were HIV positive, yielding a prevalence of 7.1%. Twenty-three patients (57.5%) were newly diagnosed with HIV infection. In multivariable analysis, two factors were associated with HIV infection: living alone (aOR = 5.83; 95%CI = [2.26-14.53]) and being <60 years (aOR = 3.12; 95%CI = [1.51-6.66]). Conclusion The majority of older adults in this study accepted testing for HIV and almost three in five HIV positive older adults were newly diagnosed with HIV as a result of this testing. There is an urgent need to integrate older adults into responses to the HIV epidemic and to strengthen targeted prevention care and treatment in this population.	[Gbeasor-Komlanvi, Fifonsi Adjidossi; Junior Sadio, Arnold, Jr.; Ekouevi, Didier Koumavi] Univ Lome, Fac Sci Sante, Dept Sante Publ, Lome, Togo; [Gbeasor-Komlanvi, Fifonsi Adjidossi; Zida-Compaore, Wendpouire Ida Carine; Junior Sadio, Arnold, Jr.; Tchankoni, Martin Kouame; Kadangha, Balakiyem Magnim; Ekouevi, Didier Koumavi] Ctr Africain Rech Epidemiol & Sante Publ, Lome, Togo; [Salou, Mounerou; Dagnra, Anoumou Claver] Univ Lome, Lab Biol Mol & Immunol, Lome, Togo; [Dagnra, Anoumou Claver] Programme Natl Lutte Sida & Infect Sexuellement T, Lome, Togo; [Ekouevi, Didier Koumavi] Univ Bordeaux, ISPED, INSERM U1219 Bordeaux Populat Hlth Res, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux	Gbeasor-Komlanvi, FA (corresponding author), Univ Lome, Fac Sci Sante, Dept Sante Publ, Lome, Togo.; Gbeasor-Komlanvi, FA (corresponding author), Ctr Africain Rech Epidemiol & Sante Publ, Lome, Togo.	fifonsi.gbeasor@gmail.com		TCHANKONI, Martin Kouame/0000-0001-9873-3293; ZIDA - COMPAORE, Wendpouire Ida Carine/0000-0001-5584-8111; GBEASOR-KOMLANVI, Fifonsi Adjidossi/0000-0002-1744-0454; Sadio, Arnold Junior/0000-0001-5893-0663				Adekeye OA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043618; Akanji BO, 2002, J AM GERIATR SOC, V50, P1289, DOI 10.1046/j.1532-5415.2002.50319.x; Ama N. O., 2015, Journal of AIDS and Clinical Research, V6, P511; [Anonymous], 2017, COLORECTAL DIS; Balestre E, 2012, AIDS, V26, P951, DOI 10.1097/QAD.0b013e3283528ad4; Brooks JT, 2012, AM J PUBLIC HEALTH, V102, P1516, DOI 10.2105/AJPH.2012.300844; Center for Disease Control and Prevention, 2020, HIV OLD AM; Center for Disease Control and Prevention, 2018, HIV PEOPL AG 50; Center for Disease Control and Prevention, 2020, HIV TEST; Ekouevi DK, 2020, INT J INFECT DIS, V95, P162, DOI 10.1016/j.ijid.2020.02.016; Ford CL, 2015, SEX TRANSM DIS, V42, P405, DOI 10.1097/OLQ.0000000000000305; Gbeasor-Komlanvi FA, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01907-y; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Harris TG, 2018, AIDS, V32, P1563, DOI 10.1097/QAD.0000000000001870; Hazra A, 2017, J THORAC DIS, V9, P4125, DOI 10.21037/jtd.2017.09.14; Hu X, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0221-7; Joint United Nations Programme on HIV/AIDS, 2020, TOGO; Joint United Nations Programme on HIV/AIDS, 2020, AIDS INF; Joint United Nations Programme on HIV/AIDS, 2014, GAP REP PEOPL AG 50; Joint United Nations Programme on HIV/AIDS, 2013, HIV AG; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Kiplagat J, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0941-x; Mabaso M, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1055-6; Matlho K, 2019, AJAR-AFR J AIDS RES, V18, P18, DOI 10.2989/16085906.2018.1552162; Metallidis S, 2013, INT J INFECT DIS, V17, pE883, DOI 10.1016/j.ijid.2013.02.023; Mtei L N, 2001, East Afr Med J, V78, P144; Mtenga SM, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.28941; Mtowa A, 2017, AIDS CARE, V29, P1162, DOI 10.1080/09540121.2017.1308462; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Nabukenya AM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6027-z; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Negin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162967; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Rosenberg MS, 2017, JAIDS-J ACQ IMM DEF, V74, pE9, DOI 10.1097/QAI.0000000000001173; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Shisana O, 2016, AIDS CARE, V28, P234, DOI 10.1080/09540121.2015.1080790; Tavoschi L, 2017, LANCET HIV, V4, pE514, DOI 10.1016/S2352-3018(17)30155-8; The Joint United Nations Programme on HIV/AIDS, 2016, GLOB AIDS UPD; Vollmer S, 2017, AIDS BEHAV, V21, pS101, DOI 10.1007/s10461-016-1591-7; Wandera SO, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8193-z; WHO, 2011, US ASS REC INF EST H; Youssef E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6118-x	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246151	10.1371/journal.pone.0246151	http://dx.doi.org/10.1371/journal.pone.0246151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529263	Green Published, gold			2022-12-26	WOS:000616736200050
J	Lin, CC; Blessing, AM; Pulliam, TL; Shi, Y; Wilkenfeld, SR; Han, JJ; Murray, MM; Pham, AH; Duong, K; Brun, SN; Shaw, RJ; Ittmann, MM; Frigo, DE				Lin, Chenchu; Blessing, Alicia M.; Pulliam, Thomas L.; Shi, Yan; Wilkenfeld, Sandi R.; Han, Jenny J.; Murray, Mollianne M.; Pham, Alexander H.; Duong, Kevin; Brun, Sonja N.; Shaw, Reuben J.; Ittmann, Michael M.; Frigo, Daniel E.			Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling	ONCOGENE			English	Article							PROTEIN-KINASE KINASE; ANDROGEN RECEPTOR; CELL-GROWTH; TARGETING AUTOPHAGY; SURVIVAL MECHANISM; ULK1; AMPK; PHOSPHORYLATION; DEPRIVATION; AXIS	Previous work has suggested androgen receptor (AR) signaling mediates prostate cancer progression in part through the modulation of autophagy. However, clinical trials testing autophagy inhibition using chloroquine derivatives in men with castration-resistant prostate cancer (CRPC) have yet to yield promising results, potentially due to the side effects of this class of compounds. We hypothesized that identification of the upstream activators of autophagy in prostate cancer could highlight alternative, context-dependent targets for blocking this important cellular process during disease progression. Here, we used molecular, genetic, and pharmacological approaches to elucidate an AR-mediated autophagy cascade involving Ca2+/calmodulin-dependent protein kinase kinase 2 (CAMKK2; a kinase with a restricted expression profile), 5'-AMP-activated protein kinase (AMPK), and Unc-51 like autophagy activating kinase 1 (ULK1), but independent of canonical mechanistic target of rapamycin (mTOR) activity. Increased CAMKK2-AMPK-ULK1 signaling correlated with disease progression in genetic mouse models and patient tumor samples. Importantly, CAMKK2 disruption impaired tumor growth and prolonged survival in multiple CRPC preclinical mouse models. Similarly, an inhibitor of AMPK-ULK1 blocked autophagy, cell growth, and colony formation in prostate cancer cells. Collectively, our findings converge to demonstrate that AR can co-opt the CAMKK2-AMPK-ULK1 signaling cascade to promote prostate cancer by increasing autophagy. Thus, this pathway may represent an alternative autophagic target in CRPC.	[Lin, Chenchu; Pulliam, Thomas L.; Wilkenfeld, Sandi R.; Han, Jenny J.; Murray, Mollianne M.; Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Lin, Chenchu; Wilkenfeld, Sandi R.; Duong, Kevin] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Blessing, Alicia M.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Blessing, Alicia M.; Pulliam, Thomas L.; Shi, Yan; Pham, Alexander H.; Frigo, Daniel E.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA; [Blessing, Alicia M.; Pulliam, Thomas L.; Frigo, Daniel E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Brun, Sonja N.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ittmann, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX USA; [Ittmann, Michael M.] Dan L Duncan Canc Ctr, Houston, TX USA; [Ittmann, Michael M.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Frigo, Daniel E.] Houston Methodist Res Inst, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; University of Houston System; University of Houston; Salk Institute; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	Frigo, DE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.; Frigo, DE (corresponding author), Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.; Frigo, DE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.; Frigo, DE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.; Frigo, DE (corresponding author), Houston Methodist Res Inst, Houston, TX 77030 USA.	frigo@mdanderson.org		Shi, Yan/0000-0003-4580-7556; Wilkenfeld, Sandi/0000-0002-4973-8941	National Institutes of Health [NIH R01CA184208]; American Cancer Society [RSG-16-084-01-TBE]; Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship; Robert Hazelwood Graduate Fellowship for Cancer Research; CFP foundation; CCSG; NIH [P30CA016672]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship; Robert Hazelwood Graduate Fellowship for Cancer Research; CFP foundation; CCSG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Mondira Kundu, Christopher Counter and Nancy Weigel for plasmids and reagents, Kenneth Dunner, Jr. in the High Resolution Electron Microscopy Core Facility at MDACC for help with TEM, and Dr. Jeff Spencer for help with sgRNA design. This work was supported by grants from the National Institutes of Health (NIH R01CA184208 to DEF), American Cancer Society (RSG-16-084-01-TBE to DEF), an Institutional Research Grant (to DEF) and generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program (to DEF). This work was also supported by an Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship, Robert Hazelwood Graduate Fellowship for Cancer Research (to CL) and MD Anderson Odyssey fellow supported by the CFP foundation (to AMB). Electron microscopy was performed by the CCSG-funded MDACC High Resolution Electron Microscopy Facility while histology was performed with the CCSG-funded MDACC Research Histology Core Laboratory, NIH grant P30CA016672.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amaravadi RK, 2019, CANCER DISCOV, V9, P1167, DOI 10.1158/2159-8290.CD-19-0292; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Asquith CRM, 2018, MOLECULES, V23, DOI 10.3390/molecules23051221; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett HL, 2013, BJU INT, V111, P672, DOI 10.1111/j.1464-410X.2012.11409.x; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blessing AM, 2017, AUTOPHAGY, V13, P506, DOI 10.1080/15548627.2016.1268300; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaturvedi AP, 2019, ADV EXP MED BIOL, V1210, P333, DOI 10.1007/978-3-030-32656-2_15; Chhipa RR, 2011, CELL SIGNAL, V23, P1466, DOI 10.1016/j.cellsig.2011.04.008; Comincini Sergio, 2018, J CANC METASTASIS TR, V4; Dadwal UC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00335; Daskalaki I, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00104; Dite TA, 2018, J BIOL CHEM, V293, P8874, DOI 10.1074/jbc.RA118.003547; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hardie DG, 2011, EMBO J, V30, P634, DOI 10.1038/emboj.2011.12; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Kaini RR, 2012, BIOCHEM BIOPH RES CO, V425, P150, DOI 10.1016/j.bbrc.2012.07.054; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Khan AS, 2017, NAT REV UROL, V14, P164, DOI 10.1038/nrurol.2016.272; Kim J, 2011, CELL CYCLE, V10, P1337, DOI 10.4161/cc.10.9.15291; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kranzbuhler B, 2019, PROSTATE, V79, P206, DOI 10.1002/pros.23725; Kukimoto-Niino M, 2011, J BIOL CHEM, V286, P22570, DOI 10.1074/jbc.M111.251710; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Levy JMM, 2014, CANCER DISCOV, V4, P773, DOI 10.1158/2159-8290.CD-14-0049; Liu B, 2015, UROLOGY, V85, P1424, DOI 10.1016/j.urology.2015.03.006; Loffler AS, 2011, AUTOPHAGY, V7, P696, DOI 10.4161/auto.7.7.15451; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; Martin KR, 2018, ISCIENCE, V8, P74, DOI 10.1016/j.isci.2018.09.012; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mathew R, 2011, COLD SH Q B, V76, P389, DOI 10.1101/sqb.2012.76.011015; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mortezavi A, 2019, WORLD J UROL, V37, P351, DOI 10.1007/s00345-018-2385-5; Munkley J, 2014, ONCOTARGET, V5, P131, DOI 10.18632/oncotarget.1405; Nguyen HG, 2014, ONCOGENE, V33, P4521, DOI 10.1038/onc.2014.25; Niture Suryakant, 2018, Oncotarget, V9, P26884, DOI 10.18632/oncotarget.25529; O'Byrne SN, 2020, MOLECULES, V25, DOI 10.3390/molecules25020325; Penfold L, 2018, CANCER RES, V78, P6747, DOI 10.1158/0008-5472.CAN-18-0585; Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]; Price DJ, 2018, BIOORG MED CHEM LETT, V28, P1958, DOI 10.1016/j.bmcl.2018.03.034; Profeta GS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52795-1; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Santanam U, 2016, GENE DEV, V30, P399, DOI 10.1101/gad.274134.115; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Shat JJ, 2020, J CELL PHYSIOL, V235, P2129, DOI 10.1002/jcp.29117; Shi Y, 2013, MOL ENDOCRINOL, V27, P280, DOI 10.1210/me.2012-1260; Solitro AR, 2016, FUTURE MED CHEM, V8, P73, DOI 10.4155/fmc.15.166; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Tan Q, 2016, NEOPLASIA, V18, P347, DOI 10.1016/j.neo.2016.04.003; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tennakoon JB, 2014, ONCOGENE, V33, P5251, DOI 10.1038/onc.2013.463; Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020; Verbaanderd C, 2017, ECANCERMEDICALSCIENC, V11, DOI 10.3332/ecancer.2017.781; Wang L, 2016, EBIOMEDICINE, V7, P50, DOI 10.1016/j.ebiom.2016.03.022; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; White MA, 2018, ENDOCR-RELAT CANCER, V25, P453, DOI 10.1530/ERC-17-0051; Yang Y, 2020, CELL DEATH DIFFER, V27, P858, DOI 10.1038/s41418-019-0480-9; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhang HY, 2017, J CLIN PATHOL, V70, P383, DOI 10.1136/jclinpath-2016-203926; Zhang Yun, 2019, Sichuan Da Xue Xue Bao Yi Xue Ban, V50, P323; Zhao F, 2016, ONCOTARGET, V7, P5366, DOI 10.18632/oncotarget.6783	81	13	13	5	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1690	1705		10.1038/s41388-021-01658-z	http://dx.doi.org/10.1038/s41388-021-01658-z		FEB 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33531625	Green Accepted, Green Submitted			2022-12-26	WOS:000613991700003
J	Zhang, XY; Weng, MJ; Chen, ZQ				Zhang, Xiaoyue; Weng, Mengjia; Chen, Zhenqi			Fibroblast Growth Factor 9 (FGF9) negatively regulates the early stage of chondrogenic differentiation	PLOS ONE			English	Article							CHONDROCYTE DIFFERENTIATION; SKELETAL DEVELOPMENT; PLATE CHONDROCYTES; CELL-LINE; EXPRESSION; PROLIFERATION; PATHWAY; PROTEIN; ROLES	Fibroblast growth factor signaling is essential for mammalian bone morphogenesis and growth, involving membranous ossification and endochondral ossification. FGF9 has been shown to be an important regulator of endochondral ossification; however, its role in the early differentiation of chondrocytes remains unknown. Therefore, in this study, we aimed to determine the role of FGF9 in the early differentiation of chondrogenesis. We found an increase in FGF9 expression during proliferating chondrocyte hypertrophy in the mouse growth plate. Silencing of FGF9 promotes the growth of ATDC5 cells and promotes insulin-induced differentiation of ATDC5 chondrocytes, which is due to increased cartilage matrix formation and type II collagen (col2a1) and X (col10a1), Acan, Ihh, Mmp13 gene expression. Then, we evaluated the effects of AKT, GSK-3 beta, and mTOR. Inhibition of FGF9 significantly inhibits phosphorylation of AKT and GSK-3 beta, but does not affected the activation of mTOR. Furthermore, phosphorylation of inhibited AKT and GSK-3 beta was compensated using the AKT activator SC79, and differentiation of ATDC5 cells was inhibited. In conclusion, our results indicate that FGF9 acts as an important regulator of early chondrogenesis partly through the AKT/GSK-3 beta pathway.	[Zhang, Xiaoyue] Tongji Univ, Dept Orthodont, Affiliated Stomatol Hosp, Shanghai, Peoples R China; [Zhang, Xiaoyue; Weng, Mengjia; Chen, Zhenqi] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Weng, Mengjia; Chen, Zhenqi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthodont, Sch Med, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University	Chen, ZQ (corresponding author), Shanghai Key Lab Stomatol, Shanghai, Peoples R China.; Chen, ZQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthodont, Sch Med, Shanghai, Peoples R China.	orthochen@yeah.net			National Natural Science Foundation of China [81470765, 81271182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China [grant number grant number 81470765, 81271182]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman JR, 2017, MOL CELL PROTEOMICS, V16, P1126, DOI 10.1074/mcp.M116.064980; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Choi YA, 2009, CELL BIOL INT, V33, P887, DOI 10.1016/j.cellbi.2009.04.020; Colvin JS, 1999, DEV DYNAM, V216, P72; Correa D, 2015, OSTEOARTHR CARTILAGE, V23, P443, DOI 10.1016/j.joca.2014.11.013; Dai JW, 2012, BIOMATERIALS, V33, P7699, DOI 10.1016/j.biomaterials.2012.07.020; Degnin CR, 2010, J CELL BIOCHEM, V110, P1046, DOI 10.1002/jcb.22629; Diaz-Romero J, 2017, J CELL PHYSIOL, V232, P1979, DOI 10.1002/jcp.25720; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Hata Kenji, 2017, J Bone Metab, V24, P75, DOI 10.11005/jbm.2017.24.2.75; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Hung IH, 2016, DEV BIOL, V411, P72, DOI 10.1016/j.ydbio.2016.01.008; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Jiang M, 2017, J CELL BIOCHEM, V118, P748, DOI 10.1002/jcb.25728; Justet A, 2017, AM J PHYSIOL-LUNG C, V313, pL781, DOI 10.1152/ajplung.00508.2016; Kapadia RA, 2005, DEV BIOL, V285, P496, DOI 10.1016/j.ydbio.2005.07.029; Karuppaiah K, 2016, DEVELOPMENT, V143, P1811, DOI 10.1242/dev.131722; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Li Z, 2020, BIOCHEM BIOPH RES CO, V523, P506, DOI 10.1016/j.bbrc.2019.12.065; Litherland GJ, 2014, ARTHRITIS RHEUMATOL, V66, P2175, DOI 10.1002/art.38681; Liu CF, 2017, SEMIN CELL DEV BIOL, V62, P34, DOI 10.1016/j.semcdb.2016.10.004; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Martino MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11051; Nishimura R, 2018, HISTOCHEM CELL BIOL, V149, P353, DOI 10.1007/s00418-017-1628-7; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Perl A, 2016, NAT REV RHEUMATOL, V12, P169, DOI 10.1038/nrrheum.2015.172; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Pilquil C, 2020, J BIOL CHEM, V295, P6861, DOI 10.1074/jbc.RA119.011029; Razmara E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184475; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Samsa WE, 2017, SEMIN CELL DEV BIOL, V62, P3, DOI 10.1016/j.semcdb.2016.07.008; SantosOcampo S, 1996, J BIOL CHEM, V271, P1726, DOI 10.1074/jbc.271.3.1726; Shang J, 2014, CURR STEM CELL RES T, V9, P141, DOI 10.2174/1574888X09666131230142459; Stanton LA, 2010, J CELL MOL MED, V14, P242, DOI 10.1111/j.1582-4934.2008.00396.x; Sun MMG, 2014, BIRTH DEFECTS RES C, V102, P74, DOI 10.1002/bdrc.21062; Tang LY, 2017, HUM MOL GENET, V26, P1280, DOI 10.1093/hmg/ddx029; Toribio RE, 2010, FASEB J, V24, P1947, DOI 10.1096/fj.09-147033; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Weksler NB, 1999, BIOCHEM J, V342, P677, DOI 10.1042/0264-6021:3420677; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Zhan XT, 2019, CELL BIOCHEM FUNCT, V37, P359, DOI 10.1002/cbf.3404; Zhang DD, 2016, ACS CHEM NEUROSCI, V7, P710, DOI 10.1021/acschemneuro.5b00306; Zheng KL, 2017, ONCOTARGET, V8, P14978, DOI 10.18632/oncotarget.14785; Zhou S, 2016, OSTEOARTHR CARTILAGE, V24, P2181, DOI 10.1016/j.joca.2016.07.005	47	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0241281	10.1371/journal.pone.0241281	http://dx.doi.org/10.1371/journal.pone.0241281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529250	Green Published, gold			2022-12-26	WOS:000616736200004
J	Rodriguez, AG; Schroeder, ME; Grim, JC; Walker, CJ; Speckl, KF; Weiss, RM; Anseth, KS				Rodriguez, Andrea Gonzalez; Schroeder, Megan E.; Grim, Joseph C.; Walker, Cierra J.; Speckl, Kelly F.; Weiss, Robert M.; Anseth, Kristi S.			Tumor necrosis factor-alpha promotes and exacerbates calcification in heart valve myofibroblast populations	FASEB JOURNAL			English	Article						3D hydrogel; aortic valve disease; calcification; fibrosis; TNF&#8208; a; VIC	GROWTH-FACTOR-BETA; VALVULAR INTERSTITIAL-CELLS; TNF-ALPHA; IN-VITRO; HEMORRHAGIC-FEVER; DISEASE; STENOSIS; SELUMETINIB; ACTIVATION; FAILURE	Pro-inflammatory cytokines play critical roles in regulating valvular interstitial cell (VIC) phenotypic changes that can cause heart valve fibrosis and calcification. Tumor necrosis factor alpha (TNF-alpha) is a cytokine known to influence VIC behavior and has been reported at high levels in calcified valves ex vivo. We sought to understand the specific effects of TNF-alpha on VIC phenotypes (eg, fibroblast, profibrotic activated myofibroblasts) and its link with heart valve disorders. We characterize human aortic valve tissue from patients with valve disorders and identify a high variability of fibrotic and calcific markers between tissues. These results motivated in vitro studies to explore the effects of TNF-alpha on defined VIC fibroblasts and profibrotic activated myofibroblasts, induced via FGF-2 and TGF-beta 1 treatment. Using 3D hydrogels to culture VICs, we measure the effect of TNF-alpha (0.1-10 ng/mL) on key markers of fibrosis (eg, alpha SMA, COL1A1) and calcification (eg, RUNX2, BMP2, and calcium deposits). We observe calcification in TNF-alpha-treated VIC activated myofibroblasts and identify the MAPK/ERK signaling cascade as a potential pathway for TNF-alpha mediated calcification. Conversely, VIC fibroblasts respond to TNF-alpha with decreased calcification. Treatment of VIC profibrotic activated myofibroblast populations with TNF-alpha leads to increased calcification. Our in vitro findings correlate with findings in diseased human valves and highlight the importance of understanding the effect of cytokines and signaling pathways on specific VIC phenotypes. Finally, we reveal MAPK/ERK as a potential pathway involved in VIC-mediated matrix calcification with TNF-alpha treatment, suggesting this pathway as a potential pharmaceutical target for aortic valve disease.	[Rodriguez, Andrea Gonzalez; Grim, Joseph C.; Speckl, Kelly F.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Rodriguez, Andrea Gonzalez; Schroeder, Megan E.; Grim, Joseph C.; Walker, Cierra J.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Schroeder, Megan E.; Walker, Cierra J.; Anseth, Kristi S.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Weiss, Robert M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Iowa	Anseth, KS (corresponding author), JSC Biotechnol Bldg,Campus Box 596, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019; rodriguez, andrea/GRO-4054-2022		NIH [RO1HL132353, RO1HL142935, T32 HL007822]; American Heart Association [18IPA34170040]; Biological Sciences Initiative Fellowship;  [F31HL142223]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Biological Sciences Initiative Fellowship; 	The authors would like to thank the NIH for funding research through grants RO1HL132353 and RO1HL142935. JCG acknowledges funding from the NIH (T32 HL007822). CJW acknowledges funding from F31HL142223. KFS acknowledges funding from the Biological Sciences Initiative Fellowship. RMW acknowledges fund from American Heart Association Grant #18IPA34170040.	Aguado BA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav3233; Antoni C, 2002, CLIN EXP RHEUMATOL, V20, pS152; Benton JA, 2009, ARTERIOSCL THROM VAS, V29, P1950, DOI 10.1161/ATVBAHA.109.195271; Blaser MC., 2015, CARDIAC FIBROSIS HEA, DOI [10.1007/978-3-319-17437-2_3, DOI 10.1007/978-3-319-17437-2_3]; Bowler MA, 2015, CARDIOVASC PATHOL, V24, P1, DOI 10.1016/j.carpath.2014.08.003; Bradham WS, 2002, AM J PHYSIOL-HEART C, V282, pH1288, DOI 10.1152/ajpheart.00526.2001; Calin MV, 2009, CELL TISSUE RES, V336, P237, DOI 10.1007/s00441-009-0765-2; Casaluce F, 2017, EXPERT OPIN INV DRUG, V26, P973, DOI 10.1080/13543784.2017.1351543; Chen Y, 2016, J THORAC DIS, V8, pE1701, DOI 10.21037/jtd.2016.12.23; Colucci S., SCI WORLD J; Cush JJ, 2004, CLIN EXP RHEUMATOL, V22, pS141; Cushing MC, 2005, MATRIX BIOL, V24, P428, DOI 10.1016/j.matbio.2005.06.007; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2228, DOI 10.1002/art.23645; Dolivo DM, 2017, CYTOKINE GROWTH F R, V38, P49, DOI 10.1016/j.cytogfr.2017.09.003; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Duan B, 2016, ACTA BIOMATER, V36, P42, DOI 10.1016/j.actbio.2016.03.007; DUTKA DP, 1993, BRIT HEART J, V70, P141; Fahey T J 3rd, 1990, Cytokine, V2, P92, DOI 10.1016/1043-4666(90)90002-B; Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Fujita M, 2003, AM J RESP CELL MOL, V29, P669, DOI 10.1165/rcmb.2002-0046OC; Galeone A, 2013, INT J CARDIOL, V169, P296, DOI 10.1016/j.ijcard.2013.09.012; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; Goody PR, 2020, ARTERIOSCL THROM VAS, V40, P885, DOI 10.1161/ATVBAHA.119.313067; He CM, 2017, AMINO ACIDS, V49, P1981, DOI 10.1007/s00726-017-2432-3; HERSHKOVIZ R, 1993, SCAND J IMMUNOL, V37, P111, DOI 10.1111/j.1365-3083.1993.tb01672.x; Hjortnaes J, 2016, J MOL CELL CARDIOL, V94, P13, DOI 10.1016/j.yjmcc.2016.03.004; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Do K, 2015, INVEST NEW DRUG, V33, P720, DOI 10.1007/s10637-015-0212-z; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Lehmkuhl L, 2013, INT J CARDIOVAS IMAG, V29, P693, DOI 10.1007/s10554-012-0123-4; Li C, 2011, AM J PATHOL, V179, P1746, DOI 10.1016/j.ajpath.2011.06.007; Li G, 2017, J THORAC CARDIOV SUR, V153, P1318, DOI 10.1016/j.jtcvs.2017.01.052; Lim J, 2016, AM J PATHOL, V186, P2378, DOI 10.1016/j.ajpath.2016.05.003; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Lindman BR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.6; Liu AC, 2008, AM J PATHOL, V173, P1275, DOI 10.2353/ajpath.2008.080365; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035; Masjedi S, 2017, HEART VESSELS, V32, P217, DOI 10.1007/s00380-016-0909-8; MAUVIEL A, 1988, FEBS LETT, V236, P47, DOI 10.1016/0014-5793(88)80283-7; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Minners J, 2008, EUR HEART J, V29, P1043, DOI 10.1093/eurheartj/ehm543; Mizutani H, 1997, J DERMATOL SCI, V14, P145, DOI 10.1016/S0923-1811(96)00562-2; Moreno PR, 2011, J THORAC CARDIOV SUR, V142, P895, DOI 10.1016/j.jtcvs.2011.03.002; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; Orgaz JL, 2020, CANCER CELL, V37, P85, DOI 10.1016/j.ccell.2019.12.003; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Parhami F, 2002, CIRC RES, V91, P570, DOI 10.1161/01.RES.0000036607.05037.DA; Quinlan AMT, 2012, J BIOMED MATER RES A, V100A, P2474, DOI 10.1002/jbm.a.34162; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rodriguez AG, 2018, APL BIOENG, V2, DOI 10.1063/1.5042430; Rutkovskiy A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006339; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sarzi-Puttini P, 2005, AUTOIMMUN REV, V4, P153, DOI 10.1016/j.autrev.2004.09.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Sinagra E, 2013, EUR J INTERN MED, V24, P385, DOI 10.1016/j.ejim.2012.12.015; Sorimachi K, 1997, BIOCHEM MOL BIOL INT, V43, P79; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Wang B, 2017, CLIN SCI, V131, P411, DOI 10.1042/CS20160571; Wang R, 2014, EXP THER MED, V7, P935, DOI 10.3892/etm.2014.1529; Weiss RM, 2013, CIRC RES, V113, P209, DOI 10.1161/CIRCRESAHA.113.300153; Wypasek E, 2013, INFLAMMATION, V36, P449, DOI 10.1007/s10753-012-9565-z; YADAV M, 1991, FEMS MICROBIOL IMMUN, V89, P45, DOI 10.1016/0378-1097(91)90062-F; Yamane K, 2003, J IMMUNOL, V171, P3855, DOI 10.4049/jimmunol.171.7.3855; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Yip CYY, 2011, CARDIOVASC PATHOL, V20, P177, DOI 10.1016/j.carpath.2010.12.001; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523; Zeng QC, 2013, ARTERIOSCL THROM VAS, V33, P1580, DOI 10.1161/ATVBAHA.112.300912; Zhan Qiong, 2015, Int J Biol Sci, V11, P482, DOI 10.7150/ijbs.10905	79	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21382	10.1096/fj.202002013RR	http://dx.doi.org/10.1096/fj.202002013RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33554387	Bronze, Green Accepted			2022-12-26	WOS:000629576700003
J	Hirata, K; Suzuki, M; Iso, N; Okabe, T; Goto, H; Cho, KL; Shimizu, J				Hirata, Keisuke; Suzuki, Makoto; Iso, Naoki; Okabe, Takuhiro; Goto, Hiroshi; Cho, Kilchoon; Shimizu, Junichi			Using machine learning to investigate the relationship between domains of functioning and functional mobility in older adults	PLOS ONE			English	Article							MUSCLE STRENGTH; RISK-FACTORS; FALLS; POWER; PROBABILITY; PERFORMANCE; SARCOPENIA; CONSENSUS; WOMEN; YOUNG	Previous studies have shown that functional mobility, along with other physical functions, decreases with advanced age. However, it is still unclear which domains of functioning (body structures, body functions, and activities) are most closely related to functional mobility. This study used machine learning classification to predict the rankings of Timed Up and Go tests based on the results of four assessments (soft lean mass, FEV1/FVC, knee extension torque, and one-leg standing time). We tested whether assessment results for each level could predict functional mobility assessments in older adults. Using support vector machines for machine learning classification, we verified that the four assessments of each level could classify functional mobility. Knee extension torque (from the body function domain) was the most closely related assessment. Naturally, the classification accuracy rate increased with a larger number of assessments as explanatory variables. However, knee extension torque remained the highest of all assessments. This extended to all combinations (of 2-3 assessments) that included knee extension torque. This suggests that resistance training may help protect individuals suffering from age-related declines in functional mobility.	[Hirata, Keisuke; Suzuki, Makoto; Iso, Naoki; Okabe, Takuhiro; Goto, Hiroshi; Cho, Kilchoon; Shimizu, Junichi] Tokyo Kasei Univ, Fac Hlth Sci, Saitama, Japan		Hirata, K (corresponding author), Tokyo Kasei Univ, Fac Hlth Sci, Saitama, Japan.	hirata-ke@tokyo-kasei.ac.jp		Hirata, Keisuke/0000-0002-6623-5203				[Anonymous], 2007, DIABETES CARE S1, V30, pS4; Arai Tomoyuki, 2011, Nihon Ronen Igakkai Zasshi, V48, P539; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Buccelletti F, 2013, EUR REV MED PHARMACO, V17, P22; Bunki H, 2013, J HLTH EVALUATION PR, V40, P451; Chan OYA, 2014, AGE, V36, DOI 10.1007/s11357-014-9714-4; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chiu AYY, 2003, DISABIL REHABIL, V25, P45, DOI 10.1080/713813432; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Ferraro FV, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14076; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Furuna T, 1998, J Jpn Phys Ther Assoc, V1, P1, DOI 10.1298/jjpta.1.1; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Igarashi K, 2019, J ORAL SCI, V61, P508, DOI 10.2334/josnusd.18-0381; Ishii Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072305; Kutner M., 2004, APPL LINEAR STAT MOD; Laudani L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074227; Lee DH, 2015, NUTRIENTS, V7, P10513, DOI 10.3390/nu7125548; Lee EJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017882; Li Y, 2019, AM J HEALTH-SYST PH, V76, P301, DOI 10.1093/ajhp/zxy051; Liu YQ, 2019, INTERDISCIP SCI, V11, P738, DOI 10.1007/s12539-019-00346-7; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Macaluso A, 2003, J APPL PHYSIOL, V95, P2544, DOI 10.1152/japplphysiol.00416.2003; Macaluso A, 2003, EUR J APPL PHYSIOL, V90, P458, DOI 10.1007/s00421-003-0866-7; Mitsutake S, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180170; Morlini I., 2006, STAT METHODS APPL, V15, P3, DOI [DOI 10.1007/S10260-006-0005-9, 10.1007/s10260-006-0005-9]; Muehlbauer T, 2018, GERONTOLOGY, V64, P11, DOI 10.1159/000480150; Mundfrom D., 2018, GLMJ, V44, P24; Obuchi Shuichi, 2010, Nihon Koshu Eisei Zasshi, V57, P988; Puthoff Michael L, 2008, J Geriatr Phys Ther, V31, P24; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Sabino PG, 2010, CLINICS, V65, P599, DOI 10.1590/S1807-59322010000600007; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Sletvold O, 1996, DAN MED BULL, V43, P350; Suzuki M, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019512; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Valentine RJ, 2009, BRAIN BEHAV IMMUN, V23, P643, DOI 10.1016/j.bbi.2008.12.003	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246397	10.1371/journal.pone.0246397	http://dx.doi.org/10.1371/journal.pone.0246397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571239	gold, Green Published			2022-12-26	WOS:000618274000095
J	Moller, CM; Ellmauer, PP; Zeman, F; Bitzinger, D; Florchinger, B; Graf, BM; Zausig, YA				Moeller, Christina M.; Ellmauer, Peter-Paul; Zeman, Florian; Bitzinger, Diane; Floerchinger, Bernhard; Graf, Bernhard M.; Zausig, York A.			Postoperative acute respiratory dysfunction and the influence of antibiotics after acute type A aortic dissection surgery: A retrospective analysis	PLOS ONE			English	Article								Objectives Surgery for acute type A aortic dissection is associated with several perioperative complications, such as acute respiratory dysfunction (ARD). The aim of this study was to investigate perioperative risk factors involved in the development of ARD and whether antibiotic treatment has an impact. Methods 243 patients underwent surgery for acute type A aortic dissection between 2008 and 2017. The patients were retrospectively divided into the ARD and NON-ARD group. ARD was defined as PaO2/FiO(2) <= 200 mmHg (PF ratio) within 48 hours after surgery. All patients received either narrow- or broad-spectrum antibiotics. Results After the exclusion of 42 patients, 201 patients were analyzed. The PF ratio of the ARD group was significantly lower than of the NON-ARD group within the first 7 days. ARD patients (n = 111) were significantly older (p = .031) and had a higher body mass index (BMI) (p = .017). ARD patients required longer postoperative ventilation (2493 vs. 4695 [min], p = .006) and spent more days in the intensive care unit (7.0 vs. 8.9 [days], p = .043) compared to NON-ARD. The mortality was significantly lower for ARD than for NON-ARD patients (p = .030). The incidence of pneumonia was independent of the antibiotic treatment regime (p = .391). Renal and neurological complication rate was higher in patients treated with broad-spectrum antibiotic. Conclusion ARD is the main complication (55%) that occurs approximately 24 hours after surgery for acute type A aortic dissection. The preoperative risk factors for ARD were higher age and increased BMI. Patients on broad-spectrum antibiotics did not show an improved postoperative outcome compared to patients with narrow-spectrum antibiotics.	[Moeller, Christina M.; Ellmauer, Peter-Paul; Bitzinger, Diane; Graf, Bernhard M.; Zausig, York A.] Univ Hosp Regensburg, Dept Anesthesiol, Regensburg, Bavaria, Germany; [Zeman, Florian] Univ Hosp Regensburg, Ctr Clin Studies, Regensburg, Bavaria, Germany; [Floerchinger, Bernhard] Univ Hosp Regensburg, Dept Cardiac Surg, Regensburg, Bavaria, Germany; [Zausig, York A.] Aschaffenburg Alzenau Hosp, Dept Anesthesiol & Operat Intens Care Med, Aschaffenburg, Bavaria, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Zausig, YA (corresponding author), Univ Hosp Regensburg, Dept Anesthesiol, Regensburg, Bavaria, Germany.; Zausig, YA (corresponding author), Aschaffenburg Alzenau Hosp, Dept Anesthesiol & Operat Intens Care Med, Aschaffenburg, Bavaria, Germany.	York.zausig@ukr.de	Bitzinger, Diane/AGX-6025-2022; Zeman, Florian/GNH-3239-2022					Ahmad NH, 2018, HONG KONG J EMERG ME, V25, P98, DOI 10.1177/1024907917745155; Bronicki RA, 2016, PEDIATR CRIT CARE ME, V17, pS272, DOI 10.1097/PCC.0000000000000759; Canet J, 2014, CURR OPIN CRIT CARE, V20, P56, DOI 10.1097/MCC.0000000000000045; Chen MF, 2016, J THORAC DIS, V8, P2862, DOI 10.21037/jtd.2016.10.10; Chen SW, 2016, J CRIT CARE, V31, P139, DOI 10.1016/j.jcrc.2015.11.002; Crawford TC, 2016, VASC MED, V21, P264, DOI 10.1177/1358863X15625371; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Girdauskas E, 2010, EUR J CARDIO-THORAC, V37, P691, DOI 10.1016/j.ejcts.2009.07.016; Gottschaldt U, 2018, ANASTH INTENSIVMED, V59, P249, DOI 10.19224/ai2018.249; Hall RG, 2019, INT J ANTIMICROB AG, V53, P343, DOI 10.1016/j.ijantimicag.2018.11.002; John S, 2015, MED KLIN-INTENSIVMED, V110, P452, DOI 10.1007/s00063-014-0404-x; Kurz SD, 2017, INT J CARDIOL, V241, P326, DOI 10.1016/j.ijcard.2017.05.024; Lee TC, 2018, J CARDIAC SURG, V33, P7, DOI 10.1111/jocs.13511; Luther MK, 2018, CRIT CARE MED, V46, P12, DOI 10.1097/CCM.0000000000002769; Melvinsdottir IH, 2016, EUR J CARDIO-THORAC, V50, P1111, DOI 10.1093/ejcts/ezw235; Mui LM, 2005, ANZ J SURG, V75, P425, DOI 10.1111/j.1445-2197.2005.03397.x; Ni YN, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1615-3; Niemer M., 1979, DATENBUCH INTENSIVME, P31; Olsson C, 2013, SCAND CARDIOVASC J, V47, P352, DOI 10.3109/14017431.2013.845307; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ribaric SF, 2017, RESUSCITATION, V111, P103, DOI 10.1016/j.resuscitation.2016.11.025; Rong LQ, 2016, J THORAC DIS, V8, pE1177, DOI 10.21037/jtd.2016.10.74; Schelker E, 2009, THESIS U REGENSBURG, P10; Shen YW, 2018, J THORAC CARDIOV SUR, V155, P2267, DOI 10.1016/j.jtcvs.2018.01.085; Trimarchi S, 2005, J THORAC CARDIOV SUR, V129, P112, DOI 10.1016/j.jtcvs.2004.09.005; Waterford SD, 2018, ANN THORAC SURG, V106, P1246, DOI 10.1016/j.athoracsur.2018.03.088; Yadav H, 2017, AM J RESP CRIT CARE, V195, P725, DOI 10.1164/rccm.201609-1767CI; Yang B, 2016, ANN CARDIOTHORAC SUR, V5, P265, DOI 10.21037/acs.2016.07.04; Zhao JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118682	30	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246724	10.1371/journal.pone.0246724	http://dx.doi.org/10.1371/journal.pone.0246724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571258	gold, Green Published			2022-12-26	WOS:000620071100007
J	Polanka, BM; Kundu, S; So, KKAARM; Freiberg, MS; Gupta, SK; Zapolski, TCB; Hirsh, AT; Bedimo, RJ; Budoff, MJ; Butt, AA; Chang, CC; Gottlieb, SS; Marconi, VC; Womack, JA; Stewart, JC				Polanka, Brittanny M.; Kundu, Suman; So-Armah, Kaku A.; Freiberg, Matthew S.; Gupta, Samir K.; Zapolski, Tamika C. B.; Hirsh, Adam T.; Bedimo, Roger J.; Budoff, Matthew J.; Butt, Adeel A.; Chang, Chung-Chou H.; Gottlieb, Stephen S.; Marconi, Vincent C.; Womack, Julie A.; Stewart, Jesse C.			Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ANTIRETROVIRAL THERAPY; SLEEP DISTURBANCES; ALTERED COAGULATION; PHYSICAL-ACTIVITY; SEVERITY INDEX; D-DIMER; RISK; METAANALYSIS; PEOPLE	Background Insomnia may be a risk factor for cardiovascular disease in HIV (HIV-CVD); however, mechanisms have yet to be elucidated. Methods We examined cross-sectional associations of insomnia symptoms with biological mechanisms of HIV-CVD (immune activation, systemic inflammation, and coagulation) among 1,542 people with HIV from the Veterans Aging Cohort Study (VACS) Biomarker Cohort. Past-month insomnia symptoms were assessed by the item, "Difficulty falling or staying asleep?," with the following response options: "I do not have this symptom" or "I have this symptom and horizontal ellipsis " "it doesn't bother me," "it bothers me a little," "it bothers me," "it bothers me a lot." Circulating levels of the monocyte activation marker soluble CD14 (sCD14), inflammatory marker interleukin-6 (IL-6), and coagulation marker D-dimer were determined from blood specimens. Demographic- and fully-adjusted (CVD risk factors, potential confounders, HIV-related factors) regression models were constructed, with log-transformed biomarker variables as the outcomes. We present the exponentiated regression coefficient (exp[b]) and its 95% confidence interval (CI). Results We observed no significant associations between insomnia symptoms and sCD14 or IL-6. For D-dimer, veterans in the "Bothers a Lot" group had, on average, 17% higher D-dimer than veterans in the "No Difficulty Falling or Staying Asleep" group in the demographic-adjusted model (exp[b] = 1.17, 95%CI = 1.01-1.37, p = .04). This association was nonsignificant in the fully-adjusted model (exp[b] = 1.09, 95%CI = 0.94-1.26, p = .27). Conclusion We observed little evidence of relationships between insomnia symptoms and markers of biological mechanisms of HIV-CVD. Other mechanisms may be responsible for the insomnia-CVD relationship in HIV; however, future studies with comprehensive assessments of insomnia symptoms are warranted.	[Polanka, Brittanny M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Kundu, Suman; Freiberg, Matthew S.] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Sch Med, Nashville, TN USA; [So-Armah, Kaku A.] Boston Univ, Sch Med, Dept Med, Div Gen Internal Med, Boston, MA 02118 USA; [Gupta, Samir K.] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Zapolski, Tamika C. B.; Hirsh, Adam T.; Stewart, Jesse C.] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46205 USA; [Bedimo, Roger J.] VA North Texas Healthcare Syst, Div Infect Dis, Dallas, TX USA; [Budoff, Matthew J.] Lundquist Inst, Torrance, CA USA; [Butt, Adeel A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Butt, Adeel A.] Weill Cornell Med Coll, Doha, Qatar; [Butt, Adeel A.] Weill Cornell Med Coll, New York, NY USA; [Butt, Adeel A.] Hamad Med Corp, Doha, Qatar; [Chang, Chung-Chou H.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Gottlieb, Stephen S.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Gottlieb, Stephen S.] Baltimore VAMC, Baltimore, MD USA; [Marconi, Vincent C.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Marconi, Vincent C.] Atlanta VA Med Ctr, Atlanta, GA USA; [Marconi, Vincent C.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Womack, Julie A.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Womack, Julie A.] Yale Univ, Sch Nursing, West Haven, CT USA	Johns Hopkins University; Vanderbilt University; Boston University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Hamad Medical Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Rollins School Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Polanka, BM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA.	bpolank1@jhmi.edu	Kundu, Suman/I-2603-2019; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022; Budoff, Matthew/ABD-5175-2021; Marconi, Vincent/N-3210-2014	Kundu, Suman/0000-0002-6305-2559; Marconi, Vincent/0000-0001-8409-4689; Budoff, Matthew/0000-0002-9616-1946; Marconi, Vincent/0000-0001-8409-4689; So-Armah, Kaku/0000-0003-1505-6384; Polanka, Brittanny/0000-0002-6422-6303	National Heart, Lung, and Blood Institute/National Institutes of Health [R01HL126557]; National Institute on Alcohol Abuse and Alcoholism and Veterans Health Administration Public Health Strategic Health Core Group [U10AA13566]	National Heart, Lung, and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism and Veterans Health Administration Public Health Strategic Health Core Group(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This analysis was funded by grant R01HL126557 from the National Heart, Lung, and Blood Institute/National Institutes of Health awarded to MF, SG, and JS. The Veterans Aging Cohort Study was funded by grant U10AA13566 from the National Institute on Alcohol Abuse and Alcoholism and Veterans Health Administration Public Health Strategic Health Core Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Besedovsky L, 2019, PHYSIOL REV, V99, P1325, DOI 10.1152/physrev.00010.2018; Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; Chaput JP, 2014, PHYSIOL BEHAV, V134, P86, DOI 10.1016/j.physbeh.2013.09.006; Chen YC, 2017, SLEEP MED, V36, P38, DOI 10.1016/j.sleep.2017.04.005; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; Crum-Cianflone NF, 2012, CLIN INFECT DIS, V54, P1485, DOI 10.1093/cid/cis192; Everitt H, 2014, BRIT J GEN PRACT, V64, pE112, DOI 10.3399/bjgp14X677176; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Gay CL, 2015, BRAIN BEHAV IMMUN, V47, P58, DOI 10.1016/j.bbi.2014.11.018; Gomez-Olive FX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35584-0; He Q, 2017, EUR J PREV CARDIOL, V24, P1071, DOI 10.1177/2047487317702043; Helfand M, 2009, US PREV SERV TASK FO; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Irwin MR, 2014, SLEEP, V37, P1543, DOI 10.5665/sleep.4008; Jackowska M, 2015, SLEEP MED, V16, P768, DOI 10.1016/j.sleep.2015.02.530; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Kenedi CA, 2011, AIDS BEHAV, V15, P1803, DOI 10.1007/s10461-011-9939-5; Kent ST, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0598-1; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee KA, 2014, SLEEP, V37, P453, DOI 10.5665/sleep.3474; Li M, 2014, INT J CARDIOL, V176, P1044, DOI 10.1016/j.ijcard.2014.07.284; Liao YH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6929-4; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Matthews KA, 2010, SLEEP, V33, P1649, DOI 10.1093/sleep/33.12.1649; Mausbach BT, 2006, SLEEP, V29, P1347, DOI 10.1093/sleep/29.10.1347; Meng L, 2013, HYPERTENS RES, V36, P985, DOI 10.1038/hr.2013.70; Merikangas KR, 2014, SLEEP MED, V15, P530, DOI 10.1016/j.sleep.2013.10.011; Moore SE, 2020, J ASSOC NURSE AIDS C, V31, P249, DOI 10.1097/JNC.0000000000000125; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morlock RJ, 2006, CLIN THER, V28, P1044, DOI 10.1016/j.clinthera.2006.07.008; Motivala SJ, 2011, ANN BEHAV MED, V42, P141, DOI 10.1007/s12160-011-9280-2; Paisible AL, 2015, JAIDS-J ACQ IMM DEF, V68, P209, DOI 10.1097/QAI.0000000000000419; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Polanka BM, 2019, JAIDS-J ACQ IMM DEF, V81, P110, DOI 10.1097/QAI.0000000000001981; Prather AA, 2013, J PSYCHIATR RES, V47, P1228, DOI 10.1016/j.jpsychires.2013.05.004; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; So-Armah KA, 2016, JAIDS-J ACQ IMM DEF, V72, P206, DOI 10.1097/QAI.0000000000000954; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Stewart JC, 2020, PSYCHOSOM MED, V82, P461, DOI 10.1097/PSY.0000000000000808; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Taylor BS, 2017, JAIDS-J ACQ IMM DEF, V75, P500, DOI 10.1097/qai.0000000000001444; Taylor DJ, 2018, J CLIN SLEEP MED, V14, P459, DOI 10.5664/jcsm.7000; Thorndike FP, 2011, BEHAV SLEEP MED, V9, P216, DOI 10.1080/15402002.2011.606766; Trickey A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160460; Vachiat A, 2017, J AM COLL CARDIOL, V69, P73, DOI 10.1016/j.jacc.2016.09.979; von Kanel R, 2010, GERONTOLOGY, V56, P41, DOI 10.1159/000264654; von Kanel R, 2006, J AM GERIATR SOC, V54, P431, DOI 10.1111/j.1532-5415.2005.00642.x; Vos AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147484; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Wirth MD, 2015, AIDS BEHAV, V19, P1098, DOI 10.1007/s10461-014-0949-y; Womack JA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001035; Wu J, 2015, SLEEP MED, V16, P901, DOI 10.1016/j.sleep.2015.03.027; Zhu BQ, 2019, SLEEP MED REV, V45, P18, DOI 10.1016/j.smrv.2019.02.002	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246073	10.1371/journal.pone.0246073	http://dx.doi.org/10.1371/journal.pone.0246073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4BO	33561176	Green Published, gold			2022-12-26	WOS:000617533000043
J	Zhao, L; Wu, XH; Zheng, JN; Dong, D				Zhao, Lei; Wu, Xiaohong; Zheng, Junnian; Dong, Dong			DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution	ONCOGENE			English	Article							PROMOTER METHYLATION; METASTASIS; SEQ	DNA methylation plays a pivotal role in regulating cellular processes, and altered DNA methylation pattern is a general hallmark of cancer. However, DNA methylome in circulating tumor cells (CTCs) is still a mystery due to the lack of proper analytical techniques. We introduced an efficient workflow, LCM-mu WGBS, which can efficiently profile the DNA methylation of microdissected CTC samples. LCM-mu WGBS combines the laser capture microdissection (LCM)-based CTC capture method and whole-genome bisulfite sequencing in very small CTC population (mu WGBS) to gain insight into the DNA methylation landscape of CTCs. We herein profiled the DNA methylome of CTCs from lung cancer patients. Deriving from a comprehensive analysis of CTC methylome, a unique "CTC DNA methylation signature" that is distinct from primary lung cancer tissues was identified. Further analysis showed that promoter hypermethylation of epithelial genes is a hallmark of stable epithelial-mesenchymal transition process. Moreover, it has been suggested that CTCs are endowed with a stemness-related feature during dissemination and metastasis. This work constitutes a unique DNA methylation analysis of CTCs at single base-pair resolution, which might facilitate to propose noninvasive CTC DNA methylation biomarkers contributing to clinical diagnosis.	[Zhao, Lei; Zheng, Junnian; Dong, Dong] Xuzhou Med Univ, Canc Inst, Xuzhou, Jiangsu, Peoples R China; [Zhao, Lei; Zheng, Junnian; Dong, Dong] Xuzhou Med Univ, Affiliated Hosp, Ctr Clin Oncol, Xuzhou, Jiangsu, Peoples R China; [Zhao, Lei] East China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Wu, Xiaohong] Jiangsu Univ, Affiliated Yixing Hosp, Dept Gen Surg, Yixing 214200, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; East China Normal University; Jiangsu University	Zheng, JN; Dong, D (corresponding author), Xuzhou Med Univ, Canc Inst, Xuzhou, Jiangsu, Peoples R China.; Zheng, JN; Dong, D (corresponding author), Xuzhou Med Univ, Affiliated Hosp, Ctr Clin Oncol, Xuzhou, Jiangsu, Peoples R China.	jnzheng@xzhmu.edu.cn; ddong@xzhmu.edu.cn	Zhao, Lei/AAN-9084-2021	Zhao, Lei/0000-0001-7298-086X; Zheng, Junnian/0000-0003-0208-6410; , Dong/0000-0002-5642-7068	Xuzhou Medical University [D2019027]; Natural Science Fund for Colleges and Universities in Jiangsu Province [20KJA320007]; Training Project for Youth Teams of Science and Technology Innovation at Xuzhou Medical University [TD202008]	Xuzhou Medical University; Natural Science Fund for Colleges and Universities in Jiangsu Province; Training Project for Youth Teams of Science and Technology Innovation at Xuzhou Medical University	This work was supported by grants from Xuzhou Medical University (grant D2019027), Natural Science Fund for Colleges and Universities in Jiangsu Province (20KJA320007), and the Training Project for Youth Teams of Science and Technology Innovation at Xuzhou Medical University (TD202008).	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boral D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00196-1; Chimonidou M, 2013, MOL CANCER RES, V11, P1248, DOI 10.1158/1541-7786.MCR-13-0096; Chimonidou M, 2013, CLIN CHEM, V59, P270, DOI 10.1373/clinchem.2012.191551; Chimonidou M, 2011, CLIN CHEM, V57, P1169, DOI 10.1373/clinchem.2011.165902; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Faugeroux V, 2020, EUR UROL ONCOL, V3, P498, DOI 10.1016/j.euo.2018.12.005; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Keller L, 2019, NAT REV CANCER, V19, P553, DOI 10.1038/s41568-019-0180-2; Korthauer K, 2019, BIOSTATISTICS, V20, P367, DOI 10.1093/biostatistics/kxy007; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee CC, 2012, J BIOL CHEM, V287, P2798, DOI 10.1074/jbc.M111.258947; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu XQ, 2018, EBIOMEDICINE, V35, P244, DOI 10.1016/j.ebiom.2018.08.005; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Pantel K, 2016, ONCOGENE, V35, P1216, DOI 10.1038/onc.2015.192; Park ES, 2018, LAB CHIP, V18, P1736, DOI 10.1039/c8lc00184g; Pixberg CF, 2017, ONCOGENE, V36, P3223, DOI 10.1038/onc.2016.480; Vidal E, 2017, ONCOGENE, V36, P5648, DOI 10.1038/onc.2017.176; Wu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123976; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhang YJ, 2015, INT J CANCER, V136, P1228, DOI 10.1002/ijc.29070; Zheng GT, 2018, NUCLEIC ACIDS RES, V46, pD950, DOI 10.1093/nar/gkx1008; Zheng XQ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0419-x; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	38	10	10	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1884	1895		10.1038/s41388-021-01657-0	http://dx.doi.org/10.1038/s41388-021-01657-0		FEB 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564067	Green Published, hybrid			2022-12-26	WOS:000616489100001
J	Usman, SF; Shuaibu, IR; Durojaiye, K; Medugu, N; Iregbu, KC				Usman, Safiyya Faruk; Shuaibu, Ibraheem Rais; Durojaiye, Korede; Medugu, Nubwa; Iregbu, Kenneth Chukwuemeka			The presence of microorganisms in follicular fluid and its effect on the outcome of in vitro fertilization-embryo transfer (IVF-ET) treatment cycles	PLOS ONE			English	Article							COLONIZATION; INFERTILITY; QUALITY	Objectives To determine if the presence of microorganisms in follicular fluid of women undergoing in vitro fertilization-embryo transfer (IVF-ET) adversely affects the outcome of the treatment cycles. Methods Follicular fluid was collected from 86 women enrolled for IVF-ET at the National Hospital, Abuja from June 1, 2018 to December 1, 2018. Microscopy imaging and cultures were performed to identify bacteria and fungi in the follicular fluid and the vagina. Women with follicular fluid microorganisms were the test group while the controls were those without follicular fluid microorganisms. Fertilization and pregnancy rates were subsequently determined and their association with the presence of follicular fluid microorganisms was assessed using univariable and multivariable logistic regression modelling. Results The mean age and mean Body Mass Index (BMI) of the participants were 35(+/- 3.5) years and 28(+/- 4.9) kg/m(2) respectively. Bacteria and fungi were isolated in 17% of the follicular fluid samples collected (n = 15/86). Most common isolates were Streptococcus spp. (n = 4/15), Staphylococcus aureus (n = 7/15), Enterococcus spp. (n = 4/15), Lactobacillus species (n = 2/15) and Candida albicans (n = 2/15). There was no statistically significant difference in the fertilization rates (adjusted odds ratio [AdjOR] 0.55, 95% confidence interval [CI] 0.04-7.34; P = 0.10) and pregnancy rates (AdjOR 4.02, 95% CI 0.56-28.92; P = 0.19) between the group of women with positive follicular fluid bacterial /fungal colonization as compared against those with negative follicular fluid colonization. Conclusion Isolation of microorganisms from follicular fluid did not adversely affect fertilization and pregnancy rates following IVF-ET treatment cycles at the fertility centre of National Hospital, Abuja.	[Usman, Safiyya Faruk; Shuaibu, Ibraheem Rais; Durojaiye, Korede] Natl Hosp Abuja, Dept Obstet & Gynaecol, Abuja, Nigeria; [Medugu, Nubwa; Iregbu, Kenneth Chukwuemeka] Natl Hosp Abuja, Dept Med Microbiol, Abuja, Nigeria		Usman, SF (corresponding author), Natl Hosp Abuja, Dept Obstet & Gynaecol, Abuja, Nigeria.	safiyafaruk@yahoo.com	Medugu, Nubwa/AEV-0428-2022; Usman, Safiyya/GPK-2102-2022	Medugu, Nubwa/0000-0002-1300-7362; Usman, Safiyya/0000-0001-5166-8607				[Anonymous], PRENSA MED ARGENTINA, V106, DOI [10.47275/0032-745x-s2-004, DOI 10.47275/0032-745X-S2-004]; Bhandari HM, 2018, OBSTET GYNAECOL, V20, P167, DOI 10.1111/tog.12509; Cottell E, 1996, FERTIL STERIL, V66, P776, DOI 10.1016/S0015-0282(16)58635-X; EDWARDS RG, 1974, J REPROD FERTIL, V37, P189, DOI 10.1530/jrf.0.0370189; Elder K, 2000, IN VITRO FERTILIZATI, P152; Kim S, 2018, FERTIL STERIL, V110, pE194, DOI 10.1016/j.fertnstert.2018.07.567; Kirkwood BR, 2016, ESSENTIAL MED STAT, P413; Lin WQ, 2013, J ASSIST REPROD GEN, V30, P649, DOI 10.1007/s10815-013-9973-5; Mietzner T., 2016, MED MICROBIOLOGY, P741; Okafor NI, 2017, AFR J REPROD HEALTH, V21, P55, DOI 10.29063/ajrh2017/v21i4.6; Omokanye L. O., 2018, AFRICAN J INFERTILIT, V3, P2; Osegua K, 2014, MICROBIOLOGICAL STUD; Pelzer ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059062; Pelzer ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049965; Pelzer ES, 2011, HUM REPROD, V26, P1799, DOI 10.1093/humrep/der108; Pelzer ES, 2010, J CLIN EMBRYOL, V15, P44; Perez-Ruiz I, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120176; Recommendations from CDC the National Institutes of Health (NIH) the Centers for Disease Control and Prevention (CDC) and the HIV Medicine Association of the Infectious Disease Society of America (HIVMA/IDSA), 2009, MORBIDITY MORTALITY, V15, pRR4; Reid G, 2015, AM J REPROD IMMUNOL, V73, P1, DOI 10.1111/aji.12319; Rosen MP, 2010, FERTIL STERIL, V94, P1328, DOI 10.1016/j.fertnstert.2009.05.024; Taha Hamad lnas A, 2018, IOSR J DENT MED SCI, V17, P80; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Whitley E, 2002, CRIT CARE, V6, P335; Wu YT, 2015, J ASSIST REPROD GEN, V32, P417, DOI 10.1007/s10815-014-0419-5; Zegers-Hochschild F, 2017, FERTIL STERIL, V108, P393, DOI 10.1016/j.fertnstert.2017.06.005	25	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246644	10.1371/journal.pone.0246644	http://dx.doi.org/10.1371/journal.pone.0246644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556108	gold, Green Published			2022-12-26	WOS:000617379900050
J	Takase, T; Toyoda, T; Kobayashi, N; Inoue, T; Ishijima, T; Abe, K; Kinoshita, H; Tsuchiya, Y; Okada, S				Takase, Takahito; Toyoda, Tsudoi; Kobayashi, Naoyuki; Inoue, Takashi; Ishijima, Tomoko; Abe, Keiko; Kinoshita, Hiroshi; Tsuchiya, Youichi; Okada, Shinji			Dietary iso-alpha-acids prevent acetaldehyde-induced liver injury through Nrf2-mediated gene expression	PLOS ONE			English	Article							HOPS HUMULUS-LUPULUS; ALDEHYDE DEHYDROGENASE; OXIDATIVE STRESS; METABOLISM; PRODUCTS; ETHANOL; NRF2; DISEASE; MICE; IDENTIFICATION	Acetaldehyde is the major toxic metabolite of alcohol (ethanol) and enhances fibrosis of the liver through hepatic stellate cells. Additionally, alcohol administration causes the accumulation of reactive oxygen species (ROS), which induce hepatocyte injury-mediated lipid peroxidation. Iso-alpha-acids, called isohumulones, are bitter acids in beer. The purpose of this study was to investigate the protective effects of iso-alpha-acids against alcoholic liver injury in hepatocytes in mice. C57BL/6N mice were fed diets containing isomerized hop extract, which mainly consists of iso-alpha-acids. After 7 days of feeding, acetaldehyde was administered by a single intraperitoneal injection. The acetaldehyde-induced increases in serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were suppressed by iso-alpha-acids intake. Hepatic gene expression analyses showed the upregulation of detoxifying enzyme genes, glutathione-S-transferase (GST) and aldehyde dehydrogenase (ALDH). In vitro, iso-alpha-acids upregulated the enzymatic activities of GST and ALDH and induced the nuclear translocation of nuclear factor-erythroid-2-related factor 2 (Nfe2l2; Nrf2), a master regulator of antioxidant and detoxifying systems. These results suggest that iso-alpha-acid intake prevents acetaldehyde-induced liver injury by reducing oxidative stress via Nrf2-mediated gene expression.	[Takase, Takahito; Kobayashi, Naoyuki; Inoue, Takashi; Tsuchiya, Youichi] SAPPORO Holdings LTD, Res & Dev Div, Yaizu, Shizioka, Japan; [Takase, Takahito; Inoue, Takashi] POKKA SAPPORO Food & Beverage LTD, Fundamental Lab, Yokohama, Kanagawa, Japan; [Toyoda, Tsudoi; Ishijima, Tomoko; Abe, Keiko; Okada, Shinji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Kinoshita, Hiroshi] Kagawa Univ, Fac Med, Dept Forens Med, Kita Ku, Miki, Kagawa, Japan	Sapporo Holdings Limited; University of Tokyo; Kagawa University	Okada, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	asoka@mail.ecc.u-tokyo.ac.jp	OKADA, Shinji/AFS-7710-2022	OKADA, Shinji/0000-0002-4465-9961				Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005; ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; ANTONENKOV VD, 1987, FEBS LETT, V224, P357, DOI 10.1016/0014-5793(87)80484-2; Bland Jeffrey S., 2015, PharmaNutrition, V3, P46, DOI 10.1016/j.phanu.2015.03.001; Bokulich NA, 2013, MICROBIOL MOL BIOL R, V77, P157, DOI 10.1128/MMBR.00060-12; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chiarpotto E., 1995, ALCOHOL ALCOHOL, DOI [10.1093/oxfordjournals.alcalc.a0457898679012, DOI 10.1093/OXFORDJOURNALS.ALCALC.A0457898679012]; Dinkova-Kostova AT, 2017, ARCH BIOCHEM BIOPHYS, V617, P84, DOI 10.1016/j.abb.2016.08.005; Dostalek P, 2017, MOLECULES, V22, DOI 10.3390/molecules22101761; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hege M, 2018, NUTRITION, V45, P68, DOI 10.1016/j.nut.2017.07.010; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Igarashi K, 2000, BIOSCI BIOTECH BIOCH, V64, P1600, DOI 10.1271/bbb.64.1600; Jamal M, 2016, NEUROCHEM RES, V41, P1029, DOI 10.1007/s11064-015-1788-6; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Leung TM, 2017, CURR MOL PHARMACOL, V10, P172, DOI 10.2174/1874467208666150817111846; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Liangpunsakul S, 2016, GASTROENTEROLOGY, V150, P1786, DOI 10.1053/j.gastro.2016.02.043; LIEBER CS, 1991, ALCOHOL CLIN EXP RES, V15, P573, DOI 10.1111/j.1530-0277.1991.tb00563.x; Mahli A, 2018, LAB INVEST, V98, P1614, DOI 10.1038/s41374-018-0112-x; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Oelze M, 2011, J BIOL CHEM, V286, P8893, DOI 10.1074/jbc.M110.190017; Park EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063439; R Team Core, 2017, LANG ENV STAT COMP, P2017; Rodda LN, 2014, J ANAL TOXICOL, V38, P354, DOI 10.1093/jat/bku038; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Shearn CT, 2018, ALCOHOL CLIN EXP RES, V42, P1192, DOI 10.1111/acer.13766; SHEN H, 1993, ARCH BIOCHEM BIOPHYS, V300, P137, DOI 10.1006/abbi.1993.1019; Shin SM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/763257; Stickel F, 2017, GUT LIVER, V11, P173, DOI 10.5009/gnl16477; Suzuki T, 2017, J BIOL CHEM, V292, P16817, DOI 10.1074/jbc.R117.800169; Tan KL, 1996, BIOCHEM J, V315, P727, DOI 10.1042/bj3150727; Taniguchi Y, 2013, J AGR FOOD CHEM, V61, P3121, DOI 10.1021/jf3047187; Teschke R, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040106; Tomita J, 2017, BIOCHEM BIOPH RES CO, V484, P740, DOI 10.1016/j.bbrc.2017.01.133; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; Tuma DJ, 2003, ALCOHOL RES HEALTH, V27, P285; Ushida Y, 2013, ALCOHOL ALCOHOLISM, V48, P526, DOI 10.1093/alcalc/agt063; VINA J, 1980, BIOCHEM J, V188, P549, DOI 10.1042/bj1880549; Wang JM, 2012, BIOSCI TRENDS, V6, P89, DOI 10.5582/bst.2012.v6.2.89; Xu DW, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01428; Yokoyama A, 2008, ALCOHOL CLIN EXP RES, V32, P1607, DOI 10.1111/j.1530-0277.2008.00739.x; Yoshida K, 2015, WORLD J GASTROENTERO, V21, P10091, DOI 10.3748/wjg.v21.i35.10091; Zheng RJ, 2014, TOXICOL APPL PHARM, V279, P43, DOI 10.1016/j.taap.2014.04.026; Zhou R, 2014, BBA-GEN SUBJECTS, V1840, P209, DOI 10.1016/j.bbagen.2013.09.018	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246327	10.1371/journal.pone.0246327	http://dx.doi.org/10.1371/journal.pone.0246327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544749	Green Published, gold			2022-12-26	WOS:000617991900041
J	Abuleil, D; McCulloch, D; Thompson, B				Abuleil, Dania; McCulloch, Daphne; Thompson, Benjamin			Visual cortex cTBS increases mixed percept duration while a-tDCS has no effect on binocular rivalry	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; PHOSPHENE THRESHOLDS; DOMINANCE DURATIONS; GABA LEVELS; MODULATION; MOTOR; CONNECTIVITY	Neuromodulation of the primary visual cortex using anodal transcranial direct current stimulation (a-tDCS) can alter visual perception and enhance neuroplasticity. However, the mechanisms that underpin these effects are currently unknown. When applied to the motor cortex, a-tDCS reduces the concentration of the inhibitory neurotransmitter gamma aminobutyric acid (GABA), an effect that has been linked to increased neuroplasticity. The aim of this study was to assess whether a-tDCS also reduces GABA-mediated inhibition when applied to the human visual cortex. Changes in visual cortex inhibition were measured using the mixed percept duration in binocular rivalry. Binocular rivalry mixed percept duration has recently been advocated as a direct and sensitive measure of visual cortex inhibition whereby GABA agonists decrease mixed percept durations and agonists of the excitatory neurotransmitter acetylcholine (ACH) increase them. Our hypothesis was that visual cortex a-tDCS would increase mixed percept duration by reducing GABA-mediated inhibition and increasing cortical excitation. In addition, we measured the effect of continuous theta-burst transcranial magnetic stimulation (cTBS) of the visual cortex on binocular rivalry dynamics. When applied to the motor or visual cortex, cTBS increases GABA concentration and we therefore hypothesized that visual cortex cTBS would decrease the mixed percept duration. Binocular rivalry dynamics were recorded before and after active and sham a-tDCS (N = 15) or cTBS (N = 15). Contrary to our hypotheses, a-tDCS had no effect, whereas cTBS increased mixed percepts during rivalry. These results suggest that the neurochemical mechanisms of a-tDCS may differ between the motor and visual cortices.	[Abuleil, Dania; McCulloch, Daphne; Thompson, Benjamin] Univ Waterloo, Dept Optometry & Vis Sci, Waterloo, ON, Canada; [McCulloch, Daphne; Thompson, Benjamin] Ctr Eye & Vis Res, Hong Kong, Peoples R China; [Thompson, Benjamin] Univ Auckland, Liggins Inst, Auckland, New Zealand	University of Waterloo; University of Auckland	Abuleil, D (corresponding author), Univ Waterloo, Dept Optometry & Vis Sci, Waterloo, ON, Canada.	dania.abuleil@uwaterloo.ca			Natural Sciences and Engineering Research Council (NSERC) [RPIN-05394, RGPAS-477166]; Canadian Foundation for Innovation (CFI) [34095]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	BT received Natural Sciences and Engineering Research Council (NSERC) Grants RPIN-05394 and RGPAS-477166 (https://www.nserc-crsng.gc.ca/index_eng.asp) as well as the Canadian Foundation for Innovation (CFI; https://www.innovation.ca) Grant 34095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CPG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100350; Amadi U, 2015, BRAIN STIMUL, V8, P898, DOI 10.1016/j.brs.2015.04.010; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antonenko D, 2017, J NEUROSCI, V37, P4065, DOI 10.1523/JNEUROSCI.0079-17.2017; Bachtiar V, 2015, ELIFE, V4, DOI 10.7554/eLife.08789; Behrens JR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00238; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Cai P, 2014, EXP BRAIN RES, V232, P4035, DOI 10.1007/s00221-014-4084-9; Carmel D, 2010, CURR BIOL, V20, pR799, DOI 10.1016/j.cub.2010.07.036; Castrillon G, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay2739; Chaieb L, 2008, VISUAL NEUROSCI, V25, P77, DOI 10.1017/S0952523808080097; Clavagnier S, 2013, BRAIN STIMUL, V6, P860, DOI 10.1016/j.brs.2013.04.002; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Ding ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32605; Dwyer GE, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01145; Epperson CN, 2005, BIOL PSYCHIAT, V57, P44, DOI 10.1016/j.biopsych.2004.09.021; Girdhar A, 2018, IET IMAGE PROCESS, V12, P1, DOI 10.1049/iet-ipr.2017.0162; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Grasso PA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61626-7; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Haynes JD, 2006, NATURE, V438, P496; Heise KF, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00146; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Kim S, 2014, NEUROIMAGE, V99, P237, DOI 10.1016/j.neuroimage.2014.05.070; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Mentch J, 2019, J NEUROSCI, V39, P8398, DOI 10.1523/JNEUROSCI.0836-19.2019; Nwaroh C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222620; Patel H. J., 2017, CLIN NEUROPHYSIOL, V128, pe308, DOI 10.1016/j.clinph.2017.06.048; Pitchaimuthu K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14577-5; Rahnev D, 2013, J NEUROPHYSIOL, V110, P1811, DOI 10.1152/jn.00209.2013; Raveendran RN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232276; Reinhart RMG, 2016, CURR BIOL, V26, P1867, DOI 10.1016/j.cub.2016.05.019; Robertson CE, 2016, CURR BIOL, V26, P80, DOI 10.1016/j.cub.2015.11.019; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Sczesny-Kaiser M, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00116; Sheynin Y, 2020, J NEUROSCI, V40, P5208, DOI 10.1523/JNEUROSCI.2484-19.2020; Sheynin Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00022; Spiegel DP, 2013, NEUROTHERAPEUTICS, V10, P831, DOI 10.1007/s13311-013-0200-y; Spiegel DP, 2013, NEUROREHAB NEURAL RE, V27, P760, DOI 10.1177/1545968313491006; Spiegel DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036220; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Strigaro G, 2015, CLIN EEG NEUROSCI, V46, P208, DOI 10.1177/1550059414539481; Teo WP, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00284; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tranulis C, 2006, NEUROPHYSIOL CLIN, V36, P1, DOI 10.1016/j.neucli.2006.01.005; van Loon AM, 2013, CURR BIOL, V23, P823, DOI 10.1016/j.cub.2013.03.067; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Wilson TW, 2018, CEREB CORTEX, V28, P1597, DOI 10.1093/cercor/bhx055; Zaretskaya N, 2010, CURR BIOL, V20, P2106, DOI 10.1016/j.cub.2010.10.046	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0239349	10.1371/journal.pone.0239349	http://dx.doi.org/10.1371/journal.pone.0239349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539443	Green Submitted, Green Published, gold			2022-12-26	WOS:000616960200103
J	Clements, J; Bradford, BZ; Garcia, M; Piper, S; Huang, WJ; Zwolinska, A; Lamour, K; Hogenhout, S; Groves, RL				Clements, Justin; Bradford, Benjamin Z.; Garcia, Marjorie; Piper, Shannon; Huang, Weijie; Zwolinska, Agnieszka; Lamour, Kurt; Hogenhout, Saskia; Groves, Russell L.			'Candidatus Phytoplasma asteris' subgroups display distinct disease progression dynamics during the carrot growing season	PLOS ONE			English	Article							INSECT VECTORS; YELLOWS; HEMIPTERA	Aster Yellows phytoplasma (AYp; 'Candidatus Phytoplasma asteris') is an obligate bacterial pathogen that is the causative agent of multiple diseases in herbaceous plants. While this phytoplasma has been examined in depth for its disease characteristics, knowledge about the spatial and temporal dynamics of pathogen spread is lacking. The phytoplasma is found in plant's phloem and is vectored by leafhoppers (Cicadellidae: Hemiptera), including the aster leafhopper, Macrosteles quadrilineatus Forbes. The aster leafhopper is a migratory insect pest that overwinters in the southern United States, and historical data suggest these insects migrate from southern overwintering locations to northern latitudes annually, transmitting and driving phytoplasma infection rates as they migrate. A more in-depth understanding of the spatial, temporal and genetic determinants of Aster Yellows disease progress will lead to better integrated pest management strategies for Aster Yellows disease control. Carrot, Daucus carota L., plots were established at two planting densities in central Wisconsin and monitored during the 2018 growing season for Aster Yellows disease progression. Symptomatic carrots were sampled and assayed for the presence of the Aster Yellows phytoplasma. Aster Yellows disease progression was determined to be significantly associated with calendar date, crop density, location within the field, and phytoplasma subgroup.	[Clements, Justin] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Parma, ID USA; [Bradford, Benjamin Z.; Garcia, Marjorie; Piper, Shannon; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Huang, Weijie; Hogenhout, Saskia] John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England; [Zwolinska, Agnieszka] Natl Res Inst, Dept Virol & Bacteriol, Poznan, Poland; [Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	Idaho; University of Idaho; University of Wisconsin System; University of Wisconsin Madison; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu	Hogenhout, Saskia A/D-9266-2012; Zwolińska, Agnieszka/K-3761-2013	Hogenhout, Saskia A/0000-0003-1371-5606; Zwolińska, Agnieszka/0000-0003-2681-2915; Huang, Weijie/0000-0001-5208-6713	Human Frontiers Science Program grant [HFSP RGP0024/2015]; Plant Health Institute Strategy Programme [BB/P012574/1]; John Innes Foundation; BBSRC [BBS/E/J/000PR9798] Funding Source: UKRI	Human Frontiers Science Program grant; Plant Health Institute Strategy Programme; John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by Human Frontiers Science Program grant (HFSP RGP0024/2015) with additional funding from the Plant Health Institute Strategy Programme (BB/P012574/1) and the John Innes Foundation.	Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Chang SH, 2018, J EXP BOT, V69, P5389, DOI 10.1093/jxb/ery318; Chiykowski LN, 1965, WIS AGR EXP STN RES, V261, P21; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Clements J, 2020, J ECON ENTOMOL, V113, P604, DOI 10.1093/jee/toz356; Dietrich CH, 2005, FLA ENTOMOL, V88, P502, DOI 10.1653/0015-4040(2005)88[502:KTTFOC]2.0.CO;2; Frost KE, 2013, ENVIRON ENTOMOL, V42, P491, DOI 10.1603/EN12240; GABELMAN WH, 1994, J AM SOC HORTIC SCI, V119, P1293, DOI 10.21273/JASHS.119.6.1293; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hong SC, 2015, NEOBIOTA, V27, P37, DOI 10.3897/neobiota.27.5177; Lee IM, 2004, INT J SYST EVOL MICR, V54, P1037, DOI 10.1099/ijs.0.02843-0; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lovell DJ, 1997, PLANT PATHOL, V46, P126, DOI 10.1046/j.1365-3059.1997.d01-206.x; MacLean AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001835; Mahr S, 2015, ASTER YELLOWS; Marzachi C, 1998, ANN APPL BIOL, V133, P45, DOI 10.1111/j.1744-7348.1998.tb05801.x; Minato N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07399; Orlovskis Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00885; Pecher P, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008035; Rodgers PM, 2011, IPM PERSPECTIVES CAR; Sisterson MS, 2018, PLANT PATHOL, V67, P1388, DOI 10.1111/ppa.12833; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Sugio A, 2014, NEW PHYTOL, V202, P838, DOI 10.1111/nph.12721; Tan CM, 2016, J EXP BOT, V67, P4415, DOI 10.1093/jxb/erw225; Tomkins M, 2018, CURR OPIN PLANT BIOL, V44, P39, DOI 10.1016/j.pbi.2018.02.002; Toruno TY, 2010, MOL MICROBIOL, V77, P1406, DOI 10.1111/j.1365-2958.2010.07296.x; Werner BJ, 2009, ENVIRON ENTOMOL, V38, P1429, DOI 10.1603/022.038.0511; Yang Y, 2017, INT J SYST EVOL MICR, V67, P5290, DOI 10.1099/ijsem.0.002449	31	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0239956	10.1371/journal.pone.0239956	http://dx.doi.org/10.1371/journal.pone.0239956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539350	Green Published, gold			2022-12-26	WOS:000616960200059
J	Madduppa, H; Martaulina, R; Zairion, Z; Renjani, RM; Kawaroe, M; Anggraini, NP; Subhan, B; Verawati, I; Sani, LMI				Madduppa, Hawis; Martaulina, Rina; Zairion, Zairion; Renjani, Resha Mukti; Kawaroe, Mujizat; Anggraini, Nurlita Putri; Subhan, Beginer; Verawati, Indri; Sani, Lalu M. Iqbal			Genetic population subdivision of the blue swimming crab (Portunus pelagicus) across Indonesia inferred from mitochondrial DNA: Implication to sustainable fishery	PLOS ONE			English	Article							MOLECULAR-GENETICS; CRUSTACEA; STOCK; SIZE; CONSEQUENCES; EXTINCTION; ABUNDANCE; RECOVERY; LINNAEUS	The blue swimming crab (BSC), Portunus pelagicus (Linnaeus 1758), inhabits coastal areas of Southeast and East Asia, and is one of high fisheries commodities with an export value for Indonesia and an increasing global market demand, annually. However, the data of genetic diversity and their spatial connectivity of populations in Indonesia are not yet known, even when it is important to inform stock unit management and sustainable use. This study aimed to determine the genetic diversity and differentiation of blue swimming crabs across Indonesian populations in different Fishery Management Area (FMA), and their spatial genetic connectivity, as well as to deliver implications for sustainable fishery. A total of 297 individuals were collected and amplified using cytochrome oxidase I mitochondrial DNA. This study has showed the highest values for haplotype and nucleotide diversity in the eastern part of Indonesia, where exploitation is relatively low. Significant genetic differentiation between populations (F-ST = 0.954; p < 0.001) and the fisheries management areas (F-ST = 0.964; p < 0.001) were revealed. Low spatial connectivity was observed between populations in a distance of at least more than 60 kilometers. This study suggests that BSC populations in Indonesia, likely have several stock units, and preferably different fisheries management plans and actions across the region thoroughly and simultaneously. This would be effective for management and their sustainable conservation.	[Madduppa, Hawis; Martaulina, Rina; Renjani, Resha Mukti; Kawaroe, Mujizat; Anggraini, Nurlita Putri; Subhan, Beginer; Verawati, Indri] Inst Pertanian Bogor IPB Univ, Fac Fisheries & Marine Sci, Dept Marine Sci & Technol, Bogor, Indonesia; [Madduppa, Hawis] Indonesian Blue Swimming Crab Assoc Asosiasi Peng, Surabaya, Indonesia; [Madduppa, Hawis] Inst Pertanian Bogor IPB Univ, Ctr Coastal & Marine Resources Studies, Bogor, Indonesia; [Madduppa, Hawis; Sani, Lalu M. Iqbal] Oceanogen Environm Biotechnol Laboklinikum, Java, Indonesia; [Zairion, Zairion] Inst Pertanian Bogor IPB Univ, Fac Fisheries & Marine Sci, Dept Aquat Resources Management, Bogor, Indonesia		Madduppa, H (corresponding author), Inst Pertanian Bogor IPB Univ, Fac Fisheries & Marine Sci, Dept Marine Sci & Technol, Bogor, Indonesia.; Madduppa, H (corresponding author), Indonesian Blue Swimming Crab Assoc Asosiasi Peng, Surabaya, Indonesia.; Madduppa, H (corresponding author), Inst Pertanian Bogor IPB Univ, Ctr Coastal & Marine Resources Studies, Bogor, Indonesia.; Madduppa, H (corresponding author), Oceanogen Environm Biotechnol Laboklinikum, Java, Indonesia.	hawis@apps.ipb.ac.id	Zairion, Zairion/GPK-6332-2022; Madduppa, Hawis/ABD-7468-2021; subhan, beginer/GPK-5583-2022	Madduppa, Hawis/0000-0003-4260-5625; Sani, Lalu M Iqbal/0000-0001-5757-6113	Indonesian Blue Swimming Crab Association (APRI); Laboratory of Marine Biodiversity and Biosystematics Department of Marine Sciences and Technology Faculty of Fisheries and Marine Science, IPB University	Indonesian Blue Swimming Crab Association (APRI); Laboratory of Marine Biodiversity and Biosystematics Department of Marine Sciences and Technology Faculty of Fisheries and Marine Science, IPB University	The research was funded by the Indonesian Blue Swimming Crab Association (APRI) and the Laboratory of Marine Biodiversity and Biosystematics Department of Marine Sciences and Technology Faculty of Fisheries and Marine Science, IPB University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahemen I., 2014, APPL PHYS RES, V6, P95; [Anonymous], 2015, PULSE INT, V16, P1; Brinkman F, 2001, PHYLOGENETIC ANAL BI, P323; Bryars SR, 1999, MAR FRESHWATER RES, V50, P15, DOI 10.1071/MF98075; CARVALHO GR, 1994, REV FISH BIOL FISHER, V4, P326, DOI 10.1007/BF00042908; Chai CJ, 2017, ZOOL STUD, V56, DOI 10.6620/ZS.2017.56-26; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Dankel DJ, 2008, REV FISH BIOL FISHER, V18, P201, DOI 10.1007/s11160-007-9068-4; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V139, P23, DOI 10.1016/0022-0981(90)90035-B; Ernawati T.R.I., 2017, BIODIVERSITAS J BIOL, V18, P1705, DOI [10.13057/biodiv/d180450, DOI 10.13057/BIODIV/D180451, DOI 10.13057/BIODIV/D180450]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson AJB, FISH BIOL, V47, P103; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Ghofar A, 2018, IOP C SER EARTH ENV, V116, DOI 10.1088/1755-1315/116/1/012068; Hartl DL, 1998, GENETICS PRINCIPLES; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Heino M, 2002, B MAR SCI, V70, P639; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jefri E, 2015, BIODIVERSITAS, V16, P254, DOI DOI 10.13057/BIODIV/D160221; Kangas M., 2000, FISH RES REP FISH W, V121, P1; Kembaren Duranta D., 2018, Biodiversitas, V19, P1326; Klinbunga S, 2007, BIOCHEM GENET, V45, P725, DOI 10.1007/s10528-007-9110-1; Kurnia R, 2014, JURNAL ILMU PERTANIA, V19, P22; Lai JCY, 2010, RAFFLES B ZOOL, V58, P199; Lande R, 1987, EFFECTIVE POPULATION; Lipcius RN, 2002, MAR ECOL PROG SER, V226, P45, DOI 10.3354/meps226045; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Madduppa HH, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00080; Madduppa HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090648; Meagher TD., 1971, THESIS; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:POMFSA>2.0.CO;2; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishida T, 1998, REV RES PLAN STOCK S; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; POTTER IC, 1983, MAR BIOL, V78, P75, DOI 10.1007/BF00392974; POTTER MA, 1991, AUST J MAR FRESH RES, V42, P751; Ren GJ, 2018, MITOCHONDRIAL DNA A, V29, P192, DOI 10.1080/24701394.2016.1261855; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santos Mudjekeewis D., 2010, Philippine Journal of Science, V139, P43; Sezmis E, 2004, POPULATION GENETIC S; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smith Glen S., 1989, Asian Fisheries Science, V3, P101; Smith M. H., 1981, ECOL B STOCKHOLM, V23, P119; Sparre P., 1998, FAO FISH TECH PAP; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Sumpton Wayne D., 1994, Asian Fisheries Science, V7, P103; Tamura K, 2013, MOL BIOL EVOL, V28, P731; TAYLOR DR, 1988, AM J BOT, V75, P401, DOI 10.2307/2443987; Toha Abdul H., 2016, AACL Bioflux, V9, P458; Weiss KM., 1995, GENETIC VARIATION HU; Yap ES, 2002, MOL ECOL NOTES, V2, P30, DOI 10.1046/j.1471-8278 .2001.00136.x	57	3	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0240951	10.1371/journal.pone.0240951	http://dx.doi.org/10.1371/journal.pone.0240951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539423	Green Submitted, Green Published, gold			2022-12-26	WOS:000616960200008
J	Marwa, KJ; Mcharo, G; Mwita, S; Katabalo, D; Ruganuza, D; Kapesa, A				Marwa, Karol Julius; Mcharo, Glory; Mwita, Stanley; Katabalo, Deogratias; Ruganuza, Deodatus; Kapesa, Anthony			Disposal practices of expired and unused medications among households in Mwanza, Tanzania	PLOS ONE			English	Article							DRUG DISPOSAL; PHARMACEUTICALS; ANTIBIOTICS; MEDICINES; KNOWLEDGE; BEHAVIOR; STORAGE; IMPACT	Background The community practice towards disposal of expired and unused medications in spite of its adverse impact have been widely neglected in many developing countries. The available guidelines in Tanzania focus on the disposal of expired medications and cosmetics in hospitals and community pharmacies only. Aim The aim of this study was to assess the disposal practice of expired and unused medications at household level in Mwanza city, north-western Tanzania. Methodology The household based cross-sectional study was conducted among 359 randomly selected household members. Semi-structured questionnaires were used for interview during data collection and while STATA(R) version 13 was used for analysis. Results Out 359 households visited, 252 (70.19%) had medications kept in their houses at the time of data collection. Among them, 10 (4.0%) households had kept medications at their houses because they were still continuing with treatment while 242 (96.0%) kept unused medications which were supposed to be discarded. The main reason for keeping unused or expired medications at home was uncompleted course of treatment (199 (82.20%) after feeling that they had recovered from illness. The main reason for discarding medications were recovering from illness (141(48.7%) and expiry (136 (46.9%). The major discarding practices for medications were disposing into domestic trashes (219 (75.5%) and pit latrines (45 (15.5%). Majority of respondents (273 (76%) were aware that improper disposal of expired medications are detrimental to human health and environment in general. Conclusion Improper disposal of unused and expired medications at household level was a common practice in the study area. Tailor-made interventions by the Food and Drugs Authority (FDA) and other national as well as local stake holders are urgently needed to address the situation.	[Marwa, Karol Julius] Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania; [Mcharo, Glory; Mwita, Stanley; Katabalo, Deogratias] Catholic Univ Hlth & Allied Sci, Sch Pharm, Mwanza, Tanzania; [Ruganuza, Deodatus] Catholic Univ Hlth & Allied Sci, Dept Parasitol, Mwanza, Tanzania; [Kapesa, Anthony] Catholic Univ Hlth & Allied Sci, Dept Community Med, Mwanza, Tanzania		Marwa, KJ (corresponding author), Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania.	carol_maro@yahoo.com		Marwa, Karol/0000-0001-5237-2904				Abahussain EA, 2007, PHARM WORLD SCI, V29, P368, DOI 10.1007/s11096-006-9082-y; Abahussain EA, 2006, MED PRIN PRACT, V15, P352, DOI 10.1159/000094268; Amod F, 2008, SA PHARM J, V75, P5; Angi'enda S.A., 2016, J ANTHROPOL ARCHAEOL, V4, P1, DOI [10.15640/jaa.v4n2a1, DOI 10.15640/JAA.V4N2A1]; [Anonymous], 2009, ENVIRON HEALTH PERSP, V117, pA244, DOI 10.1289/ehp.117-a244; [Anonymous], 2014, INT J PHARM SCI RES; [Anonymous], 2009, GUIDELINES SAFE DISP; Atinafu T, 2014, INT J PHARMA SCI RES, V5, P999; Baltazary G., 2013, E AFRICAN J PUBLIC H, V10, P246; Bates C, 2011, J UROLOGY, V185, P551, DOI 10.1016/j.juro.2010.09.088; Bellan N, 2012, BRAZ J PHARM SCI, V48, P507, DOI 10.1590/S1984-82502012000300018; Bound JP, 2005, ENVIRON HEALTH PERSP, V113, P1705, DOI 10.1289/ehp.8315; Boxall ABA, 2004, EMBO REP, V5, P1110, DOI 10.1038/sj.embor.7400307; Braund R, 2009, ENVIRON INT, V35, P952, DOI 10.1016/j.envint.2009.04.003; Burns W, 2006, B WORLD HEALTH ORGAN, V84, P689; Chartier Y., 2014, SAFE MANAGEMENT WAST; Chinwendu O., 2008, FIGHT FAKE DRUGS NAF; Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P775, DOI 10.1289/ehp.5948; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Glassmeyer ST, 2009, ENVIRON INT, V35, P566, DOI 10.1016/j.envint.2008.10.007; Jones OAH, 2003, B WORLD HEALTH ORGAN, V81, P768; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kish L, 1965, SURVEY SAMPLING; Kotchen M, 2009, J ENVIRON MANAGE, V90, P1476, DOI 10.1016/j.jenvman.2008.10.002; Kuspis DA, 1996, VET HUM TOXICOL, V38, P48; Kusturica MP, 2012, INT J CLIN PHARM-NET, V34, P604, DOI 10.1007/s11096-012-9652-0; Matiko D., 2011, MANAGING DISPOSAL UN; McCullagh MC, 2012, J PAIN SYMPTOM MANAG, V43, P287, DOI 10.1016/j.jpainsymman.2011.03.024; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Persson M, 2009, ENVIRON INT, V35, P771, DOI 10.1016/j.envint.2008.10.002; Redhwan Ahmed A. N., 2010, The Thai Journal of Pharmaceutical Sciences, V34, P117; Ruhoy IS, 2008, ENVIRON INT, V34, P1157, DOI 10.1016/j.envint.2008.05.002; Ruhoy IS, 2007, SCI TOTAL ENVIRON, V388, P137, DOI 10.1016/j.scitotenv.2007.08.013; Sahoo KC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-629; Seehusen DA, 2006, J AM BOARD FAM MED, V19, P542, DOI 10.3122/jabfm.19.6.542; Smith CA, 2002, J PHARM SOC WIS, V5, P17; Ternes TA, 2004, ENVIRON SCI TECHNOL, V38, p392A, DOI 10.1021/es040639t; Tong AYC, 2011, ENVIRON INT, V37, P292, DOI 10.1016/j.envint.2010.10.002; Vollmer G., 2010, GREEN SUSTAIN PHARM; Wieczorkiewicz SM, 2013, ANN PHARMACOTHER, V47, P482, DOI 10.1345/aph.1R706; Willis C, 2000, REV MED MICROBIOL, V11, P153; XFAM O, 1999, GUIDELINES SAFE DISP	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246418	10.1371/journal.pone.0246418	http://dx.doi.org/10.1371/journal.pone.0246418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539402	gold, Green Published			2022-12-26	WOS:000616960200005
J	Mo, P; Zhao, YL; Liu, J; Gao, J; Xu, ZG				Mo Ping; Zhao Yun-Lin; Liu Jun; Gao Jian; Xu Zheng-Gang			Proposal of Lentzea deserti (Okoro et al. 2010) Nouioui et al. 2018 as a later heterotypic synonym of Lentzea atacamensis (Okoro et al. 2010) Nouioui et al. 2018 and an emended description of Lentzea atacamensis	PLOS ONE			English	Article							SP NOV.; SAMPLE; GENUS; CAVE	The taxonomic relationship of Lentzea atacamensis and Lentzea deserti were re-evaluated using comparative genome analysis. The 16S rRNA gene sequence analysis indicated that the type strains of L. atacamensis and L. deserti shared 99.7% sequence similarity. The digital DNA-DNA hybridization (dDDH) and average nucleotide identity (ANI) values between the genomes of two type strains were 88.6% and 98.8%, respectively, greater than the two recognized thresholds values of 70% dDDH and 95-96% ANI for bacterial species delineation. These results suggested that L. atacamensis and L. deserti should share the same taxonomic position. And this conclusion was further supported by similar phenotypic and chemotaxonomic features between them. Therefore, we propose that L. deserti is a later heterotypic synonym of L. atacamensis.	[Mo Ping; Zhao Yun-Lin; Liu Jun; Xu Zheng-Gang] Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China; [Gao Jian] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China; [Xu Zheng-Gang] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Central South University of Forestry & Technology; Hunan University of Science & Technology; Northwest A&F University - China	Zhao, YL; Xu, ZG (corresponding author), Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China.; Xu, ZG (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	zyl8291290@163.com; xuzhenggang@nwafu.edu.cn	Zhenggang, Xu/ABE-9095-2020	Ping, Mo/0000-0001-7102-5772	State Forestry and Grassland Bureau [2018-01]; Major Science and Technology Program of Hunan Province [2017NK1014]; Forestry Science and Technology Project of Hunan Province [XLK201825]; Key Technology R&D Program of Changsha [kq190114]; Natural Science Foundation of Hunan Province [2019JJ50027]	State Forestry and Grassland Bureau; Major Science and Technology Program of Hunan Province; Forestry Science and Technology Project of Hunan Province; Key Technology R&D Program of Changsha; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This work was supported by the State Forestry and Grassland Bureau (2018-01 to ZYL), Major Science and Technology Program of Hunan Province (2017NK1014 to ZYL), Forestry Science and Technology Project of Hunan Province (XLK201825 to ZYL), Key Technology R&D Program of Changsha (kq190114 to ZYL) and Natural Science Foundation of Hunan Province (2019JJ50027 to XZG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas R. M., 1993, HDB MICROBIOLOGICAL; Cao CL, 2017, INT J SYST EVOL MICR, V67, P4873, DOI 10.1099/ijsem.0.002400; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; Fang BZ, 2017, INT J SYST EVOL MICR, V67, P2357, DOI 10.1099/ijsem.0.001958; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; HASEGAWA T, 1983, J GEN APPL MICROBIOL, V29, P319, DOI 10.2323/jgam.29.319; Kroppenstedt RM, 1985, CHEM METHODS BACTERI, P173; Labeda DP, 2007, INT J SYST EVOL MICR, V57, P1780, DOI 10.1099/ijs.0.64245-0; LECHEVALIER M P, 1970, International Journal of Systematic Bacteriology, V20, P435; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Lee SD, 2000, INT J SYST EVOL MICR, V50, P1315, DOI 10.1099/00207713-50-3-1315; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li DM, 2018, INT J SYST EVOL MICR, V68, P3528, DOI 10.1099/ijsem.0.003024; Li DM, 2018, INT J SYST EVOL MICR, V68, P1496, DOI 10.1099/ijsem.0.002698; Li XM, 2012, INT J SYST EVOL MICR, V62, P2342, DOI 10.1099/ijs.0.033795-0; Meier-Kolthoff JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10210-3; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nouioui I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02007; Okoro CK, 2010, INT J SYST EVOL MICR, V60, P296, DOI 10.1099/ijs.0.009985-0; Parker CT, 2019, INT J SYST EVOL MICR, V69, pS7, DOI 10.1099/ijsem.0.000778; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ridgway R., 1912, COLOR STANDARDS COLO, P1, DOI DOI 10.5962/BHL.TITLE.144788; Rodriguez-R LM, 2018, NUCLEIC ACIDS RES, V46, pW282, DOI 10.1093/nar/gky467; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Xu L. H., 2007, ACTINOMYCETE SYSTEMA; YASSIN AF, 1995, INT J SYST BACTERIOL, V45, P357, DOI 10.1099/00207713-45-2-357; Yoon SH, 2017, ANTON LEEUW INT J G, V110, P1281, DOI 10.1007/s10482-017-0844-4	28	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246533	10.1371/journal.pone.0246533	http://dx.doi.org/10.1371/journal.pone.0246533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539471	gold, Green Published			2022-12-26	WOS:000616960200011
J	Serafim, AP; Duraes, RSS; Rocca, CCA; Goncalves, PD; Saffi, F; Cappellozza, A; Paulino, M; Dumas-Diniz, R; Brissos, S; Brites, R; Alho, L; Lotufo-Neto, F				Serafim, Antonio P.; Duraes, Ricardo S. S.; Rocca, Cristiana C. A.; Goncalves, Priscila D.; Saffi, Fabiana; Cappellozza, Alexandre; Paulino, Mauro; Dumas-Diniz, Rodrigo; Brissos, Sofia; Brites, Rute; Alho, Laura; Lotufo-Neto, Francisco			Exploratory study on the psychological impact of COVID-19 on the general Brazilian population	PLOS ONE			English	Article							DEPRESSION; STRESS; WORKERS; ANXIETY; HEALTH	The COVID-19 pandemic has become one of the main international concerns regarding its impact on mental health. The present study aims to investigate the prevalence of depression, anxiety, and stress symptoms, and behavioral aspects amidst the COVID-19 pandemic in a Brazilian population. An online survey was administered from May 22 to June 5, 2020 using a questionnaire comprising of sociodemographic information, the Depression, Anxiety, and Stress Scale (DASS-21), and the Coping Strategies Inventory. Participants comprised 3,000 people from Brazil's 26 states and the Federal District, with an average age of 39.8 years, women (83%), married (50.6%), graduates (70.1%) and employees (46.7%). Some contracted the virus (6.4%) and had dead friends or relatives (22.7%). There was more consumption of drugs, tobacco, medication, and food (40.8%). Almost half of participants expressed symptoms of depression (46.4%), anxiety (39.7%), and stress (42.2%). These were higher in women, people without children, students, patients with chronic diseases, and people who had contact with others diagnosed with COVID-19. The existence of a group more vulnerable to situations with a high stress burden requires greater attention regarding mental health during and after the pandemic. That said, it should be emphasized that these findings are preliminary and portray a moment still being faced by many people amid the pandemic and quarantine measures. Therefore, we understand that the magnitude of the impacts on mental health will only be more specific with continuous studies after total relaxation of the quarantine.	[Serafim, Antonio P.; Rocca, Cristiana C. A.; Goncalves, Priscila D.; Saffi, Fabiana; Lotufo-Neto, Francisco] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Serafim, Antonio P.; Duraes, Ricardo S. S.] Methodist Univ Sao Paulo, Hlth Psychol Program, Sao Paulo, Brazil; [Cappellozza, Alexandre] Univ Prebiteriana Mackenzie, Social & Appl Sci Ctr, Sao Paulo, Brazil; [Paulino, Mauro; Dumas-Diniz, Rodrigo] Ctr Res Neu Ropsychol & Cognit & Behav Intervent, Inst Clin & Forens Psychol, Mind, Lisbon, Portugal; [Brissos, Sofia] Lisbon Psychiat Hosp, Natl Legal Med Inst, Psychiat & Clin & Forens Psychol, Lisbon, Portugal; [Brites, Rute] Autonoma Univ, Dept Psychol, Lisbon, Portugal; [Alho, Laura] Univ Lusofona Humanidades & Tecnol, Digital Human Environm Interact Lab, Mind, Lisbon, Portugal	Universidade de Sao Paulo; Universidade Metodista de Sao Paulo; Universidade Presbiteriana Mackenzie; Lusofona University	Serafim, AP (corresponding author), Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil.; Serafim, AP (corresponding author), Methodist Univ Sao Paulo, Hlth Psychol Program, Sao Paulo, Brazil.	a.serafim@hc.fm.usp.br	Durães, Ricardo/AAD-3697-2022; Serafim, Antonio/L-4178-2017	Durães, Ricardo/0000-0003-1893-8120; Cappellozza, Alexandre/0000-0002-1539-1230; Serafim, Antonio/0000-0002-0676-1500; Brites, Rute/0000-0002-7617-933X; Dib Goncalves, Priscila/0000-0002-7684-0554; Paulino, Mauro/0000-0002-1204-7557; Brissos, Sofia/0000-0003-3911-9247				Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205; [Anonymous], 2020, PAIN MED, VXXX, pXXX; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Apóstolo João Luís Alves, 2006, Rev. Latino-Am. Enfermagem, V14, P863, DOI 10.1590/S0104-11692006000600006; Banerjee D, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102014; Vignola RCB, 2014, J AFFECT DISORDERS, V155, P104, DOI 10.1016/j.jad.2013.10.031; Chan ST, 2017, INT NURS REV, V64, P242, DOI 10.1111/inr.12317; Engel-Yeger B, 2016, PSYCHIAT RES, V236, P112, DOI 10.1016/j.psychres.2015.12.022; Fawaz M, 2020, INT J SOC PSYCHIATR, V66, P666, DOI 10.1177/0020764020932207; Folkman S, 2000, AM PSYCHOL, V55, P647, DOI 10.1037//0003-066X.55.6.647; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; KELLERMAN J, 1977, AM J PSYCHIAT, V134, P563; Kim SS, 2013, AM J IND MED, V56, P1245, DOI 10.1002/ajim.22201; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; MAIA Berta Rodrigues, 2020, Estud. psicol. (Campinas), V37, pe200067, DOI 10.1590/1982-0275202037e200067; Mello AF, 2007, REV BRAS PSIQUIATR, V29, pS13, DOI 10.1590/S1516-44462007000500004; Mental Health and Psychosocial Support for Staff (MHPSS),, 2020, PSYCH CTR INT FED RE; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Oliffe JL, 2014, AM J MENS HEALTH, V8, P45, DOI 10.1177/1557988313490786; Oliveira AAP, 2015, MANUAL SAUDE FAMILIA, P978; Parmar D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4588; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pinheiro GA, 2020, BRAZ J HEA REV, V3, P10470, DOI [10.34119/bjhrv3n4-264, DOI 10.34119/BJHRV3N4-264]; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Razzoli M, 2017, NEUROSCI BIOBEHAV R, V76, P154, DOI 10.1016/j.neubiorev.2017.01.026; Reidy J, 2011, STAT MATHS PSYCHOL; Santos CF, 2020, BRAZ J PSYCHIAT, V42, P329, DOI 10.1590/1516-4446-2020-0981; Savoia M.G., 1996, PSICOL USP, V7, P183, DOI [DOI 10.1590/S1678-51771996000100009, 10.1590/S1678-51771996000100009]; Sekowski M, 2020, RISK DEV POSTTRAUMAT, P3, DOI DOI 10.31234/OSF.IO/BNKVE; Serafim AD, 2020, BRAZ J PSYCHIAT, V42, P450, DOI 10.1590/1516-4446-2020-0999; Serafini G, 2012, EUR REV MED PHARMACO, V16, P1389; Smith JP, 2012, ALCOHOL RES-CURR REV, V34, P414; Tian FY, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112992; Treves-Kagan S, 2022, J FAM VIOLENCE, V37, P1, DOI 10.1007/s10896-020-00218-5; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921; Zhang J, 2020, PRECIS CLIN MED, V3, P3, DOI 10.1093/pcmedi/pbaa006	39	20	20	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245868	10.1371/journal.pone.0245868	http://dx.doi.org/10.1371/journal.pone.0245868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534820	gold, Green Published			2022-12-26	WOS:000616739700035
J	Aldrich, K; Velez-Irizarry, D; Fenger, C; Schott, M; Valberg, SJ				Aldrich, Kennedy; Velez-Irizarry, Deborah; Fenger, Clara; Schott, Melissa; Valberg, Stephanie J.			Pathways of calcium regulation, electron transport, and mitochondrial protein translation are molecular signatures of susceptibility to recurrent exertional rhabdomyolysis in Thoroughbred racehorses	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CREATINE-KINASE ACTIVITY; SKELETAL-MUSCLE; MYOPLASMIC CALCIUM; RYANODINE RECEPTOR; DANTROLENE SODIUM; CA2+ RELEASE; R PACKAGE; TYING-UP; HORSES	Recurrent exertional rhabdomyolysis (RER) is a chronic muscle disorder of unknown etiology in racehorses. A potential role of intramuscular calcium (Ca2+) dysregulation in RER has led to the use of dantrolene to prevent episodes of rhabdomyolysis. We examined differentially expressed proteins (DEP) and gene transcripts (DEG) in gluteal muscle of Thoroughbred race-trained mares after exercise among three groups of 5 horses each; 1) horses susceptible to, but not currently experiencing rhabdomyolysis, 2) healthy horses with no history of RER (control), 3) RER-susceptible horses treated with dantrolene pre-exercise (RER-D). Tandem mass tag LC/MS/MS quantitative proteomics and RNA-seq analysis (FDR <0.05) was followed by gene ontology (GO) and semantic similarity of enrichment terms. Of the 375 proteins expressed, 125 were DEP in RER-susceptible versus control, with 52 up arrow DEP mainly involving Ca2+ regulation (N = 11) (e.g. RYR1, calmodulin, calsequestrin, calpain), protein degradation (N = 6), antioxidants (N = 4), plasma membranes (N = 3), glyco(geno)lysis (N = 3) and 21 DEP being blood-borne. down arrow DEP (N = 73) were largely mitochondrial (N = 45) impacting the electron transport system (28), enzymes (6), heat shock proteins (4), and contractile proteins (12) including Ca2+ binding proteins. There were 812 DEG in RER-susceptible versus control involving the electron transfer system, the mitochondrial transcription/translational response and notably the pro-apoptotic Ca(2+-)activated mitochondrial membrane transition pore (SLC25A27, BAX, ATP5 subunits). Upregulated mitochondrial DEG frequently had downregulation of their encoded DEP with semantic similarities highlighting signaling mechanisms regulating mitochondrial protein translation. RER-susceptible horses treated with dantrolene, which slows sarcoplasmic reticulum Ca2+ release, showed no DEG compared to control horses. We conclude that RER-susceptibility is associated with alterations in proteins, genes and pathways impacting myoplasmic Ca2+ regulation, the mitochondrion and protein degradation with opposing effects on mitochondrial transcriptional/translational responses and mitochondrial protein content. RER could potentially arise from excessive sarcoplasmic reticulum Ca2+ release and subsequent mitochondrial buffering of excessive myoplasmic Ca2+.	[Aldrich, Kennedy; Velez-Irizarry, Deborah; Schott, Melissa; Valberg, Stephanie J.] Michigan State Univ, Coll Vet Med, Large Anim Clin Sci, Mary Anne McPhail Equine Performance Ctr, E Lansing, MI 48824 USA; [Fenger, Clara] Equine Integrated Med PLC, Lexington, KY USA	Michigan State University	Valberg, SJ (corresponding author), Michigan State Univ, Coll Vet Med, Large Anim Clin Sci, Mary Anne McPhail Equine Performance Ctr, E Lansing, MI 48824 USA.	valbergs@cvm.msw.edu		Valberg, Stephanie/0000-0001-5978-7010	Grayson Jockey Club Research Foundation; Mary Anne McPhail Endowment at Michigan State University; NIH [T32 OD011167]	Grayson Jockey Club Research Foundation; Mary Anne McPhail Endowment at Michigan State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by the Grayson Jockey Club Research Foundation (SJV), the Mary Anne McPhail Endowment at Michigan State University (SJV) and in part by NIH Grant T32 OD011167 to Michigan State University (KJA). The Grayson Jockey Club Research Foundation provided funds to perform the research study and partial salary for one author (DVI). CF is the owner of Equine Integrated Medicine PLC. and identified horses in her practice that were healthy controls or susceptible to RER and facilitated biopsy samples that were obtained by another author (SJV). CF did not receive any financial remuneration for participating in the study. The specific role of these authors is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson DC, 2012, J PHYSIOL-LONDON, V590, P6381, DOI 10.1113/jphysiol.2012.237925; Anyatonwu GI, 2004, BIOCHEM BIOPH RES CO, V322, P1364, DOI 10.1016/j.bbrc.2004.08.043; Barrey E, 2012, ANIM GENET, V43, P271, DOI 10.1111/j.1365-2052.2011.02246.x; Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; BEECH J, 1993, RES VET SCI, V54, P110, DOI 10.1016/0034-5288(93)90019-C; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Blazquez L, 2018, MOL CELL, V72, P496, DOI 10.1016/j.molcel.2018.09.033; Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005; Cumming J.K.F., 1994, COLOR ATLAS MUSCLE P; Dranchak PK, 2006, AM J VET RES, V67, P1395, DOI 10.2460/ajvr.67.8.1395; Edwards JGT, 2003, EQUINE VET J, V35, P707, DOI 10.2746/042516403775696221; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Fernstrom M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202; Fritz KL, 2012, ANIM GENET, V43, P730, DOI 10.1111/j.1365-2052.2012.02351.x; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Gehlert S, 2015, INT J MOL SCI, V16, P1066, DOI 10.3390/ijms16011066; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; Houben R, 2015, MITOCHONDRION, V24, P99, DOI 10.1016/j.mito.2015.07.006; Isgren CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011594; Karch J, 2014, P NATL ACAD SCI USA, V111, P10396, DOI 10.1073/pnas.1410104111; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lentz LR, 1999, AM J VET RES, V60, P992; Lentz LR, 2002, AM J VET RES, V63, P1724, DOI 10.2460/ajvr.2002.63.1724; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; LINDHOLM A, 1974, ACTA VET SCAND, V15, P287; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; LOPEZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P293, DOI 10.1007/BF00374661; MacLeay JM, 1999, AM J VET RES, V60, P250; MacLeay JM, 1999, AM J VET RES, V60, P1562; MacLeay JM, 2000, AM J VET RES, V61, P1390, DOI 10.2460/ajvr.2000.61.1390; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; McGowan CM, 2002, VET REC, V151, P623, DOI 10.1136/vr.151.21.623; McKenzie EC, 2004, AM J VET RES, V65, P74, DOI 10.2460/ajvr.2004.65.74; McKenzie EC, 2015, AM J VET RES, V76, P293, DOI 10.2460/ajvr.76.4.293; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; NISHITA T, 1995, AM J VET RES, V56, P162; Nogueira GP, 1997, BRAZ J MED BIOL RES, V30, P1237, DOI 10.1590/S0100-879X1997001000016; Norton EM, 2016, J HERED, V107, P537, DOI 10.1093/jhered/esw042; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SCHOLTE HR, 1991, EQUINE VET J, V23, P142, DOI 10.1111/j.2042-3306.1991.tb02740.x; Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00060; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Tozaki T, 2010, ANIM GENET, V41, P80, DOI 10.1111/j.1365-2052.2010.02112.x; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Valberg SJ, 1999, EQUINE VET J, V31, P43, DOI 10.1111/j.2042-3306.1999.tb03789.x; Valberg SJ, 2018, PHYSIOL GENOMICS, V50, P1036, DOI 10.1152/physiolgenomics.00044.2018; Vu B., GITHUB REPOSITORY; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wetzel P, 2002, AM J PHYSIOL-CELL PH, V283, pC1242, DOI 10.1152/ajpcell.00106.2002; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Williams ZJ, 2021, EQUINE VET J, V53, P306, DOI 10.1111/evj.13286; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhao Q, 1997, SICE '97 - PROCEEDINGS OF THE 36TH SICE ANNUAL CONFERENCE, INTERNATIONAL SESSION PAPERS, P1019, DOI 10.1109/SICE.1997.624902	64	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	2							e0244556	10.1371/journal.pone.0244556	http://dx.doi.org/10.1371/journal.pone.0244556			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2TY	33566847	Green Published, gold			2022-12-26	WOS:000616753800001
J	Perry, M; Biegert, M; Kollala, SS; Mallard, H; Su, G; Kodavati, M; Kreiling, N; Holbrook, A; Ghosal, G				Perry, Megan; Biegert, Meghan; Kollala, Sai Sundeep; Mallard, Halle; Su, Grace; Kodavati, Manohar; Kreiling, Natasha; Holbrook, Alexander; Ghosal, Gargi			USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; DVC1 C1ORF124; REGULATOR; SPARTAN/C1ORF124; UBIQUITYLATION; DEFICIENCY; MECHANISM; ENZYME	DNA-protein cross-links (DPCs) are toxic DNA lesions that interfere with DNA metabolic processes such as replication, transcription, and recombination. USP11 deubiquitinase participates in DNA repair, but the role of USP11 in DPC repair is not known. SPRTN is a replication-coupled DNA-dependent metalloprotease that cleaves proteins cross-linked to DNA to promote DPC repair. SPRTN function is tightly regulated by a monoubiquitin switch that controls SPRTN auto-proteolysis and chromatin accessibility during DPC repair. Previously, VCPIP1 and USP7 deubiquitinases have been shown to regulate SPRTN. Here, we identify USP11 as an SPRTN deubiquitinase. USP11 interacts with SPRTN and cleaves monoubiquitinated SPRTN in cells and in vitro. USP11 depletion impairs SPRTN deubiquitination and promotes SPRTN auto-proteolysis in response to formaldehyde-induced DPCs. Loss of USP11 causes an accumulation of unrepaired DPCs and cellular hypersensitivity to treatment with DPC-inducing agents. Our findings show that USP11 regulates SPRTN auto-proteolysis and SPRTN-mediated DPC repair to maintain genome stability.	[Perry, Megan; Biegert, Meghan; Kollala, Sai Sundeep; Mallard, Halle; Kreiling, Natasha; Holbrook, Alexander; Ghosal, Gargi] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Su, Grace] Doane Univ, Dept Biol, Crete, NE USA; [Kodavati, Manohar] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX USA; [Ghosal, Gargi] Fred & Pamela Buffett Canc Ctr, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	Ghosal, G (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Ghosal, G (corresponding author), Fred & Pamela Buffett Canc Ctr, Omaha, NE 68105 USA.	gargi.ghosal@unmc.edu	kodavati, manohar/V-5200-2019	kodavati, manohar/0000-0003-3939-7351; Ghosal, Gargi/0000-0001-8399-5354	National Institutes of Health grants, USA: NIGMS COBRE [P20GM121316]; NCI K22 Career Development Award [K22CA188181]	National Institutes of Health grants, USA: NIGMS COBRE; NCI K22 Career Development Award	This work was supported by National Institutes of Health grants, USA: NIGMS COBRE (P20GM121316; G. G. as project leader) and NCI K22 Career Development Award (K22CA188181) to G. G.	Alvarez-Quilon A, 2020, MOL CELL, V78, P1152, DOI 10.1016/j.molcel.2020.05.021; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Deng TG, 2018, P NATL ACAD SCI USA, V115, P4678, DOI 10.1073/pnas.1714938115; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fielden J, 2018, DNA REPAIR, V71, P198, DOI 10.1016/j.dnarep.2018.08.025; Georges A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34197-x; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Halder S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11095-y; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu QH, 2020, CELL REP, V30, P1235, DOI 10.1016/j.celrep.2019.12.067; Huang JZ, 2020, MOL CELL, V79, P824, DOI 10.1016/j.molcel.2020.06.027; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ide H, 2018, DNA REPAIR, V71, P190, DOI 10.1016/j.dnarep.2018.08.024; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Jacko AM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.371; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kiianitsa K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt171; Kim MS, 2013, NUCLEIC ACIDS RES, V41, P1661, DOI 10.1093/nar/gks1267; Larsen NB, 2019, MOL CELL, V73, P574, DOI 10.1016/j.molcel.2018.11.024; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; Li FX, 2019, CELL REP, V26, P3336, DOI 10.1016/j.celrep.2019.02.082; Li FY, 2019, NAT STRUCT MOL BIOL, V26, P155, DOI 10.1038/s41594-019-0186-1; Lin CH, 2008, J BIOL CHEM, V283, P15681, DOI 10.1074/jbc.M708278200; Lopez-Mosqueda J, 2016, ELIFE, V5, DOI 10.7554/eLife.21491; Luo QY, 2020, CELL REP, V30, P98, DOI 10.1016/j.celrep.2019.12.017; Machida Y, 2012, CELL CYCLE, V11, P3395, DOI 10.4161/cc.21694; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Maskey RS, 2017, NUCLEIC ACIDS RES, V45, P4564, DOI 10.1093/nar/gkx107; Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Serbyn N, 2020, MOL CELL, V77, P1066, DOI 10.1016/j.molcel.2019.12.007; Shah P, 2017, ONCOTARGET, V8, P96522, DOI 10.18632/oncotarget.22105; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stingele J, 2017, NAT REV MOL CELL BIO, V18, P563, DOI 10.1038/nrm.2017.56; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Stockum A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190513; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Ting X, 2019, NUCLEIC ACIDS RES, V47, P9721, DOI 10.1093/nar/gkz726; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Yu M, 2016, J BIOL CHEM, V291, P959, DOI 10.1074/jbc.M114.624478; Zhao SB, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1224	58	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100396	10.1016/j.jbc.2021.100396	http://dx.doi.org/10.1016/j.jbc.2021.100396			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567341	gold, Green Published			2022-12-26	WOS:000672866400370
J	Gebeyehu, E; Nigatu, D; Engidawork, E				Gebeyehu, Endalew; Nigatu, Desalegn; Engidawork, Ephrem			Complete symptom resolution as predictor of Helicobacter pylori eradication and factors affecting symptom resolution: Prospective follow up study	PLOS ONE			English	Article							UPPER GASTROINTESTINAL SYMPTOMS; FUNCTIONAL DYSPEPSIA; PEPTIC-ULCER; INFECTION; THERAPY; HEALTH; IMPROVEMENT; MANAGEMENT; DIAGNOSIS; DISEASE	Background Symptom resolution is the most common clinical practice during assessment and evaluation of helicobacter pylori infected patients after employing eradication therapy. Objective Prediction of eradication of H. pylori with symptom resolution and assess factors affecting symptom resolution. Method Facility based follow up study was done on consented H. pylori positive adult patients who received standard triple therapy consisting of a proton pump inhibitor, amoxicillin, and clarithromycin from May 2016 to April 2018 at Bahir Dar city in Ethiopia. Sociodemographic and clinical data was collected before and after eradication therapy by using pre-developed structured questionnaire. Both positive and negative predictive values were calculated. SPSS version 23 was used to conduct bivariate and backward stepwise multivariate logistic regression to analyze data. P-value < 0.05 at 95%CI was considered as significant. Result The study involved a total of 421 patients who completed follow up. Patients' mean age and body weight (+/- SD) were 30.63 (+/- 10.74) years and 56.71 (+/- 10.19) kg, respectively. Complete symptom resolution was achieved in 84.3% of the patients and eradication of H. pylori was successful in 90% of patients. Positive predictive value of complete symptom resolution for H. pylori eradication was 98.9% (351/355) and whereas negative predictive value was 57.6%(38/66). Factors associated with complete symptom resolution were regimen completion (AOR: 2.77 95%CI (1.12-6.86), p = 0.028) and no use of traditional homemade supplements prepared from Fenugreek or Flaxseed (AOR: 2.09 95%CI (1.22-3.58), p = 0.007). Conclusion Complete symptom resolution is a powerful predictor of success of H. pylori eradication and can be used to assess H. pylori status after eradication therapy. Assessment of complete symptom resolution should consider regimen completion and traditional practice of using homemade supplements prepared from Fenugreek or Flaxseed.	[Gebeyehu, Endalew] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia; [Nigatu, Desalegn] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Internal Med, Bahir Dar, Ethiopia; [Engidawork, Ephrem] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia	Bahir Dar University; Bahir Dar University; Addis Ababa University	Gebeyehu, E (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia.	endalew2008@gmail.com	Engidawork, Ephrem/K-7551-2019	Engidawork, Ephrem/0000-0002-9931-6421; Gebeyehu, Endalew/0000-0003-3330-4513	Bahir Dar University; Addis Ababa University	Bahir Dar University; Addis Ababa University	This study was supported by Bahir Dar and Addis Ababa Universities in the form of funds awarded to EG and allocated to graduate students to cover the per diem of data collectors, as well as laboratory materials to undertake stool antigen testing. The funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Bahir Dar University and Addis Ababa University for their support of this study. We would like to thank healthcare institutions namely Adinas General Hospital and Kidanemihret Higher Clinic for their official support that allow us to collect data. We would like to thank Abebe Fetene and Kibret Ayalew for their administrative support during data collection. Moreover, we would like to appreciative to Aklilu Gashaye for his language editing service. Finally, we thank volunteer patients for their participation in this study.	Ahmed Khan F, 2017, LIBYAN J MED SCI, V1, P29; [Anonymous], 2011, J CLIN GASTROENTEROL, V45, P383, DOI 10.1097/MCG.0b013e31820fb8f6; Atkinson NSS, 2016, DIGEST DIS SCI, V61, P19, DOI 10.1007/s10620-015-3877-4; Backert S, 2016, HELICOBACTER, V21, P19, DOI 10.1111/hel.12335; Basch Ethan, 2007, J Soc Integr Oncol, V5, P92, DOI 10.2310/7200.2007.005; Bazzoli F, 2002, GUT, V50, P33; Carraro JCC, 2012, FOOD REV INT, V28, P203, DOI 10.1080/87559129.2011.595025; Chatterjee S, 2015, FIRE J ENG TECHNOLOG, V1, P60; Chiba N, 1999, PROGR BASIC CLIN PHA, P227; COLINJONES DG, 1988, LANCET, V1, P576; Du LJ, 2016, WORLD J GASTROENTERO, V22, P3486, DOI 10.3748/wjg.v22.i12.3486; El-Serag HB, 2018, CLIN GASTROENTEROL H, V16, P992, DOI 10.1016/j.cgh.2018.03.013; Elitsur Y, 2004, J PEDIATR GASTR NUTR, V39, P64, DOI 10.1097/00005176-200407000-00013; Fendrick AM, 1999, AM J MED, V107, P133, DOI 10.1016/S0002-9343(99)00196-5; Fischbach W, 2018, DTSCH ARZTEBL INT, V115, P429, DOI 10.3238/arztebl.2018.0429; Frank L, 2000, DIGEST DIS SCI, V45, P809, DOI 10.1023/A:1005468332122; Gebeyehu E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225585; Gebeyehu E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217645; Gururatsakul M, 2010, J GASTROEN HEPATOL, V25, P1162, DOI 10.1111/j.1440-1746.2010.06269.x; Gwee KA, 2009, EUR J GASTROEN HEPAT, V21, P327, DOI 10.1097/MEG.0b013e328317b89e; HETZEL DJ, 1988, GASTROENTEROLOGY, V95, P903, DOI 10.1016/0016-5085(88)90162-X; Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6; Jaber N, 2016, CENT ASIAN J GLOB HE, V5, DOI 10.5195/cajgh.2016.192; Jaka H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4085-1; Jodaki A, 2016, MINERVA GASTROENTERO, V62, P148; Kang SJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091324; Kim Sung Eun, 2018, Korean J Gastroenterol, V72, P286, DOI 10.4166/kjg.2018.72.6.286; Labigne A, 1996, INFECT AGENT DIS, V5, P191; Laheij RJF, 1996, ALIMENT PHARM THER, V10, P843, DOI 10.1046/j.1365-2036.1996.86258000.x; Leja M, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12635; Mabek LBK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3146-1; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P1431, DOI 10.1046/j.1365-2036.2002.01285.x; Mazzoleni LE, 2011, ARCH INTERN MED, V171, P1929, DOI 10.1001/archinternmed.2011.533; McColl KEL, 1998, GUT, V42, P618, DOI 10.1136/gut.42.5.618; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Melese A, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-018-0927-3; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; O'Connor John P Anthony, 2009, Therap Adv Gastroenterol, V2, P273, DOI 10.1177/1756283X09337342; Pilotto A, 1999, HEPATO-GASTROENTEROL, V46, P245; Priy R, 2017, FLAXSEED COMPOSITION; Rokkas T, 2012, ANN GASTROENTEROL, V25, P176; Scheiman JM, 2013, J CARDIOVASC PHARM, V61, P250, DOI 10.1097/FJC.0b013e31827cb626; Shimoyama T, 2013, WORLD J GASTROENTERO, V19, P8188, DOI 10.3748/wjg.v19.i45.8188; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; Strand DS, 2017, GUT LIVER, V11, P27, DOI 10.5009/gnl15502; Suzuki H, 2017, DIGEST DIS SCI, V62, P1391, DOI 10.1007/s10620-017-4556-4; Suzuki H, 2011, J GASTROEN HEPATOL, V26, P42, DOI 10.1111/j.1440-1746.2011.06629.x; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; Vasapolli R, 2016, HELICOBACTER, V21, P30, DOI 10.1111/hel.12337; Williams D, 2001, ALIMENT PHARM THER, V15, P1769, DOI 10.1046/j.1365-2036.2001.01100.x; Yadav UCS, 2014, PHARM BIOL, V52, P243, DOI 10.3109/13880209.2013.826247; Yamamichi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088277; Yu LY, 2017, ADV THER, V34, P1070, DOI 10.1007/s12325-017-0532-9; Zhang CL, 2016, WORLD J GASTROENTERO, V22, P4585, DOI 10.3748/wjg.v22.i18.4585	55	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246624	10.1371/journal.pone.0246624	http://dx.doi.org/10.1371/journal.pone.0246624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571257	gold, Green Published			2022-12-26	WOS:000618274000073
J	Rutherford, L; Stark, A; Ablona, A; Klassen, BJ; Higgins, R; Jacobsen, H; Draenos, CJ; Card, KG; Lachowsky, NJ				Rutherford, Leo; Stark, Aeron; Ablona, Aidan; Klassen, Benjamin J.; Higgins, Robert; Jacobsen, Hanna; Draenos, Christopher J.; Card, Kiffer G.; Lachowsky, Nathan J.			Health and well-being of trans and non-binary participants in a community-based survey of gay, bisexual, and queer men, and non-binary and Two-Spirit people across Canada	PLOS ONE			English	Article							TRANSGENDER MEN; CARE; RISK; COMORBIDITY; PREVALENCE; DISORDERS; SEX	There is a paucity of population health data on the experiences of transgender, non-binary, and other gender minority gay, bisexual, and queer men, and Two-Spirit people in Canada. To address this gap, this article presents a socio-demographic and health profile of trans and non-binary participants from the community-based bilingual 2018 Sex Now Survey. Participants were recruited in-person from Pride festivals in 15 communities to self-complete an anonymous paper-and-pen questionnaire. To be eligible, participants needed to be at least 15 years old, live in Canada, either report a non-heterosexual sexual identity or report sex with a man in the past 5 years, and not report gender identity as a woman. Through community consultations the survey was inclusive of trans men, non-binary people, and Two-Spirit people. Three gender groups (cisgender, transgender, and non-binary) were created, and trans and non-binary participants were compared with their cisgender peers across a variety of demographic, mental health, sexual health, and general health indicators. Odds ratios were calculated to determine initial significance for categorical variables, and adjusted odds ratios were calculated to control for five possible confounders (age, ethnoracial identity, country of birth, sexual identity, and financial strain). Significant differences emerged across all sets of indicators, with many of these findings remaining significant after adjusting for confounding variables, including significantly higher reported rates of mental health challenges and sexual health service barriers for trans and non-binary participants compared to the cisgender group. Trans and non-binary participants were also more likely to be in polyamorous relationships. Collectively, our findings demonstrate that trans and non-binary people experience significant disadvantages compared with cisgender sexual minority men. Improved educational supports and employment protections, access to queer and gender affirming healthcare, and trauma-informed mental health services are needed to improve the health wellbeing of trans and non-binary people in Canada.	[Rutherford, Leo; Stark, Aeron; Higgins, Robert; Jacobsen, Hanna; Card, Kiffer G.; Lachowsky, Nathan J.] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada; [Ablona, Aidan] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Ablona, Aidan; Klassen, Benjamin J.; Jacobsen, Hanna; Draenos, Christopher J.; Card, Kiffer G.; Lachowsky, Nathan J.] Community Based Res Ctr, Vancouver, BC, Canada	University of Victoria	Lachowsky, NJ (corresponding author), Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada.; Lachowsky, NJ (corresponding author), Community Based Res Ctr, Vancouver, BC, Canada.	nlachowsky@uvic.ca		Klassen, Benjamin/0000-0002-8203-724X; Jacobsen, Kai/0000-0003-4610-043X; Ablona, Aidan/0000-0003-1436-6276; Card, Kiffer George/0000-0001-6545-1249	Canadian Blood Services MSM Research Fund - federal government (Health Canada); provincial and territorial ministries of health; Women and Gender Equality (WAGE) Canada; Michael Smith Foundation for Health Research [16863]	Canadian Blood Services MSM Research Fund - federal government (Health Canada); provincial and territorial ministries of health; Women and Gender Equality (WAGE) Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Sex Now 2018 received funding support from Canadian Blood Services MSM Research Fund, funded by the federal government (Health Canada) and the provincial and territorial ministries of health. The views herein do not necessarily reflect the views of Canadian Blood Services or the federal, provincial, or territorial governments of Canada. Additional in-kind contributions were received from the Public Health Agency of Canada's National Microbiology Laboratory. Additional funding for this analysis was provided by Women and Gender Equality (WAGE) Canada. NJL is supported by a Scholar Award from the Michael Smith Foundation for Health Research (#16863).	[Anonymous], 2019, TR2195 3GPP; [Anonymous], 2015, CML REV, V52, P1; Bauer GR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1867-2; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Bauer GR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-292; Beckwith N, 2019, LGBT HEALTH, V6, P51, DOI 10.1089/lgbt.2018.0136; Clark BA, 2018, INT J TRANSGENDERISM, V19, P158, DOI 10.1080/15532739.2017.1394954; Defreyne J, 2017, EXPERT REV PHARM OUT, V17, P543, DOI 10.1080/14737167.2017.1388164; Ferlatte O, 2020, J SEX RES, V57, P1005, DOI 10.1080/00224499.2020.1740148; Gilmour H, 2019, HEALTH REP, V30, P3, DOI [10.25318/82-003-x201901100001, 10.25318/82-003-x201901100001-eng]; Glynn Tiffany R, 2016, Psychol Sex Orientat Gend Divers, V3, P336; Gonzalez CA, 2017, J PRIM PREV, V38, P419, DOI 10.1007/s10935-017-0469-4; Grant J.M., 2011, INJUSTICE EVERY TURN; Herman JL, BEST PRACTICES ASKIN; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; James J., 2018, 1 HIV AIDS LEG CLIN; James S. E., 2016, REPORT US TRANSGENDE; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Noonan EJ, 2018, TEACH LEARN MED, V30, P119, DOI 10.1080/10401334.2017.1365718; Rich A, 2017, CULT HEALTH SEX, V19, P1197, DOI 10.1080/13691058.2017.1299882; Rotondi NK, 2013, AM J PUBLIC HEALTH, V103, pE11, DOI 10.2105/AJPH.2013.301348e; Safer JD, 2016, CURR OPIN ENDOCRINOL, V23, P168, DOI 10.1097/MED.0000000000000227; Scheim AI, 2014, TRANS PULSE E B, V8; Scheim AI, 2017, ADDICT BEHAV, V72, P151, DOI 10.1016/j.addbeh.2017.03.022; Scheim AI, 2017, AIDS CARE, V29, P990, DOI 10.1080/09540121.2016.1271937; Scheim AI, 2017, JAIDS-J ACQ IMM DEF, V74, pE89, DOI [10.1097/QAI.0000000000001222, 10.1097/qai.0000000000001222]; Scheim AI, 2016, J INT AIDS SOC, V19, P52, DOI 10.7448/IAS.19.3.20779; Sevelius J, 2009, J ASSOC NURSE AIDS C, V20, P398, DOI 10.1016/j.jana.2009.06.001; Sineath R Craig, 2016, Transgend Health, V1, P129; Stats Canada, LOW INC STAT AG SEX; Taylor A.B., 2020, BEING SAFE BEING ME; The TransPULSE Canada Team, 2020, REPORT HLTH HEALTH C; Veale Jaimie F, 2017, Transgend Health, V2, P207, DOI 10.1089/trgh.2017.0031; Vermeir Ella, 2018, Healthc Policy, V14, P11, DOI 10.12927/hcpol.2018.25552; Waite S, 2019, CAN REV SOCIOL, V56, P93, DOI 10.1111/cars.12232; Wilkinson L, 2018, SOC SCI RES, V74, P146, DOI 10.1016/j.ssresearch.2018.04.006; Wilson EC, 2016, AIDS BEHAV, V20, P2203, DOI 10.1007/s10461-016-1409-7	39	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246525	10.1371/journal.pone.0246525	http://dx.doi.org/10.1371/journal.pone.0246525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571252	Green Published, gold			2022-12-26	WOS:000618274000043
J	Kurth, D; Elias, D; Rasuk, MC; Contreras, M; Farias, ME				Kurth, Daniel; Elias, Dario; Rasuk, Maria Cecilia; Contreras, Manuel; Farias, Maria Eugenia			Carbon fixation and rhodopsin systems in microbial mats from hypersaline lakes Brava and Tebenquiche, Salar de Atacama, Chile	PLOS ONE			English	Article							COMPARATIVE METAGENOMICS; BACTERIAL DIVERSITY; READ ALIGNMENT; COMMUNITIES; IDENTIFICATION; ABUNDANCE; GENOME; ORIGIN; GROWTH	In this work, molecular diversity of two hypersaline microbial mats was compared by Whole Genome Shotgun (WGS) sequencing of environmental DNA from the mats. Brava and Tebenquiche are lakes in the Salar de Atacama, Chile, where microbial communities are growing in extreme conditions, including high salinity, high solar irradiance, and high levels of toxic metals and metaloids. Evaporation creates hypersaline conditions in these lakes and mineral precipitation is a characteristic geomicrobiological feature of these benthic ecosystems. The mat from Brava was more rich and diverse, with a higher number of different taxa and with species more evenly distributed. At the phylum level, Proteobacteria, Cyanobacteria, Chloroflexi, Bacteroidetes and Firmicutes were the most abundant, including similar to 75% of total sequences. At the genus level, the most abundant sequences were affilitated to anoxygenic phototropic and cyanobacterial genera. In Tebenquiche mats, Proteobacteria and Bacteroidetes covered similar to 70% of the sequences, and 13% of the sequences were affiliated to Salinibacter genus, thus addressing the lower diversity. Regardless of the differences at the taxonomic level, functionally the two mats were similar. Thus, similar roles could be fulfilled by different organisms. Carbon fixation through the Wood-Ljungdahl pathway was well represented in these datasets, and also in other mats from Andean lakes. In spite of presenting less taxonomic diversity, Tebenquiche mats showed increased abundance and variety of rhodopsin genes. Comparison with other metagenomes allowed identifying xantorhodopsins as hallmark genes not only from Brava and Tebenquiche mats, but also for other mats developing at high altitudes in similar environmental conditions.	[Kurth, Daniel; Rasuk, Maria Cecilia; Farias, Maria Eugenia] Consejo Nacl Invest Cient & Tecn, Lab Invest Microbiol Lagunas Andinas LIMLA, CCT, Planta Piloto Proc Ind Microbiol PROIMI, San Miguel De Tucuman, Argentina; [Elias, Dario] Univ Nacl Entre Rios, Fac Ingn, Oro Verde, Entre Rios, Argentina; [Contreras, Manuel] Ctr Ecol Aplicada CEA, Santiago, Chile; [Elias, Dario] Consejo Nacl Invest Cient & Tecn, CEMIC Ctr Educ Med & Invest Clin, ECLAMC Estudio Colaborat Latinoamer Malformac Con, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Farias, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, Lab Invest Microbiol Lagunas Andinas LIMLA, CCT, Planta Piloto Proc Ind Microbiol PROIMI, San Miguel De Tucuman, Argentina.	mefarias2009@gmail.com	Elias, Dario E/AHC-0074-2022; Rasuk, Maria/AAN-5887-2021	Elias, Dario E/0000-0002-6576-8569; Rasuk, Maria/0000-0002-4852-0924; Kurth, Daniel/0000-0001-8481-4359	Fondo para la Investigacio'n Cienti'fica y Tecnolo'gica (FONCYT), Argentina [PICT V Bicentenario 2010-1788, PICT V 2015-3825]; Sociedad Qui'mica y Minera de Chile; Centro de Ecologi'a Aplicada	Fondo para la Investigacio'n Cienti'fica y Tecnolo'gica (FONCYT), Argentina(FONCyT); Sociedad Qui'mica y Minera de Chile; Centro de Ecologi'a Aplicada	Financial support was provided to MEF and MC, by projects PICT V Bicentenario 2010-1788, PICT V 2015-3825 from Fondo para la Investigacio ' n Cienti ' fica y Tecnolo ' gica (FONCYT), Argentina (https://www.argentina.gob.ar/ciencia/agencia/fondo-para-la-investigacion-cientifica-ytecnologica-foncyt), Sociedad Qui ' mica y Minera de Chile (https://www.sqm.com/), and Centro de Ecologi ' a Aplicada (https://cea.cl/).DK, MCR and MEF are CONICET fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin VH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01404; Alonso H, 1996, REV GEOL CHILE, V23, P113; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, VEGAN COMMUNITY ECOL; Atamna-Ismaeel N, 2012, ENV MICROBIOL REP, V4, P209, DOI 10.1111/j.1758-2229.2011.00323.x; Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Boeuf D, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav080; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolhuis H, 2014, FEMS MICROBIOL ECOL, V90, P335, DOI 10.1111/1574-6941.12408; Bonilla-Rosso G, 2012, ASTROBIOLOGY, V12, P659, DOI 10.1089/ast.2011.0724; Bull AT, 2016, ANNU REV MICROBIOL, V70, P215, DOI 10.1146/annurev-micro-102215-095236; Burguener GF, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01096-13; Burow LC, 2014, GEOBIOLOGY, V12, P221, DOI 10.1111/gbi.12080; Cabrol NA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000818; Rasuk MC, 2016, MICROB ECOL, V71, P44, DOI 10.1007/s00248-015-0649-9; Charrad M, 2014, J STAT SOFTW, V61, P1; Demergasso C, 2003, REV CHIL HIST NAT, V76, P485; Demergasso C, 2008, EXTREMOPHILES, V12, P491, DOI 10.1007/s00792-008-0153-y; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Farias ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186867; Farias ME, 2014, EXTREMOPHILES, V18, P311, DOI 10.1007/s00792-013-0617-6; Farias ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053497; Fernandez AB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01284; Finkel OM, 2013, ISME J, V7, P448, DOI 10.1038/ismej.2012.112; Franzetti A, 2016, ISME J, V10, P2984, DOI 10.1038/ismej.2016.72; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Gorriti MF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-473; Gutierrez-Preciado A, 2018, NAT ECOL EVOL, V2, P1700, DOI 10.1038/s41559-018-0683-3; Albarracin VH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154962; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Gomez FJ, 2018, J SEDIMENT RES, V88, P727, DOI 10.2110/jsr.2018.37; Ji M, 2017, NATURE, V552, P400, DOI 10.1038/nature25014; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurth D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00896-0; Kwak MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106704; Kwon SK, 2013, GENOME BIOL EVOL, V5, P187, DOI 10.1093/gbe/evs134; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkum AWD, 2018, PHOTOSYNTHETICA, V56, P11, DOI 10.1007/s11099-018-0792-x; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lynch RC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00698; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mende DR, 2017, NUCLEIC ACIDS RES, V45, pD529, DOI 10.1093/nar/gkw989; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitchell AL, 2018, NUCLEIC ACIDS RES, V46, pD726, DOI 10.1093/nar/gkx967; Mobberley J, 2013, PHOTOSYNTH RES, V118, P125, DOI 10.1007/s11120-013-9890-6; Muller AL, 2015, ISME J, V9, P1152, DOI 10.1038/ismej.2014.208; Overmann J., 2013, PROKARYOTES, P203, DOI DOI 10.1007/978-3-642-30123-0_51; Palovaara J, 2014, P NATL ACAD SCI USA, V111, pE3650, DOI 10.1073/pnas.1402617111; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pinhassi J, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00003-16; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prieto-Barajas CM, 2018, ELECTRON J BIOTECHN, V31, P48, DOI 10.1016/j.ejbt.2017.11.001; R Core Team, 2020, R LANG ENV STAT COMP; Rabus R, 2013, PROKARYOTES PROKARYO, DOI [10.1021/bi400968e23962133, DOI 10.1021/BI400968E23962133]; Rascovan N, 2016, ISME J, V10, P299, DOI 10.1038/ismej.2015.109; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Risacher F, 2003, EARTH-SCI REV, V63, P249, DOI 10.1016/S0012-8252(03)00037-0; Rodriguez LM, 2015, ISME J, V9, P1928, DOI 10.1038/ismej.2015.5; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Ruvindy R, 2016, ISME J, V10, P183, DOI 10.1038/ismej.2015.87; Saghai A, 2017, ENVIRON MICROBIOL, V19, P2405, DOI 10.1111/1462-2920.13754; Saghai A, 2016, ENVIRON MICROBIOL, V18, P4990, DOI 10.1111/1462-2920.13456; Sancho-Tomas M, 2018, CHEM GEOL, V490, P13, DOI 10.1016/j.chemgeo.2018.04.029; Saona LA, 2019, ANAL COREGULATED ABU, DOI [10.1101/870428, DOI 10.1101/870428]; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Suzuki R, 2019, **DATA OBJECT**; Thiel V, 2010, FEMS MICROBIOL ECOL, V74, P510, DOI 10.1111/j.1574-6941.2010.00966.x; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Vollmers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063422; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Waterworth SC, 2019, METABOLIC SPECIALIZA, DOI [10.1101/818625, DOI 10.1101/818625]; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilke A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004008; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wong HL, 2018, ISME J, V12, P2619, DOI 10.1038/s41396-018-0208-8; Yau S, 2013, ISME J, V7, P1944, DOI 10.1038/ismej.2013.69	88	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246656	10.1371/journal.pone.0246656	http://dx.doi.org/10.1371/journal.pone.0246656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561170	Green Published, gold			2022-12-26	WOS:000617533000001
J	Chiu, CY; Sarwal, A; Jawed, M; Chemarthi, VS; Shabarek, N				Chiu, Chia-Yu; Sarwal, Amara; Jawed, Muzamil; Chemarthi, Venkata Sireesha; Shabarek, Nehad			Telemedicine experience of NYC Internal Medicine residents during COVID-19 pandemic	PLOS ONE			English	Article								Background The COVID-19 pandemic challenged the resilience of public health, including diagnostic testing, antiviral development and transmission prevention. In addition, it also affected the medical education of many residents and learners throughout the country. Historically, physicians undergoing their residency training were not involved in telemedicine. However, in response to the challenges faced due to COVID-19, the Accreditation Council for Graduate Medical Education (ACGME) released a provision in May 2020 to allow residents to participate in telemedicine. Method Lincoln Medical Center, located in the South Bronx of New York City, currently has 115 Internal Medicine residents, and telemedicine clinic visits have been conducted by residents since June 2020. An anonymous 25-question survey was sent to all Internal Medicine residents between August 8, 2020 to August 14, 2020. Result Of 115 residents, 95 (82.6% of the residents) replied to this questionnaire. Residents revealed feeling less confident in managing chronic diseases through telemedicine visits. The survey also shows that 83.1% of respondents prefer in-person visits during their training, 65.3% feel that the telemedicine experience will affect their future career choice, and 67.4% would prefer less than 50% of visits to be telemedicine in their future careers. Outcome The purpose of the new ACGME rules allowing telemedicine was to prevent the undertraining of residents and maintain health care for the patient during the COVID-19 pandemic. This affects residency training and the experiences of residents, which in turn can influence their future career plans.	[Chiu, Chia-Yu; Sarwal, Amara; Jawed, Muzamil; Chemarthi, Venkata Sireesha; Shabarek, Nehad] Lincoln Med Ctr, Dept Internal Med, New York, NY 10451 USA		Chiu, CY (corresponding author), Lincoln Med Ctr, Dept Internal Med, New York, NY 10451 USA.	chiuc2@nychhc.org		CHIU, CHIA-YU/0000-0002-5241-3435				Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7; [Anonymous], 2020, GUID STAT COMP BAS M; Bashshur R, 2011, TELEMED E-HEALTH, V17, P484, DOI 10.1089/tmj.2011.0103; Centers for Disease Control and Prevention, 2020, PREP TOOLS HEALTHC P; Dedeilia A, 2020, IN VIVO, V34, P1603, DOI 10.21873/invivo.11950; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Nasca Thomas J., 2020, ACGME RESPONSE CORON; Nasca Thomas J., 2020, ACGME RESPONSE COVID; Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810; Quinn Doris C, 2009, J Grad Med Educ, V1, P119, DOI 10.4300/01.01.0020; Sood S, 2007, TELEMED J E-HEALTH, V13, P573, DOI 10.1089/tmj.2006.0073; World Health Organization, 2010, TEL OPP DEV MEMB STA	12	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246762	10.1371/journal.pone.0246762	http://dx.doi.org/10.1371/journal.pone.0246762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556151	gold, Green Published			2022-12-26	WOS:000617379900061
J	Dehghankar, M; Maleki-Ravasan, N; Tahghighi, A; Karimian, F; Karami, M				Dehghankar, Maryam; Maleki-Ravasan, Naseh; Tahghighi, Azar; Karimian, Fateh; Karami, Mohsen			Bioactivities of rose-scented geranium nanoemulsions against the larvae of Anopheles stephensi and their gut bacteria	PLOS ONE			English	Article							ESSENTIAL OIL; LARVICIDAL ACTIVITY; CULEX-PIPIENS; INSECTICIDAL ACTIVITY; DIPTERA-CULICIDAE; MALARIOUS AREAS; AROMATIC PLANTS; MOSQUITO; CITRONELLOL; RESISTANCE	Anopheles stephensi with three different biotypes is a major vector of malaria in Asia. It breeds in a wide range of habitats. Therefore, safer and more sustainable methods are needed to control its immature stages rather than chemical pesticides. The larvicidal and antibacterial properties of the Pelargonium roseum essential oil (PREO) formulations were investigated against mysorensis and intermediate forms of An. stephensi in laboratory conditions. A series of nanoemulsions containing different amounts of PREO, equivalent to the calculated LC50 values for each An. stephensi form, and various quantities of surfactants and co-surfactants were developed. The physical and morphological properties of the most lethal formulations were also determined. PREO and its major components, i.e. citronellol (21.34%), L-menthone (6.41%), linalool (4.214%), and geraniol (2.19%), showed potent larvicidal activity against the studied mosquitoes. The LC50/90 values for mysorensis and intermediate forms were computed as 11.44/42.42 ppm and 12.55/47.69 ppm, respectively. The F48/F44 nanoformulations with 94% and 88% lethality for the mysorensis and intermediate forms were designated as optimized formulations. The droplet size, polydispersity index, and zeta-potential for F48/F44 were determined as 172.8/90.95 nm, 0.123/0.183, and -1.08/-2.08 mV, respectively. These results were also confirmed by TEM analysis. Prepared formulations displayed antibacterial activity against larval gut bacteria in the following order of decreasing inhibitory: LC90, optimized nanoemulsions, and LC50. PREO-based formulations were more effective against mysorensis than intermediate. Compared to the crude PREO, the overall larvicidal activity of all nanoformulations boosted by 20% and the optimized formulations by 50%. The sensitivity of insect gut bacteria may be a crucial factor in determining the outcome of the effect of toxins on target insects. The formulations designed in the present study may be a good option as a potent and selective larvicide for An. stephensi.	[Dehghankar, Maryam] Islamic Azad Univ, Fac Basic Sci, Sci & Res Branch, Tehran, Iran; [Dehghankar, Maryam; Maleki-Ravasan, Naseh; Tahghighi, Azar] Pasteur Inst Iran, Biotechnol Res Ctr, Malaria & Vector Res Grp, Tehran, Iran; [Maleki-Ravasan, Naseh] Pasteur Inst Iran, Dept Parasitol, Tehran, Iran; [Tahghighi, Azar] Pasteur Inst Iran, Dept Clin Res, Lab Med Chem, Tehran, Iran; [Karimian, Fateh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran; [Karami, Mohsen] Babol Univ Med Sci, Dept Parasitol & Mycol, Babol, Iran	Islamic Azad University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Babol University of Medical Sciences	Maleki-Ravasan, N; Tahghighi, A (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Malaria & Vector Res Grp, Tehran, Iran.; Maleki-Ravasan, N (corresponding author), Pasteur Inst Iran, Dept Parasitol, Tehran, Iran.; Tahghighi, A (corresponding author), Pasteur Inst Iran, Dept Clin Res, Lab Med Chem, Tehran, Iran.	naseh_maleki@yahoo.com; atahghighi2009@gmail.com		Karimian, Fateh/0000-0002-2576-1215; Maleki-Ravasan, Naseh/0000-0001-7209-5908	Pasteur Institute of Iran [1080]	Pasteur Institute of Iran	This research was financially supported by the Pasteur Institute of Iran (grant no. 1080 to NMR and AT).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abd El-Kareem MSM, 2020, PROCESSES, V8, DOI 10.3390/pr8020128; ACME Resistance, 2018, ACME, V17, P1; Adams J AC, 2006, PELARGONIUMS HERB SO; AHMED KS, 2001, PAKISTAN J BIOL SCI, V4, P1371; Aktar Md Wasim, 2009, Interdiscip Toxicol, V2, P1, DOI 10.2478/v10102-009-0001-7; Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; Anderasen MH, 2006, EMERGING RESISTANCE, P1; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2015, J ENTOMOL ZOOL STUD; ANYANWU GI, 1993, ANN TROP MED PARASIT, V87, P269, DOI 10.1080/00034983.1993.11812766; Aqil M, 2007, DRUG DISCOV TODAY, V12, P1061, DOI 10.1016/j.drudis.2007.09.001; Balasubramani S, 2018, MICROB PATHOGENESIS, V125, P475, DOI 10.1016/j.micpath.2018.10.017; Balasubramani S, 2017, ENVIRON SCI POLLUT R, V24, P15125, DOI 10.1007/s11356-017-9118-y; Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012; Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052; Bilia AR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/651593; Bird S., 2014, UPTODATE, V14, P339; Botas GD, 2017, MOLECULES, V22, DOI 10.3390/molecules22111990; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Campolo O, 2018, J FOOD QUALITY, DOI 10.1155/2018/6906105; Charlwood B., 1991, MED AROMATIC PLANTS, P339; Chavshin Ali Reza, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P47, DOI 10.1016/S2221-1691(14)60207-0; Chen W, 2010, S AFR J BOT, V76, P643, DOI 10.1016/j.sajb.2010.05.008; Chrustek A, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54040061; Collotta M, 2013, TOXICOLOGY, V307, P35, DOI 10.1016/j.tox.2013.01.017; COLUZZI M, 1973, Parassitologia (Rome), V15, P129; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Dada N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20367-4; Dehghan H, 2017, J ARTHROPOD-BORNE DI, V11, P515; Dhifi Wissal, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3040025; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.010, 10.1016/j.bjp.2015.02.2010]; Echeverria Javier, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6020042; El-Wakeil NE, 2013, GESUNDE PFLANZ, V65, P125, DOI 10.1007/s10343-013-0308-3; Essid R, 2017, APPL MICROBIOL BIOT, V101, P6993, DOI 10.1007/s00253-017-8442-y; Gallardo A, 2012, J MED ENTOMOL, V49, P332, DOI 10.1603/ME11142; Giunti G, 2019, IND CROP PROD, V142, DOI 10.1016/j.indcrop.2019.111869; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771; Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438; Guimaraes AC, 2019, MOLECULES, V24, DOI 10.3390/molecules24132471; Hanari-Bojd AA, 2012, J VECTOR DIS, V49, P91; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hennemann Julia, 2007, LINX, V57, P79; Hikal WM, 2017, COGENT BIOL, V3, DOI 10.1080/23312025.2017.1404274; Hoosh-Deghati H, 2017, J ARTHROPOD-BORNE DI, V11, P354; Ignasiak K, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1133-0; Isman MB, 2011, PHYTOCHEM REV, V10, P197, DOI 10.1007/s11101-010-9170-4; Jesus FLM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6756793; Karami M, 2016, J ARTHROPOD-BORNE DI, V10, P349; Karimian F, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-018-3273-y; Karimian F, 2014, JPN J INFECT DIS, V67, P361, DOI 10.7883/yoken.67.361; Karunamoorthi K, 2013, HEALTH SCOPE, V2, DOI 10.17795/jhealthscope-9840; Kaur S, 2011, Z NATURFORSCH C, V66, P260, DOI 10.5560/ZNC.2011.66c0260; Kostyukovsky M, 2002, PEST MANAG SCI, V58, P1101, DOI 10.1002/ps.548; Krishnan KS, 1961, VECTORS MALARIA INDI; Kumar Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01081; Lee H, 2018, PRIMARY CARE, V45, P393, DOI 10.1016/j.pop.2018.05.001; Lei CF, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0250-1; Lorenzi V, 2009, ANTIMICROB AGENTS CH, V53, P2209, DOI 10.1128/AAC.00919-08; Luna EC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6587150; Maleki-Ravasan N, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.777; Maleki-Ravasan N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0517-3; MANOUCHEHRI AV, 1976, TROP GEOGR MED, V28, P228; Matsuoka H, 2002, PARASITOL INT, V51, P17, DOI 10.1016/S1383-5769(01)00095-2; Mossa A. T. H., 2016, Journal of Environmental Science and Technology, V9, P354; MR4, 2014, METH AN RES MAN; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2; MULLA MS, 1994, J AM MOSQUITO CONTR, V10, P574; Nagpal BN, 2003, J MED ENTOMOL, V40, P747, DOI 10.1603/0022-2585-40.6.747; Niang EA, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/1470459; Nisha Sogan, 2018, International Journal of Mosquito Research, V5, P1; Nollet LMR, 2017, H S GREEN PESTICIDES; Noman A, 2020, SCI TOTAL ENVIRON, V699, DOI 10.1016/j.scitotenv.2019.134181; Odriozola-Serrano Isabel, 2014, Front Nutr, V1, P24, DOI 10.3389/fnut.2014.00024; Oliveira AEMFM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145835; Opender Koul, 2008, Biopesticides International, V4, P63; Osanloo M, 2018, ENVIRON SCI POLLUT R, V25, P6466, DOI 10.1007/s11356-017-0822-4; Osanloo M, 2017, IND CROP PROD, V109, P214, DOI 10.1016/j.indcrop.2017.08.037; Oshaghi M.A., 2006, Pakistan Journal of Biological Sciences, V9, P294, DOI 10.3923/pjbs.2006.294.298; Otti O, 2015, INSECT SCI, V22, P325, DOI 10.1111/1744-7917.12183; Ozkara A, 2016, ENVIRONMENTAL HLTH R; Pavela R, 2018, IND CROP PROD, V113, P46, DOI 10.1016/j.indcrop.2018.01.021; Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005; PEIRIS HTR, 1990, B ENTOMOL RES, V80, P49, DOI 10.1017/S0007485300045910; Pereira FD, 2015, PHARM BIOL, V53, P228, DOI 10.3109/13880209.2014.913299; Pietri JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207985; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Rodgers FH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006391; Roubos CR, 2014, BIOL CONTROL, V75, P28, DOI 10.1016/j.biocontrol.2014.01.006; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; RYAN MF, 1988, J CHEM ECOL, V14, P1965, DOI 10.1007/BF01013489; Sant'Anna MRV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-329; Sendi J.J., 2014, RECENT PROGR MED PLA, P129; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Soltani A, 2013, J ARTHROPOD-BORNE DI, V7, P56; Sougoufara S, 2017, J VECTOR DIS, V54, P4; Srivastava AK, 2016, HLTH EFFECTS PESTICI; SUBBARAO SK, 1987, MED VET ENTOMOL, V1, P265, DOI 10.1111/j.1365-2915.1987.tb00353.x; Sugumar S, 2014, B ENTOMOL RES, V104, P393, DOI 10.1017/S0007485313000710; SUGUNA SG, 1992, MED VET ENTOMOL, V6, P84, DOI 10.1111/j.1365-2915.1992.tb00040.x; Swamy MK, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/3012462; Sweet W. C., 1937, Indian Medical Gazette, V72, P665; Tabari MA, 2017, RES VET SCI, V114, P36, DOI 10.1016/j.rvsc.2017.03.001; Tabbabi A, 2019, AFR HEALTH SCI, V19, P1361, DOI 10.4314/ahs.v19i1.8; Tahghighi A, 2019, ASIAN PAC J TROP BIO, V9, P168, DOI 10.4103/2221-1691.256730; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; Vatandoost H, 2006, ACTA TROP, V97, P196, DOI 10.1016/j.actatropica.2005.11.002; Vatandoost H, 2012, EXP PARASITOL, V132, P470, DOI 10.1016/j.exppara.2012.09.010; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2005, GUID LAB FIELD TEST; WHO, 2013, HDB INT VECT MAN; WHO, 1999, WHO SPEC EV PUBL HLT; World Health Organization (WHO), 2009, TEM DRINK WAT US VEC, P1; Xia XF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00025; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x; Zaini A, 1975, IRAN J PUBLIC HLTH, P114	120	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246470	10.1371/journal.pone.0246470	http://dx.doi.org/10.1371/journal.pone.0246470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556110	Green Published, gold			2022-12-26	WOS:000617379900047
J	Leedale, JA; Lucendo-Villarin, B; Meseguer-Ripolles, J; Kasarinaite, A; Webb, SD; Hay, DC				Leedale, Joseph A.; Lucendo-Villarin, Baltasar; Meseguer-Ripolles, Jose; Kasarinaite, Alvile; Webb, Steven D.; Hay, David C.			Mathematical modelling of oxygen gradients in stem cell-derived liver tissue	PLOS ONE			English	Article							IN-VITRO; METABOLIC ZONATION; CULTURE; DISEASE	A major bottleneck in the study of human liver physiology is the provision of stable liver tissue in sufficient quantity. As a result, current approaches to modelling human drug efficacy and toxicity rely heavily on immortalized human and animal cell lines. These models are informative but do possess significant drawbacks. To address the issues presented by those models, researchers have turned to pluripotent stem cells (PSCs). PSCs can be generated from defined genetic backgrounds, are scalable, and capable of differentiation to all the cell types found in the human body, representing an attractive source of somatic cells for in vitro and in vivo endeavours. Although unlimited numbers of somatic cell types can be generated in vitro, their maturation still remains problematic. In order to develop high fidelity PSC-derived liver tissue, it is necessary to better understand the cell microenvironment in vitro including key elements of liver physiology. In vivo a major driver of zonated liver function is the oxygen gradient that exists from periportal to pericentral regions. In this paper, we demonstrate how cell culture conditions for PSC-derived liver sphere systems can be optimised to recapitulate physiologically relevant oxygen gradients by using mathematical modelling. The mathematical model incorporates some often-understated features and mechanisms of traditional spheroid systems such as cell-specific oxygen uptake, media volume, spheroid size, and well dimensions that can lead to a spatially heterogeneous distribution of oxygen. This mathematical modelling approach allows for the calibration and identification of culture conditions required to generate physiologically realistic function within the microtissue through recapitulation of the in vivo microenvironment.	[Leedale, Joseph A.] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England; [Lucendo-Villarin, Baltasar; Meseguer-Ripolles, Jose; Kasarinaite, Alvile; Hay, David C.] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Webb, Steven D.] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England; [Webb, Steven D.] Early Stage Res, Prod Safety, Jealotts Hill, Bracknell, Berks, England	University of Liverpool; University of Edinburgh; Liverpool John Moores University	Leedale, JA (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England.; Hay, DC (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	j.leedale@liverpool.ac.uk; davehay@talkalk.net		lucendo villarin, baltasar/0000-0003-0796-1632; Leedale, Joseph/0000-0001-9010-4126; Meseguer Ripolles, Jose/0000-0003-3721-7345	EPSRC Liverpool Centre for Mathematics in Healthcare [EP/N014499/1]; MRC Skills Development Fellowship [MR/S019332/1]; Chief Scientist Office [TCS/16/37]; Liverpool John Moores University; Syngenta; MRC [MR/S019332/1] Funding Source: UKRI	EPSRC Liverpool Centre for Mathematics in Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC Skills Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; Liverpool John Moores University; Syngenta(Syngenta); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JAL, DCH and SDW acknowledge funding support from the EPSRC Liverpool Centre for Mathematics in Healthcare (EP/N014499/1). JAL is supported by an MRC Skills Development Fellowship (MR/S019332/1). BLV and DCH acknowledge funding from the Chief Scientist Office (TCS/16/37). SDW received funding in the form of salary from Liverpool John Moores University and Syngenta. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; [Anonymous], 2019, BRAIN STIMUL MAR; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Bell SM, 2018, TOXICOL IN VITRO, V47, P213, DOI 10.1016/j.tiv.2017.11.016; Cameron K, 2015, STEM CELL REP, V5, P1250, DOI 10.1016/j.stemcr.2015.10.016; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Corning Life Sciences, 2018, LIF SCI PROD EQ; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153692; Hu GQ, 2007, BIOMED MICRODEVICES, V9, P315, DOI 10.1007/s10544-006-9035-1; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012; Kyffin JA, 2018, TOXICOL IN VITRO, V48, P262, DOI 10.1016/j.tiv.2018.01.023; Leedale J, 2014, MATH BIOSCI, V258, P33, DOI 10.1016/j.mbs.2014.09.007; Leung BM, 2015, BIOMATER SCI-UK, V3, P336, DOI 10.1039/c4bm00319e; Lucendo-Villarin B, 2021, BIOFABRICATION, V13, DOI 10.1088/1758-5090/abbdb2; Lucendo-Villarin B, 2016, J MATER CHEM B, V4, P3433, DOI 10.1039/c6tb00331a; Lucendo-Villarin B, 2019, JOVE-J VIS EXP, DOI 10.3791/59965; Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4; Rashidi H, 2018, ARCH TOXICOL, V92, P3117, DOI 10.1007/s00204-018-2280-2; Shipley RJ, 2011, BIOTECHNOL BIOENG, V108, P1450, DOI 10.1002/bit.23062; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Wang Y, 2019, ISCIENCE, V16, P206, DOI 10.1016/j.isci.2019.05.028; Wang Y, 2017, JOVE-J VIS EXP, DOI 10.3791/55355; Wenger RH, 2015, HYPOXIA, V3, P35, DOI 10.2147/HP.S92198; Yu Y, 2012, STEM CELL RES, V9, P196, DOI 10.1016/j.scr.2012.06.004	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0244070	10.1371/journal.pone.0244070	http://dx.doi.org/10.1371/journal.pone.0244070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556073	Green Published, Green Submitted, gold			2022-12-26	WOS:000617379900018
J	Rad, FA; Otaki, F; Baqain, Z; Zary, N; Al-Halabi, M				Rad, Fatemeh Amir; Otaki, Farah; Baqain, Zaid; Zary, Nabil; Al-Halabi, Manal			Rapid transition to distance learning due to COVID-19: Perceptions of postgraduate dental learners and instructors	PLOS ONE			English	Article							EDUCATORS	The outbreak of Coronavirus disease 2019(COVID-19) necessitated an abrupt transition from on campus, face-to-face sessions to online, distance learning in higher education institutions. The purpose of this study was to investigate the perceptions of postgraduate dental learners and instructors about the transition to distance learning, including the changes to the learning and teaching and its efficaciousness. A convergent mixed methods approach to research was utilized. All the instructors and postgraduate learners in a dental college were invited to participate in an online survey. Quantitative data was analyzed using descriptive and inferential analyses on SPSS for Windows version 25.0, and for the responses to the open-ended questions, multi-staged thematic analysis was utilized. Both groups of stakeholders: learners and instructors, were satisfied with the rapid transition to distance learning due to COVID-19. Instructors were significantly more satisfied than the learners. The stakeholders adapted well to the change. The perception of the stakeholders regarding the case-based scenarios significantly influenced their level of satisfaction. As perceived by the stakeholders, the transition to distance learning entailed advantages and challenges. Going through the experience enabled the stakeholders to develop informed opinions of how best to sustain learning and teaching irrespective of how matters unfold in relation to the pandemic. In conclusion, the worldwide dental education community faced unprecedented challenges due to the onset of COVID-19. From a macro perspective, decision-makers must not miss out on the valuable opportunities, inherent in the experience, to reinforce curriculums, and maximize learning and teaching.	[Rad, Fatemeh Amir; Baqain, Zaid; Al-Halabi, Manal] Mohammed Bin Rashid Univ Med & Hlth Sci, Hamden Bin Mohammed Coll Dent Med, Dubai, U Arab Emirates; [Rad, Fatemeh Amir] Univ Dundee, Ctr Med Educ, Sch Med, Med Educ Programme, Dundee, Scotland; [Otaki, Farah] Mohammed Bin Rashid Univ Med & Hlth Sci, Strategy & Inst Excellence, Dubai, U Arab Emirates; [Zary, Nabil] Mohammed Bin Rashid Univ Med & Hlth Sci, Inst Excellence Hlth Profess Educ, Dubai, U Arab Emirates	University of Dundee	Al-Halabi, M (corresponding author), Mohammed Bin Rashid Univ Med & Hlth Sci, Hamden Bin Mohammed Coll Dent Med, Dubai, U Arab Emirates.	manal.halabi@mbru.ac.ae		Al Halabi, Manal/0000-0001-9482-4614; Otaki, Farah/0000-0002-8944-4948				Anbarasi K, 2015, J Clin Exp Dent, V7, pe348, DOI 10.4317/jced.52237; Annetta LA, 2010, V LEARNING; [Anonymous], 1997, CAUS PROF PAP SER; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; Bolliger DU, 2009, DISTANCE EDUC, V30, P103, DOI 10.1080/01587910902845949; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bridges S, 2014, EUR J DENT EDUC, V18, P170, DOI 10.1111/eje.12082; Carlson ER, 2020, J ORAL MAXIL SURG, V78, P1049, DOI 10.1016/j.joms.2020.04.033; De Paepe L, 2018, OPEN LEARN, V33, P18, DOI 10.1080/02680513.2017.1414586; Dennick R, 2016, INT J MED EDUC, V7, P200, DOI 10.5116/ijme.5763.de11; Ellaway R, 2008, MED TEACH, V30, P455, DOI [10.1080/01421590802108349, 10.1080/01421590802108331]; Explorance, 2029, BAC BLUE COMM EXPL H; Fetters MD, 2019, DEV JOINT DISPLAY MI; Fetters MD, 2019, PERFORMING FUNDAMENT; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Fidalgo P, 2020, INT J EDUC TECHNOL H, V17, DOI 10.1186/s41239-020-00194-2; Flores S. A., 2017, J HUMAN RESOURCE ADU, V13; Gewin V, 2020, NATURE, V580, P295, DOI 10.1038/d41586-020-00896-7; Gibbs G., 2004, ACT LEARN HIGH EDUC, V5, P87, DOI [10.1177/1469787404040463, DOI 10.1177/1469787404040463]; Goldie JGS, 2016, MED TEACH, V38, P1064, DOI 10.3109/0142159X.2016.1173661; Guetterman TC, 2015, ANN FAM MED, V13, P554, DOI 10.1370/afm.1865; Huntley RE, 2020, J ORAL MAXIL SURG, V78, P1257, DOI 10.1016/j.joms.2020.05.026; Hussain F, 2018, BRIT DENT J, V225, P441, DOI 10.1038/sj.bdj.2018.746; Johnson RE, 2019, J MIX METHOD RES, V13, P301, DOI 10.1177/1558689817743108; Khatami S, 2011, J DENT EDUC, V75, P321; Kiger ME, 2020, MED TEACH, V42, P846, DOI 10.1080/0142159X.2020.1755030; Li HO, 2020, ACAD MED, DOI [10.1097/ACM.000000000000359432657786, DOI 10.1097/ACM.000000000000359432657786]; Maguire L. L, 2005, ONLINE J DISTANCE LE, V8, P1; Marshall AL, 2020, MAYO CLIN PROC, V95, P1135, DOI 10.1016/j.mayocp.2020.04.015; Ministry of Education-MOE United Arab Emirates, 2020, DIST LEARN TIM COVID; O'Doherty D, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1240-0; Pascoe Michael, 2018, JMIR Med Educ, V4, pe16, DOI 10.2196/mededu.9197; Romero M, 2011, DISTANCE LEARNERS WO; Rosenbaum PEL, 2012, OPEN DENT J, V6, P182, DOI 10.2174/1874210601206010182; Saddik B, 2020, RISK MANAG HEALTHC P, V13, P2395, DOI 10.2147/RMHP.S273333; Sandars J., 2020, MEDEDPUBLISH, DOI [DOI 10.15694/MEP.2020.000082.1, 10.15694/mep.2020.000082.1]; Shank P., 2020, RIGHT DIGITAL MODA 1; UBNESCO, 2020, COVID 19 ED DISR RES; World Health Organization, 2020, ARCH WHO TIM COVID 1	39	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246584	10.1371/journal.pone.0246584	http://dx.doi.org/10.1371/journal.pone.0246584			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556131	Green Published, Green Submitted, gold			2022-12-26	WOS:000617379900026
J	Soeroto, AY; Pratiwi, C; Santoso, P; Lestari, BW				Soeroto, Arto Yuwono; Pratiwi, Chica; Santoso, Prayudi; Lestari, Bony Wiem			Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CULTURE CONVERSION; DRUG-RESISTANCE; TB; COUNTRIES; SMOKING; ANEMIA; IMPACT	Background Multidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capitol of Indonesia. Objective This study aimed to evaluate factors affecting success of multidrug-resistant tuberculosis treatment in patients using longer treatment regimen in West Java Indonesia. Methods This was a retrospective cohort study of multidrug-resistant tuberculosis patients treated with longer regimen at Hasan Sadikin General Hospital from January 2015 to December 2017. Potential risk factors associated with the treatment outcome were analyzed using multiple logistic regression. Results A total of 492 patients were enrolled during the study period. Fifty percents multidrug-resistant tuberculosis patients had successful treatment outcome. Age <= 45 years, male, normal body mass index, no previous tuberculosis treatment, culture conversion <= 2 months, acid fast bacilli sputum smear <=+1 were independent factors associated with increased treatment success. Sputum culture conversion <= 2 months was the major factor affecting successful outcome (RR 2.79; 95% CI: 1.61-4.84; p-value<0.001). Human Immunodeficiency Virus infection, chronic kidney disease, and cavitary lesion were independent risk factors for unfavourable outcome. Conclusion Age, gender, body mass index, tuberculosis treatment history, time of sputum conversion, acid fast bacilli sputum smear, HIV infection, chronic kidney disease, and cavitary lesion can be used as predictors for longer multidrug-resistant tuberculosis treatment regimen outcome.	[Soeroto, Arto Yuwono; Santoso, Prayudi] Univ Padjadjaran, Fac Med, Dept Internal Med, Div Respirol & Crit Care Med,Dr Hasan Sadikin Gen, Bandung, West Java, Indonesia; [Soeroto, Arto Yuwono; Pratiwi, Chica; Santoso, Prayudi] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Dept Internal Med, Fac Med, Bandung, West Java, Indonesia; [Lestari, Bony Wiem] Univ Padjadjaran, Dept Publ Hlth, Fac Med, Bandung, West Java, Indonesia; [Lestari, Bony Wiem] Univ Padjadjaran, TB HIV Res Ctr, Fac Med, Bandung, West Java, Indonesia	Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Universitas Padjadjaran; Universitas Padjadjaran	Soeroto, AY (corresponding author), Univ Padjadjaran, Fac Med, Dept Internal Med, Div Respirol & Crit Care Med,Dr Hasan Sadikin Gen, Bandung, West Java, Indonesia.; Soeroto, AY (corresponding author), Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Dept Internal Med, Fac Med, Bandung, West Java, Indonesia.	aysoeroto@yahoo.co.id	Lestari, Bony/AAE-4012-2022	Pratiwi, Chica/0000-0002-3623-0954; Soeroto, Arto Yuwono/0000-0001-9027-2453	Lembaga Pengelola Dana Pendidikan Republic of Indonesia (LPDP RI)	Lembaga Pengelola Dana Pendidikan Republic of Indonesia (LPDP RI)	CP received funding from Lembaga Pengelola Dana Pendidikan Republic of Indonesia (LPDP RI) in the ammount of IDR 7.265.000 Funder Website: https://www.lpdp.kemenkeu.go.id.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2017, PESQUISA INT J RES, V2, P45; Azee A, 2018, INT J MYCOBACT, V7, P347, DOI 10.4103/ijmy.ijmy_140_18; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Chem ED, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4317-4; de Boer RN, 2014, TUBERCULOSIS, V94, P87, DOI 10.1016/j.tube.2013.10.005; Di Gennaro F, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9080489; Di Gennaro F, 2019, LANCET GLOB HEALTH, V7, pE707, DOI 10.1016/S2214-109X(19)30173-1; Di Gennaro F, 2017, TUBERCULOSIS, V103, P44, DOI 10.1016/j.tube.2017.01.002; Elliott E, 2014, PUBLIC HEALTH ACTION, V4, P201, DOI 10.5588/pha.14.0029; Elmi OS, 2016, MALAYS J MED SCI, V23, P17, DOI 10.21315/mjms2016.23.4.3; Falzon D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02308-2016; Fradejas Isabel, 2018, J Clin Tuberc Other Mycobact Dis, V13, P9, DOI 10.1016/j.jctube.2018.04.002; Gadallah MA, 2016, J FORMOS MED ASSOC, V115, P997, DOI 10.1016/j.jfma.2015.10.002; Heuvelings CC, 2017, INT J INFECT DIS, V56, P77, DOI 10.1016/j.ijid.2016.12.025; Irbah SN, 2019, INT J INFECT DIS, V79, P91, DOI 10.1016/j.ijid.2018.11.228; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Kang YA, 2013, RESPIRATION, V86, P472, DOI 10.1159/000348374; Kempker RR, 2015, ANTIMICROB AGENTS CH, V59, P3149, DOI 10.1128/AAC.00379-15; Kim J, 2016, INT J INFECT DIS, V42, P64, DOI 10.1016/j.ijid.2015.11.018; Kurniawati F, 2012, INT J PHARM PHARM SC, V4, P733; Liu Q, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3021-0; Lv LS, 2018, INFECT DRUG RESIST, V11, P147, DOI 10.2147/IDR.S153499; Magis-Escurra C, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02363-2016; Munoz-Torrico M, 2017, ARCH BRONCONEUMOL, V53, P245, DOI 10.1016/j.arbres.2016.10.021; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Parmar MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193903; Pazarli P, 2013, TURK THORAC J, V14, P93, DOI 10.5152/ttd.2013.20; Pizzol D, 2017, AFR HEALTH SCI, V17, P773, DOI 10.4314/ahs.v17i3.20; Pradipta IS, 2018, J INFECTION, V77, P469, DOI 10.1016/j.jinf.2018.10.004; Reis-Santos B, 2013, J BRAS PNEUMOL, V39, P585, DOI 10.1590/S1806-37132013000500009; Soeroto AY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213017; Ugarte-Gil C, 2020, CLIN INFECT DIS, V70, P780, DOI 10.1093/cid/ciz284; Velayutham BRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088045; Wen YF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3019-7; West Java Provincial Health Office, 2020, MULT RES TUB DAT AN; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2019, GLOB TUB REP, P27; Yu MC, 2018, CLIN INFECT DIS, V67, P202, DOI 10.1093/cid/ciy066	43	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246284	10.1371/journal.pone.0246284	http://dx.doi.org/10.1371/journal.pone.0246284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556094	Green Published, gold			2022-12-26	WOS:000617379900059
J	Bott, KN; Yumol, JL; Comelli, EM; Klentrou, P; Peters, SJ; Ward, WE				Bott, Kirsten N.; Yumol, Jenalyn L.; Comelli, Elena M.; Klentrou, Panagiota; Peters, Sandra J.; Ward, Wendy E.			Trabecular and cortical bone are unaltered in response to chronic lipopolysaccharide exposure via osmotic pumps in male and female CD-1 mice	PLOS ONE			English	Article							CHRONIC INFLAMMATION; OSTEOPOROSIS; DISEASE; MICROSTRUCTURE; AGE	Chronic low-grade inflammation has been identified as an underlying cause of many diseases including osteoporosis. Lipopolysaccharide (LPS) is a potent inducer of the inflammatory response that can negatively affect bone outcomes by upregulating bone resorption and inhibiting bone formation. The objective of this study was to assess the longitudinal response of trabecular and cortical bone structure and bone mineral density to LPS continuously administered for 12 weeks in male and female CD-1 mice. Mice were assigned to one of four LPS groups at 8-weeks of age: placebo (0.0 mu g/d), low (0.9 mu g/d), mid (3.6 mu g/d) and high (14.4 mu g/d) dose. Trabecular and cortical bone outcomes were measured at 8, 12, 16, and 20 weeks of age using in vivo micro-computed tomography. The anticipated serum LPS dose-dependent response was not observed. Therefore, the low, mid, and high LPS groups were combined for analysis. Compared to the placebo group, endpoint serum LPS was elevated in both males (p < 0.05) and females (p < 0.05) when all LPS treatment groups were combined. However, there was no significant change in trabecular or cortical bone outcomes in the combined LPS groups compared to the placebo following the 12-week LPS intervention for either sex. This suggests that although serum LPS was elevated following the 12-week LPS intervention, the dosages administered using the osmotic pumps was not sufficient to negatively impact trabecular or cortical bone outcomes in either male or female CD-1 mice.	[Bott, Kirsten N.; Yumol, Jenalyn L.; Comelli, Elena M.; Klentrou, Panagiota; Peters, Sandra J.; Ward, Wendy E.] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada; [Comelli, Elena M.; Ward, Wendy E.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Comelli, Elena M.] Univ Toronto, Joannah & Brian Lawson Ctr Child Nutr, Toronto, ON, Canada; [Klentrou, Panagiota; Peters, Sandra J.; Ward, Wendy E.] Brock Univ, Ctr Bone & Muscle Hlth, St Catharines, ON, Canada; [Ward, Wendy E.] Brock Univ, Dept Hlth Sci, St Catharines, ON, Canada	Brock University; University of Toronto; University of Toronto; Brock University; Brock University	Bott, KN (corresponding author), Brock Univ, Dept Kinesiol, St Catharines, ON, Canada.	kirsten.bott@gmail.com		Bott, Kirsten/0000-0001-5140-5372	Natural Science and Engineering Research Council Alexander Graham Bell Canada Graduate Scholarship; Brock University; Canada Research Chairs Program [230786]; Natural Science and Engineering Research Council [229767, 668204]; Canada Foundation for Innovation [222084]; 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund [19442, 30961]	Natural Science and Engineering Research Council Alexander Graham Bell Canada Graduate Scholarship; Brock University; Canada Research Chairs Program(Canada Research Chairs); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund	Natural Science and Engineering Research Council Alexander Graham Bell Canada Graduate Scholarship to K.N.B. Research funding provided by Brock University and the Canada Research Chairs Program to W.E.W. (grant #230786) and a Discovery Grant from the Natural Science and Engineering Research Council to S. P. (grant #229767) and W.E.W. (grant #668204). Infrastructure funding for the micro computed tomography system was provided by the Canada Foundation for Innovation to W.E.W. (grant #222084). E.M.C. holds the Lawson Family Chair in Microbiome Nutrition Research at the University of Toronto. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; Some of the equipment used in this study was supported by the 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442 and 30961. We would also like to acknowledge Dr. Amel Taibi for her assistance in handling the serum samples and Aindriu Maguire and Colton Watson for their assistance with endpoint surgeries.	Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cao JJ, 2017, J NUTR, V147, P1909, DOI 10.3945/jn.117.248302; Chen YY, 2019, CLIN THER, V41, P400, DOI 10.1016/j.clinthera.2019.02.001; Chongwatpol P, 2015, J INFLAMM RES, V8, P117, DOI 10.2147/JIR.S82261; Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010; Droke Elizabeth A, 2007, J Inflamm (Lond), V4, P17, DOI 10.1186/1476-9255-4-17; Duggan SN, 2014, CLIN GASTROENTEROL H, V12, P219, DOI 10.1016/j.cgh.2013.06.016; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Herrlich S, 2012, ADV DRUG DELIVER REV, V64, P1617, DOI 10.1016/j.addr.2012.02.003; Huang Hong, 2007, J Inflamm (Lond), V4, P22; Ingberg E, 2012, GEN COMP ENDOCR, V175, P188, DOI 10.1016/j.ygcen.2011.11.014; Kim KA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0625-7; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Liu JH, 2019, FOOD FUNCT, V10, P2847, DOI 10.1039/c8fo02051e; Longo AB, 2017, JOVE-J VIS EXP, DOI 10.3791/56346; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Mosquera Laurivette, 2015, J Vet Sci Technol, V6, P276; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Sacco SM, 2017, BONEKEY REP, V6, DOI 10.1038/bonekey.2016.87; Shen CL, 2011, OSTEOPOROSIS INT, V22, P327, DOI 10.1007/s00198-010-1209-2; Shen CL, 2010, J NUTR BIOCHEM, V21, P968, DOI 10.1016/j.jnutbio.2009.08.002; Smith BJ, 2006, BONE, V38, P378, DOI 10.1016/j.bone.2005.09.008; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Strom JO, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-39; Targher G, 2015, J ENDOCRINOL INVEST, V38, P817, DOI 10.1007/s40618-015-0315-6; THEEUWES F, 1976, ANN BIOMED ENG, V4, P343, DOI 10.1007/BF02584524; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Wright JC, 2010, AAPS J, V12, P437, DOI 10.1208/s12248-010-9199-8; Yumol Jenalyn L, 2018, Bone Rep, V8, P229, DOI 10.1016/j.bonr.2018.05.004; Zhou ZY, 2016, ACTA PHARMACOL SIN, V37, P1063, DOI 10.1038/aps.2016.21	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0243933	10.1371/journal.pone.0243933	http://dx.doi.org/10.1371/journal.pone.0243933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544708	gold, Green Published			2022-12-26	WOS:000617991900045
J	Pearson, VR; Bosse, JB; Koyuncu, OO; Scherer, J; Toruno, C; Robinson, R; Abegglen, LM; Schiffman, JD; Enquist, LW; Rall, GF				Pearson, Virginia R.; Bosse, Jens B.; Koyuncu, Orkide O.; Scherer, Julian; Toruno, Cristhian; Robinson, Rosann; Abegglen, Lisa M.; Schiffman, Joshua D.; Enquist, Lynn W.; Rall, Glenn F.			Identification of African Elephant Polyomavirus in wild elephants and the creation of a vector expressing its viral tumor antigens to transform elephant primary cells	PLOS ONE			English	Article							SMALL T-ANTIGEN; ENDOTHELIOTROPIC HERPESVIRUSES; ASIAN ELEPHANTS; HEMORRHAGIC-DISEASE; INFECTION; INSIGHT; DECLINE; MAXIMUS; EEHV3	Wild elephant populations are declining rapidly due to rampant killing for ivory and body parts, range fragmentation, and human-elephant conflict. Wild and captive elephants are further impacted by viruses, including highly pathogenic elephant endotheliotropic herpesviruses. Moreover, while the rich genetic diversity of the ancient elephant lineage is disappearing, elephants, with their low incidence of cancer, have emerged as a surprising resource in human cancer research for understanding the intrinsic cellular response to DNA damage. However, studies on cellular resistance to transformation and herpesvirus reproduction have been severely limited, in part due to the lack of established elephant cell lines to enable in vitro experiments. This report describes creation of a recombinant plasmid, pAelPyV-1-Tag, derived from a wild isolate of African Elephant Polyomavirus (AelPyV-1), that can be used to create immortalized lines of elephant cells. This isolate was extracted from a trunk nodule biopsy isolated from a wild African elephant, Loxodonta africana, in Botswana. The AelPyV-1 genome contains open-reading frames encoding the canonical large (LTag) and small (STag) tumor antigens. We cloned the entire early region spanning the LTag and overlapping STag genes from this isolate into a high-copy vector to construct a recombinant plasmid, pAelPyV-1-Tag, which effectively transformed primary elephant endothelial cells. We expect that the potential of this reagent to transform elephant primary cells will, at a minimum, facilitate study of elephant-specific herpesviruses.	[Pearson, Virginia R.; Rall, Glenn F.] Fox Chase Canc Ctr, Program Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Bosse, Jens B.] Hannover Med Sch, Inst Virol, RESIST Cluster Excellence, Ctr Struct Syst Biol, Hamburg, Germany; [Bosse, Jens B.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Koyuncu, Orkide O.; Scherer, Julian; Enquist, Lynn W.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Toruno, Cristhian; Robinson, Rosann; Abegglen, Lisa M.; Schiffman, Joshua D.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Scherer, Julian] VOR Biopharma, Cambridge, MA USA	Fox Chase Cancer Center; Hannover Medical School; Heinrich Pette Institute; Princeton University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Pearson, VR (corresponding author), Fox Chase Canc Ctr, Program Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	virginiarpearson@gmail.com	; Bosse, Jens Bernhard/D-7336-2011	ABEGGLEN, LISA/0000-0003-3607-3001; Bosse, Jens Bernhard/0000-0001-7252-5541				Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Atkins L, 2013, J ZOO WILDLIFE MED, V44, P136, DOI 10.1638/1042-7260-44.1.136; Bouchard B, 2014, J ZOO WILDLIFE MED, V45, P704, DOI 10.1638/2013-0264R1.1; Bronson E, 2017, J ZOO WILDLIFE MED, V48, P335, DOI [10.1638/2016-0063R.1, 10.1638/2016-0063r.1]; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Cerling TE, 2016, P NATL ACAD SCI USA, V113, P13330, DOI 10.1073/pnas.1614938113; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; Choudhury A., 2008, ELEPHAS MAXIMUS, DOI [10.2305/IUCN.UK.2008.RLTS.T7140A12828813., DOI 10.2305/IUCN.UK.2008.RLTS.T7140A12828813, DOI 10.2305/IUCN.UK.2008.RLTS.T7140A12828813.EN]; Dastjerdi A, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0806-5; Ferris E, 2018, CELL REP, V22, P2742, DOI 10.1016/j.celrep.2018.02.008; Fuery A, 2016, J ZOO WILDLIFE MED, V47, P319, DOI 10.1638/2015-0074.1; Fukuda T, 2016, IN VITRO CELL DEV-AN, V52, P20, DOI 10.1007/s11626-015-9943-6; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Giacobbi NS, 2015, VIROLOGY, V476, P377, DOI 10.1016/j.virol.2014.12.032; Gupta T, 2016, VIROLOGY, V487, P112, DOI 10.1016/j.virol.2015.10.003; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; ICUN, 2017, INT UN CONS NAT RED; JACOBSON ER, 1986, J AM VET MED ASSOC, V189, P1075; Khalili K, 2008, J CELL PHYSIOL, V215, P309, DOI 10.1002/jcp.21326; Kongmakee P., 2015, P 10 INT EL END HERP; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Masters NJ, 2011, VET REC, V169, p209A, DOI 10.1136/vr.d4226; Oo ZM, 2020, EMERG INFECT DIS, V26, P63, DOI 10.3201/eid2601.190159; OSSENT P, 1990, VET PATHOL, V27, P131, DOI 10.1177/030098589002700212; Pavulraj S, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100396; Pearson V. R., 2013, 9 INT WORKSH EL END; Pearson V. R., 2016, INT EL RIN CONS RES; Pearson V. R., 2013, INT EL RHIN CONS RES, P592; Pipas JM, 2009, VIROLOGY, V384, P294, DOI 10.1016/j.virol.2008.11.024; Poulsen JR, 2017, CURR BIOL, V27, pR134, DOI 10.1016/j.cub.2017.01.023; Reid CE, 2006, VET QUART, V28, P61, DOI 10.1080/01652176.2006.9695209; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Sampson C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194113; Shoshani J., 1996, PROBOSCIDEA EVOLUTIO; Siengdee P, 2018, PEERJ, V6, DOI 10.7717/peerj.4302; Sripiboon S, 2013, J ZOO WILDLIFE MED, V44, P100, DOI 10.1638/1042-7260-44.1.100; Stevens H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077884; van der Meijden E, 2015, J VIROL, V89, P9427, DOI 10.1128/JVI.00911-15; Vazquez JM, 2018, CELL REP, V24, P1765, DOI 10.1016/j.celrep.2018.07.042; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wellehan JFX, 2008, VET MICROBIOL, V127, P249, DOI 10.1016/j.vetmic.2007.08.024; Wilkie GS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06299; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111; Zechariah A, 2013, J WILDLIFE DIS, V49, P381, DOI 10.7589/2012-07-193; Zong JC, 2016, J VIROL, V90, P3028, DOI 10.1128/JVI.02936-15; Zong JC, 2014, J VIROL, V88, P13547, DOI 10.1128/JVI.01675-14	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244334	10.1371/journal.pone.0244334	http://dx.doi.org/10.1371/journal.pone.0244334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0UN	33544724	gold, Green Published			2022-12-26	WOS:000617993300005
J	Aguirrebengoa, OA; Garcia, MV; Ramirez, DA; Garcia, NG; Lopez, TP; Escribano, PC; Martin, JB; Canas, CL; Pineiro, NF; Ferrer, MEF; Lotero, MG; Gallegos, EH; Utrilla, MR; Perez, VE; Guerrero, JD; Martin, CR				Ayerdi Aguirrebengoa, Oskar; Vera Garcia, Mar; Arias Ramirez, Daniel; Gil Garcia, Natalia; Puerta Lopez, Teresa; Clavo Escribano, Petunia; Ballesteros Martin, Juan; Lejarraga Canas, Clara; Fernandez Pineiro, Nuria; Fuentes Ferrer, Manuel Enrique; Garcia Lotero, Monica; Hurtado Gallegos, Estefania; Raposo Utrilla, Montserrat; Estrada Perez, Vicente; Del Romero Guerrero, Jorge; Rodriguez Martin, Carmen			Low use of condom and high STI incidence among men who have sex with men in PrEP programs	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; INFECTIONS	Objective Since the recent introduction of preexposure prophylaxis (PrEP), several studies have reported a decrease in the use of condoms and a rise in STIs among users. This rise in risk behavior associated with the advent of PrEP is known as "risk compensation." The aim of this study is to measure clinical and behavioral changes associated with the introduction of PrEP by analyzing condom use for anal intercourse, number of sexual partners, sexualized drug use and STI incidence. Methods We performed a retrospective descriptive study of PrEP users followed every 3months over a 2-year period spanning 2017-2019 in a referral clinic specializing in STI/HIV in Madrid, Spain. One hundred ten men who have sex with men and transgender women underwent regular screening for STIs and hepatitis C virus (HCV) infection. Sociodemographic, clinical, and behavioral data were gathered for all subjects studied. Results The risk compensation observed in this study consisted primarily of a lower rate of condom use, while the number of sexual partners and recreational drug consumption remained stable. We observed a very high incidence of STIs in this sample, particularly rectal gonorrhea and chlamydia. The factors shown to be independently associated with the presence of an STI on multivariate analysis were age below 30 years and over 10 sexual partners/month. Conclusion The incidence of STI acquisition was higher than expected, indicating a need for strategies to minimize this impact, particularly among younger individuals with a higher number of sexual partners.	[Ayerdi Aguirrebengoa, Oskar; Vera Garcia, Mar; Puerta Lopez, Teresa; Clavo Escribano, Petunia; Ballesteros Martin, Juan; Lejarraga Canas, Clara; Fernandez Pineiro, Nuria; Garcia Lotero, Monica; Hurtado Gallegos, Estefania; Raposo Utrilla, Montserrat; Del Romero Guerrero, Jorge; Rodriguez Martin, Carmen] IdISSC, Ctr Sanitario Sandoval, Hosp Clin San Carlos, Madrid, Spain; [Ayerdi Aguirrebengoa, Oskar; Estrada Perez, Vicente; Rodriguez Martin, Carmen] Univ Complutense Madrid, Madrid, Spain; [Arias Ramirez, Daniel; Gil Garcia, Natalia] IdISSC, Med Interna, Hosp Clin San Carlos, Madrid, Spain; [Fuentes Ferrer, Manuel Enrique] Univ Alfonso X Sabio, Serv Med Prevent, IdISSC, Madrid, Spain; [Estrada Perez, Vicente] Hosp Fdn Jimenez Diaz, Madrid, Spain	Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos; Universidad Alfonso X el Sabio (UAX); Fundacion Jimenez Diaz	Aguirrebengoa, OA (corresponding author), IdISSC, Ctr Sanitario Sandoval, Hosp Clin San Carlos, Madrid, Spain.; Aguirrebengoa, OA (corresponding author), Univ Complutense Madrid, Madrid, Spain.	oskarayerdi@hotmail.com	Ferrer, Manuel Enrique Fuentes Ferrer ME Fuentes/L-1086-2017	Ferrer, Manuel Enrique Fuentes Ferrer ME Fuentes/0000-0002-5177-1441; AYERDI, OSKAR/0000-0002-9441-8031; Vera, Mar/0000-0002-3841-7747				Aguirrebengoa OA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228998; Beymer MR, 2018, SEX TRANSM INFECT, V94, P457, DOI 10.1136/sextrans-2017-053377; Cambiano V, 2018, LANCET INFECT DIS, V18, P85, DOI [10.1016/S1473-3099(17)30540-6, 10.1016/s1473-3099(17)30540-6]; Castro DR, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25351; Chen YH, 2019, AIDS BEHAV, V23, P1841, DOI 10.1007/s10461-018-2299-7; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Grupo de Estudio de Sida de la SEIMC (GeSIDA), 2016, RECOMENDACIONES PROF; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; O'Halloran C, 2019, INT J DRUG POLICY, V74, P246, DOI 10.1016/j.drugpo.2019.10.007; Plan Nacional Sobre el Sida-Grupo de Expertos PrEP. Ministerio de Sanidad Servicios Sociales e Igualdad, 2018, PROF PREEXP VIH ESP; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182; Nguyen VK, 2018, AIDS, V32, P523, DOI 10.1097/QAD.0000000000001718; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; World Health Organization, 2015, WHO EXP REC OR PREEX	19	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245925	10.1371/journal.pone.0245925	http://dx.doi.org/10.1371/journal.pone.0245925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539363	Green Published, gold			2022-12-26	WOS:000616960200064
J	Madewell, ZJ; Chacon-Fuentes, R; Jara, J; Mejia-Santos, H; Molina, IB; Alvis-Estrada, JP; Ortiz, MR; Coello-Licona, R; Montejo, B				Madewell, Zachary J.; Chacon-Fuentes, Rafael; Jara, Jorge; Mejia-Santos, Homer; Molina, Ida-Berenice; Alvis-Estrada, Juan Pablo; Ortiz, Maria-Renee; Coello-Licona, Rosa; Montejo, Belinda			Knowledge, attitudes, and practices of seasonal influenza vaccination in healthcare workers, Honduras	PLOS ONE			English	Article							IMMUNIZATION; DETERMINANTS; PERCEPTIONS; COVERAGE; RATES	Background Seasonal influenza is a highly contagious vaccine-preventable disease that may cause high morbidity and mortality in susceptible populations. Healthcare workers are a priority group for seasonal influenza vaccination to protect them from contracting influenza and prevent nosocomial transmission to patients. This study aimed to evaluate knowledge, attitudes, and practices (KAP) of seasonal influenza vaccination among healthcare workers in Honduras. Method From August 24 to October 21, 2018, we conducted a cross-sectional KAP survey regarding seasonal influenza vaccination to a random sample of healthcare workers who attended patients in hospitals of the Ministry of Health of Honduras (SESAL) and Honduran Social Security Institute (IHSS). We reported frequency distributions of demographics, vaccination KAP, sources of information, and reasons for non-vaccination. We used principal components factor analysis to create knowledge and attitude scores. We used linear regression to analyze associations between demographics and sources of information about the influenza vaccine, and knowledge and attitude scores. We used logistic regression to analyze associations between demographics, sources of information, knowledge scores, and attitude scores, and influenza vaccination. Result We surveyed 947 healthcare workers who attended patients in 13 SESAL hospitals and two IHSS hospitals. Only 4.6% of participants knew the seasonal influenza vaccine was composed of inactivated viruses, 94.7% believed vaccination causes flu-like symptoms, and 52.0% were vaccinated for influenza in 2018. Knowledge scores were lower for nursing assistants and other healthcare professionals compared to doctors, and higher for healthcare workers who attended a healthcare facility training (P-values <= 0.030). Attitude scores were higher for healthcare workers who attended >= 11 patients per day having <= 10 patients per day as reference, self-reported influenza vaccination in previous year, and cited trainings and informal information at the healthcare facility as sources of information for influenza vaccination (P-values <= 0.030). Factors associated with self-reported vaccination were self-reported influenza vaccination in previous year (aOR: 7.61; 95% CI: 5.24-11.04), attitude score (aOR: 1.14; 95% CI: 1.07-1.21), and worked in a SESAL hospital (aOR: 1.73; 95% CI: 1.12-2.68) having IHSS as reference. Conclusion Although influenza vaccination is required by law in Honduras and available for free in public health centers, coverage of healthcare workers in 2018 was half that reported in 2017. Lower coverage may be attributed to misconceptions of vaccination side effects.	[Madewell, Zachary J.; Chacon-Fuentes, Rafael; Jara, Jorge; Alvis-Estrada, Juan Pablo; Ortiz, Maria-Renee] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Mejia-Santos, Homer] Secretaria Salud Honduras, Unidad Vigilancia Salud, Tegucigalpa, Honduras; [Molina, Ida-Berenice] Secretaria Salud Honduras, Programa Ampliado Inmunizac, Tegucigalpa, Honduras; [Coello-Licona, Rosa; Montejo, Belinda] Inst Hondureno Seguridad Social, Vigilancia Epidemiol, Tegucigalpa, Honduras	Universidad del Valle de Guatemala	Madewell, ZJ (corresponding author), Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala.	zmadewell@ufl.edu	Madewell, Zachary/AAM-4921-2020	Madewell, Zachary/0000-0002-5667-9660; Alvis-Estrada, Juan/0000-0002-1226-9344	Centers for Disease Control and Prevention [5U01GH001003-05]; Fogarty International Center of the National Institutes of Health [D43TW009343]; University of California Global Health Institute	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute	This work was supported by the Centers for Disease Control and Prevention under CDC-UVG cooperative agreement No. 5U01GH001003-05. ZM was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW009343 and the University of California Global Health Institute.	Abu-Gharbieh Eman, 2010, Int J Med Sci, V7, P319; [Anonymous], 2016, OKNO KRAJE OCT, VXII, P9; Asma S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1528-9; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Badilla X, 2018, CONOCIMIENTOS ACTITU; Bazan M, 2017, VACCINE, V35, P2930, DOI 10.1016/j.vaccine.2017.04.021; Bean SJ, 2013, QUAL HEALTH RES, V23, P1251, DOI 10.1177/1049732313501891; Biblioteca Virtual en Salud Honduras, 2013, PROGR AMPL INM SECR; Blank PR, 2009, EXPERT REV VACCINES, V8, P425, DOI [10.1586/erv.09.7, 10.1586/ERV.09.7]; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Castaneda-Orjuela C, 2015, VACCINE, V33S, pS60; Centers for Disease Control and Prevention, 2018, NIS CHILD DAT DOC 20; Central Intelligence Agency, 2018, CENTR AM HOND 2018; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Clark SJ, 2009, AM J INFECT CONTROL, V37, P551, DOI 10.1016/j.ajic.2009.02.012; Dini G, 2018, HUM VACC IMMUNOTHER, V14, P772, DOI 10.1080/21645515.2017.1348442; Dominguez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081200; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Grohskopf LA, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6803a1; Hansen S, 2007, J HOSP INFECT, V65, P348, DOI 10.1016/j.jhin.2006.12.018; Haviari S, 2015, HUM VACC IMMUNOTHER, V11, P2522, DOI 10.1080/21645515.2015.1082014; Inoue Yusuke, 2011, Environmental Health and Preventive Medicine, V16, P320, DOI 10.1007/s12199-010-0202-x; Instituto Nacional de Estadisticas de Honduras, PROYECC POBL TOT DEP; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; James PB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4700-2; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; Karlsson LC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224330; Khan TM, 2016, VACCINE, V34, P1393, DOI 10.1016/j.vaccine.2016.01.045; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; Kuster SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026239; Loulergue P, 2009, VACCINE, V27, P4240, DOI 10.1016/j.vaccine.2009.03.039; Bermudez-Madriz JL, 2011, SALUD PUBLICA MEXICO, V53, pS209; Maltezou HC, 2008, CURR OPIN INFECT DIS, V21, P337, DOI 10.1097/QCO.0b013e3283013945; Maltezou HC, 2010, J INFECTION, V61, P252, DOI 10.1016/j.jinf.2010.06.004; Modak RM, 2012, INFECT CONT HOSP EP, V33, P1288, DOI 10.1086/667384; Nowalk MP, 2010, AM J PREV MED, V38, P237, DOI 10.1016/j.amepre.2009.11.011; Pan American Health Organization, 2018, INFL VACC COV; Pan American Health Organization, 2018, LEY VAC REP HOND GAR; Pan American Health Organization, 2019, 6 VACC CAMP SEAS INF; Pan American Health Organization, 2017, COUNTR REP HOND; Pan American Health Organization, 2018, 5051 EW PAN AM HLTH; Pan American Health Organization, 2017, SAL AM HOND; Rachiotis G, 2010, EUROSURVEILLANCE, V15, P8; Secretaria de Salud de Honduras, 2018, 4 AN EST VIG LEY VAC; The World Bank, 2019, WORLD BANK HOND 2019; To KW, 2016, J HOSP INFECT, V94, P133, DOI 10.1016/j.jhin.2016.07.003; Troeger CE, 2019, LANCET RESP MED, V7, P69, DOI [10.1016/S2213-2600(18)30496-X, 10.1016/s2213-2600(18)30496-x]; Universidad Nacional Autonoma de Honduras, 2009, AN SIT REC HUM SAL H; Vaux S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-159; Williams CarlosRivera., 2009, HIST SEGURIDAD SOCIA; World Health Organization, 2018, INFL SEAS; World Health Organization, 2009, HLTH WORKF INFR ESS; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Zimmerman RK, 2003, AM J MED, V114, P31, DOI 10.1016/S0002-9343(02)01421-3	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246379	10.1371/journal.pone.0246379	http://dx.doi.org/10.1371/journal.pone.0246379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539428	Green Published, gold			2022-12-26	WOS:000616960200014
J	Hreha, TN; Foreman, S; Duran-Pinedo, A; Morris, AR; Diaz-Rodriguez, P; Jones, JA; Ferrara, K; Bourges, A; Rodriguez, L; Koffas, MAG; Hahn, M; Hauser, AR; Barquera, B				Hreha, Teri N.; Foreman, Sara; Duran-Pinedo, Ana; Morris, Andrew R.; Diaz-Rodriguez, Patricia; Jones, J. Andrew; Ferrara, Kristina; Bourges, Anais; Rodriguez, Lauren; Koffas, Mattheos A. G.; Hahn, Mariah; Hauser, Alan R.; Barquera, Blanca			The three NADH dehydrogenases of Pseudomonas aeruginosa: Their roles in energy metabolism and links to virulence	PLOS ONE			English	Article							NA+-TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; AMINOGLYCOSIDE RESISTANCE; BINDING-SITE; COMPLEX-I; PYOCYANIN; GENES; SEQUENCE; GENOME; INACTIVATION	Pseudomonas aeruginosa is a ubiquitous opportunistic pathogen which relies on a highly adaptable metabolism to achieve broad pathogenesis. In one example of this flexibility, to catalyze the NADH:quinone oxidoreductase step of the respiratory chain, P. aeruginosa has three different enzymes: NUO, NQR and NDH2, all of which carry out the same redox function but have different energy conservation and ion transport properties. In order to better understand the roles of these enzymes, we constructed two series of mutants: (i) three single deletion mutants, each of which lacks one NADH dehydrogenase and (ii) three double deletion mutants, each of which retains only one of the three enzymes. All of the mutants grew approximately as well as wild type, when tested in rich and minimal medium and in a range of pH and [Na+] conditions, except that the strain with only NUO (Delta nqrF Delta ndh) has an extended lag phase. During exponential phase, the NADH dehydrogenases contribute to total wild-type activity in the following order: NQR > NDH2 > NUO. Some mutants, including the strain without NQR (Delta nqrF) had increased biofilm formation, pyocyanin production, and killed more efficiently in both macrophage and mouse infection models. Consistent with this, Delta nqrF showed increased transcription of genes involved in pyocyanin production.	[Hreha, Teri N.; Ferrara, Kristina; Koffas, Mattheos A. G.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Hreha, Teri N.; Foreman, Sara; Diaz-Rodriguez, Patricia; Jones, J. Andrew; Ferrara, Kristina; Bourges, Anais; Rodriguez, Lauren; Koffas, Mattheos A. G.; Hahn, Mariah; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Foreman, Sara; Barquera, Blanca] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Duran-Pinedo, Ana] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Morris, Andrew R.; Hauser, Alan R.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Diaz-Rodriguez, Patricia; Hahn, Mariah] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Jones, J. Andrew; Rodriguez, Lauren; Koffas, Mattheos A. G.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Hreha, Teri N.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Morris, Andrew R.] Abbott, Abbott Pk, IL USA; [Diaz-Rodriguez, Patricia] Univ La Laguna, Dept Chem Engn & Pharmaceut Technol, Tenerife, Spain; [Jones, J. Andrew] Miami Univ, Dept Chem Paper & Biomed Engn, Oxford, OH 45056 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University System of Florida; University of Florida; Northwestern University; Feinberg School of Medicine; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Washington University (WUSTL); Abbott Laboratories; Abbott Vascular; Universidad de la Laguna; University System of Ohio; Miami University	Barquera, B (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Barquera, B (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA.	barqub@rpi.edu	Jones, J. Andrew/AAH-3939-2020	Koffas, Mattheos/0000-0002-1405-0565; Bourges, Anais/0000-0002-1789-3816; Diaz-Rodriguez, Patricia/0000-0002-7576-2013	National Science Foundation [1616674]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation. Grant Number: 1616674 to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; [Anonymous], [No title captured]; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Bertsova YV, 2020, ARCH BIOCHEM BIOPHYS, V681, DOI 10.1016/j.abb.2020.108266; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chieda Y, 2008, FEMS MICROBIOL LETT, V278, P101, DOI 10.1111/j.1574-6968.2007.00982.x; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dolan SK, 2020, MBIO, V11, DOI 10.1128/mBio.02684-19; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fothergill JL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-45; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; GREEN SK, 1974, APPL MICROBIOL, V28, P987, DOI 10.1128/AEM.28.6.987-991.1974; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; HANCOCK REW, 1981, ANTIMICROB AGENTS CH, V19, P777, DOI 10.1128/AAC.19.5.777; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Iiyama K, 2012, J INSECT BIOTECHNOL, V80, P57, DOI [10.11416/jibs.80.2_057, DOI 10.11416/JIBS.80.2_057]; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jeukens J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087611; Jo J, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00700-19; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Koley D, 2011, P NATL ACAD SCI USA, V108, P19996, DOI 10.1073/pnas.1117298108; Krishna KV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00880; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Liang PD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231965; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez JL, 2011, FEMS MICROBIOL REV, V35, P768, DOI 10.1111/j.1574-6976.2011.00282.x; Maseda H, 2000, ANTIMICROB AGENTS CH, V44, P658, DOI 10.1128/AAC.44.3.658-664.2000; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; NICAS TI, 1984, INFECT IMMUN, V45, P470, DOI 10.1128/IAI.45.2.470-474.1984; O'Brien S, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0941-6; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Pachori P, 2019, GENES DIS, V6, P109, DOI 10.1016/j.gendis.2019.04.001; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Perinbam K, 2020, MBIO, V11, DOI 10.1128/mBio.02730-18; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Raba DA, 2018, J BIOL CHEM, V293, P15664, DOI 10.1074/jbc.RA118.003194; Schurek KN, 2008, ANTIMICROB AGENTS CH, V52, P4213, DOI 10.1128/AAC.00507-08; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Torres A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00075; Tram G., 2013, ADV MICROBIOL-NY, V3, P5, DOI [10.4236/aim.2013.32030, DOI 10.4236/AIM.2013.32030]; TSENG JT, 1972, ANTIMICROB AGENTS CH, V2, P136, DOI 10.1128/AAC.2.3.136; Vaish M, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00611-17; Vorregaard M., 2008, COMSTAT2 MODERN 3D I; Weiner-Lastinger LM, 2020, INFECT CONT HOSP EP, V41, P1, DOI 10.1017/ice.2019.296; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; ZAMBRANO MM, 1993, J BACTERIOL, V175, P5642, DOI 10.1128/JB.175.17.5642-5647.1993; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	65	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0244142	10.1371/journal.pone.0244142	http://dx.doi.org/10.1371/journal.pone.0244142			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534802	gold, Green Published			2022-12-26	WOS:000616739700061
J	Stoecklein, KS; Ortega, MS; Spate, LD; Murphy, CN; Prather, RS				Stoecklein, Katy S.; Ortega, M. Sofia; Spate, Lee D.; Murphy, Clifton N.; Prather, Randall S.			Improved cryopreservation of in vitro produced bovine embryos using FGF2, LIF, and IGF1	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; INNER CELL MASS; GROWTH-FACTOR-I; HEAT-SHOCK; PREIMPLANTATION EMBRYO; OXIDATIVE STRESS; CULTURE; OOCYTE; VIVO; BLASTOCYSTS	In vitro embryo production systems are limited by their inability to consistently produce embryos with the competency to develop to the blastocyst stage, survive cryopreservation, and establish a pregnancy. Previous work identified a combination of three cytokines [fibroblast growth factor 2 (FGF2), leukemia inhibitory factor (LIF), and insulin-like growth factor 1 (IGF1)], called FLI, that we hypothesize improve preimplantation development of bovine embryos in vitro. To test this hypothesis, FLI was supplemented into oocyte maturation or embryo culture medium. Embryos were produced in vitro using abattoir-derived oocytes and fertilized with sperm from a single bull known to have high fertility. After an 18-20 h fertilization period, putative zygotes were cultured in synthetic oviductal fluid (SOF) for 8 days. The addition of FLI to the oocyte maturation medium increased (P < 0.05) the dissociation of transzonal projections at 12, 18, and 24 h of maturation, as well as, the proportion of oocytes that reached the metaphase II stage of meiosis. Additionally, lipid content was decreased (P < 0.05) in the blastocyst stage embryo. The addition of FLI during the culture period increased development to the blastocyst stage, cytoskeleton integrity, and survival following slow freezing, as well as, decreased post thaw cell apoptosis (P < 0.05). In conclusion, the supplementation of these cytokines in vitro has the potential to alleviate some of the challenges associated with the cryo-survival of in vitro produced bovine embryos through improving embryo development and embryo quality.	[Stoecklein, Katy S.; Ortega, M. Sofia; Spate, Lee D.; Murphy, Clifton N.; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Ortega, MS (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	ortegaobandom@missouri.edu		Prather, Randall/0000-0002-6012-4035; Ortega Obando, Martha Sofia/0000-0003-4027-7314	Clifton Murphy Scholarship Fund; USDA National Needs Fellowship - USDA NIFA Grant [2019-38420-28972]	Clifton Murphy Scholarship Fund; USDA National Needs Fellowship - USDA NIFA Grant	This research is supported by the Clifton Murphy Scholarship Fund, and USDA National Needs Fellowship funded by USDA NIFA Grant 2019-38420-28972.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta DAV, 2016, THERIOGENOLOGY, V85, P1669, DOI 10.1016/j.theriogenology.2016.01.024; [Anonymous], 2020, MARK SIT, V1, P12; [Anonymous], 2003, EUR J CARDIOVASC S1, V10, pS1; [Anonymous], 2004, CHRONICLE HIGHER ED, V15, pC1; Barcelo-Fimbres M, 2007, MOL REPROD DEV, V74, P1406, DOI 10.1002/mrd.20700; Bedzhov I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002609; Block J, 2011, THERIOGENOLOGY, V76, P1602, DOI 10.1016/j.theriogenology.2011.07.025; Bonilla AQS, 2011, GROWTH HORM IGF RES, V21, P107, DOI 10.1016/j.ghir.2011.03.003; Cagnone GLM, 2013, MOL REPROD DEV, V80, P297, DOI 10.1002/mrd.22162; Crosier AE, 2000, BIOL REPROD, V62, P1459, DOI 10.1095/biolreprod62.5.1459; de Assis PM, 2015, REPROD BIOMED ONLINE, V31, P577, DOI 10.1016/j.rbmo.2015.06.014; de Sousa RV, 2017, THERIOGENOLOGY, V90, P25, DOI 10.1016/j.theriogenology.2016.11.003; del Collado M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02467-9; Dominko T, 1997, MOL REPROD DEV, V47, P456, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;456::AID-MRD13&gt;3.0.CO;2-U; Enright BP, 2000, THERIOGENOLOGY, V54, P659, DOI 10.1016/S0093-691X(00)00381-2; Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2&lt;186::AID-MRD8&gt;3.0.CO;2-N; Ferguson EM, 1999, J REPROD FERTIL, V116, P373, DOI 10.1530/jrf.0.1160373; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Frum T, 2020, REPRODUCTION, V160, pV5, DOI 10.1530/REP-20-0107; HAN YM, 1995, THERIOGENOLOGY, V44, P507, DOI 10.1016/0093-691X(95)00222-T; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; HUNTER DJ, 2019, CLIN EXP RHEUMA S120, V37, pS135; IWASAKI S, 1990, J REPROD FERTIL, V90, P279, DOI 10.1530/jrf.0.0900279; Jousan FD, 2004, BIOL REPROD, V71, P1665, DOI 10.1095/biolreprod.104.032102; Kalo D, 2011, REPROD FERT DEVELOP, V23, P876, DOI 10.1071/RD10330; Kocyigit A, 2015, CRYOBIOLOGY, V71, P64, DOI 10.1016/j.cryobiol.2015.05.068; LARSON RC, 1992, MOL REPROD DEV, V33, P432, DOI 10.1002/mrd.1080330409; Le Guienne B, 2000, THERIOGENOLOGY, V53, P346; LEIBO SP, 1993, THERIOGENOLOGY, V39, P81, DOI 10.1016/0093-691X(93)90025-Z; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; Luciano AM, 2018, ANIM REPROD, V15, P727, DOI 10.21451/1984-3143-AR2018-0021; Macaulay AD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119867; Makita M, 2014, THERIOGENOLOGY, V82, P605, DOI 10.1016/j.theriogenology.2014.05.020; McEvoy TG, 2001, REPRODUCTION, V122, P507, DOI 10.1530/rep.0.1220507; Mo XH, 2014, MOL REPROD DEV, V81, P608, DOI 10.1002/mrd.22327; Mori M, 2002, REPROD DOMEST ANIM, V37, P181, DOI 10.1046/j.1439-0531.2002.00354.x; Mucci N, 2006, THERIOGENOLOGY, V65, P1551, DOI 10.1016/j.theriogenology.2005.08.020; Nagano M, 2019, J REPROD DEVELOP, V65, P195, DOI 10.1262/jrd.2019-022; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Ortega MS, 2018, BIOL REPROD, V99, P1244, DOI 10.1093/biolre/ioy141; Ortega MS, 2016, J DAIRY SCI, V99, P9152, DOI 10.3168/jds.2016-11501; Papa S, 2019, ONCOGENE, V38, P2223, DOI 10.1038/s41388-018-0582-8; PAPAIOANNOU VE, 1988, DEVELOPMENT, V102, P793; Prates EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/692067; Qi MY, 2015, ZYGOTE, V23, P514, DOI 10.1017/S096719941400015X; Riha J, 2002, CZECH J ANIM SCI, V47, P261; Rodina TM, 2009, ANIM REPROD SCI, V111, P173, DOI 10.1016/j.anireprosci.2008.02.014; Salhab M, 2013, MOL REPROD DEV, V80, P166, DOI 10.1002/mrd.22148; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; Sirisathien S, 2003, MOL REPROD DEV, V65, P51, DOI 10.1002/mrd.10263; Sozen B, 2015, MECH DEVELOP, V138, P375, DOI 10.1016/j.mod.2015.05.002; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Sugimura S, 2018, ANIM REPROD, V15, P721, DOI 10.21451/1984-3143-AR2018-0035; Tharasanit T, 2005, REPRODUCTION, V129, P789, DOI 10.1530/rep.1.00622; Tribulo P, 2018, J DAIRY SCI, V101, P690, DOI 10.3168/jds.2017-13221; Tribulo P, 2019, METHODS MOL BIOL, V2006, P115, DOI 10.1007/978-1-4939-9566-0_8; VanSoom A, 1996, MOL REPROD DEV, V45, P171, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;171::AID-MRD10&gt;3.0.CO;2-4; Wooldridge LK, 2019, BMC DEV BIOL, V19, DOI 10.1186/s12861-019-0182-z; Xie M, 2015, REPROD FERTIL DEV, P29; Yamanaka Masaya, 1999, Animal Science Journal, V70, P444; Yang QE, 2011, BIOL REPROD, V85, P946, DOI 10.1095/biolreprod.111.093203; Yuan Y, 2017, P NATL ACAD SCI USA, V114, pE5796, DOI 10.1073/pnas.1703998114; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zijlstra C, 2008, THERIOGENOLOGY, V70, P923, DOI 10.1016/j.theriogenology.2008.05.055; Zolini AM, 2019, THERIOGENOLOGY, V133, P135, DOI 10.1016/j.theriogenology.2019.05.005	66	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0243727	10.1371/journal.pone.0243727	http://dx.doi.org/10.1371/journal.pone.0243727			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534866	Green Published, gold			2022-12-26	WOS:000616739700068
J	Buril, J; Burilova, P; Pokorna, A; Kovacova, I; Balaz, M				Buril, Jiri; Burilova, Petra; Pokorna, Andrea; Kovacova, Ingrid; Balaz, Marek			Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PREVALENCE; DIAGNOSIS; EPIDEMIOLOGY	Background Parkinson's disease is a progressive neurodegenerative disease which causes health problem that affects more patients in the past few years. To be able to offer appropriate care, epidemiological analyses are crucial at the national level and its comparison with the international situation. Aim The demographic description of reported patients with parkinsonism (including Parkinson's disease and atypical parkinsonian syndromes) according to the International Classification of Diseases (ICD-10) from the national health registries. Methods Retrospective analysis of data available from the National Health Information System-NHIS and the National Registry of Reimbursed Health Services (NRRHS). Analyzed epidemiological data are intending to determine the regional and specific prevalence of Parkinsonism in the Czech Republic. The International Classification of Diseases diagnoses (ICD-10) of G20 (Parkinson's disease-PD) and G23.1, G23.2, G23.3 (other degenerative disorders of basal ganglia), and G31.8 (another degenerative disease of basal ganglia) from the period of 2012 to 2018 were included into the analysis. Results We identified 78 453 unique patients from national registries in the period 2012 to 2018. Diagnoses of G20, G23.1, G23.2, and G31.8 were registered as the principal diagnoses in 76.6% of all individual patients. Conclusion We have found a growing number of patients coded with ICD-10 of dg. G20, G23.1, G23.2, G23.3, or G31.8 (N = 27 891 in 2012, and N = 30 612 in 2018). We have proven regional differences in the prevalence of Parkinson ' s diagnoses. Therefore we assume most likely also differences in the care of patients with PD based on the availability of specialty care centers.	[Buril, Jiri; Balaz, Marek] Masaryk Univ, Fac Med, Dept Neurol 1, Brno, Czech Republic; [Burilova, Petra; Pokorna, Andrea] Masaryk Univ, Fac Med, Dept Nursing & Midwifery, Brno, Czech Republic; [Burilova, Petra; Pokorna, Andrea; Kovacova, Ingrid] Inst Hlth Informat & Stat Czech Republ, Prague, Czech Republic; [Buril, Jiri; Balaz, Marek] St Annes Univ Hosp, Dept Neurol 1, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Buril, J (corresponding author), Masaryk Univ, Fac Med, Dept Neurol 1, Brno, Czech Republic.; Buril, J (corresponding author), St Annes Univ Hosp, Dept Neurol 1, Brno, Czech Republic.	Jirka210312@gmail.com	Búřilová, Petra/AAA-2845-2022; Búřilová, Petra/AAP-8502-2021; Pokorna, Andrea/E-5483-2019	Búřilová, Petra/0000-0002-8492-8994; Pokorna, Andrea/0000-0002-1305-6455; Buril, Jiri/0000-0002-8003-7940				Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Darweesh SKL, 2016, AM J EPIDEMIOL, V183, P1018, DOI 10.1093/aje/kwv271; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Gilman S, 2005, J NEURAL TRANSM, V112, P1687, DOI 10.1007/s00702-005-0381-6; Harding Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0198736; Hustad E, 2018, J NEUROL, V265, P2120, DOI 10.1007/s00415-018-8969-6; Isotalo J, 2017, MOVEMENT DISORD, V32, P474, DOI 10.1002/mds.26862; Kis B, 2002, NEUROLOGY, V58, P1820, DOI 10.1212/WNL.58.12.1820; Kollensperger M, 2010, MOVEMENT DISORD, V25, P2604, DOI 10.1002/mds.23192; Kucera Z, 2016, CAS LEK CESK, V155, P233; Levin J, 2016, DTSCH ARZTEBL INT, V113, P61, DOI 10.3238/arztebl.2016.0061; Mensikova K, 2013, EUR J EPIDEMIOL, V28, P833, DOI 10.1007/s10654-013-9823-x; Moisan F, 2016, J NEUROL NEUROSUR PS, V87, P952, DOI 10.1136/jnnp-2015-312283; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Pagan FL, 2012, AM J MANAG CARE, V18, pS176; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Ruzicka E, 2000, PARKINSONOVA NEMOC P, P98; Team of authors, 2012, EPIDEMIOLOGICKA ANAL; Team of authors, 2013, PARKINSONOVA NEMOC R; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wanneveich M, 2018, MOVEMENT DISORD, V33, P1449, DOI 10.1002/mds.27447	26	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246342	10.1371/journal.pone.0246342	http://dx.doi.org/10.1371/journal.pone.0246342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529251	gold, Green Published			2022-12-26	WOS:000616736200026
J	de Fluiter, KS; Codd, V; Denniff, M; Kerkhof, GF; van Beijsterveldt, IALP; Breij, LM; Samani, NJ; Abrahamse-Berkeveld, M; Hokken-Koelega, ACS				de Fluiter, Kirsten S.; Codd, Veryan; Denniff, Matthew; Kerkhof, Gerthe F.; van Beijsterveldt, Inge A. L. P.; Breij, Laura M.; Samani, Nilesh J.; Abrahamse-Berkeveld, Marieke; Hokken-Koelega, Anita C. S.			Longitudinal telomere length and body composition in healthy term-born infants during the first two years of life	PLOS ONE			English	Article							EARLY-CHILDHOOD; RISK-FACTORS; METABOLIC RISK; RAPID GROWTH; VISCERAL FAT; ASSOCIATION; BIRTH; NEWBORNS; OBESITY; STRESS	Objective Leukocyte telomere length (LTL) is one of the markers of biological aging as shortening occurs over time. Shorter LTL has been associated with adiposity and a higher risk of cardiovascular diseases. The objective was to assess LTL and LTL shortening during the first 2 years of life in healthy, term-born infants and to associate LTL shortening with potential stressors and body composition. Study design In 145 healthy, term-born infants (85 boys), we measured LTL in blood, expressed as telomere to single-gene copy ratio (T/S ratio), at 3 months and 2 years by quantitative PCR technique. Fat mass (FM) was assessed longitudinally by PEAPOD, DXA, and abdominal FM by ultrasound. Results LTL decreased by 8.5% from 3 months to 2 years (T/S ratio 4.10 vs 3.75, p<0.001). LTL shortening from 3 months to 2 years associated with FM%(R = 0.254), FM index(R = 0.243) and visceral FM(R = 0.287) at 2 years. LTL shortening tended to associate with gain in FM% from 3 to 6 months (R = 0.155, p = 0.11), in the critical window for adiposity programming. There was a trend to a shorter LTL in boys at 2 years(p = 0.056). LTL shortening from 3 months to 2 years was not different between sexes. Conclusion We present longitudinal LTL values and show that LTL shortens considerably (8.5%) during the first 2 years of life. LTL shortening during first 2 years of life was associated with FM%, FMI and visceral FM at age 2 years, suggesting that adverse adiposity programming in early life could contribute to more LTL shortening.	[de Fluiter, Kirsten S.; Kerkhof, Gerthe F.; van Beijsterveldt, Inge A. L. P.; Breij, Laura M.; Hokken-Koelega, Anita C. S.] Erasmus MC, Dept Pediat, Subdiv Endocrinol, Sophia Childrens Hosp, Rotterdam, Netherlands; [Codd, Veryan; Denniff, Matthew; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Abrahamse-Berkeveld, Marieke] Danone Nutricia Res, Utrecht, Netherlands; [Hokken-Koelega, Anita C. S.] Dutch Growth Res Fdn, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Danone Nutricia	de Fluiter, KS (corresponding author), Erasmus MC, Dept Pediat, Subdiv Endocrinol, Sophia Childrens Hosp, Rotterdam, Netherlands.	k.defluiter@erasmusmc.nl			Danone Nutricia Research; MRC [MR/M012816/1] Funding Source: UKRI	Danone Nutricia Research(Danone Nutricia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Sophia Pluto Study is an investigator-initiated study; AHK received an unrestricted research grant from Danone Nutricia Research. MAB was an employee of Danone Nutricia Research. The funder provided support for the study execution and in the form of salaries for two authors [KF, IB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Bijnens EM, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0964-8; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Breij LM, 2017, PEDIATR OBES, V12, P286, DOI 10.1111/ijpo.12139; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; de Fluiter KS, 2020, EUR J CLIN NUTR, V74, P642, DOI 10.1038/s41430-020-0578-7; de Fluiter KS, 2020, JAMA PEDIAT; de Zegher F, 2017, PEDIATR OBES, V12, P274, DOI 10.1111/ijpo.12137; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Engelfriet PM, 2013, EPIDEMIOL REV, V35, P132, DOI 10.1093/epirev/mxs011; Enlow MB, 2020, PSYCHONEUROENDOCRINO, V115, DOI 10.1016/j.psyneuen.2020.104602; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Ferreira APA, 2014, J PERINATOL, V34, P932, DOI 10.1038/jp.2014.110; Gishti O, 2015, PEDIATR RES, V77, P710, DOI 10.1038/pr.2015.29; Kajantie E, 2012, INT J EPIDEMIOL, V41, P1400, DOI 10.1093/ije/dys127; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Lee Siew-Peng, 2017, BMC Res Notes, V10, P469, DOI 10.1186/s13104-017-2791-6; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Martens DS, 2017, JAMA PEDIATR, V171, P1160, DOI 10.1001/jamapediatrics.2017.3024; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Nakamura K, 2014, GENE, V533, P199, DOI 10.1016/j.gene.2013.09.086; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pietrobelli A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121491; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Rolfe ED, 2013, J OBES, V2013, DOI 10.1155/2013/951954; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Send TS, 2017, NEUROPSYCHOPHARMACOL, V42, P2407, DOI 10.1038/npp.2017.73; Skilton MR, 2016, EUR J PREV CARDIOL, V23, P1086, DOI 10.1177/2047487315607075; Slykerman RF, 2019, GENE, V694, P97, DOI 10.1016/j.gene.2019.01.017; Smeets CCJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171825; Smeets CCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143951; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wai KM, 2018, ENVIRON POLLUT, V243, P1414, DOI 10.1016/j.envpol.2018.09.090; Xia Xian, 2017, F1000Res, V6, P860, DOI 10.12688/f1000research.10692.1; Zhan YQ, 2019, CURR OPIN CARDIOL, V34, DOI 10.1097/HCO.0000000000000613	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246400	10.1371/journal.pone.0246400	http://dx.doi.org/10.1371/journal.pone.0246400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529269	Green Published, gold			2022-12-26	WOS:000616736200068
J	Etissa, EK; Assefa, M; Ayele, BT				Etissa, Eyob Kebede; Assefa, Mathewos; Ayele, Birhanu Teshome			Prognosis of colorectal cancer in Tikur Anbessa Specialized Hospital, the only oncology center in Ethiopia	PLOS ONE			English	Article							SURVIVAL	Introduction Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females worldwide. According to the Addis Ababa cancer registry, it is the first in male and fourth in female in Ethiopia. However, there have not been studies on prognostic factors and survival of colorectal cancer. Hence, this study aimed to estimate survival time and identify prognostic factors. Methods In this institution based retrospective study, medical records review of 422 colorectal cancer patients and telephone interview was used as sources of data. Survival time was estimated using Kaplan-Meier estimator. Prognostic factors were identified using the multivariable Cox regression model. Results Patients diagnosed with rectal cancer had 76% (HR: 1.761, 95% CI: 1.173-2.644) increased risk of dying compared to colon cancer patients. Node positive patients were 3.146 (95% CI: 1.626-6.078) times likely to die compared to node-negative and metastatic cancer were 4.221 (95% CI: 2.788-6.392) times likely to die compared to non-metastatic patients. Receiving adjuvant therapy reduced the risk of death by 36.1% (HR: 0.639 (95% CI: 0.418-0.977)) compared to patients who had an only surgical resection. The median survival time was 39 months and the overall five years survival rate was 33%. Conclusions The overall survival rate was low and a majority of the patients were young at presentation. Patient's survival is largely influenced by the advanced cancer stage at presentation and delays in the administration of adjuvant therapy. Receiving adjuvant therapy was among the good prognostic factors.	[Etissa, Eyob Kebede] GAMBY Coll Med & Business Sci, Addis Ababa, Ethiopia; [Assefa, Mathewos] Addis Ababa Univ, Sch Med, Oncol Dept, Addis Ababa, Ethiopia; [Ayele, Birhanu Teshome] Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Stellenbosch, South Africa	Addis Ababa University; Stellenbosch University	Etissa, EK (corresponding author), GAMBY Coll Med & Business Sci, Addis Ababa, Ethiopia.	eyobke@gmail.com		Etissa, Eyob/0000-0001-5880-3365; Ayele, Birhanu Teshome/0000-0002-5589-8327				Agyemang-Yeboah F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209307; American Cancer Society, 2014, COL CANC FACTS FIG 2; [Anonymous], 2016, CANC FACT SHEETS COL; [Anonymous], 2016, COL CANC; [Anonymous], 2018, GLOB CANC FACTS FIG, V4th; [Anonymous], 2015, NATL CANC CONTROL PL; [Anonymous], 2017, MEDICINE, V96, pe6504; [Anonymous], 2015, LANCET, P385; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Gebremedhin A, 2012, INT NETWORK CANC TRE; Granados-Romero JJ, 2017, INT J RES MED SCI, V5, P4667, DOI [10.18203/2320-6012.ijrms20174914, DOI 10.18203/2320-6012.IJRMS20174914]; Hassan Muhammad Radzi Abu, 2016, Asian Pac J Cancer Prev, V17, P3575; Irabor D., 2017, S AFRICAN GASTROENTE, P11, DOI [10.4103/0300-1652.23407629962648, DOI 10.4103/0300-1652.23407629962648]; Kumar Shiyam, 2015, Asian Pac J Cancer Prev, V16, P4853; Laohavinij Sudsawat, 2010, Journal of the Medical Association of Thailand, V93, P1156; Magaji BA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3336-z; Majek O, 2012, BRIT J CANCER, V106, P1875, DOI 10.1038/bjc.2012.189; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Olsen M., 2015, CANC SUBSAHARAN AFRI; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sharkas GF, 2017, J ONCOL, V2017, DOI 10.1155/2017/3180762; Watson W., 2011, CLIN IMMUNOL S1, V7, pS7; World Health Organization, 2014, CANC COUNTR PROF; Yeole BB, 2001, EUR J CANCER, V37, P1402, DOI 10.1016/S0959-8049(01)00108-3; Zare-Bandamiri Mohammad, 2016, Asian Pac J Cancer Prev, V17, P159; 2015, XENOTRANSPLANTATION, V22	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246424	10.1371/journal.pone.0246424	http://dx.doi.org/10.1371/journal.pone.0246424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529268	Green Submitted, gold, Green Published			2022-12-26	WOS:000616736200018
J	Smith, AD; Garcia-Santamarina, S; Ralle, M; Loiselle, DR; Haystead, TA; Thiele, DJ				Smith, Aaron D.; Garcia-Santamarina, Sarela; Ralle, Martina; Loiselle, David R.; Haystead, Timothy A.; Thiele, Dennis J.			Transcription factor-driven alternative localization of Cryptococcus neoformans superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE ACTIVATION; TERMINAL ACETYLATION; BRITISH-COLUMBIA; IRON TRANSPORT; CODON CONTEXT; COPPER; METAL; YEAST; MITOCHONDRIA; RESISTANCE	Cryptococcus neoformans is an opportunistic fungal pathogen whose pathogenic lifestyle is linked to its ability to cope with fluctuating levels of copper (Cu), an essential metal involved in multiple virulence mechanisms, within distinct host niches. During lethal cryptococcal meningitis in the brain, C. neoformans senses a Cu-deficient environment and is highly dependent on its ability to scavenge trace levels of Cu from its host and adapt to Cu scarcity to successfully colonize this niche. In this study, we demonstrate for this critical adaptation, the Cu-sensing transcription factor Cuf1 differentially regulates the expression of the SOD1 and SOD2 superoxide dismutases in novel ways. Genetic and transcriptional analysis reveals Cuf1 specifies 5'-truncations of the SOD1 and SOD2 mRNAs through specific binding to Cu responsive elements within their respective promoter regions. This results in Cuf1-dependent repression of the highly abundant SOD1 and simultaneously induces expression of two isoforms of SOD2, the canonical mitochondrial targeted isoform and a novel alternative cytosolic isoform, from a single alternative transcript produced specifically under Cu limitation. The generation of cytosolic Sod2 during Cu limitation is required to maintain cellular antioxidant defense against superoxide stress both in vitro and in vivo. Further, decoupling Cuf1 regulation of Sod2 localization compromises the ability of C. neoformans to colonize organs in murine models of cryptococcosis. Our results provide a link between transcription factor-mediated alteration of protein localization and cell proliferation under stress, which could impact tissue colonization by a fungal pathogen.	[Smith, Aaron D.; Garcia-Santamarina, Sarela; Loiselle, David R.; Haystead, Timothy A.; Thiele, Dennis J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Thiele, Dennis J.] Duke Univ, Dept Biochem, Durham, NC 27708 USA; [Thiele, Dennis J.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Smith, Aaron D.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [Garcia-Santamarina, Sarela] European Mol Biol Lab, Heidelberg, Germany; [Thiele, Dennis J.] Sisu Pharma Inc, Chapel Hill, NC 27514 USA	Duke University; Oregon Health & Science University; Duke University; Duke University; George Mason University; European Molecular Biology Laboratory (EMBL)	Thiele, DJ (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Thiele, DJ (corresponding author), Duke Univ, Dept Biochem, Durham, NC 27708 USA.; Thiele, DJ (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Thiele, DJ (corresponding author), Sisu Pharma Inc, Chapel Hill, NC 27514 USA.	dthiele@sisupharma.com	Garcia Santamarina, Sarela/O-4477-2017	Garcia Santamarina, Sarela/0000-0002-0611-7918; Smith, Aaron/0000-0001-8864-1934	United States National Institutes of Health (NIH) [GM041840-30, DK074192]; NIH Molecular Mycology and Pathogenesis Training Program [5T32AI052080]; NIH [S10RR025512]	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Mycology and Pathogenesis Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by funds from the United States National Institutes of Health (NIH) (GM041840-30 to D. J. T.) and (DK074192 to M. R.), and the NIH Molecular Mycology and Pathogenesis Training Program (5T32AI052080 to A. D. S.). ICPMS measurements were performed in the OHSU Elemental Analysis Core with partial support from NIH (S10RR025512). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Akulich KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37905; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Besold AN, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00779-17; Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Blaby-Haas CE, 2013, CURR OPIN MICROBIOL, V16, P677, DOI 10.1016/j.mib.2013.07.019; Brancaccio D, 2017, J AM CHEM SOC, V139, P719, DOI 10.1021/jacs.6b09567; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Broxton CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168400; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen Y, 2014, MBIO, V5, DOI 10.1128/mBio.01087-13; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Culbertson EM, 2020, MOL MICROBIOL, V114, P1006, DOI 10.1111/mmi.14591; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Dickinson EK, 2000, J BIOL CHEM, V275, P26780; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; Festa RA, 2014, CHEM BIOL, V21, P977, DOI 10.1016/j.chembiol.2014.06.009; Festa RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002887; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Garcia-Santamarina S, 2018, MOL MICROBIOL, V108, P473, DOI 10.1111/mmi.13960; Garcia-Santamarina S, 2017, MBIO, V8, DOI [10.1128/mBio.01742-17, 10.1128/mbio.01742-17]; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hylander BL, 2019, J IMMUNOL, V202, P631, DOI 10.4049/jimmunol.1800621; Hyre AN, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01041-16; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Kuhn DE, 1999, J LEUKOCYTE BIOL, V66, P113, DOI 10.1002/jlb.66.1.113; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Ladomersky E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00351-17; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Montefusco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079455; Mourad A, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170391; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shen Q, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007444; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Smith AD, 2017, ANNU REV MICROBIOL, V71, P597, DOI 10.1146/annurev-micro-030117-020444; Stafford SL, 2013, BIOSCIENCE REP, V33, P541, DOI 10.1042/BSR20130014; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; Tan GQ, 2014, MOL MICROBIOL, V93, P629, DOI 10.1111/mmi.12676; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Torres AS, 2001, J BIOL CHEM, V276, P38410, DOI 10.1074/jbc.M104790200; Wallace EWJ, 2020, NUCLEIC ACIDS RES, V48, P2312, DOI 10.1093/nar/gkaa060; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Waterman SR, 2012, MBIO, V3, DOI 10.1128/mBio.00285-12; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; WISPE JR, 1989, BIOCHIM BIOPHYS ACTA, V994, P30, DOI 10.1016/0167-4838(89)90058-7; Woodacre A, 2008, MICROBIOL-SGM, V154, P1502, DOI 10.1099/mic.0.2007/013441-0; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	84	3	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100391	10.1016/j.jbc.2021.100391	http://dx.doi.org/10.1016/j.jbc.2021.100391			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567338	gold, Green Published			2022-12-26	WOS:000672866400365
J	Yeo, CT; Stancill, JS; Oleson, BJ; Schnuck, JK; Stafford, JD; Naatz, A; Hansen, PA; Corbett, JA				Yeo, Chay Teng; Stancill, Jennifer S.; Oleson, Bryndon J.; Schnuck, Jamie K.; Stafford, Joshua D.; Naatz, Aaron; Hansen, Polly A.; Corbett, John A.			Regulation of ATR-dependent DNA damage response by nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; HISTONE H2AX PHOSPHORYLATION; RIBONUCLEOTIDE REDUCTASE; METABOLIC REQUIREMENTS; OXIDATIVE-METABOLISM; INSULIN-SECRETION; ENERGY-METABOLISM; ISLET DESTRUCTION; EMCV REPLICATION; POTENTIAL ROLE	We have shown that nitric oxide limits ataxia-telangiectasia mutated signaling by inhibiting mitochondrial oxidative metabolism in a beta-cell selective manner. In this study, we examined the actions of nitric oxide on a second DNA damage response transducer kinase, ataxia-telangiectasia and Rad3-related protein (ATR). In beta-cells and non-beta-cells, nitric oxide activates ATR signaling by inhibiting ribonucleotide reductase; however, when produced at inducible nitric oxide synthase-derived (low micromolar) levels, nitric oxide impairs ATR signaling in a beta-cell selective manner. The inhibitory actions of nitric oxide are associated with impaired mitochondrial oxidative metabolism and lack of glycolytic compensation that result in a decrease in beta-cell ATP. Like nitric oxide, inhibitors of mitochondrial respiration reduce ATP levels and limit ATR signaling in a beta-cell selective manner. When non-beta-cells are forced to utilize mitochondrial oxidative metabolism for ATP generation, their response is more like beta-cells, as nitric oxide and inhibitors of mitochondrial respiration attenuate ATR signaling. These studies support a dual role for nitric oxide in regulating ATR signaling. Nitric oxide activates ATR in all cell types examined by inhibiting ribonucleotide reductase, and in a beta-cell selective manner, inducible nitric oxide synthase-derived levels of nitric oxide limit ATR signaling by attenuating mitochondrial oxidative metabolism and depleting ATP.	[Yeo, Chay Teng; Stancill, Jennifer S.; Oleson, Bryndon J.; Schnuck, Jamie K.; Stafford, Joshua D.; Naatz, Aaron; Hansen, Polly A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu			National Institutes of Health [DK-052194, AI-44458]; Juvenile Diabetes Research Foundation [2-SRA-2019-829-S-B]; American Heart Association [17PRE32530001]; National Heart, Lung, and Blood Institute [T32 HL134643]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (DK-052194 and AI-44458), Juvenile Diabetes Research Foundation grant 2-SRA-2019-829-S-B, and a gift from the Forest County Potawatomi Foundation (to J. A. C). J. D. S was funded by an American Heart Association Fellowship 17PRE32530001 (to J. D. S), and J. S. S. was supported by the National Heart, Lung, and Blood Institute grant (T32 HL134643). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnush M, 1998, J IMMUNOL, V160, P2684; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Broniowska KA, 2013, J BIOL CHEM, V288, P36567, DOI 10.1074/jbc.M113.522243; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; ERECINSKA M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P273, DOI 10.1016/0167-4838(92)90555-R; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Kulkarni A, 2008, AM J PHYSIOL-LUNG C, V294, pL998, DOI 10.1152/ajplung.00004.2008; KWON NS, 1991, J EXP MED, V174, P761, DOI 10.1084/jem.174.4.761; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LACY PE, 1994, MT SINAI J MED, V61, P170; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Liu QH, 2000, GENE DEV, V14, P1448; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oleson BJ, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113907; Oleson BJ, 2018, ANTIOXID REDOX SIGN, V29, P1432, DOI 10.1089/ars.2017.7351; Oleson BJ, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00153-19; Oleson BJ, 2018, DIABETES, V67, P898, DOI 10.2337/db17-1062; Oleson BJ, 2016, MOL CELL BIOL, V36, P2067, DOI 10.1128/MCB.00262-16; Oleson BJ, 2014, J BIOL CHEM, V289, P11454, DOI 10.1074/jbc.M113.531228; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; PANTEN U, 1975, DIABETOLOGIA, V11, P569, DOI 10.1007/BF01222108; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Puri S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02939-0; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; ROY B, 1995, BIOCHEMISTRY-US, V34, P5411, DOI 10.1021/bi00016a012; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shaheen ZR, 2020, J BIOL CHEM, V295, P2385, DOI 10.1074/jbc.RA119.010267; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Stafford JD, 2020, J BIOL CHEM, V295, P18189, DOI 10.1074/jbc.RA120.015893; Stafford JD, 2020, J BIOL CHEM, V295, P16655, DOI 10.1074/jbc.RA120.014851; Stancill JS, 2019, AM J PHYSIOL-ENDOC M, V316, pE196, DOI 10.1152/ajpendo.00229.2018; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	81	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100388	10.1016/j.jbc.2021.100388	http://dx.doi.org/10.1016/j.jbc.2021.100388			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567339	gold, Green Published			2022-12-26	WOS:000672866400362
J	Albarry, MA; Latif, M; Alreheli, AQ; Awadh, MA; Almatrafi, AM; Albalawi, AM; Basit, S				Albarry, Maan Abdullah; Latif, Muhammad; Alreheli, Ahdab Qasem; Awadh, Mohammed A.; Almatrafi, Ahmad M.; Albalawi, Alia M.; Basit, Sulman			Frameshift variant in MITF gene in a large family with Waardenburg syndrome type II and a co-segregation of a C2orf74 variant	PLOS ONE			English	Article							SOX10 GENE; HETEROZYGOUS DELETION; MISSENSE MUTATION; CHINESE FAMILY; PATIENT; HOMOZYGOSITY; LOCUS; EDNRB; SITE	Waardenburg syndrome (WS) is a hereditary disorder affecting the auditory system and pigmentation of hair, eyes, and skin. Different variants of the disease exist with the involvement of mutation in six genes. The aim of the study is to identify the genetic defects underlying Waardenburg syndrome in a large family with multiple affected individuals. Here, in this study, we recruited a large family with eleven affected individuals segregating WS type 2. We performed whole genome SNP genotyping, whole exome sequencing and segregation analysis using Sanger approach. Whole genome SNP genotyping, whole exome sequencing followed by Sanger validation of variants of interest identified a novel single nucleotide deletion mutation (c.965delA) in the MITF gene. Moreover, a rare heterozygous, missense damaging variant (c.101T>G; p.Val34Gly) in the C2orf74 has also been identified. The C2orf74 is an uncharacterized gene present in the linked region detected by DominantMapper. Variants in MITF and C2orf74 follows autosomal dominant segregation with the phenotype, however, the variant in C2orf74 is incompletely penetrant. We proposed a digenic inheritance of variants as an underlying cause of WS2 in this family.	[Albarry, Maan Abdullah; Alreheli, Ahdab Qasem] Taibah Univ, Coll Med, Dept Ophthalmol, Almadinah, Saudi Arabia; [Latif, Muhammad; Albalawi, Alia M.; Basit, Sulman] Taibah Univ, Ctr Genet & Inherited Dis, Almadinah, Saudi Arabia; [Awadh, Mohammed A.] Taibah Univ, Coll Appl Med Sci, Almadinah, Saudi Arabia; [Almatrafi, Ahmad M.] Taibah Univ, Coll Sci, Dept Biol, Almadinah, Saudi Arabia; [Albalawi, Alia M.] King Abdulaziz Univ, Coll Sci, Dept Biol, Jeddah, Saudi Arabia	Taibah University; Taibah University; Taibah University; Taibah University; King Abdulaziz University	Basit, S (corresponding author), Taibah Univ, Ctr Genet & Inherited Dis, Almadinah, Saudi Arabia.	sbasit.phd@gmail.com	Basit, Sulman/Q-7939-2018; Basit, Sulman/AAY-9763-2021; Latif, PhD, Muhammad/D-1335-2018	Basit, Sulman/0000-0003-4294-6825; Basit, Sulman/0000-0003-4294-6825; Latif, PhD, Muhammad/0000-0003-4858-3324	Deanship of Scientific Research (DSR), Taibah University Almadinah [10057]	Deanship of Scientific Research (DSR), Taibah University Almadinah	Ahmad M Almatrafi obtained funds under the research group grant number 10057 from the Deanship of Scientific Research (DSR), Taibah University Almadinah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funds were used for purchase of reagents and chemicals.	Alayadhi LY, 2016, NEUROSCIENCE, V339, P561, DOI 10.1016/j.neuroscience.2016.10.030; Albarry MA, 2019, SAUDI J OPHTHALMOL, V33, P326, DOI 10.1016/j.sjopt.2019.09.004; Barashkov Nikolay A, 2019, Int J Circumpolar Health, V78, P1630219, DOI 10.1080/22423982.2019.1630219; Basit S, 2018, CONGENIT ANOM, V58, P56, DOI 10.1111/cga.12235; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Chandra Mohan Setty L N, 2018, J Otol, V13, P105, DOI 10.1016/j.joto.2018.05.005; Chen KT, 2014, INT J PEDIATR OTORHI, V78, P926, DOI 10.1016/j.ijporl.2014.03.014; Choi EY, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0933-9; Doubaj Y, 2015, MOL SYNDROMOL, V6, P44, DOI 10.1159/000371590; Haddad NM, 2010, MOL SYNDROMOL, V1, P169, DOI 10.1159/000322891; Hazan F, 2013, MOL VIS, V19, P196; He WZ, 2015, INT J PEDIATR OTORHI, V79, P1718, DOI 10.1016/j.ijporl.2015.07.034; Hemmi A, 2018, J DERMATOL, V45, pE110, DOI 10.1111/1346-8138.14151; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Iso M, 2008, AM J MED GENET A, V146A, P2162, DOI 10.1002/ajmg.a.32403; Jabeen R, 2012, MOL BIOL REP, V39, P785, DOI 10.1007/s11033-011-0799-x; Jalilian N, 2018, INT J MOL CELL MED, V7, P17, DOI 10.22088/IJMCM.BUMS.7.1.17; Jalilian N, 2017, MOL SYNDROMOL, V8, P195, DOI 10.1159/000476020; Jalilian N, 2015, GENE, V574, P302, DOI 10.1016/j.gene.2015.08.023; Kumawat D, 2019, INDIAN J OPHTHALMOL, V67, P1481, DOI 10.4103/ijo.IJO_181_19; Lalwani AK, 1998, AM J MED GENET, V80, P406, DOI 10.1002/(SICI)1096-8628(19981204)80:4<406::AID-AJMG20>3.0.CO;2-P; Lautenschlager NT, 1996, GENET ANAL-BIOMOL E, V13, P43, DOI 10.1016/1050-3862(95)00148-4; Li HN, 2017, GENET TEST MOL BIOMA, V21, P681, DOI 10.1089/gtmb.2016.0421; Ma J, 2019, MOL MED REP, V19, P1775, DOI 10.3892/mmr.2019.9815; Ma J, 2016, INT J PEDIATR OTORHI, V85, P56, DOI 10.1016/j.ijporl.2016.03.043; Matsunaga T, 2013, ACTA OTO-LARYNGOL, V133, P345, DOI 10.3109/00016489.2012.744470; Minami SB, 2019, GENE, V704, P86, DOI 10.1016/j.gene.2019.04.023; Monma F, 2008, J DERMATOL SCI, V52, P64, DOI 10.1016/j.jdermsci.2008.05.003; Morimoto N, 2018, AURIS NASUS LARYNX, V45, P222, DOI 10.1016/j.anl.2017.03.022; Nobukuni Y, 1996, AM J HUM GENET, V59, P76; Okamura K, 2015, J DERMATOL, V42, P1211, DOI 10.1111/1346-8138.13095; Pang XH, 2019, AM J MED GENET A, V179, P243, DOI 10.1002/ajmg.a.60693; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Rauschendorf MA, 2019, PIGM CELL MELANOMA R, V32, P85, DOI 10.1111/pcmr.12733; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Rutherford A, 2018, DERMATOL ONLINE J, V24, P13; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Shi YF, 2016, EXP THER MED, V11, P1516, DOI 10.3892/etm.2016.3042; Song J, 2016, CLIN GENET, V89, P416, DOI 10.1111/cge.12631; Sun J, 2017, J HUM GENET, V62, P703, DOI 10.1038/jhg.2017.30; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Tamayo ML, 2008, AM J MED GENET A, V146A, P1026, DOI 10.1002/ajmg.a.32189; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Wang XP, 2018, J HUM GENET, V63, P639, DOI 10.1038/s10038-018-0425-z; Wollnik B, 2003, AM J MED GENET A, V122A, P42, DOI 10.1002/ajmg.a.20260; ZLOTOGORA J, 1995, AM J HUM GENET, V56, P1173	47	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246607	10.1371/journal.pone.0246607	http://dx.doi.org/10.1371/journal.pone.0246607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571247	gold, Green Published			2022-12-26	WOS:000618274000104
J	Shitara, A; Takahashi, K; Goto, M; Takahashi, H; Iwasawa, T; Onodera, Y; Makino, K; Miura, H; Shirasawa, H; Sato, W; Kumazawa, Y; Terada, Y				Shitara, Akihiro; Takahashi, Kazumasa; Goto, Mayumi; Takahashi, Harunori; Iwasawa, Takuya; Onodera, Yohei; Makino, Kenichi; Miura, Hiroshi; Shirasawa, Hiromitsu; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro			Cell-free DNA in spent culture medium effectively reflects the chromosomal status of embryos following culturing beyond implantation compared to trophectoderm biopsy	PLOS ONE			English	Article							SELF-ORGANIZATION; SUPPLEMENTATION; DIFFERENTIATION; BLASTOCYSTS	This prospective study evaluated the accuracy of non-invasive preimplantation genetic testing for aneuploidy (niPGT-A) using cell-free DNA in spent culture medium, as well as that of preimplantation genetic testing for aneuploidy (PGT-A) using trophectoderm (TE) biopsy after culturing beyond implantation. Twenty frozen blastocysts donated by 12 patients who underwent IVF at our institution were investigated. Of these, 10 were frozen on day 5 and 10 on day 6. Spent culture medium and TE cells were collected from each blastocyst after thawing, and the embryos were cultured in vitro for up to 10 days. The outgrowths after culturing beyond implantation were sampled and subjected to chromosome analysis using next-generation sequencing. Chromosomal concordance rate, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), false-positive rate (FPR), and false-negative rate (FNR) of niPGT-A and PGT-A against each outgrowth were analyzed. The concordance rate between the niPGT-A and outgrowth samples was 9/16 (56.3%), and the concordance rate between the PGT-A and outgrowth samples was 7/16 (43.8%). NiPGT-A exhibited 100% sensitivity, 87.5% specificity, 88.9% PPV, 100% NPV, 12.5% FPR, and 0% FNR. PGT-A exhibited 87.5% sensitivity, 77.8% specificity, 87.5% PPV, 75% NPV, 14.3% FPR, and 22.2% FNR. NiPGT-A may be more accurate than PGT-A in terms of ploidy diagnostic accuracy in outgrowths.	[Shitara, Akihiro; Takahashi, Kazumasa; Goto, Mayumi; Takahashi, Harunori; Iwasawa, Takuya; Onodera, Yohei; Makino, Kenichi; Miura, Hiroshi; Shirasawa, Hiromitsu; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro] Akita Univ, Dept Obstet & Gynecol, Grad Sch Med Hondo, Akita, Japan	Akita University	Shitara, A (corresponding author), Akita Univ, Dept Obstet & Gynecol, Grad Sch Med Hondo, Akita, Japan.	shitaraa@med.akita-u.ac.jp		Akihiro, Shitara/0000-0003-0293-9372	JSPS KAKENHI [18H02942]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.T . Grant Number 18H02942 . JSPS KAKENHI . https://www.jsps.go.jp/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia DE, 1996, HUM REPROD, V11, P2217; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Capalbo A, 2018, FERTIL STERIL, V110, P870, DOI 10.1016/j.fertnstert.2018.05.031; Chuang TH, 2018, MOL HUM REPROD, V24, P593, DOI 10.1093/molehr/gay043; Cimadomo D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7193075; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Duggal G, 2015, MOL HUM REPROD, V21, P410, DOI 10.1093/molehr/gav004; Duggal G, 2013, STEM CELLS DEV, V22, P3141, DOI 10.1089/scd.2013.0024; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Hardy K, 1999, REV REPROD, V4, P125; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hashimoto M, 2019, DEV CELL, V50, P138, DOI 10.1016/j.devcel.2019.05.024; Ho JR, 2018, FERTIL STERIL, V110, P467, DOI 10.1016/j.fertnstert.2018.03.036; Huang L, 2019, P NATL ACAD SCI USA, V116, P14105, DOI 10.1073/pnas.1907472116; Jiao J, 2019, HUM REPROD, V34, P1369, DOI 10.1093/humrep/dez075; Lawrenz B, 2019, HUM REPROD, V34, P998, DOI 10.1093/humrep/dez055; Maxwell SM, 2018, BEST PRACT RES CL OB, V53, P38, DOI 10.1016/j.bpobgyn.2018.07.005; McArthur SJ, 2005, FERTIL STERIL, V84, P1628, DOI 10.1016/j.fertnstert.2005.05.063; Munne S, 2006, REPROD BIOMED ONLINE, V12, P234, DOI 10.1016/S1472-6483(10)60866-8; Munne S, 2018, REPROD BIOMED ONLINE, V37, P393, DOI 10.1016/j.rbmo.2018.08.001; Munne S, 2017, FERTIL STERIL, V108, P62, DOI 10.1016/j.fertnstert.2017.05.002; O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817; Ou ZH, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-019-0253-z; Popovic M, 2019, HUM REPROD, V34, P758, DOI 10.1093/humrep/dez012; Popovic M, 2018, HUM REPROD, V33, P1342, DOI 10.1093/humrep/dey106; Sato T, 2019, HUM REPROD, V34, P2340, DOI 10.1093/humrep/dez229; Scott KL, 2013, FERTIL STERIL, V100, P608, DOI 10.1016/j.fertnstert.2013.07.004; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Spinella F, 2018, FERTIL STERIL, V109, P77, DOI 10.1016/j.fertnstert.2017.09.025; Whitney JB, 2016, J ASSIST REPROD GEN, V33, P1507, DOI 10.1007/s10815-016-0792-3; Wu YB, 2014, CELL MOL LIFE SCI, V71, P1761, DOI 10.1007/s00018-013-1466-2; Xu JJ, 2016, P NATL ACAD SCI USA, V113, P11907, DOI 10.1073/pnas.1613294113; Yeung QSY, 2019, J ASSIST REPROD GEN, V36, P1609, DOI 10.1007/s10815-019-01517-7; Zeng Y, 2013, CELL TISSUE RES, V354, P729, DOI 10.1007/s00441-013-1728-1; Zhang SP, 2016, FERTIL STERIL, V105, P1222, DOI 10.1016/j.fertnstert.2016.01.011; Zhu P, 2018, NAT GENET, V50, P12, DOI 10.1038/s41588-017-0007-6	37	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246438	10.1371/journal.pone.0246438	http://dx.doi.org/10.1371/journal.pone.0246438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571233	gold, Green Published			2022-12-26	WOS:000618274000088
J	Termrungruanglert, W; Khemapech, N; Vasuratna, A; Havanond, P; Deebukkham, P; Kulkarni, AS; Pavelyev, A				Termrungruanglert, Wichai; Khemapech, Nipon; Vasuratna, Apichai; Havanond, Piyalamporn; Deebukkham, Preyanuch; Kulkarni, Amit Sharad; Pavelyev, Andrew			The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand	PLOS ONE			English	Article							COST-EFFECTIVENESS; HPV; MODEL	Background The human papillomavirus (HPV) vaccine was introduced into Thailand's national immunization program in 2017 for 11-12 year old school girls. The objectives of this study were to examine the epidemiological consequences and cost-effectiveness of a routine quadrivalent HPV (4vHPV) vaccination and the routine 4vHPV vaccination plus 5-year catch-up vaccination by comparing with cervical cancer screening only (no vaccination) in Thailand. Method A transmission dynamic model was used to assess the cost-effectiveness of the routine 4vHPV vaccination and the routine 4vHPV vaccination plus catch-up vaccination, compared with no vaccination (screening only) in Thai population. The vaccination coverage rate assumptions were 95% in 11-12-year-old girls for the routine vaccination and 70% in 13-24 year-old females for the 5-year catch-up vaccination. Vaccination costs, direct medical costs of HPV-related diseases, and the number of quality of life years (QALYs) gained were calculated for over a 100-year time horizon with discount rate of 3%. Result The model indicated that the routine 4vHPV vaccination and the routine plus catch-up 4vHPV vaccination strategies could prevent approximately 434,130 and 472,502 cumulative cases of cervical cancer, 182,234 and 199,068 cumulative deaths from cervical cancer and 12,708,349 and 13,641,398 cumulative cases of HPV 6/11 related genital warts, respectively, when compared with no vaccination over 100 years. The estimated cost per QALY gained (ICER) when compared to no vaccination in Thailand was 8,370 THB/QALY for the routine vaccination and 9,650 THB/QALY for the routine with catch-up vaccination strategy. Conclusion Considering the recommended threshold of 160,000 THB/QALY for Thailand, the implementation of the routine 4vHPV vaccination either alone or plus the catch-up vaccination was cost-effective as compared to the cervical cancer screening only.	[Termrungruanglert, Wichai; Khemapech, Nipon; Vasuratna, Apichai; Havanond, Piyalamporn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Obstet & Gynecol, Bangkok, Thailand; [Deebukkham, Preyanuch] MSD Thailand Ltd, Bangkok, Thailand; [Kulkarni, Amit Sharad; Pavelyev, Andrew] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA	Chulalongkorn University; Merck & Company	Termrungruanglert, W (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Obstet & Gynecol, Bangkok, Thailand.	wichaiterm@yahoo.com		Termrungruanglert, Wichai/0000-0003-3510-0047				[Anonymous], 2019, HPV CANC NAT CANC I; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Braaten Kari P, 2008, Rev Obstet Gynecol, V1, P2; Bruni L, 2019, HUMAN PAPILLIMAVIRUS; Center of Policy and Strategy Ministry of Public Health, 3 NAT SURV THAI HLTH; Coe M, 2017, THAILAND COUNTRY BRI; De Vincenzo R, 2013, GYNECOL ONCOL, V130, P642, DOI 10.1016/j.ygyno.2013.05.033; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Golicki D, 2010, VALUE HEALTH, V13, P289, DOI 10.1111/j.1524-4733.2009.00596.x; Hussain R, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040629; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; Jacobson SH, 2012, EXPERT REV VACCINES, V11, P1163, DOI [10.1586/erv.12.95, 10.1586/ERV.12.95]; Kruiroongroj S, 2014, ASIAN PAC J CANCER P, V15, P5469, DOI 10.7314/APJCP.2014.15.13.5469; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; National Statistical Office Ministry of Information and Communication Technology of Thailand, REPR HLTH SURV 2009; Ngorsuraches Surachat, 2015, J Pharm Policy Pract, V8, P20, DOI 10.1186/s40545-015-0040-8; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Permsuwan Unchalee, 2014, Journal of the Medical Association of Thailand, V97, pS50; Sajirawattanakul D, 2012, GOVT URGED DROP HPV; Sanders GD, 2003, EMERG INFECT DIS, V9, P37; Sharma M, 2012, BJOG-INT J OBSTET GY, V119, P166, DOI 10.1111/j.1471-0528.2011.02974.x; Sirisamutr T, 2012, J HLTH SCI, P538; Stratton KR, 2000, VACCINES 21 CENTURY; Teerawattananon Y, 2014, Z EVIDENZ FORTBILD Q, V108, P397, DOI 10.1016/j.zefq.2014.06.017; Termrungruanglert W, 2012, VALUE HEALTH, V15, pS29, DOI 10.1016/j.jval.2011.11.007; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HUM PAP REL CANC THA; World Health Organization, 2020, HUMAN PAPILLOMAVIRUS	30	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245894	10.1371/journal.pone.0245894	http://dx.doi.org/10.1371/journal.pone.0245894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571186	gold, Green Published			2022-12-26	WOS:000618274000081
J	Murbe, D; Kriegel, M; Lange, J; Schumann, L; Hartmann, A; Fleischer, M				Muerbe, Dirk; Kriegel, Martin; Lange, Julia; Schumann, Lukas; Hartmann, Anne; Fleischer, Mario			Aerosol emission of adolescents voices during speaking, singing and shouting	PLOS ONE			English	Article							AIR-FLOW; DYNAMICS	Since the outbreak of the COVID-19 pandemic, singing activities for children and young people have been strictly regulated with far-reaching consequences for music education in schools and ensemble and choir singing in some places. This is also due to the fact, that there has been no reliable data available on aerosol emissions from adolescents speaking, singing, and shouting. By utilizing a laser particle counter in cleanroom conditions we show, that adolescents emit fewer aerosol particles during singing than what has been known so far for adults. In our data, the emission rates ranged from 16 P/s to 267 P/s for speaking, 141 P/s to 1240 P/s for singing, and 683 P/s to 4332 P/s for shouting. The data advocate an adaptation of existing risk management strategies and rules of conduct for groups of singing adolescents, like gatherings in an educational context, e.g. singing lessons or choir rehearsals.	[Muerbe, Dirk; Fleischer, Mario] Charite Univ Med Berlin, Dept Audiol & Phoniatr, Berlin, Germany; [Kriegel, Martin; Lange, Julia; Schumann, Lukas; Hartmann, Anne] Tech Univ Berlin, Hermann Rietschel Inst, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin	Fleischer, M (corresponding author), Charite Univ Med Berlin, Dept Audiol & Phoniatr, Berlin, Germany.	mario.fleischer@charite.de		Fleischer, Mario/0000-0002-6186-8298				Abuhegazy M, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0029118; Adams, 1993, A033205 CAL ENV PROT; Alsved M, 2020, AEROSOL SCI TECH, V54, P1245, DOI 10.1080/02786826.2020.1812502; American Society of Heating Refrigerating and Air-Conditioning Engineers, 2015, ASHRAE POSITION DOCU; Amis TC, 1999, J PHYSIOL-LONDON, V515, P293, DOI 10.1111/j.1469-7793.1999.293ad.x; Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Buonanno G, 2020, ENVIRON INT, V141, DOI 10.1016/j.envint.2020.105794; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Fleischer M., 2020, RISK ASSESSMENT REHE, DOI [10.14279/depositonce-10388, DOI 10.14279/DEPOSITONCE-10388]; Gregson Watson, 2020, COMP RESPIRABLE AERO, DOI [10.26434/chemrxiv.12789221.v1, DOI 10.26434/CHEMRXIV.12789221.V1]; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Hamner L, 2020, MMWR-MORBID MORTAL W, V69, P606, DOI 10.15585/mmwr.mm6919e6; Howard DM, 2010, LOGOP PHONIATR VOCO, V35, P81, DOI 10.3109/14015439.2010.482863; Jiang JJ, 2016, J VOICE, V30, P641, DOI 10.1016/j.jvoice.2015.07.018; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; McAllister A, 1998, J VOICE, V12, P166, DOI 10.1016/S0892-1997(98)80036-2; Mittal R, 2013, ANNU REV FLUID MECH, V45, P437, DOI 10.1146/annurev-fluid-011212-140636; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Murbe D, 2020, AEROSOL EMISSION IS, P1, DOI DOI 10.31219/OSF.IO/ZNJEH; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Wei JJ, 2015, BUILD ENVIRON, V93, P86, DOI 10.1016/j.buildenv.2015.06.018; Yang CQ, 2015, BUILD SIMUL-CHINA, V8, P551, DOI 10.1007/s12273-014-0227-6	24	29	29	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246819	10.1371/journal.pone.0246819	http://dx.doi.org/10.1371/journal.pone.0246819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566852	gold, Green Published			2022-12-26	WOS:000618271700032
J	Dias, SHB; Filgueiras, R; Fernandes, EI; Arcanjo, GS; da Silva, GH; Mantovani, EC; da Cunha, FF				Brant Dias, Santos Henrique; Filgueiras, Roberto; Fernandes Filho, Elpidio Inacio; Arcanjo, Gemima Santos; da Silva, Gustavo Henrique; Mantovani, Everardo Chartuni; da Cunha, Fernando Franca			Reference evapotranspiration of Brazil modeled with machine learning techniques and remote sensing	PLOS ONE			English	Article							MODIS; VALIDATION; REGRESSION; PRODUCT; ALGORITHM; FLUXES; MOD16; CROP	Reference evapotranspiration (ETo) is a fundamental parameter for hydrological studies and irrigation management. The Penman-Monteith method is the standard to estimate ETo and requires several meteorological elements. In developing countries, the number of weather stations is insufficient. Thus, free products of remote sensing with evapotranspiration information must be used for this purpose. In this context, the objective of this study was to estimate monthly ETo from potential evapotranspiration (PET) made available by MOD16 product. In this study, the monthly ETo estimated by Penman-Monteith method was considered as the standard. For this, data from 265 weather station of the National Institute of Meteorology (INMET), spread all over the Brazilian territory, were acquired for the period from 2000 to 2014 (15 years). For these months, monthly PET values from MOD16 product for all Brazil were also downloaded. By using machine learning algorithms and information from WorldClim as covariates, ETo was estimated through images from the MOD16 product. To perform the modeling of ETo, eight regression algorithms were tested: multiple linear regression; random forest; cubist; partial least squares; principal components regression; adaptive forward-backward greedy; generalized boosted regression and generalized linear model by likelihood-based boosting. Data from 2000 to 2012 (13 years) were used for training and data of 2013 and 2014 (2 years) were used to test the models. The PET made available by the MOD16 product showed higher values than those of ETo for different periods and climatic regions of Brazil. However, the MOD16 product showed good correlation with ETo, indicating that it can be used in ETo estimation. All models of machine learning were effective in improving the performance of the metrics evaluated. Cubist was the model that presented the best metrics for r(2) (0.91), NSE (0.90) and nRMSE (8.54%) and should be preferred for ETo prediction. MOD16 product is recommended to be used to predict monthly ETo, which opens possibilities for its use in several other studies.	[Brant Dias, Santos Henrique] Ponta Grossa State Univ UEPG, Agron Dept, Ponta Grossa, Parana, Brazil; [Filgueiras, Roberto; da Silva, Gustavo Henrique; Mantovani, Everardo Chartuni; da Cunha, Fernando Franca] Fed Univ Vicosa UFV, Agr Engn Dept, Vicosa, MG, Brazil; [Fernandes Filho, Elpidio Inacio] Fed Univ Vicosa UFV, Soil Dept, Vicosa, MG, Brazil; [Arcanjo, Gemima Santos] Fed Univ Bahia UFBA, Polytech Sch, Salvador, BA, Brazil	Universidade Estadual de Ponta Grossa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal da Bahia	da Cunha, FF (corresponding author), Fed Univ Vicosa UFV, Agr Engn Dept, Vicosa, MG, Brazil.	fernando.cunha@ufv.br	Filho, Elpídio Inácio Fernandes/AAE-7315-2019; Henrique da Silva, Gustavo/GPC-8495-2022; Arcanjo, Gemima/T-7494-2018	Filho, Elpídio Inácio Fernandes/0000-0002-9484-1411; Henrique da Silva, Gustavo/0000-0002-1046-7646; Arcanjo, Gemima/0000-0001-7865-7502	Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) and National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SS, 2015, J HYDROL, V527, P184, DOI 10.1016/j.jhydrol.2015.04.073; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Althoff D, 2018, CIENC AGROTEC, V42, P314, DOI 10.1590/1413-70542018423006818; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; ANDREWS DF, 1974, TECHNOMETRICS, V16, P523, DOI 10.2307/1267603; [Anonymous], 2006, R PACKAGE VERSION; [Anonymous], 2019, RELIGIONS, V10, P33; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Courault D., 2005, Irrigation and Drainage Systems, V19, P223, DOI 10.1007/s10795-005-5186-0; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; FAO, 2016, AQ WAT US; Faria RT, 2002, BOL TEC, V29; Feng Y, 2017, AGR WATER MANAGE, V193, P163, DOI 10.1016/j.agwat.2017.08.003; Fenner W, 2015, REV BRAS CLIMATOL, V15, P109, DOI [10.5380/abclima.v15i0.37309, DOI 10.5380/ABCLIMA.V15I0.37309]; Fernandes Filho EI, 2018, LABGEO COLLECTION FU; Ferreira LB, 2020, AGR WATER MANAGE, V234, DOI 10.1016/j.agwat.2020.106113; Ferreira LB, 2019, J HYDROL, V572, P556, DOI 10.1016/j.jhydrol.2019.03.028; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fisher JB, 2009, GLOBAL CHANGE BIOL, V15, P2694, DOI 10.1111/j.1365-2486.2008.01813.x; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Frondana G., 2017, THESIS; Garcia Garcia Rodrigo, 2013, Pesqui. Agropecu. Trop., V43, P218, DOI 10.1590/S1983-40632013000200014; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Harmancioglu NB, 2017, WATER RESOUR MANAG, V31, P3001, DOI 10.1007/s11269-017-1725-3; Houborg R, 2018, ISPRS J PHOTOGRAMM, V135, P173, DOI 10.1016/j.isprsjprs.2017.10.004; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Jovanovic N, 2015, WATER SA, V41, P79, DOI 10.4314/wsa.v41i1.11; Ke YH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030215; Khosravi V, 2020, ENVIRON EARTH SCI, V79, DOI 10.1007/s12665-020-8901-0; Kim HW, 2012, KSCE J CIV ENG, V16, P229, DOI 10.1007/s12205-012-0006-1; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Kustas WP, 1996, J APPL METEOROL, V35, P110, DOI 10.1175/1520-0450(1996)035<0110:SADSMO>2.0.CO;2; Li FQ, 1999, J APPL METEOROL, V38, P1644, DOI 10.1175/1520-0450(1999)038&lt;1644:EORETR&gt;2.0.CO;2; Li J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090902; Liu Y, 2018, J MT SCI-ENGL, V15, P33, DOI 10.1007/s11629-017-4564-z; LP DAAC, 2018, LAND PROC DISTR ACT; LP DAAC, 2018, MODIS REPR TOOL; Luckmann J, 2014, WATER RESOUR RES, V50, P3875, DOI 10.1002/2013WR014750; Madugundu R, 2017, HYDROL EARTH SYST SC, V21, P6135, DOI 10.5194/hess-21-6135-2017; MASSY WF, 1965, J AM STAT ASSOC, V60, P234, DOI 10.2307/2283149; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Mu QZ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000179; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Muniandy JM, 2016, AGR WATER MANAGE, V169, P77, DOI 10.1016/j.agwat.2016.02.019; Noi PT, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050398; Pinto CET, 2014, REV BRAS ENG AGR AMB, V18, P507, DOI 10.1590/S1415-43662014000500007; Polhamus A, 2013, AGR FOREST METEOROL, V169, P12, DOI 10.1016/j.agrformet.2012.10.002; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; Ramoelo A, 2014, REMOTE SENS-BASEL, V6, P7406, DOI 10.3390/rs6087406; Ramos HDC, 2017, REV BRAS CLIMATOL, V20, P211, DOI [10.5380/abclima.v20i0.43762, DOI 10.5380/ABCLIMA.V20I0.43762]; Roy DP, 2014, REMOTE SENS ENVIRON, V145, P154, DOI 10.1016/j.rse.2014.02.001; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sheffield J, 2010, J HYDROMETEOROL, V11, P253, DOI 10.1175/2009JHM1176.1; Shi ZJ, 2017, STOCH ENV RES RISK A, V31, P257, DOI 10.1007/s00477-015-1203-5; Souza V. de A., 2016, Ciencia e Natura, V38, P270; Tang RL, 2015, AGR FOREST METEOROL, V202, P69, DOI 10.1016/j.agrformet.2014.12.005; Tang RL, 2013, AGR FOREST METEOROL, V174, P28, DOI 10.1016/j.agrformet.2013.01.008; Tutz G, 2006, BIOMETRICS, V62, P961, DOI 10.1111/j.1541-0420.2006.00578.x; Westerhoff RS, 2015, REMOTE SENS ENVIRON, V169, P102, DOI 10.1016/j.rse.2015.07.021; Wilks D.S., 2011, STAT METHODS ATMOSPH; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Wing M.K.C., 2017, J STAT SOFTWARE, V28; Yao YY, 2017, AGR FOREST METEOROL, V242, P55, DOI 10.1016/j.agrformet.2017.04.011; Zhang T, 2011, IEEE T INFORM THEORY, V57, P4689, DOI 10.1109/TIT.2011.2146690; Zhang YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19124	68	8	8	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0245834	10.1371/journal.pone.0245834	http://dx.doi.org/10.1371/journal.pone.0245834			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561147	Green Published, gold			2022-12-26	WOS:000617533000048
J	Ma, YJ; Zha, JY; Yang, XK; Li, QJ; Zhang, QF; Yin, A; Beharry, Z; Huang, HW; Huang, JT; Bartlett, M; Ye, KX; Yin, H; Cai, HJ				Ma, Yongjie; Zha, Junyi; Yang, XiangKun; Li, Qianjin; Zhang, Qingfu; Yin, Amelia; Beharry, Zanna; Huang, Hanwen; Huang, Jiaoti; Bartlett, Michael; Ye, Kaixiong; Yin, Hang; Cai, Houjian			Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation	ONCOGENE			English	Article								Fatty acid metabolism is essential for the biogenesis of cellular components and ATP production to sustain proliferation of cancer cells. Long-chain fatty acyl-CoA synthetases (ACSLs), a group of rate-limiting enzymes in fatty acid metabolism, catalyze the bioconversion of exogenous or de novo synthesized fatty acids to their corresponding fatty acyl-CoAs. In this study, systematical analysis of ACSLs levels and the amount of fatty acyl-CoAs illustrated that ACSL1 were significantly associated with the levels of a broad spectrum of fatty acyl-CoAs, and were elevated in human prostate tumors. ACSL1 increased the biosynthesis of fatty acyl-CoAs including C16:0-, C18:0-, C18:1-, and C18:2-CoA, triglycerides and lipid accumulation in cancer cells. Mechanistically, ACSL1 modulated mitochondrial respiration, beta-oxidation, and ATP production through regulation of CPT1 activity. Knockdown of ACSL1 inhibited the cell cycle, and suppressed the proliferation and migration of prostate cancer cells in vitro, and growth of prostate xenograft tumors in vivo. Our study implicates ACSL1 as playing an important role in prostate tumor progression, and provides a therapeutic strategy of targeting fatty acid metabolism for the treatment of prostate cancer.	[Ma, Yongjie; Zha, Junyi; Yang, XiangKun; Li, Qianjin; Bartlett, Michael; Cai, Houjian] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Zhang, Qingfu; Huang, Jiaoti] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Yin, Amelia; Yin, Hang] Univ Georgia, Ctr Mol Med, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Beharry, Zanna] Univ Virgin Isl, Dept Chem & Phys Sci, St Thomas, VI USA; [Huang, Hanwen] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Ye, Kaixiong] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Ye, Kaixiong] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Duke University; University System of Georgia; University of Georgia; University of the Virgin Islands; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Cai, HJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	caihj@uga.edu		Zha, Junyi/0000-0003-2125-1362; Bartlett, Michael/0000-0003-0626-3234; Zhang, Qingfu/0000-0002-9891-1296; Beharry, Zanna/0000-0002-3900-8523	NIH [R01CA172495]; DOD [W81XWH-15-1-0507]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense)	This work was supported by NIH (R01CA172495) and DOD (W81XWH-15-1-0507) to HC.	BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Butler LM, 2016, ENDOCR-RELAT CANCER, V23, pR219, DOI 10.1530/ERC-15-0556; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gazi E, 2007, J LIPID RES, V48, P1846, DOI 10.1194/jlr.M700131-JLR200; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; Kim S, 2017, CANCER RES, V77, P6950, DOI 10.1158/0008-5472.CAN-17-0981; Kim S, 2017, J BIOL CHEM, V292, P18422, DOI [10.1074/jbc.M117.798827, 10.1074/jbc.m117.798827]; Koizume S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091430; Kuemmerle NB, 2011, MOL CANCER THER, V10, P427, DOI 10.1158/1535-7163.MCT-10-0802; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lloyd MD, 2013, PROG LIPID RES, V52, P220, DOI 10.1016/j.plipres.2013.01.001; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Sanchez-Martinez R, 2015, ONCOTARGET, V6, P38719, DOI 10.18632/oncotarget.5340; Schlaepfer IR, 2014, MOL CANCER THER, V13, P2361, DOI 10.1158/1535-7163.MCT-14-0183; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Vargas T, 2015, ONCOTARGET, V6, P7348, DOI 10.18632/oncotarget.3130; Wang YY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87489; Wu XY, 2015, ONCOTARGET, V6, P44849, DOI 10.18632/oncotarget.6438; Wu XY, 2014, AM J CLIN EXP UROL, V2, P111; Yan S, 2015, WORLD J GASTROENTERO, V21, P3492, DOI 10.3748/wjg.v21.i12.3492; Yang XK, 2017, ANAL CHEM, V89, P813, DOI 10.1021/acs.analchem.6b03623; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	30	19	19	3	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1806	1820		10.1038/s41388-021-01667-y	http://dx.doi.org/10.1038/s41388-021-01667-y		FEB 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564069	Green Accepted			2022-12-26	WOS:000616489100012
J	Vilone, D; Realpe-Gomez, J; Andrighetto, G				Vilone, Daniele; Realpe-Gomez, John; Andrighetto, Giulia			Evolutionary advantages of turning points in human cooperative behaviour	PLOS ONE			English	Article							EMERGENCE; GAMES	Cooperation is crucial to overcome some of the most pressing social challenges of our times, such as the spreading of infectious diseases, corruption and environmental conservation. Yet, how cooperation emerges and persists is still a puzzle for social scientists. Since human cooperation is individually costly, cooperative attitudes should have been eliminated by natural selection in favour of selfishness. Yet, cooperation is common in human societies, so there must be some features which make it evolutionarily advantageous. Using a cognitive inspired model of human cooperation, recent work Realpe-Gomez (2018) has reported signatures of criticality in human cooperative groups. Theoretical evidence suggests that being poised at a critical point provides evolutionary advantages to groups by enhancing responsiveness of these systems to external attacks. After showing that signatures of criticality can be detected in human cooperative groups composed by Moody Conditional Cooperators, in this work we show that being poised close to a turning point enhances the fitness and make individuals more resistant to invasions by free riders.	[Vilone, Daniele; Andrighetto, Giulia] Natl Res Council CNR, Inst Cognit Sci & Technol, LABSS Lab Agent Based Social Simulat, Rome, Italy; [Vilone, Daniele] Univ Carlos III Madrid, Dept Matemat, Grp Interdisciplinar Sistemas Complejos GISC, Leganes, Spain; [Realpe-Gomez, John] Lab Res Complex Syst, San Francisco, CA USA; [Realpe-Gomez, John] Univ Estadual Paulista, ICTP South Amer Inst Fundamental Res, Inst Fis Teor, Sao Paulo, Brazil; [Andrighetto, Giulia] Malardalen Univ, Vasteras, Sweden; [Andrighetto, Giulia] Inst Future Studies, Stockholm, Sweden	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Universidad Carlos III de Madrid; Universidade Estadual Paulista; Malardalen University; Institute for Futures Studies	Vilone, D (corresponding author), Natl Res Council CNR, Inst Cognit Sci & Technol, LABSS Lab Agent Based Social Simulat, Rome, Italy.; Vilone, D (corresponding author), Univ Carlos III Madrid, Dept Matemat, Grp Interdisciplinar Sistemas Complejos GISC, Leganes, Spain.	daniele.vilone@gmail.com		Realpe-Gomez, John/0000-0002-5473-2464	Knut and Wallenberg Grant "How do human norms form and change?" [2016.0167]; Horizon 2020 Framework Programme Project PROTON "Modelling the Processes leading to Organised crime and Terrorist Networks" [699824]; Eranet FLAG-ERA Call 2016 Project FuturICT 2.0 - "Large scale experiments and simulations for the second generation of FuturICT" [CUP: B84E16000780005]; Italian Research Project of National Relevance (PRIN); FAPESP [2016/01343-7]	Knut and Wallenberg Grant "How do human norms form and change?"; Horizon 2020 Framework Programme Project PROTON "Modelling the Processes leading to Organised crime and Terrorist Networks"; Eranet FLAG-ERA Call 2016 Project FuturICT 2.0 - "Large scale experiments and simulations for the second generation of FuturICT"; Italian Research Project of National Relevance (PRIN); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	For G. A. and D. V., this work was partially supported by the Knut and Wallenberg Grant "How do human norms form and change?" (2016.0167), the Horizon 2020 Framework Programme Project PROTON "Modelling the Processes leading to Organised crime and Terrorist Networks" (No.: 699824), by the Eranet FLAG-ERA Call 2016 Project FuturICT 2.0 - "Large scale experiments and simulations for the second generation of FuturICT" (CUP: B84E16000780005), and the Italian Research Project of National Relevance (PRIN) "14ALL: One for all, all for one. Reputational mechanisms for aggression, revenge, and forgiveness in intergroup relationships". J. R.-G. would like to thank FAPESP grant 2016/01343-7 for funding my visit to ICTP-SAIFR from 20-27 January 2019 where part of this work was done.	Andrighetto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064941; [Anonymous], 1963, STAT MECH; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bicchieri C., 2006, GRAMMAR SOC; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Bowles S., 2013, COOPERATIVE SPECIES; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gelblum A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8729; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grujic J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04615; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guazzini A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41773-2; Guazzini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16557; Gutierrez-Roig M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5362; Henrich J., 2005, FDN HUMAN SOCIALITY; Hidalgo J, 2014, P NATL ACAD SCI USA, V111, P10095, DOI 10.1073/pnas.1319166111; Krupka EL, 2013, J EUR ECON ASSOC, V11, P495, DOI 10.1111/jeea.12006; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Munoz MA, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.031001; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Puga-Gonzalez I, 2019, PRIMATES, V60, P233, DOI 10.1007/s10329-018-0684-5; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Realpe-Gomez J, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.042321; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Sanchez A, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aaa388; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Tessone CJ, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022803; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Vilone D, 2002, EUR PHYS J B, V30, P399, DOI 10.1140/epjb/e2002-00395-2	35	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246278	10.1371/journal.pone.0246278	http://dx.doi.org/10.1371/journal.pone.0246278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561142	gold, Green Published			2022-12-26	WOS:000617533000034
J	Yan, QX; Zeng, P; Zhou, XQ; Zhao, XY; Chen, RQ; Qiao, J; Feng, L; Zhu, ZJ; Zhang, GZ; Chen, CR				Yan, Qiuxia; Zeng, Peng; Zhou, Xiuqin; Zhao, Xiaoying; Chen, Runqiang; Qiao, Jing; Feng, Ling; Zhu, Zhenjie; Zhang, Guozhi; Chen, Cairong			RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing	ONCOGENE			English	Article								The prognosis for patients with metastatic bladder cancer (BCa) is poor, and it is not improved by current treatments. RNA-binding motif protein X-linked (RBMX) are involved in the regulation of the malignant progression of various tumors. However, the role of RBMX in BCa tumorigenicity and progression remains unclear. In this study, we found that RBMX was significantly downregulated in BCa tissues, especially in muscle-invasive BCa tissues. RBMX expression was negatively correlated with tumor stage, histological grade and poor patient prognosis. Functional assays demonstrated that RBMX inhibited BCa cell proliferation, colony formation, migration, and invasion in vitro and suppressed tumor growth and metastasis in vivo. Mechanistic investigations revealed that hnRNP A1 was an RBMX-binding protein. RBMX competitively inhibited the combination of the RGG motif in hnRNP A1 and the sequences flanking PKM exon 9, leading to the formation of lower PKM2 and higher PKM1 levels, which attenuated the tumorigenicity and progression of BCa. Moreover, RBMX inhibited aerobic glycolysis through hnRNP A1-dependent PKM alternative splicing and counteracted the PKM2 overexpression-induced aggressive phenotype of the BCa cells. In conclusion, our findings indicate that RBMX suppresses BCa tumorigenicity and progression via an hnRNP A1-mediated PKM alternative splicing mechanism. RBMX may serve as a novel prognostic biomarker for clinical intervention in BCa.	[Yan, Qiuxia; Zhou, Xiuqin; Zhao, Xiaoying; Chen, Runqiang; Qiao, Jing; Feng, Ling; Zhu, Zhenjie; Zhang, Guozhi; Chen, Cairong] Guangzhou Med Univ, Ctr Reprod Med, Qingyuan Peoples Hosp, Affiliated Hosp 6, Qingyuan, Guangdong, Peoples R China; [Zeng, Peng] Guangzhou Med Univ, Dept Urol, Qingyuan Peoples Hosp, Affiliated Hosp 6, Qingyuan, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Yan, QX; Chen, CR (corresponding author), Guangzhou Med Univ, Ctr Reprod Med, Qingyuan Peoples Hosp, Affiliated Hosp 6, Qingyuan, Guangdong, Peoples R China.	yanqiuxia1982@163.com; cairong1222@163.com		Yan, Qiuxia/0000-0002-7701-5126	National Natural Science Foundation of China [82002671]; Guangdong Basic and Applied Basic Research Foundation [2019A1515010249]; Qingyuan Science and Technology Project [2020KJJH023]; China Postdoctoral Science Foundation [2019M663398]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation; Qingyuan Science and Technology Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 82002671), Guangdong Basic and Applied Basic Research Foundation (No. 2019A1515010249), The Qingyuan Science and Technology Project (No. 2020KJJH023), and China Postdoctoral Science Foundation (No. 2019M663398). We thank Prof. Guojun Zhao and Prof. Lin Qi for providing scientific advices. We would like to thank Laboratory Animal Center, The Sixth Affiliated Hospital of Guangzhou Medical University for support in all animal experiments. Finally, we thank American Journal Experts for the English language editing.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Babjuk M, 2019, EUR UROL, V76, P639, DOI 10.1016/j.eururo.2019.08.016; Barboro P, 2014, CANCER LETT, V352, P152, DOI 10.1016/j.canlet.2014.06.019; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cambier S, 2016, EUR UROL, V69, P60, DOI 10.1016/j.eururo.2015.06.045; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Chen X, 2017, J CELL MOL MED, V21, P1266, DOI 10.1111/jcmm.12999; Chen ZY, 2019, MOL THER, V27, P326, DOI 10.1016/j.ymthe.2018.12.015; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Climente-Gonzalez H, 2017, CELL REP, V20, P2215, DOI 10.1016/j.celrep.2017.08.012; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Elliott DJ, 2019, INT J BIOCHEM CELL B, V108, P1, DOI 10.1016/j.biocel.2018.12.014; Funt SA, 2017, NAT REV CLIN ONCOL, V14, P221, DOI 10.1038/nrclinonc.2016.188; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Georgilis A, 2018, CANCER CELL, V34, P85, DOI 10.1016/j.ccell.2018.06.007; Ghosh M, 2020, NUCLEIC ACIDS RES, V48, P4492, DOI 10.1093/nar/gkaa134; Gu ZM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0392-4; Han N, 2013, J CANCER RES THER, V9, pS129, DOI 10.4103/0973-1482.122506; Heinrich B, 2009, J BIOL CHEM, V284, P14303, DOI 10.1074/jbc.M901026200; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kanhoush R, 2010, NUCLEUS-PHILA, V1, P109, DOI 10.4161/nucl.1.1.10857; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Ko CC, 2014, J BIOL CHEM, V289, P22078, DOI 10.1074/jbc.M114.553248; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Lew CR, 2015, NAT REV UROL, V12, P383, DOI 10.1038/nrurol.2015.111; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Munschauer M, 2018, NATURE, V561, P132, DOI 10.1038/s41586-018-0453-z; Ouyang YQ, 2011, INT J CANCER, V128, P2010, DOI 10.1002/ijc.25544; Ploussard G, 2014, EUR UROL, V66, P361, DOI 10.1016/j.eururo.2013.09.050; Qian SX, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0360-4; Rajeshkumar NV, 2015, CANCER RES, V75, P3355, DOI 10.1158/0008-5472.CAN-15-0108; Renieri A, 2014, LUNG CANCER, V85, P168, DOI 10.1016/j.lungcan.2014.05.020; Roy R, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1431; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Shin KH, 2008, NITRIC OXIDE-BIOL CH, V19, P125, DOI 10.1016/j.niox.2008.04.012; Shin KH, 2008, BIOCHEM BIOPH RES CO, V372, P880, DOI 10.1016/j.bbrc.2008.05.175; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Song HJ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00857-7; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Vishnu P, 2011, ONCOTARGETS THER, V4, P97, DOI 10.2147/OTT.S22875; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Wen ZL, 2020, RNA BIOL, V17, P381, DOI 10.1080/15476286.2019.1708547; Xie RH, 2019, CANCER LETT, V449, P31, DOI 10.1016/j.canlet.2019.01.041; Yang H, 2019, ONCOGENE, V38, P4915, DOI 10.1038/s41388-019-0764-z; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Zhang DL, 2018, FRONT MED-PRC, V12, P280, DOI 10.1007/s11684-017-0580-1; Zhang LF, 2015, EMBO J, V34, P2671, DOI 10.15252/embj.201591803; Zhu LY, 2019, MOL THER, V27, P1621, DOI 10.1016/j.ymthe.2019.05.023	61	18	18	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2635	2650		10.1038/s41388-021-01666-z	http://dx.doi.org/10.1038/s41388-021-01666-z		FEB 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33564070	hybrid, Green Published			2022-12-26	WOS:000616489100011
J	Assali, DR; Sidikpramana, M; Villa, AP; Falkenstein, J; Steele, AD				Assali, Dina R.; Sidikpramana, Michael; Villa, Andrew P.; Falkenstein, Jeffrey; Steele, Andrew D.			Type 1 dopamine receptor (D1R)-independent circadian food anticipatory activity in mice	PLOS ONE			English	Article							REV-ERB-ALPHA; CLOCK PROTEIN; STRIATUM; RHYTHMS; EXPRESSION; PHYSIOLOGY; MODELS; BRAIN; D1	Circadian rhythms are entrained by light and influenced by non-photic stimuli, such as feeding. The activity preceding scheduled mealtimes, food anticipatory activity (FAA), is elicited in rodents fed a limited amount at scheduled times. FAA is thought to be the output of an unidentified food entrained oscillator. Previous studies, using gene deletion and receptor pharmacology, implicated dopamine type receptor 1 (D1R) signaling in the dorsal striatum as necessary for FAA in mice. To further understand the role of D1R in promoting FAA, we utilized the Cre-lox system to create cell type-specific deletions of D1R, conditionally deleting D1R in GABA neurons using Vgat-ires-Cre line. This conditional deletion mutant had attenuated FAA, but the amount was higher than expected based on prior results using a constitutive knockout of D1R, D1R KODrago. This result prompted us to re-test the original D1R KODrago line, which expressed less FAA than controls, but only moderately so. To determine if genetic drift had diminished the effect of D1R deletion on FAA, we re-established the D1R KODrago knockout line from cryopreserved samples. The reestablished D1R KODrago-cryo had a clear impairment of FAA compared to controls, but still developed increased activity preceding mealtime across the 4 weeks of timed feeding. Finally, we tested a different deletion allele of D1R created by the Knockout Mouse Project. This line of D1R KOKOMP mice had a significant impairment in the acquisition of FAA, but eventually reached similar levels of premeal activity compared to controls after 4 weeks of timed feeding. Taken together, our results suggest that D1R signaling promotes FAA, but other dopamine receptors likely contribute to FAA given that mice lacking the D1 receptor still retain some FAA.	[Assali, Dina R.; Sidikpramana, Michael; Villa, Andrew P.; Falkenstein, Jeffrey; Steele, Andrew D.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Steele, AD (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	adsteele@cpp.edu			Whitehall Foundation; National Institute of General Medical Sciences of the National Institutes of Health [SC3GM125570]	Whitehall Foundation; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Whitehall Foundation provided a Research Grant to AS, and the National Institute of General Medical Sciences of the National Institutes of Health provided funding under Award Number SC3GM125570 to AS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; Challet E, 2019, NAT REV ENDOCRINOL, V15, P393, DOI 10.1038/s41574-019-0210-x; Chavan R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10580; Chung S, 2014, CELL, V157, P858, DOI 10.1016/j.cell.2014.03.039; Darvas M, 2011, BIOL PSYCHIAT, V69, P704, DOI 10.1016/j.biopsych.2010.09.033; Darvas M, 2010, J NEUROSCI, V30, P1158, DOI 10.1523/JNEUROSCI.4576-09.2010; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Delezie J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29386; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; Ferris MJ, 2014, P NATL ACAD SCI USA, V111, pE2751, DOI 10.1073/pnas.1407935111; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gallardo CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095990; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grippo RM, 2020, CURR BIOL, V30, P196, DOI 10.1016/j.cub.2019.11.029; Grippo RM, 2017, CURR BIOL, V27, P2465, DOI 10.1016/j.cub.2017.06.084; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P11465, DOI 10.1073/pnas.0402028101; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LeSauter J, 2020, EUR J NEUROSCI, V51, P71, DOI 10.1111/ejn.14219; Liu YY, 2012, J BIOL RHYTHM, V27, P398, DOI 10.1177/0748730412455913; Mendoza J, 2014, NEUROSCIENCE, V282, P230, DOI 10.1016/j.neuroscience.2014.07.081; Mendoza J, 2010, GENES BRAIN BEHAV, V9, P467, DOI 10.1111/j.1601-183X.2010.00576.x; Michalik M, 2015, BEHAV NEUROSCI, V129, P351, DOI 10.1037/bne0000058; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Pendergast JS, 2018, J BIOL RHYTHM, V33, P458, DOI 10.1177/0748730418789043; Pendergast JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15332-6; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sarinana J, 2014, P NATL ACAD SCI USA, V111, P8245, DOI 10.1073/pnas.1407395111; Scarpa LLWB, 2020, BIORXIV, DOI [10.1101/2020.10.23.353193, DOI 10.1101/2020.10.23.353193]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smit AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082381; Solinas M, 2019, J NEURAL TRANSM, V126, P481, DOI 10.1007/s00702-018-1957-2; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Steele AD, 2015, ELIFE, V4, DOI 10.7554/eLife.06351; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Takasu NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048892; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0242897	10.1371/journal.pone.0242897	http://dx.doi.org/10.1371/journal.pone.0242897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556069	gold, Green Submitted, Green Published			2022-12-26	WOS:000617379900009
J	Boss, K; Jahn, M; Wendt, D; Haidari, Z; Demircioglu, E; Thielmann, M; Ruhparwar, A; Kribben, A; Tyczynski, B				Boss, Kristina; Jahn, Michael; Wendt, Daniel; Haidari, Zaki; Demircioglu, Ender; Thielmann, Matthias; Ruhparwar, Arjang; Kribben, Andreas; Tyczynski, Bartosz			Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; HEMOADSORPTION; MORTALITY; SCORE; HEMOFILTRATION; GUIDELINES; SEPSIS; SIRS	Background Extracorporeal cytokine adsorption is an option in septic shock as an additional measure to treat a pathological immune response. Purpose of this study was to investigate the effects of extracorporeal cytokine adsorption on hemodynamic parameters in patients with acute kidney injury (AKI) on continuous renal replacement therapy (CRRT) and septic shock after cardiac surgery. Methods In this retrospective study, a total of 98 patients were evaluated. Hemoadsorption was performed by the CytoSorb (R) adsorber. In all patients cytokine adsorption was applied for at least 15 hours and at least one adsorber was used per patient. To compare cumulative inotrope need in order to maintain a mean arterial pressure (MAP) of >= 65 mmHg, we applied vasoactive score (VAS) for each patient before and after cytokine adsorption. A paired t-test has been performed to determine statistical significance. Results Before cytokine adsorption the mean VAS was 56.7 points. This was statistically significant decreased after cytokine adsorption (27.7 points, p< 0.0001). Before cytokine adsorption, the mean noradrenalin dose to reach a MAP of >= 65 mmHg was 0.49 mu g/kg bw/min, the mean adrenalin dose was 0.12 mu g/kg bw/min. After cytokine adsorption, significantly reduced catecholamine doses were necessary to maintain a MAP of >= 65 mmHg (0.24 mu g/kg bw/min noradrenalin; p< 0.0001 and 0.07 mu g/kg bw/min adrenalin; p < 0.0001). Moreover, there was a significant reduction of serum lactate levels after treatment (p< 0.0001). The mean SOFA-score for these patients with septic shock and AKI before cytokine adsorption was 16.7 points, the mean APACHE II-score was 30.2 points. The mean predicted in-hospital mortality rate based on this SOFA-score of 16.7 points was 77,0%, respectively 73,0% on APACHE II-score, while the all-cause in-hospital mortality rate of the patients in this study was 59.2%. Conclusion In patients with septic shock and AKI undergoing cardiac surgery, extracorporeal cytokine adsorption could significantly lower the need for postoperative inotropes. Additionally, observed versus SOFA- and APACHE II-score predicted in-hospital mortality rate was decreased.	[Boss, Kristina; Jahn, Michael; Kribben, Andreas; Tyczynski, Bartosz] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Wendt, Daniel; Haidari, Zaki; Demircioglu, Ender; Thielmann, Matthias; Ruhparwar, Arjang] Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Dept Thorac & Cardiovasc Surg, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Boss, K (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany.	Kristina.boss@uk-essen.de	Boss, Kristina/ABB-2340-2020					Akins CW, 2008, EUR J CARDIO-THORAC, V33, P523, DOI 10.1016/j.ejcts.2007.12.055; Ankawi G, 2019, BLOOD PURIFICAT, V48, P196, DOI 10.1159/000500013; Becher T, 2013, CRIT CARE, V17, DOI 10.1186/cc12562; BELLOMO R, 1993, CRIT CARE MED, V21, P522, DOI 10.1097/00003246-199304000-00011; Bernardi MH, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1270-0; Brouwer WP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2588-1; Calabro MG, 2019, ARTIF ORGANS, V43, P189, DOI 10.1111/aor.13327; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Friesecke S, 2017, J ARTIF ORGANS, V20, P252, DOI 10.1007/s10047-017-0967-4; Haidari Z, 2020, ANN THORAC SURG, V110, P890, DOI 10.1016/j.athoracsur.2019.12.067; Hoffmann JN, 2001, WORLD J SURG, V25, P651, DOI 10.1007/s002680020027; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kogelmann K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1662-9; Koponen T, 2019, BRIT J ANAESTH, V122, P428, DOI 10.1016/j.bja.2018.12.019; McIntosh AM, 2017, PEDIATR CRIT CARE ME, V18, P750, DOI 10.1097/PCC.0000000000001191; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Poston JT, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4891; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rimmele T, 2011, CRIT CARE, V15, DOI 10.1186/cc9411; Schadler D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187015; Stahli BE, 2013, CARDIOLOGY, V126, P15, DOI 10.1159/000351438; Trager K, 2017, INT J ARTIF ORGANS, V40, P240, DOI 10.5301/ijao.5000583; Trager K, 2016, INT J ARTIF ORGANS, V39, P141, DOI 10.5301/ijao.5000492; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yamazaki Y, 2018, J ANESTH, V32, P167, DOI 10.1007/s00540-018-2447-2	26	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246299	10.1371/journal.pone.0246299	http://dx.doi.org/10.1371/journal.pone.0246299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556101	Green Published, gold			2022-12-26	WOS:000617379900013
J	Choi, YH; Lee, IH; Yang, M; Cho, YS; Jo, YH; Bae, HJ; Kim, YS; Park, JD				Choi, Yu Hyeon; Lee, In Hwa; Yang, Mihee; Cho, Yoon Sook; Jo, Yun Hee; Bae, Hye Jung; Kim, You Sun; Park, June Dong			Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study	PLOS ONE			English	Article								Despite the high prevalence of potential drug-drug interactions in pediatric intensive care units, their clinical relevance and significance are unclear. We assessed the characteristics and risk factors of clinically relevant potential drug-drug interactions to facilitate their efficient monitoring in pediatric intensive care units. This retrospective cohort study reviewed the medical records of 159 patients aged <19 years who were hospitalized in the pediatric intensive care unit at Seoul National University Hospital (Seoul, Korea) for >= 3 days between August 2019 and February 2020. Potential drug-drug interactions were screened using the Micromedex Drug-Reax(R) system. Clinical relevance of each potential drug-drug interaction was reported with official terminology, magnitude of severity, and causality, and the association with the patient's clinical characteristics was assessed. In total, 115 patients (72.3%) were exposed to 592 potential interactions of 258 drug pairs. In 16 patients (10.1%), 22 clinically relevant potential drug-drug interactions were identified for 19 drug pairs. Approximately 70% of the clinically relevant potential drug-drug interactions had a severity grade of >= 3. Exposure to potential drug-drug interactions was significantly associated with an increase in the number of administrated medications (6-7 medications, p = 0.006; >= 8, p<0.001) and prolonged hospital stays (1-2 weeks, p = 0.035; >= 2, p = 0.049). Moreover, clinically relevant potential drug-drug interactions were significantly associated with >= 8 prescribed drugs (p = 0.019), hospitalization for >= 2 weeks (p = 0.048), and >= 4 complex chronic conditions (p = 0.015). Most potential drug-drug interactions do not cause clinically relevant adverse outcomes in pediatric intensive care units. However, because the reactions that patients experience from clinically relevant potential drug-drug interactions are often very severe, there is a medical need to implement an appropriate monitoring system for potential drug-drug interactions according to the pediatric intensive care unit characteristics.	[Choi, Yu Hyeon; Kim, You Sun; Park, June Dong] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul Natl Univ Hosp, Seoul, South Korea; [Lee, In Hwa; Yang, Mihee; Cho, Yoon Sook; Jo, Yun Hee; Bae, Hye Jung] Seoul Natl Univ Hosp, Dept Pharm, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Park, JD (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul Natl Univ Hosp, Seoul, South Korea.	jdparkmd@snu.ac.kr		Park, June Dong/0000-0001-8113-1384; CHOI, YU HYEON/0000-0002-3057-0886				Alvim Mariana Macedo, 2015, Rev. bras. ter. intensiva, V27, P353, DOI 10.5935/0103-507X.20150060; Ancker JS, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0430-8; Baniasadi S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0086-4; Behera SK, 2018, INT J CLIN PHARM-NET, V40, P903, DOI 10.1007/s11096-018-0694-9; Bhatt-Mehta V, 2016, PEDIATR CRIT CARE ME, V17, P470, DOI 10.1097/PCC.0000000000000694; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; Farzanegan B, 2015, J CLIN PHARMACOL, V55, P132, DOI 10.1002/jcph.421; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Fitzmaurice MG, 2019, DRUG SAFETY, V42, P1035, DOI 10.1007/s40264-019-00829-y; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hasan SS, 2012, SINGAP MED J, V53, P526; Hassanzad M, 2018, J CLIN PHARMACOL, V58, P221, DOI 10.1002/jcph.996; International Conference on Harmonisation (ICH), 2017, CLIN INV MED PROD PE, P3; Ismail M, 2017, J CRIT CARE, V40, P243, DOI 10.1016/j.jcrc.2017.04.028; Jankovic SM, 2018, J CRIT CARE, V43, P1, DOI 10.1016/j.jcrc.2017.08.021; Kane-Gill SL, 2017, CRIT CARE MED, V45, pE877, DOI 10.1097/CCM.0000000000002533; Kim Soo Jung, 2020, [Journal of Korean Society of Health-System Pharmacists, 병원약사회지], V37, P305, DOI 10.32429/jkshp.2020.37.3.004; Mondardini MC, 2014, MINERVA ANESTESIOL, V80, P1018; Reis AMM, 2011, EUR J CLIN PHARMACOL, V67, P625, DOI 10.1007/s00228-010-0987-y; Reis AMM, 2010, PHARM WORLD SCI, V32, P822, DOI 10.1007/s11096-010-9445-2; National Cancer Institute, 2017, COMM TERM CRIT ADV E; Noor S, 2019, BMC PHARMACOL TOXICO, V20, DOI 10.1186/s40360-019-0325-7; Patel RI, 2016, J MED LIBR ASSOC, V104, P290, DOI 10.3163/1536-5050.104.4.007; Rao C, 2019, J PHARMACOL PHARMACO, V10, P63, DOI 10.4103/jpp.JPP_27_19; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Rodrigues AT, 2017, BRAZ J PHARM SCI, V53, DOI 10.1590/s2175-97902017000116109; Uijtendaal EV, 2014, PHARMACOTHERAPY, V34, P213, DOI 10.1002/phar.1395	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246754	10.1371/journal.pone.0246754	http://dx.doi.org/10.1371/journal.pone.0246754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556128	Green Published, gold			2022-12-26	WOS:000617379900036
J	Lee, CY; Liu, KT; Lu, HT; Ali, RM; Fong, AYY; Ahmad, WAW				Lee, Chuey Yan; Liu, Kien Ting; Lu, Hou Tee; Ali, Rosli Mohd; Fong, Alan Yean Yip; Ahmad, Wan Azman Wan			Sex and gender differences in presentation, treatment and outcomes in acute coronary syndrome, a 10 year study from a multi-ethnic Asian population: The Malaysian National Cardiovascular Disease Database-Acute Coronary Syndrome (NCVD-ACS) registry	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EVIDENCE-BASED THERAPIES; ACUTE CARDIAC ISCHEMIA; YOUNG-PATIENTS; HOSPITAL MORTALITY; AMERICAN-COLLEGE; WOMEN; MANAGEMENT; MEN; RISK	Background Sex and gender differences in acute coronary syndrome (ACS) have been well studied in the western population. However, limited studies have examined the trends of these differences in a multi-ethnic Asian population. Objectives To study the trends in sex and gender differences in ACS using the Malaysian NCVD-ACS Registry. Methods Data from 24 hospitals involving 35,232 ACS patients (79.44% men and 20.56% women) from 1(st.) Jan 2012 to 31(st.) Dec 2016 were analysed. Data were collected on demographic characteristics, coronary risk factors, anthropometrics, treatments and outcomes. Analyses were done for ACS as a whole and separately for ST-segment elevation myocardial infarction (STEMI), Non-STEMI and unstable angina. These were then compared to published data from March 2006 to February 2010 which included 13,591 ACS patients (75.8% men and 24.2% women). Results Women were older and more likely to have diabetes mellitus, hypertension, dyslipidemia, previous heart failure and renal failure than men. Women remained less likely to receive aspirin, beta-blocker, angiotensin-converting enzyme inhibitor (ACE-I) and statin. Women were less likely to undergo angiography and percutaneous coronary intervention (PCI) despite an overall increase. In the STEMI cohort, despite a marked increase in presentation with Killip class IV, women were less likely to received primary PCI or fibrinolysis and had longer median door-to-needle and door-to-balloon time compared to men, although these had improved. Women had higher unadjusted in-hospital, 30-Day and 1-year mortality rates compared to men for the STEMI and NSTEMI cohorts. After multivariate adjustments, 1-year mortality remained significantly higher for women with STEMI (adjusted OR: 1.31 (1.09-1.57), p<0.003) but were no longer significant for NSTEMI cohort. Conclusion Women continued to have longer system delays, receive less aggressive pharmacotherapies and invasive treatments with poorer outcome. There is an urgent need for increased effort from all stakeholders if we are to narrow this gap.	[Lee, Chuey Yan; Lu, Hou Tee] Sultanah Aminah Hosp, Dept Cardiol, Minist Hlth, Johor Baharu, Johor, Malaysia; [Liu, Kien Ting] Natl Heart Assoc Malaysia, Kuala Lumpur, Malaysia; [Ali, Rosli Mohd] Cardiac Vasc Sentral Kuala Lumpur, Kuala Lumpur, Malaysia; [Fong, Alan Yean Yip] Minist Hlth, Sarawak Heart Ctr, Dept Cardiol, Sarawak, Malaysia; [Fong, Alan Yean Yip] Sarawak Gen Hosp, Natl Inst Hlth, Clin Res Ctr, Inst Clin Res, Sarawak, Malaysia; [Ahmad, Wan Azman Wan] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Malaya	Lee, CY (corresponding author), Sultanah Aminah Hosp, Dept Cardiol, Minist Hlth, Johor Baharu, Johor, Malaysia.	chueyyanlee@gmail.com		LEE, CHUEY YAN/0000-0002-7706-2811	Ministry of Health Malaysia (MOH)	Ministry of Health Malaysia (MOH)	The National Cardiovascular Disease Database-Acute Coronary Syndrome (NCVD-ACS) Registry is funded by the Ministry of Health Malaysia (MOH), URL: https://www.moh.gov.my/and the National Heart Association of Malaysia (NHAM), URL: https://www.malaysianheart.org/The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agewall S, 2017, EUR HEART J, V38, P143, DOI 10.1093/eurheartj/ehw149; Akhter N, 2009, AM HEART J, V157, P141, DOI 10.1016/j.ahj.2008.08.012; Alexander KP, 2006, CIRCULATION, V114, P1380, DOI 10.1161/CIRCULATIONAHA.106.620815; Alfredsson J, 2007, HEART, V93, P1357, DOI 10.1136/hrt.2006.102012; Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133; Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Arora S, 2019, CIRCULATION, V139, P1047, DOI 10.1161/CIRCULATIONAHA.118.037137; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Bucholz EM, 2014, CIRCULATION, V130, P757, DOI 10.1161/CIRCULATIONAHA.114.009480; Bugiardini R, 2011, EUR HEART J, V32, P1337, DOI 10.1093/eurheartj/ehr027; Chin S P, 2008, Med J Malaysia, V63 Suppl C, P29; Coronado BE, 1997, J AM COLL CARDIOL, V29, P1490, DOI 10.1016/S0735-1097(97)00077-6; D'Onofrio G, 2015, CIRCULATION, V131, P1324, DOI 10.1161/CIRCULATIONAHA.114.012293; Department of Statistics Malaysia, 2019, POP DERM STAT; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; El-Menyar A, 2009, AM J CARDIOL, V104, P1018, DOI 10.1016/j.amjcard.2009.06.003; Elsaesser A, 2004, CIRCULATION, V109, P565, DOI 10.1161/01.CIR.0000116022.77781.26; Gabet A, 2017, EUR HEART J, V38, P1060, DOI 10.1093/eurheartj/ehx097; Haider A, 2020, EUR HEART J, V41, P1328, DOI 10.1093/eurheartj/ehz898; Heidenreich PA, 2002, AM J MED, V113, P200, DOI 10.1016/S0002-9343(02)01221-4; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Idris N, 2011, INT J WOMENS HEALTH, V3, P375, DOI 10.2147/IJWH.S15825; Kanamasa K, 2004, INTERNAL MED, V43, P911, DOI 10.2169/internalmedicine.43.911; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; Lee CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072382; Leifheit-Limson EC, 2015, J AM COLL CARDIOL, V66, P1949, DOI 10.1016/j.jacc.2015.08.859; Levine GN, 2016, CATHETER CARDIO INTE, V87, P1001, DOI 10.1002/ccd.26325; Lewis Jannet F, 2002, Curr Womens Health Rep, V2, P110; Lichtman JH, 2018, CIRCULATION, V137, P781, DOI 10.1161/CIRCULATIONAHA.117.031650; Lichtman JH, 2014, AM HEART J, V167, P376, DOI 10.1016/j.ahj.2013.11.001; Lu HT, 2014, GLOB HEART, V9, P381, DOI 10.1016/j.gheart.2014.06.001; MacIntyre K, 2001, J AM COLL CARDIOL, V38, P729, DOI 10.1016/S0735-1097(01)01465-6; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; Milcent C, 2007, CIRCULATION, V115, P833, DOI 10.1161/CIRCULATIONAHA.106.664979; Nguyen HL, 2010, CORONARY ARTERY DIS, V21, P336, DOI 10.1097/MCA.0b013e32833ce07c; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pagidipati NJ, 2016, NAT REV CARDIOL, V13, P471, DOI 10.1038/nrcardio.2016.89; Parashar S, 2009, CIRC-CARDIOVASC QUAL, V2, P33, DOI 10.1161/CIRCOUTCOMES.108.818500; Poon S, 2012, AM HEART J, V163, P66, DOI 10.1016/j.ahj.2011.09.025; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Schecter AD, 1996, AM J CARDIOL, V78, P996, DOI 10.1016/S0002-9149(96)00523-1; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Shehab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055508; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 2019, CIRCULATION, V139, P1057, DOI 10.1161/CIRCULATIONAHA.118.039298; Wan Ahmad WA, 2008, NATL CARDIOVASCULAR; Weber M, 2011, AM HEART J, V162, P81, DOI [10.1016/j.ahj.2011.04.007, 10.1016/j.ahj.2011.07.029]; Wei J, 2017, AM HEART J, V191, P30, DOI 10.1016/j.ahj.2017.06.005; WHO, 2020, TESTING SURVEY QUEST; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Xhyheri B, 2010, PROG CARDIOVASC DIS, V53, P227, DOI 10.1016/j.pcad.2010.07.004; Xu X, 2015, CIRCULATION, V131, P614, DOI 10.1161/CIRCULATIONAHA.114.012826	59	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246474	10.1371/journal.pone.0246474	http://dx.doi.org/10.1371/journal.pone.0246474			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556136	gold, Green Published			2022-12-26	WOS:000617531400009
J	Sonia, JA; Kabir, T; Islam, MMT; Kabir, Y				Sonia, Jahanara Akter; Kabir, Tohfa; Islam, M. M. Towhidul; Kabir, Yearul			Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male	PLOS ONE			English	Article							TANDEM DUPLICATION POLYMORPHISM; DEFICIT HYPERACTIVITY DISORDER; DRUG-ABUSE; COMT GENE; VAL158MET POLYMORPHISM; HEROIN DEPENDENCE; ENZYME-ACTIVITY; ADDICTION; DRD4; SUSCEPTIBILITY	Genetic risk of substance abuse is encoded mainly by central neurochemical pathways(mostly dopaminergic system) related to reinforcement and reward. In this study a functionalpolymorphism in Catechol-O-methyltransferase (COMT) (Val158Met) and the Dopamine receptor D4 gene (DRD4) (120 bp tandem duplication) has been studied in substance abused subjects. The study was carried out with 183 substance abused subjects and 175 healthy persons with no history of substance abuse. DNA was extracted and polymorphisms were analyzed using allele-specific PCR. The impact of these two polymorphisms was also analyzed on addictive characteristics (age of starting abuse, a pattern of drug habit, and period of addiction). It was found that only the heterozygous variant of COMT polymorphism (Val/Met) (p<0.05, OR = 1.66, 95% CI = 1.044-2.658) and both homozygous (p<0.05, OR = 0.43, 95% CI = 0.193-0.937) and heterozygous (p<0.05, OR = 0.37, 95% CI = 0.172-0.826) derived variants of DRD4 120 bp tandem duplication were significantly associated with risk of substance abuse compared to controls. In case of association of these polymorphisms with an age of onset, no significant difference was found among three different genotypic groups of COMT polymorphism. Whereas, the homozygous derived variant (240 bp/240 bp) of DRD4 gene was found to have a later age of onset (20.5 +/- 0.8) for substance abuse compared to heterozygous (120 bp/240 bp) (19.1 +/- 0.8) and wild type homozygous variant (120 bp/120 bp) (16.0 +/- 0.5), which was statistically significant (p<0.05). Again, in the case of the pattern of drug habit, the frequency of the Val/Val genotype is higher in polysubstance abused (>2 drugs) subjects (p<0.05) compared to the heterozygous Val/Met containing variants. An association of period of addiction was analyzed with an individual type of substance abuse and found that heroin abused subjects have a significantly higher period of addiction (11.6 +/- 1.0) compared to other abusers (p<0.01). Further, it was found that Met/Met containing variants of COMT polymorphism has a more extended period of addiction than other genetic variants in heroin abused subjects. These results indicate that genetic variability may influence the susceptibility to the risk of substance abuse and addictive characteristics.	[Sonia, Jahanara Akter] Gono Bishwabidyalay, Dept Biochem & Mol Biol, Saver, Bangladesh; [Kabir, Tohfa] Primeasia Univ, Dept Biochem, Dhaka, Bangladesh; [Islam, M. M. Towhidul; Kabir, Yearul] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh	University of Dhaka	Kabir, Y (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.	ykabir@yahoo.com	Kabir, Yearul/N-7299-2015	Kabir, Yearul/0000-0002-0242-9199	Ministry of Science and Technology, Government of the People's Republic of Bangladesh	Ministry of Science and Technology, Government of the People's Republic of Bangladesh	The first author gratefully acknowledges to the Ministry of Science and Technology, Government of the People's Republic of Bangladesh for providing financial support in her research through NST fellowship.	Ahad MdAbdul., 2017, IOSR J HUMANITIES SO, V22, P27, DOI [DOI 10.9790/0837-2205072731, 10.9790/0837-2205072731]; [Anonymous], 2016, ANN DRUG REP, P10; Bailes SM, 2007, POULTRY SCI, V86, P102, DOI 10.1093/ps/86.1.102; Bhaduri N, 2006, AM J MED GENET B, V141B, P61, DOI 10.1002/ajmg.b.30225; Cami J, 2003, NEW ENGL J MED, V349, P975, DOI 10.1056/NEJMra023160; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cheng CY, 2005, MOL BRAIN RES, V140, P86, DOI 10.1016/j.molbrainres.2005.07.008; Chien CC, 2010, WORLD J BIOL PSYCHIA, V11, P409, DOI 10.3109/15622970903304459; Craddock N, 2006, MOL PSYCHIATR, V11, P446, DOI 10.1038/sj.mp.4001808; D'Souza UM, 2004, BIOL PSYCHIAT, V56, P691, DOI 10.1016/j.biopsych.2004.08.008; Dennis ML, 2005, J SUBST ABUSE TREAT, V28, pS51, DOI 10.1016/j.jsat.2004.10.013; Di Ciano P, 2014, ADV PHARMACOL, V69, P301, DOI 10.1016/B978-0-12-420118-7.00008-1; Ducci F, 2012, PSYCHIAT CLIN N AM, V35, P495, DOI 10.1016/j.psc.2012.03.010; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P1, DOI DOI 10.1155/2015/528103; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Hendershot CS, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-17; Herman MA, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00018; Hoda F, 1996, BIOCHEM BIOPH RES CO, V228, P780, DOI 10.1006/bbrc.1996.1731; Horowitz R, 2000, AM J MED GENET, V96, P599, DOI 10.1002/1096-8628(20001009)96:5<599::AID-AJMG4>3.3.CO;2-F; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; Hosen MB, 2015, ASIA-PAC J CLIN ONCO, V11, P78, DOI 10.1111/ajco.12291; Hou HF, 2010, BRAIN RES, V1353, P245, DOI 10.1016/j.brainres.2010.07.022; Hser YI, 2015, HARVARD REV PSYCHIAT, V23, P76, DOI 10.1097/HRP.0000000000000052; Isir ABB, 2008, AM J FOREN MED PATH, V29, P320, DOI 10.1097/PAF.0b013e3181847e56; Jugurnauth SK, 2011, PHARMACOGENET GENOM, V21, P731, DOI 10.1097/FPC.0b013e32834a53f9; Kereszturi E, 2007, AM J MED GENET B, V144B, P231, DOI 10.1002/ajmg.b.30444; Konstitutsionnyy vestnik, 2019, KONSTITUTSIONNYY VES, V4, P19; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten Thomas R, 2002, Sci Pract Perspect, V1, P13; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Li T, 2004, AM J MED GENET B, V129B, P120, DOI 10.1002/ajmg.b.30024; Lohoff FW, 2008, NEUROPSYCHOPHARMACOL, V33, P3078, DOI 10.1038/npp.2008.126; Meng C, 2012, GENET TEST MOL BIOMA, V16, P1044, DOI 10.1089/gtmb.2012.0016; Mushahid, 2017, ASIA PACIFIC J MULTI, V5, P1; NIDA, 2018, UND DRUG US ADD; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Oosterhuis BE, 2008, AM J MED GENET B, V147B, P793, DOI 10.1002/ajmg.b.30716; Rahman M, 2004, J HEALTH POPUL NUTR, V22, P98; Seaman MI, 1999, AM J MED GENET, V88, P705, DOI 10.1002/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; Szilagyi Agnes, 2005, Neuropsychopharmacol Hung, V7, P28; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Tunbridge EM, 2012, CNS NEUROL DISORD-DR, V11, P306; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Voruganti LNP, 2001, PSYCHIAT RES-NEUROIM, V107, P173, DOI 10.1016/S0925-4927(01)00104-4; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yorgason JT, 2020, PSYCHOPHARMACOLOGY, V237, P1317, DOI 10.1007/s00213-020-05459-2	50	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246462	10.1371/journal.pone.0246462	http://dx.doi.org/10.1371/journal.pone.0246462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544778	Green Published, gold			2022-12-26	WOS:000617991900021
J	Kiyaga, C; Narayan, V; McConnell, I; Elyanu, P; Kisaakye, LN; Joseph, E; Kekitiinwa, A; Grosz, J				Kiyaga, Charles; Narayan, Vijay; McConnell, Ian; Elyanu, Peter; Kisaakye, Linda Nabitaka; Joseph, Eleanor; Kekitiinwa, Adeodata; Grosz, Jeff			Uganda's "EID Systems Strengthening" model produces significant gains in testing, linkage, and retention of HIV-exposed and infected infants: An impact evaluation	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; EARLY-DIAGNOSIS; DISEASE PROGRESSION; SCALE-UP; MORTALITY; PREVENTION; COUNTRIES; MOTHERS; AFRICA	Introduction A review of Uganda's HIV Early Infant Diagnosis (EID) program in 2010 revealed poor retention outcomes for HIV-exposed infants (HEI) after testing. The review informed development of the 'EID Systems Strengthening' model: a set of integrated initiatives at health facilities to improve testing, retention, and clinical care of HIV-exposed and infected infants. The program model was piloted at several facilities and later scaled countrywide. This mixed-methods study evaluates the program's impact and assesses its implementation. Methods We conducted a retrospective cohort study at 12 health facilities in Uganda, comprising all HEI tested by DNA PCR from June 2011 to May 2014 (n = 707). Cohort data were collected manually at the health facilities and analyzed. To assess impact, retention outcomes were statistically compared to the baseline study's cohort outcomes. We conducted a cross-sectional qualitative assessment of program implementation through 1) structured clinic observation and 2) key informant interviews with health workers, district officials, NGO technical managers, and EID trainers (n = 51). Results The evaluation cohort comprised 707 HEI (67 HIV+). The baseline study cohort contained 1268 HEI (244 HIV+). Among infants testing HIV+, retention in care at an ART clinic increased from 23% (57/244) to 66% (44/67) (p < .0001). Initiation of HIV+ infants on ART increased from 36% (27/75) to 92% (46/50) (p < .0001). HEI receiving 1st PCR results increased from 57% (718/1268) to 73% (518/707) (p < .0001). Among breastfeeding HEI with negative 1st PCR, 55% (192/352) received a confirmatory PCR test, a substantial increase from baseline period. Testing coverage improved significantly: HIV+ pregnant women who brought their infants for testing after birth increased from 18% (67/367) to 52% (175/334) (p < .0001). HEI were tested younger: mean age at DBS test decreased from 6.96 to 4.21 months (p < .0001). Clinical care for HEI was provided more consistently. Implementation fidelity was strong for most program components. The strongest contributory interventions were establishment of 'EID Care Points', integration of clinical care, longitudinal patient tracking, and regular health worker mentorship. Gaps included limited follow up of lost infants, inconsistent buy-in/ownership of health facility management, and challenges sustaining health worker motivation. Discussion Uganda's 'EID Systems Strengthening' model has produced significant gains in testing and retention of HEI and HIV+ infants, yet the country still faces major challenges. The 3 core concepts of Uganda's model are applicable to any country: establish a central service point for HEI, equip it to provide high-quality care and tracking, and develop systems to link HEI to the service point. Uganda's experience has shown the importance of intensively targeting systemic bottlenecks to HEI retention at facility level, a necessary complement to deploying rapidly scalable technologies and other higher-level initiatives.	[Kiyaga, Charles; Elyanu, Peter; Kisaakye, Linda Nabitaka] Minist Hlth AIDS Control Programme, Kampala, Uganda; [Narayan, Vijay; McConnell, Ian; Joseph, Eleanor; Grosz, Jeff] Clinton Hlth Access Initiat, Kampala, Uganda; [Kekitiinwa, Adeodata] Baylor Coll Med, Kampala, Uganda	Baylor College of Medicine	Narayan, V (corresponding author), Clinton Hlth Access Initiat, Kampala, Uganda.	vijay.narayan.5@gmail.com	Elyanu, Peter James/B-9760-2019	Elyanu, Peter James/0000-0002-4075-622X; Narayan, Vijay/0000-0003-3890-7321	Ministry of Health	Ministry of Health	We would like to thank the health workers who volunteered their time to participate in this study. Simon Peter Waswa of CHAI played a critical role in all components of field implementation at the study sites. Deidre Thompson and Evan Klaus of CHAI provided valuable technical support. Rebecca Nakidde in the national EID office provided key administrative support. Dr. Zainab Akol and Dr. Godfrey Esiru from the Ministry of Health provided high-level government support for the study.	Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; Bardfield J, 2014, INT J QUAL HEALTH C, V26, P613, DOI 10.1093/intqhc/mzu085; Bhardwaj S, 2014, SAMJ S AFR MED J, V104, P239, DOI [10.7196/samj.7605, 10.7196/SAMJ.7605]; Bianchi F, 2019, LANCET HIV, V6, pE373, DOI 10.1016/S2352-3018(19)30033-5; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Carlucci JG, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25209; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Diallo K, 2016, MMWR-MORBID MORTAL W, V65, P1285, DOI 10.15585/mmwr.mm6546a2; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Dunning L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189226; Esiru G, 2013, 20 C RETR OPP INF CR; Essajee S, 2017, JAIDS-J ACQ IMM DEF, V75, pS51, DOI [10.1097/qai.0000000000001319, 10.1097/QAI.0000000000001319]; Essajee S, 2015, J INT AIDS SOC, V18, P14, DOI 10.7448/IAS.18.7.20299; Ghadrshenas A, 2013, AIDS, V27, pS197, DOI 10.1097/QAD.0000000000000104; Goga AE, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4393-5; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; Jani IV, 2018, AIDS, V32, P1453, DOI [10.1097/QAD.0000000000001846, 10.1097/qad.0000000000001846]; JICK TD, 1979, ADMIN SCI QUART, V24, P602, DOI 10.2307/2392366; Kiyaga C, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3275-6; Kiyaga C, 2015, J PUBLIC HEALTH POL, V36, P153, DOI 10.1057/jphp.2015.7; Kiyaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078609; Lilian RR, 2012, J CLIN MICROBIOL, V50, P2373, DOI 10.1128/JCM.00431-12; Mallampati D, 2017, JAIDS-J ACQ IMM DEF, V75, P308, DOI 10.1097/QAI.0000000000001387; McCann NC, 2020, JAIDS-J ACQ IMM DEF, V84, pS12, DOI 10.1097/QAI.0000000000002384; MEASURE Evaluation, 2018, EV PARTN HIV FREE SU; Mofenson L, 2020, JAIDS-J ACQ IMM DEF, V84, pS1, DOI 10.1097/QAI.0000000000002366; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Muhumuza S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187605; Mwenda R, 2018, CLIN INFECT DIS, V67, P701, DOI 10.1093/cid/ciy169; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nsubuga-Nyombi Tamara, 2019, J Int Assoc Provid AIDS Care, V18, p2325958219857724, DOI 10.1177/2325958219857724; Obai G, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-1998-5; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Phelps BR, 2013, AIDS, V27, pS207, DOI 10.1097/QAD.0000000000000095; Phiri NA, 2017, PUBLIC HEALTH ACTION, V7, P83, DOI 10.5588/pha.16.0119; Rao KD, 2014, HEALTH POLICY PLANN, V29, P495, DOI 10.1093/heapol/czt035; Ritchie LMP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024907; Rustagi AS, 2016, JAIDS-J ACQ IMM DEF, V72, pE68, DOI 10.1097/QAI.0000000000001023; Technau K, 2016, 8 INT WORKSH HIV PED; Uganda Ministry of Health, 2019, HIV PROGR DAT; Uganda Ministry of Health, 2010, HIV PROGR DAT; UNAIDS, 2020, FACT SHEET LAT GLOB; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Vojnov L, 2017, JAIDS-J ACQ IMM DEF, V76, P522, DOI [10.1097/QAI.0000000000001526, 10.1097/qai.0000000000001526]; Wendo C, 2003, LANCET, V362, P542, DOI 10.1016/S0140-6736(03)14154-2; WHO, 2017, NOV POINT OF CAR TOO; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2010, ANT THER HIV INF INF; Youngleson MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013891	51	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246546	10.1371/journal.pone.0246546	http://dx.doi.org/10.1371/journal.pone.0246546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539425	Green Published, gold			2022-12-26	WOS:000616960200015
J	Ohgami, N; Iizuka, A; Hirai, H; Yajima, I; Iida, M; Shimada, A; Tsuzuki, T; Jijiwa, M; Asai, N; Takahashi, M; Kato, M				Ohgami, Nobutaka; Iizuka, Akira; Hirai, Hirokazu; Yajima, Ichiro; Iida, Machiko; Shimada, Atsuyoshi; Tsuzuki, Toyonori; Jijiwa, Mayumi; Asai, Naoya; Takahashi, Masahide; Kato, Masashi			Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY-THYROID CARCINOMA; ENDOTHELIN RECEPTOR B; SONIC HEDGEHOG; TYROSINE KINASE; GENE; PROLIFERATION; MECHANISMS; NEURONS; SYSTEM; FAMILY	The c-RET proto-oncogene encodes a receptor-tyrosine kinase. Loss-of-function mutations of RET have been shown to be associated with Hirschsprung disease and Down's syndrome (HSCR-DS) in humans. DS is known to involve cerebellar hypoplasia, which is characterized by reduced cerebellar size. Despite the fact that c-Ret has been shown to be associated with HSCR-DS in humans and to be expressed in Purkinje cells (PCs) in experimental animals, there is limited information about the role of activity of c-Ret/c-RET kinase in cerebellar hypoplasia. We found that a loss-of-function mutation of c-Ret Y1062 in PCs causes cerebellar hypoplasia in c-Ret mutant mice. Wild-type mice had increased phosphorylation of c-Ret in PCs during postnatal development, while c-Ret mutant mice had postnatal hypoplasia of the cerebellum with immature neurite outgrowth in PCs and granule cells (GCs). c-Ret mutant mice also showed decreased numbers of glial fibers and mitogenic sonic hedgehog (Shh)-positive vesicles in the external germinal layer of PCs. c-Ret-mediated cerebellar hypoplasia was rescued by subcutaneous injection of a smoothened agonist (SAG) as well as by reduced expression of Patched1, a negative regulator for Shh. Our results suggest that the loss-of-function mutation of c-Ret Y1062 results in the development of cerebellar hypoplasia via impairment of the Shh-mediated development of GCs and glial fibers in mice with HSCR-DS.	[Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan; [Ohgami, Nobutaka; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi, Japan; [Iizuka, Akira; Hirai, Hirokazu] Gunma Univ, Dept Neurophysiol & Neural Repair, Grad Sch Med, Maebashi, Gumma, Japan; [Shimada, Atsuyoshi] Kyorin Univ, Fac Hlth Sci, Pathol Res Team, Mitaka, Tokyo, Japan; [Tsuzuki, Toyonori] Aichi Med Univ Hosp, Dept Surg Pathol, Nagakute, Aichi, Japan; [Jijiwa, Mayumi; Takahashi, Masahide] Nagoya Univ, Dept Pathol, Grad Sch Med, Nagoya, Aichi, Japan; [Asai, Naoya] Fujita Hlth Univ, Dept Pathol, Toyoake, Aichi, Japan; [Takahashi, Masahide] Fujita Hlth Univ, Int Ctr Cell & Gene Therapy, Toyoake, Aichi, Japan	Nagoya University; Chubu University; Gunma University; Kyorin University; Aichi Medical University; Nagoya University; Fujita Health University; Fujita Health University	Kato, M (corresponding author), Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan.; Kato, M (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi, Japan.	katomasa@med.nagoya-u.ac.jp	Kato, Masashi/AAG-3755-2021; Hirai, Hirokazu/ABP-1143-2022; KATO, Masashi/I-7250-2014; Tsuzuki, Toyonori/GRJ-7409-2022	Kato, Masashi/0000-0002-8951-3640; Tsuzuki, Toyonori/0000-0002-4855-4366; Iida, Machiko/0000-0002-2286-9167; Hirai, Hirokazu/0000-0002-0721-4293	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [15H01743, 15H02588, 19H01147, 17KT0033, 20H03929, 20K21708]; AEON Environmental Foundation; Mirai-Program Small Start Type from the Japan Science and Technology Agency (JST); Grant Program of Innovation for Future Society; Kobayashi International Scholarship Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AEON Environmental Foundation; Mirai-Program Small Start Type from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grant Program of Innovation for Future Society; Kobayashi International Scholarship Foundation	We thank Drs Matthew P. Scott and Masashi Yanagisawa for providing Patched1-KO mice and Ednrb-KO mice, respectively. This study was supported in part by Grants-in-Aid for Scientific Research (A) (15H01743, 15H02588, and 19H01147) and (B) (17KT0033 and 20H03929) and challenging Exploratory Research (20K21708) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), AEON Environmental Foundation, Mirai-Program Small Start Type from the Japan Science and Technology Agency (JST), Grant Program of Innovation for Future Society and Kobayashi International Scholarship Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Beug ST, 2011, MOL CELL NEUROSCI, V46, P583, DOI 10.1016/j.mcn.2010.12.009; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Campbell C, 2016, J CELL SCI, V129, P3832, DOI 10.1242/jcs.183541; Cheng FY, 2018, DEV BIOL, V440, P152, DOI 10.1016/j.ydbio.2018.05.015; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; ColucciDAmato GL, 1996, CELL GROWTH DIFFER, V7, P1081; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Currier DG, 2012, PROG BRAIN RES, V197, P223, DOI 10.1016/B978-0-444-54299-1.00011-X; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Drosten M, 2006, NAT CLIN PRACT ONCOL, V3, P564, DOI 10.1038/ncponc0610; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Gustin JA, 2007, J NEUROCHEM, V102, P1184, DOI 10.1111/j.1471-4159.2007.04624.x; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Ida-Eto M, 2011, J BIOL CHEM, V286, P29621, DOI 10.1074/jbc.M111.236802; Iida M, 2020, AGING CELL, V19, DOI 10.1111/acel.13273; Iizuka A, 2016, BRAIN STRUCT FUNCT, V221, P2879, DOI 10.1007/s00429-015-1077-9; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Johanson V, 2007, ENDOCR-RELAT CANCER, V14, P433, DOI 10.1677/ERC-06-0033; Ju B, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.10; Kato M, 2002, CANCER RES, V62, P2414; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Moore S W, 1998, Semin Pediatr Surg, V7, P156; Moore SW, 2012, J PEDIATR SURG, V47, P299, DOI 10.1016/j.jpedsurg.2011.11.018; Moore SW, 2006, PEDIATR SURG INT, V22, P305, DOI 10.1007/s00383-006-1655-2; Negishi-Oshino R, 2019, ARCH TOXICOL, V93, P3219, DOI 10.1007/s00204-019-02587-3; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Petralia Ronald S, 2011, Commun Integr Biol, V4, P775; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Sergaki MC, 2017, CELL REP, V19, P1977, DOI 10.1016/j.celrep.2017.05.030; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Vaillant C, 2009, CEREBELLUM, V8, P291, DOI 10.1007/s12311-009-0094-8; Vidovic M, 2008, CELL MOL NEUROBIOL, V28, P1129, DOI 10.1007/s10571-008-9292-z; Vohra BPS, 2006, DEV BIOL, V298, P259, DOI 10.1016/j.ydbio.2006.06.033; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang W, 2004, J BIOL CHEM, V279, P53491, DOI 10.1074/jbc.M410370200; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Yajima I, 2017, ARCH TOXICOL, V91, P3507, DOI 10.1007/s00204-017-1975-0; Zaahl MG, 2003, MOL CELL PROBE, V17, P49, DOI 10.1016/S0890-8508(03)00003-3	48	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100389	10.1016/j.jbc.2021.100389	http://dx.doi.org/10.1016/j.jbc.2021.100389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33561442	Green Published, gold			2022-12-26	WOS:000672866400363
J	Erickson-Davis, C; Korzybska, H				Erickson-Davis, Cordelia; Korzybska, Helma			What do blind people "see" with retinal prostheses? Observations and qualitative reports of epiretinal implant users	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; PERFORMANCE; VISION; TRIAL	Introduction Retinal implants have now been approved and commercially available for certain clinical populations for over 5 years, with hundreds of individuals implanted, scores of them closely followed in research trials. Despite these numbers, however, few data are available that would help us answer basic questions regarding the nature and outcomes of artificial vision: what do recipients see when the device is turned on for the first time, and how does that change over time? Methods Semi-structured interviews and observations were undertaken at two sites in France and the UK with 16 recipients who had received either the Argus II or IRIS II devices. Data were collected at various time points in the process that implant recipients went through in receiving and learning to use the device, including initial evaluation, implantation, initial activation and systems fitting, re-education and finally post-education. These data were supplemented with data from interviews conducted with vision rehabilitation specialists at the clinical sites and clinical researchers at the device manufacturers (Second Sight and Pixium Vision). Observational and interview data were transcribed, coded and analyzed using an approach guided by Interpretative Phenomenological Analysis (IPA). Results Implant recipients described the perceptual experience produced by their epiretinal implants as fundamentally, qualitatively different than natural vision. All used terms that invoked electrical stimuli to describe the appearance of their percepts, yet the characteristics used to describe the percepts varied significantly between recipients. Artificial vision for these recipients was a highly specific, learned skill-set that combined particular bodily techniques, associative learning and deductive reasoning in order to build a "lexicon of flashes"-a distinct perceptual vocabulary that they then used to decompose, recompose and interpret their surroundings. The percept did not transform over time; rather, the recipient became better at interpreting the signals they received, using cognitive techniques. The process of using the device never ceased to be cognitively fatiguing, and did not come without risk or cost to the recipient. In exchange, recipients received hope and purpose through participation, as well as a new kind of sensory signal that may not have afforded practical or functional use in daily life but, for some, provided a kind of "contemplative perception" that recipients tailored to individualized activities. Conclusion Attending to the qualitative reports of implant recipients regarding the experience of artificial vision provides valuable information not captured by extant clinical outcome measures.	[Erickson-Davis, Cordelia] Stanford Univ, Stanford Sch Med, Palo Alto, CA 94305 USA; [Erickson-Davis, Cordelia] Stanford Univ, Stanford Anthropol Dept, Palo Alto, CA 94305 USA; [Korzybska, Helma] Paris Nanterre Univ, Lab Ethnol & Comparat Sociol LESC, Nanterre, France	Stanford University; Stanford University	Erickson-Davis, C (corresponding author), Stanford Univ, Stanford Sch Med, Palo Alto, CA 94305 USA.; Erickson-Davis, C (corresponding author), Stanford Univ, Stanford Anthropol Dept, Palo Alto, CA 94305 USA.; Korzybska, H (corresponding author), Paris Nanterre Univ, Lab Ethnol & Comparat Sociol LESC, Nanterre, France.	cred22@stanford.edu; helrnakorzybska@gmail.com			NSF [1753701]; National Science Foundation; Dissertation Fieldwork Grant, Wenner Gren Foundation	NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Dissertation Fieldwork Grant, Wenner Gren Foundation	CED - NSF Award #1753701. National Science Foundation https://nsf.gov/awardsearch/showAward?AWD_ID= 1753701&HistoricalAwards=false. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CED -Dissertation Fieldwork Grant, Wenner Gren Foundation http://www.wennergren.org/grantees/erickson-davis-cordelia-roberta.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action A, 2004, COLLECTION REPRESENT; Ahuja AK, 2011, BRIT J OPHTHALMOL, V95, P539, DOI 10.1136/bjo.2010.179622; ALLEN CH, 2015, OPHTHALMOLOGY, V122, P1547, DOI DOI 10.1016/J.OPHTHA.2015.04.032; Anzul M., 2003, DOING QUALITATIVE RE, DOI [10.4324/9780203448502, DOI 10.4324/9780203448502]; Ayton LN, ARTIFICIAL VISION 20, P125; Bach M, 2010, INVEST OPHTH VIS SCI, V51, P1255, DOI 10.1167/iovs.09-3512; Bentley, TVST 2019; BENTLEY Sharon A., 2019, CLIN EXP OPTOM; Blamey PJ, 2013, PSYCHOPHYSICS SUPRAC; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Busskamp V, 2012, GENE THER, V19, P169, DOI 10.1038/gt.2011.155; Cajal M, 2013, SURDITES IMPLANTS CO; Candau Joel, 2000, MEMOIRE EXPERIENCES; Chen SC, 2009, VISION RES, V49, P2329, DOI 10.1016/j.visres.2009.07.003; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; Chichilnisky EJ, 2018, United States patent, Patent No. [US 9,990,861, 9990861]; CRAWFORD CASSANDRA, 2014, PHANTOM LIMB AMPUTAT; CSORDAS T, 2001, EMBODIMENT EXPERIENC; da Cruz L, 2016, OPHTHALMOLOGY, V123, P2248, DOI 10.1016/j.ophtha.2016.06.049; da Cruz L, 2013, BRIT J OPHTHALMOL, V97, P632, DOI 10.1136/bjophthalmol-2012-301525; DALYNDON CRU, 2012, INVEST OPHTH VIS SCI, V53, P2720; Demchinsky AM, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aafc76; Discover Argus II, 2 SIGHT OFFICIAL WEB; DOBELLE WH, 1979, NEUROSURGERY, V5, P521, DOI 10.1227/00006123-197910000-00022; Downey G, 2007, WAYS KNOWING ANTHROP; Duncan JL, 2017, CLIN EXP OPTOM, V100, P144, DOI 10.1111/cxo.12444; Gardien E., 2008, RELIANCE, V28, P123; GIBBS Graham R, 2007, THEMATIC CODING CATE, P38; Golden JR, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aaf270; Gourinat, 2015, REV ETHIQUE THEOLOGI, V4, P75; Hornig R, ARTIFICIAL VISION 20, P99; Howes D., 1991, VARIETIES SENSORY EX; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Ingold T., 2002, PERCEPTION ENV ESSAY; Jung JH, 2015, VISION RES, V111, P182, DOI 10.1016/j.visres.2014.10.023; Klauke S, 2011, INVEST OPHTH VIS SCI, V52, P449, DOI 10.1167/iovs.09-4410; Luhrmann T. M., 1991, PERSUASIONS WITCHS C; Luhrmann Tanya M., 2012, GOD TALKS BACK UNDER; Luo YHL, 2016, AM J OPHTHALMOL, V170, P100, DOI 10.1016/j.ajo.2016.07.021; Marshall C., 2006, DESIGNING QUALITATIV; McNeil Rod, 2016, EYE NEWS, V23; Michael BOYNTON Geoffrey BEYELER, 2017, PULSE2PERCEPT PYTHON, P148015; Muqit MMK, 2019, OPHTHALMOLOGY, V126, P637, DOI 10.1016/j.ophtha.2018.11.010; Naumann J., 2012, SEARCH PARADISE PATI; Richard G., 2009, ARVO M, V50, P4226; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Rizzo S, 2014, AM J OPHTHALMOL, V157, P1282, DOI 10.1016/j.ajo.2014.02.039; SARA G, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0134369; SecondSightEurope, 2012, SIGHT ARG 2 RET PROS; Smith JA., 1999, QUALITATIVE HLTH PSY, P218, DOI [10.4135/9781446217870.n14, DOI 10.4135/9781446217870.N14]; Stanislao RIZZO, 2019, RETINA-J RET VIT DIS; Stingl K, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00445; Stingl K, 2015, VISION RES, V111, P149, DOI 10.1016/j.visres.2015.03.001; Stingl K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0077; Stronks HC, 2014, EXPERT REV MED DEVIC, V11, P23, DOI 10.1586/17434440.2014.862494; Tang Peter H., 2016, ARG 2 SURG VID 06 34; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; US Food and Drug Administration, 2013, INV DEV EX IDE GUID; Winance M, 2016, ALTER, V10, P99, DOI 10.1016/j.alter.2016.02.005; Zrenner E, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.7.3; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	61	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0229189	10.1371/journal.pone.0229189	http://dx.doi.org/10.1371/journal.pone.0229189			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566851	gold, Green Submitted, Green Published			2022-12-26	WOS:000618271700031
J	Balouch, B; Nagorsky, H; Pham, T; LaGraff, JT; Chu-LaGraff, Q				Balouch, Bailey; Nagorsky, Halle; Pham, Truc; LaGraff, James Thai; Chu-LaGraff, Quynh			Human INCL fibroblasts display abnormal mitochondrial and lysosomal networks and heightened susceptibility to ROS-induced cell death	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; CATHEPSIN-D; MOUSE MODEL; INFANTILE; APOPTOSIS; DEFICIENCY; NEURODEGENERATION; ACTIVATION; MUTATIONS; CLN3	Infantile Neuronal Ceroid Lipofuscinosis (INCL) is a pediatric neurodegenerative disorder characterized by progressive retinal and central nervous system deterioration during infancy. This lysosomal storage disorder results from a deficiency in the Palmitoyl Protein Thioesterase 1 (PPT1) enzyme-a lysosomal hydrolase which cleaves fatty acid chains such as palmitate from lipid-modified proteins. In the absence of PPT1 activity, these proteins fail to be degraded, leading to the accumulation of autofluorescence storage material in the lysosome. The underlying molecular mechanisms leading to INCL pathology remain poorly understood. A role for oxidative stress has been postulated, yet little evidence has been reported to support this possibility. Here we present a comprehensive cellular characterization of human PPT1-deficient fibroblast cells harboring Met1Ile and Tyr247His compound heterozygous mutations. We detected autofluorescence storage material and observed distinct organellar abnormalities of the lysosomal and mitochondrial structures, which supported previous postulations about the role of ER, mitochondria and oxidative stress in INCL. An increase in the number of lysosomal structures was found in INCL patient fibroblasts, which suggested an upregulation of lysosomal biogenesis, and an association with endoplasmic reticulum stress response. The mitochondrial network also displayed abnormal spherical punctate morphology instead of normal elongated tubules with extensive branching, supporting the involvement of mitochondrial and oxidative stress in INCL cell death. Autofluorescence accumulation and lysosomal pathologies can be mitigated in the presence of conditioned wild type media suggesting that a partial restoration via passive introduction of the enzyme into the cellular environment may be possible. We also demonstrated, for the first time, that human INCL fibroblasts have a heightened susceptibility to exogenous reactive oxygen species (ROS)-induced cell death, which suggested an elevated basal level of endogenous ROS in the mutant cell. Collectively, these findings support the role of intracellular organellar networks in INCL pathology, possibly due to oxidative stress.	[Balouch, Bailey; Nagorsky, Halle; Chu-LaGraff, Quynh] Union Coll, Neurosci Program, Schenectady, NY 12308 USA; [Pham, Truc; LaGraff, James Thai; Chu-LaGraff, Quynh] Union Coll, Dept Biol, Schenectady, NY 12308 USA; [Balouch, Bailey] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Pham, Truc] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [LaGraff, James Thai] Harvard Med Sch, Dept Genet, Howard Hughes Med Inst, Boston, MA 02115 USA	Union College; Union College; Drexel University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Chu-LaGraff, Q (corresponding author), Union Coll, Neurosci Program, Schenectady, NY 12308 USA.; Chu-LaGraff, Q (corresponding author), Union Coll, Dept Biol, Schenectady, NY 12308 USA.	chulagrq@union.edu		, Bailey/0000-0002-7016-1374				Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Brandes MS, 2020, ASN NEURO, V12, DOI 10.1177/1759091419899782; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Das AK, 2001, HUM MOL GENET, V10, P1431, DOI 10.1093/hmg/10.13.1431; Das AK, 1998, J CLIN INVEST, V102, P361, DOI 10.1172/JCI3112; Dearborn JT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12752; Demers-Lamarche J, 2016, J BIOL CHEM, V291, P10263, DOI 10.1074/jbc.M115.695825; Dvorak-Ewell M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012194; Geraets RD, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0414-2; Getty AL, 2011, CELL MOL LIFE SCI, V68, P453, DOI 10.1007/s00018-010-0468-6; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; Glaser RL, 2003, GENE, V312, P271, DOI 10.1016/S0378-1119(03)00623-1; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hayes JD, 2017, MOL CELL, V68, P5, DOI 10.1016/j.molcel.2017.09.023; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaattela M, 2004, CELL DEATH DIFFER, V11, P135, DOI 10.1038/sj.cdd.4401333; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Khaibullina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048733; Kim SJ, 2006, HUM MOL GENET, V15, P1580, DOI 10.1093/hmg/ddl078; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967; Lojewski X, 2014, HUM MOL GENET, V23, P2005, DOI 10.1093/hmg/ddt596; Lyly A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-22; Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Marotta D, 2017, BBA-MOL BASIS DIS, V1863, P1273, DOI 10.1016/j.bbadis.2017.04.003; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Miller JN, 2015, HUM MOL GENET, V24, P185, DOI 10.1093/hmg/ddu428; Mole SE, 2019, LANCET NEUROL, V18, P107, DOI 10.1016/S1474-4422(18)30368-5; Mole SE, 1999, HUM MUTAT, V14, P199; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mukherjee AB, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0300-6; Mukhopadhyay S, 2020, CANCER RES, V80, P1630, DOI 10.1158/0008-5472.CAN-19-1363; Myllykangas L, 2005, NEUROBIOL DIS, V19, P194, DOI 10.1016/j.nbd.2004.12.019; Pezzini F, 2011, BIOCHEM BIOPH RES CO, V416, P159, DOI 10.1016/j.bbrc.2011.11.016; Rafelski SM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-71; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Saffari A, 2017, J INHERIT METAB DIS, V40, P631, DOI 10.1007/s10545-017-0048-0; Santavuori P, 2000, Suppl Clin Neurophysiol, V53, P443, DOI 10.1016/S1567-424X(09)70193-X; Sarkar C, 2013, NAT NEUROSCI, V16, P1608, DOI 10.1038/nn.3526; Sarkar C, 2011, MOL GENET METAB, V104, P338, DOI 10.1016/j.ymgme.2011.05.021; Seehafer SS, 2009, BIOCHEM BIOPH RES CO, V382, P247, DOI 10.1016/j.bbrc.2009.02.099; Tamaki SJ, 2009, CELL STEM CELL, V5, P310, DOI 10.1016/j.stem.2009.05.022; Teramoto S, 1999, JPN J PHARMACOL, V79, P33, DOI 10.1254/jjp.79.33; van Diggelen OP, 1999, MOL GENET METAB, V66, P240, DOI 10.1006/mgme.1999.2809; Vanhanen SL, 2004, NEUROPEDIATRICS, V35, P27, DOI 10.1055/s-2004-815788; Wisniewski KE, 2001, ADV GENET, V45, P1, DOI 10.1016/S0065-2660(01)45002-4; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0239689	10.1371/journal.pone.0239689	http://dx.doi.org/10.1371/journal.pone.0239689			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561134	Green Published, gold, Green Submitted			2022-12-26	WOS:000617533000013
J	Bukauskas, A; Koronaki, A; Lee, TU; Ott, D; Al Asali, MW; Jalia, A; Bashford, T; Gatoo, A; Newman, J; Gattas, JM; Shah, DU; Ramage, M				Bukauskas, Aurimas; Koronaki, Antiopi; Lee, Ting-Uei; Ott, Daniel; Al Asali, M. Wesam; Jalia, Aftab; Bashford, Tom; Gatoo, Ana; Newman, Josh; Gattas, Joseph M.; Shah, Darshil U.; Ramage, Michael			Curved-crease origami face shields for infection control	PLOS ONE			English	Article								The COVID-19 pandemic has created enormous global demand for personal protective equipment (PPE). Face shields are an important component of PPE for front-line workers in the context of the COVID-19 pandemic, providing protection of the face from splashes and sprays of virus-containing fluids. Existing face shield designs and manufacturing procedures may not allow for production and distribution of face shields in sufficient volume to meet global demand, particularly in Low and Middle-Income countries. This paper presents a simple, fast, and cost-effective curved-crease origami technique for transforming flat sheets of flexible plastic material into face shields for infection control. It is further shown that the design could be produced using a variety of manufacturing methods, ranging from manual techniques to high-volume die-cutting and creasing. This demonstrates the potential for the design to be applied in a variety of contexts depending on available materials, manufacturing capabilities and labour. An easily implemented and flexible physical-digital parametric design methodology for rapidly exploring and refining variations on the design is presented, potentially allowing others to adapt the design to accommodate a wide range of ergonomic and protection requirements.	[Bukauskas, Aurimas; Koronaki, Antiopi; Al Asali, M. Wesam; Jalia, Aftab; Gatoo, Ana; Shah, Darshil U.; Ramage, Michael] Univ Cambridge, Ctr Nat Mat Innovat, Dept Architecture, Cambridge, England; [Lee, Ting-Uei; Gattas, Joseph M.] Univ Queensland, Sch Civil Engn, St Lucia, Qld, Australia; [Ott, Daniel] Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge, England; [Bashford, Tom] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, NI HR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Bashford, Tom] Univ Cambridge, Engn Design Ctr, Dept Engn, Healthcare Design Grp, Cambridge, England; [Newman, Josh] Univ Brighton, Sch Media, Brighton, E Sussex, England	University of Cambridge; University of Queensland; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Brighton	Bukauskas, A (corresponding author), Univ Cambridge, Ctr Nat Mat Innovat, Dept Architecture, Cambridge, England.	ab2005@cam.ac.uk	Bashford, Tom/H-9586-2019; Shah, Darshil U/C-3050-2013; Gattas, Joseph/J-7438-2015	Bashford, Tom/0000-0003-0228-9779; Shah, Darshil U/0000-0002-8078-6802; Newman, Josh/0000-0002-3104-2719; Gattas, Joseph/0000-0002-0878-583X; Lee, Ting-Uei/0000-0002-4003-8172; Al Asali, M. Wesam/0000-0001-8782-216X; Koronaki, Antiopi/0000-0002-7125-6965	Government's modern industrial strategy by Innovate UK, part of UK Research and Innovation; National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative; University of Cambridge; INTERREG IV Cross Channel programme through the FLOWER project; Australian Research Council [DP160103279]	Government's modern industrial strategy by Innovate UK, part of UK Research and Innovation(UK Research & Innovation (UKRI)Innovate UK); National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative(National Institute for Health Research (NIHR)); University of Cambridge(University of Cambridge); INTERREG IV Cross Channel programme through the FLOWER project; Australian Research Council(Australian Research Council)	This research forms part of Centre for Digital Built Britain's work within the Construction Innovation Hub. The funding was provided through the Government's modern industrial strategy by Innovate UK, part of UK Research and Innovation (MHR, DUS, AB, AK, AJ). https://www.cdbb.cam.ac.uk/The research was supported by the National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge (MHR, TB). https://www.brainmic.nihr.ac.uk/The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. DUS and MHR thank the INTERREG IV Cross Channel programme for partial funding of this work through the FLOWER project. http://flower-project.eu/The University of Queensland authors (TL, JMG) gratefully acknowledge the financial support provided by the Australian Research Council DP160103279. https://researchdata.edu.au/discovery-projects-grant-iddp160103279/664162 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addenbrooke's Hospital, 2020, OP SOURC FAC SHIELD; AmbroPlastics, 2020, PLAST MED FAC SHIELD; [Anonymous], 2017, TECHN CONS ADD MAN M; [Anonymous], 2020, BBC NEWS; [Anonymous], 2020, NIKE NEWS 0407; Centres for Disease Control and Prevention, 2020, OP CONS PERS PROT EQ; Centres for Disease Control and Prevention, 2020, STRAT OPT SUPPL EYE; Chagas AM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000730; Cui W, 2018, ORIGAMI 7 SEVENTH IN, V4, P1329; Delimont IL, 2015, J MECH ROBOT, V7, DOI 10.1115/1.4029325; Demaine ED, 2011, ORIGAMI(5): FIFTH INTERNATIONAL MEETING OF ORIGAMI SCIENCE, MATHEMATICS, AND EDUCATION, P39; Durney MW, 2009, United States patent US, Patent No. [8,114,524 B2, 8114524]; Euler L., 1774, METHODUS INVENIENDI, VI, P1744; Foster + Partners, 2020, DES REUS FAC VIS REL; Gallagher MB, 2020, INITIATES MASS MANUF; Headley Pratt Consulting, 1996, UND PLAST FILM; HUFFMAN DA, 1976, IEEE T COMPUT, V25, P1010, DOI 10.1109/TC.1976.1674542; IE School of Architecture and Design, 2020, IE U FAB LAB JOINS C; Klein K., 2020, 5 RISD GRADUATES DES; Lee TU, 2019, INT J MECH SCI, V151, P322, DOI 10.1016/j.ijmecsci.2018.11.005; Lee TU, 2018, INT J SOLIDS STRUCT, V136, P13, DOI 10.1016/j.ijsolstr.2017.11.029; Lewis J, 2020, J MAR BIOL ASSOC UK, V100, P1, DOI 10.1017/S0025315420000144; Lindsley WG, 2014, J OCCUP ENVIRON HYG, V11, P509, DOI 10.1080/15459624.2013.877591; Luke TDW, 2020, METABOLITES, V10, DOI 10.3390/metabo10060247; Manufacturing Technology Centre, 2020, PPE SUPP OUR FRONTL; McElwain W.\, 2022, SCRIPT ELASTIC BENDI; McMahon DE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008412; Mitani J, 2011, PACIFIC C COMPUTER G, P21; Mostaghimi A, 2020, MED-CAMBRIDGE, V1, P139, DOI 10.1016/j.medj.2020.06.003; Onoyama T, 2020, DIGEST ENDOSC, V32, P998, DOI 10.1111/den.13780; Parshley L., 2020, VOX 0617; Perencevich EN, 2020, JAMA-J AM MED ASSOC, V323, P2252, DOI 10.1001/jama.2020.7477; Prusa J., 2020, 3D PRINTED FACE SHIE; Roberge RJ, 2016, J OCCUP ENVIRON HYG, V13, P239, DOI 10.1080/15459624.2015.1095302; Shi Q, 2020, ENG STRUCT, V209, DOI 10.1016/j.engstruct.2020.110218; Street F., 2020, CNN; Tago M, 2021, QJM-INT J MED, V114, P284, DOI 10.1093/qjmed/hcaa277; UK Medical Research Council, 2020, IS MY STUD RES; University of Bath, 2020, U BATH ENG HAVE NOW; University of Edingburgh, 2020, STUD START UP PROT N; University of Nottingham, 2020, NOTT ENG PROD CERT 3; University of Sheffield Advanced Manufacturing Research Centre, 2020, PROT FAC SHIELDS PRI; University of Stuttgart Institute for Computational Design and Construction, 2020, FAC SHIELD FOLD U ST; WHO, 2020, COVID 19 ESS SUPPL F; WHO, 2020, RAT US PERS PROT EQ	45	2	2	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245737	10.1371/journal.pone.0245737	http://dx.doi.org/10.1371/journal.pone.0245737			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556092	gold, Green Published, Green Submitted			2022-12-26	WOS:000617379900024
J	Nguyen, KA; Peer, N; Kengne, AP				Nguyen, Kim A.; Peer, Nasheeta; Kengne, Andre P.			Associations of gamma-glutamyl transferase with cardio-metabolic diseases in people living with HIV infection in South Africa	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ALANINE AMINOTRANSFERASE; OBSERVATIONAL COHORT; RISK-FACTOR; MORTALITY; ADULTS; HYPERTENSION; POPULATION; PREDICTION; THERAPY	Background Gamma-glutamyl transferase (GGT) has recently been reported as a biomarker for cardiovascular (CVD) risk in general populations. We investigated the associations of GGT with cardio-metabolic diseases and CVD risk in South Africans living with HIV. Methods In this cross-sectional study, HIV-infected adults were randomly recruited across 17 HIV clinics in the Western Cape Province. Homeostatic model assessment for insulin resistance (HOMA-IR), hypertension, diabetes, metabolic syndrome by Joint Interim Statement criteria (JIS-MS), a >= 5% and >= 10% predicted risk for a CVD event within 10 years by the Framingham risk score (10-years-CVD risk) were computed. Associations between GGT and cardio-metabolic trait were explored using linear and binomial logistic regressions adjusted for age, gender, lifestyle behaviours and HIV-related characteristics. Results Among 709 participants (561 women, mean age 38.6 years), log-GGT was positively associated with waist circumference (beta=2.75; p<0.001), diastolic blood pressure (beta=1.65; p=0.006), total cholesterol (beta=0.21; p<0.001), low-density lipoprotein-cholesterol (beta=0.16; p<0.001), high-density lipoprotein-cholesterol and log-triglycerides (both beta=0.12; p<0.001), fasting plasma glucose (beta=0.19; p=0.031), 2-hour-post-glucose-load plasma glucose (beta=0.26; p=0.007), HOMA-IR (beta=0.13; p=0.001), log-high-sensitivity C-reactive-protein (beta=0.3; p<0.001) in linear regression analyses; with hypertension [OR=1.41 (95%CI, 1.13-1.75); p=0.001], JIS-MS [OR=1.33 (1.05-1.68); p=0.016], >= 5% 10-year-CVD risk [OR=1.55 (1.24-1.9400); p<0.001] and >= 10% 10-year-CVD risk [OR=1.56 (1.08-2.23); p=0.016] but not with diabetes [OR=1.24 (0.88-1.71), p=0.205] in logistic regression analyses. Conclusions In this study, GGT levels were associated with cardio-metabolic variables independent of HIV specific attributes. If confirmed in longitudinal studies, GGT evaluation maybe included in CVD risk monitoring strategies in people living with HIV.	[Nguyen, Kim A.; Peer, Nasheeta; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Nguyen, Kim A.; Peer, Nasheeta; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Durban, South Africa; [Peer, Nasheeta; Kengne, Andre P.] Univ Cape Town, Dept Med, Cape Town, South Africa	South African Medical Research Council; South African Medical Research Council; University of Cape Town	Nguyen, KA (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.; Nguyen, KA (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Durban, South Africa.	Kim.Nguyen@mrc.ac.za		Kengne, Andre Pascal/0000-0002-5183-131X; Peer, Nasheeta/0000-0003-2131-8344	South African Medical Research Council through its Division of Research Capacity Development; South African National Treasury	South African Medical Research Council through its Division of Research Capacity Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Treasury	The work reported herein was made possible through funding by the South African Medical Research Council through its Division of Research Capacity Development under the SAMRC Intramural Postdoctoral Programme from funding received from the South African National Treasury. The content hereof is the sole responsibility of the authors and do not necessarily represent the official views of the SAMRC or the funders.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ballocca F, 2016, PROG CARDIOVASC DIS, V58, P565, DOI 10.1016/j.pcad.2016.02.008; Begovac J, 2015, CROAT MED J, V56, P14, DOI 10.3325/cmj.2015.56.14; BRYANT Systems, 2015, BRYANT RES SYST WEB; Choi KM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19700-8; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2012, J INFECT DIS, V205, pS362, DOI 10.1093/infdis/jis196; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; Fourie CMT, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05173-6; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grinspoon SK, 2008, JAIDS-J ACQ IMM DEF, V48, P369, DOI 10.1161/CIRCULATIONAHA.107.189622; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kengne AP, 2012, J HEPATOL, V57, P1083, DOI 10.1016/j.jhep.2012.06.034; Kunutsor SK, 2015, J HYPERTENS, V33, P2373, DOI 10.1097/HJH.0000000000000763; Lang S, 2015, ARCH CARDIOVASC DIS, V108, P206, DOI 10.1016/j.acvd.2015.01.004; Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Liu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048878; Matsha TE, 2014, EUR J PREV CARDIOL, V21, P1541, DOI 10.1177/2047487313501967; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ngala R. A., 2015, Trends in Medical Research, V10, P1, DOI 10.3923/tmr.2015.1.11; Nguyen KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183029; Nguyen KA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060299; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; NILSSEN O, 1994, AM J EPIDEMIOL, V139, P787, DOI 10.1093/oxfordjournals.aje.a117075; Ortblad KF, 2013, LANCET, V381, P105; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Paolicchi A, 2004, CIRCULATION, V109, P1440, DOI 10.1161/01.CIR.0000120558.41356.E6; Ren J, 2015, J AM SOC HYPERTENS, V9, P951, DOI 10.1016/j.jash.2015.09.014; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Shankar A, 2007, CIRC J, V71, P1567, DOI 10.1253/circj.71.1567; Strijdom H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2158-y; Tang LZ, 2018, POSTGRAD MED J, V94, P641, DOI 10.1136/postgradmedj-2018-135644; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Turgut O, 2011, J ATHEROSCLER THROMB, V18, P177, DOI 10.5551/jat.6189; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yi SW, 2017, ATHEROSCLEROSIS, V265, P102, DOI 10.1016/j.atherosclerosis.2017.08.028	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246131	10.1371/journal.pone.0246131	http://dx.doi.org/10.1371/journal.pone.0246131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544719	Green Published, gold			2022-12-26	WOS:000617991900007
J	Carter, G; Woodward, B; Ohmit, A; Gleissner, A; Short, M				Carter, Gregory; Woodward, Brennan; Ohmit, Anita; Gleissner, Andrew; Short, Meredith			Primary care providers as a critical access point to HIV information and services for African American and Latinx communities	PLOS ONE			English	Article							BLACK; MEN; GAY; PREVENTION; BARRIERS; SEX	Purpose This study aimed to examine the association between confidence in accessing HIV services, primary sources of HIV information, and primary care provider status for African American and Latinx individuals in Indiana. Methods An online survey was disseminated to African American and Latinx individuals using snowball and social media recruitment methods, resulting in a final sample size of n = 308. A multivariable linear regression analysis was performed to examine the relationships between confidence accessing HIV services, primary care provider status, sexual identification, and sources of HIV information. Results Of the total respondents, 62.5% (n = 193) identified as male and 36.9% (n = 114) identified as female. Most identified as African American (72.5%, n = 224), followed by 27.2% (n = 84) who identified as Latinx. Participants who used their primary care providers as a primary source of obtaining HIV information had a significantly higher level of comfort with accessing HIV services. Those who identified family members as a primary source of HIV information and those who identified as bisexual demonstrated a lower level of confidence in accessing HIV services. Discussion This study's results enhance our understanding of marginalization within minority groups regarding sexual identification and accessing HIV services. These results also offer insight into the importance of healthcare access because having a primary care provider was a strong predictor of increased confidence in accessing HIV services.	[Carter, Gregory; Woodward, Brennan; Gleissner, Andrew] Indiana Univ, Sch Nursing, Bloomington, IN 47405 USA; [Ohmit, Anita] Indiana Minor Hlth Coalit, Indianapolis, IN USA; [Short, Meredith] Posit Link Bloomington Indiana, Bloomington, IN USA	Indiana University System; Indiana University Bloomington	Carter, G (corresponding author), Indiana Univ, Sch Nursing, Bloomington, IN 47405 USA.	Gracarte@IU.edu	Carter, Gregory/AAF-2259-2020	Carter, Gregory/0000-0001-9974-5587	Indiana Minority Health Coalition	Indiana Minority Health Coalition	This research was funded by a research grant from the Indiana Minority Health Coalition.	[Anonymous], 2019, HIV US DEP AR; Cahill S, 2017, AIDS CARE, V29, P1351, DOI 10.1080/09540121.2017.1300633; Centers for Disease Control and Prevention, 2019, HIV AFR AM; Centers for Disease Control and Prevention, 2020, HIV HISP LAT; Centers for Disease Control and Prevention, 2019, BEN FOUT SCREEN; Crosby RA, 2021, ESSENTIALS PUBLIC HL; Dailey AF, 2017, MMWR-MORBID MORTAL W, V66, P1300, DOI 10.15585/mmwr.mm6647e1; Gilead Sciences, 2019, TRUV PREP PREEXP PRO; James TG, 2018, J AM COLL HEALTH, V66, P561, DOI 10.1080/07448481.2018.1432623; Kagee A, 2017, AIDS CARE, V29, P280, DOI 10.1080/09540121.2016.1259453; Kaiser Family Foundation, 2017, UN RAT NON RAC ETHN; Kaiser Family Foundation, 2018, UIND HLTH COV UN; Kaiser Family Foundation, 2017, AD AD LIV HIV DIAGN; Kinsler JJ, 2013, AIDS CARE, V25, P1442, DOI 10.1080/09540121.2013.772283; Levison JH, 2017, AIDS PATIENT CARE ST, V31, P394, DOI 10.1089/apc.2017.0084; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Mamle A, 2013, J PRIMARY CARE COMMU, V4; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Owens DK, 2019, PREEXPOSURE PROPHYLA; Rhodes SD, 2017, AM J PUBLIC HEALTH, V107, P969, DOI 10.2105/AJPH.2017.303814; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stewart J, 2017, MENT HEALTH RELIG CU, V20, P478, DOI 10.1080/13674676.2017.1358256; Voisin DR, 2013, J ADOLESCENCE, V36, P111, DOI 10.1016/j.adolescence.2012.09.009; Wood S, 2018, AIDS, V32, P895, DOI [10.1097/QAD.0000000000001772, 10.1097/qad.0000000000001772]	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246016	10.1371/journal.pone.0246016	http://dx.doi.org/10.1371/journal.pone.0246016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539465	gold, Green Published			2022-12-26	WOS:000616960200012
J	Gonzalez, VT; Lindgard, B; Reiersen, R; Hagen, SB; Brathen, KA				Gonzalez, Victoria T.; Lindgard, Bente; Reiersen, Rigmor; Hagen, Snorre B.; Brathen, Kari Anne			Niche construction mediates climate effects on recovery of tundra heathlands after extreme event	PLOS ONE			English	Article							WINTER WARMING EVENTS; EMPETRUM-HERMAPHRODITUM; PLANT COMMUNITY; ARCTIC TUNDRA; VEGETATION; ECOSYSTEMS; DATABASE; TRAITS; FOREST; DAMAGE	Climate change is expected to increase the frequency and intensity of extreme events in northern ecosystems. The outcome of these events across the landscape, might be mediated by species effects, such as niche construction, with likely consequences on vegetation resilience. To test this hypothesis, we simulated an extreme event by removing aboveground vegetation in tundra heathlands dominated by the allelopathic dwarf shrub Empetrum nigrum, a strong niche constructor. We tested the hypothesis under different climate regimes along a 200-km long gradient from oceanic to continental climate in Northern Norway. We studied the vegetation recovery process over ten years along the climatic gradient. The recovery of E. nigrum and subordinate species was low and flattened out after five years at all locations along the climatic gradient, causing low vegetation cover at the end of the study in extreme event plots. Natural seed recruitment was low at all sites, however, the addition of seeds from faster growing species did not promote vegetation recovery. A soil bioassay from 8 years after the vegetation was removed, suggested the allelopathic effect of E. nigrum was still present in the soil environment. Our results provide evidence of how a common niche constructor species can dramatically affect ecosystem recovery along a climatic gradient after extreme events in habitats where it is dominant. By its extremely slow regrowth and it preventing establishment of faster growing species, this study increases our knowledge on the possible outcomes when extreme events harm niche constructors in the tundra.	[Gonzalez, Victoria T.; Lindgard, Bente; Reiersen, Rigmor; Brathen, Kari Anne] UiT Arctic Univ & Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Gonzalez, Victoria T.; Hagen, Snorre B.] NIBIO Norwegian Inst Bioecon Res, Dept Ecosyst Barents Reg, Svanvik, Norway	UiT The Arctic University of Tromso; Norwegian Institute of Bioeconomy Research	Gonzalez, VT (corresponding author), UiT Arctic Univ & Norway, Dept Arctic & Marine Biol, Tromso, Norway.; Gonzalez, VT (corresponding author), NIBIO Norwegian Inst Bioecon Res, Dept Ecosyst Barents Reg, Svanvik, Norway.	victoria.gonzalez@nibio.no		Brathen, Kari Anne/0000-0003-0942-1074; , Victoria/0000-0002-3997-1803	UiT-The Arctic University of Norway	UiT-The Arctic University of Norway	The study was funded by a grant from UiT-The Arctic University of Norway provided to Victoria T. Gonzalez. The publication charges for this article have been funded by a grant from the publication fund of UiT-The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2010, GLOBAL CHANGE BIOL, V16, P1071, DOI 10.1111/j.1365-2486.2009.01999.x; Attorre F, 2007, INT J CLIMATOL, V27, P1825, DOI 10.1002/joc.1495; Austrheim G, 2008, OIKOS, V117, P837, DOI 10.1111/j.0030-1299.2008.16543.x; Bjerke JW, 2011, J ECOL, V99, P1481, DOI 10.1111/j.1365-2745.2011.01859.x; Bokhorst S, 2010, PHYSIOL PLANTARUM, V140, P128, DOI 10.1111/j.1399-3054.2010.01386.x; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Brathen KA, 2004, J VEG SCI, V15, P653, DOI 10.1111/j.1654-1103.2004.tb02307.x; Brathen KA, 2018, PERSPECT PLANT ECOL, V30, P71, DOI 10.1016/j.ppees.2017.06.005; Brathen KA, 2015, J ECOL, V103, P701, DOI 10.1111/1365-2745.12380; Brathen KA, 2010, J VEG SCI, V21, P786, DOI 10.1111/j.1654-1103.2010.01188.x; Buntgen U, 2015, J ECOL, V103, P489, DOI 10.1111/1365-2745.12361; Cornelissen JHC, 2001, J ECOL, V89, P984, DOI 10.1111/j.1365-2745.2001.00625.x; Dahlgren J, 2009, EVOL ECOL RES, V11, P1205; Epstein HE, 2017, TUNDRA GREENNESS; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gonzalez VT, 2019, PEERJ, V7, DOI 10.7717/peerj.6967; Gonzalez VT, 2015, NORD J BOT, V33, P225, DOI 10.1111/njb.00559; Graae BJ, 2011, OECOLOGIA, V166, P565, DOI 10.1007/s00442-010-1878-8; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kivinen S, 2017, CLIMATE, V5, DOI 10.3390/cli5010016; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Korner C, 1999, ALPINE PLANT LIFE FU; Larsson EL, 2003, NORD J BOT, V23, P333, DOI 10.1111/j.1756-1051.2003.tb00402.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Miller A, 2012, MOL ECOL, V21, P1036, DOI 10.1111/j.1365-294X.2012.05467.x; Mod HK, 2016, J BIOGEOGR, V43, P2412, DOI 10.1111/jbi.12794; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; NILSSON MC, 1992, J CHEM ECOL, V18, P1857, DOI 10.1007/BF02751109; Nilsson MC, 2002, OIKOS, V97, P3, DOI 10.1034/j.1600-0706.2002.970101.x; Nilsson MC, 1998, OIKOS, V81, P6, DOI 10.2307/3546462; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; Olofsson J, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0486; Olofsson J, 2011, NAT CLIM CHANGE, V1, P220, DOI 10.1038/NCLIMATE1142; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Phoenix GK, 2016, GLOBAL CHANGE BIOL, V22, P2960, DOI 10.1111/gcb.13261; Pinheiro J, 2017, **DATA OBJECT**, V3, P1; R Development Core Team, 2016, LANG ENV STAT COMP R; Ravolainen VT, 2010, ECOSYSTEMS, V13, P157, DOI 10.1007/s10021-009-9308-7; SHEVTSOVA A, 1995, J ECOL, V83, P263, DOI 10.2307/2261565; Tybirk K, 2000, AMBIO, V29, P90, DOI 10.1639/0044-7447(2000)029[0090:NEDEFA]2.0.CO;2; Vikhamar-Schuler D, 2016, J CLIMATE, V29, P6223, DOI 10.1175/JCLI-D-15-0763.1; Vowles T, 2019, J ECOL, V107, P650, DOI 10.1111/1365-2745.13081; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; WorldClim, 2017, FREE CLIM DAT EC MOD; ZACKRISSON O, 1992, CAN J FOREST RES, V22, P1310, DOI 10.1139/x92-174	46	1	1	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245929	10.1371/journal.pone.0245929	http://dx.doi.org/10.1371/journal.pone.0245929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539380	Green Published, gold			2022-12-26	WOS:000616960200094
J	Valente, D; Palama, A; Gentaz, E				Valente, Dannyelle; Palama, Amaya; Gentaz, Edouard			Exploring 3D miniatures with action simulations by finger gestures: Study of a new embodied design for blind and sighted children	PLOS ONE			English	Article							PICTURE; IDENTIFICATION; RECOGNITION; MEMORY	Tactile books for blind children generally contain tactile illustrations referring to a visual world that can be difficult to understand. This study investigates an innovative way to present content to be explored by touch. Following embodied approaches and evidence about the advantages of manipulations in tactile processing, we examined 3D miniatures that children explored using their middle and index fingers to simulate leg movements. This "Action simulations by finger gestures-ASFG" procedure has a symbolic relevance in the context of blindness. The aim of the present study was to show how the ASFG procedure facilitates the identification of objects by blind and sighted children. Experiment 1 examined the identification of 3D miniatures of action objects (e.g. the toboggan, trampoline) by 8 early blind and 15 sighted children, aged 7 to 12, who explored with the ASFG procedure. Results revealed that objects were very well identified by the two groups of children. Results confirmed hypotheses that ASFG procedures are relevant in the identification process regardless of the visual status of subjects. Experiment (control) 2 studied identification of tactile pictures of same action objects by 8 different early blind and 15 sighted children, aged 7 to 12. Results confirmed that almost all objects obtained lower recognition scores in tactile pictures than in 3D miniatures by both groups and showed surprisingly higher scores in blind children than in sighted children. Taken together, our study provides evidence of the contribution of sensorimotor simulation in the identification of objects by touch and brings innovative solutions in book design for blind people. Moreover, it means that only the ASFG procedure has a very inclusive potential to be relevant for a larger number of subjects, regardless of their visual skills.	[Valente, Dannyelle; Palama, Amaya; Gentaz, Edouard] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Valente, Dannyelle] Univ Lumiere Lyon 2, Dept Dev Psychol, Bron, France	University of Geneva; Universite Lyon 2	Valente, D (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.; Valente, D (corresponding author), Univ Lumiere Lyon 2, Dept Dev Psychol, Bron, France.	dannyelle.valente@univ-lyon2.fr		Valente, Dannyelle/0000-0003-2686-4379; Gentaz, Edouard/0000-0003-0574-5557	Swiss National Science Foundation (FNS) [100019_162688]	Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF))	Grant: Edouard Gentaz (EG) Swiss National Science Foundation (FNS) FNS N degrees 100019_162688 http://www.snf.ch/en/Pages/default.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, SCI SERIES, V112, pF1, DOI 10.1017/ajil.2018.46; Bara F, ANAE; Bara F, 2018, J VISUAL IMPAIR BLIN, V112, P759, DOI 10.1177/0145482X1811200610; Bara F, 2014, J DEV PHYS DISABIL, V26, P151, DOI 10.1007/s10882-013-9352-2; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Cappagli G, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00029; Cordier F, 1981, CAHIERS PSYCHOL COGN, V1, P75; Darras B., 1996, COMMENCEMENT ETAIT I; FREIDES D, 1974, PSYCHOL BULL, V81, P284, DOI 10.1037/h0036331; Freides D., HUMAN INFORM PROCESS; Gentaz E., 2018, MAIN CERVEAU TOUCHER; Gentaz E., 2003, TOUCHING KNOWING COG; Goldin-Meadow S, 2009, PSYCHOL SCI, V20, P267, DOI 10.1111/j.1467-9280.2009.02297.x; Gori M, 2014, BRAIN, V137, P288, DOI 10.1093/brain/awt311; Hainselin M., 2013, REV NEUROPSYCHOL, V5, P129, DOI DOI 10.3917/RNE.052.0129; Heller MA, 1996, PERCEPT PSYCHOPHYS, V58, P310, DOI 10.3758/BF03211884; HELLER MA, 1989, PERCEPTION, V18, P379, DOI 10.1068/p180379; Heller MA, 2014, PSYCHOL TOUCH BLINDN; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Kennedy, 1993, DRAWING BLIND; KLATZKY RL, 1993, PERCEPT PSYCHOPHYS, V54, P170, DOI 10.3758/BF03211752; Lebaz S, 2012, PSYCHOL RES-PSYCH FO, V76, P667, DOI 10.1007/s00426-011-0351-6; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; Macedonia M, 2011, HUM BRAIN MAPP, V32, P982, DOI 10.1002/hbm.21084; Madan CR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00507; MILLAR S, 1975, PERCEPTION, V4, P363, DOI 10.1068/p040363; Mulligan NW, 2003, MEM COGNITION, V31, P412, DOI 10.3758/BF03194399; Picard D, 2012, J VISUAL IMPAIR BLIN, V106, P427, DOI 10.1177/0145482X1210600705; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Theurel A, 2013, J EXP PSYCHOL-APPL, V19, P233, DOI 10.1037/a0034255; Thompson LJ, 2006, EUR PSYCHOL, V11, P110, DOI 10.1027/1016-9040.11.2.110; Thompson LJ, 2003, PERCEPTION, V32, P887, DOI 10.1068/p5020; Valente D, 2019, ANAE, V159, P68; Valente D, ENFANCE; Valente D, 2015, P 11 EUR AC DES C EA; Valente D., 2015, DESSIN BOUT DOIGTS E; Valente D, 2020, ANAE, V165, P202; Valente D., 2013, MEI HANDICAP ET COMM, V36, P77; Valente D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214371; Versace R., 2018, COGNITION INCARNEE C; Vinter A, 2012, RES DEV DISABIL, V33, P1819, DOI 10.1016/j.ridd.2012.05.001; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	43	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245472	10.1371/journal.pone.0245472	http://dx.doi.org/10.1371/journal.pone.0245472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2HP	33534814	Green Published, gold			2022-12-26	WOS:000616720600002
J	Patel, AB; Veeraiah, P; Shameem, M; Kumar, JM; Saba, K				Patel, Anant Bahadur; Veeraiah, Pandichelvam; Shameem, Mohammad; Kumar, Jerald Mahesh; Saba, Kamal			Impaired GABAergic and glutamatergic neurometabolic activity in aged mice brain as measured by H-1-[C-13]-NMR spectroscopy	FASEB JOURNAL			English	Article						H-1&#8208; [C-13]&#8208; NMR spectroscopy; ATP; brain energy metabolism; GABA; glutamate	MAGNETIC-RESONANCE-SPECTROSCOPY; ENERGY-METABOLISM; RAT-BRAIN; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; GLUCOSE-OXIDATION; MEMORY DEFICITS; GABA SYNTHESIS; AGING BRAIN; CORTEX	Healthy aging is associated with a decline in cognitive function, and is a major risk factor for many neurodegenerative diseases. Although, there are several evidence that brain mitochondrial function is altered with aging its significance at the cellular level is elusive. In this study, we have investigated mitochondrial TCA cycle and neurotransmitter cycle fluxes associated with glutamatergic, GABAergic neurons and astroglia in the cerebral cortex and hippocampus of young (6 months) and aged (24 months) C57BL6 mice by using H-1-[C-13]-NMR spectroscopy together with timed infusion of C-13-labeled glucose and acetate. The ratio V-Cyc/V-TCA was determined from a steady-state [2-C-13]acetate experiment. Metabolic fluxes were obtained by fitting a three-compartment metabolic model to C-13 turnover of amino acids from glucose. Levels of glutamate, aspartate and taurine were reduced in the cerebral cortex, while glutamine and choline were elevated in the hippocampus of aged mice. Interestingly, the rate of acetate oxidation increased in the cerebral cortex, while the flux of mitochondrial TCA cycle of glutamatergic neurons decreased in the cerebral cortex (P < .0001) and hippocampus (P = .025) of aged mice. The glutamate-glutamine neurotransmitter cycle flux was reduced in the cerebral cortex (P < .0001). The GABAergic TCA cycle flux was reduced in the cerebral cortex (P = .0008), while GABA-glutamine neurotransmitter cycling flux was also reduced in the cerebral cortex (P = .011) and hippocampus (P = .042) of aged brain. In conclusion, the reduction in excitatory and inhibitory neurotransmitter activity of glutamatergic and GABAergic neurons in the cerebral cortex and hippocampus correlates qualitatively with declined cognitive function in aged mice.	[Patel, Anant Bahadur; Veeraiah, Pandichelvam; Shameem, Mohammad; Kumar, Jerald Mahesh; Saba, Kamal] CSIR Ctr Cellular & Mol Biol, NMR Microimaging & Spect, Uppal Rd, Hyderabad 500007, India; [Patel, Anant Bahadur; Saba, Kamal] Acad Sci & Innovat Res AcSIR, Ghaziabad, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Academy of Scientific & Innovative Research (AcSIR)	Patel, AB (corresponding author), CSIR Ctr Cellular & Mol Biol, NMR Microimaging & Spect, Uppal Rd, Hyderabad 500007, India.	abpatel@ccmb.res.in	Shameem, Mohammad/K-1632-2019; Veeraiah, Pandichelvam/AAS-4134-2020	Shameem, Mohammad/0000-0003-0578-2622; Veeraiah, Pandichelvam/0000-0002-9149-7483				Aanerud J, 2012, J CEREBR BLOOD F MET, V32, P1177, DOI 10.1038/jcbfm.2012.18; Bagga P, 2013, J NEUROCHEM, V127, P365, DOI 10.1111/jnc.12407; Barreto G, 2010, J NEUROSURG ANESTH, V22, P214, DOI 10.1097/ANA.0b013e3181d56c98; BENEDETTI MS, 1990, J NEUR TR S, V29, P259; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; BURNS A, 1992, AGE AGEING, V21, P316, DOI 10.1093/ageing/21.5.316; Canas PM, 2009, NEUROBIOL AGING, V30, P1877, DOI 10.1016/j.neurobiolaging.2008.01.003; Chakravarty S, 2017, BBA-MOL BASIS DIS, V1863, P152, DOI 10.1016/j.bbadis.2016.09.014; Chang L, 2009, MAGN RESON IMAGING, V27, P142, DOI 10.1016/j.mri.2008.06.002; Chen LH, 2019, NEUROSCI LETT, V708, DOI 10.1016/j.neulet.2019.134341; de Graaf RA, 2003, MAGNET RESON MED, V49, P37, DOI 10.1002/mrm.10348; Duarte JMN, 2014, NEUROBIOL AGING, V35, P1660, DOI 10.1016/j.neurobiolaging.2014.01.135; Duarte JMN, 2013, J NEUROCHEM, V126, P579, DOI 10.1111/jnc.12333; Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Goodall EF, 2018, NEUROPATH APPL NEURO, V44, P328, DOI 10.1111/nan.12408; Haider S, 2014, AGE, V36, P1291, DOI 10.1007/s11357-014-9653-0; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Harris JL, 2014, NEUROBIOL AGING, V35, P1686, DOI 10.1016/j.neurobiolaging.2014.01.018; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; HOYER S, 1985, ARCH GERONTOL GERIAT, V4, P193, DOI 10.1016/0167-4943(85)90001-9; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Kalpouzos G, 2009, NEUROBIOL AGING, V30, P112, DOI 10.1016/j.neurobiolaging.2007.05.019; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kaur M, 2008, BIOGERONTOLOGY, V9, P441, DOI 10.1007/s10522-008-9168-0; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Legrand A, 1998, BRAIN RES, V802, P125, DOI 10.1016/S0006-8993(98)00580-0; Lin AL, 2014, J CEREBR BLOOD F MET, V34, P1440, DOI 10.1038/jcbfm.2014.114; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lores-Arnaiz S, 2011, NEUROSCIENCE, V188, P117, DOI 10.1016/j.neuroscience.2011.04.060; Lores-Arnaiz S, 2016, NEUROCHEM RES, V41, P353, DOI 10.1007/s11064-015-1817-5; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mahesh Kumar MJ., 2014, P INT SOC MAGN RESON, V22, P62; Mason GF, 2003, BRAIN RES PROTOC, V10, P181, DOI 10.1016/S1385-299X(02)00217-9; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mishra PK, 2018, J NEUROCHEM, V146, P722, DOI 10.1111/jnc.14544; Mishra PK, 2020, NEUROCHEM INT, V137, DOI 10.1016/j.neuint.2020.104750; No HJ, 2019, REV ESP MED NUCL IMA, V38, P160, DOI 10.1016/j.remn.2018.12.001; Nozaki Y, 2020, P NATL ACAD SCI USA, V117, P8166, DOI 10.1073/pnas.1921694117; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Patel AB, 2004, J CEREBR BLOOD F MET, V24, P972, DOI 10.1097/01.WCB.0000126234.16188.71; Patel AB, 2001, BRAIN RES, V919, P207, DOI 10.1016/S0006-8993(01)03015-3; Patel AB., 2012, P INT SOC MAGN RESON, V20, P1823; Patel AB, 2018, J CEREBR BLOOD F MET, V38, P1213, DOI 10.1177/0271678X17709463; Patel AB, 2010, J CEREBR BLOOD F MET, V30, P1200, DOI 10.1038/jcbfm.2010.2; Pathaki SS, 2017, NEUROPSYCHOPHARMACOL, V42, P854, DOI 10.1038/npp.2016.231; Peng SL, 2014, NEUROIMAGE, V98, P176, DOI 10.1016/j.neuroimage.2014.04.078; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; Petrosillo G, 2008, NEUROCHEM INT, V53, P126, DOI 10.1016/j.neuint.2008.07.001; Pistell PJ, 2012, NEUROBIOL AGING, V33, P2431, DOI 10.1016/j.neurobiolaging.2011.12.004; Raininko R, 2010, ACTA RADIOL, V51, P309, DOI 10.3109/02841850903476564; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Reutzel M, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4060769; Sailasuta N, 2008, MAGN RESON IMAGING, V26, P667, DOI 10.1016/j.mri.2007.06.007; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SARANSAARI P, 1995, MECH AGEING DEV, V81, P61, DOI 10.1016/0047-6374(95)01583-L; Schmitz B, 2018, J NEUROIMAGING, V28, P416, DOI 10.1111/jon.12514; Schuff N, 2006, ADV EXP MED BIOL, V576, P241; SCHULZ J, 1994, J IMMUNOL METHODS, V167, P1, DOI 10.1016/0022-1759(94)90069-8; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Shen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051517; Sure VN, 2018, GEROSCIENCE, V40, P365, DOI 10.1007/s11357-018-0037-8; Takanashi J, 2015, MAGN RESON MED SCI, V14, P85, DOI 10.2463/mrms.2014-0064; Tiwari V, 2014, J NEUROCHEM, V128, P628, DOI 10.1111/jnc.12508; Tiwari V, 2013, J CEREBR BLOOD F MET, V33, P1523, DOI 10.1038/jcbfm.2013.114; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116	71	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21321	10.1096/fj.202001704RR	http://dx.doi.org/10.1096/fj.202001704RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33543543				2022-12-26	WOS:000647789600067
J	Vaneyck, J; Segers-Nolten, I; Broersen, K; Claessens, MMAE				Vaneyck, Jonathan; Segers-Nolten, Ine; Broersen, Kerensa; Claessens, Mireille M. A. E.			Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS; PATHOLOGIES; NUCLEATION; IMPACT; BRAIN; TAU	The aggregation of the protein alpha-synuclein (aSyn) into amyloid fibrils in the human brain is associated with the development of several neurodegenerative diseases, including Parkinson's disease. The previously observed prion-like spreading of aSyn aggregation throughout the brain and the finding that heterologous cross-seeding of amyloid aggregation occurs in vitro for some proteins suggest that exposure to amyloids in general may pose a risk for disease development. To elucidate which protein fibril characteristics determine if and how heterologous amyloid seeding can occur, we investigated the potential of amyloid fibrils formed from proteins found in food, hen egg white lysozyme, and bovine milk beta-lactoglobulin to cross-seed aSyn aggregation in the test tube. We observed that amyloid fibrils from lysozyme, but not beta-lactoglobulin, potently cross-seeded the aggregation of aSyn as indicated by a significantly shorter lag phase of aSyn aggregation in the presence of lysozyme fibrils. The cross-seeding effect of lysozyme was found to be primarily driven by a surface-mediated nucleation mechanism. The differential seeding effect of lysozyme and beta-lactoglobulin on aSyn aggregation could be explained on the basis of binding affinity, binding site, and electrostatic interactions. Our results indicate that heterologous seeding of proteins may occur depending on the physicochemical characteristics of the seed protein fibril. Our findings suggest that heterologous seeding has the potential to determine the pathogenesis of neurodegenerative amyloid diseases.	[Vaneyck, Jonathan; Segers-Nolten, Ine; Claessens, Mireille M. A. E.] Univ Twente, MESA Inst Nanotechnol, Nanobiophys, Enschede, Netherlands; [Broersen, Kerensa] Univ Twente, Tech Med Ctr, Appl Stem Cell Technol, Enschede, Netherlands	University of Twente; University of Twente	Vaneyck, J (corresponding author), Univ Twente, MESA Inst Nanotechnol, Nanobiophys, Enschede, Netherlands.	j.vaneyck@utwente.nl		Vaneyck, Jonathan/0000-0003-3095-7420	Netherlands Organization for Scientific Research, Biotechnology and Safety Research Programme [15784]	Netherlands Organization for Scientific Research, Biotechnology and Safety Research Programme	We thank the Netherlands Organization for Scientific Research, Biotechnology and Safety Research Programme, project 15784, for funding.	Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Arnaudov LN, 2006, BIOMACROMOLECULES, V7, P3490, DOI 10.1021/bm060584i; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brunnstrom H, 2009, AM J GERIAT PSYCHIAT, V17, P664, DOI 10.1097/JGP.0b013e3181a6516e; Challis C, 2020, NAT NEUROSCI, V23, P327, DOI 10.1038/s41593-020-0589-7; Chaudhuri P, 2019, AGEING RES REV, V56, DOI 10.1016/j.arr.2019.100937; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Echavarri C, 2012, J ALZHEIMERS DIS, V30, P909, DOI 10.3233/JAD-2012-111400; EDWARDS LL, 1991, MOVEMENT DISORD, V6, P151, DOI 10.1002/mds.870060211; Faas FGA, 2009, BIOPHYS J, V97, P1148, DOI 10.1016/j.bpj.2009.06.015; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hamada D, 2009, J MOL BIOL, V386, P878, DOI 10.1016/j.jmb.2008.12.038; Hashimoto M, 2000, AM J PATHOL, V156, P734, DOI 10.1016/S0002-9440(10)64777-3; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Jansens KJA, 2019, COMPR REV FOOD SCI F, V18, P84, DOI 10.1111/1541-4337.12404; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez-Saiz R, 2014, MOL NUTR FOOD RES, V58, P614, DOI 10.1002/mnfr.201300442; Katorcha E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006563; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Knowles TPJ, 2016, ADV MATER, V28, P6546, DOI 10.1002/adma.201505961; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kroes-Nijboer A, 2012, FARADAY DISCUSS, V158, P125, DOI 10.1039/c2fd20031g; McCann H, 2016, MOVEMENT DISORD, V31, P152, DOI 10.1002/mds.26421; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Nicolai T, 2013, CURR OPIN COLLOID IN, V18, P249, DOI 10.1016/j.cocis.2013.03.001; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Ren BP, 2019, J MATER CHEM B, V7, P7267, DOI 10.1039/c9tb01871a; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Sidhu A, 2017, ACS CHEM NEUROSCI, V8, P538, DOI 10.1021/acschemneuro.6b00287; Sidhu A, 2016, ACS CHEM NEUROSCI, V7, P719, DOI 10.1021/acschemneuro.5b00322; Sidhu A, 2014, BBA-PROTEINS PROTEOM, V1844, P2127, DOI 10.1016/j.bbapap.2014.09.007; Singhrao SK, 1998, EXP NEUROL, V150, P213, DOI 10.1006/exnr.1998.6778; Tiiman A, 2015, AIP ADV, V5, DOI 10.1063/1.4921071; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; Uemura N, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0257-5; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	48	12	13	3	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100358	10.1016/j.jbc.2021.100358	http://dx.doi.org/10.1016/j.jbc.2021.100358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539920	Green Published, gold			2022-12-26	WOS:000672866400332
J	Zhu, XB; Jin, CM; Pan, QR; Hu, X				Zhu, Xiaobing; Jin, Chengmeng; Pan, Qiangrong; Hu, Xun			Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MOLECULAR-MECHANISM; GLUCOSE-METABOLISM; INHIBITION; THERMODYNAMICS; INACTIVATION; IODOACETATE; GLUTATHIONE; RESISTANCE	Previous studies have identified GAPDH as a promising target for treating cancer and modulating immunity because its inhibition reduces glycolysis in cells (cancer cells and immune cells) with the Warburg effect, a modified form of cellular metabolism found in cancer cells. However, the quantitative relationship between GAPDH and the aerobic glycolysis remains unknown. Here, using siRNA-mediated knockdown of GAPDH expression and iodoacetate-dependent inhibition of enzyme activity, we examined the quantitative relationship between GAPDH activity and glycolysis rate. We found that glycolytic rates were unaffected by the reduction of GAPDH activity down to 19% +/- 4.8% relative to untreated controls. However, further reduction of GAPDH activity below this level caused proportional reductions in the glycolysis rate. GAPDH knockdown or inhibition also simultaneously increased the concentration of glyceraldehyde 3-phosphate (GA3P, the substrate of GAPDH). This increased GA3P concentration countered the effect of GAPDH knockdown or inhibition and stabilized the glycolysis rate by promoting GAPDH activity. Mechanistically, the intracellular GA3P concentration is controlled by the Gibbs free energy of the reactions upstream of GAPDH. The thermodynamic state of the reactions along the glycolysis pathway was only affected when GAPDH activity was reduced below 19% +/- 4.8%. Doing so moved the reactions catalyzed by GAPDH + PGK1 (phosphoglycerate kinase 1, the enzyme immediate downstream of GAPDH) away from the near-equilibrium state, revealing an important biochemical basis to interpret the rate control of glycolysis by GAPDH. Collectively, we resolved the numerical relationship between GAPDH and glycolysis in cancer cells with the Warburg effect and interpreted the underlying mechanism.	[Zhu, Xiaobing; Jin, Chengmeng; Pan, Qiangrong; Hu, Xun] Zhejiang Univ, Canc Inst,Sch Med, China Natl Minist Educ,Zhejiang Prov Key Lab Mol, Key Lab Canc Intervent & Prevent,Affiliated Hosp, Hangzhou, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Canc Inst,Sch Med, China Natl Minist Educ,Zhejiang Prov Key Lab Mol, Key Lab Canc Intervent & Prevent,Affiliated Hosp, Hangzhou, Peoples R China.	huxun@zju.edu.cn			China National 973 project [2013CB911303]; China Natural Science Foundation [81470126, 82073038]; Zhejiang Provincial Department of Sciences and Technologies [2018C03009]; Fundamental Research Funds for the Central Universities [2017XZZX001-01, 2019FZJD009]; National Ministry of Education, China	China National 973 project(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Sciences and Technologies; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Ministry of Education, China(Ministry of Education, China)	This work has been supported in part by the China National 973 project (2013CB911303), China Natural Science Foundation projects (81470126, 82073038), a key project (2018C03009) funded by Zhejiang Provincial Department of Sciences and Technologies, the Fundamental Research Funds for the Central Universities (2017XZZX001-01, 2019FZJD009), and the National Ministry of Education, China, to X. H.	Alberty Robert A, 2006, Methods Biochem Anal, V48, P1; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; CAMPBELLBURK SL, 1987, BIOCHEMISTRY-US, V26, P7483, DOI 10.1021/bi00397a043; Carneiro AS, 2011, CHEM PHYS LETT, V514, P336, DOI 10.1016/j.cplett.2011.08.051; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Dai ZW, 2018, J BIOL CHEM, V293, P19725, DOI 10.1074/jbc.RA118.004372; DONNOVAN L, 1975, THERMOCHIM ACTA, V11, P151, DOI 10.1016/0040-6031(75)80018-9; Giachelli CM, 2003, J AM SOC NEPHROL, V14, pS300, DOI 10.1097/01.ASN.0000081663.52165.66; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Jin CM, 2020, J BIOL CHEM, V295, P6425, DOI 10.1074/jbc.RA119.012312; KELETI T, 1972, BIOCHIM BIOPHYS ACTA, V268, P285, DOI 10.1016/0005-2744(72)90323-3; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; LAMBEIR AM, 1991, EUR J BIOCHEM, V198, P429, DOI 10.1111/j.1432-1033.1991.tb16032.x; Li X., 2011, DATABASE, V2011; Liao S., 2019, NAT COMMUN, V10; Liberti MV, 2020, J BIOL CHEM, V295, P111, DOI 10.1074/jbc.RA119.010903; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Locasale Jason W, 2018, Curr Opin Syst Biol, V8, P32, DOI 10.1016/j.coisb.2017.11.005; Martyniuk CJ, 2011, CHEM RES TOXICOL, V24, P2302, DOI 10.1021/tx200437y; Mendez E, 2008, BIOCHEM MOL BIOL EDU, V36, P116, DOI 10.1002/bmb.20157; Mountassif D, 2009, ACTA BIOCH BIOPH SIN, V41, P399, DOI 10.1093/abbs/gmp026; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; POLGAR L, 1975, EUR J BIOCHEM, V51, P63, DOI 10.1111/j.1432-1033.1975.tb03907.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; REKHARSKY MV, 1981, THERMOCHIM ACTA, V46, P89, DOI 10.1016/0040-6031(81)80234-1; SABRI MI, 1971, J NEUROCHEM, V18, P1509, DOI 10.1111/j.1471-4159.1971.tb00013.x; SAKAI K, 1990, EUR J BIOCHEM, V193, P195, DOI 10.1111/j.1432-1033.1990.tb19323.x; SAKAI K, 1988, BIOCHIM BIOPHYS ACTA, V952, P297, DOI 10.1016/0167-4838(88)90130-6; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shi YH, 2005, J BIOL CHEM, V280, P41805, DOI 10.1074/jbc.M505181200; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Varga A, 2009, FEBS LETT, V583, P3660, DOI 10.1016/j.febslet.2009.10.048; WILLIAMSON JR, 1967, J BIOL CHEM, V242, P4476; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Ying MF, 2019, J BIOL CHEM, V294, P9615, DOI 10.1074/jbc.RA119.007841; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08277-3; Zhong XY, 2018, CELL REP, V24, P3207, DOI 10.1016/j.celrep.2018.08.066	54	4	4	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100369	10.1016/j.jbc.2021.100369	http://dx.doi.org/10.1016/j.jbc.2021.100369			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545174	Green Published, gold			2022-12-26	WOS:000672866400343
J	Yanai, H; Yoshikawa, K; Ishida, M; Tsuta, K; Sekimoto, M; Sugie, T				Yanai, Hirotsugu; Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Tsuta, Koji; Sekimoto, Mitsugu; Sugie, Tomoharu			Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study	PLOS ONE			English	Article								Background Stromal reaction is an important prognostic factor in several cancers, and the presence of myxoid change was assessed as a poor prognostic factor in colorectal cancer. However, the prognostic significance of myxoid change in triple-negative breast cancer (TNBC) remains unknown. This study aimed to determine the prognostic significance of myxoid change and fibrotic focus (FF), which is a fibrotic area within the tumor and considered a poor prognostic indicator in patients with TNBC. Methods We enrolled 62 patients with TNBC and reviewed the surgically resected specimens to evaluate myxoid change and FF in the tumor using previously outlined criteria. We evaluated tumor-infiltrating lymphocytes (TILs) using hematoxylin and eosin slides. Overall survival (OS) and relapse-free survival (RFS) were compared based on the presence of myxoid change and/or FF, and the risk factors for RFS were analyzed. Results Myxoid change and FF were observed in 25.8% and 33.9% of specimens, respectively. Based on stromal lymphocyte infiltration, 19 patients (30.6%) had high TILs, while the remaining 43 patients (69.4%) had low/intermediate TILs. Presence of myxoid change was significantly correlated with poor OS and RFS (p = 0.040 and 0.031, respectively). FF was also significantly correlated with poor OS and RFS (p = 0.012 and 0.028, respectively). The combination of myxoid change and FF was an independent and poor prognostic factor according to the multivariate analysis (HR 11.61; 95% CI 1.027-131.2; p = 0.048). Presence of myxoid change and FF were significantly associated with low/intermediate TILs in the stroma (p = 0.013). Conclusions Histopathological assessment of myxoid change and FF in TNBC may be a useful, practical, and easily assessable method for predicting prognosis in patients with TNBC, which should be confirmed in larger prospective studies. Diagnostic criteria for the establishment of myxoid change and FF in TNBC must be established, and their underlying molecular events must be clarified.	[Yanai, Hirotsugu; Yoshikawa, Katsuhiro; Sekimoto, Mitsugu; Sugie, Tomoharu] Kansai Med Univ, Dept Surg, Osaka, Japan; [Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Tsuta, Koji] Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan	Kansai Medical University; Kansai Medical University	Ishida, M (corresponding author), Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan.	ishidamt@hirakata.kmu.ac.jp		Yanai, Hirotsugu/0000-0002-5097-6365				Ahn S, 2012, TUMOR BIOL, V33, P1573, DOI 10.1007/s13277-012-0411-6; Chen IX, 2019, P NATL ACAD SCI USA, V116, P4558, DOI 10.1073/pnas.1815515116; Denkert C, 2018, LANCET ONCOL, V19, P40, DOI 10.1016/S1470-2045(17)30904-X; Eiro N, 2019, CANCERS, V11, DOI 10.3390/cancers11050664; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gujam FJA, 2014, BRIT J CANCER, V111, P157, DOI 10.1038/bjc.2014.279; Hasebe T, 2002, MODERN PATHOL, V15, P502, DOI 10.1038/modpathol.3880555; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Liu TY, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00060; Moorman AM, 2012, EJSO-EUR J SURG ONC, V38, P307, DOI 10.1016/j.ejso.2012.01.002; Mujtaba SS, 2013, ANN SURG ONCOL, V20, P2842, DOI 10.1245/s10434-013-2955-0; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Ueno H, 2019, AM J SURG PATHOL, V43, P1015, DOI 10.1097/PAS.0000000000001272; Ueno H, 2015, ANN SURG ONCOL, V22, P1504, DOI 10.1245/s10434-014-4149-9; Van den Eynden GG, 2007, HISTOPATHOLOGY, V51, P440, DOI 10.1111/j.1365-2559.2007.02761.x; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Wernicke M, 2003, MODERN PATHOL, V16, P99, DOI 10.1097/01.MP.0000051582.75890.2D; Wu Q, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01068; Zhai QL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223325	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245725	10.1371/journal.pone.0245725	http://dx.doi.org/10.1371/journal.pone.0245725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571189	Green Published, gold			2022-12-26	WOS:000618274000007
J	Choi, Y; Park, JH; Kim, DH; Kim, HJ; Suh, E; Kim, KH; Ahn, JJ; Lee, GN; Jung, JH; Han, K; Shin, YN				Choi, Yeonjoo; Park, Joo-Hyun; Kim, Do-Hoon; Kim, Hyun Jin; Suh, Euijung; Kim, Ki-Hoon; Ahn, Jae Joon; Lee, Gyu-Na; Jung, Jin-Hyung; Han, Kyungdo; Shin, You-Na			Association between cotinine-verified smoking status and moderately increased albuminuria in the middle-aged and older population in Korea: A nationwide population-based study	PLOS ONE			English	Article								Objectives Although several self-reported questionnaire-based studies have found an association between smoking and moderately increased albuminuria, this result remains controversial. We investigated whether moderately increased albuminuria was associated with smoking status, verified by urinary cotinine (an objective biomarker of tobacco exposure), using population-based, nationally representative data. Methods This study included 2059 participants aged >= 50 years from the 2014 Korean National Health and Nutrition Examination Survey. Individuals with a urinary cotinine level >= 50 ng/mL were identified as cotinine-verified smokers. Moderately increased albuminuria was defined as a urine albumin-to-creatinine ratio ranging between >= 30 mg/g and < 300 mg/g. Multivariable logistic regression was used to evaluate the association between cotinine-verified smoking status and moderately increased albuminuria. Results Among the study participants, 16.9% were cotinine-verified smokers, 84.8% of whom were men. After adjustment for multiple covariates, cotinine-verified smokers showed a significant positive association with moderately increased albuminuria (adjusted odds ratio: 4.37, 95% confidence interval: 1.63-11.71) compared with cotinine-verified non-smokers. The association between urinary cotinine and moderately increased albuminuria did not differ with age, sex, obesity, or comorbidities (P-value for interaction > 0.05 in all cases). Conclusion This large-scale observational study showed that cotinine-verified smoking is associated with moderately increased albuminuria in the Korean middle-aged and older general population, suggesting that smoking must be strictly controlled to reduce the risk of moderately increased albuminuria.	[Choi, Yeonjoo; Park, Joo-Hyun; Kim, Do-Hoon; Kim, Hyun Jin; Suh, Euijung; Kim, Ki-Hoon; Ahn, Jae Joon] Korea Univ, Coll Med, Dept Family Med, Ansan Hosp, Ansan, South Korea; [Lee, Gyu-Na; Jung, Jin-Hyung] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Han, Kyungdo] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Shin, You-Na] Korea Med Inst, Suwon Ctr, Suwon, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Soongsil University	Park, JH; Kim, DH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Ansan Hosp, Ansan, South Korea.	joohyun_park@naver.com; kmcfm@hanmail.net		Choi, Yeonjoo/0000-0001-9807-6879; Kim, Do Hoon/0000-0001-7421-4501; Park, Joo-hyun/0000-0002-4358-4208	Korea Medical Institute Research Fund [Q1711451]	Korea Medical Institute Research Fund	This paper was supported by Korea Medical Institute Research Fund (Q1711451) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535; Andronico G, 2005, NEPHROLOGY, V10, P483, DOI 10.1111/j.1440-1797.2005.00458.x; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P19; Atthobari J, 2006, CLIN THER, V28, P432, DOI 10.1016/j.clinthera.2006.03.012; Bansilal S, 2015, INT J CARDIOL, V201, pS1, DOI 10.1016/S0167-5273(15)31026-3; Barbato A, 2019, KIDNEY BLOOD PRESS R, V44, P33, DOI 10.1159/000498830; Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Dulger H, 2011, RENAL FAILURE, V33, P475, DOI 10.3109/0886022X.2011.577922; Ejerblad E, 2004, J AM SOC NEPHROL, V15, P2178, DOI 10.1097/01.ASN.0000135048.35659.10; Gao X, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1052-1; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; GRASSI G, 1994, CIRCULATION, V90, P248, DOI 10.1161/01.CIR.90.1.248; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hogan SL, 2007, RENAL FAILURE, V29, P133, DOI 10.1080/08860220601098888; Holl RW, 1998, DIABETES CARE, V21, P787, DOI 10.2337/diacare.21.5.787; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Ikeda Y, 1997, DIABETES RES CLIN PR, V36, P57, DOI 10.1016/S0168-8227(97)01370-3; Jee SH, 2005, ARCH INTERN MED, V165, P2299, DOI 10.1001/archinte.165.19.2299; Jee SH, 2010, DIABETES CARE, V33, P2567, DOI 10.2337/dc10-0261; Jha V, 2018, KIDNEY INT, V94, P462, DOI 10.1016/j.kint.2018.05.009; Jones-Burton C, 2007, AM J NEPHROL, V27, P342, DOI 10.1159/000103382; Jung S, 2012, TUBERC RESPIR DIS, V73, P210, DOI 10.4046/trd.2012.73.4.210; Kar D, 2019, ACTA DIABETOL, V56, P839, DOI 10.1007/s00592-019-01293-x; Kim BJ, 2017, BLOOD PRESSURE, V26, P303, DOI 10.1080/08037051.2017.1344539; KIOWSKI W, 1994, CIRCULATION, V90, P27, DOI 10.1161/01.CIR.90.1.27; Kunutsor SK, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008726, 10.1161/jaha.118.008726]; Maddatu J, 2017, TRANSL RES, V184, P101, DOI 10.1016/j.trsl.2017.02.004; METCALF PA, 1993, CLIN CHEM, V39, P1793; Nam GE, 2014, SUBST USE MISUSE, V49, P1426, DOI 10.3109/10826084.2014.912227; Nilsson PM, 2004, DIABETES METAB, V30, P261, DOI 10.1016/S1262-3636(07)70117-9; O'Seaghdha CM, 2010, AM J KIDNEY DIS, V56, P852, DOI 10.1053/j.ajkd.2010.04.013; Orth SR, 2000, NEPHRON, V86, P12, DOI 10.1159/000045708; Pijls LTJ, 2001, DIABETES RES CLIN PR, V52, P133, DOI 10.1016/S0168-8227(00)00246-1; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Prakash S, 2009, SEMIN NEPHROL, V29, P497, DOI 10.1016/j.semnephrol.2009.06.006; Saito K, 2007, DIABETES CARE, V30, P1286, DOI 10.2337/dc06-2149; Scott LJ, 2001, DIABETES, V50, P2842, DOI 10.2337/diabetes.50.12.2842; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Toto Robert D, 2004, J Clin Hypertens (Greenwich), V6, P2, DOI 10.1111/j.1524-6175.2004.4064.x; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Yoon HJ, 2009, HYPERTENS RES, V32, P214, DOI 10.1038/hr.2008.37; Yu JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192980	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246017	10.1371/journal.pone.0246017	http://dx.doi.org/10.1371/journal.pone.0246017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566809	Green Published, gold			2022-12-26	WOS:000618271700004
J	de Andrade, MIS; Oliveira, JS; Leal, VS; Cabral, PC; de Lira, PIC				Siqueira de Andrade, Maria Izabel; Oliveira, Juliana Souza; Leal, Vanessa Sa; Cabral, Poliana Coelho; de Lira, Pedro Israel Cabral			Independent predictors of insulin resistance in Brazilian adolescents: Results of the study of cardiovascular risk in adolescents-Brazil	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; HOMA-IR; CHILDREN; SENSITIVITY; EXERCISE; GLUCOSE; OBESITY; YOUTH	Considering the current changes in dietary patterns and the increasing prevalence of excess weight throughout the world, several studies have reported insulin resistance, which is a key driver of many chronic diseases, to be an important public health problem in all age groups. Therefore, the aim of the present study was to identify the prevalence and independent predictors of insulin resistance in Brazilian adolescents. A cross-sectional study was conducted with a probabilistic, representative sample of Brazilian adolescents (n = 37,023) who participated in the Study of Cardiovascular Risk in Adolescents. Data were collected on demographic, socioeconomic, lifestyle, anthropometric, and biochemical characteristics as well as antioxidant micronutrient intake (vitamins A, C, E, zinc, and selenium). Insulin resistance was determined using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and classified based on the 75th percentile of the sample distribution. Insulin resistance was detected in 27% of the adolescents and was more prevalent among those aged 12 to 14 years (PR: 1.26 [95%CI: 1.13;1.41]), those residing in the southern and south-eastern regions of the country (PR: 1.47 [95%CI: 1.27;1.70]), those who were physically inactive (PR: 1.12 [95%CI: 1.02;1.23]), and those did not consume alcohol (PR: 1.50 [95%CI: 1.13;1.99]). The prevalence of insulin resistance was 2.5-fold higher among individuals with severe obesity (PR: 2.49 [95%CI: 2.07;3.00]). Waist circumference indicative of cardiovascular risk and high serum triglyceride levels increased the likelihood of insulin resistance (PR: 1.37 [95%CI: 1.19;1.59] and 1.60 [95%CI: 1.45;1.78], respectively). The prevalence of the outcome was higher among adolescents in the lower quartiles of vitamin E intake (p<0.05). In the present study, the prevalence of insulin resistance was high among Brazilian adolescents and we identified sociodemographic, lifestyle, anthropometric, biochemical, and dietary predictors of this outcome.	[Siqueira de Andrade, Maria Izabel; Oliveira, Juliana Souza; Leal, Vanessa Sa; Cabral, Poliana Coelho; de Lira, Pedro Israel Cabral] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil; [Oliveira, Juliana Souza; Leal, Vanessa Sa] Univ Fed Pernambuco, Ctr Acad Vitoria, Nucleo Nutr, Vitoria De Santo Antao, PE, Brazil; [Siqueira de Andrade, Maria Izabel] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil; [Siqueira de Andrade, Maria Izabel] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Alagoas	de Andrade, MIS (corresponding author), Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil.; de Andrade, MIS (corresponding author), Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil.; de Andrade, MIS (corresponding author), Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil.	andrademizabel@gmail.com	Cabral, Poliana Coelho/AAX-9405-2021	Cabral, Poliana Coelho/0000-0002-2709-4823	Financiadora de Estudos e Projetos (FINEP [Study and Project Funding Agency]) [01090421]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [National Council of Scientific and Technological Research]) [565037/2010-2, 405.009/2012-7]	Financiadora de Estudos e Projetos (FINEP [Study and Project Funding Agency]); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [National Council of Scientific and Technological Research])	YYYY This work was supported by Brazilian fostering agencies Financiadora de Estudos e Projetos (FINEP [Study and Project Funding Agency]) (grant number: 01090421) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [National Council of Scientific and Technological Research]) (grant numbers: 565037/2010-2, 405.009/2012-7).	Aldhoon-Hainerova I, 2017, METABOLISM, V67, P90, DOI 10.1016/j.metabol.2016.10.005; Andrade Maria Izabel Siqueira de, 2016, Rev. paul. pediatr., V34, P234, DOI [10.1016/j.rpped.2015.08.006, 10.1016/j.rppede.2016.01.004]; [Anonymous], 2005, Arq. Bras. Cardiol., V85, P3, DOI 10.1590/S0066-782X2005002500001; [Anonymous], 2017, INT J TECHNOL ASSESS, V33, P1, DOI 10.1017/S0266078417000050; [Anonymous], 2005, REV BRAS MED ESPORTE; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Baba R, 2010, NAGOYA J MED SCI, V72, P161; Balkau B, 2008, DIABETES, V57, P2613, DOI 10.2337/db07-1605; Bloch KV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1442-x; Costa CS, 2019, NUTR METAB CARDIOVAS, V29, P177, DOI 10.1016/j.numecd.2018.11.003; Cunha E del BB, 2018, INT J CARDIOVASC SCI, P31367; Silva Cleliani de Cassia da, 2014, Rev. paul. pediatr., V32, P221, DOI 10.1590/0103-0582201432210713; Faria ER, 2014, RASBRAN, V6, P21; Fedewa MV, 2014, PEDIATRICS, V133, pE163, DOI 10.1542/peds.2013-2718; Fox C, 2017, J AM OSTEOPATH ASSOC, V117, P689, DOI 10.7556/jaoa.2017.135; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gingras V, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0759-0; Gobato Amanda Oliva, 2014, Rev. paul. pediatr., V32, P55, DOI 10.1590/S0103-05822014000100010; Instituto Brasileiro de Geografia e Estatistica, 2008, HOUS BUDG SURV 2008; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kelsey MM, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0751-5; de Vasconcellos MTL, 2015, CAD SAUDE PUBLICA, V31, P921, DOI 10.1590/0102-311X00043214; Ling JCY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36270; Lopez-Sandoval J, 2018, ACTA ENDOCRINOL-BUCH, V14, P330, DOI 10.4183/aeb.2018.330; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Montonen J, 2004, DIABETES CARE, V27, P362, DOI 10.2337/diacare.27.2.362; Vieira CENK, 2013, REV LAT-AM ENFERM, V21, P1220, DOI 10.1590/0104-1169.2870.2357; Niki E, 2015, KOREAN J INTERN MED, V30, P571, DOI 10.3904/kjim.2015.30.5.571; Palhares Heloísa Marcelina da Cunha, 2018, Rev. paul. pediatr., V36, P301, DOI 10.1590/1984-0462/;2018;36;3;00017; Perng W, 2019, ANN HUM BIOL, V46, P205, DOI 10.1080/03014460.2019.1638967; Qi QB, 2017, J CLIN ENDOCR METAB, V102, P185, DOI 10.1210/jc.2016-2279; Rocco ER, 2011, ARQ BRAS ENDOCRINOL, V55, P638, DOI 10.1590/S0004-27302011000800020; Rocha NP, 2017, J PEDIAT-BRAZIL, V93, P214, DOI 10.1016/j.jped.2017.01.002; Sapunar J, 2018, REV MED CHILE, V146, P978, DOI 10.4067/s0034-98872018000900978; Shashaj B, 2016, ACTA DIABETOL, V53, P251, DOI 10.1007/s00592-015-0782-4; Sigwalt FR, 2014, REV BRAS ENFERM, V67, P43, DOI 10.5935/0034-7167.20140005; de Morais PRS, 2016, ARQ BRAS CARDIOL, V106, P319, DOI 10.5935/abc.20160041; de Andrade MIS, 2020, REV PAUL PEDIATR, V38, DOI 10.1590/1984-0462/2020/38/2019016; Son WM, 2017, CLIN EXP HYPERTENS, V39, P546, DOI 10.1080/10641963.2017.1288742; Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005; Souza MR, 2004, ARQ CIENC SAUDE, V11, P215; Werneck AO, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54060096; World Health Organization, 2006, WHO CHILD GROWTH STA; Xu RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095008	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246445	10.1371/journal.pone.0246445	http://dx.doi.org/10.1371/journal.pone.0246445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561171	Green Published, gold			2022-12-26	WOS:000617533000052
J	Casas-Aparicio, GA; Leon-Rodriguez, I; Alvarado-de la Barrera, C; Gonzalez-Navarro, M; Peralta-Prado, AB; Luna-Villalobos, Y; Velasco-Morales, A; Calderon-Davila, N; Ormsby, CE; Avila-Rios, S				Casas-Aparicio, Gustavo A.; Leon-Rodriguez, Isabel; Alvarado-de la Barrera, Claudia; Gonzalez-Navarro, Mauricio; Peralta-Prado, Amy B.; Luna-Villalobos, Yara; Velasco-Morales, Alejandro; Calderon-Davila, Natalia; Ormsby, Christopher E.; Avila-Rios, Santiago			Acute kidney injury in patients with severe COVID-19 in Mexico	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; INFECTION; OUTCOMES; OBESITY; DISEASE; WUHAN	Introduction Some patients with COVID-19 pneumonia present systemic disease involving multiple systems. There is limited information about the clinical characteristics and events leading to acute kidney injury (AKI). We described the factors associated with the development of AKI and explored the relation of AKI and mortality in Mexican population with severe COVID-19. Methods We retrospectively reviewed the medical records of individuals with severe pneumonia caused by SARS-CoV-2 hospitalized at the largest third-level reference institution for COVID-19 care in Mexico between March and April 2020. Demographic information, comorbidities, clinical and laboratory data, dates of invasive mechanical ventilation (IMV) and hospitalization, mechanical-ventilator settings and use of vasoactive drugs were recorded. Results Of 99 patients studied, 58 developed AKI (58.6%). The risk factors for AKI were older age (OR = 1.07, 95% CI = 1.01-1.13, p = 0.024); obesity (OR = 6.58, 95% CI = 1.8-24.05, p = 0.040); and the need for IMV (OR = 6.18, CI = 1.29-29.58, p = 0.023). The risk factors for mortality were obesity (OR = 5.57, 95% CI = 1.48-20.93, p = 0.011); requirement of vasoactive drugs on admission (OR = 5.35, 95% CI = 1.16-24.61, p = 0.031); and AKI (OR = 8.61, 95% CI = 2.24-33.1, p = 0.002). In-hospital mortality was significantly higher in patients with AKI stage 3 (79.3%) and AKI stage 2 (68.7%) compared with those with AKI stage 1 (25%; p = 0.004). Fifty-three patients underwent the furosemide stress test (FST) to predict progression to AKI stage 3. Of those, 12 progressed to AKI stage 3 (22%). The ROC curve for the FST had an AUC of 0.681 (p = 0.009); a sensitivity of 81.6% and a specificity of 54.5%. Conclusions AKI was common in our cohort of patients with severe pneumonia caused by SARS-CoV-2 infection. The risk factors for AKI were older age, obesity and the need for of IMV on admission. The risk factors for mortality were obesity, requirement of vasoactive drugs on admission and AKI. Mortality was more frequent in patients with AKI stages 2-3. The FST had an acceptable predictive capacity to identify patients progressing to AKI stage 3.	[Casas-Aparicio, Gustavo A.; Leon-Rodriguez, Isabel; Alvarado-de la Barrera, Claudia; Gonzalez-Navarro, Mauricio; Peralta-Prado, Amy B.; Luna-Villalobos, Yara; Ormsby, Christopher E.; Avila-Rios, Santiago] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Velasco-Morales, Alejandro; Calderon-Davila, Natalia] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico		Casas-Aparicio, GA (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	gustavo.casas@cieni.org.mx	Avila-Rios, Santiago/AAB-4383-2020	Peralta Prado, Amy Bethel/0000-0002-6379-9134; Gonzalez-Navarro, Mauricio/0000-0001-5247-2083				[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4; Bellomo R, 2008, CRIT CARE MED, V36, pS179, DOI 10.1097/CCM.0b013e318169167f; Bose RJC, 2020, DRUG DISCOV TODAY, V25, P1559, DOI 10.1016/j.drudis.2020.06.021; Chawla LS, 2013, CRIT CARE, V17, DOI 10.1186/cc13015; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; De Rosa S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1218-4; de Salud Secretaria, 2016, ENCUESTA NACL SALUD; Deng Y, 2020, CHINESE MED J-PEKING, V133, P1261, DOI 10.1097/CM9.0000000000000824; Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hegde V, 2013, CLIN MICROBIOL INFEC, V19, P314, DOI 10.1111/1469-0691.12157; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; KDIGO, CLIN PRACT GUID AC K; Lee K, 2009, GLOB INST, P1; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Moore PK, 2018, AM J KIDNEY DIS, V72, P136, DOI 10.1053/j.ajkd.2017.11.021; Ospina-Tascon GA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2756-3; Parikh CR, 2017, J AM SOC NEPHROL, V28, P3699, DOI 10.1681/ASN.2017010055; Park KC, 2017, CARDIOVASC RES, V113, P1708, DOI 10.1093/cvr/cvx183; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Qu R, 2020, J MED VIROL, V92, P1533, DOI 10.1002/jmv.25767; Ramirez-Sandoval JC, 2021, BLOOD PURIFICAT, V50, P355, DOI 10.1159/000510996; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Seller-Perez G, 2016, MED INTENSIVA, V40, P374, DOI 10.1016/j.medin.2016.05.002; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, 2020, MENT HLTH PSYCH CONS; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]; Zhang L, 2018, INT J LAB HEMATOL, V40, P503, DOI 10.1111/ijlh.12864; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	39	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246595	10.1371/journal.pone.0246595	http://dx.doi.org/10.1371/journal.pone.0246595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556150	Green Published, gold			2022-12-26	WOS:000617379900042
J	Hennein, R; Mew, EJ; Lowe, SR				Hennein, Rachel; Mew, Emma J.; Lowe, Sarah R.			Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States	PLOS ONE			English	Article							RESPIRATORY SYNDROME-CORONAVIRUS; DEPRESSION; PHYSICIANS; SCREEN; IMPACT	Background Healthcare workers are at increased risk of adverse mental health outcomes during the COVID-19 pandemic. Studies are warranted that examine socio-ecological factors associated with these outcomes to inform interventions that support healthcare workers during future disease outbreaks. Methods We conducted an online cross-sectional study of healthcare workers during May 2020 to assess the socio-ecological predictors of mental health outcomes during the COVID-19 pandemic. We assessed factors at four socio-ecological levels: individual (e.g., gender), interpersonal (e.g., social support), institutional (e.g., personal protective equipment availability), and community (e.g., healthcare worker stigma). The Personal Health Questionnaire-9, Generalized Anxiety Disorder-7, Primary Care Post-Traumatic Stress Disorder, and Alcohol Use Disorders Identification Test-Concise scales assessed probable major depression (MD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), and alcohol use disorder (AUD), respectively. Multivariable logistic regression models were used to assess unadjusted and adjusted associations between socio-ecological factors and mental health outcomes. Results Of the 1,092 participants, 72.0% were female, 51.9% were frontline workers, and the mean age was 40.4 years (standard deviation = 11.5). Based on cut-off scores, 13.9%, 15.6%, 22.8%, and 42.8% had probable MD, GAD, PTSD, and AUD, respectively. In the multivariable adjusted models, needing more social support was associated with significantly higher odds of probable MD, GAD, PTSD, and AUD. The significance of other factors varied across the outcomes. For example, at the individual level, female gender was associated with probable PTSD. At the institutional level, lower team cohesion was associated with probable PTSD, and difficulty following hospital policies with probable MD. At the community level, higher healthcare worker stigma was associated with probable PTSD and AUD, decreased satisfaction with the national government response with probable GAD, and higher media exposure with probable GAD and PTSD. Conclusions These findings can inform targeted interventions that promote healthcare workers' psychological resilience during disease outbreaks.	[Hennein, Rachel] Yale Univ, Yale Sch Med, New Haven, CT 06520 USA; [Hennein, Rachel] Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Mew, Emma J.] Yale Univ, Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Lowe, Sarah R.] Yale Univ, Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Hennein, R (corresponding author), Yale Univ, Yale Sch Med, New Haven, CT 06520 USA.; Hennein, R (corresponding author), Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	Rachel.Hennein@Yale.edu		Hennein, Rachel/0000-0001-6855-0402	Yale University's COVID-19 Response Coordination Team; National Institutes of Health Medical Scientist Training Program [T32GM007205]	Yale University's COVID-19 Response Coordination Team; National Institutes of Health Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RH and SL received funding support from Yale University's COVID-19 Response Coordination Team. RH received funding support from the National Institutes of Health Medical Scientist Training Program (Training Grant T32GM007205). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Breazzano MP, 2020, J CLIN INVEST, V130, P4726, DOI [10.1172/JCI139587, 10.1172/JCI139587.]; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bureau of Labor Statistics, 2018, STAT OCC EMPL STAT S; Cabarkapa Sonja, 2020, Brain Behav Immun Health, V8, P100144, DOI 10.1016/j.bbih.2020.100144; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control Prevention, 2022, SOC EC MOD FRAM PREV; Cheng P, 2020, COMMUNITY MENT HLT J, V56, P786, DOI 10.1007/s10597-020-00624-5; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Elbay RY, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113130; Evanoff BA, 2020, J MED INTERNET RES, V22, DOI 10.2196/21366; Eyre DW, 2020, ELIFE, V9, DOI 10.7554/eLife.60675; Filut A, 2020, ACAD MED, V95, P1796, DOI 10.1097/ACM.0000000000003651; Gadermann AM, 2012, DEPRESS ANXIETY, V29, P797, DOI 10.1002/da.21924; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Graetz I, 2014, HEALTH SERV RES, V49, P438, DOI 10.1111/1475-6773.12136; Hennein R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240646; Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831; Jung H, 2020, WORKPLACE HEALTH SAF, V68, P337, DOI 10.1177/2165079919897693; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303; Kim Y, 2018, AM J INFECT CONTROL, V46, P781, DOI 10.1016/j.ajic.2018.01.012; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krystal JH, 2021, GEN HOSP PSYCHIAT, V68, P12, DOI 10.1016/j.genhosppsych.2020.11.005; Kwaning KM, 2020, ACAD MED, V95, P1787, DOI 10.1097/ACM.0000000000003621; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Ohman-Strickland PA, 2007, HEALTH SERV RES, V42, P1257, DOI 10.1111/j.1475-6773.2006.00644.x; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007; Silczuk A, 2020, J PUBLIC HEALTH-UK, V42, P461, DOI 10.1093/pubmed/fdaa110; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; U.S. Census Bureau, 2017, 2000 CENS 2017 AM CO; United States Department of Health and Human Services Health Resources and Services Administration National Center for Health Workforce Analysis, 2017, SEX RAC ETHN DIV US; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923549; Yang J, 2020, COMPR PSYCHIAT, V103, DOI 10.1016/j.comppsych.2020.152198; Zhang SX, 2020, BRAIN BEHAV IMMUN, V87, P144, DOI 10.1016/j.bbi.2020.05.010; Zhu J, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00206	48	47	48	10	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246602	10.1371/journal.pone.0246602	http://dx.doi.org/10.1371/journal.pone.0246602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544761	gold, Green Published			2022-12-26	WOS:000617991900043
J	McGrath, SL; Huang, SH; Kobryn, K				McGrath, Siobhan L.; Huang, Shu Hui; Kobryn, Kerri			Single stranded DNA annealing is a conserved activity of telomere resolvases	PLOS ONE			English	Article							LINEAR PLASMID PROPHAGE; LYME-DISEASE SPIROCHETE; COLI RECO PROTEIN; BORRELIA-BURGDORFERI; BIDIRECTIONAL REPLICATION; BETA-PROTEIN; REST; PROTELOMERASE; SEQUENCE; N-15	Bacterial species of the genera Agrobacterium and Borrelia possess chromosomes terminated by hairpin telomeres. Replication produces dimeric replication intermediates fused via replicated telomere junctions. A specialized class of enzymes, referred to as telomere resolvases, promotes the resolution of the replicated intermediate into linear monomers terminated by hairpin telomeres. Telomere resolution is catalyzed via DNA cleavage and rejoining events mechanistically similar to those promoted by topoisomerase-IB and tyrosine recombinase enzymes. Examination of the borrelial telomere resolvase, ResT, revealed unanticipated multifunctionality; aside from its expected telomere resolution activity ResT possessed a singled-stranded DNA (ssDNA) annealing activity that extended to both naked ssDNA and ssDNA complexed with its cognate single-stranded DNA binding protein (SSB). At present, the role this DNA annealing activity plays in vivo remains unknown. We have demonstrated here that single-stranded DNA annealing is also a conserved property of the agrobacterial telomere resolvase, TelA. This activity in TelA similarly extends to both naked ssDNA and ssDNA bound by its cognate SSB. TelA's annealing activity was shown to stem from the N-terminal domain; removal of this domain abolished annealing without affecting telomere resolution. Further, independent expression of the N-terminal domain of TelA produced a functional annealing protein. We suggest that the apparent conservation of annealing activity in two telomere resolvases, from distantly related bacterial species, implies a role for this activity in hairpin telomere metabolism. Our demonstration of the separation of the telomere resolution and annealing activities of TelA provides a platform for future experiments aimed at identifying the role DNA annealing performs in vivo.	[McGrath, Siobhan L.; Huang, Shu Hui; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	kerri.kobryn@usask.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 043822017]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	KK is supported by grant RGPIN 043822017 from the Natural Sciences and Engineering Research Council of Canada (NSERC) URL: https://www.nserc-crsng.gc.ca/index_eng.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bandy NJ, 2014, J BACTERIOL, V196, P2396, DOI 10.1128/JB.01435-13; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briffotaux J, 2010, J BIOL CHEM, V285, P41010, DOI 10.1074/jbc.M110.150060; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gupta R, 2013, NUCLEIC ACIDS RES, V41, P2284, DOI 10.1093/nar/gks1298; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; Huang SH, 2016, NUCLEIC ACIDS RES, V44, P5288, DOI 10.1093/nar/gkw344; Huang WM, 2012, J BIOL CHEM, V287, P25551, DOI 10.1074/jbc.M112.369488; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Karakousis G, 1998, J MOL BIOL, V276, P721, DOI 10.1006/jmbi.1997.1573; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0023-2014; LAPADATTAPOLSKY M, 1995, NUCLEIC ACIDS RES, V23, P2434, DOI 10.1093/nar/23.13.2434; Li Z, 1998, J MOL BIOL, V276, P733, DOI 10.1006/jmbi.1997.1572; Liu J, 2011, METHODS MOL BIOL, V745, P363, DOI 10.1007/978-1-61779-129-1_21; Lucyshyn D, 2015, NUCLEIC ACIDS RES, V43, P6062, DOI 10.1093/nar/gkv497; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Mardanov AV, 2009, J MOL BIOL, V391, P261, DOI 10.1016/j.jmb.2009.06.021; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; Ohki R, 2001, MOL CELL BIOL, V21, P5753, DOI 10.1128/MCB.21.17.5753-5766.2001; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shi K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001472; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Zabala B, 2009, J VIROL, V83, P9313, DOI 10.1128/JVI.00672-09	38	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246212	10.1371/journal.pone.0246212	http://dx.doi.org/10.1371/journal.pone.0246212			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539370	Green Published, gold			2022-12-26	WOS:000616960200071
J	Thang, NT; Pham, LT; Vu, DT; Tran, SH; Vu, LT; Bui, VN; Bui, AN; Hoang, TD; Vu, TT; Hung, NV; Magnusson, U; Lundkvist, A; Lindahl, J				Thang Nguyen-Tien; Long Thanh Pham; Duoc Trong Vu; Son Hai Tran; Lieu Thi Vu; Vuong Nghia Bui; Anh Ngoc Bui; Trung Duc Hoang; Thanh Thi Vu; Hung Nguyen-Viet; Magnusson, Ulf; Lundkvist, Ake; Lindahl, Johanna			Knowledge and practice on prevention of mosquito-borne diseases in livestock-keeping and non-livestock-keeping communities in Hanoi city, Vietnam: A mixed-method study	PLOS ONE			English	Article								Mosquito-borne diseases (MBDs) are causing high morbidity and mortality for humans. Urban livestock keeping is still common in cities around the world. The animals may serve as reservoirs for zoonotic MBDs, which increase the risks for humans. Here we assess the knowledge and practices related to MBDs in households with livestock and without livestock and explore the perceptions of the health care sector about MBDs and livestock keeping in Hanoi city of Vietnam in a cross-sectional study. A quantitative survey was conducted including 513 households with and without livestock-keeping in six districts and complemented with qualitative surveys with four health staff from Hanoi Center of Disease Control and three district health centers. The quantitative survey indicated that the participants possessed basic knowledge on MBDs with an average score of 18.3 out of 35, of which non-livestock-keeping households had a better knowledge than households keeping livestock (p<0.05). Both household categories had low score, 3.5 out of 11, regarding preventive practices against MBDs. The negative binomial model showed that occupation and location of living were factors associated to the knowledge on MBDs. Farmers were likely to have better preventive practices as compared to office workers (p<0.05). Those who had better knowledge also had more adequate preventive practices against MBDs (p<0.001). The qualitative survey revealed that livestock keeping was determined as increasing risks of MBDs due to the increase of mosquito population. It is recommended that community campaigns to raise the awareness and change behavior on MBDs should be organized based on collaboration between the health sector and the veterinary sector for households with and without livestock living in central urban and peri-urban areas. Further studies are needed to confirm the association between urban livestock keeping and potential increasing risks of MBDs such as dengue and Japanese encephalitis.	[Thang Nguyen-Tien; Long Thanh Pham; Lundkvist, Ake; Lindahl, Johanna] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Thang Nguyen-Tien; Long Thanh Pham; Hung Nguyen-Viet; Lindahl, Johanna] Int Livestock Res Inst, Hanoi, Vietnam; [Duoc Trong Vu; Son Hai Tran; Lieu Thi Vu] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Vuong Nghia Bui; Anh Ngoc Bui; Trung Duc Hoang; Thanh Thi Vu] Natl Inst Vet Res, Hanoi, Vietnam; [Hung Nguyen-Viet] Hanoi Univ Publ Hlth, Hanoi, Vietnam; [Magnusson, Ulf; Lindahl, Johanna] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	Uppsala University; National Institute of Hygiene & Epidemiology (NIHE); Hanoi University of Public Health; Swedish University of Agricultural Sciences	Thang, NT (corresponding author), Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.; Thang, NT (corresponding author), Int Livestock Res Inst, Hanoi, Vietnam.	Thang.T.Nguyen@cgiar.org	Nguyen-Viet, Hung/AHH-2981-2022; Pham, Long/GNP-6477-2022; Nguyen-Viet, Hung/F-6498-2012; Lindahl, Johanna/AFJ-4911-2022	Nguyen-Viet, Hung/0000-0003-1549-2733; Nguyen-Viet, Hung/0000-0001-9877-0596; PHAM, Long Thanh/0000-0001-7093-7032; Nguyen-Tien, Thang/0000-0003-3704-6363	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2016-00364]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	This study was a part of the "Metropolitan Mosquitoes Project" funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas, grant number 2016-00364) awarded to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghazali KAA, 2020, ONE HEAL; Alyousefi TAA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1895-2; Anand T, 2014, ANN MED HEALTH SCI R, V4, P227, DOI 10.4103/2141-9248.129048; [Anonymous], 2014, J CLIN DIAGN RES, V8; Boratne A V., 2010, J VECTOR BORNE DIS; Boratne AV, 2010, INDIAN J MED SPEC, V1, P91, DOI 10.7713/ijms.2010.0024; Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028; GSO, 2018, STAT DAT AGR FOR FIS; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Jakobsen F, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007774; Jayalath T, 2018, INT J MED RES HEAL S; Kumar K. R., 2006, Dengue Bulletin, V30, P270; Leslie TE, 2017, GLOBAL HEALTH ACTION, V10, DOI [10.1080/16549716.2017.1350394, 1]; Lindahl J, 2012, AM J TROP MED HYG, V87, P1076, DOI 10.4269/ajtmh.2012.12-0315; Lindahl JF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002153; Mayxay M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-434; Mejia R, 2016, OCCUP DIS ENV MED; Mulderij-Jansen V, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008136; Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1; Or Rashid MH, 2018, J INFECT DIS THER; PATEL AB, 2011, NATL J MED RES, V1, P45; Phuong HL, 2008, SE ASIAN J TROP MED; Sarmiento-Senior D, 2019, BIOMEDICA; Seyoum A, 2002, East Afr Med J, V79, P485; Shafie A, 2016, J AM MOSQUITO CONTR, V32, P273, DOI 10.2987/16-6604.1; Sulistyawati S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061013; Thang Nguyen-Tien, 2019, Infection Ecology & Epidemiology, V9, P1660129, DOI 10.1080/20008686.2019.1660129; Thang NT, 2019, AM J TROP MED HYG; Toan DTT, 2015, EPIDEMIOL INFECT, V143, P1594, DOI 10.1017/S0950268814002647; Toteva M, 2018, GUIDELINES METHODS E, P158; Van Nguyen H TT, 2019, INT J ENV RES PUBLIC; Virk A, 2016, J COMMUN DIS; WHO, 2009, WHO TECH REP SER, V958, P1; Wilder-Smith A, 2017, LANCET INFECT DIS, DOI [10.1016/S1473-3099(16)30518-728011234, DOI 10.1016/S1473-3099(16)30518-728011234]; Wu C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101227; Yadav S, 2017, INT J MED SCI PUBLIC	40	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246032	10.1371/journal.pone.0246032	http://dx.doi.org/10.1371/journal.pone.0246032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539377	Green Published, gold			2022-12-26	WOS:000616960200099
J	Theadom, A; Hardaker, N; Bray, C; Siegert, R; Henshall, K; Forch, K; Fernando, K; King, D; Fulcher, M; Jewell, S; Shaikh, N; Gottgtroy, RB; Hume, P				Theadom, Alice; Hardaker, Natalie; Bray, Charlotte; Siegert, Richard; Henshall, Kevin; Forch, Katherine; Fernando, Kris; King, Doug; Fulcher, Mark; Jewell, Sam; Shaikh, Nusratnaaz; Gottgtroy, Renata Bastos; Hume, Patria			The Brain Injury Screening Tool (BIST): Tool development, factor structure and validity	PLOS ONE			English	Article							CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; MILD	Currently health care pathways (the combination and order of services that a patient receives to manage their injury) following a mild traumatic brain injury vary considerably. Some clinicians lack confidence in injury recognition, management and knowing when to refer. A clinical expert group developed the Brain Injury Screening Tool (BIST) to provide guidance on health care pathways based on clinical indicators of poor recovery. The tool aims to facilitate access to specialist services (if required) to improve longer term prognosis. The tool was developed using a three-step process including: 1) domain mapping; 2) item development and 3) item testing and review. An online retrospective survey of 114 adults (>16 years) who had experienced a mild brain injury in the past 10 years was used to determine the initial psychometric properties of the 15-item symptom scale of the BIST. Participants were randomised to complete the BIST and one of two existing symptom scales; the Rivermead Post-concussion Symptom Questionnaire (RPQ) or the Sports Concussion Assessment Test (SCAT-5) symptom scale to determine concurrent validity. Participant responses to the BIST symptom scale items were used to determine scale reliability using Cronbach's alpha. A principal components analysis explored the underlying factor structure. Spearman's correlation coefficients determined concurrent validity with the RPQ and SCAT-5 symptom scales. The 15 items were found to require a reading age of 6-8 years old using readability statistics. High concurrent validity was shown against the RPQ (r = 0.91) and SCAT-5 (r = 0.90). The BIST total symptom scale (alpha = 0.94) and the three factors identified demonstrated excellent internal consistency: physical/emotional (alpha = 0.90), cognitive (alpha = 0.92) and vestibular-ocular (alpha = 0.80). This study provides evidence to support the utility, internal consistency, factor structure and concurrent validity of the BIST. Further research is warranted to determine the utility of the BIST scoring criteria and responsiveness to change in patients.	[Theadom, Alice; King, Doug; Shaikh, Nusratnaaz; Gottgtroy, Renata Bastos; Hume, Patria] Auckland Univ Technol, TBI Network, Auckland, New Zealand; [Theadom, Alice; Bray, Charlotte; Siegert, Richard; Forch, Katherine; Shaikh, Nusratnaaz] Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand; [Hardaker, Natalie] Accid Compensat Corp, Wellington, New Zealand; [Hardaker, Natalie; King, Doug; Gottgtroy, Renata Bastos; Hume, Patria] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Henshall, Kevin] Counties Manukau Dist Hlth Board, Trauma Serv, Auckland, New Zealand; [Forch, Katherine; Fulcher, Mark] Axis Sports Med, Auckland, New Zealand; [Fernando, Kris] Active, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Jewell, Sam] Wellington Sports Med, Wellington, New Zealand	Auckland University of Technology; Auckland University of Technology; Auckland University of Technology; University of New England	Theadom, A (corresponding author), Auckland Univ Technol, TBI Network, Auckland, New Zealand.; Theadom, A (corresponding author), Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand.	alice.theadom@aut.ac.nz	Shaikh, Nusratnaaz/ABE-2407-2021; Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Henshall, Kevin/0000-0003-2744-1546; Shaikh, Nusratnaaz/0000-0001-8157-226X; Theadom, Alice/0000-0003-0351-6216				Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Gravel J, 2020, EMERG MED J, V37, P338, DOI 10.1136/emermed-2019-209054; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Irving G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017902; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maxtone S, 2020, NZJP, V48, P70; McGeown JP, 2020, SPORTS MED, V50, P1191, DOI 10.1007/s40279-019-01240-4; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Medvedev ON, 2018, PEERJ, V6, DOI 10.7717/peerj.5676; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reid D, 2018, 4 ACC COMP CORP NZ; Robinson M., 2019, ELECT THESIS DISSERT; Seel RT, 2016, NEUROREHABILITATION, V39, P371, DOI 10.3233/NRE-161369; Sikkema JA, 2018, EXAMINATION PSYCHOME; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	29	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246512	10.1371/journal.pone.0246512	http://dx.doi.org/10.1371/journal.pone.0246512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539482	Green Published, gold			2022-12-26	WOS:000616960200029
J	Koskenvuo, JW; Saarinen, I; Ahonen, S; Tommiska, J; Weckstrom, S; Seppala, EH; Tuupanen, S; Kangas-Kontio, T; Schleit, J; Helio, K; Hathaway, J; Gummesson, A; Dahlberg, P; Ojala, TH; Vepsalainen, V; Kytola, V; Muona, M; Sistonen, J; Salmenpera, P; Gentile, M; Paananen, J; Myllykangas, S; Alastalo, TP; Helio, T				Koskenvuo, Juha W.; Saarinen, Inka; Ahonen, Saija; Tommiska, Johanna; Weckstrom, Sini; Seppala, Eija H.; Tuupanen, Sari; Kangas-Kontio, Tiia; Schleit, Jennifer; Helio, Krista; Hathaway, Julie; Gummesson, Anders; Dahlberg, Pia; Ojala, Tiina H.; Vepsalainen, Ville; Kytola, Ville; Muona, Mikko; Sistonen, Johanna; Salmenpera, Pertteli; Gentile, Massimiliano; Paananen, Jussi; Myllykangas, Samuel; Alastalo, Tero-Pekka; Helio, Tiina			Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy	PLOS ONE			English	Article							N-RAP; MUTATIONS; GENETICS; LOCALIZATION; LANDSCAPE; PROTEIN	Background Familial dilated cardiomyopathy (DCM) is typically a monogenic disorder with dominant inheritance. Although over 40 genes have been linked to DCM, more than half of the patients undergoing comprehensive genetic testing are left without molecular diagnosis. Recently, biallelic protein-truncating variants (PTVs) in the nebulin-related anchoring protein gene (NRAP) were identified in a few patients with sporadic DCM. Methods and results We determined the frequency of rare NRAP variants in a cohort of DCM patients and control patients to further evaluate role of this gene in cardiomyopathies. A retrospective analysis of our internal variant database consisting of 31,639 individuals who underwent genetic testing (either panel or direct exome sequencing) was performed. The DCM group included 577 patients with either a confirmed or suspected DCM diagnosis. A control cohort of 31,062 individuals, including 25,912 individuals with non-cardiac (control group) and 5,150 with non-DCM cardiac indications (Non-DCM cardiac group). Biallelic (n = 6) or two (n = 5) NRAP variants (two PTVs or PTV+missense) were identified in 11 unrelated probands with DCM (1.9%) but none of the controls. None of the 11 probands had an alternative molecular diagnosis. Family member testing supports co-segregation. Biallelic or potentially biallelic NRAP variants were enriched in DCM vs. controls (OR 1052, p<0.0001). Based on the frequency of NRAP PTVs in the gnomAD reference population, and predicting full penetrance, biallelic NRAP variants could explain 0.25%-2.46% of all DCM cases. Conclusion Loss-of-function in NRAP is a cause for autosomal recessive dilated cardiomyopathy, supporting its inclusion in comprehensive genetic testing.	[Koskenvuo, Juha W.; Saarinen, Inka; Ahonen, Saija; Tommiska, Johanna; Seppala, Eija H.; Tuupanen, Sari; Kangas-Kontio, Tiia; Schleit, Jennifer; Helio, Krista; Kytola, Ville; Muona, Mikko; Sistonen, Johanna; Salmenpera, Pertteli; Gentile, Massimiliano; Paananen, Jussi; Myllykangas, Samuel] Blueprint Genet Quest Diagnost Co, Espoo, Finland; [Weckstrom, Sini; Helio, Tiina] Univ Helsinki, Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Hathaway, Julie; Alastalo, Tero-Pekka] Blueprint Genet Inc Quest Diagnost Co, Seattle, WA USA; [Gummesson, Anders] Sahlgrens Univ Hosp, Dept Clin Genet & Genom, Gothenburg, Sweden; [Dahlberg, Pia] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Ojala, Tiina H.] Helsinki Univ Hosp, Dept Pediat Cardiol, Helsinki, Finland; [Ojala, Tiina H.] Univ Helsinki, Helsinki, Finland; [Vepsalainen, Ville] Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland	University of Helsinki; Helsinki University Central Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Kuopio University Hospital; University of Eastern Finland	Koskenvuo, JW (corresponding author), Blueprint Genet Quest Diagnost Co, Espoo, Finland.	juha.koskenvuo@blueprintgenetics.com		Helio, Krista/0000-0001-6244-1969; Paananen, Jussi/0000-0001-5100-4907; Gummesson, Anders/0000-0003-0024-960X	Finnish Foundation for Cardiovascular Research; Aarne Koskelo Foundation; Special Governmental Subsidy (EVO) grants	Finnish Foundation for Cardiovascular Research; Aarne Koskelo Foundation; Special Governmental Subsidy (EVO) grants	This work was supported by grants from the Finnish Foundation for Cardiovascular Research (TH), Aarne Koskelo Foundation (TH), Special Governmental Subsidy (EVO) grants (TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2018, JBCGENETICS, V1; Akinrinade O, 2015, EUR HEART J, V36, P2327, DOI 10.1093/eurheartj/ehv253; Almomani R, 2016, J AM COLL CARDIOL, V67, P515, DOI 10.1016/j.jacc.2015.10.093; Cahill TJ, 2013, CIRC RES, V113, P660, DOI 10.1161/CIRCRESAHA.113.300282; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Ehler E, 2001, J CELL BIOL, V153, P763, DOI 10.1083/jcb.153.4.763; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Garcia-Pavia P, 2011, HEART, V97, P1744, DOI 10.1136/hrt.2011.227967; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Hasselberg NE, 2018, EUR HEART J, V39, P853, DOI 10.1093/eurheartj/ehx596; Henderson CA, 2017, COMPR PHYSIOL, V7, P891, DOI 10.1002/cphy.c160033; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Iuso A, 2018, AM J HUM GENET, V102, P1018, DOI 10.1016/j.ajhg.2018.03.022; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Lu SJ, 2003, J CELL SCI, V116, P2169, DOI 10.1242/jcs.00425; Luo G, 1999, BIOCHEMISTRY-US, V38, P6135, DOI 10.1021/bi982395t; Martin AR, 2019, NAT GENET, V51, P1560, DOI 10.1038/s41588-019-0528-2; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 2013, DISCOV MED, V15, P43; Monies D, 2017, HUM GENET, V136, P921, DOI 10.1007/s00439-017-1821-8; Muhammad E, 2015, HUM MOL GENET, V24, P7227, DOI 10.1093/hmg/ddv423; Ollila L, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000474; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Qadri S, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0442-3; Theis JL, 2011, CIRC-CARDIOVASC GENE, V4, P585, DOI 10.1161/CIRCGENETICS.111.961052; Truszkowska GT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03189-8; Vasilescu C, 2018, J AM COLL CARDIOL, V72, P2324, DOI 10.1016/j.jacc.2018.08.2171; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Zhang RQ, 2001, BIOCHEMISTRY-US, V40, P14898, DOI 10.1021/bi0107445	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245681	10.1371/journal.pone.0245681	http://dx.doi.org/10.1371/journal.pone.0245681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534821	Green Published, gold			2022-12-26	WOS:000616739700008
J	Krasowski, DT; Wadzuk, B; Jacko, B				Krasowski, Devin Thomas; Wadzuk, Bridget; Jacko, Brian			Feasibility of using an energy balance to measure evapotranspiration in green stormwater infrastructure	PLOS ONE			English	Article							WATER; IMAGERY; STRESS	Effective green stormwater infrastructure (GSI) design requires comprehensive quantification of the volume of water that can be treated or removed over a given time period. It is recognized that evapotranspiration (ET) can be a substantial pathway for stormwater volume reduction in bioretention systems. However, measuring ET is often difficult and expensive, such as with lysimeters or a mass balance approach. This research focused on a new technique for quantifying ET in bioretention systems by exploring an approach using thermal imaging to calculate ET by measuring the flux of energy at the canopy surface. This thermal imaging approach was compared to ET measurements given by a traditional mass balance approach. The experimental setup had three benchtop scale vegetated lysimeters planted with Switchgrass. Time lapse thermal images of the Switchgrass plants were taken at 10 second intervals and paired with meteorological data. The data were used in an energy balance to estimate the mass of water lost from the lysimeter plant/soil system. That mass was compared to the change in weight measured by weighing the lysimeter before and after the data collection period. For comparison, reference ET was also calculated for the vegetated systems using three common reference ET equations. The uncalibrated energy balance equation developed here estimated an averaged ET over 12 data collection days within 1 mm of the mass balance measured ET. These findings demonstrate the feasibility of using a thermal image energy balance technique to estimate ET.	[Krasowski, Devin Thomas; Wadzuk, Bridget; Jacko, Brian] Villanova Univ, Villanova Ctr Resilient Water Syst, Dept Civil & Environm Engn, Villanova, PA 19085 USA	Villanova University	Krasowski, DT (corresponding author), Villanova Univ, Villanova Ctr Resilient Water Syst, Dept Civil & Environm Engn, Villanova, PA 19085 USA.	devink1331@gmail.com			Villanova University Department of Civil and Environmental Engineering	Villanova University Department of Civil and Environmental Engineering	This work was funded by a grant applied for by and awarded to Dr. Bridget Wadzuk (BW). This internal grant from the Villanova University Department of Civil and Environmental Engineering (https://www1.villanova.edu/university/engineering/academic-programs/departments/civil-environmental.html) was awarded to fund tuition and provide a stipend for one Master's student (DTK) to carry out the research and to provide compensation to undergraduate research assistants (BJ).	A&D Company, 2006, GP SER INSTR MAN; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Anderson MC, 2012, REMOTE SENS ENVIRON, V122, P50, DOI 10.1016/j.rse.2011.08.025; Brenner C, 2018, INT J REMOTE SENS, V39, P5141, DOI 10.1080/01431161.2018.1471550; Campbell Scientific, 2001, HMP50 TEMP REL HUM P; Chirouze J, 2014, HYDROL EARTH SYST SC, V18, P1165, DOI 10.5194/hess-18-1165-2014; Decagon Devices, 2016, LEAF POR OP MAN; DelVecchio T, 2020, J SUSTAIN WATER BUIL, V6, DOI 10.1061/JSWBAY.0000894; DiGiovanni K, 2013, J HYDROL ENG, V18, P99, DOI 10.1061/(ASCE)HE.1943-5584.0000572; Ebrahimian A, 2019, SCI TOTAL ENVIRON, V688, P797, DOI 10.1016/j.scitotenv.2019.06.256; Feng YC, 2016, J HYDROL, V542, P744, DOI 10.1016/j.jhydrol.2016.09.044; FLIR, 2010, US MAN FLIR EXX SER, P206; HENDERSONSELLERS B, 1984, Q J ROY METEOR SOC, V110, P1186, DOI 10.1002/qj.49711046626; Hikosaka K., 2016, ADV PHOTOSYNTHESIS R, P171, DOI [10.1007/978-94-017-7291-4_6, DOI 10.1007/978-94-017-7291-4_6]; Huskeflux, 2017, NR01 RA01 NET RAD US; Idso SB, 1977, J ENVIRON QUAL, DOI [10.2134/jeq1977.00472425000600040036x, DOI 10.2134/JEQ1977.00472425000600040036X]; Jennings AA, 2015, J ENVIRON ENG, V141, DOI 10.1061/(ASCE)EE.1943-7870.0000967; Jensen M.E., 2016, EVAPORATION EVAPOTRA; Maes WH, 2012, J EXP BOT, V63, P4671, DOI 10.1093/jxb/ers165; Mathworks, 2019, MATLAB R2018A; Miller JN, 2016, GCB BIOENERGY, V8, P818, DOI 10.1111/gcbb.12291; Ng AWY, 2017, J CONSTR ENG M, V143, DOI 10.1061/(ASCE)CO.1943-7862.0001221; Page GFM, 2018, AGR FOREST METEOROL, V256, P304, DOI 10.1016/j.agrformet.2018.02.023; Sanford WE, 2013, J AM WATER RESOUR AS, V49, P217, DOI 10.1111/jawr.12010; Triana F, 2015, GCB BIOENERGY, V7, P811, DOI 10.1111/gcbb.12172; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Voyde E, 2010, J HYDROL ENG, V15, P395, DOI 10.1061/(ASCE)HE.1943-5584.0000141; Wadzuk BM, 2013, J IRRIG DRAIN E, V139, P995, DOI 10.1061/(ASCE)IR.1943-4774.0000643; Walter I. A., 2000, WATERSHED MANAGEMENT, DOI 10.1061/40499(2000)126; Watson W., 2011, CLIN IMMUNOL S1, V7, pS7; Zhu Y, 2019, PROC SPIE, V11008, DOI 10.1117/12.2519216	31	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246286	10.1371/journal.pone.0246286	http://dx.doi.org/10.1371/journal.pone.0246286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534861	Green Published, gold			2022-12-26	WOS:000616739700060
J	Kang, TZE; Zhu, LN; Yang, D; Ding, DB; Zhu, XX; Wan, YCE; Liu, JX; Ramakrishnan, S; Chan, LL; Chan, SY; Wang, X; Gan, HY; Han, JH; Ishibashi, T; Li, Q; Chan, KM				Kang, Tze Zhen Evangeline; Zhu, Lina; Yang, Du; Ding, Dongbo; Zhu, Xiaoxuan; Wan, Yi Ching Esther; Liu, Jiaxian; Ramakrishnan, Saravanan; Chan, Landon Long; Chan, Siu Yuen; Wang, Xin; Gan, Haiyun; Han, Junhong; Ishibashi, Toyotaka; Li, Qing; Chan, Kui Ming			The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R/BIOCONDUCTOR PACKAGE; DRIVER MUTATIONS; READ ALIGNMENT; GENES; CHROMATIN; METHYLATION; REPROGRAMS; PROTEINS; TUMOR; H2B	The recent discovery of the cancer-associated E76K mutation in histone H2B (H2BE76-to-K) in several types of cancers revealed a new class of oncohistone. H2BE76K weakens the stability of histone octamers, alters gene expression, and promotes colony formation. However, the mechanism linking the H2BE76K mutation to cancer development remains largely unknown. In this study, we knock in the H2BE76K mutation in MDA-MB-231 breast cancer cells using CRISPR/Cas9 and show that the E76K mutant histone H2B preferentially localizes to genic regions. Interestingly, genes upregulated in the H2BE76K mutant cells are enriched for the E76K mutant H2B and are involved in cell adhesion and proliferation pathways. We focused on one H2BE76K target gene, ADAM19 (a disintegrin and metalloproteinase-domain-containing protein 19), a gene highly expressed in various human cancers including breast invasive carcinoma, and demonstrate that H2BE76K directly promotes ADAM19 transcription by facilitating efficient transcription along the gene body. ADAM19 depletion reduced the colony formation ability of the H2BE76K mutant cells, whereas wild-type MDA-MB-231 cells overexpressing ADAM19 mimics the colony formation phenotype of the H2BE76K mutant cells. Collectively, our data demonstrate the mechanism by which H2BE76K deregulates the expression of genes that control oncogenic properties through a combined effect of its specific genomic localization and nucleosome destabilization effect.	[Kang, Tze Zhen Evangeline; Zhu, Lina; Zhu, Xiaoxuan; Wan, Yi Ching Esther; Liu, Jiaxian; Ramakrishnan, Saravanan; Wang, Xin; Chan, Kui Ming] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Kang, Tze Zhen Evangeline; Zhu, Lina; Zhu, Xiaoxuan; Wan, Yi Ching Esther; Liu, Jiaxian; Ramakrishnan, Saravanan; Wang, Xin; Chan, Kui Ming] City Univ Hong Kong, Key Lab Biochip Technol, Biotech & Hlth Ctr, Shenzhen Res Inst, Shenzhen, Peoples R China; [Yang, Du; Li, Qing] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing, Peoples R China; [Yang, Du; Li, Qing] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Ding, Dongbo; Ishibashi, Toyotaka] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Chan, Landon Long] Princess Margaret Hosp, Dept Oncol, Hong Kong, Peoples R China; [Chan, Siu Yuen] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China; [Gan, Haiyun] Chinese Acad Sci, Guangdong Prov Key Lab Synthet Genom, CAS Key Lab Quantitat Engn Biol, Shenzhen Inst Synthet Biol,Shenzhen Inst Adv Tech, Shenzhen, Peoples R China; [Gan, Haiyun] Chinese Acad Sci, Shenzhen Key Lab Synthet Genom, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Han, Junhong] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, West China Med Sch, Chengdu, Sichuan, Peoples R China; [Han, Junhong] Sichuan Univ, Canc Ctr, West China Hosp, West China Med Sch, Chengdu, Sichuan, Peoples R China	City University of Hong Kong; City University of Hong Kong; Peking University; Peking University; Hong Kong University of Science & Technology; University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Sichuan University; Sichuan University	Chan, KM (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China.; Chan, KM (corresponding author), City Univ Hong Kong, Key Lab Biochip Technol, Biotech & Hlth Ctr, Shenzhen Res Inst, Shenzhen, Peoples R China.	Ming.chan@cityu.edu.hk		ZHU, Xiaoxuan/0000-0002-1664-8034; WAN, Yi Ching Esther/0000-0002-5916-3336; ZHU, Lina/0000-0002-8558-2120	Research Grants Council Hong Kong [17101814, 21100615, 11102118, 11101919, 11102317, C7007-17GF]; Shenzhen Science and Technology Fund Program [JCYJ20170818104203065, JCYJ20180307124019360, JCYJ20170307091256048]; National Natural Science Foundation of China [81802384]; Hong Kong Epigenomics Project of the EpiHK	Research Grants Council Hong Kong(Hong Kong Research Grants Council); Shenzhen Science and Technology Fund Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Epigenomics Project of the EpiHK	This work was supported by grants from Research Grants Council Hong Kong [Project No. 17101814, 21100615, 11102118, 11101919 (K. M. C.), 11102317 (X. W.), and C7007-17GF (K. M. C.], the Shenzhen Science and Technology Fund Program Project No. JCYJ20170818104203065, JCYJ20180307124019360 (K. M. C.), JCYJ20170307091256048 (X. W.), and National Natural Science Foundation of China [Project No. 81802384 (X. W.)]. This work was also supported by the Hong Kong Epigenomics Project of the EpiHK (K. M. C.).	Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; Aktary Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078388; Arimura Y, 2018, NUCLEIC ACIDS RES, V46, P10007, DOI 10.1093/nar/gky661; Audia JE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019521; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bennett RL, 2019, CANCER DISCOV, V9, P1438, DOI 10.1158/2159-8290.CD-19-0393; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; De P, 2016, ONCOTARGET, V7, P43124, DOI 10.18632/oncotarget.8988; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Gao F., 2017, ISMB ECCB 2017; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Holen I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3201; Huang H, 2014, CELL, V159, P458, DOI 10.1016/j.cell.2014.09.037; Huang P, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0304-4; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meers MP, 2019, ELIFE, V8, DOI 10.7554/eLife.46314; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Nacev BA, 2019, NATURE, V567, P473, DOI 10.1038/s41586-019-1038-1; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Wan YCE, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0131-0; Wan Yi Ching Esther, 2018, Curr Pharmacol Rep, V4, P292, DOI 10.1007/s40495-018-0141-6; Wang Y., 2018, ONCOIMMUNOLOGY, V7, P1; Witwicki RM, 2018, CELL REP, V25, P1255, DOI 10.1016/j.celrep.2018.10.023; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	53	4	4	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100374	10.1016/j.jbc.2021.100374	http://dx.doi.org/10.1016/j.jbc.2021.100374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548228	gold, Green Published			2022-12-26	WOS:000672866400348
J	Kim, W; Watanabe, H; Lomoio, S; Tesco, G				Kim, WonHee; Watanabe, Hiroto; Lomoio, Selene; Tesco, Giuseppina			Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; POLYSIALIC ACID SYNTHESIS; LONG-TERM POTENTIATION; GATED SODIUM-CHANNELS; CLEAVING ENZYME BACE1; MICE DEFICIENT; CLOSE HOMOLOG; MOSSY FIBER; PSA-NCAM	Neural cell adhesion molecules 1 (NCAM1) and 2 (NCAM2) belong to the cell adhesion molecules of the immunoglobulin superfamily and have been shown to regulate formation, maturation, and maintenance of synapses. NCAM1 and NCAM2 undergo proteolysis, but the identity of all the proteases involved and how proteolysis is used to regulate their functions are not known. We report here that NCAM1 and NCAM2 are BACE1 substrates in vivo. NCAM1 and NCAM2 overexpressed in HEK cells were both cleaved by metalloproteinases or BACE1, and NCAM2 was also processed by gamma-secretase. We identified the BACE1 cleavage site of NCAM1 (at Glu 671) and NCAM2 (at Glu 663) using mass spectrometry and site-directed mutagenesis. Next, we assessed BACE1-mediated processing of NCAM1 and NCAM2 in the mouse brain during aging. NCAM1 and NCAM2 were cleaved in the olfactory bulb of BACE1+/+ but not BACE1-/- mice at postnatal day 10 (P10), 4 and 12 months of age. In the hippocampus, a BACE1-specific soluble fragment of NCAM1 (sNCAM1 beta) was only detected at P10. However, we observed an accumulation of full-length NCAM1 in hippocampal synaptosomes in 4-mont-hold BACE1-/- mice. We also found that polysialylated NCAM1 (PSA-NCAM1) levels were increased in BACE1-/- mice at P10 and demonstrated that BACE1 cleaves both NCAM1 and PSA-NCAM1 in vitro. In contrast, we did not find evidence for BACE1-dependent NCAM2 processing in the hippocampus at any age analyzed. In summary, our data demonstrate that BACE1 differentially processes NCAM1 and NCAM2 depending on the region of brain, subcellular localization, and age in vivo.	[Kim, WonHee; Watanabe, Hiroto; Lomoio, Selene; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu		Kim, WonHee/0000-0001-5530-7606	BrightFocus Foundation [A201902F]; National Institutes of Health and Alzheimer's Disease Research fellowship [R01NS092497]	BrightFocus Foundation(BrightFocus Foundation); National Institutes of Health and Alzheimer's Disease Research fellowship	This work was supported by Award Number R01NS092497 (to G. T.) from National Institutes of Health and Alzheimer's Disease Research fellowship (A201902F) from BrightFocus Foundation (to W. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisa B, 2010, J ALZHEIMERS DIS, V20, P659, DOI 10.3233/JAD-2010-1398; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brennaman LH, 2014, J NEUROCHEM, V128, P267, DOI 10.1111/jnc.12468; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Coppieters N, 2019, BRAIN RES, V1710, P199, DOI 10.1016/j.brainres.2018.12.035; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dislich B, 2015, MOL CELL PROTEOMICS, V14, P2550, DOI 10.1074/mcp.M114.041533; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Egan MF, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0520-1; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans Gareth J O, 2015, Cold Spring Harb Protoc, V2015, P462, DOI 10.1101/pdb.prot083469; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; He WX, 2014, J BIOL CHEM, V289, P20630, DOI 10.1074/jbc.M114.579862; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Henley D, 2019, NEW ENGL J MED, V380, P1483, DOI 10.1056/NEJMc1813435; Heyden A, 2008, NEUROSCIENCE, V155, P221, DOI 10.1016/j.neuroscience.2008.04.080; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hu XY, 2018, J EXP MED, V215, P927, DOI 10.1084/jem.20171831; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim W, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0239-7; Kimura A, 2016, J BIOL CHEM, V291, P24041, DOI 10.1074/jbc.M116.744722; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kitazume S, 2006, GLYCOCONJUGATE J, V23, P437, DOI 10.1007/s10719-006-6671-x; Krebs J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00106, 10.3389/fnins.2011.00107]; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Leshchyns'ka I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9836; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Lombardo S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56329-7; Lundgren JL, 2015, J NEUROCHEM, V135, P606, DOI 10.1111/jnc.13287; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Pollock N, 2018, MICROBES INFECT, V20, P228, DOI 10.1016/j.micinf.2017.12.011; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rasmussen KK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27089-7; Njavro JR, 2020, FASEB J, V34, P2465, DOI 10.1096/fj.201902347R; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Schauenburg L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19530-8; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Seki T, 1998, J NEUROSCI, V18, P3757; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Shen HM, 1999, ANAT RECORD, V256, P448, DOI 10.1002/(SICI)1097-0185(19991201)256:4<448::AID-AR11>3.0.CO;2-8; Shetty A, 2013, J NEUROSCI, V33, P16828, DOI 10.1523/JNEUROSCI.2192-13.2013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Tenreiro P, 2017, ANAL BIOCHEM, V517, P1, DOI 10.1016/j.ab.2016.10.015; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wennstrom M, 2012, DEGENER NEUROL NEURO, V2, P65, DOI 10.2147/DNND.S19829; Wessels AM, 2020, ALZHEIMERS DEMENT, V16, P1483, DOI 10.1002/alz.12164; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yan XX, 2012, EXP NEUROL, V235, P228, DOI 10.1016/j.expneurol.2012.01.003; YANG PF, 1994, J BIOL CHEM, V269, P23039; Yoo SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.349; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465; Zhu KC, 2018, BIOL PSYCHIAT, V83, P428, DOI 10.1016/j.biopsych.2016.12.023	112	8	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100372	10.1016/j.jbc.2021.100372	http://dx.doi.org/10.1016/j.jbc.2021.100372			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548223	gold, Green Published			2022-12-26	WOS:000672866400346
J	Harasymowicz, NS; Rashidi, N; Savadipour, A; Wu, CL; Tang, RH; Bramley, J; Buchser, W; Guilak, F				Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Bramley, John; Buchser, William; Guilak, Farshid			Single-cell RNA sequencing reveals the induction of novel myeloid and myeloid-associated cell populations in visceral fat with long-term obesity	FASEB JOURNAL			English	Article						adipokine; canonical correlation analysis; collagen; fibrotic; metabolic syndrome; scRNA&#8208; seq	HYALURONAN RECEPTOR LYVE-1; ADIPOSE-TISSUE MACROPHAGES; DIET-INDUCED OBESITY; BONE-MARROW; PROGENITOR CELLS; DENDRITIC CELLS; IN-VIVO; FIBROCYTES; EXPRESSION; MICE	Macrophages and other immune cells are important contributors to obesity-associated inflammation; however, the cellular identities of these specific populations remain unknown. In this study, we identified individual populations of myeloid cells found in mouse epididymal/visceral adipose tissue by single-cell RNA sequencing, immunofluorescence, and flow cytometry. Multiple canonical correlation analysis identified 11 unique myeloid and myeloid-associate cell populations. In obese mice, we detected an increased percentage of monocyte-derived pro-inflammatory cells expressing Cd9 and Trem2, as well as significantly decreased percentages of multiple cell populations, including tissue-resident cells expressing Lyve1, Mafb, and Mrc1. We have identified and validated a novel myeloid/macrophage population defined by Ly6a expression, exhibiting both myeloid and mesenchymal characteristics, which increased with obesity and showed high pro-fibrotic characteristics in vitro. Our mouse adipose tissue myeloid cell atlas provides an important resource to investigate obesity-associated inflammation and fibrosis.	[Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA; [Harasymowicz, Natalia S.; Rashidi, Neda; Savadipour, Alireza; Wu, Chia-Lung; Tang, Ruhang; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA; [Rashidi, Neda; Savadipour, Alireza; Guilak, Farshid] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA; [Bramley, John; Buchser, William] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Guilak, F (corresponding author), Ctr Regenerat Med, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA.	guilak@wustl.edu		Buchser, William/0000-0002-6675-6359	HHS \ National Institutes of Health (NIH) [AG15768, AG46927]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: AG15768; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: AG46927	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caslin HL, 2020, IMMUNOL REV, V295, P101, DOI 10.1111/imr.12853; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Cousin B, 2003, BIOCHEM BIOPH RES CO, V301, P1016, DOI 10.1016/S0006-291X(03)00061-5; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Eto H, 2013, STEM CELLS DEV, V22, P985, DOI 10.1089/scd.2012.0442; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Griffin TM, 2008, BIORHEOLOGY, V45, P387, DOI 10.3233/BIR-2008-0485; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923; Harasymowicz NS, 2020, ARTHRITIS RHEUMATOL, V72, P632, DOI 10.1002/art.41147; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Huang ZF, 2008, SCANNING, V30, P452, DOI 10.1002/sca.20130; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; LaRue AC, 2006, EXP HEMATOL, V34, P208, DOI 10.1016/j.exphem.2005.10.009; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.06.008, 10.1016/j.immuni.2018.12.009]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; McDonald LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180724; Minchenko D., 2013, CELLBIO, V02, P45, DOI [10.4236/cellbio.2013.22006, DOI 10.4236/CELLBIO.2013.22006]; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mraz M, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/5481725; Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Poczobutt JM, 2016, J IMMUNOL, V196, P2847, DOI 10.4049/jimmunol.1502364; Psaltis PJ, 2012, CIRCULATION, V125, P592, DOI 10.1161/CIRCULATIONAHA.111.059360; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Sharma M., 2019, IMMUNOMETABOLISM, V1; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sidles SJ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1648614; Silva HM, 2019, J EXP MED, V216, P786, DOI 10.1084/jem.20181049; Singer G, 2007, MICROCIRCULATION, V14, P375, DOI 10.1080/10739680701283158; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Stock AT, 2019, J IMMUNOL, V202, P3282, DOI 10.4049/jimmunol.1900071; Tang-Huau TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04985-0; Tokunaga M, 2014, MATRIX BIOL, V36, P28, DOI 10.1016/j.matbio.2014.03.005; Toledo-Flores D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43765-8; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Weinstock Ada, 2019, Immunometabolism, V1, DOI 10.20900/immunometab20190008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CL, 2013, INT J OBESITY, V37, P1079, DOI 10.1038/ijo.2012.171; Xia Y, 2019, AUTOPHAGY, V15, P960, DOI 10.1080/15548627.2019.1569916; Xu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04726-3	66	11	11	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21417	10.1096/fj.202001970R	http://dx.doi.org/10.1096/fj.202001970R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566380	Bronze, Green Accepted			2022-12-26	WOS:000629576700017
J	Gershuny, J; Sullivan, O; Sevilla, A; Vega-Rapun, M; Foliano, F; de Grignon, JL; Harms, T; Walthery, P				Gershuny, Jonathan; Sullivan, Oriel; Sevilla, Almudena; Vega-Rapun, Marga; Foliano, Francesca; de Grignon, Juana Lamote; Harms, Teresa; Walthery, Pierre			A new perspective from time use research on the effects of social restrictions on COVID-19 behavioral infection risk	PLOS ONE			English	Article								We present findings from three waves of a population-representative, UK time-use diary survey conducted both pre- and in real time during full 'lockdown', and again following the easing of social restrictions. We used an innovative online diary instrument that has proved both reliable and quick-to-field. Combining diary information on activity, location, and co-presence to estimate infection risks associated with daily behavior, we show clear changes in risk-associated behavior between the pre, full-lockdown and post full-lockdown periods. We document a shift from more to less risky daily behavior patterns (combinations of activity/location/co-presence categories) between the pre-pandemic pattern and full lockdown in May/June 2020, followed by a reversion (although not a complete reversal) of those patterns in August 2020 following the end of the first lockdown. Because, in general, a populations' time use changes relatively slowly, the behavioral changes revealed may be interpreted as a consequence of the UK COVID-19 lockdown social restrictions and their subsequent relaxation.	[Gershuny, Jonathan; Sullivan, Oriel; Sevilla, Almudena; Vega-Rapun, Marga; Foliano, Francesca; de Grignon, Juana Lamote; Harms, Teresa; Walthery, Pierre] UCL, Ctr Time Use Res, Social Res Inst, London, England	University of London; University College London	Sullivan, O (corresponding author), UCL, Ctr Time Use Res, Social Res Inst, London, England.	o.sullivan@ucl.ac.uk		Sullivan, Oriel/0000-0002-0995-5888; Walthery, Pierre/0000-0001-7297-1795	UK Economic and Social Research Council (ESRC); ESRC [ES/S010149/1]	UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research is supported by the UK Economic and Social Research Council (ESRC). JG, PI of ESRC grant ES/S010149/1 'New Frontiers in Time Use Research' https://eur01.safelinks. protection.outlook.com/?url=https%3A%2F% 2Fesrc.ukri.org%2F&data=04%7C01%7C% 7C0bbe2756e20e4a0e0dfa08d8b1a2dc6d% 7C1faf88fea9984c5b93c9210a11d9a5c2%7C0% 7C0%7C637454660496329238%7CUnknown% 7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQI joiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D %7C1000&sdata=B%2B4cFC0t2MD2Mp3JAtN Gku5OkwtFyQjzCIyhMgp98nU%3D&reserved=0 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R. B, 2020, COVID EC        0511; ANDERSON R M, 1991; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 1962, MULTINATIONAL TIME U; Cornwell B, 2019, ANNU REV SOCIOL, V45, P301, DOI 10.1146/annurev-soc-073018-022416; De Cao E, 2014, BIOSTATISTICS, V15, P470, DOI 10.1093/biostatistics/kxu008; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Gershuny J., 2019, WHAT WE REALLY ALL D; Gershuny J, 2020, SOCIOL METHODOL, V50, P318, DOI 10.1177/0081175019884591; Hethcote HW, MODELS INFECT HUMAN; Hoang T, 2019, EPIDEMIOLOGY, V30, P723, DOI 10.1097/EDE.0000000000001047; Gimenez-Nadal JI, 2012, EUR ECON REV, V56, P1338, DOI 10.1016/j.euroecorev.2012.02.011; Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8; Klepac P, 2018, EPIDEMICS-NETH, V24, P49, DOI 10.1016/j.epidem.2018.03.003; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Price GN, EFFECT SOCIAL DISTAN, DOI [10.13140/RG.2.2.30632.32007, DOI 10.13140/RG.2.2.30632.32007]; Ramey VA, 2009, AM ECON J-MACROECON, V1, P189, DOI 10.1257/mac.1.2.189; Silverwood R.K.S., 2020, COVID 19 SURVEY 5 NA; Sullivan O, 2020, J TIME USE RES, DOI [10.32797/jtur-2020-1, DOI 10.32797/JTUR-2020-1]; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	22	13	13	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245551	10.1371/journal.pone.0245551	http://dx.doi.org/10.1371/journal.pone.0245551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566858	Green Published, gold			2022-12-26	WOS:000618271700053
J	Grunwald, ATD; Roy, S; Alves-Pinto, A; Lampe, R				Gruenwald, Alexander T. D.; Roy, Susmita; Alves-Pinto, Ana; Lampe, Renee			Assessment of adolescent idiopathic scoliosis from body scanner image by finite element simulations	PLOS ONE			English	Article								Adolescent idiopathic scoliosis, is a three-dimensional spinal deformity characterized by lateral curvature and axial rotation around the vertical body axis of the spine, the cause of which is yet unknown. The fast progression entails regular clinical monitoring, including X-rays. Here we present an approach to evaluate scoliosis from the three-dimensional image of a patient's torso, captured by an ionizing radiation free body scanner, in combination with a model of the ribcage and spine. A skeletal structure of the ribcage and vertebral column was modelled with computer aided designed software and was used as an initial structure for macroscopic finite element method simulations. The basic vertebral column model was created for an adult female in an upright position. The model was then used to simulate the patient specific scoliotic spine configurations. The simulations showed that a lateral translation of a vertebral body results in an effective axial rotation and could reproduce the spinal curvatures. The combined method of three-dimensional body scan and finite element model simulations thus provide quantitative anatomical information about the position, rotation and inclination of the thoracic and lumbar vertebrae within a three-dimensional torso. Furthermore, the simulations showed unequal distributions of stress and strain profiles across the intervertebral discs, due to their distortions, which might help to further understand the pathogenesis of scoliosis.	[Gruenwald, Alexander T. D.; Roy, Susmita; Alves-Pinto, Ana; Lampe, Renee] Tech Univ Munich, Sch Med, Orthopaed Dept, Klinikum Rechts Isar, Munich, Germany; [Lampe, Renee] Tech Univ Munich, Markus Wurth Professorship, Munich, Germany	Technical University of Munich; Technical University of Munich	Lampe, R (corresponding author), Tech Univ Munich, Sch Med, Orthopaed Dept, Klinikum Rechts Isar, Munich, Germany.; Lampe, R (corresponding author), Tech Univ Munich, Markus Wurth Professorship, Munich, Germany.	Renee.Lampe@tum.de			Wurth Foundation; Klaus Tschira Foundation [00.333.2017]; Buhl-Strohmaier Foundation	Wurth Foundation; Klaus Tschira Foundation; Buhl-Strohmaier Foundation	This study was supported in the form of funding by Wurth Foundation awarded to ATDG and RL, funding from Klaus Tschira Foundation (Grant No. 00.333.2017) awarded to SR and RL, and funding from Buhl-Strohmaier Foundation awarded to AAP and RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew AM, 2015, J MECH BEHAV BIOMED, V41, P302, DOI 10.1016/j.jmbbm.2014.09.002; Agnew AM, 2013, ANN BIOMED ENG, V41, P2501, DOI 10.1007/s10439-013-0875-6; Berryman F, 2008, EUR SPINE J, V17, P663, DOI 10.1007/s00586-007-0581-x; Bibby Susan R S, 2002, Stud Health Technol Inform, V91, P419; Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9; Cobb RJ, 1948, AM ACAD ORTHOP SURG, V5, P261; de Seze M., 2012, Annals of Physical and Rehabilitation Medicine, V55, P128, DOI 10.1016/j.rehab.2012.01.003; Deng YC, 1999, SAE TRANSACTIONS, V108, P1193; Dietrich M, 1991, Proc Inst Mech Eng H, V205, P19, DOI 10.1243/PIME_PROC_1991_205_257_02; Drerup B, 2014, SCOLIOSIS SPINAL DIS, V9, DOI 10.1186/s13013-014-0022-7; Drevelle X, 2008, STUD HEALTH TECHNOL, V140, P85, DOI 10.3233/978-1-58603-888-5-85; Fagan MJ, 2002, P I MECH ENG H, V216, P281, DOI 10.1243/09544110260216568; Fleming A, 2001, J ANAT, V199, P177, DOI 10.1017/S0021878201008044; Forman JL, 2011, J BIOMECH, V44, P910, DOI 10.1016/j.jbiomech.2010.11.034; Gardner A, 2017, SCOLIOSIS SPINAL DIS, V12, DOI 10.1186/s13013-017-0140-0; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; GROSSMAN TW, 1995, J PEDIATR ORTHOPED, V15, P535, DOI 10.1097/01241398-199507000-00025; Guo X, 2005, EUR SPINE J, V14, P862, DOI 10.1007/s00586-005-1002-7; Gwinner J, 1988, ACTA APPL MATH, V11, P191, DOI [10.1007/BF00047287, DOI 10.1007/BF00047287]; Haverfield ZA, 2019, QUANTIFYING VARIATIO; Hefti F, 2013, J CHILD ORTHOP, V7, P17, DOI 10.1007/s11832-012-0460-9; Holcombe SA, 2017, J ANAT, V231, P229, DOI 10.1111/joa.12632; Holcombe SA, 2016, J BIOMECH, V49, P2995, DOI 10.1016/j.jbiomech.2016.07.021; Kikanloo SR, 2019, ASIAN SPINE J, V13, P519, DOI 10.31616/asj.2018.0096; Lafage V, 2004, Comput Aided Surg, V9, P17, DOI 10.3109/10929080400006390; Lan C-C, 2013, CHANGHUA J MED, V11, P26; Lavecchia CE, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0829; Law M, 2016, EUR J RADIOL, V85, P625, DOI 10.1016/j.ejrad.2015.12.032; LEE M, 1995, J BIOMECH, V28, P1403, DOI 10.1016/0021-9290(95)00001-X; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Liebsch C, 2019, J BIOMECH, V94, P147, DOI 10.1016/j.jbiomech.2019.07.041; Lu YM, 1996, SPINE, V21, P2570, DOI 10.1097/00007632-199611150-00006; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; Meir A, 2008, P I MECH ENG H, V222, P209, DOI 10.1243/09544119JEIM303; MIZRAHI J, 1993, SPINE, V18, P2088, DOI 10.1097/00007632-199310001-00028; MORELAND MS, 1981, MED INSTRUM, V15, P129; Ogden R.W., 2013, NONLINEAR ELASTIC DE; Overaker DW, 1999, J BIOMECH ENG-T ASME, V121, P542, DOI 10.1115/1.2835085; Oxborrow NJ, 2000, ARCH DIS CHILD, V83, P453, DOI 10.1136/adc.83.5.453; Patias P, 2010, SCOLIOSIS SPINAL DIS, V5, DOI 10.1186/1748-7161-5-12; Pezowicz C, 2012, ACTA BIOENG BIOMECH, V14, P53, DOI 10.5277/abb120207; Poredos P, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0044-5; Poulard D, 2015, 24 INT TECHN C ENH S; Roy S, 2020, BIOCYBERN BIOMED ENG, V40, P1486, DOI 10.1016/j.bbe.2020.09.001; Roy S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4715720; Selthofer R, 2006, COLLEGIUM ANTROPOL, V30, P43; Staheli LT., 2001, PRACTICE PEDIAT ORTH; STOKES IAF, 1990, J BIOMECH, V23, P589, DOI 10.1016/0021-9290(90)90051-4; STOKES IAF, 1991, J BIOMECH, V24, P753, DOI 10.1016/0021-9290(91)90339-O; Stokes IAF, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-16; Thometz JG, 2000, J PEDIATR ORTHOPED, V20, P512; Tittel K., 1990, BESCHREIBENDE FUNKTI, V11th; VANNEUVILLE G, 1995, SURG RADIOL ANAT, V17, P53, DOI 10.1007/BF01629500; Wang JL, 1998, CLIN BIOMECH, V13, pS16, DOI 10.1016/S0268-0033(97)00070-3; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; WILLNER S, 1979, ARCH ORTHOP TRAUM SU, V95, P181, DOI 10.1007/BF00460117; XIONG B, 1994, J ORTHOPAED RES, V12, P113, DOI 10.1002/jor.1100120114; Yang HS, 2016, J BIOMECH, V49, P1134, DOI 10.1016/j.jbiomech.2016.02.045; Zhu Y, 2017, APPL BIONICS BIOMECH, V2017, DOI 10.1155/2017/2471368; Zhu Y, 2013, COMPUT METHOD BIOMEC, V16, P191, DOI 10.1080/10255842.2013.815888	60	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0243736	10.1371/journal.pone.0243736	http://dx.doi.org/10.1371/journal.pone.0243736			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566808	Green Published, gold			2022-12-26	WOS:000618271700049
J	Guo, ZY; Dai, YC; Hu, WT; Zhang, YS; Cao, ZF; Pei, WW; Liu, NG; Nie, J; Wu, AQ; Mao, WD; Chang, L; Li, BY; Pei, HL; Hei, TK; Zhou, GM				Guo, Ziyang; Dai, Yingchu; Hu, Wentao; Zhang, Yongsheng; Cao, Zhifei; Pei, Weiwei; Liu, Ningang; Nie, Jing; Wu, Anqing; Mao, Weidong; Chang, Lei; Li, Bingyan; Pei, Hailong; Hei, Tom K.; Zhou, Guangming			The long noncoding RNA CRYBG3 induces aneuploidy by interfering with spindle assembly checkpoint via direct binding with Bub3	ONCOGENE			English	Article								Aneuploidy is a hallmark of genomic instability that leads to tumor initiation, progression, and metastasis. CDC20, Bub1, and Bub3 form the mitosis checkpoint complex (MCC) that binds the anaphase-promoting complex or cyclosome (APC/C), a crucial factor of the spindle assembly checkpoint (SAC), to ensure the bi-directional attachment and proper segregation of all sister chromosomes. However, just how MCC is regulated to ensure normal mitosis during cellular division remains unclear. In the present study, we demonstrated that LNC CRYBG3, an ionizing radiation-inducible long noncoding RNA, directly binds with Bub3 and interrupts its interaction with CDC20 to result in aneuploidy. The 261-317 (S3) residual of the LNC CRYBG3 sequence is critical for its interaction with Bub3 protein. Overexpression of LNC CRYBG3 leads to aneuploidy and promotes tumorigenesis and metastasis of lung cancer cells, implying that LNC CRYBG3 is a novel oncogene. These findings provide a novel mechanistic basis for the pathogenesis of NSCLC after exposure to ionizing radiation as well as a potential target for the diagnosis, treatment, and prognosis of an often fatal disease.	[Guo, Ziyang; Dai, Yingchu; Hu, Wentao; Pei, Weiwei; Liu, Ningang; Nie, Jing; Wu, Anqing; Chang, Lei; Li, Bingyan; Pei, Hailong; Zhou, Guangming] Soochow Univ, State Key Lab Radiat Med & Protect, Collaborat Innovat Ctr Radiol Med Jiangsu Higher, Sch Radiat Med & Protect,Inst Space Life Sci,Med, Suzhou 215123, Peoples R China; [Guo, Ziyang; Hei, Tom K.] Columbia Univ, Ctr Radiol Res, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA; [Zhang, Yongsheng; Cao, Zhifei; Mao, Weidong] Soochow Univ, Med Coll, Affiliated Hosp 2, Dept Pathol, Suzhou 215123, Peoples R China	Soochow University - China; Columbia University; Soochow University - China	Pei, HL; Zhou, GM (corresponding author), Soochow Univ, State Key Lab Radiat Med & Protect, Collaborat Innovat Ctr Radiol Med Jiangsu Higher, Sch Radiat Med & Protect,Inst Space Life Sci,Med, Suzhou 215123, Peoples R China.; Hei, TK (corresponding author), Columbia Univ, Ctr Radiol Res, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA.	hlpei@suda.edu.cn; tkh1@cumc.columbia.edu; gmzhou@suda.edu.cn	li, bing/GWQ-9617-2022; Liu, Ning-Ang/GLN-4757-2022		China National Natural Science Foundation [82073480, 81773463, 81872622]; National Key R&D Program of China [2018YFC0115704]; US National Institutes of Health [R01-ES 011804-10]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the China National Natural Science Foundation awards (Nos. 82073480, 81773463, 81872622), National Key R&D Program of China (No. 2018YFC0115704), and the US National Institutes of Health grant R01-ES 011804-10.	Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen HY, 2018, J CANCER, V9, P2580, DOI 10.7150/jca.24896; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Guo ZY, 2019, CHEM BIOL DRUG DES, V93, P874, DOI 10.1111/cbdd.13477; Gurley Kay E, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot077446; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HOLLIDAY R, 1989, TRENDS GENET, V5, P42, DOI 10.1016/0168-9525(89)90020-6; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hu WT, 2014, RNA BIOL, V11, P1189, DOI 10.4161/rna.34345; Hu WTY, 2014, J RADIAT RES, V55, P10, DOI 10.1093/jrr/rrt078; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lischetti T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970484; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Ma MZ, 2016, CANCER RES, V76, P5361, DOI 10.1158/0008-5472.CAN-15-3047; MANCHESTER KL, 1995, TRENDS CELL BIOL, V5, P384, DOI 10.1016/S0962-8924(00)89080-7; McWhorter JE, 1929, ANN SURG, V90, P1, DOI 10.1097/00000658-192907000-00001; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Overlack K, 2017, CURR BIOL, V27, P2915, DOI 10.1016/j.cub.2017.08.033; Park YH, 2015, TOXICOL APPL PHARM, V287, P240, DOI 10.1016/j.taap.2015.06.008; Pei HL, 2018, CANCER RES, V78, P4563, DOI 10.1158/0008-5472.CAN-18-0988; Pei HL, 2018, CELL CYCLE, V17, P1115, DOI 10.1080/15384101.2018.1480217; Pei HL, 2017, CELL CYCLE, V16, P113, DOI 10.1080/15384101.2016.1259039; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rasnick D, 1999, BIOCHEM J, V340, P621, DOI 10.1042/0264-6021:3400621; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Rodrigues CFD, 2009, MUTAT RES-FUND MOL M, V670, P42, DOI 10.1016/j.mrfmmm.2009.07.004; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Sun M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.256; Sun M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-68; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wang Y, 2013, CANCER RES, V73, P4801, DOI 10.1158/0008-5472.CAN-12-3273; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; White NM, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-3498; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zhang EB, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1523-0; Zhiwei W, 2013, CURR PHARM DESIGN, V19; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	51	10	10	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1821	1835		10.1038/s41388-020-01601-8	http://dx.doi.org/10.1038/s41388-020-01601-8		FEB 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564066	hybrid, Green Published			2022-12-26	WOS:000616489100004
J	Ridwan, ES; Wiratama, BS; Lin, MY; Hou, WH; Liu, MF; Chen, CM; Hadi, H; Tan, MP; Tsai, PS				Ridwan, Edi Sampurno; Wiratama, Bayu Satria; Lin, Mei-Yu; Hou, Wen-Hsuan; Liu, Megan Fang; Chen, Ching-Min; Hadi, Hamam; Tan, Maw Pin; Tsai, Pei-Shan			Peak expiratory flow rate and sarcopenia risk in older Indonesian people: A nationwide survey	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; ASIAN WORKING GROUP; BODY-MASS; PREVALENCE; ADULTS; CONSENSUS; HEALTH; TISSUE	Reduced peak expiratory flow is a common physiological change in older individuals and age is an important predictor for sarcopenia. We analyzed nationwide survey data to determine the relationship between peak expiratory flow rate and sarcopenia in older Indonesians. Community-dwelling Indonesian individuals aged >= 60 years (n = 2422; mean age = 67.21 y) from the fifth-wave data of the Indonesian Family Life Survey was selected. Sarcopenia was diagnosed based on handgrip strength, gait speed, and appendicular skeletal muscle mass measurements. Peak expiratory flow rates (PEFRs) were categorized according to their percentage of predicted flow rates as <50%, 50% to 80%, and >80%. Confounders previously determined to be associated with sarcopenia occurrence were included. Sarcopenia prevalence was 50.25%. After adjustment for confounders, PEFRs of <50% and 50% to 80% were associated with an increased sarcopenia risk (odds ratio = 5.22 and 1.88, respectively) compared with PEFRs of >80%. Poor lung function was independently associated with sarcopenia occurrence. Future studies should explore the usefulness of PEFR as a risk factor of sarcopenia.	[Ridwan, Edi Sampurno] Univ Alma Ata, Fac Hlth Sci, Dept Nursing, Yogyakarta, Indonesia; [Ridwan, Edi Sampurno; Hou, Wen-Hsuan; Tsai, Pei-Shan] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Wiratama, Bayu Satria] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Wiratama, Bayu Satria] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Biostat Epidemiol & Populat Hlth, Yogyakarta, Indonesia; [Lin, Mei-Yu] Tzu Chi Univ Sci & Technol, Dept Nursing, Hualien, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hou, Wen-Hsuan; Liu, Megan Fang] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ Hosp, Ctr Evidence Based Med, Dept Educ, Taipei, Taiwan; [Chen, Ching-Min] Natl Cheng Kung Univ, Coll Med, Dept Nursing, Tainan, Taiwan; [Hadi, Hamam] Univ Alma Ata, Fac Hlth Sci, Dept Nutr, Yogyakarta, Indonesia; [Tan, Maw Pin] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Tsai, Pei-Shan] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Wan Fang Hosp, Ctr Nursing & Healthcare Res Clin Practice Applic, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Gadjah Mada University; Tzu Chi University of Science & Technology; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Cheng Kung University; Universiti Malaya; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital	Tsai, PS (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.; Tsai, PS (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan.; Tsai, PS (corresponding author), Taipei Med Univ, Wan Fang Hosp, Ctr Nursing & Healthcare Res Clin Practice Applic, Taipei, Taiwan.; Tsai, PS (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan.	ptsai@tmu.edu.tw	Hadi, Hamam/AAT-3473-2021; Ridwan, Edi Sampurno/AAH-8475-2021; Tan, Maw Pin/G-6917-2011; wiratama, bayu satria/AAP-4336-2021; Chen, Ching-Min/AAY-6119-2021; Hou, Wen-Hsuan/ABB-2903-2021; wiratama, bayu satria/GQA-7407-2022	Hadi, Hamam/0000-0002-1945-2539; Ridwan, Edi Sampurno/0000-0003-3711-0601; Tan, Maw Pin/0000-0002-3400-8540; wiratama, bayu satria/0000-0001-9965-778X; Chen, Ching-Min/0000-0003-3433-8950; Hou, Wen-Hsuan/0000-0002-4376-6298; wiratama, bayu satria/0000-0001-9965-778X				Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9; Beaudart C, 2015, EXP GERONTOL, V69, P103, DOI 10.1016/j.exger.2015.05.003; Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548; Chang KV, 2017, AGE AGEING, V46, P738, DOI 10.1093/ageing/afx094; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Coelho HJ, 2018, J AGING RES, V2018, DOI 10.1155/2018/9758040; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de l I, 2018, J CLIN GASTROENTEROL, V52, pe63; Deniz O, 2021, AGING CLIN EXP RES, V33, P573, DOI 10.1007/s40520-020-01565-5; DeVrieze BW, 2020, PEAK FLOW RATE MEASU; Dziechciaz M, 2014, ANN AGR ENV MED, V21, P835, DOI 10.5604/12321966.1129943; Falcon Laura J, 2017, Fed Pract, V34, P24; Fukuoka Y, 2019, J DIABETES INVEST, V10, P322, DOI 10.1111/jdi.12908; Gao LL, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.07.020; Goates S, 2019, J FRALITY AGING, V8, P93, DOI 10.14283/jfa.2019.10; Han PP, 2016, J GERONTOL A-BIOL, V71, P529, DOI 10.1093/gerona/glv108; Hong S, 2016, J CLIN GERONTOL GERI, V7, P141, DOI 10.1016/j.jcgg.2016.05.002; HU S, 2018, SENSORS, V18, P1; Jeon YK, 2015, OSTEOPOROSIS INT, V26, P2423, DOI 10.1007/s00198-015-3152-8; Kera T, 2018, AGING CLIN EXP RES, V30, P331, DOI 10.1007/s40520-017-0777-9; Kim H, 2016, GERIATR GERONTOL INT, V16, P110, DOI 10.1111/ggi.12723; Kulkarni B, 2013, J APPL PHYSIOL, V115, P1156, DOI 10.1152/japplphysiol.00777.2013; Landi F, 2020, J CACHEXIA SARCOPENI, V11, P38, DOI 10.1002/jcsm.12485; Lim JU, 2017, INT J CHRONIC OBSTR, V12, P2465, DOI 10.2147/COPD.S141295; Makizako Hyuma, 2019, Phys Ther Res, V22, P53, DOI 10.1298/ptr.R0005; Makizako H, 2017, PHYS THER, V97, P417, DOI 10.2522/ptj.20150665; Martin NRW, 2017, J CELL BIOCHEM, V118, P2599, DOI 10.1002/jcb.25982; Martinez-Arnau FM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092727; Ohara DG, 2018, J NUTR HEALTH AGING, V22, P952, DOI 10.1007/s12603-018-1079-4; Pacifico J, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110801; Park CH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012281; Pothirat C, 2015, INT J CHRONIC OBSTR, V10, P1213, DOI 10.2147/COPD.S85166; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Santos Vanessa Ribeiro dos, 2018, Rev. bras. ortop., V53, P300, DOI 10.1016/j.rboe.2017.09.002; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; Shin HI, 2017, ANN REHABIL MED-ARM, V41, P686, DOI 10.5535/arm.2017.41.4.686; Sikoki B., 2016, WR11431NIANICHD; Sofer T, 2014, STAT SINICA, V24, P1633, DOI 10.5705/ss.2013.019; Sprung J, 2006, CAN J ANAESTH, V53, P1244, DOI 10.1007/BF03021586; StataCorp, 2015, STAT STAT SOFTW REL; Thomas ET, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028150; Vilagut G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155431; Wen X, 2011, ASIA PAC J CLIN NUTR, V20, P551; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	45	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246179	10.1371/journal.pone.0246179	http://dx.doi.org/10.1371/journal.pone.0246179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561132	gold, Green Published			2022-12-26	WOS:000617533000011
J	Lee, DY; Chae, SJ; Cho, SR; Choi, W; Kim, CK; Han, MG				Lee, Deog-Yong; Chae, Su-Jin; Cho, Seung-Rye; Choi, Wooyoung; Kim, Chang-Ki; Han, Myung-Guk			Nationwide seroprevalence of hepatitis A in South Korea from 2009 to 2019	PLOS ONE			English	Article								Hepatitis A, an acute type of hepatitis caused by the hepatitis A virus, occurs worldwide. Following the 2009 hepatitis A epidemic in South Korea, patient outbreak reports were collectively converted to an "all-patient report" in 2011, and national immunization programs were introduced for children in 2015. In this study, we aimed to analyze the changes and characteristics of hepatitis A antibody titers in South Korea following the epidemic. The results of hepatitis A antibody tests performed at clinical laboratories from 2009 to 2019 were analyzed based on year, age, region, sex, and medical institution. The average 2009-2018 positive anti-hepatitis A virus immunoglobulin G rate was 51.8%, but it increased (56.06%) in 2019. Significantly different antibody-positive rates were observed based on age: <10 years, 54.5%; 20-29 years, 19.5%; >= 50 years, almost 100%. The positive rate of individuals in their teens and 20s gradually increased, whereas that of those in their 30s and 40s gradually decreased. Males had higher antibody-positive rates than females, and samples from higher-level general hospitals exhibited higher antibody rates. The positive anti-hepatitis A virus immunoglobulin M rates gradually decreased after 2009 and were <1% after 2012. However, a high positive rate of 3.69% was observed in 2019 when there was an epidemic. Anti-hepatitis A virus immunoglobulin G-positive rates were similar throughout the year, but the anti-hepatitis A virus immunoglobulin M-positive rates increased from January, peaked in April, and decreased from July, exhibiting distinct seasonality. This is considered to be related to groundwater pollution during the spring drought season. The introduction of the "all-patient report" and national vaccination program for children has had an effective influence on hepatitis A management. However, for hepatitis A prevention, policy considerations for high-risk age groups with low antibody-positive rates will be necessary.	[Lee, Deog-Yong; Chae, Su-Jin; Cho, Seung-Rye; Choi, Wooyoung; Han, Myung-Guk] Korea Ctr Dis Control & Prevent, Div Viral Dis, Ctr Lab Control Infect Dis, Osong, South Korea; [Kim, Chang-Ki] Seoul Clin Labs, Yongin, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention	Han, MG (corresponding author), Korea Ctr Dis Control & Prevent, Div Viral Dis, Ctr Lab Control Infect Dis, Osong, South Korea.	mghan@korea.kr		Lee, Deog-Yong/0000-0003-4481-4789	hepatitis A surveillance project [4837-301, 4838-303]	hepatitis A surveillance project	This study was conducted under the fund of the hepatitis A surveillance project (Project No. 4837-301 and 4838-303) managed by the Korea Disease Control and Prevention Agency, KDCA (previously, KCDC).	Ching KZ, 2002, J GEN VIROL, V83, P53, DOI 10.1099/0022-1317-83-1-53; Cristina J, 2007, VIRUS RES, V127, P151, DOI 10.1016/j.virusres.2007.01.005; Fares Auda, 2015, J Family Med Prim Care, V4, P96, DOI 10.4103/2249-4863.152263; Foster MA, 2019, MMWR-MORBID MORTAL W, V68, P413, DOI 10.15585/mmwr.mm6818a2; Jenson HB, 2004, CURR OPIN PEDIATR, V16, P89, DOI 10.1097/00008480-200402000-00017; Kim KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170432; Korea Centers for Disease Control and Prevention, 2020, INF DIS PORT; Lee Donghun, 2011, Korean J Hepatol, V17, P44, DOI 10.3350/kjhep.2011.17.1.44; Matheny SC, 2012, AM FAM PHYSICIAN, V86, P1027; Moon S, 2016, J KOREAN MED SCI, V31, P67, DOI 10.3346/jkms.2016.31.1.67; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Park JH, 2015, FOODBORNE PATHOG DIS, V12, P221, DOI 10.1089/fpd.2014.1879; Yoon JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186257	13	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245162	10.1371/journal.pone.0245162	http://dx.doi.org/10.1371/journal.pone.0245162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556072	Green Published, gold			2022-12-26	WOS:000617379900007
J	Pandurangi, RS; Tomasetti, M; Verapazham, ST; Paulmurugan, R; Ma, C; Rajput, S; Anjanappa, M; Nakshatri, H				Pandurangi, Raghu S.; Tomasetti, Marco; Verapazham, Sekar T.; Paulmurugan, Ramasamy; Ma, Cynthia; Rajput, Sandeep; Anjanappa, Manjushree; Nakshatri, Harikrishna			A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; ALPHA-TOCOPHERYL SUCCINATE; NF-KAPPA-B; CATHEPSIN-B; DEFICIENT ACTIVATION; MULTIDRUG-RESISTANCE; CELLS; DOXORUBICIN; EXPRESSION; CD95	Cancer cells develop tactics to circumvent the interventions by desensitizing themselves to interventions. Amongst many, the principle routes of desensitization include a) activation of survival pathways (e.g. NF-kB, PARP) and b) downregulation of cell death pathways (e.g. CD95/CD95L). As a result, it requires high therapeutic dose to achieve tumor regression which, in turn damages normal cells through the collateral effects. Methods are needed to sensitize the low and non-responsive resistant tumor cells including cancer stem cells (CSCs) in order to evoke a better response from the current treatments. Current treatments including chemotherapy can induce cell death only in bulk cancer cells sparing CSCs and cancer resistant cells (CRCs) which are shown to be responsible for high recurrence of disease and low patient survival. Here, we report several novel tumor targeted sensitizers derived from the natural Vitamin E analogue (AMP-001-003). The drug design is based on a novel concept "A priori activation of apoptosis pathways of tumor technology (AAAPT) which is designed to activate specific cell death pathways and inhibit survival pathways simultaneously and selectively in cancer cells sparing normal cells. Our results indicate that AMP-001-003 sensitize various types of cancer cells including MDA-MB-231 (triple negative breast cancer), PC3 (prostate cancer) and A543 (lung cancer) cells resulting in reducing the IC-50 of doxorubicin in vitro when used as a combination. At higher doses, AMP-001 acts as an anti-tumor agent on its own. The synergy between AMP-001 and doxorubicin could pave a new pathway to use AAAPT leading molecules as neoadjuvant to chemotherapy to achieve better efficacy and reduced off-target toxicity compared to the current treatments.	[Pandurangi, Raghu S.] Sci Engi Medco Solut Inc, St Charles, MO 63303 USA; [Tomasetti, Marco] Polytech Univ Marche, Dept Clin & Mol Sci, Sect Expt & Occupat Med, Ancona, Italy; [Verapazham, Sekar T.; Paulmurugan, Ramasamy] Stanford Univ, Sch Med, Canary Ctr Canc Early Detect, Mol Imaging Program Stanford MIPS,Dept Radiol, Palo Alto, CA 94304 USA; [Ma, Cynthia; Rajput, Sandeep] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Anjanappa, Manjushree; Nakshatri, Harikrishna] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Marche Polytechnic University; Stanford University; Siteman Cancer Center; Washington University (WUSTL); Indiana University System; Indiana University Bloomington	Pandurangi, RS (corresponding author), Sci Engi Medco Solut Inc, St Charles, MO 63303 USA.	raghuaa66@yahoo.com		Paulmurugan, Ramasamy/0000-0001-7155-4738	NIH [R43CA183353]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All the funding or sources of support received during this study was from NIH R43CA183353 only. There was no additional external funding received for this study. Funding organization did not play any roles in designing experiments, data collection, analysis or any decision to publish the data. NIH has provided only financial support to Sci-Engi-Medco Solutions Inc SEMCO through salary (RP, PI) and research cost.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Ali M, 2011, MOL CANCER THER, V10, P2320, DOI 10.1158/1535-7163.MCT-11-0356; Yau Meng-Choy Arthur Charles, 2011, J Orthop Surg (Hong Kong), V19, P1; [Anonymous], 2014, REG ANESTH PAIN MED; Benzer F, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22030; Bloomgarden ZT, 2016, J DIABETES, V8, P4, DOI 10.1111/1753-0407.12345; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chung EJ, 1999, ACTA ONCOL, V38, P449; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dubowchik GM, 2002, BIOCONJUGATE CHEM, V13, P855, DOI 10.1021/bc025536j; Ebert MPA, 2005, PROTEOMICS, V5, P1693, DOI 10.1002/pmic.200401030; Friesen C, 1997, LEUKEMIA, V11, P1833, DOI 10.1038/sj.leu.2400827; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Hainaut P, 2013, CURR OPIN ONCOL, V25, P50, DOI 10.1097/CCO.0b013e32835b651e; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; IC-50 of chemo drugs: Kline, 2011, BREAST CANCER RES, P13, DOI [10.1186/bcr2801 21214929, DOI 10.1186/BCR2801 21214929]; Ireland DJ, 2008, FOOD CHEM TOXICOL, V46, P508, DOI 10.1016/j.fct.2007.08.030; Joseph I, 2004, EJC S, V2-8, P473; Kaltschmidt C, 2019, CANCERS, V11, DOI 10.3390/cancers11050655; Kawada A, 1996, BRIT J DERMATOL, V135, P905, DOI 10.1046/j.1365-2133.1996.d01-1093.x; Krammer PH, 1997, CELL DEATH DIFFER, V4, P362, DOI 10.1038/sj.cdd.4400252; Kruszewski WJ, 2004, NEOPLASMA, V51, P38; Kuriyama H, 2002, NEURO-ONCOLOGY, V4, P179, DOI 10.1093/neuonc/4.3.179; Lebert JM, 2018, CURR ONCOL, V25, pS142, DOI 10.3747/co.25.3954; Liang L, 2012, J CONTROL RELEASE, V160, P618, DOI 10.1016/j.jconrel.2012.02.020; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lory Santarelli, COMBINED CIRCULATING, V90, P457; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; May S.K S, 2007, BIOLOGICAL CHEMISTRY, V281, P10540; MEYN RE, 1995, ANTI-CANCER DRUG, V6, P443, DOI 10.1097/00001813-199506000-00013; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Moon DO, 2009, ARCH PHARM RES, V32, P1351, DOI 10.1007/s12272-009-2002-7; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Olivera A, 2012, INT IMMUNOPHARMACOL, V12, P368, DOI 10.1016/j.intimp.2011.12.009; Pandurangi Raghu, COMPOSITIONS METHODS, Patent No. WO/2017/131911; Pathan RA, 2010, INDIAN J PHARMACOL, V42, P44, DOI 10.4103/0253-7613.62411; Peter ME, 2015, CELL DEATH DIFFER, V22, P549, DOI 10.1038/cdd.2015.3; Pratt MR, 2009, CHEM BIOL, V16, P1001, DOI 10.1016/j.chembiol.2009.07.011; Raghu Pandurangi, 2019, J MED CHEM; Ramp U, 2000, BRIT J CANCER, V82, P1851, DOI 10.1054/bjoc.2000.1155; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Ruan Hang, 2015, Horiz Cancer Res, V56, P23; Sekar TV, 2014, THERANOSTICS, V4, P460, DOI 10.7150/thno.8077; Shao LJ, 2012, TRANSL CANCER RES, V1, P100, DOI 10.3978/j.issn.2218-676X.2012.05.04; SMETS LA, 1994, ANTI-CANCER DRUG, V5, P3, DOI 10.1097/00001813-199402000-00001; Srinivasarao M, 2015, NAT REV DRUG DISCOV, V14, P203, DOI 10.1038/nrd4519; Stepan Koudelka, J PHARM SCI, V99, P2434, DOI [10.1002/jps.22002 20039382, DOI 10.1002/JPS.22002 20039382]; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tomasetti M, 2004, BRIT J CANCER, V90, P1644, DOI 10.1038/sj.bjc.6601707; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Wuchter C, 1999, LEUKEMIA, V13, P1943, DOI 10.1038/sj.leu.2401605; Yamasaki F, 2007, MOL CANCER THER, V6, P2168, DOI 10.1158/1535-7163.MCT-06-0514; Young-EE Kwon, 2007, ANTICANCER RES, V27, P321	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0225869	10.1371/journal.pone.0225869	http://dx.doi.org/10.1371/journal.pone.0225869			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556062	Green Published, gold, Green Submitted			2022-12-26	WOS:000617531400004
J	Sinha, M; Tadepalli, P; Ramsey, SA				Sinha, Meghamala; Tadepalli, Prasad; Ramsey, Stephen A.			Voting-based integration algorithm improves causal network learning from interventional and observational data: An application to cell signaling network inference	PLOS ONE			English	Article							BAYESIAN NETWORKS	In order to increase statistical power for learning a causal network, data are often pooled from multiple observational and interventional experiments. However, if the direct effects of interventions are uncertain, multi-experiment data pooling can result in false causal discoveries. We present a new method, "Learn and Vote," for inferring causal interactions from multi-experiment datasets. In our method, experiment-specific networks are learned from the data and then combined by weighted averaging to construct a consensus network. Through empirical studies on synthetic and real-world datasets, we found that for most of the larger-sized network datasets that we analyzed, our method is more accurate than state-of-the-art network inference approaches.	[Sinha, Meghamala; Tadepalli, Prasad; Ramsey, Stephen A.] Oregon State Univ, Sch Elect Engn & Comp Sci, Corvallis, OR 97331 USA; [Ramsey, Stephen A.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sinha, M (corresponding author), Oregon State Univ, Sch Elect Engn & Comp Sci, Corvallis, OR 97331 USA.	sinham@oregonstate.edu			National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Biomedical Data Translator program [OT2TR002520]	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Biomedical Data Translator program	Research reported in this publication was supported in part by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Biomedical Data Translator program (award OT2TR002520 to SAR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ADV NEURAL INFORM PR; Beinlich I. A., 1989, AIME 89. Second European Conference on Artificial Intelligence in Medicine Proceedings, P247; Binder J, 1997, MACH LEARN, V29, P213, DOI 10.1023/A:1007421730016; Chatterjee D., 2016, BAYES MOD APPL WORKS, P44; Chatterjee D, 2019, US Patent App, Patent No. [15/756,576, 15756576]; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; Claassen T, 2010, ADV NEURAL INFORM PR, P415; Claassen T., 2010, ADV NEURAL INFORM PR, P415; Cooper GF, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P116; Eaton D, 2007, ARTIFICIAL INTELLIGE, P107; Eberhardt F, 2006, STUD FUZZ SOFT COMP, V194, P97; Eberhardt F, 2008, SYNTHESE, V163, P433, DOI 10.1007/s11229-007-9293-3; GLOVER F, 1986, COMPUT OPER RES, V13, P533, DOI 10.1016/0305-0548(86)90048-1; Hagmayer Y., 2007, CAUSAL LEARNING PSYC, P86, DOI DOI 10.1093/ACPROF:OSO/9780195176803.003.0007; Hauser A, 2012, J MACH LEARN RES, V13, P2409; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; KOLLER D., 2009, PROBABILISTIC GRAPHI; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; Mani S, 2012, ARXIV12066853; Mooij JM, 2016, ARXIV16110351; Neuberg LG, 2003, ECONOMET THEOR, V19, P675, DOI 10.1017/S026646603004109; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl J, 1998, HANDBOOK OF DEFEASIBLE REASONING AND UNCERTAINTY MANAGEMENT SYSTEMS, VOL 1, P367; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Pearl J., 2018, BOOK WHY NEW SCI CAU, V1st ed.; Peters J, 2016, J R STAT SOC B, V78, P947, DOI 10.1111/rssb.12167; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Silander T, 2012, ARXIV PREPRINT ARXIV; Sinha M., 2015, THESIS; Sinha M., 2019, THESIS; Sinha M, 2019, POOLING VS VOTING EM; Spirtes P., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P499; Spirtes P., 2000, CAUSATION PREDICTION; Tian Jin, 2001, P 17 C UNCERTAINTY A, P512; Triantafillou S, 2015, J MACH LEARN RES, V16, P2147	41	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245776	10.1371/journal.pone.0245776	http://dx.doi.org/10.1371/journal.pone.0245776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556096	gold, Green Published, Green Submitted			2022-12-26	WOS:000617531400003
J	Yang, RL; Wu, ZJ; Qian, XM				Yang, Ruiliang; Wu, Zijiang; Qian, Xiaoming			Evaluating the influential factors for life preserver donning tests	PLOS ONE			English	Article							PERFORMANCE	Life preservers often play a vital role in ensuring passenger safety in water-related accidents, while the difficulty of donning life preservers has been repeatedly proved even in a donning test. To evaluate the influencing factors for life preserver donning tests, 109 college students and 42 villagers were chosen as subjects. A total of fourteen variables with seven categorical variables and seven continuous variables were considered as potential influencing factors. T-test and one-way analysis of variance (ANOVA, for three or more categories) were used to judge whether grouping in categorical variables had a significant effect on the donning performance. Then all variables were offered into the stepwise linear regression (SLR) to evaluate the influential factors for life preserver donning tests. Results showed that four of fourteen variables, including gender, instruction condition, age group, and tool test time (representing the subject's flexibility), had a significant effect on the donning performance. To evaluate the relationship between the donning performance and influencing factors, models of the retrieving time, the opening time, and the donning time were built based on the SLR analysis. The paper also highlights recommendations for modification of the donning test procedure, which helps to improve the validation and reliability of life preserver donning tests.	[Yang, Ruiliang] Tiangong Univ, Key Lab Modern Electromech Equipment Technol, Tianjin, Peoples R China; [Wu, Zijiang; Qian, Xiaoming] Tiangong Univ, Sch Text Sci & Engn, Tianjin, Peoples R China	Tiangong University; Tiangong University	Qian, XM (corresponding author), Tiangong Univ, Sch Text Sci & Engn, Tianjin, Peoples R China.	qxm@tiangong.edu.cn			National Natural Science Foundation of China [U1933111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. U1933111).	Adarsh S, 2018, AIN SHAMS ENG J, V9, P1839, DOI 10.1016/j.asej.2016.10.014; [Anonymous], 2017, TSOC13G; Bao T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219737; Bauer IL, 2002, J TRAVEL MED, V9, P132, DOI 10.2310/7060.2002.23848; Chittaro L, 2018, SAFETY SCI, V102, P159, DOI 10.1016/j.ssci.2017.10.012; Corbett CL, 2014, DOTFAAAM1414; Gopang MA, 2017, SAFETY SCI, V93, P127, DOI 10.1016/j.ssci.2016.11.024; Gowdy V, 2003, DOTFAAAM039; Jones MD, 2021, SPORTS MED, V51, P503, DOI 10.1007/s40279-020-01388-4; MacDonald CV, 2016, INT J IND ERGONOM, V54, P19, DOI 10.1016/j.ergon.2015.12.003; National Transportation Safety Board, 2010, NTSBAAR1003; Rasmussen PG, 1983, AAC119835; Rueschhoff BJ, 1985, DOTFAAAM8511; Runnarong N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221320; Sialino LD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226342; Stokes GS, 1999, HUM RESOUR MANAGE R, V9, P185, DOI 10.1016/S1053-4822(99)00018-2; Tahliani JM, 1996, DOTFAAAR95112; Yang RL, 2020, INT J AEROSP PSYCHOL, V30, P77, DOI 10.1080/24721840.2020.1742123	18	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246705	10.1371/journal.pone.0246705	http://dx.doi.org/10.1371/journal.pone.0246705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556145	gold, Green Published			2022-12-26	WOS:000617531400005
J	Brewen, CJ; Berrill, JP; Ritchie, MW; Boston, K; Dagley, CM; Jones, B; Coppoletta, M; Burnett, CL				Brewen, Cerena J.; Berrill, John-Pascal; Ritchie, Martin W.; Boston, Kevin; Dagley, Christa M.; Jones, Bobette; Coppoletta, Michelle; Burnett, Coye L.			76-year decline and recovery of aspen mediated by contrasting fire regimes: Long-unburned, infrequent and frequent mixed-severity wildfire	PLOS ONE			English	Article							SIERRA-NEVADA; POPULUS-TREMULOIDES; QUAKING ASPEN; STANDS; CALIFORNIA; REGENERATION; SUCCESSION; FORESTS; RESTORATION; RECRUITMENT	Quaking aspen (Populus tremuloides) is a valued, minor component on northeastern California landscapes. It provides a wide range of ecosystem services and has been in decline throughout the region for the last century. This decline may be explained partially by the lack of fire on the landscape due to heavier fire suppression, as aspen benefit from fire that eliminates conifer competition and stimulates reproduction through root suckering. However, there is little known about how aspen stand area changes in response to overlapping fire. Our study area in northeastern California on the Lassen, Modoc and Plumas National Forests has experienced recent large mixed-severity wildfires where aspen was present, providing an opportunity to study the re-introduction of fire. We observed two time periods; a 52-year absence of fire from 1941 to 1993 preceding a 24-year period of wildfire activity from 1993 to 2017. We utilized aerial photos and satellite imagery to delineate aspen stands and assess conifer cover percent. We chose aspen stands in areas where wildfires overlapped (twice-burned), where only a single wildfire burned, and areas that did not burn within the recent 24-year period. We observed these same stands within the first period of fire exclusion for comparison (i.e., 1941-1993). In the absence of fire, all aspen stand areas declined and all stands experienced increases in conifer composition. After wildfire, stands that burned experienced a release from conifer competition and increased in stand area. Stands that burned twice or at high severity experienced a larger removal of conifer competition than stands that burned once at low severity, promoting expansion of aspen stand area. Stands with less edge:area ratio also expanded in area more with fire present. Across both time periods, stand movement, where aspen stand footprints were mostly in new areas compared to footprints of previous years, was highest in smaller stands. In the fire exclusion period, smaller stands exhibited greater loss of area and changes in location (movement) than in the return of fire period, highlighting their vulnerability to loss via succession to conifers in the absence of disturbances that provide adequate growing space for aspen over time.	[Brewen, Cerena J.; Jones, Bobette] US Forest Serv, USDA, Lassen Natl Forest, Susanville, CA 96130 USA; [Berrill, John-Pascal; Dagley, Christa M.] Humboldt State Univ, Dept Forestry & Wildland Resources, Arcata, CA 95521 USA; [Ritchie, Martin W.] US Forest Serv, USDA, Pacific Southwest Res Stn, Redding, CA USA; [Boston, Kevin] Norwegian Inst Bioecon, As, Norway; [Coppoletta, Michelle] US Forest Serv, USDA, Sierra Cascade Prov, Quincy, CA USA; [Burnett, Coye L.] US Forest Serv, USDA, Lassen Natl Forest, Chester, CA USA	United States Department of Agriculture (USDA); United States Forest Service; California State University System; California State Polytechnic University, Humboldt; United States Department of Agriculture (USDA); United States Forest Service; Norwegian Institute of Bioeconomy Research; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Brewen, CJ (corresponding author), US Forest Serv, USDA, Lassen Natl Forest, Susanville, CA 96130 USA.	cjb24@humboldt.edu		Coppoletta, Michelle/0000-0001-5640-3237	USDA Forest Service Joint Venture Agreement [15-JV-11272139-032]; Humboldt State University; USDA National Institute of Food and Agriculture, McIntire-Stennis Cooperative Forestry Research Project [ME042043]	USDA Forest Service Joint Venture Agreement; Humboldt State University; USDA National Institute of Food and Agriculture, McIntire-Stennis Cooperative Forestry Research Project	JPB and MWR received funding from USDA Forest Service Joint Venture Agreement No.15-JV-11272139-032 with Humboldt State University, and JPB received support from the USDA National Institute of Food and Agriculture, McIntire-Stennis Cooperative Forestry Research Project No. ME042043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Baker WL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00046.1; Barr AG, 2007, GLOBAL CHANGE BIOL, V13, P561, DOI 10.1111/j.1365-2486.2006.01220.x; Bartos D. L., 1998, Rangelands, V20, P17; BARTOS DL, 1981, J RANGE MANAGE, V34, P315, DOI 10.2307/3897859; Berrill JP, 2017, FOREST ECOL MANAG, V400, P511, DOI 10.1016/j.foreco.2017.06.001; Berrill JP, 2016, ECOL RESTOR, V34, P236, DOI 10.3368/er.34.3.236; Berrill JP, 2012, GEOGRAPHIC PATTERNS; Calder WJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00119.1; Chong GW, 2001, USDA ROCKY, P261; Collins BM, 2007, FRONT ECOL ENVIRON, V5, P523, DOI 10.1890/1540-9295(2007)5[523:MNWISN]2.0.CO;2; Collins BM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00026.1; Collins BM, 2009, ECOSYSTEMS, V12, P114, DOI 10.1007/s10021-008-9211-7; Coppoletta M, 2016, ECOL APPL, V26, P686, DOI 10.1890/15-0225; Crotteau J. S., 2015, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P377; DeByle NV, RM119 USDA FORS SERV; Di Orio AP, 2005, FOREST ECOL MANAG, V206, P307, DOI 10.1016/j.foreco.2004.11.011; ESRI, 2011, ARCGIS DESKT REL 10; Fraser E, 2004, FOREST CHRON, V80, P251, DOI 10.5558/tfc80251-2; Goward SN, 2001, REMOTE SENS ENVIRON, V78, P3, DOI 10.1016/S0034-4257(01)00262-0; Hammett EJ, 2017, FIRE ECOL, V13, P91, DOI 10.4996/fireecology.1301091; Helmer EH, 2000, INT J REMOTE SENS, V21, P2163, DOI 10.1080/01431160050029495; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Jones BE, 2005, RESTOR ECOL, V13, P373, DOI 10.1111/j.1526-100X.2005.00046.x; Kalcounis MC, 1998, J WILDLIFE MANAGE, V62, P603, DOI 10.2307/3802336; Key CH, 2005, 164LA155 ROCK MOUNT, V164; Keyser TL, 2005, CAN J FOREST RES, V35, P2679, DOI 10.1139/X05-180; Krasnow KD, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00354.1; Krasnow KD, 2012, FIRE ECOL, V8, P104, DOI 10.4996/fireecology.0803104; Kuhn TJ, 2011, PLANT ECOL, V212, P1451, DOI 10.1007/s11258-011-9920-4; Kulakowski D, 2013, FOREST ECOL MANAG, V299, P52, DOI 10.1016/j.foreco.2013.01.004; Kulakowski D, 2013, J VEG SCI, V24, P168, DOI 10.1111/j.1654-1103.2012.01437.x; Kutner M., 2005, APPL LINEAR STAT MOD; Leckie DG, 2003, REMOTE SENS ENVIRON, V85, P355, DOI 10.1016/S0034-4257(03)00013-0; Lenth RV., 2021, EMMEANS ESTIMATED MA; Maxwell JD, 2019, OECOLOGIA, V189, P1061, DOI 10.1007/s00442-019-04370-8; McCullough SA, 2013, ENVIRON MONIT ASSESS, V185, P5563, DOI 10.1007/s10661-012-2967-4; McKelvey KS, 1996, SIERRA NEVADA ECOSYS, V2, P37; Moore RT, 2011, AM GEOPH UN FALL M; Nemens DG, 2018, FOREST ECOL MANAG, V427, P143, DOI 10.1016/j.foreco.2018.05.023; Oaten DK, 2008, NORTHWEST SCI, V82, P276, DOI 10.3955/0029-344X-82.4.276; PARSONS DJ, 1979, FOREST ECOL MANAG, V2, P21, DOI 10.1016/0378-1127(79)90034-3; Perala DA, 1979, REGENERATION PRODUCT; R Core Team, 2020, R LANG ENV STAT COMP; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Rhodes AC, 2017, FOREST ECOL MANAG, V397, P39, DOI 10.1016/j.foreco.2017.04.014; Richardson T. Will, 2004, Transactions of the Western Section of the Wildlife Society, V40, P68; Rogers PC, 2007, NAT AREA J, V27, P183, DOI 10.3375/0885-8608(2007)27[183:AITSNR]2.0.CO;2; Rogers PC, 2014, FOREST SCI, V60, P345, DOI 10.5849/forsci.12-156; Rogers PC, 2013, FOREST ECOL MANAG, V299, P1, DOI 10.1016/j.foreco.2012.11.008; Shepperd WD, RMRSGTR178 USDA FOR; Shinneman DJ, 2013, FOREST ECOL MANAG, V299, P22, DOI 10.1016/j.foreco.2012.11.032; Skinner C. N., 2009, Fire Ecology, V5, P76; Stephens SL, 2007, FOREST ECOL MANAG, V251, P205, DOI 10.1016/j.foreco.2007.06.005; Sugihara NG, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P1; Van de Water KM, 2011, FIRE ECOL, V7, P26, DOI 10.4996/fireecology.0703026; Van Wagtendonk J., 2007, FIRE ECOL, V4, P3; WALSH SJ, 1980, REMOTE SENS ENVIRON, V9, P11, DOI 10.1016/0034-4257(80)90044-9; Wan HY, 2014, FOREST ECOL MANAG, V329, P59, DOI 10.1016/j.foreco.2014.06.006; Webb GK, 2019, ISSUES INFORM SYSTEM, V20, P22; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winternitz BL, 1980, INT86 USDA, P247	67	2	2	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0232995	10.1371/journal.pone.0232995	http://dx.doi.org/10.1371/journal.pone.0232995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539349	Green Published, gold, Green Submitted			2022-12-26	WOS:000616960200042
J	Blaney, A; Jampachaisri, K; Huss, MK; Pacharinsak, C				Blaney, Alexandra; Jampachaisri, Katechan; Huss, Monika K.; Pacharinsak, Cholawat			Sustained release buprenorphine effectively attenuates postoperative hypersensitivity in an incisional pain model in neonatal rats (Rattus norvegicus)	PLOS ONE			English	Article							BODY-TEMPERATURE; ANALGESIA; RESPONSES; DRUGS	Despite the need for safe and effective postoperative analgesia in neonates, research regarding pain management in neonatal rodents is relatively limited. Here, we investigate whether sustained release buprenorphine (Bup SR) effectively attenuates thermal hypersensitivity in a neonatal rat model of incisional pain. Male and female postnatal day 3 Sprague Dawley rat pups (n = 34) were randomly assigned to one of four treatment groups: 1) saline (control), 0.1 mL, once subcutaneously (SC); 2) buprenorphine HCl (Bup HCl), 0.05 mg/kg, once SC; 3) low dose Bup SR (low-SR), 0.5 mg/kg, once SC; 4) high dose Bup SR (high-SR), 1 mg/kg, once SC. Pups were anesthetized with sevoflurane and a 0.5-cm long skin incision was made over the left lateral thigh. The underlying muscle was dissected and closed using surgical glue. Thermal hypersensitivity testing was performed at 24 h prior to surgery and subsequently at 1, 4, 8, 24, and 48 h post-surgery using an infrared diode laser. Thermal hypersensitivity was attenuated at 1 h post-surgery in the Bup HCl group, while it was attenuated through the entire postoperative period in both low-SR and high-SR groups. This data suggests that a single dose of low-SR (0.5 mg/kg) or high-SR (1 mg/kg) effectively attenuates thermal hypersensitivity for at least 8 h in neonatal rat pups.	[Blaney, Alexandra; Huss, Monika K.; Pacharinsak, Cholawat] Stanford Univ, Dept Comparat Med, Sch Med, Stanford, CA 94305 USA; [Jampachaisri, Katechan] Naresuan Univ, Dept Math, Phitsanulok, Thailand	Stanford University; Naresuan University	Blaney, A; Pacharinsak, C (corresponding author), Stanford Univ, Dept Comparat Med, Sch Med, Stanford, CA 94305 USA.	amblaney@stanford.edu; cholawat@stanford.edu						Al-Rubaie A, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0816-x; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Carbone ET, 2012, J AM ASSOC LAB ANIM, V51, P815; Chen A, 2015, PAIN MED, V16, pS27, DOI 10.1111/pme.12915; Chum HH, 2014, J AM ASSOC LAB ANIM, V53, P193; COWAN A, 1992, CLIN EXP PHARMACOL P, V19, P47, DOI 10.1111/j.1440-1681.1992.tb00396.x; Davidson S, 2010, BRAIN RES, V1307, P43, DOI 10.1016/j.brainres.2009.10.024; DESANTIS DT, 1984, DEV PSYCHOBIOL, V17, P255, DOI 10.1002/dev.420170306; FANSELOW MS, 1988, PHARMACOL BIOCHEM BE, V31, P431, DOI 10.1016/0091-3057(88)90370-X; Foley PL, 2011, J AM ASSOC LAB ANIM, V50, P198; Gennaro M, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5089321; Hall RW, 2009, CLIN PERINATOL, V36, P15, DOI 10.1016/j.clp.2008.09.007; Ilback NG, 2008, LAB ANIM-UK, V42, P149, DOI 10.1258/la.2007.06002e; Institute for Laboratory Animal Research NRC, 2011, GUIDE CARE USE LAB A, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Institute for Laboratory Animal Research NRC, 2003, NEUROSCI BEHAV RES, P102, DOI [10.17226/10732, DOI 10.17226/10732]; Johnson RE, 2005, J PAIN SYMPTOM MANAG, V29, P297, DOI 10.1016/j.jpainsymman.2004.07.005; Kang SC, 2017, J AM ASSOC LAB ANIM, V56, P63; LARSSON BA, 1995, ACTA ANAESTH SCAND, V39, P1028, DOI 10.1111/j.1399-6576.1995.tb04223.x; Mahmoud AI, 2014, NAT PROTOC, V9, P305, DOI 10.1038/nprot.2014.021; Marsh D, 1999, PAIN, V82, P33, DOI 10.1016/S0304-3959(99)00029-9; MAUNUKSELA EL, 1988, BRIT J ANAESTH, V60, P48, DOI 10.1093/bja/60.1.48; McKeon GP, 2011, J AM ASSOC LAB ANIM, V50, P192; Ohlsson A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011219.pub4; Pathan H, 2012, BRIT J PAIN, V6, P11, DOI 10.1177/2049463712438493; Perry M, 2018, CRIT CARE NURS CLIN, V30, P549, DOI 10.1016/j.cnc.2018.07.013; Posner LP, 2010, VET ANAESTH ANALG, V37, P35, DOI 10.1111/j.1467-2995.2009.00508.x; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Schwaller F, 2014, EUR J NEUROSCI, V39, P344, DOI 10.1111/ejn.12414; Seymour TL, 2016, J AM ASSOC LAB ANIM, V55, P300; Shafford HL, 2008, VET ANAESTH ANALG, V35, P326, DOI 10.1111/j.1467-2995.2007.00383.x; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; Thiede AJ, 2014, J AM ASSOC LAB ANIM, V53, P692; Vicencio-Rosas E, 2018, J PAIN RES, V11, P549, DOI 10.2147/JPR.S153903; Victoria NC, 2016, EXP NEUROL, V275, P261, DOI 10.1016/j.expneurol.2015.07.017; Vinall J, 2012, PAIN, V153, P1374, DOI 10.1016/j.pain.2012.02.007; Wilson-Smith Elaine M, 2011, Rev Pain, V5, P4, DOI 10.1177/204946371100500303; Yassen A, 2008, PHARM RES, V25, P183, DOI 10.1007/s11095-007-9440-z	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246213	10.1371/journal.pone.0246213	http://dx.doi.org/10.1371/journal.pone.0246213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534864	Green Published, gold			2022-12-26	WOS:000616739700014
J	Gao, XP; Zhuang, JG; Zhao, L; Wei, W; Xu, FD				Gao, Xiuping; Zhuang, Jianguo; Zhao, Lei; Wei, Wan; Xu, Fadi			Cross-effect of TRPV1 and EP3 receptor on coughs and bronchopulmonary C-neural activities	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VAGAL SENSORY NEURONS; PROSTAGLANDIN E-2; POTENTIAL VANILLOID-1; INFLAMMATORY MEDIATORS; SUBSTANCE-P; CAPSAICIN; AIRWAY; DESENSITIZATION; ACTIVATION	Prostaglandin E-2 (PGE(2))-induced coughs in vivo and vagal nerve depolarization in vitro are inhibited by systemic and local administration of prostaglandin EP3 receptor (L-798106) and TRPV1 antagonists (JNJ 17203212). These results indicate a modulating effect of TRPV1 on the EP3 receptor-mediated cough responses to PGE(2) likely through the vagal sensory nerve. This study aimed to determine whether 1) inhalation of aerosolized JNJ 17203212 and L-798106 affected cough responses to citric acid (CA, mainly stimulating TRPV1) and PGE(2); 2) TRPV1 and EP3 receptor morphologically are co-expressed and electrophysiologically functioned in the individual of vagal pulmonary C-neurons (cell bodies of bronchopulmonary C-fibers in the nodose/jugular ganglia); and 3) there was a cross-effect of TRPV1 and EP3 receptor on these neural excitations. To this end, aerosolized CA or PGE(2) was inhaled by unanesthetized guinea pigs pretreated without or with each antagonist given in aerosol form. Immunofluorescence was applied to identify the co-expression of TRPV1 and EP3 receptor in vagal pulmonary C-neurons (retrogradely traced by DiI). Whole-cell voltage patch clamp approach was used to detect capsaicin (CAP)- and PGE(2)-induced currents in individual vagal pulmonary C-neurons and determine the effects of the TRPV1 and EP3 receptor antagonists on the evoked currents. We found that PGE(2)-induced cough was attenuated by JNJ 17203212 or L-798106 and CA-evoked cough greatly suppressed only by JNJ 17203212. Approximately 1/4 of vagal pulmonary C-neurons co-expressed EP3 with a cell size < 20 mu m. Both CAP- and PGE(2)-induced currents could be recorded in the individuals of some vagal pulmonary C-neurons. The former was largely inhibited only by JNJ 17203212, while the latter was suppressed by JNJ 17203212 or L-798106. The similarity of the cross-effect of both antagonists on cough and vagal pulmonary C-neural activity suggests that a subgroup of vagal pulmonary C-neurons co-expressing TRPV1 and EP3 receptor is, at least in part, responsible for the cough response to PGE(2).	[Gao, Xiuping; Zhuang, Jianguo; Zhao, Lei; Wei, Wan; Xu, Fadi] Lovelace Biomed Res Inst, Pathophysiol Program, Albuquerque, NM 87108 USA; [Zhao, Lei] Beijing Sport Univ, Dept Exercise Physiol, Beijing, Peoples R China; [Wei, Wan] Beijing Univ Chinese Med, Dongfang Hosp, Beijing, Peoples R China	Lovelace Respiratory Research Institute; Beijing Sport University; Beijing University of Chinese Medicine	Xu, FD (corresponding author), Lovelace Biomed Res Inst, Pathophysiol Program, Albuquerque, NM 87108 USA.	fxu@lrri.org			Lovelace Respiratory Research Institute	Lovelace Respiratory Research Institute	This study is supported by institutional funding of Lovelace Respiratory Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar YA, 2013, CELL CALCIUM, V54, P362, DOI 10.1016/j.ceca.2013.08.005; AN SZ, 1994, BIOCHEMISTRY-US, V33, P14496, DOI 10.1021/bi00252a016; [Anonymous], 2017, LANCET HIV, V2017, pPE475; BANNER AS, 1986, LUNG, V164, P79, DOI 10.1007/BF02713631; Bergren DR, 2006, J APPL PHYSIOL, V100, P1918, DOI 10.1152/japplphysiol.01276.2005; Bhattacharya A, 2007, J PHARMACOL EXP THER, V323, P665, DOI 10.1124/jpet.107.127258; Birring SS, 2004, AM J RESP CRIT CARE, V169, P15, DOI 10.1164/rccm.200308-1092OC; Bonvini SJ, 2017, PULM PHARMACOL THER, V47, P21, DOI 10.1016/j.pupt.2017.06.009; Brooks SM, 2008, LUNG, V186, pS88, DOI 10.1007/s00408-007-9068-0; Canning B. J., 2009, V187, P23, DOI 10.1007/978-3-540-79842-2_2; Canning BJ, 2011, AM J PHYSIOL-REG I, V300, pR369, DOI 10.1152/ajpregu.00044.2010; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHOUDRY NB, 1989, AM REV RESPIR DIS, V140, P137, DOI 10.1164/ajrccm/140.1.137; Chung K. F., 2009, V187, P1, DOI 10.1007/978-3-540-79842-2_1; COLERIDGE HM, 1976, NATURE, V264, P451, DOI 10.1038/264451a0; Corboz MR, 2017, J PHARMACOL EXP THER, V363, P348, DOI 10.1124/jpet.117.242099; COSTELLO JF, 1985, BRIT J CLIN PHARMACO, V20, P355, DOI 10.1111/j.1365-2125.1985.tb05077.x; Ek M, 1998, J NEUROSCI, V18, P9471; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; FORSBERG K, 1986, ACTA PHYSIOL SCAND, V128, P319, DOI 10.1111/j.1748-1716.1986.tb07981.x; Forsberg K, 1988, Pulm Pharmacol, V1, P33, DOI 10.1016/0952-0600(88)90008-7; Gao XP, 2017, FASEB J, V31, P4325, DOI 10.1096/fj.201700163R; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; GAWIN AZ, 1993, J APPL PHYSIOL, V75, P798, DOI 10.1152/jappl.1993.75.2.798; Geppetti P, 2006, EUR J PHARMACOL, V533, P207, DOI 10.1016/j.ejphar.2005.12.063; Gouin O, 2017, PROTEIN CELL, V8, P644, DOI 10.1007/s13238-017-0395-5; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Gu QH, 2003, J NEUROPHYSIOL, V89, P1985, DOI 10.1152/jn.00748.2002; Gu QH, 2006, AM J PHYSIOL-LUNG C, V291, pL58, DOI 10.1152/ajplung.00517.2005; Hatae N, 2002, J BIOCHEM, V131, P781, DOI 10.1093/oxfordjournals.jbchem.a003165; Ho CY, 2000, AM J RESP CRIT CARE, V162, P528, DOI 10.1164/ajrccm.162.2.9910059; HOLTZMAN MJ, 1991, AM REV RESPIR DIS, V143, P188, DOI 10.1164/ajrccm/143.1.188; Hu HJ, 2002, J NEUROSCI, V22, P7444; Hunter DD, 1999, AM J RESP CRIT CARE, V159, P1943, DOI 10.1164/ajrccm.159.6.9808078; Ishiura Yoshihisa, 2007, Cough, V3, P2, DOI 10.1186/1745-9974-3-2; ITO S, 1991, J NEUROCHEM, V56, P531, DOI 10.1111/j.1471-4159.1991.tb08182.x; Jones RL, 2011, BRIT J PHARMACOL, V162, P863, DOI 10.1111/j.1476-5381.2010.01087.x; JORRES R, 1995, EUR RESPIR J, V8, P416, DOI 10.1183/09031936.95.08030416; KARLSSON JA, 1988, J APPL PHYSIOL, V65, P1007, DOI 10.1152/jappl.1988.65.3.1007; KAWAKAMI Y, 1973, EUR J CLIN PHARMACOL, V6, P127, DOI 10.1007/BF00562439; Kim Sojin, 2015, Biochem Biophys Res Commun, V456, P167, DOI 10.1016/j.bbrc.2014.11.053; Kopp UC, 2004, AM J PHYSIOL-RENAL, V287, pF1269, DOI 10.1152/ajprenal.00230.2004; Kwong K, 2002, J APPL PHYSIOL, V93, P1419, DOI 10.1152/japplphysiol.00382.2002; Kwong K, 1998, J APPL PHYSIOL, V84, P417, DOI 10.1152/jappl.1998.84.2.417; Lazarus M, 2006, MOL NUTR FOOD RES, V50, P451, DOI 10.1002/mnfr.200500207; Lee LY, 2015, PULM PHARMACOL THER, V35, P87, DOI 10.1016/j.pupt.2015.08.003; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; LEE LY, 1995, J APPL PHYSIOL, V79, P1679, DOI 10.1152/jappl.1995.79.5.1679; Liu LY, 2020, J BIOL CHEM, V295, P8174, DOI 10.1074/jbc.RA119.012505; LIU MC, 1988, PROSTAGLANDINS, V35, P67, DOI 10.1016/0090-6980(88)90275-4; Lopshire JC, 1998, J NEUROSCI, V18, P6081; LUNDBERG JM, 1983, NATURE, V302, P251, DOI 10.1038/302251a0; Maher SA, 2011, CURR OPIN PHARMACOL, V11, P248, DOI 10.1016/j.coph.2011.06.005; Maher SA, 2010, LUNG, V188, pS9, DOI 10.1007/s00408-009-9190-2; Maher SA, 2009, AM J RESP CRIT CARE, V180, P923, DOI 10.1164/rccm.200903-0388OC; MAPP CE, 1991, BRIT J PHARMACOL, V104, P49, DOI 10.1111/j.1476-5381.1991.tb12383.x; MARTINS MA, 1993, AM REV RESPIR DIS, V147, P466, DOI 10.1164/ajrccm/147.2.466; Matsumoto S, 2005, BRIT J PHARMACOL, V145, P503, DOI 10.1038/sj.bjp.0706212; McGarvey LPA, 1998, INT J CLIN PRACT, V52, P158; MOHAMMED SP, 1993, J PHYSIOL-LONDON, V469, P51, DOI 10.1113/jphysiol.1993.sp019804; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nasra J BM, 2007, AM J RESP CRIT CARE, V41, pA667; Natura G, 2013, P NATL ACAD SCI USA, V110, P13648, DOI 10.1073/pnas.1300820110; Profita M, 2003, J ALLERGY CLIN IMMUN, V112, P709, DOI 10.1016/S0091-6749(03)01889-X; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schappert Susan M, 2006, Vital Health Stat 13, P1; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Storozhuk MV, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5806321; Sugimoto Y, 2003, LIFE SCI, V74, P135, DOI 10.1016/j.lfs.2003.09.002; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Tanaka M, 2005, J PHARMACOL SCI, V99, P77, DOI 10.1254/jphs.FPJ05014X; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Vyklicky L, 2008, PHYSIOL RES, V57, pS59, DOI 10.33549/physiolres.931478; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Zhang GF, 2007, RESP PHYSIOL NEUROBI, V156, P241, DOI 10.1016/j.resp.2006.11.003; Zhao L, 2019, FASEB J, V33, P10731, DOI 10.1096/fj.201900279RR; Zhao L, 2016, TOXICOL APPL PHARM, V290, P107, DOI 10.1016/j.taap.2015.10.023; Zhuang JG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217366; Zhuang JG, 2015, AM J PHYSIOL-LUNG C, V308, pL922, DOI 10.1152/ajplung.00241.2014	84	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246375	10.1371/journal.pone.0246375	http://dx.doi.org/10.1371/journal.pone.0246375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529249	gold, Green Published			2022-12-26	WOS:000616736200008
J	Park, T; Large, N; Curran, T				Park, Taeju; Large, Neka; Curran, Tom			Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN CRK; EPITHELIAL-MESENCHYMAL TRANSITION; GASTRIC-CANCER; INTRATUMORAL HETEROGENEITY; MALIGNANT FEATURE; POOR-PROGNOSIS; TGF-BETA; EXPRESSION; PROLIFERATION; INVASION	The expression levels of CT10 regulator of kinase (Crk) and Crk-like (CrkL) are elevated in many human cancers, including glioblastoma (GBM), and are believed to contribute to poor prognosis. Although Crk and CrkL have been proposed as therapeutic targets in these tumors, the lack of a reliable, quantitative assay to measure Crk and CrkL activity has hindered development of inhibitors. Here, we knocked down Crk, CrkL, or both using siRNAs in a human GBM cell line, U-118MG, to determine the respective, quantitative contributions of Crk and CrkL to cellular phenotypes. The combined use of specific and potent Crk and CrkL siRNAs induced effective knockdown of CrkII, CrkI, and CrkL. Whereas Crk knockdown did not affect cell morphology, proliferation, adhesion, or invasion, CrkL knockdown caused shrinkage of cells and inhibition of cell proliferation, adhesion, and invasion. Crk/CrkL double knockdown resulted in more pronounced morphological alterations and more robust inhibition of proliferation, adhesion, and invasion. Furthermore, Crk/CrkL double knockdown completely blocked cell migration, and this effect was rescued by transient overexpression of CrkL but not of Crk. Quantification of protein levels indicated that CrkL is expressed more abundantly than CrkII and CrkI in U-118MG cells. These results demonstrate both the predominant role of CrkL and the essential overlapping functions of Crk and CrkL in U-118MG cells. Furthermore, our study indicates that migration of U-118MG cells depends entirely on Crk and CrkL. Thus, impedance-based, real-time measurement of tumor cell migration represents a robust assay for monitoring Crk and CrkL activities.	[Park, Taeju; Large, Neka; Curran, Tom] Childrens Mercy Kansas City, Childrens Mercy Res Inst, Kansas City, MO 64108 USA; [Park, Taeju; Curran, Tom] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	Park, T (corresponding author), Childrens Mercy Kansas City, Childrens Mercy Res Inst, Kansas City, MO 64108 USA.; Park, T (corresponding author), Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA.	tjpark@cmh.edu	Curran, Tom/C-1164-2008	Curran, Tom/0000-0003-1444-7551; Park, Taeju/0000-0003-3897-3994	Tom Keaveny Endowed Fund for Pediatric Cancer Research; MCA Partners Advisory Board grant from Children's Mercy Hospital; University of Kansas Cancer Center (KUCC)	Tom Keaveny Endowed Fund for Pediatric Cancer Research; MCA Partners Advisory Board grant from Children's Mercy Hospital; University of Kansas Cancer Center (KUCC)	This work was supported by Tom Keaveny Endowed Fund for Pediatric Cancer Research (to T. P.) and by a MCA Partners Advisory Board grant from Children's Mercy Hospital (CMH) and the University of Kansas Cancer Center (KUCC) (to T. P.).	Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cai L, 2017, ONCOL LETT, V13, P51, DOI 10.3892/ol.2016.5394; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cheng SM, 2015, TUMOR BIOL, V36, P915, DOI 10.1007/s13277-014-2724-0; Collins TN, 2018, ELIFE, V7, DOI 10.7554/eLife.32586; Dai YQ, 2011, CELL BIOCHEM FUNCT, V29, P625, DOI 10.1002/cbf.1797; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dhupkar Pooja, 2016, Biochem Biophys Rep, V8, P382, DOI 10.1016/j.bbrep.2016.10.009; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Elmansuri AZ, 2016, ONCOTARGET, V7, P27094, DOI 10.18632/oncotarget.8314; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; Feng RH, 2018, CANCER BIOMARK, V21, P335, DOI 10.3233/CBM-170472; Franke FC, 2020, INT J CANCER, V147, P1715, DOI 10.1002/ijc.32955; Franke FC, 2019, CELL MOL GASTROENTER, V7, P33, DOI 10.1016/j.jcmgh.2018.08.007; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Huang YP, 2015, J CLIN INVEST, V125, P1019, DOI 10.1172/JCI77278; Itakura M, 2013, BRIT J CANCER, V109, P1100, DOI 10.1038/bjc.2013.440; Ji H, 2016, ONCOL LETT, V12, P3811, DOI 10.3892/ol.2016.5160; Klank RL, 2017, CELL REP, V19, P668, DOI 10.1016/j.celrep.2017.03.074; Kumar S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1376155; Kumar S, 2018, MOL CANCER RES, V16, P173, DOI 10.1158/1541-7786.MCR-17-0242; Kumar S, 2015, ONCOTARGET, V6, P37792, DOI 10.18632/oncotarget.6096; Lefranc F, 2018, CANCER TREAT REV, V68, P145, DOI 10.1016/j.ctrv.2018.06.017; Li X, 2014, EUR REV MED PHARMACO, V18, P2031; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lv SZ, 2013, J MOL NEUROSCI, V51, P1046, DOI 10.1007/s12031-013-0096-3; Matsumoto R, 2015, CANCER SCI, V106, P709, DOI 10.1111/cas.12662; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mudduluru G, 2020, JOVE-J VIS EXP, DOI 10.3791/60997; Nabekura T, 2018, J IMMUNOL, V200, P3420, DOI 10.4049/jimmunol.1701639; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Park TJ, 2014, ONCOGENE, V33, P5121, DOI 10.1038/onc.2013.453; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Park T, 2016, J BIOL CHEM, V291, P26273, DOI 10.1074/jbc.M116.764613; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ren YL, 2017, J BIOL CHEM, V292, P17939, DOI 10.1074/jbc.M116.773978; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Shi X, 2018, ONCOL RES, V26, P987, DOI 10.3727/096504017X15140534417184; Smith CL, 2016, CELL REP, V15, P2616, DOI 10.1016/j.celrep.2016.05.042; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Song QL, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5671-8; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Takino T, 2003, CANCER RES, V63, P2335; Velasquez C, 2019, J ONCOL, V2019, DOI 10.1155/2019/1740763; Wang J, 2011, MOL CARCINOGEN, V50, P506, DOI 10.1002/mc.20745; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003; Wang L, 2007, BIOCHEM BIOPH RES CO, V362, P976, DOI 10.1016/j.bbrc.2007.08.106; Wang LL, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0633-4; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Yamada S, 2011, CANCER LETT, V303, P84, DOI 10.1016/j.canlet.2011.01.004; Yanagi H, 2012, BIOCHEM BIOPH RES CO, V418, P104, DOI 10.1016/j.bbrc.2011.12.142; Yang XS, 2014, TUMOR BIOL, V35, P12435, DOI 10.1007/s13277-014-2561-1; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Yue S, 2016, ONCOTARGETS THER, V9, P6127, DOI 10.2147/OTT.S87778; Zhao TT, 2013, TUMOR BIOL, V34, P2891, DOI 10.1007/s13277-013-0851-7	59	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100390	10.1016/j.jbc.2021.100390	http://dx.doi.org/10.1016/j.jbc.2021.100390			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33561443	gold, Green Published			2022-12-26	WOS:000672866400364
J	Ichiyama, Y; Obata, S; Saishin, Y; Sawada, O; Kakinoki, M; Sawada, T; Kubota, Y; Ohji, M				Ichiyama, Yusuke; Obata, Shumpei; Saishin, Yoshitsugu; Sawada, Osamu; Kakinoki, Masashi; Sawada, Tomoko; Kubota, Yoshiaki; Ohji, Masahito			The systemic antiangiogenic effect of intravitreal aflibercept injection in a mouse model of retinopathy of prematurity	FASEB JOURNAL			English	Article						anti&#8208; vascular endothelial growth factor; fellow eye; hematogenous effect; retinopathy of prematurity; systemic effect	ENDOTHELIAL GROWTH-FACTOR; VEGF; BEVACIZUMAB; ANGIOGENESIS; INHIBITION; LETHALITY; LASER	Retinopathy of prematurity (ROP) is a leading cause of childhood blindness and intravitreal anti-vascular endothelial growth factor (VEGF) injection is becoming a first-line choice for treatment of ROP. However, there is a major concern that intravitreally injected anti-VEGF agents could escape from the eye into the systemic circulation and impair systemic development. Moreover, escaped anti-VEGF agents could have an effect on the retina of the fellow eye. In this study, we investigated the hematogenous effect of a single intravitreal anti-VEGF injection in a mouse model of ROP. Here, we showed that single intravitreal aflibercept injection to one eye can affect body weight gain, the fellow eye, and renal vessels, although no apparent effect was observed in brain vessels. Furthermore, this hematogenous effect was dose-dependent. Our results provide very important insights into the clinical use of anti-VEGF agents for ROP treatment.	[Ichiyama, Yusuke; Obata, Shumpei; Saishin, Yoshitsugu; Sawada, Osamu; Kakinoki, Masashi; Sawada, Tomoko; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Seta Tsukinowacho, Otsu, Shiga 5202192, Japan; [Kubota, Yoshiaki] Keio Univ, Dept Anat, Sch Med, Tokyo, Japan	Shiga University of Medical Science; Keio University	Ichiyama, Y (corresponding author), Shiga Univ Med Sci, Dept Ophthalmol, Seta Tsukinowacho, Otsu, Shiga 5202192, Japan.	ichiyama@belle.shiga-med.ac.jp	Ichiyama, Yusuke/AAN-5983-2021		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19K18877, 2019-R-117, E00000559]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 19K18877; Novartis | Alcon, Grant/Award Number: 2019-R-117 and E00000559	Arima M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230678; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fan YY, 2019, OPHTHALMOLOGY, V126, P1567, DOI 10.1016/j.ophtha.2019.03.048; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fish JE, 2017, DEVELOPMENT, V144, P2428, DOI 10.1242/dev.146050; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hong YR, 2015, RETINA-J RET VIT DIS, V35, P1772, DOI 10.1097/IAE.0000000000000535; Huang CY, 2018, GRAEF ARCH CLIN EXP, V256, P479, DOI 10.1007/s00417-017-3878-4; Hwang CK, 2015, OPHTHALMOLOGY, V122, P1008, DOI 10.1016/j.ophtha.2014.12.017; Iacobelli S, 2007, AM J PERINAT, V24, P587, DOI 10.1055/s-2007-992173; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Kennedy KA, 2018, J AAPOS, V22, P61, DOI 10.1016/j.jaapos.2017.10.006; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lien RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148019; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; Natarajan G, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3537; Ogura S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90905; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Okuno Y, 2012, NAT MED, V18, P1208, DOI 10.1038/nm.2846; Roohipoor R, 2018, OPHTHALMOL RETINA, V2, P942, DOI 10.1016/j.oret.2018.01.017; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2019, LANCET, V394, P1551, DOI 10.1016/S0140-6736(19)31344-3; Tan JJ, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/4353129; Tang F, 2019, ANGIOGENESIS, V22, P369, DOI 10.1007/s10456-019-09662-4; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Tschulakow A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113701; Valencia AM, 2017, EXP LUNG RES, V43, P120, DOI 10.1080/01902148.2017.1306897; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Wallace DK, 2017, JAMA OPHTHALMOL, V135, P654, DOI 10.1001/jamaophthalmol.2017.1055; Wood EH, 2018, OSLI RETINA, V49, pE102, DOI 10.3928/23258160-20180907-16; Zhou Y, 2016, GRAEF ARCH CLIN EXP, V254, P31, DOI 10.1007/s00417-015-2996-0	39	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21390	10.1096/fj.202002414R	http://dx.doi.org/10.1096/fj.202002414R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566381	Bronze			2022-12-26	WOS:000629576700039
J	Kemas, AM; Youhanna, S; Shafagh, RZ; Lauschke, VM				Kemas, Aurino M.; Youhanna, Sonia; Shafagh, Reza Zandi; Lauschke, Volker M.			Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume	FASEB JOURNAL			English	Article						glucose disposition; insulin resistance; off&#8208; stoichiometric thiol&#8208; ene; organotypic cell culture; thiol&#8208; Michael addition reaction; type 2 diabetes	HORSERADISH-PEROXIDASE; HEPATOCYTE SPHEROIDS; ANIMAL-MODELS; CELL-CULTURE; METABOLISM; SYSTEMS	The liver plays a central role in glucose homeostasis and hepatic insulin resistance constitutes a key feature of type 2 diabetes. However, platforms that accurately mimic human hepatic glucose disposition and allow for rapid and scalable quantification of glucose consumption dynamics are lacking. Here, we developed and optimized a colorimetric glucose assay based on the glucose oxidase-peroxidase system and demonstrate that the system can monitor glucose consumption in 3D primary human liver cell cultures over multiple days. The system was highly sensitive (limit of detection of 3.5 mu M) and exceptionally accurate (R-2 = 0.999) while requiring only nanoliter input volumes (250 nL), enabling longitudinal profiling of individual liver microtissues. By utilizing a novel polymer, off-stoichiometric thiol-ene (OSTE), and click-chemistry based on thiol-Michael additions, we furthermore show that the assay can be covalently bound to custom-build chips, facilitating the integration of the sensor into microfluidic devices. Using this system, we find that glucose uptake of our 3D human liver cultures closely resembles human hepatic glucose uptake in vivo as measured by euglycemic-hyperinsulinemic clamp. By comparing isogenic insulin-resistant and insulin-sensitive liver cultures we furthermore show that insulin and extracellular glucose levels account for 55% and 45% of hepatic glucose consumption, respectively. In conclusion, the presented data show that the integration of accurate and scalable nanoliter glucose sensors with physiologically relevant organotypic human liver models enables longitudinal profiling of hepatic glucose consumption dynamics that will facilitate studies into the biology and pathobiology of glycemic control, as well as antidiabetic drug screening.	[Kemas, Aurino M.; Youhanna, Sonia; Shafagh, Reza Zandi; Lauschke, Volker M.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Shafagh, Reza Zandi] KTH Royal Inst Tech, Dept Micro & Nanosyst, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Lauschke, VM (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.	volker.lauschke@ki.se	Shafagh, Reza Zandi/AAH-4641-2020; Lauschke, Volker/O-3014-2017	Shafagh, Reza Zandi/0000-0003-4322-6192; Kemas, Aurino M./0000-0001-9031-4748; Lauschke, Volker/0000-0002-1140-6204	Vetenskapsradet (VR) [2019-01837]; Innovative Medicines Initiative (IMI) [875510]	Vetenskapsradet (VR)(Swedish Research Council); Innovative Medicines Initiative (IMI)	Vetenskapsradet (VR), Grant/Award Number: 2016-01153; Vetenskapsradet (VR), Grant/Award Number: 201601154; Vetenskapsradet (VR), Grant/Award Number: 2019-01837; Innovative Medicines Initiative (IMI), Grant/Award Number: 875510	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; [Anonymous], 2015, Nat Rev Dis Primers, V1, P15039, DOI 10.1038/nrdp.2015.39; Bell CC, 2017, DRUG METAB DISPOS, V45, P419, DOI 10.1124/dmd.116.074369; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Chadt A, 2020, PFLUG ARCH EUR J PHY, V472, P1273, DOI 10.1007/s00424-020-02417-x; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Curcio E, 2007, BIOMATERIALS, V28, P5487, DOI 10.1016/j.biomaterials.2007.08.033; Davidson MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28178; Davidson MD, 2015, TISSUE ENG PART C-ME, V21, P716, DOI [10.1089/ten.tec.2014.0512, 10.1089/ten.TEC.2014.0512]; Ekhlaspour Laya, 2017, J Diabetes Sci Technol, V11, P558, DOI 10.1177/1932296816672237; Ewart L, 2018, ANNU REV PHARMACOL, V58, P65, DOI 10.1146/annurev-pharmtox-010617-052722; Fornera S, 2010, ANAL BIOCHEM, V407, P293, DOI 10.1016/j.ab.2010.07.034; Gonzales WV, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040800; Heller A, 2008, CHEM REV, V108, P2482, DOI 10.1021/cr068069y; Honka MJ, 2018, EUR J ENDOCRINOL, V178, P523, DOI 10.1530/EJE-17-0882; Hurrell T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040964; Iozzo P, 2003, J NUCL MED, V44, P682; JAKOBSEN LK, 1960, SCAND J CLIN LAB INV, V12, P76, DOI 10.3109/00365516009046170; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Kemas AM, 2021, FASEB J, V35, DOI 10.1096/fj.202001989RR; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kozyra M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32722-6; Lauschke VM, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800347; Lauschke VM, 2016, HEPATOLOGY, V64, P1743, DOI 10.1002/hep.28780; Lauschke VM, 2016, PHARMACOGENOMICS, V17, P917, DOI 10.2217/pgs-2016-0023; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Li HX, 2019, NAT MED, V25, P850, DOI 10.1038/s41591-019-0404-8; Lin C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1829148; Lu YH, 2012, BIOTECHNOL BIOENG, V109, P595, DOI 10.1002/bit.23349; Messner Simon, 2018, Appl In Vitro Toxicol, V4, P1, DOI 10.1089/aivt.2017.0022; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Nagarajan SR, 2019, AM J PHYSIOL-ENDOC M, V316, pE578, DOI 10.1152/ajpendo.00365.2018; Nair DP, 2014, CHEM MATER, V26, P724, DOI 10.1021/cm402180t; Navale Archana M, 2016, Biophys Rev, V8, P5, DOI 10.1007/s12551-015-0186-2; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; PORSTMANN B, 1981, J CLIN CHEM CLIN BIO, V19, P435; Rebel Annette, 2012, J Diabetes Sci Technol, V6, P396; Sandstrom N, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/7/075002; Sandstrom N, 2017, J MICROMECH MICROENG, V27, DOI 10.1088/1361-6439/aa91fd; Santoleri D, 2019, CELL MOL GASTROENTER, V7, P447, DOI 10.1016/j.jcmgh.2018.10.016; Shafagh RZ, 2019, MICROSYST NANOENG, V5, DOI 10.1038/s41378-019-0065-2; Shafagh RZ, 2018, ACS NANO, V12, P9940, DOI 10.1021/acsnano.8b03709; Shen JX, 2020, CHEM RES TOXICOL, V33, P38, DOI 10.1021/acs.chemrestox.9b00245; Steiner MS, 2011, CHEM SOC REV, V40, P4805, DOI 10.1039/c1cs15063d; Tam CS, 2012, DIABETES CARE, V35, P1605, DOI 10.2337/dc11-2339; Underhill GH, 2018, CELL MOL GASTROENTER, V5, P426, DOI 10.1016/j.jcmgh.2017.11.012; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vojinovic V, 2004, J MOL CATAL B-ENZYM, V28, P129, DOI 10.1016/j.molcatb.2004.02.003; Vorrink SU, 2017, FASEB J, V31, P2696, DOI 10.1096/fj.201601375R; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wei JJ, 2020, J TISSUE ENG REGEN M, V14, P774, DOI 10.1002/term.3042; Wilson ZE, 2003, BRIT J CLIN PHARMACO, V56, P433, DOI 10.1046/j.1365-2125.2003.01881.x; Yamamoto Norio, 2015, Curr Protoc Pharmacol, V71, DOI 10.1002/0471141755.ph1214s71; Zhang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13982; Zhou YT, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01093	59	16	16	5	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21305	10.1096/fj.202001989RR	http://dx.doi.org/10.1096/fj.202001989RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566368	hybrid			2022-12-26	WOS:000629576700052
J	Lee, SJ; Kim, SJ; Jo, DH; Park, KS; Kim, JH				Lee, Seok Jae; Kim, Soo-Jin; Jo, Dong Hyun; Park, Kyu-Sang; Kim, Jeong Hun			Blockade of mTORC1-NOX signaling pathway inhibits TGF-beta 1-mediated senescence-like structural alterations of the retinal pigment epithelium	FASEB JOURNAL			English	Article						epithelial&#8208; mesenchymal transition; retinal pigment epithelium; senescence; TGF&#8208; &#946; 1; mTORC1&#8208; NOX signaling		The retinal pigment epithelium (RPE) undergoes characteristic structural changes and epithelial-mesenchymal transition (EMT) during normal aging, which are exacerbated in age-related macular degeneration (AMD). Although the pathogenic mechanisms of aging and AMD remain unclear, transforming growth factor-beta 1 (TGF-beta 1) is known to induce oxidative stress, morphometric changes, and EMT as a senescence-promoting factor. In this study, we examined whether intravitreal injection of TGF-beta 1 into the mouse eye elicits senescence-like morphological alterations in the RPE and if this can be prevented by suppressing mammalian target of rapamycin complex 1 (mTORC1) or NADPH oxidase (NOX) signaling. We verified that intravitreal TGF-beta 1-induced stress fiber formation and EMT in RPE cells, along with age-associated morphometric changes, including increased variation in cell size and reduced cell density. In RPE cells, exogenous TGF-beta 1 increased endogenous expression of TGF-beta 1 and upregulated Smad3-ERK1/2-mTORC1 signaling, increasing reactive oxygen species (ROS) production and EMT. We demonstrated that inhibition of the mTORC1-NOX4 pathway by pretreatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an activator of AMP-dependent protein kinase, or GKT137831, a NOX1/4 inhibitor, decreased ROS generation, prevented stress fiber formation, attenuated EMT, and improved the regularity of the RPE structure in vitro and in vivo. These results suggest that intravitreal TGF-beta 1 injection could be used as a screening model to investigate the aging-related structural and functional changes to the RPE. Furthermore, the regulation of TGF-beta-mTORC1-NOX signaling could be a potential therapeutic target for reducing pathogenic alterations in aged RPE and AMD.	[Lee, Seok Jae; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 03080, South Korea; [Lee, Seok Jae; Kim, Jeong Hun] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Kim, Soo-Jin; Park, Kyu-Sang] Yonsei Univ, Dept Physiol, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea; [Jo, Dong Hyun] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Med, Seoul, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Jeong Hun] Korea Res Inst Biosci & Biotechnol, Adv Biomed Res Ctr, Daejeon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 03080, South Korea.; Park, KS (corresponding author), Yonsei Univ, Dept Physiol, Wonju Coll Med, Wonju 220701, Gangwon Do, South Korea.	qsang@yonsei.ac.kr; steph25@snu.ac.kr		Kim, Jeong Hun/0000-0003-2957-1766; Lee, Seok Jae/0000-0003-1523-0012	Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2018M3D1A1058826]; National Research Foundation of Korea (NRF) [2015M3A7B6027946]; Development of Platform Technology for Innovative Medical Measurements - Korea Research Institute of Standards and Science [KRISS-2020-GP2020-0004]; Medical Research Center Program - Ministry of Science and ICT [2017R1A5A2015369]	Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT(National Research Foundation of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Development of Platform Technology for Innovative Medical Measurements - Korea Research Institute of Standards and Science; Medical Research Center Program - Ministry of Science and ICT	This research was supported by the Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2018M3D1A1058826 to JHK), the National Research Foundation of Korea (NRF) Grants (2015M3A7B6027946 to JHK), the Development of Platform Technology for Innovative Medical Measurements funded by Korea Research Institute of Standards and Science (KRISS-2020-GP2020-0004 to JHK), and the Medical Research Center Program funded by the Ministry of Science and ICT (2017R1A5A2015369 to K.-S.P).	Antikainen H, 2017, AGING CELL, V16, P1219, DOI 10.1111/acel.12689; Bai YJ, 2014, MOL VIS, V20, P1258; Bhatia SK, 2016, MOL VIS, V22, P898; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554; Chen M, 2016, AGING CELL, V15, P436, DOI 10.1111/acel.12447; Choi K, 2012, MOL VIS, V18, P1010; Cichon MA, 2014, ONCOTARGET, V5, P2827, DOI 10.18632/oncotarget.1940; Das R, 2019, KIDNEY INT, V96, P927, DOI 10.1016/j.kint.2019.05.006; Das R, 2015, J BIOL CHEM, V290, P30830, DOI 10.1074/jbc.M115.703116; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Ghosh S, 2018, INVEST OPHTH VIS SCI, V59, P104, DOI 10.1167/iovs.18-24132; Golestaneh N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.453; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hindupur SK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019141; Hirsch L, 2015, CYTOKINE, V71, P394, DOI 10.1016/j.cyto.2014.11.014; Huang JC, 2019, THERANOSTICS, V9, P1170, DOI 10.7150/thno.26281; Hyttinen JMT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225800; Jarman ER, 2014, AM J RESP CELL MOL, V50, P158, DOI 10.1165/rcmb.2013-0174OC; Kim SJ, 2020, BIOCHEM BIOPH RES CO, V529, P747, DOI 10.1016/j.bbrc.2020.06.034; Kimura K, 2015, J MOL MED, V93, P749, DOI 10.1007/s00109-015-1289-8; Lee SJ., 2021, FASEB J, V35; Li NS, 2016, TUMOR BIOL, V37, P8249, DOI 10.1007/s13277-015-4639-9; Matoba R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181481; Muller C, 2018, STEM CELL REP, V10, P1075, DOI 10.1016/j.stemcr.2018.01.017; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; Papageorgis Panagiotis, 2017, Critical Reviews in Oncogenesis, V22, P313, DOI 10.1615/CritRevOncog.2017025134; Radeke MJ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0183-x; Roehlecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071570; Santos F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040891; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Shu DY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124271; Stone JD, 2015, AM J PHYSIOL-HEART C, V309, pH251, DOI 10.1152/ajpheart.00846.2014; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tarau IS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143578; Teixeira G, 2017, BRIT J PHARMACOL, V174, P1647, DOI 10.1111/bph.13532; Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002; Tosi GM, 2017, INVEST OPHTH VIS SCI, V58, P162, DOI 10.1167/iovs.16-20922; Wilkinson-Berka JL, 2014, ANTIOXID REDOX SIGN, V20, P2726, DOI 10.1089/ars.2013.5357; Wu D, 2019, FASEB J, V33, P2498, DOI 10.1096/fj.201801227R; Yang J, 2018, INT J MOL MED, V42, P123, DOI 10.3892/ijmm.2018.3612; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Zhou M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00501	47	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21403	10.1096/fj.202001939RR	http://dx.doi.org/10.1096/fj.202001939RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559185				2022-12-26	WOS:000629576700028
J	Nissinen, TA; Hentila, J; Fachada, V; Lautaoja, JH; Pasternack, A; Ritvos, O; Kivela, R; Hulmi, JJ				Nissinen, Tuuli A.; Hentila, Jaakko; Fachada, Vasco; Lautaoja, Juulia H.; Pasternack, Arja; Ritvos, Olli; Kivela, Riikka; Hulmi, Juha J.			Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting	FASEB JOURNAL			English	Article						activins; myostatin; mechanistic target of rapamycin protein; physical activity; fasting		Blocking of myostatin and activins effectively counteracts muscle atrophy. However, the potential interaction with physical inactivity and fasting in the regulation of muscle protein synthesis is poorly understood. We used blockade of myostatin and activins by recombinant adeno-associated virus (rAAV)-mediated follistatin (FS288) overexpression in mouse tibialis anterior muscle. To investigate the effects on muscle protein synthesis, muscles were collected 7 days after rAAV-injection in the nighttime or in the daytime representing high and low levels of activity and feeding, respectively, or after overnight fasting, refeeding, or ad libitum feeding. Muscle protein synthesis was increased by FS288 independent of the time of the day or the feeding status. However, the activation of mTORC1 signaling by FS288 was attenuated in the daytime and by overnight fasting. FS288 also increased the amount of mTOR colocalized with lysosomes, but did not alter their localization toward the sarcolemma. This study shows that FS288 gene delivery increases muscle protein synthesis largely independent of diurnal fluctuations in physical activity and food intake or feeding status, overriding the physiological signals. This is important for eg cachectic and sarcopenic patients with reduced physical activity and appetite. The FS288-induced increase in mTORC1 signaling and protein synthesis may be in part driven by increased amount of mTOR colocalized with lysosomes, but not by their localization toward sarcolemma.	[Nissinen, Tuuli A.; Hentila, Jaakko; Fachada, Vasco; Lautaoja, Juulia H.; Hulmi, Juha J.] Univ Jyvaskyla, Fac Sport & Hlth Sci, NeuroMuscular Res Ctr, Rautpohjankatu 8, Jyvaskyla 40014, Finland; [Pasternack, Arja; Ritvos, Olli] Univ Helsinki, Fac Med, Dept Physiol, Helsinki, Finland; [Kivela, Riikka] Univ Helsinki, Fac Med, Res Programs Unit, Stem Cells & Metab Res Program, Helsinki, Finland; [Kivela, Riikka] Wihuri Res Inst, Helsinki, Finland	University of Jyvaskyla; University of Helsinki; University of Helsinki; Wihuri Research Institute	Hulmi, JJ (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, NeuroMuscular Res Ctr, Rautpohjankatu 8, Jyvaskyla 40014, Finland.	juha.hulmi@jyu.fi	Ritvos, Olli/GWC-2442-2022; Hentilä, Jaakko/GQI-1596-2022; Kivela, Riikka/I-2859-2016	Ritvos, Olli/0000-0001-7017-6931; Lautaoja, Juulia/0000-0003-2037-829X; Fachada, Vasco/0000-0002-6575-1943; Kivela, Riikka/0000-0002-2686-8890; Hentila, Jaakko/0000-0001-8211-8827; Hulmi, Juha/0000-0003-3813-2124; Pasternack, Arja/0000-0002-6088-4245	Academy of Finland [275922, 297245]; Ellen and Artturi Nyyssonen Foundation	Academy of Finland(Academy of Finland); Ellen and Artturi Nyyssonen Foundation	Academy of Finland, Grant/Award Number: 275922 and 297245; Ellen and Artturi Nyyssonen Foundation	Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; Ahren B, 2000, ACTA PHYSIOL SCAND, V169, P325, DOI 10.1046/j.1365-201x.2000.00746.x; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Brook MS, 2016, ACTA PHYSIOL, V216, P15, DOI 10.1111/apha.12532; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Collins-Hooper H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120524; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Davey JR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85477; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Han XQ, 2019, J CACHEXIA SARCOPENI, V10, P1241, DOI 10.1002/jcsm.12474; Hashimoto O, 2000, CELL SIGNAL, V12, P565, DOI 10.1016/S0898-6568(00)00099-1; Hentila J, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13069; Hodson N, 2019, EXERC SPORT SCI REV, V47, P46, DOI 10.1249/JES.0000000000000173; Hodson N, 2017, AM J PHYSIOL-CELL PH, V313, pC604, DOI 10.1152/ajpcell.00176.2017; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE171, DOI 10.1152/ajpendo.00065.2013; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Hulmi JJ, 2009, J APPL PHYSIOL, V106, P1720, DOI 10.1152/japplphysiol.00087.2009; Jacobs BL, 2014, J MUSCLE RES CELL M, V35, P11, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kmiec Z, 2005, GERONTOLOGY, V51, P357, DOI 10.1159/000088698; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lessard SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05439-3; MacDonald EM, 2014, DIS MODEL MECH, V7, P471, DOI 10.1242/dmm.014126; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Nissinen TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32695; Nissinen TA., 2021, FASEB J, V35; Nissinen TA, 2018, J CACHEXIA SARCOPENI, V9, P514, DOI 10.1002/jcsm.12310; OGATA ES, 1978, J NUTR, V108, P759, DOI 10.1093/jn/108.5.759; Oikawa SY, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00075; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; REEDS PJ, 1986, BIOSCIENCE REP, V6, P209, DOI 10.1007/BF01115008; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sedliak M, 2018, CHRONOBIOL INT, V35, P450, DOI 10.1080/07420528.2017.1411360; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sepulveda PV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17535; Shavlakadze T, 2013, AM J PHYSIOL-CELL PH, V305, pC26, DOI 10.1152/ajpcell.00027.2013; Shavlakadze T, 2013, J NUTR, V143, P403, DOI 10.3945/jn.112.171967; Silvennoinen M, 2014, J NEUROSCI METH, V235, P51, DOI 10.1016/j.jneumeth.2014.06.027; Song Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05483-x; Toledo M, 2016, INT J CANCER, V138, P2021, DOI 10.1002/ijc.29930; Welle S, 2011, AM J PHYSIOL-ENDOC M, V300, pE993, DOI 10.1152/ajpendo.00509.2010; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	58	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21387	10.1096/fj.202002008R	http://dx.doi.org/10.1096/fj.202002008R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559263	hybrid, Green Published			2022-12-26	WOS:000629576700008
J	Gabriel, T; Wondu, K; Dilebo, J				Gabriel, Tesfaye; Wondu, Kebede; Dilebo, Jemal			Valorization of khat (Catha edulis) waste for the production of cellulose fibers and nanocrystals	PLOS ONE			English	Article							IN-VITRO EVALUATION; BANANA PSEUDO-STEM; MICROCRYSTALLINE CELLULOSE; CONTROLLED-RELEASE; EXTRACTION; NANOCELLULOSE; FORMULATION; GEL; HEMICELLULOSE; NANOWHISKERS	Cellulose fibers (C-40 and C-80) were extracted from khat (Catha edulis) waste (KW) with chlorine-free process using 40% formic acid/40% acetic acid (C-40), and 80% formic acid/80% acetic acid (C-80) at the pretreatment stage, followed by further delignification and bleaching stages. Cellulose nanocrystals (CNCs40 and CNCs80) were then isolated from C-40 and C-80 with sulfuric acid hydrolysis, respectively. Thus, the current study aims to isolate cellulose fibers and CNCs from KW as alternative source. The KW, cellulose fibers, and CNCs were investigated for yield, chemical composition, functionality, crystallinity, morphology, and thermal stability. CNCs were also evaluated for colloidal stability, particle size, and their influence on in vitro diclofenac sodium release from gel formulations preliminarily. The FTIR spectra analysis showed the removal of most hemicellulose and lignin from the cellulose fibers. The XRD results indicated that chemical pretreatments and acid hydrolysis significantly increased the crystallinity of cellulose fibers and CNCs. The cellulose fibers and CNCs exhibited Cellulose I-beta crystalline lattice. TEM analysis revealed formation of needle-shaped nanoscale rods (length: 101.55-162.96 nm; aspect ratio: 12.84-22.73). The hydrodynamic size, polydispersity index, and zeta potential of the CNCS ranged from 222.8-362.8 nm; 0.297-0.461, and -45.7 to -75.3 mV, respectively. CNCs40 exhibited superior properties to CNCs80 in terms of aspect ratio, and colloidal and thermal stability. Gel formulations containing high proportion of CNCs sustained diclofenac sodium release (< 50%/cm(2)) over 12 h. This study suggests that cellulose fibers and nanocrystals can be successfully obtained from abundant and unexploited source, KW for value-added industrial applications.	[Gabriel, Tesfaye; Wondu, Kebede; Dilebo, Jemal] Addis Ababa Univ, Sch Pharm, Dept Pharmaceut & Social Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Gabriel, T (corresponding author), Addis Ababa Univ, Sch Pharm, Dept Pharmaceut & Social Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	tesfaye.gabriel@aau.edu.et		Dalalo, Tesfaye Gabriel/0000-0002-8111-0513				Abdel-Halim ES, 2014, ARAB J CHEM, V7, P362, DOI 10.1016/j.arabjc.2013.05.006; Abitbol T, 2016, CURR OPIN BIOTECH, V39, P76, DOI 10.1016/j.copbio.2016.01.002; Agarwal J, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.49291; Aiyalu R, 2016, BRAZ J PHARM SCI, V52, P493, DOI [10.1590/S1984-82502016000300015, 10.1590/s1984-82502016000300015]; Alghooneh A, 2017, INT J FOOD PROP, V20, P2830, DOI 10.1080/10942912.2016.1253097; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Bano S, 2017, CARBOHYD POLYM, V157, P1041, DOI 10.1016/j.carbpol.2016.10.069; Benito-Gonzalez I, 2019, CELLULOSE, V26, P8007, DOI 10.1007/s10570-019-02641-4; Bettaieb F, 2015, IND CROP PROD, V72, P175, DOI 10.1016/j.indcrop.2014.12.038; Bettaieb F, 2015, CARBOHYD POLYM, V123, P99, DOI 10.1016/j.carbpol.2015.01.026; Bolla PK, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12020151; Candido RG, 2016, CARBOHYD POLYM, V152, P679, DOI 10.1016/j.carbpol.2016.07.071; Coelho CCS, 2018, CARBOHYD POLYM, V192, P327, DOI 10.1016/j.carbpol.2018.03.023; Benini KCCD, 2018, CARBOHYD POLYM, V192, P337, DOI 10.1016/j.carbpol.2018.03.055; Collazo-Bigliardi S, 2018, CARBOHYD POLYM, V191, P205, DOI 10.1016/j.carbpol.2018.03.022; Danial WH, 2020, RSC ADV, V10, P42400, DOI 10.1039/d0ra07972c; Dantas Milla Gabriela Belarmino, 2016, ScientificWorldJournal, V2016, P7394685, DOI 10.1155/2016/7394685; de Oliveira JP, 2019, INT J BIOL MACROMOL, V124, P175, DOI 10.1016/j.ijbiomac.2018.11.205; Dessie Gessesse, 2013, FAV DEM PLANT KHAT E; Du HS, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123106; Du HS, 2019, CARBOHYD POLYM, V209, P130, DOI 10.1016/j.carbpol.2019.01.020; El Achaby M, 2018, INT J BIOL MACROMOL, V117, P592, DOI 10.1016/j.ijbiomac.2018.05.201; El-Fattah MA, 2018, CARBOHYD POLYM, V183, P311, DOI 10.1016/j.carbpol.2017.12.084; EP. Cellulose,, 2013, EUR PHARM STAT WORK, V8th; Gabriel T, 2020, INT J BIOL MACROMOL, V158, P1248, DOI 10.1016/j.ijbiomac.2020.04.264; Garcia-Garcia D, 2018, CELLULOSE, V25, P2925, DOI 10.1007/s10570-018-1760-0; Golbaghi L, 2017, CARBOHYD POLYM, V174, P780, DOI 10.1016/j.carbpol.2017.06.123; Gong J, 2018, CARBOHYD POLYM, V195, P18, DOI 10.1016/j.carbpol.2018.04.039; Aguayo MG, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10101145; Haafiz MKM, 2014, CARBOHYD POLYM, V103, P119, DOI 10.1016/j.carbpol.2013.11.055; Haafiz MKM, 2013, CARBOHYD POLYM, V93, P628, DOI 10.1016/j.carbpol.2013.01.035; Jackson JK, 2011, INT J NANOMED, V6, P321, DOI 10.2147/IJN.S16749; Jahan MS, 2011, CELLULOSE, V18, P451, DOI 10.1007/s10570-010-9481-z; Kallel F, 2016, IND CROP PROD, V87, P287, DOI 10.1016/j.indcrop.2016.04.060; Kanai N, 2020, CELLULOSE, V27, P5017, DOI 10.1007/s10570-020-03113-w; Kandari LS, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-579; Kim UJ, 2010, POLYM DEGRAD STABIL, V95, P778, DOI 10.1016/j.polymdegradstab.2010.02.009; Kittipongpatana O, 2009, DRUG DEV IND PHARM, V35, P34, DOI [10.1080/03639040802144229, 10.1080/03639040802144229 ]; Klemm D, 2018, MATER TODAY, V21, P720, DOI 10.1016/j.mattod.2018.02.001; Kumar V, 2020, WASTE MANAGE, V102, P281, DOI 10.1016/j.wasman.2019.10.041; Lankalapalli S, 2012, DRUG DEV IND PHARM, V38, P815, DOI 10.3109/03639045.2011.630006; Lin LL, 2010, BIORESOURCE TECHNOL, V101, P8217, DOI 10.1016/j.biortech.2010.05.084; Liu Z, 2017, CARBOHYD POLYM, V173, P353, DOI 10.1016/j.carbpol.2017.05.079; Mariano M, 2016, IND CROP PROD, V94, P454, DOI 10.1016/j.indcrop.2016.09.011; Meng FR, 2019, IND CROP PROD, V137, P377, DOI 10.1016/j.indcrop.2019.05.025; Meng FR, 2019, COMPOS PART B-ENG, V160, P341, DOI 10.1016/j.compositesb.2018.08.048; Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9; Nichols T, 2015, PHYTOCHEM LETT, V13, P127, DOI 10.1016/j.phytol.2015.05.016; Nuruddin M, 2011, CELL CHEM TECHNOL, V45, P347; Nuruddin M, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.42990; Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438; PhEur, 2013, CELL POWD, V8th; Plackett DV, 2014, NORD PULP PAP RES J, V29, P105, DOI 10.3183/npprj-2014-29-01-p105-118; Poletto M, 2014, MATERIALS, V7, P6105, DOI 10.3390/ma7096105; Popescu MC, 2011, J MOL STRUCT, V988, P65, DOI 10.1016/j.molstruc.2010.12.004; Prado KS, 2019, INT J BIOL MACROMOL, V122, P410, DOI 10.1016/j.ijbiomac.2018.10.187; Rameshwar H. Y., 2016, International Journal of Recycling of Organic Waste in Agriculture, V5, P105, DOI 10.1007/s40093-016-0121-y; Rhim JW, 2015, CELLULOSE, V22, P407, DOI 10.1007/s10570-014-0517-7; Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059; Silverio HA, 2013, IND CROP PROD, V44, P427, DOI 10.1016/j.indcrop.2012.10.014; Singh S, 2017, INT J BIOL MACROMOL, V99, P506, DOI 10.1016/j.ijbiomac.2017.03.004; Smyth M, 2017, IND CROP PROD, V108, P257, DOI 10.1016/j.indcrop.2017.06.006; Stinson-Bagby KL, 2018, CARBOHYD POLYM, V186, P429, DOI 10.1016/j.carbpol.2018.01.054; Tarchoun AF, 2019, INT J BIOL MACROMOL, V138, P837, DOI 10.1016/j.ijbiomac.2019.07.176; Tesfaye Gabriel, 2013, Journal of Drug Delivery and Therapeutics, V3, P1; Thomas D, 2018, J DRUG DELIV SCI TEC, V46, P392, DOI 10.1016/j.jddst.2018.06.004; Tsegaye B, 2019, ENVIRON TECHNOL, V40, P1203, DOI 10.1080/09593330.2017.1418911; Ubaid M, 2016, AN ACAD BRAS CIENC, V88, P2303, DOI 10.1590/0001-3765201620160162; Wada M, 2001, CELLULOSE, V8, P183, DOI 10.1023/A:1013196220602; Wang ZH, 2019, INT J BIOL MACROMOL, V129, P1081, DOI 10.1016/j.ijbiomac.2018.07.055; Watkins D, 2015, J MATER RES TECHNOL, V4, P26, DOI 10.1016/j.jmrt.2014.10.009; Wijaya CJ, 2017, CARBOHYD POLYM, V175, P370, DOI 10.1016/j.carbpol.2017.08.004; Wuletaw Mekuria, 2018, Journal of Agricultural Extension and Rural Development, V10, P192, DOI 10.5897/JAERD2018.0984; Xiao YQ, 2019, INT J BIOL MACROMOL, V140, P225, DOI 10.1016/j.ijbiomac.2019.08.160; Xie JL, 2016, CARBOHYD POLYM, V151, P725, DOI 10.1016/j.carbpol.2016.06.011; Xing LD, 2018, CARBOHYD POLYM, V192, P184, DOI 10.1016/j.carbpol.2018.03.042; Xu QH, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9020253; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Yeasmin MS, 2015, INT J BIOL MACROMOL, V80, P725, DOI 10.1016/j.ijbiomac.2015.07.040; Zhang H, 2020, CARBOHYD POLYM, V238, DOI 10.1016/j.carbpol.2020.116180	80	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246794	10.1371/journal.pone.0246794	http://dx.doi.org/10.1371/journal.pone.0246794			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561156	Green Published, gold			2022-12-26	WOS:000617533000038
J	Netanely, D; Leibou, S; Parikh, R; Stern, N; Vaknine, H; Brenner, R; Amar, S; Factor, RH; Perluk, T; Frand, J; Nizri, E; Hershkovitz, D; Zemser-Werner, V; Levy, C; Shamir, R				Netanely, Dvir; Leibou, Stav; Parikh, Roma; Stern, Neta; Vaknine, Hananya; Brenner, Ronen; Amar, Sarah; Factor, Rivi Haiat; Perluk, Tomer; Frand, Jacob; Nizri, Eran; Hershkovitz, Dov; Zemser-Werner, Valentina; Levy, Carmit; Shamir, Ron			Classification of node-positive melanomas into prognostic subgroups using keratin, immune, and melanogenesis expression patterns	ONCOGENE			English	Article							GENE; CANCER; TOOL; CONTRIBUTES; DISCOVERY; DYNAMICS; EXPANDER; SUBTYPES; BIOLOGY	Cutaneous melanoma tumors are heterogeneous and show diverse responses to treatment. Identification of robust molecular biomarkers for classifying melanoma tumors into clinically distinct and homogenous subtypes is crucial for improving the diagnosis and treatment of the disease. In this study, we present a classification of melanoma tumors into four subtypes with different survival profiles based on three distinct gene expression signatures: keratin, immune, and melanogenesis. The melanogenesis expression pattern includes several genes that are characteristic of the melanosome organelle and correlates with worse survival, suggesting the involvement of melanosomes in melanoma aggression. We experimentally validated the secretion of melanosomes into surrounding tissues by melanoma tumors, which potentially affects the lethality of metastasis. We propose a simple molecular decision tree classifier for predicting a tumor's subtype based on representative genes from the three identified signatures. Key predictor genes were experimentally validated on melanoma samples taken from patients with varying survival outcomes. Our three-pattern approach for classifying melanoma tumors can contribute to advancing the understanding of melanoma variability and promote accurate diagnosis, prognostication, and treatment.	[Netanely, Dvir; Stern, Neta; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Leibou, Stav; Parikh, Roma; Nizri, Eran; Hershkovitz, Dov; Levy, Carmit] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Vaknine, Hananya; Brenner, Ronen; Amar, Sarah] Edith Wolfson Med Ctr, Dept Oncol, Holon, Israel; [Factor, Rivi Haiat; Perluk, Tomer; Frand, Jacob] Edith Wolfson Med Ctr, Dept Plast & Reconstruct Surg, Holon, Israel; [Nizri, Eran] Tel Aviv Sourasky Med Ctr, Dept Surg A, Tel Aviv, Israel; [Hershkovitz, Dov; Zemser-Werner, Valentina] Tel Aviv Sourasky Med Ctr, Inst Pathol, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870; Netanely, Dvir/0000-0002-6861-2332	Israeli Science Foundation [1339/18]; GermanIsraeli Project DFG [RE 4193/1-1]; United States-Israel Binational Science Foundation, Jerusal em, Israel [2016694]; United States National Science Foundation; European Research Council under the European Union [726225]; Melanoma Research Alliance [402792]; Edmond J. Safra Center for Bioinformatics, Tel Aviv University	Israeli Science Foundation(Israel Science Foundation); GermanIsraeli Project DFG(German Research Foundation (DFG)); United States-Israel Binational Science Foundation, Jerusal em, Israel(US-Israel Binational Science Foundation); United States National Science Foundation(National Science Foundation (NSF)); European Research Council under the European Union(European Research Council (ERC)); Melanoma Research Alliance; Edmond J. Safra Center for Bioinformatics, Tel Aviv University	The results published here are based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://ca ncergenome.nih.gov. The authors would like to thank Dr. Martin Lauss from Lund University for providing them with the assignment of TCGA melanoma samples to Lund subtypes. RS acknowledges the support of the Israeli Science Foundation (grant 1339/18), GermanIsraeli Project DFG RE 4193/1-1, and grant 2016694 from the United States-Israel Binational Science Foundation, Jerusal em, Israel, and the United States National Science Foundation. CL acknowledges grant support from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 726225) and Melanoma Research Alliance (402792). DN was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics, Tel Aviv University.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Apalla Z., 2017, DERMATOL PRACT CONCE, V7, DOI [10.5826/dpc.0702a01, DOI 10.5826/DPC.0702A01]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell RE, 2016, GENOME RES, V26, P601, DOI 10.1101/gr.197194.115; Bellono NW, 2014, ELIFE, V3, DOI 10.7554/eLife.04543; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Borgono CA, 2006, CLIN CANCER RES, V12, P1487, DOI 10.1158/1078-0432.CCR-05-2106; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen KG, 2009, JNCI-J NATL CANCER I, V101, P1259, DOI 10.1093/jnci/djp259; Chen KG, 2006, FROM MELANOCYTES TO MELANOMA: THE PROGRESSION TO MALIGNANCY, P591, DOI 10.1007/978-1-59259-994-3_33; Cirenajwis H, 2015, ONCOTARGET, V6, P12297, DOI 10.18632/oncotarget.3655; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Dror S, 2016, NAT CELL BIOL, V18, P1006, DOI 10.1038/ncb3399; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Horwitz RI, 1979, J CHRON DIS, V32, pII; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kabbarah O, 2005, CANCER CELL, V8, P439, DOI 10.1016/j.ccr.2005.11.008; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lauss M, 2016, J INVEST DERMATOL, V136, P2502, DOI 10.1016/j.jid.2016.05.119; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Leonardi GC, 2018, INT J ONCOL, V52, P1071, DOI 10.3892/ijo.2018.4287; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu XW, 2017, BIOMED PHARMACOTHER, V88, P595, DOI 10.1016/j.biopha.2017.01.112; Loh WY, 1997, STAT SINICA, V7, P815; Manieri NA, 2017, TRENDS IMMUNOL, V38, P20, DOI 10.1016/j.it.2016.10.002; Martins WK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-76; MATTHEWS NH, 2017, EPIDEMIOLOGY MELANOM, P3; Netanely D, 2019, PROMO INTERACTIVE TO, DOI 10.1101/629584; Netanely D, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3142-5; Netanely D, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0724-2; Nsengimana J, 2015, ONCOTARGET, V6, P11683, DOI 10.18632/oncotarget.3549; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ossio R, 2017, NAT REV CANCER, V17, P393, DOI 10.1038/nrc.2017.43; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Rajkumar S, 2016, BRIT J CANCER, V115, P145, DOI 10.1038/bjc.2016.195; Rambow F, 2015, CELL REP, V13, P840, DOI 10.1016/j.celrep.2015.09.037; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Scolyer RA, 2011, MOL ONCOL, V5, P124, DOI 10.1016/j.molonc.2011.03.002; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Shamir, PROMO PROFILER MULTI; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sher YP, 2006, CANCER RES, V66, P11763, DOI 10.1158/0008-5472.CAN-06-3165; Swetter SM, 2019, J AM ACAD DERMATOL, V80, P208, DOI 10.1016/j.jaad.2018.08.055; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Ward WH, 2017, CUTANEOUS MELANOMA: ETIOLOGY AND THERAPY, P79, DOI 10.15586/codon.cutaneousmelanoma.2017.ch6	55	4	4	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1792	1805		10.1038/s41388-021-01665-0	http://dx.doi.org/10.1038/s41388-021-01665-0		FEB 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564068	Green Published, hybrid			2022-12-26	WOS:000616489100010
J	Ye, ZD; Wang, DW; Lu, YY; He, YJ; Yu, JT; Wei, WJ; Chen, C; Wang, R; Zhang, L; Zhang, LR; Le, MTN; Cho, WC; Yang, MS; Zhang, HM; Yue, JB				Ye, Zuodong; Wang, Dawei; Lu, Yingying; He, Yunjiao; Yu, Jingting; Wei, Wenjie; Chen, Chang; Wang, Rui; Zhang, Liang; Zhang, Liangren; Le, Minh T. N.; Cho, William C.; Yang, Mengsu; Zhang, Hongmin; Yue, Jianbo			Vacuolin-1 inhibits endosomal trafficking and metastasis via CapZ beta	ONCOGENE			English	Article							ENDOCYTIC TRAFFICKING; VESICLE TRAFFICKING; CELL; INTEGRIN; GEFS; EXOCYTOSIS; EXPRESSION; REGULATORS; MORPHOLOGY; MIGRATION	Metastasis is the fundamental cause of cancer mortality, but there are still very few anti-metastatic drugs available. Endosomal trafficking has been implicated in tumor metastasis, and we have previously found that small chemical vacuolin-1 (V1) potently inhibits autophagosome-lysosome fusion and general endosomal-lysosomal degradation. Here, we assessed the anti-metastatic activity of V1 both in vitro and in vivo. V1 significantly inhibits colony formation, migration, and invasion of various cancer cells in vitro. It also compromises the assembly-disassembly dynamics of focal adhesions (FAs) by inhibiting the recycling and degradation of integrins. In various experimental or transgenic mouse models, V1 significantly suppresses the metastasis and/or tumor growth of breast cancer or melanoma. We further identified capping protein Z beta (CapZ beta) as a V1 binding protein and showed that it is required for the V1-mediated inhibition of migration and metastasis of cancer cells. Collectively, our results indicate that V1 targets CapZ beta to inhibit endosomal trafficking and metastasis.	[Ye, Zuodong; Wang, Dawei; Lu, Yingying; Yu, Jingting; Wang, Rui; Zhang, Liang; Yang, Mengsu; Yue, Jianbo] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Ye, Zuodong; Wang, Dawei; Lu, Yingying; Wang, Rui; Zhang, Liang; Yang, Mengsu; Yue, Jianbo] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [He, Yunjiao; Zhang, Hongmin] Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [He, Yunjiao; Zhang, Hongmin] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [Wei, Wenjie] South Univ Sci & Technol China, Res Core Facil, Shenzhen 518052, Peoples R China; [Chen, Chang; Zhang, Liangren] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China; [Le, Minh T. N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore; [Cho, William C.] Queen Elizabeth Hosp, Dept Clin Oncol, 30 Gascoigne Rd, Hong Kong, Peoples R China; [Yue, Jianbo] City Univ Hong Kong, Chengdu Res Inst, Chengdu, Peoples R China	City University of Hong Kong; City University of Hong Kong; Southern University of Science & Technology; Southern University of Science & Technology; Southern University of Science & Technology; Peking University; National University of Singapore; City University of Hong Kong	Yue, JB (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.; Yue, JB (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China.; Yue, JB (corresponding author), City Univ Hong Kong, Chengdu Res Inst, Chengdu, Peoples R China.	jianbyue@cityu.edu.hk	Zhang, Liang/GWM-6088-2022; Zhang, Hongmin/S-9953-2017; Yue, Jianbo/K-8002-2015	Zhang, Hongmin/0000-0003-4356-3615; Yue, Jianbo/0000-0001-6384-5447; WANG, Rui/0000-0003-3830-4133; Lu, Yingying/0000-0002-5423-9522; Ye, zuodong/0000-0002-9575-6198; ZHANG, Liang/0000-0003-3100-8593	Hong Kong Research Grant Council (RGC) [11101717, 11103620]; NSFC [21778045, 32070702, 31670753, 31501116]; Guangdong Science and Technology Program [2017B030301018]; Shenzhen Science and Technology Innovation Committee [JCYJ201602291652 35739, JCYJ20170413141331470, JCYJ20160608140912962, SYS20140509142721429]; Sichuan Provincial Science and Technology Research Grant [2019YJ0633]; CASCroucher Funding Scheme	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Program; Shenzhen Science and Technology Innovation Committee; Sichuan Provincial Science and Technology Research Grant; CASCroucher Funding Scheme	This work was supported by Hong Kong Research Grant Council (RGC) grants (11101717 and 11103620), NSFC (21778045, 32070702, 31670753, 31501116), CASCroucher Funding Scheme, Guangdong Science and Technology Program (2017B030301018), research grants from Shenzhen Science and Technology Innovation Committee (JCYJ201602291652 35739, JCYJ20170413141331470, JCYJ20160608140912962, ZD SYS20140509142721429), Sichuan Provincial Science and Technology Research Grant (2019YJ0633).	Alanko J, 2016, TRENDS CELL BIOL, V26, P391, DOI 10.1016/j.tcb.2016.02.001; Alday-Parejo B, 2019, CANCERS, V11, DOI 10.3390/cancers11070978; Alizadeh AM, 2014, TUMOR BIOL, V35, P8483, DOI 10.1007/s13277-014-2421-z; Anderson RL, 2019, NAT REV CLIN ONCOL, V16, P185, DOI 10.1038/s41571-018-0134-8; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Burridge K, 2017, FEBS J, V284, P3355, DOI 10.1111/febs.14195; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen C, 2017, MOLECULES, V22, DOI 10.3390/molecules22060891; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; di Pietro F, 2017, CURR BIOL, V27, P2452, DOI 10.1016/j.cub.2017.06.055; Dubey, STATPEARLS, P2020; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Elkin M, 2001, CURR PROTOC CELL BIO, V12; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Fontebasso Yari, 2015, Critical Reviews in Oncogenesis, V20, P449, DOI 10.1615/CritRevOncog.v20.i5-6.150; Gandalovicova A, 2017, TRENDS CANCER, V3, P391, DOI 10.1016/j.trecan.2017.04.008; Goldenring JR, 2013, NAT REV CANCER, V13, P813, DOI 10.1038/nrc3601; Gomez-Cuadrado L, 2017, DIS MODEL MECH, V10, P1061, DOI 10.1242/dmm.030403; Guerra F, 2019, CANCERS, V11, DOI 10.3390/cancers11081096; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hamidi Hellyeh, 2018, Nat Rev Cancer, V18, P533, DOI 10.1038/s41568-018-0038-z; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Johannes L, 2020, CANCER METAST REV, V39, P375, DOI 10.1007/s10555-020-09880-z; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Lamber EP, 2019, CURR OPIN CELL BIOL, V59, P34, DOI 10.1016/j.ceb.2019.03.004; Langemeyer L, 2018, TRENDS CELL BIOL, V28, P957, DOI 10.1016/j.tcb.2018.06.007; Levine Timothy P, 2013, Small GTPases, V4, P62, DOI 10.4161/sgtp.24262; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Lu YY, 2014, AUTOPHAGY, V10, P1895, DOI 10.4161/auto.32200; MacDonald E, 2018, J CELL BIOL, V217, P2549, DOI 10.1083/jcb.201710051; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mendoza P, 2014, CURR MOL MED, V14, P235, DOI 10.2174/1566524014666140128111347; Mendoza Pablo, 2014, Small GTPases, V5, pe28195, DOI 10.4161/sgtp.28195; Mukherjee K, 2016, HUM MOL GENET, V25, P1255, DOI 10.1093/hmg/ddw006; Muller Matthias P, 2018, Small GTPases, V9, P5, DOI 10.1080/21541248.2016.1276999; Naslavsky N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216499; Novick Peter, 2016, Small GTPases, V7, P252; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Park, 2019, SEMIN CANCER BIOL; Paul NR, 2015, CURR BIOL, V25, pR1092, DOI 10.1016/j.cub.2015.09.049; Pfeffer SR, 2017, MOL BIOL CELL, V28, P712, DOI 10.1091/mbc.E16-10-0737; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Rajendran V, 2018, METHODS MOL BIOL, V1692, P89, DOI 10.1007/978-1-4939-7401-6_8; Rashid OM, 2013, J THORAC DIS, V5, P385, DOI 10.3978/j.issn.2072-1439.2013.06.17; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Rosel D, 2019, TRENDS CANCER, V5, P755, DOI 10.1016/j.trecan.2019.10.011; Schmid SL, 2017, J CELL BIOL, V216, P2623, DOI 10.1083/jcb.201705017; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Shaik GM, 2009, CELL SIGNAL, V21, P1337, DOI 10.1016/j.cellsig.2009.04.001; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Yao F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138213; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	63	8	8	2	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1775	1791		10.1038/s41388-021-01662-3	http://dx.doi.org/10.1038/s41388-021-01662-3		FEB 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564074	Green Published, hybrid			2022-12-26	WOS:000616489100007
J	Tada, R; Ogasawara, M; Yamanaka, D; Sakurai, Y; Negishi, Y; Kiyono, H; Ohno, N; Kunisawa, J; Aramaki, Y				Tada, Rui; Ogasawara, Miki; Yamanaka, Daisuke; Sakurai, Yasuhiro; Negishi, Yoichi; Kiyono, Hiroshi; Ohno, Naohito; Kunisawa, Jun; Aramaki, Yukihiko			Enzymatically polymerised polyphenols prepared from various precursors potentiate antigen-specific immune responses in both mucosal and systemic compartments in mice	PLOS ONE			English	Article							INTERFERON-GAMMA SYNTHESIS; INFECTIOUS-DISEASES; LYMPHOID-TISSUES; VACCINE; TOLERANCE; EPIGALLOCATECHIN-3-GALLATE; COLONIZATION; INVOLVEMENT; REACTIVITY; ANTIBODIES	Despite significant modern medicine progress, having an infectious disease is a major risk factor for humans. Mucosal vaccination is now widely considered as the most promising strategy to defeat infectious diseases; however, only live-attenuated and inactivated mucosal vaccines are used in the clinical field. To date, no subunit mucosal vaccine was approved mainly because of the lack of safe and effective methodologies to either activate or initiate host mucosal immune responses. We have recently elucidated that intranasal administration of enzymatically polymerised caffeic acid potentiates antigen-specific mucosal and systemic antibody responses in mice. However, our earlier study has not confirmed whether these effects are specific to the polymer synthesised from caffeic acid. Here, we show that enzymatically polymerised polyphenols (EPPs) from various phenolic compounds possess mucosal adjuvant activities when administered nasally with an antigen to mice. Potentiation of antigen-specific immune responses by all EPPs tested in this study showed no clear difference among the precursors used. We found that intranasal administration of ovalbumin as the antigen, in combination with all enzymatically polymerised polyphenols used in this study, induced ovalbumin-specific mucosal IgA in the nasal cavity, bronchoalveolar lavage fluid, vaginal fluids, and systemic IgG, especially IgG1, in sera. Our results demonstrate that the mucosal adjuvant activities of polyphenols are not limited to polymerised caffeic acid but are broadly observable across the studied polyphenols. These properties of polyphenols may be advantageous for the development of safe and effective nasal vaccine systems to prevent and/or treat various infectious diseases.	[Tada, Rui; Ogasawara, Miki; Sakurai, Yasuhiro; Negishi, Yoichi; Aramaki, Yukihiko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug Delivery & Mol Biopharmaceut, Tokyo, Japan; [Yamanaka, Daisuke; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Div Mucosal Immunol, Inst Med Sci, Tokyo, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Vaccine Mat, Osaka, Japan; [Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Gut Environm Syst, Osaka, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences; University of Tokyo; University of Tokyo	Tada, R (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug Delivery & Mol Biopharmaceut, Tokyo, Japan.	rui.tada@gmail.com	Tada, Rui/M-3278-2019; Kiyono, Hiroshi/AAC-6735-2022	Tada, Rui/0000-0003-0098-9587; 	JSPS KAKENHI [15K18935, 18K06798, 16K08415, 18H02674]; Japan Agency for Medical Research and Development (AMED) [17fk0108223h0002, 17ek0410032s0102, 17fk0108207h0002, 17ak0101068h0001, 17gm1010006s0101]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by JSPS KAKENHI Grant Number 15K18935 (Grant-in-aid for Young Scientists (B) to R.T.); 18K06798 (Grant-in-Aid for Scientific Research C to R.T.); 16K08415 (Grant-in-Aid for Scientific Research C to Y.A. and R.T.); 18H02674 (Grant-in-Aid for Scientific Research (B) to J.K.). The Japan Agency for Medical Research and Development (AMED) (17fk0108223h0002, 17ek0410032s0102, 17fk0108207h0002, 17ak0101068h0001, and 17gm1010006s0101 to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshi T, 2017, VIRAL IMMUNOL, V30, P463, DOI 10.1089/vim.2017.0026; Borges O, 2010, PHARM RES-DORDR, V27, P211, DOI 10.1007/s11095-009-0011-3; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Coppo E, 2014, CURR PHARM BIOTECHNO, V15, P380, DOI 10.2174/138920101504140825121142; Corth?sy B., 2018, FRONT IMMUNOL, V9, P1, DOI DOI 10.3389/FIMMU.2018.0059329623081; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; Douce G, 1997, INFECT IMMUN, V65, P2821, DOI 10.1128/IAI.65.7.2821-2828.1997; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235; Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Kim SH, 2017, CLIN EXP VACCINE RES, V6, P15, DOI [10.7774/cevr.2017.6.1.15, 10.7774/cevr.2017.6.1.15.]; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kunisawa J, 2005, CURR MOL MED, V5, P557, DOI 10.2174/1566524054863924; Kunisawa J, 2007, YAKUGAKU ZASSHI, V127, P319, DOI 10.1248/yakushi.127.319; Le Bourvellec C, 2012, CRIT REV FOOD SCI, V52, P213, DOI 10.1080/10408398.2010.499808; Lu GL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-62; Mestecky J, 2005, VACCINE, V23, P1800, DOI 10.1016/j.vaccine.2004.11.009; Mestecky J, 2007, J IMMUNOL, V179, P5633, DOI 10.4049/jimmunol.179.9.5633; Moyes DL, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/346307; Nakahashi-Ouchida R, 2017, EXPERT REV VACCINES, V16, P1231, DOI 10.1080/14760584.2017.1395702; Newsted D, 2015, VACCINE, V33, P2399, DOI 10.1016/j.vaccine.2015.03.096; Rhee JH, 2012, CLIN EXP VACCINE RES, V1, P50, DOI 10.7774/cevr.2012.1.1.50; Sakagami Hiroshi, 1992, In Vivo (Attiki), V6, P491; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Suzuki H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21120-7; Suzuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126352; Suzuki H, 2014, YAKUGAKU ZASSHI, V134, P629, DOI 10.1248/yakushi.14-00006-3; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tada R, 2018, MOL PHARMACEUT, V15, P4226, DOI 10.1021/acs.molpharmaceut.8b00648; Tada R, 2018, INT IMMUNOPHARMACOL, V61, P385, DOI 10.1016/j.intimp.2018.06.027; Tada Rui, 2017, BMC Res Notes, V10, P68, DOI 10.1186/s13104-017-2380-8; Tada R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139785; Tada R, 2009, BIOSCI BIOTECH BIOCH, V73, P908, DOI 10.1271/bbb.80860; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Watanabe I, 2002, VACCINE, V20, P3443, DOI 10.1016/S0264-410X(02)00351-1; Yamanaka D, 2016, INT IMMUNOPHARMACOL, V38, P443, DOI 10.1016/j.intimp.2016.06.026; Yamanaka D, 2014, J FUNCT FOODS, V6, P513, DOI 10.1016/j.jff.2013.11.018; Yamanaka D, 2013, FOOD CHEM, V141, P4073, DOI 10.1016/j.foodchem.2013.06.114; Yamanaka D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036025; Zhou F, 2002, BIOSCIENCE REP, V22, P355, DOI 10.1023/A:1020103109483	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246422	10.1371/journal.pone.0246422	http://dx.doi.org/10.1371/journal.pone.0246422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556119	gold, Green Published			2022-12-26	WOS:000617379900034
J	Yang, EJ; Lee, KS; Lim, MC; Baek, JY; Han, JY; Yu, ES; Chung, SH				Yang, Eun Joo; Lee, Keun Seok; Lim, Myong Cheol; Baek, Ji Yeon; Han, Ji-Youn; Yu, Eun-Seung; Chung, Seung Hyun			Symptom perception and functioning in patients with advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; PALLIATIVE CARE; PAIN; FATIGUE; PREVALENCE; SURVIVORS; SEVERITY; INSOMNIA	Purpose To explore how symptom perception affects functioning in patients with advanced cancer. Materials and methods We conducted a cross-sectional observational study of 459 advanced cancer patients at the national cancer center. Functioning was assessed using the World Health Organization Disability Assessment Schedule (WHODAS) II, and symptoms were evaluated using the Memorial Symptom Assessment Scale-Short Form. Confirmatory factor analysis was conducted to develop a structural model based on different symptom perceptions, such as somatic sensation and experienced symptoms. Results The structural model of disability revealed a significant direct pathway involving somatic sensation (beta = 16.11, p < 0.001). Experienced symptoms significantly affected somatic sensations (beta = 0.717, p < 0.001) but were not directly associated with disability. Unidimensional models exhibited a poor fit. In contrast, a complex model with first-order (somatic sensation) and second-order (experienced symptoms) factors provided an excellent fit, with comparative fit indexes (CFIs) and Tucker Lewis indexes (TLI) of more than 0.950 threshold. Conclusions Our findings suggest that relationships to functioning may vary between somatic sensations versus experienced symptoms. The structure of symptoms is best conceptualized by direct somatic sensation and indirect experienced symptoms. A better understanding of symptom perception and the relationship between symptoms and function would facilitate the development of effective rehabilitation programs.	[Yang, Eun Joo] Seoul Natl Univ, Dept Rehabil Med, Bundang Hosp, Seongnam, South Korea; [Lee, Keun Seok] Natl Canc Ctr, Ctr Breast Canc, Res Inst & Hosp, Dept Internal Med, Goyang, South Korea; [Lim, Myong Cheol] Natl Canc Ctr, Div Tumor Immunol, Ctr Uterine Canc, Dept Obstet & Gynecol, Goyang, South Korea; [Lim, Myong Cheol] Natl Canc Ctr, Ctr Clin Trials, Goyang, South Korea; [Baek, Ji Yeon] Natl Canc Ctr, Res Inst & Hosp, Dept Internal Med, Goyang, South Korea; [Han, Ji-Youn] Natl Canc Ctr, Ctr Lung Canc, Res Inst & Hosp, Dept Internal Med, Goyang, South Korea; [Yu, Eun-Seung] Natl Canc Ctr, Res Inst & Hosp, Dept Psychiat & Behav Sci, Goyang, South Korea; [Chung, Seung Hyun] Natl Canc Ctr, Res Inst & Hosp, Dept Rehabil Med, Goyang, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chung, SH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Dept Rehabil Med, Goyang, South Korea.	shchung@ncc.re.kr		Lee, Keun Seok/0000-0001-5575-836X	SNUBH Research Fund [12-2013-018, 12-2013-023]; National Cancer Center, Republic of Korea [1010070-1]	SNUBH Research Fund; National Cancer Center, Republic of Korea	This study was supported by the SNUBH Research Fund, grant number 12-2013-018, 12-2013-023 and by an operating grant from the National Cancer Center, Republic of Korea (1010070-1).	Anderson F, 1996, J PALLIAT CARE, V12, P5, DOI 10.1177/082585979601200102; [Anonymous], 2007, E Q, V4, P2007; Beck Susan L, 2005, Oncol Nurs Forum, V32, P542; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Cheng KKF, 2011, CRIT REV ONCOL HEMAT, V78, P127, DOI 10.1016/j.critrevonc.2010.03.002; Dodd M J, 2001, Oncol Nurs Forum, V28, P465; Fodeh SJ, 2013, J PAIN SYMPTOM MANAG, V46, P500, DOI 10.1016/j.jpainsymman.2012.09.011; Gilbertson-White S, 2011, PALLIAT SUPPORT CARE, V9, P81, DOI 10.1017/S147895151000057X; Gilchrist LS, 2009, PHYS THER, V89, P286, DOI 10.2522/ptj.20070309; Henson LA, 2020, J CLIN ONCOL, V38, P905, DOI 10.1200/JCO.19.00470; Hoffman AJ, 2007, ONCOL NURS FORUM, V34, P785, DOI 10.1188/07.ONF.785-792; Javier NSC, 2011, J PALLIAT MED, V14, P638, DOI 10.1089/jpm.2010.0125; Jimenez A, 2011, J PAIN SYMPTOM MANAG, V42, P24, DOI 10.1016/j.jpainsymman.2010.10.266; Kirkova J, 2010, PALLIATIVE MED, V24, P330, DOI 10.1177/0269216309356380; Kolk AM, 2003, SOC SCI MED, V57, P2343, DOI 10.1016/S0277-9536(02)00451-3; McKibbin C, 2004, J NERV MENT DIS, V192, P405, DOI 10.1097/01.nmd.0000130133.32276.83; Miaskowski C, 1999, J PAIN SYMPTOM MANAG, V17, P320, DOI 10.1016/S0885-3924(99)00008-1; Musil CM, 1998, RES NURS HEALTH, V21, P271; Reilly CM, 2013, SUPPORT CARE CANCER, V21, P1525, DOI 10.1007/s00520-012-1688-0; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; Walsh D, 2006, SUPPORT CARE CANCER, V14, P831, DOI 10.1007/s00520-005-0899-z; Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740; Wettergren L, 2004, QUAL LIFE RES, V13, P1369, DOI 10.1023/B:QURE.0000040790.43372.69; Wyrwich K, 2009, INT CLIN PSYCHOPHARM, V24, P289, DOI 10.1097/YIC.0b013e32832d6bf4	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245987	10.1371/journal.pone.0245987	http://dx.doi.org/10.1371/journal.pone.0245987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539372	gold, Green Published			2022-12-26	WOS:000616960200097
J	Khan, AN; Ihalage, AA; Ma, YH; Liu, BY; Liu, YJ; Hao, Y				Khan, Ahsan Noor; Ihalage, Achintha Avin; Ma, Yihan; Liu, Baiyang; Liu, Yujie; Hao, Yang			Deep learning framework for subject-independent emotion detection using wireless signals	PLOS ONE			English	Article							PHYSIOLOGICAL SIGNALS; SENSOR NETWORKS; RECOGNITION; SYSTEMS	Emotion states recognition using wireless signals is an emerging area of research that has an impact on neuroscientific studies of human behaviour and well-being monitoring. Currently, standoff emotion detection is mostly reliant on the analysis of facial expressions and/or eye movements acquired from optical or video cameras. Meanwhile, although they have been widely accepted for recognizing human emotions from the multimodal data, machine learning approaches have been mostly restricted to subject dependent analyses which lack of generality. In this paper, we report an experimental study which collects heartbeat and breathing signals of 15 participants from radio frequency (RF) reflections off the body followed by novel noise filtering techniques. We propose a novel deep neural network (DNN) architecture based on the fusion of raw RF data and the processed RF signal for classifying and visualising various emotion states. The proposed model achieves high classification accuracy of 71.67% for independent subjects with 0.71, 0.72 and 0.71 precision, recall and F1-score values respectively. We have compared our results with those obtained from five different classical ML algorithms and it is established that deep learning offers a superior performance even with limited amount of raw RF and post processed time-sequence data. The deep learning model has also been validated by comparing our results with those from ECG signals. Our results indicate that using wireless signals for stand-by emotion state detection is a better alternative to other technologies with high accuracy and have much wider applications in future studies of behavioural sciences.	[Khan, Ahsan Noor; Ihalage, Achintha Avin; Ma, Yihan; Liu, Baiyang; Liu, Yujie; Hao, Yang] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England	University of London; Queen Mary University London	Hao, Y (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England.	y.hao@qmul.ac.uk	Hao, Yang/AAW-2220-2020; Hao, Yang/ABD-5658-2021; Ihalage, Achintha/AAY-7368-2021	Hao, Yang/0000-0002-9949-7226; Ihalage, Achintha/0000-0002-4250-187X; Khan, Ahsan Noor/0000-0003-0234-2410	IET AF Harvey Research Prize; EPSRC [EP/R035393/1, EP/S010009/1] Funding Source: UKRI	IET AF Harvey Research Prize; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by IET AF Harvey Research Prize.	Chanel G, 2011, IEEE T SYST MAN CY A, V41, P1052, DOI 10.1109/TSMCA.2011.2116000; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Davidson RJ, 2003, PSYCHOPHYSIOLOGY, V40, P655, DOI 10.1111/1469-8986.00067; Dias D, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082414; Dilmaghani RS, 2011, IEEE T BIOMED CIRC S, V5, P347, DOI 10.1109/TBCAS.2011.2114661; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dominguez-Jimenez JA, 2020, BIOMED SIGNAL PROCES, V55, DOI 10.1016/j.bspc.2019.101646; El Ayadi M, 2011, PATTERN RECOGN, V44, P572, DOI 10.1016/j.patcog.2010.09.020; Ferreira PM, 2018, IEEE ACCESS, V6, P53930, DOI 10.1109/ACCESS.2018.2870063; Ghasemzadeh H, 2013, IEEE SENS J, V13, P423, DOI 10.1109/JSEN.2012.2222572; Gu Y, 2020, IEEE TETCI, V4, P216, DOI 10.1109/TETCI.2019.2902438; Gupta A, 2015, IEEE INT C BIOINFORM, P1328, DOI 10.1109/BIBM.2015.7359871; Hall PS, 2012, ARTECH HSE ANTENN PR, P1; Hassan MM, 2019, INFORM FUSION, V51, P10, DOI 10.1016/j.inffus.2018.10.009; Hossain MS, 2018, IEEE INTERNET THINGS, V5, P2399, DOI 10.1109/JIOT.2017.2772959; Jeong JW, 2013, ADV MATER, V25, P6839, DOI 10.1002/adma.201301921; Kahou SE, 2016, J MULTIMODAL USER IN, V10, P99, DOI 10.1007/s12193-015-0195-2; Kanjo E, 2019, INFORM FUSION, V49, P46, DOI 10.1016/j.inffus.2018.09.001; Katsigiannis S, 2018, IEEE J BIOMED HEALTH, V22, P98, DOI 10.1109/JBHI.2017.2688239; Keren G, 2017, IEEE INT CON MULTI, P985, DOI 10.1109/ICME.2017.8019533; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kong YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34833-6; Koumakis L, 2020, COMPUT STRUCT BIOTEC, V18, P1466, DOI 10.1016/j.csbj.2020.06.017; Kragel PA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4358; Lee B, 2016, PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P434, DOI 10.1145/2975167.2975212; Li CZ, 2018, IEEE J EM SEL TOP C, V8, P165, DOI 10.1109/JETCAS.2018.2822684; Maria E, 2019, ELECTRON NOTES THEOR, V343, P35, DOI 10.1016/j.entcs.2019.04.009; Munoz MO, 2014, IEEE T ANTENN PROPAG, V62, P5268, DOI 10.1109/TAP.2014.2342751; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Ragot M, 2018, ADV INTELL SYST, V608, P15, DOI 10.1007/978-3-319-60639-2_2; Ramirez-Gallego S, 2017, INT J INTELL SYST, V32, DOI 10.1002/int.21833; Ranganathan H, 2016, IEEE WINT CONF APPL; Ren YF, 2014, IEEE IJCNN, P2851; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Sabeti M, 2009, ARTIF INTELL MED, V47, P263, DOI 10.1016/j.artmed.2009.03.003; Schmauch B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17678-4; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Shu L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18072074; Tarnowski P, 2017, PROCEDIA COMPUT SCI, V108, P1175, DOI 10.1016/j.procs.2017.05.025; Thomas J, 2017, ARXIV170403834; Wang XN, 2014, J BIOMED INFORM, V52, P406, DOI 10.1016/j.jbi.2014.08.002; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52; Zhang JH, 2020, INFORM FUSION, V59, P103, DOI 10.1016/j.inffus.2020.01.011; Zhao MM, 2016, MOBICOM'16: PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P95, DOI 10.1145/2973750.2973762	45	15	15	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0242946	10.1371/journal.pone.0242946	http://dx.doi.org/10.1371/journal.pone.0242946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534826	Green Published, gold, Green Submitted			2022-12-26	WOS:000616739700047
J	De Angelis, M; Casciaro, B; Genovese, A; Brancaccio, D; Marcocci, ME; Novellino, E; Carotenuto, A; Palamara, AT; Mangoni, ML; Nencioni, L				De Angelis, M.; Casciaro, B.; Genovese, A.; Brancaccio, D.; Marcocci, M. E.; Novellino, E.; Carotenuto, A.; Palamara, A. T.; Mangoni, M. L.; Nencioni, L.			Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action	FASEB JOURNAL			English	Article						antimicrobial peptides; antiviral agents; influenza; parainfluenza; viral infection	POLY(LACTIDE-CO-GLYCOLIDE) NANOPARTICLES; STRATEGIES; INFECTION; IDENTIFICATION; EFFICACY; PROTEIN; TARGET; CELLS	Treatment of respiratory viral infections remains a global health concern, mainly due to the inefficacy of available drugs. Therefore, the discovery of novel antiviral compounds is needed; in this context, antimicrobial peptides (AMPs) like temporins hold great promise. Here, we discovered that the harmless temporin G (TG) significantly inhibited the early life-cycle phases of influenza virus. The in vitro hemagglutinating test revealed the existence of TG interaction with the viral hemagglutinin (HA) protein. Furthermore, the hemolysis inhibition assay and the molecular docking studies confirmed a TG/HA complex formation at the level of the conserved hydrophobic stem groove of HA. Remarkably, these findings highlight the ability of TG to block the conformational rearrangements of HA2 subunit, which are essential for the viral envelope fusion with intracellular endocytic vesicles, thereby neutralizing the virus entry into the host cell. In comparison, in the case of parainfluenza virus, which penetrates host cells upon a membrane-fusion process, addition of TG to infected cells provoked ~1.2 log reduction of viral titer released in the supernatant. Nevertheless, at the same condition, an immunofluorescent assay showed that the expression of viral hemagglutinin/neuraminidase protein was not significantly reduced. This suggested a peptide-mediated block of some late steps of viral replication and therefore the impairment of the extracellular release of viral particles. Overall, our results are the first demonstration of the ability of an AMP to interfere with the replication of respiratory viruses with a different mechanism of cell entry and will open a new avenue for the development of novel therapeutic approaches against a large variety of respiratory viruses, including the recent SARS-CoV2.	[De Angelis, M.; Genovese, A.; Marcocci, M. E.; Palamara, A. T.; Nencioni, L.] Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Casciaro, B.] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Brancaccio, D.; Novellino, E.; Carotenuto, A.] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Mangoni, M. L.] Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Biochem Sci, Piazzale Aldo Moro 5, Rome, Italy	Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Sapienza University Rome	Nencioni, L (corresponding author), Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Mangoni, ML (corresponding author), Sapienza Univ Rome, Pasteur Italia Fdn Cenci Bolognetti, Dept Biochem Sci, Piazzale Aldo Moro 5, Rome, Italy.	marialuisa.mangoni@uniroma1.it	Casciaro, Bruno/X-9564-2019; brancaccio, diego/AEP-3471-2022; Nencioni, Lucia/K-5988-2016	Casciaro, Bruno/0000-0003-1295-1084; brancaccio, diego/0000-0002-2256-5534; Nencioni, Lucia/0000-0003-4427-4823; Mangoni, Maria Luisa/0000-0002-5991-5868; Marcocci, Maria Elena/0000-0003-4751-4263				Ahmed CM, 2009, J VIROL, V83, P1402, DOI 10.1128/JVI.01138-08; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Berkhout B, 2011, ANTIVIR RES, V92, P7, DOI 10.1016/j.antiviral.2011.04.002; Bizzarri BM, 2019, CATALYSTS, V9, DOI 10.3390/catal9120983; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Branche AR, 2016, SEMIN RESP CRIT CARE, V37, P538, DOI 10.1055/s-0036-1584798; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; Casciaro B., 2020, ANTIBIOTICS BASEL, V9; Casciaro B, 2020, CURR PROTEIN PEPT SC, V21, P429, DOI 10.2174/1389203720666191203101947; Casciaro B, 2020, CURR MED CHEM, V27, P1405, DOI 10.2174/0929867326666190722095408; Casciaro B, 2019, BIOMACROMOLECULES, V20, P1876, DOI 10.1021/acs.biomac.8b01829; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Checconi P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114084; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Davidson S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01946; Di Grazia A, 2014, ANTIMICROB AGENTS CH, V58, P2520, DOI 10.1128/AAC.02801-13; Di Sotto A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5919237; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Episcopio D, 2019, FASEB J, V33, P9516, DOI 10.1096/fj.201900428RR; Grieco P, 2013, BBA-BIOMEMBRANES, V1828, P652, DOI 10.1016/j.bbamem.2012.08.027; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; Hierholzer J.C., 1996, VIROLOGY METHODS MAN, P35, DOI 10.1038/s41541-021-00291-x; Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018; Kadam RU, 2017, SCIENCE, V358, P496, DOI 10.1126/science.aan0516; Krol E, 2014, ACTA BIOCHIM POL, V61, P495; Lakshmaiah Narayana J., 2020, P NATL ACAD SCI USA; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2016, CURR TOP MED CHEM, V16, P54, DOI 10.2174/1568026615666150703121403; Mangoni ML, 2011, J MED CHEM, V54, P1298, DOI 10.1021/jm1012853; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Marcocci ME, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02367-17, 10.1128/aac.02367-17]; Matarrese P, 2011, J CELL PHYSIOL, V226, P3368, DOI 10.1002/jcp.22696; Mifsud EJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104545; Mookherjee N, 2020, NAT REV DRUG DISCOV, V19, P311, DOI 10.1038/s41573-019-0058-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nicol MQ, 2012, J GEN VIROL, V93, P980, DOI 10.1099/vir.0.038679-0; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Saladino R, 2003, MED RES REV, V23, P427, DOI 10.1002/med.10036; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Sierra JM, 2017, EXPERT OPIN BIOL TH, V17, P663, DOI 10.1080/14712598.2017.1315402; Skalickova S, 2015, VIRUSES-BASEL, V7, P5428, DOI 10.3390/v7102883; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; van de Wakker SI, 2017, EUR J PHARMACOL, V809, P178, DOI 10.1016/j.ejphar.2017.05.038; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wan YL, 2010, J VIROL METHODS, V169, P359, DOI 10.1016/j.jviromet.2010.08.005; World Health Organization, INFL SEAS; Yu YS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100999; Zhang Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050405; Zhou P, 2018, NUCLEIC ACIDS RES, V46, pW443, DOI 10.1093/nar/gky357	57	14	14	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21358	10.1096/fj.202001885RR	http://dx.doi.org/10.1096/fj.202001885RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33538061	hybrid			2022-12-26	WOS:000647789600099
J	Asadi, M; Ahmadi, N; Ahmadvand, S; Jafari, AA; Safaei, A; Erfani, N; Ramezani, A				Asadi, Maryam; Ahmadi, Nahid; Ahmadvand, Simin; Jafari, Ali Akbar; Safaei, Akbar; Erfani, Nasrollah; Ramezani, Amin			Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker	PLOS ONE			English	Article							ACTIVATION	Among cancer treatment methods, targeted therapy using cancer-associated biomarkers has minimum side effects. Recently olfactory receptor (OR) family attracts the researcher's attention as a favorable biomarker of cancer. Here, a statistical approach using complete data from the human protein atlas database was used to evaluate the potential of OR51J1 gene as a cancer-associated biomarker. To confirm the findings of statistical analysis, the OR51J1 mRNA and protein expression levels in breast tumor and normal tissue were measured using quantitative Real Time PCR (qRT-PCR) and immunohistochemistry (IHC) techniques. The association with clinicopathological factors was analyzed. Statistical analysis revealed that OR51J1 has a high expression level in more than 20 types of cancer tissues without any expression in 44 normal tissues. In 15 cancer types, including breast cancer, expression score was more than 90%. The qRT-PCR analysis in breast cancer showed OR51J1 have significantly higher expression level in tumors than normal tissues (2.91 fold). The IHC results showed OR51J1 expression on other cellular subtypes than tumor and normal cells, including myoepithelium, fibroblast, and lymphocytes. OR51J1 protein expression in invasive cells, as well as its overall score, showed a significant correlation with ER and PR expression and breast cancer (BC) subtypes. Results revealed the potential of OR51J1 as a cancer-associated biomarker for the diagnosis of breast cancer at the mRNA level.	[Asadi, Maryam; Ahmadi, Nahid; Ahmadvand, Simin; Erfani, Nasrollah; Ramezani, Amin] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Shiraz, Iran; [Asadi, Maryam] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Mol Med, Shiraz, Iran; [Ahmadi, Nahid; Ramezani, Amin] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran; [Jafari, Ali Akbar] Yazd Univ, Dept Stat, Yazd, Iran; [Safaei, Akbar] Shiraz Univ Med Sci, Sch Med, Dept Pathol, Shiraz, Iran; [Erfani, Nasrollah] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; University of Yazd; Shiraz University of Medical Science; Shiraz University of Medical Science	Ramezani, A (corresponding author), Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Shiraz, Iran.; Ramezani, A (corresponding author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran.	aramezani@sums.ac.ir	Erfani, Nasrollah/C-9376-2011; Ramezani, Amin/AID-2677-2022	Erfani, Nasrollah/0000-0002-4158-9128; Ramezani, Amin/0000-0001-5655-8722	Shiraz University of Medical Sciences [97-0116-17785]	Shiraz University of Medical Sciences	The study was supported by Shiraz University of Medical Sciences (Grant No 97-0116-17785).	Abaffy T., 2015, J PHARM PHARM, V6, P4, DOI [DOI 10.4172/2153-0645.1000152, 10.4172/2153-0645.1000152]; Balotf S., 2012, Australian Journal of Crop Science, V6, P130; Buettner A, 2017, SPRINGER HDB ODOR; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Chen G, 2018, ACTA PHARM SIN B, V8, P501, DOI 10.1016/j.apsb.2018.07.003; Dash Raju, 2017, Adv Appl Bioinform Chem, V10, P11, DOI 10.2147/AABC.S115859; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gelis L, 2017, EXP DERMATOL, V26, P569, DOI 10.1111/exd.13316; Goldenberg David M, 2018, Oncotarget, V9, P28989, DOI 10.18632/oncotarget.25615; Jackson SE, 2015, INT J CANCER, V137, P262, DOI 10.1002/ijc.28940; Jena Manoj Kumar, 2018, F1000Res, V7, P274, DOI 10.12688/f1000research.14133.2; Kabel AM., 2017, J ONCOL SCI, V3, P5, DOI DOI 10.1016/J.JONS.2017.01.001; Kalbe B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00339; Kennedy K, 2018, MOL TARGETED THERAPI; Kulasingam V, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0021-2; Massberg D, 2016, ONCOTARGET, V7, P48231, DOI 10.18632/oncotarget.10197; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sandelowski M, 2009, J MIX METHOD RES, V3, P208, DOI 10.1177/1558689809334210; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Team RC, 2008, R LANGUAGE ENV STAT; Weber L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00456; Weber L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00033; Weber L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172491	25	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246752	10.1371/journal.pone.0246752	http://dx.doi.org/10.1371/journal.pone.0246752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566867	Green Published, gold			2022-12-26	WOS:000618271700043
J	Assis, JB; Cogliati, B; Esteves, E; Capurro, ML; Fonseca, DM; Sa-Nunes, A				Assis, Josiane B.; Cogliati, Bruno; Esteves, Eliane; Capurro, Margareth L.; Fonseca, Denise M.; Sa-Nunes, Anderson			Aedes aegypti mosquito saliva ameliorates acetaminophen-induced liver injury in mice	PLOS ONE			English	Article							GLAND EXTRACT; DIFFERENTIAL MODULATION; SIALOSTATIN L; PROTEIN; HEPATOTOXICITY; NECROSIS; CELLS; GLUTATHIONE; ARTHRITIS; OVERDOSE	Acetaminophen (N-acetyl-p-aminophenol, APAP) overdose is the most common cause of drug-induced liver injury (DILI). Although the primary hepatic damage is induced by APAP-derived toxic intermediates resulting from cytochrome P450 metabolism, immune components also play an important role in DILI pathophysiology. Aedes aegypti saliva is a source of bioactive molecules with in vitro anti-inflammatory and immunomodulatory activities. However, evidences on the therapeutic use of Ae. aegypti salivary preparations in animal models of relevant clinical conditions are still scarce. Thus, the present study was designed to evaluate the protective role of Ae. aegypti saliva in a murine model of APAP-induced DILI. C57BL/6 mice were exposed to Ae. aegypti bites 2 hours after APAP overdose. Biochemical and immunological parameters were evaluated in blood and liver samples at different time points after APAP administration. Exposure to Ae. aegypti saliva attenuated liver damage, as demonstrated by reduced hepatic necrosis and serum levels of alanine aminotransferase in APAP-overdosed mice. The levels of hepatic CYP2E1, the major enzyme responsible for the bioactivation of APAP, were not changed in Ae. aegypti exposed animals, suggesting no effects in the generation of hepatotoxic metabolites. On the other hand, mice treated with Ae. aegypti saliva following APAP overdose presented lower serum concentration of TNF-alpha, IL-6, IL-1 beta and IL-10, as well as reduced frequency of inflammatory cell populations in the liver, such as NKT cells, macrophages and dendritic cells. These findings show that Ae. aegypti saliva has bioactive molecules with therapeutic properties and may represent a prospective source of new compounds in the management of DILI-associated inflammatory disorders and, perhaps, many other inflammatory/autoimmune diseases.	[Assis, Josiane B.; Fonseca, Denise M.; Sa-Nunes, Anderson] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo, Brazil; [Cogliati, Bruno] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol, Sao Paulo, Brazil; [Esteves, Eliane; Capurro, Margareth L.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil; [Capurro, Margareth L.; Sa-Nunes, Anderson] Conselho Nacl Desenvolvimento Cient & Tecnol INCT, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Sa-Nunes, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo, Brazil.; Sa-Nunes, A (corresponding author), Conselho Nacl Desenvolvimento Cient & Tecnol INCT, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil.	sanunes@usp.br	Sa-Nunes, Anderson/M-5654-2019; Esteves, Eliane/H-9508-2013; Sa-Nunes, Anderson/D-8667-2012; Cogliati, Bruno/E-9956-2012; Capurro, Margareth L/F-8679-2012; Assis, Josiane/O-4455-2019	Sa-Nunes, Anderson/0000-0002-1859-4973; Sa-Nunes, Anderson/0000-0002-1859-4973; Cogliati, Bruno/0000-0002-1388-7240; Capurro, Margareth L/0000-0002-7480-2116; Assis, Josiane/0000-0001-6549-912X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-EM/CNPq) [465678/2014-9]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/09892-6, 2016/11523-2]; Nucleo de Pesquisa em Moleculas Bioativas de Artro'podes Vetores - Brasil (NAP-MOBIARVE) [12.1.17661.1.7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-EM/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Nucleo de Pesquisa em Moleculas Bioativas de Artro'podes Vetores - Brasil (NAP-MOBIARVE)	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Finance Code 001; Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-EM/CNPq) - Grant #465678/2014-9 awarded to MLC and AS-N; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - Grant #2009/09892-6 awarded to AS-N and Grant #2016/11523-2 awarded to JBA; Nucleo de Pesquisa em Moleculas Bioativas de Artro ' podes Vetores - Brasil (NAP-MOBIARVE) - Grant #12.1.17661.1.7 awarded to AS-N.	[Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2019, MONTHLY NEWSLETTER M; BISSONNETTE EY, 1993, PARASITE IMMUNOL, V15, P27, DOI 10.1111/j.1365-3024.1993.tb00569.x; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Carregaro V, 2011, J IMMUNOL, V187, P4347, DOI 10.4049/jimmunol.1003404; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Connolly MK, 2011, HEPATOLOGY, V54, P959, DOI 10.1002/hep.24429; Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13; CROSS ML, 1994, AM J TROP MED HYG, V51, P690, DOI 10.4269/ajtmh.1994.51.690; DAVIDSON DG, 1966, BRIT MED J, V2, P497, DOI 10.1136/bmj.2.5512.497; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Dhawan R, 2017, OMICS, V21, P45, DOI 10.1089/omi.2016.0160; Downs I, 2012, BIOCHEM BIOPH RES CO, V428, P245, DOI 10.1016/j.bbrc.2012.10.029; Fisher JE, 2013, J SURG RES, V180, P147, DOI 10.1016/j.jss.2012.11.051; FORREST JAH, 1982, CLIN PHARMACOKINET, V7, P93, DOI 10.2165/00003088-198207020-00001; Foureau DM, 2015, CLIN EXP IMMUNOL, V180, P40, DOI 10.1111/cei.12558; Giordano C, 2014, J CLIN TRANSL HEPATO, V2, P74, DOI 10.14218/JCTH.2014.00005; Gomes RD, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110182; Graham GG, 2005, DRUG SAFETY, V28, P227, DOI 10.2165/00002018-200528030-00004; Grespan R, 2012, INT IMMUNOPHARMACOL, V12, P603, DOI 10.1016/j.intimp.2012.02.004; HAMLYN AN, 1978, POSTGRAD MED J, V54, P400, DOI 10.1136/pgmj.54.632.400; Hastings AK, 2019, J VIROL, V93, DOI 10.1128/JVI.00395-19; Horka H, 2012, J IMMUNOL, V188, P2669, DOI 10.4049/jimmunol.1100529; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke Hartmut, 2005, Expert Opin Drug Metab Toxicol, V1, P389, DOI 10.1517/17425255.1.3.389; Jaeschke H, 2014, J CLIN TRANSL HEPATO, V2, P153, DOI 10.14218/JCTH.2014.00014; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9; Kim YC, 2018, J FUNCT FOODS, V49, P235, DOI 10.1016/j.jff.2018.08.025; Krenkel Oliver, 2014, Hepatobiliary Surg Nutr, V3, P331, DOI 10.3978/j.issn.2304-3881.2014.11.01; Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Maciel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110551; Maes M, 2016, TOXICOL MECH METHOD, V26, P88, DOI 10.3109/15376516.2015.1103000; Major JM, 2016, PHARMACOEPIDEM DR S, V25, P590, DOI 10.1002/pds.3906; Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736; Martin-Martin I, 2021, FEBS J, V288, P2014, DOI 10.1111/febs.15524; Martin-Murphy BV, 2013, HEPATOLOGY, V57, P1575, DOI 10.1002/hep.26134; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Papackova Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191353; Paveglio SA, 2007, J IMMUNOL, V178, P7064, DOI 10.4049/jimmunol.178.11.7064; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; Sa-Nunes A, 2020, TRENDS PARASITOL, P1, DOI [10.1016/j.pt.2020.11.00433303363, DOI 10.1016/J.PT.2020.11.00433303363]; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; Sales-Campos H, 2015, INT IMMUNOPHARMACOL, V26, P13, DOI 10.1016/j.intimp.2015.03.002; Sri-In C, 2019, INSECT BIOCHEM MOLEC, V111, DOI 10.1016/j.ibmb.2019.103181; Stibraniova I, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00830; Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251; Uraki R, 2019, NAT MICROBIOL, V4, P948, DOI 10.1038/s41564-019-0385-x; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Woolbright Benjamin L, 2017, J Clin Transl Res, V3, P170, DOI 10.18053/jctres.03.2017S1.003; 2013, CLIN MED INSIGHTS GA, V6, P1	59	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245788	10.1371/journal.pone.0245788	http://dx.doi.org/10.1371/journal.pone.0245788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556084	gold, Green Published			2022-12-26	WOS:000617379900038
J	Wang, N; Qi, F; Yu, HQ; Yestrepsky, BD; Larsen, SD; Shi, HL; Ji, J; Anderson, DW; Li, H; Sun, HM				Wang, Nan; Qi, Feng; Yu, Haqing; Yestrepsky, Bryan D.; Larsen, Scott D.; Shi, Honglan; Ji, Juan; Anderson, David W.; Li, Hao; Sun, Hongmin			Physicochemical properties and formulation development of a novel compound inhibiting Staphylococcus aureus biofilm formation	PLOS ONE			English	Article							EXTRACELLULAR DNA; SOLUBLE DRUGS; VIRULENCE; DISSOLUTION; RESISTANCE; SURVIVAL; SYSTEM; CLASSIFICATION; DEGRADATION; MECHANISMS	The emergence of antibiotic resistance over the past several decades has given urgency to new antibacterial strategies that apply less selective pressure. A new class of anti-virulence compounds were developed that are active against methicillin-resistant Staphylococcus aureus (MRSA), by inhibiting bacterial virulence without hindering their growth to reduce the selective pressure for resistance development. One of the compounds CCG-211790 has demonstrated potent anti-biofilm activity against MRSA. This new class of anti-virulence compounds inhibited the gene expression of virulence factors involved in biofilm formation and disrupted the biofilm structures. In this study, the physicochemical properties of CCG-211790, including morphology, solubility in pure water or in water containing sodium dodecyl sulfate, solubility in organic solvents, and stability with respect to pH were investigated for the first time. Furthermore, a topical formulation was developed to enhance the therapeutic potential of the compound. The formulation demonstrated acceptable properties for drug release, viscosity, pH, cosmetic elegance and stability of over nine months.	[Wang, Nan; Qi, Feng; Li, Hao] Univ Missouri, Dept Mech & Aerosp Engn, Columbia, MO 65211 USA; [Yu, Haqing; Sun, Hongmin] Univ Missouri, Dept Med, Div Cardiovasc Med, Columbia, MO 65211 USA; [Yestrepsky, Bryan D.; Larsen, Scott D.] Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, 428 Church St, Ann Arbor, MI 48109 USA; [Shi, Honglan] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA; [Ji, Juan] Univ Missouri, Dept Biochem, Columbia, MO USA; [Yu, Haqing; Anderson, David W.; Li, Hao] Ivogen Inc, Columbia, MO 65202 USA; [Wang, Nan] China Assoc Sci & Technol, Natl Acad Innovat Strategy, Beijing, Peoples R China; [Qi, Feng] BeiGene Beijing Co Ltd, Beijing, Peoples R China; [Yestrepsky, Bryan D.] Abbvie Inc, Worcester, MA USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; University of Missouri Columbia; AbbVie	Li, H (corresponding author), Univ Missouri, Dept Mech & Aerosp Engn, Columbia, MO 65211 USA.; Sun, HM (corresponding author), Univ Missouri, Dept Med, Div Cardiovasc Med, Columbia, MO 65211 USA.; Li, H (corresponding author), Ivogen Inc, Columbia, MO 65202 USA.	lihao@nanovamed.com; sun@health.missouri.edu		Sun, Hongmin/0000-0003-4545-2417	National Institutes of Health (NIH) [P01HL573461]; Pharmacological Sciences Training Program fellowships grant, University of Michigan Life Sciences Institute Innovation Partnership [T32 GM007767]; University of Michigan Life Sciences Institute Innovation Partnership; NIAID, NIH: Staphylococcus aureus, Strain [USA300-0114, NR-4607]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Program fellowships grant, University of Michigan Life Sciences Institute Innovation Partnership; University of Michigan Life Sciences Institute Innovation Partnership; NIAID, NIH: Staphylococcus aureus, Strain	This work was supported by National Institutes of Health (NIH) in the form of a grant awarded to HSu (P01HL573461) and a Pharmacological Sciences Training Program fellowships grant awarded to BDY (T32 GM007767), University of Michigan Life Sciences Institute Innovation Partnership in the form of grants awarded to HSu and SDL, Nanova Inc. in the form of a gift fund for the Curators of University of Missouri awarded to HSu and HL, and Ivogen Inc. in the form of a salary for DWA. The specific roles of these authors are articulated in the `author contributions' section. The reagent NRS384 was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain USA300-0114, NR-4607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WR, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5010003; Abuzar SM, 2018, INT J PHARMACEUT, V538, P1, DOI 10.1016/j.ijpharm.2017.12.041; Allen HB, 2014, JAMA DERMATOL, V150, P260, DOI 10.1001/jamadermatol.2013.8627; Anand O, 2011, AAPS J, V13, P328, DOI 10.1208/s12248-011-9272-y; [Anonymous], 2002, AM J KIDNEY DIS S1, V2, pS1; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang RK, 2013, AAPS J, V15, P41, DOI 10.1208/s12248-012-9411-0; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; Dickey SW, 2017, NAT REV DRUG DISCOV, V16, P457, DOI 10.1038/nrd.2017.23; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; FDA, 1997, SUPACSSCMC71997 FDA; FDA, 1997, IN VITRO REL APPR CH; Ginsburg D, 2016, Methods and compositions for treating bacterial infection patent, Patent No. [US9504688B2, 9504688]; Gowthamarajan K, 2010, DISSOLUT TECHNOL, V17, P24, DOI 10.14227/DT170310P24; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hua L, 2015, ANTIMICROB AGENTS CH, V59, P4526, DOI 10.1128/AAC.00510-15; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Jaskiewicz M, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040174; Jiang Y, 2002, ULTRASON SONOCHEM, V9, P163, DOI 10.1016/S1350-4177(01)00114-6; Jouyban A, 2010, HANDBOOK OF SOLUBILITY DATA FOR PHARMACEUTICALS, P1; Junyaprasert VB, 2015, ASIAN J PHARM SCI, V10, P13, DOI 10.1016/j.ajps.2014.08.005; Kawabata Y, 2011, INT J PHARMACEUT, V420, P1, DOI 10.1016/j.ijpharm.2011.08.032; Kong C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21141-2; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lehman PA, 2011, SKIN PHARMACOL PHYS, V24, P224, DOI 10.1159/000324884; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Loftin KA, 2008, J ENVIRON QUAL, V37, P378, DOI 10.2134/jeq2007.0230; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047255; Ma YB, 2012, ANTIMICROB AGENTS CH, V56, P5923, DOI 10.1128/AAC.01739-12; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Maura D, 2016, CURR OPIN MICROBIOL, V33, P41, DOI 10.1016/j.mib.2016.06.001; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Ng Shiow-Fern, 2010, Pharmaceutics, V2, P209; Okshevsky M, 2015, CRIT REV MICROBIOL, V41, P341, DOI 10.3109/1040841X.2013.841639; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Pimenta AD, 2013, INT J ANTIMICROB AG, V42, P519, DOI 10.1016/j.ijantimicag.2013.07.006; Rabin N, 2015, FUTURE MED CHEM, V7, P647, DOI 10.4155/fmc.15.7; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rath S, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12020119; Rege PR, 1998, J PHARMACEUT BIOMED, V17, P1225, DOI 10.1016/S0731-7085(97)00184-2; Rowe R.C., 2006, HDB PHARM EXCIPIENTS; Shah VP, 1999, PHARM DEV TECHNOL, V4, P377, DOI 10.1081/PDT-100101373; Sharma AK, 2017, INDIAN J MICROBIOL, V57, P1, DOI 10.1007/s12088-016-0625-1; Siewert M, 2003, AAPS PHARMSCITECH, V4, pE7, DOI DOI 10.1208/PT040107; Simon A, 2016, INT J PHARMACEUT, V512, P234, DOI 10.1016/j.ijpharm.2016.08.052; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Takagi T, 2006, MOL PHARMACEUT, V3, P631, DOI 10.1021/mp0600182; Ueda CT., 2009, PHARMACOPEIAL FORUM, V35, P750, DOI DOI 10.14227/DT170410P12; Ventola C Lee, 2015, P T, V40, P344; Ventola C Lee, 2015, P T, V40, P277; Vertzoni M, 2005, EUR J PHARM BIOPHARM, V60, P413, DOI 10.1016/j.ejpb.2005.03.002; Waldor MK, 2006, NEW ENGL J MED, V354, P296, DOI 10.1056/NEJMcibr054591; Yestrepsky BD, 2013, BIOORGAN MED CHEM, V21, P1880, DOI 10.1016/j.bmc.2013.01.046; Zhang H, 2004, DISSOLUTION TESTING, P26; Zorin S, 1999, ANN OCCUP HYG, V43, P405, DOI 10.1016/S0003-4878(99)00030-7; Zurawski DV, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9040155	65	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246408	10.1371/journal.pone.0246408	http://dx.doi.org/10.1371/journal.pone.0246408			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556134	Green Published, gold			2022-12-26	WOS:000617379900057
J	Zheng, CF; Liu, CZ; Ren, W; Li, BY; Lu, YH; Pan, ZL; Cao, WD				Zheng, Chunfeng; Liu, Chunzeng; Ren, Wei; Li, Benyin; Lu, Yuhu; Pan, Ziliang; Cao, Weidong			Flower and pod development, grain-setting characteristics and grain yield in Chinese milk vetch (Astragalus sinicus L.) in response to pre-anthesis foliar application of paclobutrazol	PLOS ONE			English	Article							FUNGI MEDIATED UPTAKE; GROWTH; WHEAT; LANTHANUM; RESIDUE; LEAVES	The number of grains per unit land area is the most important grain yield component in Chinese milk vetch. Flower and pod survival seem to be critical determinants of grain number, which is related to the number of fertile flowers and pods during the anthesis period. Flower and pod growth are frequently considered the key determinants to establish grain number. The objective of this study was to explore the influences of paclobutrazol on flower and pod development, grain-setting characteristics and grain yield in Chinese milk vetch under different concentrations of foliar spray and try to explore the physiological regulatory mechanisms. Field experiments were carried out during the 2017-2018 and 2018-2019 growing seasons at the Dayuzhuang experimental field. The experiment involved the Chinese milk vetch cultivar "Xinzi No. 1" and six levels of foliar application of paclobutrazol, 0, 200, 300, 400, 500, and 600 mg L-1, in treatments CK, T1, T2, T3, T4, and T5, respectively. Foliar spray was applied once, at the squaring stage. In comparison with the CK treatment, all of the paclobutrazol treatments yielded, to various degrees, increased values of the number of inflorescences per unit area, number of pods per unit area, grain-setting rate of pods, and number of grains per pod in all six inflorescence layers, with the largest increases observed in the T3 treatment. In the T3 treatment compared with the CK treatment, from the first to sixth inflorescence layers, the number of inflorescences per unit area was increased by 34.07-58.97%, the number of pods per unit area was increased by 39.69-68.35%, the grain number per pod was increased by 44.31-53.69%, and the grain-setting rate of pods was increased by 1.84-4.89%. An analysis of yield composition revealed that the paclobutrazol spray treatment had little impact on the grain weight of Chinese milk vetch. The correlations between the concentration of paclobutrazol spray and the grain yield of Chinese milk vetch reached a significant level. Grain yield was highest at the paclobutrazol concentration of 373.10 mg/L. The inflorescence contents of gibberellic acid 3 (GA(3)), indole-3-acetic acid (IAA), and abscisic acid (ABA) were reduced, whereas that of cytokinin (CTK) was increased, by foliar application of paclobutrazol (400 mg L-1, T3 treatment) relative to CK treatment during the stages of flowers and pods developing into grains.	[Zheng, Chunfeng; Liu, Chunzeng; Li, Benyin] Henan Acad Agr Sci, Inst Plant Nutr Agr Resources & Environm Sci, Zhengzhou, Peoples R China; [Ren, Wei] Henan Acad Agr Sci, Henan Inst Crop Mol Breeding, Zhengzhou, Peoples R China; [Lu, Yuhu; Pan, Ziliang] Xinyang Acad Agr Sci, Inst Plant Nutr Agr Resources & Environm Sci, Xinyang, Peoples R China; [Cao, Weidong] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China	Henan Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Liu, CZ (corresponding author), Henan Acad Agr Sci, Inst Plant Nutr Agr Resources & Environm Sci, Zhengzhou, Peoples R China.	zhengliu2019@126.com		liu, chunzeng/0000-0002-3149-8732	China Agriculture Research System-Green Manure [CARS-22]; Excellent Youth Science and Technology Fund of Henan Academy of Agricultural Sciences [2020YQ30]; National Key Research and Development Program [2018YFD0200200]	China Agriculture Research System-Green Manure; Excellent Youth Science and Technology Fund of Henan Academy of Agricultural Sciences; National Key Research and Development Program	This study was supported by China Agriculture Research System-Green Manure (CARS-22), Excellent Youth Science and Technology Fund of Henan Academy of Agricultural Sciences (2020YQ30), and National Key Research and Development Program (2018YFD0200200). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, JURNAL INTELEK, V9, P21; Bernier G, 2001, PLANTA, V196, P306; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Chen XH, 2007, CHEMOSPHERE, V68, P1548, DOI 10.1016/j.chemosphere.2007.02.068; Chen XH, 2009, BIOL FERT SOILS, V45, P675, DOI 10.1007/s00374-009-0379-6; Gao SJ, 2018, J INTEGR AGR, V17, P1852, DOI [10.1016/s2095-3119(17)61901-4, 10.1016/S2095-3119(17)61901-4]; Gao SJ, 2018, APPL SOIL ECOL, V124, P185, DOI 10.1016/j.apsoil.2017.09.041; Hashemabadi D, 2010, PLANT OMICS, V3, P167; Kang GZ, 2015, PHYSIOL PLANTARUM, V153, P12, DOI 10.1111/ppl.12233; Khan F. U., 2003, Indian Journal of Horticulture, V60, P192; Lee CH, 2010, AGR ECOSYST ENVIRON, V138, P343, DOI 10.1016/j.agee.2010.05.011; Lee DJ, 2007, PLANTA, V10, P425, DOI [10.1007/s00425-006-0463-117216482, DOI 10.1007/S00425-006-0463-117216482]; Lin DH, 2000, MILK VETCH CHINA, P85; Marshall A. H., 1991, Journal of Applied Seed Production, V9, P81; McDaniel CN, 1991, PLANTA, V185, P356, DOI [10.1007/BF0020105624186418, DOI 10.1007/BF0020105624186418]; Mog B, 2019, SCI HORTICULTURAE, V108, P734; Oliveira MB, 2019, SCI HORTICULTURAE, V109, P57; Papageorgiou I, 2002, HORTTECHNOLOGY, V12, P236, DOI 10.21273/HORTTECH.12.2.236; PHARIS RP, 1985, ANNU REV PLANT PHYS, V36, P517, DOI 10.1146/annurev.pp.36.060185.002505; Rajala A, 2002, PLANT GROWTH REGUL, V38, P51, DOI 10.1023/A:1020924307455; Wan SX, 2012, ACTA PRATACULTURAE S, V25, P109; Xie ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168134; Yang L, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8110261; Yang N, 2014, EUR J AGRON, V58, P63, DOI 10.1016/j.eja.2014.05.002; Zhang JJ, 2018, PLANT SOIL, V433, P201, DOI 10.1007/s11104-018-3830-3; Zhong S., 1975, ACTA PHYTOPHYSIOLOGI, V1, P56; Zhong S., 1978, ACTA PHYTOPHYSIOLOGI, V4, P86; Zhou CH, 2016, RICE SCI, V23, P132, DOI 10.1016/j.rsci.2015.11.003; Zhu B, 2014, PLANT SOIL, V374, P331, DOI 10.1007/s11104-013-1808-8; Zhu B, 2012, J INTEGR AGR, V11, P1537, DOI 10.1016/S2095-3119(12)60154-3	30	2	2	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245554	10.1371/journal.pone.0245554	http://dx.doi.org/10.1371/journal.pone.0245554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556055	Green Published, gold			2022-12-26	WOS:000617379900064
J	Aslam, M; Shafqat, A; Albassam, M; Malela-Majika, JC; Shongwe, SC				Aslam, Muhammad; Shafqat, Ambreen; Albassam, Mohammed; Malela-Majika, Jean-Claude; Shongwe, Sandile C.			A new CUSUM control chart under uncertainty with applications in petroleum and meteorology	PLOS ONE			English	Article							CONTROL SCHEMES; DEMONSTRATE; (X)OVER-BAR	In these last few decades, control charts have received a growing interest because of the important role they play by improving the quality of the products and services in industrial and non-industrial environments. Most of the existing control charts are based on the assumption of certainty and accuracy. However, in real-life applications, such as weather forecasting and stock prices, operators are not always certain about the accuracy of an observed data. To efficiently monitor such processes, this paper proposes a new cumulative sum (CUSUM) X over bar chart under the assumption of uncertainty using the neutrosophic statistic (NS). The performance of the new chart is investigated in terms of the neutrosophic run length properties using the Monte Carlo simulations approach. The efficiency of the proposed neutrosophic CUSUM (NCUSUM) X over bar chart is also compared to the one of the classical CUSUM X over bar chart. It is observed that the NCUSUM X over bar chart has very interesting properties compared to the classical CUSUM X over bar chart. The application and implementation of the NCUSUM X over bar chart are provided using simulated, petroleum and meteorological data.	[Aslam, Muhammad; Albassam, Mohammed] King Abdulaziz Univ, Fac Sci, Dept Stat, Jeddah, Saudi Arabia; [Shafqat, Ambreen] Nanjing Univ Sci & Technol, Dept Stat & Financial Math, Nanjing, Jiangsu, Peoples R China; [Malela-Majika, Jean-Claude] Univ Pretoria, Fac Nat & Agr Sci, Dept Stat, Hatfield, South Africa; [Shongwe, Sandile C.] Univ South Africa, Coll Sci Engn & Technol, Dept Stat, Pretoria, South Africa	King Abdulaziz University; Nanjing University of Science & Technology; University of Pretoria; University of South Africa	Aslam, M (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Stat, Jeddah, Saudi Arabia.	aslam_ravian@hotmail.com	Aslam, Muhammad/GRS-8220-2022; Aslam, Muhammad/E-6354-2015; Jean-Claude, Malela-Majika/X-2658-2019; Shafqat, Ambreen/AAS-2656-2021	Aslam, Muhammad/0000-0002-6071-5468; Aslam, Muhammad/0000-0003-0644-1950; Jean-Claude, Malela-Majika/0000-0001-7236-7678; Shafqat, Ambreen/0000-0002-7409-9811; Shongwe, Sandile Charles/0000-0003-2243-8196	Deanship of Scientific Research (DSR), King Abdulaziz University	Deanship of Scientific Research (DSR), King Abdulaziz University	The article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University. The authors, therefore, thankful to DSR for their technical and financial supports.	Aslam M, 2021, MEASUREMENT, V168, DOI 10.1016/j.measurement.2020.108404; Aslam M, 2019, IEEE ACCESS, V7, P25253, DOI 10.1109/ACCESS.2019.2899020; Aslam M, 2019, IEEE ACCESS, V7, P15367, DOI 10.1109/ACCESS.2019.2895162; Aslam M, 2019, INT J FUZZY SYST, V21, P433, DOI 10.1007/s40815-018-0577-1; Maldonado PAC, 2019, NEUTROSOPHIC SETS SY, V26, P27; Faraz A, 2010, QUAL QUANT, V44, P905, DOI 10.1007/s11135-009-9244-9; Haq A, 2015, QUAL RELIAB ENG INT, V31, P877, DOI 10.1002/qre.1646; Haq A, 2015, J STAT COMPUT SIM, V85, P1224, DOI 10.1080/00949655.2013.873040; Haq A, 2014, J STAT COMPUT SIM, V84, P2011, DOI 10.1080/00949655.2013.780059; Khademi M, 2014, IRAN J FUZZY SYST, V11, P55; Khalid HE, 2020, INTRO NEUTROSOPHIC S; Khan Z, 2020, J INTELL FUZZY SYST, V38, P4743, DOI 10.3233/JIFS-191439; Li ZH, 2010, INT J PROD RES, V48, P1287, DOI 10.1080/00207540802484937; LUCAS JM, 1990, TECHNOMETRICS, V32, P1, DOI 10.2307/1269835; Carballido RM, 2019, NEUTROSOPHIC SETS SY, V26, P174; Montgomery SL, 2009, J SPEC TRANSL, P6; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Panthong C, 2016, THAI J MATH, V14, P203; Pereira P, 2018, TRANSFUS APHER SCI, V57, P132, DOI 10.1016/j.transci.2018.02.022; Sabegh MHZ, 2014, IJSOM, V1, P167, DOI DOI 10.22034/2014.2.03; Sanusi RA, 2017, COMPUT IND ENG, V114, P1, DOI 10.1016/j.cie.2017.10.001; Senturk S, 2009, INFORM SCIENCES, V179, P1542, DOI 10.1016/j.ins.2008.09.022; Shafqat A, 2021, AIN SHAMS ENG J, V12, P943, DOI 10.1016/j.asej.2020.06.001; Shafqat A, 2020, IEEE ACCESS, V8, P74977, DOI 10.1109/ACCESS.2020.2989132; Shafqat A, 2018, COMMUN STAT-THEOR M, V47, P1978, DOI 10.1080/03610926.2017.1335414; Moran JCS, 2019, NEUTROSOPHIC SETS SY, V26, P18; Smarandache F, 2010, NEUTROSOPHIC TRANSDI, V4, P396, DOI [10.2139/ssrn.2721587, DOI 10.2139/SSRN.2721587]; Smarandache F., 2014, INTRO NEUTROSOPHIC S, DOI 10.13140/2.1.2780.1289; Zhao Y, 2005, IIE TRANS, V37, P1047, DOI 10.1080/07408170500232321	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246185	10.1371/journal.pone.0246185	http://dx.doi.org/10.1371/journal.pone.0246185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539442	gold, Green Published			2022-12-26	WOS:000616960200085
J	Liedberg, F; Hagberg, O; Aljabery, F; Gardmark, T; Jahnson, S; Jerlstrom, T; Montgomery, A; Sherif, A; Strock, V; Haggstrom, C; Holmberg, L				Liedberg, Fredrik; Hagberg, Oskar; Aljabery, Firas; Gardmark, Truls; Jahnson, Staffan; Jerlstrom, Tomas; Montgomery, Agneta; Sherif, Amir; Strock, Viveka; Haggstrom, Christel; Holmberg, Lars			Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study	PLOS ONE			English	Article							FOLLOW-UP; COMPLICATIONS; RISK	Background and objective To study the cumulative incidence and surgical treatment of midline incisional hernia (MIH) after cystectomy for bladder cancer. Methods In the nationwide Bladder Cancer Data Base Sweden (BladderBaSe), cystectomy was performed in 5646 individuals. Cumulative incidence MIH and surgery for MIH were investigated in relation to age, gender, comorbidity, previous laparotomy and/or inguinal hernia repair, operative technique, primary/secondary cystectomy, postoperative wound dehiscence, year of surgery, and period-specific mean annual hospital cystectomy volume (PSMAV). Results Three years after cystectomy the cumulative incidence of MIH and surgery for MIH was 8% and 4%, respectively. The cumulative incidence MIH was 12%, 9% and 7% in patients having urinary diversion with continent cutaneous pouch, orthotopic neobladder and ileal conduit. Patients with postoperative wound dehiscence had a higher three-year cumulative incidence MIH (20%) compared to 8% without. The corresponding cumulative incidence surgery for MIH three years after cystectomy was 9%, 6%, and 4% for continent cutaneous, neobladder, and conduit diversion, respectively, and 11% for individuals with postoperative wound dehiscence (vs 4% without). Using multivariable Cox regression, secondary cystectomy (HR 1.3 (1.0-1.7)), continent cutaneous diversion (HR 1.9 (1.1-2.4)), robot-assisted cystectomy (HR 1.8 (1-3.2)), wound dehiscence (HR 3.0 (2.0-4.7)), cystectomy in hospitals with PSMAV 10-25 (HR 1.4 (1.0-1.9)), as well as cystectomy during later years (HRs 2.5-3.1) were all independently associated with increased risk of MIH. Conclusions The cumulative incidence of MIH was 8% three years postoperatively, and increase over time. Avoiding postoperative wound dehiscence after midline closure is important to decrease the risk of MIH.	[Liedberg, Fredrik] Skane Univ Hosp, Dept Urol, Malmo, Sweden; [Liedberg, Fredrik; Hagberg, Oskar] Lund Univ, Inst Translat Med, Malmo, Sweden; [Hagberg, Oskar] Reg Canc Ctr South, Lund, Region Skane, Sweden; [Aljabery, Firas; Jahnson, Staffan] Linkoping Univ, Dept Clin & Expt Med, Div Urol, Linkoping, Sweden; [Gardmark, Truls] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Jerlstrom, Tomas] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Dept Urol, Orebro, Sweden; [Montgomery, Agneta] Lund Univ, Inst Clin Sci Malmo, Surg Res Unit, Lund, Sweden; [Sherif, Amir] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Strock, Viveka] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Urol, Gothenburg, Sweden; [Strock, Viveka] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Haggstrom, Christel] Umea Univ, Dept Biobank Res, Umea, Sweden; [Haggstrom, Christel; Holmberg, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Holmberg, Lars] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England	Lund University; Skane University Hospital; Lund University; Linkoping University; Danderyds Hospital; Karolinska Institutet; Orebro University; Lund University; Umea University; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Umea University; Uppsala University; University of London; King's College London	Liedberg, F (corresponding author), Skane Univ Hosp, Dept Urol, Malmo, Sweden.; Liedberg, F (corresponding author), Lund Univ, Inst Translat Med, Malmo, Sweden.	fredrik.liedbero@med.lu		Sherif, Amir/0000-0002-3675-3050; Liedberg, Fredrik/0000-0001-8193-0370; Jerlstrom, Tomas/0000-0003-4615-5238	Swedish Cancer Society [CAN 2019/62, CAN 2017/278]; Lund Medical Faculty (ALF); Skane University Hospital Research Funds; Gyllenstierna Krapperup's Foundation; Skane County Council's Research and Development Foundation [REGSKANE-622351]; Gosta Jonsson Research Foundation; Foundation of Urological Research; Hillevi Fries Research Foundation	Swedish Cancer Society(Swedish Cancer Society); Lund Medical Faculty (ALF); Skane University Hospital Research Funds; Gyllenstierna Krapperup's Foundation; Skane County Council's Research and Development Foundation; Gosta Jonsson Research Foundation; Foundation of Urological Research; Hillevi Fries Research Foundation	This work was supported by the Swedish Cancer Society (grant numbers CAN 2019/62 and CAN 2017/278), Lund Medical Faculty (ALF), Skane University Hospital Research Funds, the Gyllenstierna Krapperup's Foundation, Skane County Council's Research and Development Foundation (REGSKANE-622351), Gosta Jonsson Research Foundation, The Foundation of Urological Research (Ove and Carin Carlsson bladder cancer donation) and Hillevi Fries Research Foundation. The funding sources had no role in the study design, data analyses, interpretation or writing the manuscript.	Ali-El-Dein B, 2008, J UROLOGY, V180, P206, DOI 10.1016/j.juro.2008.03.080; Baucom RB, 2014, AM SURGEON, V80, P720; Bjork Dennis, 2015, Surg Technol Int, V26, P128; Bosanquet DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138745; Edwards DC, 2018, CAN J UROL, V25, P9573; Fink C, 2014, BRIT J SURG, V101, P51, DOI 10.1002/bjs.9364; Fridriksson JO, 2017, J SURG ONCOL, V116, P500, DOI 10.1002/jso.24687; Haggstrom C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016606; Hautmann RE, 2011, J UROLOGY, V185, P2207, DOI 10.1016/j.juro.2011.02.006; Liedberg F, 2019, BJU INT, V124, P449, DOI 10.1111/bju.14767; Liedberg F, 2017, BJU INT, V120, P530, DOI 10.1111/bju.13863; Liedberg F, 2012, SCAND J UROL NEPHROL, V46, P14, DOI 10.3109/00365599.2011.609835; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Movassaghi K, 2016, J UROLOGY, V196, P777, DOI 10.1016/j.juro.2016.03.150; Muysoms FE, 2015, HERNIA, V19, P1, DOI 10.1007/s10029-014-1342-5; Paananen I, 2014, SCAND J UROL, V48, P90, DOI 10.3109/21681805.2013.799225; Patel SV, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005661.pub2; Sanders DL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2843; Seo GH, 2018, WORLD J SURG, V42, P1192, DOI 10.1007/s00268-017-4256-4; van Hemelrijck M, 2013, BJU INT, V112, P1113, DOI 10.1111/bju.12239	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246703	10.1371/journal.pone.0246703	http://dx.doi.org/10.1371/journal.pone.0246703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539475	Green Published, gold			2022-12-26	WOS:000616960200019
J	Stearns, K; Goldklang, M; Xiao, R; Zelonina, T; Blomenkamp, K; Teckman, J; D'Armiento, JM				Stearns, Kyle; Goldklang, Monica; Xiao, Rui; Zelonina, Tina; Blomenkamp, Keith; Teckman, Jeffery; D'Armiento, Jeanine M.			Knockdown of Alpha-1 Antitrypsin with antisense oligonucleotide does not exacerbate smoke induced lung injury	PLOS ONE			English	Article							ANTIPROTEASE BALANCE; SEX-DIFFERENCES; MOUSE MODEL; COPD; PATHOGENESIS; DEFICIENCY; PROTEASE	Alpha-1 Antitrypsin (AAT) is a serum protease inhibitor that regulates increased lung protease production induced by cigarette smoking. Mutations in the Serpina1 gene cause AAT to form hepatoxic polymers, which can lead to reduced availability for the protein's primary function and severe liver disease. An AAT antisense oligonucleotide (ASO) was previously identified to be beneficial for the AATD liver disease by blocking the mutated AAT transcripts. Here we hypothesized that knockdown of AAT aggravates murine lung injury during smoke exposure and acute exacerbations of chronic obstructive pulmonary disease (COPD). C57BL/6J mice were randomly divided into 4 groups each for the smoking and smoke-flu injury models. The ASO and control (No-ASO) were injected subcutaneously starting with smoking or four days prior to influenza infection and then injected weekly at 50 mg/kg body weight. ASO treatment during a 3-month smoke exposure significantly decreased the serum and lung AAT expression, resulting in increased Cela1 expression and elastase activity. However, despite the decrease in AAT, neither the inflammatory cell counts in the bronchoalveolar lavage fluid (BALF) nor the lung structural changes were significantly worsened by ASO treatment. We observed significant differences in inflammation and emphysema due to smoke exposure, but did not observe an ASO treatment effect. Similarly, with the smoke-flu model, differences were only observed between smoke-flu and room air controls, but not as a result of ASO treatment. Off-target effects or compensatory mechanisms may account for this finding. Alternatively, the reduction of AAT with ASO treatment, while sufficient to protect from liver injury, may not be robust enough to lead to lung injury. The results also suggest that previously described AAT ASO treatment for AAT mutation related liver disease may attenuate hepatic injury without being detrimental to the lungs. These potential mechanisms need to be further investigated in order to fully understand the impact of AAT inhibition on protease-antiprotease imbalance in the murine smoke exposure model.	[Stearns, Kyle; Goldklang, Monica; Xiao, Rui; Zelonina, Tina; D'Armiento, Jeanine M.] Columbia Univ, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA; [Blomenkamp, Keith; Teckman, Jeffery] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO USA	Columbia University; Saint Louis University	D'Armiento, JM (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA.	jmd12@cumc.columbia.edu	Xiao, Rui/M-6818-2017	Xiao, Rui/0000-0001-8679-9551; Stearns, Kyle/0000-0002-5166-7927	National Institutes of Health/National Heart, Lung, and Blood Institute [R01HL086936]; American Lung Association/Alpha-1 Foundation [RG-361233]; Center for LAM and Rare Lung Disease at Columbia University	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association/Alpha-1 Foundation; Center for LAM and Rare Lung Disease at Columbia University	This work was supported by National Institutes of Health/National Heart, Lung, and Blood Institute grant R01HL086936 (J.M.D.), American Lung Association/Alpha-1 Foundation research grant RG-361233 (R.X.) and The Center for LAM and Rare Lung Disease at Columbia University. https://www.nhlbi.nih.gov/https://www.lung.org/https://www.alpha1.org/http://www.lamlab.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; [Anonymous], 2014, AM J PHYSIOL-RENAL, V306, pF286; [Anonymous], 2014, PEERJ, V2, pe447; Bodas M, 2012, CURR MOL MED, V12, P807, DOI 10.2174/156652412801318809; Borel F, 2018, P NATL ACAD SCI USA, V115, P2788, DOI 10.1073/pnas.1713689115; Chillappagari S, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0247-x; Evers MM, 2015, ADV DRUG DELIVER REV, V87, P90, DOI 10.1016/j.addr.2015.03.008; Fahndrich S, 2015, COPD, V12, P58, DOI 10.3109/15412555.2015.1023785; FAUVEAU V, 1993, INT J GYNECOL OBSTET, V40, P3, DOI 10.1016/0020-7292(93)90765-O; GADEK JE, 1990, LUNG, V168, P552, DOI 10.1007/BF02718178; Joshi R, 2018, AM J RESP CELL MOL, V59, P167, DOI 10.1165/rcmb.2017-0361OC; Kalfopoulos M, 2017, METHODS MOL BIOL, V1639, P9, DOI 10.1007/978-1-4939-7163-3_2; Kolodziejczyk Joanna, 2011, Pneumonol Alergol Pol, V79, P207; Kukkonen MK, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-36; LIEBERMAN J, 1986, CHEST, V89, P370, DOI 10.1378/chest.89.3.370; Ma Shuren, 2016, Chronic Obstr Pulm Dis, V4, P34, DOI 10.15326/jcopdf.4.1.2016.0156; McCarthy C, 2016, ANN AM THORAC SOC, V13, pS297, DOI 10.1513/AnnalsATS.201509-634KV; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Silverman GA, 2013, J PEDIATR-US, V163, P320, DOI 10.1016/j.jpeds.2013.03.077; Spurzem JR, 2005, SEMIN RESP CRIT CARE, V26, P142, DOI 10.1055/s-2005-869535; Tam A, 2016, AM J RESP CRIT CARE, V193, P825, DOI 10.1164/rccm.201503-0487OC; Wedzicha JA, 2014, CLIN CHEST MED, V35, P157, DOI 10.1016/j.ccm.2013.11.001; Xiao R, 2016, AM J RESP CELL MOL, V55, P708, DOI 10.1165/rcmb.2016-0143OC	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246040	10.1371/journal.pone.0246040	http://dx.doi.org/10.1371/journal.pone.0246040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539438	gold, Green Published			2022-12-26	WOS:000616960200117
J	Zhong, XX; Duan, MJ; Cheng, P				Zhong, Xuxu; Duan, Meijun; Cheng, Peng			Ranking-based hierarchical random mutation in differential evolution	PLOS ONE			English	Article							ALGORITHM; OPTIMIZATION; PARAMETERS; ENSEMBLE; MODELS	In order to improve the performance of differential evolution (DE), this paper proposes a ranking-based hierarchical random mutation in differential evolution (abbreviated as RHRMDE), in which two improvements are presented. First, RHRMDE introduces a hierarchical random mutation mechanism to apply the classic "DE/rand/1" and its variant on the non-inferior and inferior group determined by the fitness value. The non-inferior group employs the traditional mutation operator "DE/rand/1" with global and random characteristics, which increases the global exploration ability and population diversity. The inferior group uses the improved mutation operator "DE/rand/1" with elite and random characteristics, which enhances the local exploitation ability and convergence speed. Second, the control parameter adaptation of RHRMDE not only considers the complexity differences of various problems but also takes individual differences into account. The proposed RHRMDE is compared with five DE variants and five non-DE algorithms on 32 universal benchmark functions, and the results show that the RHRMDE is superior over the compared algorithms.	[Zhong, Xuxu] Sichuan Univ, Natl Key Lab Fundamental Sci Synthet Vis, Chengdu, Sichuan, Peoples R China; [Duan, Meijun] Xihua Univ, Sch Comp & Software Engn, Chengdu, Peoples R China; [Cheng, Peng] Sichuan Univ, Sch Aeronaut & Astronaut, Chengdu, Peoples R China	Sichuan University; Xihua University; Sichuan University	Duan, MJ (corresponding author), Xihua Univ, Sch Comp & Software Engn, Chengdu, Peoples R China.	dmj23@163.com		xuxu, zhong/0000-0001-6247-7056	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, No. U1833128.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguitoni MC, 2019, ENERGY, V181, P654, DOI 10.1016/j.energy.2019.05.211; Awad N.H., 2016, IEEE C EV COMP SAN S; Bilal, 2020, ENG APPL ARTIF INTEL, V90, DOI 10.1016/j.engappai.2020.103479; Chen Q, 2015, PROBLEM DEFINITIONS; Cui LZ, 2018, INFORM SCIENCES, V422, P122, DOI 10.1016/j.ins.2017.09.002; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Draa A, 2015, APPL SOFT COMPUT, V27, P99, DOI 10.1016/j.asoc.2014.11.003; Duan MJ, 2019, APPL INTELL, V49, P605, DOI 10.1007/s10489-018-1267-2; Epitropakis MG, 2011, IEEE T EVOLUT COMPUT, V15, P99, DOI 10.1109/TEVC.2010.2083670; Fan QQ, 2015, EXPERT SYST APPL, V42, P1551, DOI 10.1016/j.eswa.2014.09.046; Faramarzi A, 2020, EXPERT SYST APPL, V152, DOI 10.1016/j.eswa.2020.113377; Faramarzi A, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105190; Ghosh A, 2011, INFORM SCIENCES, V181, P3749, DOI 10.1016/j.ins.2011.03.010; Gong WY, 2013, SOL ENERGY, V94, P209, DOI 10.1016/j.solener.2013.05.007; Holland J.H., 1975, ADAPTATION NATURAL A; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lampinen J., 2000, P 6 INT MEND C SOFT, P76; Li H, 2020, J PETROL SCI ENG, V188, DOI 10.1016/j.petrol.2020.106916; Li SJ, 2019, SOL ENERGY, V190, P465, DOI 10.1016/j.solener.2019.08.022; Liu J, 2005, SOFT COMPUT, V9, P448, DOI 10.1007/s00500-004-0363-x; Mallipeddi R, 2011, APPL SOFT COMPUT, V11, P1679, DOI 10.1016/j.asoc.2010.04.024; Meng ZY, 2016, KNOWL-BASED SYST, V97, P144, DOI 10.1016/j.knosys.2016.01.009; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mohamed AW, 2020, INT J MACH LEARN CYB, V11, P1501, DOI 10.1007/s13042-019-01053-x; Mohamed AW, 2019, INT J MACH LEARN CYB, V10, P253, DOI 10.1007/s13042-017-0711-7; Noman N, 2011, IEEE C EVOL COMPUTAT, P2229; Piotrowski AP, 2014, APPL SOFT COMPUT, V21, P382, DOI 10.1016/j.asoc.2014.03.039; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Sarker RA, 2014, IEEE T EVOLUT COMPUT, V18, P689, DOI 10.1109/TEVC.2013.2281528; Storn R, 1996, 1996 BIENNIAL CONFERENCE OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY - NAFIPS, P519, DOI 10.1109/NAFIPS.1996.534789; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tanabe R, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P71; Tang EK, 2005, Proceedings of the 2005 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, P9; Tang LX, 2015, IEEE T EVOLUT COMPUT, V19, P560, DOI 10.1109/TEVC.2014.2360890; Viktorin A, 2019, SWARM EVOL COMPUT, V50, DOI 10.1016/j.swevo.2018.10.013; Wang SH, 2019, APPL SOFT COMPUT, V81, DOI 10.1016/j.asoc.2019.105496; Wang Y, 2018, IEEE T IND INFORM, V14, P1040, DOI 10.1109/TII.2017.2743761; Wei ZK, 2019, SOFT COMPUT, V23, P6307, DOI 10.1007/s00500-018-3285-8; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wu GH, 2016, INFORM SCIENCES, V329, P329, DOI 10.1016/j.ins.2015.09.009; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14; Zamuda A, 2016, APPL SOFT COMPUT, V42, P93, DOI 10.1016/j.asoc.2016.01.038; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613	46	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245887	10.1371/journal.pone.0245887	http://dx.doi.org/10.1371/journal.pone.0245887			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539464	gold, Green Published			2022-12-26	WOS:000616960200063
J	Huang, Q; Jackson, S; Derakhshan, S; Lee, L; Pham, E; Jackson, A; Cutter, SL				Huang, Qian; Jackson, Sarah; Derakhshan, Sahar; Lee, Logan; Pham, Erika; Jackson, Amber; Cutter, Susan L.			Urban-rural differences in COVID-19 exposures and outcomes in the South: A preliminary analysis of South Carolina	PLOS ONE			English	Article							UNITED-STATES; DISEASE; ACCESS; CORONAVIRUS; DISPARITIES; COUNTY; US	As the COVID-19 pandemic moved beyond the initial heavily impacted and urbanized Northeast region of the United States, hotspots of cases in other urban areas ensued across the country in early 2020. In South Carolina, the spatial and temporal patterns were different, initially concentrating in small towns within metro counties, then diffusing to centralized urban areas and rural areas. When mitigation restrictions were relaxed, hotspots reappeared in the major cities. This paper examines the county-scale spatial and temporal patterns of confirmed cases of COVID-19 for South Carolina from March 1(st)-September 5(th), 2020. We first describe the initial diffusion of the new confirmed cases per week across the state, which remained under 2,000 cases until Memorial Day weekend (epi week 23) then dramatically increased, peaking in mid-July (epi week 29), and slowly declining thereafter. Second, we found significant differences in cases and deaths between urban and rural counties, partially related to the timing of the number of confirmed cases and deaths and the implementation of state and local mitigations. Third, we found that the case rates and mortality rates positively correlated with pre-existing social vulnerability. There was also a negative correlation between mortality rates and county resilience patterns, as expected, suggesting that counties with higher levels of inherent resilience had fewer deaths per 100,000 population.	[Huang, Qian; Jackson, Sarah; Derakhshan, Sahar; Lee, Logan; Pham, Erika; Jackson, Amber; Cutter, Susan L.] Univ South Carolina, Dept Geog, Hazards & Vulnerabil Res Inst, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Huang, Q (corresponding author), Univ South Carolina, Dept Geog, Hazards & Vulnerabil Res Inst, Columbia, SC 29208 USA.	QH1@email.sc.edu		Derakhshan, Sahar/0000-0002-2818-0133; Huang, Qian/0000-0002-5502-1023; Lee, Logan/0000-0001-5496-281X; Jackson, Sarah/0000-0002-9662-5069	COVID-19 Research Initiative grant from the Office of the Vice President for Research at the University of South Carolina	COVID-19 Research Initiative grant from the Office of the Vice President for Research at the University of South Carolina	This work is partially supported by a COVID-19 Research Initiative grant from the Office of the Vice President for Research at the University of South Carolina. There was no other funding received for this study.	Anderson TJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1053-3; [Anonymous], 2020, WMBF NEWS 0313; [Anonymous], 2020, WIS NEWS 10 0508; [Anonymous], 2020, WLTX 0708; [Anonymous], 2020, NY TIMES; Anselin L, 2003, NEW TOOLS SPATIAL DA; Arcury TA, 2005, J RURAL HEALTH, V21, P31, DOI 10.1111/j.1748-0361.2005.tb00059.x; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Beatty DW, 2020, REQUIRED USE PROTECT; Beccari Benjamin, 2016, PLoS Curr, V8, DOI 10.1371/currents.dis.453df025e34b682e9737f95070f9b970; Bivand RS, 2018, TEST-SPAIN, V27, P716, DOI 10.1007/s11749-018-0599-x; Brown TM, 2011, J HEALTH CARE POOR U, V22, P1179, DOI 10.1353/hpu.2011.0127; CDC, 2020, COR DIS 2019 COVID 1; CDC Centers for Disease Control and Prevention (CDC), 2020, PEOPL CERT MED COND; Committee on Measuring Community Resilience, 2019, BUILD MEAS COMM RES; Cooper L., 2020, ABC15 NEWS 0803; Croft JB, 2018, MMWR-MORBID MORTAL W, V67, P205, DOI 10.15585/mmwr.mm6707a1; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2020, ENVIRON HAZARDS-UK, V19, P10, DOI 10.1080/17477891.2018.1511405; Cutter SL, 2016, ANN AM ASSOC GEOGR, V106, P1236, DOI 10.1080/24694452.2016.1194740; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Dew R., 2020, ABC COLUMBIA 0904; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; El Bcheraoui C, 2018, JAMA-J AM MED ASSOC, V319, P1248, DOI 10.1001/jama.2018.2089; Feit N, 2020, STATE; Henning-Smith C, 2021, J RURAL HEALTH, V37, P224, DOI 10.1111/jrh.12463; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Marks J., 2020, THE HERALD; Massey CN., 2010, CLIN DIABETES, V28, P20, DOI [10.2337/diaclin.28.1.20, DOI 10.2337/DIACLIN.28.1.20]; Mintzer A, 2020, FULL LIST FACE MASK; NACo, 2020, COV 19 PAND RESP COU; National League of Cities, 2020, COVID 19 LOC ACT TRA; National Rural Health Association, 2015, RUR HLTH CAR; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Patel L, 2021, J RURAL HEALTH, V37, P175, DOI 10.1111/jrh.12447; Pathman DE, 2006, HEALTH SERV RES, V41, P79, DOI 10.1111/j.1475-6773.2005.00454.x; Probst JC, 2020, AM J PUBLIC HEALTH, V110, P1325, DOI 10.2105/AJPH.2020.305703; Rivera R., 2020, LIVE 5 NEWS 0818; Samanic CM, 2020, MMWR-MORBID MORTAL W, V69, P533, DOI 10.15585/mmwr.mm6918a1; Santibanez S, 2019, SOUTH MED J, V112, P101, DOI 10.14423/SMJ.0000000000000930; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Souch JM, 2021, J RURAL HEALTH, V37, P188, DOI 10.1111/jrh.12450; South Carolina Emergency Management Division, 2020, S CAR REC FED DIS DE; Sparks PJ, 2012, INT HANDB POPUL, V3, P255, DOI 10.1007/978-94-007-1842-5_18; Thomas TL, 2014, HEALTH EDUC J, V73, P285, DOI 10.1177/0017896912471049; Trainor C., 2020, FREETIMES 0804; Treisman R., 2020, S CORONAVIRUS RELATE; Turner-Musa J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020168; United States Census Bureau, 2018, CART BOUND FIL SHAP; United States Census Bureau, 2018, ACS DEM HOUS EST; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Zahnd WE, 2018, CANCER EPIDEM BIOMAR, V27, P1265, DOI 10.1158/1055-9965.EPI-17-0430	56	45	45	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246548	10.1371/journal.pone.0246548	http://dx.doi.org/10.1371/journal.pone.0246548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534870	Green Published, gold			2022-12-26	WOS:000616739700018
J	Niriella, MA; Ediriweera, DS; Kasturiratne, A; De Silva, ST; Dassanayaka, AS; De Silva, AP; Kato, N; Pathmeswaran, A; Wickramasinghe, AR; de Silva, HJ				Niriella, Madunil Anuk; Ediriweera, Dileepa Senajith; Kasturiratne, Anuradhani; De Silva, Shamila Thivanshi; Dassanayaka, Anuradha Supun; De Silva, Arjuna Priyadarshin; Kato, Norihiro; Pathmeswaran, Arunasalam; Wickramasinghe, Ananda Rajitha; de Silva, Hithanadura Janaka			Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; FIBROSIS STAGE; RISK-FACTORS; MORTALITY; URBAN	Background The term "metabolic (dysfunction)-associated fatty liver disease" (MAFLD) is suggested alternative for "non-alcoholic fatty liver disease" (NAFLD), as it better reflects metabolic dysfunction. No study has compared outcomes of the two diagnostic criteria. Methods In an ongoing, community-based, cohort-study in suburban Sri Lanka, participants were randomly selected in 2007. They were reassessed in 2014 to evaluate new-onset metabolic traits (MTs) and cardiovascular-events (CVEs). Baseline characteristics, MTs and CVEs after 7-years were compared in NAFLD and MAFLD and vs. controls. Similarly, we compared these parameters in those excluded by the NAFLD definition but captured by the MAFLD definition and vice versa, and vs. controls. Findings Of 2985 recruited in 2007, 940 (31.5%) had NAFLD, 990 (33.1%) had MAFLD and 362 (12.1%) were controls. When compared to NAFLD, MAFLD captured an additional 2.9% and lost 1.3% individuals. At baseline, anthropometric and metabolic traits were similar in NAFLD and MAFLD. At follow-up in 7-years, the risk of having new-onset MTs and fatal/non-fatal CVEs were similar in the groups, but were significantly higher compared to controls. Those excluded by the NAFLD definition but captured by the MAFLD definition showed higher baseline MTs compared to those excluded by the MAFLD definition but captured by the NAFLD definition, and had substantially higher risk for having new-onset MTs and CVEs compared to controls. Interpretation Although NAFLD and MAFLD had similar MTs at baseline, and similar outcomes after 7-years, those who were excluded by the NAFLD definition but captured by the MAFLD definition seem at higher risk of adverse outcomes than those excluded by the MAFLD definition but captured by the NAFLD definition. Although the increase in the index population was small, redefining NAFLD as MAFLD seemed to improve clinical utility.	[Niriella, Madunil Anuk; Ediriweera, Dileepa Senajith; Kasturiratne, Anuradhani; De Silva, Shamila Thivanshi; Dassanayaka, Anuradha Supun; De Silva, Arjuna Priyadarshin; Pathmeswaran, Arunasalam; Wickramasinghe, Ananda Rajitha; de Silva, Hithanadura Janaka] Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	University Kelaniya; National Center for Global Health & Medicine - Japan	Niriella, MA (corresponding author), Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka.	maduniln@yahoo.co.uk	Ediriweera, Dileepa/J-7986-2014; Pathmeswaran, Arunasalam/H-5650-2019; Niriella, Madunil/G-7803-2016	Ediriweera, Dileepa/0000-0001-5679-2893; Pathmeswaran, Arunasalam/0000-0003-4065-2639; Niriella, Madunil/0000-0002-7213-5858	Ministry of Higher Education of Sri Lanka [HJdeS]; National Center for Global Health and Medicine, Tokyo, Japan	Ministry of Higher Education of Sri Lanka; National Center for Global Health and Medicine, Tokyo, Japan	Grants for the study were from the Ministry of Higher Education of Sri Lanka (HJdeS) and National Center for Global Health and Medicine, Tokyo, Japan (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, LIVER FIBROSIS NO OT; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chan HLY, 2007, J GASTROEN HEPATOL, V22, P801, DOI 10.1111/j.1440-1746.2007.04977.x; Cotter TG, 2020, GASTROENTEROLOGY, V158, P1851, DOI 10.1053/j.gastro.2020.01.052; Dassanayake AS, 2009, J GASTROEN HEPATOL, V24, P1284, DOI 10.1111/j.1440-1746.2009.05831.x; Diehl AM, 2004, GUT, V53, P923, DOI 10.1136/gut.2003.037309; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; Fouad Y, 2020, LIVER INT, V40, P1254, DOI 10.1111/liv.14478; Golabi P, 2018, MEDICINE, V97, DOI [10.1097/md.0000000000010214, 10.1097/MD.0000000000010214]; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Li HB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17061818; Lin S, 2020, LIVER INT, V40, P2082, DOI 10.1111/liv.14548; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Niriella MA, 2020, LIVER INT, V40, P101, DOI 10.1111/liv.14237; Niriella MA, 2017, LIVER INT, V37, P1715, DOI 10.1111/liv.13478; SCHAFFNER F, 1986, PROG LIVER DIS, V8, P283; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2021, HEPATOLOGY, V73, P1194, DOI 10.1002/hep.31420; Younossi ZM, 2013, METABOLISM, V62, P352, DOI 10.1016/j.metabol.2012.08.005	24	38	38	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245762	10.1371/journal.pone.0245762	http://dx.doi.org/10.1371/journal.pone.0245762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534815	Green Published, gold, Green Submitted			2022-12-26	WOS:000616739700013
J	Schlegel, P; Kist, AM; Kunduk, M; Durr, S; Dollinger, M; Schutzenberger, A				Schlegel, Patrick; Kist, Andreas M.; Kunduk, Melda; Duerr, Stephan; Doellinger, Michael; Schuetzenberger, Anne			Interdependencies between acoustic and high-speed videoendoscopy parameters	PLOS ONE			English	Article							VOCAL FOLD VIBRATIONS; TO-NOISE RATIO; DYNAMICS; DIAGNOSIS; INDEX	In voice research, uncovering relations between the oscillating vocal folds, being the sound source of phonation, and the resulting perceived acoustic signal are of great interest. This is especially the case in the context of voice disorders, such as functional dysphonia (FD). We investigated 250 high-speed videoendoscopy (HSV) recordings with simultaneously recorded acoustic signals (124 healthy females, 60 FD females, 44 healthy males, 22 FD males). 35 glottal area waveform (GAW) parameters and 14 acoustic parameters were calculated for each recording. Linear and non-linear relations between GAW and acoustic parameters were investigated using Pearson correlation coefficients (PCC) and distance correlation coefficients (DCC). Further, norm values for parameters obtained from 250 ms long sustained phonation data (vowel /i/) were provided. 26 PCCs in females (5.3%) and 8 in males (1.6%) were found to be statistically significant (|corr.| >= 0.3). Only minor differences were found between PCCs and DCCs, indicating presence of weak non-linear dependencies between parameters. Fundamental frequency was involved in the majority of all relevant PCCs between GAW and acoustic parameters (19 in females and 7 in males). The most distinct difference between correlations in females and males was found for the parameter Period Variability Index. The study shows only weak relations between investigated acoustic and GAW-parameters. This indicates that the reduction of the complex 3D glottal dynamics to the 1D-GAW may erase laryngeal dynamic characteristics that are reflected within the acoustic signal. Hence, other GAW parameters, 2D-, 3D-laryngeal dynamics and vocal tract parameters should be further investigated towards potential correlations to the acoustic signal.	[Schlegel, Patrick] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Schlegel, Patrick; Kist, Andreas M.; Duerr, Stephan; Doellinger, Michael; Schuetzenberger, Anne] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Div Phoniatr & Pediat Audiol, Dept Otorhinolaryngol, Erlangen, Germany; [Kunduk, Melda] Louisiana State Univ, Dept Commun Sci & Disorders, Baton Rouge, LA 70803 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; Louisiana State University System; Louisiana State University	Schlegel, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.; Schlegel, P (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Div Phoniatr & Pediat Audiol, Dept Otorhinolaryngol, Erlangen, Germany.	patrickschlegel@yahoo.de	Kist, Andreas/AAU-3236-2021	Kist, Andreas/0000-0003-3643-7776; Doellinger, Michael/0000-0003-2717-4820	Deutsche Forschungsgemeinschaft (DFG) [BO 4399/2-1, DO 1247/8-1/2, SCHU 3441/3-2, 323308998]; JoachimHerz-Stiftung Add-on fellowship; Deutsche Forschungsgemeinschaft; Friedrich-AlexanderUniversitat Erlangen-Nurnberg (FAU)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); JoachimHerz-Stiftung Add-on fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-AlexanderUniversitat Erlangen-Nurnberg (FAU)	M.D. received funding from the Deutsche Forschungsgemeinschaft (DFG) under grants BO 4399/2-1 and DO 1247/8-1/2 and A.S. under grant SCHU 3441/3-2 (all combined under no. 323308998). The project description can be found online at http://gepris.dfg.de/gepris/projekt/323308998.A.M.K.was supported by a JoachimHerz-Stiftung Add-on fellowship. The description of the funding can be found online at: http://portugueslab.com/andreas-kist-received-afellowship-from-the-joachim-herz-foundation.html.The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-AlexanderUniversitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON AE, 1990, J VOICE, V4, P287, DOI 10.1016/S0892-1997(05)80043-8; Baken R. J., 1999, CLIN MEASUREMENT SPE; Benjamini Y, 2001, ANN STAT, V29, P1165; Bielamowicz S, 1996, J SPEECH HEAR RES, V39, P126, DOI 10.1044/jshr.3901.126; Bohr C, 2013, LARYNGOSCOPE, V123, P1686, DOI 10.1002/lary.23783; Braunschweig T, 2008, MED ENG PHYS, V30, P59, DOI 10.1016/j.medengphy.2006.12.007; Chen G, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P2684; Chen G, 2013, J ACOUST SOC AM, V133, P1656, DOI 10.1121/1.4789931; Colton RH, 2014, DIAGNOSIS TREATMENT, P253; DEAL RE, 1978, J SPEECH HEAR RES, V21, P250, DOI 10.1044/jshr.2102.250; Deliyski D, 2010, LARYNGEAL EVALUATION; Dollinger M, 2012, J VOICE, V26, P726, DOI 10.1016/j.jvoice.2012.02.001; Dollinger M, 2012, LARYNGOSCOPE, V122, P2511, DOI 10.1002/lary.23568; Doellinger M, 2009, CURR BIOINFORM, V4, P101, DOI 10.2174/157489309788184774; Echternach M, 2013, J ACOUST SOC AM, V133, pEL82, DOI 10.1121/1.4773200; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Hertegard Stellan, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P152, DOI 10.1097/01.moo.0000163451.98079.ba; Hess MM, 1996, HNO, V44, P685, DOI 10.1007/s001060050076; HILLENBRAND J, 1994, J SPEECH HEAR RES, V37, P769, DOI 10.1044/jshr.3704.769; Hirai R, 2017, OTOLARYNGOLOGY HEAD, V143, P219, DOI [10.1016/j.otohns.2010.06.435, DOI 10.1016/J.OTOHNS.2010.06.435]; Hohm J, 2015, J VOICE, V29, DOI 10.1016/j.jvoice.2014.10.001; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; HONJO I, 1980, ARCH OTOLARYNGOL, V106, P149, DOI 10.1001/archotol.1980.00790270013003; HORII Y, 1980, J SPEECH HEAR RES, V23, P202, DOI 10.1044/jshr.2301.202; Hsiao TY, 2001, J FORMOS MED ASSOC, V100, P837; Inwald EC, 2011, J VOICE, V25, P576, DOI 10.1016/j.jvoice.2010.04.004; KASUYA H, 1986, J ACOUST SOC AM, V80, P1329, DOI 10.1121/1.394384; Kasuya H., 1993, 3 EUR C SPEECH COMM; KLINGHOLZ F, 1990, J VOICE, V4, P213, DOI 10.1016/S0892-1997(05)80016-5; Kreiman J, 2005, J ACOUST SOC AM, V117, P2201, DOI 10.1121/1.1858351; Kunduk M, 2010, LARYNGOSCOPE, V120, P981, DOI 10.1002/lary.20832; Lessing J., 2007, THESIS; Lohscheller J, 2008, IEEE T MED IMAGING, V27, P300, DOI 10.1109/TMI.2007.903690; Mehta DD, 2011, J ACOUST SOC AM, V130, P3999, DOI 10.1121/1.3658441; Mehta DD, 2010, ANN OTO RHINOL LARYN, V119, P1; Morris R, 2013, HDB LANGUAGE SPEECH, P455; Morton V., 1998, TEACHING VOICE PROBL, V23, P133, DOI DOI 10.1080/140154398434158; Mukaka MM, 2012, MALAWI MED J, V24, P69; Niimi S, 2000, FOLIA PHONIATR LOGO, V52, P32, DOI 10.1159/000021510; Patel RR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154586; Pedersen M., 2016, J GEN PRACT, V4, P253, DOI [10.4172/2329-9126.1000253, DOI 10.4172/2329-9126.1000253]; Petermann S, 2016, ACTA ACUST UNITED AC, V102, P284, DOI 10.3813/AAA.918944; Popolo PS, 2020, J VOICE, DOI [10.1016/j.jvoice.2020.01.02632173147, DOI 10.1016/J.JVOICE.2020.01.02632173147]; Qi YY, 1999, J ACOUST SOC AM, V105, P2532, DOI 10.1121/1.426860; Roy Nelson, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P144, DOI 10.1097/00020840-200306000-00002; Schlegel P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66405-y; Schlegel P, 2020, IEEE J TRANSL ENG HE, V8, DOI 10.1109/JTEHM.2020.2985026; Schlegel P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215168; Schlegel P, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122666; Schlegel P, 2019, J VOICE, V33, DOI 10.1016/j.jvoice.2018.04.011; Schutzenberger A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4575437; Semmler M, 2016, IEEE T MED IMAGING, V35, P1615, DOI 10.1109/TMI.2016.2521419; Sousa PA, 2015, REV PORT CARDIOL, V34, DOI 10.1016/j.repc.2014.12.008; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; TIMCKE R, 1958, ARCHIV OTOLARYNGOL, V68, P1; Titze I. R., 2000, PRINCIPLES VOICE PRO; Uloza V, 2013, J VOICE, V27, P744, DOI 10.1016/j.jvoice.2013.06.008; Uloza V, 2013, J VOICE, V27, P361, DOI 10.1016/j.jvoice.2012.12.007; Unger J, 2016, ARTIF INTELL MED, V66, P15, DOI 10.1016/j.artmed.2015.10.002; Van Houtte E, 2010, LARYNGOSCOPE, V120, P306, DOI 10.1002/lary.20696; Voigt D, 2010, ARTIF INTELL MED, V49, P51, DOI 10.1016/j.artmed.2010.01.001; Wendler J, 2005, LEHRBUCH PHONIATRIE, P139; Werth K, 2010, EUR ARCH OTO-RHINO-L, V267, P1261, DOI 10.1007/s00405-010-1214-2; WILCOX KA, 1980, J GERONTOL, V35, P194, DOI 10.1093/geronj/35.2.194; WILSON JA, 1995, BRIT MED J, V311, P1039, DOI 10.1136/bmj.311.7012.1039; Winkler Ralf, 2006, Logoped Phoniatr Vocol, V31, P51, DOI 10.1080/14015430500445534; Wurzbacher T, 2008, J ACOUST SOC AM, V123, P2324, DOI 10.1121/1.2835435; Xue SA, 2001, EDUC GERONTOL, V27, P159, DOI 10.1080/03601270151075561; YUMOTO E, 1982, J ACOUST SOC AM, V71, P1544, DOI 10.1121/1.387808; Zacharias SRC, 2018, J VOICE, V32, P216, DOI 10.1016/j.jvoice.2017.05.002	70	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246136	10.1371/journal.pone.0246136	http://dx.doi.org/10.1371/journal.pone.0246136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529244	Green Published, gold			2022-12-26	WOS:000616736200012
J	Tolay, I				Tolay, Inci			The impact of different Zinc (Zn) levels on growth and nutrient uptake of Basil (Ocimum basilicum L.) grown under salinity stress	PLOS ONE			English	Article							SALT STRESS; CHLOROPHYLL FLUORESCENCE; BIOCHEMICAL-CHANGES; WHEAT GENOTYPES; WATER RELATIONS; TOLERANCE; PHOTOSYNTHESIS; COMPONENTS; RESPONSES; SODIUM	Salinity is among the most important abiotic stresses, which negatively affect growth, nutrient uptake and yield of crop plants. Application of different micronutrients, particularly zinc (Zn) have the potential to ameliorate the negative impacts of salinity stress. However, the role of Zn in improving salinity tolerance of basil (Ocimum basilicum L.) is poorly understood. This study evaluated the impact of different Zn levels (0, 5 and 10 mg kg(-1)) on growth and nutrient acquisition traits of basil under different salinity levels (0, 0.5, 1.0 and 1.5% NaCl). Data relating to biomass production, chlorophyll index, sodium (Na), potassium (K) uptake, K/Na ratio, Zn, copper (Cu), manganese (Mn) and iron (Fe) uptake were recorded. Increasing salinity level reduced biomass production, chlorophyll index and nutrient uptake traits (except for Na and Fe accumulation) of basil. Zinc application (10 mg kg(-1)) improved biomass production, chlorophyll index and nutrient acquisition traits under normal as well as saline conditions. The reduction in chlorophyll index and biomass production was higher under 0 and 5 mg kg(-1) than 10 mg kg(-1) Zn application. The K concentration decreased under increasing salinity; however, Zn application improved K uptake under normal as well as saline conditions. Different growth and nutrient acquisition traits had negative correlations with Na accumulation; however, no positive correlation was recorded among growth and nutrient uptake traits. The results revealed that Zn application could improve the salinity tolerance of basil. However, actual biochemical and genetic mechanisms involved in Zn-induced salinity tolerance warrant further investigation.	[Tolay, Inci] Akdeniz Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Antalya, Turkey	Akdeniz University	Tolay, I (corresponding author), Akdeniz Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Antalya, Turkey.	incitolay@akdeniz.edu.tr						Abbas G, 2021, J AGRON CROP SCI, V207, P59, DOI 10.1111/jac.12451; Aktas Hakan, 2006, Turkish Journal of Agriculture and Forestry, V30, P407; Arif Y, 2020, PLANT PHYSIOL BIOCH, V156, P64, DOI 10.1016/j.plaphy.2020.08.042; BOUYOUCOS GJ, 1951, AGRON J, V43, P434, DOI 10.2134/agronj1951.00021962004300090005x; Caliskan O, 2017, ITAL J AGRON, V12, P271, DOI 10.4081/ija.2017.918; Carregosa V, 2014, COMP BIOCHEM PHYS A, V171, P36, DOI 10.1016/j.cbpa.2014.02.009; Carson PL, 1975, B DEP AGRIC EC ND AG; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; CRAMER GR, 1994, AUST J PLANT PHYSIOL, V21, P663, DOI 10.1071/PP9940663; Daneshbakhsh B, 2013, ACTA PHYSIOL PLANT, V35, P881, DOI 10.1007/s11738-012-1131-7; Daneshbakhsh B, 2013, J PLANT PHYSIOL, V170, P41, DOI 10.1016/j.jplph.2012.08.016; Degl'Innocenti E, 2009, J PLANT PHYSIOL, V166, P1968, DOI 10.1016/j.jplph.2009.06.013; Farooq S, 2017, ACTA OECOL, V84, P23, DOI 10.1016/j.actao.2017.08.004; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Hassanpouraghdam M. B., 2011, Acta Agriculturae Slovenica, V97, P93, DOI 10.2478/v10014-011-0004-x; Hoffman Glenn J., 2013, CONTROLLING SALINITY, V2nd, P160, DOI [10.13031/2013.23690, DOI 10.13031/2013.23690]; Houshmand S, 2005, FIELD CROP RES, V91, P345, DOI 10.1016/j.fcr.2004.08.004; Jackson ML, 1959, J AGR FOOD CHEM, V7, P138, DOI [10.1021/jf60096a605, DOI 10.1021/JF60096A605]; JURY WA, 1979, SOIL SCI SOC AM J, V43, P1100, DOI 10.2136/sssaj1979.03615995004300060008x; Kendirli B, 2005, IRRIG DRAIN, V54, P115, DOI 10.1002/ird.157; Khoshgoftar AH, 2006, J PLANT NUTR, V29, P1543, DOI 10.1080/01904160600848771; Kielen N.C., 2002, AGR DRAINAGE WATER M; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lee SJ, 2005, FOOD CHEM, V91, P131, DOI 10.1016/j.foodchem.2004.05.056; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Martinez-Beltran J, 2005, P INT SOL FOR, DOI [10.1128/AAC.49.12.5172-5175.2005, DOI 10.1128/AAC.49.12.5172-5175.2005]; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nadeem F, 2020, J SOIL SCI PLANT NUT, V20, P2059, DOI 10.1007/s42729-020-00275-1; Naumann JC, 2007, PHYSIOL PLANTARUM, V131, P422, DOI 10.1111/j.1399-3054.2007.00973.x; Netondo GW, 2004, CROP SCI, V44, P806, DOI 10.2135/cropsci2004.0806; Nurzynska-Wierdak R, 2012, J ESSENT OIL RES, V24, P217, DOI 10.1080/10412905.2012.676763; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pan T, 2021, CRIT REV ENV SCI TEC, V51, P791, DOI 10.1080/10643389.2020.1735231; Qadir M, 2014, NAT RESOUR FORUM, V38, P282, DOI 10.1111/1477-8947.12054; Qiu NW, 2003, NEW PHYTOL, V159, P479, DOI 10.1046/j.1469-8137.2003.00825.x; Rhoades JD, 2012, INSTRUMENTAL FIELD M, P231, DOI [10.2136/sssaspecpub30.c12, DOI 10.2136/SSSASPECPUB30.C12]; Saleh J, 2009, COMMUN SOIL SCI PLAN, V40, P3046, DOI 10.1080/00103620903261619; Saleque MA, 2005, J PLANT NUTR, V28, P865, DOI 10.1081/PLN-200055560; Shabala L, 2012, PHYSIOL PLANTARUM, V146, P26, DOI 10.1111/j.1399-3054.2012.01599.x; Shaygan M, 2017, GEODERMA, V292, P96, DOI 10.1016/j.geoderma.2017.01.007; SINGH RB, 1992, AGR WATER MANAGE, V21, P93, DOI 10.1016/0378-3774(92)90085-B; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Tarchoune I, 2013, ANN APPL BIOL, V163, P23, DOI 10.1111/aab.12036; Tarchoune I, 2012, ACTA PHYSIOL PLANT, V34, P607, DOI 10.1007/s11738-011-0861-2; Tavallali V, 2009, SCI HORTIC-AMSTERDAM, V123, P272, DOI 10.1016/j.scienta.2009.09.006; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Yeil E., 2008, THESIS; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	52	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246493	10.1371/journal.pone.0246493	http://dx.doi.org/10.1371/journal.pone.0246493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529247	gold, Green Published			2022-12-26	WOS:000616736200007
J	Tange, H; Ishibashi, D; Nakagaki, T; Taguchi, Y; Kamatari, YO; Ozawa, H; Nishida, N				Tange, Hiroya; Ishibashi, Daisuke; Nakagaki, Takehiro; Taguchi, Yuzuru; Kamatari, Yuji O.; Ozawa, Hiroki; Nishida, Noriyuki			Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE-ASSOCIATED FORM; CELL-SURFACE; AMYLOID FORMATION; PRPSC; AGGREGATION; BINDING; PROPAGATION; RECOMBINANT; INTERACT; KINETICS	Prion diseases are characterized by the accumulation of amyloid fibrils. The causative agent is an infectious amyloid that comprises solely misfolded prion protein (PrPSc). Prions can convert normal cellular prion protein (PrPC) to protease K-resistance prion protein fragment (PrP-res) in vitro; however, the intermediate steps involved in this spontaneous conversion still remain unknown. We investigated whether recombinant prion protein (rPrP) can directly convert into PrP-res via liquid-liquid phase separation (LLPS) in the absence of PrPSc. We found that rPrP underwent LLPS at the interface of the aqueous two-phase system of polyethylene glycol and dextran, whereas single-phase conditions were not inducible. Fluorescence recovery assay after photobleaching revealed that the liquid-solid phase transition occurred within a short time. The aged rPrP-gel acquired a proteinase-resistant amyloid accompanied by beta-sheet conversion, as confirmed by Western blotting, Fourier transform infrared spectroscopy, and Congo red staining. The reactions required both the N-terminal region of rPrP (amino acids 23-89) and kosmotropic salts, suggesting that the kosmotropic anions may interact with the N-terminal region of rPrP to promote LLPS. Thus, structural conversion via LLPS and liquid-solid phase transition could be the intermediate steps in the conversion of prions.	[Tange, Hiroya; Ishibashi, Daisuke; Nakagaki, Takehiro; Taguchi, Yuzuru; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki, Japan; [Tange, Hiroya; Ozawa, Hiroki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuropsychiat, Nagasaki, Japan; [Kamatari, Yuji O.] Gifu Univ, Life Sci Res Ctr, Gifu, Japan	Nagasaki University; Nagasaki University; Gifu University	Tange, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki, Japan.; Tange, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuropsychiat, Nagasaki, Japan.	bb55416003@ms.nagasaki-u.ac.jp		Tange, Hiorya/0000-0002-0871-0133; Nakagaki, Takehiro/0000-0003-1960-8326	JSPS KAKENHI [JP19K22600]; Japan Science Society [29-420]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society	This research was supported by JSPS KAKENHI JP19K22600 and Sasakawa Scientific Research Grant from The Japan Science Society 29-420.	Alsiary RA, 2020, NEUROL SCI, V41, P2389, DOI 10.1007/s10072-020-04321-9; Asenjo JA, 2011, J CHROMATOGR A, V1218, P8826, DOI 10.1016/j.chroma.2011.06.051; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Benavides J, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 2: ENGINEERING FUNDAMENTALS OF BIOTECHNOLOGY, 2ND EDITION, P697; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/nphys3532, 10.1038/NPHYS3532]; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CARLSON A, 1988, SEPAR SCI TECHNOL, V23, P785, DOI 10.1080/01496398808063140; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Dorosz J, 2009, LANGMUIR, V25, P12501, DOI 10.1021/la901750v; Ellett LJ, 2015, GLYCOBIOLOGY, V25, P745, DOI 10.1093/glycob/cwv014; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Exley C, 2010, J INORG BIOCHEM, V104, P1125, DOI 10.1016/j.jinorgbio.2010.05.012; Feng Z, 2019, J BIOL CHEM, V294, P14823, DOI 10.1074/jbc.REV119.007895; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gabryelczyk B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13469-8; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Godsave SF, 2013, NEUROBIOL AGING, V34, P1621, DOI 10.1016/j.neurobiolaging.2012.12.015; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Hackl EV, 2015, EUR BIOPHYS J BIOPHY, V44, P249, DOI 10.1007/s00249-015-1019-8; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iqbal M, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0048-8; Ishibashi D, 2019, BRAIN, V142, P1035, DOI 10.1093/brain/awz016; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Li HR, 2018, J BIOL CHEM, V293, P6090, DOI 10.1074/jbc.AC117.001037; Lu AX, 2017, CHEM SCI, V8, P6893, DOI 10.1039/c7sc01335c; Matos CO, 2020, FASEB J, V34, P365, DOI 10.1096/fj.201901897R; Metrick MA, 2019, P NATL ACAD SCI USA, V116, P23029, DOI 10.1073/pnas.1909322116; Miyazaki Y, 2019, MOL NEUROBIOL, V56, P367, DOI 10.1007/s12035-018-1088-7; Moore RA, 2007, BIOCHEMISTRY-US, V46, P7079, DOI 10.1021/bi700247y; Murthy AC, 2019, NAT STRUCT MOL BIOL, V26, P637, DOI 10.1038/s41594-019-0250-x; Nakatani N, 2018, CHEMBIOCHEM, V19, P1370, DOI 10.1002/cbic.201800066; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Rouvinski A, 2014, J CELL BIOL, V204, P423, DOI 10.1083/jcb.201308028; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sankaranarayanan K, 2012, J PHYS CHEM B, V116, P895, DOI 10.1021/jp2100733; Shibata C, 2019, PROTEIN EXPRES PURIF, V161, P57, DOI 10.1016/j.pep.2019.05.002; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Spagnolli G, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007864; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; Xiong LW, 2001, J NEUROCHEM, V79, P669, DOI 10.1046/j.1471-4159.2001.00606.x; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Yen CF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600014; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	82	20	20	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100367	10.1016/j.jbc.2021.100367	http://dx.doi.org/10.1016/j.jbc.2021.100367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545172	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400341
J	Hagenaars, TJ; Backx, A; van Rooij, EMA; Vrouenraets, RMMI; Bontje, DM; Bouma, A; Elbers, ARW				Hagenaars, Thomas J.; Backx, Anoek; van Rooij, Eugene M. A.; Vrouenraets, Roger M. M., I; Bontje, Daniel M.; Bouma, Annemarie; Elbers, Armin R. W.			Within-farm transmission characteristics of bluetongue virus serotype 8 in cattle and sheep in the Netherlands, 2007-2008	PLOS ONE			English	Article							SCHMALLENBERG VIRUS; MEDITERRANEAN BASIN; CULICOIDES; CERATOPOGONIDAE; DIPTERA; QUANTIFICATION; VACCINATION; EPIDEMIC; MIDGES; FRANCE	In 2006 and 2007, sheep and cattle farms in the Netherlands were affected by an epidemic of bluetongue virus serotype 8 (BTV-8). In order to obtain insight into the within-farm spread of the virus, five affected cattle and five affected sheep farms were longitudinally monitored between early 2007 and mid or late 2008. The farms were visited between four and seven times to collect blood samples. During each visit, all animals present in the flock or herd were sampled. The samples were analysed for the presence of BTV-8 antibodies (ELISA) and BTV-8 antigen (rRT-PCR). The observed patterns of RT-PCR positives indicate a rapid within-farm virus spread during the vector season. During vector-free periods we observed a complete rRT-PCR positivity decline within a few months. During the vector season a lower bound estimate of the basic reproduction number (R-0) ranges from 2.9-6.9 in the cattle herds (one herd not analysed), and from 1.3-3.2 in the sheep flocks in this study.	[Hagenaars, Thomas J.; Backx, Anoek; van Rooij, Eugene M. A.; Bontje, Daniel M.; Elbers, Armin R. W.] Wageningen Biovet Res, Lelystad, Netherlands; [Vrouenraets, Roger M. M., I] DAC Heerlen, Heerlen, Netherlands; [Bouma, Annemarie] Minist Agr, Nat & Food Qual, The Hague, Netherlands; [Backx, Anoek] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Hagenaars, TJ (corresponding author), Wageningen Biovet Res, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	Elbers, Armin/J-5249-2017	Elbers, Armin/0000-0001-5977-0219	Ministry of Agriculture, Nature and Food Quality [WOT-01-001-004]	Ministry of Agriculture, Nature and Food Quality	This investigation was funded in the framework of Statutory Tasks for the Ministry of Agriculture, Nature and Food Quality (WOT-01-001-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LAND TUINB 2007 S GR; Ayllon T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-34; Courtejoie N, 2018, TRANSBOUND EMERG DIS, V65, P281, DOI 10.1111/tbed.12652; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DEJONG MCM, 1994, VACCINE, V12, P761, DOI 10.1016/0264-410X(94)90229-1; Diekmann O., 2012, MATH TOOLS UNDERSTAN; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Elbers ARW, 2015, TRANSBOUND EMERG DIS, V62, P339, DOI 10.1111/tbed.12128; Elbers ARW, 2014, VET PARASITOL, V205, P330, DOI 10.1016/j.vetpar.2014.06.004; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Elbers ARW, 2009, PREV VET MED, V92, P1, DOI 10.1016/j.prevetmed.2009.08.007; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Goffredo M, 2013, PREV VET MED, V111, P230, DOI 10.1016/j.prevetmed.2013.05.014; Gubbins S, 2012, PREV VET MED, V105, P297, DOI 10.1016/j.prevetmed.2012.02.016; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; ProMED-mail, 2019, BLUET EUR GERM RP BO; ProMED-mail, 2019, BLUET EUR 04 FRANC C; ProMED-mail, 2019, BLUET EUR 03 SWITZ S; ProMED-mail, 2019, BLUET EUR 06 BELG LX; Santman-Berends IMGA, 2013, PREV VET MED, V108, P276, DOI 10.1016/j.prevetmed.2012.11.004; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Segard A, 2018, TRANSBOUND EMERG DIS, V65, pe94, DOI 10.1111/tbed.12686; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Taylor W P, 1986, Rev Sci Tech, V5, P351, DOI 10.20506/rst.5.2.256; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van Rijn PA, 2012, J VET DIAGN INVEST, V24, P469, DOI 10.1177/1040638712440986; van Schaik G, 2008, VET REC, V163, P441, DOI 10.1136/vr.163.15.441; Vannier P, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2189; Zientara S, 2013, VET MICROBIOL, V165, P33, DOI 10.1016/j.vetmic.2013.01.010	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246565	10.1371/journal.pone.0246565	http://dx.doi.org/10.1371/journal.pone.0246565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556122	gold, Green Published			2022-12-26	WOS:000617379900068
J	Mantokoudis, G; Schlapfer, N; Kellinghaus, M; Hakim, A; von Werdt, M; Caversaccio, MD; Wagner, F				Mantokoudis, Georgios; Schlapfer, Njima; Kellinghaus, Manuel; Hakim, Arsany; von Werdt, Moritz; Caversaccio, Marco D.; Wagner, Franca			Traumatic dislocation of middle ear ossicles: A new computed tomography classification predicting hearing outcome	PLOS ONE			English	Article							TEMPORAL BONE-FRACTURES; MANAGEMENT; INJURIES; CT	Objectives To assess the feasibility of radiologic measurements and find out whether hearing outcome could be predicted based on computer tomography (CT) scan evaluation in patients with temporal bone fractures and suspected ossicular joint dislocation. Methods We assessed 4002 temporal bone CT scans and identified 34 patients with reported ossicular joint dislocation due to trauma. We excluded those with no proven traumatic ossicular dislocation in CT scan and patients with bilateral temporal bone fractures. We measured four parameters such as malleus-incus axis distance, malleus-incus angle at midpoints, malleus- incus axis angle and ossicular joint space. The contralateral healthy side served as its own control. Hearing outcome 1-3 months after the index visit was analyzed. We assessed diagnostic accuracy and performed a logistic regression using radiologic measurement parameters for outcome prediction of conductive hearing loss (defined as >20dB air-bone gap). Results We found excellent inter-rater agreement on the measurement of axis deviation between incus and malleus in CT scans (interclass correlation coefficient 0.81). The larger the deviation of incus and malleus axis, the higher probability of poor hearing outcome (odds ratio (OR) 2.67 per 0.1mm, p = .006). A cut-off value for the axis deviation of 0.25mm showed a sensitivity of 0.778 and a specificity of 0.94 (p < .001) for discrimination between poor and good hearing outcome in terms of conductive hearing loss. Conclusion Adequate assessment of high resolution CT scans of temporal bone in which ossicular chain dislocation had occurred after trauma was feasible. Axis deviations of the incus and the malleus were strongly predictive for poor hearing outcome in terms of air conduction 1-3 months after trauma. We propose a 3-level classification system for hearing outcome prediction based on radiologic measures.	[Mantokoudis, Georgios; Schlapfer, Njima; von Werdt, Moritz; Caversaccio, Marco D.] Univ Bern, Univ Hosp Bern, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland; [Kellinghaus, Manuel; Hakim, Arsany; Wagner, Franca] Univ Bern, Univ Hosp Bern, Inselspital, Univ Dept Diagnost & Intervent Neuroradiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Mantokoudis, G (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland.	georgios.mantokoudis@insel.ch	Hakim, Arsany/I-2505-2019; Mantokoudis, Georgios/J-6318-2013	Hakim, Arsany/0000-0001-9431-1069; Mantokoudis, Georgios/0000-0003-2268-7811	Swiss National Science Foundation [320030_173081]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	G.M. received funding from the Swiss National Science Foundation (#320030_173081). All other authors received no external financial support for that study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, Otolaryngol Head Neck Surg, V113, P186; Basson OJ, 2009, J LARYNGOL OTOL, V123, P177, DOI 10.1017/S0022215108002454; Bogaerts M, 2014, OTOL NEUROTOL, V35, P582, DOI 10.1097/MAO.0000000000000322; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; Delrue S, 2016, J INT ADV OTOL, V12, P231, DOI 10.5152/iao.2016.2868; Ghonim MR, 2016, CLIN OTOLARYNGOL, V41, P176, DOI 10.1111/coa.12461; Gladwell M, 2008, J ORAL MAXIL SURG, V66, P513, DOI 10.1016/j.joms.2007.08.039; Grant JR, 2008, OTOL NEUROTOL, V29, P344, DOI 10.1097/MAO.0b013e3181690792; HAMMOND VT, 1980, J LARYNGOL OTOL, V94, P117, DOI 10.1017/S0022215100088551; HOUGH JVD, 1969, ANN OTO RHINOL LARYN, V78, P210, DOI 10.1177/000348946907800202; HOUGH JVD, 1968, LARYNGOSCOPE, V78, P899, DOI 10.1288/00005537-196806000-00003; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Kang HM, 2012, EUR ARCH OTO-RHINO-L, V269, P1893, DOI 10.1007/s00405-011-1849-7; KHAN AA, 1985, OTOLARYNG HEAD NECK, V93, P177, DOI 10.1177/019459988509300210; Maillot O, 2017, J NEURORADIOLOGY, V44, P333, DOI 10.1016/j.neurad.2017.04.001; Maillot O, 2016, INSIGHTS IMAGING, V7, P341, DOI 10.1007/s13244-016-0490-9; Meriot P, 1997, RADIOGRAPHICS, V17, P1445, DOI 10.1148/radiographics.17.6.9397457; Mun SK, 2017, INJURY, V48, P2879, DOI 10.1016/j.injury.2017.10.041; Presutti L, 2015, ENDOSCOPIC EAR SURG; Rafferty MA, 2006, CLIN OTOLARYNGOL, V31, P287, DOI 10.1111/j.1749-4486.2006.01267.x; SCHUBIGER O, 1986, NEURORADIOLOGY, V28, P93, DOI 10.1007/BF00327878; Singh S, 2002, J LARYNGOL OTOL, V116, P457, DOI 10.1258/0022215021911068; SWARTZ JD, 1986, LARYNGOSCOPE, V96, P1207; WRIGHT JW, 1969, ANN OTO RHINOL LARYN, V78, P263, DOI 10.1177/000348946907800206; Wysocki J, 2005, SKULL BASE-INTERD AP, V15, P99, DOI 10.1055/s-2005-870593; Yanagihara N, 1997, Ear Nose Throat J, V76, P79; Yetiser S, 2008, AM J OTOLARYNG, V29, P31, DOI 10.1016/j.amjoto.2007.01.001; Zhao B, 2008, J COMPUT ASSIST TOMO, V32, P951, DOI 10.1097/RCT.0b013e31815ba1cd	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245796	10.1371/journal.pone.0245796	http://dx.doi.org/10.1371/journal.pone.0245796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556107	Green Published, gold			2022-12-26	WOS:000617531400011
J	Hong, SW; Lee, HJ; Han, K; Moon, JM; Park, S; Soh, H; Kang, EA; Chun, J; Im, JP; Kim, JS				Hong, Seung Wook; Lee, Hyun Jung; Han, Kyungdo; Moon, Jung Min; Park, Seona; Soh, Hosim; Kang, Eun Ae; Chun, Jaeyoung; Im, Jong Pil; Kim, Joo Sung			Risk of gastrointestinal cancer in patients with an elevated level of gamma-glutamyltransferase: A nationwide population-based study	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; OXIDATIVE STRESS; METABOLIC SYNDROME; ASSOCIATION; HYPERINSULINEMIA; COHORT	Emerging evidence that an elevated serum gamma-glutamyltransferase (GGT) level is associated with an increased risk of gastrointestinal cancer, but still controversial. The aim of this study to assess the relationship between GGT level and risk of gastrointestinal cancer, and the contribution of the interaction of hyperglycemia with elevated GGT level to the incidence of gastrointestinal cancer by the stratified analysis. A total of 8,120,665 Koreans who received medical checkups in 2009 were included. Subjects were classified according to the quartile of GGT level for women and men. The incidence rates of gastrointestinal cancer for each group were analyzed using Cox proportional hazards models. During follow-up, 129,853 cases of gastrointestinal cancer newly occurred (esophagus, 3,792; stomach, 57,932; and colorectal, 68,789 cases). The highest GGT quartile group showed an increased risk of gastrointestinal cancer (esophagus, hazard ratio = 2.408 [95% confidence interval, 2.184-2.654]; stomach, 1.121 [1.093-1.149]; and colorectal, 1.185 [1.158-1.211]). The risk increased significantly with the rise in GGT quartile level, regardless of the site of cancer. The stratified analysis according to glycemic status showed that the effect of elevated GGT was predominant in the risk of esophageal cancer. The effect of elevated GGT further increased the risk of stomach and colorectal cancers in diabetic patients. An elevated level of GGT was associated with an increased risk of gastrointestinal cancer, regardless of the site of cancer. The effect of the increase in GGT level on the risk of gastrointestinal cancer depended on the type of cancer and glycemic status.	[Hong, Seung Wook; Lee, Hyun Jung; Moon, Jung Min; Park, Seona; Soh, Hosim; Kang, Eun Ae; Im, Jong Pil; Kim, Joo Sung] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Dept Med Stat, Coll Med, Seoul, South Korea; [Chun, Jaeyoung] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Hong, Seung Wook] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Catholic University of Korea; Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	guswjd80@gmail.com	Cheon, Jae Hee/B-4523-2015; Chun, Jaeyoung/G-2921-2015	Cheon, Jae Hee/0000-0002-2282-8904; Chun, Jaeyoung/0000-0002-4212-0380				Choi YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177053; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; Dixon JL, 2016, DIS ESOPHAGUS, V29, P747, DOI 10.1111/dote.12402; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Franzini M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12356-w; Hanigan MH, 2014, ADV CANCER RES, V122, P103, DOI 10.1016/B978-0-12-420117-0.00003-7; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1998, CHEM-BIOL INTERACT, V112, P333, DOI 10.1016/S0009-2797(97)00170-1; Hsu IR, 2007, AM J CLIN NUTR, V86, p867S, DOI 10.1093/ajcn/86.3.867S; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Kim MK, 2018, CIRCULATION, V138, P2627, DOI [10.1161/CIRCULATIONAHA.118.034978, 10.1161/circulationaha.118.034978]; Komlosh A, 2002, CARCINOGENESIS, V23, P669, DOI 10.1093/carcin/23.4.669; Kunutsor SK, 2015, INT J CANCER, V136, P1162, DOI 10.1002/ijc.29084; Kunutsor SK, 2014, ANN EPIDEMIOL, V24, P809, DOI 10.1016/j.annepidem.2014.09.001; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Ma YA, 2018, BRIT J CANCER, V119, P1436, DOI 10.1038/s41416-018-0314-4; Melvin JC, 2012, INT J MOL EPIDEMIOL, V3, P276; Miao ZF, 2017, ONCOTARGET, V8, P44881, DOI 10.18632/oncotarget.16487; Mok Y, 2016, INT J CANCER, V138, P311, DOI 10.1002/ijc.29659; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Nano J, 2017, INT J EPIDEMIOL, V46, P1400, DOI 10.1093/ije/dyx006; Ndrepepa G, 2018, CLIN CHIM ACTA, V476, P130, DOI 10.1016/j.cca.2017.11.026; Orgel E, 2013, CURR DIABETES REP, V13, P213, DOI 10.1007/s11892-012-0356-6; Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259; Qi JY, 2019, J DIABETES, V11, P878, DOI 10.1111/1753-0407.12926; Sabanayagam C, 2009, EUR J EPIDEMIOL, V24, P369, DOI 10.1007/s10654-009-9346-7; Skyler JS, 2017, DIABETES, V66, P241, DOI 10.2337/db16-0806; Stranges S, 2005, HYPERTENSION, V46, P1186, DOI 10.1161/01.HYP.0000185688.81320.4d; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Teschke R, 1980, Adv Exp Med Biol, V132, P647; Tsuboya T, 2012, J EPIDEMIOL, V22, P144, DOI 10.2188/jea.JE20110071; Tsujimoto T, 2017, INT J CANCER, V141, P102, DOI 10.1002/ijc.30729; Valent F, 2015, J DIABETES COMPLICAT, V29, P1056, DOI 10.1016/j.jdiacomp.2015.07.017; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Wang S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44844; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Wu J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-294; Xu B, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007944	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245052	10.1371/journal.pone.0245052	http://dx.doi.org/10.1371/journal.pone.0245052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544706	Green Published, gold			2022-12-26	WOS:000617991900020
J	Yu, GC; Feng, HF; Feng, S; Zhao, J; Xu, J				Yu, Gongchao; Feng, Huifen; Feng, Shuang; Zhao, Jing; Xu, Jing			Forecasting hand-foot-and-mouth disease cases using wavelet-based SARIMA-NNAR hybrid model	PLOS ONE			English	Article							TIME-SERIES; NEURAL-NETWORK; ARIMA; CHINA	Background Hand-foot-and-mouth disease_(HFMD) is one of the most typical diseases in children that is associated with high morbidity. Reliable forecasting is crucial for prevention and control. Recently, hybrid models have become popular, and wavelet analysis has been widely performed. Better prediction accuracy may be achieved using wavelet-based hybrid models. Thus, our aim is to forecast number of HFMD cases with wavelet-based hybrid models. Materials and methods We fitted a wavelet-based seasonal autoregressive integrated moving average (SARIMA)-neural network nonlinear autoregressive (NNAR) hybrid model with HFMD weekly cases from 2009 to 2016 in Zhengzhou, China. Additionally, a single SARIMA model, simplex NNAR model, and pure SARIMA-NNAR hybrid model were established for comparison and estimation. Results The wavelet-based SARIMA-NNAR hybrid model demonstrates excellent performance whether in fitting or forecasting compared with other models. Its fitted and forecasting time series are similar to the actual observed time series. Conclusions The wavelet-based SARIMA-NNAR hybrid model fitted in this study is suitable for forecasting the number of HFMD cases. Hence, it will facilitate the prevention and control of HFMD.	[Yu, Gongchao; Feng, Huifen; Feng, Shuang; Zhao, Jing; Xu, Jing] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Feng, HF (corresponding author), Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China.	huifen.feng@163.com		Yu, Gongchao/0000-0003-0937-4685	National Natural Science Foundation of China [81473030]; Henan Province Special Project of Key Research, Development and Promotion [192102310376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province Special Project of Key Research, Development and Promotion	This work was supported by the National Natural Science Foundation of China (grant number 81473030) and the Henan Province Special Project of Key Research, Development and Promotion (grant number 192102310376).	Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Feng HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087916; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Hyndman R.J., FORECASTING PRINCIPL; Jin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142064; Kaastra I, 1996, NEUROCOMPUTING, V10, P215, DOI 10.1016/0925-2312(95)00039-9; Li J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217474; Li XH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/316250; Liu L, 2016, EPIDEMIOL INFECT, V144, P144, DOI [10.1017/S0950268815001144, 10.1017/S0950268815001582]; Liu SJ, 2018, INT J BIOMETEOROL, V62, P565, DOI 10.1007/s00484-017-1465-3; Liu WD, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4457-6; Purwanto, 2012, APPL INTELL, V37, P511, DOI 10.1007/s10489-012-0344-1; Qi L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020270; Qiu J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48259-1; Shafaei M., 2016, Journal of Water and Land Development, P27; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Taskaya-Temizel T, 2005, NEURAL NETWORKS, V18, P781, DOI 10.1016/j.neunet.2005.06.003; Tian CW, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800362X, 10.1017/s095026881800362x]; Wang F, 2013, ENVIRON MANAGE, V51, P1044, DOI 10.1007/s00267-013-0029-5; Wang H, 2018, EPIDEMIOL INFECT, V146, P935, DOI 10.1017/S0950268818001115; Wang J, 2017, SCI REPORTS; Wang KW, 2017, EPIDEMIOL INFECT, V145, P1118, DOI 10.1017/S0950268816003216; Wang YW, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025773; Wang YB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208404; Yolcu U, 2013, DECIS SUPPORT SYST, V54, P1340, DOI 10.1016/j.dss.2012.12.006; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018; Zhang GP, 2007, INFORM SCIENCES, V177, P5329, DOI 10.1016/j.ins.2007.06.015; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhou LL, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0616-8; Zhou LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104875; Zhuang ZC, 2015, VIRUSES-BASEL, V7, P6400, DOI 10.3390/v7122947; Zou JJ, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014195, 10.1097/md.0000000000014195]	35	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246673	10.1371/journal.pone.0246673	http://dx.doi.org/10.1371/journal.pone.0246673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544752	Green Published, gold, Green Submitted			2022-12-26	WOS:000617991900032
J	Herzeel, C; Costanza, P; Decap, D; Fostier, J; Wuyts, R; Verachtert, W				Herzeel, Charlotte; Costanza, Pascal; Decap, Dries; Fostier, Jan; Wuyts, Roel; Verachtert, Wilfried			Multithreaded variant calling in elPrep 5	PLOS ONE			English	Article								We present elPrep 5, which updates the elPrep framework for processing sequencing alignment/map files with variant calling. elPrep 5 can now execute the full pipeline described by the GATK Best Practices for variant calling, which consists of PCR and optical duplicate marking, sorting by coordinate order, base quality score recalibration, and variant calling using the haplotype caller algorithm. elPrep 5 produces identical BAM and VCF output as GATK4 while significantly reducing the runtime by parallelizing and merging the execution of the pipeline steps. Our benchmarks show that elPrep 5 speeds up the runtime of the variant calling pipeline by a factor 8-16x on both whole-exome and whole-genome data while using the same hardware resources as GATK4. This makes elPrep 5 a suitable drop-in replacement for GATK4 when faster execution times are needed.	[Herzeel, Charlotte; Costanza, Pascal; Decap, Dries; Fostier, Jan; Wuyts, Roel] IMEC, ExaSci Life Lab, Leuven, Belgium; [Decap, Dries; Fostier, Jan; Verachtert, Wilfried] Univ Ghent, IMEC, Dept Informat Technol, Ghent, Belgium	IMEC; Ghent University; IMEC	Herzeel, C (corresponding author), IMEC, ExaSci Life Lab, Leuven, Belgium.	Charlotte.Herzeel@imec.be	Wuyts, Roel/GXV-7014-2022; Fostier, Jan/A-8275-2012	Fostier, Jan/0000-0002-9994-8269; Wuyts, Roel/0000-0003-4236-995X; Herzeel, Charlotte/0000-0002-9319-9885	Flemish Government (Dutch: Vlaamse Overheid) (AI Research Program); Flanders Innovation & Entrepreneurship (VLAIO) (Dutch: Agentschap Innoveren en Ondernemen (BE)) via the ATHENA project [HBC.2019.2528]	Flemish Government (Dutch: Vlaamse Overheid) (AI Research Program); Flanders Innovation & Entrepreneurship (VLAIO) (Dutch: Agentschap Innoveren en Ondernemen (BE)) via the ATHENA project	This research received funding from the Flemish Government (Dutch: Vlaamse Overheid) (AI Research Program). This research also received funding from Flanders Innovation & Entrepreneurship (VLAIO) (Dutch: Agentschap Innoveren en Ondernemen (BE)) via the ATHENA project HBC.2019.2528. Charlotte Herzeel, Pascal Costanza, Dries Decap, Jan Fostier, Roel Wuyts and Wilfried Verachtert are employees of IMEC vzw, Belgium; Dries Decap and Jan Fostier are employees of Ghent University, Ghent, Belgium. The specific role of each author is articulated in the "author contributions" section.	Abedjan Z., 2019, DATA SCI HEALTHCARE, P3, DOI 10.1007/978-3-030-05249-2_1; [Anonymous], [No title captured]; Costanza P, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2903-5; Decap D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174575; Decap D, 2015, BIOINFORMATICS, V31, P2482, DOI 10.1093/bioinformatics/btv179; Deng LQ, 2016, IEEE INT C BIOINFORM, P576, DOI 10.1109/BIBM.2016.7822584; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ebbert MTW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1097-3; Herten K, 2017, 17 ANN M BELG SOC HU; Herzeel C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209523; Herzeel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132868; Hong MH, 2020, CANCER-AM CANCER SOC, V126, P4521, DOI 10.1002/cncr.33123; Icahn School of Medicine at Mount Sinai, 2012, HIGH COV WHOL EX SEQ; Masoumi Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082038; Palmeira L, 2018, 18 ANN M BELG SOC HU; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tian SL, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1279-z; Van der Auwera G.A., 2020, GENOMICS CLOUD USING, V1st ed.	18	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0244471	10.1371/journal.pone.0244471	http://dx.doi.org/10.1371/journal.pone.0244471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539352	gold, Green Submitted, Green Published			2022-12-26	WOS:000616960200009
J	Chen, Q; Ran, L; Li, MY; Tan, XD				Chen, Qi; Ran, Li; Li, Mengying; Tan, Xiaodong			Health-related quality of life of middle-aged and elderly people with hypertension: A cross-sectional survey from a rural area in China	PLOS ONE			English	Article							TEA CONSUMPTION; SLEEP QUALITY; BLOOD-PRESSURE; PREVALENCE; CARE; ASSOCIATION; COUNTRIES; EDUCATION; INSOMNIA; ADULTS	Objective To evaluate health-related quality of life (HRQoL) of middle-aged and elderly people with hypertension in Enshi, China, and to explore the important correlates defining HRQoL. Methods From April through July 2018, a self-monitoring intervention program for hypertension control was implemented in a remote area of central China. Participants completed a cross-sectional survey which included demographic characteristics, the Health-related Quality of Life Survey, and the Pittsburgh Sleep Quality Index Survey. Univariate analysis was performed by analysis of variance, and multiple linear regression analysis was used to analyze the influencing factors of HRQoL in middle-aged and elderly hypertensive patients. In the multivariate analysis, the variables with P <= 0.05 in the single factor analysis were combined with the professional significance to establish a multiple linear regression model. Results Information from 500 participants was available for analysis. Among them, the scores of PCS and MCS was 31.66 +/- 9.50 and 41.38 +/- 10.69, respectively. Multivariable regression analyses showed that higher education and sleep quality, and moderate physical activity (30 minutes for at least five days a week) had a positive influence on PCS scores. Higher monthly family income (3,000-5,000 yen ) and sleep quality, regular tea-drinking, having 30 minutes of moderate physical activity at least five days a week were positively associated with MCS scores. Conclusion The overall HRQoL for rural middle-aged and elderly hypertensive patients in Xuan'en county of Hubei province was poor. Effective relevant measures for the above factors were urgently needed to improve the quality of life for the elderly in rural areas. Awareness of these relevant factors could help health care professionals provide better supportive care.	[Chen, Qi; Ran, Li; Li, Mengying; Tan, Xiaodong] Wuhan Univ, Sch Hlth Sci, Dept Occupat & Environm Hlth, Wuhan, Hubei, Peoples R China	Wuhan University	Tan, XD (corresponding author), Wuhan Univ, Sch Hlth Sci, Dept Occupat & Environm Hlth, Wuhan, Hubei, Peoples R China.	00300469@whu.edu.cn	Chen, Qi/AAJ-4958-2021	Chen, Qi/0000-0001-5126-3837	Wuhan University [2018-1602000-03-02]	Wuhan University	This work was supported by the 2018 College Students' Summer Social Practice of "San Xia Xiang Program" of Wuhan University (2018-1602000-03-02). The funders had no role in the manuscript, and the views expressed are solely those of the authors.	Andersen Matthias Nubling, 2008, COMPUTATION STANDARD, V127, P171; Bardage C, 2001, J CLIN EPIDEMIOL, V54, P172, DOI 10.1016/S0895-4356(00)00293-6; Borjesson M, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095786; Brown David W, 2006, J Phys Act Health, V3, P137, DOI 10.1123/jpah.3.2.137; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chei CL, 2018, EUR J NUTR, V57, P1333, DOI 10.1007/s00394-017-1412-4; Cote Isabelle, 2004, Can J Clin Pharmacol, V11, pe232; Flatz A, 2015, INT J GEN MED, V8, P87, DOI 10.2147/IJGM.S77139; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Hodgson JM, 2003, J NUTR, V133, P2883, DOI 10.1093/jn/133.9.2883; Li J, 2013, ARCH GERONTOL GERIAT, V56, P237, DOI 10.1016/j.archger.2012.08.002; Li W, 2016, J HUM HYPERTENS, V30, P11, DOI 10.1038/jhh.2015.45; Li YP, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3672; Liang ZR, 2019, QUAL LIFE RES, V28, P2069, DOI 10.1007/s11136-019-02139-3; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Marchionni M, 2008, SKULL BASE-INTERD AP, V18, P213, DOI 10.1055/s-2007-1023230; Nanda U, 1998, EVAL HEALTH PROF, V21, P179, DOI 10.1177/016327879802100204; NELSON L, 1986, LANCET, V2, P473, DOI 10.1016/S0140-6736(86)90354-5; Nilsson PM, 2001, J INTERN MED, V250, P521, DOI 10.1046/j.1365-2796.2001.00913.x; O'Brien E, 2017, J CLIN HYPERTENS, V19, P564, DOI 10.1111/jch.12998; Pan CW, 2017, J NUTR HEALTH AGING, V21, P480, DOI 10.1007/s12603-016-0784-0; Pickett K, 2016, BRIT J DERMATOL, V174, P1228, DOI 10.1111/bjd.14435; Ramsay P, 2011, CURR OPIN CRIT CARE, V17, P510, DOI 10.1097/MCC.0b013e32834a4bd4; Romero M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-664; Song T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2238-8; STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M; Summerskill W, 2018, LANCET, V391, P2086, DOI 10.1016/S0140-6736(18)30608-1; Trevisol DJ, 2011, J HYPERTENS, V29, P179, DOI 10.1097/HJH.0b013e328340d76f; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tuzun H, 2015, CENT EUR J PUBL HEAL, V23, P188; Ware JE., 2002, SF 12 SCORE SF 12 PH, V4; Wong WS, 2011, J SLEEP RES, V20, P117, DOI 10.1111/j.1365-2869.2010.00822.x; Youssef R M, 2005, East Mediterr Health J, V11, P109; Zhang HQ, 2020, CHEMOSPHERE, V256, DOI 10.1016/j.chemosphere.2020.127108; Zhang HQ, 2019, SLEEP MED, V58, P27, DOI 10.1016/j.sleep.2019.03.001; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15083-4; Zhang YL, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1536-x	38	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246409	10.1371/journal.pone.0246409	http://dx.doi.org/10.1371/journal.pone.0246409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529252	Green Published, Green Submitted, gold			2022-12-26	WOS:000616736200060
J	Muller, M; Wuthrich, F; Federspiel, A; Wiest, R; Egloff, N; Reichenbach, S; Exadaktylos, A; Juni, P; Curatolo, M; Walther, S				Muller, Monika; Wuthrich, Florian; Federspiel, Andrea; Wiest, Roland; Egloff, Niklaus; Reichenbach, Stephan; Exadaktylos, Aristomenis; Juni, Peter; Curatolo, Michele; Walther, Sebastian			Altered central pain processing in fibromyalgia-A multimodal neuroimaging case-control study using arterial spin labelling	PLOS ONE			English	Article							PERFUSION; CONNECTIVITY; PARCELLATION; METAANALYSIS; DEPRESSION; PATTERNS; BURDEN; HEALTH	Fibromyalgia is characterized by chronic pain and a striking discrepancy between objective signs of tissue damage and severity of pain. Function and structural alterations in brain areas involved in pain processing may explain this feature. Previous case-control studies in fibromyalgia focused on acute pain processing using experimentally-evoked pain paradigms. Yet, these studies do not allow conclusions about chronic, stimulus-independent pain. Resting-state cerebral blood flow (rsCBF) acquired by arterial spin labelling (ASL) may be a more accurate marker for chronic pain. The objective was to integrate four different functional and structural neuroimaging markers to evaluate the neural correlate of chronic, stimulus-independent pain using a resting-state paradigm. In line with the pathophysiological concept of enhanced central pain processing we hypothesized that rsCBF is increased in fibromyalgia in areas involved in processing of acute pain. We performed an age matched case-control study of 32 female fibromyalgia patients and 32 pain-free controls and calculated group differences in rsCBF, resting state functional connectivity, grey matter volume and cortical thickness using whole-brain and region of interest analyses. We adjusted all analyses for depression and anxiety. As centrally acting drugs are likely to interfere with neuroimaging markers, we performed a subgroup analysis limited to patients not taking such drugs. We found no differences between cases and controls in rsCBF of the thalamus, the basal ganglia, the insula, the somatosensory cortex, the prefrontal cortex, the anterior cingulum and supplementary motor area as brain areas previously identified to be involved in acute processing in fibromyalgia. The results remained robust across all neuroimaging markers and when limiting the study population to patients not taking centrally acting drugs and matched controls. In conclusion, we found no evidence for functional or structural alterations in brain areas involved in acute pain processing in fibromyalgia that could reflect neural correlates of chronic stimulus-independent pain.	[Muller, Monika] Inselspital Bern, Univ Clin Anesthesiol & Pain Med, Bern, Switzerland; [Muller, Monika; Wuthrich, Florian; Federspiel, Andrea; Walther, Sebastian] Univ Hosp Psychiat & Psychotherapy, Translat Res Ctr, Bern, Switzerland; [Wiest, Roland] Inselspital Bern, Dept Neuroradiol, Univ Clin Radiol, Bern, Switzerland; [Egloff, Niklaus] Inselspital Bern, Dept Psychosomat Med, Univ Clin Internal Med, Bern, Switzerland; [Reichenbach, Stephan] Inselspital Bern, Univ Clin Rheumatol Clin Immunol & Allergol, Bern, Switzerland; [Reichenbach, Stephan] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Exadaktylos, Aristomenis] Inselspital Bern, Univ Hosp Bern, Emergency Serv, Bern, Switzerland; [Juni, Peter] Univ Toronto, Appl Hlth Res Ctr AHRC, Dept Med, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Curatolo, Michele] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Washington; University of Washington Seattle	Curatolo, M (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	curatolo@uw.edu	Juni, Peter/Q-8700-2016; Walther, Sebastian/E-3486-2010	Juni, Peter/0000-0002-5985-0670; Walther, Sebastian/0000-0003-4026-3561; Wuthrich, Florian/0000-0001-6007-8668	Bangerter-Rhyner Foundation	Bangerter-Rhyner Foundation	The research team with Michele Curatolo as main applicant were awarded a grant by the Bangerter-Rhyner Foundation to support the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BURCKHARDT CS, 1993, J RHEUMATOL, V20, P475; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Cantisani A, 2016, ACTA PSYCHIAT SCAND, V134, P329, DOI 10.1111/acps.12625; Ceko M, 2020, NEUROIMAGE, V216, DOI 10.1016/j.neuroimage.2020.116877; Ceko M, 2013, NEUROIMAGE-CLIN, V3, P249, DOI 10.1016/j.nicl.2013.08.015; Chan CLW, 2012, J ALTERN COMPLEM MED, V18, P641, DOI 10.1089/acm.2011.0347; Cheng CA, 2019, COMPLEMENT THER MED, V46, P1, DOI 10.1016/j.ctim.2019.07.007; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Dehghan M, 2016, HUM BRAIN MAPP, V37, P1749, DOI 10.1002/hbm.23132; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Feraco P, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10060395; Hoffman DL, 2008, INT J CLIN PRACT, V62, P115, DOI 10.1111/j.1742-1241.2007.01638.x; Howard MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017096; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Laux L., 1981, STATE TRAIT ANGSTINV; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Liu J, 2013, PAIN, V154, P110, DOI 10.1016/j.pain.2012.09.016; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Morley S, 2002, PAIN, V99, P289, DOI 10.1016/S0304-3959(02)00137-9; Murakami M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0718-y; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Offenbaecher M, 2000, J RHEUMATOL, V27, P1984; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pauer L, 2011, J RHEUMATOL, V38, P2643, DOI 10.3899/jrheum.110569; Pfeiffer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018362; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Ramirez-Mahaluf JP, 2017, CEREB CORTEX, V27, P660, DOI 10.1093/cercor/bhv249; Robinson ME, 2011, J PAIN, V12, P436, DOI 10.1016/j.jpain.2010.10.003; Robinson RL, 2012, PAIN MED, V13, P1366, DOI 10.1111/j.1526-4637.2012.01475.x; Robinson RL, 2003, J RHEUMATOL, V30, P1318; Shi HC, 2016, SEMIN ARTHRITIS RHEU, V46, P330, DOI 10.1016/j.semarthrit.2016.06.002; Shokouhi M, 2016, CLIN J PAIN, V32, P495, DOI 10.1097/AJP.0000000000000295; Tracey I, 2010, PAIN, V148, P359, DOI 10.1016/j.pain.2009.11.009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Walther S, 2017, SCHIZOPHRENIA BULL, V43, P972, DOI 10.1093/schbul/sbw140; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wasan AD, 2011, ANESTHESIOLOGY, V115, P364, DOI 10.1097/ALN.0b013e318220e880; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Youssef AM, 2014, PAIN, V155, P467, DOI 10.1016/j.pain.2013.11.008	51	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0235879	10.1371/journal.pone.0235879	http://dx.doi.org/10.1371/journal.pone.0235879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529254	Green Submitted, Green Published, gold			2022-12-26	WOS:000616736200071
J	Buchan, SA; Daneman, N; Wang, J; Wilson, SE; Garber, G; Wormsbecker, AE; Antoniou, T; Deeks, SL				Buchan, Sarah A.; Daneman, Nick; Wang, Jun; Wilson, Sarah E.; Garber, Gary; Wormsbecker, Anne E.; Antoniou, Tony; Deeks, Shelley L.			Herpes zoster in older adults in Ontario, 2002-2016: Investigating incidence and exploring equity	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTHERPETIC NEURALGIA; RISK-FACTORS; VARICELLA VACCINATION; IMPACT; FRAILTY; HEALTH; COST; CARE	Older adults are at increased risk of herpes zoster (HZ) and post-herpetic neuralgia (PHN) and HZ vaccines are available to help prevent infection. The objective of our study was to provide updated data on incidence of HZ and PHN related to clinical and demographic factors in older adults to inform immunization practices. We conducted a population-based, retrospective cohort study and included all cases of HZ seen in outpatient, emergency department, and hospital settings for adults aged 65 years and over between April 1, 2002 to August 31, 2016 in Ontario, Canada. We calculated the incidence of HZ and PHN, and estimated the proportion within each subgroup that developed PHN. We also assessed incidence by neighbourhood-level income quintile before and after the availability of vaccine for private purchase. The average annual incidence of HZ in any setting was 59.0 per 10,000 older adults, with higher incidence in outpatient as opposed to hospital settings. Incidence was higher in the oldest age groups, females, and those classified as immunocompromised or frail. Relative to the pre-vaccine era, the disparities in incidence of HZ by neighbourhood-level income increased, with higher rates of HZ and PHN seen in those residing in lower income quintiles. Additional prevention efforts should be targeted toward adults who are immunocompromised, frail, and those living in lower socioeconomic quintiles. Future work should assess the impact of the zoster vaccine program with a particular focus on equity in the publicly-funded era.	[Buchan, Sarah A.; Daneman, Nick; Wang, Jun; Wilson, Sarah E.; Garber, Gary; Deeks, Shelley L.] Publ Hlth Ontario, Hlth Protect, Toronto, ON, Canada; [Buchan, Sarah A.; Daneman, Nick; Wang, Jun; Wilson, Sarah E.; Antoniou, Tony] ICES, Populat & Publ Hlth, Toronto, ON, Canada; [Buchan, Sarah A.; Wilson, Sarah E.; Deeks, Shelley L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Daneman, Nick] Sunnybrook Res Inst, Toronto, ON, Canada; [Daneman, Nick] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON, Canada; [Daneman, Nick; Garber, Gary] Univ Toronto, Dept Med, Toronto, ON, Canada; [Daneman, Nick] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Garber, Gary] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Garber, Gary] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wormsbecker, Anne E.; Antoniou, Tony] Unity Hlth Toronto, Toronto, ON, Canada; [Wormsbecker, Anne E.] Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Antoniou, Tony] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Buchan, SA (corresponding author), Publ Hlth Ontario, Hlth Protect, Toronto, ON, Canada.; Buchan, SA (corresponding author), ICES, Populat & Publ Hlth, Toronto, ON, Canada.; Buchan, SA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	sarah.buchan@oahpp.ca		Buchan, Sarah/0000-0002-5286-8974	Public Health Ontario; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Public Health Ontario; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by Public Health Ontario. Additionally, this study was supported by ICES, which is funded by an annual. Grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of this material are based on data and information compiled and provided by: Cancer Care Ontario (CCO), MOHLTC, and the Canadian Institute of Health Information (CIHI). The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. We thank IMS Brogan Inc. for use of their Drug Information Database.	Antoniou T, 2014, CLIN INFECT DIS, V58, P350, DOI 10.1093/cid/cit745; Carvalho ACA, 2018, AGEING RES REV, V48, P145, DOI 10.1016/j.arr.2018.10.009; Boyce T, 2019, EUROSURVEILLANCE, V24, P17, DOI 10.2807/1560-7917.ES.2019.24.2.1800204; Buchan SA, 2019, CLIN INFECT DIS; Caruso Calogero, 2009, Immun Ageing, V6, P10, DOI 10.1186/1742-4933-6-10; Chen N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006866.pub3; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Drolet M, 2019, CAN MED ASSOC J, V191, pE932, DOI 10.1503/cmaj.190274; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; Esteban-Vasallo MD, 2014, HUM VACC IMMUNOTHER, V10, P1650, DOI 10.4161/hv.28620; Forbes HJ, 2016, NEUROLOGY, V87, P94, DOI 10.1212/WNL.0000000000002808; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gruneir A, 2018, CAN MED ASSOC J, V190, pE1124, DOI 10.1503/cmaj.180290; Harpaz R, 2018, J INFECT DIS, V218, pS57, DOI 10.1093/infdis/jiy418; Hillebrand K, 2015, J INFECTION, V70, P178, DOI 10.1016/j.jinf.2014.08.018; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Humes EA, 2015, OPEN FORUM INFECT DI, V2, P2795; Jain A, 2018, BRIT J DERMATOL, V178, P1324, DOI 10.1111/bjd.16399; John Hopkins Bloomberg School of Public Health, 2009, J HOPK ADJ CLIN GROU; Kawai K, 2017, MAYO CLIN PROC, V92, P1806, DOI 10.1016/j.mayocp.2017.10.009; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Klompas M, 2011, MAYO CLIN PROC, V86, P1146, DOI 10.4065/mcp.2011.0305; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Letellier MC, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/3285327; Liu XC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1098; Lukas K, 2012, J PUBLIC HEALTH-HEID, V20, P441, DOI 10.1007/s10389-011-0481-8; Marra F., 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw205, DOI 10.1093/OFID/OFW205]; Marra F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1898-z; McElhaney JE, 2019, J GERONTOL A-BIOL, V74, P1239, DOI 10.1093/gerona/glz085; McElhaney JE, 2010, EXPERT REV VACCINES, V9, P27, DOI [10.1586/erv.10.31, 10.1586/ERV.10.31]; Ontario Ministry of Health and Long Term Care, 2016, PUBL FUND SHINGL HER; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Philip RK, 2018, EXPERT REV VACCINES, V17, P851, DOI 10.1080/14760584.2018.1527690; Reynolds MA, 2008, J INFECT DIS, V197, pS224, DOI 10.1086/522162; Russell ML, 2014, VACCINE, V32, P6319, DOI 10.1016/j.vaccine.2013.09.018; Sato K, 2017, J DERMATOL, V44, P414, DOI 10.1111/1346-8138.13639; Schmidt SAJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1369-6; Schroder C, 2017, J INFECTION, V75, P207, DOI 10.1016/j.jinf.2017.06.010; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; Tanuseputro P, 2011, VACCINE, V29, P8580, DOI 10.1016/j.vaccine.2011.09.024; Tate J, 2019, VACCINE, V37, P6581, DOI 10.1016/j.vaccine.2019.09.016; The National Advisory Committee on Immunization (NACI), 2018, UPD REC US HERP ZOST; Tran DTT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009882; Turner NM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021241; Wang GC, 2016, J AM GERIATR SOC, V64, P998, DOI 10.1111/jgs.14090; Ward C, 2017, VACCINE, V35, P2372, DOI 10.1016/j.vaccine.2017.03.042; Wolfson LJ, 2019, CLIN INFECT DIS; Xing XF, 2017, PAIN PHYSICIAN, V20, P471; Zorzoli E, 2018, AGING CLIN EXP RES, V30, P693, DOI 10.1007/s40520-018-0956-3	50	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246086	10.1371/journal.pone.0246086	http://dx.doi.org/10.1371/journal.pone.0246086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571224	Green Published, gold			2022-12-26	WOS:000618274000049
J	Kassaw, MW; Abebe, AM; Kassie, AM; Abate, BB; Masresha, SA				Kassaw, Mesfin Wudu; Abebe, Ayele Mamo; Kassie, Ayelign Mengesha; Abate, Biruk Beletew; Masresha, Seteamlak Adane			Trends of proximate low birth weight and associations among children under-five years of age: Evidence from the 2016 Ethiopian demographic and health survey data	PLOS ONE			English	Article								Background Low birth weight puts a newborn at increased risk of death and illness, and limits their productivity in the adulthood period later. The incidence of low birth weight has been selected as an important indicator for monitoring major health goals by the World Summit for Children. The 2014 World Health Organization estimation of child death indicated that 4.53% of total deaths in Ethiopia were due to low birth weight. The aim of this study was to assess trends of proximate low birth weight and associations of low birth weight with potential determinants from 2011 to 2016. Methods This study used the 2016 Ethiopian Demographic and Health Survey data (EDHS) as data sources. According to the 2016 EDHS data, all the regions were stratified into urban and rural areas. The variable "size of child" measured according to the report of mothers before two weeks of the EDHS takes placed. The study sample refined from EDHS data and used for this further analysis were 7919 children. A logistic regression model was used to assess the association of proximate low birth weight and potential determinates of proximate low birth weight. But, the data were tested to model fitness and were fitted to Hosmer-Leme-show-goodness of fit. Results The prevalence of proximate low birth weight in Ethiopia was 26.9% (2132), (95%CI = 25.4, 27.9). Of the prevalence of child size in year from 2011 to 2016, 17.1% was very small, and 9.8% was small. In the final multivariate logistic regression model, region (AOR = xx), (955%CI = xx), Afar (AOR = 2.44), (95%CI = 1.82, 3.27), Somalia (AOR = 0.73), (95%CI = 0.55, 0.97), Benishangul-Gumz (AOR = 0.48), (95%CI = 0.35, 0.67), SNNPR (AOR = 0.67), (95%CI = 0.48, 0.93), religion, Protestant (AOR = 0.76), (95%CI = 0.60, 0.95), residence, rural (AOR = 1.39), (95%CI = 1.07, 1.81), child sex, female (AOR = 1.43), (95%CI = 1.29, 1.59), birth type, multiple birth during first parity (AOR = 2.18), (95%CI = 1.41, 3.37), multiple birth during second parity (AOR = 2.92), (95%CI = 1.86, 4.58), preparedness for birth, wanted latter child (AOR = 1.26), (95%CI = 1.09, 1.47), fast and rapid breathing (AOR = 1.22), (95%CI = 1.02, 1.45), maternal education, unable to read and write (AOR = 1.46), (95%CI = 1.56, 2.17), and maternal age, 15-19 years old (AOR = 1.86), (95%CI = 1.19, 2.92) associated with proximate low birth weight. Conclusions The proximate LBW prevalence as indicated by small child size is high. Region, religion, residence, birth type, preparedness for birth, fast and rapid breathing, maternal education, and maternal age were associated with proximate low birth weight. Health institutions should mitigating measures on low birth weight with a special emphasis on factors identified in this study.	[Kassaw, Mesfin Wudu; Kassie, Ayelign Mengesha; Abate, Biruk Beletew] Woldia Univ, Coll Hlth Sci, Dept Nursing, Woldia, Ethiopia; [Abebe, Ayele Mamo] Debre Berhan Univ, Coll Hlth Sci, Dept Nursing, Debre Berhan, Ethiopia; [Masresha, Seteamlak Adane] Woldia Univ, Coll Hlth Sci, Dept Publ Hlth, Woldia, Ethiopia		Kassaw, MW (corresponding author), Woldia Univ, Coll Hlth Sci, Dept Nursing, Woldia, Ethiopia.	mesfine12a@gmail.com	Abebe, Ayele Mamo/AAE-4589-2020	Abebe, Ayele Mamo/0000-0002-1801-8167; Kassaw, Mesfin Wudu/0000-0002-6327-7723; Masresha, Seteamlak Adane/0000-0002-0028-8943				Ahmad B., 1999, M GOALS 1990 WORLD S, P78; Alemu T, 2016, ETHIOP J HEALTH SCI, V26, P243, DOI 10.4314/ejhs.v26i3.7; [Anonymous], 2017, WOMEN HLTH, P1; Anthony D., 2017, GENERATION 2030 AFRI; Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34; Assefa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039957; AYLWARD GP, 1989, J PEDIATR-US, V115, P515, DOI 10.1016/S0022-3476(89)80273-2; Azoumah K, 2011, Archives de pediatrie: organe officiel de la Societe francaise de pediatrie, V18; Berhane M, 2019, ETHIOP J HEALTH SCI, V29, P677, DOI 10.4314/ejhs.v29i6.4; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Boerma JT, 1996, B WORLD HEALTH ORGAN, V74, P209; Central Statistical Agency (CSA) and ORC Macro, 2005, ETH DEM HLTH SURV 20; Central Statistical Agency (CSA) Ethiopia, ETH DEM HLTH SURV 20; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Channon AAR, 2011, J BIOSOC SCI, V43, P555, DOI 10.1017/S0021932011000198; Channon AAR, 2011, MATERN CHILD HLTH J, V15, P12, DOI 10.1007/s10995-009-0553-3; Coutinho PR, 2009, REV ASSOC MED BRAS, V55, P692, DOI 10.1590/S0104-42302009000600013; Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y; Eggleston E, 2000, J BIOSOC SCI, V32, P373, DOI 10.1017/S0021932000003734; Endalamaw A, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0586-6; Ethiopia Minister of Health, 2005, EV REP IMPL 2000 200; Federal Ministry of Health E.a.P.W. UNICEF and partners, 2015, FINAL ETHIOPIA INTER; Feresu SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129705; Fulton C, 2013, BMJ OPEN QUAL, V2; Gebremedhin M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0658-1; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Goldenberg RL, 2007, AM J CLIN NUTR, V85, p584S, DOI 10.1093/ajcn/85.2.584S; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Islam MM, 2014, MATERN CHILD HLTH J, V18, P1462, DOI 10.1007/s10995-013-1386-7; Kumlachew Wale, 2018, BMC Res Notes, V11, P611, DOI 10.1186/s13104-018-3723-9; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Mazharul M, 2018, SMALL SIZE BIRTH PRE; Mbuagbaw L, 2010, PAEDIATR PERINAT EP, V24, P383, DOI 10.1111/j.1365-3016.2010.01128.x; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Mekonen HK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0507-2; MORENO L, 1990, SOC SCI MED, V31, P491, DOI 10.1016/0277-9536(90)90045-T; Mulatu H., 2017, GLOBAL J MED RES, P17; Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192; Sema A, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2965094; Seyum T., 2015, GEN MED OPEN ACCESS, V2015; Sharma SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123962; Soon T, 2012, GLOBAL ACTION REPORT; Talie A, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/3587239; Tilahun T, 2015, SCI TECHNOLOGY ARTS, V4, P134, DOI [10.4314/star.v4i1.23, DOI 10.4314/STAR.V4I1.23]; UNICEF, MON SIT CHILDR WOM L; VICTORA CG, 1989, AM J EPIDEMIOL, V129, P1032, DOI 10.1093/oxfordjournals.aje.a115207; Viengsakhone L, 2010, NAGOYA J MED SCI, V72, P51; Wachamo TM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213054; Wardlaw T, 2004, LOW BIRTH WEIGHT COU; World Health Organization, 2019, LOW BIRTH WEIGHT DEA; World Health Organization, 2014, TARG WWGN 2025 LOW B; World Health Organization, GLOB TARG 2025 IMPR	53	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246587	10.1371/journal.pone.0246587	http://dx.doi.org/10.1371/journal.pone.0246587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566864	gold, Green Published			2022-12-26	WOS:000618271700028
J	Phillips, S; Scheffrahn, RH; Piel, A; Stewart, F; Agbor, A; Brazzola, G; Tickle, A; Sommer, V; Dieguez, P; Wessling, EG; Arandjelovic, M; Kuhl, H; Boesch, C; Oelze, VM				Phillips, Seth; Scheffrahn, Rudolf H.; Piel, Alex; Stewart, Fiona; Agbor, Anthony; Brazzola, Gregory; Tickle, Alexander; Sommer, Volker; Dieguez, Paula; Wessling, Erin G.; Arandjelovic, Mimi; Kuhl, Hjalmar; Boesch, Christophe; Oelze, Vicky M.			Limited evidence of C-4 plant consumption in mound building Macrotermes termites from savanna woodland chimpanzee sites	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; WILD CHIMPANZEES; PAN-TROGLODYTES; NICHE DIFFERENTIATION; NATIONAL-PARK; FOOD-HABITS; CARBON; DIET; ISOPTERA; ECOLOGY	Stable isotope analysis is an increasingly used molecular tool to reconstruct the diet and ecology of elusive primates such as unhabituated chimpanzees. The consumption of C-4 plant feeding termites by chimpanzees may partly explain the relatively high carbon isotope values reported for some chimpanzee communities. However, the modest availability of termite isotope data as well as the diversity and cryptic ecology of termites potentially consumed by chimpanzees obscures our ability to assess the plausibility of these termites as a C-4 resource. Here we report the carbon and nitrogen isotope values from 79 Macrotermes termite samples from six savanna woodland chimpanzee research sites across equatorial Africa. Using mixing models, we estimated the proportion of Macrotermes C-4 plant consumption across savanna woodland sites. Additionally, we tested for isotopic differences between termite colonies in different vegetation types and between the social castes within the same colony in a subset of 47 samples from 12 mounds. We found that Macrotermes carbon isotope values were indistinguishable from those of C-3 plants. Only 5 to 15% of Macrotermes diets were comprised of C-4 plants across sites, suggesting that they cannot be considered a C-4 food resource substantially influencing the isotope signatures of consumers. In the Macrotermes subsample, vegetation type and caste were significantly correlated with termite carbon values, but not with nitrogen isotope values. Large Macrotermes soldiers, preferentially consumed by chimpanzees, had comparably low carbon isotope values relative to other termite castes. We conclude that Macrotermes consumption is unlikely to result in high carbon isotope values in either extant chimpanzees or fossil hominins.	[Phillips, Seth; Oelze, Vicky M.] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; [Scheffrahn, Rudolf H.] Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Piel, Alex; Sommer, Volker] UCL, Dept Anthropol, London, England; [Stewart, Fiona] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England; [Agbor, Anthony; Brazzola, Gregory; Tickle, Alexander; Dieguez, Paula; Arandjelovic, Mimi; Kuhl, Hjalmar; Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Sommer, Volker] Gashaka Primate Project, Serti, Taraba, Nigeria; [Wessling, Erin G.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA USA; [Kuhl, Hjalmar] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	University of California System; University of California Santa Cruz; University of London; University College London; Liverpool John Moores University; Max Planck Society; Harvard University	Oelze, VM (corresponding author), Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA.	voelze@ucsc.edu		Piel, Alexander/0000-0002-4674-537X	Max Planck Society; Max Planck Society Innovation Fund; Heinz L. Krekeler Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Society Innovation Fund; Heinz L. Krekeler Foundation	This study was generously funded by the Max Planck Society, the Max Planck Society Innovation Fund, and the Heinz L. Krekeler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington DA, 2002, T AM FISH SOC, V131, P337, DOI 10.1577/1548-8659(2002)131<0337:PEOSIA>2.0.CO;2; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; BADERTSCHER S, 1983, BEHAV ECOL SOCIOBIOL, V12, P115, DOI 10.1007/BF00343201; Blumenthal SA, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22488; Boesch C, 2014, PAN AFRICAN PROGRAMM; Boesch C, 2020, NAT HUM BEHAV, V4, P910, DOI 10.1038/s41562-020-0890-1; Boesch C, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22613; Bogart SL, 2011, AM J PHYS ANTHROPOL, V145, P11, DOI 10.1002/ajpa.21452; BOUTTON TW, 1983, OECOLOGIA, V59, P1, DOI 10.1007/BF00388065; Brandl R, 2007, MOL PHYLOGENET EVOL, V45, P239, DOI 10.1016/j.ympev.2007.07.007; Carlson BA, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22540; Carlson BA, 2014, J HUM EVOL, V76, P107, DOI 10.1016/j.jhevol.2014.06.001; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; Crowley BE, 2012, INT J PRIMATOL, V33, P673, DOI 10.1007/s10764-012-9582-7; Darlington Johanna P. E. C., 1994, P105; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; Fox J., 2012, PACKAGECAR; Graham HV, 2014, GEOCHIM COSMOCHIM AC, V144, P82, DOI 10.1016/j.gca.2014.08.032; Hicks TC, 2020, J PRIMATOL; Hyodo F, 2015, ENTOMOL SCI, V18, P295, DOI 10.1111/ens.12128; Jesus FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137650; Kalumanga E, 2017, AFR J ECOL, V55, P91, DOI 10.1111/aje.12326; Korb J, 1998, INSECT SOC, V45, P51, DOI 10.1007/s000400050068; Korb J, 2001, AFR J ECOL, V39, P257, DOI 10.1046/j.1365-2028.2001.00312.x; Korb J, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P349, DOI 10.1007/978-90-481-3977-4_13; Kuhl HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22219; Lee-Thorp J, 2012, P NATL ACAD SCI USA, V109, P20369, DOI 10.1073/pnas.1204209109; Lee-Thorp JA, 2010, PHILOS T R SOC B, V365, P3389, DOI 10.1098/rstb.2010.0059; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; LEPAGE M, 1993, J TROP ECOL, V9, P303, DOI 10.1017/S0266467400007343; Lesnik JJ, 2018, EDIBLE INSECTS AND HUMAN EVOLUTION, P1; Lesnik JJ, 2014, J HUM EVOL, V71, P94, DOI 10.1016/j.jhevol.2013.07.015; Lesnik Julie J., 2011, Paleoanthropology, V2011, P268; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Loudon JE, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22552; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; MCGREW WC, 1979, MAN, V14, P185, DOI 10.2307/2801563; Mills AJ, 2009, J ZOOL, V278, P24, DOI 10.1111/j.1469-7998.2008.00544.x; Mundry R, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22499; O'Malley RC, 2014, J HUM EVOL, V71, P46, DOI 10.1016/j.jhevol.2013.09.014; Oelze VM, 2016, J HUM EVOL, V101, P1, DOI 10.1016/j.jhevol.2016.08.007; Oelze VM, 2014, J HUM EVOL, V66, P95, DOI 10.1016/j.jhevol.2013.10.003; Parnell A., 2011, SIAR STABLE ISOTOPE; Piel AK, 2017, J HUM EVOL, V112, P57, DOI 10.1016/j.jhevol.2017.08.016; POMEROY DE, 1978, J APPL ECOL, V15, P51, DOI 10.2307/2402920; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Pruetz Jill D., 2006, P161; Reynolds V, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22978; Ruelle JE, 1970, BRIT MUS NAT HIST B; Sandberg PA, 2012, AM J PRIMATOL, V74, P969, DOI 10.1002/ajp.22053; SANDS W A, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P167; Sanz C, 2004, AM NAT, V164, P567, DOI 10.1086/424803; Sanz CM, 2014, J HUM EVOL, V71, P28, DOI 10.1016/j.jhevol.2013.07.017; Sanz CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0416; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Schoeninger MJ, 2016, AM J PRIMATOL, V78, P1055, DOI 10.1002/ajp.22496; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; Schyra J, 2019, ECOL ENTOMOL, V44, P190, DOI 10.1111/een.12687; Seymour CL, 2014, SOIL BIOL BIOCHEM, V68, P95, DOI 10.1016/j.soilbio.2013.09.022; SIEBER R, 1981, INSECT SOC, V28, P371, DOI 10.1007/BF02224194; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Smith CC, 2010, J HUM EVOL, V58, P43, DOI 10.1016/j.jhevol.2009.08.001; Sommer V, 2017, AM J PHYS ANTHROPOL, V162, P328, DOI 10.1002/ajpa.23122; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sponheimer M, 2005, J HUM EVOL, V48, P301, DOI 10.1016/j.jhevol.2004.11.008; Sponheimer M, 2003, COMP BIOCHEM PHYS A, V136, P27, DOI 10.1016/S1095-6433(03)00065-5; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Stewart FA, 2014, PRIMATES, V55, P35, DOI 10.1007/s10329-013-0362-6; SUZUKI S, 1995, BEHAVIOUR, V132, P219, DOI 10.1163/156853995X00711; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Tagg N, 2018, AM J PHYS ANTHROPOL, V166, P510, DOI 10.1002/ajpa.23478; Tayasu I, 2002, ECOL ENTOMOL, V27, P355, DOI 10.1046/j.1365-2311.2002.00414.x; Tayasu I, 1997, ECOL ENTOMOL, V22, P343, DOI 10.1046/j.1365-2311.1997.00070.x; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Tillberg CV, 2006, INSECT SOC, V53, P65, DOI 10.1007/s00040-005-0836-7; Traniello JFA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P141; Vaidyanathan G, 2011, NATURE, V476, P266, DOI 10.1038/476266a; van Casteren A, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0115-6; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; van der Merwe NJ, 2003, J HUM EVOL, V44, P581, DOI 10.1016/S0047-2484(03)00050-2; van Lawick-Goodall J., 1968, Animal Behaviour Monographs, V1, P161; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Vesala R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53153-x; Webb SC, 1998, J EXP BIOL, V201, P2903; Webster TH, 2014, J HUM EVOL, V71, P20, DOI 10.1016/j.jhevol.2014.02.005; Wessling EG, 2020, BIORXIV; Wessling EG, 2019, AM J PHYS ANTHROPOL, V168, P665, DOI 10.1002/ajpa.23782; White L.J.T., 2000, CONSERVATION RES AFR; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wrangham R. W., 1996, CHIMPANZEE CULTURES; Wynn JG, 2013, P NATL ACAD SCI USA, V110, P10495, DOI 10.1073/pnas.1222559110; Zalewski Marcin, 2012, Baltic Journal of Coleopterology, V12, P91	98	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0244685	10.1371/journal.pone.0244685	http://dx.doi.org/10.1371/journal.pone.0244685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566803	Green Published, Green Accepted, gold			2022-12-26	WOS:000618271700029
J	Zhao, YF; Bunch, TD; Isom, SC				Zhao, Yuanfeng; Bunch, Thomas D.; Isom, S. Clay			Effects of electrical biostimulation and silver ions on porcine fibroblast cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO; ANTIBACTERIAL ACTIVITY; MAMMALIAN-CELLS; NANOPARTICLES; BACTERIAL; TOXICITY; BIOSYNTHESIS; CYTOTOXICITY; STIMULATION	The medical applications of electrical biostimulation and silver ions have been evaluated in laboratory experiments and clinical studies for more than two decades. Their effects on preventing infection and promoting wound healing have been described. However, little is known about the role of electrical biostimulation and/or silver ion on changes in cellular transcriptome dynamics. To our knowledge, few studies have been conducted to investigate the potential of electrical biostimulation and silver ions in cell reprogramming. Besides, it is essential to assess any possible adverse effects or potential benefits of the silver ions on mammalian cells to address its safety concerns and to improve silver medical products. In this study, we investigated transcriptomic changes in porcine fibroblast cells in response to electrical biostimulation in the presence of silver ions. Exposed cells presented distinct morphological changes after treatment, which was mainly due to the exposure of silver ions rather than the electrical current itself. Gene expression analyses suggested that electrical biostimulation and silver ions did not increase the expression of pluripotency genes. Interestingly, a set of genes related to cellular metabolic processes were differentially expressed after cells were exposed to electrically generated silver ions for 21 hours. We found that 2.00 mg/L of electrically generated silver ion caused an increase of ATP generation and an increase of the total pool of NAD(+) and NADH, while ROS production did not change. Aside from toxic effects, the results reported herein demonstrate the alternative effects of silver ions on mammalian cells, especially an oxidative phosphorylation burst. To our knowledge, this response of mammalian cells to silver ions has not been described previously. Although the function of this burst is not understood, it may lead to alterations in cellular activities such as metabolic remodeling and cell reprogramming, and/or serve an as-yet unknown function in neutralization or detoxification of the silver ions within the cells.	[Zhao, Yuanfeng; Bunch, Thomas D.; Isom, S. Clay] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Isom, SC (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	clay.isom@usu.edu		Zhao, Yuanfeng/0000-0002-3849-4048				Abercrombie M, 1978, J Clin Pathol Suppl (R Coll Pathol), V12, P1; Adams DS, 2013, CELL TISSUE RES, V352, P95, DOI 10.1007/s00441-012-1329-4; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Becker RO, 2000, ELECTRO MAGNETOBIOL, V19, P1, DOI 10.1081/JBC-100100293; Behra R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0396; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V10, P856, DOI 10.1128/AAC.10.5.856; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; BOURGUIGNON GJ, 1987, FASEB J, V1, P398, DOI 10.1096/fasebj.1.5.3678699; Cortese-Krott MM, 2009, FREE RADICAL BIO MED, V47, P1570, DOI 10.1016/j.freeradbiomed.2009.08.023; Dakal TC, 2016, FRONT MICROBIOL, V7, DOI 10.7389/fmicb.2016.01831; David L, 2014, STEM CELL RES, V12, P754, DOI 10.1016/j.scr.2014.03.007; Dunnill C, 2017, INT WOUND J, V14, P89, DOI 10.1111/iwj.12557; Ema M, 2017, REPROD TOXICOL, V67, P149, DOI 10.1016/j.reprotox.2017.01.005; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Foldbjerg R, 2012, TOXICOL SCI, V130, P145, DOI 10.1093/toxsci/kfs225; Folmes CDL, 2012, CIRC RES, V110, P526, DOI 10.1161/RES.0b013e31824ae5c1; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gao XG, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0265-6; Georgantzopoulou A, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0117-9; Greulich C, 2012, RSC ADV, V2, P6981, DOI 10.1039/c2ra20684f; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Hawkins KE, 2016, CELL REP, V14, P1883, DOI 10.1016/j.celrep.2016.02.003; Herzog F, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-11; Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; HOSTYNEK JJ, 1993, CRIT REV TOXICOL, V23, P171, DOI 10.3109/10408449309117116; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt RW, 2009, INT J MOL SCI, V10, P4515, DOI 10.3390/ijms10104515; Hussmann B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/763096; Isom SC, 2013, PHYSIOL GENOMICS, V45, P577, DOI 10.1152/physiolgenomics.00094.2012; Javaid A, 2018, BIONANOSCIENCE, V8, P43, DOI 10.1007/s12668-017-0496-x; Jiravova J, 2016, FOOD CHEM TOXICOL, V96, P50, DOI 10.1016/j.fct.2016.07.015; Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07; Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018; Kang JS, 2016, BIOCHEM BIOPH RES CO, V479, P753, DOI 10.1016/j.bbrc.2016.09.139; Kedziora A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020444; Kida YS, 2015, CELL STEM CELL, V16, P547, DOI 10.1016/j.stem.2015.03.001; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23; Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q; Lansdown ABG, 1997, BRIT J DERMATOL, V137, P728; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Lee Raphael C., 1993, Journal of Burn Care and Rehabilitation, V14, P319, DOI 10.1097/00004630-199305000-00003; Leppik L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24892-0; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Mathieu J, 2017, DEVELOPMENT, V144, P541, DOI 10.1242/dev.128389; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Miyazawa H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.131110; Mohiti-Asli M, 2016, TISSUE ENG PT A, V22, P1258, DOI 10.1089/ten.tea.2016.0063; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pandian SRK, 2010, BRAZ J MICROBIOL, V41, P805, DOI 10.1590/S1517-83822010000300033; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Russell A D, 1994, Prog Med Chem, V31, P351; Selden G, 1998, BODY ELECT ELECTROMA; Shanthi S, 2016, MICROB PATHOGENESIS, V93, P70, DOI 10.1016/j.micpath.2016.01.014; Sim W, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7040093; Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Suasnavas EA, 2015, ANIM REPROD SCI, V154, P128, DOI 10.1016/j.anireprosci.2015.01.012; Sutterlin S, 2012, ACTA DERM-VENEREOL, V92, P34, DOI 10.2340/00015555-1170; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vrcek IV, 2016, ENVIRON TOXICOL, V31, P679, DOI 10.1002/tox.22081; Whitworth KM, 2009, MOL REPROD DEV, V76, P490, DOI 10.1002/mrd.20987; Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xu LM, 2011, MATER EXPRESS, V1, P74, DOI 10.1166/mex.2011.1010; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; YANG WP, 1984, EXP CELL RES, V155, P92, DOI 10.1016/0014-4827(84)90770-5; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yoshimaru T, 2006, FREE RADICAL BIO MED, V40, P1949, DOI 10.1016/j.freeradbiomed.2006.01.023; Zhang SK, 2013, TOXICOL IN VITRO, V27, P739, DOI 10.1016/j.tiv.2012.12.003; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	84	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246847	10.1371/journal.pone.0246847	http://dx.doi.org/10.1371/journal.pone.0246847			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566869	gold, Green Published			2022-12-26	WOS:000618271700047
J	Jin, TY; Patel, SJ; Van Lehn, RC				Jin, Tianyi; Patel, Samarthaben J.; Van Lehn, Reid C.			Molecular simulations of lipid membrane partitioning and translocation by bacterial quorum sensing modulators	PLOS ONE			English	Article							L-HOMOSERINE LACTONES; TO-CELL COMMUNICATION; PSEUDOMONAS-AERUGINOSA; ACTIVE EFFLUX; DYNAMICS SIMULATIONS; COSMO-RS; VIRULENCE; REVEALS; MODEL; PERMEABILITY	Quorum sensing (QS) is a bacterial communication process mediated by both native and non-native small-molecule quorum sensing modulators (QSMs), many of which have been synthesized to disrupt QS pathways. While structure-activity relationships have been developed to relate QSM structure to the activation or inhibition of QS receptors, less is known about the transport mechanisms that enable QSMs to cross the lipid membrane and access intracellular receptors. In this study, we used atomistic MD simulations and an implicit solvent model, called COSMOmic, to analyze the partitioning and translocation of QSMs across lipid bilayers. We performed umbrella sampling at atomistic resolution to calculate partitioning and translocation free energies for a set of naturally occurring QSMs, then used COSMOmic to screen the water-membrane partition and translocation free energies for 50 native and non-native QSMs that target LasR, one of the LuxR family of quorum-sensing receptors. This screening procedure revealed the influence of systematic changes to head and tail group structures on membrane partitioning and translocation free energies at a significantly reduced computational cost compared to atomistic MD simulations. Comparisons with previously determined QSM activities suggest that QSMs that are least likely to partition into the bilayer are also less active. This work thus demonstrates the ability of the computational protocol to interrogate QSM-bilayer interactions which may help guide the design of new QSMs with engineered membrane interactions.	[Jin, Tianyi; Patel, Samarthaben J.; Van Lehn, Reid C.] Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Van Lehn, RC (corresponding author), Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA.	vanlehn@wisc.edu		Jin, Tianyi/0000-0002-9974-2041	National Science Foundation [MCB 1817292]	National Science Foundation(National Science Foundation (NSF))	R. C. V. was awarded funding by the National Science Foundation under Grant No. MCB 1817292. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Awoonor-Williams E, 2016, BBA-BIOMEMBRANES, V1858, P1672, DOI 10.1016/j.bbamem.2015.12.014; Barth C, 2012, LANGMUIR, V28, P8456, DOI 10.1021/la301241s; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bittermann K, 2014, J PHYS CHEM B, V118, P14833, DOI 10.1021/jp509348a; Bradley R, 2013, POLYMERS-BASEL, V5, P890, DOI 10.3390/polym5030890; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Davis BM, 2011, BIOPHYS J, V101, P245, DOI 10.1016/j.bpj.2011.05.033; Davis BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013522; Deep Antariksh, 2011, J Lab Physicians, V3, P4, DOI 10.4103/0974-2727.78553; Eckert F, 2002, AICHE J, V48, P369, DOI 10.1002/aic.690480220; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gahan CG, 2020, J PHYS CHEM B, V124, P3616, DOI 10.1021/acs.jpcb.0c00496; Gerdt JP, 2017, ACS CHEM BIOL, V12, P2457, DOI 10.1021/acschembio.7b00458; Gerdt JP, 2014, CHEM BIOL, V21, P1361, DOI 10.1016/j.chembiol.2014.08.008; Geske GD, 2008, BIOORG MED CHEM LETT, V18, P5978, DOI 10.1016/j.bmcl.2008.07.089; Geske GD, 2008, CHEMBIOCHEM, V9, P389, DOI 10.1002/cbic.200700551; Geske GD, 2007, J AM CHEM SOC, V129, P13613, DOI 10.1021/ja074135h; Haque S, 2018, MICROB PATHOGENESIS, V121, P293, DOI 10.1016/j.micpath.2018.05.046; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Ingram T, 2013, LANGMUIR, V29, P3527, DOI 10.1021/la305035b; Jakobtorweihen S, 2017, CHEM-ING-TECH, V89, P1288, DOI 10.1002/cite.201700061; Jakobtorweihen S, 2013, J COMPUT CHEM, V34, P1332, DOI 10.1002/jcc.23262; Jakubczyk D, 2012, ANAL BIOANAL CHEM, V403, P473, DOI 10.1007/s00216-012-5839-4; Jiang Q, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2015978; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kamaraju K, 2011, BIOCHEMISTRY-US, V50, P6983, DOI 10.1021/bi200684z; Kim S, 2017, J COMPUT CHEM, V38, P1879, DOI 10.1002/jcc.24829; Klamt A, 2008, J PHYS CHEM B, V112, P12148, DOI 10.1021/jp801736k; Lee CT, 2016, J CHEM INF MODEL, V56, P721, DOI 10.1021/acs.jcim.6b00022; Loverde SM, 2014, J PHYS CHEM LETT, V5, P1659, DOI 10.1021/jz500321d; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mattmann ME, 2011, CHEMBIOCHEM, V12, P942, DOI 10.1002/cbic.201000708; McInnis CE, 2011, BIOORGAN MED CHEM, V19, P4820, DOI 10.1016/j.bmc.2011.06.071; McInnis CE, 2011, BIOORGAN MED CHEM, V19, P4812, DOI 10.1016/j.bmc.2011.06.072; Menichetti R, 2019, ACS CENTRAL SCI, V5, P290, DOI 10.1021/acscentsci.8b00718; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moore JD, 2015, J AM CHEM SOC, V137, P14626, DOI 10.1021/jacs.5b06728; Moore JD, 2014, CHEMBIOCHEM, V15, P435, DOI 10.1002/cbic.201300701; Neale C, 2011, J CHEM THEORY COMPUT, V7, P4175, DOI 10.1021/ct200316w; Paloncyova M, 2014, J CHEM THEORY COMPUT, V10, P4143, DOI 10.1021/ct500419b; Paloncyova M, 2014, J PHYS CHEM B, V118, P1030, DOI 10.1021/jp4112052; Patel SJ, 2018, J PHYS CHEM B, V122, P10337, DOI 10.1021/acs.jpcb.8b06613; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Shen ZZ, 2020, IND ENG CHEM RES, V59, P7755, DOI 10.1021/acs.iecr.9b06086; Shinoda W, 2016, BBA-BIOMEMBRANES, V1858, P2254, DOI 10.1016/j.bbamem.2016.03.032; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Toyofuku M, 2017, ISME J, V11, P1504, DOI 10.1038/ismej.2017.13; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welsh MA, 2016, FEMS MICROBIOL REV, V40, P774, DOI 10.1093/femsre/fuw009; Welsh MA, 2016, CELL CHEM BIOL, V23, P361, DOI 10.1016/j.chembiol.2016.01.006; Whiteley M, 2017, NATURE, V551, P313, DOI 10.1038/nature24624; Yoo B, 2014, SOFT MATTER, V10, P8641, DOI 10.1039/c4sm01528b	66	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246187	10.1371/journal.pone.0246187	http://dx.doi.org/10.1371/journal.pone.0246187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561158	gold, Green Published			2022-12-26	WOS:000617533000023
J	Linder, S; Abu-Omar, K; Geidl, W; Messing, S; Sarshar, M; Reimers, AK; Ziemainz, H				Linder, Stephanie; Abu-Omar, Karim; Geidl, Wolfgang; Messing, Sven; Sarshar, Mustafa; Reimers, Anne K.; Ziemainz, Heiko			Physical inactivity in healthy, obese, and diabetic adults in Germany: An analysis of related socio-demographic variables	PLOS ONE			English	Article							SEDENTARY LIFE-STYLES; OLDER-ADULTS; ACTIVITY PARTICIPATION; BARRIERS; CHILDREN; RISK; PREVALENCE; INTERVIEW; MELLITUS; DISEASE	Background Adults with diabetes or obesity are more likely to be physically inactive than healthy adults. Physical activity is essential in the management of both diseases, necessitating targeted interventions in these groups. This study analysed physical inactivity (defined as not taking part in leisure-time physical activity) in over 100,000 adults in Germany considering their body mass index and the presence of diabetes. Furthermore, the relationship between specific socio-demographic factors with physical inactivity was investigated, particularly focussing diabetic and obese people, to refine the identification of risk-groups for targeted interventions on physical activity promotion. Methods Data from 13 population-based health surveys conducted in Germany from 1997 to 2018 were used. The relevant variables extracted from these datasets were merged and employed in the analyses. We included data from 129,886 individuals in the BMI analyses and 58,311 individuals in the diabetes analyses. Logistic regression analyses were performed to identify the importance of six socio-demographic variables (age, sex/gender, education, income, employment, and migration) for the risk of physical inactivity. Results Obese and diabetic people reported a higher prevalence of physical inactivity than those who were not affected. Logistic regression analyses revealed advanced age, low education level, and low household income as risk factors for physical inactivity in all groups. A two-sided migration background and unemployment also indicated a higher probability of physical inactivity. Conclusion Similar socio-demographic barriers appear to be important determinants of physical inactivity, regardless of BMI status or the presence of diabetes. However, physical activity promoting interventions in obese and diabetic adults should consider the specific disease-related characteristics of these groups. A special need for target group specific physical activity programmes in adults from ethnic minorities or of advanced age was further identified.	[Linder, Stephanie; Abu-Omar, Karim; Reimers, Anne K.; Ziemainz, Heiko] Friedrich Alexander Univ Erlangen Nuremberg, Dept Sport Sci & Sport, Div Phys Act & Publ Hlth, Erlangen, Germany; [Geidl, Wolfgang; Messing, Sven] Friedrich Alexander Univ Erlangen Nuremberg, Dept Sport Sci & Sport, Div Exercise & Hlth, Erlangen, Germany; [Sarshar, Mustafa] Otto von Guericke Univ, Dept Sport Sci, Div Hlth & Phys Act, Magdeburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Otto von Guericke University	Linder, S (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Sport Sci & Sport, Div Phys Act & Publ Hlth, Erlangen, Germany.	stephanie.linder@fau.de	Geidl, Wolfgang/AAA-7136-2022	Geidl, Wolfgang/0000-0002-7106-7742; Linder, Stephanie/0000-0002-5272-548X; Messing, Sven/0000-0002-9645-4079	European Commission [QLK6-CT-2001-00360, SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812, 211909, 227822, 261982]; German Ministry of Education and Research; U.S. National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: No211909, SHARE-LEAP: No227822, SHARE M4: No261982). Additional funding from the German Ministry of Education and Research, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064) and from various national funding sources is gratefully acknowledged (see www.share-project.org).	Ae B, 2012, LANCET, V6736; [Anonymous], 2002, AM DEMOGRAPHICS, V24, pS4; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2015, BUSINESS ETHICS Q, V25, pv; [Anonymous], 2014, INT DURCH SPORT PROG; [Anonymous], 2017, LATE NIGHT WITH SETH; Ashe MC, 2009, GERONTOLOGY, V55, P64, DOI 10.1159/000141518; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Borsch-Supan A., 2015, RELEASE VERSION 1 0; Caperchione CM, 2009, SPORTS MED, V39, P167, DOI 10.2165/00007256-200939030-00001; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Dagenais GR, 2003, CAN J CARDIOL, V19, P1387; Demarest S, 2014, EUR J PUBLIC HEALTH, V24, P199, DOI 10.1093/eurpub/ckt061; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; GESIS, 2018, ZA5240 DAT FIL VERS; GESIS, 2012, ZA3000 DAT FIL VERS; GESIS, 2011, ZA3762 DAT FIL VERS; GESIS, 2018, ZA5664 DAT FIL VERS; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Haley C, 2010, J AGING PHYS ACTIV, V18, P375, DOI 10.1123/japa.18.4.375; Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706; Heidemann C, 2017, J HLTH MONIT, V2, P43; Holtermann A, 2012, HB B J SPORTS; Horne M, 2013, ETHNIC HEALTH, V18, P626, DOI 10.1080/13557858.2013.814762; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jacobs E, 2020, DIABETIC MED, V37, P1723, DOI 10.1111/dme.14100; Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206; Kobel S, 2019, PUBLIC HEALTH, V173, P75, DOI 10.1016/j.puhe.2019.05.009; Krems C, 2004, J SPORT MED PHYS FIT, V44, P71; Kuczmarski M, 2001, DIETETIC MN J A 2001; Lammle L, 2012, EUR J PUBLIC HEALTH, V22, P880, DOI 10.1093/eurpub/ckr191; Lahti J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101548; Langoien LJ, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0554-3; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Livingstone MBE, 2001, PUBLIC HEALTH NUTR, V4, P1107, DOI 10.1079/PHN2001192; Luzak A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172503; Malter F., 2015, SHARE WAVE 5 INNOVAT; Marques A, 2016, PEERJ, V4, DOI 10.7717/peerj.2066; Marques A, 2015, PREV MED, V81, P333, DOI 10.1016/j.ypmed.2015.09.018; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128; Morrissey SL, 2006, J SCHOOL HEALTH, V76, P512, DOI 10.1111/j.1746-1561.2006.00150.x; Moschny A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-559; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; O'Driscoll T, 2014, J IMMIGR MINOR HEALT, V16, P515, DOI 10.1007/s10903-013-9857-x; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Pitsavos C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-37; Riebe D, 2009, J AGING HEALTH, V21, P1159, DOI 10.1177/0898264309350076; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2018, GERM HLTH UPD 2014 2; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2015, GERM HLTH INT EX SUR; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2014, GERM HLTH UPD 2009 G; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2014, GERM HLTH UPD 2012 G; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2014, GERM TEL HLTH SURV G; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2016, SCI USE FILE 4 VERS; Robert Koch Institute Department of Epidemiology and Health Monitoring, 2014, GERM HLTH UPD 2010 G; Rommel A, 2015, BUNDESGESUNDHEITSBLA, V58, P543, DOI 10.1007/s00103-015-2145-2; Rutten A, 2007, GESUNDHEITSWESEN, V69, P393, DOI 10.1055/s-2007-984440; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Slagter SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140599; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Steene-Johannessen J, 2016, ARE SELF REPORT MEAS; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Toft BS, 2015, INT J QUAL STUD HEAL, V10, DOI 10.3402/qhw.v10.28577; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Vanden Bosch ML, 2015, WESTERN J NURS RES, V37, P1581, DOI 10.1177/0193945914541333; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; Waxenegger A, 2018, CENT EUR J PUBL HEAL, V26, P132, DOI 10.21101/cejph.a4917; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Zhao GX, 2011, J AM GERIATR SOC, V59, P132, DOI 10.1111/j.1532-5415.2010.03236.x	76	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246634	10.1371/journal.pone.0246634	http://dx.doi.org/10.1371/journal.pone.0246634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4BO	33561175	Green Published, gold			2022-12-26	WOS:000617533000029
J	Takei, S; Kobayashi, K; Takagi, E				Takei, Shin-ya; Kobayashi, Kenta; Takagi, Etsuro			Distribution pattern of entry holes of the tree-killing bark beetle Polygraphus proximus	PLOS ONE			English	Article							IPS-CALLIGRAPHUS COLEOPTERA; PINE PHLOEM THICKNESS; K-FUNCTION; SCOLYTIDAE; CURCULIONIDAE; BEHAVIOR; ECOLOGY; TYPOGRAPHUS; COMPETITION; MORTALITY	Bark beetles attack their hosts at uniform intervals to avoid intraspecific competition in the phloem. Bark texture and phloem thickness also affect bark beetle attacks, and the bark characteristics are not spatially homogeneous; therefore, the distribution patterns of entry holes can demonstrate an aggregated distribution. Polygraphus proximus Blandford (Coleoptera: Scolytinae) is a non-aggressive phloephagous bark beetle that feeds on Far Eastern firs. They have caused mass mortality in Russia and Japan. However, the distribution pattern of entry holes of P. proximus and spatial relationships with bark characteristics have not been studied. Thus, we investigated the distribution pattern of entry holes of P. proximus. The distribution of entry holes was significantly uniform in most cases. As the attack density increased, an aggregated distribution pattern within a short distance (< 4.0 cm) was observed. The rough bark had a significantly higher number of entry holes than the remaining bark. The distribution pattern of entry holes demonstrated a significantly aggregated spatial association with rough bark. Finally, rough bark around knots had significantly thicker phloem than the remaining barks. These suggest that P. proximus may preferentially attack rough bark to reproduce in the thicker phloem under a rough bark surface.	[Takei, Shin-ya; Kobayashi, Kenta; Takagi, Etsuro] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Tourism Sci, Hachioji, Tokyo, Japan	Tokyo Metropolitan University	Takagi, E (corresponding author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Tourism Sci, Hachioji, Tokyo, Japan.	e_t@tmu.ac.jp		Takagi, Etsuro/0000-0003-4006-4853	JSPS KAKENHI [ET 19K15874]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	ET 19K15874 JSPS KAKENHI https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman GD, 1976, USDA FOREST SERV RES, V209; ANDERBRANT O, 1985, OIKOS, V45, P89, DOI 10.2307/3565226; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baranchikov Y, 2010, P 21ST US DEP AGR IN, P12; BYERS JA, 1989, HOLARCTIC ECOL, V12, P466; BYERS JA, 1992, J ANIM ECOL, V61, P759, DOI 10.2307/5629; BYERS JA, 1984, ENVIRON ENTOMOL, V13, P1191, DOI 10.1093/ee/13.5.1191; BYERS JA, 1989, EXPERIENTIA, V45, P271, DOI 10.1007/BF01951813; Chiba S, 2020, JAPANESE FOREST SOC, P108, DOI [10.4005/jjfs.102.108, DOI 10.4005/JJFS.102.108]; Diggle PJ, 1983, STAT ANAL SPATIAL PO, DOI [10.1111/j.1469-8749.1983.tb13748.x6852388, DOI 10.1111/J.1469-8749.1983.TB13748.X6852388]; Dixon PM, 2014, WILEY STATSREF STAT, V3, P1796, DOI [10.1002/9781118445112.stat07751, DOI 10.1002/9781118445112.STAT07751]; Dooley EM, 2015, ENVIRON ENTOMOL, V44, P1384, DOI 10.1093/ee/nvv107; EPPO, 2014, PEST RISK ANAL POLYG; ESRI, 2018, ARCGIS 10 6; Ferrenberg S, 2014, FUNCT ECOL, V28, P837, DOI 10.1111/1365-2435.12228; HAACK RA, 1987, ENVIRON ENTOMOL, V16, P428, DOI 10.1093/ee/16.2.428; HAACK RA, 1984, CAN ENTOMOL, V116, P625, DOI 10.4039/Ent116625-4; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; HADLEY KS, 1993, CAN J FOREST RES, V23, P479, DOI 10.1139/x93-066; Hedden RL, 1972, ANAL SPATIAL ATTACK; Kabe M, 1959, ILLUSTRATIONS GALLER; Kerchev I. A., 2014, Russian Journal of Biological Invasions, V5, P176, DOI 10.1134/S2075111714030072; Kerchev IA., 2014, ENTOMOL REV, V94, P1059, DOI [10.1134/S0013873814080028, DOI 10.1134/S0013873814080028]; Kharuk VI, 2019, CONTEMP PROBL ECOL+, V12, P299, DOI 10.1134/S199542551904005X; Kobayashi K, 2020, J INSECT SCI, V20, DOI 10.1093/jisesa/ieaa140; KOHYAMA T, 1984, OECOLOGIA, V62, P156, DOI 10.1007/BF00379008; Koizumi C., 1977, B GOVT FOREST EXPT S, V297, P1; Kononov A, 2016, AGR FOREST ENTOMOL, V18, P294, DOI 10.1111/afe.12161; MENDEL Z, 1985, PHYTOPARASITICA, V13, P21, DOI 10.1007/BF02994434; Nobuchi A., 1966, Bulletin of the Government Forest Experiment Station = Ringyo Shikenjo kenkyu hokoku, P1; Nobuchi A., 1980, BARK BEETLES ASSOCIA; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; PAYNTER QE, 1990, J INSECT BEHAV, V3, P529, DOI 10.1007/BF01052016; R Core Team, 2020, R LANG ENV STAT COMP; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Robins GL, 1997, ECOL ENTOMOL, V22, P329, DOI 10.1046/j.1365-2311.1997.00068.x; Takagi E, 2021, FOREST ECOL MANAG, V479, DOI 10.1016/j.foreco.2020.118617; Takagi E, 2018, FOREST ECOL MANAG, V428, P14, DOI 10.1016/j.foreco.2018.06.030; Toffin E, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170454; Tokuda M, 2008, APPL ENTOMOL ZOOL, V43, P1, DOI 10.1303/aez.2008.1; Yamada I, 2003, GEOGR ANAL, V35, P97, DOI 10.1353/geo.2003.0005	42	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246812	10.1371/journal.pone.0246812	http://dx.doi.org/10.1371/journal.pone.0246812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561182	Green Published, gold			2022-12-26	WOS:000617533000004
J	Lazarova, M; Kim, Y; Steinle, A				Lazarova, Mariya; Kim, Younghoon; Steinle, Alexander			The NKG2D ligand ULBP4 is not expressed by human monocytes	PLOS ONE			English	Article							T-CELLS; DOWN-REGULATION; CUTTING EDGE; NK CELLS; RECEPTOR; ACTIVATION; MICA; CYTOTOXICITY; CONTRIBUTES; MOLECULES	The C-type lectin-like receptor NKG2D contributes to the immunosurveillance of virally infected and malignant cells by cytotoxic lymphocytes. A peculiar and puzzling feature of the NKG2D-based immunorecognition system is the high number of ligands for this single immunoreceptor. In humans, there are a total of eight NKG2D ligands (NKG2DL) comprising two members of the MIC (MICA, MICB) and six members of the ULBP family of glycoproteins (ULBP1 to ULBP6). While MICA has been extensively studied with regard to its biochemistry, cellular expression and function, very little is known about the NKG2DL ULBP4. This is, at least in part, due to its rather restricted expression by very few cell lines and tissues. Recently, constitutive ULBP4 expression by human monocytes was reported, questioning the view of tissue-restricted ULBP4 expression. Here, we scrutinized ULBP4 expression by human peripheral blood mononuclear cells and monocytes by analyzing ULBP4 transcripts and ULBP4 surface expression. In contrast to MICA, there was no ULBP4 expression detectable, neither by freshly isolated monocytes nor by PAMP-activated monocytes. However, a commercial antibody erroneously indicated surface ULBP4 on monocytes due to a non-ULBP4-specific binding activity, emphasizing the critical importance of validated reagents for life sciences. Collectively, our data show that ULBP4 is not expressed by monocytes, and likely also not by other peripheral blood immune cells, and therefore exhibits an expression pattern rather distinct from other human NKG2DL.	[Lazarova, Mariya; Kim, Younghoon; Steinle, Alexander] Goethe Univ Frankfurt Main, Inst Mol Med, Frankfurt, Germany; [Steinle, Alexander] Frankfurt Canc Inst, Frankfurt, Germany	Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ Frankfurt Main, Inst Mol Med, Frankfurt, Germany.; Steinle, A (corresponding author), Frankfurt Canc Inst, Frankfurt, Germany.	alexander.steinle@kgu.de		Steinle, Alexander/0000-0001-5081-8503				Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Raneros AB, 2015, GENES IMMUN, V16, P71, DOI 10.1038/gene.2014.58; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Baumeister SH, 2019, CANCER IMMUNOL RES, V7, P100, DOI 10.1158/2326-6066.CIR-18-0307; Carapito R, 2015, IMMUNOL REV, V267, P88, DOI 10.1111/imr.12328; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Codo P, 2014, ONCOTARGET, V5, P7651, DOI 10.18632/oncotarget.2287; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Heinemann A, 2012, CANCER RES, V72, P460, DOI 10.1158/0008-5472.CAN-11-1977; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jonjic S, 2008, EUR J IMMUNOL, V38, P2952, DOI 10.1002/eji.200838823; Kloss M, 2008, J IMMUNOL, V181, P6711, DOI 10.4049/jimmunol.181.10.6711; Lanier LL, 2015, CANCER IMMUNOL RES, V3, P575, DOI 10.1158/2326-6066.CIR-15-0098; Lazarova M, 2019, EXPERT OPIN THER TAR, V23, P281, DOI 10.1080/14728222.2019.1580693; Liu G, 2010, J IMMUNOL, V184, P3346, DOI 10.4049/jimmunol.0903789; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Muller S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000723; Murad JM, 2018, CYTOTHERAPY, V20, P952, DOI 10.1016/j.jcyt.2018.05.001; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Sester M, 2010, J IMMUNOL, V184, P255, DOI 10.4049/jimmunol.0902343; Sharma N, 2019, BLOOD ADV, V3, P1563, DOI 10.1182/bloodadvances.2018025742; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Uhlen M, 2019, SCIENCE, V366, P1471, DOI 10.1126/science.aax9198; Ullrich E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26097; Van Cutsem E, 2019, ANN ONCOL, V30; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Zoller T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00620	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246726	10.1371/journal.pone.0246726	http://dx.doi.org/10.1371/journal.pone.0246726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556116	Green Submitted, Green Published, gold			2022-12-26	WOS:000617379900055
J	Cooley, JR; Hebert, JJ; de Zoete, A; Jensen, TS; Algra, PR; Kjaer, P; Walker, BF				Cooley, J. R.; Hebert, J. J.; de Zoete, A.; Jensen, T. S.; Algra, P. R.; Kjaer, P.; Walker, B. F.			Assessing lumbar paraspinal muscle cross-sectional area and fat composition with T1 versus T2-weighted magnetic resonance imaging: Reliability and concurrent validity	PLOS ONE			English	Article							LOW-BACK-PAIN; MULTIFIDUS; DEGENERATION; MORPHOLOGY; LEVEL; PSOAS; SIZE	Purpose Studies using magnetic resonance imaging to assess lumbar multifidus cross-sectional area frequently utilize T1 or T2-weighted sequences, but seldom provide the rationale for their sequence choice. However, technical considerations between their acquisition protocols could impact on the ability to assess lumbar multifidus anatomy or its fat/muscle distinction. Our objectives were to examine the concurrent validity of lumbar multifidus morphology measures of T2 compared to T1-weighted sequences, and to assess the reliability of repeated lumbar multifidus measures. Methods The lumbar multifidus total cross-sectional area of 45 patients was measured bilaterally at L4 and L5, with histogram analysis determining the muscle/fat threshold values per muscle. Images were later re-randomized and re-assessed for intra-rater reliability. Matched images were visually rated for consistency of outlining between both image sequences. Bland-Altman bias, limits of agreement, and plots were calculated for differences in total cross-sectional area and percentage fat between and within sequences, and intra-rater reliability analysed. Results T1-weighted total cross-sectional area measures were systematically larger than T2 (0.2 cm(2)), with limits of agreement <+/- 10% at both spinal levels. For percentage fat, no systematic bias occurred, but limits of agreement approached +/- 15%. Visually, muscle outlining was consistent between sequences, with substantial mismatches occurring in <5% of cases. Intra-rater reliability was excellent (ICC: 0.981-0.998); with bias and limits of agreement less than 1% and +/- 5%, respectively. Conclusion Total cross-sectional area measures and outlining of muscle boundaries were consistent between sequences, and intra-rater reliability for total cross-sectional area and percentage fat was high indicating that either MRI sequence could be used interchangeably for this purpose. However, further studies comparing the accuracy of various methods for distinguishing fat from muscle are recommended.	[Cooley, J. R.; Hebert, J. J.; Walker, B. F.] Murdoch Univ, Coll Sci Hlth Engn & Educ, Murdoch, WA, Australia; [Hebert, J. J.] Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada; [de Zoete, A.] Vrije Univ, Fac Sci, Dept Hlth Sci, Amsterdam, Netherlands; [de Zoete, A.] Vrije Univ, Amsterdam Movement Sci Res Inst, Amsterdam, Netherlands; [Jensen, T. S.] Reg Hosp Silkeborg, Dept Diagnost Imaging, Silkeborg, Denmark; [Jensen, T. S.; Kjaer, P.] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense M, Denmark; [Jensen, T. S.] Nordic Inst Chiropract & Clin Biomech, Odense M, Denmark; [Algra, P. R.] Alkmaar, Noordwest Ziekenhuisgrp, Alkmaar, Netherlands; [Kjaer, P.] UCL Univ Coll, Hlth Sci Res Ctr, Odense M, Denmark	Murdoch University; University of New Brunswick; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Southern Denmark; Medical Center Of Alkmaar	Cooley, JR (corresponding author), Murdoch Univ, Coll Sci Hlth Engn & Educ, Murdoch, WA, Australia.	J.Cooley@murdoch.edu.au	Jensen, Tue Secher/P-7400-2019; Cooley, Jeffrey/GSD-7229-2022; Kjaer, Per/C-1210-2009	Jensen, Tue Secher/0000-0002-7456-4306; Hebert, Jeffrey/0000-0002-6959-325X; Kjaer, Per/0000-0001-5340-8649; de Zoete, Annemarie/0000-0002-1421-3862; Walker, Bruce/0000-0002-8506-6740	Chiropractic Australia Research Foundation	Chiropractic Australia Research Foundation	This project was partially funded through a PhD scholarship (JRC) from the Chiropractic Australia Research Foundation (formerly COCA Research Ltd.) https://chiropracticaustralia.org.au/research/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker KL, 2004, SPINE, V29, pE515, DOI 10.1097/01.brs.0000144405.11661.eb; Battie MC, 2012, SPINE J, V12, P932, DOI 10.1016/j.spinee.2012.08.020; Beneck GJ, 2012, ARCH PHYS MED REHAB, V93, P300, DOI 10.1016/j.apmr.2011.09.017; Bonekamp S, 2008, INT J OBESITY, V32, P100, DOI 10.1038/sj.ijo.0803696; Chen YY, 2014, EUR SPINE J, V23, P999, DOI 10.1007/s00586-013-3148-z; Cheng C., 2010, CRIT REV PHYS REHABI, V22, P279, DOI [10.1615/CritRevPhysRehabilMed.v22.i1-4.120, DOI 10.1615/CRITREVPHYSREHABILMED.V22.I1-4.120]; Cooley JR, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2266-5; Crawford RJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-016-1378-z; D'hooge R, 2013, CLIN J PAIN, V29, P187, DOI 10.1097/AJP.0b013e31824ed170; Danneels LA, 2000, EUR SPINE J, V9, P266, DOI 10.1007/s005860000190; Dickx N, 2008, SPINE, V33, pE983, DOI 10.1097/BRS.0b013e31818917d0; Fan SW, 2010, EUR SPINE J, V19, P316, DOI 10.1007/s00586-009-1191-6; Fortin M, 2015, SCAND J MED SCI SPOR, V25, P880, DOI 10.1111/sms.12301; Fortin M, 2012, PHYS THER, V92, P853, DOI 10.2522/ptj.20110380; Gille O, 2007, SPINE, V32, P1236, DOI 10.1097/BRS.0b013e31805471fe; HIDES JA, 1994, SPINE, V19, P165, DOI 10.1097/00007632-199401001-00009; Hyun SJ, 2016, CLIN SPINE SURG, V29, P441, DOI 10.1097/BSD.0b013e3182aa28b0; Jindal G, 2011, MAGN RESON IMAGING C, V19, P475, DOI 10.1016/j.mric.2011.05.013; Kamaz M, 2007, DIAGN INTERV RADIOL, V13, P144; Kim H, 2013, EUR SPINE J, V22, P1332, DOI 10.1007/s00586-013-2740-6; Kim WH, 2011, J KOREAN NEUROSURG S, V50, P201, DOI 10.3340/jkns.2011.50.3.201; Kjaer P, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-2; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kulig K, 2009, AM J PHYS MED REHAB, V88, P355, DOI 10.1097/PHM.0b013e31819c506d; Liao JJZ, 2010, PHARM STAT, V9, P125, DOI 10.1002/pst.382; McMahon KL, 2011, J ORTHOP SPORT PHYS, V41, P806, DOI 10.2519/jospt.2011.3576; Mengiardi B, 2006, RADIOLOGY, V240, P786, DOI 10.1148/radiol.2403050820; Niemelainen R, 2011, SPINE, V36, P2152, DOI 10.1097/BRS.0b013e318204b05a; Paalanne N, 2011, SPINE, V36, P1961, DOI 10.1097/BRS.0b013e3181fef890; Singh R, 2016, EUR SPINE J, V25, P2864, DOI 10.1007/s00586-016-4698-7; Sions JM, 2015, J GERIATR PHYS THER, V38, P33, DOI 10.1519/JPT.0000000000000021; Stokes M J, 1992, Eur Spine J, V1, P38, DOI 10.1007/BF00302141; Suh DW, 2017, J BACK MUSCULOSKELET, V30, P403, DOI 10.3233/BMR-150352; Wallwork TL, 2009, MANUAL THER, V14, P496, DOI 10.1016/j.math.2008.09.006; Wan Q, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140546	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244633	10.1371/journal.pone.0244633	http://dx.doi.org/10.1371/journal.pone.0244633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544707	Green Submitted, Green Published, gold			2022-12-26	WOS:000617991900004
J	Ikeda, K; Tienda, AA; Harrison, FE; Kawakami, K				Ikeda, Keiko; Tienda, Adriana A.; Harrison, Fiona E.; Kawakami, Kiyoshi			Decreased content of ascorbic acid (vitamin C) in the brain of knockout mouse models of Na+,K+-ATPase-related neurologic disorders	PLOS ONE			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; INCREASED OXIDATIVE STRESS; ATPASE ALPHA-2 SUBUNIT; DE-NOVO MUTATIONS; ALTERNATING HEMIPLEGIA; SODIUM-PUMP; K-ATPASE; DYSTONIA-PARKINSONISM; NEURONAL-ACTIVITY; DEFICIENT MICE	Na+,K+-ATPase is a crucial protein responsible for maintaining the electrochemical gradients across the cell membrane. The Na+,K+-ATPase is comprised of catalytic alpha, beta, and gamma subunits. In adult brains, the alpha 3 subunit, encoded by ATP1A3, is predominantly expressed in neurons, whereas the alpha 2 subunit, encoded by ATP1A2, is expressed in glial cells. In foetal brains, the alpha 2 is expressed in neurons as well. Mutations in alpha subunits cause a variety of neurologic disorders. Notably, the onset of symptoms in ATP1A2- and ATP1A3-related neurologic disorders is usually triggered by physiological or psychological stressors. To gain insight into the distinct roles of the alpha 2 and alpha 3 subunits in the developing foetal brain, whose developmental dysfunction may be a predisposing factor of neurologic disorders, we compared the phenotypes of mouse foetuses with double homozygous knockout of Atp1a2 and Atp1a3 (alpha 2 alpha 3-dKO) to those with single knockout. The brain haemorrhage phenotype of alpha 2 alpha 3-dKO was similar to that of homozygous knockout of the gene encoding ascorbic acid (ASC or vitamin C) transporter, SVCT2. The alpha 2 alpha 3-dKO brain showed significantly decreased level of ASC compared with the wild-type (WT) and single knockout. We found that the ASC content in the basal ganglia and cerebellum was significantly lower in the adult Atp1a3 heterozygous knockout mouse (alpha 3-HT) than in the WT. Interestingly, we observed a significant decrease in the ASC level in the basal ganglia and cerebellum of alpha 3-HT in the peripartum period, during which mice are under physiological stress. These observations indicate that the alpha 2 and alpha 3 subunits independently contribute to the ASC level in the foetal brain and that the alpha 3 subunit contributes to ASC transport in the adult basal ganglia and cerebellum. We propose that decreases in ASC levels may affect neural network development and are linked to the pathophysiology of ATP1A2- and ATP1A3-related neurologic disorders.	[Ikeda, Keiko] Natl Hosp Org, Dept Clin Res, Grp Pathophysiol, Murayama Med Ctr, Tokyo, Japan; [Ikeda, Keiko; Kawakami, Kiyoshi] Jichi Med Univ, Ctr Mol Med, Div Cell Biol, Shimotsuke, Tochigi, Japan; [Tienda, Adriana A.; Harrison, Fiona E.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Jichi Medical University; Vanderbilt University	Ikeda, K (corresponding author), Natl Hosp Org, Dept Clin Res, Grp Pathophysiol, Murayama Med Ctr, Tokyo, Japan.; Ikeda, K (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Cell Biol, Shimotsuke, Tochigi, Japan.	ikeda-k@murayama-hosp.jp		Ikeda, Keiko/0000-0003-4864-8597; Tienda, Adriana/0000-0001-7549-762X	Japan Society for the Promotion of Science (JSPS) KAKENHI [18K06968]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KI, 18K06968, Japan Society for the Promotion of Science (JSPS) KAKENHI, https://www.jsps.go.jp/english/e-grants/data/kakenhi_pamph_e.pdf, NO.	ADLARD BPF, 1974, ARCH DIS CHILD, V49, P278, DOI 10.1136/adc.49.4.278; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Brashear A, 2008, GENEREV, P1993; Calero CI, 2011, J NEUROSCI, V31, P9672, DOI 10.1523/JNEUROSCI.5157-10.2011; Capo I, 2015, VET PATHOL, V52, P1263, DOI 10.1177/0300985814561270; Castaneda MS, 2018, BRAIN, V141, P3308, DOI 10.1093/brain/awy283; Castro MJ, 2008, CLIN GENET, V73, P37, DOI 10.1111/j.1399-0004.2007.00918.x; Chatron N, 2019, BRAIN, V142, P3367, DOI 10.1093/brain/awz272; Chen Y, 2012, GENES BRAIN BEHAV, V11, P269, DOI 10.1111/j.1601-183X.2011.00762.x; Ciani E, 1996, BRAIN RES, V728, P1; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Dard R, 2015, DEV MED CHILD NEUROL, V57, P1183, DOI 10.1111/dmcn.12927; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Dixit S, 2015, ACS CHEM NEUROSCI, V6, P570, DOI 10.1021/cn500308h; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Figueroa-Mendez R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00397; Friedrich T, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00239; Gambhir JK, 1997, CLIN BIOCHEM, V30, P351, DOI 10.1016/S0009-9120(96)00007-0; Ghusayni R, 2020, EUR J PAEDIATR NEURO, V26, P15, DOI 10.1016/j.ejpn.2020.02.001; Gillen AE, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108023; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Harriott AM, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-46; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; Harrison FE, 2008, J NEUROCHEM, V106, P1198, DOI 10.1111/j.1471-4159.2008.05469.x; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hata E, 2016, INT IMMUNOL, V28, P283, DOI 10.1093/intimm/dxv072; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Helseth AR, 2018, NEUROBIOL DIS, V119, P100, DOI 10.1016/j.nbd.2018.07.028; Hill KE, 2003, AM J CLIN NUTR, V77, P1484, DOI 10.1093/ajcn/77.6.1484; Holm TH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00209; Horvath GA, 2011, CEPHALALGIA, V31, P1580, DOI 10.1177/0333102411420584; Hunanyan AS, 2018, EPILEPSIA, V59, P1455, DOI 10.1111/epi.14441; Hunanyan AS, 2015, EPILEPSIA, V56, P82, DOI 10.1111/epi.12878; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Ikeda K, 2003, J NEUROSCI, V23, P4667; Ikeda K, 2019, BRAIN RES, V1720, DOI 10.1016/j.brainres.2019.06.008; Ikeda K, 2017, BRAIN RES, V1666, P27, DOI 10.1016/j.brainres.2017.04.014; Ikeda K, 2013, J PHYSIOL-LONDON, V591, P3433, DOI 10.1113/jphysiol.2012.247817; Isaksen TJ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00161; Karner E, 2012, COGN BEHAV NEUROL, V25, P85, DOI 10.1097/WNN.0b013e318259cb36; Kawakami K, 2005, OBES RES, V13, P1661, DOI 10.1038/oby.2005.204; Kawakami K, 2006, CELL MOL BIOL, V52, P92, DOI 10.1170/T766; Kinoshita PF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00195; Knapp PE, 2000, DEV BRAIN RES, V125, P89, DOI 10.1016/S0165-3806(00)00125-5; KRATZING CC, 1982, INT J VITAM NUTR RES, V52, P326; Kurihara K, 2019, J CLIN BIOCHEM NUTR, V65, P209, DOI 10.3164/jcbn.19-41; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Lingrel J, 2003, ANN NY ACAD SCI, V986, P354, DOI 10.1111/j.1749-6632.2003.tb07214.x; Liu J, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0392-5; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Mi DJ, 2018, NEUROBIOL AGING, V71, P241, DOI 10.1016/j.neurobiolaging.2018.08.002; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Monteiro FP, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.01.014; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Onimaru H, 2007, J PHYSIOL-LONDON, V584, P271, DOI 10.1113/jphysiol.2007.136572; Paciorkowski AR, 2015, EPILEPSIA, V56, P422, DOI 10.1111/epi.12914; Pierce MR, 2013, NUTR NEUROSCI, V16, P160, DOI 10.1179/1476830512Y.0000000042; Pivovarov AS, 2019, INVERTEBR NEUROSCI, V19, DOI 10.1007/s10158-018-0221-7; Prange L, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000466; REBEC GV, 1994, PROG NEUROBIOL, V43, P537, DOI 10.1016/0301-0082(94)90052-3; Rice ME, 1998, NEUROSCIENCE, V82, P1213; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Severino M, 2020, J NEUROL, V267, P1300, DOI 10.1007/s00415-020-09698-3; Sgaravatti AM, 2009, METAB BRAIN DIS, V24, P271, DOI 10.1007/s11011-009-9136-7; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Sugimoto H, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12435; Sugimoto H, 2014, BEHAV BRAIN RES, V272, P100, DOI 10.1016/j.bbr.2014.06.048; Sweney MT, 2015, PEDIATR NEUROL, V52, P56, DOI 10.1016/j.pediatrneurol.2014.09.015; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Uchitel J, 2019, NEUROLOGY, V93, pE1248, DOI 10.1212/WNL.0000000000008159; Unekawa M, 2018, CEPHALALGIA, V38, P1515, DOI 10.1177/0333102417738249; Volpe J J, 1998, Semin Pediatr Neurol, V5, P135, DOI 10.1016/S1071-9091(98)80030-2; Ward MS, 2013, J NEUROCHEM, V124, P363, DOI 10.1111/jnc.12069; Warner TA, 2015, EPILEPSY RES, V110, P20, DOI 10.1016/j.eplepsyres.2014.11.017; Winawer MR, 2013, EPILEPSIA, V54, P288, DOI 10.1111/epi.12072; Yano ST, 2017, PEDIATR NEUROL, V73, P101, DOI 10.1016/j.pediatrneurol.2017.04.022; Zarcone D, 2017, NEUROL SCI, V38, pS73, DOI 10.1007/s10072-017-2902-0; Zielman R, 2014, CEPHALALGIA, V34, P959, DOI 10.1177/0333102414527016	87	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246678	10.1371/journal.pone.0246678	http://dx.doi.org/10.1371/journal.pone.0246678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544780	Green Submitted, gold, Green Published			2022-12-26	WOS:000617991900028
J	Chin, CH; Tseng, LM; Chao, TC; Wang, TJ; Wu, SF; Liang, SY				Chin, Chia-Hui; Tseng, Ling-Ming; Chao, Ta-Chung; Wang, Tsae-Jyy; Wu, Shu-Fang; Liang, Shu-Yuan			Self-care as a mediator between symptom-management self-efficacy and quality of life in women with breast cancer	PLOS ONE			English	Article							EORTC QLQ-C30; VALIDATION; DISTRESS; QUESTIONNAIRE; CHEMOTHERAPY; TRANSLATION; OUTPATIENTS; EDUCATION; PROGRAM; PAIN	Background The important role of self-efficacy in facilitating health behavior and, in turn, promoting health outcomes has been widely presumed in the theoretical literature. However, little research has focused on the mechanism by which self-care mediates the relationship between symptom-management self-efficacy and quality of life (QOL) in breast cancer patients. Objective The purpose of this study was to examine the relationship between symptom-management self-efficacy and quality of life in Taiwanese oncology outpatients with breast cancer and then proposes self-care as a mediator between these two factors. Methods This cross-sectional study enrolled 201 oncology outpatients at one teaching hospital in metropolitan Taipei City, Taiwan. The research instruments included the Symptom-Management Self-Efficacy Scale-Cancer (SMSES-Breast Ca.), the Self-Care Scale, and the European Organization for Research & Treatment of Cancer Quality of Life Group Questionnaire (EORTC-QLQ-C30). Results Symptom-management self-efficacy (SMSE) was directly associated with the QOL of the participants (beta = 5.94, p < .001). Moreover, SMSE was indirectly associated with QOL through self-care. Self-care was found to mediate the relationship between symptom-management self-efficacy and global QOL (indirect effect = 0.54, 95% CI 0.12 to 1.18). The level of 95% CI was significant. Conclusions The present study supports that self-efficacy beliefs and self-care both significantly and positively influence the quality of life of patients.	[Chin, Chia-Hui] Shin Kong Wu Ho Mem Hosp, Dept Nursing, Taipei, Taiwan; [Tseng, Ling-Ming; Chao, Ta-Chung] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Wang, Tsae-Jyy; Wu, Shu-Fang; Liang, Shu-Yuan] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Taipei Veterans General Hospital; National Taipei University of Nursing & Health Science (NTUNHS)	Liang, SY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan.	shuyuan@ntunhs.edu.tw			Shin Kong Wu Ho-Su Memorial Hospital in Taiwan [DN-PC-107-002]	Shin Kong Wu Ho-Su Memorial Hospital in Taiwan	The research was supported by the Shin Kong Wu Ho-Su Memorial Hospital in Taiwan (DN-PC-107-002). Initials of the authors who received each award: Shu-Yuan Liang & Chia-Hui Chin Grant numbers awarded to each author:DN-PC-107-002 ~The full name of each funder:Shin Kong Wu Ho-Su Memorial Hospital in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Adamowicz K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01389-x; Arraras JI, 2002, PSYCHO-ONCOL, V11, P249, DOI 10.1002/pon.555; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bandura A., 1986, SOCIAL FDN THOUGHT A; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Becker MH, 1974, HLTH BELIEF MODEL PE; Byar Katherine L, 2006, Oncol Nurs Forum, V33, pE18, DOI 10.1188/06.ONF.E18-E26; Chen AMH, 2014, RES SOC ADMIN PHARM, V10, P378, DOI 10.1016/j.sapharm.2013.07.001; Heckman JE, 2011, J UROLOGY, V186, P1855, DOI 10.1016/j.juro.2011.06.059; HILL RJ, 1977, CONTEMP SOCIOL, V6, P244, DOI 10.2307/2065853; Hoopman R, 2006, EUR J CANCER, V42, P1839, DOI 10.1016/j.ejca.2005.08.047; Huang FF, 2018, PSYCHOL HEALTH MED, V23, P804, DOI 10.1080/13548506.2018.1434216; Kim HJ, 2009, J NURS SCHOLARSHIP, V41, P158, DOI 10.1111/j.1547-5069.2009.01267.x; Krikorian S, 2019, J ONCOL PHARM PRACT, V25, P1590, DOI 10.1177/1078155218800384; Lehto US, 2019, QUAL LIFE RES, V28, P677, DOI 10.1007/s11136-018-2069-z; Liang SY, 2015, ASIAN NURS RES, V9, P312, DOI 10.1016/j.anr.2015.09.001; Liang SY, 2016, CANCER NURS, V39, P67, DOI 10.1097/NCC.0000000000000244; Liang SY, 2008, PSYCHO-ONCOLOGY, V17, P1100, DOI 10.1002/pon.1326; Park KU, 2008, ONCOLOGY-BASEL, V74, P7, DOI 10.1159/000143212; Pool MK, 2012, GASTROENTEROL NURS, V35, P332, DOI 10.1097/SGA.0b013e3182605f86; Porter LS, 2008, PAIN, V137, P306, DOI 10.1016/j.pain.2007.09.010; Richardson LC, 2007, BREAST J, V13, P581, DOI 10.1111/j.1524-4741.2007.00512.x; Royer HR, 2009, ONCOL NURS FORUM, V36, P463, DOI 10.1188/09.ONF.463-470; Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615; Sharma A, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/269510; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Wang SP, 2011, J NURS RES, V19, P257, DOI 10.1097/JNR.0b013e318237f08d; Wang ZX, 2019, COMPLEMENT THER MED, V43, P165, DOI 10.1016/j.ctim.2019.01.027; Weber BA, 2004, PSYCHO-ONCOL, V13, P47, DOI 10.1002/pon.718; White LL, 2019, ONCOL NURS FORUM, V46, P113, DOI 10.1188/19.ONF.113-128; Wood LJ, 2006, ONCOL NURS FORUM, V33, P535, DOI 10.1188/06.ONF.535-542; Yang W., 1996, THESIS; Zhao H, 2000, QUAL LIFE RES, V9, P129, DOI 10.1023/A:1008981520920	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246430	10.1371/journal.pone.0246430	http://dx.doi.org/10.1371/journal.pone.0246430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539460	Green Published, gold			2022-12-26	WOS:000616960200100
J	Gupta, SK; Deng, Q; Gupta, TB; Maclean, P; Jores, J; Heiser, A; Wedlock, DN				Gupta, Sandeep K.; Deng, Qing; Gupta, Tanushree B.; Maclean, Paul; Jores, Joerg; Heiser, Axel; Wedlock, D. Neil			Recombinase polymerase amplification assay combined with a dipstick-readout for rapid detection of Mycoplasma ovipneumoniae infections	PLOS ONE			English	Article							RESPIRATORY-DISEASE; PNEUMONIA; SHEEP; VIRUS; LAMBS	Mycoplasma ovipneumoniae infects both sheep and goats causing pneumonia resulting in considerable economic losses worldwide. Current diagnosis methods such as bacteriological culture, serology, and PCR are time consuming and require sophisticated laboratory setups. Here we report the development of two rapid, specific and sensitive assays; an isothermal DNA amplification using recombinase polymerase amplification (RPA) and a real-time PCR for the detection of M. ovipneumoniae. The target for both assays is a specific region of gene WP_069098309.1, which encodes a hypothetical protein and is conserved in the genome sequences of ten publicly available M. ovipneumoniae strains. The RPA assay performed well at 39 degrees C for 20 min and was combined with a lateral flow dipstick (RPA-LFD) for easy visualization of the amplicons. The detection limit of the RPA-LFD assay was nine genome copies of M. ovipneumoniae per reaction and was comparable to sensitivity of the real-time PCR assay. Both assays showed no cross-reaction with 38 other ovine and caprine pathogenic microorganisms and two parasites of ruminants, demonstrating a high degree of specificity. The assays were validated using bronchoalveolar lavage fluid and nasal swab samples collected from sheep. The positive rate of RPA-LFD (97.4%) was higher than the real-time PCR (95.8%) with DNA as a template purified from the clinical samples. The RPA assay was significantly better at detecting M. ovipneumoniae in clinical samples compared to the real-time PCR when DNA extraction was omitted (50% and 34.4% positive rate for RPA-LFD and real-time PCR respectively). The RPA-LFD developed here allows easy and rapid detection of M. ovipneumoniae infection without DNA extraction, suggesting its potential as a point-of-care test for field settings.	[Gupta, Sandeep K.; Deng, Qing; Heiser, Axel; Wedlock, D. Neil] AgResearch, Anim Hlth, Hopkirk Res Inst, Grasslands Res Ctr, Palmerston North, New Zealand; [Gupta, Tanushree B.] AgResearch, Food Safety & Assurance, Hopkirk Res Inst, Grasslands Res Ctr, Palmerston North, New Zealand; [Maclean, Paul] AgResearch, Grasslands Res Ctr, Bioinformat & Stat, Palmerston North, New Zealand; [Jores, Joerg] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland	AgResearch - New Zealand; AgResearch - New Zealand; AgResearch - New Zealand; University of Bern	Gupta, SK (corresponding author), AgResearch, Anim Hlth, Hopkirk Res Inst, Grasslands Res Ctr, Palmerston North, New Zealand.	sandeep.gupta@agresearch.co.nz		Gupta, Sandeep/0000-0002-9746-0075; Jores, Joerg/0000-0003-3790-5746; Maclean, Paul/0000-0001-8898-8276; Heiser, Axel/0000-0003-0389-6132	AgResearch Curiosity Fund through the Strategic Science Investment Fund - Ministry of Business, Innovation and Employment (Wellington, New Zealand)	AgResearch Curiosity Fund through the Strategic Science Investment Fund - Ministry of Business, Innovation and Employment (Wellington, New Zealand)	This work was supported by an AgResearch Curiosity Fund awarded to SKG, funded through the Strategic Science Investment Fund supported by the Ministry of Business, Innovation and Employment (Wellington, New Zealand). The funder provided support in the form of salaries for authors SKG and QD as well as research reagents and consumables, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section'.	Abd El Wahed Ahmed, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.a7f1db2c7d66c3fc0ea0a774305d319e; Aebischer A, 2014, J CLIN MICROBIOL, V52, P1883, DOI 10.1128/JCM.00167-14; Alley M R, 1975, N Z Vet J, V23, P113, DOI 10.1080/00480169.1975.34211; Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Azari AA, 2020, TROP ANIM HEALTH PRO, V52, P1043, DOI 10.1007/s11250-019-02098-4; Bhamla MS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0009; Bridgeman BJ, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.01375-19; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cornelissen JBWJ, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1023-6; Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829; Daniel JA, 2006, AM J VET RES, V67, P890, DOI 10.2460/ajvr.67.5.890; Glendinning L, 2016, APPL ENVIRON MICROB, V82, P3225, DOI 10.1128/AEM.00540-16; Goodwin-Ray KA, 2008, NEW ZEAL VET J, V56, P107, DOI 10.1080/00480169.2008.36818; Gupta Sandeep K, 2016, Biochem Biophys Rep, V8, P261, DOI 10.1016/j.bbrep.2016.09.001; Gupta TB, 2018, J FOOD SAFETY, V38, DOI 10.1111/jfs.12430; Hansen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168733; Hu JQ, 2019, J MICROBIOL METH, V158, P25, DOI 10.1016/j.mimet.2019.01.018; James A, 2015, EXPERT REV MOL DIAGN, V15, P1475, DOI 10.1586/14737159.2015.1090877; Kamath PL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51444-x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lacasta D, 2008, SMALL RUMINANT RES, V80, P28, DOI 10.1016/j.smallrumres.2008.08.004; Liljander A, 2015, J CLIN MICROBIOL, V53, P2810, DOI 10.1128/JCM.00623-15; Lindstrom L, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0409-1; Lobato IM, 2018, TRAC-TREND ANAL CHEM, V98, P19, DOI 10.1016/j.trac.2017.10.015; Manlove K, 2019, PREV VET MED, V168, P30, DOI 10.1016/j.prevetmed.2019.04.006; Moore MD, 2017, SCI REP-UK, V7, DOI 10.1038/srep40244; Navarro T, 2019, SMALL RUMINANT RES, V180, P106, DOI 10.1016/j.smallrumres.2019.07.013; Nicholas RAJ, 2008, SMALL RUMINANT RES, V76, P92, DOI 10.1016/j.smallrumres.2007.12.014; Rebelo AR, 2011, J VET DIAGN INVEST, V23, P932, DOI 10.1177/1040638711416846; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROBINSON RA, 1983, VET CLIN N AM-LARGE, V5, P539; Taylor JD, 2010, CAN VET J, V51, P1095; Wang JF, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02387-3; Whitford H. W., 1994, P12; Yang FL, 2014, J VET MED SCI, V76, P1631, DOI 10.1292/jvms.14-0094; Yang Y, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0792-7; Yang Y, 2016, VIRUS GENES, V52, P883, DOI 10.1007/s11262-016-1378-y; Zhang J, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2601-5	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246573	10.1371/journal.pone.0246573	http://dx.doi.org/10.1371/journal.pone.0246573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539437	Green Published, gold			2022-12-26	WOS:000616960200067
J	Nalam, VJ; Han, JL; Pitt, WJ; Acharya, SR; Nachappa, P				Nalam, Vamsi J.; Han, Jinlong; Pitt, William Jacob; Acharya, Shailesh Raj; Nachappa, Punya			Location, location, location: Feeding site affects aphid performance by altering access and quality of nutrients	PLOS ONE			English	Article							POPULICOLA THOMAS HOMOPTERA; WITHIN-PLANT DISTRIBUTION; SOYBEAN APHID; PHLOEM-SAP; NUTRITIONAL QUALITY; MYZUS-PERSICAE; HEMIPTERA; TRICHOMES; INFESTATION; MANAGEMENT	Aphid feeding behavior and performance on a given host plant are influenced by the plants' physical and chemical traits, including structural characters such as trichomes and nutritional composition. In this study, we determined the feeding behavior and performance of soybean aphids (Aphis glycines) on the stem, the adaxial (upper), and the abaxial (lower) leaf surfaces during early vegetative growth of soybean plants. Using the electrical penetration graph technique, we found that aphids feeding on the stem took the longest time to begin probing. Once aphids began probing, the sieve elements were more conducive to feeding, as evidenced by less salivation on the stem than either leaf surface. In whole-plant assays, stems harbored higher aphid populations, and aphids had shorter development time on stems than the adaxial and the abaxial leaf surfaces. We compared trichome density and length on the stem, the adaxial, and the abaxial leaf surfaces to investigate whether plant trichomes affected aphid feeding and performance. There were higher density and longer trichomes on stems, which likely resulted in aphids taking a longer time to probe. Still a negative impact on aphid population growth was not observed. Analysis of phloem sap composition revealed that vascular sap-enriched exudates from stems had higher sugars and amino acids than exudates from leaves. In artificial diet feeding assays, the population of aphids reared on a diet supplemented with stem exudates was higher than on a diet supplemented with leaf petiole exudates which is in agreement with results of the whole-plant assays. In summary, our findings suggest that the performance of soybean aphids on a specific plant location is primarily driven by accessibility and the quality of phloem composition rather than structural traits.	[Nalam, Vamsi J.; Pitt, William Jacob; Acharya, Shailesh Raj; Nachappa, Punya] Colorado State Univ, Dept Agr Biol, Ft Collins, CO 80523 USA; [Han, Jinlong] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA	Colorado State University; University of North Carolina; North Carolina State University	Nalam, VJ; Nachappa, P (corresponding author), Colorado State Univ, Dept Agr Biol, Ft Collins, CO 80523 USA.	vamsi.nalam@colostate.edu; punya.nachappa@colostate.edu		Nachappa, Punya/0000-0002-9673-9939	Office of the Vice President for Funding at Colorado State University; NIFAAFRI Seed Grant [2017-08469]	Office of the Vice President for Funding at Colorado State University; NIFAAFRI Seed Grant	This work was partially supported by the Office of the Vice President for Funding at Colorado State University to P.N and V.J.N, and by NIFAAFRI Seed Grant 2017-08469 to V.J.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberet RC, 2009, ENVIRON ENTOMOL, V38, P1765, DOI 10.1603/022.038.0630; Cole RA, 1997, ENTOMOL EXP APPL, V85, P121, DOI 10.1023/A:1003049105464; COLEMAN JS, 1988, ENVIRON ENTOMOL, V17, P207, DOI 10.1093/ee/17.2.207; Costamagna AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056394; Costamagna AC, 2011, BIOL CONTROL, V57, P184, DOI 10.1016/j.biocontrol.2011.03.006; Dai HJ, 2010, INSECT SCI, V17, P406, DOI 10.1111/j.1744-7917.2009.01305.x; De Clercq P, 2000, BIOL CONTROL, V18, P65, DOI 10.1006/bcon.1999.0808; Dixon A.F.G., 2012, APHID ECOLOGY OPTIMI; DIXON AFG, 1976, ECOL ENTOMOL, V1, P275, DOI 10.1111/j.1365-2311.1976.tb01232.x; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Ebert TA, 2018, J INSECT BEHAV, V31, P119, DOI 10.1007/s10905-018-9666-0; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Goodspeed D, 2012, P NATL ACAD SCI USA, V109, P4674, DOI 10.1073/pnas.1116368109; Gould GG, 2007, ENVIRON ENTOMOL, V36, P1212, DOI 10.1603/0046-225X(2007)36[1212:VIECPD]2.0.CO;2; HARRINGTON R, 1990, J ANIM ECOL, V59, P1177, DOI 10.2307/5039; Jakobs R, 2019, NEW PHYTOL, V221, P503, DOI 10.1111/nph.15335; Jander G, 2012, P NATL ACAD SCI USA, V109, P4343, DOI 10.1073/pnas.1201443109; Karley AJ, 2002, J EXP BIOL, V205, P3009; KHAN ZR, 1986, ENTOMOL EXP APPL, V42, P109, DOI 10.1007/BF00343536; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Krupke CH, 2017, PEST MANAG SCI, V73, P2184, DOI 10.1002/ps.4602; Legrand A, 2000, ENVIRON ENTOMOL, V29, P987, DOI 10.1603/0046-225X-29.5.987; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Li Y, 2004, J ECON ENTOMOL, V97, P1106, DOI 10.1603/0022-0493(2004)097[1106:EOTRSG]2.0.CO;2; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McCornack BP, 2008, J ECON ENTOMOL, V101, P1488, DOI 10.1603/0022-0493(2008)101[1488:WDOSAH]2.0.CO;2; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Montllor C.B., 1991, P125; Nachappa P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00552; Nalam V, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2950; Noma T, 2010, ENVIRON ENTOMOL, V39, P31, DOI 10.1603/EN09073; Norris D.M., 1980, BREEDING PLANTS INSE, P23; Panda Niranjan, 1995; Pompon J, 2011, J INSECT PHYSIOL, V57, P1317, DOI 10.1016/j.jinsphys.2011.06.007; Pompon J, 2010, J INSECT PHYSIOL, V56, P610, DOI 10.1016/j.jinsphys.2009.12.009; Prado E, 1997, ENTOMOL EXP APPL, V82, P189, DOI 10.1023/A:1002952806375; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Pritchard SR, 2017, THESIS; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rhainds M, 2010, ENVIRON ENTOMOL, V39, P484, DOI 10.1603/EN09034; Rhoades D. F., 1979, HERBIVORES THEIR INT, P3; Risebrow A, 1987, NUTR ECOLOGY INSECTS, P422; Ritchie S.W., 1985, 53 IOW STAT U SCI TE; Rutledge CE, 2006, J ECON ENTOMOL, V99, P60, DOI 10.1603/0022-0493(2006)099[0060:SPSAPG]2.0.CO;2; Salvador-Recatala V, 2015, JOVE-J VIS EXP, DOI 10.3791/52826; SOROKA JJ, 1991, J ECON ENTOMOL, V84, P1951, DOI 10.1093/jee/84.6.1951; Styrsky JD, 2006, BIOL CONTROL, V36, P375, DOI 10.1016/j.biocontrol.2005.10.003; Tilmon KJ, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10016; Tjallingii W.F., 1988, P95; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; TJALLINGII WF, 1995, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 6, 1995, P163; Walsh SC, 2020, MOL REPROD DEV, V87, P174, DOI 10.1002/mrd.23306; Walter AJ, 2007, ENVIRON ENTOMOL, V36, P26, DOI 10.1603/0046-225X(2007)36[26:SPDASP]2.0.CO;2; Wille BD, 2008, J ECON ENTOMOL, V101, P1228, DOI 10.1603/0022-0493(2008)101[1228:EOADFR]2.0.CO;2	56	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245380	10.1371/journal.pone.0245380	http://dx.doi.org/10.1371/journal.pone.0245380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539358	Green Published, Green Submitted, gold			2022-12-26	WOS:000616960200044
J	Suwabe, Y; Nakano, R; Namba, S; Yachiku, N; Kuji, M; Sugimura, M; Kitanaka, N; Kitanaka, T; Konno, T; Sugiya, H; Nakayama, T				Suwabe, Yoko; Nakano, Rei; Namba, Shinichi; Yachiku, Naoya; Kuji, Manami; Sugimura, Mana; Kitanaka, Nanako; Kitanaka, Taku; Konno, Tadayoshi; Sugiya, Hiroshi; Nakayama, Tomohiro			Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER 3; NEURON-LIKE CELLS; MALIGNANT-MELANOMA; CANCER-CELLS; EXPRESSION; 2-DEOXY-D-GLUCOSE; INHIBITION; HEXOKINASE; GLYCOLYSIS; PROTEIN	The rate of glucose uptake dramatically increases in cancer cells even in the presence of oxygen and fully functioning mitochondria. Cancer cells produce ATP by glycolysis rather than oxidative phosphorylation under aerobic conditions, a process termed as the "Warburg effect." In the present study, we treated canine melanoma cells with the glucose analog 2-deoxy-D-glucose (2-DG) and investigated its effect on cell growth. 2-DG attenuated cell growth in a time- and dose-dependent manner. Cell growth was also inhibited following treatment with the glucose transporter (GLUT) inhibitor WZB-117. The treatment of 2-DG and WZB-117 attenuated the glucose consumption, lactate secretion and glucose uptake of the cells. The mRNA expression of the subtypes of GLUT was examined and GLUT1 and GLUT3 were found to be expressed in melanoma cells. The growth, glucose consumption and lactate secretion of melanoma cells transfected with siRNAs of specific for GLUT1 and GLUT3 was suppressed. These findings suggest that glucose uptake via GLUT1 and GLUT3 plays a crucial role for the growth of canine melanoma cells.	[Suwabe, Yoko; Nakano, Rei; Namba, Shinichi; Yachiku, Naoya; Kuji, Manami; Sugimura, Mana; Kitanaka, Nanako; Kitanaka, Taku; Nakayama, Tomohiro] Nihon Univ, Coll Bioresource Sci, Labs Vet Radiotherapy, Fujisawa, Kanagawa, Japan; [Nakano, Rei] RIKEN, Lab Cellular Funct Convers Technol, Ctr Integrat Med Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa, Japan; [Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Labs Vet Biochem, Fujisawa, Kanagawa, Japan	Nihon University; RIKEN; Nihon University	Nakayama, T (corresponding author), Nihon Univ, Coll Bioresource Sci, Labs Vet Radiotherapy, Fujisawa, Kanagawa, Japan.	nakayama.tomohiro80@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022	Namba, Shinichi/0000-0002-9182-3656	Ministry of Education, Science, Sports, and Culture of Japan [18K14594, 19K06389]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (grant no. 18K14594; R.N., grant no.; 19K06389; T.N.) from the Ministry of Education, Science, Sports, and Culture of Japan (https://www.jsps.go.jp/jgrantsinaid/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Ancey PB, 2018, FEBS J, V285, P2926, DOI 10.1111/febs.14577; Atherton MJ, 2016, VET IMMUNOL IMMUNOP, V169, P15, DOI 10.1016/j.vetimm.2015.11.003; Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; BELL GI, 1993, J BIOL CHEM, V268, P19161; Bergman PJ, 2007, CLIN TECH SMALL AN P, V22, P55, DOI 10.1053/j.ctsap.2007.03.004; BERTONI JM, 1981, J NEUROCHEM, V37, P1523, DOI 10.1111/j.1471-4159.1981.tb06322.x; Calvo MB, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/205357; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN W, 1992, BIOCHIMIE, V74, P867, DOI 10.1016/0300-9084(92)90070-U; Chen X, 2017, ONCOTARGET, V8, P13206, DOI 10.18632/oncotarget.14570; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; CRAIK JD, 1995, THROMB RES, V79, P461, DOI 10.1016/0049-3848(95)00136-F; Dura M, 2019, PATHOL ONCOL RES, V25, P361, DOI 10.1007/s12253-017-0363-7; Endo Y, 2019, TISSUE CELL, V61, P67, DOI 10.1016/j.tice.2019.09.003; Giammarioli AM, 2012, INT J CANCER, V131, pE337, DOI 10.1002/ijc.26420; Grover-McKay M, 1999, BBA-BIOMEMBRANES, V1416, P145, DOI 10.1016/S0005-2736(98)00216-8; HATANAKA M, 1974, BIOCHIM BIOPHYS ACTA, V355, P77, DOI 10.1016/0304-419X(74)90008-0; Hernandez B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020394; Inoue K, 2004, J VET MED SCI, V66, P1437, DOI 10.1292/jvms.66.1437; Jozwiak P, 2012, MOL MED REP, V6, P601, DOI 10.3892/mmr.2012.969; Kitanaka N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222869; Kitanaka N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220262; Kitanaka N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208955; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Koch A, 2015, ONCOTARGET, V6, P32748, DOI 10.18632/oncotarget.4977; Konno T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166707; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krzeslak A, 2012, PATHOL ONCOL RES, V18, P721, DOI 10.1007/s12253-012-9500-5; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Long WT, 2015, CELL HEALTH CYTOSKEL, V7, P167, DOI 10.2147/CHC.S60484; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nakano R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229892; Nakano R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26473-7; Nakano R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141581; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Nakano R, 2013, AM J VET RES, V74, P1311, DOI 10.2460/ajvr.74.10.1311; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; Parente P, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-34; Park SG, 2012, NUCL MED BIOL, V39, P1167, DOI 10.1016/j.nucmedbio.2012.07.003; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Ruby KN, 2019, MELANOMA RES, V29, P603, DOI 10.1097/CMR.0000000000000626; Shimanishi M, 2013, J ORAL PATHOL MED, V42, P382, DOI 10.1111/jop.12028; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Starska K, 2015, TUMOR BIOL, V36, P2309, DOI 10.1007/s13277-014-2838-4; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; WICK AN, 1957, J BIOL CHEM, V224, P963; YAMAMOTO T, 1990, BIOCHEM BIOPH RES CO, V170, P223, DOI 10.1016/0006-291X(90)91263-R; Yan SF, 2016, ANTICANCER RES, V36, P2871; Yoshitake R, 2017, VET J, V221, P38, DOI 10.1016/j.tvjl.2017.02.001; Younes M, 1996, CANCER RES, V56, P1164; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zhuang Y, 2018, ARCH IRAN MED, V21, P73	62	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0243859	10.1371/journal.pone.0243859	http://dx.doi.org/10.1371/journal.pone.0243859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539362	gold, Green Published			2022-12-26	WOS:000616960200078
J	Tan, Y; Li, QL; Zhao, Y; Wei, HR; Wang, JW; Baker, CJ; Liu, QZ; Wei, W				Tan, Yue; Li, Qingliang; Zhao, Yan; Wei, Hairong; Wang, Jiawei; Baker, Con Jacyn; Liu, Qingzhong; Wei, Wei			Integration of metabolomics and existing omics data reveals new insights into phytoplasma-induced metabolic reprogramming in host plants	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CHERRY VIRESCENCE DISEASE; SWEET CHERRY; TRANSCRIPTOME ANALYSIS; ARABIDOPSIS-THALIANA; PROTEOMIC ANALYSIS; INSECT VECTORS; JASMONIC ACID; INFECTION; BIOSYNTHESIS	Phytoplasmas are cell wall-less bacteria that induce abnormal plant growth and various diseases, causing severe economic loss. Phytoplasmas are highly dependent on nutrients imported from host cells because they have lost many genes involved in essential metabolic pathways during reductive evolution. However, metabolic crosstalk between phytoplasmas and host plants and the mechanisms of phytoplasma nutrient acquisition remain poorly understood. In this study, using metabolomics approach, sweet cherry virescence (SCV) phytoplasma-induced metabolite alterations in sweet cherry trees were investigated. A total of 676 metabolites were identified in SCV phytoplasma-infected and mock inoculated leaves, of which 187 metabolites were differentially expressed, with an overwhelming majority belonging to carbohydrates, fatty acids/lipids, amino acids, and flavonoids. Available omics data of interactions between plant and phytoplasma were also deciphered and integrated into the present study. The results demonstrated that phytoplasma infection promoted glycolysis and pentose phosphate pathway activities, which provide energy and nutrients, and facilitate biosynthesis of necessary low-molecular metabolites. Our findings indicated that phytoplasma can induce reprograming of plant metabolism to obtain nutrients for its own replication and infection. The findings from this study provide new insight into interactions of host plants and phytoplasmas from a nutrient acquisition perspective.	[Tan, Yue; Wei, Hairong; Wang, Jiawei; Liu, Qingzhong] Shandong Inst Pomol, Tai An, Shandong, Peoples R China; [Li, Qingliang] Zaozhuang Univ, Coll Life Sci, Zaozhuang, Peoples R China; [Zhao, Yan; Baker, Con Jacyn; Wei, Wei] ARS, USDA, Mol Plant Pathol Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	Zaozhuang University; United States Department of Agriculture (USDA)	Liu, QZ (corresponding author), Shandong Inst Pomol, Tai An, Shandong, Peoples R China.; Wei, W (corresponding author), ARS, USDA, Mol Plant Pathol Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA.	qzliu001@126.com; wei.wei@usda.gov		WEI, WEI/0000-0003-3561-913X	Shandong Provincial Natural Science Foundation, China [ZR2018BC039]; Special Found for Fruit Innovation Team of Shandong Modern Agricultural Technology System [SDAIT-06-04]; US Department of Agriculture, Agricultural Research Service [8042-22000-306-00D]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Special Found for Fruit Innovation Team of Shandong Modern Agricultural Technology System; US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by Shandong Provincial Natural Science Foundation, China (ZR2018BC039) and Special Found for Fruit Innovation Team of Shandong Modern Agricultural Technology System (SDAIT-06-04), and the US Department of Agriculture, Agricultural Research Service (Project number 8042-22000-306-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; [Anonymous], LIPIDWEB, DOI DOI 10.1167/iovs.12-9724; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Barroso JB, 1999, J BIOL CHEM, V274, P36729, DOI 10.1074/jbc.274.51.36729; Bertaccini A., 2014, AM J PLANT SCI, DOI [10.4236/ajps.2014.53037, DOI 10.4236/AJPS.2014.53037]; Bizarro CV, 2007, GENET MOL BIOL, V30, P190, DOI 10.1590/S1415-47572007000200005; Cambiaghi A, 2017, BRIEF BIOINFORM, V18, P498, DOI 10.1093/bib/bbw031; CAMM EL, 1973, PHYTOCHEMISTRY, V12, P961, DOI 10.1016/0031-9422(73)85001-0; Cao H, 2019, METABOLITES, V9, DOI 10.3390/metabo9100215; Cao XB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00342; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; CONDREA E, 1980, EXPERIENTIA, V36, P531, DOI 10.1007/BF01965781; Corpas FJ, 2009, NEW PHYTOL, V184, P9, DOI 10.1111/j.1469-8137.2009.02989.x; Avila AC, 2019, PHYSIOL MOL PLANT P, V106, P129, DOI 10.1016/j.pmpp.2019.01.002; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dermastia M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00477; Ding F, 2016, SCI REP-UK, V6, DOI 10.1038/srep32741; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Fan GQ, 2015, GENES GENOM, V37, P913, DOI 10.1007/s13258-015-0321-2; Fan GQ, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1948-y; Fan XP, 2017, SCI HORTIC-AMSTERDAM, V226, P50, DOI 10.1016/j.scienta.2017.08.026; Feng SB, 2007, J AGR FOOD CHEM, V55, P8589, DOI 10.1021/jf0716735; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Gai YP, 2014, PLANT CELL ENVIRON, V37, P1474, DOI 10.1111/pce.12255; Gao R, 2011, J PLANT PATHOL, V93, P465; Gedvilaite A, 2014, MICROBIOL RES, V169, P388, DOI 10.1016/j.micres.2013.08.007; Harwood J. L., 1980, 1 PLANT ACYL LIPIDS, P1; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Isner JC, 2012, J EXP BOT, V63, P3199, DOI 10.1093/jxb/ers045; Isner JC, 2018, FUNCT PLANT BIOL, V45, P93, DOI [10.1071/FP16337, 10.1071/fp16337]; Ji XL, 2009, PROTEOMICS, V9, P5328, DOI 10.1002/pmic.200900012; Jiang Hua, 2004, Journal of General Plant Pathology, V70, P168, DOI 10.1007/s10327-004-0103-1; Junqueira A, 2004, PHYSIOL MOL PLANT P, V65, P181, DOI 10.1016/j.pmpp.2005.01.005; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kong XM, 2018, PLANT CELL PHYSIOL, V59, P167, DOI 10.1093/pcp/pcx171; Kube M, 2012, SCI WORLD J, DOI 10.1100/2012/185942; Lepka P, 1999, PHYSIOL MOL PLANT P, V55, P59, DOI 10.1006/pmpp.1999.0202; Luge T, 2014, PROTEOMICS, V14, P1882, DOI 10.1002/pmic.201300551; Mardi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130425; Margaria P, 2014, PLANT CELL ENVIRON, V37, P2183, DOI 10.1111/pce.12332; Margaria P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-38; Margaria P, 2011, PROTEOMICS, V11, P212, DOI 10.1002/pmic.201000409; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Maust BE, 2003, PHYTOPATHOLOGY, V93, P976, DOI 10.1094/PHYTO.2003.93.8.976; Meier S, 2009, PLANT SIGNAL BEHAV, V4, P307, DOI 10.4161/psb.4.4.8066; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; Michaud M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00002; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Mou HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077217; MUNDER PG, 1979, SPRINGER SEMIN IMMUN, V2, P187, DOI 10.1007/BF01891668; Mur LAJ, 2005, PLANT PHYSIOL, V138, P1247, DOI 10.1104/pp.104.055772; Nejat N, 2015, MOL GENET GENOMICS, V290, P1899, DOI 10.1007/s00438-015-1046-2; Nishiguchi S, 2018, J PESTIC SCI, V43, P191, DOI 10.1584/jpestics.D18-022; OKITA TW, 1980, PLANT PHYSIOL, V66, P870, DOI 10.1104/pp.66.5.870; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Oshima K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00230; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; Prats E, 2005, MOL PLANT PATHOL, V6, P65, DOI 10.1111/j.1364-3703.2004.00266.x; Prezelj N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00711; PRIETO JA, 1992, J AM OIL CHEM SOC, V69, P1019, DOI 10.1007/BF02541069; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Silva Z, 2005, J BACTERIOL, V187, P1210, DOI 10.1128/JB.187.4.1210-1218.2005; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Taheri F, 2011, MOL BIOSYST, V7, P3028, DOI 10.1039/c1mb05268c; Tan Y, 2019, ANN APPL BIOL, V175, P69, DOI 10.1111/aab.12511; Tan Y, 2015, PHYSIOL MOL PLANT P, V92, P22, DOI 10.1016/j.pmpp.2015.08.012; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Tony Swain, 1979, PHENOLICS ENV BIOCH, P617; Tsikas D, 2015, AMINO ACIDS, V47, P1697, DOI 10.1007/s00726-015-2055-5; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang HY, 2018, GENE, V665, P82, DOI 10.1016/j.gene.2018.04.070; Wang JW, 2014, PLANT DIS, V98, P419, DOI 10.1094/PDIS-07-13-0787-PDN; Wang JW, 2018, CROP PROT, V106, P13, DOI 10.1016/j.cropro.2017.12.005; Wang J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5075-1; Wang SC, 2016, FOOD CHEM, V199, P8, DOI 10.1016/j.foodchem.2015.11.113; Wang Z, 2017, PEERJ, V5, DOI 10.7717/peerj.3495; Wei W, 2013, P NATL ACAD SCI USA, V110, P19149, DOI 10.1073/pnas.1318489110; Wei Z, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/6542075; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Wu YF, 2010, PLANT DIS, V94, P977, DOI 10.1094/PDIS-94-8-0977; Xue CL, 2018, PHYTOPATHOLOGY, V108, P1067, DOI 10.1094/PHYTO-02-18-0058-R; Yang M, 2019, PLANT SCI, V289, DOI 10.1016/j.plantsci.2019.110282; Ye X, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.80; Yuan DJ, 2016, PROG LIPID RES, V64, P85, DOI 10.1016/j.plipres.2016.08.004; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang SS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1395480; Zhao YC, 2013, PLANT PHYSIOL, V163, P555, DOI 10.1104/pp.112.213371; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	93	6	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246203	10.1371/journal.pone.0246203	http://dx.doi.org/10.1371/journal.pone.0246203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539421	Green Published, gold			2022-12-26	WOS:000616960200115
J	Vazquez-Cancela, O; Souto-Lopez, L; Vazquez-Lago, JM; Lopez, A; Figueiras, A				Vazquez-Cancela, Olalla; Souto-Lopez, Laura; Vazquez-Lago, Juan M.; Lopez, Ana; Figueiras, Adolfo			Factors determining antibiotic use in the general population: A qualitative study in Spain	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ATTITUDES; BELIEFS; PERSPECTIVES; PERCEPTIONS; KNOWLEDGE; RISK	Background Antibiotic resistance is an important Public Health problem and many studies link it to antibiotic misuse. The population plays a key role in such misuse. Objective The aim of this study was thus to explore the factors that might influence antibiotic use and resistance in the general population. Methods Qualitative research using the focus group (FG) method. Groups were formed by reference to the following criteria: age (over and under 65 years); place of origin; and educational/professional qualifications. FG sessions were recorded, transcribed and then separately analysed by two researchers working independently. Written informed consent was obtained from all participants. Results Eleven FGs were formed with a total of 75 participants. The principal factors identified as possible determinants of antibiotic misuse were: (i) lack of knowledge about antibiotics; (ii) doctor-patient relationship problems; (iii) problems of adherence; and, (iv) use without medical prescription. Antibiotic resistance is a phenomenon unknown to the population and is perceived as an individual problem, with the term "resistance" being confused with "tolerance". None of the groups reported that information about resistance had been disseminated by the health care sector. Conclusions The public is unaware of the important role it plays in the advance of antimicrobial resistance. There is evidence of diverse factors, many of them modifiable, which might account for antibiotic misuse. Better understanding these factors could be useful in drawing up specific strategies aimed at improving antibiotic use.	[Vazquez-Cancela, Olalla; Souto-Lopez, Laura; Vazquez-Lago, Juan M.; Figueiras, Adolfo] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, La Coruna, Corunna, Spain; [Vazquez-Cancela, Olalla; Vazquez-Lago, Juan M.] Univ Hosp Santiago de Compostela, La Coruna, Corunna, Spain; [Vazquez-Lago, Juan M.; Figueiras, Adolfo] Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Lopez, Ana] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, A Coruna, Spain; [Figueiras, Adolfo] CIBER Epidemiol & Salud Publ CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Vazquez-Lago, JM (corresponding author), Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, La Coruna, Corunna, Spain.; Vazquez-Lago, JM (corresponding author), Univ Hosp Santiago de Compostela, La Coruna, Corunna, Spain.; Vazquez-Lago, JM (corresponding author), Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain.	juan.manuel.vanmez.lago@sergas.es	Vazquez-Lago, Juan/M-2632-2016; Figueiras Guzman, Adolfo/K-8563-2015	Vazquez-Lago, Juan/0000-0003-3457-9957; vazquez, olalla/0000-0001-5306-9587; Figueiras Guzman, Adolfo/0000-0002-5766-8672	Instituto de Salud Carlos III Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016, The European Regional Development Fund (ERDF) [PI081239, PI09/90609]	Instituto de Salud Carlos III Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016, The European Regional Development Fund (ERDF)	This work was supported in part by the Instituto de Salud Carlos III (PI081239, PI09/90609) Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016, The European Regional Development Fund (ERDF). https://www.isciii.es/QueHacemos/Financiacion/Paginas/default.aspx.	[Anonymous], 2016, RAP RISK ASS CARB RE; [Anonymous], 2017, EU REP MOR EV LINK A; Brookes-Howell L, 2012, J GEN INTERN MED, V27, P766, DOI 10.1007/s11606-011-1916-1; Brooks L, 2008, FAM PRACT, V25, P341, DOI 10.1093/fampra/cmn037; Campos Jose, 2010, Enferm Infecc Microbiol Clin, V28 Suppl 4, P50, DOI 10.1016/S0213-005X(10)70044-6; CDC, 2013, ANTIBIOTIC RESISTANC; Chandy Sujith J, 2013, Indian J Med Ethics, V10, P20; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; DXSP-Direccion Xeral de Saude Publica, 2016, B EPIDEMIOLOXICO GAL, VXXVIII, P11; Gonzalez-del Castillo J, 2017, ENFERM INFEC MICR CL, V35, P208, DOI [10.1016/j.eimc.2015.10.005, 10.1016/j.eimce.2017.03.004]; Gonzalez-Gonzalez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141820; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hawkings NJ, 2007, J ANTIMICROB CHEMOTH, V59, P1155, DOI 10.1093/jac/dkm103; Jin CG, 2011, HEALTH RISK SOC, V13, P433, DOI 10.1080/13698575.2011.596188; Kandeel A, 2014, ANTIBIOTICS-BASEL, V3, P632, DOI 10.3390/antibiotics3040632; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Lado E, 2008, J EVAL CLIN PRACT, V14, P453, DOI 10.1111/j.1365-2753.2007.00901.x; Larson EL, 2006, NURS RES, V55, P94, DOI 10.1097/00006199-200603000-00004; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; March Cerda J C, 1999, Gac Sanit, V13, P312; McCullough AR, 2016, J ANTIMICROB CHEMOTH, V71, P27, DOI 10.1093/jac/dkv310; Norris P, 2013, ANTIBIOTICS-BASEL, V2, P465, DOI 10.3390/antibiotics2040465; Prieto Rodriguez M A, 2002, Aten Primaria, V29, P366; Public Health England, 2014, ENGL SURV PROGR ANT; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Roque F, 2013, INT J CLIN PHARM-NET, V35, P417, DOI 10.1007/s11096-013-9753-4; Roura DA, 2014, FMC FORMACION MED CO, V21, P538; Sahoo KC, 2014, HEALTH EXPECT, V17, P651, DOI 10.1111/j.1369-7625.2012.00789.x; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Solis-Ovando F, 2017, ENFERM INFEC MICR CL, V35, P396, DOI [10.1016/j.eimce.2016.07.002, 10.1016/j.eimc.2016.07.009]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vazquez-Lago J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015674; Vazquez-Lago JM, 2012, FAM PRACT, V29, P352, DOI 10.1093/fampra/cmr084; Wun YT, 2013, PHARMACOEPIDEM DR S, V22, P241, DOI 10.1002/pds.3339; Zapata-Cachafeiro M, 2014, J ANTIMICROB CHEMOTH, V69, P3156, DOI 10.1093/jac/dku229	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246506	10.1371/journal.pone.0246506	http://dx.doi.org/10.1371/journal.pone.0246506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539449	Green Published, gold			2022-12-26	WOS:000616960200084
J	Diamond, A; Lye, CT; Prasad, D; Abbott, D				Diamond, Adele; Lye, Carolyn T.; Prasad, Deepali; Abbott, David			One size does not fit all: Assuming the same normal body temperature for everyone is not justified	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SLEEP; OLDER; COLDER; MEN; PERFORMANCE; ONSET; WOMEN; SITE	Despite the increasing personalization of medicine, surprisingly similar to 37.0 degrees C (98.6 degrees F) continues as the estimate of normal temperature. We investigated between-subject and within-subject thermal variability, whether a significant percentage of individuals have a low mean oral temperature, and whether these differ by sex, age, time of day, ethnicity, body mass index (BMI), or menstrual phase. Oral temperature was measured by Life Brand(R) Fast-Read Digital Oral Thermometers and sampled 14 times over two weeks, seven morning and seven evening readings. The volunteer sample consisted of 96 adults (42 men, 54 women; 27 couples, 42 singletons), ages 18-67 years. We found sizeable individual differences in body temperature and that the normal temperature of many individuals is considerably lower than 37.0 degrees C (98.6 degrees F). Mean temperatures ranged from 35.2 degrees C (95.4 degrees F) to 37.4 degrees C (99.3 degrees F). The mean temperature across all participants was 36.1 degrees C (97.0 degrees F)-lower than most studies have reported, consistent with recent evidence of temperature declining over decades. 77% had mean temperatures at least 0.55 degrees C (1 degrees F) lower than 37.0 degrees C (98.6 degrees F). Mean temperature did not differ by age, but women had higher temperatures than men, even within a couple with room temperature and warmth of clothing equated. Although oral temperature varied widely across individuals, it showed marked stability within individuals over days. Variability of temperature over days did not differ by sex, but was larger among younger adults. Using 37.0 degrees C (98.6 degrees F) as the assumed normal temperature for everyone can result in healthcare professionals failing to detect a serious fever in individuals with a low normal temperature or obtaining false negatives for those individuals when using temperature to screen for COVID-19, mistaking their elevated temperature as normal. Some have called for lowering the estimate of normal temperature slightly (e.g., 0.2 degrees C [0.36 degrees F]). That still seems an overly high estimate. More important, using any standardized "normal" temperature will lead to errors for many people. Individual differences are simply too great. Personalizing body temperature is needed. Temperature could be measured at yearly doctor visits, as blood pressure is now. That would be simple to implement. Since our results show marked thermal stability within an individual, sampling temperature only once yearly could provide an accurate indication of a person's normal temperature at that time of day. Such records over time would also provide a more accurate understanding of how temperature changes over the lifespan.	[Diamond, Adele; Abbott, David] Univ British Columbia, Dept Psychiat, Dev Cognit Neurosci Program, Vancouver, BC, Canada; [Lye, Carolyn T.] Sentinel Secondary, W Vancouver, BC, Canada; [Prasad, Deepali] Crofton House, Vancouver, BC, Canada; [Lye, Carolyn T.] Yale Univ, Med & Law, New Haven, CT USA; [Prasad, Deepali] Univ British Columbia, Chem & Biol Engn, Vancouver, BC, Canada	University of British Columbia; Yale University; University of British Columbia	Diamond, A (corresponding author), Univ British Columbia, Dept Psychiat, Dev Cognit Neurosci Program, Vancouver, BC, Canada.	adele.diamond@ubc.ca		Diamond, Adele/0000-0002-1453-6434	Canada Research Chair award (CRC) [950-27472]; Canada Foundation for Innovation (CFI) [202163]	Canada Research Chair award (CRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	AD gratefully acknowledges financial support from a Canada Research Chair award (CRC #950-27472) and a grant from the Canada Foundation for Innovation (CFI #202163). URLs are: https://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx and https://www.innovation.ca/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM JM, 1954, J PHYSIOL-LONDON, V125, pP21; Adhi Mehreen, 2008, J Pak Med Assoc, V58, P580; ATKINSON G, 1993, ERGONOMICS, V36, P273, DOI 10.1080/00140139308967882; Baker FC, 2001, J PHYSIOL-LONDON, V530, P565, DOI 10.1111/j.1469-7793.2001.0565k.x; BARRETT J, 1993, SLEEP, V16, P93; Cagnacci A, 1997, FERTIL STERIL, V68, P421, DOI 10.1016/S0015-0282(97)00242-2; CAMPBELL SS, 1994, CHRONOBIOL INT, V11, P126, DOI 10.3109/07420529409055899; EDELSBERG JS, 1993, JAMA-J AM MED ASSOC, V269, P1250, DOI 10.1001/jama.1993.03500100047014; ERIKSSON H, 1985, ACTA MED SCAND, V217, P347; Geneva II, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz032; Gomolin IH, 2005, J AM GERIATR SOC, V53, P2170, DOI 10.1111/j.1532-5415.2005.00500.x; Gomolin IH, 2007, J AM MED DIR ASSOC, V8, P335, DOI 10.1016/j.jamda.2007.04.005; KEILSON L, 1985, JAMA-J AM MED ASSOC, V254, P1781, DOI 10.1001/jama.254.13.1781; Kelly G, 2006, ALTERN MED REV, V11, P278; Krauchi K, 1999, NATURE, V401, P36, DOI 10.1038/43366; Lu SH, 2010, J CLIN NURS, V19, P4, DOI 10.1111/j.1365-2702.2009.02945.x; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; MACKOWIAK PA, 1994, CLIN INFECT DIS, V18, P458, DOI 10.1093/clinids/18.3.458; MASON DJ, 1988, NURS RES, V37, P276; McGann K P, 1993, Arch Fam Med, V2, P1265, DOI 10.1001/archfami.2.12.1265; Moul DE, 2002, J BIOL RHYTHM, V17, P447, DOI 10.1177/074873002237139; Nakamura K, 1997, INT J BIOMETEOROL, V40, P103, DOI 10.1007/s004840050027; PRIMROSE W R, 1982, Journal of Clinical and Experimental Gerontology, V4, P151; Protsiv M, 2020, ELIFE, V9, DOI 10.7554/eLife.49555; Rabinowitz RP, 1996, ARCH INTERN MED, V156, P777, DOI 10.1001/archinte.156.7.777; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Szymusiak R, 2018, HAND CLINIC, V156, P341, DOI 10.1016/B978-0-444-63912-7.00020-5; Waalen J, 2011, J GERONTOL A-BIOL, V66, P487, DOI 10.1093/gerona/glr001; WEBB P, 1993, EUR J APPL PHYSIOL O, V66, P174, DOI 10.1007/BF01427059; Wright KP, 1999, BEHAV BRAIN RES, V103, P185, DOI 10.1016/S0166-4328(99)00042-X; Wunderlich C.A., 1869, AM J MED SCI, V57, P425, DOI DOI 10.1097/00000441-186904000-00021; Wunderlich CA, 1871, MED TTHERMOMETRY HUM; Wunderlich CA, 1868, VERHALTEN EIAENWARME	33	6	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245257	10.1371/journal.pone.0245257	http://dx.doi.org/10.1371/journal.pone.0245257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534845	Green Published, gold			2022-12-26	WOS:000616739700023
J	Nagano, T; Kakuma, T; Umezu, Y; Yanagawa, T				Nagano, Tomohiko; Kakuma, Tatsuyuki; Umezu, Yuichi; Yanagawa, Takashi			Nutritional status and activities of daily living in patients with Parkinson's disease	PLOS ONE			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; MALNUTRITION; RELIABILITY; STROKE	Patients with Parkinson's disease are often frail and likely to be malnourished. Several studies have reported the adverse effects of malnutrition on functional outcomes; however, the association between nutritional status and activities of daily living is unclear among patients with Parkinson's disease. This study aimed to investigate the relationship between nutritional status and activities of daily living in patients with Parkinson's disease. We conducted a retrospective cohort study with the data of 124 patients who were consecutively admitted to a rehabilitation hospital in Japan, among whom the data of 61 patients were included in the analyses. The Controlling Nutritional Status score was used to measure the nutritional status of the participants, and the motor subdomain of the Functional Independence Measure was used to assess the activities of daily living. Piecewise linear mixed-effects models were fitted to the data after adjusting for confounding factors. A poor nutritional status (i.e., Controlling Nutritional Status score >3) was significantly associated with a poor Functional Independence Measure gain, which was defined as difference in the score values of the Functional Independence Measures between discharge and admission. Our findings could aid in developing nutritional intervention programs for patients with Parkinson's disease by employing the Controlling Nutritional Status score to improve their activities of daily living.	[Nagano, Tomohiko; Umezu, Yuichi] Kokura Rehabil Hosp, Kitakyushu, Fukuoka, Japan; [Kakuma, Tatsuyuki; Yanagawa, Takashi] Kurume Univ, Biostat Ctr, Kurume, Fukuoka, Japan	Kurume University	Nagano, T (corresponding author), Kokura Rehabil Hosp, Kitakyushu, Fukuoka, Japan.	nagano838@gmail.com		Nagano, Tomohiko/0000-0001-6313-0097				Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028; Earley W, 2019, AM J PSYCHIAT, V176, P439, DOI 10.1176/appi.ajp.2018.18070824; Harimoto N, 2018, ANN SURG ONCOL, V25, P3316, DOI 10.1245/s10434-018-6672-6; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Kishimoto H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2655; Kokura Y, 2016, J STROKE CEREBROVASC, V25, P1335, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.048; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Kuroda D, 2018, GASTRIC CANCER, V21, P204, DOI 10.1007/s10120-017-0744-3; Lin TK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165727; Lombard K, 2014, J NUTR HEALTH AGING, V18, P649, DOI 10.1007/s12603-014-0490-8; Ma K, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00001; Narumi T, 2013, J CARDIOL, V62, P307, DOI 10.1016/j.jjcc.2013.05.007; Nishioka S, 2018, J ACAD NUTR DIET, V118, P1270, DOI 10.1016/j.jand.2018.02.012; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Shidfar Farzad, 2016, Med J Islam Repub Iran, V30, P454; Thomas DR, 2002, AM J CLIN NUTR, V75, P308, DOI 10.1093/ajcn/75.2.308; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; van der Marck MA, 2012, PARKINSONISM RELAT D, V18, P263, DOI 10.1016/j.parkreldis.2011.10.016; Visvanathan R, 2004, AGE AGEING, V33, P260, DOI 10.1093/ageing/afh078	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246329	10.1371/journal.pone.0246329	http://dx.doi.org/10.1371/journal.pone.0246329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529255	Green Published, gold			2022-12-26	WOS:000616736200059
J	Chinnarasu, S; Alogaili, F; Bove, KE; Jaeschke, A; Hui, DY				Chinnarasu, Sivaprakasam; Alogaili, Fawzi; Bove, Kevin E.; Jaeschke, Anja; Hui, David Y.			Hepatic LDL receptor-related protein-1 deficiency alters mitochondrial dynamics through phosphatidylinositol 4,5-bisphosphate reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; LRP1; CARDIOLIPIN; BIOSYNTHESIS; ADAPTER; LIPIDS	The LDL receptor-related protein 1 (LRP1) is a multifunctional transmembrane protein with endocytosis and signal transduction functions. Previous studies have shown that hepatic LRP1 deficiency exacerbates diet-induced steatohepatitis and insulin resistance via mechanisms related to increased lysosome and mitochondria permeability and dysfunction. The current study examined the impact of LRP1 deficiency on mitochondrial function in the liver. Hepatocytes isolated from liver-specific LRP1 knockout (hLrp1(-/-)) mice showed reduced oxygen consumption compared with control mouse hepatocytes. The mitochondria in hLrp1(-/-) mouse livers have an abnormal morphology and their membranes contain significantly less anionic phospholipids, including lower levels of phosphatidylethanolamine and cardiolipin that increase mitochondrial fission and impair fusion. Additional studies showed that LRP1 complexes with phosphatidylinositol 4-phosphate 5-kinase like protein-1 (PIP5KL1) and phosphatidylinositol 4-phosphate 5-kinase-1 beta (PIP5K1 beta). The absence of LRP1 reduces the levels of both PIP5KL1 and PIP5K1 beta in the plasma membrane and also lowers phosphatidylinositol(4,5) bisphosphate (PI(4,5)P-2) levels in hepatocytes. These data indicate that LRP1 recruits PIP5KL1 and PIP5K1 beta to the plasma membrane for PI(4,5)P-2 biosynthesis. The lack of LRP1 reduces lipid kinase expression, leading to lower PI(4,5)P-2 levels, thereby decreasing the availability of this lipid metabolite in the cardiolipin biosynthesis pathway to cause cardiolipin reduction and the impairment in mitochondria homeostasis. Taken together, the current study identifies another signaling mechanism by which LRP1 regulates cell functions: binding and recruitment of PIP5KL1 and PIP5K1 beta to the membrane for PI(4,5)P-2 synthesis. In addition, it highlights the importance of this mechanism for maintaining the integrity and functions of intracellular organelles.	[Chinnarasu, Sivaprakasam; Alogaili, Fawzi; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Metab Dis Res Ctr, Cincinnati, OH 45221 USA; [Bove, Kevin E.] Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Metab Dis Res Ctr, Cincinnati, OH 45221 USA.	huidy@ucmail.uc.edu		COJANDARAJ, Dr LOUIS/0000-0002-5264-6546	NIH [DK074932]; Higher Committee for Education Development in Iraq	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Committee for Education Development in Iraq	This study was supported by NIH grant DK074932 to D. Y. H. F. A. received scholarship support from the Higher Committee for Education Development in Iraq. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acoba MG, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202003131; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Alogaili F, 2020, J BIOL CHEM, V295, P4631, DOI 10.1074/jbc.RA119.012361; Au DT, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7902841; Ban T, 2018, BBA-BIOENERGETICS, V1859, P951, DOI 10.1016/j.bbabio.2018.05.016; Basford JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082026; Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Blunsom NJ, 2019, BBA-MOL CELL BIOL L, V1864, P1072, DOI 10.1016/j.bbalip.2019.03.002; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chang JD, 2004, J BIOL CHEM, V279, P11672, DOI 10.1074/jbc.M309721200; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Frohman MA, 2015, J MOL MED, V93, P263, DOI 10.1007/s00109-014-1237-z; Gaultier A, 2010, J PROTEOME RES, V9, P6689, DOI 10.1021/pr1008288; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hamlin AN, 2018, J BIOL CHEM, V293, P9674, DOI 10.1074/jbc.RA118.001952; Hamlin AN, 2016, J BIOL CHEM, V291, P16610, DOI 10.1074/jbc.M116.717744; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hollie NI, 2014, BBA-MOL CELL BIOL L, V1841, P888, DOI 10.1016/j.bbalip.2013.11.013; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; HOSTETLER KY, 1971, BIOCHIM BIOPHYS ACTA, V239, P113, DOI 10.1016/0005-2760(71)90201-3; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Konaniah ES, 2017, ARTERIOSCL THROM VAS, V37, P1046, DOI 10.1161/ATVBAHA.117.309414; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Luo L, 2018, CELL REP, V24, P3033, DOI 10.1016/j.celrep.2018.08.028; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Maxwell JT, 2018, JOVE-J VIS EXP, DOI 10.3791/57225; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Rosivatz E, 2011, CELL SIGNAL, V23, P478, DOI 10.1016/j.cellsig.2010.10.025; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Suski JM, 2014, NAT PROTOC, V9, P312, DOI 10.1038/nprot.2014.016; Tan XJ, 2015, J CELL SCI, V128, P4047, DOI 10.1242/jcs.175208; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Valencia CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156738; Van Gool B, 2019, MOL NEUROBIOL, V56, P7234, DOI 10.1007/s12035-019-1594-2; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Woldt E, 2011, J BIOL CHEM, V286, P16775, DOI 10.1074/jbc.M110.212878; Xian XD, 2017, ELIFE, V6, DOI 10.75549/eLife.29292; Xu FY, 1998, MOL CELL BIOCHEM, V188, P217, DOI 10.1023/A:1006815210718; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yang LY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0772-7	48	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100370	10.1016/j.jbc.2021.100370	http://dx.doi.org/10.1016/j.jbc.2021.100370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548224	gold, Green Published			2022-12-26	WOS:000672866400344
J	Kontou, G; Ng, SFJ; Cardarelli, RA; Howden, JH; Choi, C; Ren, Q; Santos, MAR; Bope, CE; Dengler, JS; Kelley, MR; Davies, PA; Kittler, JT; Brandon, NJ; Moss, SJ; Smalley, JL				Kontou, Georgina; Ng, Shu Fun Josephine; Cardarelli, Ross A.; Howden, Jack H.; Choi, Catherine; Ren, Qiu; Santos, Miguel A. Rodriguez; Bope, Christopher E.; Dengler, Jake S.; Kelley, Matt R.; Davies, Paul A.; Kittler, Josef T.; Brandon, Nicholas J.; Moss, Stephen J.; Smalley, Joshua L.			KCC2 is required for the survival of mature neurons but not for their development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE COTRANSPORTER KCC2; TNF-ALPHA; ACTIVATION; HYPEREXCITABILITY; DISRUPTION; EPILEPSY; FODRIN; INJURY; GLIA	The K+/Cl- cotransporter KCC2 (SLC12A5) allows mature neurons in the CNS to maintain low intracellular Cl- levels that are critical in mediating fast hyperpolarizing synaptic inhibition via type A gamma-aminobutyric acid receptors (GABA(A)Rs). In accordance with this, compromised KCC2 activity results in seizures, but whether such deficits directly contribute to the subsequent changes in neuronal structure and viability that lead to epileptogenesis remains to be assessed. Canonical hyperpolarizing GABA(A)R currents develop postnatally, which reflect a progressive increase in KCC2 expression levels and activity. To investigate the role that KCC2 plays in regulating neuronal viability and architecture, we have conditionally ablated KCC2 expression in developing and mature neurons. Decreasing KCC2 expression in mature neurons resulted in the rapid activation of the extrinsic apoptotic pathway. Intriguingly, direct pharmacological inhibition of KCC2 in mature neurons was sufficient to rapidly induce apoptosis, an effect that was not abrogated via blockade of neuronal depolarization using tetrodotoxin (TTX). In contrast, ablating KCC2 expression in immature neurons had no discernable effects on their subsequent development, arborization, or dendritic structure. However, removing KCC2 in immature neurons was sufficient to ablate the subsequent postnatal development of hyperpolarizing GABA(A)R currents. Collectively, our results demonstrate that KCC2 plays a critical role in neuronal survival by limiting apoptosis, and mature neurons are highly sensitive to the loss of KCC2 function. In contrast, KCC2 appears to play a minimal role in mediating neuronal development or architecture.	[Kontou, Georgina; Ng, Shu Fun Josephine; Cardarelli, Ross A.; Brandon, Nicholas J.; Moss, Stephen J.] Tufts Univ, AstraZeneca, Tufts Lab Basic & Translat Neurosci, Sch Med, Boston, MA 02155 USA; [Kontou, Georgina; Ng, Shu Fun Josephine; Cardarelli, Ross A.; Choi, Catherine; Ren, Qiu; Santos, Miguel A. Rodriguez; Bope, Christopher E.; Dengler, Jake S.; Kelley, Matt R.; Davies, Paul A.; Moss, Stephen J.; Smalley, Joshua L.] Tufts Univ, Dept Neurosci, Sch Med, Boston, MA 02155 USA; [Howden, Jack H.; Kittler, Josef T.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Brandon, Nicholas J.] AstraZeneca, Neurosci, IMED Biotech Unit, Boston, MA USA	AstraZeneca; Tufts University; Tufts University; University of London; University College London; AstraZeneca	Moss, SJ (corresponding author), Tufts Univ, AstraZeneca, Tufts Lab Basic & Translat Neurosci, Sch Med, Boston, MA 02155 USA.; Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Sch Med, Boston, MA 02155 USA.; Moss, SJ (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	Stephen.Moss@Tufts.edu	Ng, Shu Fun Josephine/AAH-4384-2021	Howden, Jack/0000-0001-9303-2076; Choi, Catherine/0000-0002-3215-9601; Smalley, Joshua/0000-0002-7437-6655; Ng, Shu Fun Josephine/0000-0003-4567-1409	National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke [NS051195, NS056359, NS081735, NS087662, NS108378, R21NS080064, R21NS111338, R21NS111064]; NIH, United Sates; National Institute of Mental Health [MH097446]; AstraZeneca Postdoctoral Program, United States; BBSRC [1775200] Funding Source: UKRI	National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, United Sates; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AstraZeneca Postdoctoral Program, United States(AstraZeneca); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke Grants NS051195 (S. J. M.), NS056359 (S. J. M.), NS081735 (S. J. M.), NS087662 (S. J. M.), NS108378 (S. J. M. and P. A. D.), R21NS080064 (S. J. M.), R21NS111338 (P. A. D.), R21NS111064 (P. A. D.); NIH, United Sates; National Institute of Mental Health Grant MH097446 (S. J. M. and P. A. D.). G. K. was a fellow of and funded by the AstraZeneca Postdoctoral Program, United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Awad PN, 2018, CEREB CORTEX, V28, P4049, DOI 10.1093/cercor/bhy198; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; Bengzon J, 2002, PROG BRAIN RES, V135, P111; Chen LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00196-7; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Fiumelli H, 2013, CEREB CORTEX, V23, P378, DOI 10.1093/cercor/bhs027; Friedel P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0354; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kelley MR, 2018, EBIOMEDICINE, V32, P62, DOI 10.1016/j.ebiom.2018.05.029; Kelley MR, 2016, NEUROPHARMACOLOGY, V108, P103, DOI 10.1016/j.neuropharm.2016.04.029; Lee REC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39519; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mavrovic M, 2020, EMBO REP, V21, DOI 10.15252/embr.201948880; Meller R, 2006, EPILEPSY RES, V70, P3, DOI 10.1016/j.eplepsyres.2006.02.002; Melon LC, 2018, PSYCHONEUROENDOCRINO, V90, P182, DOI 10.1016/j.psyneuen.2017.12.003; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Moore YE, 2018, P NATL ACAD SCI USA, V115, P10166, DOI 10.1073/pnas.1810134115; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Munoz A, 2007, EPILEPSIA, V48, P663, DOI 10.1111/j.1528-1167.2007.00986.x; NIXON RA, 1986, J NEUROSCI, V6, P1264; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pisella LI, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aay0300; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Saito T, 2017, CLIN GENET, V92, P654, DOI 10.1111/cge.13049; Saitsu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30072; Schiavon E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sedmak G, 2016, CEREB CORTEX, V26, P4574, DOI 10.1093/cercor/bhv218; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Smalley JL, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.563091; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Teocchi MA, 2016, MEDIAT INFLAMM, V2016, P1; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007	48	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100364	10.1016/j.jbc.2021.100364	http://dx.doi.org/10.1016/j.jbc.2021.100364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539918	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400338
J	Liu, K; Graves, JD; Lin, FT; Lin, WC				Liu, Kang; Graves, Joshua D.; Lin, Fang-Tsyr; Lin, Weei-Chin			Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; BINDING; P53; RECRUITMENT; MECHANISM; SITES; ETAA1	Topoisomerase II beta-binding protein 1 (TopBP1) is involved in cellular replication among other functions and is known to activate ATR/Chk1 during replicative stress. TopBP1 is also expressed at high levels in many cancers. However, the impact of TopBP1 overexpression on ATR/Chk1 activation and cancer development has not been investigated. Here we demonstrate that the degree of ATR/Chk1 activation is regulated by TopBP1 in a biphasic, concentration-dependent manner in a non-transformed MCF10A cell line and several cancer cell lines, including H1299, MDA-MB468, and U2OS. At low levels, TopBP1 activates ATR/Chk1, but once TopBP1 protein accumulates above an optimal level, it paradoxically leads to lower activation of ATR/Chk1. This is due to the perturbation of ATR-TopBP1 interaction and ATR chromatin loading by excessive TopBP1. Overexpression of TopBP1 thus hinders the ATR/Chk1 checkpoint response, leading to the impairment of genome integrity as demonstrated by the cytokinesis-block micronucleus assay. In contrast, moderate depletion of TopBP1 by shRNA in TopBP1-overexpressing cancer cells enhanced ATR/Chk1 activation and S-phase checkpoint response after replicative stress. The clinical significance of these findings is supported by an association between TopBP1 overexpression and genome instability in many types of human cancer. Taken together, our study illustrates an unexpected relationship between the levels of TopBP1 and the final functional outcome and suggests TopBP1 overexpression as a new mechanism directly contributing to genomic instability during tumorigenesis.U	[Liu, Kang; Graves, Joshua D.; Lin, Fang-Tsyr; Lin, Weei-Chin] Baylor Coll Med, Sect Hematol Oncol, Dept Med, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), Baylor Coll Med, Sect Hematol Oncol, Dept Med, Houston, TX 77030 USA.; Lin, WC (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	weeichil@bcm.edu		Lin, Weei-Chin/0000-0002-6804-3205	National Institutes of Health [R01CA100857]; Rivkin Center for Ovarian Cancer Pilot Award [R01CA203824]; Department of Defense [W81XWH-18-1-0329, W81XWH-19-1-0369]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rivkin Center for Ovarian Cancer Pilot Award; Department of Defense(United States Department of Defense)	This work was supported by National Institutes of Health Grants R01CA100857, Rivkin Center for Ovarian Cancer Pilot Award (to W.-C. L.) and R01CA203824 and Department of Defense Grants, W81XWH-18-1-0329 and W81XWH-19-1-0369 (to W.-C. L. and F.-T. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo J, 2016, J BIOL CHEM, V291, P13124, DOI 10.1074/jbc.M116.729194; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Chowdhury P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6476; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Haahr P, 2016, NAT CELL BIOL, V18, P1196, DOI 10.1038/ncb3422; Hintzsche H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21680-8; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lee YC, 2016, CURR BIOL, V26, P3257, DOI 10.1016/j.cub.2016.10.030; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00599-19; Liu K, 2017, P NATL ACAD SCI USA, V114, pE3766, DOI 10.1073/pnas.1619832114; Liu K, 2013, MOL CELL BIOL, V33, P4685, DOI 10.1128/MCB.00373-13; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Schlomm T, 2016, EUR UROL, V69, P1157, DOI 10.1016/j.eururo.2016.02.024; Thomas P, 2011, METHODS MOL BIOL, V682, P217, DOI 10.1007/978-1-60327-409-8_16; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Wu DP, 2017, EUR REV MED PHARMACO, V21, P4022; Yan S, 2009, CELL CYCLE, V8, P2877, DOI 10.4161/cc.8.18.9485; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829	25	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100382	10.1016/j.jbc.2021.100382	http://dx.doi.org/10.1016/j.jbc.2021.100382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556369	gold, Green Published			2022-12-26	WOS:000672866400356
J	Choi, W; Lee, HW; Pak, B; Han, O; Kim, M; Jin, SW				Choi, Woosoung; Lee, Heon-Woo; Pak, Boryeong; Han, Orjin; Kim, Minjung; Jin, Suk-Won			Transcriptomic analysis identifies novel targets for individual bone morphogenetic protein type 1 receptors in endothelial cells	FASEB JOURNAL			English	Article						ALK2; BMP signaling; BMPR1; endothelial cell; transcriptomics	I RECEPTOR; OLIGOMERIZATION; BETA; ACTIVATION; DIVERSITY; COMPLEXES; MODE; ALK1	Bone Morphogenetic Protein (BMP) signaling regulates diverse biological processes. Upon ligand binding, BMP receptors (BMPRs) phosphorylate SMAD1/5 and other noncanonical downstream effectors to induce transcription of downstream targets. However, the precise role of individual BMP receptors in this process remains largely unknown due to the complexity of downstream signaling and the innate promiscuity of ligand-receptor interaction. To delineate unique downstream effectors of individual BMPR1s, we analyzed the transcriptome of human umbilical endothelial cells (HUVECs) expressing three distinct constitutively active BMPR1s of which expression was detected in endothelial cells (ECs). From our analyses, we identified a number of novel downstream targets of BMPR1s in ECs. More importantly, we found that each BMPR1 possesses a distinctive set of downstream effectors, suggesting that each BMPR1 is likely to retain unique function in ECs. Taken together, our analyses suggest that each BMPR1 regulates downstream targets non-redundantly in ECs to create context-dependent outcomes of the BMP signaling.	[Choi, Woosoung; Pak, Boryeong; Han, Orjin; Kim, Minjung; Jin, Suk-Won] Gwangju Inst Sci & Technol, Cell Logist Res Ctr, Gwangju, South Korea; [Choi, Woosoung; Pak, Boryeong; Han, Orjin; Kim, Minjung; Jin, Suk-Won] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Lee, Heon-Woo; Jin, Suk-Won] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT USA; [Lee, Heon-Woo; Jin, Suk-Won] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Yale University; Yale University	Jin, SW (corresponding author), Gwangju Inst Sci & Technol, Cell Logist Res Ctr, Gwangju, South Korea.; Jin, SW (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea.	sukwonjin@gist.ac.kr	Lee, Heon-Woo/AAN-6241-2021; Lee, Heon-Woo/GZL-9270-2022; Choi, Woosoung/ABF-2933-2020	Lee, Heon-Woo/0000-0002-0620-6937; Choi, Woosoung/0000-0002-8017-3838	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL114820]; National Research Foundation of Korea (NRF) [NRF-2016R1A5A1007318, NRF-2017R1A2B2007211, NRF2019R1A2C2088125]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL114820; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2016R1A5A1007318, NRF-2017R1A2B2007211 and NRF2019R1A2C2088125	Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Choi W., 2021, FASEB J, V35; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Gomez-Puerto MC, 2019, J PATHOL, V247, P9, DOI 10.1002/path.5170; Guo XD, 2013, CELL RES, V23, P142, DOI 10.1038/cr.2012.180; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Kim JD, 2014, ARTERIOSCL THROM VAS, V34, P1838, DOI 10.1161/ATVBAHA.114.303219; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lee HW, 2017, ARTERIOSCL THROM VAS, V37, P657, DOI 10.1161/ATVBAHA.116.308422; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Lowery JW, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022327; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Park WB, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e84; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Traeger L, 2018, FREE RADICAL BIO MED, V129, P127, DOI 10.1016/j.freeradbiomed.2018.09.021; Varley JE, 1998, DEV BIOL, V196, P107, DOI 10.1006/dbio.1998.8853; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	33	3	3	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21386	10.1096/fj.202002071R	http://dx.doi.org/10.1096/fj.202002071R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565137	Green Accepted			2022-12-26	WOS:000629576700007
J	Kudo, K; Inoue, T; Sonoda, N; Ogawa, Y; Inoguchi, T				Kudo, Kana; Inoue, Tomoaki; Sonoda, Noriyuki; Ogawa, Yoshihiro; Inoguchi, Toyoshi			Relationship between serum bilirubin levels, urinary biopyrrin levels, and retinopathy in patients with diabetes	PLOS ONE			English	Article							OXYGENASE-1 MESSENGER-RNA; OXIDATIVE STRESS; NADPH OXIDASE; HYPERGLYCEMIA; EXPRESSION; COMPLICATIONS; ASSOCIATION; ANTIOXIDANT; SEVERITY; DISEASE	Objective Previous reports have indicated that serum bilirubin levels may be associated with diabetic retinopathy. However, the detailed mechanism is not fully understood. In this study, we evaluated the relationship between the severity of diabetic retinopathy and various factors including bilirubin levels and factors influencing bilirubin metabolism. Methods The study participants consisted of 94 consecutive patients with diabetes mellitus admitted to Kyushu University Hospital from April 2011 to July 2012. The patients were classified into three groups: no retinopathy (NDR), simple retinopathy (SDR), and pre-proliferative or proliferative retinopathy (PDR). The relationship between the severity of retinopathy and various factors was evaluated using univariate and logistic regression analyses. In addition, multivariate regression analysis was performed to evaluate the significant determinants for bilirubin levels. Results In univariate analysis, a significant difference was found among NDR, SDR and PDR in bilirubin levels, duration of diabetes, systolic blood pressure, and macroalbuminuria. Logistic regression analysis showed that PDR was significantly associated with bilirubin levels, duration of diabetes, and systolic blood pressure (OR 0.737, 95% CI 0.570-0.952, P = 0.012; OR 1.085, 95% CI 1.024-1.149, P = 0.006; OR 1.036, 95% CI 1.011-1.062, P = 0.005, respectively). In turn, multivariate regression analysis showed that bilirubin levels were negatively associated with high-sensitivity C-reactive protein levels and PDR, but positively correlated with urinary biopyrrin levels, oxidized metabolites of bilirubin. Conclusion PDR was negatively associated with bilirubin levels. This negative association may be due to a decreased production of bilirubin rather than its increased consumption considering the positive association between bilirubin and biopyrrin levels.	[Kudo, Kana; Inoue, Tomoaki; Sonoda, Noriyuki; Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Internal Med & Bioregulatory Sci, Fukuoka, Japan; [Inoguchi, Toyoshi] Fukuoka City Med Assoc, Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan	Kyushu University	Inoguchi, T (corresponding author), Fukuoka City Med Assoc, Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan.	toyoshi.inoguchi@gmail.com		Ogawa, Yoshihiro/0000-0002-0834-2836; Inoguchi, Toyoshi/0000-0002-7344-6199	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Funding program "Innovation Center for Medical Redox Navigation")	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Funding program "Innovation Center for Medical Redox Navigation")	This work was supported in part by a grant for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Funding program "Innovation Center for Medical Redox Navigation"). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for the study.	Abbasi A, 2015, DIABETES, V64, P1459, DOI 10.2337/db14-0228; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; daSilva JL, 1997, CURR EYE RES, V16, P380, DOI 10.1076/ceyr.16.4.380.10695; David JA, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/4826724; Di Filippo C, 2005, DIABETES, V54, P803; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Fan JW, 2012, INVEST OPHTH VIS SCI, V53, P6541, DOI 10.1167/iovs.11-9241; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Hokamaki J, 2004, J AM COLL CARDIOL, V43, P1880, DOI 10.1016/j.jacc.2004.01.028; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Inoguchi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43543-6; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Koya D, 2003, J AM SOC NEPHROL, V14, pS250, DOI 10.1097/01.ASN.0000077412.07578.44; Kronenberg F, 2002, EUR J HUM GENET, V10, P539, DOI 10.1038/sj.ejhg.5200842; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lin JP, 2003, AM J HUM GENET, V72, P1029, DOI 10.1086/373964; Pan HZ, 2008, BRIT J OPHTHALMOL, V92, P548, DOI 10.1136/bjo.2007.130542; Peng YF, 2017, CLIN CHIM ACTA, V469, P187, DOI 10.1016/j.cca.2017.04.006; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sekioka R, 2015, J DIABETES COMPLICAT, V29, P218, DOI 10.1016/j.jdiacomp.2014.12.002; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shimoharada K, 1998, CLIN CHEM, V44, P2554; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Takei R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223302; Vitek L, 2017, PHYSIOL RES, V66, pS11, DOI 10.33549/physiolres.933581; Vitek L, 2010, SCAND J RHEUMATOL, V39, P480, DOI 10.3109/03009741003742748; YAMAGUCHI T, 1994, J BIOCHEM-TOKYO, V116, P298, DOI 10.1093/oxfordjournals.jbchem.a124523; Yamamoto M, 2017, CIRC J, V81, P1678, DOI 10.1253/circj.CJ-16-1116; Yasuda M, 2011, OPHTHALMOLOGY, V118, P1423, DOI 10.1016/j.ophtha.2010.12.009; Zhao XJ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/5256460; Zhu B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161649	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0243407	10.1371/journal.pone.0243407	http://dx.doi.org/10.1371/journal.pone.0243407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571217	gold, Green Published, Green Submitted			2022-12-26	WOS:000618274000053
J	Aaron, KA; Vaughan, J; Gupta, R; Ali, NES; Beth, AH; Moore, JM; Ma, YF; Ahmad, I; Jackler, RK; Vaisbuch, Y				Aaron, Ksenia A.; Vaughan, John; Gupta, Raghav; Ali, Noor-E-Seher; Beth, Alicia H.; Moore, Justin M.; Ma, Yifei; Ahmad, Iram; Jackler, Robert K.; Vaisbuch, Yona			The risk of ergonomic injury across surgical specialties	PLOS ONE			English	Article							MUSCULOSKELETAL SYMPTOMS; SURGEONS; IMPACT; ENVIRONMENT; DISCOMFORT	Objective Lack of ergonomic training and poor ergonomic habits during the operation leads to musculoskeletal pain and affects the surgeon's life outside of work. The objective of the study was to evaluate the severity of ergonomic hazards in the surgical profession across a wide range of surgical subspecialties. We conducted intraoperative observations using Rapid Entire Body Assessment (REBA) score system to identify ergonomic hazards. Additionally, each of the ten surgical subspecialty departments were sent an optional 14 question survey which evaluated ergonomic practice, environmental infrastructure, and prior ergonomic training or education. A total of 91 surgeons received intraoperative observation and were evaluated on the REBA scale with a minimum score of 0 (low ergonomic risk <3) and a maximum score of 10 (high ergonomic risk 8-10). And a total of 389 surgeons received the survey and 167 (43%) surgeons responded. Of the respondents, 69.7% reported suffering from musculoskeletal pain. Furthermore, 54.9% of the surgeons reported suffering from the highest level of pain when standing during surgery, while only 14.4% experienced pain when sitting. Importantly, 47.7% stated the pain impacted their work, while 59.5% reported pain affecting quality of life outside of work. Only 23.8% of surgeons had any prior ergonomic education. Both our subjective and objective data suggest that pain and disability induced by poor ergonomics are widespread among the surgical community and confirm that surgeons rarely receive ergonomic training. Intraoperative observational findings identified that the majority of observed surgeons displayed poor posture, particularly a poor cervical angle and use of ergonomic setups, both of which increase ergonomic risk hazards. This data supports the need for a comprehensive ergonomic interventional program for the surgical team and offers potential targets for future intervention.	[Aaron, Ksenia A.; Ali, Noor-E-Seher; Ma, Yifei; Ahmad, Iram; Jackler, Robert K.; Vaisbuch, Yona] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Aaron, Ksenia A.; Ali, Noor-E-Seher; Ma, Yifei; Ahmad, Iram; Jackler, Robert K.; Vaisbuch, Yona] Stanford Univ, Sch Med, Div Otol Neurotol Lateral Skull Base Surg, Stanford, CA 94305 USA; [Vaughan, John; Beth, Alicia H.] Stanford Hlth Care, Environm Hlth & Safety Dept, Stanford, CA USA; [Vaughan, John; Beth, Alicia H.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Gupta, Raghav] Rutgers New Jersey Med Sch, Newark, NJ USA; [Moore, Justin M.] Boston Univ, Boston Med Ctr, Dept Neurosurg, Boston, MA 02215 USA	Stanford University; Stanford University; Stanford University; Stanford University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston Medical Center; Boston University	Vaisbuch, Y (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.; Vaisbuch, Y (corresponding author), Stanford Univ, Sch Med, Div Otol Neurotol Lateral Skull Base Surg, Stanford, CA 94305 USA.	yona_v@rmc.gov.il		jackler, robert/0000-0003-2525-8377				Agarwal S, 2018, ERGONOMICS, V61, P538, DOI 10.1080/00140139.2017.1402960; Berguer R, 1999, ARCH SURG-CHICAGO, V134, P1011, DOI 10.1001/archsurg.134.9.1011; Catanzarite T, 2018, FEMALE PELVIC MED RE, V24, P1, DOI 10.1097/SPV.0000000000000456; Cavanagh J, 2012, AM J OTOLARYNG, V33, P441, DOI 10.1016/j.amjoto.2011.10.022; Davis WT, 2014, J SURG RES, V189, P207, DOI 10.1016/j.jss.2014.03.013; Dickinson RL, 1914, J AMER MED ASSOC, V63, P763; Hallbeck MS, 2017, APPL ERGON, V60, P334, DOI 10.1016/j.apergo.2016.12.006; Hansraj Kenneth K, 2014, Surg Technol Int, V25, P277; Hignett S, 2000, APPL ERGON, V31, P201, DOI 10.1016/S0003-6870(99)00039-3; Howarth AL, 2019, J RECONSTR MICROSURG, V35, P322, DOI 10.1055/s-0038-1675177; Janowitz IL, 2006, APPL ERGON, V37, P641, DOI 10.1016/j.apergo.2005.08.004; Khan R, 2020, GASTROINTEST ENDOSC, V92, P1070, DOI 10.1016/j.gie.2020.03.3754; Kofler M, 2002, EUR J APPL PHYSIOL, V86, P492, DOI 10.1007/s00421-002-0576-6; Park A, 2010, J AM COLL SURGEONS, V210, P306, DOI 10.1016/j.jamcollsurg.2009.10.017; Rodman C, 2020, OTOLARYNG HEAD NECK, V163, P1186, DOI 10.1177/0194599820932851; Sari V, 2010, MINIM INVASIV THER, V19, P105, DOI 10.3109/13645701003643972; Schlussel AT, 2019, CLIN COLON RECT SURG, V32, P424, DOI 10.1055/s-0039-1693026; Sergesketter AR, 2019, J SURG RES, V236, P238, DOI 10.1016/j.jss.2018.11.035; Stucky CCH, 2018, ANN MED SURG, V27, P1, DOI 10.1016/j.amsu.2017.12.013; Stylopoulos N, 2003, SURG CLIN N AM, V83, P1321, DOI 10.1016/S0039-6109(03)00161-0; Szeto GPY, 2012, J SURG RES, V172, pE19, DOI 10.1016/j.jss.2011.08.004; Ho TVT, 2018, LARYNGOSCOPE, V128, P632, DOI 10.1002/lary.26859; Vaisbuch Y, 2019, LARYNGOSCOPE, V129, P370, DOI 10.1002/lary.27496; Voss RK, 2017, J AM COLL SURGEONS, V224, P16, DOI 10.1016/j.jamcollsurg.2016.09.013; Wong K, 2017, AM J OTOLARYNG, V38, P213, DOI 10.1016/j.amjoto.2017.01.013	25	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0244868	10.1371/journal.pone.0244868	http://dx.doi.org/10.1371/journal.pone.0244868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4BO	33561117	Green Published, gold			2022-12-26	WOS:000617533000049
J	Best, CM; Pyatt, AZ; Roden, J; Behnke, M; Phillips, K				Best, Caroline M.; Pyatt, Alison Z.; Roden, Janet; Behnke, Malgorzata; Phillips, Kate			Sheep farmers' attitudes towards lameness control: Qualitative exploration of factors affecting adoption of the lameness Five-Point Plan	PLOS ONE			English	Article							OVINE DIGITAL DERMATITIS; MASTITIS CONTROL PROGRAM; DAIRY FARMERS; JOHNES-DISEASE; HEALTH MANAGEMENT; PIG FARMERS; CATTLE; PERCEPTIONS; VETERINARIANS; PREVALENCE	In 2014, best-practice recommendations to treat and control lameness in sheep in the UK were consolidated into a national program, the Five-Point Plan (5PP). As recent evidence suggests that only the minority of sheep farmers are implementing all management practices listed in the 5PP, qualitative investigation is vital to ensure future promotion is aligned with psychological and contextual factors affecting farmers' decision-making. This qualitative study sought to explore farmers' attitudes and the factors affecting uptake of best-practice measures listed in the 5PP. Semi-structured interviews were conducted in 2019 with 12 sheep farmers from England and Wales. In accordance with Thematic Analysis and the principles of Grounded Theory, data collection and analysis were performed iteratively. Two overarching themes, delineated by subthemes, emerged during analysis; (1) Barriers to adoption of 5PP measures and (2) Motivation to adopt 5PP measures. Various farmer-centric factors and physical resources were identified as key barriers or obstacles that limited farmers' ability to implement 5PP measures outright, or restricted their ability to make changes to facilitate future adoption. Conversely, internal and external influences were identified to increase farmers' willingness and motivation to implement practices listed on the 5PP. Heterogeneity in farmer perceptions, attitudes, experiences and circumstances identified in this study highlights the difficulty in promoting a one-size-fits-all lameness control plan, where a unique combination of intrinsic factors, social influences, and physical restrictions affect implementation. Future initiatives should focus on removing barriers by changing farmers' perceptions and mindset towards lameness control, and building farmers' confidence in their ability to implement practices. Furthermore, farmers' social licence to farm and their desire to improve their reputation within society, presents an important opportunity to further engage farmers in implementing control practices. Increasing peer-to-peer knowledge transfer opportunities and effective farmer-veterinarian communication and rapport could help establish 5PP measures as normative behaviours.	[Best, Caroline M.; Roden, Janet; Behnke, Malgorzata; Phillips, Kate] Harper Adams Univ, Dept Vet Hlth & Anim Sci, Newport, Shrops, England; [Pyatt, Alison Z.] Hartpury Univ, Equine Dept, Hartpury, Glos, England		Best, CM (corresponding author), Harper Adams Univ, Dept Vet Hlth & Anim Sci, Newport, Shrops, England.	cbest@harper-adams.ac.uk	Behnke, Malgorzata/AFQ-8453-2022; Pyatt, Alison/AAB-5622-2019	Behnke, Malgorzata/0000-0003-4352-6312; Pyatt, Alison/0000-0003-4006-3076; Best, Caroline/0000-0002-5622-0040	MSD Animal Health; Perry Foundation; Harper Adams Silcock Fellowship	MSD Animal Health(Merck & CompanyIntervet International B.V.); Perry Foundation; Harper Adams Silcock Fellowship	CMB is funded by the Harper Adams Silcock Fellowship, MSD Animal Health and the Perry Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon P, 2014, PREV VET MED, V116, P223, DOI 10.1016/j.prevetmed.2013.08.004; Angell JW, 2014, PREV VET MED, V113, P132, DOI 10.1016/j.prevetmed.2013.09.014; Bard AM, 2019, J DAIRY SCI, V102, P10379, DOI 10.3168/jds.2019-16364; Bellet C, 2015, PREV VET MED, V122, P381, DOI 10.1016/j.prevetmed.2015.07.008; Bennett R M, 2014, Vet J, V199, P72, DOI 10.1016/j.tvjl.2013.09.068; Best CM, 2020, PREV VET MED, V181, DOI 10.1016/j.prevetmed.2020.105064; Block ES, 2012, INT J QUAL METH, V11, P428, DOI 10.1177/160940691201100409; Braun V., 2022, THEMATIC ANAL PRACTI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brennan ML, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6100061; Bruijnis M, 2013, LIVEST SCI, V155, P103, DOI 10.1016/j.livsci.2013.04.005; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Clements RH, 2014, VET REC, V175, P225, DOI 10.1136/vr.102161; Clifton R, 2020, J RURAL STUD, V74, P67, DOI 10.1016/j.jrurstud.2019.11.014; Coleman G, 2018, ANIM FRONT, V8, P14, DOI 10.1093/af/vfx004; Cresswell L., 2013, Livestock, V18, P166, DOI 10.12968/live.2013.18.5.166; Delpont M, 2021, TRANSBOUND EMERG DIS, V68, P51, DOI 10.1111/tbed.13462; Dickins A, 2016, PREV VET MED, V130, P86, DOI 10.1016/j.prevetmed.2016.06.009; Elliott J, 2011, LIVEST SCI, V140, P103, DOI 10.1016/j.livsci.2011.02.015; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Fischer K, 2019, J DAIRY SCI, V102, P2724, DOI 10.3168/jds.2018-15015; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Garforth C, 2006, LIVEST SCI, V103, P158, DOI 10.1016/j.livsci.2006.02.006; Gascoigne E, 2019, IN PRACTICE, V41, P177, DOI 10.1136/inp.l1530; Grant C, 2018, PREV VET MED, V149, P82, DOI 10.1016/j.prevetmed.2017.11.013; Green L, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00161; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Hall J, 2012, VET REC, V170, P441, DOI 10.1136/vr.100318; Heffernan C, 2008, PREV VET MED, V87, P358, DOI 10.1016/j.prevetmed.2008.05.007; Hidano A, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00320; Horseman SV, 2014, ANIM WELFARE, V23, P157, DOI 10.7120/09627286.23.2.157; Jack C, 2017, PREV VET MED, V139, P134, DOI 10.1016/j.prevetmed.2017.01.018; Jansen J, 2010, J DAIRY SCI, V93, P5737, DOI 10.3168/jds.2010-3318; Kaler J, 2013, PREV VET MED, V112, P370, DOI 10.1016/j.prevetmed.2013.09.009; Kristensen E, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-50; Kvale S., 2009, INTERVIEWS LEARNING; Laanen M, 2014, PREV VET MED, V115, P1, DOI 10.1016/j.prevetmed.2014.03.015; Lam TJGM, 2013, J DAIRY SCI, V96, P1301, DOI 10.3168/jds.2012-5958; Leach KA, 2010, RES VET SCI, V89, P311, DOI 10.1016/j.rvsc.2010.02.014; Leach KA, 2010, RES VET SCI, V89, P318, DOI 10.1016/j.rvsc.2010.02.017; Marier E, 2016, PREV VET MED, V133, P22, DOI 10.1016/j.prevetmed.2016.09.009; Martin P, 2011, DEFENDING THE SOCIAL LICENCE OF FARMING: ISSUES, CHALLENGES AND NEW DIRECTIONS FOR AGRICULTURE, P3; McAloon CG, 2017, PREV VET MED, V141, P7, DOI 10.1016/j.prevetmed.2017.04.001; McGrath C, 2019, MED TEACH, V41, P1002, DOI 10.1080/0142159X.2018.1497149; Morgan-Davies C, 2006, LIVEST SCI, V104, P268, DOI 10.1016/j.livsci.2006.04.024; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; O'Kane H, 2017, PREV VET MED, V139, P123, DOI 10.1016/j.prevetmed.2016.05.009; Olmos G, 2018, PREV VET MED, V157, P115, DOI 10.1016/j.prevetmed.2018.06.009; Prosser NS, 2019, PREV VET MED, V173, DOI 10.1016/j.prevetmed.2019.104801; Relun A, 2013, ANIMAL, V7, P1542, DOI 10.1017/S1751731113000803; Richens IF, 2015, VET REC, V177, P465, DOI 10.1136/vr.103415; Ritter C, 2016, J DAIRY SCI, V99, P9114, DOI 10.3168/jds.2016-10896; Ritter C, 2015, J DAIRY SCI, V98, P7831, DOI 10.3168/jds.2015-9789; Ritter C, 2019, J DAIRY SCI, V102, P4280, DOI 10.3168/jds.2018-15825; Roche SM, 2019, J DAIRY SCI, V102, P4476, DOI 10.3168/jds.2018-15944; Roche SM, 2015, J DAIRY SCI, V98, P5222, DOI 10.3168/jds.2014-8765; Shortall O, 2018, SOCIOL RURALIS, V58, P583, DOI 10.1111/soru.12205; Sok J, 2015, FOOD POLICY, V57, P40, DOI 10.1016/j.foodpol.2015.09.006; Sorge U, 2010, J DAIRY SCI, V93, P1491, DOI 10.3168/jds.2009-2447; Sturges JE., 2004, QUAL RES, V4, P107, DOI [DOI 10.1177/1468794104041110, 10.1177/1468794104041110]; Swinkels JM, 2015, J DAIRY SCI, V98, P2369, DOI 10.3168/jds.2014-8488; Tunstall J, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00094; Urquhart, 2013, GROUNDED THEORY QUAL; Wassink GJ, 2010, PREV VET MED, V96, P65, DOI 10.1016/j.prevetmed.2010.06.002; Whay HR, 2012, VET J, V193, P617, DOI 10.1016/j.tvjl.2012.06.041; Winter JR, 2015, PREV VET MED, V122, P121, DOI 10.1016/j.prevetmed.2015.09.014; Witt J, 2018, PREV VET MED, V157, P125, DOI 10.1016/j.prevetmed.2018.06.013	68	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246798	10.1371/journal.pone.0246798	http://dx.doi.org/10.1371/journal.pone.0246798			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4BO	33561148	Green Accepted, gold, Green Published			2022-12-26	WOS:000617533000031
J	Tang, SW; Xian, YJ; Wang, F; Luo, C; Song, W; Xie, SQ; Chen, XF; Cao, AP; Li, HB; Liu, HF				Tang, Shouwu; Xian, Yajie; Wang, Fei; Luo, Cheng; Song, Wu; Xie, Shuangquan; Chen, Xifeng; Cao, Aiping; Li, Hongbin; Liu, Haifeng			Comparative transcriptome analysis of leaves during early stages of chilling stress in two different chilling-tolerant brown-fiber cotton cultivars	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CHLOROPLAST DEVELOPMENT; FREEZING TOLERANCE; DROUGHT TOLERANCE; COLD; ARABIDOPSIS; GENE; EXPRESSION; METABOLISM; INTERPLAY	Chilling stress generates significant inhibition of normal growth and development of cotton plants and lead to severe reduction of fiber quality and yield. Currently, little is known for the molecular mechanism of brown-fiber cotton (BFC) to respond to chilling stress. Herein, RNA-sequencing (RNA-seq)-based comparative analysis of leaves under 4 degrees C treatment in two different-tolerant BFC cultivars, chilling-sensitive (CS) XC20 and chilling-tolerant (CT) Z1612, was performed to investigate the response mechanism. A total of 72650 unigenes were identified with eight commonly used databases. Venn diagram analysis identified 1194 differentially expressed genes (DEGs) with significant up-regulation in all comparison groups. Furthermore, enrichment analyses of COG and KEGG, as well as qRT-PCR validation, indicated that 279 genes were discovered as up-regulated DEGs (UDEGs) with constant significant increased expression in CT cultivar Z1612 groups at the dimensions of both each comparison group and treatment time, locating in the enriched pathways of signal transduction, protein and carbohydrate metabolism, and cell component. Moreover, the comprehensive analyses of gene expression, physiological index and intracellular metabolite detections, and ascorbate antioxidative metabolism measurement validated the functional contributions of these identified candidate genes and pathways to chilling stress. Together, this study for the first time report the candidate key genes and metabolic pathways responding to chilling stress in BFC, and provide the effective reference for understanding the regulatory mechanism of low temperature adaptation in cotton.	[Tang, Shouwu; Xian, Yajie; Wang, Fei; Xie, Shuangquan; Chen, Xifeng; Cao, Aiping; Li, Hongbin] Shihezi Univ, Coll Life Sci, Key Lab Xinjiang Phytomed Resource & Utilizat, Minist Educ, Shihezi, Peoples R China; [Tang, Shouwu; Luo, Cheng; Song, Wu; Liu, Haifeng] China Colored Cotton Grp Co Ltd, Urumqi, Peoples R China	Shihezi University	Cao, AP; Li, HB (corresponding author), Shihezi Univ, Coll Life Sci, Key Lab Xinjiang Phytomed Resource & Utilizat, Minist Educ, Shihezi, Peoples R China.; Liu, HF (corresponding author), China Colored Cotton Grp Co Ltd, Urumqi, Peoples R China.	caoaiping@shzu.edu.cn; lihb@shzu.edu.cn; cncclhf@163.com		Li, Hongbin/0000-0001-5350-7540	Science and Technology Project of Bingtuan [2016AC017, 2019CB009]; Young and Innovative Talents of Bingtuan [2019CB031]; Tianshan Cedar Project of Xinjiang [2019XS20]	Science and Technology Project of Bingtuan; Young and Innovative Talents of Bingtuan; Tianshan Cedar Project of Xinjiang	This research was funded by Science and Technology Project of Bingtuan, grant number 2016AC017 and 2019CB009, Young and Innovative Talents of Bingtuan, grant number 2019CB031, and Tianshan Cedar Project of Xinjiang, grant number 2019XS20. The funder only provided the support in the form of the research materials and salaries for authors [S.T., C.L., W.S., and H.L.], but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum SA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00069; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Basu Supratim, 2016, F1000Res, V5, DOI 10.12688/f1000research.7678.1; Blas-Sevillano RH, 2018, CARBOHYD POLYM, V197, P246, DOI 10.1016/j.carbpol.2018.06.006; Boccalandro HE, 2003, PLANT PHYSIOL, V133, P1539, DOI 10.1104/pp.103.029579; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Ding YL, 2020, MOL PLANT, V13, P544, DOI 10.1016/j.molp.2020.02.004; Feng HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129490; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; FRY SC, 1986, ANNU REV PLANT PHYS, V37, P165, DOI 10.1146/annurev.arplant.37.1.165; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Gan P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205046; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gong XD, 2014, J INTEGR PLANT BIOL, V56, P400, DOI 10.1111/jipb.12138; GUYE MG, 1987, PLANT PHYSIOL BIOCH, V25, P717; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jongdee B, 2002, FIELD CROP RES, V76, P153, DOI 10.1016/S0378-4290(02)00036-9; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kasamo K, 2000, PLANT CELL PHYSIOL, V41, P840, DOI 10.1093/pcp/pcd002; Khan T, 2015, ENVIRON SCI POLLUT R, V22, P14178, DOI 10.1007/s11356-015-4658-5; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kim Yunhee, 2003, Journal of Plant Biotechnology, V30, P399; Kong FJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1007, DOI 10.1271/bbb.80780; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Li H, 2017, DEV CELL, V43, P630, DOI 10.1016/j.devcel.2017.09.025; Li YJ, 2013, J PROTEOMICS, V78, P374, DOI 10.1016/j.jprot.2012.10.005; Liu HF, 2018, PEERJ, V6, DOI 10.7717/peerj.4537; Liu XM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01715; Lukatkin AS, 2012, ZEMDIRBYSTE, V99, P111; Marla SR, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.03.0025; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Morita R, 2017, BIOSCI BIOTECH BIOCH, V81, P271, DOI 10.1080/09168451.2016.1249452; Murthy M.S.S., 2001, RESONANCE, V6, P29, DOI [10.1007/BF02913764, DOI 10.1007/BF02913764]; Nejad T. S., 2010, REP OPIN, V2, P47; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Noh SA, 2009, PLANT BIOTECHNOL REP, V3, P75, DOI 10.1007/s11816-008-0077-0; Rekarte-Cowie I, 2008, J EXP BOT, V59, P4205, DOI 10.1093/jxb/ern262; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shi YT, 2015, PLANT CELL PHYSIOL, V56, P7, DOI 10.1093/pcp/pcu115; Sivankalyani V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01579; Song YP, 2013, PLANT CELL REP, V32, P1407, DOI 10.1007/s00299-013-1454-x; Stefanowska M, 1999, ANN BOT-LONDON, V84, P313, DOI 10.1006/anbo.1999.0924; Sun Q.M., 2000, CHIN B BOT, V17, P289; Sun SC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194838; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Tong XC, 2019, MOLECULES, V24, DOI 10.3390/molecules24091837; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang K, 2017, PLANT CELL ENVIRON, V40, P1531, DOI 10.1111/pce.12951; Wang XL, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00215; Wang YL, 2017, GENES GENOM, V39, P127, DOI 10.1007/s13258-016-0471-x; Xu J, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24525; Yang ZR, 2020, TRENDS PLANT SCI, V25, P488, DOI 10.1016/j.tplants.2019.12.011; Yun HS, 2007, J PLANT BIOL, V50, P65, DOI 10.1007/BF03030602; Zhang CF, 2010, FOOD CHEM, V120, P864, DOI 10.1016/j.foodchem.2009.11.029; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu YC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121612	62	1	1	10	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246801	10.1371/journal.pone.0246801	http://dx.doi.org/10.1371/journal.pone.0246801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561168	gold, Green Published			2022-12-26	WOS:000617533000047
J	Zhang, XZ; Dai, C; Jin, ZL; Dykas, S; Zhang, GJ				Zhang, Xinzhe; Dai, Chen; Jin, Zunlong; Dykas, Slawomir; Zhang, Guojie			Coupling analysis of contra-rotating fan interstage pressure pulsation and blade vibration based on wavelet reconstruction	PLOS ONE			English	Article							BEHAVIOR	In recent years, the flow characteristics research of the interstage region in counter-rotating axial fans in terms of fluid dynamics has attracted much attention. Especially, the dynamic relationship between interstage pressure pulsation and blade vibration in counter-rotating axial fans has not yet been clarified. This paper performs the signal processing method of wavelet decomposition and reconstruction in time-frequency analysis process. Under different flow conditions, weak-coupling numerical simulation program is employed to analyze the fluid-structure coupling interaction between interstage pressure pulsations and blade vibrations in counter-rotating axial fans. The results indicate that the fluid-structure coupling interaction field in the interstage of counter-rotating axial fans mainly excites the first-order vibration of the second-stage blade. At the same time, the consistency between the pulsation frequency and the vibration frequency of the airflow reflects the good coupling property. Two stage blades cut the airflow to cause field changes and airflow pulsation, and then, airflow pulsation causes blades deformation and produces vibrations of the same frequency at the blade. The deformation of the blades, in turn, causes the flow field changes. Rotating stall, vortex movement and breakdown produced low-frequency airflow pulsation and vortex vibration of the blade.	[Zhang, Xinzhe] Zhengzhou Univ Aeronaut, Sch Aeronaut Engn, Zhengzhou, Peoples R China; [Zhang, Xinzhe; Dai, Chen; Jin, Zunlong; Zhang, Guojie] Zhengzhou Univ, Sch Mech & Power Engn, Zhengzhou, Peoples R China; [Zhang, Xinzhe] Censtar Sci & Technol Corp Ltd, Zhengzhou, Peoples R China; [Dykas, Slawomir] Silesian Tech Univ, Dept Power Engn & Turbomachinery, Gliwice, Poland	Zhengzhou University of Aeronautics; Zhengzhou University; Silesian University of Technology	Dai, C; Zhang, GJ (corresponding author), Zhengzhou Univ, Sch Mech & Power Engn, Zhengzhou, Peoples R China.	dai_c_zzu@126.com; zhangguojie2018@zzu.edu.cn	zhang, xinzhe/HHN-2453-2022	Dykas, Slawomir/0000-0002-0151-0438; Zhang, Guojie/0000-0003-1993-165X	Science and Technology R&D Program of Henan Province of China [192102210056]	Science and Technology R&D Program of Henan Province of China	This study was funded by Science and Technology R&D Program of Henan Province of China to XZ (No.192102210056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelterman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061846; Ahmed MU, 2012, IEEE SIGNAL PROC LET, V19, P91, DOI 10.1109/LSP.2011.2180713; [Anonymous], 2013, Acta Phys. Sin., V62, P1, DOI 10.7498/APS.62.130504; Brazhe AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105879; Ding HB, 2019, ENERG CONVERS MANAGE, V196, P1089, DOI 10.1016/j.enconman.2019.06.066; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Ge ZX, 2007, THEOTY WAVELET IMPLE; He Qiudong, 2011, Journal of Mechanical Engineering, V47, P122, DOI 10.3901/JME.2011.24.122; Hu Han-hui, 2007, Journal of Central South University (Science and Technology), V38, P1169; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Moin P, 2002, INT J HEAT FLUID FL, V23, P710, DOI 10.1016/S0142-727X(02)00167-4; Musha T, 2004, APPL ACOUST, V65, P705, DOI 10.1016/j.apacoust.2003.12.006; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Sang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110733; Shao Shu-Yi, 2013, Acta Physica Sinica, V62, DOI 10.7498/aps.62.130504; SISTO F, 1984, AIAA J, V22, P1646, DOI 10.2514/3.8831; Spalart PR, 2000, INT J HEAT FLUID FL, V21, P252, DOI 10.1016/S0142-727X(00)00007-2; Takens F., 1981, LECT NOTES MATH, V898, P361; von Flotow A, 2000, AEROSP CONF PROC, P433, DOI 10.1109/AERO.2000.877917; Wang Jun, 2006, Journal of Huazhong University of Science and Technology, V34, P81; Yoo HH, 2001, J SOUND VIB, V240, P891, DOI 10.1006/jsvi.2000.3258; Zhang AG, 2020, COGN NEURODYNAMICS, V14, P849, DOI 10.1007/s11571-020-09612-7; Zhang GJ, 2020, ENERGY, V212, DOI 10.1016/j.energy.2020.118690; Zhang GJ, 2021, INT J HEAT MASS TRAN, V165, DOI 10.1016/j.ijheatmasstransfer.2020.120654; Zhang GJ, 2020, APPL THERM ENG, V171, DOI 10.1016/j.applthermaleng.2020.115090; Zhang GJ, 2019, ENERGY, V187, DOI 10.1016/j.energy.2019.115982; Zhang GJ, 2019, APPL THERM ENG, V163, DOI 10.1016/j.applthermaleng.2019.114388; Zhang GJ, 2019, INT J MULTIPHAS FLOW, V120, DOI 10.1016/j.ijmultiphaseflow.2019.103083; Zhang GJ, 2019, INT J MULTIPHAS FLOW, V114, P180, DOI 10.1016/j.ijmultiphaseflow.2019.03.005; Zhang GJ, 2019, ENERG CONVERS MANAGE, V181, P159, DOI 10.1016/j.enconman.2018.12.001	33	0	0	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0245985	10.1371/journal.pone.0245985	http://dx.doi.org/10.1371/journal.pone.0245985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561130	gold, Green Published			2022-12-26	WOS:000617533000030
J	Zhong, YW; Li, HL; Chen, LL				Zhong, Yawen; Li, Hailing; Chen, Leilei			Construction project risk prediction model based on EW-FAHP and one dimensional convolution neural network	PLOS ONE			English	Article								In order to solve the problem of low accuracy of traditional construction project risk prediction, a project risk prediction model based on EW-FAHP and 1D-CNN(One Dimensional Convolution Neural Network) is proposed. Firstly, the risk evaluation index value of construction project is selected by literature analysis method, and the comprehensive weight of risk index is obtained by combining entropy weight method (EW) and fuzzy analytic hierarchy process (FAHP). The risk weight is input into the 1D-CNN model for training and learning, and the prediction values of construction period risk and cost risk are output to realize the risk prediction. The experimental results show that the average absolute error of the construction period risk and cost risk of the risk prediction model proposed in this paper is below 0.1%, which can meet the risk prediction of construction projects with high accuracy.	[Zhong, Yawen] Southwest Petr Univ, Sch Engn, Nanchong, Peoples R China; [Li, Hailing] Xihua Univ, Sch Civil Engn & Environm, Chengdu, Peoples R China; [Chen, Leilei] Sichuan Univ Sci & Engn, Artificial Intelligence Key Lab Sichuan Prov, Zigong, Peoples R China	Southwest Petroleum University; Xihua University; Sichuan University of Science & Engineering	Zhong, YW (corresponding author), Southwest Petr Univ, Sch Engn, Nanchong, Peoples R China.	arwenzyw@163.com		ya wen, zhong/0000-0001-7438-6661	National Natural Science Foundation of China [11705122, 61640223]; Sichuan Provincial Department of Science and Technology Project [2019YJ0477]; Artificial intelligence Sichuan Key Laboratory Project [2019RYY01]; Nanchong Science and Technology Bureau Project [19SXHZ0040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Department of Science and Technology Project; Artificial intelligence Sichuan Key Laboratory Project; Nanchong Science and Technology Bureau Project	[This research was supported by National Natural Science Foundation of China (Nos. 11705122, 61640223), Sichuan Provincial Department of Science and Technology Project (No. 2019YJ0477), Artificial intelligence Sichuan Key Laboratory Project (No.2019RYY01), Nanchong Science and Technology Bureau Project (No.19SXHZ0040)]	[Anonymous], 2017, PHARM CHEM, V9, P70; Anysz H, 2019, INT J ENVIRON SCI TE, V16, P5369, DOI 10.1007/s13762-018-1892-7; Badi I., 2019, DECIS MAKING, V2, P19; Chen K, 2019, J SAFETY ENV, V19, P226; Ehsani E, 2017, NEURAL COMPUT APPL, V28, P2193, DOI 10.1007/s00521-015-2160-0; Gao CL, 2018, GEOTECH GEOL ENG, V36, P1621, DOI 10.1007/s10706-017-0415-5; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Guo YH, 2017, J CIVIL ENG MANAGEME, V34, P44; Henle J, 2018, MATH INTELL, V40, P76, DOI 10.1007/s00283-018-9804-8; Jin J., 2019, J RAILW ENG SOC, V3, P103; Khorram S, 2020, NAT HAZARDS, V103, P1709, DOI 10.1007/s11069-020-04160-z; Li SC, 2019, B ENG GEOL ENVIRON, V78, P1761, DOI 10.1007/s10064-017-1214-1; Mulgan G, 2018, AI SOC, V33, P631, DOI 10.1007/s00146-018-0861-5; Petrovic I., 2020, DECIS MAK APPL MANAG, V3, P146, DOI [10.31181/dmame2003134p, DOI 10.31181/DMAME2003134P]; Shi YC, 2017, J CIVIL ENG MANAGEME, V34, P44; Stankovi M., 2019, DECIS MAKING, V2, P86, DOI [10.31181/dmame1901086s, DOI 10.31181/DMAME1901086S]; Wang X., 2017, INTELLIGENT EVALUATI, V14, P59; Xiao QD, J XINYANG NORMAL U N; Zhou F. Y., 2017, CHIN J COMPUT, V40, P1229, DOI [DOI 10.11897/SP.J.1016.2017.01229, 10.11897/SP.J.1016.2017.01229]; Zhou J, 2020, B ENG GEOL ENVIRON, V79, P4265, DOI 10.1007/s10064-020-01788-w	25	2	2	13	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246539	10.1371/journal.pone.0246539	http://dx.doi.org/10.1371/journal.pone.0246539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561173	Green Published, gold			2022-12-26	WOS:000617533000006
J	Fang, Y; Coulter, JA; Wu, JY; Liu, LJ; Li, XC; Dong, Y; Ma, L; Pu, YY; Sun, BL; Niu, ZX; Jin, JJ; Zhao, YH; Mi, WB; Xu, YZ; Sun, WC				Fang, Yan; Coulter, Jeffrey A.; Wu, Junyan; Liu, Lijun; Li, Xuecai; Dong, Yun; Ma, Li; Pu, Yuanyuan; Sun, Bolin; Niu, Zaoxia; Jin, Jiaojiao; Zhao, Yuhong; Mi, Wenbo; Xu, Yaozhao; Sun, Wancang			Identification of differentially expressed genes involved in amino acid and lipid accumulation of winter turnip rape (Brassica rapa L.) in response to cold stress	PLOS ONE			English	Article							FREEZING TOLERANCE; ARABIDOPSIS; PROLINE; OVEREXPRESSION; TRANSCRIPTOME; ACCLIMATION; DATABASE; PATHWAY; RICE; CROP	Winter turnip rape (Brassica rapa L.) is an important overwintering oil crop that is widely planted in northwestern China. It considered to be a good genetic resource for cold-tolerant research because its roots can survive harsh winter conditions. Here, we performed comparative transcriptomics analysis of the roots of two winter turnip rape varieties, Longyou7 (L7, strong cold tolerance) and Tianyou2 (T2, low cold tolerance), under normal condition (CK) and cold stress (CT) condition. A total of 8,366 differentially expressed genes (DEGs) were detected between the two L7 root groups (L7CK_VS_L7CT), and 8,106 DEGs were detected for T2CK_VS_T2CT. Among the DEGs, two omega-3 fatty acid desaturase (FAD3), two delta-9 acyl-lipid desaturase 2 (ADS2), one diacylglycerol kinase (DGK), and one 3-ketoacyl-CoA synthase 2 (KCS2) were differentially expressed in the two varieties and identified to be related to fatty acid synthesis. Four glutamine synthetase cytosolic isozymes (GLN), serine acetyltransferase 1 (SAT1), and serine acetyltransferase 3 (SAT3) were down-regulated under cold stress, while S-adenosylmethionine decarboxylase proenzyme 1 (AMD1) had an up-regulation tendency in response to cold stress in the two samples. Moreover, the delta-1-pyrroline-5-carboxylate synthase (P5CS), delta-ornithine aminotransferase (delta-OAT), alanine-glyoxylate transaminase (AGXT), branched-chain-amino-acid transaminase (ilvE), alpha-aminoadipic semialdehyde synthase (AASS), Tyrosine aminotransferase (TAT) and arginine decarboxylase related to amino acid metabolism were identified in two cultivars variously expressed under cold stress. The above DEGs related to amino acid metabolism were suspected to the reason for amino acids content change. The RNA-seq data were validated by real-time quantitative RT-PCR of 19 randomly selected genes. The findings of our study provide the gene expression profile between two varieties of winter turnip rape, which lay the foundation for a deeper understanding of the highly complex regulatory mechanisms in plants during cold treatment.	[Fang, Yan; Wu, Junyan; Liu, Lijun; Li, Xuecai; Ma, Li; Pu, Yuanyuan; Sun, Bolin; Niu, Zaoxia; Jin, Jiaojiao; Zhao, Yuhong; Mi, Wenbo; Sun, Wancang] Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Peoples R China; [Fang, Yan; Wu, Junyan; Liu, Lijun; Li, Xuecai; Ma, Li; Pu, Yuanyuan; Sun, Bolin; Niu, Zaoxia; Jin, Jiaojiao; Zhao, Yuhong; Mi, Wenbo; Sun, Wancang] Gansu Agr Univ, Coll Agron, Lanzhou, Peoples R China; [Coulter, Jeffrey A.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Dong, Yun] Gansu Acad Agr Sci, Crop Res Inst, Lanzhou, Peoples R China; [Xu, Yaozhao] Hexi Univ, Coll Agron & Biotechnol, Zhangye, Peoples R China	Gansu Agricultural University; University of Minnesota System; University of Minnesota Twin Cities; Hexi University	Sun, WC (corresponding author), Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Peoples R China.; Sun, WC (corresponding author), Gansu Agr Univ, Coll Agron, Lanzhou, Peoples R China.	18293121851@163.com	; Yang, Xiaoming/GRJ-9483-2022	Coulter, Jeffrey/0000-0003-4609-4551; Yang, Xiaoming/0000-0002-1792-6921	Gansu Provincial Key Laboratory of Aridland Crop Science, Gansu Agricultural University [GSCS-2017-10]; National Natural Science Foundation of China [31860388]; Utilization Technology of Rapeseed Heterosis and Creation of Strong Heterosis of China [2016YFD0101300]; Agriculture Research System of China [CARS-12]	Gansu Provincial Key Laboratory of Aridland Crop Science, Gansu Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Utilization Technology of Rapeseed Heterosis and Creation of Strong Heterosis of China; Agriculture Research System of China	This work was supported by Gansu Provincial Key Laboratory of Aridland Crop Science, Gansu Agricultural University (No. GSCS-2017-10); the National Natural Science Foundation of China (No. 31860388); the Utilization Technology of Rapeseed Heterosis and Creation of Strong Heterosis of China (No. 2016YFD0101300) and the Agriculture Research System of China (CARS-12).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2006, YB INT LAW COMMISSIO, VII; [Anonymous], 2013, AESTHETIC SURG J S, V22, p1S; [Anonymous], 2007, COMPUTER, V40, pc4; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arisz SA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai B, 2015, INT J MOL SCI, V16, P11398, DOI 10.3390/ijms160511398; Barrero-Sicilia C, 2017, PLANT SCI, V263, P194, DOI 10.1016/j.plantsci.2017.07.017; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Calzadilla PI, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00374; Chen JQ, 2003, THEOR APPL GENET, V107, P972, DOI 10.1007/s00122-003-1346-5; Chen MJ, 2013, PLANT CELL, V25, P1430, DOI 10.1105/tpc.113.111179; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; D'Angeli S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111889; Deng YY, 2006, INTEGRATED NR DATAB, V32; Dinari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052757; Fang X., 2019, ABIOTECH, V1, P97; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gomez-Merino FC, 2004, J BIOL CHEM, V279, P8230, DOI 10.1074/jbc.M312187200; Guo JB, 2020, PLANT SCI, V297, DOI 10.1016/j.plantsci.2020.110525; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hwang I, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4376598; Jeon J, 2013, J PLANT BIOL, V56, P69, DOI 10.1007/s12374-013-0903-y; Jia X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2554-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Lee JH, 2010, MOL BIOL REP, V37, P3455, DOI 10.1007/s11033-009-9937-0; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Lei ZX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24751-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOS D, 1993, FEBS LETT, V318, P57, DOI 10.1016/0014-5793(93)81327-V; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Maruyama K, 2014, PLANT PHYSIOL, V164, P1759, DOI 10.1104/pp.113.231720; Meng C, 2015, PLANT PHYSIOL BIOCH, V96, P388, DOI 10.1016/j.plaphy.2015.08.019; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; NAIDU BP, 1991, PHYTOCHEMISTRY, V30, P407, DOI 10.1016/0031-9422(91)83693-F; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Rahman A, 2013, PHYSIOL PLANTARUM, V147, P28, DOI 10.1111/j.1399-3054.2012.01617.x; Rai VK, 2002, BIOL PLANTARUM, V45, P481, DOI 10.1023/A:1022308229759; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riva-Roveda L, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0909-y; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sakata T, 2014, PLANT PHYSIOL, V164, P2011, DOI 10.1104/pp.113.234401; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Sharma S, 2011, PLANT PHYSIOL, V157, P292, DOI 10.1104/pp.111.183210; Singh N, 2020, GENE, V762, DOI 10.1016/j.gene.2020.145104; Sun W, 2016, NORTHWARD MOVEMENT D; Sun W-C, 2011, ACTA AGRONOMICA SINI, V36, P2124; Sun XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24066; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Taibi K, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1464-5; Takahashi D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00090; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Tuulos A, 2015, J AGR SCI-CAMBRIDGE, V153, P222, DOI 10.1017/S002185961400015X; Wang X, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153796; Wu ZG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01653; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang R, 2013, STUDY EFFECTS DIFFER; Yang XY, 2019, IND CROP PROD, V135, P283, DOI 10.1016/j.indcrop.2019.04.056; Zeng XC, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1242-4; Zhao L, 2009, PLANT BIOTECHNOL J, V7, P550, DOI 10.1111/j.1467-7652.2009.00423.x; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	71	5	6	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245494	10.1371/journal.pone.0245494	http://dx.doi.org/10.1371/journal.pone.0245494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556109	gold, Green Published			2022-12-26	WOS:000617379900027
J	Kim, J; Yoon, SJ; Jo, MW				Kim, Juyoung; Yoon, Seok-Jun; Jo, Min-Woo			Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; DURATION; INCIDENT; DEATH; RISK	Background The burden of diabetes is considerable not only globally but also nationally within Korea. The Global Burden of Disease study derived the disability-adjusted life years (DALYs) of diabetes depending on its complications as individual severity using prevalence-based approach from 2017. Conversely, the Korean National Burden of Disease study based on an incidence-based approach does not incorporate the severity of diseases. This study aimed to simulate incidence-based DALYs of type 2 diabetes mellitus (T2DM), given diabetic complications as disease severity using a Markov model. Methods We developed a model with six Markov states, including incident and existing prevalent cases of diabetes and its complications and death. We assumed that diabetes and its complications would not be cured. The cycle length was one year, and the endpoint of the simulation was 100 years. A 5% discount rate was adopted in the analysis. Transition cases were counted by 5-year age groups above 30 years of age. Age- and sex-specific transition probabilities were calculated based on the incident rate. Results The total DALY estimates of T2DM were 5,417 and 3,934 per 100,000 population in men and women, respectively. The years of life lost in men were relatively higher than those in women in most age groups except the 80-84 age group. The distribution of years lived with disability by gender and age group showed a bell shape, peaking in the 55-59 age group in men and 65-69 age group in women. Conclusions The burden of T2DM considering its complications was larger compared to the outcomes from previous studies, with more precise morbid duration using the Markov model.	[Kim, Juyoung; Jo, Min-Woo] Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol, Coll Med, Seoul, South Korea; [Kim, Juyoung; Jo, Min-Woo] Univ Ulsan, Dept Prevent Med, Coll Med, Seoul, South Korea; [Yoon, Seok-Jun] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Korea University; Korea University Medicine (KU Medicine)	Jo, MW (corresponding author), Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol, Coll Med, Seoul, South Korea.; Jo, MW (corresponding author), Univ Ulsan, Dept Prevent Med, Coll Med, Seoul, South Korea.	mdjominwoo@gmail.com		Yoon, Seok-Jun/0000-0003-3297-0071; Kim, Juyoung/0000-0002-5442-5106	Korean Health Technology RD Project [HI18C0446]	Korean Health Technology RD Project	This study was supported by a grant from the Korean Health Technology R&D Project (HI18C0446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, EPIDEMIOLOGY GORDIS, V5th; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Brun E, 2000, DIABETES CARE, V23, P1119, DOI 10.2337/diacare.23.8.1119; Cho SW, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e74; Doves Watve M., 2013, DIPLOMATS DIABETES D, V1st; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Dudel C, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00217-0; Dugan Joy, 2017, Clin Diabetes, V35, P232, DOI 10.2337/cd16-0052; Feng X, 2020, INT J TECHNOL ASSESS, V36, P96, DOI 10.1017/S0266462320000124; Fowler MJ, 2011, CLIN DIABETES, V29, P116, DOI [10.2337/diaclin.29.3.116, DOI 10.2337/DIACLIN.29.3.116]; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Hayashino Y, 2017, J DIABETES INVEST, V8, P243, DOI 10.1111/jdi.12550; Institute for Health Metrics and Evalution, 2020, GBD COMP VIZ HUB; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kang YM, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0451-0; Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001; Kim SH, 2017, J NEPHROL, V30, P787, DOI 10.1007/s40620-017-0380-3; Kim YE, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e75; Korea Informative Classification of Diseases, 2020, KOR STAND CLASS DIS; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Li S, 2019, DIABETES METAB J, V43, P319, DOI 10.4093/dmj.2018.0060; Mamtani R, 2014, PHARMACOEPIDEM DR S, V23, P111, DOI 10.1002/pds.3557; Ock M, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e60; Ock M, 2016, J KOREAN MED SCI, V31, pS129, DOI 10.3346/jkms.2016.31.S2.S129; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Oh W, 2016, BIG DATA-US, V4, P25, DOI 10.1089/big.2015.0029; Oostvogels AJJM, 2015, EPIDEMIOL INFECT, V143, P1791, DOI 10.1017/S0950268814001940; Park B, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e69; Raghavan S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011295; Roberts AW, 2015, J COMP EFFECT RES, V4, P27, DOI 10.2217/cer.14.53; Salehidoost R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60142-y; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shin JY, 2019, EPIDEMIOL HEALTH, V41, DOI 10.4178/epih.e2019029; Song SO, 2014, TRENDS DIABETES INCI; Song SO, 2016, ENDOCRINOL METAB, V31, P292, DOI 10.3803/EnM.2016.31.2.292; Struijk EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074294; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wachter KW., 2014, ESSENTIAL DEMOGRAPHI; Woodward M, 2003, DIABETES CARE, V26, P360; World Health Organization, 2019, CLASS DIAB MELL; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zoungas S, 2014, DIABETOLOGIA, V57, P2465, DOI 10.1007/s00125-014-3369-7	42	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246635	10.1371/journal.pone.0246635	http://dx.doi.org/10.1371/journal.pone.0246635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556138	Green Published, gold			2022-12-26	WOS:000617379900037
J	Li, L; Zhu, GR; Wu, DF; Xu, HL; Ma, PF; Liu, J; Li, ZC; He, YJ; Li, CH; Wu, P				Li, Long; Zhu, Gaoru; Wu, Dafang; Xu, Honglei; Ma, Peifang; Liu, Jie; Li, Zhaocheng; He, Yinjie; Li, Chenghui; Wu, Pan			Land suitability assessment for supporting transport planning based on carrying capacity and construction demand	PLOS ONE			English	Article							URBANIZATION; RESOURCES; CHINA; EXPANSION; FRAMEWORK; SHANGHAI; IMPACT; POLICY; AREA; CITY	With the rapid global urbanization, the unlimited increasing transportation infrastructure has met the needs of urban expansion, but it has caused a series of ecological problems lacking consideration of ecological conservation. The land suitability assessment for supporting transport planning based on carrying capacity and demand for construction is an effective way to promote urban socioeconomic development and ecological conservation. Therefore, we constructed a logical framework of resources and environment supporting, traffic construction demand driving, and ecological protection red line and basic farmland constraining, and applied the analytic hierarchy process (AHP), GIS, three-dimensional magic cube method, and gravity model to evaluate the suitability of expressway development in Sichuan Province, China. The results showed that the spatial difference in the carrying capacity of resources and environment and the demand for expressway construction was relatively high in Sichuan, and those in eastern cities were even higher. The land suitability for supporting transport planning was relatively high, and the suitable areas with a grade from 8 to 10, accounted for 20.77% of the total study area, which could almost meet the demand for transportation infrastructure construction. The land suitability performed a circle structure with Chengdu as the core and gradually decreasing to the periphery. Overall, this study adds new insights to transport planning reform in other similar regions around the world and can provide important references for regional development planning and environmental protection.	[Li, Long; Wu, Dafang; Ma, Peifang; Li, Zhaocheng; Li, Chenghui; Wu, Pan] Guangzhou Univ, Sch Geog & Remote Sensing, Guangzhou, Peoples R China; [Zhu, Gaoru; Xu, Honglei; Liu, Jie] Minist Transport, Planning & Res Inst, Beijing, Peoples R China; [He, Yinjie] Renmin Univ China, Sch Publ Adm & Policy, Beijing, Peoples R China	Guangzhou University; Renmin University of China	Wu, DF (corresponding author), Guangzhou Univ, Sch Geog & Remote Sensing, Guangzhou, Peoples R China.; Zhu, GR (corresponding author), Minist Transport, Planning & Res Inst, Beijing, Peoples R China.	zhugaoru@foxmail.com; wudaf2004@163.com	WU, Da-fang/AER-9311-2022	WU, Da-fang/0000-0001-8720-0598	National Natural Science Foundation of China [41101078]; Key Science and Technology Projects in Transportation industry of China [2018-MS5-127]; Science and Technology Project of Henan Provincial Department of Transportation [2020G-2-15]; Postgraduate Demonstration Course Construction Project of Guangdong Province [2017SFKC32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Projects in Transportation industry of China; Science and Technology Project of Henan Provincial Department of Transportation; Postgraduate Demonstration Course Construction Project of Guangdong Province	This research was funded by National Natural Science Foundation of China (No. 41101078), Key Science and Technology Projects in Transportation industry of China (No.2018-MS5-127), Science and Technology Project of Henan Provincial Department of Transportation (No.2020G-2-15), and Postgraduate Demonstration Course Construction Project of Guangdong Province (No.2017SFKC32).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanho RA, 2017, SUSTAIN CITIES SOC, V32, P181, DOI 10.1016/j.scs.2017.03.026; AlKheder S, 2020, J CLEAN PROD, V260, DOI 10.1016/j.jclepro.2020.121048; Alpkokin P, 2012, LAND USE POLICY, V29, P536, DOI 10.1016/j.landusepol.2011.09.007; [Anonymous], 2017, ALZHEIMERS RES THER, V9, P14; [Anonymous], 2020, J INTENSIVE CARE, V8, P29, DOI [10.1186/s40560-020-00445, DOI 10.1186/S40560-020-00445-]; [Anonymous], 2018, BRIEF REPORTS REV, V13, P12, DOI [10.1142/S1793292018500704, DOI 10.1142/S17932920185007041850070]; Arvin SA, 2002, AUTOMAT CONSTR, V11, P213, DOI 10.1016/S0926-5805(00)00099-6; Byron CJ, 2015, AQUACULTURE, V447, P15, DOI 10.1016/j.aquaculture.2014.08.030; Chen BB, 2015, NAT HAZARDS, V75, P2637, DOI 10.1007/s11069-014-1451-6; Chen LG, 2017, HABITAT INT, V67, P148, DOI 10.1016/j.habitatint.2017.07.005; Chen MX, 2020, J GEOGR SCI, V30, P705, DOI 10.1007/s11442-020-1751-6; Chen N, 2020, J CLEAN PROD, V260, DOI 10.1016/j.jclepro.2020.121042; Dong M, 2018, B ENG GEOL ENVIRON, V77, P1203, DOI 10.1007/s10064-017-1069-5; Dong SC, 2018, J GEOGR SCI, V28, P900, DOI 10.1007/s11442-018-1512-y; Du J, 2012, ENVIRON MONIT ASSESS, V184, P5807, DOI 10.1007/s10661-011-2383-1; Du YW, 2020, J CLEAN PROD, V252, DOI 10.1016/j.jclepro.2019.119655; Dunnett A, 2018, ECOL MODEL, V381, P23, DOI 10.1016/j.ecolmodel.2018.04.008; Feng L, 2014, MAR POLLUT BULL, V89, P102, DOI 10.1016/j.marpolbul.2014.10.029; Gao Z.Y., 2019, COMPUT ENV URBAN SYS, V77, P10; Gomez C, 2019, J AMB INTEL SMART EN, V11, P23, DOI 10.3233/AIS-180509; Grasland C, 2020, INT COMMUN GAZ, V82, P231, DOI 10.1177/1748048518825091; Hao LN, 2019, ECOL INDIC, V102, P33, DOI 10.1016/j.ecolind.2019.01.053; Huang C, 2020, BIOTROPICA, V52, P196, DOI 10.1111/btp.12726; Li Q, 2019, SCI TOTAL ENVIRON, V657, P1051, DOI 10.1016/j.scitotenv.2018.12.118; Li RM, 2018, CHINA GEOL, V1, P556, DOI 10.31035/cg2018050; Liu T., 2020, LAND USE POL, V94, P13; Liu WC, 2020, J TRANSP GEOGR, V88, DOI 10.1016/j.jtrangeo.2020.102822; Liu Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051759; Mitchell G, 2005, J ENVIRON MANAGE, V77, P212, DOI 10.1016/j.jenvman.2005.04.013; Niu FQ, 2020, J GEOGR SCI, V30, P319, DOI 10.1007/s11442-020-1730-y; Sagar BSD, 2019, IEEE T EMERG TOP COM, V7, P230, DOI 10.1109/TETC.2016.2633436; Song DM, 2016, OCEAN COAST MANAGE, V134, P129, DOI 10.1016/j.ocecoaman.2016.10.004; Sun MY, 2020, APPL GEOGR, V116, DOI 10.1016/j.apgeog.2020.102170; Tang F, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106719; Tercan E, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106549; Wang J, 2018, HABITAT INT, V71, P1, DOI 10.1016/j.habitatint.2017.10.010; Wang R, 2017, RESOUR POLICY, V53, P20, DOI 10.1016/j.resourpol.2017.05.012; Wang XS, 2019, ACCIDENT ANAL PREV, V125, P249, DOI 10.1016/j.aap.2019.02.014; Wang ZY, 2018, COMPUT ENVIRON URBAN, V70, P53, DOI 10.1016/j.compenvurbsys.2018.02.001; Wei YHD, 2017, LANDSCAPE URBAN PLAN, V163, P17, DOI 10.1016/j.landurbplan.2017.02.019; Wey WM, 2016, HABITAT INT, V55, P109, DOI 10.1016/j.habitatint.2016.03.003; Wu YZ, 2018, HABITAT INT, V77, P40, DOI 10.1016/j.habitatint.2018.05.008; Xia FZ, 2016, HABITAT INT, V51, P48, DOI 10.1016/j.habitatint.2015.10.012; Xie XT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030900; Yang J, 2020, SCI TOTAL ENVIRON, V717, DOI 10.1016/j.scitotenv.2020.137151; You HY, 2016, HABITAT INT, V53, P115, DOI 10.1016/j.habitatint.2015.11.001; Zhang C.J., 2019, SUSTAINABILITY, V11, P21; Zhang J, 2019, J HYDROL, V568, P96, DOI 10.1016/j.jhydrol.2018.10.059; Zhang L.B., 2020, SUSTAINABILITY, V12, P16; Zhang M, 2018, ENVIRON IMPACT ASSES, V68, P90, DOI 10.1016/j.eiar.2017.11.002; Zhang N, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010290; Zhao PJ, 2010, ENVIRON PLANN A, V42, P2467, DOI 10.1068/a4350; Zhou T, 2018, CITIES, V75, P59, DOI 10.1016/j.cities.2018.01.001; Zhou Y, 2019, LAND USE POLICY, V82, P339, DOI 10.1016/j.landusepol.2018.12.024	54	5	6	10	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246374	10.1371/journal.pone.0246374	http://dx.doi.org/10.1371/journal.pone.0246374			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556065	Green Published, gold			2022-12-26	WOS:000617379900010
J	Leul, A; Hailu, T; Abraham, L; Bayray, A; Terefe, W; Godefay, H; Fantaye, M; Qazi, SA; Aboubaker, S; Bin Nisar, Y; Bahl, R; Tekle, E; Mulugeta, A				Leul, Abadi; Hailu, Tadele; Abraham, Loko; Bayray, Alemayehu; Terefe, Wondwossen; Godefay, Hagos; Fantaye, Mengesha; Qazi, Shamim Ahmad; Aboubaker, Samira; Bin Nisar, Yasir; Bahl, Rajiv; Tekle, Ephrem; Mulugeta, Afework			Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research	PLOS ONE			English	Article							INJECTABLE PROCAINE BENZYLPENICILLIN; SIMPLIFIED ANTIBIOTIC REGIMENS; COMMUNITY-HEALTH WORKERS; OPEN-LABEL; PLUS GENTAMICIN; CLINICAL SIGNS; TRIAL; CARE	Background Neonatal bacterial infections are a common cause of death, which can be managed well with inpatient treatment. Unfortunately, many families in low resource settings do not accept referral to a hospital. The World Health Organization (WHO) developed a guideline for management of young infants up to 2 months of age with possible serious bacterial infection (PSBI) when referral is not feasible. Government of Ethiopia with WHO evaluated the feasibility of implementing this guideline to increase coverage of treatment. Objective The objective of this study was to implement a simplified antibiotic regimen (2 days gentamicin injection and 7 days oral amoxicillin) for management of sick young infants with PSBI in a programme setting when referral was not feasible to identify at least 80% of PSBI cases, achieve an overall adequate treatment coverage of at least 80% and document the challenges and opportunities for implementation at the community level in two districts in Tigray, Ethiopia. Methods Using implementation research, we applied the PSBI guideline in a programme setting from January 2016 to August 2017 in Raya Alamata and Raya Azebo Woredas (districts) in Southern Tigray, Ethiopia with a population of 260884. Policy dialogue was held with decision-makers, programme implementers and stakeholders at federal, regional and district levels, and a Technical Support Unit (TSU) was established. Health Extension Workers (HEWs) working at the health posts and supervisors working at the health centres were trained in WHO guideline to manage sick young infants when referral was not feasible. Communities were sensitized towards appropriate home care. Results We identified 854 young infants with any sign of PSBI in the study population of 7857 live births. The expected live births during the study period were 9821. Assuming 10% of neonates will have any sign of PSBI within the first 2 months of life (n = 982), the coverage of appropriate treatment of PSBI cases in our study area was 87% (854/982). Of the 854 sick young infants, 333 (39%) were taken directly to a hospital and 521 (61%) were identified by HEW at health posts. Of the 521 young infants, 27 (5.2%) had signs of critical illness, 181 (34.7%) had signs of clinical severe infection, whereas 313 (60.1%) young infants 7-59 days of age had only fast breathing pneumonia. All young infants with critical illness accepted referral to a hospital, while 117/181 (64.6%) infants with clinical severe infection accepted referral. Families of 64 (35.3%) infants with clinical severe infection refused referral and were treated at the health post with injectable gentamicin for 2 days plus oral amoxicillin for 7 days. All 64 completed recommended gentamicin doses and 63/64 (98%) completed recommended amoxicillin doses. Of 313 young infants, 7-59 days with pneumonia who were treated by the HEWs without referral with oral amoxicillin for 7 days, 310 (99%) received all 14 doses. No deaths were reported among those treated on an outpatient basis at health posts. But 35/477 (7%) deaths occurred among young infants treated at hospital. Conclusions When referral is not feasible, young infants with PSBI can be managed appropriately at health posts by HEWs in the existing health system in Ethiopia with high coverage, low treatment failure and a low case fatality rate. Moreover, fast breathing pneumonia in infants 7-59 days of age can be successfully treated at the health post without referral. Relatively higher mortality in sick young infants at the referral level health facilities warrants further investigation.	[Leul, Abadi; Hailu, Tadele; Abraham, Loko] Mekelle Univ, Sch Med, Dept Paediat & Child Hlth, Mekelle, Ethiopia; [Bayray, Alemayehu; Terefe, Wondwossen; Mulugeta, Afework] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Godefay, Hagos] Tigray Hlth Bur, Mekelle, Ethiopia; [Fantaye, Mengesha] Alamata Hosp, Alamata, Tigray, Ethiopia; [Qazi, Shamim Ahmad; Aboubaker, Samira] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Bin Nisar, Yasir; Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth & A, Geneva, Switzerland; [Tekle, Ephrem] Fed Minist Hlth, Maternal & Child Hlth Directorate, Addis Ababa, Ethiopia	Mekelle University; Mekelle University; World Health Organization; World Health Organization; Federal Ministry of Health - Ethiopia (FMOH)	Leul, A (corresponding author), Mekelle Univ, Sch Med, Dept Paediat & Child Hlth, Mekelle, Ethiopia.	tsiabadi@yahoo.com	Nisar, Yasir Bin/AFO-2407-2022	Mulugeta, Afework/0000-0003-0707-4363	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation through a grant to the World Health Organization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRIcan NEonatal Sepsis Trial Group, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS26, DOI 10.1097/INF.0b013e31829ff7d1; Applegate JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229988; Applegate JA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001643; Awasthi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234212; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Central Statistical Agency (CSA), 2016, ETH ICF ETH DEM HLTH; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Debeb HG, 2016, NO ETHIOPIA; Duysburgh E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0562-8; Government of Ethiopia, 2018, INT COMM MAN NEWB CH; Guenther T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229248; Hailegebriel TD, 2017, GLOB HEALTH-SCI PRAC, V5, P202, DOI 10.9745/GHSP-D-16-00312; Khanal S, 2011, J HEALTH POPUL NUTR, V29, P255, DOI 10.3329/jhpn.v29i3.7873; Kozuki N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2330-0; McPherson R, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010422; Mir F, 2017, LANCET GLOB HEALTH, V5, pE177, DOI [10.1016/s2214-109x(16)30335-7, 10.1016/S2214-109X(16)30335-7]; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Population Census Commission, 2007, ETH STAT REP 2007 PO; Rahman AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232675; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Simieneh MM, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3897-4; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; The Federal Democratic Republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Tigray Regional Health Bureau, 2013, ANN PROF 2013 MEK; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6; UNICEF WHO World Bank, 2019, UN POP DIV LEV TREND; UNICEF WHO World Bank, 2017, UN POP DIV LEV TREND; Wammanda RD, 2020, IMPLEMENTATION WHO G; WHO, 2013, GUID MAN COMM ILLN L, V2nd; WHO UNICEF, 2009, JOINT STAT HOM VIS; World Health Organization, 2019, INT MAN CHILDH ILLN; World Health Organization, 2015, GUID MAN POSS SER BA	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244192	10.1371/journal.pone.0244192	http://dx.doi.org/10.1371/journal.pone.0244192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544712	Green Published, gold			2022-12-26	WOS:000617991900014
J	Simwaka, J; Seheri, M; Mulundu, G; Kaonga, P; Mwenda, JM; Chilengi, R; Mpabalwani, E; Munsaka, S				Simwaka, Julia; Seheri, Mapaseka; Mulundu, Gina; Kaonga, Patrick; Mwenda, Jason M.; Chilengi, Roma; Mpabalwani, Evans; Munsaka, Sody			Rotavirus breakthrough infections responsible for gastroenteritis in vaccinated infants who presented with acute diarrhoea at University Teaching Hospitals, Children's Hospital in 2016, in Lusaka Zambia	PLOS ONE			English	Article							1ST 2 YEARS; LESS-THAN-5 YEARS; DOUBLE-BLIND; PREVALENCE; GENOTYPES; EFFICACY; LIFE	Background In Zambia, before rotavirus vaccine introduction, the virus accounted for about 10 million episodes of diarrhoea, 63 000 hospitalisations and 15 000 deaths in 2015, making diarrhoea the third leading cause of death after pneumonia and malaria. In Zambia, despite the introduction of the vaccine acute diarrhoea due to rotaviruses has continued to affect children aged five years and below. This study aimed to characterise the rotavirus genotypes which were responsible for diarrhoeal infections in vaccinated infants aged 2 to 12 months and to determine the relationship between rotavirus strains and the severity of diarrhoea in 2016. Methods Stool samples from infants aged 2 to 12 months who presented to the hospital with acute diarrhoea of three or more episodes in 24 hours were tested for group A rotavirus. All positive specimens that had enough sample were genotyped using reverse transcriptase Polymerase Chain Reaction (RT-PCR). A 20-point Vesikari clinical score between 1-5 was considered as mild, 6-10 as moderate and greater or equal to 11 as severe. Results A total of 424 stool specimens were tested of which 153 (36%, 95% CI 31.5% to 40.9%) were positive for VP6 rotavirus antigen. The age-specific rotavirus infections decreased significantly (p = 0.041) from 2-4 months, 32.0% (49/118) followed by a 38.8% (70/181) infection rate in the 5-8 months' category and subsequently dropped in the infants aged 9-12 months with a positivity rate of 27.2%. 38.5% of infants who received a single dose, 34.5% of those who received a complete dose and 45.2% (19/42) of the unvaccinated tested positive for rotavirus. The predominant rotavirus genotypes included G2P[6] 36%, G1P[8] 32%, mixed infections 19%, G2P[4] 6%, G1P[6] 4% and G9P[6] 3%. Discussion and conclusion Results suggest breakthrough infection of heterotypic strains (G2P[6] (36%), homotypic, G1P[8] (32%) and mixed infections (19%) raises concerns about the effects of the vaccination on the rotavirus diversity, considering the selective pressure that rotavirus vaccines could exert on viral populations. This data indicates that the rotavirus vaccine has generally reduced the severity of diarrhoea despite the detection of the virus strains.	[Simwaka, Julia] Univ Zambia, Sch Med, Dept Pathol & Microbiol, Lusaka, Zambia; [Simwaka, Julia; Mulundu, Gina; Munsaka, Sody] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Seheri, Mapaseka] WHO Reg Off Africa WHO AFRO, Brazzaville, Rep Congo; [Kaonga, Patrick] Univ Zambia, Sch Publ Hlth, Dept Epidemiol & Biostat, Lusaka, Zambia; [Kaonga, Patrick] Univ Teaching Hosp, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia; [Mwenda, Jason M.] Sefako Makgatho Hlth Sci Univ, South African Med Res Council, Dept Virol, Diarrhoea Pathogens Res Unit, Pretoria, South Africa; [Mwenda, Jason M.] Sefako Makgatho Hlth Sci Univ, South African Med Res Council, WHO AFRO Rotavirus Reg Reference Lab, Pretoria, South Africa; [Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mpabalwani, Evans] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia	University of Zambia; University of Zambia; University of Zambia; University of Zambia; Sefako Makgatho Health Sciences University; South African Medical Research Council; Sefako Makgatho Health Sciences University; South African Medical Research Council; University of Zambia	Simwaka, J (corresponding author), Univ Zambia, Sch Med, Dept Pathol & Microbiol, Lusaka, Zambia.; Simwaka, J (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	juliasimwaka1@gmail.com	Munsaka, Sody/AAD-9186-2022	Munsaka, Sody/0000-0002-6917-3888	WHO	WHO(World Health Organization)	Financial support for test kits used to test samples come from WHO. The funders had no role in the design of the study, collection, analysis, and interpretation of data and in writing the manuscript.	Afrad MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-320; Aladin F, 2010, J CLIN VIROL, V47, P340, DOI 10.1016/j.jcv.2010.01.004; Ali Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161345; [Anonymous], 2002, GEN PROT 1 HOSP BAS; [Anonymous], 2015, WORLD J VACCINES, DOI DOI 10.4236/WJV.2015.51006; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Beres LK, 2016, CLIN INFECT DIS, V62, pS175, DOI 10.1093/cid/civ1206; Bucardo F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.01.022; Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f; Cunliffe NA, 2012, VACCINE, V30, pA36, DOI 10.1016/j.vaccine.2011.09.120; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Heylen E, 2016, J INFECT DIS, V214, P1039, DOI 10.1093/infdis/jiw247; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Huang PW, 2012, J VIROL, V86, P4833, DOI 10.1128/JVI.05507-11; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Jere KC, 2018, J VIROL, V92, DOI 10.1128/JVI.01246-17; Kaonga P, 2017, AM J TROP MED HYG, V97, P1603, DOI 10.4269/ajtmh.17-0365; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Mpabalwani EM, 2016, CLIN INFECT DIS, V62, pS183, DOI 10.1093/cid/civ1027; Muendo C, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1291-8; Mukaratirwa Arnold, 2018, Vaccine, V36, P7248, DOI 10.1016/j.vaccine.2018.03.069; Munsaka S, 2018, PEDIAT INFECT DIS, V3, P4; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Paulke-Korinek M, 2013, VACCINE, V31, P2686, DOI 10.1016/j.vaccine.2013.04.001; Pelaez-Carvajal D, 2014, J MED VIROL, V86, P1083, DOI 10.1002/jmv.23899; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Seheri L M, 2018, Vaccine, V36, P7222, DOI 10.1016/j.vaccine.2017.11.068; Sherchand JB, 2018, VACCINE, V36, P7841, DOI 10.1016/j.vaccine.2018.07.044; Sibomana Hassan, 2018, Vaccine, V36, P7135, DOI 10.1016/j.vaccine.2018.01.072; Simwaka J C, 2018, Vaccine, V36, P7243, DOI 10.1016/j.vaccine.2018.03.035; Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213; Tagbo BN, 2018, VACCINE, V36, P7759, DOI 10.1016/j.vaccine.2018.03.084; Tanaka T, 2017, JAPANESE J INFECT DI; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vizzi E, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0721-9	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246025	10.1371/journal.pone.0246025	http://dx.doi.org/10.1371/journal.pone.0246025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539399	gold, Green Published			2022-12-26	WOS:000616960200023
J	King, L; Flaus, A; Holian, E; Golden, A				King, Lydia; Flaus, Andrew; Holian, Emma; Golden, Aaron			Survival outcomes are associated with genomic instability in luminal breast cancers	PLOS ONE			English	Article							LANDSCAPE	Breast cancer is the leading cause of cancer related death among women. Breast cancers are generally diagnosed and treated based on clinical and histopathological features, along with subtype classification determined by the Prosigna Breast Cancer Prognostic Gene Signature Assay (also known as PAM50). Currently the copy number alteration (CNA) landscape of the tumour is not considered. We set out to examine the role of genomic instability (GI) in breast cancer survival since CNAs reflect GI and correlate with survival in other cancers. We focused on the 70% of breast cancers classified as luminal and carried out a comprehensive survival and association analysis using Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) data to determine whether CNA Score Quartiles derived from absolute CNA counts are associated with survival. Analysis revealed that patients diagnosed with luminal A breast cancer have a CNA landscape associated with disease specific survival, suggesting that CNA Score can provide a statistically robust prognostic factor. Furthermore, stratification of patients into subtypes based on gene expression has shown that luminal A and B cases overlap, and it is in this region we largely observe luminal A cases with reduced survival outlook. Therefore, luminal A breast cancer patients with quantitatively elevated CNA counts may benefit from more aggressive therapy. This demonstrates how individual genomic landscapes can facilitate personalisation of therapeutic interventions to optimise survival outcomes.	[King, Lydia] Natl Univ Ireland Galway, SFI Ctr Res Training Genom Data Sci, Galway, Ireland; [King, Lydia; Holian, Emma; Golden, Aaron] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Bioinformat & Biostat Res Cluster, Galway, Ireland; [Flaus, Andrew] Natl Univ Ireland Galway, Ctr Chromosome Biol, Sch Nat Sci, Biochem, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Golden, A (corresponding author), Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Bioinformat & Biostat Res Cluster, Galway, Ireland.	aaron.golden@nuigalway.ie		Holian, Emma/0000-0003-1763-7422; King, Lydia/0000-0002-0696-9811	NUI Galway's Office of the Vice President for Equality and Diversity	NUI Galway's Office of the Vice President for Equality and Diversity	NUI Galway's Office of the Vice President for Equality and Diversity provided support in the form of an Athena Swan Midcareer Lecturer Research Capacity Building Grant awarded to AG which was used to cover the publication costs. No additional external funding was received for this study.	Aapro M, 2006, EJC SUPPL, V4, P1, DOI 10.1016/S1359-6349(06)80001-7; ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2015, J MACH LEARN RES, V16, P3905; Kalimutho M, 2019, TRENDS PHARMACOL SCI, V40, P198, DOI 10.1016/j.tips.2019.01.005; Kalimutho M, 2015, TRENDS PHARMACOL SCI, V36, P822, DOI 10.1016/j.tips.2015.08.009; Langlands FE, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120601; Lee JK, 2016, ANNU REV PATHOL-MECH, V11, P283, DOI 10.1146/annurev-pathol-012615-044446; Li ZB, 2020, INT J ONCOL, V56, P522, DOI 10.3892/ijo.2019.4950; Mathur S, 2017, BIOMED REP, V7, P3, DOI 10.3892/br.2017.922; Mayakonda A., 2018, MAFTOOLS EFFICIENT C; Nielsen T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-177; Ohnstad HO, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0911-9; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rodriguez-Rodriguez L, 2016, GYNECOL ONCOL, V141, P2, DOI 10.1016/j.ygyno.2016.02.021; Russnes HG, 2017, AM J PATHOL, V187, P2152, DOI 10.1016/j.ajpath.2017.04.022; Saadatmand S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4901; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stopsack KH, 2019, P NATL ACAD SCI USA, V116, P11390, DOI 10.1073/pnas.1902645116; Therneau T.M., 2000, MODELING SURVIVAL DA; Tishchenko I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158259; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Tot T, 2011, BREAST CANCER: A LOBAR DISEASE, P1, DOI 10.1007/978-1-84996-314-5; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Zhang LF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00421	36	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245042	10.1371/journal.pone.0245042	http://dx.doi.org/10.1371/journal.pone.0245042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2HP	33534788	Green Published, gold, Green Submitted			2022-12-26	WOS:000616720600001
J	Zhao, YW; Liu, YH				Zhao, Yawu; Liu, Yihui			OCLSTM: Optimized convolutional and long short-term memory neural network model for protein secondary structure prediction	PLOS ONE			English	Article							MACHINE	Protein secondary structure prediction is extremely important for determining the spatial structure and function of proteins. In this paper, we apply an optimized convolutional neural network and long short-term memory neural network models to protein secondary structure prediction, which is called OCLSTM. We use an optimized convolutional neural network to extract local features between amino acid residues. Then use the bidirectional long short-term memory neural network to extract the remote interactions between the internal residues of the protein sequence to predict the protein structure. Experiments are performed on CASP10, CASP11, CASP12, CB513, and 25PDB datasets, and the good performance of 84.68%, 82.36%, 82.91%, 84.21% and 85.08% is achieved respectively. Experimental results show that the model can achieve better results.	[Zhao, Yawu; Liu, Yihui] Qilu Univ Technol, Shandong Acad Sci, Sch Comp Sci & Technol, Jinan, Peoples R China	Qilu University of Technology	Liu, YH (corresponding author), Qilu Univ Technol, Shandong Acad Sci, Sch Comp Sci & Technol, Jinan, Peoples R China.	yxl@qlu.edu.cn		zhao, yawu/0000-0002-7278-3097	National Natural Science Foundation of China [61375013]; Natural Science Foundation of Shandong Province [ZR2013FM020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported in part by the National Natural Science Foundation of China under Grant 61375013 and the Natural Science Foundation of Shandong Province under grant ZR2013FM020.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Aydin Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-154; Burgard W, 2007, ACTIVE POLICY LEARNI; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fang C, 2018, PROTEINS, V86, P592, DOI 10.1002/prot.25487; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Guo YB, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2940-0; Heffernan R, 2017, BIOINFORMATICS; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hu HJ, 2004, IEEE T NANOBIOSCI, V3, P265, DOI 10.1109/TNB.2004.837906; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kedarisetti KD, 2006, BIOCHEM BIOPH RES CO, V348, P981, DOI 10.1016/j.bbrc.2006.07.141; Khajah M, 2016, CHI C HUMAN FACTORS; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LI Z, 2016, INT JOINT C ARTIFICI; Liu YC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2306-6; Ma YM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28084-8; Magnan CN, 2014, BIOINFORMATICS, V30, P2592, DOI 10.1093/bioinformatics/btu352; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Schuldt C, 2004, INT C PATT RECOG, P32, DOI 10.1109/ICPR.2004.1334462; Shahriari B, 2016, P IEEE, V104, P148, DOI 10.1109/JPROC.2015.2494218; Snderby S K, 2014, COMPUTERENCE; Snoke J, 2012, ADV NEURAL INFORM PR, P4; Vanchinathan H, 2014, ACM C RECOMMENDER SY; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18962; Yang YD, 2018, BRIEF BIOINFORM, V19, P482, DOI 10.1093/bib/bbw129; Zhou JY, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2067-8	34	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245982	10.1371/journal.pone.0245982	http://dx.doi.org/10.1371/journal.pone.0245982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534819	Green Published, gold			2022-12-26	WOS:000616739700044
J	Gai, N; Aoyama, K; Faraoni, D; Goldenberg, NM; Levin, DN; Maynes, JT; McVey, MJ; Munshey, F; Siddiqui, A; Switzer, T; Steinberg, BE				Gai, Nan; Aoyama, Kazuyoshi; Faraoni, David; Goldenberg, Neil M.; Levin, David N.; Maynes, Jason T.; McVey, Mark J.; Munshey, Farrukh; Siddiqui, Asad; Switzer, Timothy; Steinberg, Benjamin E.			General medical publications during COVID-19 show increased dissemination despite lower validation	PLOS ONE			English	Article								Background The COVID-19 pandemic has yielded an unprecedented quantity of new publications, contributing to an overwhelming quantity of information and leading to the rapid dissemination of less stringently validated information. Yet, a formal analysis of how the medical literature has changed during the pandemic is lacking. In this analysis, we aimed to quantify how scientific publications changed at the outset of the COVID-19 pandemic. Methods We performed a cross-sectional bibliometric study of published studies in four high-impact medical journals to identify differences in the characteristics of COVID-19 related publications compared to non-pandemic studies. Original investigations related to SARS-CoV-2 and COVID-19 published in March and April 2020 were identified and compared to non-COVID-19 research publications over the same two-month period in 2019 and 2020. Extracted data included publication characteristics, study characteristics, author characteristics, and impact metrics. Our primary measure was principal component analysis (PCA) of publication characteristics and impact metrics across groups. Results We identified 402 publications that met inclusion criteria: 76 were related to COVID-19; 154 and 172 were non-COVID publications over the same period in 2020 and 2019, respectively. PCA utilizing the collected bibliometric data revealed segregation of the COVID-19 literature subset from both groups of non-COVID literature (2019 and 2020). COVID-19 publications were more likely to describe prospective observational (31.6%) or case series (41.8%) studies without industry funding as compared with non-COVID articles, which were represented primarily by randomized controlled trials (32.5% and 36.6% in the non-COVID literature from 2020 and 2019, respectively). Conclusions In this cross-sectional study of publications in four general medical journals, COVID-related articles were significantly different from non-COVID articles based on article characteristics and impact metrics. COVID-related studies were generally shorter articles reporting observational studies with less literature cited and fewer study sites, suggestive of more limited scientific support. They nevertheless had much higher dissemination.	[Gai, Nan; Aoyama, Kazuyoshi; Faraoni, David; Goldenberg, Neil M.; Levin, David N.; Maynes, Jason T.; McVey, Mark J.; Munshey, Farrukh; Siddiqui, Asad; Switzer, Timothy; Steinberg, Benjamin E.] Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON, Canada; [Aoyama, Kazuyoshi] SickKids Res Inst, Program Child Hlth Evaluat Sci, Toronto, ON, Canada; [Goldenberg, Neil M.] SickKids Res Inst, Program Cell Biol, Toronto, ON, Canada; [Maynes, Jason T.] SickKids Res Inst, Program Mol Med, Toronto, ON, Canada; [McVey, Mark J.] SickKids Res Inst, Program Translat Med, Toronto, ON, Canada; [Steinberg, Benjamin E.] SickKids Res Inst, Program Neurosci & Mental Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Steinberg, BE (corresponding author), Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON, Canada.; Steinberg, BE (corresponding author), SickKids Res Inst, Program Neurosci & Mental Hlth, Toronto, ON, Canada.	benjamin.steinberg@sickkids.ca		McVey, Mark/0000-0002-0918-7030	Department of Anesthesia and Pain Medicine at the Hospital for Sick Children	Department of Anesthesia and Pain Medicine at the Hospital for Sick Children	Funding was provided through departmental funds from the Department of Anesthesia and Pain Medicine at the Hospital for Sick Children.	Adaptive Platform Trials Coalition, 2019, Nat Rev Drug Discov, V18, P797, DOI 10.1038/s41573-019-0034-3; Balaphas A, 2020, J EPIDEMIOL COMMUN H, V74, P766, DOI 10.1136/jech-2020-214617; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P1256, DOI 10.1001/jama.2020.3980; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P2262, DOI 10.1001/jama.2020.8115; Califf RM, 2020, JAMA-J AM MED ASSOC, V324, P625, DOI 10.1001/jama.2020.13319; Cheng MHP, 2020, CAN MED ASSOC J, V192, pE405, DOI 10.1503/cmaj.200438; Clarivate Web of Science, 2020, WEB SCI J CITATION R; Dean NE, 2020, NEW ENGL J MED, V382, P1366, DOI 10.1056/NEJMsb1905390; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; London AJ, 2020, SCIENCE, V368, P476, DOI 10.1126/science.abc1731; McDermott MM, 2020, JAMA-J AM MED ASSOC, V323, P2135, DOI 10.1001/jama.2020.4689; Pundi K, 2020, JAMA INTERN MED, V180, P1398, DOI 10.1001/jamainternmed.2020.2904; Salazar JW, 2020, JAMA INTERN MED, V180, P1400, DOI 10.1001/jamainternmed.2020.2882; Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659; The Johns Hopkins University, 2020, 2019 NOV COR RES COM; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang LL, 2020, ARXIV200410706; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Zarin DA, 2019, JAMA-J AM MED ASSOC, V322, P813, DOI 10.1001/jama.2019.9892	19	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246427	10.1371/journal.pone.0246427	http://dx.doi.org/10.1371/journal.pone.0246427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529266	gold, Green Published			2022-12-26	WOS:000616736200019
J	Muttineni, R; Kammili, N; Bingi, TC; Rao, MR; Putty, K; Dholaniya, PS; Puli, RK; Pakalapati, S; Saritha, S; Shekar, K; Doodipala, MR; Upadhyay, AA; Bosinger, SE; Amara, RR; Kondapi, AK				Muttineni, Radhakrishna; Kammili, Nagamani; Bingi, Thrilok Chander; Rao, Raja M.; Putty, Kalyani; Dholaniya, Pankaj Singh; Puli, Ravi Kumar; Pakalapati, Sunitha; Saritha, S.; Shekar, K.; Doodipala, Mallikarjuna Reddy; Upadhyay, Amit A.; Bosinger, Steven E.; Amara, Rama R.; Kondapi, Anand K.			Clinical and whole genome characterization of SARS-CoV-2 in India	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; WEB SERVER; CORONAVIRUS; PROTEIN	We report clinical profile of hundred and nine patients with SARS CoV-2 infection, and whole genome sequences (WGS) of seven virus isolates from the first reported cases in India, with various international travel histories. Comorbidities such as diabetes, hypertension, and cardiovascular disease were frequently associated with severity of the disease. WBC and neutrophil counts showed an increase, while lymphocyte counts decreased in patients with severe infection suggesting a possible neutrophil mediated organ damage, while immune activity may be diminished with decrease in lymphocytes leading to disease severity. Increase in SGOT, SGPT and blood urea suggests the functional deficiencies of liver, heart, and kidney in patients who succumbed to the disease when compared to the group of recovered patients. The WGS analysis showed that these isolates were classified into two clades: I/A3i, and A2a (four according to GISAID: O, L, GR, and GH). Further, WGS phylogeny and travel history together indicate possible transmission from Middle East and Europe. Three S protein variants: Wuhan reference, D614G, and Y28H were identified predicted to possess different binding affinities to host ACE2.	[Muttineni, Radhakrishna; Shekar, K.] Osmania Univ, Dept Zool, Virus Res Lab, Hyderabad, India; [Kammili, Nagamani; Pakalapati, Sunitha] Gandhi Med Coll & Hosp, Dept Microbiol, Secunderabad, India; [Bingi, Thrilok Chander; Rao, Raja M.] Gandhi Med Coll & Hosp, Dept Gen Med, Secunderabad, India; [Putty, Kalyani] PVNR Telangana Vet Univ, Coll Vet Sci, Dept Vet Biotechnol, Hyderabad, India; [Dholaniya, Pankaj Singh; Saritha, S.; Kondapi, Anand K.] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad, India; [Puli, Ravi Kumar] Govt Telangana, Telangana State Council Sci & Technol, Hyderabad, India; [Doodipala, Mallikarjuna Reddy] GITAM Univ, Dept Math, Hyderabad, India; [Upadhyay, Amit A.; Amara, Rama R.] Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Bosinger, Steven E.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kondapi, Anand K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Osmania University; Gandhi Medical College & Hospital, Hyderabad; Gandhi Medical College & Hospital, Hyderabad; University of Hyderabad; Gandhi Institute of Technology & Management (GITAM); Emory University; Emory University; Colorado State University	Kondapi, AK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad, India.; Amara, RR (corresponding author), Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.; Kondapi, AK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	ramara@emory.edu; akondapi@gmail.com	Upadhyay, Amit/R-5056-2019; Amara, Rama/AAO-8136-2021	Upadhyay, Amit/0000-0002-0952-4164; Bingi, Thrilok Chander/0000-0002-6151-3868; Dholaniya, Pankaj Singh/0000-0001-8615-9861; Reddy Doodipala, Mallikarjuna/0000-0002-6917-1401				[Anonymous], INDIA WHO CORONAVIRU, DOI https://covid19.who.int/region/searo/country/in; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Banu S., 2020, DISTRICT PHYLOGENETI, DOI [10.1101/2020.05.31.126136, DOI 10.1101/2020.05.31.126136]; Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Bhattacharjee B., 2020, PHYLOGENETIC CLUSTER, DOI [10.1101/2020.05.28.122143, DOI 10.1101/2020.05.28.122143]; Bonow RO, 2020, JAMA CARDIOL, V5, P751, DOI 10.1001/jamacardio.2020.1105; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brouard JS, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0359-0; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chang CK, 2009, J VIROL, V83, P2255, DOI 10.1128/JVI.02001-08; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Cho SJ, 2020, ANNU REV PHYSIOL, V82, P433, DOI 10.1146/annurev-physiol-021119-034610; Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001; Deng Y, 2020, CHINESE MED J-PEKING, V133, P1261, DOI 10.1097/CM9.0000000000000824; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kin N, 2015, VIRUSES-BASEL, V7, P2358, DOI 10.3390/v7052358; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Ladha KS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008990; Leggett Richard M., 2013, Frontiers in Genetics, V4, P288, DOI 10.3389/fgene.2013.00288; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li TS, 2004, J INFECT DIS, V189, P648, DOI 10.1086/381535; Lillie PJ, 2020, J INFECTION, V80, P600, DOI 10.1016/j.jinf.2020.02.020; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj VS, 2014, CURR OPIN VIROL, V5, P58, DOI 10.1016/j.coviro.2014.01.010; Richman DD, CLIN VIROLOGY, V4th; Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Xue LC, 2016, BIOINFORMATICS, V32, P3676, DOI 10.1093/bioinformatics/btw514; Yadav PD, 2020, INDIAN J MED RES, V151, P200, DOI 10.4103/ijmr.IJMR_663_20; Yao X H, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P411, DOI 10.3760/cma.j.cn112151-20200312-00193; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246173	10.1371/journal.pone.0246173	http://dx.doi.org/10.1371/journal.pone.0246173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529260	Green Published, gold			2022-12-26	WOS:000616736200013
J	Xie, ZJ; Xin, SL; Chang, C; Zhou, HJ; Zhao, XF; Jiao, FH; Chen, C; Li, T				Xie, Zhi-Jiang; Xin, Shuan-Li; Chang, Chao; Zhou, Hai-Jing; Zhao, Xiu-Feng; Jiao, Feng-Hui; Chen, Chuan; Li, Tao			Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome	PLOS ONE			English	Article							PLATELET REACTIVITY; ADAPT-DES; CLOPIDOGREL; INTERVENTION; ATHEROSCLEROSIS; RISK; CARE	This study was to compare the efficacy and safety of combined glycoprotein IIb/IIIa inhibitor (GPI) and ticagrelor versus ticagrelor in patients with acute coronary syndrome (ACS). An observational study was conducted using the Improving Care for Cardiovascular Disease in China-ACS project. Totally, 13,264 patients with ACS and received combination therapy or ticagrelor therapy were analyzed. The primary outcome was the composite of major cardiovascular events (MACE: all-cause mortality, myocardial infarction [MI], stent thrombosis, cardiogenic shock, and ischemic stroke), and secondary outcomes included all-cause mortality, MI, stent thrombosis, cardiogenic shock, and ischemic stroke. The multivariable adjusted analysis indicated that combination therapy was associated with an increased risk of major cardiovascular events (MACE) (P = 0.001), any bleeding (P<0.001), and major bleeding (P = 0.005). Moreover, the multivariable adjusted for propensity score-matched (PSM) analysis suggested that combination therapy produced additional risk of MACE (P = 0.014), any bleeding (P<0.001), and major bleeding (P = 0.005). Moreover, PSM analysis suggested that combination therapy was associated with greater risk of stent thrombosis (P = 0.012) and intracranial bleeding (P = 0.020). Combined GPI and ticagrelor therapies did not have any beneficial effects on MACE, stent thrombosis, intracranial bleeding, any bleeding, or major bleeding.	[Xie, Zhi-Jiang; Xin, Shuan-Li; Chang, Chao; Zhou, Hai-Jing; Zhao, Xiu-Feng; Jiao, Feng-Hui; Chen, Chuan] Handan First Hosp, Dept Cardiol, Handan, Peoples R China; [Li, Tao] Handan Cent Hosp, Dept Gynecol, Handan, Peoples R China		Xin, SL (corresponding author), Handan First Hosp, Dept Cardiol, Handan, Peoples R China.	latitude607@163.com						Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; Angiolillo DJ, 2016, J AM COLL CARDIOL, V67, P603, DOI 10.1016/j.jacc.2015.11.044; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Dodd KS, 2011, J AM GERIATR SOC, V59, P506, DOI 10.1111/j.1532-5415.2010.03305.x; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Hao YC, 2016, AM HEART J, V179, P107, DOI 10.1016/j.ahj.2016.06.005; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; Judge HM, 2005, PLATELETS, V16, P398, DOI 10.1080/09537100500163226; Karathanos A, 2019, CAN J CARDIOL, V35, P1576, DOI 10.1016/j.cjca.2019.05.003; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Mangiacapra F, 2010, JACC-CARDIOVASC INTE, V3, P35, DOI 10.1016/j.jcin.2009.10.024; Mathews R, 2011, AM J CARDIOL, V107, P1136, DOI 10.1016/j.amjcard.2010.12.009; Steinhubl SR, 2001, CIRCULATION, V103, P2572; Stone GW, 2007, LANCET, V369, P907, DOI 10.1016/S0140-6736(07)60450-4; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang TY, 2011, CIRCULATION, V123, P722, DOI 10.1161/CIRCULATIONAHA.110.958041; Yun KH, 2016, JACC-CARDIOVASC IMAG, V9, P849, DOI 10.1016/j.jcmg.2015.08.019; Zhao GQ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008100; Zhou MG, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0793-x	24	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246166	10.1371/journal.pone.0246166	http://dx.doi.org/10.1371/journal.pone.0246166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529262	gold, Green Published			2022-12-26	WOS:000616736200063
J	Hierro-Yap, C; Subrtova, K; Gahura, O; Panicucci, B; Dewar, C; Chinopoulos, C; Schnaufer, A; Zikova, A				Hierro-Yap, Carolina; Subrtova, Karolina; Gahura, Ondrej; Panicucci, Brian; Dewar, Caroline; Chinopoulos, Christos; Schnaufer, Achim; Zikova, Alena			Bioenergetic consequences of FoF1-ATP synthase/ATPase deficiency in two life cycle stages of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE EXPRESSION SYSTEM; BLOOD-STREAM FORM; ATP SYNTHASE; ALTERNATIVE OXIDASE; KINETOPLAST DNA; ENERGY-METABOLISM; GLYCOLYTIC FLUX; PROTEIN; SUBUNITS; COMPLEX	Mitochondrial ATP synthase is a reversible nanomotor synthesizing or hydrolyzing ATP depending on the potential across the membrane in which it is embedded. In the unicellular parasite Trypanosoma brucei, the direction of the complex depends on the life cycle stage of this digenetic parasite: in the midgut of the tsetse fly vector (procyclic form), the FoF1-ATP synthase generates ATP by oxidative phosphorylation, whereas in the mammalian bloodstream form, this complex hydrolyzes ATP and maintains mitochondrial membrane potential (Delta Psi m). The trypanosome FoF1-ATP synthase contains numerous lineage-specific subunits whose roles remain unknown. Here, we seek to elucidate the function of the lineage-specific protein Tb1, the largest membrane-bound subunit. In procyclic form cells, Tb1 silencing resulted in a decrease of FoF1-ATP synthase monomers and dimers, rerouting of mitochondrial electron transfer to the alternative oxidase, reduced growth rate and cellular ATP levels, and elevated Delta Psi m and total cellular reactive oxygen species levels. In bloodstream form parasites, RNAi silencing of Tb1 by similar to 90% resulted in decreased FoF1-ATPase monomers and dimers, but it had no apparent effect on growth. The same findings were obtained by silencing of the oligomycin sensitivity-conferring protein, a conserved subunit in T. brucei FoF1-ATP synthase. However, as expected, nearly complete Tb1 or oligomycin sensitivity-conferring protein suppression was lethal because of the inability to sustain Delta Psi m. The diminishment of FoF1-ATPase complexes was further accompanied by a decreased ADP/ATP ratio and reduced oxygen consumption via the alternative oxidase. Our data illuminate the often diametrically opposed bioenergetic consequences of FoF1-ATP synthase loss in insect versus mammalian forms of the parasite.	[Hierro-Yap, Carolina; Subrtova, Karolina; Gahura, Ondrej; Panicucci, Brian; Zikova, Alena] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Hierro-Yap, Carolina; Zikova, Alena] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Subrtova, Karolina; Dewar, Caroline; Schnaufer, Achim] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Budapest, Hungary; [Dewar, Caroline] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Edinburgh; Semmelweis University; University of Bern	Zikova, A (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.; Zikova, A (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	azikova@paru.cas.cz	Gahura, Ondřej/G-7885-2014	Gahura, Ondřej/0000-0002-2925-4763; Schnaufer, Achim/0000-0003-2132-5560; Subrtova, Karolina/0000-0001-9147-7063; Hierro-Yap, Carolina/0000-0001-9014-9551; Dewar, Caroline/0000-0002-0107-6985	Czech Science Foundation [18-17529S]; European Regional Development Fund; Ministry of Education, Youth and Sport [CZ.02.1.01/0.0/0.0/16_019/0000759]; UK Medical Research Council, United Kingdom [MR/L019701/1]; NKFIH [KH129567, K135027]; MRC [MR/L019701/1] Funding Source: UKRI	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); Ministry of Education, Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic); UK Medical Research Council, United Kingdom; NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Czech Science Foundation (18-17529S) and European Regional Development Fund and Ministry of Education, Youth and Sport (CZ.02.1.01/0.0/0.0/16_019/0000759) to A. Z., a Senior Fellowship from the UK Medical Research Council, United Kingdom (MR/L019701/1) to A. S., and by grants from NKFIH [KH129567] and [K135027] to C. C.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; Agbe A, 1995, J PARASITOL, V81, P968, DOI 10.2307/3284050; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bakker BM, 1999, P NATL ACAD SCI USA, V96, P10098, DOI 10.1073/pnas.96.18.10098; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brun R, 1998, VET PARASITOL, V79, P95, DOI 10.1016/S0304-4017(98)00146-0; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Carnes J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003404; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Chen XJ, 2000, INT REV CYTOL, V194, P197; Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Chowdhury SR, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150244; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Eze AA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004791; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Figueiredo L. M., 2017, F1000RES, V6; Flaspohler JA, 2010, EUKARYOT CELL, V9, P1702, DOI 10.1128/EC.00106-10; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; FUTAI M, 1983, MICROBIOL REV, V47, P285, DOI 10.1128/MMBR.47.3.285-312.1983; Gahura O, 2018, FEBS J, V285, P4413, DOI 10.1111/febs.14672; Gahura O, 2018, FEBS J, V285, P614, DOI 10.1111/febs.14364; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Giordani F, 2016, PARASITOLOGY, V143, P1862, DOI 10.1017/S0031182016001268; Gnipova A, 2012, MOL BIOCHEM PARASIT, V184, P90, DOI 10.1016/j.molbiopara.2012.04.013; Gould MK, 2014, ANTIMICROB AGENTS CH, V58, P2925, DOI 10.1128/AAC.00122-14; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Horvath A, 2005, MOL MICROBIOL, V58, P116, DOI 10.1111/j.1365-2958.2005.04813.x; KIAIRA JK, 1994, BIOTECHNOL APPL BIOC, V20, P347, DOI 10.1111/j.1470-8744.1994.tb00322.x; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Luevano-Martinez LA, 2020, FEBS LETT, V594, P2150, DOI 10.1002/1873-3468.13790; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; MILLER PGG, 1980, J GEN MICROBIOL, V116, P391; Miranda-Astudillo H, 2014, BBA-BIOENERGETICS, V1837, P1, DOI 10.1016/j.bbabio.2013.08.001; Montgomery MG, 2018, P NATL ACAD SCI USA, V115, P2102, DOI 10.1073/pnas.1720940115; Motta MCM, 2008, CURR PHARM DESIGN, V14, P847, DOI 10.2174/138161208784041051; Muhleip A, 2019, ELIFE, V8, DOI 10.7554/eLife.51179; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Panicucci B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005552; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Perez E, 2014, MITOCHONDRION, V19, P338, DOI 10.1016/j.mito.2014.02.001; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Prochazkova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23472-6; RUYTER GJG, 1991, J BACTERIOL, V173, P6184, DOI 10.1128/jb.173.19.6184-6191.1991; Salunke R, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006128; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2010, TRENDS PARASITOL, V26, P557, DOI 10.1016/j.pt.2010.08.001; SHAPIRO TA, 1990, P NATL ACAD SCI USA, V87, P950, DOI 10.1073/pnas.87.3.950; STUART KD, 1971, J CELL BIOL, V49, P189, DOI 10.1083/jcb.49.1.189; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; van Hellemond JJ, 2005, ADV MICROB PHYSIOL, V50, P199, DOI 10.1016/S0065-2911(05)50005-5; van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060; Vertommen D, 2008, MOL BIOCHEM PARASIT, V158, P189, DOI 10.1016/j.molbiopara.2007.12.008; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	78	7	7	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100357	10.1016/j.jbc.2021.100357	http://dx.doi.org/10.1016/j.jbc.2021.100357			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539923	gold, Green Published			2022-12-26	WOS:000672866400331
J	Medapati, MR; Singh, N; Bhagirath, AY; Duan, KM; Triggs-Raine, B; Batista, EL; Chelikani, P				Medapati, Manoj Reddy; Singh, Nisha; Bhagirath, Anjali Yadav; Duan, Kangmin; Triggs-Raine, Barbara; Batista, Eraldo L.; Chelikani, Prashen			Bitter taste receptor T2R14 detects quorum sensing molecules from cariogenic Streptococcus mutans and mediates innate immune responses in gingival epithelial cells	FASEB JOURNAL			English	Article						competence stimulating peptide (CSP); gingival epithelial cell (GEC); host&#8208; pathogen interaction; innate immune responses; S; mutans	NF-KAPPA-B; PROTEIN-KINASE; ACTIVATION; EXPRESSION; PEPTIDE; FIBROBLASTS; INDUCTION; MECHANISM; GENOTYPE; CARIES	Host-pathogen interactions play an important role in defining the outcome of a disease. Recent studies have shown that the bacterial quorum sensing molecules (QSM) can interact with host cell membrane proteins, mainly G protein-coupled receptors (GPCRs), and induce innate immune responses. However, few studies have examined QSM-GPCR interactions and their influence on oral innate immune responses. In this study, we examined the role of bitter taste receptor T2R14 in sensing competence stimulating peptides (CSPs) secreted by cariogenic bacterium Streptococcus mutans and in mediating innate immune responses in gingival epithelial cells (GECs). Transcriptomic and western blot analyses identify T2R14 to be highly expressed in GECs. Our data show that only CSP-1 from S. mutans induces robust intracellular calcium mobilization compared to CSP-2 and CSP-3. By using CRISPR-Cas9, we demonstrate that CSP-1 induced calcium signaling and secretion of cytokines CXCL-8/IL-8, TNF-alpha, and IL-6 is mediated through T2R14 in GECs. Interestingly, the NF-kB signaling activated by CSP-1 in GECs was independent of T2R14. CSP-1-primed GECs attracted differentiated HL-60 immune cells (dHL-60) and this effect was abolished in T2R14 knock down GECs and also in cells primed with T2R14 antagonist 6-Methoxyflavone (6-MF). Our findings identify S. mutans CSP-1 as a peptide ligand for the T2R family. Our study establishes a novel host-pathogen interaction between cariogenic S. mutans CSP-1 and T2R14 in GECs leading to an innate immune response. Collectively, these findings suggest T2Rs as potential therapeutic targets to modulate innate immune responses upon oral bacterial infections.	[Medapati, Manoj Reddy; Singh, Nisha; Bhagirath, Anjali Yadav; Duan, Kangmin; Chelikani, Prashen] Univ Manitoba, Rady Fac Hlth Sci, Dr Gerald Niznick Coll Dent, Manitoba Chemosensory Biol Res Grp, Winnipeg, MB, Canada; [Medapati, Manoj Reddy; Singh, Nisha; Bhagirath, Anjali Yadav; Duan, Kangmin; Chelikani, Prashen] Univ Manitoba, Rady Fac Hlth Sci, Dr Gerald Niznick Coll Dent, Dept Oral Biol, Winnipeg, MB, Canada; [Bhagirath, Anjali Yadav; Duan, Kangmin; Triggs-Raine, Barbara; Chelikani, Prashen] Univ Manitoba, Childrens Hosp Res Inst Manitoba CHRIM, Winnipeg, MB, Canada; [Triggs-Raine, Barbara] Univ Manitoba, Rady Fac Hlth Sci, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Batista, Eraldo L.] Univ Manitoba, Rady Fac Hlth Sci, Dr Gerald Niznick Coll Dent, Dept Dent Diagnost & Clin Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Manitoba Chemosensory Biol Res Grp, D319, Winnipeg, MB R3E 0W4, Canada.; Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, 780 Bannatyne Ave, Winnipeg, MB R3E 0W4, Canada.	Prashen.Chelikani@umanitoba.ca	Bhagirath, Anjali Y./AAN-7643-2020; Medapati, Manoj Reddy/AAO-8337-2021; Batista, Eraldo/ABC-2646-2020; Medapati, Manoj Reddy/AFK-7969-2022	Bhagirath, Anjali Y./0000-0001-5175-0811; Medapati, Manoj Reddy/0000-0002-6342-5546; Triggs-Raine, Barbara/0000-0003-4719-6779; Batista Junior, Eraldo/0000-0003-0429-3560; Chelikani, Prashen/0000-0003-1129-7957; Duan, Kangmin/0000-0002-3016-786X	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [PJT-159731]; Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-04099, RGPIN-2020-05670]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: PJT-159731; Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: RGPIN-2014-04099 and RGPIN-2020-05670	Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Alfonso-Prieto M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00029; Allen JA, 2017, FASEB J, V31; Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Bikash CR, 2018, ACS INFECT DIS, V4, P1385, DOI 10.1021/acsinfecdis.8b00115; Boneschansker L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5787; Braschi B, 2019, NUCLEIC ACIDS RES, V47, pD786, DOI 10.1093/nar/gky930; Bufe B, 2015, J BIOL CHEM, V290, P7369, DOI 10.1074/jbc.M114.626747; Chandler JD, 2015, AM J RESP CELL MOL, V53, P193, DOI 10.1165/rcmb.2014-0208OC; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Feng P, 2015, BRAIN BEHAV IMMUN, V49, P32, DOI 10.1016/j.bbi.2015.04.001; Freund JR, 2018, J BIOL CHEM, V293, P9824, DOI 10.1074/jbc.RA117.001005; Gil S, 2015, MOL IMMUNOL, V68, P663, DOI 10.1016/j.molimm.2015.10.012; Gopallawa I, 2021, CELL MOL LIFE SCI, V78, P271, DOI 10.1007/s00018-020-03494-y; Gu Q, 2017, AM J PHYSIOL-LUNG C, V312, P1326, DOI 10.1152/ajplung.00468.2016; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; HILLMAN JD, 1987, J DENT RES, V66, P1092, DOI 10.1177/00220345870660060101; Horst OV, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-9; Hossain MS, 2012, J BACTERIOL, V194, P5886, DOI 10.1128/JB.01381-12; Jaggupilli A, 2018, ACS INFECT DIS, V4, P1146, DOI 10.1021/acsinfecdis.8b00094; Jaggupilli A, 2017, MOL CELL BIOCHEM, V426, P137, DOI 10.1007/s11010-016-2902-z; Kaur H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09334-3; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Meyle J, 2017, J CLIN PERIODONTOL, V44, P1215, DOI 10.1111/jcpe.12781; Millius A, 2010, METHODS MOL BIOL, V591, P147, DOI 10.1007/978-1-60761-404-3_9; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x; Pundir P, 2019, CELL HOST MICROBE, V26, P114, DOI 10.1016/j.chom.2019.06.003; Qiao H, 2009, FREE RADICAL BIO MED, V46, P1221, DOI 10.1016/j.freeradbiomed.2009.02.004; Ra C, 2017, J DENT ORAL HEALTH, V3, P1; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rasoamanana R, 2012, P NUTR SOC, V71, P446, DOI 10.1017/S0029665112000110; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Satoh A, 2006, AM J PHYSIOL-GASTR L, V291, pG432, DOI 10.1152/ajpgi.00579.2005; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shahrestanifar M, 1999, J BIOL CHEM, V274, P3828, DOI 10.1074/jbc.274.6.3828; Shaik FA, 2019, AM J PHYSIOL-LUNG C, V316, pL45, DOI 10.1152/ajplung.00169.2018; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Shandilya J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.343; Shultz S, 2008, J Biomol Tech, V19, P267; Singh N, 2020, MOL CELL BIOCHEM, V465, P199, DOI 10.1007/s11010-019-03679-5; Siripurapu P, 2017, J BIOL CHEM, V292, P17482, DOI 10.1074/jbc.M117.787838; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Syvitski RT, 2007, J BACTERIOL, V189, P1441, DOI 10.1128/JB.00832-06; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; Tanzer J M, 2001, J Dent Educ, V65, P1028; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiley SZ, 2018, FASEB J, V32, P1170, DOI 10.1096/fj.201700834R; Yadav VK, 2018, INT J MED MICROBIOL, V308, P858, DOI 10.1016/j.ijmm.2018.07.009; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12505-x; Zhu H, 2008, EYE CONTACT LENS, V34, P179, DOI 10.1097/ICL.0b013e318159afde; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	64	13	13	6	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21375	10.1096/fj.202000208R	http://dx.doi.org/10.1096/fj.202000208R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559200	Green Submitted			2022-12-26	WOS:000629576700021
J	Perez-Calpe, AV; Larranaga, A; von Schiller, D; Elosegi, A				Perez-Calpe, Ana Victoria; Larranaga, Aitor; von Schiller, Daniel; Elosegi, Arturo			Interactive effects of discharge reduction and fine sediments on stream biofilm metabolism	PLOS ONE			English	Article							NUTRIENT ENRICHMENT; WATER ABSTRACTION; PERIPHYTON BIOMASS; RIVER; FLOW; DAMS; VELOCITY; IMPACTS; CONSEQUENCES; ACCUMULATION	Discharge reduction, as caused by water diversion for hydropower, and fine sediments deposition, are prevalent stressors that may affect multiple ecosystem functions in streams. Periphytic biofilms play a key role in stream ecosystem functioning and are potentially affected by these stressors and their interaction. We experimentally assessed the interactive effects of discharge and fine sediments on biofilm metabolism in artificial indoor channels using a factorial split-plot design with two explanatory variables: water discharge (20, 39, 62, 141 and 174 cm(3) s(-1)) and fine sediments (no sediment or 1100 mg L-1 of sediments). We incubated artificial tiles for 25 days in an unpolluted stream to allow biofilm colonization, and then placed them into the indoor channels for acclimation for 18 days. Subsequently, we manipulated water discharge and fine sediments and, after 17 days, we measured biofilm chlorophyll-a concentration and metabolism. Water velocity (range, 0.5 to 3.0 cm s(-1)) and sediment deposition (range, 6.1 to 16.6 mg cm(-2)) increased with discharge, the latter showing that the effect of increased inputs prevailed over sloughing. In the no-sediment treatments, discharge did not affect biofilm metabolism, but reduced chlorophyll-a. Sediments, probably as a consequence of nutrients released, promoted metabolism of biofilm and chlorophyll-a, which became independent of water discharge. Our results indicate that pulses of fine sediments can promote biofilm algal biomass and metabolism, but show interactive effects with discharge. Although discharge reduction can affect the abundance of basal resources for food webs, its complex interactions with fine sediments make it difficult to forecast the extent and direction of the changes.	[Perez-Calpe, Ana Victoria; Larranaga, Aitor; Elosegi, Arturo] Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Bilbao, Spain; [von Schiller, Daniel] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain	University of Basque Country; University of Barcelona	Perez-Calpe, AV (corresponding author), Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Bilbao, Spain.	anavictoria.perez@ehu.eus	von Schiller, Daniel/C-1384-2009; Elosegi, Arturo/B-7796-2009	von Schiller, Daniel/0000-0002-9493-3244; Elosegi, Arturo/0000-0001-8809-8484; Perez-Calpe, Ana Victoria/0000-0001-5505-9489; LARRANAGA ARRIZABALAGA, AITOR/0000-0002-0185-9154	Spanish Department of Economy, Industry and Competitiveness [GL2016-77487-R, BES-2017-081959]; European Social Fund; Basque Government (Consolidated Research Group) [IT951-16]; Biscay Province Council [61/2015]	Spanish Department of Economy, Industry and Competitiveness; European Social Fund(European Social Fund (ESF)); Basque Government (Consolidated Research Group)(Basque Government); Biscay Province Council	This research was funded by the Spanish Department of Economy, Industry and Competitiveness through the project GL2016-77487-R (DIVERSION), the European Social Fund, the Basque Government (Consolidated Research Group IT951-16) and the Biscay Province Council (61/2015). AVPC carried out this work thanks to a pre-doctoral grant by the Spanish Department of Economy, Industry and Competitiveness (BES-2017-081959). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2009, FLUJO ENERGIA ECOSIS; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; [Anonymous], **DATA OBJECT**; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; Aristi I, 2016, ENVIRON POLLUT, V212, P208, DOI 10.1016/j.envpol.2016.01.067; Aristi I, 2014, FRESHWATER BIOL, V59, P1816, DOI 10.1111/fwb.12385; Arroita M, 2017, FRESHWATER BIOL, V62, P243, DOI 10.1111/fwb.12864; Arroita M, 2015, SCI TOTAL ENVIRON, V503, P233, DOI 10.1016/j.scitotenv.2014.06.124; Baattrup-Pedersen A, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139331; Baekkelie KAE, 2017, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2017041; Battin TJ, 2016, NAT REV MICROBIOL, V14, P251, DOI 10.1038/nrmicro.2016.15; Benejam L, 2016, ECOL FRESHW FISH, V25, P295, DOI 10.1111/eff.12210; Biggs BJF, 1996, REGUL RIVER, V12, P251, DOI 10.1002/(SICI)1099-1646(199603)12:2/3<251::AID-RRR393>3.0.CO;2-X; BIGGS BJF, 1994, FRESHWATER BIOL, V32, P49, DOI 10.1111/j.1365-2427.1994.tb00865.x; Biggs BJF, 1998, J PHYCOL, V34, P598, DOI 10.1046/j.1529-8817.1998.340598.x; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Buendia C, 2016, LAND DEGRAD DEV, V27, P1045, DOI 10.1002/ldr.2348; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Chase JW, 2017, WATER QUAL RES J CAN, V52, P151, DOI 10.2166/wqrj.2017.038; Chester H, 2006, HYDROBIOLOGIA, V572, P275, DOI 10.1007/s10750-006-0219-8; DAVIESCOLLEY RJ, 1992, HYDROBIOLOGIA, V248, P215, DOI 10.1007/BF00006149; Death RG, 2009, FRESHWATER BIOL, V54, P2037, DOI 10.1111/j.1365-2427.2009.02182.x; Dewson ZS, 2007, J N AM BENTHOL SOC, V26, P401, DOI 10.1899/06-110.1; Echenique-Subiabre I, 2016, WATER RES, V101, P341, DOI 10.1016/j.watres.2016.05.081; Elosegi A, 2013, HYDROBIOLOGIA, V712, P129, DOI 10.1007/s10750-012-1226-6; Environmental Protection Agency, 2007, 6500 ENV PROT AG; Francoeur SN, 2006, HYDROBIOLOGIA, V561, P59, DOI 10.1007/s10750-005-1604-4; Gonzalez JM, 2013, HYDROBIOLOGIA, V712, P117, DOI 10.1007/s10750-012-1144-7; GUASCH H, 1995, FRESHWATER BIOL, V33, P373, DOI 10.1111/j.1365-2427.1995.tb00399.x; Harris TD, 2015, LAKE RESERV MANAGE, V31, P127, DOI 10.1080/10402381.2015.1025153; Hondzo M, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001409; HORNER RR, 1981, CAN J FISH AQUAT SCI, V38, P449, DOI 10.1139/f81-062; Izagirre O, 2009, SCI TOTAL ENVIRON, V407, P5694, DOI 10.1016/j.scitotenv.2009.06.049; Kaller MD, 2004, HYDROBIOLOGIA, V518, P95, DOI 10.1023/B:HYDR.0000025059.82197.35; Kemp P, 2011, HYDROL PROCESS, V25, P1800, DOI 10.1002/hyp.7940; Kendrick MR, 2015, FRESHWATER BIOL, V60, P2323, DOI 10.1111/fwb.12659; LAMBERTI GA, 1983, ECOLOGY, V64, P1124, DOI 10.2307/1937823; LAU YL, 1993, WATER RES, V27, P355, DOI 10.1016/0043-1354(93)90034-F; Louhi P, 2017, CAN J FISH AQUAT SCI, V74, P32, DOI 10.1139/cjfas-2015-0530; Magbanua FS, 2016, FRESHW SCI, V35, P139, DOI 10.1086/684363; Martinez A, 2013, HYDROBIOLOGIA, V711, P31, DOI 10.1007/s10750-013-1459-z; Matthaei CD, 2010, J APPL ECOL, V47, P639, DOI 10.1111/j.1365-2664.2010.01809.x; McKay SF, 2006, RIVER RES APPL, P1032; McKenzie M, 2020, HYDROBIOLOGIA, V847, P697, DOI 10.1007/s10750-019-04131-x; Mendoza-Lera C, 2012, RIVER RES APPL, V28, P13, DOI 10.1002/rra.1434; Mori T, 2018, AQUAT SCI, V80, DOI 10.1007/s00027-017-0552-1; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; PERRY W B, 1982, Northwest Science, V56, P48; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Ponsati L, 2014, RIVER RES APPL, V22, P1085; REARDON J, 1966, CLIN CHIM ACTA, V14, P403, DOI 10.1016/0009-8981(66)90120-3; Rehg KJ, 2005, HYDROL PROCESS, V19, P413, DOI 10.1002/hyp.5540; Reid AJ, 2019, BIOL REV, V94, P849, DOI 10.1111/brv.12480; Romani AM, 2016, ECOLOGY WATER QUALIT; Sabater S, 2019, MULTIPLE STRESSORS IN RIVER ECOSYSTEMS: STATUS, IMPACTS AND PROSPECTS FOR THE FUTURE, P1, DOI 10.1016/C2016-0-01770-9; Sabater S, 2000, SCI TOTAL ENVIRON, V263, P185, DOI 10.1016/S0048-9697(00)00702-6; Sabater S, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00014; Sandin L, 2009, FRESHWATER BIOL, V54, P2017, DOI 10.1111/j.1365-2427.2009.02313.x; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; US EPA, 2000, EPA822B00002 OFF SCI; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wagenhoff A, 2013, FRESHWATER BIOL, V58, P1849, DOI 10.1111/fwb.12174; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Yamada H, 2002, RIVER RES APPL, V18, P481, DOI 10.1002/rra.688; Zabaleta A, 2007, CATENA, V71, P179, DOI 10.1016/j.catena.2006.06.007	66	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246719	10.1371/journal.pone.0246719	http://dx.doi.org/10.1371/journal.pone.0246719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571231	Green Published, gold			2022-12-26	WOS:000618274000109
J	Pamphlett, R; Doble, PA; Bishop, DP				Pamphlett, Roger; Doble, Philip A.; Bishop, David P.			Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism	PLOS ONE			English	Article							CADMIUM EXPOSURE; LEAD; EPIDEMIOLOGY; LOCALIZATION; DISEASE; PREVALENCE; TOXICOLOGY	Objective Mercury and other toxic metals have been suggested to be involved in thyroid disorders, but the distribution and prevalence of mercury in the human thyroid gland is not known. We therefore used two elemental bio-imaging techniques to look at the distribution of mercury and other toxic metals in the thyroid glands of people over a wide range of ages. Materials and methods Formalin-fixed paraffin-embedded thyroid tissue blocks were obtained from 115 people aged 1-104 years old, with varied clinicopathological conditions, who had thyroid samples removed during forensic/coronial autopsies. Seven-micron sections from these tissue blocks were used to detect intracellular inorganic mercury using autometallography. The presence of mercury was confirmed using laser ablation-inductively coupled plasma-mass spectrometry which can detect multiple elements. Results Mercury was found on autometallography in the thyroid follicular cells of 4% of people aged 1-29 years, 9% aged 30-59 years, and 38% aged 60-104 years. Laser ablation-inductively coupled plasma-mass spectrometry confirmed the presence of mercury in samples staining with autometallography, and detected cadmium, lead, iron, nickel and silver in selected samples. Conclusions The proportion of people with mercury in their thyroid follicular cells increases with age, until it is present in over one-third of people aged 60 years and over. Other toxic metals in thyroid cells could enhance mercury toxicity. Mercury can trigger genotoxicity, autoimmune reactions, and oxidative damage, which raises the possibility that mercury could play a role in the pathogenesis of thyroid cancers, autoimmune thyroiditis, and hypothyroidism.	[Pamphlett, Roger] Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Doble, Philip A.; Bishop, David P.] Univ Technol Sydney, Sch Math & Phys Sci, Elemental Bioimaging Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Technology Sydney	Pamphlett, R (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au	Bishop, David/F-2891-2019	Bishop, David/0000-0002-6533-4410	Australian Research Council [DP170100036, DP190102361]; Australian Research Council Discovery Early Career Researcher Award [DE180100194]; National Institute of Health [R21AR072950]; Aimee Stacy Memorial bequest; Ignacy Burnett bequest	Australian Research Council(Australian Research Council); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aimee Stacy Memorial bequest; Ignacy Burnett bequest	No specific funding for this project was received. However, the authors receive the following support not specific to this study: RP is supported by the Aimee Stacy Memorial and Ignacy Burnett bequests. PAD is supported by Australian Research Council Discovery Project Grants DP170100036 and DP190102361. DPB is supported by an Australian Research Council Discovery Early Career Researcher Award DE180100194. PAD and DPB are supported by a National Institute of Health Grant R21AR072950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12; Andreoli V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010093; Andrioli M, 2015, ENDOCRINE, V50, P807, DOI 10.1007/s12020-015-0581-2; Bjorkman L, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-30; Bridges CC, 2017, ARCH TOXICOL, V91, P63, DOI 10.1007/s00204-016-1803-y; Buha A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051501; Carcangiu ML, 1997, HISTOLOGY PATHOLOGIS, V2nd, P1075; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; Chen AM, 2013, ENVIRON HEALTH PERSP, V121, P181, DOI 10.1289/ehp.1205239; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P219, DOI 10.1177/33.3.2579122; DANSCHER G, 1986, HISTOCHEM J, V18, P109, DOI 10.1007/BF01675364; de Paiva CR, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00053; Duntas LH, 2008, NAT CLIN PRACT ENDOC, V4, P454, DOI 10.1038/ncpendmet0896; Duntas LH, 2006, THYROID, V16, P455, DOI 10.1089/thy.2006.16.455; EDWARDS CQ, 1983, ARCH INTERN MED, V143, P1890, DOI 10.1001/archinte.143.10.1890; Ferrari SM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00050; Guzzi G, 2006, AM J FOREN MED PATH, V27, P42, DOI 10.1097/01.paf.0000201177.62921.c8; HANSEN JC, 1989, SCI TOTAL ENVIRON, V78, P23, DOI 10.1016/0048-9697(89)90020-X; Hansen PS, 2006, EUR J ENDOCRINOL, V154, P29, DOI 10.1530/eje.1.02060; Hoshi N, 2007, ENDOCRINOLOGY, V148, P4251, DOI 10.1210/en.2006-0490; Joneidi Z, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108642; Karimi R, 2014, INT J HYG ENVIR HEAL, V217, P758, DOI 10.1016/j.ijheh.2014.03.007; KHAYAT A, 1984, ACTA PHARMACOL TOX, V55, P145; Kim J, 2020, NAT REV ENDOCRINOL, V16, P17, DOI 10.1038/s41574-019-0263-x; Kim SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40708-1; Kitahara CM, 2016, NAT REV ENDOCRINOL, V12, P646, DOI 10.1038/nrendo.2016.110; Krieg EF, 2016, AM J IND MED, V59, P583, DOI 10.1002/ajim.22591; Lavoie RA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24938-3; Leese GP, 2008, CLIN ENDOCRINOL, V68, P311, DOI 10.1111/j.1365-2265.2007.03051.x; Malandrino P, 2020, THYROID, V30, P290, DOI 10.1089/thy.2019.0244; Maliepaard M, 2001, CANCER RES, V61, P3458; Mancini A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6757154; Mao BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20728-z; Maqbool F, 2017, J ENVIRON SCI HEAL C, V35, P29, DOI 10.1080/10590501.2016.1278299; Marotta V, 2020, CRIT REV ONCOL HEMAT, V150, DOI 10.1016/j.critrevonc.2020.102950; Mato E, 2014, J MOL ENDOCRINOL, V52, P289, DOI 10.1530/JME-14-0051; McLeod DSA, 2012, ENDOCRINE, V42, P252, DOI 10.1007/s12020-012-9703-2; Nersesyan A, 2016, MUTAT RES-REV MUTAT, V770, P119, DOI 10.1016/j.mrrev.2016.04.002; Nie XM, 2017, ENVIRON POLLUT, V230, P320, DOI 10.1016/j.envpol.2017.06.052; Noureldine SI, 2015, CURR OPIN ONCOL, V27, P21, DOI 10.1097/CCO.0000000000000150; Pamphlett R, 1998, J NEUROL SCI, V159, P121, DOI 10.1016/S0022-510X(98)00161-0; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238990; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233300; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228226; Pamphlett R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00419; Perga S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00311; Pollard KM, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.02.001; Pollard KM, 2010, CHEM RES TOXICOL, V23, P455, DOI 10.1021/tx9003787; Rana SVS, 2014, BIOL TRACE ELEM RES, V160, P1, DOI 10.1007/s12011-014-0023-7; Saranac L, 2011, HORM RES PAEDIAT, V75, P157, DOI 10.1159/000324442; Stojsavljevic A, 2020, EXPOS HEALTH, V12, P255, DOI 10.1007/s12403-019-00309-9; Stojsavljevic A, 2020, ENVIRON RES, V186, DOI 10.1016/j.envres.2020.109538; Streets DG, 2018, SCI TOTAL ENVIRON, V615, P131, DOI 10.1016/j.scitotenv.2017.09.207; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Ventura M, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/1297658; Vigneri R, 2020, J CLIN ENDOCR METAB, V105, pE2639, DOI 10.1210/clinem/dgaa223; Vigneri R, 2015, CURR OPIN ONCOL, V27, P1, DOI 10.1097/CCO.0000000000000148; Zhu X, 2000, Environ Health Prev Med, V4, P174, DOI 10.1007/BF02931255	63	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246748	10.1371/journal.pone.0246748	http://dx.doi.org/10.1371/journal.pone.0246748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561145	Green Published, gold			2022-12-26	WOS:000617533000019
J	Ko, K; Nagashima, S; Bunthen, E; Ouoba, S; Akita, T; Sugiyama, A; Ohisa, M; Sakaguchi, T; Tahara, H; Ohge, H; Ohdan, H; Kubo, T; Kishita, E; Kuwabara, M; Takahashi, K; Tanaka, J				Ko, Ko; Nagashima, Shintaro; Bunthen, E.; Ouoba, Serge; Akita, Tomoyuki; Sugiyama, Aya; Ohisa, Masayuki; Sakaguchi, Takemasa; Tahara, Hidetoshi; Ohge, Hiroki; Ohdan, Hideki; Kubo, Tatsuhiko; Kishita, Eisaku; Kuwabara, Masao; Takahashi, Kazuaki; Tanaka, Junko			Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; PROTEASE	Background In this study, we performed molecular characterization of SARS-CoV-2 strains in Hiroshima and its mutation pattern between the first and second waves of the outbreak. Method A total of 55 nasal swab samples from the first wave in Hiroshima and 13 from the second wave were examined quantitatively by RT-qPCR and qualitatively by nested PCR using specific primers. Four samples from each wave underwent next-generation sequencing and phylogenetic tree analysis including controls and all sequences retrieved in Japan from GISAID and GenBank. Subsequently, mutations were examined. Results Viral load ranged 7.85 x 10(1)-1.42 x 10(8) copies/ml. Of 68 samples, one was Asian type-O, 65 were European type-GR, and 2 were undetectable. Phylogenetic tree analysis indicated that Japan was infected with various Asian strains (L, S, V, O) from January through April. By second week of March, European strains (G, GH, GR) had appeared, and GR strains became predominant after mid-March. The first case in Hiroshima was classified as Asian strain O, and the rest were GR strains. Then, second wave of GR strains appeared independently with 11-15 base mutations. Comparing the first- and second-wave GR strains, mutation rate was 1.17-1.36 x 10(-3) base substitutions per site per year; in addition, amino acid changes occurred at S1361P and P3371S in ORF1a, A314V in ORF1b, and P151L in N. All seven GR strains were D614G variants with R202K and G203R mutations in N. A single-nucleotide insertion in ORF8 that causes a defect in ORF8 protein was found in one isolate (S66) from the second wave. Conclusion Our findings reveal the evolutionary hierarchy of SARS-CoV-2 in Japan. The predominant D614G variants and a new form of ORF8 deletion in Hiroshima provide the clue for role of viral factor in local outbreaks of SARS-CoV-2.	[Ko, Ko; Nagashima, Shintaro; Bunthen, E.; Ouoba, Serge; Akita, Tomoyuki; Sugiyama, Aya; Ohisa, Masayuki; Takahashi, Kazuaki; Tanaka, Junko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan; [Bunthen, E.] Minist Hlth, Payment Certificat Agcy, Phnom Penh, Cambodia; [Ouoba, Serge] Unite Rech Clin Nanoro URCN, Nanoro, Burkina Faso; [Sakaguchi, Takemasa] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Biol, Hiroshima, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Kubo, Tatsuhiko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Kishita, Eisaku] Hiroshima Prefecture Hlth & Welf Bur, Hiroshima, Japan; [Kuwabara, Masao] Hiroshima Prefectural Ctr Dis Control & Prevent, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Tanaka, J (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan.	jun-tanaka@hiroshima-u.ac.jp		Ko, Ko/0000-0002-6961-2000; OUOBA, Serge/0000-0002-3944-0033	Government Academia Collaboration of Hiroshima Prefecture	Government Academia Collaboration of Hiroshima Prefecture	This study was partly funded by a grant from the Government Academia Collaboration of Hiroshima Prefecture. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report. There was no additional external funding received for this study.	Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gong YN, 2020, EMERG MICROBES INFEC, V9, P1457, DOI 10.1080/22221751.2020.1782271; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hsin WC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0449-x; Islam MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70812-6; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031; Office HP, 2020, ANN REP POP STAT BAS; Office HP, 2020, REP NOV COR INF HIR; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Ramani T, 2015, INT J TOXICOL, V34, P355, DOI 10.1177/1091581815584918; Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004; Shi XJ, 2020, PROTEIN SCI, V29, P1924, DOI 10.1002/pro.3913; Shimamoto Y, 2015, BIOORGAN MED CHEM, V23, P876, DOI 10.1016/j.bmc.2014.12.028; Su YCF, 2020, MBIO, V11, DOI 10.1128/mBio.01610-20; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Toyoshima Y, 2020, J HUM GENET, V65, P1075, DOI 10.1038/s10038-020-0808-9; World Health Organization, 2020, Q A COVID 19 CHAG DI; Yamamoto C, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050551; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8	26	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246383	10.1371/journal.pone.0246383	http://dx.doi.org/10.1371/journal.pone.0246383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0UN	33544733	Green Published, gold			2022-12-26	WOS:000617993300003
J	Marina, M; Torrado, P; Baudry, S; Duchateau, J				Marina, Michel; Torrado, Priscila; Baudry, Stephane; Duchateau, Jacques			Forearm muscles fatigue induced by repetitive braking on a motorcycle is best discriminated by specific kinetic parameters	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXERTIONAL COMPARTMENT SYNDROME; ISOMETRIC FORCE-TIME; TORQUE DEVELOPMENT; NEUROMUSCULAR FATIGUE; RELAXATION-TIME; CONTRACTION; STRENGTH; VOLUNTARY; INTERMITTENT	Maneuvering a motorcycle in racing conditions or for prolonged time is sufficiently demanding that on many occasions forearm muscles reach a state of functional failure when riders cannot properly brake or operate the throttle. This study intends to discriminate which ones of the several dynamometric parameters used in the literature to characterize the Force-time (F-t) curve during voluntary contractions are more sensitive to neuromuscular fatigue in simulated motorcycle-riding conditions. Thirty-three adults performed an intermittent fatiguing protocol (IFP) that simulated the brake-pulling and throttle-twisting actions, by using a hydraulic system equipped with a pressure sensor. Sixty pressure-time (P-t) curve parameters, including the rate of pressure development (RPD) and area under the curve were measured to characterize the time course of the braking maximal voluntary contraction (MVC). Two types of variables were used to analyze the P-t curve: 1) Times interval (from 0 to 30-50-100-500-1000 and 2000 ms); 2) Percentages of MVC (10-30-60-90%MVC). Overall significant (p <= 0.05) fatigue-related declines were observed only at time intervals longer than 100 ms and contraction intensities higher than 30%MVC. Strong and significant linear declines (p < 0.001) were observed at 500 ms and 1 s for normalized pressures, as well as for the ratio RPD60%MVC/MVC (p < 0.003) throughout the IFP. Our results suggest considering RPD at time windows of 0-500 ms and 0-1 s, and contraction intensities comprised between 30% and 60% of MVC, as more suitable criteria to study fatigue-related decrements in performance rather than the classical MVC force.	[Marina, Michel; Torrado, Priscila] Univ Barcelona, Res Grp Phys Act & Hlth GRAFiS, Inst Natl Educ Fis Catalunya, Barcelona, Spain; [Torrado, Priscila] Univ Pompeu Fabra, Sch Hlth Sci, TecnoCampus Mataro, Mataro, Spain; [Baudry, Stephane; Duchateau, Jacques] Univ Libre Bruxelles, Lab Appl Biol & Neurophysiol, Brussels, Belgium	University of Barcelona; Pompeu Fabra University; Universite Libre de Bruxelles	Marina, M (corresponding author), Univ Barcelona, Res Grp Phys Act & Hlth GRAFiS, Inst Natl Educ Fis Catalunya, Barcelona, Spain.	michel.marina.1964@gmail.com	Torrado, Priscila/I-4258-2015; Marina, Michel/I-4551-2015	Torrado, Priscila/0000-0001-5938-9100; Marina, Michel/0000-0001-7783-5178	Spanish Ministry of Economy [DEP2015-70701-P]	Spanish Ministry of Economy(Spanish Government)	Author who received the award: Michel Marina ~ Funder: the Spanish Ministry of Economy and the European Funds for Regional Development ~ Grant number: DEP2015-70701-P (MINECO/FEDER) ~ URL: http://www.ciencia.gob.es/portal/site/MICINN/~ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Angelozzi M, 2012, J ORTHOP SPORT PHYS, V42, P772, DOI 10.2519/jospt.2012.3780; [Anonymous], 2016, THE TOTAL AUDIENCE R; Balshaw TG, 2016, J APPL PHYSIOL, V120, P1364, DOI 10.1152/japplphysiol.00091.2016; Barrera-Ochoa S, 2016, CLIN J SPORT MED, V26, P108, DOI 10.1097/JSM.0000000000000216; Barry BK, 2005, EXP BRAIN RES, V162, P122, DOI 10.1007/s00221-004-2127-3; BAWA P, 1983, J PHYSIOL-LONDON, V339, P123, DOI 10.1113/jphysiol.1983.sp014707; BEMBEN MG, 1990, RES Q EXERCISE SPORT, V61, P96, DOI 10.1080/02701367.1990.10607484; Blackwell JR, 1999, APPL ERGON, V30, P401, DOI 10.1016/S0003-6870(98)00055-6; Bredenkamp J., 1980, THEORIE PLANUNG PSYC; Brown JS, 2011, J HAND SURG-EUR VOL, V36E, P413, DOI 10.1177/1753193410397900; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Croutzet Pierre, 2009, Tech Hand Up Extrem Surg, V13, P137, DOI 10.1097/BTH.0b013e3181aa9193; D'Artibale E, 2020, INT J SPORTS SCI COA, V15, P728, DOI 10.1177/1747954120941162; D'Artibale E, 2018, SPORTS MED, V48, P1345, DOI 10.1007/s40279-018-0895-3; D'Artibale E, 2018, J SPORT SCI, V36, P1061, DOI 10.1080/02640414.2017.1355064; de Ruiter CJ, 2004, J APPL PHYSIOL, V97, P1693, DOI 10.1152/japplphysiol.00230.2004; Del Vecchio A, 2018, J APPL PHYSIOL, V125, P1218, DOI 10.1152/japplphysiol.00025.2018; Del Vecchio A, 2019, J PHYSIOL-LONDON, V597, P2445, DOI 10.1113/JP277396; DESMEDT JE, 1977, J PHYSIOL-LONDON, V264, P673, DOI 10.1113/jphysiol.1977.sp011689; DESMEDT JE, 1977, NATURE, V267, P717, DOI 10.1038/267717a0; Duchateau J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00234; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Enoka RM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029702; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; EWING JL, 1984, RES Q EXERCISE SPORT, V55, P17, DOI 10.1080/02701367.1984.10605350; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Folland JP, 2014, SCAND J MED SCI SPOR, V24, P894, DOI 10.1111/sms.12131; Gondolini G, 2019, CLIN J SPORT MED, V29, P476, DOI 10.1097/JSM.0000000000000539; Goubier JN, 2003, BRIT J SPORT MED, V37, P452, DOI 10.1136/bjsm.37.5.452; Gruber M, 2004, EUR J APPL PHYSIOL, V92, P98, DOI 10.1007/s00421-004-1080-y; Gruber M, 2007, J STRENGTH COND RES, V21, P274, DOI 10.1519/00124278-200702000-00049; HAKKINEN K, 1985, ACTA PHYSIOL SCAND, V125, P573, DOI 10.1111/j.1748-1716.1985.tb07759.x; Jenkins NDM, 2014, INT J SPORTS MED, V35, P1190, DOI 10.1055/s-0034-1375696; KEARNEY JT, 1981, MED SCI SPORT EXER, V13, P339; Klass M, 2008, J APPL PHYSIOL, V104, P739, DOI 10.1152/japplphysiol.00550.2007; Linnamo V, 1998, EUR J APPL PHYSIOL, V77, P176; Maffiuletti NA, 2016, EUR J APPL PHYSIOL, V116, P1091, DOI 10.1007/s00421-016-3346-6; Mamaghani Nasser Koleini, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P29; Marina M, 2015, SCAND J MED SCI SPOR, V25, P406, DOI 10.1111/sms.12220; Marina M, 2013, J ELECTROMYOGR KINES, V23, P84, DOI 10.1016/j.jelekin.2012.08.008; Marina M, 2011, J ELECTROMYOGR KINES, V21, P255, DOI 10.1016/j.jelekin.2010.11.008; MILLER RG, 1981, EXP NEUROL, V73, P267, DOI 10.1016/0014-4886(81)90061-3; MILLER RG, 1979, ANN NEUROL, V6, P51, DOI 10.1002/ana.410060112; Penailillo L, 2015, SCAND J MED SCI SPOR, V25, P417, DOI 10.1111/sms.12241; ROYCE J, 1962, RES QUART, V33, P444, DOI 10.1080/10671188.1962.10616476; SILVERSTEIN BA, 1986, BRIT J IND MED, V43, P779; Sogaard K, 2006, J PHYSIOL-LONDON, V573, P511, DOI 10.1113/jphysiol.2005.103598; Soo Y, 2012, INT J IND ERGONOM, V42, P103, DOI 10.1016/j.ergon.2011.10.004; STEPHENS JA, 1972, J PHYSIOL-LONDON, V220, P1; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; THORSTENSSON A, 1976, ACTA PHYSIOL SCAND, V98, P318, DOI 10.1111/j.1748-1716.1976.tb10316.x; Tillin NA, 2013, J ELECTROMYOGR KINES, V23, P991, DOI 10.1016/j.jelekin.2013.04.015; Tillin NA, 2012, P ROY SOC B-BIOL SCI, V279, P2106, DOI 10.1098/rspb.2011.2109; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; Tillin NA, 2013, J SPORT SCI, V31, P66, DOI 10.1080/02640414.2012.720704; Torrado P, 2015, INT J SPORTS MED, V36, P922, DOI 10.1055/s-0035-1549959; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; VIITASALO JT, 1981, ACTA PHYSIOL SCAND, V111, P87, DOI 10.1111/j.1748-1716.1981.tb06709.x; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Zandi H, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012518	62	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246242	10.1371/journal.pone.0246242	http://dx.doi.org/10.1371/journal.pone.0246242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0UN	33544741	Green Published, gold			2022-12-26	WOS:000617993300010
J	Yasugi, M; Hatoya, S; Motooka, D; Matsumoto, Y; Shimamura, S; Tani, H; Furuya, M; Mie, K; Miyake, M; Nakamura, S; Shimada, T				Yasugi, Mayo; Hatoya, Shingo; Motooka, Daisuke; Matsumoto, Yuki; Shimamura, Shunsuke; Tani, Hiroyuki; Furuya, Masaru; Mie, Keiichiro; Miyake, Masami; Nakamura, Shota; Shimada, Terumasa			Whole-genome analyses of extended-spectrum or AmpC beta-lactamase-producing Escherichia coli isolates from companion dogs in Japan	PLOS ONE			English	Article							SEQUENCE TYPE 131; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; PUBLIC-HEALTH; NUCLEOTIDE-SEQUENCE; INCI1 PLASMIDS; ISECP1-MEDIATED TRANSPOSITION; CARRYING BLA(CMY-2); MOLECULAR DIVERSITY; HOUSEHOLD MEMBERS	The emergence and global spread of extended-spectrum or AmpC beta-lactamase (ESBL/AmpC)-producing Enterobacteriaceae in companion animals have led to the hypothesis that companion animals might be reservoirs for cross-species transmission because of their close contact with humans. However, current knowledge in this field is limited; therefore, the role of companion animals in cross-species transmission remains to be elucidated. Herein, we studied ESBL/AmpC-producing Enterobacteriaceae, Escherichia coli in particular, isolated from extraintestinal sites and feces of companion dogs. Whole-genome sequencing analysis revealed that (i) extraintestinal E. coli isolates were most closely related to those isolated from feces from the same dog, (ii) chromosomal sequences in the ST131/C1-M27 clade isolated from companion dogs were highly similar to those in the ST131/C1-M27 clade of human origin, (iii) certain plasmids, such as IncFII/pMLST F1:A2:B20/bla(CTX-M-27), IncI1/pMLST16/bla(CTX-M-15), or IncI1/bla(CMY-2) from dog-derived E. coli isolates, shared high homology with those from several human-derived Enterobacteriaceae, (iv) chromosomal bla(CTX-M-14) was identified in the ST38 isolate from a companion dog, and (v) eight out of 14 tested ESBL/AmpC-producing E. coli isolates (i.e., ST131, ST68, ST405, and ST998) belonged to the human extraintestinal pathogenic E. coli (ExPEC) group. All of the bla-coding plasmids that were sequenced genome-wide were capable of horizontal transfer. These results suggest that companion dogs can spread ESBL/AmpC-producing ExPEC via their feces. Furthermore, at least some ESBL/AmpC-producing ExPECs and bla-coding plasmids can be transmitted between humans and companion dogs. Thus, companion dogs can act as an important reservoir for ESBL/AmpC-producing E. coli in the community.	[Yasugi, Mayo; Hatoya, Shingo; Shimamura, Shunsuke; Tani, Hiroyuki; Furuya, Masaru; Mie, Keiichiro; Miyake, Masami; Shimada, Terumasa] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Yasugi, Mayo; Shimada, Terumasa] Osaka Prefecture Univ, Asian Hlth Sci Res Inst, Izumisano, Osaka, Japan; [Motooka, Daisuke; Matsumoto, Yuki; Nakamura, Shota] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka University	Yasugi, M (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan.; Yasugi, M (corresponding author), Osaka Prefecture Univ, Asian Hlth Sci Res Inst, Izumisano, Osaka, Japan.	shishimaru@vet.osakafu-u.ac.jp		Furuya, Masaru/0000-0003-3276-7903; Yasugi, Mayo/0000-0002-9688-2006	JSPS KAKENHI [20K10432]; Grant for 2018 Joint Research Project of the Research Institute for Microbial Diseases, Osaka University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant for 2018 Joint Research Project of the Research Institute for Microbial Diseases, Osaka University	This work was supported in part by JSPS KAKENHI Grant Number 20K10432 to M.Y, and T. S., and the Grant for 2018 Joint Research Project of the Research Institute for Microbial Diseases, Osaka University, to M.Y., D.M., and S.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtova K, 2012, ANTIMICROB AGENTS CH, V56, P4013, DOI 10.1128/AAC.05859-11; [Anonymous], 2013, PREPRINTS; Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Bevan ER, 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI 10.1093/jac/dkx146; Bi DX, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00764-18; Birgy A, 2017, EMERG INFECT DIS, V23, P885, DOI 10.3201/eid2305.161865; Bogaerts P, 2015, MICROB DRUG RESIST, V21, P643, DOI 10.1089/mdr.2014.0284; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Canica MMM, 1997, J MOL EVOL, V44, P57, DOI 10.1007/PL00006121; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2018, PLASMID, DOI [10.1016/j.plasmid.2018.12.00130529488, DOI 10.1016/J.PLASMID.2018.12.00130529488]; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Castellanos LR, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02546-18, 10.1128/aac.02546-18]; Castellanos LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170777; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; Chavda KD, 2016, ANTIMICROB AGENTS CH, V60, P4073, DOI 10.1128/AAC.00452-16; Chen YY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02852; Chiu CH, 2004, LANCET, V363, P1285, DOI 10.1016/S0140-6736(04)16003-0; Clermont O, 2015, MICROBIOL-SGM, V161, P980, DOI 10.1099/mic.0.000063; Clinical and Laboratory Standards Institute, M100S CLIN LAB STAND; Clinical Laboratory Standard Institute, 2015, M07A10 CLIN LAB STAN, VTwelfth; da Silva KC, 2017, DIAGN MICR INFEC DIS, V87, P64, DOI 10.1016/j.diagmicrobio.2016.10.001; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; DERBYSHIRE KM, 1987, P NATL ACAD SCI USA, V84, P8049, DOI 10.1073/pnas.84.22.8049; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P2263, DOI 10.1093/jac/dkr310; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Feng Y, 2021, NUCLEIC ACIDS RES, V49, pD644, DOI 10.1093/nar/gkaa821; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Ghosh H, 2017, EMERG INFECT DIS, V23, P1754, DOI 10.3201/eid2310.170938; Gronthal T, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.27.1700497; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Hamamoto K, 2019, J GLOB ANTIMICROB RE, V17, P53, DOI 10.1016/j.jgar.2018.11.006; Hamamoto K, 2016, ANTIMICROB AGENTS CH, V60, P2582, DOI 10.1128/AAC.00108-16; Hansen KH, 2016, APPL ENVIRON MICROB, V82, P4705, DOI 10.1128/AEM.00495-16; Harada K, 2012, COMP IMMUNOL MICROB, V35, P139, DOI 10.1016/j.cimid.2011.12.005; Harada S, 2012, ANTIMICROB AGENTS CH, V56, P1093, DOI 10.1128/AAC.00258-11; Harmer CJ, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000291; Hayashi W, 2018, INT J FOOD MICROBIOL, V284, P98, DOI 10.1016/j.ijfoodmicro.2018.08.003; Hirai I, 2013, INT J ANTIMICROB AG, V42, P500, DOI 10.1016/j.ijantimicag.2013.08.005; Hong JS, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00674; IIDA S, 1984, MOL GEN GENET, V198, P84, DOI 10.1007/BF00328705; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jamborova I, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00519-18; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johansson MHK, 2021, J ANTIMICROB CHEMOTH, V76, P101, DOI 10.1093/jac/dkaa390; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Johnson JR, 2006, CLIN INFECT DIS, V43, pE101, DOI 10.1086/508541; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Johnson JR, 2001, INFECT IMMUN, V69, P1306, DOI 10.1128/IAI.69.3.1306-1314.2001; Johnson TJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00121-16; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kawamura Kumiko, 2017, Food Saf (Tokyo), V5, P122, DOI 10.14252/foodsafetyfscj.2017011; KIM EH, 1994, MICROBIOL IMMUNOL, V38, P31, DOI 10.1111/j.1348-0421.1994.tb01741.x; Kim JS, 2015, EMERG INFECT DIS, V21, P1247, DOI 10.3201/eid2107.150363; Kim JS, 2014, INT J ANTIMICROB AG, V44, P533, DOI 10.1016/j.ijantimicag.2014.08.007; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; Kudo H, 2019, J ANTIBIOT, V72, P79, DOI 10.1038/s41429-018-0113-4; Lin YT, 2015, ANTIMICROB AGENTS CH, V59, P5000, DOI 10.1128/AAC.00492-15; Lloyd DH, 2007, CLIN INFECT DIS, V45, pS148, DOI 10.1086/519254; Loncaric I, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9070387; Maeyama Y, 2018, VET MICROBIOL, V216, P183, DOI 10.1016/j.vetmic.2018.02.020; Manges AR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0006-2012; Matsumoto Y, 2019, EMERG MICROBES INFEC, V8, P1043, DOI 10.1080/22221751.2019.1637702; Matsumura Y, 2016, EMERG INFECT DIS, V22, P1900, DOI 10.3201/eid2211.160519; Matsumura Y, 2015, J ANTIMICROB CHEMOTH, V70, P1639, DOI 10.1093/jac/dkv017; Meini S, 2019, INFECTION, V47, P363, DOI 10.1007/s15010-019-01291-9; Mena A, 2006, J CLIN MICROBIOL, V44, P2831, DOI 10.1128/JCM.00418-06; MOLLET B, 1983, NUCLEIC ACIDS RES, V11, P6319, DOI 10.1093/nar/11.18.6319; Navon-Venezia S, 2017, FEMS MICROBIOL REV, V41, P252, DOI 10.1093/femsre/fux013; Nicolas E, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0060-2014; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Peirano G, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02610-16, 10.1128/aac.02610-16]; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pietsch M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4976-3; Pightling AW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01482; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout Johann D D, 2017, F1000Res, V6, DOI 10.12688/f1000research.10609.1; Pomba C, 2017, J ANTIMICROB CHEMOTH, V72, P957, DOI 10.1093/jac/dkw481; Pomba-Feria C, 2003, FEMS MICROBIOL LETT, V220, P177, DOI 10.1016/S0378-1097(03)00123-X; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Roer L, 2017, J CLIN MICROBIOL, V55, P2538, DOI 10.1128/JCM.00737-17; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Saltykova A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192504; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; Sidjabat HE, 2014, INT J ANTIMICROB AG, V44, P203, DOI 10.1016/j.ijantimicag.2014.04.016; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Su LH, 2006, J ANTIMICROB CHEMOTH, V57, P424, DOI 10.1093/jac/dki478; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; Tagg KA, 2014, ANTIMICROB AGENTS CH, V58, P4949, DOI 10.1128/AAC.02773-14; Tanizawa Y, 2016, BIOSCI MICROB FOOD H, V35, P173, DOI 10.12938/bmfh.16-003; Tavakoli N, 2000, PLASMID, V44, P66, DOI 10.1006/plas.1999.1460; Tchesnokova V, 2019, P NATL ACAD SCI USA, V116, P14740, DOI 10.1073/pnas.1903002116; The AMR One Health Surveillance Committee, 2019, NIPP AMR ON HLTH REP; The AMR One Health Surveillance Committee, 2018, NIPP AMR ON HLTH REP; Toombs-Ruane LJ, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01613-20; Umeda K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227605; Umeda K, 2019, J MED MICROBIOL, V68, P339, DOI 10.1099/jmm.0.000933; Underwood AP, 2013, J CLIN MICROBIOL, V51, P232, DOI 10.1128/JCM.01696-12; van den Bunt G, 2020, J ANTIMICROB CHEMOTH, V75, P342, DOI 10.1093/jac/dkz462; Verdet C, 2009, ANTIMICROB AGENTS CH, V53, P4002, DOI 10.1128/AAC.00753-08; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wong MHY, 2016, ANTIMICROB AGENTS CH, V60, P982, DOI 10.1128/AAC.02746-15; Yagi T, 2005, J CLIN MICROBIOL, V43, P2551, DOI 10.1128/JCM.43.6.2551-2558.2005; Yagi T, 2000, FEMS MICROBIOL LETT, V184, P53, DOI 10.1111/j.1574-6968.2000.tb08989.x; Yao H, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01610; Ying JC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00831; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zong ZY, 2010, ANTIMICROB AGENTS CH, V54, P3039, DOI 10.1128/AAC.00041-10; 2014, GLOB STAT REP VIOL, P1	124	4	4	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246482	10.1371/journal.pone.0246482	http://dx.doi.org/10.1371/journal.pone.0246482			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544781	gold, Green Published			2022-12-26	WOS:000617991900048
J	Christen, M; Brugger, P; Fabrikant, SI				Christen, Markus; Brugger, Peter; Fabrikant, Sara Irina			Susceptibility of domain experts to color manipulation indicate a need for design principles in data visualization	PLOS ONE			English	Article								Color is key for the visual encoding of data, yet its use reportedly affects decision making in important ways. We examined the impact of various popular color schemes on experts' and lay peoples' map-based decisions in two, geography and neuroscience, scenarios, in an online visualization experiment. We found that changes in color mappings influence domain experts, especially neuroimaging experts, more in their decision-making than novices. Geographic visualization experts exhibited more trust in the unfavorable rainbow color scale than would have been predicted by their suitability ratings and their training, which renders them sensitive to scale appropriateness. Our empirical results make a strong call for increasing scientists' awareness for and training in perceptually salient and cognitively informed design principles in data visualization.	[Christen, Markus] Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland; [Christen, Markus; Fabrikant, Sara Irina] Univ Zurich, Digital Soc Initiat, Zurich, Switzerland; [Brugger, Peter] Univ Hosp Zurich, Dept Psychiat, Zurich, Switzerland; [Brugger, Peter] Rehabil Ctr Valens, Valens, Switzerland; [Fabrikant, Sara Irina] Univ Zurich, Dept Geog, Geog Informat Visualizat & Anal Unit, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Christen, M (corresponding author), Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland.; Christen, M (corresponding author), Univ Zurich, Digital Soc Initiat, Zurich, Switzerland.	christen@ethik.uzh.ch	; Fabrikant, Sara/B-9320-2014	Brugger, Peter/0000-0002-5137-0314; Fabrikant, Sara/0000-0003-1263-8792	Cogito Foundation (Wollerau, Switzerland) [R-129/09]; European Research Council [740426]	Cogito Foundation (Wollerau, Switzerland); European Research Council(European Research Council (ERC)European Commission)	Cogito Foundation (Wollerau, Switzerland) under grant no. R-129/09 (M. Christen) -European Research Council, GeoViSense Project under grant number 740426 (S. Fabrikant).	Bera P, 2016, COMMUN ACM, V59, P50, DOI 10.1145/2818993; Bertin J., 1967, SEMIOLOGY GRAPHICS D; Borner K, 2019, P NATL ACAD SCI USA, V116, P1857, DOI 10.1073/pnas.1807180116; Borkin MA, 2011, IEEE T VIS COMPUT GR, V17, P2479, DOI 10.1109/TVCG.2011.192; Borland D, 2007, IEEE COMPUT GRAPH, V27, P14, DOI 10.1109/MCG.2007.323435; Brewer C.A., 1999, P SECT STAT GRAPH AN, P55; Brewer C.A., 1994, VISUALIZATION MODERN, P269; Christen M, 2013, NEUROIMAGE, V73, P30, DOI 10.1016/j.neuroimage.2013.01.068; Crameri F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19160-7; Eddins S., 2014, RAINBOW COLOR MAP CR; Fabrikant SI, 2010, ANN ASSOC AM GEOGR, V100, P13, DOI 10.1080/00045600903362378; Garlandini S, 2009, LECT NOTES COMPUT SC, V5756, P195, DOI 10.1007/978-3-642-03832-7_12; Gehlenborg N, 2012, NAT METHODS, V9, P769, DOI 10.1038/nmeth.2134; Hawkins E., 2014, END RAINBOW OPEN LET; Heath LJ, 2019, HYPERTENS PREGNANCY, V38, P1, DOI 10.1080/10641955.2018.1538378; Hegarty M., 2009, CARTOGRAPHICA, V44, P171, DOI DOI 10.3138/CARTO.44.3.171; Hegarty M, 2010, J EXP PSYCHOL LEARN, V36, P37, DOI 10.1037/a0017683; Keehner M, 2011, PSYCHON B REV, V18, P422, DOI 10.3758/s13423-010-0048-7; Light A., 2004, EOS T AM GEOPHYS UN, V85, P385, DOI [10.1029/2004EO400002, DOI 10.1029/2004EO400002, 10.1029/2004-o400002, DOI 10.1029/2004-O400002, DOI 10.1029/2004E0400002]; Moreland K., 2016, P HUM VIS EL IM FEB; Palsky G., 1999, CYBERGEO EUR J GEOGR, V85; Peck EM, 2019, P 2019 CHI C HUM FAC, P1; Rogowitz BE, 1998, IEEE SPECTRUM, V35, P52, DOI 10.1109/6.736450; Sammons JI, 2004, EOS, V85, P498; Schloss KB, 2019, IEEE T VIS COMPUT GR, V25, P810, DOI 10.1109/TVCG.2018.2865147; Schott GD, 2010, NEUROSCIENTIST, V16, P508, DOI 10.1177/1073858409355817; Silva S, 2011, COMPUT GRAPH-UK, V35, P320, DOI 10.1016/j.cag.2010.11.015; Tufte ER., 1997, VISUAL EXPLANATIONS; WARE C, 1988, IEEE COMPUT GRAPH, V8, P41, DOI 10.1109/38.7760; Ware C, 2008, MORG KAUF SER INTER, P1; Wong B, 2010, NAT METHODS, V7, P573, DOI 10.1038/nmeth0810-573	32	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246479	10.1371/journal.pone.0246479	http://dx.doi.org/10.1371/journal.pone.0246479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539461	Green Published, gold			2022-12-26	WOS:000616960200030
J	Fiseha, T; Ahmed, E; Chalie, S; Gebreweld, A				Fiseha, Temesgen; Ahmed, Ermiyas; Chalie, Semagn; Gebreweld, Angesom			Prevalence and associated factors of impaired renal function and albuminuria among adult patients admitted to a hospital in Northeast Ethiopia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; PROTEINURIA; OPPORTUNITY; MANAGEMENT; OUTCOMES; RISK; CARE	Background Chronic kidney disease (CKD) is increasingly common in hospitalized patients and is associated with increased risk for in-hospital morbidity and mortality. However, data regarding the prevalence of CKD in the African hospitalized patient population are limited. We therefore examined the prevalence and associated factors of impaired renal function and albuminuria among adult patients admitted to the internal medicine wards of a hospital in Northeast Ethiopia. Methods A cross-sectional study was conducted from January 1 to April 30, 2020 at the inpatient settings of Dessie referral hospital. Data on demographics and medical history were obtained, and serum creatinine and albuminuria were analyzed. Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD) equation. CKD was defined as impaired eGFR (<60 ml/min/1.73m(2)) and/or albuminuria. Univariate and multivariable analysis were conducted to determine factors associated with impaired eGFR and albuminuria. Results A total of 369 patients were included in this study. The prevalence of impaired eGFR was 19.0% (95%CI: 15.2%-23.2%) and albuminuria was 30.9% (95%CI: 26.3%-35.7%). Overall, 33.9% (95%CI: 29.2%-38.9%) of the patients had some degree of CKD, but only 21.6% (95%CI: 15.1%-29.4%) were aware of their renal disease. In multivariable analysis, older age, a family history of kidney disease, diabetes, hypertension and HIV were independently associated with both impaired eGFR and albuminuria while male gender was independently associated with only albuminuria. Conclusions CKD is common in adult patients admitted to the internal medicine wards, but only few patients are aware of their condition. These findings highlight the need for feasible approaches to timely identify kidney disease and raise awareness on the importance of detection and early intervention in the inpatient settings.	[Fiseha, Temesgen; Ahmed, Ermiyas; Chalie, Semagn] Wollo Univ, Coll Med & Hlth Sci, Dept Clin Lab Sci, Dessie, Ethiopia; [Gebreweld, Angesom] Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia	Mekelle University	Fiseha, T (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Clin Lab Sci, Dessie, Ethiopia.	temafiseha@gmail.com						Adugna T, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1153-5; Annear NMP, 2008, QJM-INT J MED, V101, P91, DOI 10.1093/qjmed/hcm130; [Anonymous], 2015, INT J MED BIOMEDICAL; Aung Win Myint, 2015, Hosp Pract (1995), V43, P101, DOI 10.1080/21548331.2015.1026789; Banda Justor, 2010, Med J Zambia, V37, P136; Bohlouli B, 2016, CLIN J AM SOC NEPHRO, V11, P956, DOI 10.2215/CJN.09450915; Gutierrez BC, 2011, NEFROLOGIA, V31, P70, DOI 10.3265/Nefrologia.pre2010.May.10284; Chao CT, 2017, SCI REP-UK, V7, DOI 10.1038/srep42030; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Corsonello A, 2005, ARCH INTERN MED, V165, P790, DOI 10.1001/archinte.165.7.790; de Francisco ALM, 2010, EUR J INTERN MED, V21, P327, DOI 10.1016/j.ejim.2010.04.011; De Wilde M, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0869-6; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferris M, 2009, AM J MED SCI, V337, P93, DOI 10.1097/MAJ.0b013e318181288e; Fowler MJ, 2009, CLIN DIABETES, V27, P119; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hogan M., 2009, NEPHROL, V2, P9; Hsieh YM, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0229-x; Kaba ML, 2016, SAUDI J KIDNEY DIS T, V27, P1073, DOI 10.4103/1319-2442.190916; Karam Z, 2013, CLIN GERIATR MED, V29, P555, DOI 10.1016/j.cger.2013.05.006; Kobayashi S, REN REPLACE THER, V6, P5; Gomez PJL, 2019, NEFROLOGIA, V39, P379, DOI 10.1016/j.nefro.2018.08.011; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Liu BC, 2008, CLIN CHIM ACTA, V387, P128, DOI 10.1016/j.cca.2007.09.020; Luders F, 2017, ANGIOLOGY, V68, P145, DOI 10.1177/0003319716638797; Mallappallil Mary, 2014, Clin Pract (Lond), V11, P525; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClellan WM, 1997, AM J KIDNEY DIS, V29, P368, DOI 10.1016/S0272-6386(97)90197-9; Mwenda V, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.321.18114; Ngu K, 2017, INTERN MED J, V47, P62, DOI 10.1111/imj.13231; Pinho Natalia Alencar de, 2015, Braz. J. Nephrol., V37, P91, DOI 10.5935/0101-2800.20150013; Raji YR, 2018, INDIAN J NEPHROL, V28, P21, DOI 10.4103/ijn.IJN_225_16; Rwegerera GM, 2017, NIGER J CLIN PRACT, V20, P313, DOI 10.4103/1119-3077.187335; Saunders Milda R, 2017, Health Lit Res Pract, V1, pe117, DOI 10.3928/24748307-20170608-01; Saunders MR, 2015, J HOSP MED, V10, P619, DOI 10.1002/jhm.2395; Seliger SL, 2008, J AM SOC NEPHROL, V19, P2414, DOI 10.1681/ASN.2008010022; Singh AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-114; Stratton S, 2014, US PHARM, V39, P56; Su GB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11861-2; Swanepoel CR, 2018, KIDNEY INT, V93, P545, DOI 10.1016/j.kint.2017.11.007; Tarantini L, 2010, J CARDIOVASC MED, V11, P234, DOI 10.2459/JCM.0b013e3283334e12; Yong TY, 2013, QJM-INT J MED, V106, P59, DOI 10.1093/qjmed/hcs192	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246509	10.1371/journal.pone.0246509	http://dx.doi.org/10.1371/journal.pone.0246509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539455	gold, Green Published			2022-12-26	WOS:000616960200045
J	Kobayashi, Y; Oguro, A; Hirata, Y; Imaoka, S				Kobayashi, Yukino; Oguro, Ami; Hirata, Yuta; Imaoka, Susumu			The regulation of Hypoxia-Inducible Factor-1 (HIF-1alpha) expression by Protein Disulfide Isomerase (PDI)	PLOS ONE			English	Article							NF-KAPPA-B; BISPHENOL-A; DIRECT PHOSPHORYLATION; DNA-BINDING; HIF-1-ALPHA; DEGRADATION; ACTIVATION; PATHWAY; STABILIZATION; MECHANISMS	Hypoxia-inducible factor-1alpha (HIF-1alpha), a transcription factor, plays a critical role in adaption to hypoxia, which is a major feature of diseases, including cancer. Protein disulfide isomerase (PDI) is up-regulated in numerous cancers and leads to cancer progression. PDI, a member of the TRX superfamily, regulates the transcriptional activities of several transcription factors. To investigate the mechanisms by which PDI affects the function of HIF-1alpha, the overexpression or knockdown of PDI was performed. The overexpression of PDI decreased HIF-1alpha expression in the human hepatocarcinoma cell line, Hep3B, whereas the knockdown of endogenous PDI increased its expression. NH4Cl inhibited the decrease in HIF-1alpha expression by PDI overexpression, suggesting that HIF-1alpha was degraded by the lysosomal pathway. HIF-1alpha is transferred to lysosomal membranes by heat shock cognate 70 kDa protein (HSC70). The knockdown of HSC70 abolished the decrease, and PDI facilitated the interaction between HIF-1alpha and HSC70. HIF-1alpha directly interacted with PDI. PDI exists not only in the endoplasmic reticulum (ER), but also in the cytosol. Hypoxia increased cytosolic PDI. We also investigated changes in the redox state of HIF-1alpha using PEG-maleimide, which binds to thiols synthesized from disulfide bonds by reduction. An up-shift in the HIF-1alpha band by the overexpression of PDI was detected, suggesting that PDI formed disulfide bond in HIF-1alpha. HIF-1alpha oxidized by PDI was not degraded in HSC70-knockdown cells, indicating that the formation of disulfide bond in HIF-1alpha was important for decreases in HIF-1alpha expression. To the best of our knowledge, this is the first study to show the regulation of the expression and redox state of HIF-1alpha by PDI. We also demonstrated that PDI formed disulfide bonds in HIF-1alpha 1-245 aa and decreased its expression. In conclusion, the present results showed that PDI is a novel factor regulating HIF-1alpha through lysosome-dependent degradation by changes in its redox state.	[Kobayashi, Yukino; Oguro, Ami; Hirata, Yuta; Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Gakuen, Sanda, Japan; [Oguro, Ami] Hiroshima Univ, Grad Sch Integrated Sci Life, Program Biomed Sci, Higashihiroshima, Japan	Kwansei Gakuin University; Hiroshima University	Imaoka, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Gakuen, Sanda, Japan.	imaoka@kwansei.ac.jp			Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant [21310045]	Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant	This study was supported by Grant Number 21310045 from the Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant (Grant-in-Aid for Scientific Research B) (https://www.jsps.go.jp/english/e-grants/index.html).SI received the reward. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Benham AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0403; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bullen JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0583; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Cassavaugh JM, 2011, J CELL BIOCHEM, V112, P3882, DOI 10.1002/jcb.23321; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Clive DR, 1996, CELL BIOCHEM FUNCT, V14, P49, DOI 10.1002/cbf.638; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Feng WM, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0077-1; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Hashimoto S, 2013, J BIOL CHEM, V288, P1706, DOI 10.1074/jbc.M112.365239; Hashimoto S, 2012, J BIOCHEM, V151, P35, DOI 10.1093/jb/mvr122; Herzog J, 2016, ONCOTARGET, V7, P27108, DOI 10.18632/oncotarget.8342; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; IMAOKA S, 1987, BIOCHIM BIOPHYS ACTA, V916, P358, DOI 10.1016/0167-4838(87)90181-6; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jin WS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-61; Jun Jonathan C, 2017, Curr Sleep Med Rep, V3, P1, DOI 10.1007/s40675-017-0062-7; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kang X, 2010, ONCOGENE, V29, P5568, DOI 10.1038/onc.2010.297; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kim KM, 2018, ONCOL LETT, V16, P5753, DOI 10.3892/ol.2018.9339; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Kobayashi Y, 2018, BIOL PHARM BULL, V41, P374, DOI 10.1248/bpb.b17-00693; Kutomi G, 2013, CANCER SCI, V104, P1091, DOI 10.1111/cas.12177; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lee E, 2017, BMB REP, V50, P401, DOI 10.5483/BMBRep.2017.50.8.107; Lee G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18928; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Lv X, 2017, GENES DIS, V4, P19, DOI 10.1016/j.gendis.2016.11.003; Miyake Y, 2014, CHEM RES TOXICOL, V27, P501, DOI 10.1021/tx400357q; Moilanen A, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800090; Na KS, 2007, MOL CELLS, V24, P261; Nytko KJ, 2011, BLOOD, V117, P5485, DOI 10.1182/blood-2010-09-307637; Oguro A, 2009, DRUG METAB PHARMACOK, V24, P438, DOI 10.2133/dmpk.24.438; Osada M, 2002, J BIOL CHEM, V277, P23367, DOI 10.1074/jbc.M112413200; Popielarski M, 2019, AM J CANCER RES, V9, P1554; Samanta S, 2017, ONCOTARGET, V8, P103543, DOI 10.18632/oncotarget.21569; Schultz-Norton JR, 2006, MOL ENDOCRINOL, V20, P1982, DOI 10.1210/me.2006-0006; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Takei N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09976-7; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Welsh SJ, 2002, CANCER RES, V62, P5089; Whittal RM, 2000, BIOCHEMISTRY-US, V39, P8406, DOI 10.1021/bi000282f; WROBLEWSKI VJ, 1992, DIABETES, V41, P539, DOI 10.2337/diabetes.41.4.539; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Xu SL, 2014, DRUG DISCOV TODAY, V19, P222, DOI 10.1016/j.drudis.2013.10.017; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75	59	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246531	10.1371/journal.pone.0246531	http://dx.doi.org/10.1371/journal.pone.0246531			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0ZY	33539422	Green Published, gold			2022-12-26	WOS:000617317500001
J	Cai, R; Zhang, Q; Wang, YQ; Yong, WL; Zhao, R; Pang, WJ				Cai, Rui; Zhang, Que; Wang, Yingqian; Yong, Wenlong; Zhao, Rui; Pang, Weijun			Lnc-ORA interacts with microRNA-532-3p and IGF2BP2 to inhibit skeletal muscle myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-NONCODING RNA; TRANSCRIPTIONAL MECHANISMS; UBIQUITIN LIGASES; ATROPHY; DIFFERENTIATION; EXPRESSION; ADIPOGENESIS; CLASSIFICATION; STABILITY; REVEALS	Skeletal muscle is one of the most important organs of the animal body. Long noncoding RNAs play a crucial role in the regulation of skeletal muscle development via several mechanisms. We recently identified obesity-related lncRNA (lnc-ORA) in a search for long noncoding RNAs that influence adipogenesis, finding it impacted adipocyte differentiation by regulating the PI3K/protein kinase B/mammalian target of rapamycin pathway. However, whether lnc-ORA has additional roles, specifically in skeletal muscle myogenesis, is not known. Here, we found that lnc-ORA was significantly differentially expressed with age in mouse skeletal muscle tissue and predominantly located in the cytoplasm. Overexpression of lnc-ORA promoted C2C12 myoblast proliferation and inhibited myoblast differentiation. In contrast, lnc-ORA knockdown repressed myoblast proliferation and facilitated myoblast differentiation. Interestingly, silencing of lnc-ORA rescued dexamethasone-induced muscle atrophy in vitro. Furthermore, adeno-associated virus 9-mediated overexpression of lnc-ORA decreased muscle mass and the cross-sectional area of muscle fiber by upregulating the levels of muscle atrophy-related genes and downregulating the levels of myogenic differentiation-related genes in vivo. Mechanistically, lnc-ORA inhibited skeletal muscle myogenesis by acting as a sponge of miR-532-3p, which targets the phosphatase and tensin homolog gene; the resultant changes in phosphatase and tensin homolog suppressed the PI3K/protein kinase B signaling pathway. In addition, lnc-ORA interacted with insulin-like growth factor 2 mRNA-binding protein 2 and reduced the stability of myogenesis genes, such as myogenic differentiation 1 and myosin heavy chain. Collectively, these findings indicate that lnc-ORA could be a novel underlying regulator of skeletal muscle development.	[Cai, Rui; Zhang, Que; Wang, Yingqian; Yong, Wenlong; Zhao, Rui; Pang, Weijun] Northwest A&F Univ, Lab Anim Fat Deposit & Muscle Dev, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Pang, WJ (corresponding author), Northwest A&F Univ, Lab Anim Fat Deposit & Muscle Dev, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	pwj1226@nwsuaf.edu.cn	Cai, Rui/GRO-1869-2022		National Natural Science Foundation [31872979, 31572366]; National Key Research and Development Program of China [2017YFD0502002]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by grants from the National Natural Science Foundation (31872979 and 31572366) and the National Key Research and Development Program of China (2017YFD0502002).	Alessio E, 2019, NUCLEIC ACIDS RES, V47, P1653, DOI 10.1093/nar/gkz007; Ballarino M, 2015, MOL CELL BIOL, V35, P728, DOI 10.1128/MCB.01394-14; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Cai R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050477; Cai R, 2018, J BIOL CHEM, V293, P19177, DOI 10.1074/jbc.RA118.003198; Cai R, 2018, BBA-MOL CELL BIOL L, V1863, P420, DOI 10.1016/j.bbalip.2018.01.005; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen XN, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.2; Chen Z, 2018, STEM CELLS, V36, P1097, DOI 10.1002/stem.2824; d'Ydewalle C, 2017, NEURON, V93, P66, DOI 10.1016/j.neuron.2016.11.033; Dou ML, 2020, J BIOL CHEM, V295, P4937, DOI 10.1074/jbc.RA119.010498; Dumitru A, 2018, ADV EXP MED BIOL, V1088, P73, DOI 10.1007/978-981-13-1435-3_4; Geng TT, 2018, DIABETES, V67, P2183, DOI 10.2337/db18-0370; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; Hitachi K, 2019, EMBO REP, V20, DOI 10.15252/embr.201847468; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Jandura A, 2017, TRENDS GENET, V33, P665, DOI 10.1016/j.tig.2017.08.002; Jarroux J, 2017, ADV EXP MED BIOL, V1008, P1, DOI 10.1007/978-981-10-5203-3_1; Jiao JQ, 2017, CURR OPIN PHARMACOL, V34, P1, DOI 10.1016/j.coph.2017.03.009; Jin JJ, 2018, P NATL ACAD SCI USA, V115, pE9802, DOI 10.1073/pnas.1801471115; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li ZH, 2019, J CACHEXIA SARCOPENI, V10, P391, DOI 10.1002/jcsm.12374; Liang TT, 2018, FASEB J, V32, P377, DOI 10.1096/fj.201700560RR; Ma ML, 2017, RNA BIOL, V14, P347, DOI 10.1080/15476286.2017.1279786; Ma YW, 2017, FEBS J, V284, P3262, DOI 10.1111/febs.14188; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Pin F, 2019, FASEB J, V33, P7778, DOI 10.1096/fj.201802799R; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Song CC, 2018, EPIGENETICS-US, V13, P591, DOI 10.1080/15592294.2018.1481705; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun LJ, 2018, J CACHEXIA SARCOPENI, V9, P962, DOI 10.1002/jcsm.12321; Sun XM, 2016, BBA-MOL CELL RES, V1863, P2835, DOI 10.1016/j.bbamcr.2016.08.014; Wang GQ, 2015, J AGR FOOD CHEM, V63, P6212, DOI 10.1021/acs.jafc.5b01680; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wang SS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091107; Wang Y, 2014, GENE, V539, P117, DOI 10.1016/j.gene.2014.01.037; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Wimmer RJ, 2015, J NUTR BIOCHEM, V26, P1559, DOI 10.1016/j.jnutbio.2015.07.023; Yu XH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14016; Zhang XX, 2020, J GENET GENOMICS, V47, P466, DOI 10.1016/j.jgg.2020.07.003; Zhang ZK, 2018, MOL THER, V26, P2669, DOI 10.1016/j.ymthe.2018.09.014; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026	51	9	9	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100376	10.1016/j.jbc.2021.100376	http://dx.doi.org/10.1016/j.jbc.2021.100376			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548229	Green Published, gold			2022-12-26	WOS:000672866400350
J	Toth, AD; Garger, D; Prokop, S; Soltesz-Katona, E; Varnai, P; Balla, A; Turu, G; Hunyady, L				Toth, Andras David; Garger, Daniel; Prokop, Susanne; Soltesz-Katona, Eszter; Varnai, Peter; Balla, Andras; Turu, Gabor; Hunyady, Laszlo			A general method for quantifying ligand binding to unmodified receptors using Gaussia luciferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET RESIDENCE TIME; ANGIOTENSIN RECEPTOR; STRUCTURAL BASIS; SELECTIVITY; CELLS; LOCALIZATION; FLUORESCENCE; CONSTANT; KINETICS; FATE	Reliable measurement of ligand binding to cell surface receptors is of outstanding biological and pharmacological importance. Resonance energy transfer-based assays are powerful approaches to achieve this goal, but the currently available methods are hindered by the necessity of receptor tagging, which can potentially alter ligand binding properties. Therefore, we developed a tag-free system to measure ligand. receptor interactions in live cells using the Gaussia luciferase (GLuc) as a bioluminescence resonance energy transfer donor. GLuc is as small as the commonly applied Nanoluciferase but has enhanced brightness, and its proper substrate is the frequently used coelenterazine. In our assay, bystander bioluminescence resonance energy transfer is detected between a GLuc-based extracellular surface biosensor and fluorescent ligands bound to their unmodified receptors. The broad spectrum of applications includes equilibrium and kinetic ligand binding measurements for both labeled and competitive unlabeled ligands, and the assay can be utilized for different classes of plasma membrane receptors. Furthermore, the assay is suitable for high-throughput screening, as evidenced by the identification of novel alpha(1) adrenergic receptor ligands. Our data demonstrate that GLuc-based biosensors provide a simple, sensitive, and cost-efficient platform for drug characterization and development.	[Toth, Andras David; Garger, Daniel; Prokop, Susanne; Soltesz-Katona, Eszter; Varnai, Peter; Balla, Andras; Turu, Gabor; Hunyady, Laszlo] Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary; [Toth, Andras David; Soltesz-Katona, Eszter; Varnai, Peter; Balla, Andras; Turu, Gabor; Hunyady, Laszlo] Eotvos Lorand Res Network, MTA SE Lab Mol Physiol, Budapest, Hungary; [Toth, Andras David] Semmelweis Univ, Dept Internal Med & Hematol, Budapest, Hungary; [Prokop, Susanne] Semmelweis Univ, Szentagothai Janos Doctoral Sch Neurosci, Budapest, Hungary	Semmelweis University; Eotvos Lorand Research Network; Semmelweis University; Semmelweis University	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary.; Hunyady, L (corresponding author), Eotvos Lorand Res Network, MTA SE Lab Mol Physiol, Budapest, Hungary.	hunyady.laszlo@med.semmelweis-univ.hu	Toth, Andras David/I-8898-2017	Toth, Andras David/0000-0003-2746-9370	Hungarian National Research, Development and Innovation Fund [NKFI K116954, NVKP_16-1-2016-0039]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3-III-SE-23, UNKP-20-3-II-SE-33]	Hungarian National Research, Development and Innovation Fund; New National Excellence Program of the Ministry of Human Capacities	This work was supported by the Hungarian National Research, Development and Innovation Fund (grants NKFI K116954 and NVKP_16-1-2016-0039) and the New National Excellence Program of the Ministry of Human Capacities (UNKP-17-3-III-SE-23, UNKP-20-3-II-SE-33).	Al-Sabah S, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01271; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS21, DOI 10.1111/bph.14748; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; Brothers SP, 2003, J CLIN ENDOCR METAB, V88, P6107, DOI 10.1210/jc.2003-031047; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christiansen E, 2016, J MED CHEM, V59, P4849, DOI 10.1021/acs.jmedchem.6b00202; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; de Witte WEA, 2016, TRENDS PHARMACOL SCI, V37, P831, DOI 10.1016/j.tips.2016.06.008; Emami-Nemini A, 2013, NAT PROTOC, V8, P1307, DOI 10.1038/nprot.2013.073; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Gyombolai P, 2015, J MOL ENDOCRINOL, V54, P75, DOI 10.1530/JME-14-0219; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Inouye S, 2013, BIOCHEM BIOPH RES CO, V437, P23, DOI 10.1016/j.bbrc.2013.06.026; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Kilpatrick LE, 2017, BIOCHEM PHARMACOL, V136, P62, DOI 10.1016/j.bcp.2017.04.006; Kozielewicz P, 2020, MOL PHARMACOL, V97, P23, DOI 10.1124/mol.119.118158; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lindberg E, 2013, CHEM SCI, V4, P4395, DOI 10.1039/c3sc51985f; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mocking TAM, 2018, MOL PHARMACOL, V94, P1371, DOI 10.1124/mol.118.113373; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Stoddart LA, 2018, TRENDS PHARMACOL SCI, V39, P136, DOI 10.1016/j.tips.2017.10.006; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Szakadati G, 2015, MOL PHARMACOL, V87, P972, DOI 10.1124/mol.114.097030; Szekeres M, 2012, J BIOL CHEM, V287, P31540, DOI 10.1074/jbc.M112.346296; Toth AD, 2018, J BIOL CHEM, V293, P876, DOI 10.1074/jbc.M117.813139; Toth AD, 2017, MOL CELL ENDOCRINOL, V442, P113, DOI 10.1016/j.mce.2016.11.027; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; Toth JT, 2016, BBA-MOL CELL BIOL L, V1861, P177, DOI 10.1016/j.bbalip.2015.12.005; Vauquelin G, 2016, BRIT J PHARMACOL, V173, P2319, DOI 10.1111/bph.13504; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wingler LM, 2019, CELL, V176, P479, DOI 10.1016/j.cell.2018.12.006; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang HT, 2017, NATURE, V544, P327, DOI 10.1038/nature22035; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	2	2	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100366	10.1016/j.jbc.2021.100366	http://dx.doi.org/10.1016/j.jbc.2021.100366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545176	Green Published, Green Accepted, gold			2022-12-26	WOS:000672866400340
J	Stanley, SK; Klas, A; Clarke, EJR; Walker, I				Stanley, Samantha K.; Klas, Anna; Clarke, Edward J. R.; Walker, Iain			The effects of a temporal framing manipulation on environmentalism: A replication and extension	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; RIGHT-WING AUTHORITARIANISM; CLIMATE-CHANGE; TIME PERSPECTIVE; POLITICAL CONSERVATISM; CHANGE ATTITUDES; PARADIGM SCALE; PSYCHOLOGY; PREFERENCES; MITIGATION	Recent research promotes comparing the current state of the environment with the past (and not the future) to increase the pro-environmental attitudes of those on the political right. We aimed to replicate this temporal framing effect and extend on research in this area by testing the potential drivers of the effect. Across two large-scale replication studies, we found limited evidence that past comparisons (relative to future comparisons) increase pro-environmentalism among those with a more conservative political ideology, thus precluding a full investigation into the mediators of the effect. Where the effect was present, it was not consistent across studies. In Study One, conservatives reported greater certainty that climate change was real after viewing past comparisons, as the environmental changes were perceived as more certain. However, in Study Two, the temporal framing condition interacted with political orientation to instead undermine the certainty about climate change among political liberals in the past-focused condition. Together, these studies present the first evidence of backfire from temporal frames, and do not support the efficacy of past comparisons for increasing conservatives' environmentalism. We echo recent calls for open science principles, including preregistration and efforts to replicate existing work, and suggest the replication of other methods of inducing temporal comparisons.	[Stanley, Samantha K.; Walker, Iain] Univ Canberra, Ctr Appl Psychol, Canberra, ACT, Australia; [Stanley, Samantha K.; Walker, Iain] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Klas, Anna] Deakin Univ, Sch Psychol, Misinformat Lab, Geelong, Vic, Australia; [Clarke, Edward J. R.] Federat Univ Australia, Sch Sci Psychol & Sport, Berwick, Vic, Australia	University of Canberra; Australian National University; Deakin University; Federation University Australia	Stanley, SK (corresponding author), Univ Canberra, Ctr Appl Psychol, Canberra, ACT, Australia.; Stanley, SK (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	Samantha.Stanley@anu.edu.au	Walker, Iain/G-5457-2010; Stanley, Samantha K./GLR-4253-2022	Walker, Iain/0000-0002-1020-5873; Stanley, Samantha K./0000-0002-1272-5768; Klas, Dr Anna/0000-0002-6590-5164; Clarke, Edward/0000-0002-6441-7150	Faculty of Health Seed Grant from the University of Canberra	Faculty of Health Seed Grant from the University of Canberra	SKS and IW received a Faculty of Health Seed Grant from the University of Canberra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemeyer, 1996, AUTHORITARIAN SPECTE; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; [Anonymous], 2015, BMJ, V349, pg7647; [Anonymous], 2015, ADOLESCENT TIME INVE; Anvari F., 2018, COMPREHENSIVE RESULT, V3, P266, DOI [DOI 10.1080/23743603.2019.1684822, 10.1080/23743603.2019.1684822]; Baldwin M, 2018, EUR J SOC PSYCHOL, V48, P433, DOI 10.1002/ejsp.2348; Baldwin M, 2016, P NATL ACAD SCI USA, V113, P14953, DOI 10.1073/pnas.1610834113; Barnett MD, 2019, J APPL SOC PSYCHOL, V49, P647, DOI 10.1111/jasp.12624; Bateman TS, 2016, GLOBAL ENVIRON CHANG, V41, P206, DOI 10.1016/j.gloenvcha.2016.11.001; Bernstein J, 2019, J ENVIRON EDUC, V50, P73, DOI 10.1080/00958964.2018.1512946; Blake KR, 2020, PERS SOC PSYCHOL B, V46, P1702, DOI 10.1177/0146167220913363; Brulle RJ, 2014, CLIMATIC CHANGE, V122, P681, DOI 10.1007/s10584-013-1018-7; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caprara G, 2009, ASIAN J SOC PSYCHOL, V12, P82, DOI 10.1111/j.1467-839X.2009.01274.x; Clarke EJR, 2019, J APPL SOC PSYCHOL, V49, P349, DOI 10.1111/jasp.12585; Clayton S, 2013, SOC JUSTICE RES, V26, P301, DOI 10.1007/s11211-013-0185-z; Delicado A, 2012, ENVIRON EDUC RES, V18, P831, DOI 10.1080/13504622.2012.683849; Duckitt J, 2010, POLIT PSYCHOL, V31, P685, DOI 10.1111/j.1467-9221.2010.00781.x; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Dunlap RE, 2008, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.1.3-18; Ellis Christopher., 2012, IDEOLOGY AM; Everett JAC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01152; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Federico CM, 2018, POLIT PSYCHOL, V39, P3, DOI 10.1111/pops.12477; Feinberg M, 2013, PSYCHOL SCI, V24, P56, DOI 10.1177/0956797612449177; Feldman L, 2018, J COMMUN, V68, P503, DOI 10.1093/joc/jqy011; Feldman S, 2013, POL PSYCHOL; Feygina I, 2010, PERS SOC PSYCHOL B, V36, P326, DOI 10.1177/0146167209351435; Frimer JA, 2020, J RES PERS, V84, DOI 10.1016/j.jrp.2019.103906; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hakkinen K, 2014, PERS INDIV DIFFER, V70, P62, DOI 10.1016/j.paid.2014.06.030; Harring N, 2017, ENVIRON POLIT, V26, P278, DOI 10.1080/09644016.2016.1244965; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hayes A., 2017, INTRO MEDIATION MODE; Heimberg L. K., 1963, THESIS; Ho AK, 2015, J PERS SOC PSYCHOL, V109, P1003, DOI 10.1037/pspi0000033; Holden Emily., 2019, GUARDIAN 1105; Hornsey MJ, 2018, NAT CLIM CHANGE, V8, P614, DOI 10.1038/s41558-018-0157-2; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Jacques PJ, 2008, ENVIRON POLIT, V17, P349, DOI 10.1080/09644010802055576; Jessani Z, 2018, PERS INDIV DIFFER, V131, P121, DOI 10.1016/j.paid.2018.04.033; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kidwell B, 2013, J CONSUM RES, V40, P350, DOI 10.1086/670610; Kim I, 2021, J ENVIRON PSYCHOL, V73, DOI 10.1016/j.jenvp.2020.101547; Klar S, 2014, PUBLIC OPIN QUART, V78, P344, DOI 10.1093/poq/nfu010; Klas A, 2020, ELGAR HDB ENERGY ENV; Klein RA, 2014, SOC PSYCHOL; Lammers J, 2020, EUR J SOC PSYCHOL, V50, P943, DOI 10.1002/ejsp.2673; Levine AS, 2017, CLIMATIC CHANGE, V142, P301, DOI 10.1007/s10584-017-1952-x; Lilienfeld SO, 2017, PERSPECT PSYCHOL SCI, V12, P660, DOI 10.1177/1745691616687745; Liu JH, 2012, ANAL SOC ISS PUB POL, V12, P190, DOI 10.1111/j.1530-2415.2011.01275.x; Loy LS, 2020, J ENVIRON PSYCHOL, V67, DOI 10.1016/j.jenvp.2020.101388; Lyu HC, 2016, TIME SOC, V25, P533, DOI 10.1177/0961463X16662669; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Martin GN, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00523; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; McCright AM, 2016, TOP COGN SCI, V8, P76, DOI 10.1111/tops.12171; McCright AM, 2016, ENVIRON POLIT, V25, P338, DOI 10.1080/09644016.2015.1090371; McCright AM, 2000, SOC PROBL, V47, P499, DOI 10.1525/sp.2000.47.4.03x0305s; McCright AM, 2003, SOC PROBL, V50, P348, DOI 10.1525/sp.2003.50.3.348; Milfont TL, 2012, INT J PSYCHOL, V47, P325, DOI 10.1080/00207594.2011.647029; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; Nisbet EC, 2013, J COMMUN, V63, P766, DOI 10.1111/jcom.12040; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Oreskes N, 2010, NATURE, V465, P686, DOI 10.1038/465686a; Oreskes Naomi, 2011, MERCHANTS DOUBT HAND; Owens S, 2008, ENERG POLICY, V36, P4412, DOI 10.1016/j.enpol.2008.09.031; Petrovic N, 2014, CLIMATIC CHANGE, V126, P245, DOI 10.1007/s10584-014-1192-2; Poortinga W, 2019, GLOBAL ENVIRON CHANG, V55, P25, DOI 10.1016/j.gloenvcha.2019.01.007; Brito PQ, 2018, EVENT MANAGE, V22, P609, DOI 10.3727/152599518X15300559276967; Reese G., 2012, ECOPSYCHOLOGY, V4, P232, DOI [DOI 10.1089/ECO.2012.0035, DOI 10.1089/EC0.2012.0035]; Rickard LN, 2016, GLOBAL ENVIRON CHANG, V38, P97, DOI 10.1016/j.gloenvcha.2016.03.003; Roh S, 2015, SCI COMMUN, V37, P340, DOI 10.1177/1075547015575181; Saad A, 2018, ENVIRON JUSTICE, V11, P47, DOI 10.1089/env.2017.0033; Schuldt JP, 2011, PUBLIC OPIN QUART, V75, P115, DOI 10.1093/poq/nfq073; Shell DF, 2001, CONTEMP EDUC PSYCHOL, V26, P481, DOI 10.1006/ceps.2000.1073; Shrout PE, 2018, ANNU REV PSYCHOL, V69, P487, DOI 10.1146/annurev-psych-122216-011845; Sidanius J., 1999, SOCIAL DOMINANCE INT; Soutter ARB, 2020, J ENVIRON PSYCHOL, V69, DOI 10.1016/j.jenvp.2020.101413; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Stanley SK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219067; Stanley SK, 2019, J ENVIRON PSYCHOL, V61, P46, DOI 10.1016/j.jenvp.2018.12.002; Stanley SK, 2017, PERS INDIV DIFFER, V108, P174, DOI 10.1016/j.paid.2016.11.059; Stanley SK, 2017, PERS INDIV DIFFER, V107, P228, DOI 10.1016/j.paid.2016.11.051; Treier S, 2009, PUBLIC OPIN QUART, V73, P679, DOI 10.1093/poq/nfp067; van Leeuwen F, 2009, PERS INDIV DIFFER, V47, P169, DOI 10.1016/j.paid.2009.02.017; Wang S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00230; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Wingen T, 2020, SOC PSYCHOL PERS SCI, V11, P454, DOI 10.1177/1948550619877412; Wolsko C, 2016, J EXP SOC PSYCHOL, V65, P7, DOI 10.1016/j.jesp.2016.02.005; Zhang JW, 2013, TIME SOC, V22, P391, DOI 10.1177/0961463X12441174; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	95	2	2	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246058	10.1371/journal.pone.0246058	http://dx.doi.org/10.1371/journal.pone.0246058			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571222	gold, Green Published			2022-12-26	WOS:000618274000063
J	Carus, L; Castillo, I				Carus, Luis; Castillo, Isabel			Injury prevention: Individual factors affecting adult recreational snowboarders' actual and estimated speeds on regular slopes	PLOS ONE			English	Article								Speed is a main factor affecting the kinematic of snow-sports accidents and the degree of severity of the resulting injuries. The aim of this study was to measure on-slope actual maximum speeds of snowboarders and to assess their ability to accurately them with regard to individual factors such as gender, skill level, age and risk-taking behaviour and actual maximum speed. The data were obtained from a sample of 312 (67% male, 33% female) adult recreational snowboarders taking lessons in one of the major resorts in the Spanish Pyrenees. The Pearson correlation coefficient was used to investigate the relationship between maximal measured actual speed and estimated speed for all participants. Multiple linear regression analysis was used to estimate the impact of individual factors on both the snowboarders' actual maximum speed and their error of estimation. The Pearson correlation coefficient between estimated and actual maximum speed was 0.52 (P < 0.001) for all participants. They underestimated their actual maximum speed on average by 10.05 km/h or 28.62%. All assessed factors were shown to significantly affect the snowboarders' actual maximum speed. However, gender, skill level, age and actual maximum speed were shown to significantly affect the snowboarders' error of estimation, while risk-taking behavior did not. Gender, skill level, age and risk-taking behaviour are associated with the actual maximum speed at which snowboarders ride, while the same individual factors, except for risk-taking behaviour, and their snowboarding speed seem to affect the ability to estimate actual maximum speeds in adult recreational snowboarders. The ability to estimate actual speed accurately is an important factor to avoid accidents on ski slopes and, therefore, having snowboarders informed about the benefits of speed self-awareness is a key matter for prevention purposes.	[Carus, Luis] Univ Zaragoza, Dept Business Management, Huesca, Aragon, Spain; [Castillo, Isabel] Univ Zaragoza, Dept Stat Methods, Huesca, Aragon, Spain	University of Zaragoza; University of Zaragoza	Carus, L (corresponding author), Univ Zaragoza, Dept Business Management, Huesca, Aragon, Spain.	carus@unizar.es	Carus, Luis/AAT-1698-2021	Carus, Luis/0000-0001-6159-2554				Aschauer E, 2007, UNFALLCHIRURG, V110, P301, DOI 10.1007/s00113-007-1263-1; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Bailly N., 2017, SNOW SPORTS TRAUMA S, P163; Bailly N, 2018, WILD ENVIRON MED, V29, P151, DOI 10.1016/j.wem.2017.11.007; Bergstrom KA, 2004, BRIT J SPORT MED, V38, P264, DOI 10.1136/bjsm.2002.000270; Brunner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132002; Carus L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010316; Ribalaygua LC, 2010, ACCIDENT ANAL PREV, V42, P468, DOI 10.1016/j.aap.2009.09.009; Chamarro A, 2009, ACCIDENT ANAL PREV, V41, P197, DOI 10.1016/j.aap.2008.10.012; Dickson TJ., 2017, SNOW SPORTS TRAUMA S, P175, DOI DOI 10.1007/978-3-319-52755; Dickson TJ., 2015, SKIING TRAUMA SAFETY, P141; Dickson TJ, 2012, J ASTM INT, V9, P184, DOI [10.1520/JAI104490, DOI 10.1520/JAI104490]; Dickson TJ, 2011, PROCEDIA ENGINEER, V13, P470, DOI 10.1016/j.proeng.2011.05.116; Gil J., 2008, COMO GESTIONAR INSTA; Goulet C, 2000, AM SOC TEST MATER, V1397, P139, DOI 10.1520/STP12872S; Harley Erin M., 2010, Journal of ASTM International, V7, DOI 10.1520/JAI102829; Hildebrandt C, 2011, ACCIDENT ANAL PREV, V43, P1421, DOI 10.1016/j.aap.2011.02.018; Internationale de Ski (FIS), 2002, 10 FIS RUL COND UPD; Internationale de Ski (FIS), 1967, 10 FIS RUL COND; Koehle MS, 2002, SPORTS MED, V32, P785, DOI 10.2165/00007256-200232120-00003; Posch M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082916; Richards Darrin, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101406; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; Scher IS, 2020, J SCI MED SPORT, P1, DOI [10.1016/j.jsams.2019.11.010, DOI 10.1016/J.JSAMS.2019.11.010]; Schmitt KU, 2014, EUR J SPORT SCI, V14, pS165, DOI 10.1080/17461391.2012.666267; SCIALFA CT, 1991, PSYCHOL AGING, V6, P60, DOI 10.1037/0882-7974.6.1.60; Shealy JE, 2006, SKI TRAU SAF, V16, P27; Shealy JE, 2000, AM SOC TEST MATER, V1397, P132, DOI 10.1520/STP12871S; Shealy JE., 2008, SKI CAN, V37, P50; Shealy JE., 2005, J ASTM INT, V2, P1, DOI 10.1520/JAI12092; Sulheim S, 2007, KNEE SURG SPORT TR A, V15, P665, DOI 10.1007/s00167-006-0122-x; Supej M, 2011, RES Q EXERCISE SPORT, V82, P400, DOI 10.1080/02701367.2011.10599772; Takakuwa T, 1997, J ORTHOP SCI, V2, P367, DOI [10.1007/BF02488923, DOI 10.1007/BF02488923]	36	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246931	10.1371/journal.pone.0246931	http://dx.doi.org/10.1371/journal.pone.0246931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566833	Green Published, gold			2022-12-26	WOS:000618271700001
J	Rutten, B; Young, S; Rhedin, M; Olsson, M; Kurian, N; Syed, F; Beech, A; Fidock, M; Newbold, P; Singh, D; Platt, A; Hughes, G				Rutten, Bert; Young, Simon; Rhedin, Magdalena; Olsson, Marita; Kurian, Nisha; Syed, Farhat; Beech, Augusta; Fidock, Mark; Newbold, Paul; Singh, Dave; Platt, Adam; Hughes, Glen			Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker	PLOS ONE			English	Article							HETEROGENEITY; DEGRANULATION; RESPONSES	There is a growing body of evidence for the utility of eosinophil-derived neurotoxin (EDN) as a biomarker in asthma, including association with eosinophilic airway inflammation, assessment of disease severity and potential for predicting pathogenic risks, including exacerbations. However, to interpret any biomarker data with confidence, it is first important to understand the preanalytical factors and biological variation that may affect its reliable measurement and results interpretation. In this study we defined the healthy serum EDN reference range for men and women as 1.98 to 26.10 ng/mL, with no significant gender differences. Smoking did not impact the mean EDN levels and no circadian rhythm was identified for EDN, unlike blood eosinophils (EOS) where levels peaked at 00:00h. EDN expression in different cell types was investigated and shown to occur primarily in eosinophils, indicating they are likely to be the main cellular repository for EDN. We also confirm that the quantification of serum EDN is not influenced by the type of storage tube used, and it is stable at ambient temperature or when refrigerated for at least 7 days and for up to one year when frozen at -20 degrees C or -80 degrees C. In summary, EDN is a stable biomarker that may prove useful in precision medicine approaches by enabling the identification of a subpopulation of asthma patients with activated eosinophils and a more severe form of the disease.	[Rutten, Bert; Young, Simon; Kurian, Nisha; Syed, Farhat; Fidock, Mark; Hughes, Glen] AstraZeneca, Precis Med, Oncol R&D, Cambridge, England; [Rhedin, Magdalena] AstraZeneca, Biopharmaceut R&D, COPD IPF Biosci Res & Early Dev Resp & Immunol, Gothenburg, Sweden; [Olsson, Marita] AstraZeneca, Biopharmaceut R&D, Early Resp & Immunol Stat, Gothenburg, Sweden; [Beech, Augusta; Singh, Dave] Univ Manchester, Manchester Univ NHS Fdn Hosp Trust, Med Evaluat Unit, Manchester, Lancs, England; [Newbold, Paul] AstraZeneca, Biopharmaceut R&D, Late Stage Resp & Immunol, Gaithersburg, MD USA; [Platt, Adam] AstraZeneca, Biopharmaceut R&D, Translat Sci & Expt Med Res & Early Dev, Cambridge, England	AstraZeneca; AstraZeneca; AstraZeneca; University of Manchester; AstraZeneca; AstraZeneca	Hughes, G (corresponding author), AstraZeneca, Precis Med, Oncol R&D, Cambridge, England.	glen.hughes@astrazeneca.com		Rutten, Bart/0000-0002-9834-6346	AstraZeneca	AstraZeneca(AstraZeneca)	BR, SY, MR, MO, NK, FS, MF, PN, AP, GH are employees of AstraZeneca. AstraZeneca provided financial support in the form of salaries, research materials and clinical trial costs. AstraZeneca did not have any further role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The role of these authors are articulated in the authors contribution section.	Agache I, 2016, ALLERGY, V71, P1192, DOI 10.1111/all.12906; Agache I, 2016, ALLERGOL INT, V65, P243, DOI 10.1016/j.alit.2016.04.011; BACH MK, 1990, INT ARCH ALLER A IMM, V93, P323, DOI 10.1159/000235261; Bonfield TL, 2012, CURR OPIN ALLERGY CL, V12, P60, DOI 10.1097/ACI.0b013e32834edb5b; Carr TF, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0112-5; Clinical and Laboratory Standards Institute's (CLSI), C28A3 CLSI; Cottin V, 1998, J ALLERGY CLIN IMMUN, V101, P116, DOI 10.1016/S0091-6749(98)70202-7; de Groot Jantina C, 2015, ERJ Open Res, V1; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Durrington HJ, 2018, AM J RESP CRIT CARE, V198, P1578, DOI 10.1164/rccm.201807-1289LE; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GLEICH GJ, 1999, INTERLEUKIN 5 MOL DR, P1; Global Initiative for Asthma, 2020, REV FR DALLERGOL DIM; Kim Chang-Keun, 2013, Korean J Pediatr, V56, P8, DOI 10.3345/kjp.2013.56.1.8; Kim CK, 2011, J ASTHMA, V48, P994, DOI 10.3109/02770903.2011.623335; Kwon N, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100119; Lee Y, 2019, ALLERGY ASTHMA IMMUN, V11, P394, DOI 10.4168/aair.2019.11.3.394; Panzer SE, 2003, J ALLERGY CLIN IMMUN, V111, P308, DOI 10.1067/mai.2003.65; Park YM, 2010, ALLERGY ASTHMA IMMUN, V2, P87, DOI 10.4168/aair.2010.2.2.87; Pedersen B, 1996, AM J RESP CRIT CARE, V153, P1519, DOI 10.1164/ajrccm.153.5.8630596; Pica-Mendez AM, 2010, CLIN CHIM ACTA, V411, P1833, DOI 10.1016/j.cca.2010.07.019; Rosenberg HF, 2015, INT J MOL SCI, V16, P15442, DOI 10.3390/ijms160715442; SCuhadar S, 2013, OA BIOTECHNOLOGY, V2, P1; Tsuda T, 2019, INT IMMUNOL, V31, P33, DOI 10.1093/intimm/dxy061; TURNERWARWICK M, 1989, J ROY COLL GEN PRACT, V39, P239; Pham TH, 2016, RESP MED, V111, P21, DOI 10.1016/j.rmed.2016.01.003; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246627	10.1371/journal.pone.0246627	http://dx.doi.org/10.1371/journal.pone.0246627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566823	Green Published, gold			2022-12-26	WOS:000618271700021
J	Jorge, MH; Ford, WM; Sweeten, SE; Freeze, SR; True, MC; St Germain, MJ; Taylor, H; Gorman, KM; Garrison, EP; Cherry, MJ				Jorge, Marcelo H.; Ford, W. Mark; Sweeten, Sara E.; Freeze, Samuel R.; True, Michael C.; St Germain, Michael J.; Taylor, Hila; Gorman, Katherine M.; Garrison, Elina P.; Cherry, Michael J.			Winter roost selection of Lasiurine tree bats in a pyric landscape	PLOS ONE			English	Article							UPPER COASTAL-PLAIN; EASTERN RED BATS; PRESCRIBED FIRE; SEMINOLE BATS; SITE SELECTION; PINE; HABITAT; FORESTS; ECOSYSTEMS; WILDLIFE	Day-roost selection by Lasiurine tree bats during winter and their response to dormant season fires is unknown in the southeastern United States where dormant season burning is widely applied. Although fires historically were predominantly growing season, they now occur in the dormant season in this part of the Coastal Plain to support a myriad of stewardship activities, including habitat management for game species. To examine the response of bats to landscape condition and the application of prescribed fire, in the winter of 2019, we mist-netted and affixed radio-transmitters to 16 Lasiurine bats, primarily Seminole bats (Lasiurus seminolus) at Camp Blanding Joint Training Center in northern Florida. We then located day-roost sites to describe roost attributes. For five Seminole bats, one eastern red bat (Lasiurus borealis), and one hoary bat (Lasiurus cinereus), we applied prescribed burns in the roost area to observe bat response in real-time. Generally, Seminole bats selected day-roosts in mesic forest stands with high mean fire return intervals. At the roost tree scale, Seminole day-roosts tended to be larger, taller and in higher canopy dominance classes than surrounding trees. Seminole bats roosted in longleaf (Pinus palustris), slash (Pinus elliotii) and loblolly pine (Pinus taeda) more than expected based on availability, whereas sweetbay (Magnolia virginiana), water oak (Quercus nigra) and turkey oak (Quercus laevis), were roosted in less than expected based on availability. Of the seven roosts subjected to prescribed burns, only one male Seminole bat and one male eastern red bat evacuated during or immediately following burning. In both cases, these bats had day-roosted at heights lower than the majority of other day-roosts observed during our study. Our results suggest Seminole bats choose winter day-roosts that both maximize solar exposure and minimize risks associated with fire. Nonetheless, because selected day-roosts largely were fire-dependent or tolerant tree species, application of fire does need to periodically occur to promote recruitment and retention of suitable roost sites.	[Jorge, Marcelo H.; Sweeten, Sara E.; Freeze, Samuel R.; True, Michael C.; Taylor, Hila; Gorman, Katherine M.] Virginia Polytech Inst & State Univ, Coll Nat Resources & Environm, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Ford, W. Mark] US Geol Survey, Virginia Cooperat Fish & Wildlife Res Unit, Blacksburg, VA 24061 USA; [St Germain, Michael J.] Virginia Polytech Inst & State Univ, Conservat Management Inst, Blacksburg, VA 24061 USA; [Garrison, Elina P.] Texas A&M Univ Kingsville, Caesar Kleberg Wildlife Res Inst, Kingsville, TX USA; [Cherry, Michael J.] Florida Fish & Wildlife Conservat Commiss, Gainesville, FL USA	Virginia Polytechnic Institute & State University; United States Department of the Interior; United States Geological Survey; Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University Kingsville; Florida Fish & Wildlife Conservation Commission	Ford, WM (corresponding author), US Geol Survey, Virginia Cooperat Fish & Wildlife Res Unit, Blacksburg, VA 24061 USA.	wmford@vt.edu		True, Michael/0000-0002-8257-4651; Ford, Mark/0000-0002-9611-594X; Jorge, Marcelo/0000-0002-0309-0561	U.S. Department of Defense Legacy Resources Program [HQ0034-18-2-0012]	U.S. Department of Defense Legacy Resources Program	WMF and MJC received funding for this research which was U.S. Department of Defense Legacy Resources Program award HQ0034-18-2-0012 https://www.denix.osd.mil/legacy/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; [Anonymous], 2002, AUSTR NURSING J N FI, V9, P13; [Anonymous], [No title captured]; [Anonymous], 2012, US FOR SERV GEN TECH; ANTHONY ELP, 1998, ECOLOGICAL BEHAV MET, P47; Armitage DW, 2012, J MAMMAL, V93, P102, DOI 10.1644/11-MAMM-A-169.1; Austin LV, 2020, J FORESTRY RES, V31, P1255, DOI 10.1007/s11676-019-00923-y; Bosso L, 2018, INT J WILDLAND FIRE, V27, P756, DOI [10.1071/WF18072, 10.1071/wf18072]; Boyles JG, 2006, FOREST ECOL MANAG, V222, P108, DOI 10.1016/j.foreco.2005.09.024; Brennan LA, 1998, T N AM WILDL NAT RES, V63, P402; Brockway D.G., 2005, SRS83 USDA FOR SERV, P1; Brockway DG, 1997, FOREST ECOL MANAG, V96, P167, DOI 10.1016/S0378-1127(96)03939-4; Brockway DG, 2000, FOREST ECOL MANAG, V137, P121, DOI 10.1016/S0378-1127(99)00321-7; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Brower J. E., 1984, FIELD LAB METHODS GE; Brown J.K., 2000, RMRSGTR42 USDA FOR S, V2, P257; Carter TC, 2002, ROLE FIRE NONGAME WI, P139; Christensen N.L., 1981, FIRE REGIMES ECOSYST, V112, P136; CLINE SP, 1980, J WILDLIFE MANAGE, V44, P773, DOI 10.2307/3808305; Committee for the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016, 2017, J JPN SOC INTENSIVE, V24, ps1; CONSTANTINE DENNY G., 1958, JOUR MAMMALS, V39, P64, DOI 10.2307/1376610; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; de Torrez ECB, 2018, FIRE ECOL, V14, DOI 10.1186/s42408-018-0006-8; Deuel NR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186402; Dickinson MB, 2010, CAN J FOREST RES, V40, P2187, DOI 10.1139/X10-148; Dickinson Matthew B., 2009, U S Forest Service General Technical Report NRS, V46, P51; Doty AC, 2018, PHYSIOL BEHAV, V185, P31, DOI 10.1016/j.physbeh.2017.12.019; Doty AC, 2016, J COMP PHYSIOL B, V186, P937, DOI 10.1007/s00360-016-1003-3; Dunbar MB, 2006, J MAMMAL, V87, P1096, DOI 10.1644/05-MAMM-A-254R3.1; Faraway JJ, 2016, EXTENDING LINEAR MOD, DOI DOI 10.1201/B21296; Ford WM, 2006, J WILDLIFE MANAGE, V70, P1200, DOI 10.2193/0022-541X(2006)70[1200:PAAOBA]2.0.CO;2; Ford WM, 2016, FIRE ECOL, V12, P13, DOI 10.4996/fireecology.1202013; FROST CC, 1993, P TALL TIMB FIR EC C, V18, P17; Frost CC, 1990, FORESTRY 1990S A CHA, P26; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Harper CA, 2016, FIRE ECOL, V12, P127, DOI 10.4996/fireecology.1202127; Hein CD, 2005, SOUTHEAST NAT, V4, P473, DOI 10.1656/1528-7092(2005)004[0473:WRSBSB]2.0.CO;2; Hein CD, 2008, J MAMMAL, V89, P964, DOI 10.1644/07-MAMM-A-335.1; Hendricks JJ, 2002, CAN J FOREST RES, V32, P928, DOI [10.1139/x02-020, 10.1139/X02-020]; Hiers JK, 2007, ECOL APPL, V17, P806, DOI 10.1890/06-1015; Jenning WL, 1958, THESIS; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson JB, 2010, J FISH WILDL MANAG, V1, P111, DOI 10.3996/042010-JFWM-007; Johnson JB, 2009, FOREST ECOL MANAG, V258, P233, DOI 10.1016/j.foreco.2009.04.008; Jorge MH, 2020, FOREST ECOL MANAG, V461, DOI 10.1016/j.foreco.2020.117939; Jorge MH, 2020, ECOSPHERE; Kirby RB, 2017, RESTOR ECOL, V25, P424, DOI 10.1111/rec.12455; Kirkman LK, 2006, APPL VEG SCI, V9, P67, DOI 10.1658/1402-2001(2006)9[67:CMOPPE]2.0.CO;2; Knapp E. E., 2009, General Technical Report - Pacific Southwest Research Station, USDA Forest Service; Kush J. S., 2004, Ecological Restoration, V22, P6, DOI 10.3368/er.22.1.6; Landers J.L., 1991, HIGH INTENSITY FIRE, P61; LANDERS JL, 1995, J FOREST, V93, P39; Landers JL, 1986, TALL TIMBERS RES STA, V6; Lashley MA, 2015, FIRE ECOL, V11, P62, DOI 10.4996/fireecology.1103062; Law B, 2018, AUSTRAL ECOL, V43, P706, DOI 10.1111/aec.12617; Layne JT, 2009, THESIS; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Loeb SC, 2008, FOREST ECOL MANAG, V255, P3185, DOI 10.1016/j.foreco.2007.10.060; Lourenco SI, 2004, BIOL CONSERV, V119, P237, DOI 10.1016/j.biocon.2003.11.006; Menzel MA, 2000, PROCEEDINGS OF THE FIFTY-FOURTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P304; Menzel MA, 2001, AM MIDL NAT, V145, P112, DOI 10.1674/0003-0031(2001)145[0112:TRCOSA]2.0.CO;2; Menzel MA, 1998, CAN J ZOOL, V76, P630, DOI 10.1139/cjz-76-4-630; Menzel MA, 2002, NE376 USDA FOR SERV; Menzel Michael A., 1999, Florida Scientist, V62, P185; Mikula P, 2016, MAMMAL REV, V46, P160, DOI 10.1111/mam.12060; Moorman Christopher E., 1999, Bat Research News, V40, P74; Mormann BM, 2007, J WILDLIFE MANAGE, V71, P213, DOI 10.2193/2005-622; Muthersbaugh MS, 2019, J FISH WILDL MANAG, V10, P180, DOI 10.3996/082018-JFWM-072; Myers R.L., 1990, P150; Neal JL, 1965, 1 OR STAT U FOR RES; Nocera T, 2019, GLOB ECOL CONSERV, V18, DOI 10.1016/j.gecco.2019.e00633; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Nyland R.D., 1996, MCGRAW HILL SERIES F, V8; Perry RW, 2007, AM MIDL NAT, V158, P361, DOI 10.1674/0003-0031(2007)158[361:SRBAMS]2.0.CO;2; Perry RW, 2018, J MAMMAL, V99, P1478, DOI 10.1093/jmammal/gyy135; Perry RW, 2015, INT J WILDLAND FIRE, V24, P544, DOI 10.1071/WF14119; R Core Team, 2021, R LANGUAGE ENV STAT; Robbins LE, 1992, TALL TIMBERS RES STA, V8; Rodrigue Jane L., 2001, Bat Research News, V42, P48; Saugey David A., 1998, Journal of the Arkansas Academy of Science, V52, P92; Scesny AA, 2006, THESIS; Silvis A, 2012, INT J FOR RES, DOI 10.1155/2012/148106; Steel ZL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52875-2; Stoddard H.L., 1931, BOBWHITE QUAIL ITS H; WALDROP TA, 1992, FOREST ECOL MANAG, V47, P195, DOI 10.1016/0378-1127(92)90274-D; Zar J.H., 1996, BIOSTAT ANAL	87	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0245695	10.1371/journal.pone.0245695	http://dx.doi.org/10.1371/journal.pone.0245695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561128	Green Published, gold			2022-12-26	WOS:000617533000024
J	Petersen, CA; Terveen, DC; Quist, T; Taravati, P; Ding, L; Oetting, TA; Chen, PP				Petersen, Christine A.; Terveen, Daniel C.; Quist, Tyler; Taravati, Parisa; Ding, Leona; Oetting, Thomas A.; Chen, Philip P.			Accuracy of partial coherence interferometry in patients with large inter-eye axial length difference	PLOS ONE			English	Article							REFRACTIVE OUTCOMES; BIOMETRY	Background To determine accuracy of partial coherence interferometry (PCI) in patients with large inter-eye axial eye length (AEL) difference. Methods Patients undergoing cataract surgery at two academic medical centers with an inter-eye axial eye length (AEL) difference of > 0.30 mm were identified and were matched to control patients without inter-eye AEL difference > 0.30 mm on the basis of age, sex, and AEL. The expected post-operative refraction for the implanted IOL was calculated using SRK/T, Holladay II, and Hoffer Q formulae. The main outcome measures were the refractive prediction error and the equivalence of the refractive outcomes between the subjects and controls. Results Review of 2212 eyes from 1617 patients found 131 eyes of 93 patients which met inclusion criteria. These were matched to 131 control eyes of 115 patients. The mean AEL was 24.92 +/- 1.50 mm. The mean absolute error (MAE) ranged from 0.47 D to 0.69 D, and was not statistically different between subjects and controls. The refractive prediction error was equivalent between the cases and controls, with no significant difference between the MAE for any formula, nor in the number of cases vs. controls with a refractive prediction error of at least 0.50 D or 1.00 D. Conclusions Among eyes in our study population, good-quality PCI data was equally accurate in patients with or without an inter-eye AEL difference > 0.30 mm. Confirmatory AEL measurements using different AEL measuring modalities in patients with a large inter-eye AEL difference may not be necessary.	[Petersen, Christine A.; Taravati, Parisa; Ding, Leona; Chen, Philip P.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Terveen, Daniel C.; Quist, Tyler; Oetting, Thomas A.] Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa	Petersen, CA (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	chrispe@uw.edu		Petersen, Christine/0000-0002-8400-3721; Chen, Philip/0000-0001-9558-9492; Oetting, Thomas/0000-0003-1764-610X; Taravati, Parisa/0000-0002-0263-4344	Research to Prevent Blindness	Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This study was supported by the following grants: 1) Research to Prevent Blindness unrestricted grant to the University of Washington: authors CAP, PT, LD, PPC. Website: https://www.rpbusa.org/rpb/.2) Research to Prevent Blindness unrestricted grant to the University of Iowa: authors DCT, TQ, TAO. Website: https://www.rpbusa.org/rpb/.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristodemou P, 2011, J CATARACT REFR SURG, V37, P63, DOI 10.1016/j.jcrs.2010.07.032; Brogan K, 2019, BRIT J OPHTHALMOL, V103, P539, DOI 10.1136/bjophthalmol-2018-312209; Cartwright NEK, 2010, EYE, V24, P894, DOI 10.1038/eye.2009.196; Connors R, 2002, J CATARACT REFR SURG, V28, P235, DOI 10.1016/S0886-3350(01)01179-8; Drexler W, 1998, AM J OPHTHALMOL, V126, P524, DOI 10.1016/S0002-9394(98)00113-5; Findl O, 2001, J CATARACT REFR SURG, V27, P861, DOI 10.1016/S0886-3350(00)00699-4; HOFFER KJ, 1980, AM J OPHTHALMOL, V90, P360, DOI 10.1016/S0002-9394(14)74917-7; Kansal V, 2018, OPHTHALMOLOGY, V125, P972, DOI 10.1016/j.ophtha.2018.01.021; OLSEN T, 1987, J CATARACT REFR SURG, V13, P141, DOI 10.1016/S0886-3350(87)80128-1; Rajan MS, 2008, J CATARACT REFR SURG, V34, P76, DOI 10.1016/j.jcrs.2007.08.023; Rajan MS, 2002, EYE, V16, P552, DOI 10.1038/sj.eye.6700157; The Royal College of Ophthalmologists, 2010, CAT SURG GUID; Wickremasinghe S, 2004, INVEST OPHTH VIS SCI, V45, P776, DOI 10.1167/iovs.03-0456	13	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246721	10.1371/journal.pone.0246721	http://dx.doi.org/10.1371/journal.pone.0246721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561129	Green Published, gold			2022-12-26	WOS:000617533000045
J	Rasheed, MA; Chand, P; Ahmed, S; Sharif, H; Hoodbhoy, Z; Siddiqui, A; Hasan, BS				Rasheed, Muneera A.; Chand, Prem; Ahmed, Saad; Sharif, Hamza; Hoodbhoy, Zahra; Siddiqui, Ayat; Hasan, Babar S.			Use of artificial intelligence on Electroencephalogram (EEG) waveforms to predict failure in early school grades in children from a rural cohort in Pakistan	PLOS ONE			English	Article							PROGRAM; POWER	Universal primary education is critical for individual academic growth and overall adult productivity of nations. Estimates indicate that 25% of 59 million primary age out of school children drop out and early grade failure is one of the factors. An objective and feasible screening measure to identify at-risk children in the early grades can help to design appropriate interventions. The objective of this study was to use a Machine Learning algorithm to evaluate the power of Electroencephalogram (EEG) data collected at age 4 in predicting academic achievement at age 8 among rural children in Pakistan. Demographic and EEG data from 96 children of a cohort along with their academic achievement in grade 1-2 measured using an academic achievement test of Math and language at the age of 7-8 years was used to develop the machine learning algorithm. K- Nearest Neighbor (KNN) classifier was used on different model combinations of EEG, sociodemographic and home environment variables. KNN model was evaluated using 5 Stratified Folds based on the sensitivity and specificity. In the current dataset, 55% and 74% failed in the mathematics and language test respectively. On testing data across each fold, the mean sensitivity and specificity was calculated. Sensitivity was similar when EEG variables were combined with sociodemographic, and home environment (Math = 58.7%, Language = 66.3%) variables but specificity improved (Math = 43.4% to 50.6% and Language = 32% to 60%). The model requires further validation for EEG to be used as a screening measure with adequate sensitivity and specificity to identify children in their preschool age who may be at high risk of failure in early grades.	[Rasheed, Muneera A.; Chand, Prem; Hoodbhoy, Zahra; Siddiqui, Ayat; Hasan, Babar S.] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Ahmed, Saad; Sharif, Hamza] Ephlux Pvt Ltd, Dept Artificial Intelligence, Karachi, Pakistan	Aga Khan University	Rasheed, MA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	Muneera.rasheed@uib.no			Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway [223269]	Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway	This work was funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway to the Centre for Intervention Science in Maternal and Child Health (CISMAC; Project No. 223269).	Alghamdi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179805; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], 2015, SUST DEV GOAL; Cheng Q R, 2016, Zhonghua Er Ke Za Zhi, V54, P913, DOI 10.3760/cma.j.issn.0578-1310.2016.12.008; Craw S., 2011, ENCY MACHINE LEARNIN, P171, DOI 10.1007/978-0-387-30164-8_110; Crosnoe R, 2002, J ADOLESCENT RES, V17, P143, DOI 10.1177/0743558402172003; Dekker G. W., 2009, P INT C ED DAT MIN; Drake F., 2001, PYTHON REFERENCE MAN; Dubeck MM, 2015, INT J EDUC DEV, V40, P315, DOI 10.1016/j.ijedudev.2014.11.004; Ecker-Lyster M., 2016, J RISK ISSUES, V19, P24; Entwisle DR, 2005, AM J SOCIOL, V110, P1458, DOI 10.1086/428444; Ghassemi Marzyeh, 2018, ARXIV PREPRINT ARXIV; Glewwe P, 2001, WORLD BANK ECON REV, V15, P81, DOI 10.1093/wber/15.1.81; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hsu DA, 2016, CLIN NEUROPHYSIOL, V127, P1196, DOI 10.1016/j.clinph.2015.07.027; Husain SF, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.11.047; Ibrahim Z, 2007, PREDICTING STUDENTS; Isbell E, 2019, DEV PSYCHOBIOL, V61, P495, DOI 10.1002/dev.21809; Kamal Madeeha, 2009, Oman Med J, V24, P212, DOI 10.5001/omj.2009.42; Khoe HCH, 2020, SURG ENDOSC, V34, P5604, DOI 10.1007/s00464-019-07331-7; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kotsiantis SB, 2003, INT C KNOWL BAS INT; Lai C., 2017, BJ PSYCH ADV, V23, P324, DOI DOI 10.1192/APT.BP.115.015610; Lichtenberger EO, 2005, MENT RETARD DEV D R, V11, P197, DOI 10.1002/mrdd.20076; Marks GN, 2010, SCH EFF SCH IMPROV, V21, P267, DOI 10.1080/09243451003694364; Marquez-Vera C, 2013, APPL INTELL, V38, P315, DOI 10.1007/s10489-012-0374-8; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Ministry of Education, 2015, PHIL ED ALL 2015 REV; Ng MC, 2017, SEIZURE-EUR J EPILEP, V49, P5, DOI 10.1016/j.seizure.2017.05.003; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Platas LM, 2014, EARLY GRADE MATH ASS; Project TB, 2016, FACT DRIV LACK ACC E; Rasheed A, 2018, INT J FINANC STUD, V6, DOI 10.3390/ijfs6030077; Si Y., 2020, ACTA EPILEPTOL; Studies NIoP, 2018, PAK DEM HLTH SURV 20; Tan MJ, 2015, INT J EMERG TECHNOL, V10, P11, DOI 10.3991/ijet.v10i1.4189; Tarullo AR, 2017, DEV COGN NEUROS-NETH, V26, P1, DOI 10.1016/j.dcn.2017.03.007; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; The United Nations Educational Scientific and Cultural Organization (UNESCO), 2014, UNESCO ED STRATEGY 2; UIo, 2018, DAT SUST DEV GOALS; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wechsler D., 2012, WECHSLER PRESCHOOL P, VFourth; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Yousafzai AK, 2014, LANCET, V384, P1282, DOI 10.1016/S0140-6736(14)60455-4	45	3	3	9	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246236	10.1371/journal.pone.0246236	http://dx.doi.org/10.1371/journal.pone.0246236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556088	gold, Green Published			2022-12-26	WOS:000617531400010
J	Wu, KHH; Hornsby, WE; Klunder, B; Krause, A; Driscoll, A; Kulka, J; Bickett-Hickok, R; Fellows, A; Graham, S; Kaleba, EO; Hayek, SS; Shi, X; Sutton, NR; Douville, N; Mukherjee, B; Jamerson, K; Brummett, CM; Willer, CJ				Wu, Kuan-Han H.; Hornsby, Whitney E.; Klunder, Bethany; Krause, Amelia; Driscoll, Anisa; Kulka, John; Bickett-Hickok, Ryan; Fellows, Austin; Graham, Sarah; Kaleba, Erin O.; Hayek, Salim S.; Shi, Xu; Sutton, Nadia R.; Douville, Nicholas; Mukherjee, Bhramar; Jamerson, Kenneth; Brummett, Chad M.; Willer, Cristen J.			Exposure and risk factors for COVID-19 and the impact of staying home on Michigan residents	PLOS ONE			English	Article							NEW-YORK-CITY; OUTCOMES; HEALTH	COVID-19 has had a substantial impact on clinical care and lifestyles globally. The State of Michigan reports over 80,000 positive COVID-19 tests between March 1, 2020 and July 29, 2020. We surveyed 8,041 Michigan Medicine biorepository participants in late June 2020. We found that 55% of COVID-19 cases reported no known exposure to family members or to someone outside the house diagnosed with COVID-19. A significantly higher rate of COVID-19 cases were employed as essential workers (45% vs 19%, p = 9x10(-12)). COVID-19 cases reporting a fever were more likely to require hospitalization (categorized as severe; OR = 4.4 [95% CI: 1.6-12.5, p = 0.005]) whereas respondents reporting rhinorrhea was less likely to require hospitalization (categorized as mild-to-moderate; OR = 0.16 [95% CI: 0.04-0.73, p = 0.018]). African-Americans reported higher rates of being diagnosed with COVID-19 (OR = 4.0 [95% CI: 2.2-7.2, p = 5x10(-6)]), as well as higher rates of exposure to family or someone outside the household diagnosed with COVID-19, an annual household income < $40,000, living in rental housing, and chronic diseases. During the Executive Order in Michigan, African Americans, women, and the lowest income group reported worsening health behaviors and higher overall concern for the potential detrimental effects of the pandemic. The higher risk of contracting COVID-19 observed among African Americans may be due to the increased rates of working as essential employees, lower socioeconomic status, and exposure to known positive cases. Continued efforts should focus on COVID-19 prevention and mitigation strategies, as well as address the inequality gaps that result in higher risks for both short-term and long-term health outcomes.	[Wu, Kuan-Han H.; Willer, Cristen J.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Hornsby, Whitney E.; Klunder, Bethany; Krause, Amelia; Graham, Sarah; Hayek, Salim S.; Sutton, Nadia R.; Jamerson, Kenneth; Willer, Cristen J.] Michigan Med, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Driscoll, Anisa; Kaleba, Erin O.] Michigan Med Off Res, Data Off Clin & Translat Res, Ann Arbor, MI USA; [Driscoll, Anisa; Kulka, John; Bickett-Hickok, Ryan; Fellows, Austin] Univ Michigan, Precis Hlth Initiat, Ann Arbor, MI 48109 USA; [Shi, Xu; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Douville, Nicholas; Brummett, Chad M.] Michigan Med, Dept Anesthesiol, Ann Arbor, MI USA; [Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Willer, CJ (corresponding author), Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Michigan Med, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA.	cristen@umich.edu	Hayek, Salim S./E-6932-2013	Hayek, Salim S./0000-0003-0180-349X; Sutton, Nadia/0000-0002-0968-3085	National Institutes of Health [R35-HL135824, R01-HL142023, R01-DK075787, R01-HL109946]; Foundation for Anesthesia Education and Research (FAER) -Mentored Research Training Grant; University of Michigan Rogel Cancer Center; Michigan Institute of Data Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Anesthesia Education and Research (FAER) -Mentored Research Training Grant; University of Michigan Rogel Cancer Center; Michigan Institute of Data Science	Funding Source Dr. Willer is supported by National Institutes of Health grants R35-HL135824, R01-HL142023, R01-DK075787, and R01-HL109946 Dr. Douville is supported by the Foundation for Anesthesia Education and Research (FAER) -Mentored Research Training Grant. Dr. Mukherjee is supported by the University of Michigan Rogel Cancer Center and the Michigan Institute of Data Science.	[Anonymous], 2020, SOCIAL DETERMINANTS; [Anonymous], COVID 19 HOST GENETI; [Anonymous], 2018, INCOME POVERTY UNITE; [Anonymous], CORONAVIRUS MICHIGAN; [Anonymous], CLIN MANAGEMENT COVI; [Anonymous], CORONAVIRUS DIS COVI; [Anonymous], INFORM CONSENT; [Anonymous], 1994, ANN ACAD MED SINGAP, V23, P129; Coronavirus Disease, 2019, COVID 19 CAS DAT; Coronavirus Disease, 2019, COVID 19 2020 INTERI; Coronavirus Disease, 2019, COVID 19 ASS RISK FA; Cummings Matthew J, 2020, medRxiv, DOI [10.1016/S0140-6736(20)31189-2, 10.1101/2020.04.15.20067157]; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Foldi M, 2020, OBES REV, V21, DOI 10.1111/obr.13095; Fritsche LG, 2018, AM J HUM GENET, V102, P1048, DOI 10.1016/j.ajhg.2018.04.001; Garcia-Fernandez L, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1934; Hu Y, 2020, NEW ENGL J MED, V382, P1708; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Love-Nichols J, 2021, J GENET COUNS, V30, P645, DOI 10.1002/jgc4.1341; Magasi S, 2012, QUAL LIFE RES, V21, P739, DOI 10.1007/s11136-011-9990-8; Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0; McNeely J, 2016, ANN INTERN MED, V165, P690, DOI 10.7326/M16-0317; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Nienhuis CP, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239036; Norton EL, 2020, J THORAC CARDIOVASC, DOI [10.1016/j.jtcvs.2020.01.094 32199657, DOI 10.1016/J.JTCVS.2020.01.094 32199657]; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Racial Data Dashboard, RAC DAT DASHB COVID; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Spector-Bagdady K, 2020, NEW ENGL J MED, V382, P2072, DOI 10.1056/NEJMp1915298; Tai DBG, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa815 32562416, DOI 10.1093/CID/CIAA815 32562416]; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolford BN, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002476; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15481; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246447	10.1371/journal.pone.0246447	http://dx.doi.org/10.1371/journal.pone.0246447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556117	Green Submitted, gold, Green Published			2022-12-26	WOS:000617379900049
J	Fish, LA; Jones, EJH				Fish, Laurel A.; Jones, Emily J. H.			A survey on the attitudes of parents with young children on in-home monitoring technologies and study designs for infant research	PLOS ONE			English	Article							NEEDS	Remote in-home infant monitoring technologies hold great promise for increasing the scalability and safety of infant research (including in regard to the current Covid-19 pandemic), but remain rarely employed. These technologies hold a number of fundamental challenges and ethical concerns that need addressing to aid the success of this fast-growing field. In particular, the responsible development of such technologies requires caregiver input. We conducted a survey of the opinions of 410 caregivers on the viability, privacy and data access of remote in-home monitoring technologies and study designs. Infant-friendly wearable devices (such as sensing body suits) were viewed favourably. Caregivers were marginally more likely to accept video and audio recording in the home if data was anonymised (through automated processing) at point of collection, particularly when observations were lengthy. Caregivers were more open to international data sharing for anonymous data. Caregivers were interested in viewing all types of data, but were particularly keen to access video and audio recordings for censoring purposes (i.e., to delete data segments). Taken together, our results indicate generally positive attitudes to remote in-home monitoring technologies and studies for infant research but highlight specific considerations such as safety, privacy and family practicalities (e.g. multiple caregivers, visitors and varying schedules) that must be taken into account when developing future studies.	[Fish, Laurel A.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Jones, Emily J. H.] Birkbeck Univ London, Ctr Brain & Cognit Dev, London, England	University of London; King's College London; University of London; Birkbeck University London	Fish, LA (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	laurel.fish@kcl.ac.uk		Jones, Emily/0000-0001-5747-9540; Fish, Laurel/0000-0001-5905-655X	European Community [642990]; Innovative Medicines Initiative Joint Undertaking [115300]; European Union; Innovative Medicines Initiative 2 Joint Undertaking [777394]; European Union's Horizon 2020 research	European Community(European Commission); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); Innovative Medicines Initiative 2 Joint Undertaking; European Union's Horizon 2020 research	This collection of data has been supported by a grant from the European Community's Horizon 2020 Program (https://ec.europa.eu/programmes/horizon2020/en) under grant agreement no 642990 (EJ), and the Innovative Medicines Initiative Joint Undertaking (https://www.eu-aims.eu/imprint/) under grant agreement no 115300 (EJ), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and EFPIA companies' in kind contribution. The results leading to this project has been supported by AIMS2 (https://www.aims-2trials.eu), which received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 (EJ). This Joint Undertaking receives support from the European Union's Horizon 2020 research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, SENSORS BASEL, DOI DOI 10.20944/PREPRINTS201903.0164.V1; APA, 2014, APA ETH COD ADDR OBT; Azhari A, 2020, INFANT BEHAV DEV, V58, DOI 10.1016/j.infbeh.2019.101389; Ballieux H, 2016, INFANT CHILD DEV, V25, P95, DOI 10.1002/icd.1914; Bergelson E, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12715; Bonafide CP, 2017, JAMA-J AM MED ASSOC, V317, P353, DOI 10.1001/jama.2016.19137; Boonzaaijer M, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1779-x; Bouwstra S, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P162, DOI 10.1109/P3644.39; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Casillas M, 2019, COLLABRA-PSYCHOL, V5, DOI 10.1525/collabra.209; Chen W., 2010, P 5 INT C BOD AR NET, P188, DOI [DOI 10.1145/2221924.2221960, 10.1145/2221924.2221960]; Curtindale LM, 2019, J EXP CHILD PSYCHOL, V178, P283, DOI 10.1016/j.jecp.2018.10.006; Dahl A, 2017, CHILD DEV PERSPECT, V11, P79, DOI 10.1111/cdep.12217; de Barbaro K, 2019, DEV PSYCHOBIOL, V61, P444, DOI 10.1002/dev.21831; Fausey CM, 2016, COGNITION, V152, P101, DOI 10.1016/j.cognition.2016.03.005; General Data Protection Regulation (GDPR), 2018, GEN DATA PROTECTION; Gilkerson J, 2017, AM J SPEECH-LANG PAT, V26, P248, DOI 10.1044/2016_AJSLP-15-0169; Hall ML, 2018, ASSIST TECHNOL, V30, P251, DOI 10.1080/10400435.2017.1320690; Harari GM, 2016, PERSPECT PSYCHOL SCI, V11, P838, DOI 10.1177/1745691616650285; IBM, 2017, IBM SPSS STAT SOFTW; Iqbal SA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002333; Junqing Wang, 2017, Proceedings of the ACM on Human-Computer Interaction, V1, DOI 10.1145/3134743; Kidwell MC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002456; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Lee DK, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12615; Levin H, 2019, J CHEM INF MODEL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Lobo MA, 2019, PHYS THER, V99, P647, DOI 10.1093/ptj/pzz024; Memon SF, 2020, IET CIRC DEVICE SYST, V14, P115, DOI 10.1049/iet-cds.2018.5447; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Mindell JA, 2016, J SLEEP RES, V25, P508, DOI 10.1111/jsr.12414; Nava E, 2016, CORTEX, V84, P124, DOI 10.1016/j.cortex.2016.07.011; Nosek BA, 2018, P NATL ACAD SCI USA, V115, P2600, DOI 10.1073/pnas.1708274114; Porges SW, 2019, DEV PSYCHOBIOL, V61, P942, DOI 10.1002/dev.21841; R Core Team, 2016, R FDN STAT COMP; Richards JA, 2008, LENA AUTOMATIC VOCAL; Rogers E, 2015, J MED DEVICES, V9, DOI 10.1115/1.4030550; Schmuckler MA, 2001, INFANCY, V2, P419, DOI 10.1207/S15327078IN0204_02; Singh M, 2010, IEEE INT SYM WRBL CO; Singh Y, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4338-z; Smith A., 2009, LEXIMANCER PTY LTD; Spittle AJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013446; Sugden NA, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2019.105070; Taylor-Pashow KML, 2019, SOLVENT EXTR ION EXC, V37, P1, DOI 10.1080/07366299.2019.1592924; VanDam M, 2016, SEMIN SPEECH LANG, V37, P128, DOI 10.1055/s-0036-1580745; Wang Y, 2017, AM ANN DEAF, V162, P295, DOI 10.1353/aad.2017.0028; Wass S., 2020, PSYARXIV, DOI [10.31234/osf.io/5zvuf, DOI 10.31234/OSF.IO/5ZVUF]; Yao Xuewen, 2019, Proc ACM Interact Mob Wearable Ubiquitous Technol, V3, DOI 10.1145/3328935; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245793	10.1371/journal.pone.0245793	http://dx.doi.org/10.1371/journal.pone.0245793			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544777	Green Published, gold			2022-12-26	WOS:000617991900052
J	Hathaway, CA; Siegel, EM; Chung, CH; Pabbathi, S; Vidrine, J; Vadaparampil, S; Tworoger, SS				Hathaway, Cassandra A.; Siegel, Erin M.; Chung, Christine H.; Pabbathi, Smitha; Vidrine, Jennifer; Vadaparampil, Susan; Tworoger, Shelley S.			Utilizing a large-scale biobanking registry to assess patient priorities and preferences for cancer research and education	PLOS ONE			English	Article								Patients consented to biobanking studies typically do not specify research conducted on their samples and data. Our objective was to gauge cancer biobanking participant preferences on research topics. Patient-participants of a biobanking study at a comprehensive cancer center who had an appointment within the last 5 years, had a valid email address, and with a last known vital status of alive, were emailed a newsletter containing a link to a survey about preferences and priorities for research. The survey assessed demographics and research interest in three domains: cancer site, cancer-related topics, and issues faced by cancer patients. 37,384 participants were contacted through email to participate in the survey. 16,158 participants (43.2%) opened the email, 1,626 (4.3% overall, 10% of those who opened the email) completed the survey, and 1,291 (79.4% of those who completed the survey) selected at least one research priority. Among those who selected at least one research priorities for cancer-relevant topics, the most commonly selected were cancer treatment (66%), clinical trials (54%), and cancer prevention (53%). Similarly, the most selected priorities for cancer-related issues faced by patients were physical side effects of cancer (57%), talking to the oncologist (53%), and emotional challenges due to cancer (47%). Differences by gender were observed, with females reporting more interest in research generally. Cancer patients participating in a biobanking protocol prioritized research on treatments, prevention and side effects, which varied by gender.	[Hathaway, Cassandra A.; Siegel, Erin M.; Tworoger, Shelley S.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Chung, Christine H.] H Lee Moffitt Canc Ctr & Res Inst, Dept Head & Neck Endocrine Oncol, Tampa, FL USA; [Pabbathi, Smitha] H Lee Moffitt Canc Ctr & Res Inst, Dept Survivorship, Tampa, FL USA; [Vidrine, Jennifer; Vadaparampil, Susan] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Vadaparampil, Susan] H Lee Moffitt Canc Ctr & Res Inst, Off Community Outreach Engagement & Equ, Tampa, FL USA; [Tworoger, Shelley S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Tworoger, SS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA.; Tworoger, SS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	Shelley.Tworoger@moffitt.org	Hathaway, Cassandra/GZN-1900-2022	Vidrine, Jennifer/0000-0002-9997-4459; Hathaway, Cassandra/0000-0002-2919-0499	NCI designated Comprehensive Cancer Center [P30-CA076292]	NCI designated Comprehensive Cancer Center	This research was made possible through the Total Cancer Care Protocol at the H. Lee Moffitt Cancer Center & Research Institute and by the Participant Research, Interventions, & Measurement (PRISM) Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center (P30-CA076292). We would like to acknowledge the work of Kyle Hawkins, Pamela Wilson and Amanda Bloomer in the design, content development, and dissemination of the Total Cancer Care electronic newsletter (eLetter) and our patients who have agreed to participate in the TCC biobanking cohort.	[Anonymous], 2012, DRUG SAFETY UPDATE, V6, pA1; Astrin JJ, 2016, BIOPRESERV BIOBANK, V14, P65, DOI 10.1089/bio.2015.0019; Barnes R, 2020, BIOPRESERV BIOBANK, V18, P204, DOI 10.1089/bio.2019.0090; Braun KL, 2014, BIOPRESERV BIOBANK, V12, P106, DOI 10.1089/bio.2013.0083; Caixeiro NJ, 2016, EUR J HUM GENET, V24, P626, DOI 10.1038/ejhg.2015.191; Castillo-Pelayo T, 2015, BIOPRESERV BIOBANK, V13, P172, DOI 10.1089/bio.2014.0061; Coppola L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1922-3; Corner J, 2007, BRIT J CANCER, V96, P875, DOI 10.1038/sj.bjc.6603662; Davidson M, 2019, EUR J CANCER, V121, P40, DOI 10.1016/j.ejca.2019.08.010; De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244; Domaradzki J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122209; Gordon L, 2007, PSYCHO-ONCOL, V16, P1130, DOI 10.1002/pon.1182; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Hathcock MA, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00009; Health NIo, 2008, SIT REC ICD 0 3 WHO; Jaffee EM, 2017, LANCET ONCOL, V18, pE653, DOI 10.1016/S1470-2045(17)30698-8; Keesing S, 2018, WOMENS HEALTH, V14, DOI 10.1177/1745505718756381; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; Link Michael W, 2006, Prev Chronic Dis, V3, pA09; Long CR, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0422-5; Long CR, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2200-4; Long CR, 2016, CLIN TRIALS, V13, P582, DOI 10.1177/1740774516665598; Master Z, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-8; Pabbathi S, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.5_suppl.207; Paras-Bravo P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041302; Patil S, 2018, ONCOL REV, V12, P33, DOI 10.4081/oncol.2018.357; Pritlove C, 2019, QUAL HEALTH RES, V29, P758, DOI 10.1177/1049732318803885; Purvis Rachel S, 2017, AJOB Empir Bioeth, V8, P69, DOI 10.1080/23294515.2017.1310146; Rahm AK, 2013, J COMMUN GENET, V4, P445, DOI 10.1007/s12687-013-0146-0	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246686	10.1371/journal.pone.0246686	http://dx.doi.org/10.1371/journal.pone.0246686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544776	Green Published, gold			2022-12-26	WOS:000617991900057
J	Yanagawa, S; Tahara, H; Shirouzu, T; Kawai, S; Tanaka, Y; Ide, K; Akimoto, S; Ohdan, H				Yanagawa, Senichiro; Tahara, Hiroyuki; Shirouzu, Takayuki; Kawai, Shintaro; Tanaka, Yuka; Ide, Kentaro; Akimoto, Shuji; Ohdan, Hideki			Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA)	PLOS ONE			English	Article							CHRONIC REJECTION; T-CELLS; HUMAN B; CD40; SYSTEM; MICE	In organ transplantation, human leukocyte antigen (HLA)-mismatch grafts not only induce the activation of cellular mediated immune response but also the development of chronic antibody-mediated rejection due to the donor-specific anti-HLA antibody (DSA) produced by B cells and plasma cells interacting with the graft endothelium. Significant improvement in long-term survival after transplantation can be expected if antibody-mediated rejection due to the DSA can be overcome. However, the mechanism of producing or controlling the DSA remains to be elucidated. In recent decades, "humanized" mouse models have been widely used for the basic research of human immune systems, but a humanized mouse model to analyze the mechanism of DSA production has not been established yet. Thus, we aimed to create a humanized mouse using a severe immunodeficiency mouse (NSG mouse) administered with human peripheral blood mononuclear cells (PBMCs). Initially, we detected a very low level of human total-IgG and no anti-HLA antibodies (Abs) in these mice. In our next attempt, we mixed PBMCs of various HLA antigenic combinations with or without regulatory T cells and preconditioned them by culturing on feeder cells stably transfected with human CD40 ligand (h-CD40L) alone or with h-CD40L and human B cell activating factor (h-BAFF). They were subsequently co-cultured with the corresponding irradiated stimulator PBMCs, and all cells were administered into naive NSG mice. Although all three humanized models had sufficient human total-IgG and anti-HLA antibody production, allospecific anti-HLA Ab production was prominently suppressed whereas non-specific anti-HLA Abs were sufficiently detected. Therefore, this novel humanized mouse model might be useful for analyzing the mechanism of anti-allogeneic human B cell tolerance induction.	[Yanagawa, Senichiro; Tahara, Hiroyuki; Tanaka, Yuka; Ide, Kentaro; Akimoto, Shuji; Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Shirouzu, Takayuki; Kawai, Shintaro] Wakunaga Pharmaceut Co Ltd, Mol Diagnost Div, Osaka, Japan	Hiroshima University; Wakunaga Pharmaceutical Co., Ltd.	Tahara, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan.	htahara@hiroshima-u.ac.jp	Ide, Kentaro/G-4757-2019	Ide, Kentaro/0000-0002-2293-1688; Tahara, Hiroyuki/0000-0002-4925-6037	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI JP 25893143, 15K10025, KAKENHI 18K08597]; Wakunaga Pharmaceutical Co., Ltd. (Osaka, Japan)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wakunaga Pharmaceutical Co., Ltd. (Osaka, Japan)	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant Numbers KAKENHI JP 25893143 to HT, KAKENHI 15K10025 to HT and KAKENHI 18K08597 to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of this funder: https://www.jsps.go.jp/j-grantsinaid/. There is no funding support from Wakunaga Pharmaceutical Co., Ltd. (Osaka, Japan).	Ahmadi T, 2008, IMMUNOLOGY, V124, P129, DOI 10.1111/j.1365-2567.2007.02749.x; Andrade D, 2011, ARTHRITIS RHEUM-US, V63, P2764, DOI 10.1002/art.30424; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Harman Benjamin C, 2014, Curr Drug Discov Technol, V11, P65; Hogenes M, 2014, TRANSPLANT REV-ORLAN, V28, P103, DOI 10.1016/j.trre.2014.02.002; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kaneku H, 2012, LIVER TRANSPLANT, V18, P984, DOI 10.1002/lt.23451; Kenney LL, 2016, AM J TRANSPLANT, V16, P389, DOI 10.1111/ajt.13520; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Nakauchi Y, 2015, EXP HEMATOL, V43, P79, DOI 10.1016/j.exphem.2014.10.008; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; O'Leary JG, 2011, AM J TRANSPLANT, V11, P1868, DOI 10.1111/j.1600-6143.2011.03593.x; Otten HG, 2013, CLIN EXP IMMUNOL, V173, P536, DOI 10.1111/cei.12127; Sicard A, 2012, AM J TRANSPLANT, V12, P1708, DOI 10.1111/j.1600-6143.2012.04009.x; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; URASHIMA M, 1995, BLOOD, V85, P1903, DOI 10.1182/blood.V85.7.1903.bloodjournal8571903; Villaudy J, 2014, J IMMUNOL METHODS, V410, P18, DOI 10.1016/j.jim.2014.06.010; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Zhang TS, 2015, IMMUNOTHERAPY-UK, V7, P899, DOI 10.2217/IMT.15.54	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0236614	10.1371/journal.pone.0236614	http://dx.doi.org/10.1371/journal.pone.0236614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544740	gold, Green Submitted, Green Published			2022-12-26	WOS:000617991900013
J	Arafa, A; Senosy, S; Sheerah, HA; St Louis, K				Arafa, Ahmed; Senosy, Shaimaa; Sheerah, Haytham A.; St Louis, Kenneth			Public attitudes towards people who stutter in South Egypt	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-REPORTED EXPERIENCE; STUDENTS; PROBABILITY; KNOWLEDGE; IMPACT	Purpose Stuttering is a multifactorial speech disorder with significant social and psychological consequences. There is a lack of knowledge about public attitudes towards people who stutter (PWS) and the factors that can determine such attitudes in underprivileged communities. This study aimed to assess the public attitudes in South Egypt towards PWS and compare our results with those stored in a reference database representing 180 different samples. Methods A multi-stage random sampling approach was used to recruit 650 people from Beni-Suef City in South Egypt. All participants were interviewed using the Arabic version of the Public Opinion Survey of Human Attributes-Stuttering (POSHA-S) after getting their informed consent. This instrument assesses people's Beliefs and Self Reactions towards PWS in addition to their sociodemographic characteristics. Results The Beliefs and Self Reactions subscores in addition to the Overall Stuttering Score of the Egyptian sample were remarkably lower than the median values of the reference database (12 versus 34), (-4 versus 2), and (4 versus 18), respectively. TV, radio, and films were the main sources of knowledge about stuttering. Egyptian participants who reported average to high income were more likely to have a positive attitude (>= 50% of Overall Stuttering Score) towards PWS than their counterparts with low income (Odds Ratio = 1.57, 95% Confidence Interval: 1.08-2.28). Conclusion People in South Egypt showed a less positive attitude towards PWS compared with other populations worldwide. Further studies should focus on changing the public attitudes towards PWS through awareness programs that consider the cultural perspectives of the society.	[Arafa, Ahmed; Senosy, Shaimaa] Beni Suef Univ, Fac Med, Dept Publ Hlth, Bani Suwayf, Egypt; [Arafa, Ahmed; Sheerah, Haytham A.] Osaka Univ, Grad Sch Med, Dept Social Med, Osaka, Japan; [St Louis, Kenneth] West Virginia Univ, Dept Commun Sci & Disorders, Morgantown, WV 26506 USA	Egyptian Knowledge Bank (EKB); Beni Suef University; Osaka University; West Virginia University	Arafa, A (corresponding author), Beni Suef Univ, Fac Med, Dept Publ Hlth, Bani Suwayf, Egypt.; Arafa, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Social Med, Osaka, Japan.	ahmed011172@med.bsu.edu.sg	Arafa, Ahmed/GNH-2073-2022; senosy, Shaimaa Ahmed/F-2692-2018; , Ahmed/AAJ-3610-2020	senosy, Shaimaa Ahmed/0000-0001-9380-8997; , Ahmed/0000-0002-3335-2243; Sheerah, Haytham/0000-0001-5949-6803				Abdalla FA, 2012, J FLUENCY DISORD, V37, P54, DOI 10.1016/j.jfludis.2011.11.007; Al-Khaledi M, 2009, J FLUENCY DISORD, V34, P44, DOI 10.1016/j.jfludis.2009.02.003; [Anonymous], 2005, TAIPEI TIMES, V10, P12; Betz IR, 2008, J COMMUN DISORD, V41, P259, DOI 10.1016/j.jcomdis.2007.10.003; Blood GW, 2007, PERCEPT MOTOR SKILL, V104, P1060, DOI 10.2466/PMS.104.4.1060-1066; Blood GW, 2011, PERCEPT MOTOR SKILL, V113, P353, DOI 10.2466/07.10.15.17.PMS.113.5.353-364; Central Agency for Public Mobilization and Statistics (CAPMAS), EG STAT FIN RES 2017; Craig A, 2003, PERCEPT MOTOR SKILL, V97, P235, DOI 10.2466/PMS.97.5.235-245; Craig A, 2010, J FLUENCY DISORD, V35, P159, DOI 10.1016/j.jfludis.2010.08.002; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Flynn TW, 2011, J FLUENCY DISORD, V36, P110, DOI 10.1016/j.jfludis.2011.04.002; Groner Stephen, 2016, Contemp Issues Commun Sci Disord, V43, P255; Ip ML, 2012, INT J SPEECH-LANG PA, V14, P543, DOI 10.3109/17549507.2012.712158; Klassen TR, 2001, PERCEPT MOTOR SKILL, V92, P551, DOI 10.2466/PMS.92.2.551-559; Klompas M, 2004, J FLUENCY DISORD, V29, P275, DOI 10.1016/j.jfludis.2004.10.001; Louis K. O St., 2009, CONT ISSUES COMMUNIC, V36, P101; Louis KOS, 2009, J FLUENCY DISORD, V34, P11, DOI 10.1016/j.jfludis.2009.02.001; Nabieh El-Adawy AA-S, 2020, SPEECH LANG HEAR, P1; Ozdemir RS, 2011, J FLUENCY DISORD, V36, P318, DOI 10.1016/j.jfludis.2011.07.002; Ozdemir RS, 2011, J FLUENCY DISORD, V36, P262, DOI 10.1016/j.jfludis.2011.01.003; Przepiorka AM, 2013, INT J LANG COMM DIS, V48, P703, DOI 10.1111/1460-6984.12041; Safwat RF, 2014, EGYPT J OTOLARYNGOL, V30, P151, DOI 10.4103/1012-5574.133220; St Louis KO, 2016, J COMMUN DISORD, V62, P115, DOI 10.1016/j.jcomdis.2016.05.010; St Louis KO, 2012, CAN J SPEECH-LANG PA, V36, P116; St Louis KO, 2014, J FLUENCY DISORD, V39, P34, DOI 10.1016/j.jfludis.2013.10.001; St Louis KO, 2012, J COMMUN DISORD, V45, P129, DOI 10.1016/j.jcomdis.2011.12.001; Valente ARS, 2017, J FLUENCY DISORD, V52, P37, DOI 10.1016/j.jfludis.2017.03.001; Yairi E, 2013, J FLUENCY DISORD, V38, P66, DOI 10.1016/j.jfludis.2012.11.002	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245673	10.1371/journal.pone.0245673	http://dx.doi.org/10.1371/journal.pone.0245673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539373	Green Published, gold			2022-12-26	WOS:000616960200055
J	Kumar, S; Purakayastha, DR; Kapil, A; Saha, S; Dawood, FS; Das, BK; Amarchand, R; Kumar, R; Lafond, KE; Jain, S; Krishnan, A				Kumar, Sambuddha; Purakayastha, Debjani Ram; Kapil, Arti; Saha, Siddhartha; Dawood, Fatimah S.; Das, Bimal Kumar; Amarchand, Ritvik; Kumar, Rakesh; Lafond, Kathryn E.; Jain, Seema; Krishnan, Anand			Carriage rates and antimicrobial sensitivity of pneumococci in the upper respiratory tract of children less than ten years old, in a north Indian rural community	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; SEROTYPE DISTRIBUTION; DISEASE; COLONIZATION; VACCINES	Pneumococcal carriage studies are important for vaccine introduction and treatment strategies. Pneumococcal carriage rates estimated in this cohort study among children in a rural community of northern India. Between August 2012 and August 2014, trained nurses made weekly home visits to screen enrolled children aged <10 years for acute upper or lower respiratory infections (AURI/ALRI) in Ballabgarh, Haryana. Nasal swab from infants aged <1year and throat swab from children aged >= 1 year were collected. All specimens were cultured for pneumococci; isolates were serotyped and subjected to antimicrobial susceptibility testing. During the study period, 4348 nasal/throat swabs collected from children with clinical features of ARI (836 ALRI, 2492 AURI) and from 1020 asymptomatic children. Overall pneumococcal carriage was 5.1%, the highest carriage rate among children <1 year of age (22.6%). The detection rates were higher among children with ARI (5.6%; 95% CI: 4.8-6.4) than asymptomatic children (3.3%; 95% CI: 2.3-4.6). Among 220 pneumococcal isolates, 42 diverse serotypes were identified, with 6B/C (8.6%), 19A (7.2%), 19F (6.8%), 23F (6.4%), 35A/B/C (6.4%), 15B (5%), 14 (4.5%) and 11A/C/D (3.2%) accounting for 50%. Forty-five percent of the serotypes identified are included in the current formulation of 13-valent pneumococcal conjugate vaccine. Ninety-six percent of isolates were resistant to co-trimoxazole, 9% were resistant to erythromycin, and 10% had intermediate resistance to penicillin with minimum inhibitory concentration ranges (0.125 to 1.5 mu g/ml). Pneumococcal detection was relatively low among children in our study community but demonstrated a diverse range of serotypes and half of these serotypes would be covered by the current formulation of 13-valent pneumococcal vaccine.	[Kumar, Sambuddha; Kapil, Arti; Das, Bimal Kumar] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Purakayastha, Debjani Ram; Amarchand, Ritvik; Kumar, Rakesh; Lafond, Kathryn E.; Krishnan, Anand] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Saha, Siddhartha; Dawood, Fatimah S.; Jain, Seema] Ctr Dis Control & Prevent, Atlanta, GA USA	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Centers for Disease Control & Prevention - USA	Das, BK (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi, India.	tezpur.bimal@gmail.com	Krishnan, Anand/D-8537-2012	Krishnan, Anand/0000-0002-9173-7811; Ram Purakayastha, Debjani/0000-0003-0120-7612; Saha, Siddhartha/0000-0002-7494-267X	All India Institute of Medical Sciences, New Delhi, India [U01-IP000492]; Center for Disease Control and Prevention, Atlanta, USA [U01-IP000492]	All India Institute of Medical Sciences, New Delhi, India; Center for Disease Control and Prevention, Atlanta, USA	This study was funded under the cooperative agreement between the All India Institute of Medical Sciences, New Delhi, India and Center for Disease Control and Prevention, Atlanta, USA (U01-IP000492). Sambuddha Kumar, Debjani Ram Purakayastha, Arti Kapil, Siddhartha Saha, Fatimah S. Dawood, Bimal Kumar Das, Ritvik Amarchand, Rakesh Kumar, Kathryn E. Lafond, Anand Krishnan were all involved in the planning of the study and development of the study protocols and tools. Debjani Ram Purakayastha, Rakesh Kumar, Ritvik Amarchand coordinated communitybased surveillance activities. Sambuddha Kumar, Bimal Kumar Das and Arti Kapil performed the bacteriological studies. Sambuddha Kumar, Rakesh Kumar, Ritvik Amarchand and Siddhartha Saha analyzed the data. Sambuddha Kumar, Arti Kapil drafted the manuscript. Siddhartha Saha, Seema Jain, Kathryn E. Lafond, Fatimah S. Dawood, Anand Krishnan provided overall supervision for the project activities. All the authors have read and reviewed the manuscript.	Balaji V, 2015, INDIAN J MED RES, V142, P286, DOI 10.4103/0971-5916.166588; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Batuwanthudawe R, 2009, CLIN INFECT DIS, V48, pS136, DOI 10.1086/596492; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Coles CL, 2001, PEDIATR INFECT DIS J, V20, P289, DOI 10.1097/00006454-200103000-00014; Devi U, 2012, INDIAN J MED RES, V136, P495; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; Jain A, 2005, TROP MED INT HEALTH, V10, P234, DOI 10.1111/j.1365-3156.2004.01379.x; Jebaraj R, 1999, EPIDEMIOL INFECT, V123, P383, DOI 10.1017/S0950268899003131; Krishnan A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1188-1; Kumar KLR, 2014, INDIAN J MED RES, V140, P216; Kumar R, 2016, VACCINE, V34, P2622, DOI 10.1016/j.vaccine.2016.03.071; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Manoharan A, 2017, LANCET INFECT DIS, V17, P305, DOI [10.1016/s1473-3099(16)30466-2, 10.1016/S1473-3099(16)30466-2]; Mathew JL, 2015, J GLOB HEALTH, V5, P223, DOI 10.7189/jogh.05.020418; Morpeth SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29119-w; Murdoch DR, 2020, CLIN INFECT DIS, V70, P1589, DOI 10.1093/cid/ciz484; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rodrigues CMC, 2017, CURR THER RES CLIN E, V84, pE7, DOI 10.1016/j.curtheres.2017.01.002; Sachdeva A, 2017, INDIAN PEDIATR, V54, P445, DOI 10.1007/s13312-017-1044-z; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Tripathy Jaya Prasad, 2018, Perspect Clin Res, V9, P76, DOI 10.4103/picr.PICR_75_17; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Wattal C, 2007, INDIAN J PEDIATR, V74, P905, DOI 10.1007/s12098-007-0166-z; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; World Health Organization, 2003, INT MAN NEON CHILDH; World Health Organization, 2004, AC CAR INT MAN AD AD	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246522	10.1371/journal.pone.0246522	http://dx.doi.org/10.1371/journal.pone.0246522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539406	gold, Green Published			2022-12-26	WOS:000616960200057
J	Li, Y; Song, QP; Li, L; Sun, W; Zhang, C				Li, Yang; Song, Qipeng; Li, Li; Sun, Wei; Zhang, Cui			Tai Chi practitioners have lower fall risks under dual-task conditions during stair descending	PLOS ONE			English	Article							CENTER-OF-MASS; GROUND REACTION FORCES; OLDER-ADULTS; DYNAMIC STABILITY; BALANCE CONTROL; POSTURAL CONTROL; BODY STABILITY; FOOT CLEARANCE; COGNITIVE TASK; GAIT	Stairs are among the most hazardous locations, and stair descending contributes to a high risk of falls among the elderly under dual-task (DT) conditions. The purpose of this study was to determine whether the practitioners of Tai Chi (TC), one type of mind-body exercise, have lower fall risks under DT conditions during stair descending, compared with their no-exercise (NE) counterparts. Fifteen TC practitioners with at least 10 years of experience in TC and fifteen NE participants were recruited in this study. They were asked to descend a six-step staircase under single-task (ST) and DT conditions. An eight-camera motion analysis system and two force plates were used for data collection. Results showed group by DT interactions in walking velocity (p = 0.016) and center of mass-center of pressure inclination angle (COM-COP IA) in the anteroposterior directions (p = 0.026). Group effects observed with foot clearance (p = 0.031), trunk (p = 0.041) and head (p = 0.002) tilt angles, and COM-COP IA in the mediolateral (p = 0.006) directions. Significant DT effects only detected in foot clearance (p = 0.004). Although both groups of participants adopted a more cautious gait strategy under the dual-task condition, the TC practitioners were less influenced by the DT paradigm than their NE counterparts. Our observations indicated that TC practitioners have lower fall risks under DT conditions during stair descending.	[Li, Yang] Nanjing Forestry Univ, Dept Phys Educ, Nanjing, Jiangsu, Peoples R China; [Song, Qipeng; Sun, Wei] Shandong Sport Univ, Coll Sports & Hlth, Jinan, Shandong, Peoples R China; [Li, Li] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA USA; [Zhang, Cui] Shandong Inst Sport Sci, Lab Biomech, Jinan, Shandong, Peoples R China	Nanjing Forestry University; Shandong Sport University; University System of Georgia; Georgia Southern University	Song, QP (corresponding author), Shandong Sport Univ, Coll Sports & Hlth, Jinan, Shandong, Peoples R China.	songqipeng@sdpei.edu.cn		Song, Qipeng/0000-0002-4103-9193; Song, Qipeng/0000-0002-7073-3643; /0000-0001-5902-9762	China Shandong Key Research and Development Plan [2017G006043]; China Scholarship Council [201809370020]; Natural Science Foundation of China [31700815]	China Shandong Key Research and Development Plan; China Scholarship Council(China Scholarship Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Q.S.:China Shandong Key Research and Development Plan (2017G006043), and China Scholarship Council (201809370020). W.S.:Natural Science Foundation of China (31700815)	Barrett RS, 2010, GAIT POSTURE, V32, P429, DOI 10.1016/j.gaitpost.2010.07.010; Beauchet O, 2008, J AM GERIATR SOC, V56, P181, DOI 10.1111/j.1532-5415.2007.01464.x; Blazewick DH, 2018, AM J EMERG MED, V36, P608, DOI 10.1016/j.ajem.2017.09.034; Bosse I, 2012, HUM MOVEMENT SCI, V31, P1560, DOI 10.1016/j.humov.2012.05.003; Buckley JG, 2005, GAIT POSTURE, V22, P146, DOI 10.1016/j.gaitpost.2004.08.006; Burgener SC, 2008, AM J ALZHEIMERS DIS, V23, P382, DOI 10.1177/1533317508317527; Cayless SM, 2001, APPL ERGON, V32, P155, DOI 10.1016/S0003-6870(00)00052-1; Chalmers GR, 2002, J GERONTOL A-BIOL, V57, pB321, DOI 10.1093/gerona/57.8.B321; Chien HL, 2014, GAIT POSTURE, V39, P1045, DOI 10.1016/j.gaitpost.2014.01.007; Chien HL, 2013, GAIT POSTURE, V38, P391, DOI 10.1016/j.gaitpost.2012.12.015; COHEN HH, 1985, J SAFETY RES, V16, P171, DOI 10.1016/0022-4375(85)90004-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; Delafontaine A, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20185059; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Hsue BJ, 2014, ARCH PHYS MED REHAB, V95, P1860, DOI 10.1016/j.apmr.2014.05.001; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lam L C W, 2014, Hong Kong Med J, V20, P20; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; Li FZ, 2007, J AGING PHYS ACTIV, V15, P139, DOI 10.1123/japa.15.2.139; Li FZ, 2014, ARCH GERONTOL GERIAT, V58, P434, DOI 10.1016/j.archger.2013.12.003; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; Li L, 2019, J SPORT HEALTH SCI, V8, P218, DOI 10.1016/j.jshs.2018.09.010; Li L, 2010, AM J CHINESE MED, V38, P449, DOI 10.1142/S0192415X1000797X; Lu HL, 2017, HUM MOVEMENT SCI, V54, P354, DOI 10.1016/j.humov.2017.06.004; Lu HL, 2017, GAIT POSTURE, V51, P109, DOI 10.1016/j.gaitpost.2016.09.030; Madehkhaksar F, 2016, GAIT POSTURE, V43, P114, DOI 10.1016/j.gaitpost.2015.09.009; McCrory JL, 2014, CLIN BIOMECH, V29, P143, DOI 10.1016/j.clinbiomech.2013.11.020; Mian OS, 2007, GAIT POSTURE, V26, P463, DOI 10.1016/j.gaitpost.2006.11.202; Novak AC, 2016, APPL ERGON, V52, P275, DOI 10.1016/j.apergo.2015.07.027; Ojha HA, 2009, PHYS THER, V89, P1080, DOI 10.2522/ptj.20080187; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Pijnappels M, 2008, EUR J APPL PHYSIOL, V102, P585, DOI 10.1007/s00421-007-0613-6; Qu XD, 2015, J BIOMECH, V48, P4059, DOI 10.1016/j.jbiomech.2015.10.004; Roys MS, 2001, APPL ERGON, V32, P135, DOI 10.1016/S0003-6870(00)00049-1; Sheehan RC, 2012, APPL ERGON, V43, P473, DOI 10.1016/j.apergo.2011.07.004; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Simoni D, 2013, CLIN BIOMECH, V28, P692, DOI 10.1016/j.clinbiomech.2013.05.011; Song QP, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10061979; Song QP, 2018, SPORT BIOMECH, V17, P402, DOI 10.1080/14763141.2017.1358761; Song QP, 2017, RES SPORTS MED, V25, P197, DOI 10.1080/15438627.2017.1282363; Song QP, 2014, RES SPORTS MED, V22, P172, DOI 10.1080/15438627.2014.881823; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vallabhajosula S, 2015, J BIOMECH, V48, P921, DOI 10.1016/j.jbiomech.2015.02.024; Wayne PM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00332; Wiesmeier IK, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00097; Woollacott MH, 1997, PHYS THER, V77, P646, DOI 10.1093/ptj/77.6.646; Yao J, 2019, RES SPORTS MED, V27, P121, DOI 10.1080/15438627.2018.1502184; Yiou E, 2017, WORLD J ORTHOP, V8, P815, DOI 10.5312/wjo.v8.i11.815; Zhang C, 2015, RES SPORTS MED, V23, P102, DOI 10.1080/15438627.2014.915835; Zhang C, 2011, GAIT POSTURE, V34, P191, DOI 10.1016/j.gaitpost.2011.04.008; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492; Zietz D, 2011, GAIT POSTURE, V34, P279, DOI 10.1016/j.gaitpost.2011.05.017	56	1	1	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246292	10.1371/journal.pone.0246292	http://dx.doi.org/10.1371/journal.pone.0246292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539403	gold, Green Published			2022-12-26	WOS:000616960200073
J	Liu, JL; Wu, JF; Liu, SR; Li, MD; Hu, KC; Li, K				Liu, Jialin; Wu, Jinfa; Liu, Siru; Li, Mengdie; Hu, Kunchang; Li, Ke			Predicting mortality of patients with acute kidney injury in the ICU using XGBoost model	PLOS ONE			English	Article							LOGISTIC-REGRESSION; SELECTION; ADULTS	Purpose The goal of this study is to construct a mortality prediction model using the XGBoot (eXtreme Gradient Boosting) decision tree model for AKI (acute kidney injury) patients in the ICU (intensive care unit), and to compare its performance with that of three other machine learning models. Methods We used the eICU Collaborative Research Database (eICU-CRD) for model development and performance comparison. The prediction performance of the XGBoot model was compared with the other three machine learning models. These models included LR (logistic regression), SVM (support vector machines), and RF (random forest). In the model comparison, the AUROC (area under receiver operating curve), accuracy, precision, recall, and F1 score were used to evaluate the predictive performance of each model. Results A total of 7548 AKI patients were analyzed in this study. The overall in-hospital mortality of AKI patients was 16.35%. The best performing algorithm in this study was XGBoost with the highest AUROC (0.796, p < 0.01), F1(0.922, p < 0.01) and accuracy (0.860). The precision (0.860) and recall (0.994) of the XGBoost model rank second among the four models. Conclusion XGBoot model had obvious advantages of performance compared to the other machine learning models. This will be helpful for risk identification and early intervention for AKI patients at risk of death.	[Liu, Jialin] Sichuan Univ, West China Hosp, Informat Ctr, Chengdu, Sichuan, Peoples R China; [Liu, Jialin] West China Med Sch, Dept Med Informat, Chengdu, Sichuan, Peoples R China; [Wu, Jinfa; Li, Mengdie; Hu, Kunchang; Li, Ke] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Sichuan, Peoples R China; [Liu, Siru] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA	Sichuan University; University of Electronic Science & Technology of China; Utah System of Higher Education; University of Utah	Li, K (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Sichuan, Peoples R China.	colinlike@163.com	Liu, Siru/AAM-8737-2021; Liu, Siru/GYA-2297-2022	Liu, Siru/0000-0002-5003-5354; 	Sichuan Science and Technology Program [2020YFS0162]; Special project of central government guiding local science and technology development [2020ZYD001]; Sichuan Science and technology support plan project [2019JDPT0008]	Sichuan Science and Technology Program; Special project of central government guiding local science and technology development; Sichuan Science and technology support plan project	Jialin Liu, Sichuan Science and Technology Program under Grant No. 2020YFS0162. Ke Li,Special project of central government guiding local science and technology development under Grant No.2020ZYD001. Sichuan Science and technology support plan project NO.2019JDPT0008. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algamal ZY, 2015, EXPERT SYST APPL, V42, P9326, DOI 10.1016/j.eswa.2015.08.016; Ampomah EK, 2020, INFORMATION, V11, DOI 10.3390/info11060332; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; Bahrambeygi B, 2017, EGYPT J REMOTE SENS, V20, P1, DOI 10.1016/j.ejrs.2017.01.007; Biau G., 2010, J MACHINE LEARNING R, V13, P1063; Caicedo-Torres W, 2019, J BIOMED INFORM, V98, DOI 10.1016/j.jbi.2019.103269; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chen T., 2016, ARXIV160302754CS; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Chen X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46420-4; Demirjian S, 2011, CLIN J AM SOC NEPHRO, V6, P2114, DOI 10.2215/CJN.02900311; Essay P, 2019, JMIR MED INF, V7, DOI 10.2196/13006; Grams ME, 2015, AM J KIDNEY DIS, V66, P591, DOI 10.1053/j.ajkd.2015.02.337; Holmes J, 2017, KIDNEY INT REP, V2, P342, DOI 10.1016/j.ekir.2016.12.001; Hoste EAJ, 2018, NAT REV NEPHROL, V14, P607, DOI 10.1038/s41581-018-0052-0; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kothiwale V A, 2018, J Assoc Physicians India, V66, P59; Kwon JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224502; Lee HC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110428; Lee J., 2016, SECONDARY ANAL ELECT, P315; Lin K, 2019, INT J MED INFORM, V125, P55, DOI 10.1016/j.ijmedinf.2019.02.002; Lv H., 2019, J HEBEI ACAD SCI, V36, P37, DOI 10.16191/j.cnki.hbkx.2019.03.005; Mayampurath A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220640; Mueller SQ, 2020, APPL ECON, V52, P4512, DOI 10.1080/00036846.2020.1736502; Muthukrishnan R, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTER APPLICATIONS (ICACA), P18, DOI 10.1109/ICACA.2016.7887916; Ogunleye AA, 2019, IEEE ACM T COMPUT BI, V10, P1109; Ottenbacher KJ, 2001, J CLIN EPIDEMIOL, V54, P1159, DOI 10.1016/S0895-4356(01)00395-X; Parreco J, 2019, AM SURGEON, V85, P725; Pollard TJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.178; Rufaida SI, 2020, WIREL NETW, V26, P6215, DOI 10.1007/s11276-020-02428-7; Shipe ME, 2019, J THORAC DIS, V11, pS574, DOI 10.21037/jtd.2019.01.25; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593; Zheng HT, 2017, ENERGIES, V10, DOI 10.3390/en10081168	35	25	25	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246306	10.1371/journal.pone.0246306	http://dx.doi.org/10.1371/journal.pone.0246306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539390	Green Published, gold			2022-12-26	WOS:000616960200016
J	Mabvouna, RB; Adogaye, SB; Nkamedjie, PMP; Wondeu, ALD; Sobze, MS; Kemogne, JB; Colizzi, V				Mabvouna, Rodrigue Biguioh; Adogaye, Sali Ben Bechir; Nkamedjie, Patrick Martial Pete; Wondeu, Andrillene Laure Deutou; Sobze, Martin Sanou; Kemogne, Jean Blaise; Colizzi, Vittorio			Microbiological quality and genotoxicity of domestic water sources: A combined approach using Micro Biological Survey method and mutagenesis assay (micronucleus test) in root tips of Vicia faba in the West region of Cameroon	PLOS ONE			English	Article							DRINKING-WATER; SURFACE-WATER; DISINFECTANTS; COLIFORMS	At least 2.1 billion people around the world use contaminated drinking water, causing 485,000 diarrheal deaths each year, mostly among children under 5 years old. A study conducted 10 years ago in Bafoussam (West Cameroon) recorded concentrations of bacteria among surface and groundwater. High levels of bicarbonates, phosphates, chlorides and suspended matters were also found. The aim of this study was to assess the microbiological and chemical qualities of domestic water sources in 5 localities of the West region of Cameroon. Water samples from 22 water sources (wells, springs, water drilling and river) were aseptically collected in plastic bottles and transferred in 50 ml sterile tubes. For chlorinated water sources, 1 ml of Thiosulfate was added to the water sample; immediately placed in an ice box and transported to the laboratory for analysis. Water temperature and pH were measured on site. The microbiological quality of water was determined by testing Total Coliforms (TC) using the Micro Biological Survey method. 1 ml of each water sample was inoculated in the MBS vial initially rehydrated with 10 ml of sterile distilled water. The initial color of the vials is red. Color changes were monitored at three different time intervals (12h, 19h and 24h), corresponding to three levels of contamination. The chemical quality of water was assessed using micronucleus (MN) test in selected Vicia faba seeds secondary root tips permanently mounted in Dibutylphthalate Polystyrene Xylene mountant for histology after 72 hours of direct exposition in water samples and in dark. The mitotic indices and MN frequencies were evaluated in 10 root tips per site analysing 5000 cells per tip. Statistical analyses were done using Stata IC/15.0 software. The Student t-test was used for mean comparison and the significance level was set at 1%. The majority of samples were collected from wells (63.6%). The mean water pH ranged from 5.5 to 8.3 and the temperature varied from 23 to 26 degrees C. A very high concentration of TC [>10(3) CFU/ml] was found in 8 (36.4%) samples. 10 (45.5%) and 2 (9.1%) samples turned yellow at 19 and 24 hours respectively after incubation corresponding to TC concentration of [10<x<10(3) CFU/ml] and [1<x< 10 CFU/ml]. The MN frequency was higher (P <= 0.01) compared to the negative control in 9 (40.9%) water samples indicating significant genotoxic effects of these water sources. This study highlighted the poor quality of domestic water sources in West region of Cameroon and the need to conduct regular monitoring of drinking water sources. Community capacity building on water treatment methods, including good wastes management should be implemented to help improve water quality.	[Mabvouna, Rodrigue Biguioh; Adogaye, Sali Ben Bechir; Colizzi, Vittorio] Univ Roma Tor Vergata, Fac Med & Surg, Rome, Italy; [Nkamedjie, Patrick Martial Pete] Inst Res Socioecon Dev & Commun IRESCO, Yaounde, Cameroon; [Wondeu, Andrillene Laure Deutou; Kemogne, Jean Blaise] Evangel Univ Cameroon, Mboua Bandjoun, Cameroon; [Sobze, Martin Sanou] Univ Dschang, Fac Med & Pharmaceut Sci, Dschang, Cameroon	University of Rome Tor Vergata	Mabvouna, RB (corresponding author), Univ Roma Tor Vergata, Fac Med & Surg, Rome, Italy.	rodrigue.biguioh@yahoo.fr		Mabvouna, Rodrigue/0000-0001-5872-2303; , SALI BEN BECHIR ADOGAYE/0000-0001-9611-0842	Bread for the World (Brot fur die Welt)	Bread for the World (Brot fur die Welt)	This study was supported by Bread for the World (Brot fur die Welt). https://www.brotfuer-die-welt.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, METHOD 1604 TOTAL CO; [Anonymous], PROGR DRINK WAT SAN; Arienzo A, 2015, INT J ENV RES PUB HE, V12, P10314, DOI 10.3390/ijerph120910314; Australian government National health and research council, 2003, REC CHANG US COL MIC; Beraud E, 2007, MUTAT RES-GEN TOX EN, V633, P112, DOI 10.1016/j.mrgentox.2006.05.013; BERG G, 1978, APPL ENVIRON MICROB, V36, P880, DOI 10.1128/AEM.36.6.880-884.1978; Bianca Gustavino, 2013, 1327 ISTISAN I SUP S, DOI [10.1093/ANNONC/MDT244, DOI 10.1093/ANNONC/MDT244]; Bolognesi C, 2011, MUTAGENESIS, V26, P205, DOI 10.1093/mutage/geq073; Bureau Central des Recensements et des Etudes de Population-Ministere de l'Economie de la Planification et de l'Amenagement du Territoire, 2011, CAM REC GEN POP HAB; DEGRASSI F, 1982, MUTAT RES, V97, P19, DOI 10.1016/0165-1161(82)90016-4; El Hajjouji H, 2007, MUTAT RES-GEN TOX EN, V634, P25, DOI 10.1016/j.mrgentox.2007.05.015; Feretti D, 2012, J PUBLIC HEALTH RES, V1, P31, DOI 10.4081/jphr.2012.e7; GAUTHIER L, 1989, MUTAGENESIS, V4, P170, DOI 10.1093/mutage/4.3.170; Gionfriddo M, 2018, J PUBLIC HEALTH AFR, V9, P154, DOI 10.4081/jphia.2018.905; Gustavino B., 2012, Journal of Water Resource and Protection, V4, P638, DOI 10.4236/jwarp.2012.48074; HAZEN TC, 1988, TOXIC ASSESS, V3, P461, DOI 10.1002/tox.2540030504; Helmer R, 1997, WATER POLLUTION CONT, P459; Lacaze E, 2011, SCI TOTAL ENVIRON, V409, P3230, DOI 10.1016/j.scitotenv.2011.05.012; Madikizela B, 2014, J ETHNOPHARMACOL, V153, P386, DOI 10.1016/j.jep.2014.02.034; Mccasland M, 2012, NITRATE HLTH EFFECTS, DOI [10.3109/08990220.2012.686936, DOI 10.3109/08990220.2012.686936]; Micro Biological Survey, 2019, MBS HACCP WATER EAS; Misik M, 2011, MUTAGENESIS, V26, P215, DOI 10.1093/mutage/geq080; Monarca S, 2005, ENVIRON MOL MUTAGEN, V46, P96, DOI 10.1002/em.20137; Monarca S, 2003, ENVIRON MOL MUTAGEN, V41, P353, DOI 10.1002/em.10161; Moyo S, 2004, PHYS CHEM EARTH, V29, P1295, DOI 10.1016/j.pce.2004.09.012; Mpakam HG, 2006, VERTIGO REV ELECT SC, DOI [10.4000/2377, DOI 10.4000/2377]; NICHOLSON K.N., 2017, ENV MANAG SUSTAIN DE, V6, P411; Ohe T, 2004, MUTAT RES-REV MUTAT, V567, P109, DOI 10.1016/j.mrrev.2004.08.003; Rather IA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00830; RIZZONI M, 1995, SCI TOTAL ENVIRON, V162, P127, DOI 10.1016/0048-9697(95)04444-6; Rompre A, 2002, J MICROBIOL METH, V49, P31, DOI 10.1016/S0167-7012(01)00351-7; Song YF, 2007, J ENVIRON MONITOR, V9, P182, DOI [10.1039/b124246, 10.1039/B614246J]; Steenkamp V, 2005, MUTAT RES-GEN TOX EN, V581, P35, DOI 10.1016/j.mrgentox.2004.10.009; Taylor JLS, 2003, ENVIRON MOL MUTAGEN, V42, P144, DOI 10.1002/em.10184; US EPA, CONT CAND LIST CCL R; USEPA (US Environmental Protection Agency), 2006, NITR NITR TEACH CHEM; White PA, 2004, MUTAT RES-REV MUTAT, V567, P227, DOI 10.1016/j.mrrev.2004.09.003; WHO, 2011, GUID DRINK WAT QUAL; WHO, 1996, WATER QUALITY WASTE, V2nd; WHO (World Health Organisation), 1997, GUID DRINK WAT QUAL; World Health Organization, 2000, GLOB WAT SUPPL SAN A; Yi M, 2010, ENVIRON TOXICOL, V25, P124, DOI 10.1002/tox.20482	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245379	10.1371/journal.pone.0245379	http://dx.doi.org/10.1371/journal.pone.0245379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539444	Green Published, gold			2022-12-26	WOS:000616960200081
J	Aschale, A; Adane, M; Getachew, M; Faris, K; Gebretsadik, D; Sisay, T; Dewau, R; Chanie, MG; Muche, A; Zerga, AA; Lingerew, M; Gebrehiwot, M; Berhanu, L; Ademas, A; Abebe, M; Ketema, G; Yirsaw, M; Bogale, K; Ayele, FY; Melaku, MS; Amsalu, ET; Bitew, G; Keleb, A; Berihun, G; Natnael, T; Hassen, S; Yenuss, M; Dagne, M; Feleke, A; Kloos, H				Aschale, Awoke; Adane, Metadel; Getachew, Melaku; Faris, Kebede; Gebretsadik, Daniel; Sisay, Tadesse; Dewau, Reta; Chanie, Muluken Genetu; Muche, Amare; Zerga, Aregash Abebayehu; Lingerew, Mistir; Gebrehiwot, Mesfin; Berhanu, Leykun; Ademas, Ayechew; Abebe, Masresha; Ketema, Gebremariam; Yirsaw, Mengistie; Bogale, Kassahun; Ayele, Fanos Yeshanew; Melaku, Mequannent Sharew; Amsalu, Erkihun Tadesse; Bitew, Gedamnesh; Keleb, Awoke; Berihun, Gete; Natnael, Tarikuwa; Hassen, Seada; Yenuss, Mohammed; Dagne, Mengesha; Feleke, Alelgne; Kloos, Helmut			Water, sanitation, and hygiene conditions and prevalence of intestinal parasitosis among primary school children in Dessie City, Ethiopia	PLOS ONE			English	Article							SCHOOLCHILDREN; EPIDEMIOLOGY; INFECTIONS; TOWN	Background Intestinal parasitosis is a major public health problem that affects the health of primary school children in low- and middle-income countries where water, sanitation, and hygiene (WASH) conditions are deficient. Since there is a paucity of information on the prevalence and associated factors of this problem among primary school children in Dessie City in Ethiopia, this study was designed to address these gaps. Methods A school-based cross-sectional study was conducted among 407 stratified-sampled primary school children in five primary schools at Dessie City from April to June 2018. Data were collected using a pretested structured questionnaire, an observation checklist and laboratory analysis of stool samples. Stool specimen from each study participant was collected using clean, properly labeled and leak-proof stool cup. A portion of stool from each study participant collected sample was processed using saline wet mount technique and examined by microscope. The remaining specimens were preserved with 10% formalin and transported to Dessie Comprehensive Specialized Hospital laboratory to be processed by using formol-ether concentration technique. Then, slide smears were prepared from each processed stool specimen and finally, it was microscopically examined with 10x as well as 40x objectives for the presence or absence of intestinal parasites. Factors significantly associated with intestinal parasitosis were determined using binary logistic regression model at 95% CI (confidence interval). Thus, bivariate (COR [crude odds ratio]) and multivariable (AOR [adjusted odds ratio]) logistic regression analyses were carried out. From the multivariable analysis, variables having a p-value of less than 0.05 were declared as factors significantly associated with intestinal parasitosis among primary school children. Main findings The overall prevalence of intestinal parasitosis was found to be 16.0% (95% CI: 12.5-19.4%), of these, 50.8% were positive for protozoa, 32.2% for helminth infections and 16.9% for double co-infections. Entamoeba histolytica was the most prevalent parasite (29.2%), followed by Giardia lamblia (21.5%), Ascaris lumbricoides (18.5%), Hymenolepis nana (9.2%) and Enterobius vermicularis (4.6%). Prevalence rates were similar among government (16.3%) and private (15.7%) school children. Water consumption was less than 5 liters per capita per day in 4 of the 5 schools. Thirty-eight (9.3%) of primary school students reported that they practiced open defecation. About two-thirds (285, 70.0%) said they always washed their hands after defecation. Mother's education (illiterate) (AOR = 3.3; 95% CI: 1.20-9.37), father's education (illiterate) (AOR = 3.9; 95% CI: 1.40-10.82), fathers who could read and write (AOR = 3.3; 95% CI: 1.25-7.86), handwashing before meal (sometimes) (AOR = 2.2; 95% CI: 1.11-4.17) and poor knowledge of WASH (AOR = 9.3; 95% CI: 2.17-16.70) were statistically associated with presence of intestinal parasitic infections. Conclusion We concluded that the prevalence of intestinal parasitosis in the study area among Grades 4-8 primary school children had public health significance. Factors significantly associated with intestinal parasitosis among primary school children's were illiterate mothers and fathers, irregular handwashing of children before meals, and poor knowledge of WASH. Health education to improve students' WASH knowledge and mass deworming for parasites are recommended as preventive measures; and improvements to the quality of WASH facilities in primary schools are strongly recommended to support these measures.	[Aschale, Awoke] Dessie Comprehens Specialized Hosp, Hyg & Environm Hlth Infect Prevent & Control Unit, Dessie, Ethiopia; [Adane, Metadel; Getachew, Melaku; Faris, Kebede; Sisay, Tadesse; Lingerew, Mistir; Gebrehiwot, Mesfin; Berhanu, Leykun; Ademas, Ayechew; Abebe, Masresha; Keleb, Awoke; Berihun, Gete; Natnael, Tarikuwa; Hassen, Seada; Yenuss, Mohammed; Dagne, Mengesha; Feleke, Alelgne] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia; [Gebretsadik, Daniel] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia; [Dewau, Reta; Muche, Amare; Amsalu, Erkihun Tadesse; Bitew, Gedamnesh] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia; [Chanie, Muluken Genetu] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Syst & Policy, Dessie, Ethiopia; [Zerga, Aregash Abebayehu; Ayele, Fanos Yeshanew] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Nutr, Dessie, Ethiopia; [Ketema, Gebremariam; Yirsaw, Mengistie; Bogale, Kassahun] Wollo Univ, Coll Med & Hlth Sci, Dept Pharm, Dessie, Ethiopia; [Melaku, Mequannent Sharew] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Informat, Gondar, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of Gondar; University of California System; University of California San Francisco	Adane, M (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	metadel.adane2@gmail.com	ayele, fanos/AAA-5299-2022; Hassen, Seada/GOH-0623-2022; muche, amare/GNW-4693-2022; Tadesse, Erkihun/AAS-1819-2021; Keleb, Awoke/AGX-2940-2022; Dewau, Reta/AAA-4202-2022; Ademas, Ayechew/AAO-4212-2021; Ademas, Ayechew/AAG-5984-2021; Berhanu, Leykun/AAC-6695-2022; Damtew, Mesfin Gebrehiwot/W-2543-2019; Weldehanna, Daniel/ABA-8617-2020; Adane, Metadel/AFQ-9478-2022	Keleb, Awoke/0000-0002-7510-3448; Dewau, Reta/0000-0001-6531-2468; Ademas, Ayechew/0000-0003-2602-162X; Ademas, Ayechew/0000-0003-2602-162X; Berhanu, Leykun/0000-0002-2998-0917; Damtew, Mesfin Gebrehiwot/0000-0002-8124-5151; Weldehanna, Daniel/0000-0001-5032-5143; Adane, Metadel/0000-0002-7039-4768; Genetu Chanie, MULUKEN/0000-0001-7059-1449; Bogale, Kassahun/0000-0001-7358-6741				Abossie A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-166; Alamir M., 2013, Health, V5, P1697, DOI 10.4236/health.2013.510228; Alemu M, 2019, ETHIOP J HEALTH SCI, V29, P923, DOI 10.4314/ejhs.v29i1.14; Andualem MA., 2014, J PUBL HLTH RES, V2, P248, DOI DOI 10.12691/AJPHR-2-6-6; [Anonymous], 2017, JLSRF, V3, pA104; [Anonymous], 2019, INT J BIOMEDICAL MAT; Ansha MG, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/9813743; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; Chelkeba L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8222-y; Debalke S, 2013, ETHIOP J HEALTH SCI, V23, P237, DOI 10.4314/ejhs.v23i3.6; Dessie City Adminstration (DCA), 2017, DESS TOWN ED DEP 201; Eleni Kidane, 2014, International Journal of Current Microbiology and Applied Sciences, V3, P11; En WL, 2011, SE ASIAN J TROP MED, V42, P1022; Fentie T, 2013, T ROY SOC TROP MED H, V107, P480, DOI 10.1093/trstmh/trt056; Fewtrell L, 2007, WATER SANITATION HYG, V15; Gebretsadik D, 2020, PEDIATR HEALTH MED T, V11, P179, DOI 10.2147/PHMT.S252061; Gebretsadik Daniel, 2018, BMC Res Notes, V11, P771, DOI 10.1186/s13104-018-3888-2; Gebreyohanns A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204259; Global Health Council, 2013, WAT SAN HYG GLOB HLT; Hailegebriel T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2466-x; Hernandez PC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218681; Hosmer JD, 2013, APPL LOGISTIC REGRES; Jejaw A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1952-6; Liao CW, 2016, AFR HEALTH SCI, V16, P690, DOI 10.4314/ahs.v16i3.8; Mahmud MA, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-019-4871-2; Montgomery MA, 2007, ENVIRON SCI TECHNOL, V41, P17, DOI 10.1021/es072435t; Okyay P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-64; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Ryan E., 2017, BASELINE ASSESSMENT, P1; Salem DAB, 2013, INT J INFECT DIS, V17, pE343, DOI 10.1016/j.ijid.2012.11.022; Sejdini A, 2011, ANN TROP MED PARASIT, V105, P241, DOI 10.1179/136485911X12987676649584; Sitotaw B, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3971-x; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Vedachalam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176272; Vivas A P, 2010, J Prev Med Hyg, V51, P73; Workneh T, 2014, J BACTERIOL PARASITO, V15, P1, DOI DOI 10.4172/2155-9597.1000181	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245463	10.1371/journal.pone.0245463	http://dx.doi.org/10.1371/journal.pone.0245463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534792	gold, Green Published			2022-12-26	WOS:000616739700040
J	De Sio, S; La Torre, G; Buomprisco, G; Lapteva, E; Perri, R; Corbosiero, P; Ferraro, P; Giovannetti, A; Greco, E; Cedrone, F				De Sio, Simone; La Torre, Giuseppe; Buomprisco, Giuseppe; Lapteva, Ekaterina; Perri, Roberto; Corbosiero, Paola; Ferraro, Pietro; Giovannetti, Arianna; Greco, Emilio; Cedrone, Fabrizio			Consequences of COVID19-pandemic lockdown on Italian occupational physicians' psychosocial health	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; MENTAL-HEALTH; STRESS; COVID-19; CARE; LONELINESS; DISTRESS; BURNOUT; IMPACT; STAFF	COVID-19 was declared a pandemic on March 12, 2020. Italy has been the most affected country in the world, right after China. Healthcare workers (HCWs) were among the hardest hit by this event from both a working and psychological point of view. The aim of this web-based cross-sectional study is to assess the consequences of the COVID-19 pandemic on Italian Occupational Physicians' well-being and psychological distress, in relation to demographic and occupational characteristic, lifestyle and habits during the lockdown period. We conducted a web-based cross-sectional survey questionnaire from April 1 to April 21(st), 2020. To evaluate the level of psychological distress and the level of well-being, the general Health Questionnaire-12 (GHQ-12) and the WHO-5 Wellbeing Index were utilized. Since the statistical assumptions were respected, we proceeded with an analysis of variance (ANOVA) to ascertain the differences between the averages of the scores of the GHQ-12. Doctors who live in the most affected regions have a prevalence of psychological distress higher than their colleagues from the rest of Italy. ANOVA shows significant differences relating to the female gender, and to the life changes provoked by the lockdown for example not feeling sheltered at home or suffering from loneliness. This study showed a high prevalence of psychological distress in occupational physicians. To prevent the occurrence of mental disorders among Occupational Physicians, it is urgent to put in place policies of psychological support and well-being preservation.	[De Sio, Simone; Buomprisco, Giuseppe; Lapteva, Ekaterina; Perri, Roberto; Corbosiero, Paola] Sapienza Univ Rome, RU Occupat Med, Rome, Italy; [La Torre, Giuseppe] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Ferraro, Pietro] ASL Foggia, Dept Prevent, Foggia, Italy; [Giovannetti, Arianna] Italian Inst Social Welf, INPS, Rome, Italy; [Greco, Emilio] Link Campus Univ, Rome, Italy; [Cedrone, Fabrizio] Univ G dAnnunzio, Postgrad Sch Hyg & Prevent Med, Chieti, Italy	Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara	De Sio, S (corresponding author), Sapienza Univ Rome, RU Occupat Med, Rome, Italy.	simone.desio@uniroma1.it	Cedrone, Fabrizio/X-2692-2019	De Sio, Simone/0000-0003-4538-3941; Greco, Emilio/0000-0001-9810-5852; Ferraro, Pietro/0000-0002-9149-1647				Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3; Cedrone F, 2017, SALUTE E SOC, V3, P136; De Sio S, 2020, EUR REV MED PHARMACO, V24, P7869, DOI 10.26355/eurrev_202007_22292; De Sio S, 2020, EUR REV MED PHARMACO, V24, P821, DOI 10.26355/eurrev_202001_20065; De Sio S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3209787; De Sio S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7340781; Firenze A, 2020, MED LAV, V111, P46, DOI 10.23749/mdl.v111i1.8795; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Goulia P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-322; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Holi MM, 2003, NORD J PSYCHIAT, V57, P233, DOI 10.1080/08039480310001418; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Marano G, 2020, EUR REV MED PHARMACO, V24, P10225, DOI 10.26355/eurrev_202010_23246; Mattei A, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00098; Mazza M, 2020, MINERVA CARDIOANGIOL, DOI [10.23736/S0026-4725.20.05309-832397693, DOI 10.23736/S0026-4725.20.05309-832397693]; Mazza M, 2020, BIPOLAR DISORD, V22, P870, DOI 10.1111/bdi.13015; Mazza M, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113046; McManus IC, 2002, LANCET, V359, P2089, DOI 10.1016/S0140-6736(02)08915-8; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; PARIENTE P, 1990, Encephale, V16, P459; Phua DH, 2005, ACAD EMERG MED, V12, P322, DOI 10.1197/j.aem.2004.11.015; Rambaldini G, 2005, J GEN INTERN MED, V20, P381, DOI 10.1111/j.1525-1497.2005.0099.x; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Watson SB, 2011, J INDIVID DIFFER, V32, P39, DOI 10.1027/1614-0001/a000033; Yang JW, 2018, ANN OCCUP ENVIRON ME, V30, DOI 10.1186/s40557-018-0250-z; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958	28	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0243194	10.1371/journal.pone.0243194	http://dx.doi.org/10.1371/journal.pone.0243194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534805	gold, Green Published			2022-12-26	WOS:000616739700020
J	Tawre, MS; Kamble, EE; Kumkar, SN; Mulani, MS; Pardesi, KR				Tawre, Madhumita S.; Kamble, Ekta E.; Kumkar, Shital N.; Mulani, Mansura S.; Pardesi, Karishma R.			Antibiofilm and antipersister activity of acetic acid against extensively drug resistant Pseudomonas aeruginosa PAW1	PLOS ONE			English	Article							PERSISTER CELLS; IN-VITRO; ANTIBIOTICS; BIOFILM; PATHOGENS	Pseudomonas aeruginosa is an ESKAPE pathogen associated with difficult-to-treat burn wound and surgical-site infections. This study aimed to characterise an extensively drug resistant (XDR) P. aeruginosa isolate (designated PAW1) and to investigate the antibiofilm and antipersister effect of acetic acid on PAW1. PAW1 was identified using biotypic (VITEK) and genotypic (16S rDNA) analysis. Minimum inhibitory concentration (MIC) and disc susceptibility testing showed high level resistance against all antibiotics from classes including beta lactams, cephems, carbapenems and fluoroquinolones. It was therefore identified as extensively drug resistant (XDR), showing resistance to all antibiotics except for, aminoglycoside (gentamicin and netilmicin) and lipopeptides (polymyxin B). Time kill assays showed antibiotic tolerant, persister cell formation in presence of 100X MICs of gentamicin and polymyxin B. Other virulence traits such as ability to produce lipase, protease, haemolysin, and siderophores and to form biofilms were additional factors which may contribute to its pathogenicity. PAW1 showed promising susceptibility against acetic acid with MIC and minimum biofilm inhibitory concentration of 0.156% (v/v). Percent viability of PAW1 was dependent on dose and treatment time of acetic acid. 0.625% acetic acid treatment of 5 minutes was effective in killing >90% planktonic cells showing lesser toxicity to L929 cells (IC50 = 0.625%). Biofilm disruption caused due to acetic acid was also dose dependent, showing 40.57% disruption after treatment with 0.625% acetic acid for 5 minutes. FESEM imaging and live dead staining of planktonic and biofilm forms of PAW1 confirmed that acetic acid treatment caused 19.04% of cell shrinkage and disruption of extracellular matrix resulting in killing of cells. Antipersister activity of acetic acid was demonstrated by showing complete killing of PAW1 at 4X MIC. Overall, this study characterised an XDR isolate P. aeruginosa showing resistance and tolerance to various antibiotics. Antipersister and antibiofilm effect of acetic acid demonstrates the importance of forgotten topical agents as an effective strategy to treat XDR pathogens.	[Tawre, Madhumita S.; Kamble, Ekta E.; Kumkar, Shital N.; Mulani, Mansura S.; Pardesi, Karishma R.] Savitribai Phule Pune Univ, Dept Microbiol, Pune, Maharashtra, India	Savitribai Phule Pune University	Pardesi, KR (corresponding author), Savitribai Phule Pune Univ, Dept Microbiol, Pune, Maharashtra, India.	karishma@unipune.ac.in	; Pardesi, Karishma/D-5827-2012	KAMBLE, EKTA/0000-0001-6835-6351; Mulani, Mansura/0000-0002-1122-6879; Pardesi, Karishma/0000-0001-7535-6317	UPE-Phase II program [UGC-262-A-2]; DST-PURSE [GOI-A-670]; CSIR-SRF [09/137-0557/2015-EMR/I]	UPE-Phase II program; DST-PURSE; CSIR-SRF(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the financial grant received under the UPE-Phase II program (UGC-262-A-2) and DST-PURSE (GOI-A-670) implemented at SPPU. MST worked as a project fellow under UPE-Phase II; EEK is a recipient of CSIR-SRF (09/137-0557/2015-EMR/I).	Agrawal KS, 2017, INDIAN J PLAST SURG, V50, P273, DOI 10.4103/ijps.IJPS_245_16; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Basavraj Nagoba, 2008, European Journal of General Medicine, V5, P104; Beier RC, 2015, J APPL MICROBIOL, V118, P326, DOI 10.1111/jam.12707; Benie CKD, 2017, EUR J MICROBIOL IMMU, V7, P55, DOI 10.1556/1886.2016.00039; Bjarnsholt T, 2015, ADV WOUND CARE, V4, P363, DOI 10.1089/wound.2014.0554; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Dou JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050617; Dusane Devendra H, 2011, Biofouling, V27, P645, DOI 10.1080/08927014.2011.594883; Fleming D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29121-2; Gaidhani SV, 2014, INDIAN J MED RES, V140, P665; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Grassi L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01917; Halstead FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136190; Jeong HS, 2015, ARCH PLAST SURG-APS, V42, P59, DOI 10.5999/aps.2015.42.1.59; Kamble E, 2020, MICROBIAL DRUG RESIS, P1, DOI [10.1089/mdr.2019.0202 31393205, DOI 10.1089/MDR.2019.0202 31393205]; Kaye KS, 2017, INT J ANTIMICROB AG, V49, P542, DOI 10.1016/j.ijantimicag.2016.11.020; Kramer A, 2018, SKIN PHARMACOL PHYS, V31, P28, DOI 10.1159/000481545; Lee K, 2017, J MICROBIOL BIOTECHN, V27, P1053, DOI 10.4014/jmb.1611.11056; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2019, PERSISTER CELLS AND INFECTIOUS DISEASE, P59, DOI 10.1007/978-3-030-25241-0_4; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Ma JG, 2018, J THORAC DIS, V10, P377, DOI 10.21037/jtd.2017.12.109; Madhusudhan VL, 2016, INT WOUND J, V13, P1129, DOI 10.1111/iwj.12428; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mlynarcik P, 2017, BIOMED PAP, V161, P58, DOI 10.5507/bp.2016.057; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Nagoba BS, 2013, J INFECT PUBLIC HEAL, V6, P410, DOI 10.1016/j.jiph.2013.05.005; Newman JW, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx124; Okabe S, 2014, J GASTROEN HEPATOL, V29, P65, DOI 10.1111/jgh.12775; Pardesi K.R., 2019, RECENT ADV BIOTECHNO; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Ryssel H, 2009, BURNS, V35, P695, DOI 10.1016/j.burns.2008.11.009; Sasirekha Bakthavatchalu, 2016, Agriculture and Natural Resources, V50, P250, DOI 10.1016/j.anres.2016.02.003; Singh R, 2006, APPL MICROBIOL BIOT, V70, P679, DOI 10.1007/s00253-005-0138-z; Sloss J M, 1993, J R Army Med Corps, V139, P49; Tebano G, 2019, INT J ANTIMICROB AG, V54, P273, DOI 10.1016/j.ijantimicag.2019.06.017; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Wiegand C, 2009, SKIN PHARMACOL PHYS, V22, P74, DOI 10.1159/000178866	42	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246020	10.1371/journal.pone.0246020	http://dx.doi.org/10.1371/journal.pone.0246020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529248	Green Published, gold			2022-12-26	WOS:000616736200025
J	Mariotti, M; Rogowska-Wrzesinska, A; Hagglund, P; Davies, MJ				Mariotti, Michele; Rogowska-Wrzesinska, Adelina; Hagglund, Per; Davies, Michael J.			Cross-linking and modification of fibronectin by peroxynitrous acid: Mapping and quantification of damage provides a new model for domain interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE-DERIVED OXIDANTS; PLASMA FIBRONECTIN; EXTRACELLULAR-MATRIX; OXIDATIVE DAMAGE; AMINO-ACIDS; PROTEIN; BINDING; O,O'-DITYROSINE; GENERATION; NITRATION	Fibronectin (FN) is an abundant glycoprotein found in plasma and the extracellular matrix (ECM). It is present at high concentrations at sites of tissue damage, where it is exposed to oxidants generated by activated leukocytes, including peroxynitrous acid (ONOOH) formed from nitric oxide (from inducible nitric oxide synthase) and superoxide radicals (from NADPH oxidases and other sources). ONOOH reacts rapidly with the abundant tyrosine and tryptophan residues in ECM proteins, resulting in the formation of 3-nitrotyrosine, dityrosine, and 6-nitrotryptophan. We have shown previously that human plasma FN is readily modified by ONOOH, but the extent and location of modifications, and the role of FN structure (compact versus extended) in determining these factors is poorly understood. Here, we provide a detailed LC-MS analysis of ONOOH-induced FN modifications, including the extent of their formation and the sites of intramolecular and intermolecular cross-links, including Tyr-Tyr, Trp-Trp, and Tyr-Trp linkages. The localization of these cross-links to specific domains provides novel data on the interactions between different modules in the compact conformation of plasma FN and allows us to propose a model of its unknown quaternary structure. Interestingly, the pattern of modifications is significantly different to that generated by another inflammatory oxidant, HOCl, in both extent and sites. The characterization and quantification of these modifications offers the possibility of the use of these materials as specific biomarkers of ECM modification and turnover in the many pathologies associated with inflammation-associated fibrosis.	[Mariotti, Michele; Hagglund, Per; Davies, Michael J.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Copenhagen, Denmark; [Rogowska-Wrzesinska, Adelina] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Rogowska-Wrzesinska, Adelina] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Odense, Denmark	University of Copenhagen; University of Southern Denmark; University of Southern Denmark	Hagglund, P; Davies, MJ (corresponding author), Univ Copenhagen, Panum Inst, Dept Biomed Sci, Copenhagen, Denmark.	pmh@sund.ku.dk; davies@sund.ku.dk	Davies, Michael/GWV-2527-2022; Davies, Michael J/H-4939-2011; Davies, Michael/AGX-9184-2022; Rogowska-Wrzesinska, Adelina/F-2888-2013	Davies, Michael J/0000-0002-5196-6919; Davies, Michael/0000-0002-5196-6919; Rogowska-Wrzesinska, Adelina/0000-0002-9876-0061; Hagglund, Per/0000-0002-6627-7518	Novo Nordisk Foundation [NNF13OC0004294]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors are grateful to the Novo Nordisk Foundation (Grant NNF13OC0004294 to M. J. D.) for financial support.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Ambesi A, 2014, J CELL SCI, V127, P3805, DOI 10.1242/jcs.150458; Baldus S, 2002, FREE RADICAL BIO MED, V33, P1010, DOI 10.1016/S0891-5849(02)00993-0; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Bhattacharjee S, 2001, ARCH BIOCHEM BIOPHYS, V395, P69, DOI 10.1006/abbi.2001.2557; BOHLE DS, 1994, J AM CHEM SOC, V116, P7423, DOI 10.1021/ja00095a062; Cai H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57299-6; Cao Y, 2015, CANCER LETT, V360, P141, DOI 10.1016/j.canlet.2015.01.041; Chuang CY, 2014, FREE RADICAL RES, V48, P970, DOI 10.3109/10715762.2014.920087; Chuang CY, 2014, BIOCHEM J, V459, P313, DOI 10.1042/BJ20131471; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Curtis MP, 2011, CHEM RES TOXICOL, V24, P418, DOI 10.1021/tx100380d; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Degendorfer G, 2018, FREE RADICAL BIO MED, V115, P202, DOI 10.1016/j.freeradbiomed.2017.11.019; Degendorfer G, 2016, FREE RADICAL BIO MED, V97, P602, DOI 10.1016/j.freeradbiomed.2016.06.013; Degendorfer G, 2015, FREE RADICAL BIO MED, V89, P721, DOI 10.1016/j.freeradbiomed.2015.09.018; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; Ferrer-Sueta G, 2018, CHEM REV, V118, P462, DOI 10.1021/acs.chemrev.7b00568; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Halliwell B., 2015, Free radicals in biology and medicine; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Leeuwenburgh C, 1999, FREE RADICAL BIO MED, V27, P186, DOI 10.1016/S0891-5849(99)00071-4; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mariotti M, 2018, J PROTEOME RES, V17, P2017, DOI 10.1021/acs.jproteome.7b00881; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; Moore KJ, 2012, EMBO MOL MED, V4, P561, DOI 10.1002/emmm.201200238; Nybo T, 2018, REDOX BIOL, V19, P388, DOI 10.1016/j.redox.2018.09.005; Orhan H, 2005, J CHROMATOGR B, V827, P104, DOI 10.1016/j.jchromb.2005.03.043; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pennathur S, 2016, AM J RESP CRIT CARE, V193, P861, DOI 10.1164/rccm.201505-0992OC; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Song KS, 2001, ATHEROSCLEROSIS, V154, P449, DOI 10.1016/S0021-9150(00)00490-1; STENMAN S, 1980, ACTA MED SCAND, P165; STENMAN S, 1978, J EXP MED, V147, P1054, DOI 10.1084/jem.147.4.1054; Teng N, 2017, REDOX REP, V22, P51, DOI 10.1080/13510002.2016.1256119; Theocharis AD, 2019, FEBS J, V286, P2830, DOI 10.1111/febs.14818; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Uppu RM, 1996, ANAL BIOCHEM, V236, P242, DOI 10.1006/abio.1996.0162; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; Vanichkitrungruang S, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101641; Vanichkitrungruang S, 2019, FREE RADICAL BIO MED, V136, P118, DOI 10.1016/j.freeradbiomed.2019.04.003; Vavalle JP, 2007, J THROMB HAEMOST, V5, P864, DOI 10.1111/j.1538-7836.2007.02420.x; Walker EJ, 2019, P NATL ACAD SCI USA, V116, P6081, DOI 10.1073/pnas.1819851116; Walraven M, 2018, MATRIX BIOL, V71-72, P205, DOI 10.1016/j.matbio.2018.02.020; White ES, 2011, IUBMB LIFE, V63, P538, DOI 10.1002/iub.493; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Zollinger AJ, 2017, MATRIX BIOL, V60-61, P27, DOI 10.1016/j.matbio.2016.07.011	64	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100360	10.1016/j.jbc.2021.100360	http://dx.doi.org/10.1016/j.jbc.2021.100360			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539924	gold, Green Published			2022-12-26	WOS:000672866400334
J	Rayani, K; Seffernick, J; Li, AY; Davis, JP; Spuches, AM; Van Petegem, F; Solaro, RJ; Lindert, S; Tibbits, GF				Rayani, Kaveh; Seffernick, Justin; Li, Alison Yueh; Davis, Jonathan P.; Spuches, Anne Marie; Van Petegem, Filip; Solaro, R. John; Lindert, Steffen; Tibbits, Glen F.			Binding of calcium and magnesium to human cardiac troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKINNED MUSCLE-FIBERS; SR2&-ACTIVATED TENSION GENERATION; ISOTHERMAL TITRATION CALORIMETRY; SKELETAL-MUSCLE; EF-HAND; HEAT-CAPACITY; CA2+ BINDING; CA2+-BINDING PROPERTIES; CONTRACTILE ACTIVATION; STRUCTURAL TRANSITION	Cardiac muscle thin filaments are composed of actin, tropomyosin, and troponin that change conformation in response to Ca2+ binding, triggering muscle contraction. Human cardiac troponin C (cTnC) is the Ca2+-sensing component of the thin filament. It contains structural sites (III/IV) that bind both Ca2+ and Mg2+ and a regulatory site (II) that has been thought to bind only Ca2+. Binding of Ca2+ at this site initiates a series of conformational changes that culminate in force production. However, the mechanisms that underpin the regulation of binding at site II remain unclear. Here, we have quantified the interaction between site II and Ca2+/Mg2+ through isothermal titration calorimetry and thermodynamic integration simulations. Direct and competitive binding titrations with WT N-terminal cTnC and full-length cTnC indicate that physiologically relevant concentrations of both Ca2+/Mg2+ interacted with the same locus. Moreover, the D67A/D73A N-terminal cTnC construct in which two coordinating residues within site II were removed was found to have significantly reduced affinity for both cations. In addition, 1 mM Mg2+ caused a 1.4-fold lower affinity for Ca2+. These experiments strongly suggest that cytosolic-free Mg2+ occupies a significant population of the available site II. Interaction of Mg2+ with site II of cTnC likely has important functional consequences for the heart both at baseline as well as in diseased states that decrease or increase the availability of Mg2+, such as secondary hyper-parathyroidism or ischemia, respectively.	[Rayani, Kaveh; Li, Alison Yueh; Tibbits, Glen F.] Simon Fraser Univ, Mol Cardiac Physiol Grp, Burnaby, BC, Canada; [Seffernick, Justin; Lindert, Steffen] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Li, Alison Yueh; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Spuches, Anne Marie] East Carolina Univ, Dept Chem, 300 Sci & Technol Bldg, Greenville, NC USA; [Solaro, R. John] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Solaro, R. John] Univ Illinois, Coll Med, Ctr Cardiovasc Res, Chicago, IL USA; [Tibbits, Glen F.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Tibbits, Glen F.] BC Childrens Hosp, Cardiac Grp, Res Inst, Vancouver, BC, Canada	Simon Fraser University; University System of Ohio; Ohio State University; University of British Columbia; University System of Ohio; Ohio State University; University of North Carolina; East Carolina University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Simon Fraser University; BC Childrens Hospital; University of British Columbia	Tibbits, GF (corresponding author), Simon Fraser Univ, Mol Cardiac Physiol Grp, Burnaby, BC, Canada.; Tibbits, GF (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada.; Tibbits, GF (corresponding author), BC Childrens Hosp, Cardiac Grp, Res Inst, Vancouver, BC, Canada.	tibbits@sfu.ca	Lindert, Steffen/K-3558-2013	Lindert, Steffen/0000-0002-3976-3473; Tibbits, Glen/0000-0002-2586-3115	Canadian Institutes of Health Research [PJT-148964]; National Sciences and Engineering Research Council Canada Graduate Scholarship-Doctoral fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council Canada Graduate Scholarship-Doctoral fellowship	This work was primarily supported by a grant from the Canadian Institutes of Health Research (PJT-148964) to G. F. T. K. R. was supported by the National Sciences and Engineering Research Council Canada Graduate Scholarship-Doctoral fellowship.	Allen K, 2000, J APPL PHYSIOL, V88, P180, DOI 10.1152/jappl.2000.88.1.180; ALLEN TS, 1992, BIOPHYS J, V61, P399, DOI 10.1016/S0006-3495(92)81846-5; Amano T, 2000, BRIT J PHARMACOL, V130, P731, DOI 10.1038/sj.bjp.0703361; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; ASHLEY CC, 1977, J PHYSIOL-LONDON, V270, P627, DOI 10.1113/jphysiol.1977.sp011972; Badr MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164222; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; BEST PM, 1977, J PHYSIOL-LONDON, V265, P1; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Bowman JD, 2018, J PHYS CHEM B, V122, P7874, DOI 10.1021/acs.jpcb.8b05435; Brini M, 2012, COMPR PHYSIOL, V2, P1045, DOI 10.1002/cphy.c110034; Carafoli E, 2016, J BIOL CHEM, V291, P20849, DOI 10.1074/jbc.R116.735894; Case, 2016, AMBER 2016 REFERENCE, P1, DOI DOI 10.13140/RG.2.2.27958.70729; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Cefaratti C, 2007, MOL CELL BIOCHEM, V303, P63, DOI 10.1007/s11010-007-9456-z; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHEUNG JY, 1989, AM J PHYSIOL, V256, pC1120, DOI 10.1152/ajpcell.1989.256.6.C1120; Dai LJ, 1997, KIDNEY INT, V51, P1008, DOI 10.1038/ki.1997.141; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 2002, J BIOL CHEM, V277, P49716, DOI 10.1074/jbc.M208488200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; DONALDSON SKB, 1975, J GEN PHYSIOL, V66, P427, DOI 10.1085/jgp.66.4.427; DONALDSON SKB, 1978, J GEN PHYSIOL, V71, P645, DOI 10.1085/jgp.71.6.645; Ebashi S, 1980, Mol Biol Biochem Biophys, V32, P183; EBASHI S, 1988, BIOPHYS CHEM, V29, P137, DOI 10.1016/0301-4622(88)87033-9; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P497, DOI 10.1113/jphysiol.1975.sp011027; Fagan TE, 2001, AM J PHYSIOL-GASTR L, V280, pG1145, DOI 10.1152/ajpgi.2001.280.6.G1145; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; FOLLENIUS A, 1984, BIOCHEM BIOPH RES CO, V119, P1154, DOI 10.1016/0006-291X(84)90896-9; FRANCOIS JM, 1993, J MUSCLE RES CELL M, V14, P585, DOI 10.1007/BF00141555; Fuchs F, 2011, BIOCHEM BIOPH RES CO, V408, P697, DOI 10.1016/j.bbrc.2011.04.092; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Gillis TE, 2005, PHYSIOL GENOMICS, V22, P1, DOI 10.1152/physiolgenomics.00007.2005; Gillis TE, 2003, BIOCHEMISTRY-US, V42, P6418, DOI 10.1021/bi0340494; Gillis TE, 2003, AM J PHYSIOL-CELL PH, V284, pC1176, DOI 10.1152/ajpcell.00339.2002; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; GODT RE, 1974, J GEN PHYSIOL, V63, P722, DOI 10.1085/jgp.63.6.722; GODT RE, 1984, ADV EXP MED BIOL, V170, P569; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; Grossoehme NE, 2010, J BIOL INORG CHEM, V15, P1183, DOI 10.1007/s00775-010-0693-3; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; HONGO K, 1994, JPN J PHYSIOL, V44, P357, DOI 10.2170/jjphysiol.44.357; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Howarth Frank C., 1994, Magnesium Research, V7, P187; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; JOHNSON JD, 1994, J BIOL CHEM, V269, P8919; Johnson RA, 2019, BBA-PROTEINS PROTEOM, V1867, P359, DOI 10.1016/j.bbapap.2019.01.004; KAWASAKI Y, 1972, BIOCHEM BIOPH RES CO, V49, P898, DOI 10.1016/0006-291X(72)90297-5; KERRICK WGL, 1975, PFLUG ARCH EUR J PHY, V358, P195, DOI 10.1007/BF00587216; Kirschenlohr HL, 2000, BIOCHEM J, V346, P385, DOI 10.1042/0264-6021:3460385; KOHAMA K, 1980, J BIOCHEM, V88, P591, DOI 10.1093/oxfordjournals.jbchem.a133007; Kolte D, 2014, CARDIOL REV, V22, P182, DOI 10.1097/CRD.0000000000000003; KOMETANI K, 1983, BIOCHEM BIOPH RES CO, V114, P162, DOI 10.1016/0006-291X(83)91608-X; Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223; LEAVIS PC, 1978, ARCH BIOCHEM BIOPHYS, V186, P411, DOI 10.1016/0003-9861(78)90453-8; Leelananda SP, 2016, BEILSTEIN J ORG CHEM, V12, P2694, DOI 10.3762/bjoc.12.267; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079363; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LI MX, 1995, BIOCHEMISTRY-US, V34, P8330, DOI 10.1021/bi00026a014; LI MX, 1994, BIOCHEMISTRY-US, V33, P917, DOI 10.1021/bi00170a010; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; MORIMOTO S, 1991, J BIOCHEM-TOKYO, V109, P120, DOI 10.1093/oxfordjournals.jbchem.a123331; Morsy MS, 2017, AM J MED SCI, V354, P335, DOI 10.1016/j.amjms.2017.02.008; MURRAY AC, 1972, BIOCHEMISTRY-US, V11, P2622, DOI 10.1021/bi00764a012; Nara M, 2013, BIOPOLYMERS, V99, P342, DOI 10.1002/bip.22176; OGAWA Y, 1985, J BIOCHEM-TOKYO, V97, P1011, DOI 10.1093/oxfordjournals.jbchem.a135143; PAN BS, 1987, J BIOL CHEM, V262, P7839; Panteva MT, 2015, J COMPUT CHEM, V36, P970, DOI 10.1002/jcc.23881; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1975, J BIOL CHEM, V250, P4628; POTTER JD, 1981, FED PROC, V40, P2653; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; REID RE, 1995, ARCH BIOCHEM BIOPHYS, V323, P115, DOI 10.1006/abbi.1995.0016; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Rocklin GJ, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4826261; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Sacco C, 2012, J BIOL INORG CHEM, V17, P531, DOI 10.1007/s00775-012-0874-3; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; SEAMON KB, 1977, BIOCHEMISTRY-US, V16, P4039, DOI 10.1021/bi00637a016; She MD, 1998, EUR J BIOCHEM, V252, P600, DOI 10.1046/j.1432-1327.1998.2520600.x; Shirts MR., 2010, DRUG DESIGN STRUCTUR, P61, DOI [10.1017/cbo9780511730412.007, DOI 10.1017/CBO9780511730412.007]; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Siddiqui JK, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00632; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Skowronsky RA, 2013, J BIOL INORG CHEM, V18, P49, DOI 10.1007/s00775-012-0948-2; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; SMITH DW, 1977, J CHEM EDUC, V54, P540, DOI 10.1021/ed054p540; SOLARO RJ, 1976, CIRC RES, V39, P8, DOI 10.1161/01.RES.39.1.8; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Steinbrecher T, 2011, J COMPUT CHEM, V32, P3253, DOI 10.1002/jcc.21909; STEPHENSON DG, 1982, J PHYSIOL-LONDON, V333, P637, DOI 10.1113/jphysiol.1982.sp014473; Stevens CM, 2017, J BIOL CHEM, V292, P11915, DOI 10.1074/jbc.M116.770776; Stevens CM, 2016, BIOPHYS J, V111, P38, DOI 10.1016/j.bpj.2016.05.029; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Tanaka H, 2013, FEBS LETT, V587, P2612, DOI 10.1016/j.febslet.2013.06.042; Tessman PA, 1998, AM J PHYSIOL-GASTR L, V275, pG1106, DOI 10.1152/ajpgi.1998.275.5.G1106; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2001, BIOCHEMISTRY-US, V40, P3348, DOI 10.1021/bi0021333; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; VORMANN J, 1987, MAGNESIUM, V6, P220; Wang KQ, 2020, J PHYSIOL-LONDON, V598, P1169, DOI 10.1113/JP279307; Wang SQ, 1997, CRYOBIOLOGY, V35, P193, DOI 10.1006/cryo.1997.2040; Wilcox DE, 2008, INORG CHIM ACTA, V361, P857, DOI 10.1016/j.ica.2007.10.032; WNUK W, 1984, J BIOL CHEM, V259, P9017; Wolf FI, 1996, ARCH BIOCHEM BIOPHYS, V331, P194, DOI 10.1006/abbi.1996.0298; YAMADA K, 1982, J BIOCHEM-TOKYO, V92, P1505, DOI 10.1093/oxfordjournals.jbchem.a134075; YAMADA K, 1978, BIOCHIM BIOPHYS ACTA, V535, P342, DOI 10.1016/0005-2795(78)90100-9; Yamada K, 2003, ADV EXP MED BIOL, V538, P203; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yumoto F, 2001, EUR J BIOCHEM, V268, P6284, DOI 10.1046/j.1432-1327.2001.02583.x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	130	7	8	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100350	10.1016/j.jbc.2021.100350	http://dx.doi.org/10.1016/j.jbc.2021.100350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548225	gold, Green Published			2022-12-26	WOS:000672866400324
J	Avni, D; Harikumar, KB; Sanyal, AJ; Spiegel, S				Avni, Dorit; Harikumar, Kuzhuvelil B.; Sanyal, Arun J.; Spiegel, Sarah			Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNF alpha-dependent inflammation and apoptosis	FASEB JOURNAL			English	Article						acute liver failure; apoptosis; cytokines; sphingosine kinase		Acute liver failure (ALF) causes severe liver dysfunction that can lead to multi-organ failure and death. Previous studies suggest that sphingosine kinase 1 (SphK1) protects against hepatocyte injury, yet not much is still known about its involvement in ALF. This study examines the role of SphK1 in D-galactosamine (GalN)/lipopolysaccharide (LPS)-induced ALF, which is a well-established experimental mouse model that mimics the fulminant hepatitis. Here we report that deletion of SphK1, but not SphK2, dramatically decreased GalN/LPS-induced liver damage, hepatic apoptosis, serum alanine aminotransferase levels, and mortality rate compared to wild-type mice. Whereas GalN/LPS treatment-induced hepatic activation of NF-kappa B and JNK in wild-type and SphK2(-/-) mice, these signaling pathways were reduced in SphK1(-/-) mice. Moreover, repression of ALF in SphK1(-/-) mice correlated with decreased expression of the pro-inflammatory cytokine TNF alpha. Adoptive transfer experiments indicated that SphK1 in bone marrow-derived infiltrating immune cells but not in host liver-resident cells, contribute to the development of ALF. Interestingly, LPS-induced TNF alpha production was drastically suppressed in SphK1-deleted macrophages, whereas IL-10 expression was markedly enhanced, suggesting a switch to the anti-inflammatory phenotype. Finally, treatment with a specific SphK1 inhibitor ameliorated inflammation and protected mice from ALF. Our findings suggest that SphK1 regulates TNF alpha secretion from macrophages and inhibition or deletion of SphK1 mitigated ALF. Thus, a potent inhibitor of SphK1 could potentially be a therapeutic agent for fulminant hepatitis.	[Avni, Dorit; Harikumar, Kuzhuvelil B.; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Sch Med, Richmond, VA 23298 USA; [Avni, Dorit] Migal Galilee Technol Ctr, Galilee Res Inst, MIGAL Bldg,Tarshish St, Qiryat Shemona, Israel; [Harikumar, Kuzhuvelil B.] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India	Virginia Commonwealth University; Virginia Commonwealth University; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Avni, D; Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA.	dorita@migal.org.il; sarah.spiegel@vcuhealth.org		Avni, Dorit/0000-0002-0444-881X	National Institutes of Health [RO1GM043880]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1GM043880 (to SS)	Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; ATILLASOY E, 1995, ANNU REV MED, V46, P181; Avni D., 2021, FASEB J, V35; Avni D, 2010, IMMUNOLOGY, V129, P375, DOI 10.1111/j.1365-2567.2009.03188.x; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Chan G, 2009, LIVER TRANSPLANT, V15, P1696, DOI 10.1002/lt.21931; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Coldewey SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27594; Dong XT, 2019, EXP THER MED, V17, P3835, DOI 10.3892/etm.2019.7450; Guillot A, 2019, HEPATOL COMMUN, V3, P730, DOI 10.1002/hep4.1356; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019; Tunon MJ, 2009, WORLD J GASTROENTERO, V15, P3086, DOI 10.3748/wjg.15.3086; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Kaneko T, 2006, BIOCHEM BIOPH RES CO, V345, P85, DOI 10.1016/j.bbrc.2006.04.067; Kleuser B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030722; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lei YC, 2015, WORLD J GASTROENTERO, V21, P13438, DOI 10.3748/wjg.v21.i48.13438; Lei YC, 2015, WORLD J GASTROENTERO, V21, P13055, DOI 10.3748/wjg.v21.i46.13055; LEIST M, 1995, AM J PATHOL, V146, P1220; Li LJ, 2020, CELL DEATH DIFFER, V27, P1924, DOI 10.1038/s41418-019-0471-x; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu Y, 2013, J PATHOL, V230, P365, DOI 10.1002/path.4194; Louis H, 1997, HEPATOLOGY, V25, P1382, DOI 10.1002/hep.510250614; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Megidish T, 1998, J BIOL CHEM, V273, P21834, DOI 10.1074/jbc.273.34.21834; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Mucke VT, 2020, HEPATOL COMMUN, V4, P1477, DOI 10.1002/hep4.1561; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nakama T, 2001, HEPATOLOGY, V33, P1441, DOI 10.1053/jhep.2001.24561; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Nowatari T, 2015, HEPATOL RES, V45, P1136, DOI 10.1111/hepr.12446; Olleros ML, 2010, J HEPATOL, V53, P1059, DOI 10.1016/j.jhep.2010.05.029; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Park WJ, 2020, MOL CELLS, V43, P419, DOI 10.14348/molcells.2020.0054; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; ROLANDO N, 1990, HEPATOLOGY, V11, P49, DOI 10.1002/hep.1840110110; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Saliba F, 2013, J HEPATOL, V59, P6, DOI 10.1016/j.jhep.2013.04.001; Santucci L, 1996, GASTROENTEROLOGY, V111, P736, DOI 10.1053/gast.1996.v111.pm8780580; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Stravitz RT, 2019, LANCET, V394, P869, DOI 10.1016/S0140-6736(19)31894-X; Tian T, 2016, UNITED EUR GASTROENT, V4, P677, DOI 10.1177/2050640616637968; Wang K, 2010, LAB INVEST, V90, P257, DOI 10.1038/labinvest.2009.129; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Weigert A, 2019, BBA-MOL CELL BIOL L, V1864, P1235, DOI 10.1016/j.bbalip.2019.05.008; Winkler MS, 2019, J INTENSIVE CARE, V7, DOI 10.1186/s40560-019-0376-2; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13423; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	60	3	3	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21415	10.1096/fj.202002540R	http://dx.doi.org/10.1096/fj.202002540R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566377	Bronze, Green Accepted			2022-12-26	WOS:000629576700015
J	Feng, X; Wei, Z; Tao, X; Du, Y; Wu, J; Yu, YH; Yu, HD; Zhao, HB				Feng, Xuan; Wei, Zhi; Tao, Xiang; Du, Yan; Wu, Jing; Yu, Yinhua; Yu, Huandi; Zhao, Hongbo			PLAC8 promotes the autophagic activity and improves the growth priority of human trophoblast cells	FASEB JOURNAL			English	Article						autophagy; p53; PLAC8; proliferation; trophoblast		Autophagy plays an important role in the normal development and function of trophoblast cells and is precisely regulated during pregnancy. Dysregulated autophagy contributes to the abnormal proliferation of trophoblasts, which is closely related to the occurrence of pregnancy-related diseases. Placenta specific 8 (PLAC8, Onzin) is a multifaceted protein proven to promote autophagy and potentiate various tumor progression. Its role in trophoblasts remains elusive. In our present study, PLAC8 expression was detected in tissues of first-trimester placentas (n = 5), term placentas (n = 5), choriocarcinoma (n = 5), and placental site trophoblastic tumor (n = 5). PLAC8 expression was increased in gestational neoplasms compared with normal pregnancies. mCherry-EGFP-LC3B reporter and transmission electron microscopy confirmed PLAC8 promoted the autophagic flux of human trophoblast cells. Both gain-of-function and loss-of-function experiments demonstrated PLAC8-regulated autophagy-related genes, including ATG5, ATG12, and Beclin-1. In addition, our data showed that PLAC8 co-localized with p53 and promoted its degradation, and p53 re-expression partially abrogated the PLAC8-induced autophagy activity. Furthermore, the overexpression of PLAC8 promoted cell viability and proliferation, acting as a protective mechanism of trophoblasts against the cytotoxicity of etoposide (VP-16). Such a phenomenon was effectively abrogated by autophagy inhibitors 3-methyladenine (3-MA) and chloroquine (CQ). In conclusion, PLAC8-induced autophagy to promote the proliferation of trophoblasts. This study provided insights into the mechanism of PLAC8-induced autophagy in trophoblasts, which is significant for a wide range of gestational diseases and may contribute to developing novel treatment strategies for trophoblastic diseases.	[Feng, Xuan; Wei, Zhi; Tao, Xiang; Du, Yan; Wu, Jing; Yu, Yinhua; Yu, Huandi; Zhao, Hongbo] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, 128 Shenyang Rd, Shanghai 200011, Peoples R China; [Feng, Xuan; Wei, Zhi; Tao, Xiang; Du, Yan; Wu, Jing; Yu, Yinhua; Yu, Huandi; Zhao, Hongbo] Fudan Univ, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai, Peoples R China	Fudan University; Fudan University	Yu, HD; Zhao, HB (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, 128 Shenyang Rd, Shanghai 200011, Peoples R China.	yuhuandi1019@gmail.com; zhaohongbo01@sina.com	Wang, Jin/GYA-2019-2022; Du, Yan/AAD-5510-2020; wang, jing/GVT-8700-2022; Wu, Jing/GZK-5063-2022	Du, Yan/0000-0001-5413-7836; zhi, WEI/0000-0002-8971-045X	National Natural Science Foundation of China [81971394, 81571457]; Shanghai Pujiang Program [15PJ1400900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was funded by the National Natural Science Foundation of China [grant number: 81971394, 81571457], the Shanghai Pujiang Program [grant number: 15PJ1400900]	Abd Rahman R, 2018, J MATERN-FETAL NEO M, V31, P525, DOI 10.1080/14767058.2017.1289511; Al-Bari MAA, 2020, ANN NY ACAD SCI, V1467, P3, DOI 10.1111/nyas.14305; Avagliano L, 2015, REPROD SCI, V22, P838, DOI 10.1177/1933719114565036; Cha HH, 2014, REPROD SCI, V21, P612, DOI 10.1177/1933719113508816; Chang WL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.148932; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Du Y, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0572-5; DUNCAN DA, 1989, HUM PATHOL, V20, P370, DOI 10.1016/0046-8177(89)90047-6; Feng X, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00937; Gauster M, 2018, CELL MOL LIFE SCI, V75, P1839, DOI 10.1007/s00018-017-2695-6; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Gong Jin-Sung, 2014, Clin Exp Reprod Med, V41, P97, DOI 10.5653/cerm.2014.41.3.97; Huang ML, 2020, J CELL MOL MED, V24, P7778, DOI 10.1111/jcmm.15409; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Jackson WT, 2013, AUTOPHAGY, V9, P1905, DOI 10.4161/auto.26819; Jia YL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0580-3; Kaistha BP, 2016, CANCER RES, V76, P96, DOI 10.1158/0008-5472.CAN-15-0216; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Kolluru V, 2017, CANCER LETT, V408, P121, DOI 10.1016/j.canlet.2017.08.023; Lacroix MC, 2002, PLACENTA, V23, pS87, DOI 10.1053/plac.2002.0811; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Li CX, 2014, J CLIN INVEST, V124, P2172, DOI 10.1172/JCI71103; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Manu KA, 2019, CANCERS, V11, DOI 10.3390/cancers11081112; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2020, CURR OPIN CELL BIOL, V63, P1, DOI 10.1016/j.ceb.2019.12.001; Nakashima A, 2017, J REPROD IMMUNOL, V123, P17, DOI 10.1016/j.jri.2017.08.006; Nakashima A, 2017, J OBSTET GYNAECOL RE, V43, P633, DOI 10.1111/jog.13292; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Oh Soo-Young, 2017, Obstet Gynecol Sci, V60, P241, DOI 10.5468/ogs.2017.60.3.241; Ravanan P, 2017, LIFE SCI, V188, P53, DOI 10.1016/j.lfs.2017.08.029; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Saito S, 2013, PLACENTA, V34, pS79, DOI 10.1016/j.placenta.2012.11.026; Saito S, 2014, J REPROD IMMUNOL, V101, P80, DOI 10.1016/j.jri.2013.06.002; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Shen Y, 2015, EXP CELL RES, V334, P207, DOI 10.1016/j.yexcr.2015.04.010; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Tamargo-Gomez I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123812; Tang JJ, 2015, CANCER LETT, V363, P101, DOI 10.1016/j.canlet.2015.04.014; Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131; Wargasetia TL, 2015, INT J REPROD BIOMED, V13, P413; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	45	7	8	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21351	10.1096/fj.202002075RR	http://dx.doi.org/10.1096/fj.202002075RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570788	Bronze			2022-12-26	WOS:000629576700044
J	Kwon, JA; Chambers, GM; Luciani, F; Zhang, L; Kinathil, S; Kim, D; Thein, HH; Botha, W; Thompson, S; Lloyd, A; Yap, L; Gray, RT; Butler, T				Kwon, Jisoo A.; Chambers, Georgina M.; Luciani, Fabio; Zhang, Lei; Kinathil, Shamin; Kim, Dennis; Thein, Hla-Hla; Botha, Willings; Thompson, Sandra; Lloyd, Andrew; Yap, Lorraine; Gray, Richard T.; Butler, Tony			Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis	PLOS ONE			English	Article							HCV GENOTYPE 1; VIRUS-INFECTION; SOFOSBUVIR; PREVENTION; COMBINATION; LEDIPASVIR; THERAPY; INMATES	In Australian prisons approximately 20% of inmates are chronically infected with hepatitis C virus (HCV), providing an important population for targeted treatment and prevention. A dynamic mathematical model of HCV transmission was used to assess the impact of increasing direct-acting antiviral (DAA) treatment uptake on HCV incidence and prevalence in the prisons in New South Wales, Australia, and to assess the cost-effectiveness of alternate treatment strategies. We developed four separate models reflecting different average prison lengths of stay (LOS) of 2, 6, 24, and 36 months. Each model considered four DAA treatment coverage scenarios of 10% (status-quo), 25%, 50%, and 90% over 2016-2045. For each model and scenario, we estimated the lifetime burden of disease, costs and changes in quality-adjusted life years (QALYs) in prison and in the community during 2016-2075. Costs and QALYs were discounted 3.5% annually and adjusted to 2015 Australian dollars. Compared to treating 10% of infected prisoners, increasing DAA coverage to 25%, 50%, and 90% reduced HCV incidence in prisons by 9-33% (2-months LOS), 26-65% (6-months LOS), 37-70% (24-months LOS), and 35-65% (36-months LOS). DAA treatment was highly cost-effective among all LOS models at conservative willingness-to-pay thresholds. DAA therapy became increasingly cost-effective with increasing coverage. Compared to 10% treatment coverage, the incremental cost per QALY ranged from $497-$569 (2-months LOS), -$280-$323 (6-months LOS), -$432-$426 (24-months LOS), and -$245-$477 (36-months LOS). Treating more than 25% of HCV-infected prisoners with DAA therapy is highly cost-effective. This study shows that treating HCV-infected prisoners is highly cost-effective and should be a government priority for the global HCV elimination effort.	[Kwon, Jisoo A.; Zhang, Lei; Kinathil, Shamin; Kim, Dennis; Lloyd, Andrew; Yap, Lorraine; Gray, Richard T.; Butler, Tony] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Chambers, Georgina M.] UNSW Sydney, Natl Perinatal Epidemiol & Stat Unit NPESU, Ctr Big Data Res Hlth, Sydney, NSW, Australia; [Chambers, Georgina M.] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Luciani, Fabio] UNSW, Sch Med Sci, Fac Med, Sydney, NSW, Australia; [Zhang, Lei] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Thein, Hla-Hla] Univ Toronto, Toronto Gen Hosp, Toronto Hlth Econ & Technol Assessment Collaborat, Res Inst, Toronto, ON, Canada; [Thein, Hla-Hla] Univ Hlth Network, Toronto, ON, Canada; [Botha, Willings] RTI Hlth Solut, Res Triangle Pk, NC USA; [Thompson, Sandra] Combined Univ Rural Hlth, Geraldton, WA, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Research Triangle Institute	Chambers, GM (corresponding author), UNSW Sydney, Natl Perinatal Epidemiol & Stat Unit NPESU, Ctr Big Data Res Hlth, Sydney, NSW, Australia.; Chambers, GM (corresponding author), UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.	g.chambers@unsw.edu.au	Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017; Lloyd, Andrew/AFJ-8960-2022; Thompson, Sandra/H-5955-2014	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Kwon, Jisoo Amy/0000-0003-2829-6694; Gray, Richard/0000-0002-2885-0483; Botha, Willings/0000-0002-7375-7229; Thompson, Sandra/0000-0003-0327-7155; Chambers, Georgina/0000-0003-0215-3249	National Health and Medical Research Council of Australia (NHMRC) [1137587]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	AL is funded by a Practitioner Fellowship from the National Health and Medical Research Council of Australia (NHMRC, No.1137587). FL is supported by NHMRC CDA fellowship, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. WB received salary support from RTI Health Solutions, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.'	Australian Bureau of Statistics (ABS), PRIS AUSTR 2020; Australian Government Department of Health, PHARM BEN SCHEM; Blogg J, 2020, INT J DRUG POLICY, V77, DOI 10.1016/j.drugpo.2019.11.005; Boonwaat L, 2010, MED J AUSTRALIA, V192, P496, DOI 10.5694/j.1326-5377.2010.tb03605.x; Bretana NA, 2020, ADDICTION, V115, P901, DOI 10.1111/add.14830; Briggs A, 2006, DECISION MODELLING H; Butler T, 1999, AUST NZ J PUBL HEAL, V23, P377, DOI 10.1111/j.1467-842X.1999.tb01278.x; Butler T., 2017, NATL PRISON ENTRANTS; Butler T, 2007, AUST NZ J PUBL HEAL, V31, P44, DOI 10.1111/j.1753-6405.2007.00009.x; Commonwealth of Australia, 2015, NAT HOSP COST DAT CO; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; Cunningham EB, 2017, J VIRAL HEPATITIS, V24, P733, DOI 10.1111/jvh.12701; del Campo C, 2019, OPER RES HEALTH CARE, V21, P32, DOI 10.1016/j.orhc.2019.04.001; Dore GJ, 2017, J HEPATOL, V67, P419, DOI 10.1016/j.jhep.2017.03.035; Edney LC, 2018, PHARMACOECONOMICS, V36, P239, DOI 10.1007/s40273-017-0585-2; ESTEBAN JI, 1989, LANCET, V2, P294; European Monitoring Centre for Drugs and Drug Addiction, 2016, HEP C DRUG US EUR EP; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Gray A., 2011, APPL METHODS COST EF; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hajarizadeh B, 2016, LANCET GASTROENTEROL, V1, P317, DOI 10.1016/S2468-1253(16)30075-9; HCVPWG (Hepatitis C Virus Projections Working Group), 2006, EST PROJ HEP C VIR E; He TH, 2016, ANN INTERN MED, V164, P84, DOI 10.7326/M15-0617; Hickman M, 2015, CURR OPIN INFECT DIS, V28, P576, DOI 10.1097/QCO.0000000000000216; Kirby Institute, 2018, HIV VIR HEP SEX TRAN; Kwon JA, 2019, J VIRAL HEPATITIS, V26, P83, DOI 10.1111/jvh.13013; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Liu S, 2014, ANN INTERN MED, V161, P546, DOI 10.7326/M14-0602; Lloyd AR, 2013, CLIN INFECT DIS, V56, P1078, DOI 10.1093/cid/cis1202; Luciani F, 2014, ADDICTION, V109, P1695, DOI 10.1111/add.12643; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Overton K, 2019, INT J DRUG POLICY, V72, P123, DOI 10.1016/j.drugpo.2019.02.013; Papaluca T, 2019, MED J AUSTRALIA, V210, P390, DOI 10.5694/mja2.50140; Philip B, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14543; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Scott N, 2018, J VIRAL HEPATITIS, V25, P1472, DOI 10.1111/jvh.12975; Spaulding AC, 2012, JAMA-J AM MED ASSOC, V307, P1259, DOI 10.1001/jama.2012.374; The Kirby Institute, 2016, HIV VIR HEP SEX TRAN; The Pharmaceutical Benefits Advisory Committee (PBAC), 2016, OV RAT EC EV; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; VLAHOV D, 1993, EUR J EPIDEMIOL, V9, P566, DOI 10.1007/BF00209538; Vroling H, 2018, J VIRAL HEPATITIS, V25, P1406, DOI 10.1111/jvh.12998	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245896	10.1371/journal.pone.0245896	http://dx.doi.org/10.1371/journal.pone.0245896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571196	Green Published, gold			2022-12-26	WOS:000618274000069
J	Li, MX; Qiang, J; Bao, JW; Tao, YF; Zhu, HJ; Xu, P				Li, Ming Xiao; Qiang, Jun; Bao, Jing Wen; Tao, Yi Fan; Zhu, Hao Jun; Xu, Pao			Growth performance, physiological parameters, and transcript levels of lipid metabolism-related genes in hybrid yellow catfish (Tachysurus fulvidraco female x Pseudobagrus vachellii male) fed diets containing Siberian ginseng	PLOS ONE			English	Article							1,25-DIHYDROXYVITAMIN D-3; EXPRESSION; DISEASE; SUPPLEMENTATION; ACID; OVEREXPRESSION; EXTRACT; 3T3-L1; LIPASE; PLASMA	In high-density aquaculture, fish health can suffer because of excessive feeding, which causes fatty liver disease. Siberian ginseng (Acanthopanax senticosus) has been used as a feed additive to promote animal growth, immunity, and lipid metabolism. In this study, we explored the effects of A. senticosus on the physiology of hybrid yellow catfish (Tachysurus fulvidraco female x Pseudobagrus vachellii male). A control group and five groups fed diets containing A. senticosus (0.5, 1, 2, 4, and 8 g A. senticosus/kg feed) were established and maintained for 8 weeks. Dietary supplementation with A. senticosus at 4 g/kg promoted growth of the hybrid yellow catfish. Serum total cholesterol (TC) and triacylglycerol (TG) levels at 2 g/kg A. senticosus (TC: 1.31 mmol/L; TG: 1.08 mmol/L) were significantly lower than in the control group (TC: 1.51 mmol/L; TG: 1.41 mmol/L), and 4 g/kg A. senticosus (17.20 mu mol/g tissue) reduced the liver TG level compared with the control group (21.36 mu mol/g tissue) (P <0.05). Comparative transcriptomic analysis of liver tissue between the control group and the group showing optimum growth (4 g/kg A. senticosus) revealed 820 differentially expressed genes and 44 significantly enriched pathways, especially lipid metabolism pathways such as unsaturated fatty acid and fatty acid metabolism. The transcript levels of five lipid metabolism-related genes were determined by quantitative real-time PCR. The results showed that 2-4 g/kg A. senticosus supplementation reduced the FADS2, ELOVL2, CYP24a, and PLPP3 transcript levels and 4 g/kg A. senticosus increased the DIO2 transcript level (P <0.05), leading to altered synthesis of TG and thyroxine and reduced fat deposition in the liver. Our results show that dietary A. senticosus affects the regulation of fat metabolism and promotes the growth of hybrid yellow catfish. A. senticosus is a healthy feed additive, and the appropriate dietary supplementation rate is 2-4 g/kg.	[Li, Ming Xiao; Xu, Pao] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China; [Qiang, Jun; Bao, Jing Wen; Tao, Yi Fan; Zhu, Hao Jun; Xu, Pao] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fishes & Germplasm Resources U, Minist Agr, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Xu, P (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fishes & Germplasm Resources U, Minist Agr, Wuxi, Jiangsu, Peoples R China.	Xup@ffrc.cn		LI, Mingxiao/0000-0003-1295-6811	Natural Science Foundation of Jiangsu Province, China [BK20181137]; Project of Six Talent Peaks in Jiangsu Province [NY-133]; Chinese Academy of Fishery Sciences [2020TD37]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Project of Six Talent Peaks in Jiangsu Province; Chinese Academy of Fishery Sciences	This work was supported financially by the Natural Science Foundation of Jiangsu Province, China [Grant no. BK20181137], Project of Six Talent Peaks in Jiangsu Province (NY-133) and the Chinese Academy of Fishery Sciences (Project 2020TD37). Funding was awarded to JQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; [Anonymous], 2002, NEPHROL DIAL TRANSPL, V17, P63; [Anonymous], 2004, CHIN J AGR BIOTECHNO; [Anonymous], 2009, JT COMM PERSPECT, V28, P11; [Anonymous], 2020, CHINA FISHERY STAT Y; Bae YJ, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0547-x; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Bradley D, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/2464652; Chen QL, 2015, COMP BIOCHEM PHYS B, V184, P19, DOI 10.1016/j.cbpb.2015.02.004; Chen QL, 2013, ARCH ENVIRON CON TOX, V64, P301, DOI 10.1007/s00244-012-9835-7; Chen RZ, 2011, FOOD CHEM, V127, P434, DOI 10.1016/j.foodchem.2010.12.143; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Du ZY, 2006, AQUACULT INT, V14, P247, DOI 10.1007/s10499-005-9029-7; Du ZY, 2006, BRIT J NUTR, V95, P905, DOI 10.1079/BJN20061733; Espe M, 2010, AMINO ACIDS, V39, P449, DOI 10.1007/s00726-009-0461-2; Fang J, 2009, LIVEST SCI, V123, P268, DOI 10.1016/j.livsci.2008.11.020; Gabriel NN, 2015, FISH SHELLFISH IMMUN, V44, P504, DOI 10.1016/j.fsi.2015.03.002; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Huang Kai, 2007, Journal of Fishery Sciences of China, V14, P257; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jung J, 2003, PLANTA MED, V69, P610, DOI 10.1055/s-2003-41127; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kobayashi T, 2007, FEBS LETT, V581, P3157, DOI 10.1016/j.febslet.2007.05.081; Komprda T, 2014, CZECH J ANIM SCI, V59, P391, DOI 10.17221/7650-CJAS; Lee SY, 2004, ARCH PHARM RES, V27, P106, DOI 10.1007/BF02980055; [雷燕妮 Lei Yanni], 2014, [动物医学进展, Progress in Veterinary Medicine], V35, P64; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D., 2016, PROG VET MED, V37, P114, DOI [DOI 10.3969/J.ISSN.1007-5038.2016.01.026, 10.16437/j.cnki.1007-5038.2016.01.026, DOI 10.16437/J.CNKI.1007-5038.2016.01.026]; Li KS, 2015, COMP BIOCHEM PHYS B, V190, P16, DOI 10.1016/j.cbpb.2015.08.006; Li MX, 2019, ANIM NUTR, V31, P5801, DOI [10.3969/j.issn.1006-267x.2019.12.046, DOI 10.3969/J.ISSN.1006-267X.2019.12.046]; Li XZ, 2013, PHYTOMEDICINE, V20, P1219, DOI 10.1016/j.phymed.2013.06.002; Liu HW, 2011, AGR SCI CHINA, V10, P1262, DOI 10.1016/S1671-2927(11)60118-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Lu KL, 2013, FISHERIES SCI, V79, P661, DOI 10.1007/s12562-013-0635-4; Luo Z, 2016, COMP BIOCHEM PHYS B, V202, P1, DOI 10.1016/j.cbpb.2016.07.005; Ma XY, 2015, FISH PHYSIOL BIOCHEM, V41, P937, DOI 10.1007/s10695-015-0059-4; Ma XY, 2019, CHINA ANIM HUSB VET, V46, P652; Mu YN, 2020, FISH SHELLFISH IMMUN, V98, P738, DOI 10.1016/j.fsi.2019.11.021; Mueller PA, 2019, ARTERIOSCL THROM VAS, V39, P2261, DOI 10.1161/ATVBAHA.119.313056; NAYAK PK, 1987, J PINEAL RES, V4, P387, DOI 10.1111/j.1600-079X.1987.tb00878.x; Nguyen TM, 2004, J BIOL CHEM, V279, P7591, DOI 10.1074/jbc.M309517200; Panyod S, 2020, J TRADIT COMPL MED, V10, P260, DOI 10.1016/j.jtcme.2020.02.008; Park SH, 2006, ARCH PHARM RES, V29, P768, DOI 10.1007/BF02974078; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Pirgon O, 2013, OBES RES CLIN PRACT, V7, pE275, DOI 10.1016/j.orcp.2012.01.004; Qiang J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224995; Qiang J, 2019, FISH SHELLFISH IMMUN, V92, P395, DOI 10.1016/j.fsi.2019.06.026; Qiang J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01422; Rohrbach T, 2017, CRIT REV BIOCHEM MOL, V52, P543, DOI 10.1080/10409238.2017.1337706; Ruan G., 2005, FEED IND, V26, P34, DOI [10.3969/j.issn.1001-991X.2005.24.010, DOI 10.3969/J.ISSN.1001-991X.2005.24.010]; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; [睢大员 Sui Dayuan], 2004, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V30, P56; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Tan XY, 2009, AQUACULTURE, V296, P96, DOI 10.1016/j.aquaculture.2009.08.001; Tao YF, 2018, GENE, V660, P1, DOI 10.1016/j.gene.2018.03.064; Taylor JF, 2019, COMP BIOCHEM PHYS B, V227, P106, DOI 10.1016/j.cbpb.2018.10.004; Goncalves AT, 2014, COMP BIOCHEM PHYS B, V176, P9, DOI 10.1016/j.cbpb.2014.07.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varet H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157022; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wang XX, 2015, AQUAC RES, V46, P272, DOI 10.1111/are.12176; Xiong YY, 2014, AQUACULTURE, V433, P299, DOI 10.1016/j.aquaculture.2014.06.009; Yamazaki T, 2007, TOXICOL IN VITRO, V21, P1530, DOI 10.1016/j.tiv.2007.04.016; Yan FuYong, 2010, Scientia Agricultura Sinica, V43, P4490; Yi JM, 2001, CLIN CHIM ACTA, V312, P163, DOI 10.1016/S0009-8981(01)00613-1; Yi JM, 2002, J ETHNOPHARMACOL, V79, P347, DOI 10.1016/S0378-8741(01)00403-2; Yin GJ, 2009, FISH SHELLFISH IMMUN, V26, P140, DOI 10.1016/j.fsi.2008.08.015; Yu Ming-chao, 2010, Journal of Tropical Oceanography, V29, P132; [周歧存 Zhou Qicun], 2004, [水产学报, Journal of Fisheries of China], V28, P155; Zhuang HL, 2007, CHEM-BIOL INTERACT, V170, P114, DOI 10.1016/j.cbi.2007.07.012	72	3	3	10	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246417	10.1371/journal.pone.0246417	http://dx.doi.org/10.1371/journal.pone.0246417			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571255	Green Published, gold			2022-12-26	WOS:000618274000008
J	Madewell, ZJ; Chacon-Fuentes, R; Jara, J; Mejia-Santos, H; Molina, IB; Alvis-Estrada, JP; Espinal, R				Madewell, Zachary J.; Chacon-Fuentes, Rafael; Jara, Jorge; Mejia-Santos, Homer; Molina, Ida-Berenice; Alvis-Estrada, Juan Pablo; Espinal, Raul			Knowledge, attitudes, and practices of seasonal influenza vaccination among older adults in nursing homes and daycare centers, Honduras	PLOS ONE			English	Article							ELDERLY-PEOPLE; IMPACT	Background Older adults represent 70-90% of seasonal influenza-related deaths and 50-70% of influenza-related hospitalizations. Vaccination is the most efficient means of preventing influenza and reducing influenza-related illnesses. We aimed to describe knowledge, attitudes, and practices (KAP) of seasonal influenza vaccination among older adults in Honduras. Methods From August 29-October 26, 2018, we conducted a cross-sectional KAP survey regarding seasonal influenza vaccinations to samples of older adults 1) admitted to nursing homes and 2) attending daycare centers. We used the Minimental State Examination (MMSE) psychometric tool to assess the cognitive status of older adults and included participants with scores of >= 23 points in the survey. We reported frequency distributions for demographics, KAP of influenza virus and vaccination, and vaccination coverage. We used logistic regression to analyze associations between demographics and verified influenza vaccination. Results Of 511 MMSE participants, 341 completed the survey (95 adults in 12 nursing homes and 246 older adults in ten daycare centers). Almost all participants knew that influenza causes severe illness and may be transmitted from person to person, vaccination is safe and protects against disease, and older adults have greater risk of complications. Of 284 participants with verified vaccinations, 81.3% were vaccinated for influenza: 87.9% attending daycare centers and 61.4% in nursing homes. Among all participants, verified current influenza vaccination was associated with self-reported influenza vaccination in previous year (aOR: 14.05; 95% CI: 5.36-36.81); no formal education (aOR: 4.83; 95% CI: 1.63-14.37) or primary school education (aOR: 4.51; 95% CI: 1.79-11.37) having >= secondary as reference; and indigenous (aOR: 4.55; 95% CI: 1.18-17.49) having Mestizo as reference. Reasons for vaccination were perceived self-benefits, protection against influenza complications, favorable vaccination hours, and healthcare provider recommendations. Conclusion Four-fifths of older adults were vaccinated for seasonal influenza. Educational efforts provided in conjunction with vaccination campaigns resulted in high knowledge of influenza virus, transmission, and vaccination. Further outreach regarding disease risks and vaccine safety needs to be directed towards older adults in nursing homes who had lower knowledge and coverage than older adults in daycare centers.	[Madewell, Zachary J.; Chacon-Fuentes, Rafael; Jara, Jorge; Alvis-Estrada, Juan Pablo] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Mejia-Santos, Homer] Secretaria Salud Honduras, Unidad Vigilancia Salud, Tegucigalpa, Honduras; [Molina, Ida-Berenice] Secretaria Salud Honduras, Programa Ampliado Inmunizac, Tegucigalpa, Honduras; [Espinal, Raul] Secretaria Estado Despachos Interior & Poblac Hon, Direcc Gen Adulto Mayor, Tegucigalpa, Honduras	Universidad del Valle de Guatemala	Madewell, ZJ (corresponding author), Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala.	zmadewell@ufl.edu	Madewell, Zachary/AAM-4921-2020	Madewell, Zachary/0000-0002-5667-9660; Alvis-Estrada, Juan/0000-0002-1226-9344	Centers for Disease Control and Prevention [5U01GH00100305]; Fogarty International Center of the National Institutes of Health [D43TW009343]; University of California Global Health Institute	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute	This work was supported by the Centers for Disease Control and Prevention under CDCUVG cooperative agreement No. 5U01GH00100305. ZM was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW009343 and the University of California Global Health Institute.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Armstrong K, 1999, J GEN INTERN MED, V14, P695, DOI 10.1046/j.1525-1497.1999.11098.x; Azziz-Baumgartner E, 2015, EMERG INFECT DIS, V21, P1209, DOI 10.3201/eid2107.140788; Tran BX, 2018, PATIENT PREFER ADHER, V12, P1717, DOI 10.2147/PPA.S171362; Badilla X, 2018, CONOCIMIENTOS ACTITU; Biblioteca Virtual en Salud Honduras, 2013, PROGR AMPL INM SECR; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Centers for Disease Control and Prevention, 2018, NIS CHILD DAT DOC 20; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Dardalas I, 2019, AGING CLIN EXPT RES, P1; de Andrade FB, 2017, HUM VACC IMMUNOTHER, V13, P103, DOI 10.1080/21645515.2016.1228501; Direccion General del Adulto Mayor, 2013, LIST HOG AT AD MAYOR; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Dyda A, 2015, VACCINE, V33, P3299, DOI 10.1016/j.vaccine.2015.05.046; Gazibara T, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-018-0159-8; Gobierno de la Republica de Honduras, 2019, HAC SAL UN LOGR AV D; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Kan T, 2018, PUBLIC HEALTH, V156, P67, DOI 10.1016/j.puhe.2017.12.007; Korkmaz P, 2019, CENT EUR J PUBL HEAL, V27, P44, DOI 10.21101/cejph.a5231; Llamas-Velasco S, 2015, REV NEUROLOGIA, V61, P363, DOI 10.33588/rn.6108.2015107; Mejia DHM, 2017, ESTIMACION CARGA MED; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Nichol KL, 2005, DRUG AGING, V22, P495, DOI 10.2165/00002512-200522060-00004; Nowalk MP, 2004, J AM GERIATR SOC, V52, P25, DOI 10.1111/j.1532-5415.2004.52006.x; Pan American Health Organization, 2018, INFL VACC COV; Pan American Health Organization, 2019, 6 VACC CAMP SEAS INF; Pan American Health Organization, 2013, SE REV POL NAC AD MA; Pan American Health Organization, 2017, COUNTR REP HOND; Pan American Health Organization, 2018, LEY VAC REP HOND GAR; Pan American Health Organization, 2016, WHO PAHO REG M SEAS; Pan American Health Organization, 2018, SAL IN VAC INFL GRUP; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; Rikin S, 2018, J COMMUN HEALTH, V43, P201, DOI 10.1007/s10900-017-0404-x; Ropero-Alvarez A, 2014, GLOBAL VACCINE IMMUN, P4; Ropero-Alvarez AM, 2016, HUM VACC IMMUNOTHER, V12, P2206, DOI 10.1080/21645515.2016.1157240; Ryu SY, 2011, INT J ENV RES PUB HE, V8, P4197, DOI 10.3390/ijerph8114197; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Secretaria de Desarrollo e Inclusion Social, 2016, POL NAC ENV AD MAYOR; Secretaria de Desarrollo e Inclusion Social, 2015, PLAN ACC ENV ACT SAL; Secretaria de Salud de Honduras, 2010, MULT PLAN EXP PROGR; Secretaria de Salud de Honduras, 2018, 4 AN EST VIG LEY VAC; Secretaria de Salud de Honduras, 2015, EST CARG MED INFL HO; Smetana J, 2018, HUM VACC IMMUNOTHER, V14, P540, DOI 10.1080/21645515.2017.1343226; Thomas RE, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005188.pub4; Wendlandt R, 2018, VACCINE, V36, P2673, DOI 10.1016/j.vaccine.2018.03.052; World Bank, 2019, WORLD BANK ZAMB; World Health Organization, 2018, INFL SEAS; Wu SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017459; Zimmerman RK, 2004, AM J PREV MED, V26, P1, DOI 10.1016/j.amepre.2003.09.020; Zimmerman RK, 2003, AM J MED, V114, P31, DOI 10.1016/S0002-9343(02)01421-3	51	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246382	10.1371/journal.pone.0246382	http://dx.doi.org/10.1371/journal.pone.0246382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571242	Green Published, gold			2022-12-26	WOS:000618274000029
J	Li, XL; Su, X; Liu, R; Pan, YS; Fang, JK; Cao, LJ; Feng, C; Shang, QW; Chen, YJ; Shao, CS; Shi, YF				Li, Xiaolei; Su, Xiao; Liu, Rui; Pan, Yongsha; Fang, Jiankai; Cao, Lijuan; Feng, Chao; Shang, Qianwen; Chen, Yongjing; Shao, Changshun; Shi, Yufang			HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression	ONCOGENE			English	Article								Despite the widespread use of the blockade of immune checkpoints, for a significant number of cancer patients, these therapies have proven ineffective, presumably due to the immunosuppressive nature of the tumor microenvironment (TME). Critical drivers of immune escape in the TME include tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), which not only mediate immune suppression, but also facilitate metastatic dissemination and impart resistance to immunotherapies. Thus, strategies that convert them into tumor fighters may offer great therapeutic potential. In this study, we evaluated whether pharmacologic modulation of macrophage phenotype by HDAC inhibitors (HDACi) could produce an anti-tumor effect. We demonstrated that low-dose HDACi trichostatin-A (TSA) markedly reshaped the tumor immune microenvironment by modulating the suppressive activity of infiltrating macrophages and inhibiting the recruitment of MDSCs in various tumors. These actions, in turn, augmented anti-tumor immune responses and further enhanced anti-tumor effects of immunotherapies. HDAC inhibition, however, also upregulated PD-L1, thereby limiting the beneficial therapeutic effects. Indeed, combining low-dose TSA with anti-PD-L1 in this model significantly enhanced the durability of tumor reduction and prolonged survival of tumor-bearing mice, compared with the effect of either treatment alone. These data introduce HDAC inhibition as a potential means to harness the anti-tumor potential of macrophages in cancer therapy.	[Li, Xiaolei; Su, Xiao; Liu, Rui; Pan, Yongsha; Fang, Jiankai; Cao, Lijuan; Feng, Chao; Shang, Qianwen; Chen, Yongjing; Shao, Changshun; Shi, Yufang] Soochow Univ, Affiliated Hosp 1, State Key Lab Radiat Med & Protect, Inst Translat Med,Med Coll, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Shao, CS; Shi, YF (corresponding author), Soochow Univ, Affiliated Hosp 1, State Key Lab Radiat Med & Protect, Inst Translat Med,Med Coll, Suzhou 215123, Jiangsu, Peoples R China.	shaoc@suda.edu.cn; yfshi@suda.edu.cn	Shi, Yufang/AAE-4431-2020; li, Xiaolei/V-1383-2019; Shao, Changshun/AAD-8977-2022	Shi, Yufang/0000-0001-8964-319X; li, Xiaolei/0000-0002-2697-6496; Shao, Changshun/0000-0003-2618-9342	National Natural Science Foundation of China [81930085, 81672797, 81530043]; National Key R&D Program of China [2018YFA0107500]; State Key Laboratory of Radiation Medicine and Protection, Soochow University [GZN1201804, GZN1201903]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [20KJB180005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; State Key Laboratory of Radiation Medicine and Protection, Soochow University; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81930085, 81672797, and 81530043), National Key R&D Program of China (2018YFA0107500), State Key Laboratory of Radiation Medicine and Protection, Soochow University (GZN1201804 and GZN1201903), and The Natural Science Foundation of the Jiangsu Higher Education Institutions of China (20KJB180005).	Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Armeanu S, 2005, CANCER RES, V65, P6321, DOI 10.1158/0008-5472.CAN-04-4252; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Cao K, 2015, ONCOGENE, V34, P5960, DOI 10.1038/onc.2015.46; Christiansen AJ, 2011, P NATL ACAD SCI USA, V108, P4141, DOI 10.1073/pnas.1011037108; Cittera E, 2007, J IMMUNOL, V178, P6616, DOI 10.4049/jimmunol.178.10.6616; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; Cui SN, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105973; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; Flores-Toro JA, 2020, P NATL ACAD SCI USA, V117, P1129, DOI 10.1073/pnas.1910856117; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Gul N, 2015, CANCER RES, V75, P5008, DOI 10.1158/0008-5472.CAN-15-1330; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Kim YD, 2020, J CANCER, V11, P4059, DOI 10.7150/jca.44622; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Laengle J, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000195; Li XL, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1102-3; Li XL, 2019, CELL MOL IMMUNOL, V16, P28, DOI 10.1038/s41423-018-0086-z; Li XL, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0578-4; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Lu ZH, 2020, NATURE, V579, P284, DOI 10.1038/s41586-020-2054-x; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Morel D, 2020, NAT REV CLIN ONCOL, V17, P91, DOI 10.1038/s41571-019-0267-4; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nguyen A, 2018, CELL REP, V24, P642, DOI 10.1016/j.celrep.2018.06.040; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Nywening TM, 2018, GUT, V67, P1112, DOI 10.1136/gutjnl-2017-313738; Orillion A, 2017, CLIN CANCER RES, V23, P5187, DOI 10.1158/1078-0432.CCR-17-0741; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Topper MJ, 2020, NAT REV CLIN ONCOL, V17, P75, DOI 10.1038/s41571-019-0266-5; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; VANROOIJEN N, 1988, VIRCHOWS ARCH B, V54, P241; Xie ZQ, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1734268; Xiong HZ, 2019, CANCER RES, V79, P1493, DOI 10.1158/0008-5472.CAN-18-3208; Yau HL, 2019, TRENDS CELL BIOL, V29, P31, DOI 10.1016/j.tcb.2018.07.006	55	32	32	4	26	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1836	1850		10.1038/s41388-020-01636-x	http://dx.doi.org/10.1038/s41388-020-01636-x		FEB 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564072	Green Published, hybrid			2022-12-26	WOS:000616489100003
J	Dawkins, BA; Le, TT; McKinney, BA				Dawkins, Bryan A.; Le, Trang T.; McKinney, Brett A.			Theoretical properties of distance distributions and novel metrics for nearest-neighbor feature selection	PLOS ONE			English	Article								The performance of nearest-neighbor feature selection and prediction methods depends on the metric for computing neighborhoods and the distribution properties of the underlying data. Recent work to improve nearest-neighbor feature selection algorithms has focused on new neighborhood estimation methods and distance metrics. However, little attention has been given to the distributional properties of pairwise distances as a function of the metric or data type. Thus, we derive general analytical expressions for the mean and variance of pairwise distances for L-q metrics for normal and uniform random data with p attributes and m instances. The distribution moment formulas and detailed derivations provide a resource for understanding the distance properties for metrics and data types commonly used with nearest-neighbor methods, and the derivations provide the starting point for the following novel results. We use extreme value theory to derive the mean and variance for metrics that are normalized by the range of each attribute (difference of max and min). We derive analytical formulas for a new metric for genetic variants, which are categorical variables that occur in genome-wide association studies (GWAS). The genetic distance distributions account for minor allele frequency and the transition/transversion ratio. We introduce a new metric for resting-state functional MRI data (rs-fMRI) and derive its distance distribution properties. This metric is applicable to correlation-based predictors derived from time-series data. The analytical means and variances are in strong agreement with simulation results. We also use simulations to explore the sensitivity of the expected means and variances in the presence of correlation and interactions in the data. These analytical results and new metrics can be used to inform the optimization of nearest neighbor methods for a broad range of studies, including gene expression, GWAS, and fMRI data.	[Dawkins, Bryan A.] Oklahoma Med Res Fdn, Genes & Human Dis, Oklahoma City, OK 73104 USA; [Le, Trang T.] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [McKinney, Brett A.] Univ Tulsa, Dept Math, Tulsa, OK 74104 USA; [McKinney, Brett A.] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA	Oklahoma Medical Research Foundation; University of Pennsylvania; University of Tulsa; University of Tulsa	McKinney, BA (corresponding author), Univ Tulsa, Dept Math, Tulsa, OK 74104 USA.; McKinney, BA (corresponding author), Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA.	brett.mcKinney@gmail.com		McKinney, Brett/0000-0002-9494-8833; Le, Trang/0000-0003-3737-6565	National Institute of Health [GM121312]; William K. Warren Jr.	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William K. Warren Jr.	This work was supported in part by the National Institute of Health GM121312 and the William K. Warren Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabnejad M, 2018, BIODATA MIN, V11, DOI 10.1186/s13040-018-0186-4; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Chatterjee S, 2014, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-3-319-03886-5_1; Cramer H., 1999, MATH METHODS STAT, V1; Dickie DA, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00001; Gotts SJ, 2012, BRAIN, V135, P2711, DOI 10.1093/brain/aws160; GUMBEL EJ, 1947, ANN MATH STAT, V18, P384, DOI 10.1214/aoms/1177730387; Hay E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005410; Khan MJ, 2021, EGYPT INFORM J, V22, P201, DOI 10.1016/j.eij.2020.08.002; Khan MJ, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8040519; Lareau CA, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0040-x; Le TT, 2020, BIOINFORMATICS, V36, P2770, DOI 10.1093/bioinformatics/btaa024; Le TT, 2019, BIOINFORMATICS, V35, P1358, DOI 10.1093/bioinformatics/bty788; Le TT, 2017, BIOINFORMATICS, V33, P2906, DOI 10.1093/bioinformatics/btx298; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; LIU H, 2019, PLOS ONE, V14; McKinney BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081527; Miller I, 2004, MATH STAT APPL, V7th; Parvandeh S, 2020, BIOINFORMATICS, V36, P3093, DOI 10.1093/bioinformatics/btaa046; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Sundermann B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00692; Urbanowicz RJ, 2018, J BIOMED INFORM, V85, P168, DOI 10.1016/j.jbi.2018.07.015; Urbanowicz RJ, 2018, J BIOMED INFORM, V85, P189, DOI 10.1016/j.jbi.2018.07.014; Venkataraman Archana, 2010, Conf Comput Vis Pattern Recognit Workshops, P63; Vergun S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00038; Victor TA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016620; Wang DF, 2018, GENOM PROTEOM BIOINF, V16, P320, DOI 10.1016/j.gpb.2018.08.003; Wasserman L., 2004, ALL STAT CONCISE COU, V26	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246761	10.1371/journal.pone.0246761	http://dx.doi.org/10.1371/journal.pone.0246761			67	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556091	gold, Green Published, Green Submitted			2022-12-26	WOS:000617379900063
J	Noh, J; Danuser, G				Noh, Jungsik; Danuser, Gaudenz			Estimation of the fraction of COVID-19 infected people in US states and countries worldwide	PLOS ONE			English	Article								Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, daily counts of confirmed cases and deaths have been publicly reported in real-time to control the virus spread. However, substantial undocumented infections have obscured the true size of the currently infected population, which is arguably the most critical number for public health policy decisions. We developed a machine learning framework to estimate time courses of actual new COVID-19 cases and current infections in all 50 U.S. states and the 50 most infected countries from reported test results and deaths. Using published epidemiological parameters, our algorithm optimized slowly varying daily ascertainment rates and a time course of currently infected cases each day. Severe under-ascertainment of COVID-19 cases was found to be universal across U.S. states and countries worldwide. In 25 out of the 50 countries, actual cumulative cases were estimated to be 5-20 times greater than the confirmed cases. Our estimates of cumulative incidence were in line with the existing seroprevalence rates in 46 U.S. states. Our framework projected for countries like Belgium, Brazil, and the U.S. that similar to 10% of the population has been infected once. In the U.S. states like Louisiana, Georgia, and Florida, more than 4% of the population was estimated to be currently infected, as of September 3, 2020, while in New York this fraction is 0.12%. The estimation of the actual fraction of currently infected people is crucial for any definition of public health policies, which up to this point may have been misguided by the reliance on confirmed cases.	[Noh, Jungsik; Danuser, Gaudenz] Univ Texas Southwestern Med Ctr Dallas, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Noh, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA.	jungsik.noh@utsouthwestern.edu		Danuser, Gaudenz/0000-0001-8583-2014; Noh, Jungsik/0000-0003-1823-8589	Lyda Hill Philanthropies	Lyda Hill Philanthropies	This work was supported by Lyda Hill Philanthropies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Centers for Disease Control and Prevention, COMM LAB SER SURV DA; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Mallapaty S, 2020, NATURE, V582, P467, DOI 10.1038/d41586-020-01738-2; Noh J., ESTIMATION DAILY ASC; Olson DR, 2020, MMWR-MORBID MORTAL W, V69, P603, DOI 10.15585/mmwr.mm6919e5; Rosenberg ES, 2020, ANN EPIDEMIOL, V48, P23, DOI 10.1016/j.annepidem.2020.06.004; Shioda K, 2020, JAMA INTERN MED, V180, P1569, DOI 10.1001/jamainternmed.2020.5542; Struchiner C., 2020, REMARKABLE VARIABILI, DOI 10.1101/2020.05.30.20117531; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]	14	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246772	10.1371/journal.pone.0246772	http://dx.doi.org/10.1371/journal.pone.0246772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556142	Green Published, Green Submitted, gold			2022-12-26	WOS:000617379900014
J	Pei, M; Zou, DH; Gao, Y; Zhang, JH; Huang, P; Wang, JW; Huang, J; Li, ZD; Chen, YJ				Pei, Ming; Zou, Donghua; Gao, Yong; Zhang, Jianhua; Huang, Ping; Wang, Jiawen; Huang, Jiang; Li, Zhengdong; Chen, Yijiu			The influence of sample geometry and size on porcine aortic material properties from uniaxial tensile tests using custom-designed tissue cutters, clamps and molds	PLOS ONE			English	Article							BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; FAILURE PROPERTIES; DAMAGE EXPERIMENTS; ABDOMINAL AORTAS; ELASTIC-MODULUS; ANEURYSM; LAYER; STRENGTH; WALL	The aim of this study was to identify the influence of specimen geometry and size on the results of aortic uniaxial tensile tests using custom-designed tissue cutters, clamps and molds. Six descending thoracic aortas from pigs were used for rectangular sample tests, in which the circumferential and axial specimens had widths of 6 mm, 8 mm and 10 mm. The other six aortas were used for the dog-bone-shaped sample tests and were punched into circumferential, axial and oblique specimens with widths of 2 mm, 4 mm and 6 mm. We performed uniaxial tensile tests on the specimens and compared the test results. The results showed that mid-sample failure occurred in 85.2% of the dog-bone-shaped specimens and in 11.1% of the rectangular samples, which could be caused by Saint-Venant's principle. Therefore, rectangular specimens were not suitable for aortic uniaxial tensile testing performed until rupture. The results also showed that the size effect of the aorta conformed to Weibull theory, and dog-bone-shaped specimens with a width of 4 mm were the optimal choice for aortic uniaxial tensile testing performed until rupture.	[Pei, Ming; Chen, Yijiu] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Sichuan, Peoples R China; [Pei, Ming; Zou, Donghua; Zhang, Jianhua; Huang, Ping; Li, Zhengdong; Chen, Yijiu] Acad Forens Sci, Shanghai Key Lab Forens Med, Minist Justice, Shanghai, Peoples R China; [Pei, Ming] Xuzhou Publ Secur Bur, Inst Forens Sci, Xuzhou, Jiangsu, Peoples R China; [Zou, Donghua; Wang, Jiawen; Huang, Jiang] Guizhou Med Univ, Sch Forens Med, Guiyang, Guizhou, Peoples R China; [Gao, Yong] Univ Shanghai Sci & Technol, Sch Mech Engn, Shanghai, Peoples R China; [Li, Zhengdong] Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai, Peoples R China	Sichuan University; Institute of Forensic Science Ministry of Justice PRC; Guizhou Medical University; University of Shanghai for Science & Technology; Fudan University	Chen, YJ (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Sichuan, Peoples R China.; Li, ZD; Chen, YJ (corresponding author), Acad Forens Sci, Shanghai Key Lab Forens Med, Minist Justice, Shanghai, Peoples R China.; Li, ZD (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai, Peoples R China.	lizd@ssfjd.cn; cyj1347@163.com			Council of National Science Foundation of China [81701863, 81722027]; Shanghai Key Laboratory of Forensic Medicine [17DZ2273200]; Shanghai Forensic Service Platform [19DZ2290900]; Central Research Institute Public Project [GY2020G-4]; Opening Project of Shanghai Key Laboratory of Crime Scene Evidence [2019XCWZK03]; National Nature Science Foundation of China [81660309]	Council of National Science Foundation of China; Shanghai Key Laboratory of Forensic Medicine; Shanghai Forensic Service Platform; Central Research Institute Public Project; Opening Project of Shanghai Key Laboratory of Crime Scene Evidence; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Council of National Science Foundation of China (No. 81701863, 81722027), Shanghai Key Laboratory of Forensic Medicine (No.17DZ2273200), Shanghai Forensic Service Platform (No. 19DZ2290900), Central Research Institute Public Project (No. GY2020G-4), Opening Project of Shanghai Key Laboratory of Crime Scene Evidence (No. 2019XCWZK03) and National Nature Science Foundation of China (No.81660309). Xuzhou Xinyou Industrial Control Technology Development Co., LTD. provided support in designing and manufacturing the customized tools in this study. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulameer H, 2019, J VASC SURG, V69, P378, DOI 10.1016/j.jvs.2018.03.435; Ali AH, 2020, COMPOS PART B-ENG, V195, DOI 10.1016/j.compositesb.2020.108059; Amabili M, 2019, J MECH BEHAV BIOMED, V99, P27, DOI 10.1016/j.jmbbm.2019.07.008; Ambepitiya SGH, 2010, FORENSIC SCI MED PAT, V6, P121, DOI 10.1007/s12024-009-9137-1; Arnabili M, 2019, J MECH BEHAV BIOMED, V99, P186, DOI 10.1016/j.jmbbm.2019.07.010; Bank LC, 2006, PROPERTIES FRP REINF, P129; Benjeddou O, 2020, POLYM TEST, V86, DOI 10.1016/j.polymertesting.2020.106498; CAREW TE, 1968, CIRC RES, V23, P61, DOI 10.1161/01.RES.23.1.61; Danzer R, 2007, ENG FRACT MECH, V74, P2919, DOI 10.1016/j.engfracmech.2006.05.028; Danzer R, 2008, ADV ENG MATER, V10, P275, DOI 10.1002/adem.200700347; Di Martino ES, 2006, J VASC SURG, V43, P570, DOI 10.1016/j.jvs.2005.10.072; Duprey A, 2010, EUR J VASC ENDOVASC, V39, P700, DOI 10.1016/j.ejvs.2010.02.015; Ferrara A, 2016, J MECH BEHAV BIOMED, V53, P257, DOI 10.1016/j.jmbbm.2015.08.021; Garcia-Herrera CM, 2012, MED BIOL ENG COMPUT, V50, P559, DOI 10.1007/s11517-012-0876-x; Guinea GV, 2010, PHYSIOL MEAS, V31, P1553, DOI 10.1088/0967-3334/31/12/001; HE CM, 1994, J VASC SURG, V20, P6, DOI 10.1016/0741-5214(94)90169-4; Hibbeler R.C., 2011, STRESS CONCENTRATION, P158; Hibbeler R.C., 2011, SAINT VENANTS PRINCI, P119; Hiller RJ, 2010, EMERG MED J, V27, P368, DOI 10.1136/emj.2009.075978; Hollaway LC, 2010, CONSTR BUILD MATER, V24, P2419, DOI 10.1016/j.conbuildmat.2010.04.062; Holzapfel GA, 2006, J THEOR BIOL, V238, P290, DOI 10.1016/j.jtbi.2005.05.006; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Kent KC, 2014, NEW ENGL J MED, V371, P2101, DOI 10.1056/NEJMcp1401430; Khanafer K, 2013, EUR J VASC ENDOVASC, V45, P332, DOI 10.1016/j.ejvs.2012.12.015; Khanafer K, 2011, J THORAC CARDIOV SUR, V142, P682, DOI 10.1016/j.jtcvs.2010.09.068; Li Y, 2015, J FORENSIC SCI, V60, P1206, DOI 10.1111/1556-4029.12768; MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0; Monteiro FNP, 2011, J FORENSIC SCI, V56, P1054, DOI 10.1111/j.1556-4029.2011.01748.x; Campillo BM, 2019, REV ESP CARDIOL, V72, P553, DOI 10.1016/j.rec.2018.07.008; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; Pichamuthu JE, 2013, ANN THORAC SURG, V96, P2147, DOI 10.1016/j.athoracsur.2013.07.001; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Pierce FT., 1926, J TEXT I, V17, P355; Raghavan ML, 2011, J BIOMECH, V44, P2501, DOI 10.1016/j.jbiomech.2011.06.004; Raghavan ML, 1996, ANN BIOMED ENG, V24, P573, DOI 10.1007/BF02684226; Reeps C, 2013, BIOMECH MODEL MECHAN, V12, P717, DOI 10.1007/s10237-012-0436-1; Ripple MG, 2008, AM J FOREN MED PATH, V29, P123, DOI 10.1097/PAF.0b013e318173f067; Rudinska LI, 2016, RESUSCITATION, V103, P66, DOI 10.1016/j.resuscitation.2016.04.002; Sang C, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039577; Sassani SG, 2015, J BIOMECH, V48, P3757, DOI 10.1016/j.jbiomech.2015.08.028; Sassani SG, 2015, J MECH BEHAV BIOMED, V49, P141, DOI 10.1016/j.jmbbm.2015.04.027; Schriefl AJ, 2012, J R SOC INTERFACE, V9, P1275, DOI 10.1098/rsif.2011.0727; SHEREBRIN MH, 1989, CAN J PHYSIOL PHARM, V67, P871, DOI 10.1139/y89-136; Sherifova S, 2019, ACTA BIOMATER, V99, P443, DOI 10.1016/j.actbio.2019.08.038; Shkrum MJ, 1999, J FORENSIC SCI, V44, P44; Sokolis DP, 2012, MED BIOL ENG COMPUT, V50, P1227, DOI 10.1007/s11517-012-0949-x; Sokolis DP, 2012, COMPUT METHOD BIOMEC, V15, P231, DOI 10.1080/10255842.2010.522186; Sommer G, 2016, J BIOMECH, V49, P2374, DOI 10.1016/j.jbiomech.2016.02.042; Srettabunjong S, 2018, J FORENSIC SCI, V63, P608, DOI 10.1111/1556-4029.13558; Sutherland LS, 1999, COMPOS SCI TECHNOL, V59, P209, DOI 10.1016/S0266-3538(98)00065-7; Teixeira PGR, 2011, J TRAUMA, V70, P197, DOI 10.1097/TA.0b013e3181df68b3; Teng ZZ, 2015, ANN BIOMED ENG, V43, P2745, DOI 10.1007/s10439-015-1323-6; Trlica J, 2019, EUR J TRAUMA EMERG S, V45, P943, DOI 10.1007/s00068-018-01063-4; Vallabhaneni SR, 2004, J ENDOVASC THER, V11, P494, DOI 10.1583/04-1239.1; VONMALTZAHN WW, 1984, J BIOMECH, V17, P839, DOI 10.1016/0021-9290(84)90142-8; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Walraevens J, 2008, MED ENG PHYS, V30, P1098, DOI 10.1016/j.medengphy.2008.01.006; Weibull W., 1939, STAT THEORY STRENGTH; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; XIE JP, 1995, J BIOMECH ENG-T ASME, V117, P136, DOI 10.1115/1.2792261; Xiong J, 2008, J VASC SURG, V48, P189, DOI 10.1016/j.jvs.2007.12.053; YU QL, 1993, AM J PHYSIOL, V265, pH52, DOI 10.1152/ajpheart.1993.265.1.H52	62	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0244390	10.1371/journal.pone.0244390	http://dx.doi.org/10.1371/journal.pone.0244390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556052	Green Published, gold			2022-12-26	WOS:000617379900019
J	Smart, JJ; Grammer, GL				Smart, Jonathan J.; Grammer, Gretchen L.			Modernising fish and shark growth curves with Bayesian length-at-age models	PLOS ONE			English	Article							VALIDATED AGE; HELICOLENUS-PERCOIDES; MULTIMODEL INFERENCE; ISURUS-OXYRINCHUS; SHORTFIN MAKO; LIFE-HISTORY; VARIABILITY; PARAMETERS; FRAMEWORK; PERCH	Growth modelling is a fundamental component of fisheries assessments but is often hindered by poor quality data from biased sampling. Several methods have attempted to account for sample bias in growth analyses. However, in many cases this bias is not overcome, especially when large individuals are under-sampled. In growth models, two key parameters have a direct biological interpretation: L-0, which should correspond to length-at-birth and L-infinity, which should approximate the average length of full-grown individuals. Here, we present an approach of fitting Bayesian growth models using Markov Chain Monte Carlo (MCMC), with informative priors on these parameters to improve the biological plausibility of growth estimates. A generalised framework is provided in an R package 'BayesGrowth', which removes the hurdle of programming an MCMC model for new users. Four case studies representing different sampling scenarios as well as three simulations with different selectivity functions were used to compare this Bayesian framework to standard frequentist growth models. The Bayesian models either outperformed or matched the results of frequentist growth models in all examples, demonstrating the broad benefits offered by this approach. This study highlights the impact that Bayesian models could provide in age and growth studies if applied more routinely rather than being limited to only complex or sophisticated applications.	[Smart, Jonathan J.; Grammer, Gretchen L.] SARDI Aquat Sci, West Beach, SA, Australia; [Smart, Jonathan J.; Grammer, Gretchen L.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia	University of Adelaide	Smart, JJ (corresponding author), SARDI Aquat Sci, West Beach, SA, Australia.; Smart, JJ (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.	jonathan.smart@sa.gov.au		Grammer, Gretchen/0000-0003-1605-8007; Smart, Jonathan/0000-0003-2070-3208				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alos J, 2010, ICES J MAR SCI, V67, P502, DOI 10.1093/icesjms/fsp265; [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.3777743; [Anonymous], 2019, R LANG ENV STAT COMP; Beverton R.J.H., 1957, FISH INVEST SER, P19; Bijak J, 2016, POP STUD-J DEMOG, V70, P1, DOI 10.1080/00324728.2015.1122826; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Caltabellotta FP, 2021, MAR FRESHWATER RES, V72, P432, DOI 10.1071/MF19370; Caltabellotta FP, 2019, J FISH BIOL, V95, P1236, DOI 10.1111/jfb.14123; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chambers MS, 2017, ECOL MODEL, V355, P1, DOI 10.1016/j.ecolmodel.2017.03.026; Dono F, 2015, ENVIRON BIOL FISH, V98, P517, DOI 10.1007/s10641-014-0284-1; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Emmons S, AGE GROWTH TIGER SHA; Farrell ED, 2010, ICES J MAR SCI, V67, P931, DOI 10.1093/icesjms/fsp295; FRANCIS RICC, 1990, J FISH BIOL, V36, P883, DOI 10.1111/j.1095-8649.1990.tb05636.x; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; Frater PN, 2020, FISH RES, V225, DOI 10.1016/j.fishres.2019.105464; Gabry J., 2020, BAYESPLOT PLOTTING B; Gelman A, 2020, LOO EFFICIENT LEAVE; Goldman KJ, 2012, CRC MAR BIOL SER, P423; Grant MI, 2018, MAR FRESHWATER RES, V69, P562, DOI 10.1071/MF17163; Gwinn DC, 2010, FISH RES, V105, P75, DOI 10.1016/j.fishres.2010.03.005; Haddon M., 2012, MODELLING QUANTITATI, V2nd; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; He JX, 2007, T AM FISH SOC, V136, P318, DOI 10.1577/T06-108.1; Helser TE, 2004, ECOL MODEL, V178, P399, DOI 10.1016/j.ecolmodel.2004.02.013; KAILOLA PJ, 1993, AUSTR FISHERIES RESO; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Link WA, 2002, J WILDLIFE MANAGE, V66, P277, DOI 10.2307/3803160; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; Matthias BG, 2018, FISH RES, V198, P209, DOI 10.1016/j.fishres.2017.08.018; McAuley RB, 2006, ENVIRON BIOL FISH, V77, P385, DOI 10.1007/s10641-006-9126-0; Morat F, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00711-y; Natanson LJ, 2006, ENVIRON BIOL FISH, V77, P367, DOI 10.1007/s10641-006-9127-z; Ogle DH, 2015, INTRODUCTORY FISHERI; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Paul LJ, 2009, FISH RES, V95, P169, DOI 10.1016/j.fishres.2008.08.011; Pavlov D.A., 2013, J ICHTHYOL, V53, P52, DOI DOI 10.1134/S0032945213010116; Pilling GM, 2002, CAN J FISH AQUAT SCI, V59, P424, DOI 10.1139/F02-022; Quince C, 2008, J THEOR BIOL, V254, P207, DOI 10.1016/j.jtbi.2008.05.030; Sammons SM, 2009, N AM J FISH MANAGE, V29, P101, DOI 10.1577/M07-140.1; Scherrer SR, 2021, FISH RES, V233, DOI 10.1016/j.fishres.2020.105753; Shertzer KW, 2017, FISH RES, V185, P83, DOI 10.1016/j.fishres.2016.09.032; Siegfried KI, 2006, ENVIRON BIOL FISH, V77, P301, DOI 10.1007/s10641-006-9112-6; Sigourney DB, 2012, ECOL MODEL, V247, P125, DOI 10.1016/j.ecolmodel.2012.08.009; Simpfendorfer CA, 2002, MAR FRESHWATER RES, V53, P567, DOI 10.1071/MF01131; Smart JJ, 2020, BAYESGROWTH ESTIMATE; Smart JJ, 2017, CORAL REEFS, V36, P577, DOI 10.1007/s00338-016-1533-x; Smart JJ, 2016, FISH FISH, V17, P955, DOI 10.1111/faf.12154; Smart JJ, 2013, AQUAT CONSERV, V23, P124, DOI 10.1002/aqc.2274; Stan Development Team, 2016, RSTAN R INT STAN; Stevens JD, 1984, OBSERVATIONS BIOL DI; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vincenzi S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003828; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Ward HGM, 2017, CAN J FISH AQUAT SCI, V74, P464, DOI 10.1139/cjfas-2016-0023; Ward T, 2007, REPORT 2002 061; White WT, 2018, SHARKS RAYS PAPUA NE; Wilson KL, 2019, J ANIM ECOL, V88, P717, DOI 10.1111/1365-2656.12965; Wilson KL, 2018, METHODS ECOL EVOL, V9, P822, DOI 10.1111/2041-210X.12931; WITHELL AF, 1988, AUST J MAR FRESH RES, V39, P441; Yokouchi K, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0269; Zhou SJ, 2020, ICES J MAR SCI, V77, P613, DOI 10.1093/icesjms/fsz241	66	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246734	10.1371/journal.pone.0246734	http://dx.doi.org/10.1371/journal.pone.0246734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556124	gold, Green Published			2022-12-26	WOS:000617379900004
J	Nielsen, MJ; Baines, P; Jennings, R; Siner, S; Kolamunnage-Dona, R; Newland, P; Peak, M; Chesters, C; Jeffers, G; Downey, C; Broughton, C; McColl, L; Preston, J; McKeever, A; Paulus, S; Cunliffe, N; Carrol, ED				Nielsen, Maryke J.; Baines, Paul; Jennings, Rebecca; Siner, Sarah; Kolamunnage-Dona, Ruwanthi; Newland, Paul; Peak, Matthew; Chesters, Christine; Jeffers, Graham; Downey, Colin; Broughton, Caroline; McColl, Lynsey; Preston, Jennifer; McKeever, Anthony; Paulus, Stephane; Cunliffe, Nigel; Carrol, Enitan D.			Procalcitonin, C-reactive protein, neutrophil gelatinase-associated lipocalin, resistin and the APTT waveform for the early diagnosis of serious bacterial infection and prediction of outcome in critically ill children	PLOS ONE			English	Article							PEDIATRIC SEVERE SEPSIS; ORGAN DYSFUNCTION; SEVERITY; COAGULATION; INFORMATION; BACTEREMIA; MORTALITY; SHOCK	Objective Bacterial Infections remains a leading cause of death in the Paediatric Intensive Care Unit (PICU). In this era of rising antimicrobial resistance, new tools are needed to guide antimicrobial use. The aim of this study was to investigate the accuracy of procalcitonin (PCT), neutrophil gelatinase-associated lipocalin (NGAL), resistin, activated partial thromboplastin time (aPTT) waveform and C-reactive protein (CRP) for the diagnosis of serious bacterial infection (SBI) in children on admission to PICU and their use as prognostic indicators. Setting A regional PICU in the United Kingdom. Patients Consecutive PICU admissions between October 2010 and June 2012. Measurements Blood samples were collected daily for biomarker measurement. The primary outcome measure was performance of study biomarkers for diagnosis of SBI on admission to PICU based on clinical, radiological and microbiological criteria. Secondary outcomes included durations of PICU stay and invasive ventilation and 28-day mortality. Patients were followed up to day 28 post-admission. Main results A total of 657 patients were included in the study. 92 patients (14%) fulfilled criteria for SBI. 28-day mortality was 2.6% (17/657), but 8.7% (8/92) for patients with SBI. The combination of PCT, resistin, plasma NGAL and CRP resulted in the greatest net reclassification improvement compared to CRP alone (0.69, p<0.005) with 10.5% reduction in correct classification of patients with SBI (p 0.52) but a 78% improvement in correct classification of patients without events (p <0.005). A statistical model of prolonged duration of PICU stay found log-transformed maximum values of biomarkers performed better than first recorded biomarkers. The final model included maximum values of CRP, plasma NGAL, lymphocyte and platelet count (AUC 79%, 95% CI 73.7% to 84.2%). Longitudinal profiles of biomarkers showed PCT levels to decrease most rapidly following admission SBI. Conclusion Combinations of biomarkers, including PCT, may improve accurate and timely identification of SBI on admission to PICU.	[Nielsen, Maryke J.; Broughton, Caroline; Paulus, Stephane; Cunliffe, Nigel; Carrol, Enitan D.] Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England; [Nielsen, Maryke J.] Malawi Liverpool Wellcome Trust Clin Res Facil, Blantyre, Malawi; [Nielsen, Maryke J.; Cunliffe, Nigel; Carrol, Enitan D.] Liverpool Hlth Partners, Liverpool, Merseyside, England; [Baines, Paul; Siner, Sarah] Crit Care Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Baines, Paul] Univ Birmingham, Med Eth Soc & Hist, Birmingham, W Midlands, England; [Jennings, Rebecca; Peak, Matthew] Alder Hey Childrens NHS Fdn Trust, Clin Res Business Unit, Liverpool, Merseyside, England; [Kolamunnage-Dona, Ruwanthi; Jeffers, Graham; Preston, Jennifer] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England; [Newland, Paul] Sidra Med, Dept Pathol, Doha, Qatar; [Chesters, Christine] Alder Hey Childrens NHS Fdn Trust, Clin Biochem, Liverpool, Merseyside, England; [Downey, Colin] Royal Liverpool & Broadgreen Univ Hosp Trust, Haematol, Liverpool, Merseyside, England; [McColl, Lynsey] Select Stat Serv, Exeter, Devon, England; [McKeever, Anthony] Univ Liverpool, Sch Med, Liverpool, Merseyside, England; [Cunliffe, Nigel] Alder Hey Childrens NHS Fdn Trust, Clin Microbiol, Liverpool, Merseyside, England; [Carrol, Enitan D.] Alder Hey Childrens NHS Fdn Trust, Dept Infect Dis, Liverpool, Merseyside, England	University of Liverpool; University of Birmingham; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Sidra Medical & Research Center; Alder Hey Children's NHS Foundation Trust; Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust	Nielsen, MJ (corresponding author), Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England.; Nielsen, MJ (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Facil, Blantyre, Malawi.; Nielsen, MJ (corresponding author), Liverpool Hlth Partners, Liverpool, Merseyside, England.	m.nielsen@liverpool.ac.uk		Nielsen, Maryke Joanne/0000-0001-7148-520X; Paulus, Stephane/0000-0002-0703-9114	NIHR Liverpool Biomedical Research Centre in Microbial Diseases; Alder Hey Charity; Wellcome Trust Research Training Fellowship [203919/Z/16/Z]; MRC [MR/M013227/1] Funding Source: UKRI	NIHR Liverpool Biomedical Research Centre in Microbial Diseases; Alder Hey Charity; Wellcome Trust Research Training Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded jointly by the NIHR Liverpool Biomedical Research Centre in Microbial Diseases and the Alder Hey Charity awarded to EC. MJN is supported by a Wellcome Trust Research Training Fellowship (award reference 203919/Z/16/Z). The funders had no role in the study design, data collection and analysis, decision to publics, or preparation of the manuscript.	[Anonymous], 2020, BIOMARKER GUIDED DUR; [Anonymous], 2003, OJ, V29, P55; Bjorkqvist M, 2004, ACTA PAEDIATR, V93, P534, DOI 10.1080/08035250410024754; Boeddha NP, 2018, MORTALITY MORBIDITY, P1; Carrol ED, 2005, CRIT CARE MED, V33, P224, DOI 10.1097/01.CCM.0000150742.57817.EE; Davidson J, 2013, PEDIATR RES, V74, P413, DOI 10.1038/pr.2013.124; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Dempfle CEH, 2004, CRIT CARE MED, V32, P520, DOI 10.1097/01.CCM.0000110678.52863.F3; Downey C, 1997, BRIT J HAEMATOL, V98, P68, DOI 10.1046/j.1365-2141.1997.1062972.x; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Folgori Laura, 2016, Lancet Infect Dis, V16, pe178, DOI 10.1016/S1473-3099(16)00069-4; Goldstein B, INT PEDIAT SEPSIS CO; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Irwin AD, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2853; Irwin AD, 2015, PEDIATRICS, V135, P635, DOI 10.1542/peds.2014-2061; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Mathot F, 2015, PEDIATR CRIT CARE ME, V16, P104, DOI 10.1097/PCC.0000000000000300; Nakvasina M.A., 2016, Vestn. Voronezh. Gos. Univ., Ser.: Khim., Biol., Farm., P67, DOI [DOI 10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]; Paize F, 2011, PEDIATR CRIT CARE ME, V12, pE322, DOI 10.1097/PCC.0b013e3182231034; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rey C, 2007, INTENS CARE MED, V33, P477, DOI 10.1007/s00134-006-0509-7; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stocker M, 2017, LANCET, V390, P871, DOI [10.1016/S0140-6736(17)31444-7, 10.1016/s0140-6736(17)31444-7]; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; Vassiliadi DA, 2012, J CRIT CARE, V27, P400, DOI 10.1016/j.jcrc.2012.04.007; Wang B, 2015, SHOCK, V44, P234, DOI 10.1097/SHK.0000000000000408; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246027	10.1371/journal.pone.0246027	http://dx.doi.org/10.1371/journal.pone.0246027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544738	Green Published, gold			2022-12-26	WOS:000617991900025
J	Schwaber, JL; Korbie, D; Andersen, S; Lin, E; Chrysanthopoulos, PK; Trau, M; Nielsen, LK				Schwaber, Jessica L.; Korbie, Darren; Andersen, Stacey; Lin, Erica; Chrysanthopoulos, Panagiotis K.; Trau, Matt; Nielsen, Lars K.			Network mapping of primary CD34+cells by Ampliseq based whole transcriptome targeted resequencing identifies unexplored differentiation regulatory relationships	PLOS ONE			English	Article							STIMULATING FACTOR-RECEPTOR; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; HUMAN-NEUTROPHILS; FLOW-CYTOMETRY; PROTEINS; CELLS; CHEMOTHERAPY; DEFICIENT; MORBIDITY	With the exception of a few master transcription factors, regulators of neutrophil maturation are poorly annotated in the intermediate phenotypes between the granulocyte-macrophage progenitor (GMP) and the mature neutrophil phenotype. Additional challenges in identifying gene expression regulators in differentiation pathways relate to challenges wherein starting cell populations are heterogeneous in lineage potential and development, are spread across various states of quiescence, as well as sample quality and input limitations. These factors contribute to data variability make it difficult to draw simple regulatory inferences. In response we have applied a multi-omics approach using primary blood progenitor cells primed for homogeneous proliferation and granulocyte differentiation states which combines whole transcriptome resequencing (Ampliseq RNA) supported by droplet digital PCR (ddPCR) validation and mass spectrometry-based proteomics in a hypothesis-generation study of neutrophil differentiation pathways. Primary CD34+ cells isolated from human cord blood were first precultured in non-lineage driving medium to achieve an active, proliferating phenotype from which a neutrophil primed progenitor was isolated and cultured in neutrophil lineage supportive medium. Samples were then taken at 24-hour intervals over 9 days and analysed by Ampliseq RNA and mass spectrometry. The Ampliseq dataset depth, breadth and quality allowed for several unexplored transcriptional regulators and ncRNAs to be identified using a combinatorial approach of hierarchical clustering, enriched transcription factor binding motifs, and network mapping. Network mapping in particular increased comprehension of neutrophil differentiation regulatory relationships by implicating ARNT, NHLH1, PLAG1, and 6 non-coding RNAs associated with PU.1 regulation as cell-engineering targets with the potential to increase total neutrophil culture output. Overall, this study develops and demonstrates an effective new hypothesis generation methodology for transcriptome profiling during differentiation, thereby enabling identification of novel gene targets for editing interventions.	[Schwaber, Jessica L.] Avectas, Toronto, ON, Canada; [Korbie, Darren; Lin, Erica; Trau, Matt; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Andersen, Stacey] Univ Queensland, Australian Inst Mol Biosci, St Lucia, Qld, Australia; [Chrysanthopoulos, Panagiotis K.] BlueRock Therapeut, Toronto, ON, Canada	University of Queensland; University of Queensland	Schwaber, JL (corresponding author), Avectas, Toronto, ON, Canada.	jessica.schwaber@gmail.com		ANDERSEN, Stacey/0000-0002-1741-2832; Schwaber, Jessica/0000-0003-4028-9462; Trau, Matt/0000-0001-5516-1280	Stem Cells Australia - the Australian Research Council Special Research Initiative in Stem Cell Science [SR110001002 LKN (2)]; National Breast Cancer Foundation [CG-12-07]	Stem Cells Australia - the Australian Research Council Special Research Initiative in Stem Cell Science(Australian Research Council); National Breast Cancer Foundation	This work was funded by: (1) Stem Cells Australia - the Australian Research Council Special Research Initiative in Stem Cell Science (http://www.stemcellsaustralia.edu.au) Grant Number: SR110001002 LKN (2) National Breast Cancer Foundation (https://www.nationalbreastcancer.org) Grant Number: CG-12-07 MT The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. Jessica Schwaber was employed by Avectas at the time of manuscript submission. Panos Chrysanthopoulos was employed by BlueRock Therapeutics at the time of manuscript submission. Jessica Schwaber conducted wet-lab, data analysis, and manuscript preparation work during post-doctoral work at AIBN, UQ. Minor manuscript editing was conducted while employed at AVROBIO as manager of manufacturing and at Avectas as director of cell and gene therapy. Panagiotis Chrysanthopoulos conducted wet-lab, data analysis and manuscript preparation work during post-doctoral work at AIBN, UQ. Minor manuscript editing was conducted while employed at BlueRock therapeutics as senior scientist. Jessica Schwaber and Panos Chrysanthopoulos received no specific funding for minor manuscript editing efforts listed above while employed at AVROBIO and BlueRock Therapeutics, respectively. The funder provided support in the form of salaries for authors Jessica Schwaber and Panagiotis Chrysanthopoulos, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; [Anonymous], 2015, Obstet Gynecol, V126, pe44, DOI 10.1097/AOG.0000000000001106; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; B D.F, 1992, DEV BIOL NEUTROPHILS, V2; Bao JX, 2000, DEVELOPMENT, V127, P425; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blay JY, 1996, J CLIN ONCOL, V14, P636, DOI 10.1200/JCO.1996.14.2.636; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Borregaard N, 1995, Clin Exp Immunol, V101 Suppl 1, P6; BOW EJ, 1994, CANCER-AM CANCER SOC, V74, P52, DOI 10.1002/1097-0142(19940701)74:1<52::AID-CNCR2820740110>3.0.CO;2-G; Brunck MEG, 2014, STEM CELL TRANSL MED, V3, P541, DOI 10.5966/sctm.2013-0145; Casado FL, 2010, BLOOD CELL MOL DIS, V44, P199, DOI 10.1016/j.bcmd.2010.01.005; Chabner BA, 1996, ANTICANCER DRUGS CAN, V4th, P325; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; CRAMER E, 1985, BLOOD, V65, P423; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Gorczyca W, 2011, METHOD CELL BIOL, V103, P221, DOI 10.1016/B978-0-12-385493-3.00010-3; Gratama JW, 1998, CYTOMETRY, V34, P128, DOI 10.1002/(SICI)1097-0320(19980615)34:3<128::AID-CYTO3>3.0.CO;2-D; Gullberg U, 1997, EUR J HAEMATOL, V58, P137; Hasegawa Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005428; Jagasia MH, 2005, BONE MARROW TRANSPL, V35, P1165, DOI 10.1038/sj.bmt.1704994; Kappler U, 2013, METALLOMICS, V5, P325, DOI 10.1039/c2mt20230a; Keeney M, 1998, CYTOMETRY, V34, P280, DOI 10.1002/(SICI)1097-0320(19981215)34:6<280::AID-CYTO6>3.0.CO;2-H; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Landrette SF, 2005, BLOOD, V105, P2900, DOI 10.1182/blood-2004-09-3630; Lecuyer E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703939200; LIPKOWITZ S, 1992, J BIOL CHEM, V267, P21065; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsumura K, 2017, ONCOGENE, V36, P1191, DOI 10.1038/onc.2016.282; Mora-Jensen H, 2011, J LEUKOCYTE BIOL, V90, P629, DOI 10.1189/jlb.0311123; Nielsen LK, 2007, AUSTRALIA2008; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Patz M, 2010, LEUKEMIA LYMPHOMA, V51, P1379, DOI 10.3109/10428194.2010.496016; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pruenster M, 2016, PHARMACOL THERAPEUT, V167, P120, DOI 10.1016/j.pharmthera.2016.07.015; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Salomon-Nguyen F, 2000, P NATL ACAD SCI USA, V97, P6757, DOI 10.1073/pnas.120162297; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Schwaber JL, 2016, CURR OPIN HEMATOL, V23, P72, DOI 10.1097/MOH.0000000000000205; Schwartzberg Lee S, 2006, Clin Cornerstone, V8 Suppl 5, pS5, DOI 10.1016/S1098-3597(06)80053-0; Scott C, 2014, AM J PHYSIOL-CELL PH, V307, pC349, DOI 10.1152/ajpcell.00306.2013; Shinjo K, 1997, LEUKEMIA LYMPHOMA, V25, P37, DOI 10.3109/10428199709042494; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Smith BW, 2013, BLOOD, V122, P376, DOI 10.1182/blood-2012-11-466722; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Tardif MR, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/296149; Thandapani P, 2015, ELIFE, V4, DOI 10.7554/eLife.06234; Timmins NE, 2009, BIOTECHNOL BIOENG, V104, P832, DOI 10.1002/bit.22433; Tonon L, 2010, NUCLEIC ACIDS RES, V38, pW286, DOI 10.1093/nar/gkq473; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Wood B, 2004, METHOD CELL BIOL, V75, P559; WRIGHT DG, 1979, J IMMUNOL, V123, P285; Yan SR, 2004, IMMUNOL CELL BIOL, V82, P435, DOI 10.1111/j.0818-9641.2004.01268.x; Yu X, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12329; Zeddies S, 2014, HAEMATOLOGICA, V99, P1555, DOI 10.3324/haematol.2014.106567; Zeng CW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-693; Zhang Y, 2015, J PROTEOME RES, V14, P4359, DOI 10.1021/acs.jproteome.5b00543; Ziglam HM, 2007, INT J ANTIMICROB AG, V29, P430, DOI 10.1016/j.ijantimicag.2006.12.009	70	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246107	10.1371/journal.pone.0246107	http://dx.doi.org/10.1371/journal.pone.0246107			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544756	Green Published, gold			2022-12-26	WOS:000617991900017
J	Benya, PD; Kavanaugh, A; Zakarian, M; Soderlind, P; Jashashvili, T; Zhang, NL; Waldorff, EI; Ryaby, JT; Billi, F				Benya, Paul D.; Kavanaugh, Aaron; Zakarian, Martin; Soderlind, Philip; Jashashvili, Tea; Zhang, Nianli; Waldorff, Erik, I; Ryaby, James T.; Billi, Fabrizio			Pulsed electromagnetic field (PEMF) transiently stimulates the rate of mineralization in a 3-dimensional ring culture model of osteogenesis	PLOS ONE			English	Article							IN-VITRO; BONE; DIFFERENTIATION; OSTEOBLAST; CELL; OSTEOCYTE	Pulsed Electromagnetic Field (PEMF) has shown efficacy in bone repair and yet the optimum characteristics of this modality and its molecular mechanism remain unclear. To determine the effects of timing of PEMF treatment, we present a novel three-dimensional culture model of osteogenesis that demonstrates strong de novo generation of collagen and mineral matrix and exhibits stimulation by PEMF in multiple stages over 62 days of culture. Mouse postnatal day 2 calvarial pre-osteoblasts were cast within and around Teflon rings by polymerization of fibrinogen and cultured suspended without contact with tissue culture plastic. Ring constructs were exposed to PEMF for 4h/day for the entire culture (Daily), or just during Day1-Day10, Day11-Day 27, or Day28-Day63 and cultured without PEMF for the preceding or remaining days, and compared to no-PEMF controls. PEMF was conducted as HF Physio, 40.85 kHz frequency with a 67 ms burst period and an amplitude of 1.19 mT. Osteogenesis was kinetically monitored by repeated fluorescence measurements of continuously present Alizarin Red S (ARS) and periodically confirmed by micro-CT. PEMF treatment induced early-onset and statistically significant transient stimulation (similar to 4-fold) of the mineralization rate when PEMF was applied Daily, or during D1-D10 and D11-D27. Stimulation was apparent but not significant between D28-D63 by ARS but was significant at D63 by micro-CT. PEMF also shifted the micro-CT density profiles to higher densities in each PEMF treatment group. Ring culture generated tissue with a mineral:matrix ratio of 2.0 by thermogravimetric analysis (80% of the calvaria control), and the deposited crystal structure was 50% hydroxyapatite by X-ray diffraction (63% of the calvaria and femur controls), independent of PEMF. These results were consistent with backscatter, secondary electron, and elemental analysis by scanning electron microscopy. Thus, in a defined, strong osteogenic environment, PEMF applied at different times was capable of further stimulation of osteogenesis with the potential to enhance bone repair.	[Benya, Paul D.; Kavanaugh, Aaron; Zakarian, Martin; Billi, Fabrizio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Soderlind, Philip] Univ Calif Los Angeles, Dept Architecture & Urban Design, Los Angeles, CA USA; [Jashashvili, Tea] Univ Southern Calif, Keck Sch Med, Mol Imaging Ctr, Dept Radiol, Los Angeles, CA 90007 USA; [Zhang, Nianli; Waldorff, Erik, I; Ryaby, James T.] Orthofix Med Inc, Lewisville, TX USA; [Zakarian, Martin] Univ Calif Los Angeles, Sch Nursing, UCLA AIDS Inst, Los Angeles, CA USA; [Jashashvili, Tea] Univ Southern Calif, Keck Sch Med, Dept Integrat Anat Sci, Los Angeles, CA 90007 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of Southern California	Billi, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	f.billi@ucla.edu	Billi, Fabrizio/AAJ-4830-2021; Benya, Paul/I-3449-2015	Billi, Fabrizio/0000-0003-2217-7694; Benya, Paul/0000-0002-1060-7127	Orthofix Medical Inc, Lewisville, TX, USA; Orthopaedic Institute for Children, Los Angeles, CA, USA	Orthofix Medical Inc, Lewisville, TX, USA; Orthopaedic Institute for Children, Los Angeles, CA, USA	This research was supported by grants to FB from Orthofix Medical Inc, Lewisville, TX, USA; orthofix.com. PDB, AK, MZ, and FB, received salary support, and PS and TJ received fee-for-service support. NZ, EIW, and JTR are employed by Orthofix. Publication fees were paid by Orthofix. Orthofix participated in study design and preparation of the manuscript through the author contributions of NZ, EIW, and JTR. Support was also provided by grants to FB from the Orthopaedic Institute for Children, Los Angeles, CA, USA, OIC. com. FB received salary and general research support. OIC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Addison WN, 2015, BONE, V71, P244, DOI 10.1016/j.bone.2014.11.003; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Billi F, 2012, CLIN ORTHOP RELAT R, V470, P339, DOI 10.1007/s11999-011-2058-9; Blank M, 2019, CURR OSTEOPOROS REP, V17, P270, DOI 10.1007/s11914-019-00524-y; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Chepda T, 2001, IN VITRO CELL DEV-AN, V37, P26; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Dallas SL, 2012, METHODS MOL BIOL, V816, P425, DOI 10.1007/978-1-61779-415-5_26; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Demol J, 2011, EUR CELLS MATER, V21, P272, DOI 10.22203/eCM.v021a21; Ehnert S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122028; Foley KT, 2008, SPINE J, V8, P436, DOI 10.1016/j.spinee.2007.06.006; Garland D E, 1991, Contemp Orthop, V22, P295; Hayrapetyan A, 2015, TISSUE ENG PART B-RE, V21, P75, DOI [10.1089/ten.teb.2014.0119, 10.1089/ten.TEB.2014.0119]; He ZM, 2018, BONE, V106, P194, DOI 10.1016/j.bone.2017.09.020; Henmi A, 2016, J BONE MINER METAB, V34, P41, DOI 10.1007/s00774-014-0647-x; HOLDEN JL, 1995, J BONE MINER RES, V10, P1400; Howell PGT, 2003, CALCIFIED TISSUE INT, V72, P745, DOI 10.1007/s00223-002-2010-9; Huegel J, 2018, J SHOULDER ELB SURG, V27, P553, DOI 10.1016/j.jse.2017.09.024; Lee YS, 2016, WOUND REPAIR REGEN, V24, P302, DOI 10.1111/wrr.12397; Lou XX, 2015, STEM CELL REV REP, V11, P645, DOI 10.1007/s12015-015-9594-8; Madupalli H, 2017, J SOLID STATE CHEM, V255, P27, DOI 10.1016/j.jssc.2017.07.025; Mandair GS, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2014.115; Massari L, 2019, INT ORTHOP, V43, P539, DOI 10.1007/s00264-018-4274-3; Matsumoto Y, 2013, STEROIDS, V78, P513, DOI 10.1016/j.steroids.2013.02.011; McCarthy TL, 2003, J BIOL CHEM, V278, P43121, DOI 10.1074/jbc.M306531200; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mikami Y, DEXAMETHASONE MODULA, DOI [10.1002/jcp.22392, DOI 10.1002/JCP.22392]; Min HY, 2019, STEROIDS, V149, DOI 10.1016/j.steroids.2019.05.004; MOONEY V, 1990, SPINE, V15, P708, DOI 10.1097/00007632-199007000-00016; Mooney V, 1993, Surg Technol Int, V2, P405; Parate D, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1566-5; Petecchia L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13856; Rodriguez-Florez N, 2015, J BONE MINER RES, V30, P786, DOI 10.1002/jbmr.2414; Rodriguez-Navarro AB, 2006, J APPL CRYSTALLOGR, V39, P905, DOI 10.1107/S0021889806042488; Ross CL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00266; Selvamurugan N, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2450327; Selvarnurugan N, 2007, J ORTHOP RES, V25, P1213, DOI 10.1002/jor.20409; Tang XY, 2019, SPINE, V44, pE1290, DOI 10.1097/BRS.0000000000003136; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; Toosi S, 2020, BIOFACTORS, V46, P326, DOI 10.1002/biof.1598; Vincenzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065561; Vrahnas C, 2019, NAT COMMUN, P1, DOI [10.1038/s41467-018-07882-8, DOI 10.1038/S41467-018-07882-8]; Waldorff EI, 2017, J ORTHOP TRANSL, V9, P60, DOI 10.1016/j.jot.2017.02.006; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0244223	10.1371/journal.pone.0244223	http://dx.doi.org/10.1371/journal.pone.0244223			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539401	gold, Green Submitted, Green Published			2022-12-26	WOS:000616960200058
J	Chen, JL; Guo, J; Mao, P; Yang, JD; Jiang, S; He, W; Lin, CX; Lien, K				Chen, Jyu-Lin; Guo, Jia; Mao, Ping; Yang, Jundi; Jiang, Shan; He, Wei; Lin, Chen-Xi; Lien, Kathy			Are the factors associated with overweight/general obesity and abdominal obesity different depending on menopausal status?	PLOS ONE			English	Article							DOSE-RESPONSE METAANALYSIS; PHYSICAL-ACTIVITY LEVELS; CHINESE ADULTS; CARDIOVASCULAR-DISEASE; ANTHROPOMETRIC FACTORS; SEX-DIFFERENCES; BREAST-CANCER; WEIGHT-GAIN; RISK; SLEEP	Rapid modernization in China has impacted the daily lives and health of women, including a rise in obesity. However, little is known about the impact of menopausal status, behavior, and psychosocial factors on the risk of obesity for rural women in China. The aim of this study is to identify risk factors, including demographic information (education, family history of T2DM, menopausal status), obesity-related behavior, and psychosocial factors associated with overweight/general obesity and abdominal obesity. In a cross-sectional study design, participants had their weight, height, and waist circumference measured and completed questionnaires regarding family demographics, obesity-related health behaviors (physical activity, diet, sleep), and psychosocial information (stress, social support, and self-efficacy related to physical activity and healthy diet). A total of 646 women were included in this study; 46.6% were overweight/generally obese, and 48% had abdominal obesity. Postmenopausal women had a higher prevalence of general and central obesity. Regular physical activity decreased the risk for overweight/general obesity and abdominal obesity (OR = .41 and .31, respectively, p = .04) in premenopausal women. Postmenopausal women who had not breastfed their infants and reported moderate/high-stress had a higher risk for overweight/general obesity (OR = 3.93, and 2, respectively) and those who reported less than 6 hours of sleep per day increased their risk for abdominal obesity (OR = 2.08). Different factors associated with obesity were found in Chinese women, depending on menopausal status. Future studies should examine the impact of menopause on a woman's risk for obesity, as well as develop tailored interventions to improve health, well-being and reduce the risk of obesity.	[Chen, Jyu-Lin; Lin, Chen-Xi; Lien, Kathy] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Guo, Jia; Yang, Jundi] Cent South Univ, Xiangya Sch Nursing, Changsha, Peoples R China; [Mao, Ping; He, Wei] Cent South Univ, Xiangya Hosp 3, Nursing Dept, Changsha, Hunan, Peoples R China; [Jiang, Shan] Southeast Univ, Zhongda Hosp, Nursing Dept, Nanjing, Jiangsu, Peoples R China	University of California System; University of California San Francisco; Central South University; Central South University; Southeast University - China	Guo, J (corresponding author), Cent South Univ, Xiangya Sch Nursing, Changsha, Peoples R China.	guojia621@163.com						Al-Safi ZA, 2015, BEST PRACT RES CL OB, V29, P548, DOI 10.1016/j.bpobgyn.2014.12.002; Amadou A, 2013, OBES REV, V14, P665, DOI 10.1111/obr.12028; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Aune D, 2015, ANN ONCOL, V26, P1635, DOI 10.1093/annonc/mdv142; Aune D, 2015, INT J CANCER, V136, P1888, DOI 10.1002/ijc.29207; Berge JM, 2011, PEDIATRICS, V127, P881, DOI 10.1542/peds.2010-3218; Chen GC, 2016, OBES REV, V17, P1167, DOI 10.1111/obr.12443; Chen YJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7633-0; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Du P, 2017, J EPIDEMIOL, V27, P282, DOI 10.1016/j.je.2017.03.001; Freitas FV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197699; Guo J, 2018, PUBLIC HEALTH NURS, V35, P18, DOI 10.1111/phn.12380; Hachul H, 2009, EUR J OBSTET GYN R B, V145, P81, DOI 10.1016/j.ejogrb.2009.03.019; Hankinson AL, 2010, JAMA-J AM MED ASSOC, V304, P2603, DOI 10.1001/jama.2010.1843; Hendryx M, 2019, J GERONTOL B; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Huang FF, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02520-4; Islam F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233754; Landstedt E, 2016, INT J CIRCUMPOL HEAL, V75, DOI 10.3402/ijch.v75.31781; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Li YC, 2017, BIOMED ENVIRON SCI, V30, P863, DOI 10.3967/bes2017.117; Link JC, 2017, ANNU REV NUTR, V37, P225, DOI 10.1146/annurev-nutr-071816-064827; Liu RQ, 2017, J CLIN SLEEP MED, V13, P565, DOI 10.5664/jcsm.6544; Monda KL, 2008, EUR J CLIN NUTR, V62, P1318, DOI 10.1038/sj.ejcn.1602849; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Ng NYH, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002953; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Patel SR, 2009, OBES REV, V10, P61, DOI 10.1111/j.1467-789X.2009.00664.x; Pinto KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194190; SALLIS J F, 1988, Health Education Research, V3, P283, DOI 10.1093/her/3.3.283; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Schrijnders D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190870; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Tian Y, 2016, LANCET DIABETES ENDO, V4, P487, DOI 10.1016/S2213-8587(16)00081-4; Tomiyama AJ, 2019, ANNU REV PSYCHOL, V70, P703, DOI 10.1146/annurev-psych-010418-102936; van der Valk ES, 2018, CURR OBES REP, V7, P193, DOI 10.1007/s13679-018-0306-y; Wang R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010828; Wang YF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111112; Wu YL, 2014, SLEEP MED, V15, P1456, DOI 10.1016/j.sleep.2014.07.018; Xiao Yingting, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P232; Xu XL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111346; Yang YH, 2020, OBESITY FACTS, V13, P179, DOI 10.1159/000506078; Yin ZN, 2018, INT HEALTH, V10, P391, DOI 10.1093/inthealth/ihx072; Yu CQ, 2015, NUTRIENTS, V7, P5834, DOI 10.3390/nu7075253; Yu SW, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6509083; Zang JJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0364-z; Zhang T, 2019, AM J HEALTH BEHAV, V43, P168, DOI 10.5993/AJHB.43.1.14	50	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245150	10.1371/journal.pone.0245150	http://dx.doi.org/10.1371/journal.pone.0245150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539356	Green Published, gold			2022-12-26	WOS:000616960200060
J	Chen, LL; Shen, W				Chen, Lingling; Shen, Wei			Spatiotemporal differentiation of urban-rural income disparity and its driving force in the Yangtze River Economic Belt during 2000-2017	PLOS ONE			English	Article							INEQUALITY; RESIDENTS; GROWTH; CHINA	The income imbalance between urban and rural areas has seriously affected social fairness and justice and has become a key factor restricting the sustainable development of the economy and society. The analysis of the spatiotemporal laws and causes of urban-rural income disparity is of great significance to realizing the coordinated and integrated development of regional urban and rural areas. In this study, the coefficient of variation, Theil decomposition index, spatial autocorrelation method and GeoDetector model were used to analyze the spatiotemporal characteristics of the urban-rural income gap and its driving force in the Yangtze River Economic Belt from 2000 to 2017. The results show that the per capita disposable income of urban and rural residents in the study area shows a trend of rapid growth from 2000 to 2017. The urban-rural income gap in the study area showed an inverted "U"-shaped development process as a whole, and the relative difference showed an increasing trend. Regarding the spatial pattern, the study area showed a significant east-west differentiation pattern. The spatial distribution of the urban-rural income gap in the study area has an obvious positive spatial correlation, that is, the phenomena of high-value agglomeration and low-value agglomeration were significant. The economic development level, the industrial structure, the regional development policy, transportation, topographical conditions and resource endowments can strongly explain the spatial differentiation pattern of the urban-rural income gap in the study area. The spatial differentiation pattern of the urban-rural income gap is affected by both natural factors and socioeconomic factors. Among them, socioeconomic factors are the dominant factors, followed by natural factors. There is a significant interaction between natural factors and socio-economic factors, and the combination of socio-economic factors and adverse natural factors can significantly affect the regional urban-rural income gap.	[Chen, Lingling] Zhengzhou Tourism Coll, Zhengzhou, Peoples R China; [Shen, Wei] Henan Univ, Coll Environm & Planning, Kaifeng, Peoples R China; [Shen, Wei] Henan Univ, Key Lab Geospatial Technol Middle & Lower Yellow, Kaifeng, Peoples R China	Henan University; Henan University	Shen, W (corresponding author), Henan Univ, Coll Environm & Planning, Kaifeng, Peoples R China.; Shen, W (corresponding author), Henan Univ, Key Lab Geospatial Technol Middle & Lower Yellow, Kaifeng, Peoples R China.	shenwei@henu.edu.cn	Chen, Ling-Ling/AAY-3547-2021	Shen, Wei/0000-0003-1288-028X	National Natural Science Foundation of China [41671536]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China under Grant 41671536.	AHLUWALIA MS, 1979, J DEV ECON, V6, P299, DOI 10.1016/0304-3878(79)90020-8; Akita T, 2003, ANN REGIONAL SCI, V37, P55, DOI 10.1007/s001680200107; Cao HH, 2010, REG STUD, V44, P965, DOI 10.1080/00343400903401550; Chi Y, 2018, ECOL INDIC, V89, P880, DOI 10.1016/j.ecolind.2017.12.025; Chi Y, 2018, SCI TOTAL ENVIRON, V634, P1445, DOI 10.1016/j.scitotenv.2018.04.085; [丁志伟 Ding Zhiwei], 2015, [地理研究, Geographical Research], V34, P131; Douglass M, 1998, THIRD WORLD PLAN REV, V20, P1; Duan H.Y., 2018, INQUIRY EC ISSUES, V39, P101; Fbi J.C.H., 1964, EC J, V77, P480; [付占辉 Fu Zhanhui], 2019, [地理科学, Scientia Geographica Sinica], V39, P1473; GOULD WTS, 1982, AREA, V14, P334; Jiang X.J., 2019, MODERN URBAN RES, V26, P109; Ju Y.U., 2014, ECON GEOGR, V34, P79, DOI [10.15957/j.cnki.jjdl.2014.03.015, DOI 10.15957/J.CNKI.JJDL.2014.03.015]; Kang J. Y., 2017, E CHINA EC MANAGEMEN, V31, P67; Kuznets S, 1955, AM ECON REV, V45, P1; Lewis, 1954, MANCHESTER SCH EC SO, V22, P139, DOI [DOI 10.1111/J.1467-9957.1954.TB00021.X, 10.1111/j.1467-9957.1954.tb00021.x]; Li G., 2019, INQUIRY EC ISSUES, V40, P72; [李健旋 Li Jianxuan], 2018, [中国管理科学, Chinese Journal of Management Science], V26, P34; [刘彦随 Liu Yansui], 2017, [地理学报, Acta Geographica Sinica], V72, P161; Ma X, 2018, COMPUT ECON, V52, P1153, DOI 10.1007/s10614-017-9759-4; Pan J., 2014, ECON GEOGR, V34, P60, DOI DOI 10.15957/J.CNKI.JJDL.2014.06.001; Pan WB, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062547; Peng WF, 2019, J CLEAN PROD, V233, P353, DOI 10.1016/j.jclepro.2019.05.355; ROBINSON S, 1976, AM ECON REV, V66, P437; Sao Paulo (Estado). Secretaria de Estado da Saude de Sao Paulo; Centro de Referencia e Treinamento em DST/Aids, 2011, BEPA, V8, P15; ShipBuilding Industry, 2012, SHIPBUILDING IND, V6, P46; [王劲峰 Wang Jinfeng], 2017, [地理学报, Acta Geographica Sinica], V72, P116; Wang YH, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0382-x; Wu P., 2016, J IND TECHNOLOGICAL, V34, P114; Xu X.H., 2014, INT EC TRADE RES, V30, P17; [杨国安 Yang Guoan], 2010, [地理科学进展, Progress in Geography], V29, P961; Yang JC., 2016, ECON GEOGR, V36, P99, DOI [10.15957/j.cnki.jjdl.2016.07.013, DOI 10.15957/J.CNKI.JJDL.2016.07.013]; [张改素 Zhang Gaisu], 2017, [经济地理, Economic Geography], V37, P42; Zhang J.J., 2018, ACTA GEOGRAPHICA SIN, V29, P598; Zhang Y.C., 2018, INQUIRY EC ISSUES, V39, P62; Zhao XY, 2018, J GEOGR SCI, V28, P741, DOI 10.1007/s11442-018-1502-0; [周侃 Zhou Kan], 2016, [地理学报, Acta Geographica Sinica], V71, P1911	37	12	12	29	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245961	10.1371/journal.pone.0245961	http://dx.doi.org/10.1371/journal.pone.0245961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539430	gold, Green Published			2022-12-26	WOS:000616960200013
J	Jung, YH; Shamsiev, K; Mamadjonov, N; Jeung, KW; Lee, HY; Lee, BK; Kang, BS; Heo, T; Min, YI				Jung, Yong Hun; Shamsiev, Kamoljon; Mamadjonov, Najmiddin; Jeung, Kyung Woon; Lee, Hyoung Youn; Lee, Byung Kook; Kang, Byung Soo; Heo, Tag; Min, Yong Il			Relationship of common hemodynamic and respiratory target parameters with brain tissue oxygen tension in the absence of hypoxemia or hypotension after cardiac arrest: A post-hoc analysis of an experimental study using a pig model	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; ARTERIAL CARBON-DIOXIDE; INTENSIVE-CARE-UNIT; CEREBRAL-BLOOD-FLOW; PARTIAL-PRESSURE; CARDIOPULMONARY-RESUSCITATION; CEREBROVASCULAR REACTIVITY; HYPEROXIA; ASSOCIATION; HYPOXIA	Brain tissue oxygen tension (PbtO(2))-guided care, a therapeutic strategy to treat or prevent cerebral hypoxia through modifying determinants of cerebral oxygen delivery, including arterial oxygen tension (PaO2), end-tidal carbon dioxide (ETCO2), and mean arterial pressure (MAP), has recently been introduced. Studies have reported that cerebral hypoxia occurs after cardiac arrest in the absence of hypoxemia or hypotension. To obtain preliminary information on the degree to which PbtO(2) is responsive to changes in the common target variables for PbtO(2)-guided care in conditions without hypoxemia or hypotension, we investigated the relationships between the common target variables for PbtO(2)-guided care and PbtO(2) using data from an experimental study in which the animals did not experience hypoxemia or hypotension after resuscitation. We retrospectively analyzed 170 sets of MAP, ETCO2, PaO2, PbtO(2), and cerebral microcirculation parameters obtained during the 60-min post-resuscitation period in 10 pigs resuscitated from ventricular fibrillation cardiac arrest. PbtO(2) and cerebral microcirculation parameters were measured on parietal cortices exposed through burr holes. Multiple linear mixed effect models were used to test the independent effects of each variable on PbtO(2). Despite the absence of arterial hypoxemia or hypotension, seven (70%) animals experienced cerebral hypoxia (defined as PbtO(2) <20 mmHg). Linear mixed effect models revealed that neither MAP nor ETCO2 were related to PbtO(2). PaO2 had a significant linear relationship with PbtO(2) after adjusting for significant covariates (P = 0.030), but it could explain only 17.5% of the total PbtO(2) variance (semi-partial R-2 = 0.175; 95% confidence interval, 0.086-0.282). In conclusion, MAP and ETCO2 were not significantly related to PbtO(2) in animals without hypoxemia or hypotension during the early post-resuscitation period. PaO2 had a significant linear association with PbtO(2), but its ability to explain PbtO(2) variance was small.	[Jung, Yong Hun; Jeung, Kyung Woon; Lee, Hyoung Youn; Lee, Byung Kook; Heo, Tag; Min, Yong Il] Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea; [Jung, Yong Hun; Jeung, Kyung Woon; Lee, Byung Kook; Heo, Tag; Min, Yong Il] Chonnam Natl Univ, Dept Emergency Med, Med Sch, Gwangju, South Korea; [Shamsiev, Kamoljon; Mamadjonov, Najmiddin] Chonnam Natl Univ, Dept Med Sci, Grad Sch, Gwangju, South Korea; [Kang, Byung Soo] Chosun Univ, Coll Med, Dept Med Sci, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University; Chosun University	Jeung, KW (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea.; Jeung, KW (corresponding author), Chonnam Natl Univ, Dept Emergency Med, Med Sch, Gwangju, South Korea.	neoneti@hanmail.net	Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448	Chonnam National University Hwasun Hospital Institute for Biomedical Science [HCRI 20010]	Chonnam National University Hwasun Hospital Institute for Biomedical Science	This study was supported by a grant (HCRI 20010) from Chonnam National University Hwasun Hospital Institute for Biomedical Science (Recipient: KWJ). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameloot K, 2015, RESUSCITATION, V90, P121, DOI 10.1016/j.resuscitation.2015.03.001; Bein B, 2006, EUR J ANAESTH, V23, P501, DOI 10.1017/S0265021506000366; Bhate TD, 2015, RESUSCITATION, V97, P1, DOI 10.1016/j.resuscitation.2015.08.023; Bisschops LLA, 2010, CRIT CARE MED, V38, P1542, DOI 10.1097/CCM.0b013e3181e2cc1e; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; Buunk G, 1997, STROKE, V28, P1569, DOI 10.1161/01.STR.28.8.1569; Callaway CW, 2015, CIRCULATION, V132, pS84, DOI 10.1161/CIR.0000000000000273; Cavus E, 2006, RESUSCITATION, V71, P97, DOI 10.1016/j.resuscitation.2006.03.007; Cho YC, 2011, EMERG MED J, V28, P40, DOI 10.1136/emj.2010.099911; CLARK LC, 1958, J THORAC SURG, V36, P488; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Drabek T, 2014, RESUSCITATION, V85, P964, DOI 10.1016/j.resuscitation.2014.03.314; Elmer J, 2018, RESUSCITATION, V129, P121, DOI 10.1016/j.resuscitation.2018.04.013; GERMON TJ, 1994, BRIT J ANAESTH, V73, P503, DOI 10.1093/bja/73.4.503; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jakkula P, 2018, INTENS CARE MED, V44, P2091, DOI 10.1007/s00134-018-5446-8; Janz DR, 2012, CRIT CARE MED, V40, P3135, DOI 10.1097/CCM.0b013e3182656976; KAGSTROM E, 1983, ACTA PHYSIOL SCAND, V118, P281, DOI 10.1111/j.1748-1716.1983.tb07272.x; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kilgannon JH, 2014, CRIT CARE MED, V42, P2083, DOI 10.1097/CCM.0000000000000406; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lee HY, 2020, CARDIOVASC DRUG THER, V34, P619, DOI 10.1007/s10557-020-07026-5; Leidorf A, 2014, TURK NEUROSURG, V24, P913, DOI [10.5137/1019-5149JTN.11808-14.1, 10.5137/1019-5149.JTN.11808-14.1]; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Mader MM, 2018, NEUROCRIT CARE, V29, P291, DOI 10.1007/s12028-018-0541-9; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manole MD, 2014, PEDIATR RES, V75, P295, DOI 10.1038/pr.2013.220; Manole MD, 2009, J CEREBR BLOOD F MET, V29, P197, DOI 10.1038/jcbfm.2008.112; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Mullner M, 1996, STROKE, V27, P59, DOI 10.1161/01.STR.27.1.59; Nelskyla A, 2017, RESUSCITATION, V116, P1, DOI 10.1016/j.resuscitation.2017.04.022; NEMOTO EM, 1975, STROKE, V6, P425, DOI 10.1161/01.STR.6.4.425; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Ong MEH, 2015, RESUSCITATION, V96, P100, DOI 10.1016/j.resuscitation.2015.07.026; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Perkins GD, 2018, NEW ENGL J MED, V379, P711, DOI 10.1056/NEJMoa1806842; PETERSON JI, 1984, ANAL CHEM, V56, P62, DOI 10.1021/ac00265a017; Putzer G, 2016, RESUSCITATION, V104, P1, DOI 10.1016/j.resuscitation.2016.03.027; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; Roberts BW, 2018, CIRCULATION, V137, P2114, DOI 10.1161/CIRCULATIONAHA.117.032054; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Sekhon MS, 2020, CRIT CARE MED, V48, P378, DOI 10.1097/CCM.0000000000004138; Sekhon MS, 2019, CRIT CARE MED, V47, P960, DOI 10.1097/CCM.0000000000003745; Serne EH, 2001, HYPERTENSION, V38, P238, DOI 10.1161/01.HYP.38.2.238; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6; Ter Minassian A, 1999, ANESTHESIOLOGY, V91, P985; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; Vaagenes P, 1997, RESUSCITATION, V35, P41, DOI 10.1016/S0300-9572(97)01108-8; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wang CC, 2016, J SURG RES, V200, P669, DOI 10.1016/j.jss.2015.10.005	60	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245931	10.1371/journal.pone.0245931	http://dx.doi.org/10.1371/journal.pone.0245931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539360	gold, Green Published			2022-12-26	WOS:000616960200083
J	Jaumotte, JD; Saarma, M; Zigmond, MJ				Jaumotte, Juliann D.; Saarma, Mart; Zigmond, Michael J.			Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP+ in dissociated cultures from rat mesencephalon	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GDNF; PARTIAL LESION MODEL; CELL-LINE; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; TGF-BETA; PROMOTES TUMORIGENESIS; NIGROSTRIATAL SYSTEM; CHOLINERGIC NEURONS; PERSEPHIN PROMOTE	Parkinson's disease is associated with the loss of dopamine (DA) neurons in ventral mesencephalon. We have previously reported that no single neurotrophic factor we tested protected DA neurons from the dopaminergic toxin 1-methyl-4-phenylpyridinium (MPP+) in dissociated cultures isolated from the P0 rat substantia nigra, but that a combination of five neurotrophic factors was protective. We now report that cerebral DA neurotrophic factor (CDNF) and a variant of neurturin (NRTN), N4, were also not protective when provided alone but were protective when added together. In cultures isolated from the substantia nigra, MPP+ (10 mu M) decreased tyrosine hydroxylase-positive cells to 41.7 +/- 5.4% of vehicle control. Although treatment of cultures with 100 ng/ml of either CDNF or N4 individually before and after toxin exposure did not significantly increase survival in MPP+-treated cultures, when the two trophic factors were added together at 100 ng/ml each, survival of cells was increased 28.2 +/- 6.1% above the effect of MPP+ alone. In cultures isolated from the ventral tegmental area, another DA rich area, a higher dose of MPP+ (1 mM) was required to produce an EC50 in TH-positive cells but, as in the substantia nigra, only the combination of CDNF and N4 (100 ng/ml each) was successful at increasing the survival of these cells compared to MPP+ alone (by 22.5 +/- 3.5%). These data support previous findings that CDNF and N4 may be of therapeutic value for treatment of PD, but suggest that they may need to be administered together.	[Jaumotte, Juliann D.; Zigmond, Michael J.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Jaumotte, Juliann D.; Zigmond, Michael J.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Saarma, Mart] Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki	Jaumotte, JD (corresponding author), Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA.; Jaumotte, JD (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.	jaumottejd@pitt.edu			Jane and Aatos Erkko Foundationjaes.fi; Academy of Finland-aka.fi; NTF Therapeutics, Inc.	Jane and Aatos Erkko Foundationjaes.fi; Academy of Finland-aka.fi; NTF Therapeutics, Inc.	MS:Jane and Aatos Erkko Foundationjaes.fi, the Academy of Finland-aka.fi, and NTF Therapeutics, Inc., No website The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MS:Jane and Aatos Erkko Foundation, the Academy of Finland, and NTF Therapeutics, Inc The Funders had no role in study design, data collection and analysis, decision to publish or preparation or the manuscript.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Akerud P, 1999, J NEUROCHEM, V73, P70, DOI 10.1046/j.1471-4159.1999.0730070.x; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Back S, 2013, BRAIN BEHAV, V3, P75, DOI 10.1002/brb3.117; Backman CM, 2006, MOL CELL ENDOCRINOL, V252, P160, DOI 10.1016/j.mce.2006.03.013; Bai XR, 2018, J CHEMOTHERAPY, V30, P172, DOI [10.1080/1120009X.2018.1425279, 10.1080/1120009x.2018.1425279]; Bartus RT, 2015, NEUROBIOL DIS, V78, P162, DOI 10.1016/j.nbd.2015.03.023; Bartus RT, 2017, NEUROBIOL DIS, V97, P156, DOI 10.1016/j.nbd.2016.03.027; Bartus RT, 2017, NEUROBIOL DIS, V97, P169, DOI 10.1016/j.nbd.2016.03.026; Boada J, 2000, BIOCHEM BIOPH RES CO, V268, P916, DOI 10.1006/bbrc.2000.2232; Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; Cordero-Llana O, 2015, MOL THER, V23, P244, DOI 10.1038/mt.2014.206; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Defazio G, 1996, BRAIN RES BULL, V40, P257, DOI 10.1016/0361-9230(96)00041-X; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Fernandez A, 2014, PLASMID, V76, P15, DOI 10.1016/j.plasmid.2014.09.001; Fjord-Larsen L, 2005, EXP NEUROL, V195, P49, DOI 10.1016/j.expneurol.2005.03.006; Garea-Rodriguez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149776; Golden JP, 2003, EXP NEUROL, V184, P447, DOI 10.1016/j.expneurol.2003.07.999; Gonzalez-Aparicio R, 2010, EXP NEUROL, V226, P136, DOI 10.1016/j.expneurol.2010.08.016; Gonzalez-Hernandez T, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00140; GOULD E, 1986, NEUROSCI LETT, V63, P315, DOI 10.1016/0304-3940(86)90377-0; Grondin R, 2008, CELL TRANSPLANT, V17, P373, DOI 10.3727/096368908784423256; Hamilton JF, 2001, EXP NEUROL, V168, P155, DOI 10.1006/exnr.2000.7571; Herran E, 2014, INT J NANOMED, V9, P2677, DOI 10.2147/IJN.S61940; Herzog CD, 2007, MOVEMENT DISORD, V22, P1124, DOI 10.1002/mds.21503; Hoane MR, 1999, EXP NEUROL, V160, P235, DOI 10.1006/exnr.1999.7175; Horger BA, 1998, J NEUROSCI, V18, P4929; Hunot S, 1996, J NEURAL TRANSM, V103, P1043, DOI 10.1007/BF01291789; Jackson-Lewis V, 2005, NEUROTOX RES, V7, P193, DOI 10.1007/BF03036449; Jang B, 2016, ADV DRUG DELIVER REV, V98, P113, DOI 10.1016/j.addr.2015.10.023; Jaumotte JD, 2005, MOL BRAIN RES, V134, P139, DOI 10.1016/j.molbrainres.2004.11.018; Jaumotte JD, 2016, EUR J NEUROSCI, V44, P1691, DOI 10.1111/ejn.13252; Jaumotte JD, 2014, J NEUROSCI RES, V92, P1425, DOI 10.1002/jnr.23425; Kazim SF, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0119-y; Keifer OP, 2014, PHARMACOL THERAPEUT, V141, P261, DOI 10.1016/j.pharmthera.2013.10.009; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Krieglstein K, 1998, J NEUROSCI, V18, P9822; Lam CT, 2011, CLIN CANCER RES, V17, P3123, DOI 10.1158/1078-0432.CCR-10-2802; LAVERTY R, 1978, DRUGS, V16, P418, DOI 10.2165/00003495-197816050-00003; Lee SH, 1996, NEUROSCI LETT, V214, P199, DOI 10.1016/0304-3940(96)12913-X; Lindholm D, 2016, CELL MOL LIFE SCI, V73, P1365, DOI 10.1007/s00018-015-2101-1; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Mei JM, 2014, NEUROL SCI, V35, P1275, DOI 10.1007/s10072-014-1700-1; Mei JM, 2015, MOL MED REP, V12, P297, DOI 10.3892/mmr.2015.3388; Nadella R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0209-0; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Oiwa Y, 2002, BRAIN RES, V947, P271, DOI 10.1016/S0006-8993(02)02934-7; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Olanow CW, 2015, ANN NEUROL, V78, P248, DOI 10.1002/ana.24436; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Parmar MS, 2015, INT J DEV NEUROSCI, V46, P44, DOI 10.1016/j.ijdevneu.2015.06.009; Parmar MS, 2014, NEUROBIOL AGING, V35, P669, DOI 10.1016/j.neurobiolaging.2013.09.031; Rathbun C., 2018, ANTIRETROVIRAL THERA, DOI [10.1371/journal.pone.0197665, DOI 10.1371/JOURNAL.PONE.0197665]; Ren XM, 2013, EXP NEUROL, V248, P148, DOI 10.1016/j.expneurol.2013.06.002; Reyes-Corona D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188239; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rider CC, 2003, BIOCHEM SOC T, V31, P337, DOI 10.1042/BST0310337; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Roussa E, 2004, NEUROBIOL DIS, V16, P300, DOI 10.1016/j.nbd.2004.03.006; Runeberg-Roos P, 2016, NEUROBIOL DIS, V96, P335, DOI 10.1016/j.nbd.2016.07.008; Sandmark J, 2018, J BIOL CHEM, V293, P5492, DOI 10.1074/jbc.RA117.000820; Schober A, 2007, NEUROBIOL DIS, V25, P378, DOI 10.1016/j.nbd.2006.10.005; Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861; Sun M, 2005, BRAIN RES, V1052, P119, DOI 10.1016/j.brainres.2005.05.072; SUZUKI K, 1990, ADV NEUROL, V53, P215; Tovar-y-Romo LB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00061; Tseng JL, 1998, NEUROREPORT, V9, P1817, DOI 10.1097/00001756-199806010-00027; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; Voutilainen MH, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0117-16.2017; Voutilainen MH, 2011, EXP NEUROL, V228, P99, DOI 10.1016/j.expneurol.2010.12.013; Wang LZ, 2017, INT J MED SCI, V14, P340, DOI 10.7150/ijms.18623; Whone A, 2019, BRAIN, V142, P512, DOI 10.1093/brain/awz023; Whone AL, 2019, J PARKINSON DIS, V9, P301, DOI 10.3233/JPD-191576; Zhang HY, 2013, J HUNTINGTONS DIS, V2, P69, DOI 10.3233/JHD-120026; Zhang XY, 2016, ONCOL LETT, V12, P4301, DOI 10.3892/ol.2016.5242; Zihlmann KB, 2005, BRAIN RES BULL, V68, P42, DOI 10.1016/j.brainresbull.2004.10.012	80	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245663	10.1371/journal.pone.0245663	http://dx.doi.org/10.1371/journal.pone.0245663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534843	Green Published, gold			2022-12-26	WOS:000616739700042
J	Olivas-Martinez, A; Cardenas-Fragoso, JL; Jimenez, JV; Lozano-Cruz, OA; Ortiz-Brizuela, E; Tovar-Mendez, VH; Medrano-Borromeo, C; Martinez-Valenzuela, A; Roman-Montes, CM; Martinez-Guerra, B; Gonzalez-Lara, MF; Hernandez-Gilsoul, T; Herrero, AG; Tamez-Flores, KM; Ochoa-Hein, E; Ponce-de-Leon, A; Galindo-Fraga, A; Kershenobich-Stalnikowitz, D; Sifuentes-Osornio, J				Olivas-Martinez, Antonio; Luis Cardenas-Fragoso, Jose; Victor Jimenez, Jose; Arturo Lozano-Cruz, Oscar; Ortiz-Brizuela, Edgar; Hugo Tovar-Mendez, Victor; Medrano-Borromeo, Carla; Martinez-Valenzuela, Alejandra; Marina Roman-Montes, Carla; Martinez-Guerra, Bernardo; Fernanda Gonzalez-Lara, Maria; Hernandez-Gilsoul, Thierry; Gulias Herrero, Alfonso; Maria Tamez-Flores, Karla; Ochoa-Hein, Eric; Ponce-de-Leon, Alfredo; Galindo-Fraga, Arturo; Kershenobich-Stalnikowitz, David; Sifuentes-Osornio, Jose			In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT	Background As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has remained in Latin America, Mexico has become the third country with the highest death rate worldwide. Data regarding in-hospital mortality and its risk factors, as well as the impact of hospital overcrowding in Latin America has not been thoroughly explored. Methods and findings In this prospective cohort study, we enrolled consecutive adult patients hospitalized with severe confirmed COVID-19 pneumonia at a SARS-CoV-2 referral center in Mexico City from February 26th, 2020, to June 5th, 2020. A total of 800 patients were admitted with confirmed diagnosis, mean age was 51.9 +/- 13.9 years, 61% were males, 85% were either obese or overweight, 30% had hypertension and 26% type 2 diabetes. From those 800, 559 recovered (69.9%) and 241 died (30.1%). Among survivors, 101 (18%) received invasive mechanical ventilation (IMV) and 458 (82%) were managed outside the intensive care unit (ICU); mortality in the ICU was 49%. From the non-survivors, 45.6% (n = 110) did not receive full support due to lack of ICU bed availability. Within this subgroup the main cause of death was acute respiratory distress syndrome (ARDS) in 95% of the cases, whereas among the non-survivors who received full (n = 105) support the main cause of death was septic shock (45%) followed by ARDS (29%). The main risk factors associated with in-hospital death were male sex (RR 2.05, 95% CI 1.34-3.12), obesity (RR 1.62, 95% CI 1.14-2.32)-in particular morbid obesity (RR 3.38, 95%CI 1.63-7.00)-and oxygen saturation < 80% on admission (RR 4.8, 95%CI 3.26-7.31). Conclusions In this study we found similar in-hospital and ICU mortality, as well as risk factors for mortality, compared to previous reports. However, 45% of the patients who did not survive justified admission to ICU but did not receive IMV / ICU care due to the unavailability of ICU beds. Furthermore, mortality rate over time was mainly due to the availability of ICU beds, indirectly suggesting that overcrowding was one of the main factors that contributed to hospital mortality.	[Olivas-Martinez, Antonio; Luis Cardenas-Fragoso, Jose; Victor Jimenez, Jose; Arturo Lozano-Cruz, Oscar; Hugo Tovar-Mendez, Victor; Gulias Herrero, Alfonso; Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico; [Olivas-Martinez, Antonio] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Ortiz-Brizuela, Edgar; Medrano-Borromeo, Carla; Martinez-Valenzuela, Alejandra; Marina Roman-Montes, Carla; Martinez-Guerra, Bernardo; Fernanda Gonzalez-Lara, Maria; Maria Tamez-Flores, Karla; Ochoa-Hein, Eric; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Hernandez-Gilsoul, Thierry] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Emergency Dept, Mexico City, DF, Mexico; [Galindo-Fraga, Arturo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Epidemiol, Mexico City, DF, Mexico; [Kershenobich-Stalnikowitz, David] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Gen Directors Off, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Washington; University of Washington Seattle; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Sifuentes-Osornio, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico.	sifuentesosornio@gmail.com	Olivas-Martinez, Antonio/GNP-3729-2022; Ortiz-Brizuela, Edgar/U-6302-2019	Olivas-Martinez, Antonio/0000-0003-2779-0068; Ortiz-Brizuela, Edgar/0000-0001-7169-8459; Jimenez, Jose Victor/0000-0002-9209-0327; Hernandez-Gilsoul, Thierry/0000-0002-9389-9945; Roman Montes, Carla Marina/0000-0002-2509-618X; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Martinez-Guerra, Bernardo Alfonso/0000-0002-5191-2179				[Anonymous], 2020, CHEST, DOI DOI 10.1016/J.CHEST.2020.07.028; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Basto-Abreu A, 2020, SALUD PUBLICA MEXICO, V62, P50, DOI 10.21149/10752; Berenguer J, 2020, CLIN MICROBIOL INFEC, V26, P1525, DOI 10.1016/j.cmi.2020.07.024; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Burki T, 2020, LANCET INFECT DIS, V20, P547, DOI 10.1016/S1473-3099(20)30303-0; Cardoso LTQ, 2007, CRIT CARE, V11, P94, DOI [10.1186/cc5881, DOI 10.1186/CC5881]; Cardoso LTQ, 2011, CRIT CARE, V15, DOI 10.1186/cc9975; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cowan RM, 2005, CRIT CARE, V9, P291, DOI 10.1186/cc2981; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Encuesta nacional de Salud y Nutricion, 2018, PRES RES; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Gutierrez JP, 2012, NATL HLTH NUTR SURVE; Hernandez H., 2020, COM NO 061 GOB AN RE; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1201; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Ortiz-Brizuela E, 2020, REV INVEST CLIN, V72, P165, DOI [10.24875/ric.20000334, 10.24875/RIC.20000334, 10.24875/RIC.20000211, 10.24875/ric.20000211]; Phua J, 2020, CRIT CARE MED, V48, P654, DOI 10.1097/CCM.0000000000004222; Quah P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03006-1; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rieg S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242127; Schuler MS, 2017, AM J EPIDEMIOL, V185, P65, DOI 10.1093/aje/kww165; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6726; Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270; Vincent JL, 2020, LANCET RESP MED, V8, P430, DOI 10.1016/S2213-2600(20)30165-X; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wallace DJ, 2015, AM J RESP CRIT CARE, V191, P410, DOI 10.1164/rccm.201409-1746OC; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Bello-Chavolla OY, 2020, J CLIN ENDOCR METAB, V105, P2752, DOI 10.1210/clinem/dgaa346; Zuniga-Moya JC, 2021, CLIN INFECT DIS, V72, pE476, DOI 10.1093/cid/ciaa1188	43	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245772	10.1371/journal.pone.0245772	http://dx.doi.org/10.1371/journal.pone.0245772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534813	gold, Green Published			2022-12-26	WOS:000616739700022
J	Tome, R; Rangel, MA; Gibson-Davis, CM; Bellows, L				Tome, Romina; Rangel, Marcos A.; Gibson-Davis, Christina M.; Bellows, Laura			Heightened immigration enforcement impacts US citizens' birth outcomes: Evidence from early ICE interventions in North Carolina	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PREGNANCY; STRESS; HEALTH; DEPORTATION; ASSOCIATION; CHILDREN; ANXIETY; INDEX	We examine how increased Immigration and Customs Enforcement (ICE) activities impacted newborn health and prenatal care utilization in North Carolina around the time Section 287(g) of the Immigration and Nationality Act was first being implemented within the state. Focusing on administrative data between 2004 and 2006, we conduct difference-in-differences and triple-difference case-control regression analysis. Pregnancies were classified by levels of potential exposure to immigration enforcement depending on parental nativity and educational attainment. Contrast groups were foreign-born parents residing in nonadopting counties and all US-born non-Hispanic parents. The introduction of the program was estimated to decrease birth weight by 58.54 grams (95% confidence interval [CI], -83.52 to -33.54) with effects likely following from reduced intrauterine growth. These results are shown to coexist with a worsening in the timing of initiation and frequency of prenatal care received. Since birth outcomes influence health, education, and earnings trajectories, our findings suggest that the uptick in ICE activities can have large socioeconomic costs over US-born citizens.	[Tome, Romina; Rangel, Marcos A.; Gibson-Davis, Christina M.; Bellows, Laura] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Tome, Romina] Amer Inst Res, Washington, DC USA; [Bellows, Laura] Univ Virginia, Curry Sch Educ & Human Dev, Charlottesville, VA USA	Duke University; American Institutes for Research; University of Virginia	Gibson-Davis, CM (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.	cgibson@duke.edu	Bellows, Laura/AAS-6882-2021	Bellows, Laura/0000-0003-4388-0696; De Almeida Rangel, Marcos/0000-0001-9527-5127	NICHD NIH HHS [P2C HD065563] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abraham S, 2018, SSRN ELECT J; Aizer A, 2014, SCIENCE, V344, P856, DOI 10.1126/science.1251872; Almond D, 2011, REV ECON STAT, V93, P387, DOI 10.1162/REST_a_00089; Arbona C, 2010, HISPANIC J BEHAV SCI, V32, P362, DOI 10.1177/0739986310373210; Arriaga F, 2017, SOCIOL RACE ETHNIC, V3, P417, DOI 10.1177/2332649217700923; Athey S., 2018, W24963 NBER; Barbazanges A, 1996, J NEUROSCI, V16, P3943; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Brabeck KM, 2014, AM J ORTHOPSYCHIAT, V84, P496, DOI 10.1037/ort0000011; Capps R., 2011, DELEGATION DIVERGENC; Capps R., 2018, REVVING DEPORTATION; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Castaneda H, 2015, ANNU REV PUBL HEALTH, V36, P375, DOI 10.1146/annurev-publhealth-032013-182419; Chaudry A., 2010, INT MIGR REV, DOI DOI 10.1111/IMRE.12106.16; Dee TS, 2020, AM EDUC RES J, V57, P694, DOI 10.3102/0002831219860816; Dreby J, 2012, J MARRIAGE FAM, V74, P829, DOI 10.1111/j.1741-3737.2012.00989.x; East C.N., 2018, 11486 IZA DP; Eika L, 2019, J POLIT ECON, V127, P2795, DOI 10.1086/702018; Ellis M, 2016, ANN AM ASSOC GEOGR, V106, P891, DOI 10.1080/24694452.2015.1135725; Gemmill A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7084; Golash-Boza T, 2013, LAT STUD, V11, P271, DOI 10.1057/lst.2013.14; Gonzalez-Barrera A., 2016, US IMMIGRANT DEPORTA; Goodman-Bacon, 2018, W25018 NBER; Governor's Office of Hispanic/Latino Affairs, 2011, DEMOGRAPHIC TRENDS H; Hagan J, 2003, INT MIGR REV, V37, P444; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Hoffman S, 1996, PAEDIATR PERINAT EP, V10, P380, DOI 10.1111/j.1365-3016.1996.tb00063.x; Hoynes H, 2011, J PUBLIC ECON, V95, P813, DOI 10.1016/j.jpubeco.2010.12.006; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Koball H., 2015, HLTH SOCIAL SERVICE; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242; Nguyen MT, 2016, URBAN STUD, V53, P302, DOI 10.1177/0042098014563029; Majzoub JA, 1999, AM J OBSTET GYNECOL, V180, pS242, DOI 10.1016/S0002-9378(99)70708-8; McLean M, 1999, TRENDS ENDOCRIN MET, V10, P174, DOI 10.1016/S1043-2760(98)00146-5; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Nguyen M. T., 2010, 287 G PROGRAM COSTS; Novak NL, 2017, INT J EPIDEMIOL, V46, P839, DOI 10.1093/ije/dyw346; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Passel J.S., 2019, US UNAUTHORIZED IMMI; Passel J.S., 2019, MEXICANS DECLINE LES; Pham H., 2018, WASH LEE L REV, V75, P1253; Potochnick S, 2017, J IMMIGR MINOR HEALT, V19, P1042, DOI 10.1007/s10903-016-0464-5; Rhodes SD, 2015, AM J PUBLIC HEALTH, V105, P329, DOI 10.2105/AJPH.2014.302218; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; Torche F, 2019, AM J EPIDEMIOL, V188, P24, DOI 10.1093/aje/kwy218; US President, 2017, EXECUTIVE ORDER ENHA; Wallace SP, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2018.10.016; Watson T, 2014, AM ECON J-ECON POLIC, V6, P313, DOI 10.1257/pol.6.3.313; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041; Yang SM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-104; Young MED, 2019, AM J PUBLIC HEALTH, V109, P1171, DOI [10.2105/ajph.2019.305171, 10.2105/AJPH.2019.305171]; Young MED, 2019, ETHNIC HEALTH, V24, P960, DOI 10.1080/13557858.2017.1390074; Yu B, 2018, ACTA PAEDIATR, V107, P86, DOI 10.1111/apa.13993	59	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245020	10.1371/journal.pone.0245020	http://dx.doi.org/10.1371/journal.pone.0245020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534807	Green Published, gold			2022-12-26	WOS:000616739700037
J	Yang, YM; Hu, XQ; Liu, P; Chen, L; Peng, H; Wang, QM; Zhang, Q				Yang, Yanmei; Hu, Xianqi; Liu, Pei; Chen, Li; Peng, Huan; Wang, Qiaomei; Zhang, Qi			A new root-knot nematode, Meloidogyne vitis sp. nov. (Nematoda: Meloidogynidae), parasitizing grape in Yunnan	PLOS ONE			English	Article							N.-SP NEMATODA; MOLECULAR CHARACTERIZATION; IDENTIFICATION; DNA; COFFEE; CROPS; RDNA; FLORIDENSIS; POPULATIONS; ROOTSTOCKS	An unknown root-knot nematode was found at high density on grape roots collected from Yunnan Province. Morphometric traits and measurements, isozyme phenotypes, and molecular analysis clearly differentiated this nematode from previously described root-knot nematodes. This new species is described, illustrated and named Meloidogyne vitis sp. nov. The new species can be distinguished from other Meloidogyne spp. by a unique combination of characters. Females display a prominent neck, an excretory pore is located on the ventral region between 23rd and 25th annule behind lips, an EP/ST ratio of approximately 2.5 (1.98-2.96), a perineal pattern with two large and prominent phasmids, and a labial disc fused with the medial lips to form a dumbbell-shaped structure. Males display an obvious head region, a labial disc fused with the medial lips to form a dumbbell-shaped structure, no lateral lips, a prominent slit-like opening between the labial disc and medial lips, a distinct sunken appearance of the middle of the medial lips, and four incisures in the lateral field. Second-stage juveniles are characterized by a head region with slightly wrinkled mark, a labial disc fused with the medial lips to form a dumbbell-shaped structure, a slightly sunken appearance of the middle of the medial lips, a slit-like amphidial openings between the labial disc and lateral lips, and four incisures in the lateral field. The new species has rare Mdh (N3d) and Est phenotypes (VF1). Phylogenetic analysis based on ITS1-5.8S-ITS2, D2D3 fragments of rDNA, and coxI and coxII fragments of mtDNA sequences clearly separated the new species from other root-knot nematodes, and the closest relative was Meloidogyne mali. Meloidogyne mali was collected for amplifying these sequences as mentioned above, which were compared with the corresponding sequences of new species, the result showed that all of these sequences with highly base divergence (48-210 base divergence). Moreover, sequence characterized amplified region (SCAR) primers for rapid identification of this new species were designed.	[Yang, Yanmei; Hu, Xianqi; Liu, Pei; Wang, Qiaomei; Zhang, Qi] Yunnan Agr Univ, Coll Plant Protect, Kunming, Yunnan, Peoples R China; [Yang, Yanmei; Hu, Xianqi; Liu, Pei; Wang, Qiaomei; Zhang, Qi] Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China; [Chen, Li] Shanxi Acad Agr Sci, Wheat Res Inst, Linfen, Shanxi, Peoples R China; [Peng, Huan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Yunnan Agricultural University; Yunnan Agricultural University; Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Hu, XQ (corresponding author), Yunnan Agr Univ, Coll Plant Protect, Kunming, Yunnan, Peoples R China.; Hu, XQ (corresponding author), Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China.	xqh@ynau.edu.cn		Pei, LIU/0000-0002-0280-9933	National Key Research and Development Project [2018YFD0201202, 2017YFD0200601]	National Key Research and Development Project	This work was supported by grants from the National Key Research and Development Project (Nos. 2018YFD0201202; 2017YFD0200601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; Ahmed M, 2016, SOIL-GERMANY, V2, P257, DOI 10.5194/soil-2-257-2016; Ali N, 2015, EUR J PLANT PATHOL, V143, P25, DOI 10.1007/s10658-015-0662-3; [Anonymous], 1988, Natl Inst Health Consens Dev Conf Consens Statement, V7, P1; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Baidoo R, 2016, J NEMATOL, V48, P193; Blok VC, 1997, J NEMATOL, V29, P16; Carneiro RMDG, 2007, NEMATOLOGY, V9, P635, DOI 10.1163/156854107782024794; Carneiro RMDG, 2014, NEMATOLOGY, V16, P289, DOI 10.1163/15685411-00002765; Castillo P, 2009, PLANT PATHOL, V58, P606, DOI 10.1111/j.1365-3059.2008.01991.x; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; EISENBACK J D, 1979, Scanning Electron Microscopy, P223; EISENBACK JD, 1980, J NEMATOL, V12, P300; Elling AA, 2013, PHYTOPATHOLOGY, V103, P1092, DOI 10.1094/PHYTO-01-13-0019-RVW; Esbenshade P. R., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P115; ESBENSHADE PR, 1985, J NEMATOL, V17, P6; ESBENSHADE PR, 1990, J NEMATOL, V22, P10; Esmenjaud Daniel, 2009, V4, P195, DOI 10.1007/978-1-4020-9858-1_8; Garcia LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121142; Fourie H, 2001, NEMATOLOGY, V3, P675, DOI 10.1163/156854101753536046; FRANKLIN M T, 1961, J Helminthol, VSuppl, P85; FRANKLIN MARY T., 1965, NEMATOLOGICA, V11, P79; Gao Y, 2007, HEBEI FRUITS, P1; Ge JJ, 2018, CHINESE ENTRY PHYTOS, V1st; GOLDEN AM, 1981, J NEMATOL, V13, P393; Handoo ZA, 2005, J NEMATOL, V37, P343; Handoo ZA, 2004, J NEMATOL, V36, P20; Howland AD, 2015, J NEMATOL, V47, P141; Htay C, 2016, EUR J PLANT PATHOL, V146, P281, DOI 10.1007/s10658-016-0913-y; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; ITOH Y, 1969, Applied Entomology and Zoology, V4, P194; Janssen T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172190; Kiewnick S, 2015, PHYTOPATHOLOGY, V105, P1245, DOI 10.1094/PHYTO-12-14-0364-R; Kiewnick S, 2014, EUR J PLANT PATHOL, V140, P97, DOI 10.1007/s10658-014-0446-1; Krithika V., 2015, Agricultural Reviews, V36, P313; Landa BB, 2008, PLANT DIS, V92, P1104, DOI 10.1094/PDIS-92-7-1104; Li HY, 2006, PLANT CELL PHYSIOL, V47, P154, DOI 10.1093/pcp/pci231; [廖金铃 Liao Jinling], 2003, [华中农业大学学报, Journal of Huazhong Agricultural University], V22, P544; Liu GK, 2001, J SHENYANG AGR U, V32, P167; Liu Y, 2017, ANHUI AGR SCI B, V23, P76; Maleita CM, 2016, PLANT DIS, V100, P1725, DOI 10.1094/PDIS-01-16-0112-RE; MCLEOD RW, 1973, NEMATOLOGICA, V19, P561, DOI 10.1163/187529273X00583; Muniz MDS, 2008, NEMATOLOGY, V10, P897, DOI 10.1163/156854108786161418; Nicol J. M., 1999, Australian Journal of Grape and Wine Research, V5, P109, DOI 10.1111/j.1755-0238.1999.tb00295.x; Niu J., 2011, PRELIMINARY STUDY BA; POWERS TO, 1993, J NEMATOL, V25, P1; Powers TO, 1997, J NEMATOL, V29, P441; Rahmani M., 2015, Australian Journal of Crop Science, V9, P55; Randig O, 2002, GENOME, V45, P862, DOI [10.1139/g02-054, 10.1139/G02-054]; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Smith BP, 2017, AUST J GRAPE WINE R, V23, P125, DOI 10.1111/ajgw.12242; Smith HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193121; Smith T, 2015, NEMATROPICA, V45, P138; STIRLING GR, 1984, AUST J EXP AGR, V24, P277, DOI 10.1071/EA9840277; Tao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182627; Trinh QP, 2019, J HELMINTHOL, V93, P242, DOI [10.1017/S0022149X18000202, 10.1017/s0022149x18000202]; VRAIN TC, 1992, FUND APPL NEMATOL, V15, P563; Wu B., 2018, THESIS, DOI [10.27159/d.cnki.ghzsu.2018.000405, DOI 10.27159/D.CNKI.GHZSU.2018.000405]; Wu Y., 2011, THESIS, DOI [10.7666/d.y1878300, DOI 10.7666/D.Y1878300]; Xie H., 2000, TAXONOMY PLANT NEMAT, V1st; Xie H., 2005, TAXONOMY PLANT NEMAT; Yang YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069463; Ye WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143556; Zhang Y, 2015, INT J GYNECOL CANCER, V25, P4, DOI 10.1097/IGC.0000000000000314; Zijlstra C, 2004, EUR J PLANT PATHOL, V110, P855, DOI 10.1007/s10658-004-2492-6; 2010, ROOTKNOT NEMATODES, P1; 2014, CHEM BIOL, V21, P1	67	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245201	10.1371/journal.pone.0245201	http://dx.doi.org/10.1371/journal.pone.0245201			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534787	Green Published, gold			2022-12-26	WOS:000616739700015
J	Bukiya, AN; Leo, MD; Jaggar, JH; Dopico, AM				Bukiya, Anna N.; Leo, M. Dennis; Jaggar, Jonathan H.; Dopico, Alex M.			Cholesterol activates BK channels by increasing KCNMB1 protein levels in the plasmalemma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; MEMBRANE CHOLESTEROL; BETA-1 SUBUNIT; CALCIUM; KINETICS; COMPLEX; VASOCONSTRICTION; ORGANIZATION; SPECIFICITY	Calcium-/voltage-gated, large-conductance potassium channels (BKs) control critical physiological processes, including smooth muscle contraction. Numerous observations concur that elevated membrane cholesterol (CLR) inhibits the activity of homomeric BKs consisting of channel-forming alpha subunits. In mammalian smooth muscle, however, native BKs include accessory KCNMB1 (beta(1)) subunits, which enable BK activation at physiological intracellular calcium. Here, we studied the effect of CLR enrichment on BK currents from rat cerebral artery myocytes. Using inside-out patches from middle cerebral artery (MCA) myocytes at [Ca2+](free)=30 mu M, we detected BK activation in response to in vivo and in vitro CLR enrichment of myocytes. While a significant increase in myocyte CLR was achieved within 5 min of CLR in vitro loading, this brief CLR enrichment of membrane patches decreased BK currents, indicating that BK activation by CLR requires a protracted cellular process. Indeed, blocking intracellular protein trafficking with brefeldin A (BFA) not only prevented BK activation but led to channel inhibition upon CLR enrichment. Surface protein biotinylation followed by Western blotting showed that BFA blocked the increase in plasmalemmal KCNMB1 levels achieved via CLR enrichment. Moreover, CLR enrichment of arteries with naturally high KCNMB1 levels, such as basilar and coronary arteries, failed to activate BK currents. Finally, CLR enrichment failed to activate BK channels in MCA myocytes from KCNMB1(-/-) mouse while activation was detected in their wild-type (C57BL/6) counterparts. In conclusion, the switch in CLR regulation of BK from inhibition to activation is determined by a trafficking-dependent increase in membrane levels of KCNMB1 subunits.	[Bukiya, Anna N.; Dopico, Alex M.] Univ Tennessee, Coll Med, Dept Pharmacol Addict Sci & Toxicol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Leo, M. Dennis; Jaggar, Jonathan H.] Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Bukiya, AN; Dopico, AM (corresponding author), Univ Tennessee, Coll Med, Dept Pharmacol Addict Sci & Toxicol, Hlth Sci Ctr, Memphis, TN 38163 USA.	abukiya@uthsc.edu; adopico@uthsc.edu			NIH [AA023764, HL147315, HL148941, HL133256, HL137745]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AA023764 (A. B.), HL147315 (A. D.), HL148941 (A. B. and A. D.), HL133256, and HL137745 (J. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babiychuk EB, 2004, J MEMBRANE BIOL, V198, P95, DOI 10.1007/s00232-004-0663-1; Bailey CS, 2019, J GEN PHYSIOL, V151, P1173, DOI 10.1085/jgp.201912457; Bentzen BH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00389; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; BREGESTOVSKI PD, 1989, BIOMED BIOCHIM ACTA, V48, pS382; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Budiyanto M., 2019, J PHYS C SER, V1417; Bukiya A., 2017, ADDICTIVE SUBSTANCES, P355; Bukiya A, 2014, ALCOHOL CLIN EXP RES, V38, P1216, DOI 10.1111/acer.12373; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2011, ARTERIOSCL THROM VAS, V31, P2410, DOI 10.1161/ATVBAHA.111.233965; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; Choubey A, 2013, BIOPHYS J, V104, P2429, DOI 10.1016/j.bpj.2013.04.036; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; Dopico AM, 2012, PHARMACOL THERAPEUT, V135, P133, DOI 10.1016/j.pharmthera.2012.05.002; Dopico AM, 2018, PFLUG ARCH EUR J PHY, V470, P1271, DOI 10.1007/s00424-018-2151-y; Evanson KW, 2014, CIRC RES, V115, P423, DOI 10.1161/CIRCRESAHA.115.303407; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Geng YY, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00532; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Gonzalez-Perez V, 2019, ANNU REV PHYSIOL, V81, P113, DOI 10.1146/annurev-physiol-022516-034038; Gu RX, 2019, J CHEM THEORY COMPUT, V15, P2064, DOI 10.1021/acs.jctc.8b00933; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; JAGANNATHAN SN, 1974, J CLIN INVEST, V54, P366, DOI 10.1172/JCI107772; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jiang QX, 2019, ADV EXP MED BIOL, V1115, P167, DOI 10.1007/978-3-030-04278-3_8; Kuntamallappanavar G, 2017, PFLUG ARCH EUR J PHY, V469, P263, DOI 10.1007/s00424-016-1929-z; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Lange Y, 2016, CHEM PHYS LIPIDS, V199, P74, DOI 10.1016/j.chemphyslip.2016.02.003; Latorre R, 2017, PHYSIOL REV, V97, P39, DOI 10.1152/physrev.00001.2016; Leo MD, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5417; Leo MD, 2015, AM J PHYSIOL-CELL PH, V309, pC392, DOI 10.1152/ajpcell.00127.2015; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; MIETTINEN M, 1994, MODERN PATHOL, V7, P82; North K, 2018, J PHARMACOL EXP THER, V367, P234, DOI 10.1124/jpet.118.250514; Ogasawara F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39973-x; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Palacio S, 2015, ALCOHOL CLIN EXP RES, V39, P1619, DOI 10.1111/acer.12808; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; Prendergast C, 2010, CELL CALCIUM, V47, P84, DOI 10.1016/j.ceca.2009.11.009; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Ridsdale A, 2006, MOL BIOL CELL, V17, P1593, DOI 10.1091/mbc.E05-02-0100; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Silberberg SD, 1996, BIOPHYS J, V70, P2640, DOI 10.1016/S0006-3495(96)79833-8; Singh AK, 2012, J BIOL CHEM, V287, P20509, DOI 10.1074/jbc.M112.356261; Slayden A, 2020, JOVE-J VIS EXP, DOI 10.3791/60734; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Tajima N, 2011, J BIOL CHEM, V286, P5624, DOI 10.1074/jbc.M110.149898; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Wen DH, 2013, AM J PHYSIOL-RENAL, V305, pF463, DOI 10.1152/ajprenal.00171.2013; Wiecha J, 1997, BASIC RES CARDIOL, V92, P233, DOI 10.1007/BF00788518; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572; Zhai X, 2017, CIRC RES, V121, P650, DOI 10.1161/CIRCRESAHA.117.311102	69	4	4	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100381	10.1016/j.jbc.2021.100381	http://dx.doi.org/10.1016/j.jbc.2021.100381			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556372	gold, Green Published			2022-12-26	WOS:000672866400355
J	Liu, XX; Liu, XY; Zhou, CC; Lv, JN; He, XB; Liu, YY; Xie, HH; Wang, B; Lv, XJ; Tang, LC; Li, MC; Liu, CB; Zhao, JZ; Liu, Y; Song, ZM; Gu, F				Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Changbao; Zhao, Junzhao; Liu, Yong; Song, Zongming; Gu, Feng			Engineered FnCas12a with enhanced activity through directional evolution in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPF1; DNA; ENDONUCLEASE; RNA; COMPLEX; MICE	Clustered regularly interspaced short palindromic repeat-Cas12a has been harnessed to manipulate the human genome; however, low cleavage efficiency and stringent protospacer adjacent motif hinder the use of Cas12a-based therapy and applications. Here, we have described a directional evolving and screening system in human cells to identify novel FnCas12a variants with high activity. By using this system, we identified IV-79 (enhanced activity FnCas12a, eaFnCas12a), which possessed higher DNA cleavage activity than WT FnCas12a. Furthermore, to widen the target selection spectrum, eaFnCas12a was engineered through site-directed mutagenesis. eaFnCas12a and one engineered variant (eaFnCas12a-RR), used for correcting human RS1 mutation responsible for X-linked retinoschisis, had a 3.28- to 4.04-fold improved activity compared with WT. Collectively, eaFnCas12a and its engineered variants can be used for genome-editing applications that requires high activity.	[Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Yong; Song, Zongming; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab, Wenzhou, Zhejiang, Peoples R China; [Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Yong; Song, Zongming; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Key Lab Vis Sci,Minist Hlth, Wenzhou, Zhejiang, Peoples R China; [Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Yong; Song, Zongming; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Clin Coll 2, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Song, Zongming] Henan Prov Peoples Hosp, Henan Eye Hosp, Henan Eye Inst, Zhengzhou, Henan, Peoples R China; [Song, Zongming] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Henan, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Zhengzhou University; Zhengzhou University	Gu, F (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab, Wenzhou, Zhejiang, Peoples R China.; Gu, F (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Key Lab Vis Sci,Minist Hlth, Wenzhou, Zhejiang, Peoples R China.; Gu, F (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	gufenguw@gmail.com	liu, yuanyuan/GWZ-5838-2022	Gu, Feng/0000-0002-9019-2960; Gu, Feng/0000-0002-9600-8407	National Key R&D Program of China [2018YFA0107304]; National Natural Science Foundation of China [81201181, 81670882]; Science and Technology Project of Zhejiang Province [2017C37176]; Natural Science Foundation of Zhejiang Provincial [LQ18C060003]; Zhejiang Provincial &Ministry of Health research fund for medical sciences [WKJ-ZJ-1828]; Wenzhou City Key Innovation Team of Reproductive Genetics Grant, Zhejiang, China [C20170007]; Lin He's Academician Workstation of New Medicine and Clinical Translation [17331209, 18331105]; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University [J02-20190201]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province; Natural Science Foundation of Zhejiang Provincial(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial &Ministry of Health research fund for medical sciences; Wenzhou City Key Innovation Team of Reproductive Genetics Grant, Zhejiang, China; Lin He's Academician Workstation of New Medicine and Clinical Translation; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University	This work was supported by grants from National Key R&D Program of China (2018YFA0107304), National Natural Science Foundation of China (81201181 and 81670882), Science and Technology Project of Zhejiang Province (2017C37176), Natural Science Foundation of Zhejiang Provincial (LQ18C060003), Zhejiang Provincial &Ministry of Health research fund for medical sciences (WKJ-ZJ-1828), Wenzhou City Key Innovation Team of Reproductive Genetics Grant, Zhejiang, China (No. C20170007), Lin He's Academician Workstation of New Medicine and Clinical Translation (17331209 and 18331105) and Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University (J02-20190201).	Ambrosio L, 2019, INVEST OPHTH VIS SCI, V60, P4872, DOI 10.1167/iovs.19-27897; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Chen D, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00453; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chen XY, 2018, ISCIENCE, V6, P247, DOI 10.1016/j.isci.2018.08.001; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Lin L, 2018, MOL THER, V26, P2650, DOI 10.1016/j.ymthe.2018.08.021; Lin QP, 2020, NAT BIOTECHNOL, V38, P582, DOI 10.1038/s41587-020-0455-x; Moon SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06129-w; Park HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05641-3; Schindele P, 2018, FEBS LETT, V592, P1954, DOI 10.1002/1873-3468.13073; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Tang Lianchao, 2019, Cell Regen, V8, P44, DOI 10.1016/j.cr.2019.08.002; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.18; Teng F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1620-8; Toth E, 2018, NUCLEIC ACIDS RES, V46, P10272, DOI 10.1093/nar/gky815; Tu MJ, 2017, NUCLEIC ACIDS RES, V45, P11295, DOI 10.1093/nar/gkx783; Wu WY, 2018, NAT CHEM BIOL, V14, P642, DOI 10.1038/s41589-018-0080-x; Xie HH, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000747; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang FY, 2018, J GENET GENOMICS, V45, P329, DOI 10.1016/j.jgg.2018.02.009; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814; Zhu HC, 2020, NAT REV MOL CELL BIO, V21, P661, DOI 10.1038/s41580-020-00288-9	37	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100394	10.1016/j.jbc.2021.100394	http://dx.doi.org/10.1016/j.jbc.2021.100394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567342	Green Published, gold			2022-12-26	WOS:000672866400368
J	Hatayama, K; Chen, RH; Hanson, J; Teshigawara, K; Qiu, J; Santoso, A; Disdier, C; Nakada, S; Chen, XD; Nishibori, M; Lim, YP; Stonestreet, BS				Hatayama, Kazuki; Chen, Ray H.; Hanson, Jordan; Teshigawara, Kiyoshi; Qiu, Joseph; Santoso, Andre; Disdier, Clemence; Nakada, Sakura; Chen, Xiaodi; Nishibori, Masahiro; Lim, Yow-Pin; Stonestreet, Barbara S.			High-mobility group box-1 and inter-alpha inhibitor proteins: In vitro binding and co-localization in cerebral cortex after hypoxic-ischemic injury	FASEB JOURNAL			English	Article						brain injury; high&#8208; mobility group box 1; hypoxia&#8208; ischemia; inter&#8208; alpha inhibitor proteins; inter&#8208; alpha inhibitor proteins		The high-mobility group box-1 (HMGB1) protein is a transcription-regulating protein located in the nucleus. However, it serves as a damage-associated molecular pattern protein that activates immune cells and stimulates inflammatory cytokines to accentuate neuroinflammation after release from damaged cells. In contrast, Inter-alpha Inhibitor Proteins (IAIPs) are proteins with immunomodulatory effects including inhibition of pro-inflammatory cytokines. We have demonstrated that IAIPs exhibit neuroprotective properties in neonatal rats exposed to hypoxic-ischemic (HI) brain injury. In addition, previous studies have suggested that the light chain of IAIPs, bikunin, may exert its anti-inflammatory effects by inhibiting HMGB1 in a variety of different injury models in adult subjects. The objectives of the current study were to confirm whether HMGB1 is a target of IAIPs by investigating the potential binding characteristics of HMGB1 and IAIPs in vitro, and co-localization in vivo in cerebral cortices after exposure to HI injury. Solid-phase binding assays and surface plasmon resonance (SPR) were used to determine the physical binding characteristics between IAIPs and HMGB1. Cellular localizations of IAIPs-HMGB1 in neonatal rat cortex were visualized by double labeling with anti-IAIPs and anti-HMGB1 antibodies. Solid-phase binding and SPR demonstrated specific binding between IAIPs and HMGB1 in vitro. Cortical cytoplasmic and nuclear co-localization of IAIPs and HMGB1 were detected by immunofluorescent staining in control and rats immediately and 3 hours after HI. In conclusion, HMGB1 and IAIPs exhibit direct binding in vitro and co-localization in vivo in neonatal rats exposed to HI brain injury suggesting HMGB1 could be a target of IAIPs.	[Hatayama, Kazuki; Chen, Ray H.; Hanson, Jordan; Disdier, Clemence; Nakada, Sakura; Chen, Xiaodi; Stonestreet, Barbara S.] Brown Univ, Women & Infants Hosp Rhode Isl, Alpert Med Sch, Providence, RI 02905 USA; [Teshigawara, Kiyoshi; Nishibori, Masahiro] Okayama Univ, Grad Sch Med, Dept Pharmacol, Okayama, Japan; [Qiu, Joseph; Santoso, Andre; Lim, Yow-Pin] ProThera Biol Inc, Providence, RI USA; [Lim, Yow-Pin] Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02905 USA	Brown University; Women & Infants Hospital Rhode Island; Okayama University; Brown University	Stonestreet, BS (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Dept Pediat, Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	bstonestreet@wihri.org	Chen, Ray/GRJ-6736-2022; disdier, clemence/GWV-3085-2022	disdier, clemence/0000-0003-3107-3459; Chen, Xiaodi/0000-0002-1860-2814	NIH [1R21NS095130, 1R21NS096525, 2R01HD057100, 2R44 NS084575]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH (1R21NS095130, 1R21NS096525, 2R01HD057100, 2R44 NS084575).	Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Barrios-Anderson A, 2019, J NEUROPATH EXP NEUR, V78, P742, DOI 10.1093/jnen/nlz051; Bianchi ME, 2004, TRENDS CELL BIOL, V14, P287, DOI 10.1016/j.tcb.2004.04.004; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chaaban H, 2015, BLOOD, V125, P2286, DOI 10.1182/blood-2014-06-582759; Chaaban H, 2010, J PEDIATR-US, V157, P757, DOI 10.1016/j.jpeds.2010.04.075; Chaaban H, 2009, J PEDIATR-US, V154, P620, DOI 10.1016/j.jpeds.2008.10.008; Chen HM, 2014, INT J CLIN EXP MED, V7, P1483; Chen XD, 2019, EXP NEUROL, V317, P244, DOI 10.1016/j.expneurol.2019.03.013; Chen XD, 2019, EXP NEUROL, V311, P1, DOI 10.1016/j.expneurol.2018.09.007; COWAN WM, 1979, SCI AM, V241, P112, DOI 10.1038/scientificamerican0979-112; Delsesto D, 2011, CONTRIB MICROBIOL, V17, P137, DOI 10.1159/000324030; Disdier C, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060101; Disdier C, 2018, INT J DEV NEUROSCI, V65, P54, DOI 10.1016/j.ijdevneu.2017.10.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Gaudet CM, 2016, BEHAV BRAIN RES, V302, P88, DOI 10.1016/j.bbr.2016.01.016; Gulke E, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418774254; Hatayama K., 2021, FASEB J, V35; Htwe SS, 2018, BLOOD ADV, V2, P1923, DOI 10.1182/bloodadvances.2018018986; Kim B, 2020, J NEUROSCI RES, V98, P869, DOI 10.1002/jnr.24565; Kim SW, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0747-x; Koga Y, 2010, NEUROL RES, V32, P925, DOI 10.1179/016164110X12645013515133; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Li XF, 2018, EXP NEUROL, V302, P68, DOI 10.1016/j.expneurol.2017.12.016; Lim Yow-Pin, 2013, R I Med J (2013), V96, P16; Lim YP, 2005, J CHROMATOGR A, V1065, P39, DOI 10.1016/j.chroma.2004.11.006; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Liu M, 2017, BIOMED PHARMACOTHER, V85, P412, DOI 10.1016/j.biopha.2016.11.044; Liu W, 2018, ONCOL LETT, V16, P4057, DOI 10.3892/ol.2018.9123; Logsdon AF, 2020, J CEREBR BLOOD F MET, V40, P1090, DOI 10.1177/0271678X19859465; Luo YP, 2017, INT J MOL MED, V39, P297, DOI 10.3892/ijmm.2016.2828; Magna M, 2016, CLIN THER, V38, P1029, DOI 10.1016/j.clinthera.2016.02.029; Nishibori M, 2019, J PHARMACOL SCI, V140, P94, DOI 10.1016/j.jphs.2019.04.006; Opal SM, 2011, SHOCK, V35, P42, DOI 10.1097/SHK.0b013e3181e83204; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rumajogee P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00057; Sadowska GB, 2015, J CEREBR BLOOD F MET, V35, P1388, DOI 10.1038/jcbfm.2015.134; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shah BA, 2017, J PEDIATR-US, V180, P135, DOI 10.1016/j.jpeds.2016.09.016; Singh K, 2010, PEDIATR RES, V68, P242, DOI 10.1203/00006450-201011001-00474; Spasova MS, 2017, DEV NEUROBIOL, V77, P726, DOI 10.1002/dneu.22451; Spasova MS, 2014, EXP BIOL MED, V239, P724, DOI 10.1177/1535370213519195; Sun Nian-Kang, 2005, Chang Gung Med J, V28, P673; Takahashi HK, 2013, EUR J PHARMACOL, V701, P194, DOI 10.1016/j.ejphar.2012.11.058; Threlkeld SW, 2017, BRAIN BEHAV IMMUN, V64, P173, DOI 10.1016/j.bbi.2017.03.004; Threlkeld SW, 2014, EXP NEUROL, V261, P424, DOI 10.1016/j.expneurol.2014.07.012; Tian QY, 2014, METHODS MOL BIOL, V1155, P163, DOI 10.1007/978-1-4939-0669-7_14; Tong Y, 2014, INT J MED SCI, V11, P337, DOI 10.7150/ijms.7861; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Wang DL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030643; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang SY, 2015, GENET MOL RES, V14, P4344, DOI 10.4238/2015.April.30.7; Wang WK, 2017, EXP THER MED, V14, P2497, DOI 10.3892/etm.2017.4824; Wu RQ, 2004, CRIT CARE MED, V32, P1747, DOI 10.1097/01.CCM.0000132903.14121.0E; Xu B, 2020, BRAIN RES, V1726, DOI 10.1016/j.brainres.2019.146495; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Ye YZ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00127; Zhang J, 2016, J NEUROPATH EXP NEUR, V75, P527, DOI 10.1093/jnen/nlw030; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458	69	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21399	10.1096/fj.202002109RR	http://dx.doi.org/10.1096/fj.202002109RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33559227				2022-12-26	WOS:000629576700050
J	O'Donnell, L; Rebourcet, D; Dagley, LF; Sgaier, R; Infusini, G; O'Shaughnessy, PJ; Chalmel, F; Fietz, D; Weidner, W; Legrand, JMD; Hobbs, RM; McLachlan, RI; Webb, AI; Pilatz, A; Diemer, T; Smith, LB; Stanton, PG				O'Donnell, Liza; Rebourcet, Diane; Dagley, Laura F.; Sgaier, Raouda; Infusini, Giuseppe; O'Shaughnessy, Peter J.; Chalmel, Frederic; Fietz, Daniela; Weidner, Wolfgang; Legrand, Julien M. D.; Hobbs, Robin M.; McLachlan, Robert, I; Webb, Andrew, I; Pilatz, Adrian; Diemer, Thorsten; Smith, Lee B.; Stanton, Peter G.			Sperm proteins and cancer-testis antigens are released by the seminiferous tubules in mice and men	FASEB JOURNAL			English	Article						biomarker; cancer&#8208; testis antigen; interstitial fluid; sperm; testis	PLASMA PROTEOME DATABASE; REGULATORY T-CELLS; CANCER/TESTIS ANTIGENS; SERTOLI-CELLS; ANTISPERM ANTIBODIES; SAMPLE PREPARATION; MESSENGER-RNAS; EXPRESSION; MOUSE; IDENTIFICATION	Sperm develop from puberty in the seminiferous tubules, inside the blood-testis barrier to prevent their recognition as "non-self" by the immune system, and it is widely assumed that human sperm-specific proteins cannot access the circulatory or immune systems. Sperm-specific proteins aberrantly expressed in cancer, known as cancer-testis antigens (CTAs), are often pursued as cancer biomarkers and therapeutic targets based on the assumption they are neoantigens absent from the circulation in healthy men. Here, we identify a wide range of germ cell-derived and sperm-specific proteins, including multiple CTAs, that are selectively deposited by the Sertoli cells of the adult mouse and human seminiferous tubules into testicular interstitial fluid (TIF) that is "outside" the blood-testis barrier. From TIF, the proteins can access the circulatory- and immune systems. Disruption of spermatogenesis decreases the abundance of these proteins in mouse TIF, and a sperm-specific CTA is significantly decreased in TIF from infertile men, suggesting that exposure of certain CTAs to the immune system could depend on fertility status. The results provide a rationale for the development of blood-based tests useful in the management of male infertility and indicate CTA candidates for cancer immunotherapy and biomarker development that could show sex-specific and male-fertility-related responses.	[O'Donnell, Liza; Sgaier, Raouda; Legrand, Julien M. D.; Hobbs, Robin M.; McLachlan, Robert, I; Stanton, Peter G.] Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia; [O'Donnell, Liza; Sgaier, Raouda; Legrand, Julien M. D.; Hobbs, Robin M.; McLachlan, Robert, I; Stanton, Peter G.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [O'Donnell, Liza; Rebourcet, Diane; Smith, Lee B.] Univ Newcastle, Fac Sci, Callaghan, NSW, Australia; [Dagley, Laura F.; Infusini, Giuseppe; Webb, Andrew, I] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Dagley, Laura F.; Infusini, Giuseppe; Webb, Andrew, I] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Sgaier, Raouda; Weidner, Wolfgang; Pilatz, Adrian; Diemer, Thorsten] Justus Liebig Univ Giessen, Med Fac, Dept Urol Pediat Urol & Androl, UKGM GmbH, Giessen, Germany; [O'Shaughnessy, Peter J.; Chalmel, Frederic] Univ Rennes, Irset Inst Rech Sante Environm & Travail, UMR S 1085, INSERM,EHESP, Rennes, France; [Fietz, Daniela] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Smith, Lee B.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Hudson Institute of Medical Research; Monash University; University of Newcastle; Walter & Eliza Hall Institute; University of Melbourne; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Justus Liebig University Giessen; University of Edinburgh	O'Donnell, L (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	Liza.ODonnell@hudson.org.au	Chalmel, Frédéric/L-5360-2018; Chalmel, Frédéric/AAM-1079-2021; Legrand, Julien/I-9365-2017	Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Legrand, Julien/0000-0001-5577-5645; Smith, Lee/0000-0002-4103-3074	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J015105/1]; Department of Health | National Health and Medical Research Council (NHMRC) [10099002]; Victorian State Government Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft (DFG); Medical Research Council Program Grant Award [MR/N002970/1]; Society for Endocrinology	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Medical Research Council Program Grant Award; Society for Endocrinology	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/J015105/1; Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: 10099002; Victorian State Government Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft (DFG); Medical Research Council Program Grant Award, Grant/Award Number: MR/N002970/1; Society for Endocrinology	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Barton G., 2018, PROTEUS R PACKAGE DO; Bates CA, 1997, BRIT J UROL, V80, P691, DOI 10.1046/j.1464-410X.1997.00379.x; Bergmann M, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P155, DOI 10.1007/978-3-540-78355-8_11; BREUCKER H, 1985, CELL TISSUE RES, V240, P303; Bruggeman JW, 2018, ONCOGENE, V37, P5694, DOI 10.1038/s41388-018-0357-2; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chen HL, 2017, MOL CELL ENDOCRINOL, V445, P65, DOI 10.1016/j.mce.2016.10.010; Chiriva-Internati M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-61; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dabaja AA, 2013, ASIAN J ANDROL, V15, P35, DOI 10.1038/aja.2012.141; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Djureinovic D, 2018, LUNG CANCER, V125, P157, DOI 10.1016/j.lungcan.2018.09.012; DYM M, 1974, AM J ANAT, V140, P1, DOI 10.1002/aja.1001400102; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Gjerstorff MF, 2015, ONCOTARGET, V6, P15772, DOI 10.18632/oncotarget.4694; Gordeeva O, 2018, SEMIN CANCER BIOL, V53, P75, DOI 10.1016/j.semcancer.2018.08.006; Hedger MP, 2011, J ANDROL, V32, P625, DOI 10.2164/jandrol.111.012989; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Itoh M, 1999, AM J REPROD IMMUNOL, V42, P321; Jagadish N, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078965; Jones PA, 2019, NAT REV CANCER, V19, P151, DOI 10.1038/s41568-019-0109-9; Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011; Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152; Li XY, 2018, FASEB J, V32, P1653, DOI 10.1096/fj.201700681R; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Luconi M, 2011, FRONT BIOSCI-LANDMRK, V16, P1315, DOI 10.2741/3791; Luo B, 2013, INT J CLIN EXP PATHO, V6, P2835; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Marconi M, 2012, EUR UROL, V62, P713, DOI 10.1016/j.eururo.2012.03.004; Meinhardt A, 2018, J LEUKOCYTE BIOL, V104, P757, DOI 10.1002/JLB.3MR0318-086RR; Meinhardt A, 2011, MOL CELL ENDOCRINOL, V335, P60, DOI 10.1016/j.mce.2010.03.022; Mirandola L, 2015, ONCOTARGET, V6, P2812, DOI 10.18632/oncotarget.2802; Morales CR, 2002, DEV BIOL, V246, P480, DOI 10.1006/dbio.2002.0679; Mossadegh-Keller N, 2018, CELL IMMUNOL, V330, P120, DOI 10.1016/j.cellimm.2018.03.009; Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Naito M, 2012, MED MOL MORPHOL, V45, P185, DOI 10.1007/s00795-012-0587-2; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Olesen IA, 2018, HUM REPROD, V33, P1963, DOI 10.1093/humrep/dey283; Osuru HP, 2014, MOL REPROD DEV, V81, P896, DOI 10.1002/mrd.22358; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peterson C, 1999, MOL HUM REPROD, V5, P627, DOI 10.1093/molehr/5.7.627; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rival C, 2013, J REPROD IMMUNOL, V100, P66, DOI 10.1016/j.jri.2013.08.004; RUSSELL LD, 1987, GAMETE RES, V17, P43, DOI 10.1002/mrd.1120170106; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; Samy ET, 2006, IMMUNOL REV, V212, P170, DOI 10.1111/j.0105-2896.2006.00404.x; Schooten E, 2018, CANCER TREAT REV, V67, P54, DOI 10.1016/j.ctrv.2018.04.009; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHARPE RM, 1992, INT J ANDROL, V15, P201, DOI 10.1111/j.1365-2605.1992.tb01340.x; Shires K, 2018, CRIT REV ONCOL HEMAT, V132, P17, DOI 10.1016/j.critrevonc.2018.09.010; Sielaff M, 2017, J PROTEOME RES, V16, P4060, DOI 10.1021/acs.jproteome.7b00433; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith LB, 2015, ANDROLOGY-US, V3, P1035, DOI 10.1111/andr.12107; Soffientini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4357-3; Song MH, 2012, ONCOL REP, V28, P1792, DOI 10.3892/or.2012.2002; Stanton PG, 2016, SEMIN CELL DEV BIOL, V59, P166, DOI 10.1016/j.semcdb.2016.06.018; Stanton PG, 2016, PROTEOMICS, V16, P2391, DOI 10.1002/pmic.201600107; Suryavathi V, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121095; Takahashi K, 2007, INT J ANDROL, V30, P21, DOI 10.1111/j.1365-2605.2006.00704.x; Thomas R, 2020, CANCER IMMUNOL IMMUN, V69, P449, DOI 10.1007/s00262-020-02480-4; Tung KSK, 2017, J CLIN INVEST, V127, P1046, DOI 10.1172/JCI89927; TUNG KSK, 1987, J IMMUNOL, V138, P752; TUNG KSK, 1975, CLIN EXP IMMUNOL, V20, P93; TURNER TT, 1984, ENDOCRINOLOGY, V115, P1925, DOI 10.1210/endo-115-5-1925; Ueda Shugo, 2018, Oncotarget, V9, P35997, DOI 10.18632/oncotarget.26323; Wang ZQ, 2004, CLIN CANCER RES, V10, P6544, DOI 10.1158/1078-0432.CCR-04-0911; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wosnitzer Matthew, 2014, Spermatogenesis, V4, pe28218; Xiao CY, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12786	83	10	10	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21397	10.1096/fj.202002484R	http://dx.doi.org/10.1096/fj.202002484R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565176	Green Published, hybrid			2022-12-26	WOS:000629576700047
J	Hernandez, MN; Lindow, SE				Hernandez, Monica N.; Lindow, Steven E.			Contact-dependent traits in Pseudomonas syringae B728a	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SURFACE; PATHOGEN; BACTERIA; STRESS; COLI; BIOAVAILABILITY; HETEROGENEITY; AERUGINOSA; MOTILITY	Production of the biosurfactant syringafactin by the plant pathogen Pseudomonas syringae B728a is a surface contact-dependent trait. Expression of syfA, as measured using a gfp reporter gene fusion was low in planktonic cells in liquid cultures but over 4-fold higher in cells immobilized on surfaces as varied as glass, plastic, paper, parafilm, agar, membrane filters, and leaves. Induction of syfA as measured by GFP fluorescence was rapid, occurring within two hours after immobilization of cells on surfaces. Comparison of the global transcriptome by RNA sequencing of planktonic cells in a nutrient medium with that of cells immobilized for 2 hours on filters placed on this solidified medium revealed that, in addition to syfA, 3156 other genes were differentially expressed. Genes repressed in immobilized cells included those involved in quaternary ammonium compound (QAC) metabolism and transport, compatible solute production, carbohydrate metabolism and transport, organic acid metabolism and transport, phytotoxin synthesis and transport, amino acid metabolism and transport, and secondary metabolism. Genes induced in immobilized cells included syfA plus those involved in translation, siderophore synthesis and transport, nucleotide metabolism and transport, flagellar synthesis and motility, lipopolysaccharide (LPS) synthesis and transport, energy generation, transcription, chemosensing and chemotaxis, replication and DNA repair, iron-sulfur proteins, peptidoglycan/cell wall polymers, terpenoid backbone synthesis, iron metabolism and transport, and cell division. That many genes are rapidly differentially expressed upon transfer of cells from a planktonic to an immobilized state suggests that cells experience the two environments differently. It seems possible that surface contact initiates anticipatory changes in P. syringae gene expression, which enables rapid and appropriate physiological responses to the different environmental conditions such as might occur in a biofilm. Such responses could help cells survive transitions from aquatic habitats fostering planktonic traits to attachment on surfaces, conditions that alternatively occur on leaves.	[Hernandez, Monica N.; Lindow, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Hernandez, Monica N.] Oregon State Univ, Southern Oregon Res & Extens Ctr, Dept Bot & Plant Pathol, Central Point, OR 97502 USA	University of California System; University of California Berkeley; Oregon State University	Hernandez, MN (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Hernandez, MN (corresponding author), Oregon State Univ, Southern Oregon Res & Extens Ctr, Dept Bot & Plant Pathol, Central Point, OR 97502 USA.	monica.hernandez@oregonstate.edu			NIH [S10 OD018174]; National Science Foundation Louis Stokes Alliances for Minority Participation Bridge to the Doctorate Fellowship [1249249]; William Carroll Smith Fellowship; Chancellor's Fellowship for Graduate Study	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Louis Stokes Alliances for Minority Participation Bridge to the Doctorate Fellowship; William Carroll Smith Fellowship; Chancellor's Fellowship for Graduate Study	This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. This work was also supported by the National Science Foundation Louis Stokes Alliances for Minority Participation Bridge to the Doctorate Fellowship (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1249249), the Chancellor's Fellowship for Graduate Study (https://grad.berkeley.edu/admissions/apply/fellowshipsentering/), and the William Carroll Smith Fellowship. These fellowships were awarded to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Alcalde-Rico M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01483; Axtell CA, 2002, APPL ENVIRON MICROB, V68, P4604, DOI 10.1128/AEM.68.9.4604-4612.2002; Banerjee S, 2011, J FOOD ENG, V102, P287, DOI 10.1016/j.jfoodeng.2010.08.025; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Berti AD, 2007, J BACTERIOL, V189, P6312, DOI 10.1128/JB.00725-07; Bhomkar P, 2010, GENE REGUL SYST BIO, V4, P1, DOI 10.4137/GRSB.S4525; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Burch AY, 2014, ENVIRON MICROBIOL, V16, P2086, DOI 10.1111/1462-2920.12437; Burch AY, 2011, ENVIRON MICROBIOL, V13, P2681, DOI 10.1111/j.1462-2920.2011.02534.x; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chang CY, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02671; Dublan MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110416; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Dulla G, 2005, ASM NEWS, V71, P469; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fones H, 2012, FEMS MICROBIOL LETT, V327, P1, DOI 10.1111/j.1574-6968.2011.02449.x; HAEFELE DM, 1987, APPL ENVIRON MICROB, V53, P2528, DOI 10.1128/AEM.53.10.2528-2533.1987; Hernandez MN, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01014-19; Hess FD, 2000, WEED TECHNOL, V14, P807, DOI 10.1614/0890-037X(2000)014[0807:IOSWPC]2.0.CO;2; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Joyner DC, 2000, MICROBIOL-UK, V146, P2435, DOI 10.1099/00221287-146-10-2435; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kimkes TEP, 2020, FEMS MICROBIOL REV, V44, P106, DOI 10.1093/femsre/fuz029; KING EO, 1954, J LAB CLIN MED, V44, P301; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; O'Toole GA, 2016, CURR OPIN MICROBIOL, V30, P139, DOI 10.1016/j.mib.2016.02.004; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; R Core Team, 2020, R LANG ENV STAT COMP; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Remus-Emsermann MNP, 2010, ISME J, V4, P215, DOI 10.1038/ismej.2009.110; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Temple TN, 2004, PHYTOPATHOLOGY, V94, P1286, DOI 10.1094/PHYTO.2004.94.12.1286; Tuson HH, 2013, SOFT MATTER, V9, P4368, DOI 10.1039/c3sm27705d; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; Wilson M, 1999, APPL ENVIRON MICROB, V65, P1435; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Wood LF, 2009, MOL MICROBIOL, V72, P183, DOI 10.1111/j.1365-2958.2009.06635.x; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110	53	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0241655	10.1371/journal.pone.0241655	http://dx.doi.org/10.1371/journal.pone.0241655			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571230	gold, Green Published, Green Submitted			2022-12-26	WOS:000620071100002
J	Madewell, ZJ; Chacon-Fuentes, R; Jara, J; Mejia-Santos, H; Molina, IB; Alvis-Estrada, JP; Coello-Licona, R; Montejo, B				Madewell, Zachary J.; Chacon-Fuentes, Rafael; Jara, Jorge; Mejia-Santos, Homer; Molina, Ida-Berenice; Alvis-Estrada, Juan Pablo; Coello-Licona, Rosa; Montejo, Belinda			Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras	PLOS ONE			English	Article							PREGNANT-WOMEN; RESPIRATORY ILLNESS; A(H1N1) INFLUENZA; UNITED-STATES; IMMUNIZATION; BARRIERS; SAFETY	Background Influenza during pregnancy may cause serious neonatal outcomes including stillbirth, fetal distress, preterm birth, congenital abnormalities, and stunted growth. Pregnant women are the highest priority group for seasonal influenza vaccination, but low coverage has been repeatedly reported in this population. Understanding reasons for and for not receiving the seasonal influenza vaccine is needed to design communication strategies to increase vaccination coverage. This study aimed to describe knowledge, attitudes, and practices (KAP) of seasonal influenza vaccination among women giving birth in public maternity hospitals in Honduras. Methods From August 20-October 8, 2018, we conducted a cross-sectional KAP survey regarding seasonal influenza vaccinations to a sample of postpartum women who gave birth in maternity hospitals and clinics from the Ministry of Health of Honduras and Honduran Social Security Institute. We reported frequency distributions for demographics, KAP of influenza vaccine, and vaccination coverage. We used logistic regression to analyze unadjusted and adjusted associations between sociodemographic characteristics and influenza vaccination. Results We surveyed 842 postpartum women in 17 healthcare facilities. Of 534 postpartum women with term pregnancy and verified vaccinations, 417 (78.1%; 95% CI: 74.6-81.6%) were vaccinated for influenza. Factors associated with verified influenza vaccination included receipt of vaccination recommendations by a healthcare worker during prenatal check-ups (aOR: 16.46; 95% CI: 9.73-27.85), concurrent chronic disease (aOR: 5.00; 95% CI: 1.25-20.07), and influenza vaccination of other children in the household (aOR: 2.28; 95% CI: 1.19-4.39). The most cited reasons for vaccination were perceived benefits for both mother and infant and easy access. Reasons for non-vaccination were: vaccine was not offered and fear of side effects, harm to the infant, and needles or pain caused by injection. Conclusion Influenza vaccination was well received among postpartum women in Honduras. Increasing clinician recommendations for vaccination and assuring the vaccine is readily available to women during prenatal visits may increase vaccination rates.	[Madewell, Zachary J.; Chacon-Fuentes, Rafael; Jara, Jorge; Alvis-Estrada, Juan Pablo] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Mejia-Santos, Homer] Secretaria Salud Honduras, Unidad Vigilancia Salud, Tegucigalpa, Honduras; [Molina, Ida-Berenice] Secretaria Salud Honduras, Programa Ampliado Inmunizac, Tegucigalpa, Honduras; [Coello-Licona, Rosa; Montejo, Belinda] Inst Hondureno Seguridad Social, Vigilancia Epidemiol, Tegucigalpa, Honduras	Universidad del Valle de Guatemala	Madewell, ZJ (corresponding author), Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala.	zmadewell@ufl.edu	Madewell, Zachary/AAM-4921-2020	Madewell, Zachary/0000-0002-5667-9660; Alvis-Estrada, Juan/0000-0002-1226-9344	Centers for Disease Control and Prevention [5U01GH00100305]; Fogarty International Center of the National Institutes of Health [D43TW009343]; University of California Global Health Institute	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute	This work was supported by the Centers for Disease Control and Prevention under CDCUVG cooperative agreement No. 5U01GH00100305. ZM was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW009343 and the University of California Global Health Institute.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2016, OKNO KRAJE OCT, VXII, P9; Arriola CS, 2016, VACCINE, V34, P1086, DOI 10.1016/j.vaccine.2015.12.065; Azziz-Baumgartner E, 2015, EMERG INFECT DIS, V21, P1209, DOI 10.3201/eid2107.140788; Badilla X, 2018, CONOCIMIENTOS ACTITU; Bartolo S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236793; Blanchard-Rohner G, 2012, J MATERN-FETAL NEO M, V25, P1800, DOI 10.3109/14767058.2012.663835; Blondel B, 2012, VACCINE, V30, P5661, DOI 10.1016/j.vaccine.2012.06.077; Bodeker B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1970-4; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Callaghan WM, 2010, OBSTET GYNECOL, V115, P919, DOI 10.1097/AOG.0b013e3181d99d85; Centers for Disease Control and Prevention, 2019, KEY FACTS INFL FLU; Centers for Disease Control and Prevention, 2018, NIS CHILD DAT DOC 20; Chacon-Fuentes R, 2018, CONOCIMIENTOS ACTITU; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Davis MM, 2002, J GEN INTERN MED, V17, P670, DOI 10.1046/j.1525-1497.2002.11040.x; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Fell DB, 2017, BJOG-INT J OBSTET GY, V124, P48, DOI 10.1111/1471-0528.14143; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI 10.1111/ajt.13505; Groom HC, 2016, AM J PREV MED, V50, P480, DOI 10.1016/j.amepre.2015.08.017; Hughey E, 2018, HONDURAS NATL DISAST; Mayet AY, 2017, SAUDI PHARM J, V25, P76, DOI 10.1016/j.jsps.2015.12.001; Meijer WJ, 2015, ACTA OBSTET GYN SCAN, V94, P797, DOI 10.1111/aogs.12680; Mutsaerts E, 2016, EXPERT REV VACCINES, V15, P1055, DOI 10.1080/14760584.2016.1192473; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Pan American Health Organization, 2019, 6 VACC CAMP SEAS INF; Pan American Health Organization, HLTH SYST PROF HOND; Pan American Health Organization, 2014, EV MULT EF VAC INFL; Pan American Health Organization, 2013, EC ENTR PAIS CON MAS; Pan American Health Organization, 2016, WHO PAHO REG M SEAS; Pan American Health Organization, 2017, OCT VAMP NAC VAC INF; Pan American Health Organization, 2020, VACC MOST EFF INT PR; Pan American Health Organization, 2018, SAL IN VAC INFL GRUP; Pan American Health Organization, COUNTR REP HOND; Pan American Health Organization, 2020, IMM AM 2020 SUMM 202; Panda B, 2011, J MATERN-FETAL NEO M, V24, P402, DOI 10.3109/14767058.2010.497882; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; Prospero E, 2019, INFLUENZA OTHER RESP, V13, P201, DOI 10.1111/irv.12600; Ropero-Alvarez A, 2014, GLOBAL VACCINE IMMUN, P4; Ropero-Alvarez AM, 2016, HUM VACC IMMUNOTHER, V12, P2206, DOI 10.1080/21645515.2016.1157240; Shakib JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2360; The World Bank, WORLD BANK HOND 2019; Troeger CE, 2019, LANCET RESP MED, V7, P69, DOI [10.1016/S2213-2600(18)30496-X, 10.1016/s2213-2600(18)30496-x]; Vilca LM, 2020, EUR J OBSTET GYN R B, V247, P10, DOI 10.1016/j.ejogrb.2020.02.007; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849; World Health Organization, INFL SEAS; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Yuen CYS, 2013, VACCINE, V31, P5281, DOI 10.1016/j.vaccine.2013.08.063	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246385	10.1371/journal.pone.0246385	http://dx.doi.org/10.1371/journal.pone.0246385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571256	gold, Green Published			2022-12-26	WOS:000618274000026
J	Ranjan, M; Khokhani, D; Nayaka, S; Srivastava, S; Keyser, ZP; Ranjan, A				Ranjan, Manish; Khokhani, Devanshi; Nayaka, Sanjeeva; Srivastava, Suchi; Keyser, Zachary P.; Ranjan, Ashish			Genomic diversity and organization of complex polysaccharide biosynthesis clusters in the genus Dickeya	PLOS ONE			English	Article							PLANT DEFENSE RESPONSES; ESCHERICHIA-COLI K-12; DNA-DNA HYBRIDIZATION; O-ANTIGEN; SP-NOV.; BACTERIAL LIPOPOLYSACCHARIDES; PATHOGENICITY ISLANDS; IDENTIFICATION; MODULATION; SEQUENCE	The pectinolytic genus Dickeya (formerly Erwinia chrysanthemi) comprises numerous pathogenic species which cause diseases in various crops and ornamental plants across the globe. Their pathogenicity is governed by complex multi-factorial processes of adaptive virulence gene regulation. Extracellular polysaccharides and lipopolysaccharides present on bacterial envelope surface play a significant role in the virulence of phytopathogenic bacteria. However, very little is known about the genomic location, diversity, and organization of the polysaccharide and lipopolysaccharide biosynthetic gene clusters in Dickeya. In the present study, we report the diversity and structural organization of the group 4 capsule (G4C)/O-antigen capsule, putative O-antigen lipopolysaccharide, enterobacterial common antigen, and core lipopolysaccharide biosynthesis clusters from 54 Dickeya strains. The presence of these clusters suggests that Dickeya has both capsule and lipopolysaccharide carrying O-antigen to their external surface. These gene clusters are key regulatory components in the composition and structure of the outer surface of Dickeya. The O-antigen capsule/group 4 capsule (G4C) coding region shows a variation in gene content and organization. Based on nucleotide sequence homology in these Dickeya strains, two distinct groups, G4C group I and G4C group II, exist. However, comparatively less variation is observed in the putative O-antigen lipopolysaccharide cluster in Dickeya spp. except for in Dickeya zeae. Also, enterobacterial common antigen and core lipopolysaccharide biosynthesis clusters are present mostly as conserved genomic regions. The variation in the O-antigen capsule and putative O-antigen lipopolysaccharide coding region in relation to their phylogeny suggests a role of multiple horizontal gene transfer (HGT) events. These multiple HGT processes might have been manifested into the current heterogeneity of O-antigen capsules and O-antigen lipopolysaccharides in Dickeya strains during its evolution.	[Ranjan, Manish; Nayaka, Sanjeeva; Srivastava, Suchi] CSIR Natl Bot Res Inst CSIR NBRI, Lucknow, Uttar Pradesh, India; [Khokhani, Devanshi] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Khokhani, Devanshi; Ranjan, Ashish] Univ Minnesota Twin Cities, Dept Plant Pathol, St Paul, MN 55108 USA; [Keyser, Zachary P.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Ranjan, Ashish] Univ Hyderabad, Dept Plant Sci SLS, Hyderabad, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Hyderabad	Ranjan, A (corresponding author), Univ Minnesota Twin Cities, Dept Plant Pathol, St Paul, MN 55108 USA.; Ranjan, A (corresponding author), Univ Hyderabad, Dept Plant Sci SLS, Hyderabad, India.	ashishranjan2005@gmail.com		Ranjan, Ashish/0000-0002-6711-2088; Nayaka, Sanjeeva/0000-0001-6541-2362	Department of Biotechnology, India, Ramalingaswami Re-entry Fellowship [BT/HRD/35/02/2006]; Department of Plant Pathology, University of Minnesota-Twin Cities, US [1750-11031-20088END00E0822-5669146]	Department of Biotechnology, India, Ramalingaswami Re-entry Fellowship; Department of Plant Pathology, University of Minnesota-Twin Cities, US	AR was supported by Department of Biotechnology, India (http://dbtindia.gov.in/), Ramalingaswami Re-entry Fellowship no. BT/HRD/35/02/2006 and currently, he is supported by Stakman Endowment fund 1750-11031-20088END00E0822-5669146 from Department of Plant Pathology, University of Minnesota-Twin Cities, US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Andrianopoulos K, 1998, J BACTERIOL, V180, P998, DOI 10.1128/JB.180.4.998-1001.1998; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Bellieny-Rabelo D, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02050-18; Boels IC, 2004, J BACTERIOL, V186, P1239, DOI 10.1128/JB.186.5.1239-1248.2004; BURKHOLDER WH, 1953, PHYTOPATHOLOGY, V43, P522; Buttimer Colin, 2017, Front Microbiol, V8, P34, DOI 10.3389/fmicb.2017.00034; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charkowski AO, 2018, ANNU REV PHYTOPATHOL, V56, P269, DOI 10.1146/annurev-phyto-080417-045906; Cress BF, 2014, FEMS MICROBIOL REV, V38, P660, DOI [10.1111/1574-6976.12056, 10.1111/1574-69]; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Erbs G, 2010, SUBCELL BIOCHEM, V53, P387, DOI 10.1007/978-90-481-9078-2_17; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/j.1365-2958.1994.tb01071.x; Holt KE, 2020, ISME J, V14, P1713, DOI 10.1038/s41396-020-0628-0; Hu M, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1300-y; Kabanova AP, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03288; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Li CH, 2014, MOL PLANT MICROBE IN, V27, P471, DOI 10.1094/MPMI-08-13-0248-R; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Marrero G, 2013, INT J SYST EVOL MICR, V63, P3524, DOI 10.1099/ijs.0.046490-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Miajlovic H, 2014, FEMS MICROBIOL LETT, V354, P1, DOI 10.1111/1574-6968.12419; Newman MA, 1997, MOL PLANT MICROBE IN, V10, P926, DOI 10.1094/MPMI.1997.10.7.926; Newman MA, 2001, EUR J PLANT PATHOL, V107, P95, DOI 10.1023/A:1008738817551; Newman MA, 2007, J ENDOTOXIN RES, V13, P69, DOI 10.1177/0968051907079399; Ogier JC, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1546-z; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Ossowska K, 2017, CARBOHYD RES, V445, P40, DOI 10.1016/j.carres.2017.04.001; Parkinson N, 2014, INT J SYST EVOL MICR, V64, P2264, DOI 10.1099/ijs.0.058693-0; Patil PB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-40; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Peyraud R, 2017, PLANT J, V90, P720, DOI 10.1111/tpj.13429; Rahim R, 2000, MICROBIOL-UK, V146, P2803, DOI 10.1099/00221287-146-11-2803; Rahn A, 2003, J BACTERIOL, V185, P5882, DOI 10.1128/JB.185.19.5882-5890.2003; Rapicavoli JN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02861-5; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; Rendueles O, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007862; Rendueles O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006525; Reverchon S, 2013, ENV MICROBIOL REP, V5, P622, DOI 10.1111/1758-2229.12073; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rudolph KWE, 1994, ROLE EXTRACELLULAR P, DOI [10.1007/978-94-011-0746-4_25, DOI 10.1007/978-94-011-0746-4_25]; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Thomassin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082475; Tian YL, 2016, INT J SYST EVOL MICR, V66, P2831, DOI 10.1099/ijsem.0.001060; Toth IK, 2011, PLANT PATHOL, DOI [10.1111/j.1365-3059.2011.02552.x, DOI 10.1111/J.1365-3059.2011.02552.X]; van der Wolf JM, 2014, INT J SYST EVOL MICR, V64, P768, DOI 10.1099/ijs.0.052944-0; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	63	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245727	10.1371/journal.pone.0245727	http://dx.doi.org/10.1371/journal.pone.0245727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571209	gold, Green Published			2022-12-26	WOS:000618274000010
J	Mabotja, MC; Levin, J; Kawonga, M				Mabotja, Mantwa Chisale; Levin, Jonathan; Kawonga, Mary			Beliefs and perceptions regarding cervical cancer and screening associated with Pap smear uptake in Johannesburg: A cross-sectional study	PLOS ONE			English	Article								Background Cervical cancer is a major global public health concern, with 85% of cases occurring in low- and middle-income countries. In South Africa, it is the second most common cancer amongst women. Screening and treatment of cervical cancer precursor lesions is associated with a lower incidence and mortality. This research determines the associations between women's beliefs about cervical cancer and screening and the uptake of Papanicolaou (Pap) smears in Johannesburg, where cervical screening uptake is suboptimal. Methods This research was approved by the University of Witwatersrand Human Research Ethics Committee (Medical), clearance certificate number: M170243 and the Johannesburg District Heath Research Committee prior to conducting the study. All participants signed a consent form prior to participating in this study. This cross-sectional analytical study used an interviewer-administered validated measurement scale based on the Health Belief Model (HBM) to describe health beliefs regarding cervical cancer and screening among 280 women aged 30 years and older, attending Johannesburg primary care facilities in 2017. Logistic regression models, with robust estimation of variance to account for clustering of women within clinics, were fitted to identify health beliefs (perceived susceptibility, severity, barriers and benefit, cues to action, and self-efficacy) associated with ever having had a Pap smear (screening uptake), while controlling for knowledge of screening and potential confounders. Results Of the 280 women, 177 (63.2%) had ever been screened, 180 (64.3%) were never married, 199 (71.1%) attained secondary education and 133 (47.5%) were employed full time. Women of older age (AOR = 1.6 for a 5-year increase in age; CI: 1.3-1.9; P<0.001), with higher knowledge scores (AOR = 2.5 for a 5-point increase in knowledge score; 95% CI:1.0-6.3;P = 0.051), with lower perceived barriers scores (AOR = 0.4 for a 5-point increase in barriers score; 95% CI:0.3-0.5; P<0.001) and higher perceived severity scores (AOR = 1.3 for a 5-point increase in severity score; 95% CI:1.0-1.6; P = 0.017) were more likely to have had a Pap smear. Conclusions This study shows that women who take up screening are older, more knowledgeable regarding cervical cancer and screening, less likely to perceive screening barriers, and more likely to perceive cervical cancer as a severe disease. This highlights that for public health interventions to increase screening uptake, the focus should include tailored behaviour change communication strategies that address women's beliefs regarding screening barriers and emphasize the severity of cervical cancer.	[Mabotja, Mantwa Chisale; Levin, Jonathan; Kawonga, Mary] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Mabotja, Mantwa Chisale; Kawonga, Mary] Charlotte Maxeke Johannesburg Acad Hosp, Gauteng Prov Hlth Dept, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Mabotja, MC (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.; Mabotja, MC (corresponding author), Charlotte Maxeke Johannesburg Acad Hosp, Gauteng Prov Hlth Dept, Johannesburg, South Africa.	mc.chisale@gmail.com	Kawonga, Mary/ABC-6823-2021	Kawonga, Mary/0000-0001-9807-7847; Chisale Mabotja, Mantwa/0000-0003-4324-3515	University of Witwatersrand School of Public Health; Faculty of Health Sciences Research Committee (FRC) individual research grant	University of Witwatersrand School of Public Health; Faculty of Health Sciences Research Committee (FRC) individual research grant	Funding for data collection during the study was from the University of Witwatersrand School of Public Health seed funding and Faculty of Health Sciences Research Committee (FRC) individual research grant.	Akinyemiju TF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1098-z; [Anonymous], 2017, DISTRICT HLTH BAROME; Barker KS, 1998, EVALUATION SOUL CITY; Becker MH, 1974, BEHAV SCI PREVENTIVE, P25; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cancer Research UK, 2007, CERV CANC AW MEAS TO; Champion V, 2005, RES NURS HEALTH, V28, P329, DOI 10.1002/nur.20088; Champion V L, 1984, ANS Adv Nurs Sci, V6, P73; CHAMPION VL, 1993, NURS RES, V42, P139; Champion VL, 1997, NURS RES, V46, P331, DOI 10.1097/00006199-199711000-00006; Champion VL, 1999, RES NURS HEALTH, V22, P341, DOI 10.1002/(SICI)1098-240X(199908)22:4<341::AID-NUR8>3.0.CO;2-P; De Abreu C, 2013, AFRICAN J PRIMARY HL, V5, P1; Denny-Smith T, 2006, J AM ACAD NURSE PRAC, V18, P62, DOI 10.1111/j.1745-7599.2006.00100.x; Everatt D, 1998, BRINGING HLTH NATION; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Glanz K., 2008, HLTH BEHAV HLTH ED T; Gozum S, 2004, CANCER NURS, V27, P491; Guvenc G, 2011, J ADV NURS, V67, P428, DOI 10.1111/j.1365-2648.2010.05450.x; Hochbaum G.M., 1958, PUBLIC PARTICIPATION; Hoque M, 2009, SO AFRICAN J EPIDEM, V24, P12; Hoque M, 2008, EVALUATION CERVICAL; Hoque M, 2009, ASIAN PAC J CANCER P, V10, P1095; Hoque ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111557; Johnson CE, 2008, J LOW GENIT TRACT DI, V12, P232, DOI 10.1097/LGT.0b013e31815d8d88; Kawonga M, 2008, REPROD HEALTH MATTER, V16, P32, DOI 10.1016/S0968-8080(08)32403-3; Lee EH, 2002, CANCER NURS, V25, P391, DOI 10.1097/00002820-200210000-00010; Leyva M, 2005, THESIS U TEXAS HLTH; Massyn N., 2014, DURBAN HLTH SYSTEMS; McFarland DM, 2013, INT J WOMENS HEALTH, V5, P709, DOI 10.2147/IJWH.S50890; Mikhail BI, 2001, J NURS SCHOLARSHIP, V33, P159, DOI 10.1111/j.1547-5069.2001.00159.x; Mock J, 2007, AM J PUBLIC HEALTH, V97, P1693, DOI 10.2105/AJPH.2006.086470; Moodley J, 2006, CANCER DETECT PREV, V30, P361, DOI 10.1016/j.cdp.2006.07.005; National Department of Health. Health, 2017, CERV CANC PREV CONTR; Risi L, 2004, HEALTH EDUC RES, V19, P457, DOI 10.1093/her/cyg044; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Saei Ghare Naz Marzieh, 2018, Asian Pac J Cancer Prev, V19, P875; Samuels T, 1999, LEARNING EASY WAY EV; Sibiya N., 2012, CHALLENGES CERVICAL; Smith N, 2003, SAMJ S AFR MED J, V93, P32; Statistics SA, 2016, COMM SURV 2016 STAT; WHO, 2014, COMPR CERV CANC CONT; Wood K, 1997, SOC SCI MED, V45, P283, DOI 10.1016/S0277-9536(96)00344-9; World Health Organization, 2013, COMPR CERV CANC PREV; Wright KO, 2010, ASIAN PAC J CANCER P, V11, P137; Zelviene Ausra, 2007, Cancer Nurs, V30, pE20, DOI 10.1097/01.NCC.0000270711.72413.a6	46	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246574	10.1371/journal.pone.0246574	http://dx.doi.org/10.1371/journal.pone.0246574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566798	Green Published, gold			2022-12-26	WOS:000618271700009
J	Kudenov, MW; Scarboro, CG; Altaqui, A; Boyette, M; Yencho, GC; Williams, CM				Kudenov, Michael W.; Scarboro, Clifton G.; Altaqui, Ali; Boyette, Mike; Yencho, G. Craig; Williams, Cranos M.			Internal defect scanning of sweetpotatoes using interactance spectroscopy	PLOS ONE			English	Article							LIGHT-SCATTERING; NIR INTERACTANCE; STEADY-STATE; REFLECTANCE; FIRMNESS; QUALITY; ABSORPTION	While standard visible-light imaging offers a fast and inexpensive means of quality analysis of horticultural products, it is generally limited to measuring superficial (surface) defects. Using light at longer (near-infrared) or shorter (X-ray) wavelengths enables the detection of superficial tissue bruising and density defects, respectively; however, it does not enable the optical absorption and scattering properties of sub-dermal tissue to be quantified. This paper applies visible and near-infrared interactance spectroscopy to detect internal necrosis in sweetpotatoes and develops a Zemax scattering simulation that models the measured optical signatures for both healthy and necrotic tissue. This study demonstrates that interactance spectroscopy can detect the unique near-infrared optical signatures of necrotic tissues in sweetpotatoes down to a depth of approximately 5 +/- 0.5 mm. We anticipate that light scattering measurement methods will represent a significant improvement over the current destructive analysis methods used to assay for internal defects in sweetpotatoes.	[Kudenov, Michael W.; Scarboro, Clifton G.; Altaqui, Ali; Williams, Cranos M.] North Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA; [Boyette, Mike] North Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC USA; [Yencho, G. Craig] North Carolina State Univ, Dept Hort Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kudenov, MW (corresponding author), North Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.	mwkudeno@ncsu.edu		Kudenov, Michael/0000-0001-5601-6309; Altaqui, Ali/0000-0001-5587-0036; Yencho, G. Craig/0000-0001-6583-0628	North Carolina State University as part of the Game-Changing Research Incentive Program for Plant Sciences Initiative (GRIP4PSI)	North Carolina State University as part of the Game-Changing Research Incentive Program for Plant Sciences Initiative (GRIP4PSI)	This work was funded by North Carolina State University as part of the Game-Changing Research Incentive Program for Plant Sciences Initiative (GRIP4PSI)". It is an internally-funded project so no government or grant funding was used and there are no associated federal or pubically-accessible award numbers.	Al-Mallahi A, 2010, COMPUT ELECTRON AGR, V70, P239, DOI 10.1016/j.compag.2009.11.001; Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325; Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Backman V, 2001, IEEE J SEL TOP QUANT, V7, P887, DOI 10.1109/2944.983289; BIRTH GS, 1978, J FOOD SCI, V43, P916, DOI 10.1111/j.1365-2621.1978.tb02455.x; Fang H, 2003, IEEE J SEL TOP QUANT, V9, P267, DOI 10.1109/JSTQE.2003.812515; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; FINNEY EE, 1978, AM POTATO J, V55, P95, DOI 10.1007/BF02852096; Gou P, 2013, MEAT SCI, V95, P250, DOI 10.1016/j.meatsci.2013.05.013; Guo ZM, 2020, J FOOD ENG, V279, DOI 10.1016/j.jfoodeng.2020.109955; Hagen N, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.9.090901; Huang YP, 2018, J FOOD ENG, V222, P185, DOI 10.1016/j.jfoodeng.2017.11.030; Jiang C, 2015, HORTTECHNOLOGY, V25, P340, DOI 10.21273/HORTTECH.25.3.340; Kienle A, 1997, J OPT SOC AM A, V14, P246, DOI 10.1364/JOSAA.14.000246; Kinnunen M, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.051040; Lopez-Maestresalas A, 2016, FOOD BIOPROCESS TECH, V9, P463, DOI 10.1007/s11947-015-1639-0; Lu R., 2017, LIGHT SCATTERING TEC, DOI [10.1201/b20220, DOI 10.1201/B20220]; Lu R., 2003, DETECTION BRUISES AP, DOI [10.13031/2013.12941, DOI 10.13031/2013.12941]; Lu RF, 2020, POSTHARVEST BIOL TEC, V159, DOI 10.1016/j.postharvbio.2019.111003; MARCHANT J A, 1990, Computers and Electronics in Agriculture, V4, P235, DOI 10.1016/0168-1699(90)90022-H; MARQUET P, 1995, OPT ENG, V34, P2055, DOI 10.1117/12.204798; Mourant J R, 1996, J Biomed Opt, V1, P192, DOI 10.1117/12.231372; Nicolai BM, 2008, POSTHARVEST BIOL TEC, V47, P68, DOI 10.1016/j.postharvbio.2007.06.001; Noordam JC, 2000, P SOC PHOTO-OPT INS, V3966, P206, DOI 10.1117/12.380075; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; PEDERSEN GD, 1976, BIOPHYS J, V16, P199, DOI 10.1016/S0006-3495(76)85681-0; Pedreschi F, 2010, FOOD CHEM, V121, P616, DOI 10.1016/j.foodchem.2009.12.075; Qiu L, 2012, IEEE J SEL TOP QUANT, V18, P1073, DOI 10.1109/JSTQE.2011.2161575; Qiu L, 2010, SER MED PHYS BIOMED, P465; Rady A, 2017, POSTHARVEST BIOL TEC, V129, P37, DOI 10.1016/j.postharvbio.2017.03.007; Rady AM, 2015, COMPUT ELECTRON AGR, V117, P31, DOI 10.1016/j.compag.2015.07.002; Sun J, 2016, POSTHARVEST BIOL TEC, V119, P58, DOI 10.1016/j.postharvbio.2016.04.019; Tian YouWen, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P132; Wu D, 2013, INNOV FOOD SCI EMERG, V19, P15, DOI 10.1016/j.ifset.2013.04.016	34	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246872	10.1371/journal.pone.0246872	http://dx.doi.org/10.1371/journal.pone.0246872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561172	gold, Green Published			2022-12-26	WOS:000617533000036
J	Dian, M; Triventi, M				Dian, Mona; Triventi, Moris			The weight of school grades: Evidence of biased teachers' evaluations against overweight students in Germany	PLOS ONE			English	Article							BODY-MASS INDEX; ACADEMIC-PERFORMANCE; SOCIOECONOMIC-STATUS; GENDER STEREOTYPES; OBESITY; ACHIEVEMENT; DISCRIMINATION; PERSONALITY; CHILDHOOD; CHILDREN	Discrimination and prejudice against overweight people is common in Western societies. In this article we aim to understand whether these attitudes reverberate into the school setting, by investigating whether teachers grade overweight students more severely than comparable normal weight students. By relying on the Attribution-Value Model of Prejudice (AVMP) and previous studies, we test a series of hypotheses using data from the German National Educational Panel Study (NEPS SC3) on a sample of students enrolled in the 7(th) grade (lower secondary education). We used hierarchical ordered logit regression to assess whether overweight and obese students receive systematically lower grades by their teachers in German and mathematics, adjusting for subject-specific competences measured with a standardized test, and a rich set of socio-demographic and socio-psychological students' characteristics (e.g. the "big five"). Results suggested that overweight and obese students were more severely graded in both subjects. The penalty for overweight students, and especially for obese students, was slightly larger in German and in the lowest part of the grade distribution. There was also indication of heterogeneous penalties by gender, with overweight male students being especially penalized in math. Possible ways to help teachers in assigning grades in a fairer way are discussed at the end.	[Dian, Mona] Univ Appl Sci Worms, Dept Int Business Adm, Worms, Rhineland Palat, Germany; [Triventi, Moris] Univ Trento, Dept Sociol & Social Res, Trento, Trentino Alto A, Italy	University of Trento	Triventi, M (corresponding author), Univ Trento, Dept Sociol & Social Res, Trento, Trentino Alto A, Italy.	moris.triventi@unitn.it		Triventi, Moris/0000-0002-2713-2957				Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; Allen J. D., 2005, CLEARING HOUSE J ED, V78, P218, DOI [10.3200/TCHS.78.5.218-223, DOI 10.3200/TCHS.78.5.218-223]; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; [Anonymous], 2000, PERCENTILE DATA FILE; [Anonymous], 2017, PREV OB AD BMI 30 CR; Blossfeld HP, 2016, EDULIFE LIFELONG, pXXXI; Blossfeld HP, 2011, Z ERZIEHWISS, V14, P19, DOI 10.1007/s11618-011-0179-2; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Bonefeld M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00481; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Branigan AR, 2017, SOCIOL EDUC, V90, P25, DOI 10.1177/0038040716680271; Calogero R. M., 2007, BODY BEAUTIFUL EVOLU, P259, DOI [10.1057/9780230596887_13, DOI 10.1057/9780230596887_13]; Carr D, 2005, J HEALTH SOC BEHAV, V46, P244, DOI 10.1177/002214650504600303; Cassady JC., 2000, PRACTICAL ASSESSMENT, V7, P1, DOI [10.7275/5hym-y754, DOI 10.7275/5HYM-Y754]; Centers for Disease Control and Prevention, 2018, OV OB DEF CHILDH OB; Chamorro-Premuzic T, 2003, J RES PERS, V37, P319, DOI 10.1016/S0092-6566(02)00578-0; Close D, 2009, TEACH PHILOS, V32, P361, DOI 10.5840/teachphil200932439; Coppin G, 2014, NEUROPSYCHOLOGIA, V65, P146, DOI 10.1016/j.neuropsychologia.2014.10.004; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Crosnoe R, 2004, J HEALTH SOC BEHAV, V45, P393, DOI 10.1177/002214650404500403; Dardanoni V, 2009, BE J ECON ANAL POLI, V9; Datar A, 2006, INT J OBESITY, V30, P1449, DOI 10.1038/sj.ijo.0803311; Ding W, 2009, J HEALTH ECON, V28, P578, DOI 10.1016/j.jhealeco.2008.11.006; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Duckworth AL, 2012, J EDUC PSYCHOL, V104, P439, DOI 10.1037/a0026280; Dunkake I, 2012, Z SOZIOL, V41, P142; Florin TA, 2011, J SCHOOL HEALTH, V81, P663, DOI 10.1111/j.1746-1561.2011.00642.x; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gunstad J, 2006, Eat Weight Disord, V11, pe15; Guskey TR, 2001, EDUC LEADERSHIP, V59, P20; GUSKEY TR, 1994, EDUC LEADERSHIP, V52, P14; Heyder A, 2015, SOC PSYCHOL EDUC, V18, P467, DOI 10.1007/s11218-015-9303-0; Hjern A, 2008, ACTA PAEDIATR, V97, P112, DOI 10.1111/j.1651-2227.2007.00585.x; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; InVS, 2012, POINT EPIDEMIOLOGIQU, V37, P1; Jackson MR, 2013, METHODS MOL BIOL, V1053, P1, DOI 10.1007/978-1-62703-562-0_1; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Johnes G, 2004, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF EDUCATION, P462; Judge S, 2007, J SCHOOL HEALTH, V77, P672, DOI 10.1111/j.1746-1561.2007.00250.x; Kaestner R, 2008, 13764 NBER; Kenney EL, 2015, INT J OBESITY, V39, P1408, DOI 10.1038/ijo.2015.88; Kiss D, 2013, EDUC ECON, V21, P447, DOI 10.1080/09645292.2011.585019; Lange D, 2010, BUNDESGESUNDHEITSBLA, V53, P707, DOI 10.1007/s00103-010-1081-4; LARKIN JC, 1979, SOCIOL WORK OCCUP, V6, P312, DOI 10.1177/073088847900600303; Latner JD, 2008, INT J OBESITY, V32, P1145, DOI 10.1038/ijo.2008.53; Latner JD, 2003, OBES RES, V11, P452, DOI 10.1038/oby.2003.61; Lavy V, 2008, J PUBLIC ECON, V92, P2083, DOI 10.1016/j.jpubeco.2008.02.009; Leibniz Institute for Educational Trajectories, 2018, START COH 3 GRAD 5 S; Leibniz Institute for Educational Trajectories, 2018, NEPS START COH 3 GRA; Li YF, 2008, OBESITY, V16, P1809, DOI 10.1038/oby.2008.296; Little R.J.A., 2002, STAT ANAL MISSING DA; MacCann C, 2013, INT J OBESITY, V37, P40, DOI 10.1038/ijo.2012.47; National Center for HIV/AIDS, 2014, VIRAL HEPATITIS STD; National Educational Panel Study (NEPS), 2019, START COH GRAD 5 SC3; Neumark-Sztainer D, 1999, J NUTR EDUC, V31, P3, DOI 10.1016/S0022-3182(99)70378-X; Nitko A.J., 2001, ED ASSESSMENT STUDEN, V3rd ed; Organisation for Economic Co-operation and Development, 2012, GRAD EXP MARKS ED PO; Paul RJTJ., 1995, EMP RESPONS RIGHTS J, DOI [DOI 10.1007/BF02621279, 10.1007/BF02621279]; Pine KarenJ., 2001, CLIN CHILD PSYCHOL P, V6, P519, DOI [10.1177/1359104501006004006, DOI 10.1177/1359104501006004006]; Pohl S, 2012, NEPS TECHNICAL REPOR; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Reinert KRS, 2013, J OBES, V2013, DOI 10.1155/2013/820956; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sabia JJ, 2007, SOUTH ECON J, V73, P871, DOI 10.2307/20111933; Saguy Abigail, 2013, WHATS WRONG FAT; Salikutluk Z, 2017, EUR SOCIOL REV, V33, P368, DOI 10.1093/esr/jcx049; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Shore SM, 2008, OBESITY, V16, P1535, DOI 10.1038/oby.2008.254; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Sigfusdottir ID, 2007, HEALTH EDUC RES, V22, P70, DOI 10.1093/her/cyl044; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sprietsma M, 2013, EMPIR ECON, V45, P523, DOI 10.1007/s00181-012-0609-x; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Thoms P, 1999, J BUS PSYCHOL, V13, P339, DOI 10.1023/A:1022974232557; Uhlmann EL, 2005, PSYCHOL SCI, V16, P474; Veldwijk J, 2012, OBESITY, V20, P590, DOI 10.1038/oby.2011.327; Wagerman SA, 2007, J RES PERS, V41, P221, DOI 10.1016/j.jrp.2006.03.001; Wang SS, 2004, INT J OBESITY, V28, P1333, DOI 10.1038/sj.ijo.0802730; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilson SM, 2015, ADV SCH MENT HEALTH, V8, P231, DOI 10.1080/1754730X.2015.1074054	84	3	3	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245972	10.1371/journal.pone.0245972	http://dx.doi.org/10.1371/journal.pone.0245972			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556097	Green Published, gold			2022-12-26	WOS:000617379900032
J	Revilla, L; Mayorgas, A; Corraliza, AM; Masamunt, MC; Metwaly, A; Haller, D; Tristan, E; Carrasco, A; Esteve, M; Panes, J; Ricart, E; Lozano, JJ; Salas, A				Revilla, Lluis; Mayorgas, Aida; Corraliza, Ana M.; Masamunt, Maria C.; Metwaly, Amira; Haller, Dirk; Tristan, Eva; Carrasco, Anna; Esteve, Maria; Panes, Julian; Ricart, Elena; Lozano, Juan J.; Salas, Azucena			Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis	PLOS ONE			English	Article							INTEGRATED ANALYSIS; GUT MICROBIOME; SEQUENCES	Background Personalized medicine requires finding relationships between variables that influence a patient's phenotype and predicting an outcome. Sparse generalized canonical correlation analysis identifies relationships between different groups of variables. This method requires establishing a model of the expected interaction between those variables. Describing these interactions is challenging when the relationship is unknown or when there is no pre-established hypothesis. Thus, our aim was to develop a method to find the relationships between microbiome and host transcriptome data and the relevant clinical variables in a complex disease, such as Crohn's disease. Results We present here a method to identify interactions based on canonical correlation analysis. We show that the model is the most important factor to identify relationships between blocks using a dataset of Crohn's disease patients with longitudinal sampling. First the analysis was tested in two previously published datasets: a glioma and a Crohn's disease and ulcerative colitis dataset where we describe how to select the optimum parameters. Using such parameters, we analyzed our Crohn's disease data set. We selected the model with the highest inner average variance explained to identify relationships between transcriptome, gut microbiome and clinically relevant variables. Adding the clinically relevant variables improved the average variance explained by the model compared to multiple co-inertia analysis. Conclusions The methodology described herein provides a general framework for identifying interactions between sets of omic data and clinically relevant variables. Following this method, we found genes and microorganisms that were related to each other independently of the model, while others were specific to the model used. Thus, model selection proved crucial to finding the existing relationships in multi-omics datasets.	[Revilla, Lluis; Tristan, Eva; Carrasco, Anna; Esteve, Maria; Panes, Julian; Ricart, Elena; Lozano, Juan J.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Revilla, Lluis; Mayorgas, Aida; Corraliza, Ana M.; Masamunt, Maria C.; Panes, Julian; Ricart, Elena; Salas, Azucena] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Barcelona, Spain; [Metwaly, Amira; Haller, Dirk] Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Germany; [Haller, Dirk] Tech Univ Munich, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany; [Tristan, Eva; Carrasco, Anna; Esteve, Maria] Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Technical University of Munich; Technical University of Munich; Hospital Universitario Mutua Terrassa	Salas, A (corresponding author), Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Barcelona, Spain.	asalas1@clinic.cat		Revilla Sancho, Lluis/0000-0001-9747-2570; Haller, Dirk/0000-0002-6977-4085; Masamunt, M Carme/0000-0001-8736-1623; METWALY, AMIRA/0000-0001-5740-0230; Mayorgas, Aida/0000-0003-4467-5352	Leona and Harry Helmsley Charitable grant [2015PG-IBD005]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); Ministerio de Ciencia, Innovacion y Universidades, Spain [BES-2016-076642]	Leona and Harry Helmsley Charitable grant; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); Ministerio de Ciencia, Innovacion y Universidades, Spain(Spanish Government)	This work was supported by the Leona and Harry Helmsley Charitable grant 2015PG-IBD005; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd,); AiM is supported by grant BES-2016-076642 from the Ministerio de Ciencia, Innovacion y Universidades, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman FDD, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007727; Azimi T, 2018, APMIS, V126, P275, DOI 10.1111/apm.12814; Beale DJ, 2016, MICROBIAL METABOLOMI, P289, DOI DOI 10.1007/978-3-319-46326-1_10; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Cavill R, 2016, BRIEF BIOINFORM, V17, P891, DOI 10.1093/bib/bbv090; Chong J, 2017, METABOLITES, V7, DOI 10.3390/metabo7040062; Corraliza AM, 2019, J CROHNS COLITIS, V13, P634, DOI 10.1093/ecco-jcc/jjy203; de Souza HSP, 2017, NAT REV GASTRO HEPAT, V14, P739, DOI 10.1038/nrgastro.2017.110; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ferrer-Picon E, 2020, INFLAMM BOWEL DIS, V26, P43, DOI 10.1093/ibd/izz119; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Gaujoux R, 2019, GUT, V68, P604, DOI 10.1136/gutjnl-2017-315494; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hasler R, 2017, GUT, V66, P2087, DOI 10.1136/gutjnl-2016-311651; Hata K, 2017, DIGEST ENDOSC, V29, P26, DOI 10.1111/den.12744; Hillman ET, 2017, MICROBES ENVIRON, V32, P300, DOI 10.1264/jsme2.ME17017; Holmberg FEO, 2017, EMBO MOL MED, V9, P558, DOI 10.15252/emmm.201607260; Huang H, 2014, IMMUNOL LETT, V162, P62, DOI 10.1016/j.imlet.2014.07.014; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Lagkouvardos Ilias, 2016, Sci Rep, V6, P33721, DOI 10.1038/srep33721; Lagkouvardos I, 2015, MOL NUTR FOOD RES, V59, P1614, DOI 10.1002/mnfr.201500125; Lock EF, 2013, ANN APPL STAT, V7, P523, DOI 10.1214/12-AOAS597; Lofstedt T, 2016, ARXIV161009490; Lopez-Siles M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00281; Louca S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0420-9; Lovell D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004075; McIlroy J, 2018, ALIMENT PHARM THER, V47, P26, DOI 10.1111/apt.14384; Meng C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-162; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morgan XC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0637-x; Oyri SF, 2015, COMP IMMUNOL MICROB, V43, P36, DOI 10.1016/j.cimid.2015.10.005; Presley LL, 2012, INFLAMM BOWEL DIS, V18, P409, DOI 10.1002/ibd.21793; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Saccenti E, 2014, METABOLOMICS, V10, P361, DOI 10.1007/s11306-013-0598-6; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Stubbendieck RM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01234; Tang MS, 2017, INFLAMM BOWEL DIS, V23, P1544, DOI 10.1097/MIB.0000000000001208; Tenenhaus A, 2014, EUR J OPER RES, V238, P391, DOI 10.1016/j.ejor.2014.01.008; Tenenhaus A, 2011, PSYCHOMETRIKA, V76, P257, DOI 10.1007/s11336-011-9206-8; Tenenhaus M, 2017, PSYCHOMETRIKA, V82, P737, DOI 10.1007/s11336-017-9573-x; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Van Deun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037840; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen L, 2017, J NUTR, V147, p1468S, DOI 10.3945/jn.116.240754; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008	50	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246367	10.1371/journal.pone.0246367	http://dx.doi.org/10.1371/journal.pone.0246367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556098	Green Published, gold, Green Submitted			2022-12-26	WOS:000617379900069
J	Bittner, ML; Lopes, R; Hua, JP; Sima, C; Datta, A; Wilson-Robles, H				Bittner, Michael L.; Lopes, Rosana; Hua, Jianping; Sima, Chao; Datta, Aniruddha; Wilson-Robles, Heather			Comprehensive live-cell imaging analysis of cryptotanshinone and synergistic drug-screening effects in various human and canine cancer cell lines	PLOS ONE			English	Article							SALVIA-MILTIORRHIZA BUNGE; HUMAN BREAST-CANCER; IN-VITRO; CYCLE ARREST; TUMOR-GROWTH; APOPTOSIS; PROLIFERATION; EXPRESSION; INHIBITION; RESISTANT	Background Several studies have highlighted both the extreme anticancer effects of Cryptotanshinone (CT), a Stat3 crippling component from Salvia miltiorrhiza, as well as other STAT3 inhibitors to fight cancer. Methods Data presented in this experiment incorporates 2 years of in vitro studies applying a comprehensive live-cell drug-screening analysis of human and canine cancer cells exposed to CT at 20 mu M concentration, as well as to other drug combinations. As previously observed in other studies, dogs are natural cancer models, given to their similarity in cancer genetics, epidemiology and disease progression compared to humans. Results Results obtained from several types of human and canine cancer cells exposed to CT and varied drug combinations, verified CT efficacy at combating cancer by achieving an extremely high percentage of apoptosis within 24 hours of drug exposure. Conclusions CT anticancer efficacy in various human and canine cancer cell lines denotes its ability to interact across different biological processes and cancer regulatory cell networks, driving inhibition of cancer cell survival.	[Bittner, Michael L.; Lopes, Rosana; Hua, Jianping; Sima, Chao; Datta, Aniruddha] Texas A&M Univ, Ctr Bioinformat & Genom Syst Engn, Texas A&M Engn Expt Stn, College Stn, TX 77843 USA; [Bittner, Michael L.] Translat Genom Res Inst, Phoenix, AZ USA; [Wilson-Robles, Heather] Texas A&M Univ, Coll Vet Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Engineering Experimental Station; Translational Genomics Research Institute; Texas A&M University System; Texas A&M University College Station	Lopes, R (corresponding author), Texas A&M Univ, Ctr Bioinformat & Genom Syst Engn, Texas A&M Engn Expt Stn, College Stn, TX 77843 USA.; Wilson-Robles, H (corresponding author), Texas A&M Univ, Coll Vet Med, College Stn, TX 77843 USA.	rlopes@tamu.edu; hwilson@cvm.tamu.edu	Wilson-Robles, Heather/D-4209-2016	Wilson-Robles, Heather/0000-0002-6489-8468	National Science Foundation [ECCS-1609236, ECCS-1917166]; TEES-Agrilife Center for Bioinformatics and Genomic Systems Engineering (CBGSE) Startup Funds	National Science Foundation(National Science Foundation (NSF)); TEES-Agrilife Center for Bioinformatics and Genomic Systems Engineering (CBGSE) Startup Funds	This work was supported in part by the National Science Foundation under Grants ECCS-1609236 and ECCS-1917166 and in part by the TEES-Agrilife Center for Bioinformatics and Genomic Systems Engineering (CBGSE) Startup Funds https://urldefense.com/v3/__https://www.nsf.gov/__;!!KwNVnqRv!VZFMWMeCrnsN302XHXtCUEKedB81y4pQZnFrI8dWr7AJ_9d17MQuzrX6HX9yYb6al8$ https://www.txgen.tamu.edu/research/cbgse/The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The remaining funding for this work was provided by the Fred and Vola Palmer Chair for Comparative Oncology held by Dr. Robles.	[Anonymous], 2016, UKRAINSKA ENTOMOFAUN; Assumpcao ALFV, 2018, J VET INTERN MED, V32, P361, DOI 10.1111/jvim.14860; Buettner R, 2002, CLIN CANCER RES, V8, P945; Camporeale A, 2014, CANCERS, V6, P1579, DOI 10.3390/cancers6031579; Canadas A, 2018, J VET DIAGN INVEST, V30, P733, DOI 10.1177/1040638718789231; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Cash H, 2015, ONCOTARGET, V6, P36400, DOI 10.18632/oncotarget.5063; Cavero I, 2013, EXPERT OPIN DRUG SAF, V12, P589, DOI 10.1517/14740338.2013.798300; Chen L, 2014, MOL MED REP, V9, P2447, DOI 10.3892/mmr.2014.2093; Chen WX, 2012, CANCER PREV RES, V5, P778, DOI 10.1158/1940-6207.CAPR-11-0551; Chen WX, 2010, CANCER PREV RES, V3, P1015, DOI 10.1158/1940-6207.CAPR-10-0020; Chen ZG, 2017, ONCOTARGET, V8, P50023, DOI 10.18632/oncotarget.18483; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cui XR, 2018, ONCOTARGET, V9, P3198, DOI 10.18632/oncotarget.23226; Dougherty E.R., 2003, HANDS MORPHOLOGICAL; Escobar HM, 2004, ANTICANCER RES, V24, P3027; Fenger JM, 2014, ILAR J, V55, P69, DOI 10.1093/ilar/ilu009; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Furtek SL, 2016, ONCOTARGET, V7, P77998, DOI 10.18632/oncotarget.12868; Ganguly Debolina, 2018, Oncotarget, V9, P22095, DOI 10.18632/oncotarget.25188; Ge YQ, 2015, MOL MED REP, V12, P7782, DOI 10.3892/mmr.2015.4379; Gong Y, 2011, INT J CANCER, V129, P1042, DOI 10.1002/ijc.25678; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Gruntzig K, 2016, J COMP PATHOL, V155, P156, DOI 10.1016/j.jcpa.2016.05.011; Gustafson DL, 2018, PHARMACOL THERAPEUT, V188, P80, DOI 10.1016/j.pharmthera.2018.01.012; Heron Melonie, 2016, NCHS Data Brief, P1; Hu T, 2014, PHYTOMEDICINE, V21, P1264, DOI 10.1016/j.phymed.2014.06.013; Hua JP, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046008; Im KS, 2013, VET J, V195, P366, DOI 10.1016/j.tvjl.2012.07.014; Jiang GQ, 2017, J ETHNOPHARMACOL, V205, P33, DOI 10.1016/j.jep.2017.04.026; Juvekar A, 2016, P NATL ACAD SCI USA, V113, pE4338, DOI 10.1073/pnas.1522223113; Ke FY, 2017, DRUG DES DEV THER, V11, P1753, DOI 10.2147/DDDT.S132488; Kim JH, 2011, APOPTOSIS, V16, P696, DOI 10.1007/s10495-011-0605-1; Koh MY, 2008, MOL CANCER THER, V7, P90, DOI 10.1158/1535-7163.MCT-07-0463; Lee JW, 2007, J MICROBIOL, V45, P350; Levine RA, 2000, VET PATHOL, V37, P54, DOI 10.1354/vp.37-1-54; Li SH, 2015, CANCER BIOL THER, V16, P176, DOI 10.4161/15384047.2014.962960; Li WD, 2015, MOL CELL BIOCHEM, V406, P63, DOI 10.1007/s11010-015-2424-0; Liu XM, 2016, RSC ADV, V6, P22232, DOI 10.1039/c5ra22523j; Loukopoulos P, 2003, VET PATHOL, V40, P237, DOI 10.1354/vp.40-3-237; Lu L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.174; Lub S, 2016, ONCOTARGET, V7, P6521, DOI 10.18632/oncotarget.6658; Mannelli LD, 2018, BIOMED PHARMACOTHER, V105, P1042, DOI 10.1016/j.biopha.2018.06.047; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Murakami A, 2011, VET COMP ONCOL, V9, P219, DOI 10.1111/j.1476-5829.2010.00253.x; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pan Y, 2008, XENOBIOTICA, V38, P382, DOI [10.1080/00498250701827685, 10.1080/00498250701827685 ]; Park IJ, 2014, APOPTOSIS, V19, P615, DOI 10.1007/s10495-013-0929-0; Regan D., 2019, CLIN PATHOLOGICAL ET, P1; Saad ES, 2017, J COMP PATHOL, V156, P352, DOI 10.1016/j.jcpa.2017.03.005; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Sima C, 2015, CANCER INFORM, V14, P33, DOI 10.4137/CIN.S30799; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Sorenmo KU, 2009, VET COMP ONCOL, V7, P162, DOI 10.1111/j.1476-5829.2009.00184.x; Tse AKW, 2013, J BIOL CHEM, V288, P29923, DOI 10.1074/jbc.M113.483909; Tu QY, 2013, INT J BIOL MACROMOL, V60, P268, DOI 10.1016/j.ijbiomac.2013.05.035; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang BE, 2000, J GASTROEN HEPATOL, V15, pE67, DOI 10.1046/j.1440-1746.2000.02100.x; Wei WJ, 2017, J AGR FOOD CHEM, V65, P5985, DOI 10.1021/acs.jafc.7b02384; Wen W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0366-5; Xu ZY, 2017, CHEM-BIOL INTERACT, V273, P48, DOI 10.1016/j.cbi.2017.06.003; Ye TH, 2016, BIOMED PHARMACOTHER, V82, P319, DOI 10.1016/j.biopha.2016.05.015; Ye YT, 2017, J ETHNOPHARMACOL, V200, P107, DOI 10.1016/j.jep.2016.12.051; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu XY, 2007, CURR DRUG METAB, V8, P365, DOI 10.2174/138920007780655441; Yue PB, 2016, CANCER RES, V76, P652, DOI 10.1158/0008-5472.CAN-14-3558; Zhang XN, 2015, J BREAST CANCER, V18, P112, DOI 10.4048/jbc.2015.18.2.112; Zhang YY, 2016, AER ADV ENG RES, V49, P200; Zhou J, 2014, ASIAN PAC J CANCER P, V15, P2439, DOI 10.7314/APJCP.2014.15.6.2439	71	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0236074	10.1371/journal.pone.0236074	http://dx.doi.org/10.1371/journal.pone.0236074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544704	Green Published, gold, Green Submitted			2022-12-26	WOS:000617991900031
J	King, SD; Gray, CF; Song, LH; Mittler, R; Padilla, PA				King, Skylar D.; Gray, Chipo F.; Song, Luhua; Mittler, Ron; Padilla, Pamela A.			The mitochondrial localized CISD-3.1/CISD-3.2 proteins are required to maintain normal germline structure and function in Caenorhabditis elegans	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; WOLFRAM-SYNDROME; GENETIC-CONTROL; NEET PROTEINS; IRON; STEROIDOGENESIS; FERREDOXINS; MITONEET; LEVEL	Reproductive organs and developing tissues have high energy demands that require metabolic functions primarily supported by mitochondria function. The highly conserved CISD/NEET iron-sulfur (Fe-S) protein family regulates iron and reactive oxygen homeostasis, both of which are important for mitochondrial function. Disruption of iron and reactive oxygen homeostasis typically leads to detrimental effects. In humans, CISD dysfunction is associated with human health issues including Wolfram syndrome 2. Using C. elegans, we previously determined that the cisd-1, cisd-3.1 and cisd-3.2 have an overlapping role in the regulation of physiological germline apoptosis through the canonical programmed cell death pathway. Here, we isolated the cisd-3.2(pnIs68) mutant that resulted in physiological and fitness defects including germline abnormalities that are associated with abnormal stem cell niche and disrupted formation of bivalent chromosomes. The cisd-3.2(pnIs68) mutation led to complete disruption of the cisd-3.2 gene expression and a decrease in expression of genetically intact cisd-1 and cisd-3.1 genes suggesting an indirect impact of the cisd-3.2(pnIs68) allele. The CISD-3.2 and CISD-3.1 proteins localize to the mitochondria in many tissues throughout development. The cisd-3.2(pnIs68) mutant displays phenotypes associated with mitochondrial dysfunction, including disruption of the mitochondrial network within the germline. These results further support the idea that the CISD protein family is required for mitochondrial function that supports important functions in animals including overall fitness and germline viability.	[King, Skylar D.; Mittler, Ron] Univ Missouri, Christopher S Bond Life Sci, Coll Agr Food & Nat Resources, Div Plant Sci, Columbia, MO USA; [King, Skylar D.; Mittler, Ron] Univ Missouri, Christopher S Bond Life Sci, Sch Med, Dept Surg, Columbia, MO USA; [Gray, Chipo F.; Song, Luhua; Padilla, Pamela A.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of North Texas System; University of North Texas Denton	Padilla, PA (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.	pamela.padilla@unt.edu		King, Scott/0000-0001-6821-9234; King, Skylar/0000-0002-4150-7807	National Science Foundation; Division of Integrative Organismal Systems (IOS) [1557787]	National Science Foundation(National Science Foundation (NSF)); Division of Integrative Organismal Systems (IOS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by a grant from the National Science Foundation (https://www.nsf.gov), Division of Integrative Organismal Systems (IOS). The grant award (1557787) was to P.A.P. (PI) and R.M. (CoPI). Funders did not play in role in this study.	Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8; Aitken RJ, 2010, HUM REPROD, V25, P2415, DOI 10.1093/humrep/deq214; Al-Sheyyab M, 2001, EUR J PEDIATR, V160, P243, DOI 10.1007/s004310000704; Albertson DG, 1997, COLD SPRING HARBOR M; [Anonymous], 2013, S AFR J ANAESTH ANAL, V19, pS1; Bedaiwy MA, 2002, HUM REPROD, V17, P601, DOI 10.1093/humrep/17.3.601; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; BRENNER S, 1974, GENETICS, V77, P71; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chappel S, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/183024; Charmpilas N, 2020, CELL DEATH DIFFER, V27, P601, DOI 10.1038/s41418-019-0375-9; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crittenden Sarah L., 2008, V450, P27, DOI 10.1007/978-1-60327-214-8_2; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fox PM, 2015, GENETICS, V201, P167, DOI 10.1534/genetics.115.178061; Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hsiung KC, 2020, BIOMED J, V43, P32, DOI 10.1016/j.bj.2019.07.009; Hubbard E Jane Albert, 2005, WormBook, P1; Inupakutika MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42571; Kassahun H, 2018, DNA REPAIR, V61, P46, DOI 10.1016/j.dnarep.2017.11.009; Kawasaki I, 2007, MECH DEVELOP, V124, P237, DOI 10.1016/j.mod.2006.11.004; Kimble Judith, 2005, WormBook, P1; King SD, 2019, CELL DEATH DIFFER, V26, P162, DOI 10.1038/s41418-018-0108-5; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lipper CH, 2018, P NATL ACAD SCI USA, V115, P272, DOI 10.1073/pnas.1715842115; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; Mittler R, 2019, ANTIOXID REDOX SIGN, V30, P1083, DOI 10.1089/ars.2018.7502; Mozzillo E, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-88; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nechushtai R, 2012, PLANT CELL, V24, P2139, DOI 10.1105/tpc.112.097634; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Rondinelli M, 2015, ACTA DIABETOL, V52, P175, DOI 10.1007/s00592-014-0648-1; Rouzier C, 2017, HUM MOL GENET, V26, P1786, DOI 10.1093/hmg/ddx130; Sengupta S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23305-6; Sharma Rakesh K, 2004, Reprod Med Biol, V3, P177, DOI 10.1111/j.1447-0578.2004.00068.x; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; VILLENEUVE AM, 1994, GENETICS, V136, P887; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	53	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245174	10.1371/journal.pone.0245174	http://dx.doi.org/10.1371/journal.pone.0245174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544710	Green Published, gold			2022-12-26	WOS:000617991900019
J	Sogawa, K; Takano, S; Ishige, T; Yoshitomi, H; Kagawa, S; Furukawa, K; Takayashiki, T; Kuboki, S; Nomura, F; Ohtsuka, M				Sogawa, Kazuyuki; Takano, Shigetsugu; Ishige, Takayuki; Yoshitomi, Hideyuki; Kagawa, Shingo; Furukawa, Katsunori; Takayashiki, Tsukasa; Kuboki, Satoshi; Nomura, Fumio; Ohtsuka, Masayuki			Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; URINARY-TRACT PATHOGENS; BLOOD CULTURE BROTHS; MASS-SPECTROMETRY; SP-NOV.; BACTERIA; RESISTANT; FISTULAS; SAMPLES	Surgical site infections (SSIs) are significant and frequent perioperative complications, occurring due to the contamination of the surgical site. The late detection of SSIs, especially organ/space SSIs which are the more difficult to treat, often leads to severe complications. An effective method that can identify bacteria with a high accuracy, leading to the early detection of organ/space SSIs, is needed. Ninety-eight drainage fluid samples obtained from 22 patients with hepatobiliary pancreatic disease were analyzed to identify microorganisms using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) with a new membrane filtration protocol and rapid BACpro(R) pretreatment compared to sole rapid BACpro(R) pretreatment. The levels of detail of rapid BACpro(R) pretreatment with or without filtration were also evaluated for the accuracy of bacterial identification. We found that reliable scores for E. coli and E. faecalis were obtained by inoculation with 1.0 x 10(4) CFU/ml after preparation of the membrane filter with rapid BACpro(R), indicating approximately 10-folds more sensitive compared to sole rapid BACpro(R) pretreatment in drainage fluid specimens. Among 60 bacterial positive colonies in drainage fluid specimens, the MALDI-TOF MS and the membrane filtration with rapid BACpro(R) identified 53 isolates (88.3%) with a significantly higher accuracy, compared to 25 isolates in the rapid BACpro(R) pretreatment group (41.7%) (p < 0.001). Among the 78 strains, 14 enteric Gram-negative bacteria (93.0%) and 55 Gram-positive cocci (87.3%) were correctly identified by the membrane filtration with rapid BACpro(R) with a high reliability. This novel protocol could identify bacterial species within 30 min, at $2-$3 per sample, thus leading to cost and time savings. MALDI-TOF MS with membrane filter and rapid BACpro(R) is a quick and reliable method for bacterial identification in drainage fluids. The shortened analysis time will enable earlier selection of suitable antibiotics for treatment of organ/space SSIs to improve patients' outcomes.	[Sogawa, Kazuyuki] Azabu Univ, Sch Life & Environm Sci, Dept Biochem, Sagamihara, Kanagawa, Japan; [Takano, Shigetsugu; Yoshitomi, Hideyuki; Kagawa, Shingo; Furukawa, Katsunori; Takayashiki, Tsukasa; Kuboki, Satoshi; Ohtsuka, Masayuki] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan; [Ishige, Takayuki] Chiba Univ Hosp, Div Lab Med, Chiba, Japan; [Nomura, Fumio] Chiba Univ Hosp, Div Clin Mass Spectrometry, Chiba, Japan; [Nomura, Fumio] Chiba Univ Hosp, Div Clin Genet, Chiba, Japan	Azabu University; Chiba University; Chiba University; Chiba University; Chiba University	Takano, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan.	stakano@faculty.chiba-u.jp		Takano, Shigetsugu/0000-0002-6495-0422	 [19K07947];  [19K09113];  [19H03725]	; ; 	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI): KIBAN C (grant no. 19K07947 to KS, grant no. 19K09113 to MO, ST, SaK), and KIBAN B (grant no. 19H03725 to ST, ShK, and MO). The URL of Grant-in-Aid for Scientific Research (KAKENHI) is as follows; https://www.jsps.go.jp/english/e-grants/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2015, ASIAN SPINE J, V9, P863, DOI 10.4184/asj.2015.9.6.863; Angeletti S, 2019, INFECT GENET EVOL, V76, DOI 10.1016/j.meegid.2019.104063; Ashizawa K, 2017, J MICROBIOL METH, V139, P54, DOI 10.1016/j.mimet.2017.04.013; Burckhardt I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01744; Catry B, 2006, VET RES COMMUN, V30, P707, DOI 10.1007/s11259-006-3347-8; Cordovana M, 2019, CLIN MASS SPECTROM, V14, P3, DOI 10.1016/j.clinms.2019.06.002; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; De Carolis E, 2014, J INFECT DEV COUNTR, V8, P1081, DOI 10.3855/jidc.3623; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Florio W, 2018, CRIT REV MICROBIOL, V44, P351, DOI 10.1080/1040841X.2017.1407745; Hou TY, 2019, J FOOD DRUG ANAL, V27, P404, DOI 10.1016/j.jfda.2019.01.001; Hrabak J, 2013, CLIN MICROBIOL REV, V26, P103, DOI 10.1128/CMR.00058-12; Kawai M, 2016, SURGERY, V160, P293, DOI 10.1016/j.surg.2016.02.032; Kim Y, 2015, ANN LAB MED, V35, P416, DOI 10.3343/alm.2015.35.4.416; Kitagawa K, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22301; Ledeboer NA, 2015, J CLIN MICROBIOL, V53, P2460, DOI 10.1128/JCM.00581-15; Macaigne H, 2019, J HOSP INFECT, V102, P245, DOI 10.1016/j.jhin.2018.11.013; Maeda H, 2018, J VET MED SCI, V80, P1490, DOI 10.1292/jvms.18-0145; McMillan MT, 2016, J GASTROINTEST SURG, V20, P262, DOI 10.1007/s11605-015-2884-2; Neonakis IK, 2019, EUR J CLIN MICROBIOL, V38, P1795, DOI 10.1007/s10096-019-03620-0; Nomura F, 2020, CLIN PROTEOM, V17, DOI 10.1186/s12014-020-09278-7; Nomura F, 2015, BBA-PROTEINS PROTEOM, V1854, P528, DOI 10.1016/j.bbapap.2014.10.022; Okazaki M, 2009, INT J SYST EVOL MICR, V59, P1336, DOI 10.1099/ijs.0.000760-0; Otsuka Y, 2005, J CLIN MICROBIOL, V43, P3713, DOI 10.1128/JCM.43.8.3713-3717.2005; Oviano M, 2018, CLIN MICROBIOL INFEC, V24, P624, DOI 10.1016/j.cmi.2017.09.010; Oviano M, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00037-18; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Salimnia H, 2016, J CLIN MICROBIOL, V54, P687, DOI 10.1128/JCM.01679-15; Scohy A, 2018, EUR J CLIN MICROBIOL, V37, P2145, DOI 10.1007/s10096-018-3351-2; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Sugiura T, 2015, BRIT J SURG, V102, P1561, DOI 10.1002/bjs.9899; Tran A, 2015, J CLIN MICROBIOL, V53, P2473, DOI 10.1128/JCM.00833-15; Welker M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02711; Yang F, 2018, J HEPATO-BIL-PAN SCI, V25, P508, DOI 10.1002/jhbp.589	35	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246002	10.1371/journal.pone.0246002	http://dx.doi.org/10.1371/journal.pone.0246002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0ZY	33539441	Green Published, gold			2022-12-26	WOS:000617317500003
J	Haddawy, P; Lawpoolsri, S; Sa-Ngamuang, C; Yin, MS; Barkowsky, T; Wiratsudakul, A; Kaewkungwal, J; Khamsiriwatchara, A; Sa-Angchai, P; Sattabongkot, J; Cui, LW				Haddawy, Peter; Lawpoolsri, Saranath; Sa-Ngamuang, Chaitawat; Yin, Myat Su; Barkowsky, Thomas; Wiratsudakul, Anuwat; Kaewkungwal, Jaranit; Khamsiriwatchara, Amnat; Sa-Angchai, Patiwat; Sattabongkot, Jetsumon; Cui, Liwang			Effects of COVID-19 government travel restrictions on mobility in a rural border area of Northern Thailand: A mobile phone tracking study	PLOS ONE			English	Article							HEALTH; IMPACT	Background Thailand is among the top five countries with effective COVID-19 transmission control. This study examines how news of presence of COVID-19 in Thailand, as well as varying levels of government restriction on movement, affected human mobility in a rural Thai population along the border with Myanmar. Methods This study makes use of mobility data collected using a smartphone app. Between November 2019 and June 2020, four major events concerning information dissemination or government intervention give rise to five time intervals of analysis. Radius of gyration is used to analyze movement in each interval, and movement during government-imposed curfew. Human mobility network visualization is used to identify changes in travel patterns between main geographic locations of activity. Cross-border mobility analysis highlights potential for intervillage and intercountry disease transmission. Results Inter-village and cross-border movement was common in the pre-COVID-19 period. Radius of gyration and cross-border trips decreased following news of the first imported cases. During the government lockdown period, radius of gyration was reduced by more than 90% and cross-border movement was mostly limited to short-distance trips. Human mobility was nearly back to normal after relaxation of the lockdown. Conclusions This study provides insight into the impact of the government lockdown policy on an area with extremely low socio-economic status, poor healthcare resources, and highly active cross-border movement. The lockdown had a great impact on reducing individual mobility, including cross-border movement. The quick return to normal mobility after relaxation of the lockdown implies that close monitoring of disease should be continued to prevent a second wave.	[Haddawy, Peter; Sa-Ngamuang, Chaitawat; Yin, Myat Su] Mahidol Univ, Fac ICT, Phutthamonthon Dist, Nakhon Pathom, Thailand; [Haddawy, Peter; Barkowsky, Thomas] Univ Bremen, Bremen Spatial Cognit Ctr, Bremen, Germany; [Lawpoolsri, Saranath; Kaewkungwal, Jaranit; Sa-Angchai, Patiwat] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Lawpoolsri, Saranath; Kaewkungwal, Jaranit; Khamsiriwatchara, Amnat] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat BIOPHI, Bangkok, Thailand; [Wiratsudakul, Anuwat] Mahidol Univ, Fac Vet Sci, Phutthamonthon Dist, Nakhon Pathom, Thailand; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [Cui, Liwang] Univ S Florida, Dept Internal Med, Div Infect Dis & Internal Med, Tampa, FL 33620 USA	Mahidol University; University of Bremen; Mahidol University; Mahidol University; Mahidol University; Mahidol University; State University System of Florida; University of South Florida	Haddawy, P (corresponding author), Mahidol Univ, Fac ICT, Phutthamonthon Dist, Nakhon Pathom, Thailand.; Haddawy, P (corresponding author), Univ Bremen, Bremen Spatial Cognit Ctr, Bremen, Germany.	peter.had@mahidol.ac.th	Prachumsri, Jetsumon/AAZ-7732-2021	Sattabongkot, Jetsumon/0000-0002-3938-4588	National Institutes of Health, USA [U19AI089672]; Mahidol University Office of International Relations	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mahidol University Office of International Relations	This work was supported by the National Institutes of Health, USA (U19AI089672), and through a grant from the Mahidol University Office of International Relations to Haddawy in support of the MIRU joint unit.	[Anonymous], 2014, EURO SURVEILL; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Dechsupa S, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101802; Engle S., 2020, STAYING HOME MOBILIT, DOI [10.2139/ssrn.3565703, DOI 10.2139/SSRN.3565703]; Gonzalez MC, 2009, NATURE, V458, DOI 10.1038/nature07850; Klein B.\, 2020, ASSESSING CHANGES CO; Kowitt SD, 2015, J COMMUN HEALTH, V40, P780, DOI 10.1007/s10900-015-9999-y; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lawpoolsri S, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2763-5; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Liu W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072304; Ministry of Interior Thailand, 2020, ORD NAT CURIF; Office of the Permanent Secretary for Interior. Coronary Infection Situation Management Center, 2020, ORD TRAV RESTR LOC Q; Office of the Permanent Secretary for Interior. Coronary Infection Situation Management Center (2019) Ministry of Interior Thailand, 2020, ORD RED CURF PER; Peak CM, 2018, INT J EPIDEMIOL, V47, P1562, DOI 10.1093/ije/dyy095; Saita S, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2704-3; SINGHANETRARENARD A, 1993, SOC SCI MED, V37, P1147, DOI 10.1016/0277-9536(93)90254-2; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; World Health Organization, TIM WHOS RESP COVID	24	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245842	10.1371/journal.pone.0245842	http://dx.doi.org/10.1371/journal.pone.0245842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2HP	33534857	Green Published, gold			2022-12-26	WOS:000616720600003
J	Qi, L; Liu, T; Gao, Y; Tian, DC; Tang, WG; Li, Q; Feng, LZ; Liu, QY				Qi, Li; Liu, Tian; Gao, Yuan; Tian, Dechao; Tang, Wenge; Li, Qin; Feng, Luzhao; Liu, Qiyong			Effect of meteorological factors on the activity of influenza in Chongqing, China, 2012-2019	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; TRANSMISSION; TEMPERATURE; SEASONALITY	Background The effects of multiple meteorological factors on influenza activity remain unclear in Chongqing, the largest municipality in China. We aimed to fix this gap in this study. Methods Weekly meteorological data and influenza surveillance data in Chongqing were collected from 2012 to 2019. Distributed lag nonlinear models (DLNMs) were conducted to estimate the effects of multiple meteorological factors on influenza activity. Results Inverted J-shaped nonlinear associations between mean temperature, absolute humidity, wind speed, sunshine and influenza activity were found. The relative risks (RRs) of influenza activity increased as weekly average mean temperature fell below 18.18 degrees C, average absolute humidity fell below 12.66 g/m(3), average wind speed fell below 1.55 m/s and average sunshine fell below 2.36 hours. Taking the median values as the references, lower temperature, lower absolute humidity and windless could significantly increase the risks of influenza activity and last for 4 weeks. A J-shaped nonlinear association was observed between relative humidity and influenza activity; the risk of influenza activity increased with rising relative humidity with 78.26% as the break point. Taking the median value as the reference, high relative humidity could increase the risk of influenza activity and last for 3 weeks. In addition, we found the relationship between aggregate rainfall and influenza activity could be described with a U-shaped curve. Rainfall effect has significantly higher RR than rainless effect. Conclusions Our study shows that multiple meteorological factors have strong associations with influenza activity in Chongqing, providing evidence for developing a meteorology-based early warning system for influenza to facilitate timely response to upsurge of influenza activity.	[Qi, Li; Tang, Wenge; Li, Qin] Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Qi, Li; Gao, Yuan; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Tian] Jingzhou Ctr Dis Control & Prevent, Jingzhou, Hubei, Peoples R China; [Tian, Dechao] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Peoples R China; [Feng, Luzhao] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, QY (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Feng, LZ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing, Peoples R China.	fenglz@chinacdc.cn; liuqiyong@icdc.cn			Chongqing Health Commission Program [2019GDRC014]; China Postdoctoral Science Foundation [2019M660754]; National Key Research and Development Program of China [2017YFC0907303]	Chongqing Health Commission Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Research and Development Program of China	1. Chongqing Health Commission Program (grant number 2019GDRC014) 2. China Postdoctoral Science Foundation (grant number 2019M660754) 3. National Key Research and Development Program of China (grant number 2017YFC0907303) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Cheng YH, 2016, EPIDEMIOL INFECT, V144, P333, DOI 10.1017/S0950268815001739; Chong KC, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134727; Dai QG, 2018, SCI TOTAL ENVIRON, V645, P684, DOI 10.1016/j.scitotenv.2018.07.065; Emukule GO, 2016, INFLUENZA OTHER RESP, V10, P375, DOI 10.1111/irv.12393; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gruber-Bzura BM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082419; Guo QZ, 2019, INFLUENZA OTHER RESP, V13, P166, DOI 10.1111/irv.12617; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Liu ZD, 2019, ENVIRON RES, V172, P326, DOI 10.1016/j.envres.2019.01.053; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nishiura H, 2011, J THEOR BIOL, V272, P123, DOI 10.1016/j.jtbi.2010.12.017; Qi L, 2020, HUMAN VACCINES IMMUN, P1, DOI [10.1080/21645515.2019.169372132343618, DOI 10.1080/21645515.2019.169372132343618]; Qi L, 2020, SCI TOTAL ENVIRON, V716, DOI 10.1016/j.scitotenv.2020.136682; Qi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167866; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shoji M, 2011, TOHOKU J EXP MED, V224, P251, DOI 10.1620/tjem.224.251; Soebiyanto RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134701; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; WHO, 2018, 650 000 PEOPL RESP D; Xiao H, 2013, CHINESE SCI BULL, V58, P741, DOI 10.1007/s11434-012-5571-7; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Zhang YZ, 2020, SCI TOTAL ENVIRON, V701, DOI 10.1016/j.scitotenv.2019.134607	32	4	5	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246023	10.1371/journal.pone.0246023	http://dx.doi.org/10.1371/journal.pone.0246023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534840	gold, Green Published, Green Submitted			2022-12-26	WOS:000616739700021
J	Abdollahi, P; Vandsemb, EN; Elsaadi, S; Rost, LM; Yang, R; Hjort, MA; Andreassen, T; Misund, K; Slordahl, TS; Ro, TB; Sponaas, AM; Moestue, S; Bruheim, P; Borset, M				Abdollahi, Pegah; Vandsemb, Esten N.; Elsaadi, Samah; Rost, Lisa M.; Yang, Rui; Hjort, Magnus A.; Andreassen, Trygve; Misund, Kristine; Slordahl, Tobias S.; Ro, Torstein B.; Sponaas, Anne-Marit; Moestue, Siver; Bruheim, Per; Borset, Magne			Phosphatase of regenerating liver-3 regulates cancer cell metabolism in multiple myeloma	FASEB JOURNAL			English	Article						GLDC; glycine; serine; Warburg effect	ONE-CARBON METABOLISM; PRL-3 PHOSPHATASE; AMINO-ACIDS; GLYCINE; PROTEIN; EXPRESSION; SERINE; PROLIFERATION; METASTASIS; GLYCOLYSIS	Cancer cells often depend on microenvironment signals from molecules such as cytokines for proliferation and metabolic adaptations. PRL-3, a cytokine-induced oncogenic phosphatase, is highly expressed in multiple myeloma cells and associated with poor outcome in this cancer. We studied whether PRL-3 influences metabolism. Cells transduced to express PRL-3 had higher aerobic glycolytic rate, oxidative phosphorylation, and ATP production than the control cells. PRL-3 promoted glucose uptake and lactate excretion, enhanced the levels of proteins regulating glycolysis and enzymes in the serine/glycine synthesis pathway, a side branch of glycolysis. Moreover, mRNAs for these proteins correlated with PRL-3 expression in primary patient myeloma cells. Glycine decarboxylase (GLDC) was the most significantly induced metabolism gene. Forced GLDC downregulation partly counteracted PRL-3-induced aerobic glycolysis, indicating GLDC involvement in a PRL-3-driven Warburg effect. AMPK, HIF-1 alpha, and c-Myc, important metabolic regulators in cancer cells, were not mediators of PRL-3's metabolic effects. A phosphatase-dead PRL-3 mutant, C104S, promoted many of the metabolic changes induced by wild-type PRL-3, arguing that important metabolic effects of PRL-3 are independent of its phosphatase activity. Through this study, PRL-3 emerges as one of the key mediators of metabolic adaptations in multiple myeloma.	[Abdollahi, Pegah; Vandsemb, Esten N.; Elsaadi, Samah; Yang, Rui; Hjort, Magnus A.; Misund, Kristine; Slordahl, Tobias S.; Ro, Torstein B.; Sponaas, Anne-Marit; Moestue, Siver; Borset, Magne] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, Trondheim, Norway; [Abdollahi, Pegah; Yang, Rui] St Olays Univ Hosp, Lab Clin, Trondheim, Norway; [Rost, Lisa M.; Bruheim, Per] Norwegian Univ Sci & Technol, Fac Nat Sci, Dept Biotechnol & Food Sci, Trondheim, Norway; [Hjort, Magnus A.; Ro, Torstein B.] St Olays Univ Hosp, Childrens Clin, Trondheim, Norway; [Andreassen, Trygve] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, MR Core Facil, Trondheim, Norway; [Misund, Kristine; Slordahl, Tobias S.] St Olays Univ Hosp, Clin Med, Trondheim, Norway; [Moestue, Siver] Nord Univ, Fac Hlth Sci, Dept Pharm, Bodo, Norway; [Borset, Magne] St Olays Univ Hosp, Dept Immunol & Transfus Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Nord University	Borset, M (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7491 Trondheim, Norway.	magne.borset@ntnu.no	Abdollahi, Pegah/GON-4184-2022; Borset, Magne/AAY-1713-2021; Abdollahi, pegah/AGW-4229-2022; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Elsaadi, Samah/0000-0002-5554-0771; Rost, Lisa Marie/0000-0003-3980-8667	NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway	NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway	NTNU; Liaison Committee for Education, Research, and Innovation in Central Norway	Abdollahi P, 2017, MOL CANCER RES, V15, P69, DOI 10.1158/1541-7786.MCR-16-0212; Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Avet-Loiseau H, 2001, BLOOD, V98, P3082, DOI 10.1182/blood.V98.10.3082; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bettum IJ, 2015, CANCER LETT, V366, P71, DOI 10.1016/j.canlet.2015.06.006; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chong PSY, 2019, CANCER RES, V79, P4679, DOI 10.1158/0008-5472.CAN-19-0343; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Funato Y, 2020, DEV CELL, V55, P387, DOI 10.1016/j.devcel.2020.08.009; Funato Y, 2019, J BIOCHEM, V165, P219, DOI 10.1093/jb/mvy095; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Ganapathy-Kanniappan S, 2018, CRIT REV BIOCHEM MOL, V53, P667, DOI 10.1080/10409238.2018.1556578; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Hardy S, 2019, P NATL ACAD SCI USA, V116, P2925, DOI 10.1073/pnas.1815361116; Hardy S, 2018, FEBS J, V285, P3886, DOI 10.1111/febs.14503; Hjort MA, 2018, ONCOTARGET, V9, P3549, DOI 10.18632/oncotarget.23186; Hjort MA, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0100-2; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kang PJ, 2019, METAB ENG, V53, P35, DOI 10.1016/j.ymben.2019.02.003; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; KLEIN B, 1989, BLOOD, V73, P517; Kozlov G, 2020, J BIOL CHEM, V295, P11682, DOI 10.1074/jbc.RA120.014464; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Li QL, 2020, P NATL ACAD SCI USA, V117, P20538, DOI 10.1073/pnas.2002964117; Liu YX, 2013, GUT, V62, P571, DOI 10.1136/gutjnl-2011-301059; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lujan P, 2016, J CELL SCI, V129, P4130, DOI 10.1242/jcs.190215; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park JE, 2013, EMBO MOL MED, V5, P1351, DOI 10.1002/emmm.201202183; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Qu S, 2014, CANCER-AM CANCER SOC, V120, P2130, DOI 10.1002/cncr.28668; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Slordahl TS, 2016, ONCOTARGET, V7, P27295, DOI 10.18632/oncotarget.8422; Sogaard Caroline Krogh, 2018, Oncotarget, V9, P32448, DOI 10.18632/oncotarget.25963; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vandsemb EN, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0830-z; WARBURG O, 1956, SCIENCE, V124, P269; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Woo CC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00196; Wu SP, 2016, CLIN CANCER RES, V22, P4039, DOI 10.1158/1078-0432.CCR-15-2366; Xu HY, 2017, INT J ONCOL, V51, P1271, DOI 10.3892/ijo.2017.4090; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07132-x; Yang YY, 2018, CANCER MANAG RES, V10, P5071, DOI 10.2147/CMAR.S165344; Yang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169665; Zhang HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00147-2; Zhang MM, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100766; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhou JB, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-72; Zhou JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019798	64	12	12	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21344	10.1096/fj.202001920RR	http://dx.doi.org/10.1096/fj.202001920RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566385	Green Published, hybrid			2022-12-26	WOS:000629576700009
J	Monteiro, DA; Dole, NS; Campos, JL; Kaya, S; Schurman, CA; Belair, CD; Alliston, T				Monteiro, David A.; Dole, Neha S.; Campos, J. Luke; Kaya, Serra; Schurman, Charles A.; Belair, Cassandra D.; Alliston, Tamara			Fluid shear stress generates a unique signaling response by activating multiple TGF beta family type I receptors in osteocytes	FASEB JOURNAL			English	Article						mechanobiology; microfluidics; osteocytes; TGF-beta	MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; LATENT TGF-BETA-1; EXPRESSION; STIMULATION; STIFFNESS; ENRICHR	Bone is a dynamic tissue that constantly adapts to changing mechanical demands. The transforming growth factor beta (TGF beta) signaling pathway plays several important roles in maintaining skeletal homeostasis by both coupling the bone-forming and bone-resorbing activities of osteoblasts and osteoclasts and by playing a causal role in the anabolic response of bone to applied loads. However, the extent to which the TGF beta signaling pathway in osteocytes is directly regulated by fluid shear stress (FSS) is unknown, despite work suggesting that fluid flow along canaliculi is a dominant physical cue sensed by osteocytes following bone compression. To investigate the effects of FSS on TGF beta signaling in osteocytes, we stimulated osteocytic OCY454 cells cultured within a microfluidic platform with FSS. We find that FSS rapidly upregulates Smad2/3 phosphorylation and TGF beta target gene expression, even in the absence of added TGF beta. Indeed, relative to treatment with TGF beta, FSS induced a larger increase in levels of pSmad2/3 and Serpine1 that persisted even in the presence of a TGF beta receptor type I inhibitor. Our results show that FSS stimulation rapidly induces phosphorylation of multiple TGF beta family R-Smads by stimulating multimerization and concurrently activating several TGF beta and BMP type I receptors, in a manner that requires the activity of the corresponding ligand. While the individual roles of the TGF beta and BMP signaling pathways in bone mechanotransduction remain unclear, these results implicate that FSS activates both pathways to generate a downstream response that differs from that achieved by either ligand alone.	[Monteiro, David A.; Dole, Neha S.; Campos, J. Luke; Kaya, Serra; Schurman, Charles A.; Alliston, Tamara] Univ Calif San Francisco, Dept Orthopaed Surg, 513 Parnassus Ave,S-1155, San Francisco, CA 94143 USA; [Monteiro, David A.; Schurman, Charles A.; Alliston, Tamara] UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA USA; [Belair, Cassandra D.; Alliston, Tamara] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Belair, Cassandra D.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alliston, T (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 513 Parnassus Ave,S-1155, San Francisco, CA 94143 USA.	tamara.alliston@ucsf.edu	Kaya, Serra/J-8447-2019	Kaya, Serra/0000-0002-4979-3705; Schurman, Charles/0000-0002-5739-8481; Dole, Neha/0000-0003-4675-2649	National Science Foundation (NSF) [1636331]; HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [R01DE019284]; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21AR070403]; U.S. Department of Defense (DOD); National Institutes of Health	National Science Foundation (NSF)(National Science Foundation (NSF)); HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR); HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); U.S. Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Science Foundation (NSF), Grant/Award Number: 1636331; HHS vertical bar NIH vertical bar National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R01DE019284; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R21AR070403; U.S. Department of Defense (DOD), Grant/Award Number: NDSEG Graduate Fellowship; National Institutes of Health	Albro MB, 2012, OSTEOARTHR CARTILAGE, V20, P1374, DOI 10.1016/j.joca.2012.07.006; Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Baeyens N, 2016, J CELL BIOL, V214, P807, DOI 10.1083/jcb.201603106; Baeyens N, 2015, ELIFE, V4, DOI 10.7554/eLife.04645; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Budi EH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53490-x; Cabahug-Zuckerman P, 2018, J ORTHOP RES, V36, P642, DOI 10.1002/jor.23792; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Cook LM, 2019, ONCOGENE, V38, P6959, DOI 10.1038/s41388-019-0913-4; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; de Kroon LMG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dole NS, 2017, CELL REP, V21, P2585, DOI 10.1016/j.celrep.2017.10.115; Duan D, 2019, J BIOL CHEM, V294, P8490, DOI 10.1074/jbc.RA118.005763; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finnson KW, 2010, OSTEOARTHR CARTILAGE, V18, P1518, DOI 10.1016/j.joca.2010.09.002; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Govey PM, 2015, J BIOMECH, V48, P4327, DOI 10.1016/j.jbiomech.2015.10.045; Govey PM, 2014, J BIOMECH, V47, P1838, DOI 10.1016/j.jbiomech.2014.03.022; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Klingberg F, 2014, J CELL BIOL, V207, P283, DOI 10.1083/jcb.201402006; Kouzbari K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42302-x; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kunnen SJ, 2017, CELL MOL LIFE SCI, V74, P2283, DOI 10.1007/s00018-017-2460-x; Kutmon Martina, 2014, F1000Res, V3, P152, DOI 10.12688/f1000research.4254.2; Kwon SH, 2013, TISSUE ENG PT A, V19, P49, DOI [10.1089/ten.tea.2012.0245, 10.1089/ten.TEA.2012.0245]; Labour MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35542; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Li J, 2012, J BIOMECH, V45, P247, DOI 10.1016/j.jbiomech.2011.10.037; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyons JS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan5748; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Moore Emily R, 2018, J Mol Biochem, V7, P48; Morrell AE, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0007-x; Nguyen J, 2020, BONE, V131, DOI 10.1016/j.bone.2019.115148; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Rape AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9129; Rys JP, 2016, MATRIX BIOL, V52-54, P413, DOI 10.1016/j.matbio.2016.02.002; Rys JP, 2015, ELIFE, V4, DOI [10.7554/elife.09300, 10.7554/eLife.09300]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stanley A, 2019, J BONE MINER RES, V34, P1894, DOI 10.1002/jbmr.3760; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Utsunomiya T, 2016, INVEST OPHTH VIS SCI, V57, P6382, DOI 10.1167/iovs.16-20638; Walshe TE, 2013, ARTERIOSCL THROM VAS, V33, P2608, DOI 10.1161/ATVBAHA.113.302161; Wang WG, 2019, P NATL ACAD SCI USA, V116, P15570, DOI 10.1073/pnas.1902927116; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Wittkowske C, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00087; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Xu LCH, 2019, J ORTHOP RES, V37, P1681, DOI 10.1002/jor.24302; Yan ZD, 2018, CELL BIOL INT, V42, P1410, DOI 10.1002/cbin.11032; Zhou J, 2012, P NATL ACAD SCI USA, V109, P7770, DOI 10.1073/pnas.1205476109	67	10	10	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21263	10.1096/fj.202001998R	http://dx.doi.org/10.1096/fj.202001998R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570811	hybrid, Green Published			2022-12-26	WOS:000629576700005
J	Desalegn, Z; Deyessa, N; Teka, B; Shiferaw, W; Yohannes, M; Hailemariam, D; Addissie, A; Abagero, A; Kaba, M; Abebe, W; Abrha, A; Nega, B; Ayele, W; Haile, T; Gebrehiwot, Y; Amogne, W; Kantelhardt, EJ; Abebe, T				Desalegn, Zelalem; Deyessa, Negussie; Teka, Brhanu; Shiferaw, Welelta; Yohannes, Meron; Hailemariam, Damen; Addissie, Adamu; Abagero, Abdulnasir; Kaba, Mirgissa; Abebe, Workeabeba; Abrha, Alem; Nega, Berhanu; Ayele, Wondimu; Haile, Tewodros; Gebrehiwot, Yirgu; Amogne, Wondwossen; Kantelhardt, Eva Johanna; Abebe, Tamrat			Evaluation of COVID-19 related knowledge and preparedness in health professionals at selected health facilities in a resource-limited setting in Addis Ababa, Ethiopia	PLOS ONE			English	Article							CARE WORKERS; ATTITUDE	Background The World Health Organization has declared that infection with SARS-CoV-2 is a pandemic. Experiences with SARS in 2003 and SARS-CoV-2 have shown that health professionals are at higher risk of contracting COVID-19. Hence, it has been recommended that aperiodic wide-scale assessment of the knowledge and preparedness of health professionals regarding the current COVID-19 pandemic is critical. Objectives This study aimed to assess the knowledge and preparedness of health professionals regarding COVID-19 among selected hospitals in Addis Ababa, Ethiopia. Methods A facility-based cross-sectional study was conducted from the last week of March to early April, 2020. Government (n = 6) and private hospitals (n = 4) were included. The front-line participants with high exposure were proportionally recruited from their departments. The collected data from a self-administered questionnaire were entered using EpiData and analyzed in SPSS software. Both descriptive statistics and inferential statistics (chi-square tests) are presented. Results A total of 1334 health professionals participated in the study. The majority (675, 50.7%) of the participants were female. Of the total, 532 (39.9%) subjects were nurses/midwives, followed by doctors (397, 29.8%) and pharmacists (193, 14.5%). Of these, one-third had received formal training on COVID-19. The mean knowledge score of participants was 16.45 (+/- 4.4). Regarding knowledge about COVID-19, 783 (58.7%), 354 (26.5%), and 196 (14.7%) participants had moderate, good, and poor knowledge, respectively. Lower scores were seen in younger age groups, females, and non-physicians. Two-thirds (63.2%) of the subjects responded that they had been updated by their hospital on COVID-19. Of the total, 1020 (76.5%) participants responded that television, radio, and newspapers were their primary sources of information. Established hospital preparedness measures were confirmed by 43-57% of participants. Conclusion The current study revealed that health professionals in Addis Ababa, Ethiopia, already know important facts but had moderate overall knowledge about the COVID-19 pandemic. There were unmet needs in younger age groups, non-physicians, and females. Half of the respondents mentioning inadequate preparedness of their hospitals point to the need for more global solidarity, especially concerning the shortage of consumables and lack of equipment.	[Desalegn, Zelalem; Teka, Brhanu; Abebe, Tamrat] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Deyessa, Negussie; Hailemariam, Damen; Addissie, Adamu; Abagero, Abdulnasir; Kaba, Mirgissa; Ayele, Wondimu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Shiferaw, Welelta] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Psychiat, Addis Ababa, Ethiopia; [Yohannes, Meron] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Abebe, Workeabeba] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Pediat & Child Hlth Dept, Addis Ababa, Ethiopia; [Abrha, Alem] Yekatit 12 Hosp Med Coll, Addis Ababa, Ethiopia; [Nega, Berhanu] Addis Ababa Univ, Coll Hlth Sci, Dept Surg, Sch Med, Addis Ababa, Ethiopia; [Haile, Tewodros; Amogne, Wondwossen] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia; [Gebrehiwot, Yirgu] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Obstet & Gynecol, Addis Ababa, Ethiopia; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany	Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Martin Luther University Halle Wittenberg	Desalegn, Z (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	zelalem.desalegn@aau.edu.et	Degu, Wondwossen Amogne/GON-3590-2022; Amogne, Wondwossen/AGM-9855-2022; Kaba, Mirgissa/HGB-6272-2022	Ayele, Wondimu/0000-0001-5899-347X; Abagero, Abdulnasir/0000-0001-7178-9860; Desalegn, Zelalem/0000-0001-9643-8661	AAU [VPRTT/PY-403/2020]; Addis Ababa University	AAU; Addis Ababa University	ZD and TA received the award from AAU. Grant number: VPRTT/PY-403/2020. The fund was secured from Addis Ababa University. www.aau.edu.et We assure you that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Askarian M, 2007, INT J INFECT DIS, V11, P213, DOI 10.1016/j.ijid.2006.01.006; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; Edae CK, 2020, ASSESSMENT PREPAREDN, DOI DOI 10.1101/2020080657/V1; Elhadi M, 2020, AM J TROP MED HYG, V103, P828, DOI 10.4269/ajtmh.20-0330; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Jemal B, 2020, KNOWLEDGE ATTITUDE P, DOI [10.21203/rs.3.rs-29437/v1, DOI 10.21203/RS.3.RS-29437/V1]; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Ma XC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-24; McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4; MedScape, 2020, MEM HEALTHC WORK WHO; Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848; Ogolodom M. P., 2020, HLTH SCI J, DOI [10.36648/1791-809X.S1.002, DOI 10.36648/1791-809X.S1.002]; Olowookere SA, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/431317; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Sarani Hamed, 2015, Glob J Health Sci, V8, P193, DOI 10.5539/gjhs.v8n3p193; Tadesse DB, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100787; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Taysir A, 2020, KNOWLEDGE PREPAREDNE, DOI [10.2139/ssrn.3550294, DOI 10.2139/SSRN.3550294]; World Health Organization, WHO CALLS HLTH SAF D; World Health Organization, NOV COR COVID 19 SIT; World Health Organization, 2003, FACT SHEET; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012	29	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0244050	10.1371/journal.pone.0244050	http://dx.doi.org/10.1371/journal.pone.0244050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG7BC	33566814	gold, Green Published			2022-12-26	WOS:000617737300002
J	Feldman, M; Krylova, VL; Farrow, P; Donovan, L; Zandamela, E; Rebelo, J; Rodrigues, M; Bulo, A; Ferraz, C; Rodrigues, H; Roca-Feltrer, A; Baker, K				Feldman, Mitra; Krylova, Vera Lacey; Farrow, Poppy; Donovan, Laura; Zandamela, Edson; Rebelo, Joaquim; Rodrigues, Maria; Bulo, Antonio; Ferraz, Carlos; Rodrigues, Humberto; Roca-Feltrer, Arantxa; Baker, Kevin			Community health worker knowledge, attitudes and practices towards COVID-19: Learnings from an online cross-sectional survey using a digital health platform, UpSCALE, in Mozambique	PLOS ONE			English	Article							CARE WORKERS; OUTBREAK; WUHAN; CHINA	Healthcare workers (HCWs) are at the frontline of the Coronavirus Disease 2019 (COVID-19) pandemic response, yet there is a paucity of literature on their knowledge, attitudes and practices (KAP) in relation to the pandemic. Community Health Workers (CHWs) in Mozambique are known locally as agentes polivalentes elementares (APEs). While technical guidance surrounding COVID-19 is available to support APEs, communicating this information has been challenging due to restrictions on travel, face-to-face group meetings and training, imposed from May to August 2020. A digital health platform, upSCALE, that already supports 1,213 APEs and 299 supervisors across three provinces, is being used to support APEs on effective COVID-19 management by delivering COVID-19 sensitive SMS messages, training modules and a COVID-19 KAP survey. The KAP survey, conducted from June 2020 to August 2020, consisted of 10 questions. Of 1,065 active upSCALE APEs, 28% completed the survey. Results indicate that only a small proportion of APEs listed the correct COVID-19 symptoms, transmission routes and appropriate prevention measures (n = (25%), n = (16%) and n = (39%), respectively) specifically included in national health education materials. Misconceptions were mainly related to transmission routes, high risk individuals and asymptomatic patients. 84% said they followed all government prevention guidelines. The results from the KAP survey were used to support the rapid development and deployment of targeted COVID-19 awareness and education materials for the APEs. A follow-up KAP survey is planned for November 2020. Adapting the existing upSCALE platform enabled a better understanding, in real time, of the KAP of APEs around COVID-19 management. Subsequently, supporting delivery of tailored messages and education, vital for ensuring a successful COVID-19 response.	[Krylova, Vera Lacey; Farrow, Poppy; Donovan, Laura; Roca-Feltrer, Arantxa; Baker, Kevin] Malaria Consortium, London, England; [Zandamela, Edson; Rebelo, Joaquim; Rodrigues, Maria; Bulo, Antonio; Ferraz, Carlos] Malaria Consortium, Maputo, Mozambique; [Rodrigues, Humberto] Republ Mozamb Minist Hlth, Maputo, Mozambique; [Baker, Kevin] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden	Karolinska Institutet	Baker, K (corresponding author), Malaria Consortium, London, England.; Baker, K (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.	k.baker@malariaconsortium.org	Baker, Kevin/AAT-6449-2021	Baker, Kevin/0000-0002-2040-3662; Feldman, Mitra/0000-0002-0193-0416	Malaria Consortium US	Malaria Consortium US	Malaria Consortium US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, COVID 19 SIT UPD WHO; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; European Centre for Disease Control, 2020, COVID 19 SIT UPD WOR; Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Maxwell DN, 2020, CLIN INFECT DIS, V71, P2215, DOI 10.1093/cid/ciaa229; Nepal R, 2020, KNOWLEDGE ATTITUDE P; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Republic of Mozambique Ministry of Health, 2020, COVID 19 PAG PRINC R; Republic of Mozambique Ministry of Health, 2020, ESTR NACL RESP COM 1; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Rugarabamu S., 2020, MEDRXIV, V216, P1, DOI [10.1101/2020.04.26.20080820, DOI 10.1101/2020.04.26.20080820]; Sahin AR, 2020, EURASIAN J MED ONCOL, V4, P1, DOI 10.14744/ejmo.2020.12220; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; WHO, 2020, RESP COMM SPREAD COV, P1, DOI DOI 10.1017/DMP.2020.166; World Health Organization,, 2008, STOP TBP ADV COMM SO; World Health Organization, 2020, ARCH WHO TIM COVID 1; World Health Organization. Regional Office for E, 2020, WHOEURO2020696404315; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	24	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0244924	10.1371/journal.pone.0244924	http://dx.doi.org/10.1371/journal.pone.0244924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566850	gold, Green Submitted, Green Published			2022-12-26	WOS:000618271700023
J	Philouze, C; Turban, S; Cremers, B; Caliez, A; Lamarche, G; Bernard, C; Provost, N; Delerive, P				Philouze, Clothilde; Turban, Sophie; Cremers, Beatrice; Caliez, Audrey; Lamarche, Gwladys; Bernard, Catherine; Provost, Nicolas; Delerive, Philippe			MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle	PLOS ONE			English	Article								In type 2 diabetes (T2D), both muscle and liver are severely resistant to insulin action. Muscle insulin resistance accounts for more than 80% of the impairment in total body glucose disposal in T2D patients and is often characterized by an impaired insulin signaling. Mitsugumin 53 (MG53), a muscle-specific TRIM family protein initially identified as a key regulator of cell membrane repair machinery has been suggested to be a critical regulator of muscle insulin signaling pathway by acting as ubiquitin E3 ligase targeting both the insulin receptor and insulin receptor substrate 1 (IRS1). Here, we show using in vitro and in vivo approaches that MG53 is not a critical regulator of insulin signaling and glucose homeostasis. First, MG53 expression is not consistently regulated in skeletal muscle from various preclinical models of insulin resistance. Second, MG53 gene knock-down in muscle cells does not lead to impaired insulin response as measured by Akt phosphorylation on Serine 473 and glucose uptake. Third, recombinant human MG53 does not alter insulin response in both differentiated C2C12 and human skeletal muscle cells. Fourth, ectopic expression of MG53 in HEK293 cells lacking endogenous MG53 expression fails to alter insulin response as measured by Akt phosphorylation. Finally, both male and female mg53 -/- mice were not resistant to high fat induced obesity and glucose intolerance compared to wild-type mice. Taken together, these results strongly suggest that MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle.	[Philouze, Clothilde; Turban, Sophie; Cremers, Beatrice; Caliez, Audrey; Lamarche, Gwladys; Bernard, Catherine; Provost, Nicolas; Delerive, Philippe] Inst Rech Servier Cardiovasc & Metab Res, Suresnes, France; [Philouze, Clothilde; Turban, Sophie; Cremers, Beatrice; Caliez, Audrey; Lamarche, Gwladys; Bernard, Catherine; Provost, Nicolas; Delerive, Philippe] Inst Rech Servier, Cardiovasc & Metab Res, Suresnes, France	Servier; Institut de Recherches Internationales Servier	Delerive, P (corresponding author), Inst Rech Servier Cardiovasc & Metab Res, Suresnes, France.; Delerive, P (corresponding author), Inst Rech Servier, Cardiovasc & Metab Res, Suresnes, France.	philippe.delerive@servier.com		Philouze, Clothilde/0000-0002-0669-0263	Servier	Servier(Servier)	Servier funded this work.	[Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bian Z, 2019, NAT COMMUN, V10, P1, DOI [10.1038/s41467-018-07882-8, DOI 10.1038/S41467-018-07882-8]; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Lemckert FA, 2016, CARDIOVASC RES, V110, P178, DOI 10.1093/cvr/cvw017; Ma H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124128; Majdoubi A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01953; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Tan T, 2016, BMB REP, V49, P414, DOI 10.5483/BMBRep.2016.49.8.079; Wang Q, 2020, DIABETES, V69, P1052, DOI 10.2337/db19-0807; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Wu HK, 2019, CIRCULATION, V139, P901, DOI 10.1161/CIRCULATIONAHA.118.037216; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Zhang Y, 2017, MOL PHARMACOL, V92, P211, DOI 10.1124/mol.117.108241; Zhu H, 2019, CIRCULATION, V140, pE186, DOI 10.1161/CIRCULATIONAHA.118.039305	27	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245179	10.1371/journal.pone.0245179	http://dx.doi.org/10.1371/journal.pone.0245179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566837	Green Submitted, Green Published, gold			2022-12-26	WOS:000618271700030
J	De, ARKMR; Sawhney, S; Bhattacharya, D; Sujatha, T; Sunder, J; Ponraj, P; Ravi, SK; Mondal, S; Malakar, D; Kundu, A				De, Arun Kumar; Sawhney, Sneha; Bhattacharya, Debasis; Sujatha, T.; Sunder, Jai; Ponraj, Perumal; Ravi, S. K.; Mondal, Samiran; Malakar, Dhruba; Kundu, A.			Origin, genetic diversity and evolution of Andaman local duck, a native duck germplasm of an insular region of India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANAS-PLATYRHYNCHOS; PHYLOGENETIC ANALYSIS; POPULATION-GENETICS; MALLARD; PHYLOGEOGRAPHY; HYBRIDIZATION; POLYMORPHISM; DIVERGENCE; FUTURE	Domestic ducks are of paramount importance as a cheap source of protein in rural India. Andaman local duck (ALD) is an indigenous avian genetic resource of Andaman and Nicobar islands (ANI) and is mainly distributed in Middle and Northern parts of these islands. Negligence has brought this breed on the edge of extinction necessitating immediate conservation efforts. Here, we report the genetic diversity, population structure and matrilineal genetic root of ALD. Partial mtDNA D-loop sequences were analyzed in 71 ALD samples and analysis revealed 19 polymorphic sites and 13 haplotypes. Estimated haplotype (Hd +/- SD) and nucleotide diversity (pi +/- SD) were 0.881 +/- 0.017 and 0.00897 +/- 0.00078 respectively. The high genetic diversity of ALD indicates introgression of genetic material from other local duck breeds. In addition, it can be postulated that ALD bearing high genetic diversity has strong ability to adapt to environmental changes and can withstand impending climate change. Phylogenetic and network analysis indicate that ALD falls under Eurasian clade of mallard and ALD forms three clusters; one cluster is phylogenetically close to Southeast Asian countries, one close to Southern part of mainland India and the third one forms an independent cluster. Therefore, ALD might have migrated either from Southeast Asian countries which enjoy a close cultural bondage with ANI from time immemorial or from Southern part of India. The independent cluster may have evolved locally in these islands and natural selection pressure imposed by environmental conditions might be the driving force for evaluation of these duck haplotypes; which mimics Darwin's theory of natural selection. The results of the study will be beneficial for formulating future breeding programme and conservation strategy towards sustainable development of the duck breed.	[De, Arun Kumar; Sawhney, Sneha; Bhattacharya, Debasis; Sujatha, T.; Sunder, Jai; Ponraj, Perumal; Ravi, S. K.; Kundu, A.] ICAR Cent Isl Agr Res Inst, Anim Sci Div, Port Blair, Andaman & Nicob, India; [Mondal, Samiran] West Bengal Univ Anim & Fishery Sci, Dept Vet Pathol, Kolkata, W Bengal, India; [Malakar, Dhruba] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Island Agricultural Research Institute; West Bengal University of Animal & Fishery Sciences; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	De, ARKMR (corresponding author), ICAR Cent Isl Agr Res Inst, Anim Sci Div, Port Blair, Andaman & Nicob, India.	biotech.cari@gmail.com		De, Arun/0000-0003-0083-9300	National Bank for Agriculture and Rural Development (NABARD, Port Blair); Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/BI/04/066/2004]	National Bank for Agriculture and Rural Development (NABARD, Port Blair); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The work was funded by National Bank for Agriculture and Rural Development (NABARD, Port Blair) and Department of Biotechnology, Ministry of Science and Technology, Government of India (grant no. BT/BI/04/066/2004).	Adeola AC, 2020, ANIM GENET, V51, P485, DOI 10.1111/age.12924; Anderson S, 2003, ECOL ECON, V45, P331, DOI 10.1016/S0921-8009(03)00088-0; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; AVISE JC, 1990, EVOLUTION, V44, P1109, DOI 10.1111/j.1558-5646.1990.tb03829.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bhuiyan MSA, 2013, MOL BIOL REP, V40, P4123, DOI 10.1007/s11033-013-2522-6; Cherry P, 2008, DOMESTIC DUCK PRODUCTION: SCIENCE AND PRACTICE, P1, DOI 10.1079/9780851990545.0000; Choi N. R., 2014, KOR J POULT SCI, V41, P235; Darwin C., 1859, ORIGINS SPECIES MEAN; De AK, 2020, J GENET, V99, P1; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2011, FAO ANIM PROD HEAL G, V9; FAO Departamento para la Prosperidad Social, 2015, COM TERR MEM SIT AL, P1; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gaur U, 2016, CURR SCI INDIA, V110, P1977, DOI 10.18520/cs/v110/i10/1977-1983; Hall KR., 1985, MARITIME TRADE STATE; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hou ZC, 2012, ANIM GENET, V43, P352, DOI 10.1111/j.1365-2052.2011.02248.x; Islam M. A., 2016, ASIAN J MED BIOL RES, V2, P202, DOI DOI 10.3329/AJMBR.V2I2.29062; Ismoyowati I, 2019, IOP C SER EARTH ENV, V372; Jin SD, 2014, MOL BIOL REP, V41, P1645, DOI 10.1007/s11033-013-3012-6; Kear J., 2005, DUCKS GEESE SWANS; Khatun MM, 2012, ASIAN AUSTRAL J ANIM, V25, P751, DOI 10.5713/ajas.2011.11331; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kloss B. C., 1903, ANDAMANS NICOBARS; Knoll ArthurJ., 2010, GERMAN COLONIAL EXPE; Kraus RHS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-99; Kryger K.N., 2010, 4 FAO; Kulikova IV, 2005, AUK, V122, P949, DOI 10.1642/0004-8038(2005)122[0949:POTMAP]2.0.CO;2; Kulikova IV, 2004, AUK, V121, P930, DOI 10.1642/0004-8038(2004)121[0930:AHASGF]2.0.CO;2; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Ladoukakis ED, 2017, J BIOL RES-THESSALON, V24, DOI 10.1186/s40709-017-0060-4; Leekaew Piyanan, 2008, Kasetsart Journal Natural Sciences, V42, P41; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li HF, 2010, ARCH TIERZUCHT, V53, P609, DOI 10.5194/aab-53-609-2010; Lowe WH, 2015, TRENDS ECOL EVOL, V30, P456, DOI 10.1016/j.tree.2015.05.008; Ludwig A, 2013, ANIM GENET, V44, P383, DOI 10.1111/age.12026; Marshall Cavendish, 2007, WORLD ITS PEOPLES E; Medical Advisory Secretariat, 2008, Ont Health Technol Assess Ser, V8, P1; National Council of State Boards of Nursing, 2014, J NURSING REGULATION, V5, P3; Purwantini Dattadewi, 2013, International Journal of Poultry Science, V12, P55; Quan JQ, 2020, GLOB ECOL CONSERV, V21, DOI 10.1016/j.gecco.2019.e00829; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rissler LJ, 2016, P NATL ACAD SCI USA, V113, P8079, DOI 10.1073/pnas.1601073113; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Rouge A, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0235-y; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Selivanov V, 2008, MATH COMPUT SCI, V2, P5, DOI 10.1007/s11786-008-0042-x; Senani S, 2005, INDIAN J ANIM SCI, V75, P1189; Serjeantson D., 2014, ENCY GLOBAL ARCHAEOL, P2204; Sheriff O, 2018, COGENT FOOD AGR, V4, DOI 10.1080/23311932.2018.1459062; Sponenberg DP, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11100177; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Sultana H, 2016, ASIAN AUSTRAL J ANIM, V29, P1688, DOI 10.5713/ajas.15.1017; Sun J, INFORM TECHNOLOGY AG, V134; Tai Chein, 2001, Journal of Poultry Science, V38, P99; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbanelli S, 2002, HEREDITY, V88, P333, DOI 10.1038/sj.hdy.6800046; Velickovic N, 2016, HEREDITY, V117, P348, DOI 10.1038/hdy.2016.53; Wilson William, 1885, IMPERIAL GAZETTEER I; Wright S, 1931, GENETICS, V16, P0097; Wu ZhenYang, 2011, Journal of Biological Sciences, V11, P181, DOI 10.3923/jbs.2011.181.188; Yang WJ, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-2; Yeung CKL, 2011, MOL BIOL EVOL, V28, P473, DOI 10.1093/molbev/msq210; Zanella R, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0203-3; Zhang ZB, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy027; Zhao QB, 2019, EVOL BIOINFORM, V15, DOI 10.1177/1176934318825082	77	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0245138	10.1371/journal.pone.0245138	http://dx.doi.org/10.1371/journal.pone.0245138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561119	Green Published, gold			2022-12-26	WOS:000617533000017
J	Neto, JRD; da Silva, MV; Braga, YLL; da Costa, AWF; Fonseca, SG; Nagib, PRA; Celes, MRN; Oliveira, MAP; Machado, JR				do Carmo Neto, Jose Rodrigues; da Silva, Marcos Vinicius; Lira Braga, Yarlla Loyane; Florencio da Costa, Arthur Wilson; Fonseca, Simone Goncalves; Alo Nagib, Patricia Resende; Nunes Celes, Mara Rubia; Pelli Oliveira, Milton Adriano; Machado, Juliana Reis			Correlation between intestinal BMP2, IFN gamma, and neural death in experimental infection with Trypanosoma cruzi	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; NITRIC-OXIDE; CHAGASIC MEGACOLON; MYENTERIC PLEXUS; INTERSTITIAL-CELLS; ENTERIC NEURONS; MAST-CELLS; BONE; MACROPHAGES; PROTEIN	Megacolon is one of the main late complications of Chagas disease, affecting approximately 10% of symptomatic patients. However, studies are needed to understand the mechanisms involved in the progression of this condition. During infection by Trypanosoma cruzi (T. cruzi), an inflammatory profile sets in that is involved in neural death, and this destruction is known to be essential for megacolon progression. One of the proteins related to the maintenance of intestinal neurons is the type 2 bone morphogenetic protein (BMP2). Intestinal BMP2 homeostasis is directly involved in the maintenance of organ function. Thus, the aim of this study was to correlate the production of intestinal BMP2 with immunopathological changes in C57Bl/6 mice infected with the T. cruzi Y strain in the acute and chronic phases. The mice were infected with 1000 blood trypomastigote forms. After euthanasia, the colon was collected, divided into two fragments, and a half was used for histological analysis and the other half for BMP2, IFN gamma, TNF-alpha, and IL-10 quantification. The infection induced increased intestinal IFN gamma and BMP2 production during the acute phase as well as an increase in the inflammatory infiltrate. In contrast, a decreased number of neurons in the myenteric plexus were observed during this phase. Collagen deposition increased gradually throughout the infection, as demonstrated in the chronic phase. Additionally, a BMP2 increase during the acute phase was positively correlated with intestinal IFN gamma. In the same analyzed period, BMP2 and IFN gamma showed negative correlations with the number of neurons in the myenteric plexus. As the first report of BMP2 alteration after infection by T. cruzi, we suggest that this imbalance is not only related to neuronal damage but may also represent a new route for maintaining the intestinal proinflammatory profile during the acute phase.	[do Carmo Neto, Jose Rodrigues; Lira Braga, Yarlla Loyane; Florencio da Costa, Arthur Wilson; Fonseca, Simone Goncalves; Alo Nagib, Patricia Resende; Nunes Celes, Mara Rubia; Pelli Oliveira, Milton Adriano; Machado, Juliana Reis] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Biosci & Technol, Goiania, Go, Brazil; [da Silva, Marcos Vinicius] Univ Fed Triangulo Mineiro, Dept Microbiol Immunol & Parasitol, Inst Biol & Nat Sci, Uberaba, MG, Brazil; [Machado, Juliana Reis] Univ Fed Triangulo Mineiro, Dept Gen Pathol, Uberaba, MG, Brazil	Universidade Federal de Goias; Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro	Machado, JR (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Biosci & Technol, Goiania, Go, Brazil.; Machado, JR (corresponding author), Univ Fed Triangulo Mineiro, Dept Gen Pathol, Uberaba, MG, Brazil.	juliana.patologiageral@gmail.com	Machado, Juliana/AAY-1978-2020; do Carmo Neto, José Rodrigues/GVR-8165-2022; Silva, Marcos Vinicius/AAY-1986-2020; Celes, Mara Rubia/I-8707-2019; FONSECA, SIMONE GONÇALVES/U-9278-2019	Machado, Juliana/0000-0002-8673-7788; do Carmo Neto, José Rodrigues/0000-0002-5748-5112; Silva, Marcos Vinicius/0000-0002-2966-7621; Celes, Mara Rubia/0000-0002-4733-007X; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors appreciate the financial support of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adad SJ, 2012, VIRCHOWS ARCH, V461, P385, DOI 10.1007/s00428-012-1299-7; ADAD SJ, 1991, REV I MED TROP, V33, P443, DOI 10.1590/S0036-46651991000600004; Adad SJ, 2001, VIRCHOWS ARCH, V438, P254, DOI 10.1007/s004280000319; Ampuja M, 2018, GENE CHROMOSOME CANC, V57, P3, DOI 10.1002/gcc.22502; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Arantes RME, 2004, AM J PATHOL, V164, P1361, DOI 10.1016/S0002-9440(10)63222-1; Bleuming S, 2006, J PATHOL, V209, P190, DOI 10.1002/path.1976; Bombeiro AL, 2010, NEUROIMMUNOMODULAT, V17, P67, DOI 10.1159/000258689; Bonney KM, 2019, ANNU REV PATHOL-MECH, V14, P421, DOI 10.1146/annurev-pathol-020117-043711; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Campbell C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146322; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen K, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/901530; Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230; D'Avila DA, 2009, MEM I OSWALDO CRUZ, V104, P100, DOI 10.1590/S0074-02762009000100015; da Silva MV, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3421897; da Silveira ABM, 2007, PARASITOLOGY, V134, P789, DOI 10.1017/S0031182007002296; da Silveira ABM, 2005, PARASITOLOGY, V131, P627, DOI 10.1017/S0031182005008061; Dawson TM, 2018, ADV PHARMACOL, V82, P57, DOI 10.1016/bs.apha.2017.09.003; de Almeida-Leite CM, 2007, NEUROBIOL DIS, V25, P170, DOI 10.1016/j.nbd.2006.09.003; De Bona E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01842; de Souza AP, 2010, PARASITOL RES, V106, P1293, DOI 10.1007/s00436-010-1794-1; de Souza ND, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920180389; deAraujo-Jorge TC, 2000, DOENCA CHAGAS MANUAL; deSouza MM, 1996, MEM I OSWALDO CRUZ, V91, P217, DOI 10.1590/S0074-02761996000200018; Espinoza B, 2011, INT J BIOL SCI, V7, P1357, DOI 10.7150/ijbs.7.1357; Freitas MAR, 2017, NEUROTROPHIN EXPRESS, V1, P1013; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gao XX, 2013, AM J PHYSIOL-GASTR L, V304, pG804, DOI 10.1152/ajpgi.00306.2012; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Honore SM, 2011, AUTON NEUROSCI-BASIC, V164, P51, DOI 10.1016/j.autneu.2011.06.003; Jabari S, 2013, COLORECTAL DIS, V15, pe592, DOI 10.1111/codi.12331; Jabari S, 2014, HISTOCHEM CELL BIOL, V142, P235, DOI 10.1007/s00418-014-1250-x; Kannen V, 2018, DIGEST DIS SCI, V63, P1473, DOI 10.1007/s10620-018-5015-6; Kashima R, 2018, ACTA BIOCH BIOPH SIN, V50, P106, DOI 10.1093/abbs/gmx124; Kramer K, 2011, HISTOCHEM CELL BIOL, V136, P1, DOI 10.1007/s00418-011-0807-1; Lee KB, 2011, SPINE, V36, pE149, DOI 10.1097/BRS.0b013e3181f2d1ec; Locati M, 2014, IMMUNITY, V41, P11, DOI 10.1016/j.immuni.2014.07.002; Machado EMM, 2001, MEM I OSWALDO CRUZ, V96, P545, DOI 10.1590/S0074-02762001000400017; Machado JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/648715; Maifrino LBM, 2005, EXP PARASITOL, V111, P224, DOI 10.1016/j.exppara.2005.08.008; Mateus J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00918; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; Mitchell K, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0314-3; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; MOLINA HA, 1989, IMMUNOLOGY, V66, P289; da Siveira ABM, 2007, HUM PATHOL, V38, P1256, DOI 10.1016/j.humpath.2007.01.020; Moreira NM, 2013, INT J EXP PATHOL, V94, P426, DOI 10.1111/iep.12049; Moreira NM, 2011, AN ACAD BRAS CIENC, V83, P545, DOI 10.1590/S0001-37652011000200014; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Pandey R, 2017, TOXICOL SCI, V159, P137, DOI 10.1093/toxsci/kfx124; Pardali E, 2018, J CELL MOL MED, V22, P5429, DOI 10.1111/jcmm.13814; Pereira ND, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008667; Sanders LN, 2016, CIRC RES, V119, P434, DOI 10.1161/CIRCRESAHA.116.308700; Scharfstein J, 2009, MEM I OSWALDO CRUZ, V104, P187, DOI 10.1590/S0074-02762009000900025; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083067; TAFURI WL, 1971, VIRCHOWS ARCH A, V354, P136, DOI 10.1007/BF00548079; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Urizar AI, 2016, J INTERF CYTOK RES, V36, P20, DOI 10.1089/jir.2014.0199; Vazquez BP, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0811-8; VESPA GNR, 1994, INFECT IMMUN, V62, P5177, DOI 10.1128/IAI.62.11.5177-5182.1994; Wesley M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01856; Wu M, 2014, INT J CLIN EXP PATHO, V7, P529; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]	70	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246692	10.1371/journal.pone.0246692	http://dx.doi.org/10.1371/journal.pone.0246692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561140	gold, Green Published			2022-12-26	WOS:000617533000009
J	Heid-Picard, B; Cochand-Priollet, B; Rozenberg, F; Giang-Phang, D; Viard, JP; La Torre, V; Ghosn, J				Heid-Picard, Benoit; Cochand-Priollet, Beatrix; Rozenberg, Flore; Giang-Phang, David; Viard, Jean-Paul; La Torre, Valentina; Ghosn, Jade			Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; CERVICAL-CANCER; LESIONS; MEN; SEX; ACCURACY; WOMEN	Objectives Anal cancer, usually driven by an oncogenic Human Papillomavirus, remains a leading cause of morbidity in men who have sex with men (MSM) living with HIV, despite combined antiretroviral therapy. Various recommendations advocate to perform regular examination and proctologist-performed samples to anticipate this risk and treat locally before cancer occurrence, an efficient strategy which has the drawback of requiring the proctologist's availability. This study evaluates the acceptability, feasibility, and efficiency of self-performed samples to screen for HPV-infection and HPV-related anal dysplasia among MSM living with HIV followed in Hotel-Dieu Hospital. Methods Between February 2015 and June 2015, MSM living with HIV and referred to the day-care hospital were offered to perform an anal self-sampling for cytologic and virologic evaluation. A self-sampling kit was provided, and a tutorial video was shown. A subset of participants had a proctology appointment after they did the self-sampling, and thus had a clinical examination and an anal swab sampling performed by the proctologist, using the same sampling material. Results Anal self-sampling was offered to 103 patients, and 100 accepted. Sixty-three samples were interpretable, of which 36 (57%) were normal and 27 (43%) showed abnormal results. Virologic analysis was performed for 60 (95%) interpretable samples: 50/60 (83%) of them were positive for HPV. Among HPV-carrier patients, 42/50 (84%) were infected with at least one HR-HPV. Twenty patients had a proctologist consultation. All clinician-performed samples were interpretable and 14 (70%) self-samples were interpretable. Conclusions This study highlights the acceptable accuracy of self-sampling screening method among MSM living with HIV and try out its acceptability and feasibility as a secondary prevention device. Although it cannot replace a proctologist consultation for high risk patients, self-sampling should be studied further as one of the ways of screening for anal cancer among low-risk outpatients.	[Heid-Picard, Benoit; Ghosn, Jade] Univ Paris, Dept Infect & Trop Dis, Hop Bichat Claude Bernard, AP HP, Paris, France; [Cochand-Priollet, Beatrix] Univ Paris, Dept Pathol, Hop Cochin, AP HP, Paris, France; [Rozenberg, Flore] Univ Paris, Dept Virol, Hop Cochin, AP HP, Paris, France; [Giang-Phang, David; Viard, Jean-Paul; Ghosn, Jade] Univ Paris, Dept Infect & Trop Dis, Hop Hotel Dieu, AP HP, Paris, France; [La Torre, Valentina] Univ Paris, Diag & Therapeut Ctr, Hop Hotel Dieu, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Ghosn, J (corresponding author), Univ Paris, Dept Infect & Trop Dis, Hop Bichat Claude Bernard, AP HP, Paris, France.; Ghosn, J (corresponding author), Univ Paris, Dept Infect & Trop Dis, Hop Hotel Dieu, AP HP, Paris, France.	jade.ghosn@aphp.fr		HEID, BENOIT/0000-0002-2745-4120				Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Baussano I, 2018, INT J CANCER, V143, P1086, DOI 10.1002/ijc.31409; Bressy J., 2018, PRISE CHARGE VIH REC; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; Covert C, 2019, HUM VACC IMMUNOTHER, V15, P1962, DOI 10.1080/21645515.2018.1564438; Cranston RD, 2004, JAIDS-J ACQ IMM DEF, V36, P915, DOI 10.1097/00126334-200408010-00004; Darragh TM, 1997, ACTA CYTOL, V41, P1167, DOI 10.1159/000332840; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Goldie SJ, 2000, AM J MED, V108, P634, DOI 10.1016/S0002-9343(00)00349-1; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Heard I, 2016, J INFECT DIS, V213, P1455, DOI 10.1093/infdis/jiv751; Hicks L, 2019, OPEN HEART, V6, DOI 10.1136/openhrt-2018-000795; Lampinen Thomas M, 2006, Cytojournal, V3, P4, DOI 10.1186/1742-6413-3-4; Lampinen TM, 2006, CLIN INFECT DIS, V42, P308, DOI 10.1086/499114; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; McClymont E, 2019, CLIN INFECT DIS, V68, P788, DOI 10.1093/cid/ciy575; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ortiz AP, 2012, P R HEALTH SCI J, V31, P205; Polman NJ, 2019, PREV MED, V119, P108, DOI 10.1016/j.ypmed.2018.12.021; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Read TRH, 2013, HIV MED, V14, P491, DOI 10.1111/hiv.12035; Rosenberger JG, 2011, ARCH SEX BEHAV, V40, P281, DOI 10.1007/s10508-009-9569-4; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Tamalet C, 2016, INTERVIROLOGY, V59, P118, DOI 10.1159/000452710; Trickey A, 2017, LANCET HIV, V4, pE349, DOI 10.1016/S2352-3018(17)30066-8; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246338	10.1371/journal.pone.0246338	http://dx.doi.org/10.1371/journal.pone.0246338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561135	gold, Green Published			2022-12-26	WOS:000617533000005
J	Xiang, X; Langlois, S; St-Pierre, ME; Blinder, A; Charron, P; Graber, TE; Fowler, SL; Baird, SD; Bennett, SAL; Alain, T; Cowan, KN				Xiang, Xiao; Langlois, Stephanie; St-Pierre, Marie-Eve; Blinder, Anna; Charron, Philippe; Graber, Tyson E.; Fowler, Stephanie L.; Baird, Stephen D.; Bennett, Steffany A. L.; Alain, Tommy; Cowan, Kyle N.			Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK	ONCOGENE			English	Article								Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, is an aggressive cancer with a poor prognosis. Despite current management, the 5-year survival rate for patients with metastatic RMS is similar to 30%; underscoring the need to develop better treatment strategies. We have recently reported that pannexin 1 (PANX1) levels are downregulated in RMS and that restoring its expression inhibits RMS progression. Here, we have surveyed and characterized the molecular changes induced by PANX1 re-expression in RMS. We cataloged transcriptomic changes in this context by RNA sequencing. At the protein level, we unveiled PANX1 interactors using BioID, complemented by co-immunoprecipitation coupled to high-performance liquid chromatography/electrospray ionization tandem mass spectrometry performed in PANX1-enriched fractions. Using these data, we generated searchable public databases for the PANX1 interactome and changes to the RMS transcriptome occurring when PANX1 expression is restored. STRING network analyses revealed a PANX1 interactome involving plasma membrane and cytoskeleton-associated proteins including the previously undescribed interactor AHNAK. Indeed, AHNAK knockdown abrogated the PANX1-mediated reduction in RMS cell viability and migration. Using these unbiased approaches, we bring insight to the mechanisms by which PANX1 inhibits RMS progression, identifying the cell migration protein AHNAK as a key modifier of PANX1-mediated changes in RMS malignant properties.	[Xiang, Xiao; Langlois, Stephanie; St-Pierre, Marie-Eve; Blinder, Anna; Charron, Philippe; Graber, Tyson E.; Baird, Stephen D.; Alain, Tommy; Cowan, Kyle N.] Childrens Hosp Eastern Ontario, Res Inst, Mol Biomed Program, Ottawa, ON, Canada; [Xiang, Xiao; Blinder, Anna; Cowan, Kyle N.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Langlois, Stephanie; Cowan, Kyle N.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Surg, Ottawa, ON, Canada; [Fowler, Stephanie L.; Bennett, Steffany A. L.; Alain, Tommy] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Fowler, Stephanie L.; Bennett, Steffany A. L.] Univ Ottawa, Neural Regenerat Lab, Ottawa, ON, Canada; [Fowler, Stephanie L.; Bennett, Steffany A. L.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Fowler, Stephanie L.] UCL, UK Dementia Res Inst, London, England	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; University of London; University College London	Cowan, KN (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Mol Biomed Program, Ottawa, ON, Canada.; Cowan, KN (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Cowan, KN (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Surg, Ottawa, ON, Canada.	kcowan@cheo.on.ca		Xiang, Xiao/0000-0002-3969-1668; Fowler, Stephanie/0000-0001-6693-9959	Cancer Research Society (CRS) [19080, 21453]; Ontario Graduate Scholarship (OGS); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST)	Cancer Research Society (CRS); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST)	This study was supported by the Cancer Research Society (CRS, Operating Grants 19080 and 21453, KNC), Ontario Graduate Scholarship (OGS, XX), and Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST, XX).	Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Bennett, 2016, METHOD MOL BIOL, P9; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Boyce AKJ, 2018, BBA-BIOMEMBRANES, V1860, P72, DOI 10.1016/j.bbamem.2017.03.004; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen B, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0522-4; Chen C., 2019, FRONT ONCOL, V9, P1; Chiu YH, 2018, J GEN PHYSIOL, V150, P19, DOI 10.1085/jgp.201711888; Cowan KN, 2012, CELL COMMUN ADHES, V19, P45, DOI 10.3109/15419061.2012.712575; Cui H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005084; Dobson Christine C., 2016, Critical Reviews in Oncogenesis, V21, P221, DOI 10.1615/CritRevOncog.2016016996; Dossi E, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3796; Fowler SL, 2013, J PROTEOME RES, V12, P2597, DOI 10.1021/pr301166p; Frank SB, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0341-x; Freeman TJ, 2019, CANCERS, V11, DOI 10.3390/cancers11010102; Gentil BJ, 2003, J HISTOCHEM CYTOCHEM, V51, P339, DOI 10.1177/002215540305100309; Gentil EJ, 2005, J CELL PHYSIOL, V203, P362, DOI 10.1002/jcp.20232; Good ME, 2018, CIRC RES, V122, P606, DOI 10.1161/CIRCRESAHA.117.312380; HASHIMOTO T, 1993, J CELL SCI, V105, P275; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Keller C, 2013, FEBS J, V280, P4323, DOI 10.1111/febs.12421; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Langlois Stephanie, 2017, Adv Exp Med Biol, V925, P57, DOI 10.1007/5584_2016_53; Langlois S, 2014, J BIOL CHEM, V289, P30717, DOI 10.1074/jbc.M114.572131; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Liu HF, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109090; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma HL, 2012, MOL IMAGING, V11, P487, DOI 10.2310/7290.2012.00012; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Minde DP, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0758-y; Nie ZZ, 2000, J INVEST DERMATOL, V114, P1044, DOI 10.1046/j.1523-1747.2000.00949.x; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Peng R, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1113-3; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Pham TL, 2018, J CELL PHYSIOL, V233, P7057, DOI 10.1002/jcp.26629; Proulx AA, 1997, CELL GROWTH DIFFER, V8, P533; Puri PL, 2000, GENE DEV, V14, P574; Richter K, 2014, FASEB J, V28, P45, DOI 10.1096/fj.13-229252; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Salim C, 2009, GLIA, V57, P535, DOI 10.1002/glia.20782; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Sheppard HM, 2016, MELANOMA RES, V26, P108, DOI 10.1097/CMR.0000000000000228; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Silva TA, 2016, ONCOTARGET, V7, P49998, DOI 10.18632/oncotarget.10307; Sudo H, 2014, INT J ONCOL, V44, P530, DOI 10.3892/ijo.2013.2183; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wicki-Stordeur LE, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00287; Wicki-Stordeur LE, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-62; Wicki-Stordeur LE, 2013, CELL COMMUN ADHES, V20, P73, DOI 10.3109/15419061.2013.791681; Xiang X, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0100-4; Xu XX, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00124; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhang YL, 2017, CANCER BIOL MED, V14, P90, DOI 10.20892/j.issn.2095-3941.2016.0086; Zhang ZW, 2019, J CANCER, V10, P3860, DOI 10.7150/jca.31291	66	7	7	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1868	1883		10.1038/s41388-020-01623-2	http://dx.doi.org/10.1038/s41388-020-01623-2		FEB 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33564071	Green Published, hybrid			2022-12-26	WOS:000616489100005
J	Peng, XJ; Xie, J; Li, WZ; Xie, HW; Cai, YH; Ding, X				Peng, Xiaojue; Xie, Jian; Li, Wenzhuo; Xie, Hongwei; Cai, Yaohui; Ding, Xia			Comparison of wild rice (Oryza longistaminata) tissues identifies rhizome-specific bacterial and archaeal endophytic microbiomes communities and network structures	PLOS ONE			English	Article							ROOT-ASSOCIATED MICROBIOMES; NITROGEN-FERTILIZATION; METHANOTROPHS; RHIZOSPHERE; DIVERSITY; EVOLUTION; SEQUENCE; INSIGHTS; OXYGEN	Compared with root-associated habitats, little is known about the role of microbiota inside other rice organs, especially the rhizome of perennial wild rice, and this information may be of importance for agriculture. Oryza longistaminata is perennial wild rice with various agronomically valuable traits, including large biomass on poor soils, high nitrogen use efficiency, and resistance to insect pests and disease. Here, we compared the endophytic bacterial and archaeal communities and network structures of the rhizome to other compartments of O. longistaminata using 16S rRNA gene sequencing. Diverse microbiota and significant variation in community structure were identified among different compartments of O. longistaminata. The rhizome microbial community showed low taxonomic and phylogenetic diversity as well as the lowest network complexity among four compartments. Rhizomes exhibited less phylogenetic clustering than roots and leaves, but similar phylogenetic clustering with stems. Streptococcus, Bacillus, and Methylobacteriaceae were the major genera in the rhizome. ASVs belonging to the Enhydrobacter, YS2, and Roseburia are specifically present in the rhizome. The relative abundance of Methylobacteriaceae in the rhizome and stem was significantly higher than that in leaf and root. Noteworthy type II methanotrophs were observed across all compartments, including the dominant Methylobacteriaceae, which potentially benefits the host by facilitating CH4-dependent N-2 fixation under nitrogen nutrient-poor conditions. Our data offers a robust knowledge of host and microbiome interactions across various compartments and lends guidelines to the investigation of adaptation mechanisms of O. longistaminata in nutrient-poor environments for biofertilizer development in agriculture.	[Peng, Xiaojue; Xie, Jian; Li, Wenzhuo; Ding, Xia] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China; [Peng, Xiaojue; Ding, Xia] Nanchang Univ, Jiangxi Prov Peoples Hosp, Nanchang, Jiangxi, Peoples R China; [Xie, Hongwei; Cai, Yaohui] Jiangxi Acad Agr Sci, Jiangxi Super Rice Res & Dev Ctr, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Ding, X (corresponding author), Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China.; Ding, X (corresponding author), Nanchang Univ, Jiangxi Prov Peoples Hosp, Nanchang, Jiangxi, Peoples R China.	dingxia97@ncu.edu.cn	ding, xia/CAG-9445-2022; Peng, xiaojue/AGY-1853-2022	ding, xia/0000-0003-1535-2642; 	National Natural Science Foundation of China [31560041, 81960364, 81501162, 31960124]; Jiangxi Province Outstanding Young Talents Funding Scheme [20171BCB23020, 20171BCB23021]; Interdisciplinary Innovation Fund of Nanchang University [9166-27060003-YB11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Province Outstanding Young Talents Funding Scheme; Interdisciplinary Innovation Fund of Nanchang University	We wish to acknowledge funding from National Natural Science Foundation of China (31560041, 81960364, 81501162, 31960124), Jiangxi Province Outstanding Young Talents Funding Scheme (20171BCB23020, 20171BCB23021), Interdisciplinary Innovation Fund of Nanchang University (9166-27060003-YB11).	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Bao ZH, 2014, APPL ENVIRON MICROB, V80, P5043, DOI 10.1128/AEM.00969-14; Bao ZH, 2014, APPL ENVIRON MICROB, V80, P1995, DOI 10.1128/AEM.03646-13; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brader G, 2017, ANNU REV PHYTOPATHOL, V55, P61, DOI 10.1146/annurev-phyto-080516-035641; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHRISTENSEN PB, 1994, PLANT PHYSIOL, V105, P847, DOI 10.1104/pp.105.3.847; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Ding X, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00129; Duran P, 2018, CELL, V175, P973, DOI 10.1016/j.cell.2018.10.020; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Edwards JA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003862; Fan FF, 2019, J AGR FOOD CHEM, V67, P8766, DOI 10.1021/acs.jafc.9b02224; Gibert A, 2019, NEW PHYTOL, V222, P526, DOI 10.1111/nph.15392; He RF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-46; Hu FY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-18; Hu FY, 2003, P NATL ACAD SCI USA, V100, P4050, DOI 10.1073/pnas.0630531100; Ikeda S, 2014, MICROBES ENVIRON, V29, P50, DOI 10.1264/jsme2.ME13110; Jin J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01909; Krause S, 2010, ISME J, V4, P1603, DOI 10.1038/ismej.2010.82; Levy A, 2018, CELL HOST MICROBE, V24, P475, DOI 10.1016/j.chom.2018.09.005; Liu C, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.715; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Luke C, 2010, ENVIRON MICROBIOL, V12, P862, DOI 10.1111/j.1462-2920.2009.02131.x; Meng H, 2013, APPL MICROBIOL BIOT, V97, P2219, DOI 10.1007/s00253-012-4063-7; Minamisawa K, 2016, MICROBES ENVIRON, V31, P4, DOI 10.1264/jsme2.ME15180; Muller DB, 2016, ANNU REV GENET, V50, P211, DOI 10.1146/annurev-genet-120215-034952; Olanrewaju OS, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2364-9; Pacifico D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01256; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Qiu QF, 2009, ENV MICROBIOL REP, V1, P355, DOI 10.1111/j.1758-2229.2009.00045.x; R Core Team, 2020, R LANG ENV STAT COMP; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Rodriguez PA, 2019, MOL PLANT, V12, P804, DOI 10.1016/j.molp.2019.05.006; Roman-Reyna V, 2019, BIORXIV, DOI [10.1101/615278, DOI 10.1101/615278]; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Shenton M, 2016, RICE, V9, DOI 10.1186/s12284-016-0111-8; Shrestha M, 2010, ISME J, V4, P1545, DOI 10.1038/ismej.2010.89; Staley C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0287-1; Stein JC, 2018, NAT GENET, V50, P285, DOI 10.1038/s41588-018-0040-0; Stringlis IA, 2018, P NATL ACAD SCI USA, V115, pE5213, DOI 10.1073/pnas.1722335115; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; Tedone Fabio, 2020, Bioinspir Biomim, V15, P056006, DOI 10.1088/1748-3190/ab9a15; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Tian L, 2018, PLANT PHYSIOL BIOCH, V128, P134, DOI 10.1016/j.plaphy.2018.04.009; Uroz S, 2019, TRENDS PLANT SCI, V24, P905, DOI 10.1016/j.tplants.2019.06.008; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Wang LK, 2014, PLANT PHYSIOL, V166, P603, DOI 10.1104/pp.114.240929; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang WF, 2016, MICROBIOL RES, V188, P1, DOI 10.1016/j.micres.2016.04.009; Wang X, 2019, GENE, V684, P124, DOI 10.1016/j.gene.2018.10.064; Wei XM, 2019, RHIZOSPHERE-NETH, V10, DOI 10.1016/j.rhisph.2019.100145; Wu LQ, 2009, SYST APPL MICROBIOL, V32, P421, DOI 10.1016/j.syapm.2009.05.001; Xiong W, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00799-9; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705; Zhang JY, 2019, NAT BIOTECHNOL, V37, P676, DOI 10.1038/s41587-019-0104-4; Zhang XX, 2013, MICROB ECOL, V66, P917, DOI 10.1007/s00248-013-0293-1	62	4	4	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246687	10.1371/journal.pone.0246687	http://dx.doi.org/10.1371/journal.pone.0246687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556120	Green Published, gold			2022-12-26	WOS:000617379900065
J	Plomp, KA; Gestsdottir, H; Dobney, K; Price, N; Collard, M				Plomp, Kimberly A.; Gestsdottir, Hildur; Dobney, Keith; Price, Neil; Collard, Mark			The composition of the founding population of Iceland: A new perspective from 3D analyses of basicranial shape	PLOS ONE			English	Article							SETTLEMENT; HUMANS; PROPORTIONS; ANCESTRY; ATLANTIC; ORIGIN; IMPACT; MTDNA	The settlement of Iceland in the Viking Age has been the focus of much research, but the composition of the founding population remains the subject of debate. Some lines of evidence suggest that almost all the founding population were Scandinavian, while others indicate a mix of Scandinavians and people of Scottish and Irish ancestry. To explore this issue further, we used three-dimensional techniques to compare the basicrania of skeletons from archaeological sites in Iceland, Scandinavia, and the British Isles. Our analyses yielded two main results. One was that the founding population likely consisted of roughly equal numbers of Scandinavians and people from the British Isles. The other was that the immigrants who originated from the British Isles included individuals of southern British ancestry as well as individuals of Scottish and Irish ancestry. The first of these findings is consistent with the results of recent analyses of modern and ancient DNA, while the second is novel. Our study, therefore, strengthens the idea that the founding population was a mix of Scandinavians and people from the British Isles, but also raises a new possibility regarding the regions from which the settlers originated.	[Plomp, Kimberly A.; Dobney, Keith; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada; [Plomp, Kimberly A.; Dobney, Keith] Univ Liverpool, Dept Archaeol Class & Egyptol, Liverpool, Merseyside, England; [Gestsdottir, Hildur] Inst Archaeol, Reykjavik, Iceland; [Dobney, Keith] Univ Sydney, Sch Hist & Philosoph Inquiry, Sydney, NSW, Australia; [Dobney, Keith; Price, Neil] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Price, Neil] Uppsala Univ, Archaeol & Ancient Hist, Uppsala, Sweden	Simon Fraser University; University of Liverpool; University of Sydney; University of Aberdeen; Uppsala University	Collard, M (corresponding author), Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada.	mcollard@sfu.ca		Plomp, Kimberly/0000-0002-9932-5491	European Union's Marie Sklodowska-Curie Actions program [SAR10359]; Social Sciences and Humanities Research Council of Canada [8952011-1009]; Canada Research Chairs Program [228117, 231256]; Canada Foundation for Innovation [203808]; British Columbia Knowledge Development Fund [862-804231]; Simon Fraser University [14518]	European Union's Marie Sklodowska-Curie Actions program; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University	The study was supported by the European Union's Marie Sklodowska-Curie Actions program (SAR10359), the Social Sciences and Humanities Research Council of Canada (8952011-1009), the Canada Research Chairs Program (228117 and 231256), the Canada Foundation for Innovation (203808), the British Columbia Knowledge Development Fund (862-804231), and Simon Fraser University (14518).	Ahronson K., 2000, NOR ARCHAEOL REV, V33, P117; Als TD, 2006, EUR J HUM GENET, V14, P497, DOI 10.1038/sj.ejhg.5201578; Anon, 2002, OIE WEEKLY DIS INFOR, V15, P156; [Anonymous], 2009, EUROPEAN ETHICAL LEG, V17, P15; Arnason E, 2000, NAT GENET, V25, P373, DOI 10.1038/78036; Barrett JH, 2008, ANTIQUITY, V82, P671, DOI 10.1017/S0003598X00097301; BERRY AC, 1974, AM J PHYS ANTHROPOL, V40, P345, DOI 10.1002/ajpa.1330400306; Bookstein F L, 1997, Med Image Anal, V1, P225; Collard M, 2007, J HUM EVOL, V52, P573, DOI 10.1016/j.jhevol.2006.11.018; De Stefano GF, 1994, ISLENDINGA SAGA I TH, V13, P349; Downham C, 2017, ENGL HIST REV, V132, P1, DOI 10.1093/ehr/cex066; Ebenesersdottir SS, 2018, SCIENCE, V360, P1028, DOI 10.1126/science.aar2625; Evin A, 2016, J ARCHAEOL SCI-REP, V9, P87, DOI 10.1016/j.jasrep.2016.06.028; Evin A, 2015, PHILOS T R SOC B, V370, P138, DOI [10.1098/rstb.2015.0018, 10.1098/rstb.2013.0616]; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; Gestsdottir H., 2016, SKELETAL REPORT HOFS; Goodacre S, 2005, HEREDITY, V95, P129, DOI 10.1038/sj.hdy.6800661; Gore D., 2016, DANES WESSEX SCANDIN, P56; Haghighat SMH, 2009, IOP CONF SER-MAT SCI, V3, DOI 10.1088/1757-899X/3/1/012013; Hallgrimsson B, 2004, AM J PHYS ANTHROPOL, V124, P257, DOI 10.1002/ajpa.10365; Hanson CL, 1986, THESIS; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; HOLM Paul, 1986, PERITIA, V5, P317; Johannesson J., 1974, HIST OLD ICELANDIC C, DOI [10.1159/000271339 4855257, DOI 10.1159/000271339]; JORDE LB, 1982, HUM HERED, V32, P1, DOI 10.1159/000153251; Karlsson Gunnar, 2000, HIST ICELAND; KARRAS RM, 1990, SCAND STUD, V62, P141; Karros RM, 1988, SLAVERY SOC MEDIEVAL; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Krzewiska M, 2013, PHIL T R SOC B, V370; L'Abbe EN, 2011, FORENSIC SCI INT, V209, DOI 10.1016/j.forsciint.2011.04.002; Lebrun R., 2018, MORPHODIG OPEN SOURC; Lockwood CA, 2002, J ANAT, V201, P447, DOI 10.1046/j.1469-7580.2002.00122.x; Margaryan A, 2020, NATURE, V585, P390, DOI 10.1038/s41586-020-2688-8; McGovern TH, 2007, AM ANTHROPOL, V109, P27, DOI 10.1525/AA.2007.109.1.27; Neubauer S, 2010, J HUM EVOL, V59, P555, DOI 10.1016/j.jhevol.2010.06.011; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Orri Vesteinsson, 2010, VIKING AGE IRELAND W, P494; Palsoon A, 1932, SKIRNIR, V106, P191; Price TD, 2006, ANTIQUITY, V80, P130, DOI 10.1017/S0003598X00093315; Price TD, 2018, J N ATLANTIC, V7, P146; R Development Core Team, 2018, R LANG ENV STAT COMP; Raffield B, 2017, EVOL HUM BEHAV, V38, P315, DOI 10.1016/j.evolhumbehav.2016.10.013; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Schiffels S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10408; Schmid MME, 2015, THESIS; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; SMITH KP, 1995, WORLD ARCHAEOL, V26, P319, DOI 10.1080/00438243.1995.9980280; Steffensen J., 1975, MENNING MEINSEMDIR R; Steffensen J., 1593, J R ANTHROP I, V83, P86; Steffensen J, 1953, J R ANTHROPOL INST G, V83, P86; Sveinbjornsdottir AE, 2004, RADIOCARBON, V46, P387, DOI 10.1017/S0033822200039692; Timbrell L, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.101885; Tyrell A., 2000, HUMAN OSTEOLOGY ARCH, P289; V?steinsson O., 2014, J N ATL, V2014, P137, DOI [10.3721/037.002.sp709, DOI 10.3721/037.002.SP709]; Vesteinsson O., 2013, ENCY GLOBAL HUMAN MI; Vesteinsson O, 2012, NOR ARCHAEOL REV, V45, P206, DOI 10.1080/00293652.2012.721792; Vesteinsson Orri, 1998, SAGA BOOK, V25, P1; von Cramon-Taubadel N, 2012, J HUM EVOL, V62, P640, DOI 10.1016/j.jhevol.2012.02.007; von Cramon-Taubadel N, 2009, AM J PHYS ANTHROPOL, V140, P205, DOI 10.1002/ajpa.21041; Vusteinsson O., 2014, EUR J POSTCLASSICAL, V4, P39; WILLIAMS JT, 1993, HUM BIOL, V65, P167; Zichello JM, 2018, P NATL ACAD SCI USA, V115, P11501, DOI 10.1073/pnas.1802651115; Zoega G, 2016, INT J OSTEOARCHAEOL, V26, P574, DOI 10.1002/oa.2446; Zoega G, 2016, KEFLAVIK HEGRANES CE; Zoega G, 2015, NOR ARCHAEOL REV, V48, P105, DOI 10.1080/00293652.2015.1104382	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246059	10.1371/journal.pone.0246059	http://dx.doi.org/10.1371/journal.pone.0246059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556115	Green Published, gold			2022-12-26	WOS:000617379900017
J	Eisdorfer, JT; Phelan, MA; Keefe, KM; Rollins, MM; Campion, TJ; Rauscher, KM; Sobotka-Briner, H; Senior, M; Gordon, G; Smith, GM; Spence, AJ				Eisdorfer, Jaclyn T.; Phelan, Michael A.; Keefe, Kathleen M.; Rollins, Morgan M.; Campion, Thomas J., III; Rauscher, Kaitlyn M.; Sobotka-Briner, Hannah; Senior, Mollie; Gordon, Gabrielle; Smith, George M.; Spence, Andrew J.			Addition of angled rungs to the horizontal ladder walking task for more sensitive probing of sensorimotor changes	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; SPINAL-CORD-INJURY; CORTEX INJURY; GAIT ANALYSIS; MOUSE MODEL; DEFICITS; RATS; STIMULATION; FORELIMB; RECOVERY	One method for the evaluation of sensorimotor therapeutic interventions, the horizontal ladder walking task, analyzes locomotor changes that may occur after disease, injury, or by external manipulation. Although this task is well suited for detection of large effects, it may overlook smaller changes. The inability to detect small effect sizes may be due to a neural compensatory mechanism known as "cross limb transfer", or the contribution of the contralateral limb to estimate an injured or perturbed limb's position. The robust transfer of compensation from the contralateral limb may obscure subtle locomotor outcomes that are evoked by clinically relevant therapies, in the early onset of disease, or between higher levels of recovery. Here, we propose angled rungs as a novel modification to the horizontal ladder walking task. Easily-adjustable angled rungs force rats to locomote across a different locomotion path for each hindlimb and may therefore make information from the contralateral limb less useful. Using hM3Dq (excitatory) Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) expressed in large diameter peripheral afferents of the hindlimb in the intact animal, we characterized the sensitivity of our design to detect stepping differences by comparing locomotor changes observed on angled rungs to those observed on a standard horizontal ladder. On our novel asymmetrical ladder, activation of DREADDs resulted in significant differences in rung misses (p = 0.000011) and weight-supporting events (p = 0.049). By comparison, on a standard ladder, we did not observe differences in these parameters (p = 0.86 and p = 0.98, respectively). Additionally, no locomotor differences were detected in baseline and inactivated DREADDs trials when we compared ladder types, suggesting that the angled rungs do not change animal gait behavior unless intervention or injury is introduced. Significant changes observed with angled rungs may demonstrate more sensitive probing of locomotor changes due to the decoupling of cross limb transfer.	[Eisdorfer, Jaclyn T.; Phelan, Michael A.; Keefe, Kathleen M.; Rollins, Morgan M.; Rauscher, Kaitlyn M.; Sobotka-Briner, Hannah; Senior, Mollie; Gordon, Gabrielle; Spence, Andrew J.] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA; [Phelan, Michael A.] NEI, NIH, Bethesda, MD 20892 USA; [Campion, Thomas J., III; Smith, George M.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Smith, George M.] Shriners Hosp Pediat Res Ctr, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Eisdorfer, JT (corresponding author), Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA.	jaclyneisdorfer@temple.erh		Eisdorfer, Jaclyn/0000-0003-3285-3473	Shriners Hospitals for Children grant [85115]; Neilsen Foundation Senior Research Grant [546798]; Craig H. Neilsen Foundation; Intramural Research Program of the National Eye Institute [EY000450, EY000474, EY000546]; National Institutes of Health	Shriners Hospitals for Children grant; Neilsen Foundation Senior Research Grant; Craig H. Neilsen Foundation; Intramural Research Program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AJS was awarded the Shriners Hospitals for Children grant [#85115] as well as the Neilsen Foundation Senior Research Grant [#546798] from the The Craig H. Neilsen Foundation. MAP was supported by the Intramural Research Program of the National Eye Institute [#EY000450, #EY000474, #EY000546] from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; [Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; Antonow-Schlorke I, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/418627; ARYA T, 1991, Journal of Physiology (Cambridge), V444, P117; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Bouyer LJG, 1998, ANN NY ACAD SCI, V860, P508, DOI 10.1111/j.1749-6632.1998.tb09090.x; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Council for International Organization of Medical Science (CIOMS) and the International Council for Laboratory Animal Science, 2012, INT GUID PRINC BIOM; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Ding Y, 2001, ARTIC NEUROL RES; Farr TD, 2006, J NEUROSCI METH, V153, P104, DOI 10.1016/j.jneumeth.2005.10.011; Fischer G, 2011, J NEUROSCI METH, V199, P43, DOI 10.1016/j.jneumeth.2011.04.021; Fowler SC, 2009, BEHAV BRAIN RES, V202, P130, DOI 10.1016/j.bbr.2009.03.022; Goh JZ, 2015, INT J NANOMED, V10, P297, DOI 10.2147/IJN.S75545; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Gompf HS, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00152; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Hortobagyi T, 2005, IEEE ENG MED BIOL, V24, P22, DOI 10.1109/MEMB.2005.1384096; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Jacques SJ, 2012, MOL CELL NEUROSCI, V49, P464, DOI 10.1016/j.mcn.2012.03.002; Jendryka M, 2019, SCI REP, V9, P1; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Lavrov I, 2008, J NEUROSCI, V28, P7774, DOI 10.1523/JNEUROSCI.1069-08.2008; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; MacLaren DAA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0219-16.2016; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz GA, 2009, J VIS EXP, DOI [10.3791/120419525918, DOI 10.3791/120419525918]; Miao LQ, 2016, ELIFE, V5, DOI 10.7554/eLife.14908; Nakajima T, 2008, J BONE JOINT SURG BR, V90B, P254, DOI 10.1302/0301-620X.90B2.19808; Onifer SM, 2011, RESTOR NEUROL NEUROS, V29, P275, DOI [10.3233/RNN-2011-0598, 10.3233/RNN-2011-598]; Rasband W, IMAGEJ; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Ruddy KL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00397; Schroeder K, 2018, OSTEOARTHR CARTILAGE, V26, pS355, DOI 10.1016/j.joca.2018.02.705; Scripture E W, 1894, Science, V23, P62, DOI 10.1126/science.ns-23.574.62-a; Smith KS, 2016, BEHAV NEUROSCI, V130, P137, DOI 10.1037/bne0000135; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Sokal R.R., 2012, BIOMETRY; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Vahedipour A, 2018, J BIOMECH, V78, P77, DOI 10.1016/j.jbiomech.2018.07.020; Wallace DG, 2012, J INTEGR NEUROSCI, V11, P17, DOI 10.1142/S0219635212500021	50	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246298	10.1371/journal.pone.0246298	http://dx.doi.org/10.1371/journal.pone.0246298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544764	Green Published, gold			2022-12-26	WOS:000617991900009
J	Cheng, PC; Chang, CM; Liao, LJ; Cheng, PW; Lo, WC				Cheng, Ping-Chia; Chang, Chih-Ming; Liao, Li-Jen; Cheng, Po-Wen; Lo, Wu-Chia			The outcomes and decision-making process for neck lymph nodes with indeterminate fine-needle aspiration cytology	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; BIOPSY; HEAD; ULTRASOUND; LESIONS; SYSTEM	Objectives This study aims to propose a cytological classification, to evaluate predictive factors of the final malignancy, and to suggest a proper management strategy for neck lymph nodes (LNs) with indeterminate cytology. Methods Patients who had neck lymphadenopathy with indeterminate cytology between 2007 and 2017 were analyzed retrospectively in a tertiary medical center. Cytological classification was conducted according to the cytological descriptions. We examined the clinical characteristics according to the final diagnosis of the neck lymphadenopathy. Results According to the final diagnoses, there were 142 malignant and 95 benign neck LNs among 237 patients. Multivariate analyses using a stepwise logistic regression model showed that cytological classification [p < 0.001, OR = 5.67 (3.48-9.23)], prior history of malignancy [p = 0.01, OR = 2.97 (1.26-6.99)], long axis [p = 0.01, OR = 3.06 (1.33-7.06)], short-to-long axis (S/L) ratio [p = 0.047, OR = 2.15 (1.01-4.57)] and internal echogenicity [p = 0.01, OR = 2.72 (1.26-5.86)] were independent predictors of malignancy. Conclusions In patients who have neck LNs with indeterminate cytology, a cytological classification and four other predictors (prior history of malignancy, long axis >= 1.93 cm, S/L ratio >= 0.64 and heterogeneity of internal echogenicity) are statistically associated with the risk of malignancy and helpful in guiding further management.	[Cheng, Ping-Chia; Chang, Chih-Ming; Liao, Li-Jen; Cheng, Po-Wen; Lo, Wu-Chia] Far Eastern Mem Hosp, Dept Otolaryngol Head & Neck Surg, New Taipei, Taiwan; [Chang, Chih-Ming] Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan; [Liao, Li-Jen] Yuan Ze Univ, Dept Elect Engn, Taoyuan, Taiwan; [Liao, Li-Jen] Far Eastern Mem Hosp, Med Engn Off, New Taipei, Taiwan	Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Yuan Ze University; Far Eastern Memorial Hospital	Lo, WC (corresponding author), Far Eastern Mem Hosp, Dept Otolaryngol Head & Neck Surg, New Taipei, Taiwan.	lowuchia@gmail.com		Cheng, Ping-Chia/0000-0003-2772-0983	Far Eastern Memorial Hospital Research Program [FEMH-2016-C-026, FEMH-2017-C015]	Far Eastern Memorial Hospital Research Program	This work was supported by grants from the Far Eastern Memorial Hospital Research Program (FEMH-2016-C-026 and FEMH-2017-C015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AT, 2008, CANCER IMAGING, V8, P48, DOI 10.1102/1470-7330.2008.0006; Amar A, 2012, J ONCOL, V2012, DOI 10.1155/2012/154303; Bandoh N, 2016, DIAGN CYTOPATHOL, V44, P169, DOI 10.1002/dc.23402; Borhani AA, 2017, SEMIN ULTRASOUND CT, V38, P531, DOI 10.1053/j.sult.2017.05.007; Chang JH, 2017, ONCOTARGET, V8, P55600, DOI 10.18632/oncotarget.16340; Chau I, 2003, BRIT J CANCER, V88, P354, DOI 10.1038/sj.bjc.6600738; Cibas ES, 2017, THYROID, V27, P1341, DOI 10.1089/thy.2017.0500; Goret CC, 2015, INT J CLIN EXP PATHO, V8, P8709; Hafez NH, 2011, J EGYPT NATL CANCER, V23, P105, DOI 10.1016/j.jnci.2011.09.009; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Houcine Y, 2018, J CRANIO MAXILL SURG, V46, P1117, DOI 10.1016/j.jcms.2018.04.024; Johnson Jonas T., 2014, BAILEYS HEAD NECK SU, V5th; Layfield LJ, 2007, DIAGN CYTOPATHOL, V35, P798, DOI 10.1002/dc.20769; Liao LJ, 2010, HEAD NECK-J SCI SPEC, V32, P594, DOI 10.1002/hed.21225; Pusztaszeri MP, 2015, SEMIN DIAGN PATHOL, V32, P32, DOI 10.1053/j.semdp.2014.12.002; Rotim T, 2017, ACTA CLIN CROAT, V56, P415, DOI 10.20471/acc.2017.56.03.08; Tarantino DR, 1998, AM J SURG, V176, P413, DOI 10.1016/S0002-9610(98)00233-5; Yoshida H, 1998, ULTRASOUND MED BIOL, V24, P621, DOI 10.1016/S0301-5629(98)00025-8	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246437	10.1371/journal.pone.0246437	http://dx.doi.org/10.1371/journal.pone.0246437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539457	Green Published, gold			2022-12-26	WOS:000616960200098
J	Kirkham, AA; Goonasekera, MV; Mattiello, BC; Grenier, JG; Haykowsky, MJ; Thompson, RB				Kirkham, Amy A.; Goonasekera, Michelle, V; Mattiello, Brenna C.; Grenier, Justin G.; Haykowsky, Mark J.; Thompson, Richard B.			Reliability and reproducibility of cardiac MRI quantification of peak exercise function with long-axis views	PLOS ONE			English	Article							GLOBAL LONGITUDINAL STRAIN; VENTRICULAR VOLUME; STRESS; CARDIOTOXICITY; INTOLERANCE; RESERVE; DISEASE	The conventional approach to cardiac magnetic resonance (CMR) involving breath holds, electrocardiography-gating, and acquisition of a short-axis (SAX) image stack, introduces technical and logistical challenges for assessing exercise left ventricular (LV) function. Real-time, free-breathing CMR acquisition of long-axis (LAX) images overcomes these issues and also enables assessment of global longitudinal strain (GLS). We evaluated the reliability of a free-breathing LAX approach compared to the standard SAX approach and the reproducibility of free-breathing LAX. LV SAX (contiguous stack) and LAX (two-chamber and four-chamber) 3T CMR cine images were acquired four times within one scan in 32 women with cardiovascular risk factors (56 +/- 10 years, 28 +/- 4 kg/m(2)) as follows: 1) resting, gated-segmented, end-expiration breath-hold; 2) resting, real-time, free-breathing; 3) test-retest set of resting, real-time, free-breathing; 4) peak exercise (incremental-to-maximum, in-magnet, stepper test), real-time, free-breathing. A second scan was performed within one week in a subset (n = 5) to determine reproducibility of peak exercise measures. Reliability and agreement of the free-breathing LAX approach with the conventional SAX approach were assessed by intraclass correlation coefficient (ICC) and Bland-Altman plots, respectively. Normal control GLS reserve was also acquired in a separate set of 12 young, healthy control women (25 +/- 4 years, 22 +/- 2 kg/m(2)) for comparison. Comparisons of LV volumes and function among all techniques at rest had good-to-excellent reliability (ICC = 0.80-0.96), and excellent reliability between peak exercise free-breathing LAX and SAX evaluations (ICC = 0.92-0.96). Higher resting heart rates with free-breathing acquisitions compared to breath-hold (mean difference, limits of agreement: 5, 1-12 beats per minute) reduced reliability for cardiac output (ICC = 0.67-0.79). Reproducibility of the free-breathing LAX approach was good-to-excellent at rest and peak exercise (ICC = 0.74-0.99). GLS exercise reserve was impaired in older women at cardiovascular risk compared to young healthy women (-4.7 +/- 2.3% vs -7.4 +/- 2.1%, p = 0.001). Real-time, free-breathing CMR with LAX evaluation provides a reliable and reproducible method to assess rest and peak exercise cardiac function, including GLS.	[Kirkham, Amy A.; Goonasekera, Michelle, V; Grenier, Justin G.; Thompson, Richard B.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Mattiello, Brenna C.] Univ Alberta, Fac Kinesiol Sport & Recreat, Edmonton, AB, Canada; [Haykowsky, Mark J.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Kirkham, Amy A.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	University of Alberta; University of Alberta; University of Alberta; University of Toronto	Thompson, RB (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	richard.thompson@ualberta.ca	Kirkham, Amy/HBZ-9926-2022	Kirkham, Amy/0000-0002-3847-1225; Haykowsky, Mark/0000-0002-7217-2747; , Justin/0000-0003-1937-1111; Thompson, Richard/0000-0003-3319-4377	Susan G. Komen Foundation [PDF17483149]; Canadian Institutes of Health Research; Alberta Innovates Health Solutions	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	This study was funded by Susan G. Komen Foundation (PDF17483149, AK, RB). AK was funded by Postdoctoral Fellowships from Canadian Institutes of Health Research and Alberta Innovates Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, J AM SOC ECHOCARDIOG, DOI DOI 10.1016/J.ECHO.2018.06.010; [Anonymous], 2016, J ULTRASOUND MED, V35, P1; Beaudry RI, 2018, AM J PHYSIOL-REG I, V315, pR638, DOI 10.1152/ajpregu.00158.2018; Biering-Sorensen T, 2017, CIRC CARDIOVASC IMAG, V10, P1331; Bloomgarden DC, 1997, MAGN RESON MED, V37, P683, DOI 10.1002/mrm.1910370510; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Childs H, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-40; Civelli M, 2006, INT J CARDIOL, V111, P120, DOI 10.1016/j.ijcard.2005.07.029; Claessen G, 2014, AM J PHYSIOL-HEART C, V306, pH816, DOI 10.1152/ajpheart.00752.2013; Cognet T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-84; COTSAMIRE DL, 1987, CLIN CARDIOL, V10, P137, DOI 10.1002/clc.4960100302; Ejlersen JA, 2017, INT J CARDIOVAS IMAG, V33, P473, DOI 10.1007/s10554-016-1022-x; Ewer MS, 2008, J CLIN ONCOL, V26, P1201, DOI 10.1200/JCO.2007.14.8742; Friedrich MG, 2000, MAGN RESON MATER PHY, V11, P16, DOI 10.1016/S1352-8661(00)00101-0; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Huttin O, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001856; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kirkham AA, 2015, INT J WOMENS HEALTH, V7, P127, DOI 10.2147/IJWH.S68745; Klassen O, 2014, ACTA ONCOL, V53, P1356, DOI 10.3109/0284186X.2014.899435; Krishnasamy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127044; La Gerche A, 2013, CIRC-CARDIOVASC IMAG, V6, P329, DOI 10.1161/CIRCIMAGING.112.980037; Lancellotti P, 2008, J AM SOC ECHOCARDIOG, V21, P1331, DOI 10.1016/j.echo.2008.09.023; Larsen AH, 2018, J AM SOC ECHOCARDIOG, V31, P1116, DOI 10.1016/j.echo.2018.06.010; Le TT, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0322-1; Lech AK, 2017, KARDIOL POL, V75, P143, DOI 10.5603/KP.a2016.0131; Lipinski MJ, 2013, J AM COLL CARDIOL, V62, P826, DOI 10.1016/j.jacc.2013.03.080; Lundby C, 2017, ACTA PHYSIOL, V220, P218, DOI 10.1111/apha.12827; Pedrizzetti G, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0269-7; Pepin V, 2009, COPD, V4, P195; Poitras VJ, 2018, J APPL PHYSIOL, V124, P1117, DOI 10.1152/japplphysiol.00070.2017; Raman SV, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003811; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Roest AAW, 2001, AM J CARDIOL, V87, P601, DOI 10.1016/S0002-9149(00)01438-7; SCHILLER NB, 1979, CIRCULATION, V60, P547, DOI 10.1161/01.CIR.60.3.547; Schulz-Menger J, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00610-6; SULLIVAN MJ, 1995, PROG CARDIOVASC DIS, V38, P1, DOI 10.1016/S0033-0620(05)80011-8; Thavendiranathan P, 2014, J AM COLL CARDIOL, V63, P2751, DOI 10.1016/j.jacc.2014.01.073; Xu LY, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00680-6; Zhang J, 2008, ACAD RADIOL, V15, P40, DOI 10.1016/j.acra.2007.07.023	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245912	10.1371/journal.pone.0245912	http://dx.doi.org/10.1371/journal.pone.0245912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539447	gold, Green Published			2022-12-26	WOS:000616960200109
J	Nagel, S; Pommerenke, C; Meyer, C; MacLeod, RAF; Drexler, HG				Nagel, Stefan; Pommerenke, Claudia; Meyer, Corinna; MacLeod, Roderick A. F.; Drexler, Hans G.			Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma	PLOS ONE			English	Article							REED-STERNBERG CELLS; B-CELL; CYTOGENETIC ABNORMALITIES; COMPREHENSIVE ANALYSIS; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; HEMATOPOIETIC STEM; FUSION GENE; T-CELLS; EXPRESSION	Homeobox genes encode transcription factors which regulate basic processes in development and cell differentiation and are grouped into classes and subclasses according to sequence similarities. Here, we analyzed the activities of the 20 members strong TALE homeobox gene class in early hematopoiesis and in lymphopoiesis including developing and mature B-cells, T-cells, natural killer (NK)-cells and innate lymphoid cells (ILC). The resultant expression pattern comprised eleven genes and which we termed TALE-code enables discrimination of normal and aberrant activities of TALE homeobox genes in lymphoid malignancies. Subsequent expression analysis of TALE homeobox genes in public datasets of Hodgkin lymphoma (HL) patients revealed overexpression of IRX3, IRX4, MEIS1, MEIS3, PBX1, PBX4 and TGIF1. As paradigm we focused on PBX1 which was deregulated in about 17% HL patients. Normal PBX1 expression was restricted to hematopoietic stem cells and progenitors of T-cells and ILCs but absent in B-cells, reflecting its roles in stemness and early differentiation. HL cell line SUP-HD1 expressed enhanced PBX1 levels and served as an in vitro model to identify upstream regulators and downstream targets in this malignancy. Genomic studies of this cell line therein showed a gain of the PBX1 locus at 1q23 which may underlie its aberrant expression. Comparative expression profiling analyses of HL patients and cell lines followed by knockdown experiments revealed NFIB and TLX2 as target genes activated by PBX1. HOX proteins operate as cofactors of PBX1. Accordingly, our data showed that HOXB9 overexpressed in HL coactivated TLX2 but not NFIB while activating TNFRSF9 without PBX1. Further downstream analyses showed that TLX2 activated TBX15 which operated anti-apoptotically. Taken together, we discovered a lymphoid TALE-code and identified an aberrant network around deregulated TALE homeobox gene PBX1 which may disturb B-cell differentiation in HL by reactivation of progenitor-specific genes. These findings may provide the framework for future studies to exploit possible vulnerabilities of malignant cells in therapeutic scenarios.	[Nagel, Stefan; Pommerenke, Claudia; Meyer, Corinna; MacLeod, Roderick A. F.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de						ALLEN JD, 1995, J IMMUNOL, V154, P1531; Arribas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157761; Arribas J, 2015, APOPTOSIS, V20, P1338, DOI 10.1007/s10495-015-1155-8; Becker-Santos DD, 2017, EBIOMEDICINE, V22, P2, DOI 10.1016/j.ebiom.2017.05.027; Bodor C, 2016, CANCER METAST REV, V35, P109, DOI 10.1007/s10555-016-9608-2; Bohle V, 2013, LEUKEMIA, V27, P671, DOI 10.1038/leu.2012.280; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Borghini S, 2006, BIOCHEM J, V395, P355, DOI 10.1042/BJ20051386; Brandal P, 2008, GENE CHROMOSOME CANC, V47, P558, DOI 10.1002/gcc.20559; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chen KS, 2017, CANCER LETT, V410, P124, DOI 10.1016/j.canlet.2017.09.015; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Contarelli S, 2020, CANCERS, V12, DOI 10.3390/cancers12113299; Dimitrova L, 2014, LEUKEMIA, V28, P213, DOI 10.1038/leu.2013.211; DOHNER H, 1992, GENE CHROMOSOME CANC, V5, P392, DOI 10.1002/gcc.2870050415; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Du XL, 2006, GENOMICS, V87, P693, DOI 10.1016/j.ygeno.2006.02.003; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Ficara F, 2013, J CELL SCI, V126, P3181, DOI 10.1242/jcs.125435; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Grebbin BM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00009; Hatano M, 1997, ANAT EMBRYOL, V195, P419, DOI 10.1007/s004290050061; Ho WT, 2013, CANCER RES, V73, P652, DOI 10.1158/0008-5472.CAN-12-3849; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Holmfeldt P, 2013, BLOOD, V122, P2987, DOI 10.1182/blood-2013-04-493973; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Jackson JT, 2015, BLOOD, V125, P803, DOI 10.1182/blood-2014-06-579813; Johansson B, 1997, LEUKEMIA, V11, P1207, DOI 10.1038/sj.leu.2400718; Kamps MP, 1997, CURR TOP MICROBIOL, V220, P25; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LADANYI M, 1991, GENE CHROMOSOME CANC, V3, P294, DOI 10.1002/gcc.2870030408; Li S, 2019, J ALLERGY CLIN IMMUN, V143, P2321, DOI 10.1016/j.jaci.2019.01.047; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Ma ESK, 2017, METHODS MOL BIOL, V1541, P279, DOI 10.1007/978-1-4939-6703-2_22; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MacLeod RAF, 2017, METHODS MOL BIOL, V1541, P43, DOI 10.1007/978-1-4939-6703-2_5; Malouf C, 2018, CELL MOL LIFE SCI, V75, P417, DOI 10.1007/s00018-017-2620-z; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mendez A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004696; Merabet S, 2016, TRENDS GENET, V32, P334, DOI 10.1016/j.tig.2016.03.004; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Morgan R, 2017, ONCOTARGET, V8, P32322, DOI 10.18632/oncotarget.15971; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Nagel S, 2003, CANCER RES, V63, P5329; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Nagel Stefan, 2020, Oncotarget, V11, P3208, DOI 10.18632/oncotarget.27683; Nagel S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226212; Nagel Stefan, 2019, Oncotarget, V10, P3227, DOI 10.18632/oncotarget.26929; Nagel S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216898; Nagel Stefan, 2018, Oncotarget, V9, P37480, DOI 10.18632/oncotarget.26459; Nagel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205537; Nagel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197194; Nagel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171164; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Quentmeier H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44491-x; Rice KL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.39; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Sanchez-Beato M, 2004, J PATHOL, V204, P528, DOI 10.1002/path.1661; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Selleri L, 2001, DEVELOPMENT, V128, P3543; Selleri L, 2019, GENE DEV, V33, P258, DOI 10.1101/gad.318774.118; Sheeba CJ, 2017, CURR TOP DEV BIOL, V122, P355, DOI 10.1016/bs.ctdb.2016.08.009; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Smith E, 2004, J LEUKOCYTE BIOL, V75, P973, DOI 10.1189/jlb.1103554; Soshnikova N, 2009, EPIGENETICS-US, V4, P537, DOI 10.4161/epi.4.8.10132; Starnes LM, 2009, BLOOD, V114, P1753, DOI 10.1182/blood-2008-12-196196; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Tang SJ, 1998, DEVELOPMENT, V125, P1877; Teofili L, 2001, BLOOD, V97, P1063, DOI 10.1182/blood.V97.4.1063; Thiaville MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036054; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tsukamoto S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07596; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Weniger MA, 2016, SEMIN CANCER BIOL, V39, P32, DOI 10.1016/j.semcancer.2016.05.001; Xu WL, 2019, EBIOMEDICINE, V39, P44, DOI 10.1016/j.ebiom.2018.11.053; Xu XX, 2020, FASEB J, V34, P6479, DOI 10.1096/fj.202000121R; ZOLLINO M, 1988, EUR J HAEMATOL, V40, P193	86	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246603	10.1371/journal.pone.0246603	http://dx.doi.org/10.1371/journal.pone.0246603			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539429	Green Published, gold			2022-12-26	WOS:000616960200106
J	Ashfaq, UA; Saleem, S; Masoud, MS; Ahmad, M; Nahid, N; Bhatti, R; Almatroudi, A; Khurshid, M				Ashfaq, Usman Ali; Saleem, Saman; Masoud, Muhammad Shareef; Ahmad, Matloob; Nahid, Nazia; Bhatti, Rashid; Almatroudi, Ahmad; Khurshid, Mohsin			Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach	PLOS ONE			English	Article							PREDICTION; INFECTION; CONSENSUS; PROTEINS; ALLELES	Middle East respiratory syndrome (MERS-COV), first identified in Saudi Arabia, was caused by a novel strain of coronavirus. Outbreaks were recorded from different regions of the world, especially South Korea and the Middle East, and were correlated with a 35% mortality rate. MERS-COV is a single-stranded, positive RNA virus that reaches the host by binding to the receptor of dipeptidyl-peptides. Because of the unavailability of the vaccine available for the protection from MERS-COV infection, the rapid case detection, isolation, infection prevention has been recommended to combat MERS-COV infection. So, vaccines for the treatment of MERS-COV infection need to be developed urgently. A possible antiviral mechanism for preventing MERS-CoV infection has been considered to be MERS-CoV vaccines that elicit unique T-cell responses. In the present study, we incorporated both molecular docking and immunoinformatic approach to introduce a multiepitope vaccine (MEP) against MERS-CoV by selecting 15 conserved epitopes from seven viral proteins such as three structural proteins (envelope, membrane, and nucleoprotein) and four non-structural proteins (ORF1a, ORF8, ORF3, ORF4a). The epitopes, which were examined for non-homologous to host and antigenicity, were selected on the basis of conservation between T-cell, B-cell, and IFN-gamma epitopes. The selected epitopes were then connected to the adjuvant (beta-defensin) at the N-terminal through an AAY linker to increase the immunogenic potential. Structural modelling and physiochemical characteristic were applied to the vaccine construct developed. Afterwards the structure has been successfully docked with antigenic receptor, Toll-like receptor 3 (TLR-3) and in-silico cloning ensures that its expression efficiency is legitimate. Nonetheless the MEP presented needs tests to verify its safety and immunogenic profile.	[Ashfaq, Usman Ali; Saleem, Saman; Masoud, Muhammad Shareef; Nahid, Nazia] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Ahmad, Matloob] Govt Coll Univ, Dept Chem, Faisalabad, Pakistan; [Bhatti, Rashid] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; [Almatroudi, Ahmad] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah, Saudi Arabia; [Khurshid, Mohsin] Govt Coll Univ, Dept Microbiol, Faisalabad, Pakistan	Government College University Faisalabad; Government College University Faisalabad; University of Punjab; Qassim University; Government College University Faisalabad	Ashfaq, UA (corresponding author), Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan.	usmancemb@gmail.com	Masoud, Muhammad Shareef/F-7156-2010; Khurshid, Mohsin/N-8135-2013; Ashfaq, Usman A/D-7792-2013	Masoud, Muhammad Shareef/0000-0003-2395-7721; Khurshid, Mohsin/0000-0002-3196-2857; Ashfaq, Usman A/0000-0002-5495-805X; Almatroudi, Ahmad/0000-0002-1491-6402				Abu-Haraz A.H., 2017, ADV TECH BIOL MED, V5, P1764, DOI [10.4172/2379-1764.1000203, DOI 10.4172/2379-1764.1000203]; Ahmad B, 2019, MICROB PATHOGENESIS, V132, P243, DOI 10.1016/j.micpath.2019.05.010; Ali A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37070-z; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; [Anonymous], 2018, KLS OCT, DOI DOI 10.18502/KLS.V4I6.3094; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Bolis S, 2018, IMMUNOINFORMATICS PR; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093; Chang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070166; Choubini E, 2018, MOL IMMUNOL, V96, P88, DOI 10.1016/j.molimm.2018.03.001; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Dar HA, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030088; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Du LY, 2016, EXPERT REV VACCINES, V15, P1123, DOI 10.1586/14760584.2016.1167603; Dubey KK, 2018, BRIEF FUNCT GENOMICS, V17, P295, DOI 10.1093/bfgp/ely020; Farag EAB, 2019, SURVEY IMPLEMENTATIO, P25; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hajighahramani N, 2017, INFECT GENET EVOL, V48, P83, DOI 10.1016/j.meegid.2016.12.010; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Hussain M, 2015, CURR COMPUT-AID DRUG, V11, P84, DOI 10.2174/1573409911666150529130134; Ikram A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34254-5; Kaliamurthi S, 2019, DATA, V4, DOI 10.3390/data4010031; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Latimer B, 2014, HUM VACC IMMUNOTHER, V10, P2357, DOI 10.4161/hv.29590; Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51; Letko M, 2018, CELL REP, V24, P1730, DOI 10.1016/j.celrep.2018.07.045; MacIntyre C. Raina, 2014, Environment Systems & Decisions, V34, P383, DOI 10.1007/s10669-014-9506-5; Mangia A, 1999, J HEPATOL, V30, P984, DOI 10.1016/S0168-8278(99)80250-5; Maria R.A.R., 2017, VACCINES-BASEL; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meza B, 2017, INFECT GENET EVOL, V49, P309, DOI 10.1016/j.meegid.2017.02.007; Momtaz F, 2019, TURK J FISH AQUAT SC, V19, P149, DOI 10.4194/1303-2712-v19_2_07; Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007; Oyarzun P, 2016, HUM VACC IMMUNOTHER, V12, P763, DOI 10.1080/21645515.2015.1094595; Paganini J, 2019, MOL IMMUNOL, V112, P40, DOI 10.1016/j.molimm.2019.04.017; Pandey RK, 2018, J CELL BIOCHEM, V119, P7631, DOI 10.1002/jcb.27110; Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Prescott J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00205; Shahid F, 2020, INFECT GENET EVOL, V80, DOI 10.1016/j.meegid.2020.104199; Shey RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40833-x; Slathia PS, 2018, MICROB PATHOGENESIS, V125, P423, DOI 10.1016/j.micpath.2018.10.006; Srivastava S, 2018, INFECT DRUG RESIST, V11, P2377, DOI 10.2147/IDR.S175114; ul Qamar MT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244176; Thio CL, 2002, J VIROL, V76, P4792, DOI 10.1128/JVI.76.10.4792-4797.2002; Tong JC, 2009, DRUG DISCOV TODAY, V14, P684, DOI 10.1016/j.drudis.2009.04.001; Ul Qamar MT, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2116-8; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Woo PCY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0016-7; Yang Y, 2013, PROTEIN CELL, V4, P951, DOI 10.1007/s13238-013-3096-8; Zhang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep25049; Zhou YS, 2018, EXPERT REV VACCINES, V17, P677, DOI 10.1080/14760584.2018.1506702; Zhu BW, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1352-8; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	70	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245072	10.1371/journal.pone.0245072	http://dx.doi.org/10.1371/journal.pone.0245072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534822	gold, Green Published			2022-12-26	WOS:000616739700067
J	Jitprasertwong, P; Khamphio, M; Petsrichuang, P; Eijsink, VGH; Poolsri, W; Muanprasat, C; Rangnoi, K; Yamabhai, M				Jitprasertwong, Paiboon; Khamphio, Munthipha; Petsrichuang, Phornsiri; Eijsink, Vincent G. H.; Poolsri, Wanangkan; Muanprasat, Chatchai; Rangnoi, Kuntalee; Yamabhai, Montarop			Anti-inflammatory activity of soluble chito-oligosaccharides (CHOS) on VitD3-induced human THP-1 monocytes	PLOS ONE			English	Article							POTENTIAL APPLICATIONS; CHITOOLIGOSACCHARIDES; ACTIVATION; DIFFERENTIATION; DEGRADATION; CHITOSANASE; DAMAGE	Chito-oligosaccharides (CHOS) are oligomers of D-glucosamine and N-acetyl-glucosamine. Anti-inflammatory activities of a wide variety of CHOS mixtures have previously been reported, mainly based on studies with mouse models and murine macrophages. Since the mouse and human immune systems are quite different, gaining insight into the activity of CHOS on human cell lines, using well-characterized CHOS mixtures, is of considerable interest. Bacillus subtilis chitosanase (BsCsn46A) can efficiently convert chitosan to mixtures of water soluble low molecular weight CHOS. Here, the anti-inflammatory activity of a properly characterized CHOS mixture was studied, using human THP-1 cells that were differentiated to mature monocytes using vitamin D3. Addition of CHOS reduced the production of multiple pro-inflammatory cytokines associated with bacterial lipopolyssacharide (LPS)-stimulated inflammation, in a dose-dependent manner and without affecting cell viability. Interestingly, only minimal effects of CHOS were observed in similar experiments with phorbol 12-myristate 13-acetate- (PMA-) differentiated, macrophage-like, THP-1 cells. Altogether, in addition to showing promising biological effects of well-characterized low molecular weight soluble CHOS in a human system, the present study also points at Vitamin D3-stimulated THP-1 cells as a favorable system for assessing the anti-inflammatory activity of bioactive compounds.	[Jitprasertwong, Paiboon] Suranaree Univ Technol SUT, Sch Geriatr Oral Hlth, Inst Dent, Nakhon Ratchasima, Thailand; [Khamphio, Munthipha; Petsrichuang, Phornsiri; Rangnoi, Kuntalee; Yamabhai, Montarop] Suranaree Univ Technol SUT, Sch Biotechnol, Inst Agr Technol, Mol Biotechnol Lab, Nakhon Ratchasima, Thailand; [Eijsink, Vincent G. H.] Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, As, Norway; [Poolsri, Wanangkan; Muanprasat, Chatchai] Mahidol Univ, Ramathibodi Hosp, Fac Med, Chakri Naruebodindra Med Inst, Samut Prakan, Thailand	Norwegian University of Life Sciences; Mahidol University	Yamabhai, M (corresponding author), Suranaree Univ Technol SUT, Sch Biotechnol, Inst Agr Technol, Mol Biotechnol Lab, Nakhon Ratchasima, Thailand.	montarop@g.sut.ac.th	Yamabhai, Montarop/AAX-8731-2021; Yamabhai, Montarop/AFM-1335-2022	Jitprasertwong, Paiboon/0000-0001-6170-1685; Yamabhai, Montarop/0000-0003-2674-2419	Suranaree University of Technology (SUT) [RU12/2562]; National Research Council of Thailand (NRCT); Office of the Higher Education Commission (OHEC) under the National Research University (NRU) project [SUT3-304-55-36-18, SUT3-304-62-36-18]; SUT Fulltime Doctoral Research [61/13/2561, 61/28/2563]; Thailand Science Research and Innovation (TSRI); SUT-PhD scholarship	Suranaree University of Technology (SUT); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Office of the Higher Education Commission (OHEC) under the National Research University (NRU) project; SUT Fulltime Doctoral Research; Thailand Science Research and Innovation (TSRI); SUT-PhD scholarship	This research was supported by the Suranaree University of Technology (SUT) [grant no. RU12/2562], the National Research Council of Thailand (NRCT) and the Office of the Higher Education Commission (OHEC) under the National Research University (NRU) project [grant no. SUT3-304-55-36-18 and SUT3-304-62-36-18]. MK and KR were supported by SUT Fulltime Doctoral Research [grants no. 61/13/2561 and 61/28/2563] and Thailand Science Research and Innovation (TSRI). PP was supported by a SUT-PhD scholarship.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Basa S, 2020, J AM CHEM SOC, V142, P1975, DOI 10.1021/jacs.9b11466; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Chou TC, 2003, BIOCHEM BIOPH RES CO, V308, P403, DOI 10.1016/S0006-291X(03)01407-4; Fernandes JC, 2010, MAR DRUGS, V8, P1763, DOI 10.3390/md8061763; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Jitprasertwong P, 2014, CYTOKINE, V65, P222, DOI 10.1016/j.cyto.2013.10.008; Kaczmarek MB, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00243; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Liang S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082197; Lodhi G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/654913; Lund ME, 2016, J IMMUNOL METHODS, V430, P64, DOI 10.1016/j.jim.2016.01.012; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Marmouzi I, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4568039; MESHULAM T, 1995, J INFECT DIS, V172, P1153, DOI 10.1093/infdis/172.4.1153; Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013; Muanprasat C, 2015, BIOCHEM PHARMACOL, V96, P225, DOI 10.1016/j.bcp.2015.05.016; Pechsrichuang P, 2018, CARBOHYD POLYM, V186, P420, DOI 10.1016/j.carbpol.2018.01.059; Pechsrichuang P, 2013, BIORESOURCE TECHNOL, V127, P407, DOI 10.1016/j.biortech.2012.09.130; Rodriguez-Vita J, 2010, CYTOKINE GROWTH F R, V21, P61, DOI 10.1016/j.cytogfr.2009.11.006; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanchez A, 2018, MAR DRUGS, V16, DOI 10.3390/md16110430; Santos-Moriano P, 2019, CATALYSTS, V9, DOI 10.3390/catal9050405; Schmitz C, 2019, MAR DRUGS, V17, DOI 10.3390/md17080452; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Senevirathne M, 2011, CARBOHYD POLYM, V83, P995, DOI 10.1016/j.carbpol.2010.09.016; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2; Xing R, 2017, CARBOHYD POLYM, V157, P1288, DOI 10.1016/j.carbpol.2016.11.001; Yermak IM, 2006, BIOCHIMIE, V88, P23, DOI 10.1016/j.biochi.2005.07.004	32	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246381	10.1371/journal.pone.0246381	http://dx.doi.org/10.1371/journal.pone.0246381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534833	gold, Green Published			2022-12-26	WOS:000616739700028
J	Jones, CE; Sharick, JT; Colbert, SE; Shukla, VC; Zent, JM; Ostrowski, MC; Ghadiali, SN; Sizemore, ST; Leight, JL				Jones, Caitlin E.; Sharick, Joe T.; Colbert, Sheila E.; Shukla, Vasudha C.; Zent, Joshua M.; Ostrowski, Michael C.; Ghadiali, Samir N.; Sizemore, Steven T.; Leight, Jennifer L.			Pten regulates collagen fibrillogenesis by fibroblasts through SPARC	PLOS ONE			English	Article							PROCOLLAGEN C-PROTEINASE; CELL-MATRIX ADHESIONS; TISSUE TRANSGLUTAMINASE; PROLYL 4-HYDROXYLASE; CROSS-LINKING; STEM-CELLS; BREAST; EXPRESSION; IDENTIFICATION; ASSOCIATION	Collagen deposition contributes to both high mammographic density and breast cancer progression. Low stromal PTEN expression has been observed in as many as half of breast tumors and is associated with increases in collagen deposition, however the mechanism connecting PTEN loss to increased collagen deposition remains unclear. Here, we demonstrate that Pten knockout in fibroblasts using an Fsp-Cre;Pten(loxP/loxP) mouse model increases collagen fiber number and fiber size within the mammary gland. Pten knockout additionally upregulated Sparc transcription in fibroblasts and promoted collagen shuttling out of the cell. Interestingly, SPARC mRNA expression was observed to be significantly elevated in the tumor stroma as compared to the normal breast in several patient cohorts. While SPARC knockdown via shRNA did not affect collagen shuttling, it notably decreased assembly of exogenous collagen. In addition, SPARC knockdown decreased fibronectin assembly and alignment of the extracellular matrix in an in vitro fibroblast-derived matrix model. Overall, these data indicate upregulation of SPARC is a mechanism by which PTEN regulates collagen deposition in the mammary gland stroma.	[Jones, Caitlin E.; Sharick, Joe T.; Colbert, Sheila E.; Shukla, Vasudha C.; Zent, Joshua M.; Ghadiali, Samir N.; Leight, Jennifer L.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Ostrowski, Michael C.] Med Univ South Carolina, Hollings Canc Ctr, Dept Biochem & Mol Biol, Charleston, SC USA; [Ghadiali, Samir N.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH USA; [Ghadiali, Samir N.] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA; [Ghadiali, Samir N.] Ohio State Univ, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Coll Med, Columbus, OH USA; [Sizemore, Steven T.] Ohio State Univ, Coll Med, Dept Radiat Oncol, Columbus, OH USA; [Sizemore, Steven T.; Leight, Jennifer L.] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Medical University of South Carolina; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Leight, JL (corresponding author), Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA.; Leight, JL (corresponding author), Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA.	leight.1@osu.edu	Ghadiali, Samir/AAN-7772-2020; Leight, Jennifer L/E-5535-2015; Ghadiali, Samir N./C-5463-2012	Ghadiali, Samir/0000-0002-6845-774X; Ghadiali, Samir N./0000-0002-6845-774X; Leight, Jennifer/0000-0003-4510-1086	College of Engineering, The Ohio State University; James Comprehensive Cancer Center as startup funds; NIH cancer center [P30 CA016058]	College of Engineering, The Ohio State University; James Comprehensive Cancer Center as startup funds; NIH cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by the College of Engineering, The Ohio State University and The James Comprehensive Cancer Center as startup funds to JLL, which also supported the salary of CEJ, JTS, and JMZ. JTS received salary support from the Ohio State University Presidential Postdoctoral Scholars Program. SNG, STS, and JLL received salary support from the Ohio State University. Images presented in this report were generated using the instruments and services at the Campus Microscopy and Imaging Facility, The Ohio State University. This facility is supported in part by NIH cancer center grant P30 CA016058 to The Ohio State University, National Cancer Institute, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Engmann NJ, 2017, JAMA ONCOL, V3, P1228, DOI 10.1001/jamaoncol.2016.6326; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franco-Barraza Janusz, 2016, Curr Protoc Cell Biol, V71, DOI 10.1002/cpcb.2; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; Hung JY, 2017, ONCOTARGET, V8, P63691, DOI 10.18632/oncotarget.19475; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Jones CE, 2019, NEOPLASIA, V21, P132, DOI 10.1016/j.neo.2018.10.010; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; LEUNG MKK, 1979, J BIOL CHEM, V254, P224; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; McConnell JC, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0664-2; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Pankov Roumen, 2009, V522, P261, DOI 10.1007/978-1-59745-413-1_18; PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rosset EM, 2020, J PERIODONTAL RES, V55, P107, DOI 10.1111/jre.12694; Saunders JT, 2019, MOL BIOL CELL, V30, P2218, DOI 10.1091/mbc.E19-03-0140; Sizemore GM, 2017, ONCOGENE, V36, P2297, DOI 10.1038/onc.2016.383; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trombetta-eSilva J, 2015, J BONE MINER RES, V30, P1914, DOI 10.1002/jbmr.2522; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Xu YZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-210; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 1999, J CELL SCI, V112, P1655; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106; Zhu AJ, 2016, ONCOTARGET, V7, P76628, DOI 10.18632/oncotarget.10532; Zielinski R, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024467	65	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245653	10.1371/journal.pone.0245653	http://dx.doi.org/10.1371/journal.pone.0245653			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534863	Green Published, gold			2022-12-26	WOS:000616739700024
J	Taniguchi, R; Utani, K; Thakur, B; Ishine, K; Aladjem, MI; Shimizu, N				Taniguchi, Ryonosuke; Utani, Koichi; Thakur, Bhushan; Ishine, Kazuho; Aladjem, Mirit, I; Shimizu, Noriaki			SIRT1 stabilizes extrachromosomal gene amplification and contributes to repeat-induced gene silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOGENEOUSLY STAINING REGIONS; REPLICATION INITIATION REGION; DOUBLE MINUTES; CIRCULAR DNA; MYC GENES; ELIMINATION; CELLS; PLASMIDS	Sirtuin 1 (SIRT1) is a protein deacetylase that maintains genome stability by preventing the activation of latent replication origins. Amplified genes in cancer cells localize on either extrachromosomal double minutes (DMs) or the chromosomal homogeneously staining region. Previously, we found that a plasmid with a mammalian replication initiation region and a matrix attachment region spontaneously mimics gene amplification in cultured animal cells and efficiently generates DMs and/or an homogeneously staining region. Here, we addressed the possibility that SIRT1 might be involved in initiation region/matrix attachment region-mediated gene amplification using SIRT1-knockout human COLO 320DM cells. Consequently, we found that extrachromosomal amplification was infrequent in SIRT1-deficient cells, suggesting that DNA breakage caused by latent origin activation prevented the formation of stable extrachromosomal amplicons. Moreover, we serendipitously found that reporter gene expression from the amplified repeats, which is commonly silenced by repeat-induced gene silencing (RIGS) in SIRT1-proficient cells, was strikingly higher in SIRT1-deficient cells, especially in the culture treated with the histone deacetylase inhibitor butyrate. Compared with the SIRT1-proficient cells, the gene expression per copy was up to thousand-fold higher in the sorter-isolated highest 10% cells among the SIRT1-deficient cells. These observations suggest that SIRT1 depletion alleviates RIGS. Thus, SIRT1 may stabilize extrachromosomal amplicons and facilitate RIGS. This result could have implications in cancer malignancy and protein expression.	[Taniguchi, Ryonosuke; Ishine, Kazuho; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan; [Utani, Koichi; Thakur, Bhushan; Aladjem, Mirit, I] NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Shimizu, Noriaki] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan; [Utani, Koichi] Kanazawa Med Univ, Dept Microbiol, Uchinada, Ishikawa, Japan	Hiroshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hiroshima University; Kanazawa Medical University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan.; Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp		Thakur, Bhushan L./0000-0002-8426-3478; Utani, Koichi/0000-0002-8065-3161; Shimizu, Noriaki/0000-0002-7979-897X	AMED [JP19ae0101054]; NIH, Center of Cancer Research, National Cancer Institute	AMED; NIH, Center of Cancer Research, National Cancer Institute	This research was supported in part by AMED under Grant Number JP19ae0101054 awarded to N. S. and by the intramural program of the NIH, Center of Cancer Research, National Cancer Institute to M. I. A.	Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Asoshina M, 2019, NUCLEIC ACIDS RES, V47, P5998, DOI 10.1093/nar/gkz343; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; deCarvalho AC, 2018, NAT GENET, V50, P708, DOI 10.1038/s41588-018-0105-0; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Fusco S, 2012, CELL CYCLE, V11, P4135, DOI 10.4161/cc.22074; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Harada S, 2009, J BIOL CHEM, V284, P24320, DOI 10.1074/jbc.M109.008128; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Koche RP, 2020, NAT GENET, V52, P29, DOI 10.1038/s41588-019-0547-z; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Koo DH, 2018, P NATL ACAD SCI USA, V115, P3332, DOI 10.1073/pnas.1719354115; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mitsuda SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161288; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Oobatake Y, 2020, GENE CHROMOSOME CANC, V59, P133, DOI 10.1002/gcc.22810; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; SHIMIZU N, 1994, CANCER RES, V54, P3561; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Utani K, 2017, NUCLEIC ACIDS RES, V45, P7807, DOI 10.1093/nar/gkx468; Verhaak RGW, 2019, NAT REV CANCER, V19, P283, DOI 10.1038/s41568-019-0128-6; Von Hoff D D, 1991, Cancer Treat Res, V57, P1; VONHOFF DD, 1991, CANCER RES, V51, P6273; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WAHL GM, 1989, CANCER RES, V49, P1333; Yang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14941; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	46	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100356	10.1016/jbc.2021.100356	http://dx.doi.org/10.1016/jbc.2021.100356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539925				2022-12-26	WOS:000672866400330
J	Kandasamy, K; Tan, LG; Johana, NB; Tan, YW; Foo, W; Yeo, JSL; Ravikumar, V; Ginhoux, F; Choolani, M; Chan, JKY; Mattar, CNZ				Kandasamy, Karthikeyan; Tan, Lay Geok; Johana, Nuryanti B.; Tan, Yi Wan; Foo, Wanling; Yeo, Julie S. L.; Ravikumar, Vikashini; Ginhoux, Florent; Choolani, Mahesh; Chan, Jerry K. Y.; Mattar, Citra N. Z.			Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation	FASEB JOURNAL			English	Article						bone marrow cells; fetal therapy; hematopoietic stem and progenitor cells; intrauterine transplantation; maternal donor cells; paternal donor cells; semi&#8208; allogenic donor cells	BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; REGULATORY T-CELLS; PRENATAL TOLERANCE INDUCTION; VERSUS-HOST-DISEASE; CANINE MODEL; CHIMERISM; DELETION; ANTIGENS; MHC	Successful intrauterine hematopoietic cell transplantation (IUT) for congenital hemoglobinopathies is hampered by maternal alloresponsiveness. We investigate these interactions in semi-allogenic murine IUT. E14 fetuses (B6 females x BALB/c males) were each treated with 5E+6 maternal (B6) or paternal (BALB/c) bone marrow cells and serially monitored for chimerism (>1% engraftment), trafficked maternal immune cells, and immune responsiveness to donor cells. A total of 41.0% of maternal IUT recipients (mIUT) were chimeras (mean donor chimerism 3.0 +/- 1.3%) versus 75.0% of paternal IUT recipients (pIUT, 3.6 +/- 1.1%). Chimeras showed higher maternal microchimerism of CD4, CD8, and CD19 than non-chimeras. These maternal cells showed minimal responsiveness to B6 or BALB/c stimulation. To interrogate tolerance, mIUT were injected postnatally with 5E+6 B6 cells/pup; pIUT received BALB/c cells. IUT-treated pups showed no changes in trafficked maternal or fetal immune cell levels compared to controls. Donor-specific IgM and IgG were expressed by 1%-3% of recipients. mIUT splenocytes showed greater proliferation of regulatory T cells (Treg) upon BALB/c stimulation, while B6 stimulation upregulated the pro-inflammatory cytokines more than BALB/c. pIUT splenocytes produced identical Treg and cytokine responses to BALB/c and B6 cells, with higher Treg activity and lower pro-inflammatory cytokine expression upon exposure to BALB/c. In contrast, naive fetal splenocytes demonstrated greater alloresponsiveness to BALB/c compared to B6 cells. Thus pIUT, associated with increased maternal cell trafficking, modulates fetal Treg, and cytokine responsiveness to donor cells more efficiently than mIUT, resulting in improved engraftment. Paternal donor cells may be considered alternatively to maternal donor cells for intrauterine and postnatal transplantation to induce tolerance and maintain engraftment.	[Kandasamy, Karthikeyan; Tan, Lay Geok; Foo, Wanling; Ravikumar, Vikashini; Choolani, Mahesh; Mattar, Citra N. Z.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 119228, Singapore; [Tan, Lay Geok; Choolani, Mahesh; Mattar, Citra N. Z.] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Obstet & Gynaecol, Singapore, Singapore; [Johana, Nuryanti B.; Tan, Yi Wan; Yeo, Julie S. L.; Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Mattar, CNZ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 119228, Singapore.	citramattar@nus.edu.sg		Mattar, Citra Nurfarah/0000-0003-0068-6957; Kandasamy, Karthikeyan/0000-0001-8335-8953	MOH \ National Medical Research Council (NMRC) [NMRC/TA/0003/2012, NMRC/CSA-INV/0012/2016]	MOH \ National Medical Research Council (NMRC)(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	MOH vertical bar National Medical Research Council (NMRC), Grant/Award Number: NMRC/TA/0003/2012 and NMRC/CSA-INV/0012/2016	Alhajjat AM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00051; Araki M, 2010, J IMMUNOL, V185, P7739, DOI 10.4049/jimmunol.1001226; Ashizuka S, 2006, EXP HEMATOL, V34, P359, DOI 10.1016/j.exphem.2005.11.011; Benichou G, 1999, J IMMUNOL, V162, P352; Blakemore K, 2004, AM J OBSTET GYNECOL, V190, P960, DOI 10.1016/j.ajog.2004.01.014; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Bracamonte-Baran W, 2015, BIOMED J, V38, P39, DOI 10.4103/2319-4170.143498; Burlingham William J, 2012, Chimerism, V3, P29, DOI 10.4161/chim.21668; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012; Chou SH, 2013, CELL TRANSPLANT, V22, P711, DOI 10.3727/096368912X655172; Derderian SC, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00278; Dighe NM, 2018, EXP HEMATOL, V62, P45, DOI 10.1016/j.exphem.2018.03.006; Durkin ET, 2008, BLOOD, V112, P5245, DOI 10.1182/blood-2007-12-128116; Dutta P, 2011, AM J TRANSPLANT, V11, P1296, DOI 10.1111/j.1600-6143.2011.03484.x; Dutta Partha, 2011, Chimerism, V2, P78, DOI 10.4161/chim.2.3.18083; Dutta Partha, 2010, Chimerism, V1, P2, DOI 10.4161/chim.1.1.12667; Dutta P, 2009, BLOOD, V114, P3578, DOI 10.1182/blood-2009-03-213561; Dutta P, 2009, CURR OPIN ORGAN TRAN, V14, P439, DOI 10.1097/MOT.0b013e32832d6683; Fehr T, 2008, J IMMUNOL, V181, P4371, DOI 10.4049/jimmunol.181.6.4371; FLAKE AW, 1993, CRIT REV ONCOL HEMAT, V15, P35, DOI 10.1016/1040-8428(93)90019-Z; Fowler DH., 2019, IMMUNE BIOL ALLOGENE, P195; Frascoli M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2263; Gotherstrom C, 2014, STEM CELL TRANSL MED, V3, P255, DOI 10.5966/sctm.2013-0090; Hayashi S, 2003, EXP HEMATOL, V31, P176, DOI 10.1016/S0301-472X(02)01024-X; Hayashi S, 2002, BLOOD, V100, P804, DOI 10.1182/blood-2002-01-0016; JACOBY RO, 1969, AM J VET RES, V30, P1503; Kandasamy K., 2021, FASEB J, V35; Karnon J, 1999, CLIN LAB HAEMATOL, V21, P377, DOI 10.1046/j.1365-2257.1999.00262.x; Kim HB, 1998, J SURG RES, V77, P1, DOI 10.1006/jsre.1997.5255; Kim HB, 1999, J PEDIATR SURG, V34, P726, DOI 10.1016/S0022-3468(99)90364-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; Lee PW, 2005, TRANSPLANTATION, V79, P1084, DOI 10.1097/01.TP.0000161247.61727.67; Lee PW, 2005, EXP HEMATOL, V33, P371, DOI 10.1016/j.exphem.2004.12.002; Lin JX, 2019, ANNU REV IMMUNOL, V37, P295, DOI 10.1146/annurev-immunol-042718-041447; Liu LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031300; Masouridi-Levrat S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00362; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P683, DOI 10.1016/j.bpobgyn.2012.06.005; Mattar CNZ, 2019, FETAL DIAGN THER, V46, P175, DOI 10.1159/000493791; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Merianos D, 2008, BIOL BLOOD MARROW TR, V14, P729, DOI 10.1016/j.bbmt.2008.02.012; Merianos DJ, 2009, J CLIN INVEST, V119, P2590, DOI 10.1172/JCI38979; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Nijagal A, 2013, BLOOD, V121, P4595, DOI 10.1182/blood-2012-10-463174; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Nowlan B, 2020, HAEMATOLOGICA, V105, P71, DOI 10.3324/haematol.2018.212910; Peng B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0152-y; Peranteau WH, 2002, BLOOD, V100, P2225, DOI 10.1182/blood-2002-01-0166; Peranteau WH, 2007, BLOOD, V109, P1331, DOI 10.1182/blood-2006-04-018606; Peranteau WH, 2006, BLOOD, V108, P4268, DOI 10.1182/blood-2006-04-018986; Peranteau WH, 2015, BLOOD, V126, P1245, DOI 10.1182/blood-2015-03-636803; Peranteau WH, 2009, BIOL BLOOD MARROW TR, V15, P293, DOI 10.1016/j.bbmt.2008.11.034; Petersen SM, 2007, FETAL DIAGN THER, V22, P175, DOI 10.1159/000098711; Petersen SM, 2013, FETAL DIAGN THER, V33, P116, DOI 10.1159/000346211; Richter M, 2017, HEMATOL ONCOL CLIN N, V31, P771, DOI 10.1016/j.hoc.2017.06.001; Riley JS, 2020, BLOOD ADV, V4, P1102, DOI 10.1182/bloodadvances.2019001208; Stern M, 2008, BLOOD, V112, P2990, DOI 10.1182/blood-2008-01-135285; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Tiblad E, 2008, BEST PRACT RES CL OB, V22, P189, DOI 10.1016/j.bpobgyn.2007.07.007; Tilburgs T, 2013, AM J REPROD IMMUNOL, V69, P395, DOI 10.1111/aji.12094; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vrecenak JD, 2018, BIOL BLOOD MARROW TR, V24, P1795, DOI 10.1016/j.bbmt.2018.05.020; Vrecenak JD, 2014, BLOOD, V124, P1987, DOI 10.1182/blood-2013-11-537571; Wegorzewska M, 2014, J IMMUNOL, V192, P1938, DOI 10.4049/jimmunol.1302403; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	69	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21413	10.1096/fj.202002185RR	http://dx.doi.org/10.1096/fj.202002185RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33570785	hybrid			2022-12-26	WOS:000629576700027
J	Mora-Castro, R; Alfaro-Cordoba, M; Hernandez-Jimenez, M; Otarola, MF; Mendez-Rivera, M; Ramirez-Morales, D; Rodriguez-Rodriguez, CE; Duran-Rodriguez, A; Hanson, PE				Mora-Castro, Rebeca; Alfaro-Cordoba, Marcela; Hernandez-Jimenez, Marcela; Otarola, Mauricio Fernandez; Mendez-Rivera, Michael; Ramirez-Morales, Didier; Rodriguez-Rodriguez, Carlos E.; Duran-Rodriguez, Andres; Hanson, Paul E.			First evidence for an aposematic function of a very common color pattern in small insects	PLOS ONE			English	Article							JUMPING SPIDERS; WARNING COLORATION; PRINCIPAL EYES; PREY; EVOLUTION; PREDATORS; IDENTIFICATION; HYMENOPTERA; LYSSOMANES; SALTICIDAE	Many small parasitoid wasps have a black head, an orange mesosoma and a black metasoma (BOB color pattern), which is usually present in both sexes. A likely function of this widespread pattern is aposematic (warning) coloration, but this has never been investigated. To test this hypothesis, we presented spider predators (Lyssomanes jemineus), both field-captured and bred in captivity from eggs, to four wasp genera (Baryconus, Chromoteleia, Macroteleia and Scelio), each genus being represented by a BOB morphospecies and black morphospecies. We also used false prey, consisting of lures made of painted rice grains. Behavioral responses were analyzed with respect to presence or absence of the BOB pattern. In order to better understand the results obtained, two additional studies were performed. First, the reflection spectrum of the cuticle of the wasp and a theoretical visual sensibility of the spider were used to calculate a parameter we called "absorption contrast" that allows comparing the perception contrast between black and orange in each wasp genus as viewed by the spider. Second, acute toxicity trials with the water flea, Daphnia magna, were performed to determine toxicity differences between BOB and non-BOB wasps. At least some of the results suggest that the BOB color pattern may possibly play an aposematic role.	[Mora-Castro, Rebeca] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica; [Mora-Castro, Rebeca; Hernandez-Jimenez, Marcela] Univ Costa Rica, Ctr Invest Ciencia & Ingn Mat, San Jose, Costa Rica; [Mora-Castro, Rebeca; Otarola, Mauricio Fernandez; Hanson, Paul E.] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Alfaro-Cordoba, Marcela] Univ Costa Rica, Ctr Invest Matemat Pura & Aplicada, San Jose, Costa Rica; [Alfaro-Cordoba, Marcela] Univ Costa Rica, Escuela Estadist, San Jose, Costa Rica; [Hernandez-Jimenez, Marcela] Univ Costa Rica, Escuela Fis, San Jose, Costa Rica; [Otarola, Mauricio Fernandez] Univ Costa Rica, Ctr Invest Biodiversidad & Ecol Trop CIBET, San Jose, Costa Rica; [Mendez-Rivera, Michael; Ramirez-Morales, Didier; Rodriguez-Rodriguez, Carlos E.] Univ Costa Rica, Ctr Invest Contaminac Ambiental CICA, San Jose, Costa Rica; [Duran-Rodriguez, Andres] Univ Costa Rica, Protolab, San Jose, Costa Rica	Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica	Mora-Castro, R (corresponding author), Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica.; Mora-Castro, R (corresponding author), Univ Costa Rica, Ctr Invest Ciencia & Ingn Mat, San Jose, Costa Rica.; Mora-Castro, R (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	rebeca.mora@ucr.ac.cr	Rodríguez-Rodríguez, Carlos E./AAS-2306-2021; Córdoba, Marcela Alfaro/AAF-1805-2019	Rodríguez-Rodríguez, Carlos E./0000-0001-6923-7258; Córdoba, Marcela Alfaro/0000-0002-7703-3578; Mora Castro, Rebeca/0000-0002-2629-3839; Fernandez Otarola, Mauricio/0000-0001-9240-7569	University of Costa Rica [801A5B50]	University of Costa Rica	This work was funded by the University of Costa Rica, project 801A5B50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas LM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11021; Biamonte E, 2011, LANDSCAPE ECOL, V26, P183, DOI 10.1007/s10980-010-9564-0; BLEST AD, 1984, PROC R SOC SER B-BIO, V221, P111, DOI 10.1098/rspb.1984.0026; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; Brandley N, 2016, BEHAV ECOL, V27, P1104, DOI 10.1093/beheco/arw014; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; CLARK RJ, 1995, ETHOL ECOL EVOL, V7, P73, DOI 10.1080/08927014.1995.9522970; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; EPA, 2002, METH MEAS AC TOX EFF, P266; Exnerova A, 2006, BIOL J LINN SOC, V88, P143, DOI 10.1111/j.1095-8312.2006.00611.x; Fabricant SA, 2015, BEHAV ECOL, V26, P38, DOI 10.1093/beheco/aru157; Fabricant SA, 2014, ECOL EVOL, V4, P113, DOI 10.1002/ece3.914; FORSTER L, 1982, AM SCI, V70, P165; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Grether GF, 2004, BIOL REV, V79, P583, DOI 10.1017/S1464793103006390; Harland D. P., 2012, JUMPING SPIDERS SEE; Harland Duane P., 2000, Cimbebasia, V16, P231; Herberstein ME, 2011, SPIDER BEHAV FLEXIBI, P1; Jackson RR, 2011, J ARACHNOL, V39, P439, DOI 10.1636/Ha11-32.1; Lang A, 1999, AGR ECOSYST ENVIRON, V72, P189, DOI 10.1016/S0167-8809(98)00186-8; Marples NM, 2005, EVOLUTION, V59, P933; MASNER L, 1976, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm10897fv; Mora R, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez021; Mora-Castro Rebeca, 2019, Peckhamia, V194, P1; Mora-Castro R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218061; Nagata T, 2012, SCIENCE, V335, P469, DOI 10.1126/science.1211667; Nelson XJ, 2020, J ETHOL, V38, P185, DOI 10.1007/s10164-020-00639-1; Nelson XJ, 2012, BIOL J LINN SOC, V107, P664, DOI 10.1111/j.1095-8312.2012.01965.x; Nelson XJ, 2012, J EXP BIOL, V215, P2255, DOI 10.1242/jeb.069609; Nelson XJ, 2006, BIOL J LINN SOC, V88, P23, DOI 10.1111/j.1095-8312.2006.00598.x; Powell EC, 2019, ETHOLOGY, V125, P351, DOI 10.1111/eth.12859; Reisenman CE, 2008, ARTHROPOD-PLANT INTE, V2, P137, DOI 10.1007/s11829-008-9041-8; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Sandre SL, 2010, BEHAVIOUR, V147, P1121, DOI 10.1163/000579510X507001; Skelhorn J, 2016, BEHAV ECOL, V27, P955, DOI 10.1093/beheco/arw009; Stevens M, 2012, P ROY SOC B-BIOL SCI, V279, P417, DOI 10.1098/rspb.2011.1932; Tarsitano MS, 1999, ANIM BEHAV, V58, P255, DOI 10.1006/anbe.1999.1138; Taylor LA, 2014, ANIM BEHAV, V90, P149, DOI 10.1016/j.anbehav.2014.01.025; Thery M, 2010, ADV INSECT PHYSIOL, V38, P267, DOI 10.1016/S0065-2806(10)38001-5; Venables WN., 2002, MODERN APPL STAT S 4; Vickers ME, 2018, BEHAV ECOL, V29, P833, DOI 10.1093/beheco/ary068; Wickham H., 2019, TIDYVERSE EASILY INS; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0	44	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0237288	10.1371/journal.pone.0237288	http://dx.doi.org/10.1371/journal.pone.0237288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571212	Green Submitted, Green Published, gold			2022-12-26	WOS:000618274000101
J	Scimone, MT; Krishnamurthy, S; Maguluri, G; Preda, D; Park, J; Grimble, J; Song, M; Ban, KC; Iftimia, N				Scimone, Mark T.; Krishnamurthy, Savitri; Maguluri, Gopi; Preda, Dorin; Park, Jesung; Grimble, John; Song, Min; Ban, Kechen; Iftimia, Nicusor			Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study	PLOS ONE			English	Article							FROZEN-SECTION ANALYSIS; SENTINEL LYMPH-NODE; CONSERVING SURGERY; TOUCH PREPARATION; POSITIVE MARGINS; RE-EXCISION; CONSERVATION; RATES	Providing surgical margin information during breast cancer surgery is crucial for the success of the procedure. The margin is defined as the distance from the tumor to the cut surface of the resection specimen. The consensus among surgeons and radiation oncologists is that there should be no tumor left within 1 to maximum 2 mm from the surface of the surgical specimen. If a positive margin remains, there is substantial risk for tumor recurrence, which may also result in potentially reduced cosmesis and eventual need for mastectomy. In this paper we report a novel multimodal optical imaging instrument based on combined high-resolution confocal microscopy-optical coherence tomography imaging for assessing the presence of potential positive margins on surgical specimens. Since rapid specimen analysis is critical during surgery, this instrument also includes a fluorescence imaging channel to enable rapid identification of the areas of the specimen that have potential positive margins. This is possible by specimen incubation with a cancer specific agent prior to imaging. In this study we used a quenched contrast agent, which is activated by cancer specific enzymes, such as urokinase plasminogen activators (uPA). Using this agent or a similar one, one may limit the use of high-resolution optical imaging to only fluorescence-highlighted areas for visualizing tissue morphology at the sub-cellular scale and confirming or ruling out cancer presence. Preliminary evaluation of this technology was performed on 20 surgical specimens and testing of the optical imaging findings was performed against histopathology. The combination of the three imaging modes allowed for high correlation between optical image analysis and histological ground-truth. The initial results are encouraging, showing instrument capability to assess margins on clinical specimens with a positive predictive value of 1.0 and a negative predictive value of 0.83.	[Scimone, Mark T.; Maguluri, Gopi; Preda, Dorin; Park, Jesung; Grimble, John; Song, Min; Ban, Kechen; Iftimia, Nicusor] Phys Sci Inc, 20 New England Business Ctr, Andover, MA 01810 USA; [Krishnamurthy, Savitri] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Physical Sciences Inc.; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Iftimia, N (corresponding author), Phys Sci Inc, 20 New England Business Ctr, Andover, MA 01810 USA.	iftimia@psicorp.com		Scimone, Mark/0000-0003-0123-3765; Iftimia, Nicusor/0000-0002-7713-6972	US National Cancer Institute [PI 2R44CA173998-02A1]	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Nicusor Iftimia-PI 2R44CA173998-02A1 US National Cancer Institute The funder provided support in the form of salaries for authors [MS, SK, GM, DP, JP, JG, MS, KB, NI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Azu M, 2010, ANN SURG ONCOL, V17, P558, DOI 10.1245/s10434-009-0765-1; Blair SL, 2009, J AM COLL SURGEONS, V209, P608, DOI 10.1016/j.jamcollsurg.2009.07.026; Cendan JC, 2005, J AM COLL SURGEONS, V201, P194, DOI 10.1016/j.jamcollsurg.2005.03.014; COX CE, 1991, ARCH SURG-CHICAGO, V126, P490; Fleming FJ, 2004, EJSO-EUR J SURG ONC, V30, P233, DOI 10.1016/j.ejso.2003.11.008; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Kalinyak JE, 2014, EUR J NUCL MED MOL I, V41, P260, DOI 10.1007/s00259-013-2553-1; Kennedy KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15538; Krishnamurthy S, 2019, ARCH PATHOL LAB MED, V143, P1058, DOI 10.5858/arpa.2019-0058-RA; Maloney BW, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.10.100901; McClatchy DM, 2017, PHYS MED BIOL, V62, P8983, DOI 10.1088/1361-6560/aa94b6; McLaughlin SA, 2008, J AM COLL SURGEONS, V206, P76, DOI 10.1016/j.jamcollsurg.2007.07.021; Mendez JE, 2006, AM J SURG, V192, P538, DOI 10.1016/j.amjsurg.2006.06.009; Menes TS, 2003, ANN SURG ONCOL, V10, P1166, DOI 10.1245/ASO.2003.04.023; Meric F, 2003, CANCER, V97, P926, DOI 10.1002/cncr.11222; Morrow M, 2009, BREAST, V18, pS84, DOI 10.1016/S0960-9776(09)70279-6; Moschetta M, 2015, G CHIR, V36, P201, DOI 10.11138/gchir/2015.36.5.201; Narayanan D, 2011, AM J ROENTGENOL, V196, P971, DOI 10.2214/AJR.10.5081; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Piras D, 2010, IEEE J SEL TOP QUANT, V16, P730, DOI 10.1109/JSTQE.2009.2034870; Qiu SQ, 2018, EJSO-EUR J SURG ONC, V44, P1708, DOI 10.1016/j.ejso.2018.06.022; Savastru D, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.056001; Sharma V, 2012, BIOMED OPT EXPRESS, V3, P1825, DOI 10.1364/BOE.3.001825; Swanson GP, 2002, AM J CLIN ONCOL-CANC, V25, P438, DOI 10.1097/00000421-200210000-00002; Tan JE, 1999, AM J CLIN ONCOL-CANC, V22, P414, DOI 10.1097/00000421-199908000-00020; Thill M, 2011, BREAST, V20, P579, DOI 10.1016/j.breast.2011.08.134; Thomas G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13237-y; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Waljee JF, 2008, ANN SURG ONCOL, V15, P1297, DOI 10.1245/s10434-007-9777-x; Weyers B, 2019, FLUORESCENCE LIFETIM, DOI 10.1002/tbio.201900017; Zhang W, 2013, ONCOL REP, V29, P637, DOI 10.3892/or.2012.2148	31	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245334	10.1371/journal.pone.0245334	http://dx.doi.org/10.1371/journal.pone.0245334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571221	Green Published, gold			2022-12-26	WOS:000618274000027
J	Pham, DX; Ho, TQH; Bui, TD; Ho-Pham, LT; Nguyen, TV				Pham, Dung X.; Ho, Thao-Quyen H.; Bui, Tung D.; Ho-Pham, Lan T.; Nguyen, Tuan, V			Trends in breast cancer incidence in Ho Chi Minh City 1996-2015: A registry-based study	PLOS ONE			English	Article							MORTALITY; ASIA	The burden of breast cancer in Vietnam has not been documented. This study sought to estimate the incidence of breast cancer in Ho Chi Minh City, the largest economic center of Vietnam, from 1996 to 2015. This was a population-based study using the Ho Chi Minh City Cancer Registry as a source of data (coverage period: 1996-2015). The Registry adopted the International Classification of Diseases for Oncology, 3rd Edition for the classification of primary sites and morphology, and guidelines from the International Agency for Research on Cancer and the International Association of Cancer Registries. Using the population statistics from census data of Ho Chi Minh City, the point incidence of breast cancer for 5-year period was estimated. Based on the national population, we calculated the age-standardized rate (ASR) of breast cancer between 1996 and 2015. Overall 14,222 new cases of breast cancer (13,948 women, or 98%) had been registered during the 1996-2015 period; among whom, just over half (52%) were in the 2nd stage and 26% in the 3rd and 4th stages. In women, the median age at diagnosis was 50 years and there was a slight increase over time. The ASR of breast cancer during the 2011-2015 period was 107.4 cases per 100,000 women, representing an increase of 70% compared to the rate during the 1996-2000 period. In men, there was also a significant increase in the ASR: from 1.13 during the 1996-2001 period to 2.32 per 100,000 men during the 2011-2015 period. These very first data from Vietnam suggest that although the incidence of breast cancer in Vietnam remains relatively low, it has increased over time.	[Pham, Dung X.] Ho Chi Minh City Oncol Hosp, Ho Chi Minh City, Vietnam; [Pham, Dung X.] Pham Ngoc Thach Univ Med, Dept Oncol, Ho Chi Minh City, Vietnam; [Ho, Thao-Quyen H.] Univ Med Ctr, Dept Training & Sci Res, Ho Chi Minh City, Vietnam; [Bui, Tung D.] Ho Chi Minh City Oncol Hosp, Dept Healthcare Direct, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.] Pham Ngoc Thach Univ Med, Biomed Res Ctr, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.; Nguyen, Tuan, V] Ton Duc Thang Univ, Bone & Muscle Res Grp, Ho Chi Minh City, Vietnam; [Nguyen, Tuan, V] Garvan Inst Med Res, Bone Biol Div, Sydney, NSW, Australia; [Nguyen, Tuan, V] UNSW Sydney, UNSW Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Nguyen, Tuan, V] Univ Technol Sydney, Sch Biomed Engn, Sydney, NSW, Australia	Ton Duc Thang University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Technology Sydney	Ho-Pham, LT (corresponding author), Pham Ngoc Thach Univ Med, Biomed Res Ctr, Ho Chi Minh City, Vietnam.; Ho-Pham, LT (corresponding author), Ton Duc Thang Univ, Bone & Muscle Res Grp, Ho Chi Minh City, Vietnam.	thuclanhopham@pnt.edu.vn		Ho-Pham, Lan T/0000-0001-8382-5080				(AIHW) AIoHaW, 2019, CANC AUSTR 2019, V119; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Bridges JFP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-227; Czajkowski M, 2008, STAT MED, V27, P1508, DOI 10.1002/sim.3017; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Ferlay J, 2013, IARC CANCERBASE NO 1; Hemminki K, 2011, ONCOLOGIST, V16, P146, DOI 10.1634/theoncologist.2010-0104; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Organisation WH, BREAST CANCER-TOKYO; Park EH, 2017, J BREAST CANCER, V20, P1, DOI 10.4048/jbc.2017.20.1.1; Trieu PD, 2017, CANCER RES TREAT, V49, P990, DOI 10.4143/crt.2016.488; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Quoc NM, 1998, INT J CANCER, V76, P472, DOI 10.1002/(SICI)1097-0215(19980518)76:4&lt;472::AID-IJC5&gt;3.0.CO;2-O; R Core Team, 2020, R LANG ENV STAT COMP; Nguyen SM, 2019, CANCER CONTROL, V26, DOI 10.1177/1073274819865274; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Stanbury JF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2065-z; Stapleton SM, 2018, JAMA SURG, V153, P594, DOI 10.1001/jamasurg.2018.0035; Virani S, 2018, J EPIDEMIOL, V28, P323, DOI [10.2188/jea.je20170045, 10.2188/jea.JE20170045]; Wong FY, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0310-3; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005; Zuo TT, 2017, THORAC CANCER, V8, P214, DOI 10.1111/1759-7714.12426	26	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246800	10.1371/journal.pone.0246800	http://dx.doi.org/10.1371/journal.pone.0246800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566857	gold, Green Submitted, Green Published			2022-12-26	WOS:000618271700046
J	Sahni, PS; Singh, K; Sharma, N; Garg, R				Sahni, Pooja Swami; Singh, Kamlesh; Sharma, Nitesh; Garg, Rahul			Yoga an effective strategy for self-management of stress-related problems and wellbeing during COVID19 lockdown: A cross-sectional study	PLOS ONE			English	Article								This cross-sectional research aims to study the effect of yoga practice on the illness perception, and wellbeing of healthy adults during 4-10 weeks of lockdown due to COVID19 outbreak. A total of 668 adults (64.7% males, M = 28.12 years, SD = 9.09 years) participated in the online survey. The participants were grouped as; yoga practitioners, other spiritual practitioners, and non-practitioners based on their responses to daily practices that they follow. Yoga practitioners were further examined based on the duration of practice as; long-term, mid-term and beginners. Multivariate analysis indicates that yoga practitioners had significantly lower depression, anxiety, & stress (DASS), and higher general wellbeing (SWGB) as well as higher peace of mind (POMS) than the other two groups. The results further revealed that the yoga practitioners significantly differed in the perception of personal control, illness concern and emotional impact of COVID19. However, there was no significant difference found for the measure of resilience (BRS) in this study. Yoga practitioners also significantly differed in the cognitive reappraisal strategy for regulating their emotions than the other two groups. Interestingly, it was found that beginners -those who had started practicing yoga only during the lockdown period reported no significant difference for general wellbeing and peace of mind when compared to the mid-term practitioner. Evidence supports that yoga was found as an effective self- management strategy to cope with stress, anxiety and depression, and maintain wellbeing during COVID19 lockdown.	[Sahni, Pooja Swami; Singh, Kamlesh; Sharma, Nitesh; Garg, Rahul] Indian Inst Technol Delhi, Natl Resource Ctr Value Educ Engn, Noida, India; [Singh, Kamlesh] Indian Inst Technol Delhi, Dept Humanities & Social Sci, New Delhi, India; [Garg, Rahul] Indian Inst Technol Delhi, Dept Comp Sci & Engn, New Delhi, India; [Garg, Rahul] Indian Inst Technol Delhi, Amar Nath & Shahsi Khosla Sch Informat Technol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sahni, PS (corresponding author), Indian Inst Technol Delhi, Natl Resource Ctr Value Educ Engn, Noida, India.	pooja.sahni@nrcvee.iitd.ac.in		SINGH, KAMLESH/0000-0002-2306-4459; Sahni, Pooja/0000-0003-0592-0503				Atkinson NL, 2009, AM J HEALTH BEHAV, V33, P3; Bhatia T, 2020, INT YOGA DAY 2020 WH; Boyraz G, 2020, J LOSS TRAUMA, V25, P503, DOI 10.1080/15325024.2020.1763556; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Bussing A, EVIDENCE BASED COMPL; Cowen VS, 2005, J BODYW MOV THER, V9, P211, DOI 10.1016/j.jbmt.2004.08.001; Davis TJ, 2016, PERS INDIV DIFFER, V96, P115, DOI 10.1016/j.paid.2016.02.080; Desikachar K, 2005, INT J YOGA THER, V15, P17, DOI [10.17761/ijyt.15.1.p501l33535230737, DOI 10.17761/IJYT.15.1.P501L33535230737]; Geuens M, 2002, PSYCHOL REP, V91, P657, DOI 10.2466/PR0.91.6.657-670; Goyal Rajni, 2014, Int J Appl Basic Med Res, V4, P67, DOI 10.4103/2229-516X.136776; Grant AM, 2009, J POSIT PSYCHOL, V4, P396, DOI 10.1080/17439760902992456; Gross J, 2003, NEUROIMAGE, V48, P9, DOI [10.1037/t06463-000, DOI 10.1037/T06463-000, DOI 10.1037/0022-3514.85.2.348]; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Grossi E, 2019, CULT MED PSYCHIAT, V43, P4, DOI 10.1007/s11013-018-9593-8; Grover S, 2020, INDIAN J PSYCHIAT, V62, P354, DOI 10.4103/psychiatry.IndianJPsychiatry_427_20; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IGLEWICZ B, 1987, J QUAL TECHNOL, V19, P180, DOI 10.1080/00224065.1987.11979063; Kirkwood G, 2005, BRIT J SPORT MED, V39, P884, DOI 10.1136/bjsm.2005.018069; Lamiani G, 2015, HAEMOPHILIA, V21, P598, DOI 10.1111/hae.12654; Lau R. R., 1983, HEALTH PSYCHOL, V2, P167, DOI [10.1037/0278-6133.2.2.167, DOI 10.1037/0278-6133.2.2.167]; Lee Y-C, 2014, PSYCTESTS DATASET, DOI [10.1037/t32371-000, DOI 10.1037/T32371-000]; Lepherd L, 2020, J RELIG SPIRITUAL A, V32, P306; Leventhal H., 1984, HDB PSYCHOL HLTH, P219, DOI DOI 10.1201/9781003044307-9; Longo Y, 2017, PERS INDIV DIFFER, V109, P148, DOI 10.1016/j.paid.2017.01.005; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Meyers L. S., 2013, PERFORMING DATA ANAL; Miceli J, 2019, PSYCHO-ONCOLOGY, V28, P1513, DOI 10.1002/pon.5108; Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018; Nagendra HR, 2020, INT J YOGA, V13, P87, DOI 10.4103/ijoy.IJOY_27_20; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Rehman U, 2021, COMMUNITY MENT HLT J, V57, P42, DOI 10.1007/s10597-020-00664-x; Segal DL, 2007, AGING MENT HEALTH, V11, P415, DOI 10.1080/13607860600963588; Selamu M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2370-5; Shaikh S, 2013, INDIAN J PHYSIOTHERA, P207, DOI [10.5958/j.0973-5674.7.2.042, DOI 10.5958/J.0973-5674.7.2.042]; Singh K, 2016, INT J INDIAN PSYCHOL, V4, P5, DOI [10.4103/0972-2327.194419, DOI 10.4103/0972-2327.194419]; Singh K., 2014, POSITIVE NATIONS COM; Singh K., 2016, INDIAN J CLIN PSYCHO, V43, P58; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Smith C, 2007, COMPLEMENT THER MED, V15, P77, DOI 10.1016/j.ctim.2006.05.001; Stickley A, 2015, J AFFECT DISORDERS, V178, P142, DOI 10.1016/j.jad.2015.02.020; Tabachnick B., 2007, USING MULTIVARIATE S, V3, P402; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Van Hoof E, 2020, WORLD EC FORUM, V9; Vos RC, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0720-y; Williams L, 2011, J PSYCHOSOM RES, V70, P141, DOI 10.1016/j.jpsychores.2010.07.015; Woodyard Catherine, 2011, Int J Yoga, V4, P49, DOI 10.4103/0973-6131.85485; Yusoff MSB, 2013, ASIAN J PSYCHIATR, V6, P60, DOI 10.1016/j.ajp.2012.09.001; Zammuner VL, 2005, INT REV PSYCHIATR, V17, P355, DOI 10.1080/09540260500238348	49	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245214	10.1371/journal.pone.0245214	http://dx.doi.org/10.1371/journal.pone.0245214			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566848	Green Published, gold			2022-12-26	WOS:000618271700017
J	Sene, LD; Scarano, WR; Zapparoli, A; Gontijo, JAR; Boer, PA				Sene, Leticia de Barros; Scarano, Wellerson Rodrigo; Zapparoli, Adriana; Rocha Gontijo, Jose Antonio; Boer, Patricia Aline			Impact of gestational low-protein intake on embryonic kidney microRNA expression and in nephron progenitor cells of the male fetus	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; GENE-EXPRESSION; BETA-CATENIN; MESENCHYMAL TRANSITION; METANEPHRIC MESENCHYME; MYC; FETAL; PROLIFERATION; PODOCYTE; LET-7	Background Here, we have demonstrated that gestational low-protein (LP) intake offspring present lower birth weight, reduced nephron numbers, renal salt excretion, arterial hypertension, and renal failure development compared to regular protein (NP) intake rats in adulthood. We evaluated the expression of various miRNAs and predicted target genes in the kidney in gestational 17-days LP (DG-17) fetal metanephros to identify molecular pathways involved in the proliferation and differentiation of renal embryonic or fetal cells. Methods Pregnant Wistar rats were classified into two groups based on protein supply during pregnancy: NP (regular protein diet, 17%) or LP diet (6%). Renal miRNA sequencing (miRNA-Seq) performed on the MiSeq platform, RT-qPCR of predicted target genes, immunohistochemistry, and morphological analysis of 17-DG NP and LP offspring were performed using previously described methods. Results A total of 44 miRNAs, of which 19 were up and 25 downregulated, were identified in 17-DG LP fetuses compared to age-matched NP offspring. We selected 7 miRNAs involved in proliferation, differentiation, and cellular apoptosis. Our findings revealed reduced cell number and Six-2 and c-Myc immunoreactivity in metanephros cap (CM) and ureter bud (UB) in 17-DG LP fetuses. Ki-67 immunoreactivity in CM was 48% lesser in LP compared to age-matched NP fetuses. Conversely, in LP CM and UB, beta-catenin was 154%, and 85% increased, respectively. Furthermore, mTOR immunoreactivity was higher in LP CM (139%) and UB (104%) compared to that in NP offspring. TGF beta-1 positive cells in the UB increased by approximately 30% in the LP offspring. Moreover, ZEB1 metanephros-stained cells increased by 30% in the LP offspring. ZEB2 immunofluorescence, although present in the entire metanephros, was similar in both experimental groups. Conclusions Maternal protein restriction changes the expression of miRNAs, mRNAs, and proteins involved in proliferation, differentiation, and apoptosis during renal development. Renal ontogenic dysfunction, caused by maternal protein restriction, promotes reduced reciprocal interaction between CM and UB; consequently, a programmed and expressive decrease in nephron number occurs in the fetus.	[Sene, Leticia de Barros; Zapparoli, Adriana; Rocha Gontijo, Jose Antonio; Boer, Patricia Aline] Univ Estadual Campinas, Fetal Programming & Hydroelectrolyte Metab Lab, Nucleus Med & Expt Surg, Dept Internal Med,Fac Med Sci, Campinas, SP, Brazil; [Scarano, Wellerson Rodrigo] Sao Paulo State Univ, Biosci Inst, Dept Struct & Funct Biol, Botucatu, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual Paulista	Boer, PA (corresponding author), Univ Estadual Campinas, Fetal Programming & Hydroelectrolyte Metab Lab, Nucleus Med & Expt Surg, Dept Internal Med,Fac Med Sci, Campinas, SP, Brazil.	boer@fcm.unicamp.br	Zapparoli, Adriana/ABE-4385-2021; Gontijo, José/AAW-2644-2021; Boer, Patrícia A/P-4435-2014	Gontijo, Jose/0000-0002-4658-385X; Scarano, Wellerson Rodrigo/0000-0002-6682-2934	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/12486-5, 2014/50938-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [465699/2014-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2013/12486-5 and 2014/50938-8), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 465699/2014-6).	Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boivin FJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00081; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Bridgewater D, 2011, J AM SOC NEPHROL, V22, P718, DOI 10.1681/ASN.2010050562; Brodbeck S, 2004, MECH DEVELOP, V121, P1211, DOI 10.1016/j.mod.2004.05.019; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerqueira DM, 2017, FASEB J, V31, P3540, DOI 10.1096/fj.201700010R; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chen JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080266; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Chu JYS, 2014, AM J PHYSIOL-RENAL, V306, pF764, DOI 10.1152/ajprenal.00426.2013; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Couillard M, 2009, DEV DYNAM, V238, P405, DOI 10.1002/dvdy.21841; Davis EM, 2014, MATERN CHILD HLTH J, V18, P554, DOI 10.1007/s10995-013-1272-3; Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748; Fogelgren B, 2009, AM J PHYSIOL-RENAL, V296, pF1166, DOI 10.1152/ajprenal.90550.2008; GROBSTEIN C, 1955, J EXP ZOOL, V130, P319, DOI 10.1002/jez.1401300207; Guerke J, 2016, REPRODUCTION, V151, P465, DOI 10.1530/REP-15-0523; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kopan R, 2014, CURR TOP DEV BIOL, V107, P293, DOI 10.1016/B978-0-12-416022-4.00011-1; Langley-Evans SC, 2006, P NUTR SOC, V65, P97, DOI 10.1079/PNS2005478; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Lv XY, 2014, CELL BIOCHEM FUNCT, V32, P571, DOI 10.1002/cbf.3052; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; Marrone AK, 2014, PEDIATR NEPHROL, V29, P565, DOI 10.1007/s00467-013-2599-0; Menendez-Castro C, 2014, PEDIATR RES, V75, P697, DOI 10.1038/pr.2014.27; Menendez-Castro C, 2013, NEPHROL DIAL TRANSPL, V28, P1407, DOI 10.1093/ndt/gfs517; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Mesquita FF, 2010, NEPHROL DIAL TRANSPL, V25, P380, DOI 10.1093/ndt/gfp505; Meza-Sosa KF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00175; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Nagalakshmi VK, 2015, DEV DYNAM, V244, P444, DOI 10.1002/dvdy.24221; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Nijland MJ, 2007, J PHYSIOL-LONDON, V579, P643, DOI 10.1113/jphysiol.2006.122101; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pan CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039151; Pan XC, 2017, DEVELOPMENT, V144, P4173, DOI 10.1242/dev.153700; Phua YL, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12537; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schreuder M, 2006, KIDNEY BLOOD PRESS R, V29, P108, DOI 10.1159/000094538; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Sene LB, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.171694; Sene LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071310; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sun LJ, 2015, MED SCI MONITOR, V21, P195, DOI 10.12659/MSM.892141; Wang P, 2018, CELL REP, V24, P3554, DOI 10.1016/j.celrep.2018.08.056; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xiang C, 2016, J HUAZHONG U SCI-MED, V36, P186, DOI 10.1007/s11596-016-1564-0; Yermalovich AV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08127-4	77	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246289	10.1371/journal.pone.0246289	http://dx.doi.org/10.1371/journal.pone.0246289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544723	Green Submitted, Green Published, gold			2022-12-26	WOS:000617991900051
J	Xia, L; He, G; Feng, Y; Yu, XX; Zhao, XL; Yin, SK; Chen, ZN; Wang, J; Fan, JG; Dong, C				Xia, Li; He, Gang; Feng, Yong; Yu, Xiaoxu; Zhao, Xiaolong; Yin, Shankai; Chen, Zhengnong; Wang, Jian; Fan, Jiangang; Dong, Chuan			COVID-19 associated anxiety enhances tinnitus	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; MENTAL-DISORDERS; CLINICAL-TRIALS; LIMBIC SYSTEM; SOUND THERAPY; D PERSONALITY; PREVALENCE; VALIDATION; DEPRESSION; QUALITY	To investigate if the anxiety associated with coronavirus disease 2019 (COVID-19) is a promoting factor to tinnitus. A retrospective research design collected from 188 tinnitus patients, was used to compare the clinical characteristics of tinnitus between the patients in 2020 under pandemic pressure and those from the matching period in 2019. While anxiety was quantified using the Zung's Self-rating Anxiety Scale (SAS), tinnitus severity was evaluated using the Tinnitus Handicap Inventory (THI) questionnaire and the test of tinnitus loudness (TL). The assessments were repeated after the sound therapy plus educational counselling (STEC) for 38 patients in 2020 and 58 patients in 2019 and compared with EC alone therapy for 42 patients in 2020 and 17 patients in 2019. A large increase in anxiety was evident in 2020 in both case rate and SAS. The treatment of both methods was less effective in 2020. SAS, THI and TL were all deteriorated after the EC alone treatment in 2020, while an improvement was seen in 2019. This suggests that EC alone could not counteract the stress by COVID-19 at all, and the stress, if not managed well, can significantly increase the severity of tinnitus and associated anxiety. By using the EC subgroup in virtual control, we conclude that anxiety can serve as a promoting factor to tinnitus. We believe that this is the first study report that confirm the causative/promotive role of anxiety on tinnitus during COVID-19 pandemic.	[Xia, Li] Mianyang Cent Hosp, Dept Otolaryngol Head & Neck Surg, Mianyang, Sichuan, Peoples R China; [He, Gang; Feng, Yong; Yu, Xiaoxu; Zhao, Xiaolong; Fan, Jiangang; Dong, Chuan] Sichuan Prov Peoples Hosp, Dept Otolaryngol Head & Neck Surg, Chengdu, Sichuan, Peoples R China; [He, Gang; Feng, Yong; Yu, Xiaoxu; Zhao, Xiaolong; Fan, Jiangang; Dong, Chuan] Sichuan Acad Med Sci, Chengdu, Sichuan, Peoples R China; [Yin, Shankai; Chen, Zhengnong] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Wang, Jian] Dalhousie Univ, Sch Commun Sci & Disorders, Halifax, NS, Canada	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Shanghai Jiao Tong University; Dalhousie University	Fan, JG; Dong, C (corresponding author), Sichuan Prov Peoples Hosp, Dept Otolaryngol Head & Neck Surg, Chengdu, Sichuan, Peoples R China.; Fan, JG; Dong, C (corresponding author), Sichuan Acad Med Sci, Chengdu, Sichuan, Peoples R China.; Wang, J (corresponding author), Dalhousie Univ, Sch Commun Sci & Disorders, Halifax, NS, Canada.	jian.wang@dal.ca; entscfjg@163.com; dc1220@sina.com		Zhao, Xiao long/0000-0003-2356-272X; Wang, Jian/0000-0003-3633-6799	Health and Family Planning Commission of Sichuan Province of China [18PJ078]; National Natural Science Foundation of China [81770998]; Natural Science & Engineering Research Council of Canada [RGPIN 2017-04493]	Health and Family Planning Commission of Sichuan Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science & Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by Health and Family Planning Commission of Sichuan Province of China [18PJ078] for C.D., the National Natural Science Foundation of China [81770998] for Z.C. and Natural Science & Engineering Research Council of Canada [RGPIN 2017-04493] for J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2006, PLOS MED, V3, pe252; [Anonymous], 2015, BMJ, V2015, ph1887; Arif M, 2017, J LARYNGOL OTOL, V131, P501, DOI 10.1017/S002221511700069X; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Bartels H, 2010, OTOL NEUROTOL, V31, P11, DOI 10.1097/MAO.0b013e3181bc3dd1; Bartels H, 2010, PSYCHOSOMATICS, V51, P29, DOI 10.1176/appi.psy.51.1.29; Bauer CA, 2018, NEW ENGL J MED, V378, P1224, DOI 10.1056/NEJMcp1506631; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Brennan-Jones CG, 2020, INT J AUDIOL, V59, P161, DOI 10.1080/14992027.2019.1643503; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chen YC, 2017, HUM BRAIN MAPP, V38, P2384, DOI 10.1002/hbm.23525; Danioth L, 2020, J PSYCHOSOM RES, V135, DOI 10.1016/j.jpsychores.2020.110155; Dunstan DA, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-019-2427-6; Durai M, 2016, INT J AUDIOL, V55, P605, DOI 10.1080/14992027.2016.1198966; Gao LL, 2011, RES NURS HEALTH, V34, P49, DOI 10.1002/nur.20400; Henry J A, 2000, J Am Acad Audiol, V11, P138; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X; Ilkkaya NK, 2014, J PERIANESTH NURS, V29, P418, DOI 10.1016/j.jopan.2014.05.008; Jakovljevic M, 2020, PSYCHIAT DANUB, V32, P6, DOI 10.24869/psyd.2020.6; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; Jastreboff PJ, 1996, AM J OTOL, V17, P236; Kam ACS, 2009, CLIN OTOLARYNGOL, V34, P309, DOI 10.1111/j.1749-4486.2009.01946.x; Kapolowicz MR, 2020, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00088; Langguth B, 2015, CURR OPIN OTOLARYNGO, V23, P361, DOI 10.1097/MOO.0000000000000185; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Leaver AM, 2016, HEARING RES, V334, P49, DOI 10.1016/j.heares.2015.08.005; Liu NN, 2020, CURRENT CANC DRUG TA, DOI [10.2174/156800962066620041415141932286947, DOI 10.2174/156800962066620041415141932286947]; Liu YQ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6032525; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Lugo A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65395-1; Mahboubi H, 2017, ANN OTO RHINOL LARYN, V126, P681, DOI 10.1177/0003489417725093; Mahboubi Hossein, 2012, Int Tinnitus J, V17, P26; Malouff JM, 2011, CURR PSYCHIAT REP, V13, P31, DOI 10.1007/s11920-010-0163-1; Manchaiah V, 2018, J AM ACAD AUDIOL, V29, P936, DOI 10.3766/jaaa.17094; Mazurek B, 2019, OTOL NEUROTOL, V40, pE467, DOI 10.1097/MAO.0000000000002180; McKenna L, 2017, PSYCHOTHER PSYCHOSOM, V86, P351, DOI 10.1159/000478267; Meng ZL, 2012, CLIN EXP OTORHINOLAR, V5, P10, DOI 10.3342/ceo.2012.5.1.10; Newman CW, 2008, OTOL NEUROTOL, V29, P276, DOI 10.1097/MAO.0b013e31816569c4; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Park E, 2019, CLIN EXP OTORHINOLAR, DOI [10.21053/ceo.2019.0056331842535, DOI 10.21053/CEO.2019.0056331842535]; Park E, 2020, CLIN EXP OTORHINOLAR, V13, P234, DOI 10.21053/ceo.2019.00563; Park JM, 2018, ACTA OTO-LARYNGOL, V138, P135, DOI 10.1080/00016489.2017.1386801; Pattyn T, 2016, HEARING RES, V333, P255, DOI 10.1016/j.heares.2015.08.014; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Probst T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31166; Probst T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20382; Raghavan P, 2016, NEUROIMAG CLIN N AM, V26, P301, DOI 10.1016/j.nic.2015.12.008; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Schlee W, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00294; Trevis KJ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01262; Trevis KJ, 2016, J AFFECT DISORDERS, V204, P234, DOI 10.1016/j.jad.2016.06.055; Tyler R S, 1992, Am J Audiol, V1, P36, DOI 10.1044/1059-0889.0104.36; Tyler R, 2014, AM J AUDIOL, V23, P260, DOI 10.1044/2014_AJA-13-0014; Tyler RS, 2006, ACTA OTO-LARYNGOL, V126, P44, DOI 10.1080/03655230600895424; Tyler RS, 2020, J AM ACAD AUDIOL, V31, P6, DOI 10.3766/jaaa.18027; Tyler RS, 2007, PROG BRAIN RES, V166, P499, DOI 10.1016/S0079-6123(07)66048-8; Tyler RS, 2006, ORL-J OTO-RHIN-LARYN, V68, P14, DOI 10.1159/000090486; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; Tyler RS, 2014, HEARING J, V67, DOI [10.1097/01.HJ.0000442741.34475.9424910497, DOI 10.1097/01.HJ.0000442741.34475.9424910497]; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu KL, 2020, MED SCI MONIT BASIC, V26, DOI 10.12659/MSMBR.924085; Xu YP, 2016, EUR ARCH OTO-RHINO-L, V273, P3063, DOI 10.1007/s00405-016-3906-8; Zhang J, 2015, EUR J RADIOL, V84, P1277, DOI 10.1016/j.ejrad.2015.04.006; Ziai Kasra, 2017, Int Tinnitus J, V21, P68, DOI 10.5935/0946-5448.20170013; Zirke N, 2013, QUAL LIFE RES, V22, P263, DOI 10.1007/s11136-012-0156-0; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	74	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246328	10.1371/journal.pone.0246328	http://dx.doi.org/10.1371/journal.pone.0246328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544744	gold, Green Published, Green Submitted			2022-12-26	WOS:000617991900040
J	Ahinkorah, BO; Kang, M; Perry, L; Brooks, F; Hayen, A				Ahinkorah, Bright Opoku; Kang, Melissa; Perry, Lin; Brooks, Fiona; Hayen, Andrew			Prevalence of first adolescent pregnancy and its associated factors in sub-Saharan Africa: A multi-country analysis	PLOS ONE			English	Article							EARLY SEXUAL DEBUT; STUDENTS; BEHAVIOR; ABORTION; HEALTH	Introduction In low-and middle-income countries, pregnancy-related complications are major causes of death for young women. This study aimed to determine the prevalence of first adolescent pregnancy and its associated factors in sub-Saharan Africa. Methods We undertook a secondary analysis of cross-sectional data from Demographic and Health Surveys conducted in 32 sub-Saharan African countries between 2010 and 2018. We calculated the prevalence of first adolescent (aged 15 to 19 years) pregnancy in each country and examined associations between individual and contextual level factors and first adolescent pregnancy. Results Among all adolescents, Congo experienced the highest prevalence of first adolescent pregnancy (44.3%) and Rwanda the lowest (7.2%). However, among adolescents who had ever had sex, the prevalence ranged from 36.5% in Rwanda to 75.6% in Chad. The odds of first adolescent pregnancy was higher with increasing age, working, being married/cohabiting, having primary education only, early sexual initiation, knowledge of contraceptives, no unmet need for contraception and poorest wealth quintile. By contrast, adolescents who lived in rural areas and in the West African sub-region had lower odds of first adolescent pregnancy. Conclusion The prevalence of adolescent pregnancy in sub-Saharan African countries is high. Understanding the predictors of first adolescent pregnancy can facilitate the development of effective social policies such as family planning and comprehensive sex and relationship education in sub-Saharan Africa and can help ensure healthy lives and promotion of well-being for adolescents and their families and communities.	[Ahinkorah, Bright Opoku; Kang, Melissa] Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Ultimo, NSW, Australia; [Perry, Lin; Brooks, Fiona; Hayen, Andrew] Univ Technol Sydney, Fac Hlth, Ultimo, NSW, Australia	University of Technology Sydney; University of Technology Sydney	Ahinkorah, BO (corresponding author), Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Ultimo, NSW, Australia.	bright.o.ahinkorah@student.uts.edu.au		Hayen, Andrew/0000-0003-4046-8030				Ahinkorah B. O, 2019, J PUBLIC HLTH, P1, DOI DOI 10.1093/PUBMED/FDZ02730973958; Ahinkorah BO, 2022, INT J HEALTH POLICY, V11, P726, DOI 10.34172/ijhpm.2020.185; Ahinkorah BO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236352; Ahinkorah BO, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00382; Ajayi AI, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3707-4; Aliaga A, 2006, CLUSTER OPTIMAL SAMP; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Appiah F, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100554; Asare BY-A, 2019, INT J AFR NURS SCI, V10, P87, DOI DOI 10.1016/J.IJANS.2019.02.001; Awusabo-Asare K, 2017, PAPER PRACTICE SEXUA, DOI 10.1371/journal.pone.0185829 29020099; Ayele BGK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200898; Baatsen P, 2018, SITUATION TEENAGE PR; Baumgartner JN, 2009, INT PERSPECT SEX R H, V35, P21, DOI 10.1363/ifpp.35.021.09; Boamah EA, 2014, OPEN ACCESS J CONTR, V5, P7, DOI 10.2147/OAJC.S56485; Breuner CC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1348; Carter D, 2012, AM J NURS, V112, P15, DOI 10.1097/01.NAJ.0000412622.87884.a3; Casey SE, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003086; Collins RL, 2010, WR761 RAND HLTH; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; de Groot R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5166-6; DeVito J, 2010, J PERINAT EDUC, V19, P25, DOI 10.1624/105812410X495523; Donatus L, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.138.16888; Durowade KA, 2017, AFR HEALTH SCI, V17, P614, DOI 10.4314/ahs.v17i3.3; Gemzell-Danielsson K, 2015, WOMENS HEALTH, V11, P779, DOI 10.2217/whe.15.72; Glassman AL, 2012, CTR GLOBAL DEV WORKI; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Grindlay K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201663; Gronvik T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204327; Gunawardena N, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001499; Guzzo KB, 2019, POPUL RES POLICY REV, V38, P125, DOI 10.1007/s11113-018-9499-8; Habito CM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7451-4; Hindin MJ, 2016, B WORLD HEALTH ORGAN, V94, P159, DOI 10.2471/BLT.16.170688; ICF International, 2012, DEM HLTH SURV SAMPL; (ISTEEBU) IdSedEEdB (MSPLS) MdlSPedlLclSB International I, 2012, ENQ DEM SANT 2010; Kassa GM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0640-2; Kebede Awoke, 2018, BMC Res Notes, V11, P88, DOI 10.1186/s13104-018-3199-7; Landry M, 2013, AM J HEALTH BEHAV, V37, P422, DOI 10.5993/AJHB.37.3.15; Maness SB, 2016, PUBLIC HEALTH REP, V131, P86, DOI 10.1177/003335491613100115; Masemola-Yende J P F, 2015, Curationis, V38, P1540, DOI 10.4102/curationis.v38i2.1540; Mehra D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5586-3; Merdad L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189416; Munakampe MN, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3722-5; Nalwadda G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-530; Neal S, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01251-y; Neal S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195731; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Odejimi O, 2014, J HUMAN GROWTH DEV, V24, P135; Odimegwu C, 2016, AFR J REPROD HEALTH, V20, P94, DOI 10.29063/ajrh2016/v20i3.14; Olukoya AA, 2001, INT J GYNECOL OBSTET, V75, P137, DOI 10.1016/S0020-7292(01)00370-8; Petroni S, 2017, ANN GLOB HEALTH, V83, P781, DOI 10.1016/j.aogh.2017.09.001; Phillips SJ, 2016, INT J GYNECOL OBSTET, V132, P1, DOI 10.1016/j.ijgo.2015.10.005; Poudel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202107; Pradhan R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020229; Psaki Stephanie R., 2016, PROSPECTS, V46, P109; Sama CB, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0650-0; Sanchez-Paez DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221178; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Sheldon T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5930; Sidze EM., 2017, PAPER PRACTICE SEXUA; Solanke BL, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0093-1; UN, 2015, SUSTAINABLE DEV GOAL; UNFPA, 2013, ADOLESCENT PREGNANCY; UNFPA, 2013, MOTHERHOOD CHILDHOOD; UNICEF, 2020, CHILD MARRIAGE2020; UNICEF, 2015, CHILD MARRIAGE ADOLE; UNICEF, 2014, END CHILD MARR PROGR; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN, DOI DOI 10.1017/CBO9781107415324.004; Wado YD, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2204-z; Weisband YL, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0307-4; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World atlas, WORLD FACTS HIGH TEE; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4; Yaya S, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0219-1; Yi SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-477; Zaw PPT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1122	76	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246308	10.1371/journal.pone.0246308	http://dx.doi.org/10.1371/journal.pone.0246308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF5UW	33539394	Green Published, gold, Green Submitted			2022-12-26	WOS:000616960200018
J	Kun-Szabo, F; Gheorghita, D; Ajtai, T; Hodovany, S; Bozoki, Z; Braunitzer, G; Antal, MA				Kun-Szabo, Fruzsina; Gheorghita, Dorottya; Ajtai, Tibor; Hodovany, Szabolcs; Bozoki, Zoltan; Braunitzer, Gabor; Antal, Mark Adam			Aerosol generation and control in the dental operatory: An in vitro spectrometric study of typical clinical setups	PLOS ONE			English	Article							INFECTION-CONTROL; CONTAMINATION; SPLATTER	Dental turbines and scalers, used every day in dental operatories, feature built-in water spray that generates considerable amounts of water aerosol. The problem is that it is not exactly known how much. Since the outbreak of COVID-19, several aerosol safety recommendations have been issued-based on little empirical evidence, as almost no data are available on the exact aerosol concentrations generated during dental treatment. Similarly, little is known about the differences in the efficacy of different commercially available aerosol control systems to reduce in-treatment aerosol load. In this in vitro study, we used spectrometry to explore these questions. The time-dependent effect of conventional airing on aerosol concentrations was also studied. Everyday patient treatment situations were modeled. The test setups were defined by the applied instrument and its spray direction (high-speed turbine with direct/indirect airspray or ultrasonic scaler with indirect airspray) and the applied aerosol control system (the conventional high-volume evacuator or a lately introduced aerosol exhaustor). Two parameters were analyzed: total number concentration in the entire measurement range of the spectrometer and total number concentration within the 60 to 384 nm range. The results suggest that instrument type and spray direction significantly influence the resulting aerosol concentrations. Aerosol generation by the ultrasonic scaler is easily controlled. As for the high-speed turbine, the efficiency of control might depend on how exactly the instrument is used during a treatment. The results suggest that scenarios where the airspray is frequently directed toward the air of the operatory are the most difficult to control. The tested control systems did not differ in their efficiency, but the study could not provide conclusive results in this respect. With conventional airing through windows with a standard fan, a safety airing period of at least 15 minutes between treatments is recommended.	[Kun-Szabo, Fruzsina; Ajtai, Tibor; Hodovany, Szabolcs; Bozoki, Zoltan] Univ Szeged, Fac Sci & Informat, Dept Opt & Quantum Elect, Szeged, Hungary; [Gheorghita, Dorottya; Antal, Mark Adam] Univ Szeged, Fac Dent, Dept Esthet & Operat Dent, Szeged, Hungary; [Braunitzer, Gabor] DicomLAB Dent Ltd, Dept Res, Szeged, Hungary	Szeged University; Szeged University	Antal, MA (corresponding author), Univ Szeged, Fac Dent, Dept Esthet & Operat Dent, Szeged, Hungary.	antal.mark@szte.hu	Antal, Mark Adam/AAB-3996-2022	Antal, Mark/0000-0002-4109-9356	Hungarian National Research, Development and Innovation Office [TKP program] [NKFIH-1279-2/2020]; Hungarian Academy of Sciences [Janos Bolyai Research Scholarship]; European Commission [GINOP-2.3.2-15-2016-00036];  [UNKP-20-5]	Hungarian National Research, Development and Innovation Office [TKP program](National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Academy of Sciences [Janos Bolyai Research Scholarship]; European Commission(European CommissionEuropean Commission Joint Research Centre); 	This work was supported by the Hungarian National Research, Development and Innovation Office [NKFIH-1279-2/2020 of TKP program], the Hungarian Academy of Sciences [Janos Bolyai Research Scholarship] and UNKP-20-5 New excellence program of the and by the European Commission [GINOP-2.3.2-15-2016-00036]. dicomLAB, Ltd. did not support this work in any way.	Burton J F, 1990, Int Dent J, V40, P303; Centers for Disease Control and Prevention, 2020, INT INF PREV CONTR G; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; Desarda Hitesh, 2014, J Dent Res Dent Clin Dent Prospects, V8, P176, DOI 10.5681/joddd.2014.032; Devker Nihal R, 2012, J Contemp Dent Pract, V13, P681; GRENIER D, 1995, APPL ENVIRON MICROB, V61, P3165, DOI 10.1128/AEM.61.8.3165-3168.1995; Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207; Harrel SK, 1998, J AM DENT ASSOC, V129, P1241, DOI 10.14219/jada.archive.1998.0421; Harrel Stephen K, 2004, J Calif Dent Assoc, V32, P901; Holloman JL, 2015, J AM DENT ASSOC, V146, P27, DOI 10.1016/j.adaj.2014.10.001; Kohn WG, 2004, J AM DENT ASSOC, V135, P33, DOI 10.14219/jada.archive.2004.0019; Lee SA, 2016, J HEALTHC ENG, V2016, DOI 10.1155/2016/8572493; Leung WWF, 2020, SEP PURIF TECHNOL, V245, DOI 10.1016/j.seppur.2020.116887; McMichael TM, 2020, MMWR-MORBID MORTAL W, V69, P339, DOI 10.15585/mmwr.mm6912e1; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; Narayana T V, 2016, J Oral Maxillofac Pathol, V20, P59, DOI 10.4103/0973-029X.180931; O'Donnell MJ, 2005, J HOSP INFECT, V59, P348, DOI 10.1016/j.jhin.2004.10.001; Rupf S, 2015, CLIN ORAL INVEST, V19, P823, DOI 10.1007/s00784-014-1300-8; Spagnuolo G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062094; Van Doremalen N., 2020, AEROSOL SURFACE STAB, DOI 10.1101/2020.03.09.20033217	20	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246543	10.1371/journal.pone.0246543	http://dx.doi.org/10.1371/journal.pone.0246543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539439	Green Accepted, Green Published, gold			2022-12-26	WOS:000616960200026
J	Lee, Y; Thieme, T; Kim, H				Lee, Yerim; Thieme, Thomas; Kim, Hyojoong			Complex evolution in Aphis gossypii group (Hemiptera: Aphididae), evidence of primary host shift and hybridization between sympatric species	PLOS ONE			English	Article							MYZUS-PERSICAE HEMIPTERA; PEA APHID; MICROSATELLITE LOCI; LIFE-CYCLES; ECOLOGICAL SPECIALIZATION; POPULATION-STRUCTURE; GENOTYPIC DIVERSITY; ASEXUAL POPULATIONS; GENETIC-DIVERGENCE; SOYBEAN APHID	Aphids provide a good model system to understand the ecological speciation concept, since the majority of the species are host-specific, and they spend their entire lifecycle on certain groups of host plants. Aphid species that apparently have wide host plant ranges have often turned out to be complexes of host-specialized biotypes. Here we investigated the various host-associated populations of the two recently diverged species, Aphis gossypii and A. rhamnicola, having multiple primary hosts, to understand the complex evolution with host-associated speciation. Using mitochondrial DNA marker and nine microsatellite loci, we reconstructed the haplotype network, and analyzed the genetic structure and relationships. Approximate Bayesian computation was also used to infer the ancestral primary host and host-associated divergence, which resulted in Rhamnus being the most ancestral host for A. gossypii and A. rhamnicola. As a result, Aphis gossypii and A. rhamnicola do not randomly use their primary and secondary host plants; rather, certain biotypes use only some secondary and specific primary hosts. Some biotypes are possibly in a diverging state through specialization to specific primary hosts. Our results also indicate that a new heteroecious race can commonly be derived from the heteroecious ancestor, showing strong evidence of ecological specialization through a primary host shift in both A. gossypii and A. rhamnicola. Interestingly, A. gossypii and A. rhamnicola shared COI haplotypes with each other, thus there is a possibility of introgression by hybridization between them by cross-sharing same primary hosts. Our results contribute to a new perspective in the study of aphid evolution by identifying complex evolutionary trends in the gossypii sensu lato complex.	[Lee, Yerim; Kim, Hyojoong] Kunsan Natl Univ, Dept Biol, Anim Systemat Lab, Gunsan, South Korea; [Thieme, Thomas] BTL Biotest Lab GmbH Sagerheide, RG Phytoentomol, Gross Lusewitz, Germany	Kunsan National University	Kim, H (corresponding author), Kunsan Natl Univ, Dept Biol, Anim Systemat Lab, Gunsan, South Korea.	hkim@kunsan.ac.kr			Korea Environment Industry & Technology Institute (KEITI) through Exotic Invasive Species Management Program [2018002270005]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2018R1D1A3B07044298]	Korea Environment Industry & Technology Institute (KEITI) through Exotic Invasive Species Management Program; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	The Korea Environment Industry & Technology Institute (KEITI) through Exotic Invasive Species Management Program funded this study via a grant (2018002270005) awarded to HK. (www.keiti.re.kr) The Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education funded this study via a grant (2018R1D1A3B07044298) awarded to HK. (www.nrf.re.kr) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BTL Bio-Test Labor GmbH provided support via salary for TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. (www.biotestlab.de) The specific roles of these authors are articulated in the 'author contributions' section.	Andree K, 2010, MOL ECOL RESOUR, V10, P1098, DOI 10.1111/j.1755-0998.2010.02898.x; [Anonymous], APHIDS WORLDS HERBAC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Blackman R.L., 2021, APHIDS WORLDS PLANTS; Blackman R.L., 2000, J ECON ENTOMOL, V2; Blackman RL, 2019, APHIDS WORLDS PLANTS; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Cabrera AA, 2017, MOL ECOL RESOUR, V17, pe94, DOI 10.1111/1755-0998.12696; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; Chapman R., 2009, CHEM ECOLOGY, P99; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; Cocuzza G, 2008, B INSECTOL, V61, P125; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Delmotte F, 2003, EVOLUTION, V57, P1291, DOI 10.1111/j.0014-3820.2003.tb00337.x; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Dixon AFG, 1987, APHIDS THEIR BIOL NA, P197; Eastop VF, 1976, SURVEY WORLDS APHIDS; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favret C, 2004, MOL PHYLOGENET EVOL, V32, P139, DOI 10.1016/j.ympev.2003.12.005; Favret C., APHID SPECIES FILE; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; FSTAT Goudet J., 2002, PROGRAM ESTIMATE TES; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GULDEMOND JA, 1991, ENTOMOL EXP APPL, V58, P21, DOI 10.1007/BF00163309; Hardy NB, 2015, EVOLUTION, V69, P1423, DOI 10.1111/evo.12643; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Heie OE, 1986, APHIDOIDEA HEMIPTERA; INAIZUMI M, 1981, Kontyu, V49, P219; Inaizumi M., 1980, STUDIES LIFE CYCLE P, V37, P1; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jousselin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-295; Kanbe T, 2009, MOL ECOL, V18, P801, DOI 10.1111/j.1365-294X.2008.04077.x; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kergoat GJ, 2017, ADV BOT RES, V81, P25, DOI 10.1016/bs.abr.2016.09.005; Kim H, 2010, ANN ENTOMOL SOC AM, V103, P532, DOI 10.1603/AN09166; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; KRING JAMES B., 1959, ANN ENT SOC AMER, V52, P284, DOI 10.1093/aesa/52.3.284; Lagos-Kutz D, 2014, ZOOKEYS, P49, DOI 10.3897/zookeys.459.7850; Lee S, 2006, EC INSECTS KOREA, V28; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lee Y, 2015, B ENTOMOL RES, V105, P40, DOI 10.1017/S0007485314000704; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Lozier JD, 2007, EVOLUTION, V61, P1353, DOI 10.1111/j.1558-5646.2007.00110.x; Mackenzie A, 1996, EVOLUTION, V50, P155, DOI 10.1111/j.1558-5646.1996.tb04482.x; Margaritopoulos JT, 2007, BIOL J LINN SOC, V91, P687, DOI 10.1111/j.1095-8312.2007.00828.x; Margaritopoulos JT, 2002, B ENTOMOL RES, V92, P309, DOI 10.1079/BER2002167; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Michel AP, 2009, J ECON ENTOMOL, V102, P1389, DOI 10.1603/029.102.0368; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; Moran NA, 1999, SYST ENTOMOL, V24, P85, DOI 10.1046/j.1365-3113.1999.00076.x; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; MORAN NA, 1990, AM NAT, V136, P135, DOI 10.1086/285087; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Portnoy DS, 2014, MOL ECOL, V23, P5480, DOI 10.1111/mec.12954; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reichel K, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0388-z; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Taylor SA, 2019, NAT ECOL EVOL, V3, P170, DOI 10.1038/s41559-018-0777-y; Techer MA, 2015, APIDOLOGIE, V46, P445, DOI 10.1007/s13592-014-0335-9; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanlerberghe-Masutti F, 1999, MOL ECOL, V8, P693, DOI 10.1046/j.1365-294x.1999.00876.x; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Walsh B. J., 1864, Proceedings Entomological Society of Philadelphia, Vvol. iii, P403; Ward S.A., 1991, P202; Ward SA, 1998, J ANIM ECOL, V67, P763, DOI 10.1046/j.1365-2656.1998.00238.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Wilson ACC, 2002, HEREDITY, V88, P258, DOI [10.1038/sj.hdy.6800037, 10.1038/sj/hdy/6800037]	95	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245604	10.1371/journal.pone.0245604	http://dx.doi.org/10.1371/journal.pone.0245604			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539375	gold, Green Published			2022-12-26	WOS:000616960200004
J	Rezaei-Darzi, E; Mehdipour, P; Di Cesare, M; Farzadfar, F; Rahimzadeh, S; Nissen, L; Ahmadvand, A				Rezaei-Darzi, Ehsan; Mehdipour, Parinaz; Di Cesare, Mariachiara; Farzadfar, Farshad; Rahimzadeh, Shadi; Nissen, Lisa; Ahmadvand, Alireza			Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis	PLOS ONE			English	Article							WOMEN	Background Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 1.6% of the population in England. Novel oral anticoagulants (NOACs) are approved AF treatments that reduce stroke risk. In this study, we estimate the equality in individual NOAC prescriptions with high spatial resolution in Clinical Commissioning Groups (CCGs) across England from 2014 to 2019. Methods A Bayesian spatio-temporal model will be used to estimate and predict the individual NOAC prescription trend on 'prescription data' as an indicator of health services utilisation, using a small area analysis methodology. The main dataset in this study is the "Practice Level Prescribing in England," which contains four individual NOACs prescribed by all registered GP practices in England. We will use the defined daily dose (DDD) equivalent methodology, as recommended by the World Health Organization (WHO), to compare across space and time. Four licensed NOACs datasets will be summed per 1,000 patients at the CCG-level over time. We will also adjust for CCG-level covariates, such as demographic data, Multiple Deprivation Index, and rural-urban classification. We aim to employ the extended BYM2 model (space-time model) using the RStan package. Discussion This study suggests a new statistical modelling approach to link prescription and socioeconomic data to model pharmacoepidemiologic data. Quantifying space and time differences will allow for the evaluation of inequalities in the prescription of NOACs. The methodology will help develop geographically targeted public health interventions, campaigns, audits, or guidelines to improve areas of low prescription. This approach can be used for other medications, especially those used for chronic diseases that must be monitored over time.	[Rezaei-Darzi, Ehsan; Mehdipour, Parinaz; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran; [Rezaei-Darzi, Ehsan] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Mehdipour, Parinaz] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Di Cesare, Mariachiara; Rahimzadeh, Shadi] Middlesex Univ London, Sch Sci & Technol, Dept Nat Sci, London, England; [Nissen, Lisa; Ahmadvand, Alireza] Griffith Univ, Sch Med, Brisbane, Qld, Australia	Tehran University of Medical Sciences; Monash University; University of Melbourne; Middlesex University; Griffith University	Ahmadvand, A (corresponding author), Griffith Univ, Sch Med, Brisbane, Qld, Australia.	a.ahmadvand@griffith.edu.au	Nissen, Lisa/C-3403-2008; Ahmadvand, Alireza/J-8932-2015	Nissen, Lisa/0000-0001-5826-4605; Mehdipour, Parinaz/0000-0002-1608-8487; Ahmadvand, Alireza/0000-0001-5568-8787				Adderley NJ, 2019, HEART, V105, P27, DOI 10.1136/heartjnl-2018-312977; Agirrezabal I, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115125; Ahmad Y, 2012, DABIGATRAN ETEXILATE; Amin A, 2013, CLIN INTERV AGING, V8, P75, DOI 10.2147/CIA.S37818; [Anonymous], 2013, BAYESIAN DIS MAPPING; [Anonymous], 2013, TEXTS STAT SCI SERIE; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Di Cesare M, 2015, LANCET GLOB HEALTH, V3, pE229, DOI 10.1016/S2214-109X(15)70001-X; DiMaggio C, 2015, EPIDEMIOLOGY, V26, P247, DOI 10.1097/EDE.0000000000000222; Edwards S, 2011, RIVAROXABAN PREVENTI; GOV.UK, 2019, ENGL IND DEPR 2015; GOV.UK, 2019, ENGL IND DEPR 2019; Greenhalgh J, 2015, EDOXABAN PREVENTING; Health Do, 2013, CARDIOVASCULAR DIS O; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Ko D, 2016, NAT REV CARDIOL, V13, P321, DOI 10.1038/nrcardio.2016.45; Loo SY, 2017, BRIT J CLIN PHARMACO, V83, P2096, DOI 10.1111/bcp.13299; Mersey P., DABIGATRAN ETEXILATE; Morris M, 2019, SPAT SPATIO-TEMPORAL, V31, DOI 10.1016/j.sste.2019.100301; National Institute for Health and Care Excellence, 2020, RIV PREV ADV OUTC AC; National Institute for Health and Care Excellence, 2019, AP PREV STROK SYST E; National Institute for Health and Care Excellence, 2020, RIV TREAT PULM EMB P; National Institute for Health and Care Excellence, 2020, ED TREAT PREV DEEP T; National Institute for Health and Care Excellence, 2020, SUPP COMM ANT THER 2; National Institute for Health and Care Excellence, 2020, ATR FIBR UPD FIN SCO; National Institute for Health and Care Excellence, 2020, AP TREATM SEC PREV D; Neumann I, COMMENTS APPL ADD DO; NHS, 2019, CLIN COMM GROUP DAT; NHS Digital, 2019, PRACT LEV PRESCR DAT; NHS Digital, 2019, PAT REG GP PRACT; Office for National Statistics, 2020, LIC; Office for National Statistics, CLIN COMM GROUPS APR; Office for National Statistics, 2011, RUR RUB CLASS 2011 C; Pol D, 2019, HEART LUNG CIRC, V28, pE40, DOI 10.1016/j.hlc.2018.03.010; Rahman A., 2008, REV SMALL AREA ESTIM; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rao J., 2003, SOME NEW DEV SMALL A; Reiffel JA, 2016, AM HEART J, V177, P74, DOI 10.1016/j.ahj.2016.04.010; Research Data Australia, 2020, SERV BUILT SHAR; Riebler A, 2016, STAT METHODS MED RES, V25, P1145, DOI 10.1177/0962280216660421; Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26; Stan Development Team, 2018, RSTAN R INT STAN R P; Stan Development Team, 2018, STAN MODELING LANGUA; Stan Development Team, 2018, STAN COR LIB; Zellner A, 1995, J COMPUT APPL MATH, V64, P3, DOI 10.1016/0377-0427(95)00002-X	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246253	10.1371/journal.pone.0246253	http://dx.doi.org/10.1371/journal.pone.0246253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539391	gold, Green Published, Green Accepted			2022-12-26	WOS:000616960200010
J	Oveisgharan, S; Yu, L; Bennett, DA; Buchman, AS				Oveisgharan, Shahram; Yu, Lei; Bennett, David A.; Buchman, Aron S.			Incident mobility disability, parkinsonism, and mortality in community-dwelling older adults	PLOS ONE			English	Article							FRAILTY; SIGNS; PREVALENCE; ASSOCIATION; DIAGNOSIS; COGNITION; DEMENTIA; DISEASE	Background Mobility disability and parkinsonism are associated with decreased survival in older adults. This study examined the transition from no motor impairment to mobility disability and parkinsonism and their associations with death. Methods 867 community-dwelling older adults without mobility disability or parkinsonism at baseline were examined annually. Mobility disability was based on annual measured gait speed. Parkinsonism was based on the annual assessment of 26 items from the motor portion of the Unified Parkinson's Disease Rating Scale. A multistate Cox model simultaneously examined the incidences of mobility disability and parkinsonism and their associations with death. Results Average age at baseline was 75 years old and 318 (37%) died during 10 years of follow-up. Mobility disability was almost 2-fold more common than parkinsonism. Some participants developed mobility disability alone (42%), or parkinsonism alone (5%), while many developed both (41%). Individuals with mobility disability or parkinsonism alone had an increased risk of death, but their risk was less than the risk in individuals with both impairments. The risk of death did not depend on the order in which impairments occurred. Conclusion The varied patterns of transitions from no motor impairment to motor impairment highlights the heterogeneity of late-life motor impairment and its contribution to survival. Further studies are needed to elucidate the underlying biology of these different transitions and how they might impact survival.	[Oveisgharan, Shahram; Yu, Lei; Bennett, David A.; Buchman, Aron S.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Oveisgharan, Shahram; Yu, Lei; Bennett, David A.; Buchman, Aron S.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University; Rush University	Oveisgharan, S (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.; Oveisgharan, S (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	shahram_oveisgharan@rush.edu	Oveisgharan, Shahram/AAI-5971-2021	oveisgharan, shahram/0000-0001-6841-4830	National Institute of Health [R01AG043379, R01AG047679, R01AG056352, R01AG017917, RF1AG022018, R01NS078009, P30AG10161, R01AG15819]; National Institute of Health	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health grants, R01AG043379, R01AG047679, R01AG056352, R01AG017917, RF1AG022018, R01NS078009, P30AG10161, and R01AG15819. We embrace that "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." In addition, authors received salary through the grants supported by National Institute of Health.	Backstrom D, 2018, NEUROLOGY, V91, pE2045, DOI 10.1212/WNL.0000000000006576; Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548; Bennett DA, 1997, NEUROLOGY, V49, P1580, DOI 10.1212/WNL.49.6.1580; Bennett DA, 1999, J GERONTOL A-BIOL, V54, pM191, DOI 10.1093/gerona/54.4.M191; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Buchman AS, 2021, J GERONTOL A-BIOL, V76, P615, DOI 10.1093/gerona/glaa176; Buchman AS, 2019, NEUROLOGY, V92, pE1821, DOI 10.1212/WNL.0000000000007315; Buchman AS, 2016, NEUROLOGY, V87, P1036, DOI 10.1212/WNL.0000000000003059; Buchman AS, 2016, J GERONTOL A-BIOL, V71, P549, DOI 10.1093/gerona/glv153; Buchman AS, 2014, J GERONTOL A-BIOL, V69, P1536, DOI 10.1093/gerona/glu117; Buchman AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086262; Buchman AS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-42; Buchman Aron S, 2009, Proc Am Thorac Soc, V6, P581, DOI 10.1513/pats.200905-030RM; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cummings SR, 2014, JAMA-J AM MED ASSOC, V311, P2061, DOI 10.1001/jama.2014.3033; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Espeland MA, 2007, J GERONTOL A-BIOL, V62, P1237, DOI 10.1093/gerona/62.11.1237; Fleischman DA, 2015, NEUROLOGY, V84, P1294, DOI 10.1212/WNL.0000000000001417; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hoogendijk EO, 2019, LANCET, V394, P1365, DOI 10.1016/S0140-6736(19)31786-6; Laddu DR, 2018, J AM GERIATR SOC, V66, P706, DOI 10.1111/jgs.15273; Louis ED, 2003, NEUROLOGY, V61, P24, DOI 10.1212/01.WNL.0000072330.07328.D6; Louis ED, 2010, MOVEMENT DISORD, V25, P172, DOI 10.1002/mds.22943; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Okoro CA, 2018, MMWR-MORBID MORTAL W, V67, P882, DOI 10.15585/mmwr.mm6732a3; Oveisgharan S, 2019, GERONTOL BIOL SCI ME; Pacifico J, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110801; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Siejka TP, 2020, J GERONTOL A-BIOL, V75, P1545, DOI 10.1093/gerona/glaa024; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Yu L, 2019, NEUROEPIDEMIOLOGY, V53, P55, DOI 10.1159/000499334	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246206	10.1371/journal.pone.0246206	http://dx.doi.org/10.1371/journal.pone.0246206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534811	Green Published, gold			2022-12-26	WOS:000616739700052
J	Sun, J; Patel, K; Hume, J; Pigza, JA; Donahue, MG; Kessl, JJ				Sun, Jian; Patel, Krunal; Hume, Jared; Pigza, Julie A.; Donahue, Matthew G.; Kessl, Jacques J.			Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABERRANT PROTEIN MULTIMERIZATION; SMALL-MOLECULE INHIBITORS; ALLOSTERIC INHIBITORS; STRUCTURAL BASIS; LEDGF/P75; SITE; REPLICATION; RESISTANCE; MECHANISM; KNOCKOUT	During the integration step, human immunodeficiency virus type 1 integrase (IN) interacts with viral DNA and the cellular cofactor LEDGF/p75 to effectively integrate the reverse transcript into the host chromatin. Allosteric human immunodeficiency virus type 1 integrase inhibitors (ALLINIs) are a new class of antiviral agents that bind at the dimer interface of the IN catalytic core domain and occupy the binding site of LEDGF/p75. While originally designed to block IN-LEDGF/p75 interactions during viral integration, several of these compounds have been shown to also severely impact viral maturation through an IN multimerization mechanism. In this study, we tested the hypothesis that these dual properties of ALLINIs could be decoupled toward late stage viral replication effects by generating additional contact points between the bound ALLINI and a third subunit of IN. By sequential derivatization at position 7 of a quinoline-based ALLINI scaffold, we show that IN multimerization properties are enhanced by optimizing hydrophobic interactions between the compound and the C-terminal domain of the third IN subunit. These features not only improve the overall antiviral potencies of these compounds but also significantly shift the ALLINIs selectivity toward the viral maturation stage. Thus, we demonstrate that to fully maximize the potency of ALLINIs, the interactions between the inhibitor and all three IN subunits need to be simultaneously optimized.	[Sun, Jian; Patel, Krunal; Hume, Jared; Pigza, Julie A.; Donahue, Matthew G.; Kessl, Jacques J.] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Sun, Jian; Patel, Krunal; Kessl, Jacques J.] Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA	University of Southern Mississippi; University of Southern Mississippi	Kessl, JJ (corresponding author), Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.; Kessl, JJ (corresponding author), Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA.	Jacques.kessl@usm.edu	Donahue, Matthew/I-1687-2013	Donahue, Matthew/0000-0002-2608-1529	National Institutes of Health [AI140985, GM129751]; National Science Foundation [1848257]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	d This work was supported by National Institutes of Health Grants AI140985 (to J. J. K.), GM129751 (to M. G. D.) and the National Science Foundation Grant 1848257 (to J. A. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Bonnard D, 2018, J BIOL CHEM, V293, P6172, DOI 10.1074/jbc.M117.816793; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Deng NJ, 2016, PROTEIN SCI, V25, P1911, DOI 10.1002/pro.2997; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Elliott JL, 2020, ELIFE, V9, DOI 10.7554/eLife.54311; Engelman Alan, 2014, Microbiol Spectr, V2, P1; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Engelman AN, 2019, J BIOL CHEM, V294, P15137, DOI 10.1074/jbc.REV119.006901; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Gupta K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002584; Jentsch NG, 2018, ACS MED CHEM LETT, V9, P1007, DOI 10.1021/acsmedchemlett.8b00269; Jentsch NG, 2018, BEILSTEIN J ORG CHEM, V14, P2529, DOI 10.3762/bjoc.14.229; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2007, BBA-BIOENERGETICS, V1767, P319, DOI 10.1016/j.bbabio.2007.02.014; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kessl JJ, 2016, METHODS MOL BIOL, V1354, P149, DOI 10.1007/978-1-4939-3046-3_10; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Koneru PC, 2019, ELIFE, V8, DOI 10.7554/eLife.46344; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Patel PA, 2016, BIOORG MED CHEM LETT, V26, P4748, DOI 10.1016/j.bmcl.2016.08.037; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shkriabai N, 2014, J BIOL CHEM, V289, P26430, DOI 10.1074/jbc.M114.589572; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913	43	4	4	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100363	10.1016/j.jbc.2021.100363	http://dx.doi.org/10.1016/j.jbc.2021.100363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539919	gold, Green Published			2022-12-26	WOS:000672866400337
J	Ahmed, SE; San, O; Kara, K; Younis, R; Rasheed, A				Ahmed, Shady E.; San, Omer; Kara, Kursat; Younis, Rami; Rasheed, Adil			Multifidelity computing for coupling full and reduced order models	PLOS ONE			English	Article							FLOW; SYSTEM; EQUATIONS	Hybrid physics-machine learning models are increasingly being used in simulations of transport processes. Many complex multiphysics systems relevant to scientific and engineering applications include multiple spatiotemporal scales and comprise a multifidelity problem sharing an interface between various formulations or heterogeneous computational entities. To this end, we present a robust hybrid analysis and modeling approach combining a physics-based full order model (FOM) and a data-driven reduced order model (ROM) to form the building blocks of an integrated approach among mixed fidelity descriptions toward predictive digital twin technologies. At the interface, we introduce a long short-term memory network to bridge these high and low-fidelity models in various forms of interfacial error correction or prolongation. The proposed interface learning approaches are tested as a new way to address ROM-FOM coupling problems solving nonlinear advection-diffusion flow situations with a bifidelity setup that captures the essence of a broad class of transport processes.	[Ahmed, Shady E.; San, Omer; Kara, Kursat] Oklahoma State Univ, Sch Mech & Aerosp Engn, Stillwater, OK 74078 USA; [Younis, Rami] Univ Tulsa, McDougall Sch Petr Engn, Tulsa, OK 74104 USA; [Rasheed, Adil] Norwegian Univ Sci & Technol, Dept Engn Cybernet, Trondheim, Norway; [Rasheed, Adil] SINTEF Digital, Dept Math & Cybernet, Trondheim, Norway	Oklahoma State University System; Oklahoma State University - Stillwater; University of Tulsa; Norwegian University of Science & Technology (NTNU); SINTEF	San, O (corresponding author), Oklahoma State Univ, Sch Mech & Aerosp Engn, Stillwater, OK 74078 USA.	osan@okstate.edu	Kara, Kursat/F-2462-2011; Ahmed, Shady E./N-8835-2018; Younis, Rami/C-5483-2018; San, Omer/AAA-9282-2020	Kara, Kursat/0000-0002-2788-0234; Ahmed, Shady E./0000-0001-5548-0265; Younis, Rami/0000-0003-1050-2568; San, Omer/0000-0002-2241-4648	U.S. Department of Energy, Office of Science, Office of Advanced Scientific Computing Research [DE-SC0019290]; Norwegian Research Council [268044/E20]; Equinor [268044/E20]; Vestas [268044/E20]; Vattenfall [268044/E20]; agency of the United States Government	U.S. Department of Energy, Office of Science, Office of Advanced Scientific Computing Research(United States Department of Energy (DOE)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Equinor; Vestas; Vattenfall; agency of the United States Government	This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Advanced Scientific Computing Research under Award Number DE-SC0019290. O.S. gratefully acknowledges their support. OPWIND: Operational Control for Wind Power Plants (Grant No.: 268044/E20) project funded by the Norwegian Research Council and its industrial partners (Equinor, Vestas, Vattenfall) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclaimer: This report was prepared as an account of work sponsored by an agency of the United States Government. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof.	Ahmed SE, 2020, PHYSICA D, V409, DOI 10.1016/j.physd.2020.132471; Akhtar N, 2018, IEEE ACCESS, V6, P14410, DOI 10.1109/ACCESS.2018.2807385; [Anonymous], 2018, REDUCED ORDER MODELI; Arakawa A, 1997, J COMPUT PHYS, V135, P103, DOI 10.1006/jcph.1997.5697; Aram S, 2019, AIAA AV 2019 FOR, P3396; BERKOOZ G, 1993, ANNU REV FLUID MECH, V25, P539, DOI 10.1146/annurev.fl.25.010193.002543; Bjorkevoll KS, 2015, 2 IFAC WORKSH AUT CO; Boon WM, 2018, SIAM J NUMER ANAL, V56, P2203, DOI 10.1137/17M1139102; Brunton SL, 2020, ANNU REV FLUID MECH, V52, P477, DOI 10.1146/annurev-fluid-010719-060214; Bu FY, 2019, FUTURE GENER COMP SY, V99, P500, DOI 10.1016/j.future.2019.04.041; Chakraborty S, 2020, ARXIV200505862; Childs RE, 2016, 54 AIAA AER SCI M, P569; D'Angelo C, 2008, MATH MOD METH APPL S, V18, P1481, DOI 10.1142/S0218202508003108; E WN, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.092101; Gander MJ, 2013, DOMAIN DECOMPOSITION, P377; Ganguli R, 2020, APPL MATH MODEL, V77, P1110, DOI 10.1016/j.apm.2019.09.036; Gill A., 1982, ATMOSPHERE OCEAN DYN, V30; Gohil TB, 2015, J FLUID MECH, V783, P567, DOI 10.1017/jfm.2015.571; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Holmes P, 2012, CAMB MG MEC, P1, DOI 10.1017/CBO9780511919701; Kapteyn MG, 2022, INT J NUMER METH ENG, V123, P2986, DOI 10.1002/nme.6423; Kapteyn M.G., 2020, PHYS BASED MODELS PR; Kara K, 2018, AIAA J, V56, P4604, DOI 10.2514/1.J056715; Kevrekidis IG, 2009, ANNU REV PHYS CHEM, V60, P321, DOI 10.1146/annurev.physchem.59.032607.093610; Koklu M, 2018, AIAA J, V56, P100, DOI 10.2514/1.J055796; Koklu M, 2016, AIAA J, V54, P1125, DOI 10.2514/1.J054448; Liu JG, 2003, J SCI COMPUT, V18, P253, DOI 10.1023/A:1021168924020; Liu Z, 2019, FUTURE GENER COMP SY, V97, P1, DOI 10.1016/j.future.2019.02.068; Macpherson J, 2015, J PETROLEUM TECHNOLO, V67, P136, DOI [10.2118/0915-0136-JPT, DOI 10.2118/0915-0136-JPT]; Majda A., 2003, INTRO PDES WAVES ATM, V9; Nicolas A, 2005, INT J NUMER METH FL, V48, P349, DOI 10.1002/fld.895; Nordbotten JM, 2019, COMPUTAT GEOSCI, V23, P225, DOI 10.1007/s10596-018-9778-9; Passerini T, 2009, J ENG MATH, V64, P319, DOI 10.1007/s10665-009-9281-3; Pawar S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0012853; Peherstorfer B, 2018, SIAM REV, V60, P550, DOI 10.1137/16M1082469; Phillips E, 2013, AIAA J, V51, P819, DOI 10.2514/1.J051683; Quarteroni A, 2016, COMPUT METHOD APPL M, V302, P193, DOI 10.1016/j.cma.2016.01.007; Quarteroni A, 2003, MULTISCALE MODEL SIM, V1, P173, DOI 10.1137/S1540345902408482; Rasheed A, 2020, IEEE ACCESS, V8, P21980, DOI 10.1109/ACCESS.2020.2970143; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Reynolds WC, 2003, ANNU REV FLUID MECH, V35, P295, DOI 10.1146/annurev.fluid.35.101101.161128; Schmidt J, 2019, NPJ COMPUT MATER, V5, DOI 10.1038/s41524-019-0221-0; Shankaran S, 2001, 39 AER SCI M EXH, P974; Siddiqui MS, 2019, RENEW ENERG, V132, P1058, DOI 10.1016/j.renene.2018.07.062; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Soffientino B., 2005, OCEANOGRAPHY, V18, P16, DOI DOI 10.5670/0CEAN0G.2005.38; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tao F, 2019, IEEE T IND INFORM, V15, P2405, DOI 10.1109/TII.2018.2873186; Tyliszczak A, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4917179; van Brummelen EH, 2011, INT J NUMER METH FL, V65, P3, DOI 10.1002/fld.2465; Wan ZY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197704; Xu H, 2020, INT J AUTOM COMPUT, V17, P151, DOI 10.1007/s11633-019-1211-x; Xu JY, 2020, AIAA J, V58, P618, DOI 10.2514/1.J057959; Yu XY, 2019, IEEE T NEUR NET LEAR, V30, P2805, DOI 10.1109/TNNLS.2018.2886017	55	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246092	10.1371/journal.pone.0246092	http://dx.doi.org/10.1371/journal.pone.0246092			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571229	Green Submitted, Green Published, gold			2022-12-26	WOS:000618274000013
J	Chen, SY; Chen, ZG; Shen, Y				Chen, Siyi; Chen, Zhigang; Shen, Yan			Can improving law enforcement effectively curb illegal land use in China?	PLOS ONE			English	Article							URBAN LAND; ECONOMIC-GROWTH; FARMLAND CONVERSION; EXPANSION; MARKET; PRESSURES; POLITICS; FINANCE; STATE	In view of the current severe situation of illegal land use in China, it is of great significance to explore the impact of the evolution and promotion of land law enforcement effectiveness, which will improve China's land law enforcement system and effectively curb illegal land use. This paper explains the changes and enhancements of the effectiveness of land law enforcement since the implementation of China's National Land Supervision System in terms of the deterrence, difficulty, and strength of land law enforcement, and explores the role of land law enforcement effectiveness in changing illegal land use behaviors from a theoretical level. Then, a corresponding empirical test was carried out using the provincial panel data of Mainland China from 2007 to 2016. The results show that the increase in land law enforcement deterrence and strength will help reduce the number of illegal land use cases, but it will drive the lawbreakers to "commit major cases in desperation", leading to the increase of the degree of illegal land use; and with the decrease of land law enforcement difficulty, the degree of illegal land use will be significantly reduced. At the end of this paper, several policy suggestions are put forward to effectively curb the illegal land use from the perspective of improving the land law enforcement system and enhancing the effectiveness of law enforcement.	[Chen, Siyi; Chen, Zhigang; Shen, Yan] Nanjing Univ, Sch Geog & Ocean Sci, Nanjing, Peoples R China; [Chen, Siyi; Chen, Zhigang; Shen, Yan] Minist Nat Resources China, Key Lab Coastal Zone Exploitat & Protect, Nanjing, Peoples R China	Nanjing University; Ministry of Natural Resources of the People's Republic of China	Chen, ZG (corresponding author), Nanjing Univ, Sch Geog & Ocean Sci, Nanjing, Peoples R China.; Chen, ZG (corresponding author), Minist Nat Resources China, Key Lab Coastal Zone Exploitat & Protect, Nanjing, Peoples R China.	zgchen@nju.edu.cn			Shanghai Institute of Geological Survey	Shanghai Institute of Geological Survey	This study received funding support from the following source: Shanghai Institute of Geological Survey (http://www.sigs.cn/), awarded to ZC.	[Anonymous], 2008, NATL LAND RESOURCES, V9, P9; [Anonymous], 2011, CHINA L SCI; [Anonymous], 2010, DIRITTI DELLUOMO CRO, V2, P28; [Anonymous], 2007, INT J EVIDENCE PROOF, V11, P243; [Anonymous], 2008, WORKSH VER VAL SHIP, V1, pB7; [Anonymous], 2010, CHIROPR J, V24, P9; Becker Gary S., 1978, EC APPROACH HUMAN BE; Cao GZ, 2008, CHINA WORLD ECON, V16, P19, DOI 10.1111/j.1749-124X.2008.00104.x; Cesare Bonesana Beccaria, 2004, CRIMES PUNISHMENTS; Chen X., 2019, CHINA EC Q, V18, P99; Chen ZG, 2017, LAND USE POLICY, V63, P214, DOI 10.1016/j.landusepol.2017.01.034; Chen ZG, 2015, HABITAT INT, V49, P403, DOI 10.1016/j.habitatint.2015.06.015; Deng XZ, 2010, URBAN STUD, V47, P813, DOI 10.1177/0042098009349770; Ding CR, 2011, J REGIONAL SCI, V51, P299, DOI 10.1111/j.1467-9787.2010.00686.x; Dong Z., 2009, GOOD SUPERVISION THE; Ehlers N, 2012, SOC SEMIOT, V22, P121, DOI 10.1080/10350330.2012.640059; Gao JL, 2014, HABITAT INT, V44, P461, DOI 10.1016/j.habitatint.2014.09.002; Geymen A, 2008, ENVIRON MONIT ASSESS, V136, P449, DOI 10.1007/s10661-007-9699-x; He CF, 2014, URBAN STUD, V51, P2880, DOI 10.1177/0042098013513649; Ho SPS, 2003, CHINA QUART, P681, DOI 10.1017/S0305741003000407; Jiang Y, 2010, B SURVEYING MAPPING, V6, P65; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Leibman L, 2011, JEW HIST, V25, P13, DOI 10.1007/s10835-010-9126-7; Li J, 2014, HABITAT INT, V41, P307, DOI 10.1016/j.habitatint.2013.10.001; Li X, 2009, J INORG MATER, V24, P383, DOI 10.3724/SP.J.1077.2009.00383; Li YH, 2018, J CLEAN PROD, V178, P580, DOI 10.1016/j.jclepro.2017.12.273; Lian HP, 2019, LAND USE POLICY, V84, P12, DOI 10.1016/j.landusepol.2019.02.014; Liang R, 2010, CHINA EC Q, V1, P283; Lin GCS, 2005, ANN ASSOC AM GEOGR, V95, P411, DOI 10.1111/j.1467-8306.2005.00467.x; Liu YS, 2014, LAND USE POLICY, V40, P6, DOI 10.1016/j.landusepol.2013.03.013; [龙开胜 LONG Kaisheng], 2011, [资源科学, Resources Science], V33, P1171; Manji A, 2012, J MOD AFR STUD, V50, P467, DOI 10.1017/S0022278X12000201; MLR (Ministry of Land and Resources), 2000, CHIN LAND RES YB; MLR (Ministry of Land and Resources), 2008, CHIN LAND RES YB; Mu R, 2018, J CHIN GOV, V3, P243, DOI 10.1080/23812346.2018.1455413; POSNER RA, 1973, J LEGAL STUD, V2, P399, DOI 10.1086/467503; Tan R, 2011, CHINA ECON REV, V22, P474, DOI 10.1016/j.chieco.2011.07.013; [唐鹏 Tang Peng], 2018, [中国土地科学, China Land Science], V32, P15; Tang W.-S., 2002, ASIA PAC VIEWP, V43, P43, DOI DOI 10.1111/1467-8373.00157; Tao R, 2010, URBAN STUD, V47, P2217, DOI 10.1177/0042098009357961; Wang J, 2019, LAND-BASEL, V8, DOI 10.3390/land8110171; [王良健 Wang Liangjian], 2014, [资源科学, Resources Science], V36, P1336; [王青 Wang Qing], 2019, [中国土地科学, China Land Science], V33, P32; Wang YM, 2008, URBAN GEOGR, V29, P327, DOI 10.2747/0272-3638.29.4.327; Whiting S, 2011, URBAN STUD, V48, P569, DOI 10.1177/0042098010390242; Xie QS, 2002, URBAN STUD, V39, P1375, DOI 10.1080/00420980220142682; Yang XD, 2018, J CHIN GOV, V3, P25, DOI 10.1080/23812346.2018.1428075; [张绍阳 Zhang Shaoyang], 2017, [中国人口·资源与环境, China Population Resources and Environment], V27, P115; Zhang SM, 2014, CITIES, V41, P179, DOI 10.1016/j.cities.2014.02.010; Zhang SM, 2009, ENVIRON PLANN C, V27, P399, DOI 10.1068/c0774b; Zhao Y, 2019, MINERAL EXPLORATION, V10, P976; Zhong TY, 2014, SUSTAINABILITY-BASEL, V6, P4426, DOI 10.3390/su6074426; Zhu JM, 2009, ENVIRON PLANN A, V41, P1629, DOI 10.1068/a41147; Zhu JM, 1999, INT J URBAN REGIONAL, V23, P534, DOI 10.1111/1468-2427.00211	54	0	0	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246347	10.1371/journal.pone.0246347	http://dx.doi.org/10.1371/journal.pone.0246347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571235	gold, Green Published			2022-12-26	WOS:000618274000070
J	Krenz, U; Timmermann, D; Gorbunova, A; Lendt, M; Schmidt, S; von Steinbuechel, N				Krenz, Ugne; Timmermann, Dagmar; Gorbunova, Anastasia; Lendt, Michael; Schmidt, Silke; von Steinbuechel, Nicole			Health-related quality of life after pediatric traumatic brain injury: A qualitative comparison between children's and parents' perspectives	PLOS ONE			English	Article								Background Pediatric traumatic brain injury (TBI) may cause a wide range of symptoms, which can negatively affect the quality of life of patients and their entire families. No internationally and simultaneously developed disease-specific instrument exists for assessing pediatric health-related quality of life (HRQoL) after TBI. The aim of the current project is to provide original material from small group interviews with individuals after TBI concerning what they state is relevant for their HRQoL. This material is required for a further study to generate items for age-adapted questionnaires assessing the TBI-specific HRQoL of children and adolescents (C&A): the QOLIBRI-Kiddy/Kid/Ado and proxy versions (Quality of Life after Brain Injury-Kiddy/Kids/Adolescents/Proxy) for individuals aged 6-17 and their parents. Methods The semi-structured interviews were conducted with separate small groups of C&A (n = 19), divided into three age groups (5-7y, 8-12y, 13-17y), after mild, moderate, and severe TBI, and with groups of the corresponding parents (n = 26). All interviews lasted for about 60 minutes, were recorded and transcribed verbatim. The statements were investigated by qualitative analyses and sorted into categories relevant to the HRQoL of C&A after TBI. Only descriptive group comparisons but no pairwise comparisons between children and corresponding parents were performed. Results The analyses led to 32 subcategories, which were assigned to six main theoretically based HRQoL categories. Many agreements exist between the C&A's and parents' perspectives within the main categories, however their focus on HRQoL differs, especially concerning age-related contents. Parents of the youngest participant group already focus on topics such as autonomy, whereas this only becomes relevant for C&A from the age of eight years on. Interestingly, even 5-year-old children were able to discuss their HRQoL, which indicates the importance of a self-report instrument. Conclusions Results obtained from this qualitative study identify the content of the HRQoL dimensions important for C&A after TBI and their parents. Both, differences and similarities in the children's and the parents' views were investigated, to get a first insight in valid dimensions for the prospective questionnaires to be developed. In a future study, items for the questionnaires will be deducted from the small group interview material and psychometrically tested in C&A after TBI from Germany. This study will address whether all statements were assigned to the suitable dimensions and whether differences between C&A and parents persist.	[Krenz, Ugne; Timmermann, Dagmar; Gorbunova, Anastasia; von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany; [Lendt, Michael] St Mauritius Therapeut Clin, Neuropediat, Meerbusch, Germany; [Schmidt, Silke] Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Greifswald, Germany	University of Gottingen; Ernst Moritz Arndt Universitat Greifswald	Krenz, U (corresponding author), Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany.	ugne.krenz@med.uni-goettingen.de		Krenz, Ugne/0000-0002-0518-8781; Schmidt, Silke/0000-0002-4194-1937	Dr. Senckenbergische Stiftung Frankfurt am Main, Germany; Dr. Christ'sche Stiftung Frankfurt am Main, Germany; UniscientiaStiftung, Vaduz, Lichtenstein; Goettingen University	Dr. Senckenbergische Stiftung Frankfurt am Main, Germany; Dr. Christ'sche Stiftung Frankfurt am Main, Germany; UniscientiaStiftung, Vaduz, Lichtenstein; Goettingen University	The authors declare no competing financial interests. This work was funded by Dr. Senckenbergische Stiftung Frankfurt am Main, Germany (no grant number available) and Dr. Christ'sche Stiftung Frankfurt am Main, Germany (no grant number available), and UniscientiaStiftung, Vaduz, Lichtenstein (no grant number available). The publication was supported by the Open Access Publication Funds of the Goettingen University. The funders had no role in study design, data collection, data analysis, decision to publish, and writing the manuscript. URLs sponsors websites: Senckenbergische Stiftung: http://www.senckenbergische-stiftung.de/Dr.Christ'sche Stiftung Frankfurt am Main, Germany: https://www.ckh-stiftung.de/UniscientiaStiftung, Vaduz, Lichtenstein: foundation has no URL.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Bohn B, 2014, TRAUMA BERUFSKRANKH, V16, P425, DOI 10.1007/s10039-014-2101-7; Coghill D, 2009, J CHILD PSYCHOL PSYC, V50, P544, DOI 10.1111/j.1469-7610.2009.02008.x; Davis E, 2007, QUAL LIFE RES, V16, P863, DOI 10.1007/s11136-007-9187-3; Dorn SD, 2010, ALIMENT PHARM THER, V31, P666, DOI 10.1111/j.1365-2036.2009.04220.x; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gesellschaft fur Neonatologie und padiatrische Intensivmedizin e. V ed, 2011, LEITLINIE SCHADEL HI; Gothwal VK, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.4.15; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Heary CM, 2002, J PEDIATR PSYCHOL, V27, P47, DOI 10.1093/jpepsy/27.1.47; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Horner SD, 2000, RES NURS HEALTH, V23, P510, DOI 10.1002/1098-240X(200012)23:6<510::AID-NUR9>3.0.CO;2-L; Landolt MA, 2009, AUST NZ J PSYCHIAT, V43, P746, DOI 10.1080/00048670903001919; Langlois JA, 2000, SUMMARY RECOMMENDATI; Lendt M, 2014, MONATSSCHR KINDERH, V162, P420, DOI 10.1007/s00112-014-3114-9; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; Mayring P., 2010, HDB QUALITATIVE FORS, P601, DOI [DOI 10.1007/978-3-531-92052-8_42, 10.1007/978-3-531-92052-8_42]; Messing-Juenger M., 2018, HDB SCHAEDEL HIRN TR, P288; Morgan D. L., 1996, FOCUS GROUPS QUALITA; Morgan Myfanwy., 2002, QUAL RES, V2, P5, DOI [10.1177/1468794102002001636, DOI 10.1177/1468794102002001636]; Rajmil L, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-101; Ravens-Sieberer U., 2000, BUNDESGESUNDHEITSBLA, V43, P198, DOI [10.1007/s001030050035, DOI 10.1007/S001030050035]; Ravens-Sieberer U, 2006, PHARMACOECONOMICS, V24, P1199, DOI 10.2165/00019053-200624120-00005; Rothe K, 2014, TRAUMA BERUFSKRANKH, V16, P190, DOI 10.1007/s10039-013-2013-y; Skjerning H, 2014, QUAL LIFE RES, V23, P1883, DOI 10.1007/s11136-014-0623-x; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stewart DW, 2014, FOCUS GROUPS THEORY; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 1998, NEUE HERAUSFORDERUNG, P50; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Warschburger P, 2003, QUAL LIFE RES, V12, P291, DOI 10.1023/A:1023233308653; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Witzel A., 2012, PROBLEM CENTRED INTE; World Health Organization, CONST WHO 1948	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246514	10.1371/journal.pone.0246514	http://dx.doi.org/10.1371/journal.pone.0246514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566806	gold, Green Published			2022-12-26	WOS:000618271700038
J	Ul Hassan, M; Veerabhadrappa, R; Bhatti, A				Ul Hassan, Masood; Veerabhadrappa, Rakesh; Bhatti, Asim			Efficient neural spike sorting using data subdivision and unification	PLOS ONE			English	Article							FEATURE-SELECTION; RECORDINGS; ALGORITHMS; NEURONS; ROBUST; FUTURE; CLASSIFICATION	Neural spike sorting is prerequisite to deciphering useful information from electrophysiological data recorded from the brain, in vitro and/or in vivo. Significant advancements in nanotechnology and nanofabrication has enabled neuroscientists and engineers to capture the electrophysiological activities of the brain at very high resolution, data rate and fidelity. However, the evolution in spike sorting algorithms to deal with the aforementioned technological advancement and capability to quantify higher density data sets is somewhat limited. Both supervised and unsupervised clustering algorithms do perform well when the data to quantify is small, however, their efficiency degrades with the increase in the data size in terms of processing time and quality of spike clusters being formed. This makes neural spike sorting an inefficient process to deal with large and dense electrophysiological data recorded from brain. The presented work aims to address this challenge by providing a novel data pre-processing framework, which can enhance the efficiency of the conventional spike sorting algorithms significantly. The proposed framework is validated by applying on ten widely used algorithms and six large feature sets. Feature sets are calculated by employing PCA and Haar wavelet features on three widely adopted large electrophysiological datasets for consistency during the clustering process. A MATLAB software of the proposed mechanism is also developed and provided to assist the researchers, active in this domain.	[Ul Hassan, Masood] Deakin Univ, Sch Engn Elect & Renewable Energy, Waurn Ponds, Australia; [Ul Hassan, Masood; Veerabhadrappa, Rakesh; Bhatti, Asim] Deakin Univ, Inst Intelligent Syst Res & Innovat, Waurn Ponds, Australia	Deakin University; Deakin University	Ul Hassan, M (corresponding author), Deakin Univ, Sch Engn Elect & Renewable Energy, Waurn Ponds, Australia.; Ul Hassan, M; Bhatti, A (corresponding author), Deakin Univ, Inst Intelligent Syst Res & Innovat, Waurn Ponds, Australia.	m.ulhassan@deakin.edu.au; asim.bhatti@deakin.edu.au	Veerabhadrappa, Rakesh/AAZ-9948-2021; Bhatti, Asim/G-2082-2010	Veerabhadrappa, Rakesh/0000-0002-7653-2252; Bhatti, Asim/0000-0001-6876-1437	Neural and Cognitive Systems Lab at Institute for Intelligent Systems Research and Innovation, Deakin University	Neural and Cognitive Systems Lab at Institute for Intelligent Systems Research and Innovation, Deakin University	The research work is fully supported by Neural and Cognitive Systems Lab at Institute for Intelligent Systems Research and Innovation, Deakin University". Although we do not have any explicit external funding grant linked to this work however the work is internally funded by the lab.	Abe S, 2010, ADV PATTERN RECOGNIT, P331, DOI 10.1007/978-1-84996-098-4_7; ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; Adamos DA, 2008, COMPUT METH PROG BIO, V91, P232, DOI 10.1016/j.cmpb.2008.04.011; Aksenova TI, 2003, METHODS, V30, P178, DOI 10.1016/S1046-2023(03)00079-3; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Bache K, 2013, UCI MACHINE LEARNING, P28; Ben-David A, 2007, ENG APPL ARTIF INTEL, V20, P875, DOI 10.1016/j.engappai.2007.01.001; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Bhatti A, 2017, SER BIOENG, P1, DOI 10.1007/978-981-10-3957-7; Bhatti A, 2002, INT CONF ACOUST SPEE, P4172; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Chen X., 25 AAAI C ART INT; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Chung JE, 2017, NEURON, V95, P1381, DOI 10.1016/j.neuron.2017.08.030; Corduneanu A., 2001, ARTIF INTELL, P27, DOI DOI 10.1016/J.CSDA.2006.07.020; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I; Davidson I, 2005, LECT NOTES ARTIF INT, V3721, P59; Do TT, 2008, CONF REC ASILOMAR C, P581, DOI 10.1109/ACSSC.2008.5074472; Dokmanic I, 2015, IEEE SIGNAL PROC MAG, V32, P12, DOI 10.1109/MSP.2015.2398954; Dominique MD., 2006, J NEURAL ENG, V4; Drezner Z, 2010, COMMUN STAT-SIMUL C, V39, P693, DOI 10.1080/03610911003615816; Duarte MF, 2004, J PARALLEL DISTR COM, V64, P826, DOI 10.1016/j.jpdc.2004.03.020; Dunham MH., 2006, DATA MINING INTRO AD; Eick CF, 2004, PROC INT C TOOLS ART, P774; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Eliasmith C, 2003, NEURAL ENG; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Gaburro J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28357-2; Gaburro J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0989-4; Gaburro J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0069-2; Gibson S, 2012, IEEE SIGNAL PROC MAG, V29, P124, DOI 10.1109/MSP.2011.941880; Gibson S, 2008, IEEE ENG MED BIO, P5015, DOI 10.1109/IEMBS.2008.4650340; Hartigan J., 1975, CLUSTERING ALGORITHM; He B, 2007, NEURAL ENG; Hettiarachchi IT, 2016, NONLINEAR DYNAM, V86, P1249, DOI 10.1007/s11071-016-2961-4; Hubert M, 2008, J CHEMOMETR, V22, P235, DOI 10.1002/cem.1123; Hulata E, 2000, PHYS REV LETT, V85, P4637, DOI 10.1103/PhysRevLett.85.4637; Hulata E, 2002, J NEUROSCI METH, V117, P1, DOI 10.1016/S0165-0270(02)00032-8; Jain A. K., 1988, PRENTICE HALL ADV RE; Khudhair D, 2017, SER BIOENG, P41, DOI 10.1007/978-981-10-3957-7_2; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Kreuz T, 2013, J NEUROPHYSIOL, V109, P1457, DOI 10.1152/jn.00873.2012; Kumar V., KDD WORKSH TEXT MIN, V400, P525; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Lansey JC., BEAUTIFUL DISTINGUIS; Law MHC, 2004, IEEE T PATTERN ANAL, V26, P1154, DOI 10.1109/TPAMI.2004.71; LeCun Y., MNIST DATABASE HANDW; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Mbah AK, 2015, J STAT COMPUT SIM, V85, P3002, DOI 10.1080/00949655.2014.947986; Mishra P, 2019, ANN CARD ANAESTH, V22, P67, DOI 10.4103/aca.ACA_157_18; Mohamed S, INT C NEUR INF PROC, P553; Mussa-Ivaldi FA, 2003, TRENDS NEUROSCI, V26, P329, DOI 10.1016/S0166-2236(03)00121-8; Napoleon D., 2011, INT J COMPUT APPL, V13, P41, DOI [10.5120/1789-2471, DOI 10.5120/1789-2471]; Ozkaramanli H, 2002, SIGNAL PROCESS, V82, P1029, DOI 10.1016/S0165-1684(02)00212-8; Pachitariu M, 2016, KILOSORT REALTIME SP; Paralikar KJ, 2009, J NEUROSCI METH, V181, P27, DOI 10.1016/j.jneumeth.2009.04.014; Park HS, 2009, EXPERT SYST APPL, V36, P3336, DOI 10.1016/j.eswa.2008.01.039; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; Rousseeuw PJ, 2011, WIRES DATA MIN KNOWL, V1, P73, DOI 10.1002/widm.2; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/nnano.2012.265, 10.1038/NNANO.2012.265]; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Takekawa T, 2014, EUR J NEUROSCI, V39, P1943, DOI 10.1111/ejn.12614; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Ul Bari MA, 2017, SER BIOENG, P99, DOI 10.1007/978-981-10-3957-7_5; Ul Hassan M, 2020, IEEE SYS MAN CYBERN, P1286, DOI 10.1109/SMC42975.2020.9283347; Veerabhadrappa R, 2017, NEUROCOMPUTING, V249, P299, DOI 10.1016/j.neucom.2016.09.135; Veerabhadrappa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28533; Veerabhadrappa R, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.00034; Wehr M, SPIKE SORTING ALGORI; Wild J, 2012, J NEUROSCI METH, V203, P369, DOI 10.1016/j.jneumeth.2011.10.013; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192; Wouters J, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aace8a; Yazici B, 2007, J STAT COMPUT SIM, V77, P175, DOI 10.1080/10629360600678310; Zamani M, 2014, IEEE T NEUR SYS REH, V22, P716, DOI 10.1109/TNSRE.2014.2309678; Zhang J, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab385; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]; Zhao Z, 2004, THESIS	87	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245589	10.1371/journal.pone.0245589	http://dx.doi.org/10.1371/journal.pone.0245589			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566859	Green Published, gold			2022-12-26	WOS:000618271700033
J	Yang, CJ; Chen, AB; Chen, YS				Yang, Chunjiang; Chen, Aobo; Chen, Yashuo			College students' stress and health in the COVID-19 pandemic: The role of academic workload, separation from school, and fears of contagion	PLOS ONE			English	Article							ACCULTURATIVE STRESS; DEPRESSIVE SYMPTOMS; MEDIATING ROLE; ANXIETY; CHINA; DISCRIMINATION; ASSOCIATIONS; PERSONALITY; PREDICTORS; ATTACHMENT	The COVID-19 pandemic has unhinged the lives of people across the globe. In particular, more than 30 million Chinese college students are home-schooling, yet there is little understanding of how academic workload, separation from school, and fears of contagion lead to a decrease in their health. This study examined the relationships between Chinese college students' three critical stressors and two types of health in the COVID-19 pandemic context. We used a three-wave lagged design with a one-week interval. All the constructs were assessed by self-report in anonymous surveys during the COVID-19 pandemic. College students were asked to report their demographic information, academic workload, separation from school, fears of contagion, perceived stress, and health. The results of this study showed that academic workload, separation from school, and fears of contagion had negative effects on college students' health via perceived stress. In the COVID-19 crisis, multiple prevention and control measures focusing on college students may lead them to have different degrees of stress and health problems. Our results enrich the literature on stress and health and offer novel practical implications for all circles of the society to ensure students' health under the context of the COVID-19 epidemic.	[Yang, Chunjiang; Chen, Aobo; Chen, Yashuo] Yanshan Univ, Sch Econ & Management, Qinhuangdao, Hebei, Peoples R China	Yanshan University	Yang, CJ (corresponding author), Yanshan Univ, Sch Econ & Management, Qinhuangdao, Hebei, Peoples R China.	ycj@ysu.edu.cn			National Natural Science Foundation of China [71572170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (71572170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouserie R., 1994, EDUC PSYCHOL-US, V14, P323, DOI [10.1080/0144341940140306, DOI 10.1080/0144341940140306]; Abrams D, 2006, SOCIAL IDENTIFICATIO; Achenbach J., 2020, WASH POST; Akgun S., 2003, EDUC PSYCHOL-UK, V23, P287, DOI [10.1080/0144341032000060129, DOI 10.1080/0144341032000060129]; ALDWIN C, 1987, AM J COMMUN PSYCHOL, V15, P789, DOI 10.1007/BF00919803; Ang RP, 2006, EDUC PSYCHOL MEAS, V66, P522, DOI 10.1177/0013164405282461; Barker ET, 2018, J YOUTH ADOLESCENCE, V47, P1252, DOI 10.1007/s10964-018-0822-9; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Bettmann JE, 2017, J CHILD FAM STUD, V26, P511, DOI 10.1007/s10826-016-0577-4; Brewster ME, 2013, J COUNS PSYCHOL, V60, P543, DOI 10.1037/a0033224; Campisi J, 2017, COMPUT HUM BEHAV, V76, P211, DOI 10.1016/j.chb.2017.07.022; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Cohen S, 1994, PERCEIVED STRESS SCA; Coiro MJ, 2017, J AM COLL HEALTH, V65, P177, DOI 10.1080/07448481.2016.1266641; COOMBS RH, 1982, AM J PSYCHIAT, V139, P1490; Corsano P, 2006, ADOLESCENCE, V41, P341; Deb S., 2015, INT J PSYCHOL BEHAV, V5, P26, DOI DOI 10.5923/J.IJPBS.20150501.04; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; France MK, 2010, EDUC PSYCHOL MEAS, V70, P440, DOI 10.1177/0013164409344510; Gao WJ, 2020, J AFFECT DISORDERS, V263, P292, DOI 10.1016/j.jad.2019.11.121; Garcia-Vera MP, 2016, PSYCHOL REP, V119, P328, DOI 10.1177/0033294116658243; Glanz K., 2015, HLTH BEHAV THEORY RE; Gordon-Hollingsworth AT, 2018, J CHILD ADOLES TRAUM, V11, P205, DOI 10.1007/s40653-015-0051-2; GUISINGER S, 1994, AM PSYCHOL, V49, P104, DOI 10.1037/0003-066X.49.2.104; Han S, 2017, J MULTICULT COUNS D, V45, P111, DOI 10.1002/jmcd.12068; Heckert, 1999, COLL STUDENT J, V33, P312, DOI DOI 10.1016/S2215-0366(20)30078-X; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; HUEBNER LA, 1981, J MED EDUC, V56, P547; Hurst CS, 2013, STRESS HEALTH, V29, P275, DOI 10.1002/smi.2465; Hystad SW, 2009, SCAND J EDUC RES, V53, P421, DOI 10.1080/00313830903180349; Karaman MA, 2017, PERS INDIV DIFFER, V111, P106, DOI 10.1016/j.paid.2017.02.006; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus R.S., 1995, OCCUPATIONAL STRESS, P3; Liu ZH, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00608-w; Lorenzo-Blanco EI, 2015, J YOUTH ADOLESCENCE, V44, P1984, DOI 10.1007/s10964-015-0339-4; Main A, 2011, J COUNS PSYCHOL, V58, P410, DOI 10.1037/a0023632; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Metzger IW, 2017, J SEX RES, V54, P374, DOI 10.1080/00224499.2016.1179709; Misra R., 2004, INT J STRESS MANAGE, V11, P132, DOI [DOI 10.1037/1072-5245.11.2.132, https://doi.org/10.1037/1072-5245.11.2.132]; Ng V, 2003, PSYCHOL REP, V93, P1133, DOI 10.2466/PR0.93.8.1133-1134; Phang A, 2020, J CAREER DEV, V47, P657, DOI 10.1177/0894845318814366; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Saricam H, 2015, STUD PSYCHOL, V57, P271, DOI 10.21909/sp.2015.03.699; Sarid O, 2004, RES NURS HEALTH, V27, P370, DOI 10.1002/nur.20028; Schafer W, 1996, STRESS MANAGEMENT WE; Seligman LD, 2007, J PSYCHOL, V141, P135, DOI 10.3200/JRLP.141.2.135-146; Shiralkar MT, 2013, ACAD PSYCHIATR, V37, P158, DOI 10.1176/appi.ap.12010003; Siegel DM, 2018, ANXIETY STRESS COPIN, V31, P526, DOI 10.1080/10615806.2018.1482723; Smith ER, 1999, J PERS SOC PSYCHOL, V77, P94, DOI 10.1037/0022-3514.77.1.94; Sontag S., 1977, IMAGE WORLD; Subramani C., 2017, INDIAN J APPL RES, V7, P404, DOI DOI 10.36106/1493820733162; Sun W, 2014, INT J INFECT DIS, V28, P147, DOI 10.1016/j.ijid.2014.07.010; THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957; Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Whooley Sean, 2020, MASSDEVICE 1022; Wintre MG, 2000, J COLL STUDENT DEV, V41, P202; Yusoff MSB, 2013, ASIAN J PSYCHIATR, V6, P128, DOI 10.1016/j.ajp.2012.09.012	60	61	63	26	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246676	10.1371/journal.pone.0246676	http://dx.doi.org/10.1371/journal.pone.0246676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566824	gold, Green Published			2022-12-26	WOS:000618271700042
J	Kim, A; Boyd, L; Ringel, N; Meyer, J; Bennett, G; Lerner, V				Kim, Annie; Boyd, Leslie; Ringel, Nancy; Meyer, Jessica; Bennett, Genevieve; Lerner, Veronica			Preoperative MRI and LDH in women undergoing intra-abdominal surgery for fibroids: Effect on surgical route	PLOS ONE			English	Article							ENDOMETRIAL CANCER; UTERINE; MORCELLATION; HYSTERECTOMY; ULTRASOUND; LEIOMYOMA	Introduction Our institution implemented a preoperative protocol to identify high-risk cases for which power morcellation should be avoided. Material and methods In this retrospective cohort study, an institutional protocol requiring preoperative Magnetic Resonance Imaging with diffusion-weighted imaging and serum Lactate Dehydrogenase levels was implemented. Chart review was performed including all women who underwent intra-abdominal surgery for symptomatic fibroids from 4/23/2013 to 4/23/2015. Results A total of 1,085 women were included, 479 before and 606 after implementation of the Magnetic Resonance Imaging / Lactate Dehydrogenase protocol. The pre-protocol group had more post-menopausal women (4% vs. 2%, p = 0.022) and women using tamoxifen (2% vs. 0%, p = 0.022) than those in the post-protocol group, but baseline patient characteristics were otherwise similar between groups. Incidence of malignant pathological diagnoses did not change significantly over the time period in relation to protocol implementation. The rate of open surgery for both hysterectomy and myomectomy remained the same in the year preceding and the year following initiation of the protocol (open hysterectomy rate was 19% vs. 16% in pre- and post-protocol groups, respectively, P = 0.463, and open myomectomy rate was 10% vs. 9% rates in pre- and post-protocol groups, respectively, P = 0.776). There was a significant decrease in the use of power morcellation (66% in pre- and 50% in post-protocol cohorts, p<0.001) and an increased use of containment bags (1% in pre- and 19% in post-protocol cohort). When analyzing the subset of women who had abnormal Magnetic Resonance Imaging / and Lactate Dehydrogenase results, abnormal Magnetic Resonance Imaging results alone resulted in higher rates of open approach (65% for abnormal vs. 35% for normal). Similarly, a combination of abnormal Magnetic Resonance Imaging and Lactate Dehydrogenase tests resulted in higher rates of open approach (70% for abnormal and 17% for normal). Abnormal Lactate Dehydrogenase results alone did not influence route. Conclusions Rates of MIS procedures were decreased for women with abnormal preoperative Magnetic Resonance Imaging results. False positive results appear to be one of the main drivers for the use of an open surgical route.	[Kim, Annie; Lerner, Veronica] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Boyd, Leslie; Meyer, Jessica] New York Univ Langone Hlth, Dept Obstet & Gynecol, New York, NY USA; [Ringel, Nancy] MedStar Hlth, Dept Obstet & Gynecol, Washington, DC USA; [Bennett, Genevieve] New York Univ Langone Hlth, Dept Radiol, New York, NY USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; New York University	Lerner, V (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA.	lernervt02@gmail.com		Boyd, Leslie/0000-0001-8955-3231				Amer Coll Obstetricians Gynecologi, 2019, OBSTET GYNECOL, V133, pE238, DOI 10.1097/AOG.0000000000003126; [Anonymous], 2014, J MINIM INVAS GYN, V21, P517, DOI 10.1016/j.jmig.2014.05.010; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Barron K I, 2015, J Minim Invasive Gynecol, V22, pS2, DOI 10.1016/j.jmig.2015.08.012; Chittawar PB, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004638.pub3; Falcone T, 2002, CURR OPIN OBSTET GYN, V14, P401, DOI 10.1097/00001703-200208000-00007; Goto A, 2002, INT J GYNECOL CANCER, V12, P354, DOI 10.1046/j.1525-1438.2002.01086.x; Harris JA, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.047; Jorgensen EM, 2019, OBSTET GYNECOL, V133, P643, DOI 10.1097/AOG.0000000000003181; Lagana AS, 2020, INT J FERTIL STERIL, V14, P260, DOI 10.22074/ijfs.2020.44413; Lagana AS, 2017, ARCH GYNECOL OBSTET, V296, P855, DOI 10.1007/s00404-017-4515-5; Lerner V, 2019, J GYNECOL SURG, V35, P363, DOI 10.1089/gyn.2019.0037; Parker WH, 2012, AM J OBSTET GYNECOL, V206, P31, DOI 10.1016/j.ajog.2011.08.021; Raine-Bennett T, 2016, OBSTET GYNECOL, V127, P29, DOI 10.1097/AOG.0000000000001187; Raspagliesi F, 2017, GYNECOL ONCOL, V144, P90, DOI 10.1016/j.ygyno.2016.11.002; Scioscia M, 2020, AM J OBSTET GYNECOL, V223, P605, DOI 10.1016/j.ajog.2020.05.049; Siedhoff MT, 2017, AM J OBSTET GYNECOL, V216, P259, DOI 10.1016/j.ajog.2016.11.1039; Siedhoff MT, 2015, J SURG ONCOL, V112, P769, DOI 10.1002/jso.24010; Wright JD, 2013, OBSTET GYNECOL, V122, P233, DOI 10.1097/AOG.0b013e318299a6cf	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246807	10.1371/journal.pone.0246807	http://dx.doi.org/10.1371/journal.pone.0246807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561167	gold, Green Published			2022-12-26	WOS:000617533000014
J	Zehner, J; Royne, A; Sikorski, P				Zehner, Jennifer; Royne, Anja; Sikorski, Pawel			Calcite seed-assisted microbial induced carbonate precipitation (MICP)	PLOS ONE			English	Article							BACILLUS-PASTEURII; NUCLEATION; UREASE; CEMENTATION; IMPROVEMENT; MORPHOLOGY; GROWTH	Microbial-induced calcium carbonate precipitation (MICP) is a biological process inducing biomineralization of CaCO3. This can be used to form a solid, concrete-like material. To be able to use MICP successfully to produce solid materials, it is important to understand the formation process of the material in detail. It is well known that crystallization surfaces can influence the precipitation process. Therefore, we present in this contribution a systematic study investigating the influence of calcite seeds on the MICP process. We focus on the changes in the pH and changes of the optical density (OD) signal measured with absorption spectroscopy to analyze the precipitation process. Furthermore, optical microscopy was used to visualize the precipitation processes in the sample and connect them to changes in the pH and OD. We show, that there is a significant difference in the pH evolution between samples with and without calcite seeds present and that the shape of the pH evolution and the changes in OD can give detailed information about the mineral precipitation and transformations. In the presented experiments we show, that amorphous calcium carbonate (ACC) can also precipitate in the presence of initial calcite seeds and this can have implications for consolidated MICP materials.	[Zehner, Jennifer; Sikorski, Pawel] Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway; [Royne, Anja] Univ Oslo UiO, Njord Ctr, Dept Phys, Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo	Zehner, J (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway.	jennifer.s.zehner@ntnu.no	Sikorski, Pawel/A-2304-2009; Royne, Anja/N-2772-2014	Sikorski, Pawel/0000-0001-9413-1623; Royne, Anja/0000-0002-6868-6251	Research Council of Norway [269084/O70]; Norwegian Micro-and Nano-Fabrication Facility, NorFab under Research Council of Norway [245963/F50]	Research Council of Norway(Research Council of Norway); Norwegian Micro-and Nano-Fabrication Facility, NorFab under Research Council of Norway	This work was supported by the Research Council of Norway under project 269084/O70. Additional support was provided by Norwegian Micro-and Nano-Fabrication Facility, NorFab under Research Council of Norway project 245963/F50. https://www.forskningsradet.no/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achal V, 2009, J IND MICROBIOL BIOT, V36, P981, DOI 10.1007/s10295-009-0578-z; Cheng L, 2017, J GEOTECH GEOENVIRON, V143, DOI 10.1061/(ASCE)GT.1943-5606.0001586; Cuthbert MO, 2012, ECOL ENG, V41, P32, DOI 10.1016/j.ecoleng.2012.01.008; Dawe RA, 1997, J PETROL SCI ENG, V18, P179, DOI 10.1016/S0920-4105(97)00017-X; De Muynck W, 2010, ECOL ENG, V36, P118, DOI 10.1016/j.ecoleng.2009.02.006; DeJong JT, 2006, J GEOTECH GEOENVIRON, V132, P1381, DOI 10.1061/(ASCE)1090-0241(2006)132:11(1381); Ghosh T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210339; Gomez MG, 2015, PROC INST CIV ENG-GR, V168, P206, DOI 10.1680/grim.13.00052; Green DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13524; Hammes Frederik, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P3, DOI 10.1023/A:1015135629155; Ivanov Volodymyr, 2008, Reviews in Environmental Science and Bio/Technology, V7, P139, DOI 10.1007/s11157-007-9126-3; KALTWASSER H, 1972, ARCH MIKROBIOL, V81, P178, DOI 10.1007/BF00412327; Kim DH, 2020, WATER RESOUR RES, V56, DOI 10.1029/2019WR025420; Konrad F, 2016, CRYST GROWTH DES, V16, P6310, DOI 10.1021/acs.cgd.6b00906; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; Lioliou MG, 2007, J COLLOID INTERF SCI, V308, P421, DOI 10.1016/j.jcis.2006.12.045; Mersmann A., 1988, CHEM ENG TECHNOL, V11, P264, DOI [10.1002/ceat.270110136, DOI 10.1002/CEAT.270110136]; Mitchell AC, 2006, GEOMICROBIOL J, V23, P213, DOI 10.1080/01490450600724233; MORSDORF G, 1989, ARCH MICROBIOL, V152, P125, DOI 10.1007/BF00456089; Morse J. W., 1983, REV MINERAL, V11, P227; Mullin J., 2001, CRYSTALLIZATION CHEM; Myhr A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208643; Olderoy MO, 2011, CRYST GROWTH DES, V11, P520, DOI 10.1021/cg101337g; Rodriguez-Blanco JD, 2011, NANOSCALE, V3, P265, DOI 10.1039/c0nr00589d; Royne A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212990; Sarda D, 2009, J IND MICROBIOL BIOT, V36, P1111, DOI 10.1007/s10295-009-0581-4; Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; TAI CY, 1995, AICHE J, V41, P68, DOI 10.1002/aic.690410108; Wang Y, 2020, ARXIV200704094; Whiffin VS, 2007, GEOMICROBIOL J, V24, P417, DOI 10.1080/01490450701436505; Zehner J, 2020, RSC ADV, V10, P20485, DOI 10.1039/d0ra03897k; Zhang WC, 2018, ENVIRON SCI TECHNOL, V52, P9266, DOI 10.1021/acs.est.8b02660	32	8	9	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0240763	10.1371/journal.pone.0240763	http://dx.doi.org/10.1371/journal.pone.0240763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561160	Green Published, gold			2022-12-26	WOS:000617533000022
J	Lu, HY; Huang, APH; Kuo, LT				Lu, Hsueh-Yi; Huang, Abel Po-Hao; Kuo, Lu-Ting			Prognostic value of variables derived from heart rate variability in patients with traumatic brain injury after decompressive surgery	PLOS ONE			English	Article							GLASGOW COMA SCALE; ISCHEMIC-STROKE; MORTALITY; SCORE; PREDICTOR; DEATH	Measurement of heart rate variability can reveal autonomic nervous system function. Changes in heart rate variability can be associated with disease severity, risk of complications, and prognosis. We aimed to investigate the prognostic value of heart rate variability measurements in patients with moderate-to-severe traumatic brain injury after decompression surgery. We conducted a prospective study of 80 patients with traumatic brain injury after decompression surgery using a noninvasive electrocardiography device for data collection. Assessment of heart rate variability parameters included the time and frequency domains. The correlations between heart rate variability parameters and one-year mortality and functional outcomes were analyzed. Time domain measures of heart rate variability, using the standard deviation of the RR intervals and the square root of the mean squared differences of successive RR intervals, were statistically significantly lower in the group of patients with unfavorable outcomes and those that died. In frequency domain analysis, very low-frequency and total power were significantly higher in patients with favorable functional outcomes. High-frequency, low-frequency, and total power were statistically significantly higher in patients who survived for more than one year. Multivariate analysis using a model combining age and the Glasgow Coma Scale score with variables derived from heart rate variability substantially improved the prognostic value for predicting long-term outcome. These findings reinforced the concept that traumatic brain injury impacts the brain-heart axis and cardiac autonomic modulation even after decompression surgery, and variables derived from heart rate variability may be useful predictors of outcome.	[Lu, Hsueh-Yi] Natl Yunlin Univ Sci & Technol, Dept Ind Engn & Management, Touliu, Yunlin County, Taiwan; [Huang, Abel Po-Hao; Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan	National Yunlin University Science & Technology; National Taiwan University; National Taiwan University Hospital	Kuo, LT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.	kuoluting@gmail.com	Kuo, Lu-Ting/AAU-3205-2021	Kuo, Lu-Ting/0000-0002-1405-8700; HUANG, ABEL PO-HAO/0000-0002-5689-6761				Bauer A, 2017, INT J CARDIOL, V237, P19, DOI 10.1016/j.ijcard.2017.03.087; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Camm AJ, 1996, EUR HEART J, V17, P354; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; De Raedt S, 2015, J NEUROL SCI, V348, P24, DOI 10.1016/j.jns.2014.12.007; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ernst G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00240; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Graff B, 2013, J HYPERTENS, V31, P1629, DOI 10.1097/HJH.0b013e328361e48b; Haji-Michael PG, 2000, CRIT CARE MED, V28, P2578, DOI 10.1097/00003246-200007000-00066; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; JENNETT B, 1975, LANCET, V1, P480; Johnston Brian W, 2020, J Intensive Care Soc, V21, P148, DOI 10.1177/1751143719853744; Lakusic Nenad, 2003, Acta Med Croatica, V57, P269; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Machado-Ferrer Y, 2013, CLIN NEUROPHYSIOL, V124, P589, DOI 10.1016/j.clinph.2012.09.008; Morris JA, 2007, J AM COLL SURGEONS, V204, P885, DOI 10.1016/j.jamcollsurg.2007.01.019; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Proctor KG, 2007, J TRAUMA, V63, P33, DOI 10.1097/01.ta.0000251593.32396.df; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; Riganello F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132336; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Takabatake N, 2001, AM J RESP CRIT CARE, V163, P1314, DOI 10.1164/ajrccm.163.6.2004175; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tobaldini E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060852; Vistisen ST, 2014, BRAIN INJURY, V28, P196, DOI 10.3109/02699052.2013.860477; Werdan K, 2009, CAN J PHYSIOL PHARM, V87, P266, DOI 10.1139/Y09-012; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245792	10.1371/journal.pone.0245792	http://dx.doi.org/10.1371/journal.pone.0245792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539419	gold, Green Published			2022-12-26	WOS:000616960200053
J	Tanaka, T; Hirooka, M; Koizumi, Y; Watanabe, T; Yoshida, O; Tokumoto, Y; Nakamura, Y; Sunago, K; Yukimoto, A; Abe, M; Hiasa, Y				Tanaka, Takaaki; Hirooka, Masashi; Koizumi, Yohei; Watanabe, Takao; Yoshida, Osamu; Tokumoto, Yoshio; Nakamura, Yoshiko; Sunago, Koutarou; Yukimoto, Atsushi; Abe, Masanori; Hiasa, Yoichi			Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method	PLOS ONE			English	Article							VENOUS-PRESSURE GRADIENT; RADIATION FORCE IMPULSE; PORTAL-HYPERTENSION; ESOPHAGEAL-VARICES; CIRRHOSIS; DIAGNOSIS; MANAGEMENT; THERAPY	Background Hepatic venous pressure gradient (HVPG) is the gold standard index for evaluating portal hypertension; however, measuring HVPG is invasive. Although transient elastography (TE) is the most common procedure for evaluating organ stiffness, accurate measurement of spleen stiffness (SS) is difficult. We developed a device to demonstrate the diagnostic precision of TE and suggest this technique as a valuable new method to measure SS. Methods Of 292 consecutive patients enrolled in this single-centre, translational, cross-sectional study from June through September in 2019, 200 underwent SS measurement (SSM) using an M probe (training set, n = 130; inspection set, n = 70). We performed TE with B-mode imaging using an ultrasound-fusion method, printed new devices with a three-dimensional printer, and attached the magnetic position sensor to the convex and M probes. We evaluated the diagnostic precision of TE to evaluate the risk of esophagogastric varices (EGVs). Results The median spleen volume was 245 mL (range, 64-1,720 mL), and it took 2 minutes to acquire a B-mode image using the ultrasound-fusion method. The median success rates of TE were 83.3% and 57.6% in patients with and without the new device, respectively (p<0.001); it was 76.9% and 35.0% in patients with and without splenomegaly (<100 mL), respectively (p<0.001). In the prediction of EGVs, the areas under the receiver operating characteristic curve were 0.921 and 0.858 in patients with and without the new device, respectively (p = 0.043). When the new device was attached, the positive and negative likelihood ratios were 3.44 and 0.11, respectively. The cut-off value of SSM was 46.0 kPa. Data that were similar between the validation and training sets were obtained. Conclusions The SS can be precisely measured using this new device with TE and ultrasound-fusion method. Similarly, we can estimate the bleeding risk due to EGV using this method.	[Tanaka, Takaaki; Hirooka, Masashi; Koizumi, Yohei; Watanabe, Takao; Yoshida, Osamu; Tokumoto, Yoshio; Nakamura, Yoshiko; Sunago, Koutarou; Yukimoto, Atsushi; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan	Ehime University	Hiasa, Y (corresponding author), Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [18K07634, 18K08007]; AMED [JP20fk0210058]	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	This study was supported a part of funding from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 18K07634 to MH, and 18K08007 to YH, and from AMED under Grant Number JP20fk0210058 to YH.	Bosch J, 2006, SEMIN LIVER DIS, V26, P348, DOI 10.1055/s-2006-951603; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Buck M, 2014, HEPATOLOGY, V59, P1052, DOI 10.1002/hep.26755; Calvaruso V, 2013, J VIRAL HEPATITIS, V20, P867, DOI 10.1111/jvh.12114; Castera L, 2012, J HEPATOL, V56, P696, DOI 10.1016/j.jhep.2011.07.005; Colecchia A, 2018, J HEPATOL, V69, P308, DOI 10.1016/j.jhep.2018.04.023; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; Grace ND, 1997, AM J GASTROENTEROL, V92, P1081; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Groszmann RJ, 2004, HEPATOLOGY, V39, P280, DOI 10.1002/hep.20062; Hametner S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149230; Hiraoka A, 2010, ONCOL REP, V23, P493, DOI 10.3892/or_00000660; Hirooka M, 2011, RADIOLOGY, V261, P960, DOI 10.1148/radiol.11110156; Jensen DM, 2002, GASTROENTEROLOGY, V122, P1620, DOI 10.1053/gast.2002.33419; Koh Christopher, 2012, Clin Liver Dis (Hoboken), V1, P133, DOI 10.1002/cld.78; Kudo M, 2013, J MED ULTRASON, V40, P325, DOI 10.1007/s10396-013-0460-5; Minami Y, 2018, EUR RADIOL, V28, P1986, DOI 10.1007/s00330-017-5162-8; Perello A, 1999, HEPATOLOGY, V30, P1393; Rifai K, 2011, DIGEST LIVER DIS, V43, P491, DOI 10.1016/j.dld.2011.02.011; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Rizzo L, 2011, AM J GASTROENTEROL, V106, P2112, DOI 10.1038/ajg.2011.341; Sgouros SN, 2009, ALIMENT PHARM THER, V30, P965, DOI 10.1111/j.1365-2036.2009.04135.x; Sirli R, 2015, WORLD J GASTROENTERO, V21, P11542, DOI 10.3748/wjg.v21.i41.11542; Stefanescu H, 2011, J GASTROEN HEPATOL, V26, P164, DOI 10.1111/j.1440-1746.2010.06325.x; Takuma Y, 2013, GASTROENTEROLOGY, V144, P92, DOI 10.1053/j.gastro.2012.09.049; Thabut D, 2007, ALIMENT PHARM THER, V26, P359, DOI 10.1111/j.1365-2036.2007.03378.x	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246315	10.1371/journal.pone.0246315	http://dx.doi.org/10.1371/journal.pone.0246315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539456	gold, Green Published			2022-12-26	WOS:000616960200096
J	Habte, A; Gebiremeskel, F; Shewangizaw, M; Dessu, S; Glagn, M				Habte, Aklilu; Gebiremeskel, Feleke; Shewangizaw, Misgun; Dessu, Samuel; Glagn, Mustefa			Uptake of complete postnatal care services and its determinants among rural women in Southern Ethiopia: Community-based cross-sectional study based on the current WHO recommendation	PLOS ONE			English	Article								Background Postnatal care services are a constellation of preventive care, practices, and assessments designed to identify and manage maternal and newborn complications during the first six weeks after birth. Recognizing the role of the appropriate PNC at this critical time, the World Health Organization recommended four visits as a complete PNC for all post-partum mothers and newborns to ensure their survival. Although there have been numerous studies on the factors affecting the general PNC service in Ethiopia, there is a shortage of evidence on the use of complete postnatal care services and its determinants. Therefore, the objective of this study was to assess the uptake of full postnatal care service and its determinants among women who recently gave birth in the Ezha district of southern Ethiopia. Methods A community-based cross-sectional study was conducted in Ezha district. A two-stage sampling technique was applied. A total of 568 mothers who stayed for at least 6 weeks after childbirth from selected Kebeles were included in the study using computer-generated random numbers. Data collected through pre-established, structured, and interviewer-administered questionnaires were entered into EpiData3.1 and exported to SPPS version 23 for analysis. The Principal Components Analysis (PCA) was carried out to assess the wealth status of participants. The Multivariable logistic regression model has been fitted to identify the determinants of complete post-natal care service uptake. Results The overall uptake of complete postnatal care services in the study area was 23.9% [95% CI: (19.9, 27.5)]. The factors namely; maternal education of secondary and above [AOR: 4.31, 95%CI: 2.15, 8.05], having four and more antenatal visits [AOR: 4.03, 95%CI: 1.83, 8.85], Caesarean delivery [AOR: 3.75, 95%CI: 1.78, 7.92], having good knowledge on PNC [AOR: 4.31, 95%CI: 2.34, 9.04], and being a model household [AOR: 3.61, 95%CI: 1.97, 6.64] were recognized as determinants complete postnatal care uptake. Conclusion and recommendation Complete post-natal care services uptake in the study area was low. Thus, a due emphasis should be given to behavioral change communication activities to improve maternal knowledge on PNC and enhancing adequate ANC uptake by health workers in the district. Besides, health extension workers in the district need to work on creating a model household through continuing education, support, and follow-up.	[Habte, Aklilu] Wachemo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth, Hosanna, Ethiopia; [Gebiremeskel, Feleke; Glagn, Mustefa] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Shewangizaw, Misgun] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hlth Educ & Promot Unit, Arba Minch, Southern Ethiop, Ethiopia; [Dessu, Samuel] Wolkite Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Wolkite, Southern Ethiop, Ethiopia	Arba Minch University; Arba Minch University	Habte, A (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth, Hosanna, Ethiopia.	akliluhabte57@gmail.com	Habte, Aklilu/ABB-7649-2020; hailegebireal, aklilu habte/ABD-1527-2020	hailegebireal, aklilu habte/0000-0002-5719-4294				Abebo TA, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0256-6; Aboubaker S, 2014, J GLOB HEALTH, V4, P32, DOI 10.7189/jogh.04.020302; ACOG, 2018, PRES TASK FORC RED P; Agha S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0979-8; Akibu M, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/8625437; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Angore BN, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0140-6; [Anonymous], 2016, US ENERGY INF ADM, V2016, P7; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; [Anonymous], 2014, REC POSTN CAR MOTH N; CSAE, 2016, CENTR STAT AG ETH ET; Darega B, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0940-x; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Desta SH., 2017, INT J SOC SCI MANAG, V4, P248; Gogia S, 2016, J PERINATOL, V36, pS54, DOI 10.1038/jp.2016.33; Hodgins S., 2017, POSTNATAL CARE FOCUS; James L, 2015, CURR RES J SOC SCI, V7, P106; Jolivet RR, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1763-8; Kante AM, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0769-8; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Li C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-31; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mon A.S., 2018, WOMEN ITS DETERMINAN; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Organization WH, 2015, HLTH 2015 MDGS MILL; rajesh B, 2017, EFFECT WOMENS EMPOWE, V46, P95; Sado L, 2014, SOC SCI MED, V114, P169, DOI 10.1016/j.socscimed.2014.05.047; Sakeah E, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1926-7; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tesfahun F, 2014, MATERN CHILD HLTH J, V18, P2341, DOI 10.1007/s10995-014-1474-3; UN-DESA, 2017, SUST DEV GOAL 3 ENS; UNICEF, 2016, OP FRAM GLOB STRAT W; UNICEF, 2017, MAT NEWB HLTH DISP E; UNICEF World Health Organization World Bank Group United Nations, 2017, LEV TRENDS CHILD MOR; United Nations, 2018, SUST DEV GOALS REP 2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2017, ALL EYES MAT HLTH; WHO, 2013, WORLD HLTH STAT 2013; WHO/UNICEF, 2010, HOM VIS NEWB CHILD S; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2010, WHO TECHN CONS POSTP; World Health Organization, 2015, PREGN CHILDB POSTP N; 2018, CURR OPIN TOXICOL, V10	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246243	10.1371/journal.pone.0246243	http://dx.doi.org/10.1371/journal.pone.0246243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534844	Green Published, gold			2022-12-26	WOS:000616739700059
J	Milusheva, S; Marty, R; Bedoya, G; Williams, S; Resor, E; Legovini, A				Milusheva, Sveta; Marty, Robert; Bedoya, Guadalupe; Williams, Sarah; Resor, Elizabeth; Legovini, Arianna			Applying machine learning and geolocation techniques to social media data (Twitter) to develop a resource for urban planning	PLOS ONE			English	Article							CRASH FREQUENCY; BIG DATA	With all the recent attention focused on big data, it is easy to overlook that basic vital statistics remain difficult to obtain in most of the world. What makes this frustrating is that private companies hold potentially useful data, but it is not accessible by the people who can use it to track poverty, reduce disease, or build urban infrastructure. This project set out to test whether we can transform an openly available dataset (Twitter) into a resource for urban planning and development. We test our hypothesis by creating road traffic crash location data, which is scarce in most resource-poor environments but essential for addressing the number one cause of mortality for children over five and young adults. The research project scraped 874,588 traffic related tweets in Nairobi, Kenya, applied a machine learning model to capture the occurrence of a crash, and developed an improved geoparsing algorithm to identify its location. We geolocate 32,991 crash reports in Twitter for 2012-2020 and cluster them into 22,872 unique crashes during this period. For a subset of crashes reported on Twitter, a motorcycle delivery service was dispatched in real-time to verify the crash and its location; the results show 92% accuracy. To our knowledge this is the first geolocated dataset of crashes for the city and allowed us to produce the first crash map for Nairobi. Using a spatial clustering algorithm, we are able to locate portions of the road network (<1%) where 50% of the crashes identified occurred. Even with limitations in the representativeness of the data, the results can provide urban planners with useful information that can be used to target road safety improvements where resources are limited. The work shows how twitter data might be used to create other types of essential data for urban planning in resource poor environments.	[Milusheva, Sveta; Marty, Robert; Bedoya, Guadalupe; Legovini, Arianna] World Bank, Dev Impact Evaluat Dept, Washington, DC 20433 USA; [Williams, Sarah] MIT, Sch Architecture & Planning, Cambridge, MA USA; [Resor, Elizabeth] Univ Calif Berkeley, Sch Informat, Berkeley, CA USA	The World Bank; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Milusheva, S (corresponding author), World Bank, Dev Impact Evaluat Dept, Washington, DC 20433 USA.	smilusheva@worldbank.org		Williams, Sarah/0000-0002-8662-8506				Aggarwal C. C., 2012, MINING TEXT DATA; Al-Olimat H., 2018, P 27 INT C COMP LING; [Anonymous], 2020, MOB EC 2020; [Anonymous], 2015, GUID ROAD 8; Batty Michael, 2013, Dialogues Hum Geogr, V3, P274, DOI 10.1177/2043820613513390; Bender O, 2003, MAXIMUM ENTROPY MODE, DOI [10.3115/1119176.1119196, DOI 10.3115/1119176.1119196]; Bhargava R, 2014, CLIFF CLAVIN DETERMI; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; de Bruijn JA, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0326-9; Dhavase N, 2014, 2014 INTERNATIONAL CONFERENCE FOR CONVERGENCE OF TECHNOLOGY (I2CT); Finkel JR, 2005, P 43 ANN M ASS COMP; Gatica-Perez D, 2019, P 1 INT WORKSH FAIRN, P4; Gelernter J, 2013, GEOINFORMATICA, V17, P635, DOI 10.1007/s10707-012-0173-8; Gerber MS, 2014, DECIS SUPPORT SYST, V61, P115, DOI 10.1016/j.dss.2014.02.003; Gu YM, 2016, TRANSPORT RES C-EMER, V67, P321, DOI 10.1016/j.trc.2016.02.011; Hao JW, 2015, J URBAN MANAG, V4, P92, DOI 10.1016/j.jum.2015.11.002; IEAG, 2014, WORLD COUNTS MOB DAT; Jaidka K, 2020, P NATL ACAD SCI USA, V117, P10165, DOI 10.1073/pnas.1906364117; Karimzadeh M, 2019, T GIS, V23, P118, DOI 10.1111/tgis.12510; Kemp S, DIGITAL 2020 GLOBAL; Kitchin R, 2014, GEOJOURNAL, V79, P1, DOI 10.1007/s10708-013-9516-8; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Mai E, 2013, TRANSP RES BOARD 201; Malmasi S., 2016, C PAC ASS COMP LING, P123, DOI DOI 10.1093/OXFORDHB/9780195381979.013.0003; Meier Patrick, 2015, DIGITAL HUMANITARIAN; Middleton SE, 2014, IEEE INTELL SYST, V29, P9, DOI 10.1109/MIS.2013.126; Miller G, 2011, SCIENCE, V333, P1814, DOI 10.1126/science.333.6051.1814; Notzon F, 2015, GLOBAL PROGRAM CIVIL; Premamayudu B, 2019, INT J INNOVATIVE TEC, V8; Resch B, 2016, URBAN PLAN, V1, P114, DOI 10.17645/up.v1i2.617; Ristea A, 2020, INT J GEOGR INF SCI, V34, P1708, DOI 10.1080/13658816.2020.1719495; Ritter Alan, 2011, P 2011 C EMP METH NA; Salas A, 2017, IEEE INT C INTELL TR; Sangameswar M. V., 2017, J BIG DATA-GER, V4, P39, DOI [10.1186/s40537-017-0096-1, DOI 10.1186/S40537-017-0096-1]; Serajuddin U., 2015, DATA DEPRIVATION ANO; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142209; Steiger E, 2015, COMPUT ENVIRON URBAN, V54, P255, DOI 10.1016/j.compenvurbsys.2015.09.007; Wahab L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214966; Wang Q, 2018, P NATL ACAD SCI USA, V115, P7735, DOI 10.1073/pnas.1802537115; Williams S., 2020, DATA ACTION USING DA; World Health Organisation, 2018, GLOB STAT REP ROAD S; World Health Organization, 2010, DAT SYST ROAD SAF MA; Yang DQ, 2018, WORLD WIDE WEB, V21, P1323, DOI 10.1007/s11280-017-0515-4; Yin J., 2015, P 24 INT JOINT C ART; Zeng Q, 2016, ACCIDENT ANAL PREV, V97, P87, DOI 10.1016/j.aap.2016.08.017; Zeng Q, 2016, ANAL METHODS ACCID R, V10, P12, DOI 10.1016/j.amar.2016.03.002; Zhang ZH, 2018, TRANSPORT RES C-EMER, V86, P580, DOI 10.1016/j.trc.2017.11.027	48	14	14	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0244317	10.1371/journal.pone.0244317	http://dx.doi.org/10.1371/journal.pone.0244317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534801	gold, Green Published			2022-12-26	WOS:000616739700003
J	Park, DY; Kim, JS; Park, B; Kim, HJ				Park, Do-Yang; Kim, Ji-Su; Park, Bumhee; Kim, Hyun Jun			Risk factors and clinical prediction formula for the evaluation of obstructive sleep apnea in Asian adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BUSSELTON-HEALTH; HYPOPNEA INDEX; GUIDELINE; DRIVERS; POLICY; NEED	Obstructive sleep apnea is a highly prevalent cyclic repetitive hypoxia-normoxia respiratory sleep disorder characterized by intermittent upper-airway collapse. It is mainly diagnosed using in-laboratory polysomnography. However, the time-spatial constraints of this procedure limit its application. To overcome these limitations, there have been studies aiming to develop clinical prediction formulas for screening of obstructive sleep apnea using the risk factors for this disorder. However, the applicability of the formula is restricted by the group specific factors included in it. Therefore, we aimed to assess the risk factors for obstructive sleep apnea and develop clinical prediction formulas, which can be used in different situations, for screening and assessing this disorder. We enrolled 3,432 Asian adult participants with suspected obstructive sleep apnea who had successfully undergone in-laboratory polysomnography. All parameters were evaluated using correlation analysis and logistic regression. Among them, age, sex, hypertension, diabetes mellitus, anthropometric factors, Berlin questionnaire and Epworth Sleepiness Scale scores, and anatomical tonsil and tongue position were significantly associated with obstructive sleep apnea. To develop the clinical formulas for obstructive sleep apnea, the participants were divided into the development (n = 2,516) and validation cohorts (n = 916) based on the sleep laboratory visiting date. We developed and selected 13 formulas and divided them into those with and without physical examination based on the ease of application; subsequently, we selected suitable formulas based on the statistical analysis and clinical applicability (formula including physical exam: sensitivity, 0.776; specificity, 0.757; and AUC, 0.835; formula without physical exam: sensitivity, 0.749; specificity, 0.770; and AUC, 0.839). Analysis of the validation cohort with developed formulas showed that these models and formula had sufficient performance and goodness of fit of model. These tools can effectively utilize medical resources for obstructive sleep apnea screening in various situations.	[Park, Do-Yang; Kim, Hyun Jun] Ajou Univ, Dept Otolaryngol, Sch Med, Suwon, South Korea; [Park, Do-Yang; Kim, Hyun Jun] Ajou Univ Hosp, Sleep Ctr, Suwon, South Korea; [Kim, Ji-Su; Park, Bumhee] Ajou Univ, Ajou Res Inst Innovat Med, Off Biostat, Med Ctr, Suwon, South Korea; [Park, Bumhee] Ajou Univ, Dept Biomed Informat, Sch Med, Suwon, South Korea	Ajou University; Ajou University; Ajou University Hospital; Ajou University; Ajou University	Kim, HJ (corresponding author), Ajou Univ, Dept Otolaryngol, Sch Med, Suwon, South Korea.; Kim, HJ (corresponding author), Ajou Univ Hosp, Sleep Ctr, Suwon, South Korea.	entkhj@ajou.ac.kr		PARK, DO YANG/0000-0001-9969-3051	National Research Foundation of Korea - Korean Government [2017R1E1A1A01074543]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HC15C3415]; National Research Foundation of Korea Grant - Korean Government [NRF- 2017R1C1B1007454]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea Grant - Korean Government	This research was supported by a National Research Foundation of Korea grant funded by the Korean Government (2017R1E1A1A01074543) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HC15C3415) to HJ Kim. This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF- 2017R1C1B1007454) to DY Park.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088878; Azarbarzin A, 2019, EUR HEART J, V40, P1149, DOI 10.1093/eurheartj/ehy624; Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cheung YY, 2017, AM J CARDIOL, V119, P996, DOI 10.1016/j.amjcard.2016.11.058; Cho YW, 2011, SLEEP BREATH, V15, P377, DOI 10.1007/s11325-010-0343-6; Donovan LM, 2016, SLEEP, V39, P1353, DOI 10.5665/sleep.5962; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Filomeno R, 2016, IND HEALTH, V54, P469, DOI 10.2486/indhealth.2015-0229; Friedman Michael, 2017, Adv Otorhinolaryngol, V80, P41, DOI 10.1159/000470859; Genta PR, 2008, BRAZ J MED BIOL RES, V41, P728, DOI 10.1590/S0100-879X2008005000033; Gurubhagavatula I, 2016, J CLIN SLEEP MED, V12, P285, DOI 10.5664/jcsm.5560; Harding S M, 2001, Curr Opin Pulm Med, V7, P381, DOI 10.1097/00063198-200111000-00003; Kales SN, 2016, SLEEP, V39, P1171, DOI 10.5665/sleep.5822; Kang K, 2013, SLEEP BREATH, V17, P803, DOI 10.1007/s11325-012-0767-2; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kim ST, 2017, SLEEP BREATH, V21, P885, DOI 10.1007/s11325-017-1506-5; Kljajic Z, 2017, INT J PEDIATR OTORHI, V100, P168, DOI [10.1016/j.ijpor1.2017.06.032, 10.1016/j.ijporl.2017.06.032]; Kramer MF, 2004, AM J OTOLARYNG, V25, P173, DOI 10.1016/j.amjoto.2003.12.004; Lofaso F, 2000, EUR RESPIR J, V16, P639, DOI 10.1034/j.1399-3003.2000.16d12.x; Lorenzi G, 2015, REV PORT PNEUMOL, V21, P53, DOI 10.1016/j.rppnen.2015.02.002; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Marshall NS, 2008, SLEEP, V31, P1079; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; McNicholas WT, 2015, EUR RESPIR REV, V24, P602, DOI 10.1183/16000617.0049-2015; Ng DK, 2005, CHEST, V127, P2285, DOI 10.1378/chest.127.6.2285; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Pan MX, 2019, J THORAC DIS, V11, P4169, DOI 10.21037/jtd.2019.09.83; Pang KP, 2006, AM J OTOLARYNG, V27, P112, DOI 10.1016/j.amjoto.2005.09.002; Ramachandran SK, 2010, ANESTH ANALG, V110, P1007, DOI 10.1213/ANE.0b013e3181d489b0; Rodenstein D, 2008, J SLEEP RES, V17, P281, DOI 10.1111/j.1365-2869.2008.00669.x; Rowley JA, 2000, SLEEP, V23, P929, DOI 10.1093/sleep/23.7.929; Sahin Mustafa, 2014, Int J Otolaryngol, V2014, P438376, DOI 10.1155/2014/438376; Sanders MH, 2003, SLEEP MED, V4, P349, DOI 10.1016/S1389-9457(03)00118-7; Siwasaranond N, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9269170; Sohn SI, 2012, SLEEP BREATH, V16, P803, DOI 10.1007/s11325-011-0579-9; Su PL, 2019, J CLIN SLEEP MED, V15, P1571, DOI 10.5664/jcsm.8014; Taranto-Montemurro L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111846; Ting H, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0094-1; Tripathi A, 2018, J PROSTHODONT, V27, P716, DOI 10.1111/jopr.12627; van der Spuy I, 2018, CAN RESPIR J, V2018, DOI 10.1155/2018/6349790; Veasey SC, 2019, NEW ENGL J MED, V380, P1442, DOI 10.1056/NEJMcp1816152; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246399	10.1371/journal.pone.0246399	http://dx.doi.org/10.1371/journal.pone.0246399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529265	Green Published, gold			2022-12-26	WOS:000616736200042
J	Wang, Y; Takeshita, H; Yamamoto, K; Huang, YB; Wang, C; Nakajima, T; Nozato, Y; Fujimoto, T; Yokoyama, S; Hongyo, K; Nakagami, F; Akasaka, H; Takami, Y; Takeya, Y; Sugimoto, K; Rakugi, H				Wang, Yu; Takeshita, Hikari; Yamamoto, Koichi; Huang, Yibin; Wang, Cheng; Nakajima, Tsuneo; Nozato, Yoichi; Fujimoto, Taku; Yokoyama, Serina; Hongyo, Kazuhiro; Nakagami, Futoshi; Akasaka, Hiroshi; Takami, Yoichi; Takeya, Yasushi; Sugimoto, Ken; Rakugi, Hiromi			A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice	FASEB JOURNAL			English	Article						angiotensin II; angiotensin-converting enzyme 2; ARB; COVID-19; SARS-CoV-2	MYOCARDIAL-INFARCTION; RECEPTOR BLOCKADE; ACE2 ACTIVITY; EXPRESSION; INHIBITION; RAT; HYPERTENSION; DYSFUNCTION; COVID-19; TMPRSS2	In the early phase of the Coronavirus disease 2019 (COVID-19) pandemic, it was postulated that the renin-angiotensin-system inhibitors (RASi) increase the infection risk. This was primarily based on numerous reports, which stated that the RASi could increase the organ Angiotensin-converting enzyme 2 (ACE2), the receptor of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in rodents. RASi can theoretically antagonize the potential influence of angiotensin II (Ang II) on ACE2. However, while Ang II decreases the ACE2 levels in cultured cells, there is little evidence that supports this phenomenon in living animals. In this study, we tested whether Ang II or Ang II combined with its antagonist would alter the ACE2 and other molecules associated with the infection of SARS-CoV-2. Male C57BL6/J mice were administered vehicle, Ang II (400 ng/kg/min), or Ang II with losartan (10 mg/kg/min) for 2 weeks. ACE2 knockout mice were used as a negative control for the ACE2 assay. We found that both Ang II, which elevated blood pressure by 30 mm Hg, and Ang II with losartan, had no effect on the expression or protein activity of ACE2 in the lung, left ventricle, kidney, and ileum. Likewise, these interventions had no effect on the expression of Transmembrane Protease Serine 2 (TMPRSS2) and Furin, proteases that facilitate the virus-cell fusion, and the expression or activity of Tumor Necrosis Factor alpha-Convertase (TACE) that cleaves cell-surface ACE2. Collectively, physiological concentrations of Ang II do not modulate the molecules associated with SARS-CoV-2 infection. These results support the recent observational studies suggesting that the use of RASi is not a risk factor for COVID-19.	[Wang, Yu; Takeshita, Hikari; Yamamoto, Koichi; Huang, Yibin; Wang, Cheng; Nakajima, Tsuneo; Nozato, Yoichi; Fujimoto, Taku; Yokoyama, Serina; Hongyo, Kazuhiro; Nakagami, Futoshi; Akasaka, Hiroshi; Takami, Yoichi; Takeya, Yasushi; Sugimoto, Ken; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Yamamoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kyamamoto@geriat.med.osaka-u.ac.jp	Takeshita, Hikari/L-9812-2014	Yamamoto, Koichi/0000-0003-0107-9315	JSPS KAKENHI [J550703552];  [JP 20H03576]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by a Grant-in-Aid for Scientific Research (No. J550703552) and by JSPS KAKENHI Grant Number JP 20H03576	Agata J, 2006, HYPERTENS RES, V29, P865, DOI 10.1291/hypres.29.865; Brown JD, 2020, LANCET RESP MED, V8, pE28, DOI 10.1016/S2213-2600(20)30158-2; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Gallagher PE, 2006, AM J PHYSIOL-CELL PH, V290, pC420, DOI 10.1152/ajpcell.00409.2004; Gao C, 2020, EUR HEART J, V41, P2058, DOI 10.1093/eurheartj/ehaa433; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gonzalez AA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01212; Gowrisankar YV, 2016, J NEUROCHEM, V138, P74, DOI 10.1111/jnc.13641; Han SX, 2010, TOXICOL APPL PHARM, V245, P100, DOI 10.1016/j.taap.2010.02.009; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; HUANG H, 1989, CLIN EXP HYPERTENS A, V11, P1535, DOI 10.3109/10641968909038181; Igase M, 2005, AM J PHYSIOL-HEART C, V289, pH1013, DOI 10.1152/ajpheart.00068.2005; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Iwanami J, 2014, HYPERTENS RES, V37, P616, DOI 10.1038/hr.2014.49; Jessup JA, 2006, AM J PHYSIOL-HEART C, V291, pH2166, DOI 10.1152/ajpheart.00061.2006; Jin HY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042432, 10.1371/journal.pone.0038502]; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Karram T, 2005, AM J PHYSIOL-HEART C, V289, pH1351, DOI 10.1152/ajpheart.01186.2004; Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762; Li YC, 2015, SHOCK, V43, P395, DOI 10.1097/SHK.0000000000000302; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Marvar PJ, 2014, BIOL PSYCHIAT, V75, P864, DOI 10.1016/j.biopsych.2013.08.024; Matsuzawa Y, 2020, HYPERTENS RES, V43, P1257, DOI 10.1038/s41440-020-00535-8; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Oller J, 2015, MOL CELL BIOL, V35, P3409, DOI 10.1128/MCB.00494-15; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Pedersen KB, 2011, AM J PHYSIOL-REG I, V301, pR1293, DOI 10.1152/ajpregu.00339.2011; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Schulz A, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-37; Shibata S, 2020, HYPERTENS RES, V43, P1028, DOI 10.1038/s41440-020-0515-0; Soler MJ, 2009, AM J PHYSIOL-RENAL, V296, pF398, DOI 10.1152/ajprenal.90488.2008; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Takeda Y, 2007, AM J HYPERTENS, V20, P1119, DOI 10.1016/j.amjhyper.2007.05.008; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wang YJ, 2020, J HEPATOL, V73, P807, DOI 10.1016/j.jhep.2020.05.002; Wang Y, 2021, FASEB J, V35, DOI 10.1096/fj.202100016R; Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987; Wu CQ, 2020, HYPERTENSION, V76, pE29, DOI 10.1161/HYPERTENSIONAHA.120.15782; Wysocki J, 2015, AM J HYPERTENS, V28, P1418, DOI 10.1093/ajh/hpv054; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Zhang YH, 2015, J RENIN-ANGIO-ALDO S, V16, P292, DOI 10.1177/1470320314542829; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55550-8	56	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21419	10.1096/fj.202100016R	http://dx.doi.org/10.1096/fj.202100016R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566370	Green Published			2022-12-26	WOS:000629576700018
J	Le, HTMD; Lie, KK; Etayo, A; Ronnestad, I; Saele, O				Le, Hoang T. M. D.; Lie, Kai K.; Etayo, Angela; Ronnestad, Ivar; Saele, Oystein			Physical and nutrient stimuli differentially modulate gut motility patterns, gut transit rate, and transcriptome in an agastric fish, the ballan wrasse	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MIGRATING MOTOR COMPLEX; COLONIC BEAD EXPULSION; ACID-SENSING SYSTEMS; SMALL-BOWEL MOTILITY; FATTY-ACID; FOOD-INTAKE; GASTROINTESTINAL TRANSIT; CHOLECYSTOKININ CCK; PROXIMAL INTESTINE	The effects of nutrient and mechanical sensing on gut motility and intestinal metabolism in lower vertebrates remains largely unknown. Here we present the transcriptome response to luminal stimulation by nutrients and an inert bolus on nutrient response pathways and also the response on gut motility in a stomachless fish with a short digestive tract; the ballan wrasse (Labrus berggylta). Using an in vitro model, we differentiate how signals initiated by physical stretch (cellulose and plastic beads) and nutrients (lipid and protein) modulate the gut evacuation rate, motility patterns and the transcriptome. Intestinal stretch generated by inert cellulose initiated a faster evacuation of digesta out of the anterior intestine compared to digestible protein and lipid. Stretch on the intestine upregulated genes associated with increased muscle activity, whereas nutrients stimulated increased expression of several neuropeptides and receptors which are directly involved in gut motility regulation. Although administration of protein and lipid resulted in similar bulbous evacuation times, differences in intestinal motility, transit between the segments and gene expression between the two were observed. Lipid induced increased frequency of ripples and standing contraction in the middle section of the intestine compared to the protein group. We suggest that this difference in motility was modulated by factors [prepronociceptin (pnoca), prodynorphin (pdyn) and neuromedin U (nmu), opioid neurotransmitters and peptides] that are known to inhibit gastrointestinal motility and were upregulated by protein and not lipid. Our findings show that physical pressure in the intestine initiate contractions propelling the bolus distally, directly towards the exit, whereas the stimuli from nutrients modulates the motility to prolong the residence time of digesta in the digestive tract for optimal digestion.	[Le, Hoang T. M. D.; Lie, Kai K.; Etayo, Angela; Saele, Oystein] Inst Marine Res, Bergen, Norway; [Le, Hoang T. M. D.; Ronnestad, Ivar] UiB, Dept Biol Sci BIO, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Le, HTMD; Saele, O (corresponding author), Inst Marine Res, Bergen, Norway.; Le, HTMD (corresponding author), UiB, Dept Biol Sci BIO, Bergen, Norway.	hoang.le@skretting.com; oyse@hi.no	Rønnestad, Ivar/A-1774-2013	Rønnestad, Ivar/0000-0001-8789-0197	RESEARCH COUNCIL OF NORWAY [244170]; (Intestinal function and health of ballan wrasse)	RESEARCH COUNCIL OF NORWAY(Research Council of Norway); (Intestinal function and health of ballan wrasse)	This research was funded by the RESEARCH COUNCIL OF NORWAY, grant number 244170 (Project; Intestinal function and health of ballan wrasse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa S, 2008, REGUL PEPTIDES, V151, P147, DOI 10.1016/j.regpep.2008.08.001; ANDREWS PLR, 1993, PHILOS T ROY SOC B, V342, P363, DOI 10.1098/rstb.1993.0165; [Anonymous], 2009, FISH NEUROENDOCRINOL, P467; Arkwright JW, 2016, J BIOPHOTONICS, V9, P305, DOI 10.1002/jbio.201500187; Babaei S, 2017, GEN COMP ENDOCR, V240, P121, DOI 10.1016/j.ygcen.2016.10.003; Bertrand PP, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.21.003.2009; Bharucha AE, 2012, NEUROGASTROENT MOTIL, V24, P977, DOI 10.1111/nmo.12019; BORGSTROM S, 1975, SCAND J GASTROENTERO, V10, P599; Brijs J, 2017, J EXP BIOL, V220, P2397, DOI 10.1242/jeb.156000; Brijs J, 2017, J EXP BIOL, V220, P347, DOI 10.1242/jeb.141523; Brijs J, 2014, J EXP BIOL, V217, P3015, DOI 10.1242/jeb.101741; BUENO L, 1988, BAILLIERE CLIN GASTR, V2, P123, DOI 10.1016/0950-3528(88)90024-3; Calo G, 2000, BRIT J PHARMACOL, V129, P1261, DOI 10.1038/sj.bjp.0703219; Camilleri M, 2016, CELL MOL GASTROENTER, V2, P412, DOI 10.1016/j.jcmgh.2016.04.003; Cannon WB, 1912, AM J PHYSIOL, V30, P114, DOI 10.1152/ajplegacy.1912.30.1.114; Cannon WB, 1902, J MED RES, V7, P72; Chang E.B., 2014, GASTROINTESTINAL SYS, P35, DOI [10.1007/978-94-017-8771-0_2, DOI 10.1007/978-94-017-8771-0_2]; Chang EB, 2014, GASTROINTESTINAL NUT, P35, DOI [10.1007/978-94-017-8771-0_2, DOI 10.1007/978-94-017-8771-0_2]; CHAVKIN C, 1985, J NEUROSCI, V5, P808; Comesana S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01209; Comesana S, 2018, AM J PHYSIOL-REG I, V314, pR201, DOI 10.1152/ajpregu.00283.2017; Conde-Sieira M, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00603; D'Antona G, 2001, NEUROGASTROENT MOTIL, V13, P483, DOI 10.1046/j.1365-2982.2001.00282.x; DEFILIPPI C, 1995, NEUROGASTROENT MOTIL, V7, P229, DOI 10.1111/j.1365-2982.1995.tb00230.x; DELAET MH, 1989, NEUROCHEM INT, V14, P129, DOI 10.1016/0197-0186(89)90112-5; Deloose E, 2016, AM J PHYSIOL-GASTR L, V310, pG228, DOI 10.1152/ajpgi.00212.2015; Deloose E, 2012, NAT REV GASTRO HEPAT, V9, P271, DOI 10.1038/nrgastro.2012.57; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Druce M, 2006, ARCH DIS CHILD, V91, P183, DOI 10.1136/adc.2005.073759; Earley S, 2013, PFLUG ARCH EUR J PHY, V465, P1223, DOI 10.1007/s00424-013-1250-z; EHRLEIN HJ, 1987, AM J PHYSIOL, V253, pG259, DOI 10.1152/ajpgi.1987.253.3.G259; EHRLEIN HJ, 1983, J PHYSIOL-LONDON, V338, P75, DOI 10.1113/jphysiol.1983.sp014661; France M, 2012, NEUROGASTROENT MOTIL, V24, pe450, DOI 10.1111/j.1365-2982.2012.01981.x; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Grider John R., 1994, Journal of Nutrition, V124, p1334S, DOI 10.1093/jn/124.suppl_8.1334S; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1660, DOI 10.1152/ajpgi.00580.2006; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1162, DOI 10.1152/ajpgi.00441.2006; Gwynne RM, 2004, J PHYSIOL-LONDON, V556, P557, DOI 10.1113/jphysiol.2003.057182; Helland IB, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e82; Hennig GW, 2010, NEUROGASTROENT MOTIL, V22, pe207, DOI 10.1111/j.1365-2982.2009.01453.x; Hoffman JM, 2010, J VIS EXP, DOI [10.3791/2435 21189461, DOI 10.3791/243521189461]; Hurst NR, 2014, NEUROGASTROENT MOTIL, V26, P1586, DOI 10.1111/nmo.12425; Husebye E, 1999, NEUROGASTROENT MOTIL, V11, P141; ITOH Z, 1981, AM J PHYSIOL, V240, pG324, DOI 10.1152/ajpgi.1981.240.4.G324; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Jarry AC, 2019, FASEB J, V33, P5377, DOI 10.1096/fj.201801718R; Jiang HW, 2017, J NUTR BIOCHEM, V50, P74, DOI 10.1016/j.jnutbio.2017.08.015; KEINKE O, 1983, Q J EXP PHYSIOL CMS, V68, P675, DOI 10.1113/expphysiol.1983.sp002757; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KOSLO RJ, 1986, J PHARMACOL EXP THER, V238, P62; Kunze WAA, 1999, ANNU REV PHYSIOL, V61, P117, DOI 10.1146/annurev.physiol.61.1.117; LaForge KS, 2004, BRAIN RES BULL, V63, P119, DOI 10.1016/j.brainresbull.2004.01.008; Le HTMD, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00553; Le HTMD, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00140; LENGYEL P, 1969, BACTERIOL REV, V33, P264, DOI 10.1128/MMBR.33.2.264-301.1969; Li S, 2017, FISH SHELLFISH IMMUN, V71, P50, DOI 10.1016/j.fsi.2017.09.050; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LIE O, 1991, J CHROMATOGR-BIOMED, V565, P119, DOI 10.1016/0378-4347(91)80376-N; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacDonald E, 2009, GEN COMP ENDOCR, V161, P252, DOI 10.1016/j.ygcen.2009.01.021; McLaughlin JT, 1998, J PHYSIOL-LONDON, V513, P11, DOI 10.1111/j.1469-7793.1998.011by.x; Miguel-Aliaga I, 2012, SEMIN CELL DEV BIOL, V23, P614, DOI 10.1016/j.semcdb.2012.01.002; Morais S, 2005, J FISH BIOL, V67, P223, DOI 10.1111/j.0022-1112.2005.00731.x; Navarro-Guillen C, 2017, COMP BIOCHEM PHYS A, V203, P126, DOI 10.1016/j.cbpa.2016.09.003; Olsson C, 2001, COMP BIOCHEM PHYS A, V128, P481, DOI 10.1016/S1095-6433(00)00330-5; Pitts PM, 2017, COMP BIOCHEM PHYS A, V208, P80, DOI 10.1016/j.cbpa.2017.03.018; RAFFA RB, 1987, LIFE SCI, V41, P2229, DOI 10.1016/0024-3205(87)90520-0; Rathore RM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.69; Reed DE, 2014, NEUROGASTROENT MOTIL, V26, P1663, DOI 10.1111/nmo.12442; Ronnestad I, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00073; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; SARNA SK, 1986, AM J PHYSIOL, V250, pG213, DOI 10.1152/ajpgi.1986.250.2.G213; SCHEMANN M, 1986, GASTROENTEROLOGY, V90, P991, DOI 10.1016/0016-5085(86)90878-4; SCHMID HR, 1993, DIGEST DIS SCI, V38, P1062, DOI 10.1007/BF01295722; Schwartz GJ, 2011, PHYSIOL BEHAV, V104, P621, DOI 10.1016/j.physbeh.2011.05.003; SIEGLE ML, 1988, AM J PHYSIOL, V254, pG552, DOI 10.1152/ajpgi.1988.254.4.G552; SPILLER RC, 1988, GUT, V29, P1042, DOI 10.1136/gut.29.8.1042; Staljanssens D, 2011, PEPTIDES, V32, P607, DOI 10.1016/j.peptides.2010.11.025; SZURSZEWSKI JH, 1969, AM J PHYSIOL, V217, P1757, DOI 10.1152/ajplegacy.1969.217.6.1757; Tian J, 2018, GEN COMP ENDOCR, V257, P246, DOI 10.1016/j.ygcen.2017.10.010; Tinoco AB, 2015, COMP BIOCHEM PHYS A, V187, P193, DOI 10.1016/j.cbpa.2015.05.027; Tse G, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00182; van der Wielen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107531; Volkoff H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00540; Welcome MO, 2018, GASTROINTESTINAL PHY, P353, DOI [10.1007/978-3-319-91056-7_7, DOI 10.1007/978-3-319-91056-7_7]; Xu DD, 2016, BRIT J NUTR, V115, P379, DOI 10.1017/S0007114515004535; Yang L, 2014, GEN COMP ENDOCR, V200, P27, DOI 10.1016/j.ygcen.2014.01.016; Zhang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12646-3	89	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0247076	10.1371/journal.pone.0247076	http://dx.doi.org/10.1371/journal.pone.0247076			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571240	Green Published, gold			2022-12-26	WOS:000618274000025
J	Orfei, M; Gasparetto, M; Hensel, KO; Zellweger, F; Heuschkel, RB; Zilbauer, M				Orfei, Martina; Gasparetto, Marco; Hensel, Kai O.; Zellweger, Florian; Heuschkel, Robert B.; Zilbauer, Matthias			Guidance on the interpretation of faecal calprotectin levels in children	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DIAGNOSIS	Background Faecal calprotectin (FCP) is a powerful tool to predict inflammatory bowel disease (IBD) in patients with gastrointestinal symptoms. In the paediatric patient population, the reference value of < 50 mu g/g and the influence of age on FCP levels result in a high number of redundant investigations and specialist referrals. We assessed paediatric FCP levels, their diagnostic value and corresponding referral pathways from primary and secondary care. Methods We analysed two cohorts from a precisely defined catchment area: one consisted of all FCPs measured in this area (n = 2788). The second cohort-a subset of the first cohort-consisted of FCP values and corresponding clinical data from children who were referred for possible IBD to our department (n = 373). Results In the first cohort, 47% of FCP levels were > 50 mu g/g, 15% were >= 250 mu g/g. Children < 1y had significantly (p < 0.001) higher FCP than older children. In the second cohort, 6.7% of children with an FCP of < 250 mu g/g (or 8.6% with an FCP of < 600 mu g/g) had IBD-all featured symptoms suggestive of IBD (e.g. bloody diarrhoea, nocturnal abdominal pain, weight loss) or abnormal blood tests. 76% of patients in whom raised FCP (> 50 mu g/g) was the sole reason for being referred for suspected IBD did not have IBD. Conclusion Children with an FCP < 600 mu g/g and without matching symptoms suggestive of IBD are unlikely to have IBD. A higher FCP reference value may provide cost-effective improvement that could avoid redundant investigations and specialist referrals. A guideline for specialist referrals is proposed.	[Orfei, Martina; Gasparetto, Marco; Hensel, Kai O.; Heuschkel, Robert B.; Zilbauer, Matthias] Cambridge Univ Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge, England; [Hensel, Kai O.] Univ Witten Herdecke, Fac Hlth, Ctr Clin & Translat Res, Dept Paediat, Witten, Germany; [Zellweger, Florian] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Zellweger, Florian] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Zilbauer, Matthias] Univ Cambridge, Dept Paediat, Cambridge, England	University of Cambridge; Witten Herdecke University; University of Cambridge; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Cambridge	Orfei, M (corresponding author), Cambridge Univ Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge, England.	om1@gmx.ch		Hensel, Kai O./0000-0001-5826-6133	Gottfried-und-Julia-Bangerter-Rhyner foundation [0102/2018]; Swiss National Science Foundation SNF [172198]; Isaac Newton Trust	Gottfried-und-Julia-Bangerter-Rhyner foundation; Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF)); Isaac Newton Trust	MO was funded by the Gottfried-und-Julia-Bangerter-Rhyner foundation (ID 0102/2018). URL: www.bangerter-stiftung.ch FZ was funded by the Swiss National Science Foundation SNF (Grant No: 172198) and the Isaac Newton Trust. www.snf.ch, www.newtontrust.cam.ac.uk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buisson A, 2019, J CROHNS COLITIS, V13, P1012, DOI 10.1093/ecco-jcc/jjz023; Davidson F, 2017, ANN CLIN BIOCHEM, V54, P214, DOI 10.1177/0004563216639335; Degraeuwe PLJ, 2015, J PEDIATR GASTR NUTR, V60, P339, DOI 10.1097/MPG.0000000000000615; Dilillo D, 2019, SCAND J GASTROENTERO, V54, P586, DOI 10.1080/00365521.2019.1604799; Heida A, 2018, ARCH DIS CHILD, V103, P565, DOI 10.1136/archdischild-2017-314081; Heida A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015636; Heida A, 2016, J PEDIATR GASTR NUTR, V62, P47, DOI 10.1097/MPG.0000000000000939; Henderson P, 2014, AM J GASTROENTEROL, V109, P637, DOI 10.1038/ajg.2013.131; Holtman GA, 2017, JAMA PEDIATR, V171, P984, DOI 10.1001/jamapediatrics.2017.1736; Kapel N, 2010, J PEDIATR GASTR NUTR, V51, P542, DOI 10.1097/MPG.0b013e3181e2ad72; Kostakis ID, 2013, DIGEST DIS SCI, V58, P309, DOI 10.1007/s10620-012-2347-5; Leach ST, 2019, J PEDIAT GASTROENTER; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Oord T, 2014, SCAND J CLIN LAB INV, V74, P254, DOI 10.3109/00365513.2013.879732; Pieczarkowski S, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/8089217; R Core Team, 2018, R LANG ENV STAT COMP; Ricciuto A, 2019, CRIT REV CL LAB SCI, V56, P307, DOI 10.1080/10408363.2019.1619159; Roca M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77625-7; Roca M, 2017, J PEDIATR GASTR NUTR, V65, P394, DOI 10.1097/MPG.0000000000001542; Turner D, 2018, J PEDIATR GASTR NUTR, V67, P257, DOI 10.1097/MPG.0000000000002035; Van de Vijver E, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-2235; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; Waugh N, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17550; Yang Z, 2014, CLIN GASTROENTEROL H, V12, P253, DOI 10.1016/j.cgh.2013.06.028; Zeevenhooven J, 2020, J PEDIATR-US, V219, P76, DOI 10.1016/j.jpeds.2019.12.017; Zhu QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150725	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246091	10.1371/journal.pone.0246091	http://dx.doi.org/10.1371/journal.pone.0246091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571226	Green Published, gold			2022-12-26	WOS:000618274000014
J	Mousavi, SH; van Kouwenhove, L; Rajabi, R; Zwerver, J; Hijmans, JM				Mousavi, Seyed Hamed; van Kouwenhove, Laurens; Rajabi, Reza; Zwerver, Johannes; Hijmans, Juha M.			The effect of changing foot progression angle using real-time visual feedback on rearfoot eversion during running	PLOS ONE			English	Article								Atypical rearfoot in/eversion may be an important risk factor for running-related injuries. Prominent interventions for atypical rearfoot eversion include foot orthoses, footwear, and taping but a modification derived from gait retraining to correct atypical rearfoot in/eversion is lacking. We aimed to investigate changes in rearfoot in/eversion, subtalar pronation, medial longitudinal arch angle, and selected lower limb joint biomechanics while performing toe-in/toe-out running using real-time visual feedback. Fifteen female runners participated in this study. Subjects performed toe-in/toe-out running using real-time visual feedback on foot progression angle, which was set +/- 5 degrees from habitual foot progression angle. 3D kinematics of rearfoot in/eversion, subtalar supination/pronation, medial longitudinal arch angle, foot progression angle, hip flexion, ab/adduction and internal/external rotation, knee flexion, ankle dorsiflexion, and ankle power were analyzed. A repeated-measures ANOVA followed by pairwise comparisons was used to analyze changes between three conditions. Toe-in running compared to normal and toe-out running reduced peak rearfoot eversion (mean difference (MD) with normal = 2.1 degrees; p<0.001, MD with toe-out = 3.5 degrees; p<0.001), peak pronation (MD with normal = -2.0 degrees; p<0.001, MD with toe-out = -3.4; p = <0.001), and peak medial longitudinal arch angle (MD with normal = -0.7 degrees; p = 0.022, MD with toe-out = -0.9; p = 0.005). Toe-out running significantly increased these kinematic factors compared to normal and toe-in running. Toe-in running compared to normal running increased peak hip internal rotation (MD = 2.3; p< 0.001), and reduced peak knee flexion (MD = 1.3; p = 0.014). Toe-out running compared to normal running reduced peak hip internal rotation (MD = 2.5; p< 0.001), peak hip ab/adduction (MD = 2.5; p< 0.001), peak knee flexion (MD = 1.5; p = 0.003), peak ankle dorsiflexion (MD = 1.6; p< 0.001), and peak ankle power (MD = 1.3; p = 0.001). Runners were able to change their foot progression angle when receiving real-time visual feedback for foot progression angle. Toe-in/toe-out running altered rearfoot kinematics and medial longitudinal arch angle, therefore supporting the potential value of gait retraining focused on foot progression angle using real-time visual feedback when atypical rearfoot in/eversion needs to be modified. It should be considered that changes in foot progression angle when running is accompanied by changes in lower limb joint biomechanics.	[Mousavi, Seyed Hamed; van Kouwenhove, Laurens; Hijmans, Juha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Mousavi, Seyed Hamed; Rajabi, Reza] Univ Tehran, Fac Phys Educ & Sport Sci, Dept Hlth & Sport Med, Tehran, Iran; [Mousavi, Seyed Hamed; Zwerver, Johannes] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Zwerver, Johannes] Gelderse Vallei Hosp, Dept Sports Med, Ede, Netherlands	University of Groningen; University of Tehran; University of Groningen; Gelderse Vallei Hospital	Mousavi, SH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.; Mousavi, SH (corresponding author), Univ Tehran, Fac Phys Educ & Sport Sci, Dept Hlth & Sport Med, Tehran, Iran.; Mousavi, SH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	s.h.mousavi@umcg.nl	Rajabi, Reza/GXM-9107-2022	Zwerver, Johannes/0000-0002-8499-2806; Mousavi, Seyed Hamed/0000-0003-2906-2101; van Kouwenhove, Laurens/0000-0002-6227-8425				Aderem J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0808-7; Agresta C, 2015, J ORTHOP SPORT PHYS, V45, P576, DOI 10.2519/jospt.2015.5823; Banwell HA, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-23; Barnes A, 2011, FOOT ANKLE INT, V32, P710, DOI 10.3113/FAI.2011.0710; Blackwood CB, 2005, FOOT ANKLE INT, V26, P1074, DOI 10.1177/107110070502601213; Britt M, 2019, POTENTIAL RELATIONSH, P1; Chan ZYS, 2018, AM J SPORT MED, V46, P388, DOI 10.1177/0363546517736277; Charlton JM, 2019, J BIOMECH, V89, P123, DOI 10.1016/j.jbiomech.2019.04.012; Cheung RTH, 2011, BRIT J SPORT MED, V45, P743, DOI 10.1136/bjsm.2010.079780; Christensen M, 2013, FOOT, P22, DOI [10.1016/j.foot.2012.12.001, DOI 10.1016/J.FOOT.2012.12.001]; Desmyttere G, 2018, CLIN BIOMECH, V59, P117, DOI 10.1016/j.clinbiomech.2018.09.018; Dixon SJ, 2006, J AM PODIAT MED ASSN, V96, P305, DOI 10.7547/0960305; Ferber R, 2009, SPORTS HEALTH, V1, P242, DOI 10.1177/1941738109334272; Gagliardi C, 2018, ANN BIOMED ENG, V46, P1376, DOI 10.1007/s10439-018-2039-1; Goo YM, 2016, J PHYS THER SCI, V28, P816, DOI 10.1589/jpts.28.816; Hein T, 2014, SCAND J MED SCI SPOR, V24, pE201, DOI 10.1111/sms.12137; Hollander K, 2019, GAIT POSTURE, V72, P109, DOI 10.1016/j.gaitpost.2019.05.031; Hollander K, 2018, GAIT POSTURE, V61, P210, DOI 10.1016/j.gaitpost.2018.01.013; Isman RE, 1969, B PROSTHETICS RES, P97; Jafarnezhadgero A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216818; KERNOZEK TW, 1990, ARCH PHYS MED REHAB, V71, P988; Kim Eun-Kyung, 2016, J Phys Ther Sci, V28, P3136; Kim E, 2017, J SPORT SCI MED, V16, P137; Kuhman DJ, 2016, HUM MOVEMENT SCI, V47, P9, DOI 10.1016/j.humov.2016.01.013; Langley B, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0113-6; Lee J, 2017, J BODYW MOV THER, V21, P216, DOI [10.1016/j.jbmt.2016.07.010, 10.24231/rici.2017.21.3.216]; Levinger P, 2010, GAIT POSTURE, V32, P519, DOI 10.1016/j.gaitpost.2010.07.013; Lilley K, 2013, GAIT POSTURE, V37, P331, DOI 10.1016/j.gaitpost.2012.07.026; McClay I, 1998, FOOT ANKLE INT, V19, P26, DOI 10.1177/107110079801900105; Milner CE, 2010, J ORTHOP SPORT PHYS, V40, P59, DOI 10.2519/jospt.2010.3024; Mousavi SH, 2021, GAIT POSTURE, V83, P201, DOI 10.1016/j.gaitpost.2020.10.032; Mousavi SH, 2020, PHYS THER SPORT, V43, P27, DOI 10.1016/j.ptsp.2020.02.003; Naderi A, 2019, EUR J SPORT SCI, V19, P247, DOI 10.1080/17461391.2018.1503337; Nakamura H, 2003, J PHYS THER SCI, V15, P13, DOI [10.1589/jpts.15.13, DOI 10.1589/JPTS.15.13]; Napier C, 2015, BRIT J SPORT MED, V49, P1382, DOI 10.1136/bjsports-2014-094393; Neal BS, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/s13047-014-0055-4; Nester CJ, 1997, FOOT, V7, P86, DOI [10.1016/S0958-2592(97)90054-7, DOI 10.1016/S0958-2592(97)90054-7]; Nigg B, 2019, FOOTWEAR SCI, V11, P131, DOI 10.1080/19424280.2019.1673489; Noehren B, 2013, MED SCI SPORT EXER, V45, P1120, DOI 10.1249/MSS.0b013e31828249d2; Okamura Kazunori, 2019, Foot (Edinb), V38, P19, DOI 10.1016/j.foot.2018.11.002; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Reinking MF, 2017, SPORTS HEALTH, V9, P252, DOI 10.1177/1941738116673299; Sakaguchi M, 2015, GAIT POSTURE, V41, P557, DOI 10.1016/j.gaitpost.2014.12.014; Sangeorzan A, 2018, FOOT ANKLE CLIN, V23, P341, DOI 10.1016/j.fcl.2018.04.002; Shull PB, 2013, J ORTHOP RES, V31, P1020, DOI 10.1002/jor.22340; Simic M, 2013, OSTEOARTHR CARTILAGE, V21, P1272, DOI 10.1016/j.joca.2013.06.001; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; TIBERIO D, 1987, Journal of Orthopaedic and Sports Physical Therapy, V9, P160; Twomey D, 2010, GAIT POSTURE, V32, P1, DOI 10.1016/j.gaitpost.2010.01.021; Twomey D M, 2012, Foot (Edinb), V22, P60, DOI 10.1016/j.foot.2011.11.005; Uhlrich SD, 2018, J BIOMECH, V66, P103, DOI 10.1016/j.jbiomech.2017.11.003; van den Bogert AJ, 2013, MED BIOL ENG COMPUT, V51, P1069, DOI 10.1007/s11517-013-1076-z; van der Worp MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114937; Vannatta CN, 2020, CLIN BIOMECH, V75, DOI 10.1016/j.clinbiomech.2020.104991; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xia HS, 2017, J BIOMECH, V61, P193, DOI 10.1016/j.jbiomech.2017.07.012; Zhang XY, 2017, GAIT POSTURE, V54, P290, DOI 10.1016/j.gaitpost.2017.03.030	58	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246425	10.1371/journal.pone.0246425	http://dx.doi.org/10.1371/journal.pone.0246425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566828	Green Published, gold			2022-12-26	WOS:000618271700015
J	Cosgrove, CL; Wells, J; Nolin, AW; Putera, J; Prugh, LR				Cosgrove, Christopher L.; Wells, Jeff; Nolin, Anne W.; Putera, Judy; Prugh, Laura R.			Seasonal influence of snow conditions on Dall's sheep productivity in Wrangell-St Elias National Park and Preserve	PLOS ONE			English	Article							POPULATION-DYNAMICS; CLIMATE; CARIBOU; HABITAT; REINDEER; DENSITY; SYSTEM; ALASKA; DEER; ICE	Dall's sheep (Ovis dalli dalli) are endemic to alpine areas of sub-Arctic and Arctic northwest America and are an ungulate species of high economic and cultural importance. Populations have historically experienced large fluctuations in size, and studies have linked population declines to decreased productivity as a consequence of late-spring snow cover. However, it is not known how the seasonality of snow accumulation and characteristics such as depth and density may affect Dall's sheep productivity. We examined relationships between snow and climate conditions and summer lamb production in Wrangell-St Elias National Park and Preserve, Alaska over a 37-year study period. To produce covariates pertaining to the quality of the snowpack, a spatially-explicit snow evolution model was forced with meteorological data from a gridded climate re-analysis from 1980 to 2017 and calibrated with ground-based snow surveys and validated by snow depth data from remote cameras. The best calibrated model produced an RMSE of 0.08 m (bias 0.06 m) for snow depth compared to the remote camera data. Observed lamb-to-ewe ratios from 19 summers of survey data were regressed against seasonally aggregated modelled snow and climate properties from the preceding snow season. We found that a multiple regression model of fall snow depth and fall air temperature explained 41% of the variance in lamb-to-ewe ratios (R-2 = .41, F(2,38) = 14.89, p<0.001), with decreased lamb production following deep snow conditions and colder fall temperatures. Our results suggest the early establishment and persistence of challenging snow conditions is more important than snow conditions immediately prior to and during lambing. These findings may help wildlife managers to better anticipate Dall's sheep recruitment dynamics.	[Cosgrove, Christopher L.; Nolin, Anne W.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Wells, Jeff] Alaska Dept Fish & Game, Tok, AK USA; [Nolin, Anne W.] Univ Nevada, Dept Geog, Reno, NV USA; [Putera, Judy] Wrangell St Elias Natl Pk & Preserve & Cent Alask, Wrangell, AK USA; [Prugh, Laura R.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA USA	Oregon State University; Alaska Department of Fish & Game; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Washington; University of Washington Seattle	Cosgrove, CL (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	cosgrovc@oregonstate.edu		Cosgrove, Christopher/0000-0003-2198-5032	National Aeronautics and Space Administration Terrestrial Ecology Program [NNX15AV86A]	National Aeronautics and Space Administration Terrestrial Ecology Program	AWN and CLC received funding from grant number NNX15AV86A from the National Aeronautics and Space Administration Terrestrial Ecology Program - https://above.nasa.gov/cgi-bin/inv_pgp.pl?pgid=3379&projType=project&projID= 3379&progID=6. LRP received funding from grant number NNX15AU21A from the National Aeronautics and Space Administration Terrestrial Ecology Program - https://above.nasa.gov/cgi-bin/inv_pgp.pl?pgid=3379&projType=project&projID= 3379&progID=6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska Department of Fish and Game, 2014, WMR20143 ADF GDWC; [Anonymous], 2017, 1 ARC 2 DIG EL MOD D; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2005, J PEDIAT GASTROENTER, V41, pS39; [Anonymous], 2017, MEDICINE, V96, pe6504; Arthur SM, 2010, J WILDLIFE MANAGE, V74, P1709, DOI 10.2193/2009-322; Bieniek PA, 2012, J APPL METEOROL CLIM, V51, P1276, DOI 10.1175/JAMC-D-11-0168.1; Boelman NT, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaeec1; Boertje RD, 2019, J WILDLIFE MANAGE, V83, P610, DOI 10.1002/jwmg.21613; Bokhorst S, 2016, AMBIO, V45, P516, DOI 10.1007/s13280-016-0770-0; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Brown R, 2017, SNOW WATER ICE PERMA; BUNNELL FL, 1982, CAN J ZOOL, V60, P1, DOI 10.1139/z82-001; BURLES DW, 1984, CAN FIELD NAT, V98, P479; Callaghan TV, 2011, AMBIO, V40, P32, DOI 10.1007/s13280-011-0213-x; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; COLLINS WB, 1991, ARCTIC, V44, P217; Cooper EJ, 2014, ANNU REV ECOL EVOL S, V45, P271, DOI 10.1146/annurev-ecolsys-120213-091620; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Couturier S, 2009, J MAMMAL, V90, P442, DOI 10.1644/07-MAMM-A-279.1; Danby RK, 2005, ECOL APPL, V15, P405, DOI 10.1890/04-0043; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Domine F, 2018, ARCT SCI, V4, P813, DOI 10.1139/as-2018-0008; Douhard M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1760; DUQUETTE LS, 1988, ARCTIC, V41, P143; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Geist V., 1971, MOUNTAIN SHEEP STUDY; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; Gilbert SL, 2017, J MAMMAL, V98, P246, DOI 10.1093/jmammal/gyw167; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Hansen BB, 2010, CAN J ZOOL, V88, P170, DOI 10.1139/Z09-130; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; HOEFS M, 1984, ARCTIC, V37, P141; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Jacobson AR, 2004, ECOLOGY, V85, P1598, DOI 10.1890/02-0753; Jensen PG, 1999, CAN J ZOOL, V77, P1474, DOI 10.1139/cjz-77-9-1474; Johansson C, 2011, AMBIO, V40, P566, DOI 10.1007/s13280-011-0164-2; Kawaguchi T, 2017, CAN J ZOOL, V95, P949, DOI 10.1139/cjz-2016-0287; KELSALL JP, 1969, J MAMMAL, V50, P302, DOI 10.2307/1378347; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Lambert Koizumi C, 2011, TRC1101 YUK FISH WIL, P64; Langlois A, 2017, REMOTE SENS ENVIRON, V189, P84, DOI 10.1016/j.rse.2016.11.006; LAPERRIERE AJ, 1977, ARCTIC, V30, P101; LISTON GE, 1995, J GLACIOL, V41, P373, DOI 10.3189/S0022143000016245; Liston GE, 2006, J HYDROMETEOROL, V7, P217, DOI 10.1175/JHM486.1; Liston GE, 2002, GLOBAL CHANGE BIOL, V8, P17, DOI 10.1046/j.1354-1013.2001.00416.x; LISTON GE, 1995, J APPL METEOROL, V34, P1705, DOI 10.1175/1520-0450-34.7.1705; Liston GE, 2008, J HYDROMETEOROL, V9, P989, DOI 10.1175/2008JHM871.1; Liston GE, 2007, J GLACIOL, V53, P241, DOI 10.3189/172756507782202865; Liston GE, 2006, J HYDROMETEOROL, V7, P1259, DOI 10.1175/JHM548.1; Liston GE, 2016, ECOL MODEL, V320, P114, DOI 10.1016/j.ecolmodel.2015.09.010; Liston GE, 2011, J CLIMATE, V24, P5691, DOI 10.1175/JCLI-D-11-00081.1; Lundmark C, 2008, ARCT ANTARCT ALP RES, V40, P111, DOI 10.1657/1523-0430(06-103)[LUNDMARK]2.0.CO;2; Mahoney PJ, 2018, ECOL APPL, V28, P1715, DOI 10.1002/eap.1773; McCabe GJ, 2007, B AM METEOROL SOC, V88, P319, DOI 10.1175/BAMS-88-3-319; Mitchell CD, 2015, MAMMAL RES, V60, P21, DOI 10.1007/s13364-014-0199-4; Murie A., 1944, FAUNA SERIES, V5; MURPHY EC, 1976, J WILDLIFE MANAGE, V40, P597, DOI 10.2307/3800554; NASA Jet Propulsion Laboratory (JPL), 2009, ASTER GLOB DIG EL MO, DOI [10.5067/aster/astgtm.002, DOI 10.5067/ASTER/ASTGTM.002]; NPS-Land Resources Division, 2020, ADM BOUND NAT PARK S; ORLANSKI I, 1975, B AM METEOROL SOC, V56, P527; Ouellet F, 2017, PHYS GEOGR, V38, P143, DOI 10.1080/02723646.2016.1274200; Pan CG, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac9d3; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Portier C, 1998, J ZOOL, V245, P271, DOI 10.1111/j.1469-7998.1998.tb00101.x; Pruitt WO., 1959, ARCTIC, V12, P158, DOI [10.14430/arctic3723, DOI 10.14430/ARCTIC3723]; Pulliainen J, 2001, REMOTE SENS ENVIRON, V75, P76, DOI 10.1016/S0034-4257(00)00157-7; RACHLOW JL, 1994, J MAMMAL, V75, P328, DOI 10.2307/1382551; Rattenbury KL, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2513; Reconyx, 2017, HYPERFIRE TM HIGH PE; Reid DG, 2012, OECOLOGIA, V168, P935, DOI 10.1007/s00442-011-2167-x; Robinson BG, 2012, OIKOS, V121, P28, DOI 10.1111/j.1600-0706.2011.19408.x; Roffler GH, 2017, J MAMMAL, V98, P94, DOI 10.1093/jmammal/gyw135; Sarkar D., 2019, NLME LINEAR NONLINEA; SCHAEFER JA, 1995, OECOLOGIA, V104, P39, DOI 10.1007/BF00365560; Schmidt JH, 2012, J WILDLIFE MANAGE, V76, P317, DOI 10.1002/jwmg.216; Schults BS, 2004, NPSARNRTR200446; Serrano E, 2011, EUR J WILDLIFE RES, V57, P45, DOI 10.1007/s10344-010-0398-5; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Sexstone GA, 2018, WATER RESOUR RES, V54, P1191, DOI 10.1002/2017WR021172; Sivy KJ, 2018, CAN J ZOOL, V96, P1170, DOI 10.1139/cjz-2017-0259; STURM M, 1995, J CLIMATE, V8, P1261, DOI 10.1175/1520-0442(1995)008<1261:ASSCCS>2.0.CO;2; Sturm M, 2018, WATER RESOUR RES, V54, P9695, DOI 10.1029/2018WR023559; TELFER ES, 1984, ECOLOGY, V65, P1828, DOI 10.2307/1937779; Tyler NJC, 2010, ECOL MONOGR, V80, P197, DOI 10.1890/09-1070.1; U.S. Geological Survey. NLCD, 2015, NLCD 2011 LAND COV A; Van de Kerk M, 2020, J WILDLIFE MANAGE, V84, P1127, DOI 10.1002/jwmg.21873; van de Kerk M, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aace64; Verbyla D, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9111157; Vikhamar-Schuler D, 2013, ANN GLACIOL, V54, P214, DOI 10.3189/2013AoG62A306; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Wells JJ, 2018, ADFGDWCSMRP201846, P26; White KS, 2011, J WILDLIFE MANAGE, V75, P1731, DOI 10.1002/jwmg.238; Zuur Alain F., 2009, P1	95	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0244787	10.1371/journal.pone.0244787	http://dx.doi.org/10.1371/journal.pone.0244787			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561149	gold, Green Published			2022-12-26	WOS:000617533000046
J	Liu, XH; Suyama, K; Nose, T; Shimohigashi, M; Shimohigashi, Y				Liu, Xiaohui; Suyama, Keitaro; Nose, Takeru; Shimohigashi, Miki; Shimohigashi, Yasuyuki			Bisphenol-C is the strongest bifunctional ER alpha-agonist and ER beta-antagonist due to magnified halogen bonding	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; ENDOCRINE DISRUPTOR; BINDING CHARACTERISTICS; RISK-ASSESSMENT; EXPOSURE	We reported that bisphenol AF (BPAF) works as an agonist for estrogen receptor (ER) ER alpha but as an antagonist for ER beta. Similar results were observed for bisphenol E analogs (BPE-X) such as BPE-F, BPE-Cl, and BPE-Br, each consisting of a series of a tri-halogenated methyl group CX3 in the central alkyl moiety. It was demonstrated that the electrostatic halogen bond based on the dispersion force of halogen atoms is a major driving force in the activities of bifunctional ER alpha-agonist and ER beta-antagonist. Since the chlorine atoms present in bisphenol C (BPC) exist in a pi-pi conjugated system due to the presence of an adjacent C = C double bond, we intended to prove that BPC is also a bifunctional ER alpha-agonist and ER beta-antagonist exhibiting greatly enhanced agonist/antagonist activities. BPC was evaluated for its ability to activate ER alpha and ER beta in the luciferase reporter gene assay using HeLa cells. With high receptor-binding ability to both ERs, BPC was found to be fully active for ER alpha but inactive for ER beta. BPC's definite antagonist activity in ER beta was revealed by its inhibitory activity against 17 beta-estradiol. Thus, BPC is a bifunctional ER alpha-agonist and ER beta-antagonist. These agonist/antagonist activities were discovered to be extremely high among series of halogen-containing bisphenol compounds. This comparative structure-activity study revealed that the ascending order of ER alpha-agonist and ER beta-antagonist activities was BPE-F MUCH LESS-THAN BPE-Cl less than or similar to BPAF < BPE-Br MUCH LESS-THAN BPC. The highly intensified receptor interaction of BPC is attributable to the presence of an n-pi-pi-n conjugation system mediated through the >C = CCl2 double bond.	[Liu, Xiaohui; Suyama, Keitaro; Nose, Takeru; Shimohigashi, Yasuyuki] Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka, Japan; [Liu, Xiaohui] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Microbial Technol, Kumamoto, Japan; [Suyama, Keitaro; Nose, Takeru] Kyushu Univ, Fac Arts & Sci, Fukuoka, Japan; [Shimohigashi, Miki] Fukuoka Univ, Fac Sci, Dept Earth Syst Sci, Div Biol, Fukuoka, Japan; [Shimohigashi, Miki; Shimohigashi, Yasuyuki] Risk Sci Res Inst, Fukuoka, Japan	Kyushu University; Sojo University; Kyushu University; Fukuoka University	Liu, XH; Shimohigashi, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka, Japan.; Liu, XH (corresponding author), Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Microbial Technol, Kumamoto, Japan.; Shimohigashi, Y (corresponding author), Risk Sci Res Inst, Fukuoka, Japan.	xiaohuiscc@kyudai.jp; shimo@kyudai.jp	Suyama, Keitaro/ABE-4606-2022	LIU, Xiaohui/0000-0003-3162-429X; Nose, Takeru/0000-0001-9771-7267	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP25740024, JP15K00557, 19K12340, JP22221005, JP15H01741]; Health and Labour Sciences Research Grant for Research on the Risk of Chemical Substances from the Ministry of Health, Labour, and Welfare of Japan [H20-Chemistry-General-003]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labour Sciences Research Grant for Research on the Risk of Chemical Substances from the Ministry of Health, Labour, and Welfare of Japan	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI; grant nos. JP25740024, JP15K00557, and 19K12340 (to X.L.) and JP22221005 and JP15H01741 (to Y.S.). This work was also supported in part by a Health and Labour Sciences Research Grant for Research on the Risk of Chemical Substances from the Ministry of Health, Labour, and Welfare of Japan, under contract/grant no. H20-Chemistry-General-003 (to Y.S.).	Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; [Anonymous], NTP NTP CERHR MON PO, V83, P157; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caballero-Casero N, 2016, ANAL CHIM ACTA, V908, P22, DOI 10.1016/j.aca.2015.12.034; Cavallo G, 2016, CHEM REV, V116, P2478, DOI 10.1021/acs.chemrev.5b00484; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Clark T, 2007, J MOL MODEL, V13, P291, DOI 10.1007/s00894-006-0130-2; Cleveland WKS, 1983, United States Patent, Patent No. [4391996, US]; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Gaido KW, 1999, ENDOCRINOLOGY, V140, P5746, DOI 10.1210/en.140.12.5746; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Ghosh K, 1999, NEUROPHARMACOLOGY, V38, P361, DOI 10.1016/S0028-3908(98)00185-3; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; IUPAC, 1997, COMPENDIUM CHEM TERM, Vsecond; Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009; Krishna BM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4528-x; Liu X, 2007, FEBS J, V274, P6340, DOI 10.1111/j.1742-4658.2007.06152.x; Liu XH, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2019.115274; Liu XH, 2019, TOXICOL APPL PHARM, V377, DOI 10.1016/j.taap.2019.114610; London F., 1937, T FARADAY SOC, V33, p8B, DOI DOI 10.1039/TF937330008B; Lyon RE, 2004, INT SAMPL TECHN C, V49, P1169; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsushima A, 2010, ENVIRON HEALTH PERSP, V118, P1267, DOI 10.1289/ehp.0901819; Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928; NCBI, PUBCHEM COMP DAT; NCBI, PUBCHEM COMP DAT; NCBI (National Center for Biotechnology Information), PUBCHEM COMP DAT; Nettles KW, 2004, MOL CELL, V13, P317, DOI 10.1016/S1097-2765(04)00054-1; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Safe SH, 2002, ENVIRON HEALTH PERSP, V110, P925, DOI 10.1289/ehp.02110s6925; Sartain CV, 2016, FERTIL STERIL, V106, P820, DOI 10.1016/j.fertnstert.2016.07.1114; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Souza PCT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03774-x; Stoliarov SI, 2003, POLYMER, V44, P5469, DOI 10.1016/S0032-3861(03)00576-7; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Tanida T, 2015, J BIOL CHEM, V290, P12332, DOI 10.1074/jbc.M114.619098; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323	46	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246583	10.1371/journal.pone.0246583	http://dx.doi.org/10.1371/journal.pone.0246583			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561155	gold, Green Published			2022-12-26	WOS:000617533000021
J	Kietsiri, P; Muangnapoh, C; Lurchachaiwong, W; Lertsethtakarn, P; Bodhidatta, L; Suthienkul, O; Waters, NC; Demons, ST; Vesely, BA				Kietsiri, Paksathorn; Muangnapoh, Chonchanok; Lurchachaiwong, Woradee; Lertsethtakarn, Paphavee; Bodhidatta, Ladaporn; Suthienkul, Orasa; Waters, Norman C.; Demons, Samandra T.; Vesely, Brian A.			Characterization of Arcobacter spp. Isolated from human diarrheal, non-diarrheal and food samples in Thailand	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY PATTERNS; GENETIC DIVERSITY; CAMPYLOBACTER-JEJUNI; VIRULENCE GENES; RETAIL MEATS; SP NOV.; BUTZLERI; IDENTIFICATION; PREVALENCE; RESISTANCE	Arcobacter butzleri is an emerging zoonotic food-borne and water-borne pathogen that can cause diarrhea in humans. The global prevalence of A. butzleri infection is underestimated, and little is known about their phenotypic and genotypic characterization. The aim of this study was to determine antimicrobial susceptibility (AST) profiles, detect related virulence genes, and classify sequence type (ST) of A. butzleri isolates obtained from human stool and food samples. A total of 84 A. butzleri isolates were obtained from human diarrheal (n = 25), non-diarrheal (n = 24) stool, and food (n = 35) samples in Thailand. They were evaluated for phenotypic identification by conventional microbiological procedures and AST by Kirby-Bauer disc diffusion method as well as virulence genes detection. Representative isolates from each origin were selected based on the presence of virulence genes and AST profiles to analyze genetic diversity by multilocus sequence typing (MLST). All isolates showed resistance to nalidixic acid 40.5% (34/84), ciprofloxacin 11.9% (10/84), azithromycin 8.3% (7/84), and erythromycin 3.6% (3/84). Regarding the ten virulence genes detected, cj1349, mviN and pldA had the highest prevalence 100% (84/84), followed by tlyA 98.8% (83/84), cadF 97.6% (82/84), ciaB 71.4% (60/84), hecA and hecB 22.6% (19/84), iroE 15.5% (13/84) and irgA 10.7% (9/84), respectively. Three virulence genes were present among A. butzleri isolates of human diarrheal stool and food samples, with a significant difference observed among isolates; hecB [36% (9/25) and 8.6% (3/35)], hecA [36% (9/25) and 5.7% (2/35)], and irgA [24% (6/25) and 2.9% (1/35)] (p < 0.05), respectively. The hecA and hecB virulence genes functions are related to the mechanism of hemolysis, while irgA supports a bacterial nutritional requirement. MLST analysis of 26 A. butzleri isolates revealed that 16 novel STs exhibited high genetic diversity. The results of this study is useful for understanding potentially pathogenic and antimicrobial-resistant A. butzleri in Thailand. The pathogenic virulence markers hecB, hecA, and irgA have the potential to be developed for rapid diagnostic detection in human diarrheal stool. No significant relationships among STs and sources of origin were observed. Little is known about A. butzleri, the mechanism of action of these virulence genes, is a topic that needs further investigation.	[Kietsiri, Paksathorn; Lurchachaiwong, Woradee; Lertsethtakarn, Paphavee; Bodhidatta, Ladaporn; Waters, Norman C.; Demons, Samandra T.; Vesely, Brian A.] Armed Forces Res Inst Med Sci AFRIMS, Dept Bacterial & Parasit Dis, Bangkok, Thailand; [Kietsiri, Paksathorn; Muangnapoh, Chonchanok; Suthienkul, Orasa] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok, Thailand	Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University	Suthienkul, O (corresponding author), Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok, Thailand.	orasa.sut@mahidol.ac.th	Muangnapoh, Chonchanok/HCH-5305-2022	KIETSIRI, PAKSATHORN/0000-0001-6313-5381; Suthienkul, Orasa/0000-0001-7264-5068	Armed Forces Health Surveillance CenterGlobal Emerging Infections Surveillance and Response System (AFHSC-GEIS), Washington, D.C., USA	Armed Forces Health Surveillance CenterGlobal Emerging Infections Surveillance and Response System (AFHSC-GEIS), Washington, D.C., USA	Armed Forces Health Surveillance CenterGlobal Emerging Infections Surveillance and Response System (AFHSC-GEIS), Washington, D.C., USA provided a fund, and the authors received no specific funding for this work.	Abay S, 2012, J VET MED SCI, V74, P613, DOI 10.1292/jvms.11-0487; Alonso R, 2014, INT J FOOD MICROBIOL, V191, P125, DOI 10.1016/j.ijfoodmicro.2014.09.012; Bodhidatta L, 2013, SE ASIAN J TROP MED, V44, P259; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Collado L, 2009, INT J SYST EVOL MICR, V59, P1391, DOI 10.1099/ijs.0.003749-0; De Cesare A, 2016, J APPL MICROBIOL, V120, P165, DOI 10.1111/jam.12977; De Smet S, 2011, INT J SYST EVOL MICR, V61, P356, DOI 10.1099/ijs.0.022665-0; Dieguez AL, 2017, INT J SYST EVOL MICR, V67, P1327, DOI 10.1099/ijsem.0.001809; Douidah L, 2012, J CLIN MICROBIOL, V50, P735, DOI 10.1128/JCM.05872-11; Ferreira S, 2019, J GLOB ANTIMICROB RE, V16, P130, DOI 10.1016/j.jgar.2018.12.018; Giacometti F, 2018, INT J FOOD MICROBIOL, V277, P50, DOI 10.1016/j.ijfoodmicro.2018.04.026; GOLDBERG MB, 1990, INFECT IMMUN, V58, P55, DOI 10.1128/IAI.58.1.55-60.1990; Gonzalez I, 2000, LETT APPL MICROBIOL, V30, P207, DOI [10.1046/j.1472-765x.2000.00696.x, 10.1046/j.1472-765X.2000.00696.x]; Houf K, 2004, MICROB DRUG RESIST, V10, P243, DOI 10.1089/mdr.2004.10.243; Houf K, 2002, APPL ENVIRON MICROB, V68, P2172, DOI 10.1128/AEM.68.5.2172-2178.2002; Hsueh PR, 1997, J CLIN MICROBIOL, V35, P489, DOI 10.1128/JCM.35.2.489-491.1997; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kabeya H, 2004, INT J FOOD MICROBIOL, V90, P303, DOI 10.1016/S0168-1605(03)00322-2; Karadas G, 2013, J APPL MICROBIOL, V115, P583, DOI 10.1111/jam.12245; Kayman T, 2012, J MED MICROBIOL, V61, P1439, DOI 10.1099/jmm.0.044594-0; KIEHLBAUCH JA, 1991, J CLIN MICROBIOL, V29, P376, DOI 10.1128/JCM.29.2.376-385.1991; Konkel ME, 2005, MOL MICROBIOL, V57, P1022, DOI 10.1111/j.1365-2958.2005.04744.x; Konkel ME, 1999, MOL MICROBIOL, V32, P691, DOI 10.1046/j.1365-2958.1999.01376.x; Lehmann D, 2015, BERL MUNCH TIERARZTL, V128, P163, DOI 10.2376/0005-9366-128-163; Levican A, 2013, APPL ENVIRON MICROB, V79, P4951, DOI 10.1128/AEM.01073-13; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Merga JY, 2011, APPL ENVIRON MICROB, V77, P1646, DOI 10.1128/AEM.01964-10; Merga JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055240; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Miller WG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-196; On SLW, 2004, LETT APPL MICROBIOL, V39, P347, DOI 10.1111/j.1472-765X.2004.01584.x; Patel J.B., 2015, PERFORMANCE STANDARD; Perez-Cataluna A, 2017, J MED MICROBIOL, V66, P1736, DOI 10.1099/jmm.0.000638; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Rahimi E, 2014, BRIT POULTRY SCI, V55, P174, DOI 10.1080/00071668.2013.878783; Ramees TP, 2017, VET QUART, V37, P136, DOI 10.1080/01652176.2017.1323355; Rasmussen Louise Hesselbjerg, 2013, BMC Res Notes, V6, P322, DOI 10.1186/1756-0500-6-322; Rathlavath S, 2017, INT J FOOD MICROBIOL, V263, P32, DOI 10.1016/j.ijfoodmicro.2017.10.005; Ribeiro-Goncalves B, 2016, NUCLEIC ACIDS RES, V44, pW246, DOI 10.1093/nar/gkw359; Rivas L, 2004, INT J FOOD MICROBIOL, V91, P31, DOI 10.1016/S0168-1605(03)00328-3; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Shah AH, 2012, VET MICROBIOL, V160, P355, DOI 10.1016/j.vetmic.2012.05.037; Silha D, 2017, J GLOB ANTIMICROB RE, V9, P74, DOI 10.1016/j.jgar.2017.01.006; Son I, 2007, INT J ANTIMICROB AG, V29, P451, DOI 10.1016/j.ijantimicag.2006.10.016; Tabatabaei M, 2014, MICROB PATHOGENESIS, V66, P1, DOI 10.1016/j.micpath.2013.10.003; Teague NS, 2010, J TRAVEL MED, V17, P118, DOI 10.1111/j.1708-8305.2009.00388.x; TEE W, 1988, J CLIN MICROBIOL, V26, P2469, DOI 10.1128/JCM.26.12.2469-2473.1988; Van Driessche E, 2007, INT J FOOD MICROBIOL, V118, P20, DOI 10.1016/j.ijfoodmicro.2007.05.006; VANDAMME P, 1992, J CLIN MICROBIOL, V30, P2335, DOI 10.1128/JCM.30.9.2335-2337.1992; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; Vandenberg O, 2006, J ANTIMICROB CHEMOTH, V57, P908, DOI 10.1093/jac/dkl080; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Villarruel-Lopez A, 2003, J FOOD PROTECT, V66, P1374, DOI 10.4315/0362-028X-66.8.1374; Whiteduck-Leveillee J, 2016, J MICROBIOL METH, V121, P59, DOI 10.1016/j.mimet.2015.12.017; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Zacharow I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/956507	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246598	10.1371/journal.pone.0246598	http://dx.doi.org/10.1371/journal.pone.0246598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544770	Green Published, gold			2022-12-26	WOS:000617991900034
J	Mahboub, N; Honein-AbouHaidar, G; Rizk, R; de Vries, N				Mahboub, Nadine; Honein-AbouHaidar, Gladys; Rizk, Rana; de Vries, Nanne			People who use drugs in rehabilitation, from chaos to discipline: Advantages and pitfalls: A qualitative study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; PHYSICAL-ACTIVITY; ABUSE TREATMENT; UNIVERSITY-STUDENTS; WEIGHT-GAIN; SLEEP; PREVALENCE; ALCOHOL; ADDICTION; METHADONE	Evidence-based models emphasizing on lifestyle behaviours for the treatment of drug use is still in its infancy. The development of multicomponent effective drug use intervention programs as part of health promotion is crucial to decrease risk of relapse. This study aims at exploring the lifestyle practices including dietary intake, physical activity and sleep of people who use drugs undergoing residential rehabilitation treatment in Lebanon with its perceived benefits and pitfalls. A purposive sample of 18 males and 9 females at different stages of recovery from drug use in rehabilitation centers participated in the qualitative discussions. The six phases thematic analysis revealed three themes: chaotic lifestyle, structuredlifestyle, benefits and pitfalls, and suggestions for making rehabilitation a better experience. Participants discussed their chaotic lifestyle during addiction with poor food intake, disrupted sleep and low physical activity moving to a more disciplined routine enforcing normality in lifestyle practices with social and professionlprofessional support. The early phases of treatment were marked with increased food intake and weight gain perceived as a health indicator and the sole divergent from drugs, moving towards more structured meals and efforts to lose weight in later stages. Lack of variety of Physical activity programs taking into consideration the motivational differences among the participants was also highlighted. Measures for improving rehabilitation services in terms of promoting healthy eating behaviours and environmental control were thoroughly addressed. These findings shed the light on the challenges faced in maintaining a healthy lifestyle in rehabilitation centers and the necessities of addressing them to improve the overall rehabilitation experience, prevent relapse and inform the development of future targeted intervention programs tackling all aspects of behavioural changes.	[Mahboub, Nadine] Lebanese Int Univ, Dept Nutr & Food Sci, Beirut, Lebanon; [Mahboub, Nadine; de Vries, Nanne] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands; [Honein-AbouHaidar, Gladys] Amer Univ Beirut, Hariri Sch Nursing, Beirut, Lebanon; [Honein-AbouHaidar, Gladys] Amer Univ Beirut, Global Hlth Inst, Refugee Hlth Program, Beirut, Lebanon; [Rizk, Rana] Inst Natl Sante Publ Epidemiol Clin & Toxicol INS, Beirut, Lebanon	Maastricht University; American University of Beirut; American University of Beirut	Mahboub, N (corresponding author), Lebanese Int Univ, Dept Nutr & Food Sci, Beirut, Lebanon.; Mahboub, N (corresponding author), Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands.	nadine.mahboub@outlook.com	Honein-AbouHaidar, Gladys N./M-4308-2013	Honein-AbouHaidar, Gladys N./0000-0001-6208-7859; Mahboub, Nadine/0000-0001-5322-7661	Institut National de Sante Publique, d'Epidemiologie Clinique, et de Toxicologie (INSPECT-LB), Beirut-Lebanon	Institut National de Sante Publique, d'Epidemiologie Clinique, et de Toxicologie (INSPECT-LB), Beirut-Lebanon	This work was supported by the Institut National de Sante Publique, d'Epidemiologie Clinique, et de Toxicologie (INSPECT-LB), Beirut-Lebanon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes AM, 2019, CURR OPIN PSYCHOL, V30, P103, DOI 10.1016/j.copsyc.2019.04.001; Abrantes Ana M, 2011, Ment Health Phys Act, V4, P79; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Bardo MT, 2015, DRUG ALCOHOL DEPEN, V153, P3, DOI 10.1016/j.drugalcdep.2015.05.037; Beswick T, 2003, ADDICT BIOL, V8, P49, DOI 10.1080/1355621031000069882; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown Richard A, 2010, Ment Health Phys Act, V3, P27; Conroy DA, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0487-3; Copeland J, 2004, J SUBST ABUSE TREAT, V26, P109, DOI 10.1016/S0740-5472(03)00165-X; Cowan J, 2008, APPETITE, V50, P33, DOI 10.1016/j.appet.2007.05.006; Cunningham PM, 2016, J ADDICT RES THER, V7, DOI 10.4172/2155-6105.1000282; Davidson L, 2008, J DUAL DIAGN, V4, P273, DOI 10.1080/15504260802072396; Drumm RD, 2005, J DRUG ISSUES, V35, P607, DOI 10.1177/002204260503500311; Duterte M, 2001, J PSYCHOACTIVE DRUGS, V33, P173, DOI 10.1080/02791072.2001.10400482; Emerson MH, 2009, SUBST USE MISUSE, V44, P1553, DOI [10.1080/10826080802494750, 10.3109/10826080802494750]; Fischer J, 2012, BRIT J SPORT MED, V46, P1142, DOI 10.1136/bjsports-2011-090724; Forrester JE, 2005, PUBLIC HEALTH NUTR, V8, P61, DOI [10.1079/PHN2005667, 10.1079/PHN2004667]; GERSTEIN DR, 1990, NEW ENGL J MED, V323, P844, DOI 10.1056/NEJM199009203231230; Ghandour LA, 2012, DRUG ALCOHOL DEPEN, V121, P110, DOI 10.1016/j.drugalcdep.2011.08.021; Gimenez-Meseguer J, 2015, J PSYCHOACTIVE DRUGS, V47, P409, DOI 10.1080/02791072.2015.1102991; GOSSOP MR, 1982, DRUG ALCOHOL DEPEN, V10, P177, DOI 10.1016/0376-8716(82)90010-2; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Hodgkins CC, 2004, J ADDICT DIS, V23, P55, DOI 10.1300/J069v23n03_05; Hosker DK, 2019, CHILD ADOL PSYCH CL, V28, P171, DOI 10.1016/j.chc.2018.11.010; Hsu WY, 2012, ACTA NEUROPSYCHIATR, V24, P356, DOI 10.1111/j.1601-5215.2011.00628.x; Hubbard RL, 2003, J SUBST ABUSE TREAT, V25, P125, DOI 10.1016/S0740-5472(03)00130-2; Jeynes KD, 2017, DRUG ALCOHOL DEPEN, V179, P229, DOI 10.1016/j.drugalcdep.2017.07.006; Karam EG, 2004, DRUG ALCOHOL DEPEN, V76, P273, DOI 10.1016/j.drugalcdep.2004.06.003; Karam Elie G, 2010, J Med Liban, V58, P76; Kolarzyk Emilia, 2005, Przegl Lek, V62, P368; Lin SH, 2012, J ADDICT MED, V6, P287, DOI 10.1097/ADM.0b013e318262a9a1; Lindberg MA, 2017, ADDICT BEHAV, V66, P76, DOI 10.1016/j.addbeh.2016.11.016; Lindseth G, 2013, WESTERN J NURS RES, V35, P497, DOI 10.1177/0193945911416379; Lo CC, 2002, AM J DRUG ALCOHOL AB, V28, P625, DOI 10.1081/ADA-120015872; Lv DZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003152; Mahfoud Youssef, 2009, Psychiatry (Edgmont), V6, P38; Miller WR, 2006, J SUBST ABUSE TREAT, V31, P25, DOI 10.1016/j.jsat.2006.03.005; Nabipour S, 2014, IRAN J PUBLIC HEALTH, V43, P1022; Neale J, 2012, ADDICTION, V107, P635, DOI 10.1111/j.1360-0443.2011.03660.x; Orsini CA, 2014, APPETITE, V78, P76, DOI 10.1016/j.appet.2014.03.013; Peles E, 2009, EUR NEUROPSYCHOPHARM, V19, P581, DOI 10.1016/j.euroneuro.2009.04.001; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Powers JM, 1999, AM J ADDICTION, V8, P72; Roessler KK, 2010, SCAND J PUBLIC HEALT, V38, P664, DOI 10.1177/1403494810371249; Ross LJ, 2012, NUTRITION, V28, P738, DOI 10.1016/j.nut.2011.11.003; Saeland M, 2011, BRIT J NUTR, V105, P618, DOI 10.1017/S0007114510003971; SANTOLARIAFERNANDEZ FJ, 1995, DRUG ALCOHOL DEPEN, V38, P11, DOI 10.1016/0376-8716(94)01088-3; Schierenbeck T, 2008, SLEEP MED REV, V12, P381, DOI 10.1016/j.smrv.2007.12.004; Stein MD, 2004, J SUBST ABUSE TREAT, V26, P175, DOI 10.1016/S0740-5472(03)00191-0; Stickel A, 2016, SUBST USE MISUSE, V51, P545, DOI 10.3109/10826084.2015.1117107; Tang AM, 2011, DRUG ALCOHOL DEPEN, V118, P73, DOI 10.1016/j.drugalcdep.2011.02.020; Varela P, 1997, AM J CLIN NUTR, V66, P509; Volkow N.D., 2010, SAFESPACE; Warner BD, 2001, AM J DRUG ALCOHOL AB, V27, P265, DOI 10.1081/ADA-100103709; Warren CS, 2013, J SUBST ABUSE TREAT, V44, P494, DOI 10.1016/j.jsat.2012.08.222; Williams D.J., 2004, J SOC WORK PRACT ADD, V4, P83, DOI [10.1300/J160v04n03_06, https://doi.org/10.1300/J160v04n03_06, DOI 10.1300/J160V04N03_06]; Wolff E, 2011, EUR ARCH PSY CLIN N, V261, P186, DOI 10.1007/s00406-011-0254-y; Wood AP, 2013, J ADOLESCENCE, V36, P871, DOI 10.1016/j.adolescence.2013.07.003; Zschucke E, 2012, SCI WORLD J, DOI 10.1100/2012/901741	59	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245346	10.1371/journal.pone.0245346	http://dx.doi.org/10.1371/journal.pone.0245346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544758	gold, Green Published			2022-12-26	WOS:000617991900029
J	Dhubhghaill, SN; Miron, A; Lie, JT; Dapena, I; Oellerich, S; Melles, GRJ				Dhubhghaill, Sorcha Ni; Miron, Alina; Lie, Jessica T.; Dapena, Isabel; Oellerich, Silke; Melles, Gerrit R. J.			Preclinical testing of small diameter Descemet membrane endothelial keratoplasty grafts to increase tissue availability	PLOS ONE			English	Article							DYSTROPHY; DMEK	In this study, we describe a process of preparing, surgically manipulating, and validating a novel "small diameter" 4mm circular Descemet membrane endothelial keratoplasty (DMEK) graft in vitro. Three small diameter DMEK grafts can be prepared from a single donor endothelium and could, therefore, potentially expand the donor pool. Prior to clinical use, however, we aimed to examine each step of the process to determine the effect on the endothelial cell loss and whether or not cells retained their capacity to migrate uniformly. For this study, circular small diameter grafts, obtained from twelve corneas of ten donors deemed ineligible for transplantation, were included. Small diameter DMEK graft preparation was successful in all cases (n = 36). Endothelial cell density (ECD), determined in the eye bank on seventeen grafts, showed an average decrease from 2413 (+/- 189) cells/mm(2) before to 2240 (+/- 413) cells/mm(2) after preparation. Twenty-four grafts were used to simulate DMEK-surgery in vitro and were successfully stained with 0.06% trypan blue, loaded into a straight DMEK-injector, unfolded, positioned, and centered within the circular similar to 4mm descemetorhexis. The estimated % area populated by viable cells on the grafts decreased from on average 92 (+/- 3) % before to 78 (+/- 10) % (n = 4) after in vitro surgery. Cells displayed a capacity for uniform cell migration from all edges of the graft (n = 4) when embedded in the 3D hydrogel system. Our data show, that by using an in vitro model of DMEK-surgery it was possible to test the 4mm circular DMEK grafts from eye bank preparation to surgical implantation. The cell loss after in vitro surgery was comparable with the in vivo ECD decline early after DMEK and the capacity of the cells to migrate to potentially cover bare stroma indicates that these small diameter grafts may be a viable clinical option to treat central endothelial disease.	[Dhubhghaill, Sorcha Ni; Miron, Alina; Lie, Jessica T.; Dapena, Isabel; Oellerich, Silke; Melles, Gerrit R. J.] Netherlands Inst Innovat Ocular Surg, Rotterdam, Netherlands; [Dhubhghaill, Sorcha Ni] Antwerp Univ Hosp, Edegem, Belgium; [Miron, Alina; Dapena, Isabel; Melles, Gerrit R. J.] Melles Cornea Clin Rotterdam, Rotterdam, Netherlands; [Lie, Jessica T.; Dapena, Isabel; Melles, Gerrit R. J.] Amnitrans EyeBank Rotterdam, Rotterdam, Netherlands	University of Antwerp	Melles, GRJ (corresponding author), Netherlands Inst Innovat Ocular Surg, Rotterdam, Netherlands.; Melles, GRJ (corresponding author), Melles Cornea Clin Rotterdam, Rotterdam, Netherlands.; Melles, GRJ (corresponding author), Amnitrans EyeBank Rotterdam, Rotterdam, Netherlands.	research@niios.com	Ní Dhubhghaill, Sorcha/D-4278-2015	Ní Dhubhghaill, Sorcha/0000-0002-1115-7834				Bachmann B, 2019, CORNEA, V38, P1043, DOI 10.1097/ICO.0000000000002001; Baydoun L, 2018, ACTA OPHTHALMOL, V96, pE656, DOI 10.1111/aos.13720; Bhogal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184824; Birbal RS, 2020, AM J OPHTHALMOL, V212, P79, DOI 10.1016/j.ajo.2019.12.011; Birbal RS, 2020, CORNEA, V39, P277, DOI 10.1097/ICO.0000000000002127; Borkar DS, 2016, CORNEA, V35, P1267, DOI 10.1097/ICO.0000000000000915; Dapena I, 2011, ARCH OPHTHALMOL-CHIC, V129, P88, DOI 10.1001/archophthalmol.2010.334; Fernandez MM, 2010, MIDDLE EAST AFR J OP, V17, P5, DOI 10.4103/0974-9233.61210; Garcerant D, 2019, CURR OPIN OPHTHALMOL, V30, P275, DOI 10.1097/ICU.0000000000000579; Groeneveld-van Beek EA, 2013, ACTA OPHTHALMOL, V91, P145, DOI 10.1111/j.1755-3768.2012.02462.x; Iovieno A, 2017, CORNEA, V36, P637, DOI 10.1097/ICO.0000000000001202; Lie JT, 2010, BRIT J OPHTHALMOL, V94, P1265, DOI 10.1136/bjo.2009.171629; Miron A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225462; Miron A, 2018, ACTA OPHTHALMOL, V96, P828, DOI 10.1111/aos.13841; Moloney G, 2017, CORNEA, V36, P642, DOI 10.1097/ICO.0000000000001209; Moloney G, 2015, CAN J OPHTHALMOL, V50, P68, DOI 10.1016/j.jcjo.2014.10.014; Muller TM, 2017, CORNEA, V36, P104, DOI 10.1097/ICO.0000000000001008; Oganesyan OG, 2018, CORNEA, V37, P667, DOI 10.1097/ICO.0000000000001551; Ong HS, 2021, BRIT J OPHTHALMOL, V105, P454, DOI 10.1136/bjophthalmol-2020-316149; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Soh YQ, 2018, CORNEA, V37, P523, DOI 10.1097/ICO.0000000000001518; Tu EY, 2017, CORNEA, V36, P1559, DOI 10.1097/ICO.0000000000001351; Van den Bogerd B, 2018, SURV OPHTHALMOL, V63, P149, DOI 10.1016/j.survophthal.2017.07.004; Zygoura V, 2018, BRIT J OPHTHALMOL, V102, P1425, DOI 10.1136/bjophthalmol-2017-311398	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246516	10.1371/journal.pone.0246516	http://dx.doi.org/10.1371/journal.pone.0246516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539395	gold, Green Published			2022-12-26	WOS:000616960200034
J	Weisshaupt, N; Lehikoinen, A; Makinen, T; Koistinen, J				Weisshaupt, Nadja; Lehikoinen, Aleksi; Makinen, Terhi; Koistinen, Jarmo			Challenges and benefits of using unstructured citizen science data to estimate seasonal timing of bird migration across large scales	PLOS ONE			English	Article							DATA QUALITY; PHENOLOGY; MODELS	Millions of bird observations have been entered on online portals in the past 20 years either as checklists or arbitrary individual entries. While several hundred publications have been written on a variety of topics based on bird checklists worldwide, unstructured non-checklist observations have received little attention and praise by academia. In the present study we tested the suitability of non-checklist data to estimate key figures of large-scale migration phenology in four zones covering the whole of Finland. For that purpose, we analysed 10 years of ornithological non-checklist data including over 400 million. individuals of 115 bird species. We discuss bird- and human-induced effects to be considered in handling non-checklist data in this context and describe applied methodologies to address these effects. We calculated 5%, 50% and 95% percentile dates of spring and autumn migration period for all species in all four zones. For validation purposes we compared the temporal distributions of 43 bird species with migration phenology from standardized long-term ringing data in autumn of which 24 species (56%) showed similar medians. In a model approach, non-checklist data successfully revealed latitudinal migration progression in spring and autumn. Overall, non-checklist data proved to be well suited to determine descriptors of migration phenology in Northern Europe which are challenging to attain by any other currently available means. The effort-to-yield ratio of data processing was commensurate to the outcomes. The unprecedented spatiotemporal coverage makes non-checklist data a valuable complement to current migration databases from bird observatories. The basic concept of the present methodology is applicable to data from other bird portals, if combined with local field ornithological knowledge and literature. Species-specific descriptors of migration phenology can be potentially used in climate change studies and to support echo interpretation in radar ornithology.	[Weisshaupt, Nadja; Makinen, Terhi; Koistinen, Jarmo] Finnish Meteorol Inst, Helsinki, Finland; [Lehikoinen, Aleksi] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	Finnish Meteorological Institute; University of Helsinki	Weisshaupt, N (corresponding author), Finnish Meteorol Inst, Helsinki, Finland.	nadja.weisshaupt@fmi.fi		Weisshaupt, Nadja/0000-0003-4510-4121; Lehikoinen, Aleksi/0000-0002-1989-277X	GloBAM project; Belmont Forum; BiodivERsA joint call for research proposals, under the BiodivScen ERA-Net COFUND programme; Swiss National Science Foundation [SNF 31BD30_184120]; Belgian Federal Science Policy Office [BelSPO BR/185/A1/GloBAM-BE]; Netherlands Organisation for Scientific Research [NWO E10008]; Academy of Finland [aka 326315]; National Science Foundation [NSF 1927743]	GloBAM project; Belmont Forum; BiodivERsA joint call for research proposals, under the BiodivScen ERA-Net COFUND programme; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Academy of Finland(Academy of Finland); National Science Foundation(National Science Foundation (NSF))	NW, JK and TM have received funding as part of the GloBAM project (https://globam.science/). This project is funded through the 2017-2018 Belmont Forum and BiodivERsA joint call for research proposals (https://www.biodiversa.org), under the BiodivScen ERA-Net COFUND programme, and with the funding organisations Swiss National Science Foundation (SNF 31BD30_184120), Belgian Federal Science Policy Office (BelSPO BR/185/A1/GloBAM-BE), Netherlands Organisation for Scientific Research (NWO E10008), Academy of Finland (aka 326315) and National Science Foundation (NSF 1927743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 1990, BIRD MIGRATION; Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; Alves JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38154; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2014, IEEE POWER ELECTRON, V1, P30, DOI [10.1109/MPEL.2014.2319511, DOI 10.1109/MPEL.2014.2319511]; [Anonymous], 1915, MOSKOVSKIY ARKHITEKT, V4, P119; Arizaga J, 2011, BIRD STUDY, V58, P291, DOI 10.1080/00063657.2011.586415; Bayraktarov E, 2019, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00239; Berthold P., 1973, AUSPICIUM S, V5, P49; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Eglington SM, 2010, BIRD STUDY, V57, P129, DOI 10.1080/00063650903440648; Fink D, 2011, PROCEDIA ENVIRON SCI, V7, P50, DOI 10.1016/j.proenv.2011.07.010; FLIEGE G, 1986, Vogelwarte, V33, P257; Glutz von Blotzheim U., 1966, HDB VOGEL MITTELEURO; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Haest B, 2019, GLOBAL CHANGE BIOL, V25, P4064, DOI 10.1111/gcb.14746; Hall-Karlsson K. Susanna S., 2008, Ringing & Migration, V24, P95; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kamp J, 2016, DIVERS DISTRIB, V22, P1024, DOI 10.1111/ddi.12463; Kelling S, 2015, AMBIO, V44, pS601, DOI 10.1007/s13280-015-0710-4; Kelly JF, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1434; Knudsen E, 2007, CLIM RES, V35, P59, DOI 10.3354/cr00714; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; La Sorte FA, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150347; Lehikoinen A, 2015, TRINGA, V3, P80; Lehikoinen A, 1979, TRINGA, V27, P150; Lehikoinen A, 2019, ECOL INDIC, V101, P985, DOI 10.1016/j.ecolind.2019.01.083; Lepczyk C. A., 2020, HDB CITIZEN SCI ECOL; Liechti F., 2018, ECOGRAPHY, V42, P1; Lukyanenko R, 2016, CONSERV BIOL, V30, P447, DOI 10.1111/cobi.12706; Poyhonen M., 1995, MUUTTOLINTUJEN MATKA; Saporetti Fabio, 2015, Wader Study, V122, P60; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Snall T, 2011, BIOL CONSERV, V144, P804, DOI 10.1016/j.biocon.2010.11.010; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Supp SR, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00290.1; TISCHLER P., 2015, APUS, V20, P45; Valkama J., 2011, 3 FINNISH BREEDING B; Vansteelant WMG, 2015, J AVIAN BIOL, V46, P25, DOI 10.1111/jav.00457; von Haartman L., 1963, POHJOLAN LINNUT VARI; Vorsek P., 2008, BEST PRACTICE GUIDE; Weisshaupt N, 2021, IBIS, V163, P728, DOI 10.1111/ibi.12906; Weisshaupt N, 2017, BIRD STUDY, V64, P386, DOI 10.1080/00063657.2017.1364696; Weisshaupt N, 2017, METHODS ECOL EVOL, V8, P1133, DOI 10.1111/2041-210X.12763; Zehnder S, 2001, J ORNITHOL, V142, P173, DOI 10.1046/j.1439-0361.2001.00066.x; ZWARTS L, 1990, ARDEA, V78, P339	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246572	10.1371/journal.pone.0246572	http://dx.doi.org/10.1371/journal.pone.0246572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539480	Green Published, gold			2022-12-26	WOS:000616960200070
J	Abu-Akel, A; Spitz, A; West, R				Abu-Akel, Ahmad; Spitz, Andreas; West, Robert			The effect of spokesperson attribution on public health message sharing during the COVID-19 pandemic	PLOS ONE			English	Article							CELEBRITY ENDORSEMENTS; CRISIS COMMUNICATION; PERSUASIVE MESSAGES; PERFORMANCE; LESSONS; IMPACT	It is urgent to understand how to effectively communicate public health messages during the COVID-19 pandemic. Previous work has focused on how to formulate messages in terms of style and content, rather than on who should send them. In particular, little is known about the impact of spokesperson selection on message propagation during times of crisis. We report on the effectiveness of different public figures at promoting social distancing among 12,194 respondents from six countries that were severely affected by the COVID-19 pandemic at the time of data collection. Across countries and demographic strata, immunology expert Dr. Anthony Fauci achieved the highest level of respondents' willingness to reshare a call to social distancing, followed by a government spokesperson. Celebrity spokespersons were least effective. The likelihood of message resharing increased with age and when respondents expressed positive sentiments towards the spokesperson. These results contribute to the development of evidence-based knowledge regarding the effectiveness of prominent official and non-official public figures in communicating public health messaging in times of crisis. Our findings serve as a reminder that scientific experts and governments should not underestimate their power to inform and persuade in times of crisis and underscore the crucial importance of selecting the most effective messenger in propagating messages of lifesaving information during a pandemic.	[Abu-Akel, Ahmad] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Spitz, Andreas; West, Robert] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	West, R (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland.	robert.west@epfl.ch		Abu-Akel, Ahmad/0000-0003-3791-8643; Spitz, Andreas/0000-0002-5282-6133	EPFL/UNIL Collaborative Research on Science and Society (CROSS) Program; Swiss Data Science Center	EPFL/UNIL Collaborative Research on Science and Society (CROSS) Program; Swiss Data Science Center	AA and RW received funding by a grant from the EPFL/UNIL Collaborative Research on Science and Society (CROSS) Program. RW received financial support from the Swiss Data Science Center. RW was in part supported by a gift from Google and Facebook. Reception of these gifts does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews FM, 1986, J AM STAT ASS, DOI [10.1080/01621459.1986.10478284, DOI 10.1080/01621459.1986.10478284]; Austin John, 1960, DO THINGS WORDS; Beck CS, 2014, HEALTH COMMUN, V29, P244, DOI 10.1080/10410236.2012.741668; Berset A., ANNOUNCEMENT SWISS F; Betsch C, 2020, NAT HUM BEHAV, V4, P438, DOI 10.1038/s41562-020-0866-1; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Boin A., 2016, POLITICS CRISIS MANA; Borzekowski DLG, 2014, GENET MED, V16, P516, DOI 10.1038/gim.2013.181; Bucchi M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.e170702; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Bursztyn L., 2020, MISINFORMATION PANDE; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Feinberg M, 2019, SOC PERSONAL PSYCHOL, DOI 10.1111/spc3.12501; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Frizzell C., 2011, SOC SCI J, DOI [10.1016/j.soscij.2010.07.009, DOI 10.1016/J.SOSCIJ.2010.07.009]; Gaines BJ, 2002, PS POLITICAL SCI POL, DOI [10.1017/S1049096502000793, DOI 10.1017/S1049096502000793]; Gollust SE, 2020, J HEALTH POLIT POLIC, V45, P967, DOI 10.1215/03616878-8641506; Gollwitzer A, 2020, PREPRINT; Greyling C, 2016, REV FAITH INT AFF, V14, P118, DOI 10.1080/15570274.2016.1215829; Jackson DJ, 2018, J POLITICAL MARKETIN, V17, P301, DOI 10.1080/15377857.2018.1501530; Jackson DJ, 2005, HARV INT J PRESS-POL, V10, P80, DOI 10.1177/1081180X05279278; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Johns Hopkins University, COVID 19 INF RES JHU; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Liu M, 2020, JAMA INTERN MED, V180, P1116, DOI 10.1001/jamainternmed.2020.1764; Lyu SY, 2013, J FORMOS MED ASSOC, V112, P600, DOI 10.1016/j.jfma.2012.12.005; Matz SC, 2017, P NATL ACAD SCI USA, V114, P12714, DOI 10.1073/pnas.1710966114; Mosleh M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228882; O'Keefe D, 2002, NY TIMES BK REV, P28; O'Keefe DJ, 2008, COMMUN STUD, V59, P51, DOI 10.1080/10510970701849388; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Rimer BK, 2006, J COMMUN, V56, pS184, DOI 10.1111/j.1460-2466.2006.00289.x; ROSKOSEWOLDSEN DR, 1992, PERS SOC PSYCHOL B, V18, P19, DOI 10.1177/0146167292181004; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Seeger MW, 2006, J APPL COMMUN RES, V34, P232, DOI 10.1080/00909880600769944; Smith CT, 2014, SOC PSYCHOL-GERMANY, V45, P437, DOI 10.1027/1864-9335/a000208; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Sutton J, 2015, P NATL ACAD SCI USA, V112, P14793, DOI 10.1073/pnas.1508916112; Sutton J, 2014, INFORM COMMUN SOC, V17, P765, DOI 10.1080/1369118X.2013.862561; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742	43	16	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245100	10.1371/journal.pone.0245100	http://dx.doi.org/10.1371/journal.pone.0245100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534800	Green Submitted, Green Published, gold			2022-12-26	WOS:000616739700039
J	Pan, JK; Lin, CH; Kuo, YL; Ger, LP; Cheng, HC; Yao, YC; Hsiao, MC; Lu, PJ				Pan, Jhih-Kai; Lin, Cheng-Han; Kuo, Yao-Lung; Ger, Luo-Ping; Cheng, Hui-Chuan; Yao, Yun-Chin; Hsiao, Michael; Lu, Pei-Jung			MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer	ONCOGENE			English	Article								Brian metastasis, which is diagnosed in 30% of triple-negative breast cancer (TNBC) patients with metastasis, causes poor survival outcomes. Growing evidence has characterized miRNAs involving in breast cancer brain metastasis; however, currently, there is a lack of prognostic plasma-based indicator for brain metastasis. In this study, high level of miR-211 can act as brain metastatic prognostic marker in vivo. High miR-211 drives early and specific brain colonization through enhancing trans-blood-brain barrier (BBB) migration, BBB adherence, and stemness properties of tumor cells and causes poor survival in vivo. SOX11 and NGN2 are the downstream targets of miR-211 and negatively regulate miR-211-mediated TNBC brain metastasis in vitro and in vivo. Most importantly, high miR-211 is correlated with poor survival and brain metastasis in TNBC patients. Our findings suggest that miR-211 may be used as an indicator for TNBC brain metastasis.	[Pan, Jhih-Kai; Lin, Cheng-Han; Cheng, Hui-Chuan; Lu, Pei-Jung] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan; [Kuo, Yao-Lung] Natl Cheng Kung Univ Hosp, Dept Gen Surg, Tainan, Taiwan; [Ger, Luo-Ping] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Yao, Yun-Chin] Natl Cheng Kung Univ Hosp, Clin Med Res Ctr, Tainan, Taiwan; [Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Hsiao, Michael] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ Hosp, Dept Clin Med Res, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital	Lu, PJ (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan.; Lu, PJ (corresponding author), Natl Cheng Kung Univ Hosp, Dept Clin Med Res, Tainan, Taiwan.	pjlu2190@mail.ncku.edu.tw	Hsiao, Michael/U-6238-2019	Hsiao, Michael/0000-0001-8529-9213; Lin, Cheng-Han/0000-0001-5444-3999; Lu, Pei-Jung/0000-0002-8143-5668	Ministry of Science and Technology, Taiwan [MOST 105-2320-B-006-054, 106-2320-B-006-066-MY3, MOST 107-2320-B-006-064-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Ministry of Science and Technology, Taiwan [MOST 105-2320-B-006-054, 106-2320-B-006-066-MY3 and MOST 107-2320-B-006-064-MY3] to P-JL.	Achrol AS, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-018-0055-y; Avraham HK, 2014, J PATHOL, V232, P369, DOI 10.1002/path.4304; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chang CC, 2018, ONCOL LETT, V15, P8107, DOI 10.3892/ol.2018.8295; Chen LL, 2017, BRIT J CANCER, V117, P78, DOI 10.1038/bjc.2017.150; Chen WJ, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0047-0; Chen YF, 2016, CANCER RES, V76, P4872, DOI 10.1158/0008-5472.CAN-15-1664; Croset M, 2018, CANCER RES, V78, P5259, DOI 10.1158/0008-5472.CAN-17-3058; Debeb BG, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw026; Gril B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05030-w; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Hsu TI, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.12; Jilaveanu LB, 2015, CLIN CANCER RES, V21, P2138, DOI 10.1158/1078-0432.CCR-14-0861; Li B, 2013, ONCOGENE, V32, P2952, DOI 10.1038/onc.2012.313; Li HY, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0918-2; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu DT, 2014, ASIAN PAC J CANCER P, V15, P5483, DOI 10.7314/APJCP.2014.15.13.5483; Lyle LT, 2016, CLIN CANCER RES, V22, P5287, DOI 10.1158/1078-0432.CCR-15-1836; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Shepherd JH, 2016, ONCOTARGET, V7, P13106, DOI 10.18632/oncotarget.7437; Sirkisoon Sherona R, 2016, Front Biosci (Elite Ed), V8, P245; Tiwary S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26636-6; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu KR, 2015, J BIOL CHEM, V290, P9842, DOI 10.1074/jbc.M114.602185; Xiao YS, 2020, J CELL PHYSIOL, V235, P7295, DOI 10.1002/jcp.29629; Xing F, 2016, CANCER RES, V76, P4970, DOI 10.1158/0008-5472.CAN-15-3541; Yang Z, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919853449; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhou WC, 2017, CELL STEM CELL, V21, P591, DOI 10.1016/j.stem.2017.10.002	36	9	9	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1737	1751		10.1038/s41388-021-01654-3	http://dx.doi.org/10.1038/s41388-021-01654-3		FEB 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33536579	Green Published, hybrid			2022-12-26	WOS:000614320700001
J	Schneider, A; Kirsten, H; Lordick, F; Lordick, F; Lubbert, C; von Braun, A				Schneider, Anne; Kirsten, Holger; Lordick, Franziska; Lordick, Florian; Luebbert, Christoph; von Braun, Amrei			Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?	PLOS ONE			English	Article								Objective Understanding mild to moderate symptoms of coronavirus disease 2019 (Covid-19) is important in order to identify active cases early and thus counteract transmission. Methods In March 2020, Leipzig University Hospital established an outpatient clinic for patients potentially infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Confirmed cases with mild to moderate symptoms self-isolated at home and were followed-up by daily telephone calls for at least 14 days. Symptoms and course of illness of these patients are reported here. Results From March 20 to April 17, 2020, 1460 individuals were tested for SARS-CoV-2 by naso- or oropharyngeal swab for real-time polymerase chain reaction (RT-PCR). Covid-19 was confirmed in 91 (6.2%) patients, of which 87 were included in the final analysis. Patients presented for testing after a mean of 5.9 days (IQR = 2.0-8.5). The median age was 37.0 years (IQR = 28.5-53), and 48 (55.2%) were female. Five (5.7%) patients required hospital admission during the course of illness. Most frequently reported symptoms were fatigue (n = 64, 74%), cough (n = 58, 67%), and hyposmia/hypogeusia (n = 44, 51%). In contrast to previous reports, fever occurred in less than a third of patients (n = 25, 29%). By day 14, more than half of the patients had recovered completely (n = 37/70, 52.9%). Conclusions Fever seems to be less common in patients of relatively young age diagnosed with mild to moderate Covid-19. This suggests that body temperature alone may be an insufficient indicator of SARS-CoV-2 infection.	[Schneider, Anne; Luebbert, Christoph; von Braun, Amrei] Univ Leipzig, Dept Med 2, Div Infect Dis & Trop Med, Med Ctr, Leipzig, Germany; [Schneider, Anne; Luebbert, Christoph; von Braun, Amrei] Univ Leipzig, Interdisciplinary Ctr Infect Dis, Med Ctr, Leipzig, Germany; [Kirsten, Holger] Univ Leipzig, Med Fac, Inst Med Informat Stat & Epidemiol IMISE, Leipzig, Germany; [Kirsten, Holger] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany; [Lordick, Franziska] Univ Leipzig, Med Fac, Leipzig, Germany; [Lordick, Florian] Univ Leipzig, Dept Med Oncol Gastroenterol Hepatol Pneumol 2, Med Ctr, Leipzig, Germany; [Luebbert, Christoph] St Georg Hosp, Dept Infect Dis Trop Med Nephrol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University	von Braun, A (corresponding author), Univ Leipzig, Dept Med 2, Div Infect Dis & Trop Med, Med Ctr, Leipzig, Germany.; von Braun, A (corresponding author), Univ Leipzig, Interdisciplinary Ctr Infect Dis, Med Ctr, Leipzig, Germany.	amrei.braun@medizin.uni-leipzig.de		Kirsten, Holger/0000-0002-3126-7950; von Braun, Amrei/0000-0002-4335-8884	Leipzig University for Open Access Publishing	Leipzig University for Open Access Publishing	The authors acknowledge support from Leipzig University for Open Access Publishing.	[Anonymous], 2020, SARS COV 2 STECKBR C; Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Benezit F, 2020, LANCET INFECT DIS, V20, P1014, DOI 10.1016/S1473-3099(20)30297-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bocksberger S, 2020, HNO, V68, P440, DOI 10.1007/s00106-020-00891-4; Bohmer MM, 2020, LANCET INFECT DIS, V20, P920, DOI 10.1016/S1473-3099(20)30314-5; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Izquierdo-Dominguez A, 2020, J INVEST ALLERG CLIN, V30, P317, DOI 10.18176/jiaci.0567; Kim GU, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.04.040; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; R Core Team, 2019, R R LANG ENV STAT CO; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Sakurai A, 2020, NEW ENGL J MED, V383, P885, DOI 10.1056/NEJMc2013020; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246312	10.1371/journal.pone.0246312	http://dx.doi.org/10.1371/journal.pone.0246312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534829	gold, Green Published			2022-12-26	WOS:000616739700043
J	Shibabaw, T; Beyene, A; Awoke, A; Tirfie, M; Azage, M; Triest, L				Shibabaw, Tebkew; Beyene, Abebe; Awoke, Aymere; Tirfie, Mulat; Azage, Muluken; Triest, Ludwig			Diatom community structure in relation to environmental factors in human influenced rivers and streams in tropical Africa	PLOS ONE			English	Article							BENTHIC ALGAL ASSEMBLAGES; WATER-QUALITY ASSESSMENT; SUBTROPICAL RIVER; ULTRAVIOLET-RADIATION; SEASONAL-VARIATIONS; EPILITHIC DIATOMS; LAND-USE; URBAN; INDICATORS; INDEXES	The contemporaneous effect of natural and anthropogenic factors involved in a watershed contribution to the seasonal and spatial variation of diatom community composition is widely discussed in the scientific literature. Yet, there is a paucity of scientific evidence indicating the effect of these factors on diatoms in tropical African regions characterized by distinct dry and wet seasons and season associated human activities like rainfed agriculture are commonly practiced. We applied multivariate techniques to determine the spatio-temporal drivers of diatom assemblage and diatom species richness in human influenced rivers and streams in Ethiopia. We simultaneously collected water and diatom samples from 24 sampling points during the wet (July) and dry (February) seasons. Both water and diatom samples were processed following standard procedures. We identified 169 species belonging to 45 genera in the studied lotic systems. We found that both season and land use factors were important in defining diatom composition (PERMANOVA, p<0.05) and species richness (ANOVA, p<0.05) patterns. Diatom community composition was driven by conductivity, dissolved oxygen, pH, and turbidity parameters (Monte Carlo permutation test, p<0.05). Besides, diatom species richness was driven by dissolved oxygen, soluble reactive phosphorus, and turbidity (GLMM, p<0.05). The study highlighted physicochemical parameters influenced by seasonal variation and human activity determined the composition of diatoms. This implies that the unique feature of heavy rain during the rainy season in the region followed by extensive flooding aggravated by the steep slope from the highlands to the lowlands plays a major role in shaping the diatom autecology in the region. Therefore, in applying biomonitoring in such regions considering the effect of runoff and dilution is imperative.	[Shibabaw, Tebkew; Azage, Muluken] Bahir Dar Univ, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia; [Shibabaw, Tebkew; Awoke, Aymere; Triest, Ludwig] Vrije Univ Brussel, Dept Biol, Brussels, Belgium; [Beyene, Abebe] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Awoke, Aymere] King Abdullah Univ Sci & Technol KAUST, Red Sea Res Ctr, Biol & Environm Sci & Engn Div BESE, Thuwal, Saudi Arabia; [Tirfie, Mulat] Bahir Dar Univ, Sch Publ Hlth, Dept Nutr & Dietet, Bahir Dar, Ethiopia	Bahir Dar University; Vrije Universiteit Brussel; Jimma University; King Abdullah University of Science & Technology; Bahir Dar University	Shibabaw, T (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia.; Shibabaw, T (corresponding author), Vrije Univ Brussel, Dept Biol, Brussels, Belgium.	tebkews@gmail.com	Azage, Muluken/AAF-6515-2020	Azage, Muluken/0000-0003-3222-0158; Achenef, Tebkew Shibabaw/0000-0002-3981-4824; Triest, Ludwig/0000-0002-4946-9614	Vrije Universiteit Brussel (VUB); Jimma University institutions	Vrije Universiteit Brussel (VUB); Jimma University institutions	Vrije Universiteit Brussel (VUB) and Jimma University institutions for their financial and logistic supports during the study.	Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Ambelu A, 2013, LAKE RESERV MANAGE, V29, P143, DOI 10.1080/10402381.2013.806971; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2020, WATER ANAL HDB; [Anonymous], 2003, MULTIVARIATE ANAL EC; [Anonymous], 2007, 28107 WRC TT; [Anonymous], 2002, AM J KIDNEY DIS S1, V2, pS1; Association APH. APHA, 2013, STANDARD METHODS EXA, V21st; Barton K., 2015, PACKAGE MUMIN VERSIO, P18; Bellinger BJ, 2006, HYDROBIOLOGIA, V573, P75, DOI 10.1007/s10750-006-0262-5; Bere T, 2011, WATER SA, V37, P93; Bere T, 2018, WATER RESOURCES MANA, P15; Bere T, 2016, SCI TOTAL ENVIRON, V566, P1604, DOI 10.1016/j.scitotenv.2016.06.058; Bere T, 2014, TROP ECOL, V55, P271; Bere T, 2013, AFR J ECOL, V51, P625, DOI 10.1111/aje.12078; Beyene A., 2010, DEV VALIDATION ECOLO; Beyene A, 2014, ECOL INFORM, V19, P53, DOI 10.1016/j.ecoinf.2013.12.007; Beyene A, 2009, ECOL INDIC, V9, P381, DOI 10.1016/j.ecolind.2008.05.001; Beyene A, 2009, ENVIRON MONIT ASSESS, V153, P461, DOI 10.1007/s10661-008-0371-x; BOTHWELL ML, 1993, J PHYCOL, V29, P24, DOI 10.1111/j.1529-8817.1993.tb00276.x; Carr G.M., 2008, WATER QUALITY ECOSYS; Chapman Deborah, 1996, WATER QUALITY ASSESS, V2nd; Chen X, 2020, ENVIRON SCI POLLUT R, V27, P37581, DOI 10.1007/s11356-020-09743-8; Chessman BC, 2007, MAR FRESHWATER RES, V58, P542, DOI 10.1071/MF06220; Collins John J., 2000, ENCY APOCALYPTICISM, V1, pvii; Dalu T, 2017, SCI TOTAL ENVIRON, V601, P73, DOI 10.1016/j.scitotenv.2017.05.162; Devi R, 2008, BIORESOURCE TECHNOL, V99, P975, DOI 10.1016/j.biortech.2007.03.013; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Falkenmark M., 2004, EARTHSCAN; FUKUSHIMA S, 1994, PROC INT ASSOC THEOR, V25, P1966; Gasse F., 1986, E AFRICAN DIATOMS; GENSEMER RW, 1991, LIMNOL OCEANOGR, V36, P123, DOI 10.4319/lo.1991.36.1.0123; Haddis A, 2014, WATER ENVIRON J, V28, P173, DOI 10.1111/wej.12021; Handey N., 1974, MICROSCOPY, V32, P423; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hofmann G, 2011, BESTIMMUNGSFLORA KIE, V700, P908; Huang JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091528; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jyrkankallio-Mikkola J, 2018, ECOL INDIC, V95, P183, DOI 10.1016/j.ecolind.2018.07.030; KARR JR, 1981, ENVIRON MANAGE, V5, P55, DOI 10.1007/BF01866609; Kelly Martyn, 2000, Field Studies, V9, P583; Kloos H., 2010, WATER RESOURCES MANA; Krajenbrink HJ, 2019, PEERJ, V7, DOI 10.7717/peerj.8092; Krammer K., 2000, DIATOMS EUROPE CYMBE; Lange-Bertalot H, 2000, DIATOMS EUROPE; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leira M, 2005, WATER RES, V39, P73, DOI 10.1016/j.watres.2004.08.034; Lobo EA, 2010, LIMNETICA, V29, P323; Mangadze T, 2015, HYDROBIOLOGIA, V753, P163, DOI 10.1007/s10750-015-2203-7; Mereta ST, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-320; Mereta ST, 2013, ECOL INDIC, V29, P510, DOI 10.1016/j.ecolind.2013.01.026; Ndiritu GG, 2006, BIODIVERS CONSERV, V15, P3267, DOI 10.1007/s10531-005-0600-3; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Ouyang Y, 2006, WATER RES, V40, P3800, DOI 10.1016/j.watres.2006.08.030; Pan YD, 1999, J PHYCOL, V35, P460, DOI 10.1046/j.1529-8817.1999.3530460.x; Passy SI, 2007, ENVIRON MONIT ASSESS, V127, P409, DOI 10.1007/s10661-006-9290-x; Peters NE, 2000, WATER INT, V25, P185, DOI 10.1080/02508060008686817; Potapova MG, 2002, J BIOGEOGR, V29, P167, DOI 10.1046/j.1365-2699.2002.00668.x; Resende P, 2005, HYDROBIOLOGIA, V544, P77, DOI 10.1007/s10750-004-8335-9; ROUND FE, 1991, J APPL PHYCOL, V3, P129, DOI 10.1007/BF00003695; Saros JE, 2000, J PALEOLIMNOL, V23, P449, DOI 10.1023/A:1008186431492; Smol J.P., 2010, DIATOMS APPL ENV EAR; Soininen J, 2007, PROTIST, V158, P181, DOI 10.1016/j.protis.2006.11.002; Tan X, 2014, CLEAN-SOIL AIR WATER, V42, P20, DOI 10.1002/clen.201200152; Tan X, 2014, ENVIRON SCI POLLUT R, V21, P434, DOI 10.1007/s11356-013-1898-0; Tan X, 2013, ENVIRON SCI POLLUT R, V20, P4164, DOI 10.1007/s11356-012-1343-9; Taylor J. C., 2007, TT28207 WRC; Taylor JC, 2007, HYDROBIOLOGIA, V592, P455, DOI 10.1007/s10750-007-0788-1; Team RDC, 2019, R LANG ENV STAT COMP; Teittinen A, 2016, FRESHWATER BIOL, V61, P1509, DOI 10.1111/fwb.12791; Teittinen A, 2015, SCI TOTAL ENVIRON, V530, P279, DOI 10.1016/j.scitotenv.2015.05.101; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Triest L, 2012, HYDROBIOLOGIA, V695, P343, DOI 10.1007/s10750-012-1201-2; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; Vazquez G, 2011, HYDROBIOLOGIA, V667, P173, DOI 10.1007/s10750-011-0633-4; Vinebrooke RD, 1996, LIMNOL OCEANOGR, V41, P1035, DOI 10.4319/lo.1996.41.5.1035; Walsh G, 2009, WATER SA, V35, P579; Woiss CH, 2007, ASTA-ADV STAT ANAL, V91, P339, DOI 10.1007/s10182-007-0038-x; Wynne M. J., 1985, INTRO ALGAE STRUCTUR; Yang GY, 2009, HYDROBIOLOGIA, V632, P189, DOI 10.1007/s10750-009-9838-1	80	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246043	10.1371/journal.pone.0246043	http://dx.doi.org/10.1371/journal.pone.0246043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534796	Green Published, gold			2022-12-26	WOS:000616739700056
J	Ghanizadeh, H; Griffiths, AG; Buddenhagen, CE; Anderson, CB; Harrington, KC				Ghanizadeh, Hossein; Griffiths, Andrew G.; Buddenhagen, Christopher E.; Anderson, Craig B.; Harrington, Kerry C.			A PCR plus restriction enzyme-based technique for detecting target-enzyme mutations at position Pro-106 in glyphosate-resistant Lolium perenne	PLOS ONE			English	Article							HERBICIDE TRANSLOCATION; QUICK-TEST; RYEGRASS; MULTIFLORUM; MECHANISMS; CONFIRMATION; EVOLUTION	The first step in managing herbicide-resistant weeds is to confirm their resistance status. It is, therefore, crucial to have a rapid, reliable and cost-effective technique to assess samples for herbicide resistance. We designed and evaluated three derived cleaved amplified polymorphic sequence (dCAPS) markers for detecting glyphosate resistance in Lolium perenne. conferred by non-synonymous mutations at codon-106 in the enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene. The dCAPS markers involve amplification of the target region, digestion of the amplified products with restriction enzymes and gel-based visualisation of the digested products. The results showed that all three dCAPS markers could successfully detect mutations at codon-106 in the target enzyme. The dCAPS markers can also inform us of the zygosity state of the resistance allele and was confirmed by sequencing the target region of the EPSPS gene. The markers described here are effective quick tests for the monitoring and evaluation of the target-enzyme mechanism of glyphosate resistance in Lolium perenne.	[Ghanizadeh, Hossein; Harrington, Kerry C.] Massey Univ, Sch Agr & Environm, Palmerston North, New Zealand; [Griffiths, Andrew G.; Anderson, Craig B.] AgRes Grasslands Res Ctr, Palmerston North, New Zealand; [Buddenhagen, Christopher E.] AgResearch, Hamilton, New Zealand	Massey University; AgResearch - New Zealand; AgResearch - New Zealand	Ghanizadeh, H (corresponding author), Massey Univ, Sch Agr & Environm, Palmerston North, New Zealand.	H.Ghanizadeh@massey.ac.nz	Buddenhagen, Christopher/J-3942-2019	Buddenhagen, Christopher/0000-0002-3016-1054	New Zealand Ministry for Business Innovation and Employment [C10X1806]	New Zealand Ministry for Business Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	Financial support for the authors was provided by the Endeavour fund (C10X1806, Managing Herbicide Resistance) from the New Zealand Ministry for Business Innovation and Employment. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CB, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0336-1; Boutsalis P, 2001, WEED TECHNOL, V15, P257, DOI 10.1614/0890-037X(2001)015[0257:SQTARW]2.0.CO;2; Burgos NR, 2013, WEED SCI, V61, P4, DOI 10.1614/WS-D-12-00032.1; Chatham LA, 2015, WEED TECHNOL, V29, P48, DOI 10.1614/WT-D-14-00064.1; Cirujeda A, 2001, WEED RES, V41, P523, DOI 10.1046/j.1365-3180.2001.00255.x; Dayan FE, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8090341; Delye C, 2015, WEED SCI, V63, P91, DOI 10.1614/WS-D-13-00096.1; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; Ghanizadeh H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61104-0; Ghanizadeh H, 2016, NEW ZEAL J AGR RES, V59, P269, DOI 10.1080/00288233.2016.1189438; Ghanizadeh H, 2016, J AGR SCI TECH-IRAN, V18, P1041; Ghanizadeh H., 2015, Australian Journal of Crop Science, V9, P337; Ghanizadeh H, 2015, NEW ZEAL J AGR RES, V58, P108, DOI 10.1080/00288233.2014.981344; Ghanizadeh H., 2013, New Zealand Plant Protection, V66, P89; Ghanizadeh H, 2021, NEW ZEAL J AGR RES, V64, P471, DOI 10.1080/00288233.2019.1705863; Ghanizadeh H, 2019, CRIT REV PLANT SCI, V38, P295, DOI 10.1080/07352689.2019.1665769; Ghanizadeh H, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9080448; Ghanizadeh H, 2020, NEW ZEAL J AGR RES, V63, P416, DOI 10.1080/00288233.2019.1620296; Ghanizadeh H, 2018, NEW ZEAL J CROP HORT, V46, P346, DOI 10.1080/01140671.2018.1449124; Ghanizadeh H, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx035; Ghanizadeh H, 2017, CRIT REV PLANT SCI, V36, P24, DOI 10.1080/07352689.2017.1316134; Ghanizadeh H, 2015, PEST MANAG SCI, V71, P1617, DOI 10.1002/ps.3968; Harrington K. C., 2016, New Zealand Plant Protection, V69, P252; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; Heap I, 2014, PEST MANAG SCI, V70, P1306, DOI 10.1002/ps.3696; Kim DS, 2000, WEED SCI, V48, P695, DOI 10.1614/0043-1745(2000)048[0695:RDOPAF]2.0.CO;2; Murphy BP, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100382; Nandula VK, 2010, GLYPHOSATE RESISTANC, DOI [10.1002/hon.958, DOI 10.1002/HON.958]; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Norsworthy JK, 2012, WEED SCI, V60, P31, DOI 10.1614/WS-D-11-00155.1; Perez A, 2003, WEED RES, V43, P12, DOI 10.1046/j.1365-3180.2003.00311.x; Perez-Jones A, 2005, WEED SCI, V53, P775, DOI 10.1614/WS-04-200R.1; Porta AR, 2012, AM BIOL TEACH, V74, P256, DOI 10.1525/abt.2012.74.4.9; Powles SB, 1998, WEED SCI, V46, P604, DOI 10.1017/S0043174500091165; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Yu Q, 2015, PLANT PHYSIOL, V167, P1440, DOI 10.1104/pp.15.00146	37	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246028	10.1371/journal.pone.0246028	http://dx.doi.org/10.1371/journal.pone.0246028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529261	gold, Green Published			2022-12-26	WOS:000616736200017
J	Kline, JM; Heusinkveld, LE; Taranto, E; Martin, CB; Tomasi, AG; Hsu, IJ; Cho, K; Khillan, JS; Murphy, PM; Pontejo, SM				Kline, Jaclyn M.; Heusinkveld, Lauren E.; Taranto, Eleanor; Martin, Clare B.; Tomasi, Alessandra G.; Hsu, Isabel J.; Cho, Kyoungin; Khillan, Jaspal S.; Murphy, Philip M.; Pontejo, Sergio M.			Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE SULFATION; DRY MOTIF; EXTRACELLULAR CYSTEINES; DISULFIDE BRIDGES; CRYSTAL-STRUCTURE; LIGAND-BINDING; RESIDUES; DOMAIN; IDENTIFICATION; MUTAGENESIS	Mouse Ccr1l1 (Ccr1-like 1) encodes an orphan G-protein-coupled receptor (GPCR) with the highest homology to the inflammatory and highly promiscuous chemokine receptors Ccr1 and Ccr3 (70 and 50% amino acid identity, respectively). Ccr1l1 was first cloned in 1995, yet current knowledge of this putative chemokine receptor is limited to its gene organization and chromosomal localization. Here we report that Ccr1l1 is a Rodentia-specific gene selectively expressed in eosinophils. However, eosinophil phenotypes, development, and responsiveness to chemokines were all normal in naive Ccr1l1 knockout mice. We demonstrate for the first time that recombinant Ccr1l1 is expressed on the plasma membrane of transfected cells and contains an extracellular N terminus and an intracellular C terminus, consistent with GPCR topology. Using receptor internalization, beta-arrestin recruitment, calcium flux, and chemotaxis assays, we excluded all 37 available mouse chemokines, including Ccr1 ligands, and two viral chemokines as Ccr1l1 ligands, and demonstrated that mouse Ccr1, but not Ccr1l1, exhibits constitutive signaling activity. However, sequence analysis and structural modeling revealed that Ccr1l1 is well equipped to act as a classical signaling GPCR, with N-terminal sulfotyrosines as the only signaling and chemokine-binding determinant absent in Ccr1l1. Hereof, we show that a sulfatable N-terminal Ccr1 Y-18 residue is essential for chemotaxis and calcium responses induced by Ccl3 and Ccl9/10, but substituting the corresponding Ccr1l1 F-19 residue with tyrosine failed to confer responsiveness to Ccr1 ligands. Although Ccr1l1 remains an extreme outlier in the chemokine receptor family, our study supports that it might respond to unidentified mouse chemokine ligands in eosinophil-driven immune responses.	[Kline, Jaclyn M.; Heusinkveld, Lauren E.; Taranto, Eleanor; Martin, Clare B.; Tomasi, Alessandra G.; Hsu, Isabel J.; Murphy, Philip M.; Pontejo, Sergio M.] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cho, Kyoungin; Khillan, Jaspal S.] NIAID, Comparat Med Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pontejo, SM (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jesussergio.martinpontejo@nih.gov		Kline, Jaclyn/0000-0002-6897-5520; Hsu, Isabel/0000-0001-5867-0806; PONTEJO, SERGIO/0000-0002-7756-9831; Martin, Clare/0000-0002-1175-6562; Tomasi, Alessandra/0000-0001-9898-9838	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Barington L, 2016, J BIOL CHEM, V291, P16208, DOI 10.1074/jbc.M115.706747; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Bolus WR, 2018, MOL METAB, V8, P86, DOI 10.1016/j.molmet.2017.12.004; Bonecchi R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00224; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Chen KQ, 2018, CELL MOL IMMUNOL, V15, P324, DOI 10.1038/cmi.2017.134; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fox JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27710-9; Gao JM, 2009, ACTA PHARMACOL SIN, V30, P193, DOI 10.1038/aps.2008.24; GAO JL, 1995, J BIOL CHEM, V270, P17494, DOI 10.1074/jbc.270.29.17494; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Gustavsson M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw3657; Gustavsson M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14135; Gyombolai P, 2015, J MOL ENDOCRINOL, V54, P75, DOI 10.1530/JME-14-0219; Han XB, 2015, FEBS OPEN BIO, V5, P182, DOI 10.1016/j.fob.2015.03.001; Han XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042765; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Legler Daniel F, 2018, F1000Res, V7, P95, DOI 10.12688/f1000research.13130.1; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Limatola C, 2005, EXP CELL RES, V307, P65, DOI 10.1016/j.yexcr.2005.02.020; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; Ludeman JP, 2014, BRIT J PHARMACOL, V171, P1167, DOI 10.1111/bph.12455; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Martinez-Munoz L, 2018, J LEUKOCYTE BIOL, V104, P323, DOI 10.1002/JLB.2MR1217-503R; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Montpas N, 2015, BIOCHEMISTRY-US, V54, P1505, DOI 10.1021/bi501526s; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; Ngo T, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000656; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Nomiyama H, 2015, J LEUKOCYTE BIOL, V97, P39, DOI 10.1189/jlb.2RU0614-290R; Patel J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/459520; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Petit SJ, 2008, EUR J IMMUNOL, V38, P2337, DOI 10.1002/eji.200838269; Pontejo SM, 2018, J INNATE IMMUN, V10, P465, DOI 10.1159/000492161; Pontejo SM, 2017, J LEUKOCYTE BIOL, V102, P1199, DOI 10.1189/jlb.4RU0417-145RR; POST TW, 1995, J IMMUNOL, V155, P5299; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rosenkilde MM, 2004, J BIOL CHEM, V279, P32524, DOI 10.1074/jbc.M313392200; Rummel PC, 2013, MOL PHARMACOL, V84, P335, DOI 10.1124/mol.113.086702; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Smith JS, 2017, MOL PHARMACOL, V92, P136, DOI 10.1124/mol.117.108522; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Stephens BS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay5024; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Wasilko DJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16820-6; Weber KSC, 2001, EUR J IMMUNOL, V31, P2458, DOI 10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	77	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100373	10.1016/j.jbc.2021.100373	http://dx.doi.org/10.1016/j.jbc.2021.100373			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548230	Green Published, gold			2022-12-26	WOS:000672866400347
J	Chandrasekara, CHWMRB; Naranpanawa, DNU; Bandusekara, BS; Pushpakumara, DKNG; Wijesundera, DSA; Bandaranayake, PCG				Chandrasekara, C. H. W. M. R. Bhagya; Naranpanawa, D. Nathasha U.; Bandusekara, B. Supun; Pushpakumara, D. K. N. G.; Wijesundera, D. Siril A.; Bandaranayake, Pradeepa C. G.			Universal barcoding regions, rbcL, matK and trnH-psbA do not discriminate Cinnamomum species in Sri Lanka	PLOS ONE			English	Article								The genus Cinnamomum consists of about 250 species spread globally. Out of these, C. verum (C. zeylanicum), also known as true cinnamon or Ceylon cinnamon, has gained worldwide attention due to its culinary uses and medicinal values. Sri Lanka is the largest true cinnamon producer in the world and accounts for about 80-90% of global production. Other than the cultivated species, Sri Lankan natural vegetation is home to seven endemic wild species of the genus Cinnamomum. While these are underutilized, proper identification and characterization are essential steps in any sustainable conservation and utilization strategies. Currently, species identification is purely based on morphological traits, and intraspecific diversity has made it more challenging. In this study, all the eight Cinnamomum species found in Sri Lanka, C. capparu-coronde, C. citriodorum C. dubium, C. litseifolium, C. ovalifolium, C. rivulorum, C. sinharajaense, and C. verum were collected in triplicates and identified using typical morphological traits. DNA extracted with the same collection was assessed with universal barcoding regions, rbcL, matK, and trnH-psbA. While no intraspecific sequence differences were observed in C. citriodorum, C. rivulorum, and C. verum, the others had polymorphic sites in one, two, or all regions assessed. Interestingly, two individuals of C. sinharajaense had identical barcodes to the cultivated species C. verum, while the other one had one variable cite in matK region and three cites in trnH-psbA reigon. Further, one C. dubium and one C. capparu-coronde accession each had identical, rbcL, and trnH-psbA sequences while those had only a single nucleotide variation observed in matK region. Overall, the phylogeny of Cinnamomum species found in Sri Lanka could not be completely resolved with DNA barcoding regions studied.	[Chandrasekara, C. H. W. M. R. Bhagya; Naranpanawa, D. Nathasha U.; Bandusekara, B. Supun; Bandaranayake, Pradeepa C. G.] Univ Peradeniya, Fac Agr, Agr Biotechnol Ctr, Peradeniya, Sri Lanka; [Naranpanawa, D. Nathasha U.] Univ Peradeniya, Postgrad Inst Sci, Peradeniya, Sri Lanka; [Bandusekara, B. Supun] Univ Peradeniya, Postgrad Inst Agr, Peradeniya, Sri Lanka; [Pushpakumara, D. K. N. G.] Univ Peradeniya, Fac Agr, Dept Crop Sci, Peradeniya, Sri Lanka; [Wijesundera, D. Siril A.] Natl Inst Fundamental Studies, Kandy, Sri Lanka; [Naranpanawa, D. Nathasha U.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya; National Institute of Fundamental Studies (NIFS); University of Queensland	Bandaranayake, PCG (corresponding author), Univ Peradeniya, Fac Agr, Agr Biotechnol Ctr, Peradeniya, Sri Lanka.	pradeepag@agri.pdn.ac.lk		Bandaranayake, Pradeepa/0000-0001-8241-1775; Bandusekara, Supun/0000-0002-6382-1071	Ministry of Primary Industries and Social Empowerment through the National Science Foundation of Sri Lanka [NSF SP/CIN/2016/01]	Ministry of Primary Industries and Social Empowerment through the National Science Foundation of Sri Lanka	PCG is the PI of the grant NSF SP/CIN/2016/01 funded by the Ministry of Primary Industries and Social Empowerment through the National Science Foundation of Sri Lanka (http://www.nsf.ac.lk/) under the special Cinnamon project - Grant No: NSF SP/CIN/2016/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe PD, 2014, J NATL SCI FOUND SRI, V42, P175, DOI 10.4038/jnsfsr.v42i3.7393; Abeysinghe P. D., 2009, Research Journal of Agriculture and Biological Sciences, V5, P1079; [Anonymous], 2012, NA TIONAL RED LIST 2; Ariyarathne H.B.M.A., 2018, SRI LANKAN J BIOL, V3, P11, DOI [DOI 10.4038/SLJB.V3I1.14, 10.4038/sljb.v3i1.14]; Attanayake SRMR, 2017, NORD J BOT, V35, P385, DOI 10.1111/njb.01317; Azad R., 2016, International Journal of Minor Fruits, Medicinal and Aromatic Plants, V2, P6; Azad R, 2016, DESCRIPTORS CINNAMON, P1; Bandusekara B. S., 2020, Tropical Agricultural Research, V31, P43, DOI 10.4038/tar.v31i4.8420; Bi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19591-9; Chakrabarty T, 2018, PHYTOTAXA, V379, P274, DOI 10.11646/phytotaxa.379.3.8; Chandrasekara CHWMRB, 2018, P 7 YSF S YOUNG SCI, P22; Chen J, 2015, MOL ECOL RESOUR, V15, P337, DOI 10.1111/1755-0998.12319; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Dassanayake M, 1995, REVISED HDB FLORA CE, VIX, P236; DeSalle R, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00302; Doh EJ, 2017, GENES GENOM, V39, P101, DOI 10.1007/s13258-016-0476-5; Doyle J. J., 1987, PHYTOCHEM B, P11; Gunawardena D., 2014, POLYPHENOLS HUMAN HL, P409; Hathurusinghe HABM, 2018, INT AGR RES S, P22; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; James Smerq, 2011, International Journal of Pharmaceutical Sciences and Drug Research, V3, P260; Jayaprakasha GK, 2011, CRIT REV FOOD SCI, V51, P547, DOI 10.1080/10408391003699550; Jiao LC, 2019, PLANTA, V250, P95, DOI 10.1007/s00425-019-03150-1; Kawatra P, 2015, PHARMACOGN RES, V7, P1, DOI 10.4103/0974-8490.157990; KOSTERMANS A. J. G. H., 1961, REINWARDTIA, V6, P17; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumari HRSN, 2008, P NAT S, P29; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li Y, 2014, NORD J BOT, V32, P511, DOI 10.1111/njb.00423; Liu ZF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175788; Liyanage AS, 2010, ECO GEOGRAPHIC SURVE; Liyanage ASU, 2010, ATLAS SELECTED CROP, P11; Liyanage NMN, 2021, J CROP IMPROV, V35, P21, DOI 10.1080/15427528.2020.1795769; Liyanage NMN, 2021, J FOOD COMPOS ANAL, V96, DOI 10.1016/j.jfca.2020.103747; Liyanage T., 2017, Tropical Agricultural Research, V28, P270, DOI 10.4038/tar.v28i3.8231; Maia VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029877; Mishra R., 2016, INT J ENG SCI RES TE, V5, P749; Muhammad DRA, 2017, INT J FOOD PROP, V20, P2237, DOI 10.1080/10942912.2017.1369102; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Pathirana C. K., 2018, Ceylon Journal of Science, V47, P43, DOI 10.4038/cjs.v47i1.7485; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Ranasinghe P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-275; Ravindran P., 2003, CINNAMON CASSIA GENU; Rohde R, 2017, TAXON, V66, P1085, DOI 10.12705/665; Rohwer JG, 2019, WILLDENOWIA, V49, P383, DOI 10.3372/wi.49.49309; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Singletary K., 2019, Nutrition Today, V54, P42, DOI 10.1097/NT.0000000000000319; Sritharan R, 1984, THESIS U PERADENIYA; Swetha VP, 2014, FOOD BIOTECHNOL, V28, P183, DOI 10.1080/08905436.2014.931239; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Willis J.C., 1966, DICT FLOWERING PLANT; Yang BC, 2020, PHARMACOGN MAG, V16, P64, DOI 10.4103/pm.pm_267_19; Yang HQ, 2012, ANN BOT FENN, V49, P319, DOI 10.5735/085.049.0603; Yang HW, 2019, COMPUT ELECTRON AGR, V162, P739, DOI 10.1016/j.compag.2019.05.003	59	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245592	10.1371/journal.pone.0245592	http://dx.doi.org/10.1371/journal.pone.0245592			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566825	Green Published, gold			2022-12-26	WOS:000618271700050
J	Park, HJ; Bae, TS; Kang, SB; Baek, HH; Chang, MJ; Chang, CB				Park, Hyung Jun; Bae, Tae Soo; Kang, Seung-Baik; Baek, Hyeong Ho; Chang, Moon Jong; Chang, Chong Bum			A three-dimensional finite element analysis on the effects of implant materials and designs on periprosthetic tibial bone resorption	PLOS ONE			English	Article								Introduction Implant material is a more important factor for periprosthetic tibial bone resorption than implant design after total knee arthroplasty (TKA). The virtual perturbation study was planned to perform using single case of proximal tibia model. We determined whether the implant materials' stiffness affects the degree of periprosthetic tibial bone resorption, and whether the effect of material change with the same implant design differed according to the proximal tibial plateau areas. Materials and methods This three-dimensional finite element analysis included two cobalt-chromium (CoCr) and two titanium (Ti) tibial implants with different designs. They were implanted into the proximal tibial model reconstructed using extracted images from computed tomography. The degree of bone resorption or formation was measured using the strain energy density after applying axial load. The same analysis was performed after exchanging the materials while maintaining the design of each implant. Results The degree of periprosthetic tibial bone resorption was not determined by the type of implant materials alone. When the implant materials were changed from Ti to CoCr, the bone resorption in the medial compartment increased and vice versa. The effect of material composition's change on anterior and posterior areas varied accordingly. Conclusions Although the degree of bone resorption was associated with implant materials, it differed depending on the design of each implant. The effect on the degree of bone resorption according to the materials after TKA should be evaluated while concomitantly considering design.	[Park, Hyung Jun; Kang, Seung-Baik; Chang, Moon Jong] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Bae, Tae Soo; Baek, Hyeong Ho] Jungwon Univ, Dept Biomed Engn BME, Chungcheongbuk Do, South Korea; [Chang, Chong Bum] Seoul Natl Univ, Coll Med, Dept Orthoped Surg, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Jungwon University; Seoul National University (SNU)	Kang, SB (corresponding author), Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Orthoped Surg, Coll Med, Seoul, South Korea.	ossbkang@gmail.com		Kang, Seung-Baik/0000-0002-1184-4482	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [2017M3A9D8063538]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)	This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2017M3A9D8063538).	Akamatsu Y, 2012, ACTA ORTHOP, V83, P249, DOI 10.3109/17453674.2012.684139; Anderson AE, 2005, J BIOMECH ENG-T ASME, V127, P364, DOI 10.1115/1.1894148; Bellemans J, 2012, CLIN ORTHOP RELAT R, V470, P45, DOI 10.1007/s11999-011-1936-5; Bonutti P, 2018, J KNEE SURG, V31, P811, DOI 10.1055/s-0037-1608945; BOURNE RB, 1986, CLIN ORTHOP RELAT R, P95; Callister W. D, 2011, MAT SCI ENG; Cawley DT, 2012, CLIN BIOMECH, V27, P390, DOI 10.1016/j.clinbiomech.2011.10.011; Cerquiglini A, 2019, BONE JOINT RES, V8, P136, DOI 10.1302/2046-3758.83.BJJ-2018-0102.R2; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Dalstra M, 1993, BIOMECHANICAL ASPECT; Draper CE, 2012, J MAGN RESON IMAGING, V36, P928, DOI 10.1002/jmri.23682; Gabriel SB, 2015, MATER RES-IBERO-AM J, V18, P8, DOI 10.1590/1516-1439.329614; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; LEVITZ CL, 1995, CLIN ORTHOP RELAT R, P68; LEWIS P, 1994, CLIN ORTHOP RELAT R, P11; Lonner JH, 2001, J ARTHROPLASTY, V16, P107, DOI 10.1054/arth.2001.16486; Ma JB, 2016, INT J SURG, V36, P44, DOI 10.1016/j.ijsu.2016.10.007; Martin JR, 2017, J ARTHROPLASTY, V32, P558, DOI 10.1016/j.arth.2016.07.027; MCBROOM RJ, 1985, J BONE JOINT SURG AM, V67A, P1206, DOI 10.2106/00004623-198567080-00010; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; Nagura T, 2002, J ORTHOP RES, V20, P881, DOI 10.1016/S0736-0266(01)00178-4; Petersen MM, 1995, ACTA ORTHOP SCAND, V66, P513, DOI 10.3109/17453679509002305; Ridzwan M., 2007, J MED SCI, V7, P460, DOI DOI 10.3923/JMS.2007.460.467; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056; Scott CEH, 2012, J BONE JOINT SURG BR, V94B, P1009, DOI 10.1302/0301-620X.94B8.28289; Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32; Yoon C, 2018, J ARTHROPLASTY, V33, P2835, DOI 10.1016/j.arth.2018.04.025; Zhang QH, 2016, MED ENG PHYS, V38, P1481, DOI 10.1016/j.medengphy.2016.09.018; 이승준, 2011, [Journal of the Korean Orthopaedic Association, 대한정형외과학회지], V46, P191	30	4	4	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246866	10.1371/journal.pone.0246866	http://dx.doi.org/10.1371/journal.pone.0246866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566856	gold, Green Published			2022-12-26	WOS:000618271700019
J	Qu, TB; Du, X; Peng, YL; Guo, WQ; Zhao, CL; Losapio, G				Qu, Tongbao; Du, Xue; Peng, Yulan; Guo, Weiqiang; Zhao, Chunli; Losapio, Gianalberto			Invasive species allelopathy decreases plant growth and soil microbial activity	PLOS ONE			English	Article							LANTANA-CAMARA L.; PHYSIOLOGICAL PROFILES; RHIZOSPHERE SOIL; RHUS-TYPHINA; POPULATION; FOREST; SHRUB	According to the 'novel weapons hypothesis', invasive success depends on harmful plant biochemicals, including allelopathic antimicrobial roots exudate that directly inhibit plant growth and soil microbial activity. However, the combination of direct and soil-mediated impacts of invasive plants via allelopathy remains poorly understood. Here, we addressed the allelopathic effects of an invasive plant species (Rhus typhina) on a cultivated plant (Tagetes erecta), soil properties and microbial communities. We grew T. erecta on soil samples at increasing concentrations of R. typhina root extracts and measured both plant growth and soil physiological profile with community-level physiological profiles (CLPP) using Biolog Eco-plates incubation. We found that R. typhina root extracts inhibit both plant growth and soil microbial activity. Plant height, Root length, soil organic carbon (SOC), total nitrogen (TN) and AWCD were significantly decreased with increasing root extract concentration, and plant above-ground biomass (AGB), below-ground biomass (BGB) and total biomass (TB) were significantly decreased at 10 mg center dot mL(-1) of root extracts. In particular, root extracts significantly reduced the carbon source utilization of carbohydrates, carboxylic acids and polymers, but enhanced phenolic acid. Redundancy analysis shows that soil pH, TN, SOC and EC were the major driving factors of soil microbial activity. Our results indicate that strong allelopathic impact of root extracts on plant growth and soil microbial activity by mimicking roots exudate, providing novel insights into the role of plant-soil microbe interactions in mediating invasion success.	[Qu, Tongbao; Du, Xue; Peng, Yulan; Guo, Weiqiang; Zhao, Chunli] Jilin Agr Univ, Coll Hort, Changchun, Peoples R China; [Losapio, Gianalberto] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Jilin Agricultural University; Stanford University	Qu, TB (corresponding author), Jilin Agr Univ, Coll Hort, Changchun, Peoples R China.	qvtb@sina.com	peng, yu/GXW-2071-2022	qu, tong bao/0000-0002-3777-120X; Losapio, Gianalberto/0000-0001-7589-8706	Department of Science and Technology of Jilin Province [20190303078SF]; Swiss National Science Foundation [P2ZHP3_187938]	Department of Science and Technology of Jilin Province; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Department of Science and Technology of Jilin Province (20190303078SF). GL was supported by the Swiss National Science Foundation (P2ZHP3_187938).	Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; Ben Ghnaya A, 2016, NAT PROD RES, V30, P2058, DOI 10.1080/14786419.2015.1108973; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Chacon N, 2009, BIOL FERT SOILS, V45, P321, DOI 10.1007/s00374-008-0342-y; Chen BM, 2009, BIOL INVASIONS, V11, P1291, DOI 10.1007/s10530-008-9336-9; Chodak M, 2015, ECOL ENG, V81, P462, DOI 10.1016/j.ecoleng.2015.04.077; DOUST JL, 1988, ECOLOGY, V69, P741, DOI 10.2307/1941023; Elton C., 1958; Fan L, 2010, GEODERMA, V154, P370, DOI 10.1016/j.geoderma.2009.11.010; Gentle CB, 1997, PLANT ECOL, V132, P85, DOI 10.1023/A:1009707404802; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Khattak A, 2015, PAK J BOT, V47, P2449; Konopka A, 1998, MICROBIAL ECOL, V35, P103, DOI 10.1007/s002489900065; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Liu JK, 2018, APPL SOIL ECOL, V125, P301, DOI 10.1016/j.apsoil.2018.01.001; Liu LY, 2015, J FORESTRY RES, V26, P273, DOI 10.1007/s11676-015-0041-0; Losapio G, 2019, PLANT ECOL DIVERS, V12, P87, DOI 10.1080/17550874.2019.1626509; Maity N, 2011, J ETHNOPHARMACOL, V137, P1300, DOI 10.1016/j.jep.2011.07.064; Mureva A, 2017, PEDOBIOLOGIA, V63, P37, DOI 10.1016/j.pedobi.2017.06.006; Nishita M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-016-0028-x; Puig CG, 2018, J CHEM ECOL, V44, P658, DOI 10.1007/s10886-018-0983-8; Qu TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159680; Rutgers M, 2016, APPL SOIL ECOL, V97, P23, DOI 10.1016/j.apsoil.2015.06.007; Sharma Gyan P., 2007, Applied Ecology and Environmental Research, V5, P109; Steinlein T, 2013, PROG BOT, V74, P293, DOI 10.1007/978-3-642-30967-0_11; Svensson JR, 2013, J ECOL, V101, P140, DOI 10.1111/1365-2745.12028; Szymura TH, 2018, SCI TOTAL ENVIRON, V626, P1373, DOI 10.1016/j.scitotenv.2018.01.131; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wang C, 2017, S AFR J BOT, V111, P17, DOI 10.1016/j.sajb.2017.03.019; Wang GM, 2008, J INTEGR PLANT BIOL, V50, P522, DOI 10.1111/j.1744-7909.2008.00660.x; White Peter S., 1998, Weed Technology, V12, P744; [吴长虹 WU Changhong], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P162; Zhang KP, 2019, J SOIL SEDIMENT, V19, P2764, DOI 10.1007/s11368-019-02243-4; Zhang ZJ, 2009, TREE PHYSIOL, V29, P1307, DOI 10.1093/treephys/tpp065	38	13	13	20	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246685	10.1371/journal.pone.0246685	http://dx.doi.org/10.1371/journal.pone.0246685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561161	gold, Green Published			2022-12-26	WOS:000617533000050
J	Szczepaniak, O; Jokiel, M; Stuper-Szablewska, K; Szymanowska, D; Dziedzinski, M; Kobus-Cisowska, J				Szczepaniak, Oskar; Jokiel, Maria; Stuper-Szablewska, Kinga; Szymanowska, Daria; Dziedzinski, Marcin; Kobus-Cisowska, Joanna			Can cornelian cherry mask bitter taste of probiotic chocolate? Human TAS2R receptors and a sensory study with comprehensive characterisation of new functional product	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; DARK CHOCOLATE; POLYPHENOLS; HEALTH; COCOA; SWEET; L.	Cornelian cherry (Cornus mas L.) fruits are a valuable source of bioactive compounds that are responsible for the perception of bitter taste of chocolate products. The aim of the study was to validate the inhibitory effect of Cornus mas on the TAS2R3 and TAS2R13 bitter taste receptors and to assess the effect of masking the bitter taste of dark chocolate with the help of the sensory panel. Dark chocolate was prepared with an addition of 5% of freeze-dried cornelian cherry fruits and 10(8) CFU/g of Bacillus coagulans probiotic strains. Effect on the TAS2R receptors was evaluated in specially transfected HEK293T cells, and the inhibition ratio was measured using the calcium release test. Moreover, the total polyphenol content, antioxidant activity and simulated intestinal in vitro digestion were determined for the samples. The tested chocolate products were rich in chlorogenic, caffeic and sinapic acids. The addition of cornelian cherry positively affected the antioxidant activity. The phytochemicals of Cornus mas decreased the TAS2R13 activity by 132% after a 2-minute interaction and, % at the same time, inhibited the TAS2R3 activity by 11.5. Meanwhile, chocolate with the addition of fruit was less bitter according to the sensory panel.	[Szczepaniak, Oskar; Dziedzinski, Marcin; Kobus-Cisowska, Joanna] Poznan Univ Life Sci, Dept Gastron Sci & Funct Foods, Poznan, Poland; [Jokiel, Maria] PORT Polish Ctr Technol Dev, Wroclaw, Poland; [Stuper-Szablewska, Kinga] Poznan Univ Life Sci, Dept Chem, Poznan, Poland; [Szymanowska, Daria] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences; Poznan University of Life Sciences	Szczepaniak, O (corresponding author), Poznan Univ Life Sci, Dept Gastron Sci & Funct Foods, Poznan, Poland.	oskar.szczepaniak@up.poznan.pl	Szczepaniak, Oskar/AAG-3231-2019; Dziedziński, Marcin/AAK-4211-2020	Szczepaniak, Oskar/0000-0002-9498-819X; Szymanowska-Powalowska, Daria/0000-0002-4665-1576; Stuper-Szablewska, Kinga/0000-0002-9011-8592	Ministry of Science and Higher Education: "Support in management of scientific research and results commercialization of RAMP;D works in scientific centers and entrepreneurships"; European Union in range of Intelligent Development Operational Program 2014-2020 (Act 4.4) [MNiSW/2019/170/RID]; National Centre for Research and Development in Poland [POIR.04.01.02-00-0059/17]; Polish Ministry of Science and Higher Education [005/RID/2018/19]	Ministry of Science and Higher Education: "Support in management of scientific research and results commercialization of RAMP;D works in scientific centers and entrepreneurships"; European Union in range of Intelligent Development Operational Program 2014-2020 (Act 4.4); National Centre for Research and Development in Poland(National Centre for Research & Development, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was co-financed as a development-application project (J.K-C.): "Functional chocolate lines with cornelian cherry fruit preparations, as a matrix for pro-health ingredients", conducted within "Innovation Incubator" program, realized as a part of out-competition project of Ministry of Science and Higher Education: "Support in management of scientific research and results commercialization of R&D works in scientific centers and entrepreneurships", co-financed with sources of European Union in range of Intelligent Development Operational Program 2014-2020 (Act 4.4) MNiSW/2019/170/RID. www.gov.pl/web/science/This work was co-financed (J.K-C.) with grant POIR.04.01.02-00-0059/17 from the National Centre for Research and Development in Poland (www.ncbr.gov.pl).Publication was co-financed within the framework of the Polish Ministry of Science and Higher Education's program: "Regional Initiative Excellence" in the years 2019-2022 (No. 005/RID/2018/19)", financing amount 12 000 00 PLN. www.gov.pl/web/science/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarowicz R, 2000, J AGR FOOD CHEM, V48, P2755, DOI 10.1021/jf9911601; [Anonymous], 2016, GIDA J FOOD; Belscak-Cvitanovic A, 2012, FOOD RES INT, V48, P820, DOI 10.1016/j.foodres.2012.06.023; Cakmakci S, 2010, INT J FOOD PROP, V13, P713, DOI 10.1080/10942910902804459; Camu N, 2008, J SCI FOOD AGR, V88, P2288, DOI 10.1002/jsfa.3349; Cao J, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103643; Di Pizio A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061402; Di Pizio A, 2019, NEUROSCI LETT, V700, P56, DOI 10.1016/j.neulet.2018.04.027; Endres JR, 2009, FOOD CHEM TOXICOL, V47, P1231, DOI 10.1016/j.fct.2009.02.018; Gil-Sanchez I, 2020, FOOD RES INT, V129, DOI 10.1016/j.foodres.2019.108790; Hinneh M, 2020, FOOD RES INT, V132, DOI 10.1016/j.foodres.2020.109116; Kalman DS, 2018, J PROB HLTH, V6, P1, DOI 10.4172/2329-8901.1000190.; Kavak DD, 2018, J FOOD PROCESS PRES, V42, DOI 10.1111/jfpp.13656; Kawa-Rygielska J, 2019, FOOD CHEM, V281, P147, DOI 10.1016/j.foodchem.2018.12.093; Kawa-Rygielska J, 2018, MOLECULES, V23, DOI 10.3390/molecules23020379; Kazimierski M, 2019, ACTA SCI POLON-TECHN, V18, P5, DOI [10.17306/J.AFS.2019.0628, 10.17306/j.afs.2019.0628, 10.17306/J.AFS.0628]; Kobus-Cisowska J, 2020, CIENC RURAL, V50, DOI 10.1590/0103-8478cr20190371; Kobus-Cisowska J, 2019, FOOD FUNCT, V10, P997, DOI [10.1039/c8fo02099j, 10.1039/C8FO02099J]; Komes D, 2013, LWT-FOOD SCI TECHNOL, V53, P360, DOI 10.1016/j.lwt.2013.02.016; Konuray G, 2018, FOODS, V7, DOI 10.3390/foods7060092; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lingua MS, 2019, FOOD RES INT, V122, P496, DOI 10.1016/j.foodres.2019.05.022; Loncarevic I, 2018, LWT-FOOD SCI TECHNOL, V92, P458, DOI 10.1016/j.lwt.2018.03.002; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; McShea A, 2008, NUTR REV, V66, P630, DOI 10.1111/j.1753-4887.2008.00114.x; Mellor DD, 2018, INT J FOOD SCI TECH, V53, P33, DOI 10.1111/ijfs.13651; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Newman J, 2015, LWT-FOOD SCI TECHNOL, V63, P751, DOI 10.1016/j.lwt.2015.03.019; Ochmian I, 2019, SCI HORTIC-AMSTERDAM, V256, DOI 10.1016/j.scienta.2019.108588; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2014, INTRINSIC BITTERNESS; Salejda AM, 2018, J FOOD QUALITY, DOI 10.1155/2018/1563651; Sim SYJ, 2016, FOOD CHEM, V200, P46, DOI 10.1016/j.foodchem.2015.12.092; Stuper-Szablewska K, 2017, CHEM ECOL, V33, P949, DOI 10.1080/02757540.2017.1381689; Szczepaniak O, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050700; Szczepaniak OM, 2019, CYTA-J FOOD, V17, P781, DOI 10.1080/19476337.2019.1653378; Tarko T, 2009, FOOD TECHNOL BIOTECH, V47, P456; Toker OS, 2020, TRENDS FOOD SCI TECH, V99, P580, DOI 10.1016/j.tifs.2020.03.035; Topdas EF, 2017, KAFKAS UNIV VET FAK, V23, P691, DOI 10.9775/kvfd.2016.17298; Virgili F, 2000, FREE RADICAL BIO MED, V28, P1249, DOI 10.1016/S0891-5849(00)00244-6; Yousuf S, 2013, AAPS PHARMSCITECH, V14, P770, DOI 10.1208/s12249-013-9963-z	44	0	0	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0243871	10.1371/journal.pone.0243871	http://dx.doi.org/10.1371/journal.pone.0243871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556063	gold, Green Published			2022-12-26	WOS:000617379900035
J	Mwaka, ES; Munabi, IG; Castelnuovo, B; Kaimal, A; Kasozi, W; Kambugu, A; Musoke, P; Katabira, E				Mwaka, Erisa Sabakaki; Munabi, Ian Guyton; Castelnuovo, Barbara; Kaimal, Arvind; Kasozi, William; Kambugu, Andrew; Musoke, Philippa; Katabira, Elly			Low bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in Uganda	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; MINERAL DENSITY LOSS; INFECTED PATIENTS; RISK-FACTORS; WEIGHT-LOSS; ABACAVIR-LAMIVUDINE; HIGH PREVALENCE; FRACTURE RISK; R PACKAGE; ADULTS	Background This study set out to determine the prevalence of low bone mass following long-term exposure to antiretroviral therapy in Ugandan people living with HIV. Methods A cross-sectional study was conducted among 199 people living with HIV that had been on anti-retroviral therapy for at least 10 years. All participants had dual X-ray absorptiometry to determine their bone mineral density. The data collected included antiretroviral drug history and behavioral risk data Descriptive statistics were used to summarize the data. Inferential statistics were analyzed using multilevel binomial longitudinal Markov chain Monte Carlo mixed multivariate regression modelling using the rstanarm package. Results One hundred ninety nine adults were enrolled with equal representation of males and females. The mean age was 39.5 (SD 8.5) years. Mean durations on anti-retroviral treatment was 12.1 (SD 1.44) years, CD4 cell count was 563.9 cells/mm(3). 178 (89.5%) had viral suppression with <50 viral copies/ml. There were 4 (2.0%) and 36 (18%) participants with low bone mass of the hip and lumbar spine respectively. Each unit increase in body mass index was associated with a significant reduction in the odds for low bone mineral density of the hip and lumbar spine. The duration on and exposure to the various antiretroviral medications had no significant effect on the participant's odds for developing low bone mass. All the coefficients of the variables in a multivariable model for either hip or lumbar spine bone mass were not significant. Conclusion These results provide additional evidence that patients on long term ART achieve bone mass stabilization. Maintaining adequate body weight is important in maintaining good bone health in people on antiretroviral therapy.	[Mwaka, Erisa Sabakaki; Munabi, Ian Guyton; Kambugu, Andrew] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda; [Mwaka, Erisa Sabakaki; Castelnuovo, Barbara; Kaimal, Arvind; Kasozi, William] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Musoke, Philippa] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Kampala, Uganda; [Katabira, Elly] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University; Makerere University	Mwaka, ES (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda.; Mwaka, ES (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	erisamwaka@gmail.com	MWAKA, ERISA/C-2009-2018	MWAKA, ERISA/0000-0003-1672-9608; Kasozi, William/0000-0003-1111-6722	University of Alabama at Birmingham (UAB) Center For AIDS Research [000503356-SP002-24]; National Institutes of Health [P30AI027767-28]; Janssen pharmaceutical company	University of Alabama at Birmingham (UAB) Center For AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen pharmaceutical company	This work was supported by University of Alabama at Birmingham (UAB) Center For AIDS Research in the form of a grant awarded to ESM (000503356-SP002-24), which was a sub-award from a National Institutes of Health grant awarded to Principal Investigator Michael Saags (P30AI027767-28). Janssen pharmaceutical company provided support through a Johnson & Johnson corporate citizenship trust used to partly fund the ALT cohort at the Infectious Disease Institute-Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonge T O, 2013, J West Afr Coll Surg, V3, P1; [Anonymous], 2019, AD INT SOC CLIN DENS; Assoumou L, 2013, AIDS, V27, P2425, DOI 10.1097/QAD.0b013e32836378c3; Aydin OA, 2013, BRAZ J INFECT DIS, V17, P707, DOI 10.1016/j.bjid.2013.05.009; Battalora LA, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0393-1; BBC, 2015, J MEDIA PRACTICE, V15, P71; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bernardino JI, 2015, LANCET HIV, V2, pE464, DOI 10.1016/S2352-3018(15)00181-2; Bleicher K, 2011, BONE, V49, P1299, DOI 10.1016/j.bone.2011.08.026; Bolland MJ, 2019, CALCIFIED TISSUE INT, V105, P423, DOI 10.1007/s00223-019-00579-0; Bolland MJ, 2015, LANCET DIABETES ENDO, V3, P63, DOI 10.1016/S2213-8587(13)70181-5; Bolland MJ, 2012, CLIN ENDOCRINOL, V76, P643, DOI 10.1111/j.1365-2265.2011.04274.x; Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2015, J INFECT DIS, V212, P1241, DOI 10.1093/infdis/jiv194; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Castelnuovo B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142722; Castelnuovo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051631; Center JR, 2013, NAT REV ENDOCRINOL, V9, P630, DOI 10.1038/nrendo.2013.189; Chisati EM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227893; Collins BN, 2007, J PEDIATR-US, V150, P547, DOI 10.1016/j.jpeds.2007.01.006; COMPSTON JE, 1992, CLIN SCI, V82, P429, DOI 10.1042/cs0820429; Czerwinski Edward, 2007, Ortop Traumatol Rehabil, V9, P337; Dave JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144286; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dolan SE, 2006, J CLIN ENDOCR METAB, V91, P2938, DOI 10.1210/jc.2006-0127; Dravid A, 2014, J INT AIDS SOC, V17, P53, DOI 10.7448/IAS.17.4.19567; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Ensrud KE, 2005, J CLIN ENDOCR METAB, V90, P1998, DOI 10.1210/jc.2004-1805; Escota GV, 2016, AIDS RES HUM RETROV, V32, P59, DOI 10.1089/aid.2015.0158; Fakruddin JM, 2003, J BIOL CHEM, V278, P48251, DOI 10.1074/jbc.M304676200; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Fox J., 2005, USING R STAT COMPUTI, P2; Fux CA, 2008, ANTIVIR THER, V13, P1077; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Goh SSL, 2018, OSTEOPOROSIS INT, V29, P595, DOI 10.1007/s00198-017-4305-8; Goodrich B., 2018, RSTANARM BAYESIAN AP; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Grant PM, 2016, CURR OPIN HIV AIDS, V11, P326, DOI 10.1097/COH.0000000000000248; Grant PM, 2013, CLIN INFECT DIS, V57, P1483, DOI 10.1093/cid/cit538; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Havers F, 2014, J INFECT DIS, V210, P244, DOI 10.1093/infdis/jiu259; Hidron AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124168; HIV/AIDS JUNPo, 2019, FACT SHEET LAT GLOB; Hoy JF, 2017, J BONE MINER RES, V32, P1945, DOI 10.1002/jbmr.3183; Kanis JA, 2019, OSTEOPOROSIS INT, V30, P3, DOI [10.1007/s00198-018-4704-5, 10.1007/s00198-020-05303-5]; Kim HS, 2013, J KOREAN MED SCI, V28, P827, DOI 10.3346/jkms.2013.28.6.827; Kiragga AN, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3724-x; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Langlois JA, 2001, OSTEOPOROSIS INT, V12, P763, DOI 10.1007/s001980170053; Leib ES, 2004, J CLIN DENSITOM, V7, P1, DOI 10.1385/JCD:7:1:1; Madeddu G, 2015, EUR REV MED PHARMACO, V19, P4576; Mansueto P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/735615; Masyeni S, 2013, BALI ACTA MED INDONE, V45, P175; Matovu FK, 2016, CURR OPIN HIV AIDS, V11, P306, DOI 10.1097/COH.0000000000000274; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Meyer HE, 2008, AM J EPIDEMIOL, V168, P454, DOI 10.1093/aje/kwn151; Mirembe BG, 2016, JAIDS-J ACQ IMM DEF, V71, P287, DOI 10.1097/QAI.0000000000000858; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nolan D, 2001, AIDS, V15, P1275, DOI 10.1097/00002030-200107060-00009; Nwaka S, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-11; Ofotokun I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9282; Palermo A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060544; Paul T, 2010, ENDOCRINE PRACTICE; Neto LFSP, 2011, J CLIN DENSITOM, V14, P434, DOI 10.1016/j.jocd.2011.06.004; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Sheu A, 2016, AUST PRESCR, V39, P35, DOI 10.18773/austprescr.2016.020; Steenhoff AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117123; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Taiwo BO, 2015, CLIN INFECT DIS; Wandera B, 2014, P 21 C RETR OPP INF; Wang MWH, 2004, J CLIN INVEST, V114, P206, DOI 10.1172/JCI200415797; WHO editor World Health Organisation (WHO), 2004, SCI GROUP ASS OST PR; Wiboonchutikul S, 2012, J INT ASS PHYS AIDS; Wohl D, 2011, CHANGE VITAMIN D LEV; World Health Organization, 2016, CONS GUID US ANT DRU; Yin MT, 2011, J INFECT DIS, V203, P1705, DOI 10.1093/infdis/jir184; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	83	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246389	10.1371/journal.pone.0246389	http://dx.doi.org/10.1371/journal.pone.0246389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544754	gold, Green Published			2022-12-26	WOS:000617991900026
J	Nemeth, L; Jdanov, DA; Shkolnikov, VM				Nemeth, Laszlo; Jdanov, Dmitri A.; Shkolnikov, Vladimir M.			An open-sourced, web-based application to analyze weekly excess mortality based on the Short-term Mortality Fluctuations data series	PLOS ONE			English	Article							INFLUENZA; DEATHS; COVID-19; IMPACT	The COVID-19 pandemic stimulated the interest of scientists, decision makers and the general public in short-term mortality fluctuations caused by epidemics and other natural or man-made disasters. To address this interest and provide a basis for further research, in May 2020, the Short-term Mortality Fluctuations data series was launched as a new section of the Human Mortality Database. At present, this unique data resource provides weekly mortality death counts and rates by age and sex for 38 countries and regions. The main objective of this paper is to detail the web-based application for visualizing and analyzing the excess mortality based on the Short-term Mortality Fluctuation data series. The application yields a visual representation of the database that enhances the understanding of the underlying data. Besides, it enables the users to explore data on weekly mortality and excess mortality across years and countries. The contribution of this paper is twofold. First, to describe a visualization tool that aims to facilitate research on short-term mortality fluctuations. Second, to provide a comprehensive open-source software solution for demographic data to encourage data holders to promote their datasets in a visual framework.	[Nemeth, Laszlo; Jdanov, Dmitri A.; Shkolnikov, Vladimir M.] Max Planck Inst Demog Res, Rostock, Germany; [Jdanov, Dmitri A.; Shkolnikov, Vladimir M.] Natl Res Univ Higher Sch Econ, Moscow, Russia	Max Planck Society; HSE University (National Research University Higher School of Economics)	Nemeth, L (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	nemeth@demogr.mpg.de	Jdanov, Dmitri/F-9425-2014	Jdanov, Dmitri/0000-0003-4633-2011	Volkswagen Foundation; Basic Research Program of the National Research University Higher School of Economics	Volkswagen Foundation(Volkswagen); Basic Research Program of the National Research University Higher School of Economics	The work on the tool and the paper was supported by the Volkswagen Foundation (project "Strengthening a reliable evidence base for monitoring the COVID-19 and other disasters"). Support from the Basic Research Program of the National Research University Higher School of Economics is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev E, 1998, VESTNIK STAT, P73; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Aron J., 2020, OUR WORLD DATA; Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; HMD, 2020, HUMAN MORTALITY DATA; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8; Liddell C, 2016, J PUBLIC HEALTH-UK, V38, P806, DOI 10.1093/pubmed/fdv184; Nicoll A, 2012, EUROSURVEILLANCE, V17, P18; Nielsen J, 2019, CLIN MICROBIOL INFEC, V25, P1266, DOI 10.1016/j.cmi.2019.02.011; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Rau R, 2007, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-44902-7; SAKAMOTOMOMIYAMA M, 1978, SOC SCI MED-MED GEOG, V12, P29, DOI 10.1016/0160-8002(78)90005-9; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Team RC, 2015, R LANG ENV STAT COMP; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	21	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246663	10.1371/journal.pone.0246663	http://dx.doi.org/10.1371/journal.pone.0246663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544767	Green Published, gold			2022-12-26	WOS:000617991900022
J	Workman, AD; Jafari, A; Xiao, R; Bleier, BS				Workman, Alan D.; Jafari, Aria; Xiao, Roy; Bleier, Benjamin S.			Airborne aerosol olfactory deposition contributes to anosmia in COVID-19	PLOS ONE			English	Article								Introduction Olfactory dysfunction (OD) affects a majority of COVID-19 patients, is atypical in duration and recovery, and is associated with focal opacification and inflammation of the olfactory epithelium. Given recent increased emphasis on airborne transmission of SARS-CoV-2, the purpose of the present study was to experimentally characterize aerosol dispersion within olfactory epithelium (OE) and respiratory epithelium (RE) in human subjects, to determine if small (sub 5 mu m) airborne aerosols selectively deposit in the OE. Methods Healthy adult volunteers inhaled fluorescein-labeled nebulized 0.5-5 mu m airborne aerosol or atomized larger aerosolized droplets (30-100 mu m). Particulate deposition in the OE and RE was assessed by blue-light filter modified rigid endoscopic evaluation with subsequent image randomization, processing and quantification by a blinded reviewer. Results 0.5-5 mu m airborne aerosol deposition, as assessed by fluorescence gray value, was significantly higher in the OE than the RE bilaterally, with minimal to no deposition observed in the RE (maximum fluorescence: OE 19.5(IQR 22.5), RE 1(IQR 3.2), p<0.001; average fluorescence: OE 2.3(IQR 4.5), RE 0.1(IQR 0.2), p<0.01). Conversely, larger 30-100 mu m aerosolized droplet deposition was significantly greater in the RE than the OE (maximum fluorescence: OE 13(IQR 14.3), RE 38(IQR 45.5), p<0.01; average fluorescence: OE 1.9(IQR 2.1), RE 5.9(IQR 5.9), p<0.01). Conclusions Our data experimentally confirm that despite bypassing the majority of the upper airway, small-sized (0.5-5 mu m) airborne aerosols differentially deposit in significant concentrations within the olfactory epithelium. This provides a compelling aerodynamic mechanism to explain atypical OD in COVID-19.	[Workman, Alan D.; Jafari, Aria; Xiao, Roy; Bleier, Benjamin S.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Workman, Alan D.; Jafari, Aria; Xiao, Roy; Bleier, Benjamin S.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Workman, AD (corresponding author), Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA.; Workman, AD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Alan_Workman@meei.harvard.edu		Xiao, Roy/0000-0003-4459-0746				Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Eliezer M, 2020, JAMA OTOLARYNGOL, V146, P674, DOI 10.1001/jamaoto.2020.0832; Jones RM, 2015, J OCCUP ENVIRON MED, V57, P501, DOI 10.1097/JOM.0000000000000448; Kaye R, 2020, OTOLARYNG HEAD NECK, V163, P132, DOI 10.1177/0194599820922992; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Tong JY, 2020, OTOLARYNG HEAD NECK, V163, P3, DOI 10.1177/0194599820926473; World Health Organization, 2020, TRANSM SARS COV2 IMP; Yan CRH, 2020, INT FORUM ALLERGY RH, V10, P821, DOI 10.1002/alr.22592; Yan CG, 2021, IEEE T PATTERN ANAL, V43, P1445, DOI 10.1109/TPAMI.2020.2975798	11	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244127	10.1371/journal.pone.0244127	http://dx.doi.org/10.1371/journal.pone.0244127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544701	gold, Green Published			2022-12-26	WOS:000617991900016
J	Fujii, H; Nonaka, K; Minamikawa, MF; Endo, T; Sugiyama, A; Hamazaki, K; Iwata, H; Omura, M; Shimada, T				Fujii, Hiroshi; Nonaka, Keisuke; Minamikawa, Mai F.; Endo, Tomoko; Sugiyama, Aiko; Hamazaki, Kosuke; Iwata, Hiroyoshi; Omura, Mitsuo; Shimada, Takehiko			Allelic composition of carotenoid metabolic genes in 13 founders influences carotenoid composition in juice sac tissues of fruits among Japanese citrus breeding population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; PHYTOENE SYNTHASE; BETA-CRYPTOXANTHIN; CULTIVATED CITRUS; DIVERSITY; ACCUMULATION; EXPRESSION; MANDARIN; IDENTIFICATION	To enrich carotenoids, especially beta-cryptoxanthin, in juice sac tissues of fruits via molecular breeding in citrus, allele mining was utilized to dissect allelic variation of carotenoid metabolic genes and identify an optimum allele on the target loci characterized by expression quantitative trait (eQTL) analysis. SNPs of target carotenoid metabolic genes in 13 founders of the Japanese citrus breeding population were explored using the SureSelect target enrichment method. An independent allele was determined based on the presence or absence of reliable SNPs, using trio analysis to confirm inheritability between parent and offspring. Among the 13 founders, there were 7 PSY alleles, 7 HYb alleles, 11 ZEP alleles, 5 NCED alleles, and 4 alleles for the eQTL that control the transcription levels of PDS and ZDS among the ancestral species, indicating that some founders acquired those alleles from them. The carotenoid composition data of 263 breeding pedigrees in juice sac tissues revealed that the phenotypic variance of carotenoid composition was similar to that in the 13 founders, whereas the mean of total carotenoid content increased. This increase in total carotenoid content correlated with the increase in either or both beta-cryptoxanthin and violaxanthin in juice sac tissues. Bayesian statistical analysis between allelic composition of target genes and carotenoid composition in 263 breeding pedigrees indicated that PSY-a and ZEP-e alleles at PSY and ZEP loci had strong positive effects on increasing the total carotenoid content, including beta-cryptoxanthin and violaxanthin, in juice sac tissues. Moreover, the pyramiding of these alleles also increased the beta-cryptoxanthin content. Interestingly, the offset interaction between the alleles with increasing and decreasing effects on carotenoid content and the epistatic interaction among carotenoid metabolic genes were observed and these interactions complexed carotenoid profiles in breeding population. These results revealed that allele composition would highly influence the carotenoid composition in citrus fruits. The allelic genotype information for the examined carotenoid metabolic genes in major citrus varieties and the trio-tagged SNPs to discriminate the optimum alleles (PSY-a and ZEP-e) from the rest would promise citrus breeders carotenoid enrichment in fruit via molecular breeding.	[Fujii, Hiroshi; Nonaka, Keisuke; Endo, Tomoko; Shimada, Takehiko] Natl Agr & Food Res Org, Inst Fruit & Tea Tree Sci, Shimizu, Shizuoka, Japan; [Minamikawa, Mai F.; Hamazaki, Kosuke; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Lab Biometry & Bioinformat,Bunkyo Ku, Tokyo, Japan; [Sugiyama, Aiko; Omura, Mitsuo] Shizuoka Univ, Fac Agr, Suruga, Shizuoka, Japan	National Agriculture & Food Research Organization - Japan; University of Tokyo; Shizuoka University	Shimada, T (corresponding author), Natl Agr & Food Res Org, Inst Fruit & Tea Tree Sci, Shimizu, Shizuoka, Japan.	tshimada@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [HOR2003]; Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology) [150]; Japan Society for the Promotion of Science (JSPS) [23580055]	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, HOR2003, DNA-marker breeding project), by a grant from the Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology, 150), and by a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (JSPS), Grant Number 23580055.	Ahmed D, 2019, ANN BOT-LONDON, V123, P1231, DOI 10.1093/aob/mcz029; Ariizumi T, 2014, PLANT J, V79, P453, DOI 10.1111/tpj.12570; Bandillo N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-11; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chen CX, 2010, TREE GENET GENOMES, V6, P905, DOI 10.1007/s11295-010-0300-3; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; Davies BH, CHEM BIOCH PLANT PIG, VII, P38; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Endo T, 2016, PLANT SCI, V243, P35, DOI 10.1016/j.plantsci.2015.11.005; Fanciullino AL, 2007, J AGR FOOD CHEM, V55, P7405, DOI 10.1021/jf070711h; Fanciullino AL, 2006, J AGR FOOD CHEM, V54, P4397, DOI 10.1021/jf0526644; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fraser PD, 2007, PLANT CELL, V19, P3194, DOI 10.1105/tpc.106.049817; Fujii H., 2010, J JPN SOC HORTIC SCI, V9, P34; Fujii H, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720012500229; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Garcia-Lor A, 2012, MOL GENET GENOMICS, V287, P77, DOI 10.1007/s00438-011-0658-4; Imai A, 2017, HORTICULT J, V86, P200, DOI [10.2503/hortj.OKD-013, 10.2503/hortj.okd-013]; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Iwata H, 2013, BREEDING SCI, V63, P125, DOI 10.1270/jsbbs.63.125; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Kato M, 2006, J EXP BOT, V57, P2153, DOI 10.1093/jxb/erj172; Kato M, 2012, J JPN SOC HORTIC SCI, V81, P219, DOI 10.2503/jjshs1.81.219; Kawahara Y, 2020, BREEDING SCI, V70, P200, DOI 10.1270/jsbbs.19097; Kishimoto S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58313-y; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Lu SW, 2018, PLANT PHYSIOL, V176, P2657, DOI 10.1104/pp.17.01830; Ma G, 2018, PLANT PHYSIOL BIOCH, V129, P349, DOI 10.1016/j.plaphy.2018.06.015; Ma G, 2017, FOOD CHEM, V234, P356, DOI 10.1016/j.foodchem.2017.05.015; Ma G, 2013, PLANT PHYSIOL, V163, P682, DOI 10.1104/pp.113.223297; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Meng LJ, 2016, FIELD CROP RES, V189, P19, DOI 10.1016/j.fcr.2016.02.004; Minamikawa MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05100-x; Nisar N, 2015, MOL PLANT, V8, P68, DOI 10.1016/j.molp.2014.12.007; Osorio CE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01235; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Pascual L, 2016, PLANT SCI, V242, P120, DOI 10.1016/j.plantsci.2015.06.017; Pouchieu C, 2014, NUTR CANCER, V66, P980, DOI 10.1080/01635581.2014.936952; Rodrigo MJ, 2006, J EXP BOT, V57, P633, DOI 10.1093/jxb/erj048; Rouseff R, 1996, J AGR FOOD CHEM, V44, P2176, DOI 10.1021/jf950631q; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; STEWART I, 1973, PHYTOCHEMISTRY, V12, P2947, DOI 10.1016/0031-9422(73)80512-6; Sugiura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052643; Sugiyama A, 2017, BREEDING SCI, V67, P382, DOI 10.1270/jsbbs.17033; Sugiyama A, 2014, J JPN SOC HORTIC SCI, V83, P32, DOI 10.2503/jjshs1.CH-054; Sugiyama A, 2011, J JPN SOC HORTIC SCI, V80, P136, DOI 10.2503/jjshs1.80.136; Sugiyama A, 2010, J JPN SOC HORTIC SCI, V79, P263, DOI 10.2503/jjshs1.79.263; Sun TH, 2018, MOL PLANT, V11, P58, DOI 10.1016/j.molp.2017.09.010; Takayanagi K, 2011, J AGR FOOD CHEM, V59, P12342, DOI 10.1021/jf202821u; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Wolters AMA, 2010, PLANT MOL BIOL, V73, P659, DOI 10.1007/s11103-010-9647-y; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Wu GA, 2018, NATURE, V554, P311, DOI 10.1038/nature25447; Yamaguchi M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-36; Yamamizo C, 2010, J EXP BOT, V61, P709, DOI 10.1093/jxb/erp335; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8; Zhang YaFei, 2020, Scientia Agricultura Sinica, V53, P1874, DOI 10.3864/j.issn.0578-1752.2020.09.014; Zhu F, 2017, NEW PHYTOL, V216, P178, DOI 10.1111/nph.14684	68	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246468	10.1371/journal.pone.0246468	http://dx.doi.org/10.1371/journal.pone.0246468			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539435	gold, Green Published			2022-12-26	WOS:000616960200080
J	Koester, RP; Pignon, CP; Kesler, DC; Willison, RS; Kang, MY; Shen, Y; Priest, HD; Begemann, MB; Cook, KA; Bannon, GA; Oufattole, M				Koester, Robert P.; Pignon, Charles P.; Kesler, Dylan C.; Willison, Rebecca S.; Kang, Miyoung; Shen, Yu; Priest, Henry D.; Begemann, Matthew B.; Cook, Kevin A.; Bannon, Gary A.; Oufattole, Mohammed			Transgenic insertion of the cyanobacterial membrane protein ictB increases grain yield in Zea mays through increased photosynthesis and carbohydrate production	PLOS ONE			English	Article							CARBON-CONCENTRATING MECHANISM; LEAF PHOTOSYNTHESIS; C-4 PHOTOSYNTHESIS; HCO3-TRANSPORTER; CO2 FIXATION; PLANTS; GENE; ASSIMILATION; TEMPERATURE; EFFICIENCY	The C-4 crop maize (Zea mays) is the most widely grown cereal crop worldwide and is an essential feedstock for food and bioenergy. Improving maize yield is important to achieve food security and agricultural sustainability in the 21(st) century. One potential means to improve crop productivity is to enhance photosynthesis. ictB, a membrane protein that is highly conserved across cyanobacteria, has been shown to improve photosynthesis, and often biomass, when introduced into diverse C-3 plant species. Here, ictB from Synechococcus sp. strain PCC 7942 was inserted into maize using Agrobacterium-mediated transformation. In three controlled-environment experiments, ictB insertion increased leaf starch and sucrose content by up to 25% relative to controls. Experimental field trials in four growing seasons, spanning the Midwestern United States (Summers 2018 & 2019) and Argentina (Winter 2018 & 2019), showed an average of 3.49% grain yield improvement, by as much as 5.4% in a given season and up to 9.4% at certain trial locations. A subset of field trial locations was used to test for modification of ear traits and CYRILLIC CAPITAL LETTER EFPSII, a proxy for photosynthesis. Results suggested that yield gain in transgenics could be associated with increased CYRILLIC CAPITAL LETTER EFPSII, and the production of longer, thinner ears with more kernels. ictB localized primarily to the microsome fraction of leaf bundle-sheath cells, but not to chloroplasts. Extramembrane domains of ictB interacted in vitro with proteins involved in photosynthesis and carbohydrate metabolism. To our knowledge, this is the first published evidence of ictB insertion into a species using C-4 photosynthesis and the largest-scale demonstration of grain yield enhancement from ictB insertion in planta. Results show that ictB is a valuable yield gene in the economically important crop maize, and are an important proof of concept that transgenic manipulation of photosynthesis can be used to create economically viable crop improvement traits.	[Koester, Robert P.; Pignon, Charles P.; Kesler, Dylan C.; Willison, Rebecca S.; Kang, Miyoung; Shen, Yu; Priest, Henry D.; Begemann, Matthew B.; Cook, Kevin A.; Bannon, Gary A.; Oufattole, Mohammed] Benson Hill, St Louis, MO 63132 USA		Koester, RP; Oufattole, M (corresponding author), Benson Hill, St Louis, MO 63132 USA.	bkoester@bensonhill.com; moufattole@bensonhill.com	Pignon, Charles/I-1450-2017	Pignon, Charles/0000-0002-4237-1649	Benson Hill	Benson Hill	This work was funded by Benson Hill (https://bensonhill.com/), a for-profit agricultural technology company, as part of its research and development program. Benson Hill provided all funding for the study, including study design, data collection and analysis, manuscript preparation, publication, and salaries for all of the authors.	Ainsworth EA, 2007, J EXP BOT, V58, P579, DOI 10.1093/jxb/erl233; Altman N, 2015, NAT METHODS, V12, P165, DOI 10.1038/nmeth.3293; Amoroso G, 2003, PHOTOSYNTH RES, V77, P127, DOI 10.1023/A:1025873718682; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Atkinson N, 2017, NEW PHYTOL, V214, P655, DOI 10.1111/nph.14414; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baum ME, 2019, AGRON J, V111, P303, DOI 10.2134/agronj2018.04.0297; Behrman KD, 2016, AGR WATER MANAGE, V175, P72, DOI 10.1016/j.agwat.2016.03.009; Black CC, 1980, METHODS ENZYMOLOGY, V69, P55; Bonfil DJ, 1998, FEBS LETT, V430, P236, DOI 10.1016/S0014-5793(98)00662-0; Boto A., 2013, UNLV GAMING LJ, P11; Boto A., 2013, UNLV GAMING LJ, P11; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Dengler N.G., 1999, C4 PLANT BIOL, P133, DOI DOI 10.1007/S40292-017-0185-4; Doll NM, 2017, MOL PLANT, V10, P375, DOI 10.1016/j.molp.2017.01.008; FAOSTAT, 2019, FAOST EN DAT QC; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Gong HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140928; Gu JF, 2017, FIELD CROP RES, V200, P58, DOI 10.1016/j.fcr.2016.10.008; Guerra D, 2012, PLANT PHYSIOL, V158, P777, DOI 10.1104/pp.111.183988; Hardin SC, 2006, PLANT PHYSIOL, V141, P1106, DOI 10.1104/pp.106.078006; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hay WT, 2017, J PLANT PHYSIOL, V212, P58, DOI 10.1016/j.jplph.2017.02.003; Hennacy JH, 2020, ANNU REV PLANT BIOL, V71, P461, DOI 10.1146/annurev-arplant-081519-040100; Horton P, 2000, J EXP BOT, V51, P475, DOI 10.1093/jexbot/51.suppl_1.475; Hubbart S, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0026-6; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; KAPLAN A, 1991, PLANT PHYSIOL, V97, P851, DOI 10.1104/pp.97.3.851; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Lieman-Hurwitz J, 2003, PLANT BIOTECHNOL J, V1, P43, DOI 10.1046/j.1467-7652.2003.00003.x; Lin MT, 2014, PLANT J, V79, P1, DOI 10.1111/tpj.12536; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Majeran W, 2005, PLANT CELL, V17, P3111, DOI 10.1105/tpc.105.035519; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Massad RS, 2007, PLANT CELL ENVIRON, V30, P1191, DOI 10.1111/j.1365-3040.2007.01691.x; McGrath JM, 2014, PLANT PHYSIOL, V164, P2247, DOI 10.1104/pp.113.232611; Muller SC, 2018, IEEE T SMART GRID, V9, P14, DOI 10.1109/TSG.2016.2542824; Nolke G, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800170; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Occhialini A, 2016, PLANT J, V85, P148, DOI 10.1111/tpj.13098; Orr DJ, 2020, PLANT PHYSIOL, V182, P807, DOI 10.1104/pp.19.01193; Orr Douglas J, 2017, F1000Res, V6, P1891, DOI 10.12688/f1000research.12181.1; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Pereira SB, 2015, SCI REP-UK, V5, DOI 10.1038/srep14835; Pilkington SM, 2015, PLANT CELL ENVIRON, V38, P157, DOI 10.1111/pce.12381; Pinheiro J., 2018, **DATA OBJECT**; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257; Raines CA, 2011, PLANT PHYSIOL, V155, P36, DOI 10.1104/pp.110.168559; Raji JA, 2018, METHODS MOL BIOL, V1676, P15, DOI 10.1007/978-1-4939-7315-6_2; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rogers A, 2004, PLANT CELL ENVIRON, V27, P449, DOI 10.1111/j.1365-3040.2004.01163.x; Rolland V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00185; Rozen S, 2000, Methods Mol Biol, V132, P365; Shen BR, 2019, MOL PLANT, V12, P199, DOI 10.1016/j.molp.2018.11.013; Simkin AJ, 2015, J EXP BOT, V66, P4075, DOI 10.1093/jxb/erv204; Slattery RA, 2015, PLANT PHYSIOL, V168, P383, DOI 10.1104/pp.15.00066; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; South PF, 2019, SCIENCE, V363, P45, DOI 10.1126/science.aat9077; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Tardieu F, 2018, ANNU REV PLANT BIOL, V69, P733, DOI 10.1146/annurev-arplant-042817-040218; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Von Caemmerer S., 1999, C 4 PLANT BIOL, DOI DOI 10.1104/PP.121.2.579; von Caemmerer S, 2016, CURR OPIN PLANT BIOL, V31, P125, DOI 10.1016/j.pbi.2016.04.003; Wehrmann A, 1996, NAT BIOTECHNOL, V14, P1274, DOI 10.1038/nbt1096-1274; Weise SE, 2011, J EXP BOT, V62, P3109, DOI 10.1093/jxb/err035; WOHLLEBEN W, 1988, GENE, V70, P25, DOI 10.1016/0378-1119(88)90101-1; Wu A, 2019, NAT PLANTS, V5, P380, DOI 10.1038/s41477-019-0398-8; Wu JR, 2019, P NATL ACAD SCI USA, V116, P23850, DOI [10.1073/pnas.1902593116, 10.1073/pnas.190259311]; Xu M, 2008, PLANT CELL PHYSIOL, V49, P1672, DOI 10.1093/pcp/pcn139; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107; Yang S, 2008, PHOTOSYNTHESIS ENERG; Zheng YP, 2018, RUSS J PLANT PHYSL+, V65, P524, DOI [10.1134/S1021443718040192, 10.1134/s1021443718040192]; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	80	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246359	10.1371/journal.pone.0246359	http://dx.doi.org/10.1371/journal.pone.0246359			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539477	Green Published, gold			2022-12-26	WOS:000616960200028
J	Kristoffersen, ES; Winsvold, BS; Sandset, EC; Storstein, AM; Faiz, KW				Kristoffersen, Espen Saxhaug; Winsvold, Bendik Slagsvold; Sandset, Else Charlotte; Storstein, Anette Margrethe; Faiz, Kashif Waqar			Experiences, distress and burden among neurologists in Norway during the COVID-19 pandemic	PLOS ONE			English	Article							WORK-HOME INTERFACE; US NEUROLOGISTS; JOB STRESS; SATISFACTION; HEALTH; PHYSICIANS; BURNOUT	Background The ongoing COVID-19 pandemic has caused rapid changes in the healthcare system. Workforce reorganization, reduced standard of care and a lack of personal protection equipment (PPE) for health care workers were among the concerns raised in the first wave of the pandemic. Our aim was to explore the experiences, distress and burden among Norwegian neurologists during the first weeks of the pandemic. Methods Hospital-based neurologists in Norway (n = 400) were invited to a web-based survey in April 2020. The study focused on patient management, organizational changes and personal stress during the first weeks of the pandemic lockdown. Work-home interface stress was assessed by the Cooper Job Stress Questionnaire. Results In total, 135 neurologists participated. Seventy-three% experienced a change in their personal work situation, and 67% examined patients with suspected COVID-19 infection and neurological disease. Changed access to resources, and the perception that medical follow-up was unsatisfactory, were associated with a high degree of burden and stress. Neurologists were also worried about the potential lack of PPE and the fear of spreading SARS CoV-2 to close family members. The mean score of work-home interface stress was 2.8 with no significant differences between gender or specialist status. Reduced standard of care was reported for all neurological conditions, and in particular for non-emergency treatments. Conclusion The vast majority of neurologists in Norway experienced a change in their personal work situation during the first phase of the pandemic. The fear of becoming infected and ill was not a major contributor to burden and stress.	[Kristoffersen, Espen Saxhaug; Faiz, Kashif Waqar] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Kristoffersen, Espen Saxhaug] Univ Oslo, Dept Gen Practice, Oslo, Norway; [Winsvold, Bendik Slagsvold] Oslo Univ Hosp, Div Clin Neurosci, Dept Res Innovat & Educ, Oslo, Norway; [Winsvold, Bendik Slagsvold; Sandset, Else Charlotte] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Sandset, Else Charlotte] Norwegian Air Ambulance Fdn, Oslo, Norway; [Storstein, Anette Margrethe] Haukeland Hosp, Dept Neurol, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital	Kristoffersen, ES (corresponding author), Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway.; Kristoffersen, ES (corresponding author), Univ Oslo, Dept Gen Practice, Oslo, Norway.	e.s.kristoffersen@medisin.uio.no	Kristoffersen, Espen Saxhaug/ABD-4606-2021; Faiz, Kashif/V-2165-2019; Winsvold, Bendik/ABF-7839-2021	Kristoffersen, Espen Saxhaug/0000-0002-8999-5424; Faiz, Kashif/0000-0003-0672-6032; Winsvold, Bendik/0000-0003-4171-8919				Abdulah Deldar Morad, 2020, Sleep Med X, V2, P100017, DOI 10.1016/j.sleepx.2020.100017; Amin F, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02864-x; [Anonymous], 2019, CIRCULATION, V139, pe42; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bloem BR, 2020, JAMA NEUROL, V77, P927, DOI 10.1001/jamaneurol.2020.1452; Busis NA, 2017, NEUROLOGY, V88, P797, DOI 10.1212/WNL.0000000000003640; Conti C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242538; COOPER CL, 1989, BRIT MED J, V298, P366, DOI 10.1136/bmj.298.6670.366; Cubo E, 2020, J PARKINSON DIS, V10, P911, DOI 10.3233/JPD-202108; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Fonseca E, 2020, ACTA NEUROL SCAND, V142, P545, DOI 10.1111/ane.13335; Giusti EM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01684; Godlee F, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1605; Grossman SN, 2020, NEUROLOGY, V94, P1077, DOI 10.1212/WNL.0000000000009677; Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740; Hertzberg TK, 2016, IND HEALTH, V54, P139, DOI 10.2486/indhealth.2015-0134; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Hong Z, 2020, J MED INTERNET RES, V22, DOI 10.2196/19577; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kristoffersen ES, 2021, NEUROL SCI, V42, P791, DOI 10.1007/s10072-021-05039-y; Kristoffersen ES, 2021, ACTA NEUROL SCAND, V143, P349, DOI 10.1111/ane.13392; Kristoffersen ES, 2021, ANN CLIN TRANSL NEUR, V8, P440, DOI 10.1002/acn3.51293; Kuchenbuch M, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107376; Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Mateen FJ, 2020, J NEUROL, P1; Matthews PM, 2020, CURR OPIN NEUROL, V33, P271, DOI 10.1097/WCO.0000000000000823; McCabe R, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01781-w; Muller KI, 2017, NEUROLOGY, V89, P153, DOI 10.1212/WNL.0000000000004085; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Padda Inderbir, 2020, SN Compr Clin Med, V2, P2025, DOI 10.1007/s42399-020-00527-2; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Richter D, 2021, STROKE, V52, P716, DOI 10.1161/STROKEAHA.120.033160; Rovik JO, 2007, IND HEALTH, V45, P662, DOI 10.2486/indhealth.45.662; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sharma A, 2020, NEUROLOGY, V95, P215, DOI 10.1212/WNL.0000000000009844; Timmis K, 2020, ENVIRON MICROBIOL, V22, P1986, DOI 10.1111/1462-2920.15029; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; von Oertzen TJ, 2021, EUR J NEUROL, V28, P7, DOI 10.1111/ene.14521; World Health Organization (WHO), 2020, WHO COVID 19 PREP RE	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246567	10.1371/journal.pone.0246567	http://dx.doi.org/10.1371/journal.pone.0246567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539418	gold, Green Published			2022-12-26	WOS:000616960200105
J	Shin, HJ; Chang, JS; Kim, MS; Koh, BG; Park, HY; Kim, TO; Park, CK; Oh, IJ; Kim, YI; Lim, SC; Kim, YC; Koh, YI; Kwon, YS				Shin, Hong-Joon; Chang, Jin-Sun; Kim, Min-Suk; Koh, Bo-Gun; Park, Ha-Young; Kim, Tae-Ok; Park, Chul-Kyu; Oh, In-Jae; Kim, Yu-Il; Lim, Sung-Chul; Kim, Young-Chul; Koh, Young-Il; Kwon, Yong-Soo			Hypersensitivity reactions to multiple anti-tuberculosis drugs	PLOS ONE			English	Article							RISK-FACTORS; TUBERCULOSIS; DIAGNOSIS; SYMPTOMS	Objective This study aimed to evaluate hypersensitivity reactions to anti-tuberculosis (TB) drugs. Methods We retrospectively compared the clinical manifestations and treatment outcomes of single and multiple drug hypersensitivity reactions (DHRs). Results Twenty-eight patients were diagnosed with anti-TB DHRs using oral drug provocation tests. Of these 28 patients, 17 patients (60.7%) had DHRs to a single drug and 11 (39.3%) had multiple DHRs. The median age of patients was 57.5 years (interquartile range [IQR], 39.2-73.2). Of the total patients, 18 patients (64.3%) were men. The median number of anti-TB drugs causing multiple DHRs was 2.0 (IQR 2.0-3.0). Rifampin was the most common drug that caused DHRs in both the single and multiple DHR groups (n = 8 [47.1%] and n = 9 [52.9%], respectively). The treatment success rate was lower in the multiple DHR group than in the single DHR group; however, the difference was not statistically significant (81.8% vs. 94.1%; P = 0.543). Conclusions Multiple anti-TB DHRs were common in all patients who experienced DHRs, and rifampin was the most common causative drug. The treatment outcomes appeared to be poorer in patients with multiple DHRs than in those with single DHRs.	[Shin, Hong-Joon; Chang, Jin-Sun; Kim, Min-Suk; Koh, Bo-Gun; Park, Ha-Young; Kim, Tae-Ok; Park, Chul-Kyu; Oh, In-Jae; Kim, Yu-Il; Lim, Sung-Chul; Kim, Young-Chul; Kwon, Yong-Soo] Chonnam Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Gwangju, South Korea; [Koh, Young-Il] Chonnam Natl Univ Hosp, Dept Internal Med, Div Allergy Asthma & Clin Immunol, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital	Kwon, YS (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Gwangju, South Korea.	yskwon@jnu.ac.kr	Oh, In-Jae/AAG-5919-2020; Shin, Hong-Joon/T-4756-2018	Oh, In-Jae/0000-0003-4837-1321; Kwon, Yong-Soo/0000-0001-5121-4488; Shin, Hong-Joon/0000-0002-0146-3491	Chonnam National University Hospital Biomedical Research Institute [BCRI20013]	Chonnam National University Hospital Biomedical Research Institute	This study was supported by a grant (BCRI20013) of Chonnam National University Hospital Biomedical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bircher AJ, 2005, TOXICOLOGY, V209, P201, DOI 10.1016/j.tox.2004.12.036; Brockow K, 2002, ALLERGY, V57, P45; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Chhetri Anupa Khadka, 2008, J Pak Med Assoc, V58, P531; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Daubner B, 2012, ALLERGY, V67, P58, DOI 10.1111/j.1398-9995.2011.02720.x; Dela AI, 2017, LUNG INDIA, V34, P522, DOI 10.4103/0970-2113.217569; Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350; DHAMGAYE T, 1995, TUBERCLE LUNG DIS, V76, P181; Gex-Collet C, 2005, J INVEST ALLERG CLIN, V15, P293; HOLLAND CL, 1990, CHEST, V98, P1518, DOI 10.1378/chest.98.6.1518; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Jorg L, 2020, ALLERGY, V75, P1178, DOI 10.1111/all.14146; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Kim DH, 2014, ALLERGY ASTHMA IMMUN, V6, P183, DOI 10.4168/aair.2014.6.2.183; Kim TO, 2019, KOREAN J INTERN MED, V34, P1050, DOI 10.3904/kjim.2018.063; Kwon YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-121; Kwon YS, 2014, J KOREAN MED SCI, V29, P1226, DOI 10.3346/jkms.2014.29.9.1226; Lehloenya RJ, 2012, INT J TUBERC LUNG D, V16, P1260, DOI 10.5588/ijtld.11.0187; Lehloenya RJ, 2011, INT J TUBERC LUNG D, V15, P1649, DOI 10.5588/ijtld.10.0698; Lv XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065037; Mirakian R, 2009, CLIN EXP ALLERGY, V39, P43, DOI 10.1111/j.1365-2222.2008.03155.x; Mustafa SS, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0778-6; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OlleGoig JE, 1997, INT J TUBERC LUNG D, V1, P191; Park CK, 2016, J KOREAN MED SCI, V31, P254, DOI 10.3346/jkms.2016.31.2.254; Pichler WJ, 2017, INT ARCH ALLERGY IMM, V172, P129, DOI 10.1159/000458725; Rezakovic Saida, 2014, Inflammation & Allergy Drug Targets, V13, P241; Romano A, 2004, ALLERGY, V59, P1153, DOI 10.1111/j.1398-9995.2004.00678.x; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sekine A, 2012, RESPIR INVESTIG, V50, P70, DOI 10.1016/j.resinv.2012.04.004; Singh A, 2015, CLIN EPIDEMIOL GLOB, V3, pS80, DOI 10.1016/j.cegh.2015.10.005; Studer M, 2012, ANN DERMATOL VENER, V139, P375, DOI 10.1016/j.annder.2012.03.017; Tan W C, 2007, Med J Malaysia, V62, P143; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Zhang C, 2019, ANN ALLERG ASTHMA IM, V123, P483, DOI 10.1016/j.anai.2019.08.004	37	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246291	10.1371/journal.pone.0246291	http://dx.doi.org/10.1371/journal.pone.0246291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539388	gold, Green Published			2022-12-26	WOS:000616960200075
J	Wallander, K; Eisfeldt, J; Lindblad, M; Nilsson, D; Billiau, K; Foroughi, H; Nordenskjold, M; Lieden, A; Tham, E				Wallander, Karin; Eisfeldt, Jesper; Lindblad, Mats; Nilsson, Daniel; Billiau, Kenny; Foroughi, Hassan; Nordenskjold, Magnus; Lieden, Agne; Tham, Emma			Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients	PLOS ONE			English	Article							GASTRIC-CANCER; ESOPHAGEAL ADENOCARCINOMA; MOLECULAR CLASSIFICATION; TARGETED THERAPIES; CLONAL MOSAICISM; PLASMA DNA; HETEROGENEITY; IDENTIFICATION; SURVIVAL; SUBTYPES	Background Analysis of cell-free tumour DNA, a liquid biopsy, is a promising biomarker for cancer. We have performed a proof-of principle study to test the applicability in the clinical setting, analysing copy number alterations (CNAs) in plasma and tumour tissue from 44 patients with gastro-oesophageal cancer. Methods DNA was isolated from blood plasma and a tissue sample from each patient. Array-CGH was applied to the tissue DNA. The cell-free plasma DNA was sequenced by low-coverage whole-genome sequencing using a clinical pipeline for non-invasive prenatal testing. WISECONDOR and ichorCNA, two bioinformatic tools, were used to process the output data and were compared to each other. Results Cancer-associated CNAs could be seen in 59% (26/44) of the tissue biopsies. In the plasma samples, a targeted approach analysing 61 regions of special interest in gastro-oesophageal cancer detected cancer-associated CNAs with a z-score >5 in 11 patients. Broadening the analysis to a whole-genome view, 17/44 patients (39%) had cancer-associated CNAs using WISECONDOR and 13 (30%) using ichorCNA. Of the 26 patients with tissue-verified cancer-associated CNAs, 14 (54%) had corresponding CNAs in plasma. Potentially clinically actionable amplifications overlapping the genes VEGFA, EGFR and FGFR2 were detected in the plasma from three patients. Conclusions We conclude that low-coverage whole-genome sequencing without prior knowledge of the tumour alterations could become a useful tool for cell-free tumour DNA analysis of total CNAs in plasma from patients with gastro-oesophageal cancer.	[Wallander, Karin; Eisfeldt, Jesper; Nilsson, Daniel; Nordenskjold, Magnus; Lieden, Agne; Tham, Emma] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Wallander, Karin; Eisfeldt, Jesper; Nilsson, Daniel; Lieden, Agne; Tham, Emma] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Lindblad, Mats] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Lindblad, Mats] Karolinska Univ Hosp, Dept Upper Abdominal Dis, Stockholm, Sweden; [Billiau, Kenny; Foroughi, Hassan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Tham, E (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Tham, E (corresponding author), Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden.	emma.tham@ki.se	Nilsson, Daniel/B-8365-2009; Lindblad, Mats/AEP-3569-2022	Nilsson, Daniel/0000-0001-5831-385X; Foroughi Asl, Hassan/0000-0002-6925-9040; Nordenskjold, Magnus/0000-0002-4974-425X	Region Stockholm [K2891-2016, 581046]; European Cooperation in Science and Technology [CA17118]	Region Stockholm; European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST))	KW, ET and MN are supported by grants from Region Stockholm (combined clinical residency and PhD training program: K2891-2016 and ALF-project: grant number 581046). CA17118 (European Cooperation in Science and Technology, www.cost.eu) has provided networking support to ET.	Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; [Anonymous], 2019, AUSTRAL J VET SCI, V51, pV; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Barbany G, 2019, J INTERN MED, V286, P118, DOI 10.1111/joim.12897; Bartley AN, 2017, J CLIN ONCOL, V35, P446, DOI 10.1200/JCO.2016.69.4836; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Belic J, 2015, CLIN CHEM, V61, P838, DOI 10.1373/clinchem.2014.234286; Bettegowda C, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-5606; Cabel L, 2019, CANCERS, V11, DOI 10.3390/cancers11030396; Cancercentrum, 2020, SWEDISH NATL TREATME; Charalampakis N, 2018, CANCER MED-US, V7, P123, DOI 10.1002/cam4.1274; Chen ZH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1907-4; Chivu-Economescu M, 2018, WORLD J GASTROENTERO, V24, P1942, DOI 10.3748/wjg.v24.i18.1942; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Cohen PA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0667-6; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Creemers A, 2017, BBA-REV CANCER, V1868, P394, DOI 10.1016/j.bbcan.2017.08.002; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Davidson M, 2019, CANCERS, V11, DOI 10.3390/cancers11050736; Egyud M, 2019, ANN THORAC SURG, V108, P343, DOI 10.1016/j.athoracsur.2019.04.004; Fang WL, 2016, INT J CANCER, V138, P2974, DOI 10.1002/ijc.30018; Fiorentino F, 2016, PRENATAL DIAG, V36, P304, DOI 10.1002/pd.4780; Gao J, 2017, CANCER SCI, V108, P1881, DOI 10.1111/cas.13314; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kato S, 2018, CLIN CANCER RES, V24, P6248, DOI 10.1158/1078-0432.CCR-18-1128; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Kim ST, 2018, NAT MED, V24, P1449, DOI 10.1038/s41591-018-0101-z; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Kim Y, 2015, ANN SURG ONCOL, V22, P557, DOI 10.1245/s10434-014-4116-5; Kustanovich A, 2019, CANCER BIOL THER, V20, P1057, DOI 10.1080/15384047.2019.1598759; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Maron SB, 2019, CLIN CANCER RES, V25, P7098, DOI 10.1158/1078-0432.CCR-19-1704; Maron SB, 2017, SURG ONCOL CLIN N AM, V26, P293, DOI 10.1016/j.soc.2016.10.002; Molparia B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180647; Parikh AR, 2019, NAT MED, V25, P1415, DOI 10.1038/s41591-019-0561-9; Pasello G, 2009, MODERN PATHOL, V22, P58, DOI 10.1038/modpathol.2008.150; Pasternack H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33027-4; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Pectasides E, 2018, CANCER DISCOV, V8, P37, DOI 10.1158/2159-8290.CD-17-0395; Raman L, 2019, NUCLEIC ACIDS RES, V47, P1605, DOI 10.1093/nar/gky1263; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Rocken C, 2017, EXPERT REV MOL DIAGN, V17, P293, DOI 10.1080/14737159.2017.1286985; Sahlin E, 2014, FETAL DIAGN THER, V36, P326, DOI 10.1159/000361017; Schumacher SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176045; Shu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00520-1; Socialstyrelsen, CANC NUMB 2018; Straver R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt992; Ueda M, 2016, ONCOTARGET, V7, P62280, DOI 10.18632/oncotarget.11409; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Wan N, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6003-8; Wang Y, 2019, EBIOMEDICINE, V43, P261, DOI 10.1016/j.ebiom.2019.04.003; Xing R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09644-6; Yang W, 2014, BBA-REV CANCER, V1846, P232, DOI 10.1016/j.bbcan.2014.05.003; Zill OA, 2018, CLIN CANCER RES, V24, P3528, DOI 10.1158/1078-0432.CCR-17-3837	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245488	10.1371/journal.pone.0245488	http://dx.doi.org/10.1371/journal.pone.0245488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539436	gold, Green Published			2022-12-26	WOS:000616960200072
J	Fletcher, J; Higham, J; Longnecker, N				Fletcher, Jean; Higham, James; Longnecker, Nancy			Climate change risk perception in the USA and alignment with sustainable travel behaviours	PLOS ONE			English	Article							CONSTRUAL-LEVEL THEORY; PSYCHOLOGICAL DISTANCE; FUTURE; VEHICLES; OPTIMISM; EXPERIENCE; AGREEMENT; KNOWLEDGE; BARRIERS; BELIEFS	In an online survey of 1071 Americans conducted in October 2016, we found technological optimism, environmental beliefs, and gender to be better predictors of climate change concern than respondents' perceived ability to visualize the year 2050 and their future optimism. An important finding from this study is that in October 2016, just before the 2016 Presidential election, 74% of responding Americans were concerned about climate change. Climate change ranked as their second most serious global threat (behind terrorism). However, when asked to describe travel in the year 2050 only 29% of participants discussed lower carbon options, suggesting that actively envisioning a sustainable future was less prevalent than climate change concern. Enabling expectations and active anticipation of a low carbon future may help facilitate mitigation efforts.	[Fletcher, Jean; Longnecker, Nancy] Univ Otago, Dept Sci Commun, Dunedin, New Zealand; [Higham, James] Univ Otago, Dept Tourism, Dunedin, New Zealand; [Higham, James] Univ Stavanger, Norwegian Sch Hotel Management, Stavanger, Norway	University of Otago; University of Otago; Universitetet i Stavanger	Fletcher, J (corresponding author), Univ Otago, Dept Sci Commun, Dunedin, New Zealand.	dr.j.m.fletcher@gmail.com		Fletcher, Jean/0000-0001-7842-1137	University of Otago	University of Otago	This study received support in the form of a research scholarship from the University of Otago, awarded to JF.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson K, 2015, NAT GEOSCI, V8, P898, DOI 10.1038/ngeo2559; Bentley F.R., 2017, P 2017 CHI C EXT ABS, P1092, DOI [10.1145/3027063.3053335, DOI 10.1145/3027063.3053335]; Borick C, 2012, ISSUES GOVERNANCE ST, V46, P7; Braman D., 2012, GEOENGINEERING SCI C, P199; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brugger A, 2016, J ENVIRON PSYCHOL, V46, P125, DOI 10.1016/j.jenvp.2016.04.004; Carley S, 2013, TRANSPORT RES D-TR E, V18, P39, DOI 10.1016/j.trd.2012.09.007; Carmi N, 2014, HUM ECOL RISK ASSESS, V20, P872, DOI 10.1080/10807039.2013.798217; Corner A, 2013, GLOBAL ENVIRON CHANG, V23, P938, DOI 10.1016/j.gloenvcha.2013.06.002; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2006, CONSCIOUS COGN, V15, P342, DOI 10.1016/j.concog.2005.09.001; Dimitrov RS, 2016, GLOBAL ENVIRON POLIT, V16, P1, DOI 10.1162/GLEP_a_00361; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Eastin J, 2011, FUTURES, V43, P16, DOI 10.1016/j.futures.2010.03.001; Englehardt JD, 2016, ENVIRON SCI-WAT RES, V2, P250, DOI [10.1039/c5ew00204d, 10.1039/C5EW00204D]; EPA, 2017, CLIM CHANG SCI; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Fletcher J, 2019, FUTURES, V109, P63, DOI 10.1016/j.futures.2019.04.004; Frittaion CM, 2010, FUTURES, V42, P1156, DOI 10.1016/j.futures.2010.05.003; Fulton L, 2013, SUSTAINABILITY-BASEL, V5, P1863, DOI 10.3390/su5051863; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Harre N., 2018, PSYCHOL BETTER WORLD; Heen M.S., 2014, CTR CRIME JUSTICE PO, V1, P1, DOI [10.13140/RG.2.2.24283.62243, DOI 10.13140/RG.2.2.24283.62243]; Herek GM, 2015, AM J ORTHOPSYCHIAT, V85, pS29, DOI 10.1037/ort0000092; Hoegh-Guldberg O., 2018, GLOBAL WARMING 1 5 C, DOI DOI 10.1128/AEM.69.1.56-65.2003; Hrynowski Z, GALLUP; Jones C, 2017, RISK ANAL, V37, P331, DOI 10.1111/risa.12601; Keith DW, 2000, ANNU REV ENERG ENV, V25, P245, DOI 10.1146/annurev.energy.25.1.245; Kilbourne WE, 2002, J BUS RES, V55, P193, DOI 10.1016/S0148-2963(00)00141-7; Leiserowitz, 2009, GLOBAL WARMINGS 6 AM; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Lenzen M, 2018, NAT CLIM CHANGE, V8, P522, DOI 10.1038/s41558-018-0141-x; Longnecker N, 2016, JCOM-J SCI COMMUN, V15; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Lorenzoni I, 2006, CLIMATIC CHANGE, V77, P73, DOI 10.1007/s10584-006-9072-z; Lowe T, 2006, PUBLIC UNDERST SCI, V15, P435, DOI 10.1177/0963662506063796; Marlon J., 2019, YALE CLIMATE OPINION; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; McDonald RI, 2015, J ENVIRON PSYCHOL, V44, P109, DOI 10.1016/j.jenvp.2015.10.003; McElwee RO, 2009, CURR PSYCHOL, V28, P133, DOI 10.1007/s12144-009-9051-4; Milfont TL, 2012, RISK ANAL, V32, P1003, DOI 10.1111/j.1539-6924.2012.01800.x; Miniard D, 2020, P NATL ACAD SCI USA, V117, P7108, DOI 10.1073/pnas.1920558117; Morton C, 2017, INT J SUSTAIN TRANSP, V11, P443, DOI 10.1080/15568318.2016.1266533; Newby-Clark IR, 2003, PERS SOC PSYCHOL B, V29, P807, DOI 10.1177/0146167203029007001; Nisbet M. C., 2007, PUBLIC OPINION Q, V71, P1; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Peeters P, 2016, TRANSPORT RES D-TR E, V44, P30, DOI 10.1016/j.trd.2016.02.004; Pew Research Center, 2016, POLITICS CLIMATE; Plotz P, 2014, TRANSPORT RES A-POL, V67, P96, DOI 10.1016/j.tra.2014.06.006; Price JC, 2014, J ENVIRON PSYCHOL, V37, P8, DOI 10.1016/j.jenvp.2013.10.001; Rickard LN, 2016, GLOBAL ENVIRON CHANG, V38, P97, DOI 10.1016/j.gloenvcha.2016.03.003; Sagristano MD, 2002, J EXP PSYCHOL GEN, V131, P364, DOI 10.1037//0096-3445.131.3.364; Saldana J., 2021, CODING MANUAL QUALIT, P1; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Scott D, 2016, J SUSTAIN TOUR, V24, P933, DOI 10.1080/09669582.2016.1187623; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; SHELLEY M, 1984, J AM STAT ASSOC, V79, P240, DOI 10.2307/2288384; SHELLEY MK, 1994, ORGAN BEHAV HUM DEC, V59, P124, DOI 10.1006/obhd.1994.1053; Sheppard SRJ, 2011, FUTURES, V43, P400, DOI 10.1016/j.futures.2011.01.009; Sims R, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P599; Singh AS, 2017, ENVIRON SCI POLICY, V73, P93, DOI 10.1016/j.envsci.2017.04.011; Somanader Tanya, 2016, PRESIDENT OBAMA US F; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Tonn B, 2006, FUTURES, V38, P810, DOI 10.1016/j.futures.2005.12.005; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; United States Census Bureau, 2018, AG SEX COP US 2016; United States Census Bureau, 2017, ED ATT US 2016; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235; Zhang YX, 2017, ADV CLIM CHANG RES, V8, P213, DOI 10.1016/j.accre.2017.08.005	74	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0244545	10.1371/journal.pone.0244545	http://dx.doi.org/10.1371/journal.pone.0244545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534806	gold, Green Published			2022-12-26	WOS:000616739700049
J	Kaufmann, B; Boulle, P; Berthou, F; Fournier, M; Beran, D; Ciglenecki, I; Townsend, M; Schmidt, G; Shah, M; Cristofani, S; Cavailler, P; Foti, M; Scapozza, L				Kaufmann, Beatrice; Boulle, Philippa; Berthou, Flavien; Fournier, Margot; Beran, David; Ciglenecki, Iza; Townsend, Malcolm; Schmidt, Guillaume; Shah, Maya; Cristofani, Susanna; Cavailler, Philippe; Foti, Michelangelo; Scapozza, Leonardo			Heat-stability study of various insulin types in tropical temperature conditions: New insights towards improving diabetes care	PLOS ONE			English	Article							HPLC METHOD; LONG; HEPATOCYTES; KINETICS; LISPRO; SIZE	Strict storage recommendations for insulin are difficult to follow in hot tropical regions and even more challenging in conflict and humanitarian emergency settings, adding an extra burden to the management of people with diabetes. According to pharmacopeia unopened insulin vials must be stored in a refrigerator (2-8 degrees C), while storage at ambient temperature (25-30 degrees C) is usually permitted for the 4-week usage period during treatment. In the present work we address a critical question towards improving diabetes care in resource poor settings, namely whether insulin is stable and retains biological activity in tropical temperatures during a 4-week treatment period. To answer this question, temperature fluctuations were measured in Dagahaley refugee camp (Northern Kenya) using log tag recorders. Oscillating temperatures between 25 and 37 degrees C were observed. Insulin heat stability was assessed under these specific temperatures which were precisely reproduced in the laboratory. Different commercialized formulations of insulin were quantified weekly by high performance liquid chromatography and the results showed perfect conformity to pharmacopeia guidelines, thus confirming stability over the assessment period (four weeks). Monitoring the 3D-structure of the tested insulin by circular dichroism confirmed that insulin monomer conformation did not undergo significant modifications. The measure of insulin efficiency on insulin receptor (IR) and Akt phosphorylation in hepatic cells indicated that insulin bioactivity of the samples stored at oscillating temperature during the usage period is identical to that of the samples maintained at 2-8 degrees C. Taken together, these results indicate that insulin can be stored at such oscillating ambient temperatures for the usual four-week period of use. This enables the barrier of cold storage during use to be removed, thereby opening up the perspective for easier management of diabetes in humanitarian contexts and resource poor settings.	[Kaufmann, Beatrice; Scapozza, Leonardo] Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem, Geneva, Switzerland; [Boulle, Philippa; Ciglenecki, Iza; Townsend, Malcolm; Schmidt, Guillaume; Shah, Maya; Cristofani, Susanna; Cavailler, Philippe] Med Sans Frontieres Switzerland, Geneva, Switzerland; [Berthou, Flavien; Fournier, Margot; Foti, Michelangelo] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Beran, David] Univ Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Beran, David] Geneva Univ Hosp, Geneva, Switzerland	University of Geneva; Doctors Without Borders; University of Geneva; University of Geneva; University of Geneva	Scapozza, L (corresponding author), Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem, Geneva, Switzerland.	leonardo.scapozza@unige.ch		Scapozza, Leonardo/0000-0003-1079-648X; Foti, Michelangelo/0000-0001-7199-4135	MSF Switzerland	MSF Switzerland	The research was funded by MSF Switzerland.	ABUHESHMEH N, 2013, INT J PHARM BIOMED R, V4, P428; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banting FG, 1922, CAN MED ASSOC J, V7, P141; Basu S, 2019, LANCET DIABETES ENDO, V7, P25, DOI 10.1016/S2213-8587(18)30303-6; Beran D., 2011, DIABETES MANAG, V1, P67, DOI [DOI 10.2217/DMT.10.5, 10.2217/dmt.10.5]; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Beran D, 2016, LANCET DIABETES ENDO, V4, P275, DOI 10.1016/S2213-8587(15)00521-5; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; Calo N, 2016, GUT, V65, P1871, DOI 10.1136/gutjnl-2015-310822; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; DeFelippis MR, 2006, DIABETES TECHNOL THE, V8, P358, DOI 10.1089/dia.2006.8.358; Dische FE, 1988, INSULIN AMYLOID FIBR; Fisch A, 1987, MED AFRIQUE NOIRE, V34, P1043; Flood TM, 2015, ENDOCR PRACT, V21, P213; Gill GV, 2000, TROP MED INT HEALTH, V5, P666, DOI 10.1046/j.1365-3156.2000.00617.x; Grajower MM, 2014, ENDOCR PRACT, V20, P188, DOI 10.4158/EP13427.CO; Grajower MM, 2003, DIABETES CARE, V26, P2665, DOI 10.2337/diacare.26.9.2665; HAMEL FG, 1987, DIABETES, V36, P702, DOI 10.2337/diabetes.36.6.702; Holcombe JH, 2004, DIABETES CARE, V27, P1241, DOI 10.2337/diacare.27.5.1241; Huus K, 2005, BIOCHEMISTRY-US, V44, P11171, DOI 10.1021/bi0507940; Huus K, 2006, PHARM RES-DORDR, V23, P2611, DOI 10.1007/s11095-006-9098-y; IDF, 2013, INT DIAB FED DIAB AT, V6th; Kurouski D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036989; Leobandung W, 2002, J CONTROL RELEASE, V80, P357, DOI 10.1016/S0168-3659(02)00028-7; Mangialardo S, 2012, J RAMAN SPECTROSC, V43, P692, DOI 10.1002/jrs.3097; Moussa BA, 2010, E-J CHEM, V7, pS449, DOI 10.1155/2010/147824; Nault L, 2013, ACTA BIOMATER, V9, P5070, DOI 10.1016/j.actbio.2012.09.025; Oliva A, 2009, J PHARMACEUT BIOMED, V49, P916, DOI 10.1016/j.jpba.2009.01.024; Pharmacopeia E, 2011, MON INS HUM; PINGEL M, 1972, DIABETES, V21, P805, DOI 10.2337/diab.21.7.805; Sarmento B, 2006, BIOMED CHROMATOGR, V20, P898, DOI 10.1002/bmc.616; Selivanova OM, 2014, J PHYS CHEM B, V118, P1198, DOI 10.1021/jp4083568; Sharrow SD, 2012, DIABETES TECHNOL THE, V14, P264, DOI 10.1089/dia.2011.0125; Shnek DR, 1998, J PHARM SCI, V87, P1459, DOI 10.1021/js980074x; SkjOdt MK, 2015, WORLD DIAB C WDC 201; SMITH HW, 1985, J LIQ CHROMATOGR, V8, P419, DOI 10.1080/01483918508067090; Tantipolphan R, 2010, J PHARMACEUT BIOMED, V52, P195, DOI 10.1016/j.jpba.2010.01.014; Torosantucci R, 2011, J PHARM SCI-US, V100, P2574, DOI 10.1002/jps.22523; Veurink M, 2011, EUR J PHARM BIOPHARM, V78, P271, DOI 10.1016/j.ejpb.2010.12.018; Vimalavathini R, 2009, INDIAN J MED RES, V130, P166; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; WHO, 2016, ANN 5 GUID STAB EV V; Yousefi R, 2012, INT J BIOL MACROMOL, V51, P291, DOI 10.1016/j.ijbiomac.2012.05.021	46	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245372	10.1371/journal.pone.0245372	http://dx.doi.org/10.1371/journal.pone.0245372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534816	Green Published, gold			2022-12-26	WOS:000616739700019
J	Remonda, A; Veas, E; Luzhnica, G				Remonda, Adrian; Veas, Eduardo; Luzhnica, Granit			Comparing driving behavior of humans and autonomous driving in a professional racing simulator	PLOS ONE			English	Article							DELIBERATE PRACTICE; MOTOR; PERFORMANCE	Motorsports have become an excellent playground for testing the limits of technology, machines, and human drivers. This paper presents a study that used a professional racing simulator to compare the behavior of human and autonomous drivers under an aggressive driving scenario. A professional simulator offers a close-to-real emulation of underlying physics and vehicle dynamics, as well as a wealth of clean telemetry data. In the first study, the participants' task was to achieve the fastest lap while keeping the car on the track. We grouped the resulting laps according to the performance (lap-time), defining driving behaviors at various performance levels. An extensive analysis of vehicle control features obtained from telemetry data was performed with the goal of predicting the driving performance and informing an autonomous system. In the second part of the study, a state-of-the-art reinforcement learning (RL) algorithm was trained to control the brake, throttle and steering of the simulated racing car. We investigated how the features used to predict driving performance in humans can be used in autonomous driving. Our study investigates human driving patterns with the goal of finding traces that could improve the performance of RL approaches. Conversely, they can also be applied to training (professional) drivers to improve their racing line.	[Remonda, Adrian; Veas, Eduardo] Know Ctr, Graz, Styria, Austria; [Veas, Eduardo; Luzhnica, Granit] Graz Univ Technol, Graz, Styria, Austria	Graz University of Technology	Remonda, A (corresponding author), Know Ctr, Graz, Styria, Austria.	aremonda@know-center.at		Remonda, Adrian/0000-0002-3685-9752	AVL GmbH; KnowCenter GmbH; Know-Center; Austrian COMET Program Competence Centers for Excellent Technologies under the auspices of the Austrian Federal Ministry of Transport, Innovation and Technology; Austrian Federal Ministry of Economy, Family and Youth; State of Styria	AVL GmbH; KnowCenter GmbH; Know-Center; Austrian COMET Program Competence Centers for Excellent Technologies under the auspices of the Austrian Federal Ministry of Transport, Innovation and Technology; Austrian Federal Ministry of Economy, Family and Youth; State of Styria	The funding for this work was awarded to Adrian Remonda. This research was partially funded by AVL GmbH (www.avl.com) and KnowCenter GmbH (www.know-center.at).Know-Center is funded within the Austrian COMET Program Competence Centers for Excellent Technologies under the auspices of the Austrian Federal Ministry of Transport, Innovation and Technology, the Austrian Federal Ministry of Economy, Family and Youth and by the State of Styria. COMET is managed by the Austrian Research Promotion Agency FFG (https://www.ffg.at/en).The sponsors and funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors Adrian Remonda, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated as follows. Each named author (Adrian Remonda, Eduardo Veas and Granit Luzhnica) has substantially contributed to conducting the underlying research and drafting this manuscript. In detail, the three authors contributed to the research methodology and experimental plan. Adrian Remonda implemented the algorithms and executed the study. The three authors contributed to data analysis and reporting. Additionally, the named authors have no conflict of interest, financial or otherwise.	Barrett DGT, 2018, MEASURING ABSTRACT R; Bojarski Mariusz, 2016, arXiv; Braghin F, 2008, COMPUT STRUCT, V86, P1503, DOI 10.1016/j.compstruc.2007.04.028; Brand MT, 2017, HUM MOVEMENT SCI, V56, P54, DOI 10.1016/j.humov.2017.10.020; Cardamone L, 2010, 2010 IEEE C COMP INT; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen C, 2015, 2015 IEEE INT C COMP; Chollet F, 2019, MEASURE INTELLIGENCE; Cichy RM, 2019, TRENDS COGN SCI, V23, P305, DOI 10.1016/j.tics.2019.01.009; Dosovitskiy A., 2017, P 1 C ROBOT LEARNING; Drews P, 2017, AGGRESSIVE DEEP DRIV; El Sallab Ahmad, 2017, METALEARNING FRAMEWO; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Espie E., 2005, TORCS OPEN RACING CA; Funke CM, 2020, ARXIV200409406CSQBIO; Geiger A, 2012, PROC CVPR IEEE, P3354, DOI 10.1109/CVPR.2012.6248074; Gibson J.J., 1986, ECOLOGICAL APPROACH; Hambrick DZ, 2014, INTELLIGENCE, V45, P34, DOI 10.1016/j.intell.2013.04.001; Hohlefeld FU, 2011, NEURAL CORRELATES CO, DOI [10.17169/refubium-10445, DOI 10.17169/REFUBIUM-10445]; Hunt J. J., 2015, ARXIV150902971; Jaritz M, 2018, IEEE INT CONF ROBOT, P2070; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kanade T, 1986, CSC 86; Kiran BR., 2020, DEEP REINFORCEMENT L; Klarica AJ, 2001, BRIT J SPORT MED, V35, P290, DOI 10.1136/bjsm.35.5.290; Koenig N., 2004, 2004 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) (IEEE Cat. No.04CH37566), P2149; Koutnik J, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1061; Lappi O, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01294; Leurent E., 2018, ENV AUTONOMOUS DRIVI; Lopez PA, 2018, IEEE INT C INTELL TR, P2575, DOI 10.1109/ITSC.2018.8569938; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; METZ D, 1989, AUTOMATICA, V25, P841, DOI 10.1016/0005-1098(89)90052-6; Mnih V., 2013, ARXIV, V1312, P5602, DOI DOI 10.1038/NATURE14236; Mnih V, 2016, INT C ML; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Pomerleau D., 1990, NIPS; Potkanowicz ES, 2013, SPORTS MED, V43, P565, DOI 10.1007/s40279-013-0040-2; Quiter C, 2018, DEEPDRIVE 2 0; Remonda A, 2019, PROC WORKSHOP SCALIN; Rendon-Velez E, 2016, TRANSPORT RES F-TRAF, V41, P150, DOI 10.1016/j.trf.2016.06.013; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schoettle B., 2017, SENSOR FUSION COMP S; Schulman J., 2017, ARXIV170706347; Segers J, 2014, ANAL TECHNIQUES RACE, V2; Silver D., 2016, ARXIV151105952CS; Silver D, 2018, SCIENCE, V362, P1140, DOI 10.1126/science.aar6404; Spackman K., RACE TECH MOTORSPORT; Spielberg NA, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aaw1975; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Thrun S, 2006, J FIELD ROBOT, V23, P661, DOI 10.1002/rob.20147; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004; van Leeuwen PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186871; Wallace R. S., 1985, IJCAI; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Wu C., 2017, ARXIV PREPRINT ARXIV, P10	57	3	3	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245320	10.1371/journal.pone.0245320	http://dx.doi.org/10.1371/journal.pone.0245320			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534848	Green Published, gold			2022-12-26	WOS:000616739700011
J	Bulus, N; Brown, KL; Mernaugh, G; Bottcher, A; Dong, XY; Sanders, CR; Pozzi, A; Fassler, R; Zent, R				Bulus, Nada; Brown, Kyle L.; Mernaugh, Glenda; Boettcher, Anika; Dong, Xinyu; Sanders, Charles R.; Pozzi, Ambra; Faessler, Reinhard; Zent, Roy			Disruption of the integrin-linked kinase (ILK) pseudokinase domain affects kidney development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DISSECTION; CELL MORPHOLOGY; PROTEIN; ADHESION; BINDING; DYNAMICS; REVEALS; DIFFERENTIATION; LOCALIZATION; GENERATION		[Bulus, Nada; Brown, Kyle L.; Mernaugh, Glenda; Dong, Xinyu; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Brown, Kyle L.; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Brown, Kyle L.; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Boettcher, Anika; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, Martinsried, Germany; [Boettcher, Anika] HelmholtzZentrum, Inst Diabet & Regenerat Res, Munich, Germany; [Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Pozzi, Ambra; Zent, Roy] Vet Affairs Hosp, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vanderbilt University	Zent, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA.; Zent, R (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA.; Zent, R (corresponding author), Vet Affairs Hosp, Nashville, TN 37212 USA.	roy.zent@vumc.org		Sanders, Charles/0000-0003-2046-2862	VA Merit Awards [I01 BX002196, I01 BX002025]; ERC Award; Max Planck Society; Senior Research Career Scientist award from the Veteran Affairs;  [R01 DK069921];  [R01 DK119212];  [P30-DK114809]	VA Merit Awards; ERC Award; Max Planck Society(Max Planck SocietyFoundation CELLEX); Senior Research Career Scientist award from the Veteran Affairs; ; ; 	This work was supported by VA Merit Awards I01 BX002196 (R. Z.) and I01 BX002025 (A. P.) as well as R01 DK069921 (R. Z.) and R01 DK119212 (A. P.), ERC Award (R. F.), the Max Planck Society (R. F.), and P30-DK114809 (A. P. and R. Z.). A. P. is the recipient of a Senior Research Career Scientist award from the Veteran Affairs.	Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Diskar M, 2010, J BIOL CHEM, V285, P35910, DOI 10.1074/jbc.M110.155150; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Galindo-Murillo R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6152; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2000, PROTEINS, V38, P368, DOI 10.1002/(SICI)1097-0134(20000301)38:4<368::AID-PROT3>3.0.CO;2-R; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Larini L, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2464095; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Levinson H, 2004, ANN PLAS SURG, V52, P204, DOI 10.1097/01.sap.0000100893.35542.f6; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Miller MG, 2003, BIOCHEM BIOPH RES CO, V310, P796, DOI 10.1016/j.bbrc.2003.09.080; Mills J, 2003, J NEUROSCI, V23, P1638; Moik D, 2013, J BIOL CHEM, V288, P18863, DOI 10.1074/jbc.M113.470476; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Pozzi A, 2006, MOL BIOL CELL, V17, P2046, DOI 10.1091/mbc.E05-08-0800; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Rooney N, 2016, J CELL PHYSIOL, V231, P2408, DOI 10.1002/jcp.25390; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Tan C, 2002, J BIOL CHEM, V277, P3109, DOI 10.1074/jbc.M108673200; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Vaynberg J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06906-7; Wang H, 2016, J CHEM THEORY COMPUT, V12, P5596, DOI 10.1021/acs.jctc.6b00701; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Wu XW, 2016, J COMPUT CHEM, V37, P595, DOI 10.1002/jcc.24015; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	50	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100361	10.1016/j.jbc.2021.100361	http://dx.doi.org/10.1016/j.jbc.2021.100361			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539921	Green Published, gold			2022-12-26	WOS:000672866400335
J	Lysyk, L; Brassard, R; Arutyunova, E; Siebert, V; Jiang, ZZ; Takyi, E; Morrison, M; Young, HS; Lemberg, MK; O'Donoghue, AJ; Lemieux, MJ				Lysyk, Laine; Brassard, Raelynn; Arutyunova, Elena; Siebert, Verena; Jiang, Zhenze; Takyi, Emmanuella; Morrison, Melissa; Young, Howard S.; Lemberg, Marius K.; O'Donoghue, Anthony J.; Lemieux, M. Joanne			Insights into the catalytic properties of the mitochondrial rhomboid protease PARL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE; SUBSTRATE-SPECIFICITY; LIPID-COMPOSITION; MEMBRANE; PINK1; CLEAVAGE; CARDIOLIPIN; INHIBITORS; PROTEINS	The rhomboid protease PARL is a critical regulator of mitochondrial homeostasis through its cleavage of substrates such as PINK1, PGAM5, and Smac/Diablo, which have crucial roles in mitochondrial quality control and apoptosis. However, the catalytic properties of PARL, including the effect of lipids on the protease, have never been characterized in vitro. To address this, we isolated human PARL expressed in yeast and used FRET-based kinetic assays to measure proteolytic activity in vitro. We show that PARL activity in detergent is enhanced by cardiolipin, a lipid enriched in the mitochondrial inner membrane. Significantly higher turnover rates were observed for PARL reconstituted in proteoliposomes, with Smac/Diablo being cleaved most rapidly at a rate of 1 min-1. In contrast, PGAM5 is cleaved with the highest efficiency (k(cat)/K-M) compared with PINK1 and Smac/Diablo. In proteoliposomes, a truncated beta-cleavage form of PARL, a physiological form known to affect mitochondrial fragmentation, is more active than the full-length enzyme for hydrolysis of PINK1, PGAM5, and Smac/Diablo. Multiplex profiling of 228 peptides reveals that PARL prefers substrates with a bulky side chain such as Phe in P1, which is distinct from the preference for small side chain residues typically found with bacterial rhomboid proteases. This study using recombinant PARL provides fundamental insights into its catalytic activity and substrate preferences that enhance our understanding of its role in mitochondrial function and has implications for specific inhibitor design.	[Lysyk, Laine; Brassard, Raelynn; Arutyunova, Elena; Takyi, Emmanuella; Morrison, Melissa; Young, Howard S.; Lemieux, M. Joanne] Univ Alberta, Fac Med & Dent, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [Siebert, Verena; Lemberg, Marius K.] Ctr Mol Biol Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany; [Jiang, Zhenze; O'Donoghue, Anthony J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Alberta; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego	Lemieux, MJ (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB, Canada.	miemieux@ualberta.ca	Jiang, Zhenze/AAF-7238-2021; Lemberg, Marius K/B-8881-2016	Jiang, Zhenze/0000-0001-9570-1739; Lemieux, Joanne/0000-0003-4745-9153; Siebert, Verena/0000-0002-6951-6887; Lemberg, Marius K/0000-0002-0996-1268	Parkinson Canada; Canadian Institutes of Health Research [MOP-93557]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-06478]; Neuroscience and Mental Health Institute (Johnston Family Endowment Fund); Parkinson Alberta; Alberta Innovates Health Solutions; Parkinson Canada New Investigator Program; Deutsche Forschungsgemeinschaft (German Research Foundation) [263531414/FOR2290, Le2749/1-2]; Department of Biochemistry, University of Alberta; Neuroscience and Mental Health Institute (Brad Mates Foundation)	Parkinson Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Neuroscience and Mental Health Institute (Johnston Family Endowment Fund); Parkinson Alberta; Alberta Innovates Health Solutions; Parkinson Canada New Investigator Program; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Department of Biochemistry, University of Alberta; Neuroscience and Mental Health Institute (Brad Mates Foundation)	M. J. L. gratefully acknowledges support from the Parkinson Canada and by grants from the Canadian Institutes of Health Research (MOP-93557, Funder ID: 10.13039/501100000030), Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2016-06478), Neuroscience and Mental Health Institute (Johnston Family Endowment Fund, and the Brad Mates Foundation), Parkinson Alberta, and the Department of Biochemistry, University of Alberta and was supported in part by funding from Alberta Innovates Health Solutions and the Parkinson Canada New Investigator Program. M. K. L. was supported by the grant Le2749/1-2 of the Deutsche Forschungsgemeinschaft (German Research Foundation) as part of 263531414/FOR2290.	Alford SC, 2013, BIOL CELL, V105, P14, DOI 10.1111/boc.201200054; Arutyunova E, 2018, BIOL CHEM, V399, P1389, DOI 10.1515/hsz-2018-0255; Arutyunova E, 2016, BIOL CHEM, V397, P907, DOI 10.1515/hsz-2016-0124; Arutyunova E, 2014, EMBO J, V33, P1869, DOI 10.15252/embj.201488149; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bondar AN, 2019, CHEM REV, V119, P6162, DOI 10.1021/acs.chemrev.8b00596; Brooks CL, 2013, PROTEIN SCI, V22, P425, DOI 10.1002/pro.2223; Chan EYL, 2013, BBA-BIOMEMBRANES, V1828, P2916, DOI 10.1016/j.bbamem.2013.05.012; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; COMTE J, 1976, BIOCHIM BIOPHYS ACTA, V419, P271, DOI 10.1016/0005-2736(76)90353-9; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Fersht A., 2002, STRUCTURE MECH PROTE, V2nd, P191; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Ghosh S, 2020, P NATL ACAD SCI USA, V117, P16383, DOI 10.1073/pnas.2000640117; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Jeyaraju DV, 2011, CELL DEATH DIFFER, V18, P1531, DOI 10.1038/cdd.2011.22; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kuhnle N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.217745; Langosch D, 2017, BIOL CHEM, V398, P441, DOI 10.1515/hsz-2016-0269; Lapek JD, 2019, MOL CELL PROTEOMICS, V18, P968, DOI 10.1074/mcp.TIR118.001099; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Lu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147792; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Lysyk L, 2020, J MOL BIOL, V432, P5052, DOI 10.1016/j.jmb.2020.04.006; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Naing SH, 2018, J BIOL CHEM, V293, P4653, DOI 10.1074/jbc.RA117.001436; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; RUGGIERO FM, 1992, J NEUROCHEM, V59, P487, DOI 10.1111/j.1471-4159.1992.tb09396.x; Ryabichko S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63280-5; Saita S, 2017, NAT CELL BIOL, V19, P318, DOI 10.1038/ncb3488; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Shi G, 2017, CELL REP, V18, P1458, DOI 10.1016/j.celrep.2017.01.029; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Sik A, 2004, J BIOL CHEM, V279, P15323, DOI 10.1074/jbc.M313756200; Spinazzi M, 2019, P NATL ACAD SCI USA, V116, P277, DOI 10.1073/pnas.1811938116; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Strisovsky K, 2016, SEMIN CELL DEV BIOL, V60, P52, DOI 10.1016/j.semcdb.2016.08.021; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Ticha A, 2018, TRENDS BIOCHEM SCI, V43, P726, DOI 10.1016/j.tibs.2018.06.009; Ticha AZ, 2017, CELL CHEM BIOL, V24, P1523, DOI 10.1016/j.chembiol.2017.09.007; Ticha A, 2017, J BIOL CHEM, V292, P2703, DOI 10.1074/jbc.M116.762849; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Verhelst SHL, 2017, FEBS J, V284, P1489, DOI 10.1111/febs.13979; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zoll S, 2014, EMBO J, V33, P2408, DOI 10.15252/embj.201489367	63	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100383	10.1016/j.jbc.2021.100383	http://dx.doi.org/10.1016/j.jbc.2021.100383			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556373	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400357
J	Castro, A; Ozturk, K; Zanetti, M; Carter, H				Castro, Andrea; Ozturk, Kivilcim; Zanetti, Maurizio; Carter, Hannah			In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; T-B COOPERATION; IMMUNE-RESPONSE; STAPHYLOCOCCAL NUCLEASE; DIFFERENT DETERMINANTS; GENETIC-CONTROL; UNITED-STATES; CELL HELP; ANTIGEN; SPECIFICITY	SARS-CoV-2 antibodies develop within two weeks of infection, but wane relatively rapidly post-infection, raising concerns about whether antibody responses will provide protection upon re-exposure. Here we revisit T-B cooperation as a prerequisite for effective and durable neutralizing antibody responses centered on a mutationally constrained RBM B cell epitope. T-B cooperation requires co-processing of B and T cell epitopes by the same B cell and is subject to MHC-II restriction. We evaluated MHC-II constraints relevant to the neutralizing antibody response to a mutationally-constrained B cell epitope in the receptor binding motif (RBM) of the spike protein. Examining common MHC-II alleles, we found that peptides surrounding this key B cell epitope are predicted to bind poorly, suggesting a lack MHC-II support in T-B cooperation, impacting generation of high-potency neutralizing antibodies in the general population. Additionally, we found that multiple microbial peptides had potential for RBM cross-reactivity, supporting previous exposures as a possible source of T cell memory.	[Castro, Andrea] Univ Calif San Diego, Biomed Informat Program, La Jolla, CA 92093 USA; [Castro, Andrea; Ozturk, Kivilcim; Carter, Hannah] Univ Calif San Diego, Dept Med, Div Med Genet, La Jolla, CA 92093 USA; [Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Lab Immunol, La Jolla, CA 92093 USA; [Zanetti, Maurizio; Carter, Hannah] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Carter, H (corresponding author), Univ Calif San Diego, Dept Med, Div Med Genet, La Jolla, CA 92093 USA.; Zanetti, M (corresponding author), Univ Calif San Diego, Dept Med, Lab Immunol, La Jolla, CA 92093 USA.; Zanetti, M; Carter, H (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	mzanetti@health.ucsd.edu; hkcarter@health.ucsd.edu		Castro, Andrea/0000-0002-5873-2496	NIH National Library of Medicine Training Grant [T15LM011271]; Mark Foundation for Cancer Research [18-022-ELA]; Canadian Institute For Advanced Research (CIFAR) [FL-000655]; NIH NCI [RO1 CA220009]	NIH National Library of Medicine Training Grant; Mark Foundation for Cancer Research; Canadian Institute For Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an NIH National Library of Medicine Training Grant T15LM011271 to A.C., an Emerging Leader Award #18-022-ELA from The Mark Foundation for Cancer Research (https://themarkfoundation.org), a Canadian Institute For Advanced Research (CIFAR) (https://www.cifar.ca) fellowship #FL000655 to H.C. and NIH NCI RO1 CA220009 to M. Z. and H.C.	Alam S, 2014, J VIROL, V88, P314, DOI 10.1128/JVI.02077-13; Anczurowski M, 2018, TRENDS IMMUNOL, V39, P960, DOI 10.1016/j.it.2018.10.008; Andreatta M, 2013, BIOINFORMATICS, V29, P8, DOI 10.1093/bioinformatics/bts621; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bergthorsdottir S, 2001, J IMMUNOL, V166, P2228, DOI 10.4049/jimmunol.166.4.2228; BERZOFSKY JA, 1977, J EXP MED, V145, P111, DOI 10.1084/jem.145.1.111; BERZOFSKY JA, 1979, P NATL ACAD SCI USA, V76, P4046, DOI 10.1073/pnas.76.8.4046; BERZOFSKY JA, 1977, J EXP MED, V145, P123, DOI 10.1084/jem.145.1.123; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; CASSELL D, 1988, ANN NY ACAD SCI, V532, P51, DOI 10.1111/j.1749-6632.1988.tb36325.x; CELADA F, 1988, VACCINE, V6, P94, DOI 10.1016/S0264-410X(88)80006-9; Celada F, 1984, REGULATION IMMUNE SY, P637; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; Dosset M, 2020, CANCERS, V12, DOI 10.3390/cancers12061687; Du Z., 2017, 2017 AM TRANSP C APR; Fenwick C, 2021, J VIROL, V95, DOI 10.1128/JVI.01828-20; Gerloni M, 2000, P NATL ACAD SCI USA, V97, P13269, DOI 10.1073/pnas.230429197; Gharpure R, 2019, MMWR-MORBID MORTAL W, V68, P568, DOI 10.15585/mmwr.mm6825a3; Goldman Jason D, 2020, medRxiv, DOI 10.1101/2020.09.22.20192443; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gupta V, 2021, CLIN INFECT DIS, V73, pE2823, DOI 10.1093/cid/ciaa1451; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JANEWAY CA, 1975, J IMMUNOL, V114, P1394; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; KATZ DH, 1973, P NATL ACAD SCI USA, V70, P2624, DOI 10.1073/pnas.70.9.2624; Kreer C, 2020, CELL, V182, P1663, DOI 10.1016/j.cell.2020.08.046; Kroeger DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077346; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; MANCA F, 1985, EUR J IMMUNOL, V15, P345, DOI 10.1002/eji.1830150408; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; McAndrews KM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142386; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; MITCHISON N A, 1971, European Journal of Immunology, V1, P10, DOI 10.1002/eji.1830010103; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Mozdzanowska K, 1997, VIROLOGY, V239, P217, DOI 10.1006/viro.1997.8882; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; Parker D C, 1993, Semin Immunol, V5, P413, DOI 10.1006/smim.1993.1047; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Prevost J, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100126; RAJEWSKY K, 1967, J EXP MED, V126, P581, DOI 10.1084/jem.126.4.581; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sehnal D, 2018, MOLVA WORKSH MOL GRA; Selin LK, 2004, SEMIN IMMUNOL, V16, P335, DOI 10.1016/j.smim.2004.08.014; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; SPRENT J, 1978, J EXP MED, V147, P1159, DOI 10.1084/jem.147.4.1159; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16256-y; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; ZANETTI M, 1987, IMMUNOL TODAY, V8, P18, DOI 10.1016/0167-5699(87)90827-9; ZANETTI M, 1988, Annales de l'Institut Pasteur Immunology, V139, P192; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	85	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246731	10.1371/journal.pone.0246731	http://dx.doi.org/10.1371/journal.pone.0246731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571241	Green Published, gold			2022-12-26	WOS:000618274000064
J	Gao, S; Kotevska, O; Sorokine, A; Christian, JB				Gao, Shang; Kotevska, Olivera; Sorokine, Alexandre; Christian, J. Blair			A pre-training and self-training approach for biomedical named entity recognition	PLOS ONE			English	Article							TEXT	Named entity recognition (NER) is a key component of many scientific literature mining tasks, such as information retrieval, information extraction, and question answering; however, many modern approaches require large amounts of labeled training data in order to be effective. This severely limits the effectiveness of NER models in applications where expert annotations are difficult and expensive to obtain. In this work, we explore the effectiveness of transfer learning and semi-supervised self-training to improve the performance of NER models in biomedical settings with very limited labeled data (250-2000 labeled samples). We first pre-train a BiLSTM-CRF and a BERT model on a very large general biomedical NER corpus such as MedMentions or Semantic Medline, and then we fine-tune the model on a more specific target NER task that has very limited training data; finally, we apply semi-supervised self-training using unlabeled data to further boost model performance. We show that in NER tasks that focus on common biomedical entity types such as those in the Unified Medical Language System (UMLS), combining transfer learning with self-training enables a NER model such as a BiLSTM-CRF or BERT to obtain similar performance with the same model trained on 3x-8x the amount of labeled data. We further show that our approach can also boost performance in a low-resource application where entities types are more rare and not specifically covered in UMLS.	[Gao, Shang; Christian, J. Blair] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN 37830 USA; [Kotevska, Olivera] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN USA; [Sorokine, Alexandre] Oak Ridge Natl Lab, Geospatial Sci & Human Secur Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Gao, S; Christian, JB (corresponding author), Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN 37830 USA.	gaos@ornl.gov; christianjb@ornl.gov		Sorokine, Alexandre/0000-0001-7993-1534; Gao, Shang/0000-0003-1803-1457	Department of Energy; Laboratory Directed Research and Development (LDRD) program of Oak Ridge National Laboratory, under LDRD project [9494, DE-AC05-00OR22725]; U.S. Department of Energy [DE-AC05-00OR22725]; Office of Science of the U.S. Department of Energy [DE-AC05-00OR22725]	Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research and Development (LDRD) program of Oak Ridge National Laboratory, under LDRD project; U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	Blair Christian (BC) at Oak Ridge National Laboratory received funding from the Department of Energy (energy.gov). This funding was provided through the Laboratory Directed Research and Development (LDRD) program of Oak Ridge National Laboratory, under LDRD project No. 9494. These funds were used to facilitate this study and support of salaries for SG, OK, AS, and BC. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of the manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).This research used resources of the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725. This research used resources of the Compute and Data Environment for Science (CADES) at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725. The funding offices from the Office of Science and DOE did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	Abdallah ZS, 2017, COMPUT SPEECH LANG, V43, P34, DOI 10.1016/j.csl.2016.10.003; [Anonymous], 2010, P 2010 C EMP METH NA; [Anonymous], 2020, NERV; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bhatia Parminder, 2020, P INT WORKSH HLTH IN, P69; Dernoncourt F, 2016, DEIDENTIFICATION PAT; Devlin J., 2018, ARXIV181004805; Devlin Jacob, 2019, P ANN C N AM CHAPTER, V1, P4171; Eftimov T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179488; Gali K, 2008, P IJCNLP 08 WORKSH N, P25; Giorgi JM, 2020, BIOINFORMATICS, V36, P280, DOI 10.1093/bioinformatics/btz504; Giorgi JM, 2018, BIOINFORMATICS, V34, P4087, DOI 10.1093/bioinformatics/bty449; Gorinski PJ, 2019, ARXIV PREPRINT ARXIV; Hakala Kai, 2019, P 5THWORKSHOP BIONLP, P56, DOI [10.18653/v1/d19-5709, DOI 10.18653/V1/D19-5709, 10.18653/v1/D19-5709]; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Hong SK, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3393-1; Huang ZH, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/685404; Jie Z., 2019, P 2019 C N AM CHAPT, V1, P729, DOI [10.18653/v1/n19-1079, DOI 10.18653/V1/N19-1079]; Khan MR, 2020, ARXIV200108904; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kim D, 2019, IEEE ACCESS, V7, P73729, DOI 10.1109/ACCESS.2019.2920708; Kim J, 2019, IEEE ACCESS, V7, P70308, DOI 10.1109/ACCESS.2019.2914168; Kipf TN, 2017, ICLR 2017; Lample Guillaume, 2016, P NAACL HLT, P260, DOI [DOI 10.18653/V1/N16-1030, 10.18653/v1/N16-1030]; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Lee JY, 2018, LREC; Li J, 2022, IEEE T KNOWL DATA EN, V34, P50, DOI 10.1109/TKDE.2020.2981314; Li J, 2020, WEB CONFERENCE 2020: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2020), P429, DOI 10.1145/3366423.3380127; Li LL, 2015, IEEE T KNOWL DATA EN, V27, P250, DOI 10.1109/TKDE.2014.2320713; Liu Q, 2020, ARXIV200307278; Luan Y, 2017, ARXIV170806075; Ma XZ, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1064; Miyato T, 2019, IEEE T PATTERN ANAL, V41, P1979, DOI 10.1109/TPAMI.2018.2858821; Mohan S, 2019, AKBC 2019; Neumann M, 2019, SIGBIOMED WORKSHOP ON BIOMEDICAL NATURAL LANGUAGE PROCESSING (BIONLP 2019), P319; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Peng YF, 2019, SIGBIOMED WORKSHOP ON BIOMEDICAL NATURAL LANGUAGE PROCESSING (BIONLP 2019), P58; Petasis G, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P418; Qiu XP, 2020, SCI CHINA TECHNOL SC, V63, P1872, DOI 10.1007/s11431-020-1647-3; Ratadiya P, 2019, ARXIV191007370; Rindflesch Thomas C., 2011, Information Services & Use, V31, P15, DOI 10.3233/ISU-2011-0627; Rocktaschel T, 2012, BIOINFORMATICS, V28, P1633, DOI 10.1093/bioinformatics/bts183; Ronran C, 2020, INT CONF BIG DATA, P613, DOI 10.1109/BigComp48618.2020.00132; Ruder S., 2019, P 2019 C N AM CHAPTE, P15, DOI 10.18653/v1/N19-5004; Ruder S, 2018, ARXIV180409530; Sari Yunita, 2010, Proceedings of 2010 International Symposium on Information Technology (ITSim 2010), P563, DOI 10.1109/ITSIM.2010.5561392; Schmitt C, 2018, NATL I STANDARDS TEC; Segura-Bedmar Isabel, 2013, 2 JOINT C LEX COMP S, P341; Tafti AP, 2019, IEEE INT C BIOINFORM, P1380, DOI 10.1109/BIBM47256.2019.8982942; Taigman Y, 2017, ICLR 2017; Talukdar ParthaPratim, 2006, COMPUTATIONAL NATURA, P141; Tarvainen A, 2017, ICLR WORKSH; Temkin JM, 2003, BIOINFORMATICS, V19, P2046, DOI 10.1093/bioinformatics/btg279; van Engelen JE, 2020, MACH LEARN, V109, P373, DOI 10.1007/s10994-019-05855-6; Vlachos A., 2007, BIOL TRANSLATIONAL C, P199; Weber L, 2020, BIOINFORMATICS, V36, P295, DOI 10.1093/bioinformatics/btz528; Wolf T., 2019, ABS191003771 CORR; Wolf T., 2019, ABS191003771 CORR; Wu JD, 2009, LECT NOTES ENG COMP, P58; Xu K., 2018, AISI 2017, V639, P355, DOI [10.1007/978-3-319-64861-3, DOI 10.1007/978-3-319-64861-3, DOI 10.1007/978-3-319-64861]; Yadav Vikas, 2018, P 27 INT C COMP LING, P2145; Yao R, 2019, INT CONF UBIQ ROBOT, P12, DOI 10.1109/URAI.2019.8768707; Zafarian A, 2015, 2015 INTERNATIONAL SYMPOSIUM ON ARTIFICIAL INTELLIGENCE AND SIGNAL PROCESSING (AISP), P129, DOI 10.1109/AISP.2015.7123504; Zhang WL, 2020, IEEE T BIG DATA, V6, P322, DOI 10.1109/TBDATA.2016.2573280; Zhang YJ, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0055-0; Zoph B., 2016, P 2016 C EMP METH NA, P1568, DOI DOI 10.18653/V1/D16-1163	67	5	5	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246310	10.1371/journal.pone.0246310	http://dx.doi.org/10.1371/journal.pone.0246310			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561139	gold, Green Published			2022-12-26	WOS:000617533000037
J	Pei, D; Liu, ZM; Wu, WJ; Hu, BR				Pei, Di; Liu, Zhiming; Wu, Wenjian; Hu, Biru			Transcriptome analyses reveal the utilization of nitrogen sources and related metabolic mechanisms of Sporosarcina pasteurii	PLOS ONE			English	Article							CARBONATE PRECIPITATION; REMEDIATION; URINE	In recent years, Sporosarcina pasteurii (S. pasteurii) has become one of the most popular bacteria in microbially induced calcium carbonate precipitation (MICP). Various applications have been developed based on the efficient urease that can induce the precipitation of calcium carbonate. However, the metabolic mechanism related to biomineralization of S. pasteurii has not been clearly elucidated. The process of bacterial culture and biomineralization consumes a large amount of urea or ammonium salts, which are usually used as agricultural fertilizers, not to mention probable environmental pollutions caused by the excessive use of these raw materials. Therefore, it is urgent to reveal the mechanism of nitrogen utilization and metabolism of S. pasteurii. In this paper, we compared the growth and gene expression of S. pasteurii under three different culture conditions through transcriptome analyses. GO and KEGG analyses revealed that both ammonium and urea were direct nitrogen sources of S. pasteurii, and the bacteria could not grow normally in the absence of ammonium or urea. To the best of our knowledge, this paper is the first one to reveal the nitrogen utilization mechanism of S. pasteurii through transcriptome methods. Furthermore, the presence of ammonium might promote the synthesis of intracellular ATP and enhance the motility of the bacteria. There should be an ATP synthesis mechanism associated with urea hydrolysis catalyzed by urease in S. pasteurii.	[Pei, Di; Liu, Zhiming; Wu, Wenjian; Hu, Biru] Natl Univ Def Technol, Coll Liberal Arts & Sci, Changsha, Hunan, Peoples R China; [Liu, Zhiming] Acad Mil Med Sci, Inst Chem Def, Beijing, Peoples R China	National University of Defense Technology - China; Academy of Military Medical Sciences - China	Liu, ZM (corresponding author), Natl Univ Def Technol, Coll Liberal Arts & Sci, Changsha, Hunan, Peoples R China.; Liu, ZM (corresponding author), Acad Mil Med Sci, Inst Chem Def, Beijing, Peoples R China.	lzm@nudt.edu.cn	Liu, Zhiming/GXG-6785-2022	Liu, Zhiming/0000-0003-1819-7967; Di, Pei/0000-0001-6690-844X				Achal V, 2009, J IND MICROBIOL BIOT, V36, P433, DOI 10.1007/s10295-008-0514-7; Anbu P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1869-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BUURMAN ET, 1989, ARCH MICROBIOL, V152, P58, DOI 10.1007/BF00447012; Buurman ET, FEMS MICROBIOLOGY LE, P1; Chen HJ, 2019, WASTE BIOMASS VALORI, V10, P2887, DOI 10.1007/s12649-018-0324-8; Ednie-Brown P, 2013, ARCHIT DESIGN, V83, P84, DOI 10.1002/ad.1529; Farrell M, 2014, SOIL BIOL BIOCHEM, V77, P261, DOI 10.1016/j.soilbio.2014.07.003; Ferris FG, 1996, J CAN PETROL TECHNOL, V35, P56, DOI 10.2118/96-08-06; Fujinami S, 2009, FUTURE MICROBIOL, V4, P1137, DOI 10.2217/FMB.09.76; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; Jahns T, 1996, J BACTERIOL, V178, P403, DOI 10.1128/jb.178.2.403-409.1996; Jonkers HM, 2010, ECOL ENG, V36, P230, DOI 10.1016/j.ecoleng.2008.12.036; Jonkers HM, 2007, SPRINGER SER MATER S, V100, P195, DOI 10.1007/978-1-4020-6250-6_9; KANE J, 1971, CAN J MICROBIOL, V17, P911, DOI 10.1139/m71-145; KLEIN A, 1972, POSTEPY BIOCHEM, V18, P225; Kristiansen B., 2001, BASIC BIOTECHNOLOGY, V2nd, P239; Larson M., 2010, ARCHITECTURAL RECORD, V265, P1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma L, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-1281-z; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin D, 2012, ENVIRON SCI TECHNOL, V46, P8351, DOI 10.1021/es3015875; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MORSDORF G, 1989, ARCH MICROBIOL, V152, P125, DOI 10.1007/BF00456089; Nakamura S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9070279; Norris JR, 1981, AEROBIC ENDOSPORE FO, P337; Okyay TO, 2014, ECOL ENG, V62, P168, DOI 10.1016/j.ecoleng.2013.10.024; Pathom-aree W., 2016, MICROBIOLOGICAL RES, DOI [10.1016/j.micres.2016.03.01027242150, DOI 10.1016/J.MICRES.2016.03.01027242150]; Pei D, 2020, PROG BIOCHEM BIOPHYS, V47, P467, DOI 10.16476/j.pibb.2020.0012; Ramachandran SK, 2001, ACI MATER J, V98, P3; Randall DG, 2018, J ENVIRON CHEM ENG, V6, P2627, DOI 10.1016/j.jece.2018.04.012; Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; Wang R X, 2008, J CHINESE CERAMIC SO, P37; Wang Ruixing, 2008, Journal of the Chinese Ceramic Society, V36, P1378; Williams SL, 2016, J IND MICROBIOL BIOT, V43, P567, DOI 10.1007/s10295-015-1726-2; Yang LJ, 2016, GEODERMA, V283, P32, DOI 10.1016/j.geoderma.2016.07.022; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhu TT, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00004	38	4	4	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246818	10.1371/journal.pone.0246818	http://dx.doi.org/10.1371/journal.pone.0246818			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561150	Green Published, gold			2022-12-26	WOS:000617533000026
J	Adeniyi, O; Washington, L; Glenn, CJ; Franklin, SG; Scott, A; Aung, M; Niranjan, SJ; Jolly, PE				Adeniyi, Omolade; Washington, LaTimberly; Glenn, Christina J.; Franklin, Sarah G.; Scott, Anniecia; Aung, Maung; Niranjan, Soumya J.; Jolly, Pauline E.			The use of complementary and alternative medicine among hypertensive and type 2 diabetic patients in Western Jamaica: A mixed methods study	PLOS ONE			English	Article							PREVALENCE; MELLITUS; WARFARIN; HEALTH	Background The simultaneous or intermittent use of alternative treatments and prescription medications for hypertension and type 2 diabetes mellitus can have adverse health effects. Objectives To identify beliefs and practices associated with the use of alternative treatments for hypertension and type 2 diabetes mellitus among patients. Methods A mixed-methods study including an investigator-administered survey and focus group discussion sessions using convenience sampling was conducted among patients aged >= 18 years during May to August 2018. Descriptive statistics were used to describe and compare demographic characteristics among groups of survey participants using JMP Pro 14.0. Thematic analysis was conducted to analyze the qualitative data using NVivo. Results Most study participants (87-90%) were on prescription medication for their condition. Of survey participants, 69% reported taking their medication as prescribed and 70% felt that prescription medicine was controlling their condition. Almost all participants (98%) reported using alternative treatments, mainly herbal medications, and 73-80% felt that herbal medicines controlled their conditions. One-third believed that herbal medicines are the most effective form of treatment and should always be used instead of prescription medication. However, most participants (85%) did not believe that prescription and herbal treatments should be used simultaneously. Most (76-90%) did not discuss herbal treatments with their healthcare providers. Four themes emerged from the focus group sessions: 1) Simultaneous use of herbal and prescription medicine was perceived to be harmful, 2) Patients did not divulge their use of herbal medicine to healthcare providers, 3) Alternative medicines were perceived to be highly effective, and 4) Religiosity and family elders played key roles in herbal use. Conclusions This study provides useful insights into perceptions and use of alternative treatments by patients that can be used by healthcare providers in developing appropriate interventions to encourage proper use of prescription medicines and alternative medicines resulting in improved management of these chronic diseases.	[Adeniyi, Omolade; Washington, LaTimberly; Franklin, Sarah G.; Jolly, Pauline E.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Glenn, Christina J.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Scott, Anniecia; Aung, Maung] Minist Hlth, Epidemiol Unit, Western Reg Hlth Author, Montego Bay, St James, Jamaica; [Niranjan, Soumya J.] Univ Alabama Birmingham, Sch Hlth Profess, Hlth Serv Adm, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jolly, PE (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	jollyp@uab.edu		Jolly, Pauline/0000-0003-1718-6908	Minority Health International Research Training (MHIRT) from the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), Bethesda, Maryland, USA [T37-MD001448]; Western Regional Health Authority, Ministry of Health, Jamaica	Minority Health International Research Training (MHIRT) from the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), Bethesda, Maryland, USA; Western Regional Health Authority, Ministry of Health, Jamaica	This study was supported by the Minority Health International Research Training (MHIRT) grant no. T37-MD001448 from the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), Bethesda, Maryland, USA, and the Western Regional Health Authority, Ministry of Health, Jamaica.	Bahall M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1654-y; Bahall M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0577-8; Bopp M, 2013, FAM COMMUNITY HEALTH, V36, P182, DOI 10.1097/FCH.0b013e31828e671c; Boume PA, 2009, N AM J MED SCI, V1, P356, DOI 10.4297/najms.2009.7356; Clement Yuri N, 2005, BMC Complement Altern Med, V5, P20, DOI 10.1186/1472-6882-5-20; Delgoda R, 2010, COMPLEMENT THER MED, V18, P13, DOI 10.1016/j.ctim.2010.01.002; Ferguson TS, 2010, W INDIAN MED J, V59, P259; Izzo AA, 2005, INT J CARDIOL, V98, P1, DOI 10.1016/j.ijcard.2003.06.039; Janetzky K, 1997, AM J HEALTH-SYST PH, V54, P692, DOI 10.1093/ajhp/54.6.692; Jaramillo  A.D.G., 2017, REV COLOMBIANA ENDOC, V1, P5, DOI DOI 10.1038/S41570-016-0005; Kutner JS, 1999, SOC SCI MED, V48, P1341, DOI 10.1016/S0277-9536(98)00453-5; Lynch N, 2007, COMPLEMENT THER MED, V15, P84, DOI 10.1016/j.ctim.2006.06.007; Manafikhi R., 2015, INT J ACAD SCI RES, V3, P11; Matthews MK, 1998, NEUROLOGY, V50, P1933, DOI 10.1212/WNL.50.6.1933; Milden SP, 2004, BEHAV MED, V30, P73, DOI 10.3200/BMED.30.2.73-84; Patel SJ, 2017, ADV MED EDUC PRACT, V8, P499, DOI 10.2147/AMEP.S138572; Phil RAM, 2011, J MED PLANTS RES, V5, P2922; Picking D, 2011, J ETHNOPHARMACOL, V137, P305, DOI 10.1016/j.jep.2011.05.025; Plano J., 2018, DESIGNING CONDUCTING; Ried K, 2013, EUR J CLIN NUTR, V67, P64, DOI 10.1038/ejcn.2012.178; Ried K, 2010, MATURITAS, V67, P144, DOI 10.1016/j.maturitas.2010.06.001; SHAPIRO BS, 1995, PAIN, V61, P139, DOI 10.1016/0304-3959(94)00164-A; Sobenin IA, 2008, ACTA DIABETOL, V45, P1, DOI 10.1007/s00592-007-0011-x; Sunter WH, 1991, PHARM J, V246, P722; Taylor JR, 1999, ANN PHARMACOTHER, V33, P426, DOI 10.1345/aph.18238; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2013, WHO TRAD MED STRAT 2; World Health Organization, TRAD COMPL INT MED; Young HY, 2006, AM J CHINESE MED, V34, P545, DOI 10.1142/S0192415X06004089	30	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245163	10.1371/journal.pone.0245163	http://dx.doi.org/10.1371/journal.pone.0245163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556053	Green Published, gold			2022-12-26	WOS:000617531400001
J	Gaume, J; Grazioli, VS; Paroz, S; Fortini, C; Bertholet, N; Daeppen, JB				Gaume, Jacques; Grazioli, Veronique S.; Paroz, Sophie; Fortini, Cristiana; Bertholet, Nicolas; Daeppen, Jean-Bernard			Developing a brief motivational intervention for young adults admitted with alcohol intoxication in the emergency department - Results from an iterative qualitative design	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEAVY DRINKING; COLLEGE DRINKERS; REDUCE DRINKING; SUBSTANCE USE; SEX RISK; FEEDBACK; MEN; ADOLESCENTS; BEHAVIORS	Background Unhealthy alcohol use among young adults is a major public health concern. Brief motivational interventions for young adults in the Emergency Department (ED) have shown promising but inconsistent results. Methods Based on the literature on brief intervention and motivational interviewing efficacy and active ingredients, we developed a new motivational intervention model for young adults admitted in the ED with alcohol intoxication. Using an iterative qualitative design, we first pre-tested this model by conducting 4 experimental sessions and 8 related semi-structured interviews to evaluate clinicians' and patients' perceptions of the intervention's acceptability and feasibility. We then conducted a consultation meeting with 9 international experts using a nominal group technique. The intervention model was adjusted and finally re-tested by conducting 6 new experimental sessions and 12 related semi-structured interviews. At each round, data collected were analyzed and discussed, and the intervention model updated accordingly. Results Based on the literature, we found 6 axes for developing a new model: High level of relational factors (e.g. empathy, alliance, avoidance of confrontation); Personalized feedback; Enhance discrepancy; Evoke change talk while softening sustain talk, strengthen ability and commitment to change; Completion of a change plan; Devote more time: longer sessions and follow-up options (face-to-face, telephone, or electronic boosters; referral to treatment). A qualitative analysis of the semi-structured interviews gave important insights regarding acceptability and feasibility of the model. Adjustments were made around which information to provide and how, as well as on how to deepen discussion about change with patients having low levels of self-exploration. The experts' consultation addressed numerous points, such as information and advice giving, and booster interventions. Discussion This iterative, multi-component design resulted in the development of an intervention model embedded in recent research findings and theory advances, as well as feasible in a complex environment. The next step is a randomized controlled trial testing the efficacy of this model.	[Gaume, Jacques; Grazioli, Veronique S.; Paroz, Sophie; Fortini, Cristiana; Bertholet, Nicolas; Daeppen, Jean-Bernard] Lausanne Univ Hosp, Dept Psychiat, Addict Med, Lausanne, Switzerland; [Grazioli, Veronique S.] Univ Ctr Gen Med & Publ Hlth, Dept Vulnerabil & Social Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Gaume, J (corresponding author), Lausanne Univ Hosp, Dept Psychiat, Addict Med, Lausanne, Switzerland.	jacques.gaume@chuv.ch	Fortini, Cristiana/ABH-7985-2020	Fortini, Cristiana/0000-0002-3618-2470; fortini, cristiana/0000-0001-6090-3584; Bertholet, Nicolas/0000-0001-5064-6377; Gaume, Jacques/0000-0002-9149-0994	Swiss National Science Foundation [105319_163123]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant 105319_163123 (PI: JG), http://p3.snf.ch/project163123#.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2016, ALCOHOL ALCOHOLISM, V51, P567, DOI 10.1093/alcalc/agw035; Amrhein PC, 2003, J CONSULT CLIN PSYCH, V71, P862, DOI 10.1037/0022-006X.71.5.862; Apodaca TR, 2009, ADDICTION, V104, P705, DOI 10.1111/j.1360-0443.2009.02527.x; Baer JS, 2008, PSYCHOL ADDICT BEHAV, V22, P570, DOI 10.1037/a0013022; Barnett E, 2014, PSYCHOL ADDICT BEHAV, V28, P1212, DOI 10.1037/a0036227; Bertholet N, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13982; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Boardman T, 2006, J SUBST ABUSE TREAT, V31, P329, DOI 10.1016/j.jsat.2006.05.006; Carey KB, 2007, ADDICT BEHAV, V32, P2469, DOI 10.1016/j.addbeh.2007.05.004; Carey KB, 2012, CLIN PSYCHOL REV, V32, P690, DOI 10.1016/j.cpr.2012.08.001; Catley D, 2006, BEHAV COGN PSYCHOTH, V34, P43, DOI 10.1017/S1352465805002432; Celio MA, 2017, ADDICT RES THEORY, V25, P318, DOI 10.1080/16066359.2016.1276902; Cowell AJ, 2012, J STUD ALCOHOL DRUGS, V73, P226, DOI 10.15288/jsad.2012.73.226; Crits-Christoph P., 1991, PSYCHOTHER RES, V1, P2, DOI [DOI 10.1080/10503309112331335511, 10.1080/10503309112331335511]; Darker C, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1082-4; Field C, 2014, ANN SURG, V259, P873, DOI 10.1097/SLA.0000000000000339; Gaume J, 2008, ALCOHOL ALCOHOLISM, V43, P62, DOI 10.1093/alcalc/agm141; Gaume J, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00108; Gaume J, 2014, ALCOHOL CLIN EXP RES, V38, P2138, DOI 10.1111/acer.12469; Gaume J, 2013, J SUBST ABUSE TREAT, V44, P177, DOI 10.1016/j.jsat.2012.04.005; Gaume J, 2009, J SUBST ABUSE TREAT, V37, P151, DOI 10.1016/j.jsat.2008.12.001; Gunasekara FI, 2011, NEW ZEAL MED J, V124, P14; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Juarez P, 2006, J DRUG EDUC, V36, P233, DOI 10.2190/753N-8242-727T-G63L; Kaner EFS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Longabaugh R, 2011, CURR PSYCHIAT REP, V13, P382, DOI 10.1007/s11920-011-0220-4; Lundahl B, 2009, J CLIN PSYCHOL, V65, P1232, DOI 10.1002/jclp.20638; Magill M, 2014, J CONSULT CLIN PSYCH, V82, P973, DOI 10.1037/a0036833; Magill M, 2010, J SUBST ABUSE TREAT, V38, P299, DOI 10.1016/j.jsat.2009.12.001; Mastroleo NR, 2019, ADDICT RES THEORY, V27, P85, DOI 10.1080/16066359.2018.1444159; McCambridge J, 2014, ADDICTION, V109, P1054, DOI 10.1111/add.12388; McCambridge J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000413; McMillan SS, 2016, INT J CLIN PHARM-NET, V38, P655, DOI 10.1007/s11096-016-0257-x; McNally AM, 2005, PSYCHOL ADDICT BEHAV, V19, P79, DOI 10.1037/0893-164X.19.1.79; Miller J, 2013, STRUCTURES OF LAW AND LITERATURE: DUTY, JUSTICE, AND EVIL IN THE CULTURAL IMAGINATION, P3; Miller WR, 2015, ADDICTION, V110, P401, DOI 10.1111/add.12693; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; MILLER WR, 1993, J CONSULT CLIN PSYCH, V61, P455, DOI 10.1037/0022-006X.61.3.455; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; Moyers TB, 2005, J CONSULT CLIN PSYCH, V73, P590, DOI 10.1037/0022-006X.73.4.590; Moyers TB, 2013, PSYCHOL ADDICT BEHAV, V27, P878, DOI 10.1037/a0030274; Moyers TB, 2009, J CONSULT CLIN PSYCH, V77, P1113, DOI 10.1037/a0017189; Murphy JG, 2004, J STUD ALCOHOL, V65, P200, DOI 10.15288/jsa.2004.65.200; Newton AS, 2013, PEDIATR EMERG CARE, V29, P673, DOI 10.1097/PEC.0b013e31828ed325; Nilsen P, 2008, J SUBST ABUSE TREAT, V35, P184, DOI 10.1016/j.jsat.2007.09.008; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Rehm J, 2011, ALCOHOL RES HEALTH, V34, P135; SCHUCKIT MA, 1995, J STUD ALCOHOL, V56, P218, DOI 10.15288/jsa.1995.56.218; Smith AJ, 2003, ADDICTION, V98, P43, DOI 10.1046/j.1360-0443.2003.00251.x; Sommers MS, 2013, ALCOHOL CLIN EXP RES, V37, P1753, DOI 10.1111/acer.12142; Spirito A, 2004, J PEDIATR-US, V145, P396, DOI 10.1016/j.jpeds.2004.04.057; Stead M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4256-1; Taggart IH, 2013, J EMERG MED, V45, P962, DOI 10.1016/j.jemermed.2013.05.065; Tanner-Smith EE, 2015, J SUBST ABUSE TREAT, V51, P1, DOI 10.1016/j.jsat.2014.09.001; Tevyaw TO, 2004, ADDICTION, V99, P63, DOI 10.1111/j.1360-0443.2004.00855.x; Verelst S, 2012, ALCOHOL ALCOHOLISM, V47, P433, DOI 10.1093/alcalc/ags035; Walters ST, 2009, J CONSULT CLIN PSYCH, V77, P64, DOI 10.1037/a0014472; Walton MA, 2008, J STUD ALCOHOL DRUGS, V69, P550, DOI 10.15288/jsad.2008.69.550; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	61	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246652	10.1371/journal.pone.0246652	http://dx.doi.org/10.1371/journal.pone.0246652			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556153	Green Published, gold			2022-12-26	WOS:000617379900012
J	Oso, OG; Odaibo, AB				Oso, Opeyemi G.; Odaibo, Alex B.			Land use/land cover change, physico-chemical parameters and freshwater snails in Yewa North, Southwestern Nigeria	PLOS ONE			English	Article							POPULATION-DYNAMICS; SCHISTOSOMA-HAEMATOBIUM; BILHARZIA TRANSMISSION; BULINUS-GLOBOSUS; OGUN STATE; RIVER; EPIDEMIOLOGY; ECOLOGY; COMMUNITY; AREA	The management of ecosystem has been a major contributor to the control of diseases that are transmitted by snail intermediate hosts. The ability of freshwater snails to self-fertilize, giving rise to thousands of hatchlings, enables them to contribute immensely to the difficulty in reducing the endemicity of some infections in the world. One of the effects of land use/land cover change (LU/LCC) is deforestation, which, in turn, leads to the creation of suitable habitats for the survival of freshwater snails. This study was aimed at studying the land use/land cover change, physico-chemical parameters of water bodies and to understand the interplay between them and freshwater snails in an environment where a new industrial plant was established. Landsat TM, 1984, Landsat ETM+ 2000 and Operational land Imager (OLI) 2014 imageries of the study area were digitally processed using ERDAS Imagine. The land use classification includes settlement, water bodies, wetlands, vegetation and exposed surface. Dissolved oxygen, water temperature, pH, total dissolved solids and conductivity were measured with multipurpose digital meters. Snail sampling was done at each site for 30 minutes along the littoral zones, using a long-handled scoop (0.2mm mesh size) net once every month for 24 months. Independent t-test was used to determine the variation between seasons, Spearman's rank correlation coefficient was used to test the relationship between physico-chemical parameters and snail species while regression was used to analyze the relationship between LU/LCC and freshwater snails. Species' richness, diversity and evenness were examined using Margalef, Shannon Weiner and Equitability indexes. Snail species recovered include: Bulinus globosus, Bulinus jousseaumei, Bulinus camerunensis, Bulinus senegalensis, Bulinus forskalii, Amerianna carinatus, Ferrissia spp., Segmentorbis augustus, Lymnaea natalensis, Melanoides tuberculata, Physa acuta, Gyraulus costulatus, Indoplanorbis exuxtus and Gibbiella species. Out of the total snails recovered, M. tuberculata (2907) was the most abundant, followed by Lymnaea natalensis (1542). The highest number of snail species was recovered from Iho River while the least number of snails was recovered from Euro River. The mean and standard deviation of physico-chemical parameters of the water bodies were DO (2.13 +/- 0.9 mg/L), pH (6.80 +/- 0.4), TDS (50.58 +/- 18.8 mg/L), Temperature (26.2 +/- 0.9 degrees C) and Conductivity (74.00 +/- 27.5 mu S/cm). There was significant positive correlation between pH and B. globosus (r = 0.439; P<0.05). Dissolved oxygen showed significant positive correlation with B. globosus (r = 0.454; P<0.05) and M. tuberculata (r = 0.687; P<0.01). There was a positive significant relationship between LULCC and B. camerunensis (p<0.05). The positive relationship between LULCC and the abundance of B. globosus, B. jousseaumei was not significant. The area covered by water bodies increased from 3.72 to 4.51 kilometers; this indicates that, more suitable habitats were being created for the multiplication of freshwater snails. We therefore conclude that, increase in areas suitable for the survival of freshwater snails could lead to an increase in water-borne diseases caused by the availability of snail intermediate hosts.	[Oso, Opeyemi G.; Odaibo, Alex B.] Univ Ibadan, Parasitol Res Unit, Dept Zool, Ibadan, Nigeria	University of Ibadan	Oso, OG (corresponding author), Univ Ibadan, Parasitol Res Unit, Dept Zool, Ibadan, Nigeria.	opeyemi.immaculate@gmail.com			Wellcome Trust Funded Institute of Infectious Disease of Poverty (IIDP)	Wellcome Trust Funded Institute of Infectious Disease of Poverty (IIDP)	The authors acknowledge the financial support from Wellcome Trust Funded Institute of Infectious Disease of Poverty (IIDP) given to OGO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie H. A., 2014, International Journal of Zoological Research, V10, P42, DOI 10.3923/ijzr.2014.42.58; Akinwale Olaoluwa, 2015, Folia Malacologica, V23, P137, DOI 10.12657/folmal.023.009; [Anonymous], 1996, PRACTICAL THEOLOGY S, V11, P1; [Anonymous], 2015, BMJ, V2015, ph1887; APPLETON CC, 1974, S AFR J SCI, V70, P145; Arimoro FO, 2009, ECOL INDIC, V9, P455, DOI 10.1016/j.ecolind.2008.06.006; ASKEW EW, 1995, AM J CLIN NUTR, V61, p631S, DOI 10.1093/ajcn/61.3.631S; Assessment M.E., 2005, EC HUM WELL BEING SY, P534, DOI [10.1119/1.2344558, DOI 10.1119/1.2344558]; Beecroft G, 1987, POLLUTION MONITORING; BELOT J, 1993, J MOLLUS STUD, V59, P7, DOI 10.1093/mollus/59.1.7; Bird G, 2002, AFRICA ENV OUTLOOK P; Boelee E, 2004, TROP MED INT HEALTH, V9, P997, DOI 10.1111/j.1365-3156.2004.01301.x; Briassoulis H., 2000, WEB BOOK REGIONAL SC; Brown D., 1989, DANISH BILHARZ LAB; Brown D.S., 2002, FRESHWATER SNAILS AF; Byers JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056812; Chen RG, 2003, J NUTR, V133, P2281, DOI 10.1093/jn/133.7.2281; COULIBALY G, 1990, Journal of African Zoology, V104, P201; Cridland C. C., 1955, Journal of Tropical Medicine and Hygiene, V58, P1; Degremont AA, 1973, MANGOKY PROJECT CAMP; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DONNELLY FA, 1984, S AFR J SCI, V80, P455; DONNELLY FA, 1983, INT J PARASITOL, V13, P539, DOI 10.1016/S0020-7519(83)80025-3; Ekpo UF, 2013, GEOSPATIAL HEALTH, V7, P355, DOI 10.4081/gh.2013.92; Emere M., 2000, J BASIC APPL SCI, V9, P17; Emere M. C., 2009, NAT SCI, V7, P1; Fasona MJ, 2005, INT WORKSH HUM SEC C; Ferguson S., 2008, DETERMINANTS TRAVEL; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Geist H, 2005, IHDP NEWSLETTER, V3, P2005; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hassan A, 2012, URINE TURBIDITY MICR; Hussein Mohamed A., 2011, Egyptian Academic Journal of Biological Sciences B Zoology, V3, P11; Ikomi R. B., 2005, ZOOLOGIST, V3, P68; Jonnalagadda SB, 2001, WATER RES, V35, P2371, DOI 10.1016/S0043-1354(00)00533-9; Kariuki HC, 2004, AM J TROP MED HYG, V70, P449; Kinanpara Kone, 2013, Journal of Entomology and Zoology Studies, V1, P110; Lemon SM, 2008, WORKSH SUMM VECT BOR; Levitz S, 2013, ACTA TROP, V128, P284, DOI 10.1016/j.actatropica.2012.10.003; Lillesand T., 2015, REMOTE SENSING IMAGE; Loker ES, 2005, RES MOLLUSCAN INTERM; MADSEN H, 1988, J APPL ECOL, V25, P853, DOI 10.2307/2403751; MARTI HP, 1985, ACTA TROP, V42, P171; McCreesh N, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0503-9; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Molyneux D.H., 2008, SUSTAINING LIFE HUMA, P287; NDIFON GT, 1989, HYDROBIOLOGIA, V171, P231, DOI 10.1007/BF00008146; Ofoezie IE, 1999, HYDROBIOLOGIA, V416, P181, DOI 10.1023/A:1003875706638; Ogbeibu AE, 2002, WATER RES, V36, P2427, DOI 10.1016/S0043-1354(01)00489-4; Okwori A. E. J., 2014, British Microbiology Research Journal, V4, P255; Olofintoye LK, 1999, BIOSCI RES COMMUN, V11, P173; Opisa S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-226; Owojori O, 2006, ECOLOGY FRESHWATER S; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patz J. A., 2005, ECOSYSTEMS HUMAN WEL, P391; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; PESIGAN T P, 1958, Bull World Health Organ, V18, P345; Philipp EER, 2010, GERONTOLOGY, V56, P55, DOI 10.1159/000221004; Poertner H.O., 2005, Fish Physiology, V22, P79; Ramankutty N., 2005, IHDP UPDATE NEWS INT, V3, P4; Roberts DA, 1998, REMOTE SENSING CHANG, V9, P137; Roth O, 2010, MAR BIOL, V157, P1605, DOI 10.1007/s00227-010-1433-5; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; SALADIN B, 1980, ACTA TROP, V37, P53; Salawu OT, 2013, AFR J ECOL, V51, P441, DOI 10.1111/aje.12054; SEYMOUR RS, 1995, HERPETOLOGICA, V51, P369; Simoonga C, 2009, PARASITOLOGY, V136, P1683, DOI 10.1017/S0031182009006222; Smith NF, 2001, OECOLOGIA, V127, P115, DOI 10.1007/s004420000560; Stensgaard AS, 2006, GEOSPATIAL HEALTH, V1, P93, DOI 10.4081/gh.2006.284; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Verburg PH, 2002, ENVIRON MANAGE, V30, P391, DOI 10.1007/s00267-002-2630-x; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; WOOLHOUSE MEJ, 1992, PARASITOLOGY, V104, P443, DOI 10.1017/S0031182000063708; WOOLHOUSE MEJ, 1989, PARASITOLOGY, V98, P21, DOI 10.1017/S0031182000059655; Zheng Jiang, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P291	78	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246566	10.1371/journal.pone.0246566	http://dx.doi.org/10.1371/journal.pone.0246566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556093	Green Published, gold			2022-12-26	WOS:000617379900066
J	Shinozaki, E; Makiyama, A; Kagawa, Y; Satake, H; Tanizawa, Y; Cai, ZH; Piao, YZ				Shinozaki, Eiji; Makiyama, Akitaka; Kagawa, Yoshinori; Satake, Hironaga; Tanizawa, Yoshinori; Cai, Zhihong; Piao, Yongzhe			Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database	PLOS ONE			English	Article							POST-PROGRESSION SURVIVAL; 1ST PROGRESSION; BEVACIZUMAB; OXALIPLATIN; COMBINATION; TRIAL; COLON; FLUOROURACIL; HYPERTENSION; MULTICENTER	The objectives were to describe treatment sequences for advanced colorectal cancer (CRC), use of second-line FOLFIRI (leucovorin, 5-fluorouracil, irinotecan) plus antiangiogenic drug (bevacizumab, ramucirumab, aflibercept beta) therapy, and the factors associated with the duration of antitumor drug treatment from second-line antiangiogenic therapy in Japan. This retrospective observational study was conducted using a Japanese hospital-based administrative database. Patients were enrolled if they started adjuvant therapy (and presumably experienced early recurrence) or first-line treatment for advanced CRC between May 2016 and July 2019, and were analysed until September 2019. Factors associated with overall treatment duration from second-line treatment with FOLFIRI plus antiangiogenic drugs were explored with multivariate Cox regression analysis. The most common first-line treatments were FOLFOX (leucovorin, 5-fluorouracil, oxaliplatin) or CAPOX (capecitabine, oxaliplatin) with bevacizumab (presumed RAS-mutant CRC) and FOLFOX with panitumumab (presumed RAS-wild type CRC). The most common second-line treatments were FOLFIRI-based. Many patients did not transition to subsequent lines of therapy. For second-line treatment, antiangiogenic drugs were prescribed more often for patients with presumed RAS-mutant CRC, right-sided CRC, and independent activities of daily living (ADL). The median duration of second-line FOLFIRI plus antiangiogenic drug treatment was 4.5 months; 66.2% of patients transitioned to third-line therapy. Low body mass index and not fully independent ADL were significantly associated with shorter overall duration of antitumor drug treatment from second-line therapy. Left-sided CRC, presumed RAS-wild type CRC, previous use of oral fluoropyrimidines and use of proteinuria qualitative tests, antihypertensives, or anticholinergics during second-line therapy were significantly associated with longer treatment. Treatment of advanced CRC in Japan is consistent with both international and Japanese guidelines, but transition rates to subsequent therapies need improvement. In addition to antitumor drug treatment, better ADL, higher body mass index, management of hypertension, and proteinuria tests were associated with continuation of sequential therapy that included antiangiogenic drugs.	[Shinozaki, Eiji] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Tokyo, Japan; [Makiyama, Akitaka] Gifu Univ Hosp, Canc Ctr, Gifu, Japan; [Kagawa, Yoshinori] Osaka Gen Med Ctr, Dept Gastroenterol Surg, Osaka, Japan; [Satake, Hironaga] Kansai Med Univ Hosp, Canc Treatment Ctr, Osaka, Japan; [Tanizawa, Yoshinori; Cai, Zhihong; Piao, Yongzhe] Eli Lilly Japan KK, Med Dev Unit Japan, Kobe, Hyogo, Japan	Japanese Foundation for Cancer Research; Gifu University; Kansai Medical University; Eli Lilly	Tanizawa, Y (corresponding author), Eli Lilly Japan KK, Med Dev Unit Japan, Kobe, Hyogo, Japan.	tanizawa_yoshinori@lilly.com	Satake, Hironaga/G-6243-2013	Satake, Hironaga/0000-0001-7629-6803; cai, zhihong/0000-0002-3431-197X; Tanizawa, Yoshinori/0000-0002-5014-2483	Eli Lilly Japan K.K. - Eli Lilly Japan K.K	Eli Lilly Japan K.K. - Eli Lilly Japan K.K	This study was sponsored by Eli Lilly Japan K.K., manufacturer/licensee of ramucirumab. Medical writing assistance provided by Serina Stretton, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe - Envision Pharma Group was funded by Eli Lilly Japan K.K. The funder provided support in the form of salaries for authors (YT, ZC, and YP) and was involved in the study design, data collection, data analysis, preparation of the manuscript, and in the decision to publish.	Amna M. T. Abdullah, 2015, INT J COMPUT NETWORK, V7, P19; Baba H, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2016-000135; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Boyko EJ, 2013, J DIABETES COMPLICAT, V27, P642, DOI 10.1016/j.jdiacomp.2013.07.007; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ciombor KK, 2018, ONCOLOGIST, V23, P25, DOI 10.1634/theoncologist.2017-0203; Denda T, 2019, CANCER SCI, V110, P1032, DOI 10.1111/cas.13943; Dotan E, 2012, J NATL COMPR CANC NE, V10, P213, DOI 10.6004/jnccn.2012.0020; Fessele KL, 2018, SEMIN ONCOL NURS, V34, P168, DOI 10.1016/j.soncn.2018.03.008; Fukuda Naoki, 2018, Oncotarget, V9, P15219, DOI 10.18632/oncotarget.24635; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Hamnvik OPR, 2015, CANCER-AM CANCER SOC, V121, P311, DOI 10.1002/cncr.28972; Hashiguchi Y, 2020, INT J CLIN ONCOL, V25, P1, DOI 10.1007/s10147-019-01485-z; Holch JW, 2017, EUR J CANCER, V70, P87, DOI 10.1016/j.ejca.2016.10.007; Iizumi S, 2018, CANCER CHEMOTH PHARM, V81, P981, DOI 10.1007/s00280-018-3569-9; Imai H, 2017, THORAC CANCER, V8, P379, DOI 10.1111/1759-7714.12463; Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001; Kubicka S, 2013, ANN ONCOL, V24, P2342, DOI 10.1093/annonc/mdt231; Lafayette RA, 2014, AM J NEPHROL, V40, P75, DOI 10.1159/000365156; Lee MKC, 2019, CURR ONCOL, V26, pS7, DOI 10.3747/co.26.5719; Lim HH, 2019, TARGET ONCOL, V14, P743, DOI 10.1007/s11523-019-00683-z; Maiello E, 2017, ANN ONCOL, V28, P16; Matsuda S, 2010, ASIAN PACIFIC J DIS, V4, P55, DOI DOI 10.7223/APJDM.4.55; McMahon AD, 2000, BRIT J CLIN PHARMACO, V50, P419, DOI 10.1046/j.1365-2125.2000.00289.x; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; Ministry of Health Labour and Welfare, 2016, OV NAT CANC REG 2016; Ministry of Health Labour and Welfare. Cancer Information Service National Cancer Center Japan., CANC REG STAT VIT ST; Nakamura M., 2016, JAP J PHARMACOEPIDEM, V21, P23, DOI [10.3820/jjpe.21.23, DOI 10.3820/JJPE.21.23]; Nakayama G, 2012, CANCER CHEMOTH PHARM, V70, P575, DOI 10.1007/s00280-012-1948-1; Petrelli F, 2013, ANN ONCOL, V24, P186, DOI 10.1093/annonc/mds289; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Price TJ, 2013, EXPERT REV ANTICANC, V13, P597, DOI [10.1586/ERA.13.37, 10.1586/era.13.37]; Roviello Giandomenico, 2018, Oncotarget, V9, P22332, DOI 10.18632/oncotarget.24900; Tabernero J, 2015, LANCET ONCOL, V16, P499, DOI 10.1016/S1470-2045(15)70127-0; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Wade D T, 1988, Int Disabil Stud, V10, P64; Yamada Y, 2018, ANN ONCOL, V29, P624, DOI 10.1093/annonc/mdx816; Yoshihiro T, 2019, INT J CLIN ONCOL, V24, P508, DOI 10.1007/s10147-018-01391-w; Zhang CJ, 2018, AGING-US, V10, P1424, DOI 10.18632/aging.101478	41	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246160	10.1371/journal.pone.0246160	http://dx.doi.org/10.1371/journal.pone.0246160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556095	Green Published, gold			2022-12-26	WOS:000617379900071
J	Agutu, CA; Oduor, TH; Kombo, BK; Mugo, PM; Chira, SM; Ogada, FW; de Wit, TFR; Chege, W; van der Elst, EM; Graham, SM; Sanders, EJ				Agutu, Clara A.; Oduor, Tony H.; Kombo, Bernadette K.; Mugo, Peter M.; Chira, Salome M.; Ogada, Fred W.; de Wit, Tobias F. Rinke; Chege, Wairimu; van der Elst, Elise M.; Graham, Susan M.; Sanders, Eduard J.			High patient acceptability but low coverage of provider-initiated HIV testing among adult outpatients with symptoms of acute infectious illness in coastal Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEEKING CARE; PREVALENT	Background Only approximately one in five adults are offered HIV testing by providers when seeking care for symptoms of acute illness in Sub-Saharan Africa. Our aims were to estimate testing coverage and identify predictors of provider-initiated testing and counselling (PITC) and barriers to PITC implementation in this population. Methods We assessed HIV testing coverage among adult outpatients 18-39 years of age at four public and two private health facilities in coastal Kenya, during a 3- to 6-month surveillance period at each facility. A subset of patients who reported symptoms including fever, diarrhoea, fatigue, body aches, sore throat or genital ulcers were enrolled to complete a questionnaire independently of PITC offer. We assessed predictors of PITC in this population using generalised estimating equations and identified barriers to offering PITC through focus group discussion with healthcare workers (HCW) at each facility. Results Overall PITC coverage was 13.7% (1600 of 11,637 adults tested), with 1.9% (30) testing positive. Among 1,374 participants enrolled due to symptoms, 378 (27.5%) were offered PITC and 352 (25.6%) were tested, of whom 3.7% (13) tested positive. Among participants offered HIV testing, 93.1% accepted it; among participants not offered testing, 92.8% would have taken an HIV test if offered. The odds of completed PITC were increased among older participants (adjusted odds ratio [aOR] 1.7, 95% confidence interval [CI] 1.4-2.1 for 30-39 years, relative to 18-24 years), men (aOR 1.3, 95% CI 1.1-1.7); casual labourers (aOR 1.3, 95% CI 1.0-1.7); those paying by cash (aOR 1.2, 95% CI 1.0-1.4) or insurance (aOR 3.0, 95% CI 1.5-5.8); participants with fever (aOR 1.5, 95% CI 1.2-1.8) or genital ulcers (aOR 4.0, 95% CI 2.7-6.0); and who had tested for HIV >1 year ago (aOR 1.4, 95% CI 1.0-2.0) or had never tested (aOR 2.2, 95% CI 1.5-3.1). Provider barriers to PITC implementation included lack of HCW knowledge and confidence implementing guidelines, limited capacity and health systems constraints. Conclusion PITC coverage was low, though most patients would accept testing if offered. Missed opportunities to promote testing during care-seeking were common and innovative solutions are needed.	[Agutu, Clara A.; Oduor, Tony H.; Kombo, Bernadette K.; Mugo, Peter M.; Chira, Salome M.; Ogada, Fred W.; van der Elst, Elise M.; Graham, Susan M.; Sanders, Eduard J.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [de Wit, Tobias F. Rinke; Sanders, Eduard J.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Chege, Wairimu] NIAID, Prevent Sci Program, Div AIDS DAIDS, NIH, Rockville, MD USA; [Graham, Susan M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan M.] Univ Washington, Dept Med, Seattle, WA USA; [Graham, Susan M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford	Agutu, CA (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.	CAgutu@kemri-wellcome.org		Agutu, Clara/0000-0003-1053-4463; Graham, Susan/0000-0001-7847-8686	U.S. National Institutes of Health [R01AI124968]; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) from the Wellcome Trust [107752/Z/15/Z]; UK government; University of Washington/Fred Hutch Center for AIDS Research, an NIH-funded program [AI027757]; NIH Institutes and Centers: NIAID; NIMH; NICHD; NHLBI; NIA; NIGMS; NIDDK	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) from the Wellcome Trust; UK government; University of Washington/Fred Hutch Center for AIDS Research, an NIH-funded program; NIH Institutes and Centers: NIAID; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Tambua Mapema Plus study was funded by the U.S. National Institutes of Health [grant R01AI124968]. CAA was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant #DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government. SMG was also supported by the University of Washington/Fred Hutch Center for AIDS Research, an NIH-funded program under award number AI027757 which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK.; The authors are grateful to all the study participants and staff at the participating Tambua Mapema health facilities in Kilifi and Mombasa counties. We especially want to acknowledge the Tambua Mapema Study field team including Salome Chira, Fred Ogadah, Elizabeth Njogu, Aisha Galole, Joyce Shikuku, Bevan Wynes, Nancy Opiyo, Elizabeth Auma, Isaac Menza, Margaret Nunah and Chadrick Omondi, involved in participant recruitment, data collection and the general conduct of the study. We thank both the research team and support staff at the KEMRI Mtwapa Research Clinic and at KEMRI Wellcome Trust Research Programme, Kilifi for their continued support. We thank Benedict Orindi for providing guidance on the statistical analysis, and Jacinta Nzinga, for the qualitative analysis. We also wish to extend our gratitude to the Mombasa and Kilifi county governments of health for their support of our research activities. We thank the National AIDS and STI Control Program (NASCOP) particularly, Mary Mugambi, Violet Oramisi and Ahmed Fidhow for their assistance with national and county level testing data.	Ahmed S, 2016, TROP MED INT HEALTH, V21, P479, DOI 10.1111/tmi.12671; Ahmed S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-015-0361-7; [Anonymous], 2007, MANUAL ESTIMATING NA; Autistic Self Advocacy Network, 2021, WHO REC HIV SELF TES; Bebell LM, 2010, AIDS, V24, P1945, DOI 10.1097/QAD.0b013e32833bb732; Castro FG, 2010, J MIX METHOD RES, V4, P342, DOI 10.1177/1558689810382916; Cham HJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215654; De Cock KM, 2019, AIDS, V33, P349, DOI [10.1097/qad.0000000000002096, 10.1097/QAD.0000000000002096]; Dovel K, 2020, LANCET GLOB HEALTH, V8, pE276, DOI 10.1016/S2214-109X(19)30534-0; Evans C, 2011, AIDS CARE, V23, P1291, DOI 10.1080/09540121.2011.555751; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gichangi A, 2018, JAIDS-J ACQ IMM DEF, V79, P467, DOI 10.1097/QAI.0000000000001838; Graham SM, 2020, JMIR RES PROTOC, V9, DOI 10.2196/16198; Green J, 2013, QUALITATIVE METHODS; Havlir D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25455; Health Mo, 2019, KEN HLTH INF SYST KH, P2019; Hecht L, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0616-2; Inghels M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185117; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Kayigamba FR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1355-z; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Liamputtong P., 2011, FOCUS GROUP METHODOL, P87, DOI [10.4135/9781473957657., DOI 10.4135/9781473957657]; Mabuto T, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25367; Macharia PM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2489-9; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; McNaghten AD, 2015, JAIDS-J ACQ IMM DEF, V70, pE140, DOI 10.1097/QAI.0000000000000785; Ministry of Health National AIDS Control Council (MoH), 2018, KEN AIDS PROGR REP 2; Mwangala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143075; NASCOP, 2020, KEN POP BAS HIV IMP; NASCOP, 2018, KENPHIA 2018 PREL RE; NASCOP, 2012, ACH UN ACC KNOWL HIV; NASCOP, 2018, GUID ANT DRUGS TREAT; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; National AIDS and STI Control Programme (NASCOP), 2015, KEN HIV TEST SERV GU; National AIDS and STI Control Programme (NASCOP) Ministry of Health Kenya, 2008, NAT GUID HIV TEST CO; National AIDS & STI Control Program(NASCOP), 2017, HIV SELF TEST OP MAN; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Prins HAB, 2014, INT HEALTH, V6, P82, DOI 10.1093/inthealth/ihu024; Quinn C, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25398; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Sanders EJ, 2019, AIDS, V33, P923, DOI 10.1097/QAD.0000000000002110; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; Sanders EJ, 2014, AIDS, V28, P1357, DOI 10.1097/QAD.0000000000000245; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2019, HIV TEST SERV DASHB; WHO, 2016, HIV SELF TEST PARTN; World_Health_Organization, 2020, CONSOLIDATED GUIDELI; Yumo HA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214251	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246444	10.1371/journal.pone.0246444	http://dx.doi.org/10.1371/journal.pone.0246444			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544736	gold, Green Published			2022-12-26	WOS:000617991900056
J	Nir, N; Knitter, D; Hardt, J; Schutt, B				Nir, Nadav; Knitter, Daniel; Hardt, Jacob; Schuett, Brigitta			Human movement and gully erosion: Investigating feedback mechanisms using Frequency Ratio and Least Cost Path analysis in Tigray, Ethiopia	PLOS ONE			English	Article							GEOMORPHIC THRESHOLD CONDITIONS; SEDIMENT PRODUCTION; NORTHERN HORN; RIVER-BASIN; LAND-USE; SOIL; AFRICA; ROADS; ARCHAEOLOGY; SURFACES	The cost of human movement, whether expressed in time, effort, or distance, is a function of natural and human related variables. At the same time, human movement itself, whether on land, air or sea, causes environmental cost. We are looking into the long-term environmental relationship of this interplay. Gullies-linear landforms, which dissect the landscape-are considered to be a cost for human movement, as they can form unpassable barriers destroying present path networks. On the other hand, human movement creates pathways, which flatten the surface and decrease the water permeability potential. This process results in runoff generation and possibly gully erosion. Accordingly, the spatial relationship between pathways and gullies is investigated. In the Tigray region of the Northern Ethiopian Highlands, gullies and pathways were mapped using remote sensing data. Frequency Ratio was used for assessing pathways as a variable affecting the location of gullies while Least Cost Paths were tested to evaluate the possible constraining impact gullies have on mobility. Based on these results, it is concluded that a positive feedback exists between the cost of human movement and gully erosion. We further discuss possible effects gullies may have had on trade, territory, and political affairs in Tigray. Consequently, we suggest that movement cost and gullying may not only hold strictly environmental or movement-related implications, but also socio-cultural ones.	[Nir, Nadav; Hardt, Jacob; Schuett, Brigitta] Free Univ Berlin, Inst Geog Sci, Berlin, Germany; [Knitter, Daniel] Christian Albrechts Univ Kiel, Dept Geog, Phys Geog, Kiel, Germany	Free University of Berlin; University of Kiel	Nir, N (corresponding author), Free Univ Berlin, Inst Geog Sci, Berlin, Germany.	nadav.nir@fu-berlin.de	Hardt, Jacob/AAO-1516-2020; Nir, nadav/AFN-4347-2022; Knitter, Daniel/N-7516-2015	Hardt, Jacob/0000-0001-8485-2232; , nadav/0000-0003-0413-9205; Knitter, Daniel/0000-0003-3014-4497	Studienstiftung des Deutschen Volkes; DFG [SPP 2143, DFG 361129650, Schu949/17-1]; Freie Universitat Berlin	Studienstiftung des Deutschen Volkes; DFG(German Research Foundation (DFG)); Freie Universitat Berlin	This study was supported by the Studienstiftung des Deutschen Volkes (https://www.studienstiftung.de), by the DFG project Routes of Interaction: Interregional Contacts between the Northern Horn of Africa and the Nile Region-subproject of SPP 2143: Entangled Africa (grant number DFG 361129650; Schu949/17-1; https://gepris.dfg.de/gepris/projekt/361129650? language=en), and by the open access publication fund of the Freie Universitat Berlin.	Agostinelli C., 2013, R PACKAGE CIRCULAR C; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2001, DRUG SAFETY UPDATE, V5, pA1; Arabameri A, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7808-5; Arabarneri A, 2019, CATENA, V183, DOI 10.1016/j.catena.2019.104223; Asrat A, 2003, J STRUCT GEOL, V25, P1451, DOI 10.1016/S0191-8141(02)00182-7; Aune J.B., 1997, PROJECT REV RAMA INT; BAILEY GN, 1983, J ARCHAEOL SCI, V10, P87, DOI 10.1016/0305-4403(83)90044-4; Barbosa H, 2018, PHYS REP, V734, P1, DOI 10.1016/j.physrep.2018.01.001; Bard KA, 2000, AFR ARCHAEOL REV, V17, P65, DOI DOI 10.1023/A:1006630609041; Bennett SJ, 2000, T ASAE, V43, P641, DOI 10.13031/2013.2745; Berhane A, 2020, ETHIOPIA ENV SYST RE, V9, P1, DOI [10.1186/s40068-020-00165-6, DOI 10.1186/S40068-020-00165-6]; Bertazzini M.C., 2018, J EC GEOGRAPHY; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Beyth M., 1971, UNPUB; Billi P., 2015, LANDSCAPES LANDFORMS; Buchanan BP, 2014, HYDROL EARTH SYST SC, V18, P3279, DOI 10.5194/hess-18-3279-2014; Butzer KW, 1982, ARCHAEOLOGY HUMAN EC; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Clapham C., 2007, J ETHIOPIAN STUDIES, V40, P293; Coltorti M, 2007, GEOMORPHOLOGY, V89, P287, DOI 10.1016/j.geomorph.2006.12.007; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Contenson H.D., 1963, ETHIOPIE, V5, P41; Contenson H.d., 1961, ETHIOPIE, V4, P39; Curtis MC, 2009, AFR ARCHAEOL REV, V26, P327, DOI 10.1007/s10437-009-9062-4; Dagnew DC, 2017, ECOHYDROL HYDROBIOL, V17, P274, DOI 10.1016/j.ecohyd.2017.07.004; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; Dewitte O, 2013, GEODERMA, V211, P138, DOI 10.1016/j.geoderma.2013.07.007; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dixon B, 2009, HYDROL PROCESS, V23, P1714, DOI 10.1002/hyp.7306; Ekshtain R, 2017, GEOARCHAEOLOGY, V32, P189, DOI 10.1002/gea.21585; Faccenna C, 2019, NAT GEOSCI, V12, P1012, DOI 10.1038/s41561-019-0472-x; FAO Forest Department, 2010, FRA2010065 FAO FOR D; Fattovich R., 2012, RASSEGNA STUDI ETIOP, V4, P1; Fattovich R., 2001, ANN DETHIOPIE, V17, P3; Fattovich R, 2010, J WORLD PREHIST, V23, P145, DOI 10.1007/s10963-010-9035-1; Fattovich R, 2009, AFR ARCHAEOL REV, V26, P275, DOI 10.1007/s10437-009-9063-3; Featherstone M., 1997, GLOBAL HIST MIGRATIO, P239; Finneran N., 2007, ARCHAEOLOGY ETHIOPIA; Frankl A, 2013, GEOMORPHOLOGY, V201, P254, DOI 10.1016/j.geomorph.2013.06.025; French C, 2009, CATENA, V78, P218, DOI 10.1016/j.catena.2009.02.010; GDAL/OGR contributors, 2020, GDAL OGR GEOSP DAT A; Gebrehiwot T., 2013, Journal of Development and Agricultural Economics, V5, P104; Gebremariam S., 2009, THESIS; Ghemawat P, 2001, HARVARD BUS REV, V79, P137; Gilbertson JK, 2017, COMPUT ELECTRON AGR, V134, P151, DOI 10.1016/j.compag.2016.12.006; Gilley JE., 2005, ENCY SOILS ENV, P463, DOI DOI 10.1016/B0-12-348530-4/00262-9; Goncalves AB, 2010, INT J GEOGR INF SCI, V24, P983, DOI 10.1080/13658810903401016; Gonzalez-Ruibal A, 2010, INT J HIST ARCHAEOL, V14, P547, DOI 10.1007/s10761-010-0118-6; Gowen KM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239387; GRASS Development Team, 2020, GEOG RES AN SUPP SYS; Haburaj V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238894; Hagos M, 2010, AUSTRIAN J EARTH SCI, V103, P153; Harrower M.J., 2020, AFRICAN ARCHAEOLOGIC, P1; Harrower MJ, 2014, AFR ARCHAEOL REV, V31, P513, DOI 10.1007/s10437-014-9165-4; Henze P.B., 2000, LAYERS TIME, P44; Herzog I., 2010, 38 C COMP APPL QUANT, P431; Hijmans R.J., 2020, RASTER GEOGRAPHIC DA; Hofmann C, 1997, NATURE, V389, P838, DOI 10.1038/39853; Hussain ST, 2016, J ARCHAEOL METHOD TH, V23, P1162, DOI 10.1007/s10816-015-9263-x; Imeson A. C., 1980, Geografisch Tijdschrift, V14, P430; Japp Sarah, 2011, P SEMINAR ARABIAN ST, V41, P145; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kesler DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125113; Kidanmariam G., 2000, USE DONKEYS TRANSPOR, P53; Lamb HF, 2007, QUATERNARY SCI REV, V26, P287, DOI 10.1016/j.quascirev.2006.11.020; Lannoeye W, 2016, PHYS GEOGR, V37, P430, DOI 10.1080/02723646.2016.1234197; Leclant J., 1959, ETHIO, V3, P43, DOI DOI 10.3406/ETHIO.1959.1300; Lee MJ, 2012, INT GEOSCI REMOTE SE, P895, DOI 10.1109/IGARSS.2012.6351414; Leopold L.B., 1992, FLUVIAL PROCESSES GE; LIEBERMAN DE, 1993, CURR ANTHROPOL, V34, P599, DOI 10.1086/204209; Llobera M, 2007, J THEOR BIOL, V249, P206, DOI 10.1016/j.jtbi.2007.07.020; Machado M.J., 2015, LANDSCAPES LANDFORMS, P163; Marshall F., 2007, RETHINKING AGR ARCHA, P371; Marshall MH, 2009, PALAEOGEOGR PALAEOCL, V279, P114, DOI 10.1016/j.palaeo.2009.05.003; Martinez-Casasnovas JA, 2004, GEOMORPHOLOGY, V58, P305, DOI 10.1016/j.geomorph.2003.08.005; Mattivi Pietro, 2019, Open Geospatial Data, Software and Standards, V4, DOI 10.1186/s40965-019-0066-y; Medhin G., 2011, LIVELIHOOD ZONES ANA; Milkias P., 2005, BATTLE ADWA REFLECTI; Mousazadeh F, 2014, PROCD SOC BEHV, V120, P749, DOI 10.1016/j.sbspro.2014.02.158; Nakoinz O., 2016, BASIC CONCEPTS MODEL, DOI [10.1007/978-3-319-29538-1, DOI 10.1007/978-3-319-29538-1]; Natali C, 2013, CONTRIB MINERAL PETR, V166, P351, DOI 10.1007/s00410-013-0879-0; Naumann J, 2010, ADVANCES IN MATHEMATICAL FLUID MECHANICS, P367, DOI 10.1007/978-3-642-04068-9_23; Nyssen J, 2000, LAND DEGRAD DEV, V11, P199, DOI 10.1002/1099-145X(200005/06)11:3<199::AID-LDR376>3.0.CO;2-Y; Nyssen J, 2002, EARTH SURF PROC LAND, V27, P1267, DOI 10.1002/esp.404; Nyssen J, 2004, EARTH-SCI REV, V64, P273, DOI 10.1016/S0012-8252(03)00078-3; Nyssen J., 2020, LIBER AMICORUM PHILI, P165; Paez A, 2020, J TRANSP GEOGR, V82, DOI 10.1016/j.jtrangeo.2019.102564; Panin AV, 2009, GEOMORPHOLOGY, V108, P71, DOI 10.1016/j.geomorph.2008.06.017; Pebesma E.J., 2005, R NEWS, V5, P9; Peykani P., 2018, CLIN DIABETOLOGY, V7, P1, DOI [DOI 10.1016/S1464-2859(18)30228-1, 10.5603/dk.2018.0001]; Pfeiffer Kristina, UNPUB; Pietsch D, 2017, ARCHAEOL ANTHROP SCI, V9, P1571, DOI 10.1007/s12520-014-0180-9; Pietsch D, 2014, Z GEOMORPHOL, V58, P119, DOI 10.1127/0372-8854/2012/S-00114; Poesen J, 2003, CATENA, V50, P91, DOI 10.1016/S0341-8162(02)00143-1; Poudyal CP, 2010, ENVIRON EARTH SCI, V61, P1049, DOI 10.1007/s12665-009-0426-5; QGIS.org, 2020, QGIS GEOGR INF SYST; R Core Team, 2018, R LANG ENV STAT COMP; Rahmati O, 2016, NAT HAZARDS, V82, P1231, DOI 10.1007/s11069-016-2239-7; Raue Dietrich, COMMUNICATION; Ravenstein E.G., 1885, J STAT SOC LONDON, V48, P167; Rees WG, 2004, COMPUT GEOSCI-UK, V30, P203, DOI 10.1016/j.cageo.2003.11.001; Rojas R, 2008, J HYDROL ENG, V13, P793, DOI 10.1061/(ASCE)1084-0699(2008)13:9(793); Rossi C, 2016, FRONT MECH ENG-PRC, V11, P12, DOI 10.1007/s11465-015-0358-6; Roy J, 2019, REMOTE SENS APPL, V15, DOI 10.1016/j.rsase.2019.100247; Samani AN, 2009, J ASIAN EARTH SCI, V35, P180, DOI 10.1016/j.jseaes.2009.02.004; Schutt B., 2005, SUSTAINABLE MANAGEME, P177; Sembroni A, 2017, J MAPS, V13, P621, DOI 10.1080/17445647.2017.1351907; Senanayake S, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12091483; Seutloali KE, 2016, GEOCARTO INT, V31, P225, DOI 10.1080/10106049.2015.1047412; Sidle RC, 2004, HYDROL PROCESS, V18, P703, DOI 10.1002/hyp.1364; Tebebu T.Y., 2009, THESIS; Torri D, 2014, EARTH-SCI REV, V130, P73, DOI 10.1016/j.earscirev.2013.12.006; Valentin C, 2005, CATENA, V63, P132, DOI 10.1016/j.catena.2005.06.001; van Etten J, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i13; Vandaele K, 1996, GEOMORPHOLOGY, V16, P161, DOI 10.1016/0169-555X(95)00141-Q; Vandekerckhove L, 1998, CATENA, V33, P271, DOI 10.1016/S0341-8162(98)00068-X; Vanwalleghem T, 2005, HOLOCENE, V15, P378, DOI 10.1191/0959683605hl807rp; Verhagen P, 2019, COMPUT SOC SCI, P217, DOI 10.1007/978-3-030-04576-0_11; Verheijen FGA, 2009, EARTH-SCI REV, V94, P23, DOI 10.1016/j.earscirev.2009.02.003; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Vita-Finzi C., 1970, PROC PREHISTORIC SOC, V36, P1, DOI [10.1017/S0079497X00013074, DOI 10.1017/S0079497X00013074, 10.1017/ S0079497X00013074]; Wagenbrenner JW, 2015, FOREST ECOL MANAG, V335, P176, DOI 10.1016/j.foreco.2014.09.016; Weber A., 1929, A WEBERS THEORY LOCA; Woldekiros HS, 2019, CHUNGARA, V51, P95, DOI 10.4067/S0717-73562019005000502; Zedeno MN, 2016, HDB LANDSCAPE ARCHAE, P210; Zhang T., 2017, ADV DIFFERENCE EQUAT, V2017, P1; Zhang Y, 2019, AGR ECOSYST ENVIRON, V284, DOI 10.1016/j.agee.2019.106580; Ziegler AD, 2000, EARTH SURF PROC LAND, V25, P519, DOI 10.1002/(SICI)1096-9837(200005)25:5&lt;519::AID-ESP80&gt;3.0.CO;2-T; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	130	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245248	10.1371/journal.pone.0245248	http://dx.doi.org/10.1371/journal.pone.0245248			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544725	Green Published, gold			2022-12-26	WOS:000617991900001
J	Ogura, M; Endo, K; Suzuki, T; Homma, Y				Ogura, Masato; Endo, Kumiko; Suzuki, Toshiyuki; Homma, Yoshimi			Prenylated quinolinecarboxylic acid compound-18 prevents sensory nerve fiber outgrowth through inhibition of the interleukin-31 pathway	PLOS ONE			English	Article							ATOPIC-DERMATITIS; P21-ACTIVATED KINASES; TACROLIMUS OINTMENT; ADULT PATIENTS; NC/NGA MICE; T-CELLS; IL-31; PRURITUS; RECEPTOR; DIFFERENTIATION	Interleukin-31 (IL-31) is involved in excessive development of cutaneous sensory nerves in atopic dermatitis (AD), leading to severe pruritus. We previously reported that PQA-18, a prenylated quinolinecarboxylic acid (PQA) derivative, is an immunosuppressant with inhibition of p21-activated kinase 2 (PAK2) and improves skin lesions in Nc/Nga mice as an AD model. In the present study, we investigate the effect of PQA-18 on sensory nerves in lesional skin. PQA-18 alleviates cutaneous nerve fiber density in the skin of Nc/Nga mice. PQA-18 also inhibits IL-31-induced sensory nerve fiber outgrowth in dorsal root ganglion cultures. Signaling analysis reveals that PQA-18 suppresses phosphorylation of PAK2, Janus kinase 2, and signal transducer and activator of transcription 3 (STAT3), activated by IL-31 receptor (IL-31R), resulting in inhibition of neurite outgrowth in Neuro2A cells. Gene silencing analysis for PAK2 confirms the requirement for STAT3 phosphorylation and neurite outgrowth elicited by IL-31R activation. LC/MS/MS analysis reveals that PQA-18 prevents the formation of PAK2 activation complexes induced by IL-31R activation. These results suggest that PQA-18 inhibits the IL-31 pathway through suppressing PAK2 activity, which suppresses sensory nerve outgrowth. PQA-18 may be a valuable lead for the development of a novel drug for pruritus of AD.	[Ogura, Masato; Endo, Kumiko; Suzuki, Toshiyuki; Homma, Yoshimi] Fukushima Med Univ, Sch Med, Fukushima, Japan	Fukushima Medical University	Ogura, M (corresponding author), Fukushima Med Univ, Sch Med, Fukushima, Japan.	masato57@fmu.ac.jp		Ogura, Masato/0000-0001-9557-5023	Japan Society for the Promotion of Science [18K06702]; Fukushima Medical University [KKI29001-1]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukushima Medical University	This work was funded by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research) [grant number 18K06702 (MO): https://kaken.nii.ac.jp/ja/index/] and Fukushima Medical University (grant for Project Research) [grant number KKI29001-1 (MO)]: https://www.fmu.ac.jp].	Arai I, 2015, EXP DERMATOL, V24, P75, DOI 10.1111/exd.12587; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Ding YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144948; Feld M, 2016, J ALLERGY CLIN IMMUN, V138, P500, DOI 10.1016/j.jaci.2016.02.020; Furue M, 2018, ALLERGY, V73, P29, DOI 10.1111/all.13239; Gochnauer H, 2017, ADV EXP MED BIOL, V1027, P57, DOI 10.1007/978-3-319-64804-0_6; Hanifin JM, 2001, J AM ACAD DERMATOL, V44, pS28, DOI 10.1067/mjd.2001.109810; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kabashima K, 2020, NEW ENGL J MED, V383, P141, DOI 10.1056/NEJMoa1917006; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kasutani K, 2014, BRIT J PHARMACOL, V171, P5049, DOI 10.1111/bph.12823; Kikuchi H, 2015, BIOORGAN MED CHEM, V23, P66, DOI 10.1016/j.bmc.2014.11.024; Kim S, 2011, ANN DERMATOL, V23, P468, DOI 10.5021/ad.2011.23.4.468; Kubohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072118; Kurgonaite K, 2015, J CELL SCI, V128, P3781, DOI 10.1242/jcs.170969; Licciulli S, 2013, J BIOL CHEM, V288, P29105, DOI 10.1074/jbc.M113.510933; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Mack MR, 2018, TRENDS IMMUNOL, V39, P980, DOI 10.1016/j.it.2018.10.001; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Morris R, 2018, PROTEIN SCI, V27, P1984, DOI 10.1002/pro.3519; Newsom M, 2020, DRUGS, V80, P1041, DOI 10.1007/s40265-020-01335-7; Ogura M, 2019, BIOCHEM PHARMACOL, V162, P109, DOI 10.1016/j.bcp.2018.10.008; Ogura M, 2016, BIOCHEM PHARMACOL, V105, P55, DOI 10.1016/j.bcp.2016.01.020; Ogura M, 2014, FEBS LETT, V588, P2837, DOI 10.1016/j.febslet.2014.06.044; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Santiago-Medina M, 2013, J CELL SCI, V126, P1122, DOI 10.1242/jcs.112607; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Soter NA, 2001, J AM ACAD DERMATOL, V44, pS39, DOI 10.1067/mjd.2001.109817; Suzuki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117088; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takaoka A, 2005, EUR J PHARMACOL, V516, P180, DOI 10.1016/j.ejphar.2005.04.040; Wang Y, 2018, CELL REP, V24, P2029, DOI 10.1016/j.celrep.2018.07.061; Welsch K, 2017, EUR J IMMUNOL, V47, P1096, DOI 10.1002/eji.201646680; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Yeo D, 2017, INT J CANCER, V140, P2101, DOI 10.1002/ijc.30615; Yosipovitch G, 2020, J EUR ACAD DERMATOL, V34, P239, DOI 10.1111/jdv.15973; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246630	10.1371/journal.pone.0246630	http://dx.doi.org/10.1371/journal.pone.0246630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539470	Green Published, gold			2022-12-26	WOS:000616960200038
J	Luzuriaga-Neira, A; Sandmeier, FC; Weitzman, CL; Tracy, CR; Bauschlicher, SN; Tillett, RL; Alvarez-Ponce, D				Luzuriaga-Neira, Agusto; Sandmeier, Franziska C.; Weitzman, Chava L.; Tracy, C. Richard; Bauschlicher, Shalyn N.; Tillett, Richard L.; Alvarez-Ponce, David			Mycoplasma agassizii, an opportunistic pathogen of tortoises, shows very little genetic variation across the Mojave and Sonoran Deserts	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; RIBOSOMAL-RNA GENE; GOPHERUS-AGASSIZII; INTRASPECIFIC VARIATION; DISEASE; DIVERSITY; DYNAMICS; PATTERNS; CULTURE; STRAIN	Mycoplasma agassizii is a common cause of upper respiratory tract disease in Mojave desert tortoises (Gopherus agassizii). So far, only two strains of this bacterium have been sequenced, and very little is known about its patterns of genetic diversity. Understanding genetic variability of this pathogen is essential to implement conservation programs for their threatened, long-lived hosts. We used next generation sequencing to explore the genomic diversity of 86 cultured samples of M. agassizii collected from mostly healthy Mojave and Sonoran desert tortoises in 2011 and 2012. All samples with enough sequencing coverage exhibited a higher similarity to M. agassizii strain PS6(T) (collected in Las Vegas Valley, Nevada) than to strain 723 (collected in Sanibel Island, Florida). All eight genomes with a sequencing coverage over 2x were subjected to multiple analyses to detect single-nucleotide polymorphisms (SNPs). Strikingly, even though we detected 1373 SNPs between strains PS6(T) and 723, we did not detect any SNP between PS6(T) and our eight samples. Our whole genome analyses reveal that M. agassizii strain PS6(T) may be present across a wide geographic extent in healthy Mojave and Sonoran desert tortoises.	[Luzuriaga-Neira, Agusto; Tracy, C. Richard; Alvarez-Ponce, David] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Sandmeier, Franziska C.; Bauschlicher, Shalyn N.] Colorado State Univ, Biol Dept, Pueblo, CO 81001 USA; [Weitzman, Chava L.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA USA; [Tillett, Richard L.] Univ Nevada, Nevada Ctr Bioinformat, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Colorado State University; Virginia Polytechnic Institute & State University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Alvarez-Ponce, D (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.; Sandmeier, FC (corresponding author), Colorado State Univ, Biol Dept, Pueblo, CO 81001 USA.	franziska.sandmeier@csupueblo.edu; dap@unr.edu		Bauschlicher, Shalyn/0000-0003-0447-6260; Luzuriaga-Neira, Agusto Rey/0000-0001-5516-9661	US Fish and Wildlife Service [F19AC00070]; Nevada INBRE (National Institute of General Medical Sciences, National Institutes of Health) [P20GM103440]; National Science Foundation [MCB 1818288]	US Fish and Wildlife Service(US Fish & Wildlife Service); Nevada INBRE (National Institute of General Medical Sciences, National Institutes of Health); National Science Foundation(National Science Foundation (NSF))	This work was supported by grant F19AC00070 from the US Fish and Wildlife Service, and partially supported by Nevada INBRE (funded by grant P20GM103440 from the National Institute of General Medical Sciences, National Institutes of Health). AL and DAP were also supported by a grant from the National Science Foundation (MCB 1818288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2013, AM NAT, V181, P674, DOI 10.1086/670024; Aiello CM, 2016, J ANIM ECOL, V85, P829, DOI 10.1111/1365-2656.12511; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2018, BRIEF REPORTS REV, V13, P12, DOI [10.1142/S1793292018500704, DOI 10.1142/S17932920185007041850070]; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Atcc.org, 2020, 700616 ATCC; Becker CAM, 2015, INFECT GENET EVOL, V33, P118, DOI 10.1016/j.meegid.2015.04.019; Bonneaud C, 2011, P NATL ACAD SCI USA, V108, P7899, DOI 10.1073/pnas.1018580108; Braun J, 2014, J WILDLIFE DIS, V50, P757, DOI 10.7589/2013-09-231; Brown DR, 2004, INT J SYST EVOL MICR, V54, P1527, DOI 10.1099/ijs.0.63072-0; BROWN DR, 1995, INT J SYST BACTERIOL, V45, P348, DOI 10.1099/00207713-45-2-348; Brown MB, 1999, J CLIN MICROBIOL, V37, P2262, DOI 10.1128/JCM.37.7.2262-2269.1999; BROWN MB, 1994, INFECT IMMUN, V62, P4580, DOI 10.1128/IAI.62.10.4580-4586.1994; Brown MB, 2001, INT J SYST EVOL MICR, V51, P413, DOI 10.1099/00207713-51-2-413; Buim MR, 2010, COMP IMMUNOL MICROB, V33, P15, DOI 10.1016/j.cimid.2008.07.005; Bushnell B., 2014, BBTOOLS SOFTWARE PAC; Citti C, 2018, CURR ISSUES MOL BIOL, V29, P3, DOI 10.21775/cimb.029.003; Cummings LA, 2016, CLIN CHEM, V62, P1465, DOI 10.1373/clinchem.2016.258806; Delaney NF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002511; Dykhuizen D., 2007, EVOLUTION HLTH DIS, P185; Farmanfarmaei G, 2017, MOL CELL PROBE, V33, P1, DOI 10.1016/j.mcp.2017.01.002; Fookes MC, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4399-6; Gonzales TK, 2011, MOL CELL PROBE, V25, P222, DOI 10.1016/j.mcp.2011.08.004; Gorski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034722; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172522; Hawley DM, 2010, J EVOLUTION BIOL, V23, P1680, DOI 10.1111/j.1420-9101.2010.02035.x; Jacobson ER, 2014, VET J, V201, P257, DOI 10.1016/j.tvjl.2014.05.039; Konigsson MH, 2002, VET MICROBIOL, V85, P209, DOI 10.1016/S0378-1135(01)00517-X; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee JK, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6306-9; Marques LM, 2011, VET MICROBIOL, V152, P205, DOI 10.1016/j.vetmic.2011.04.007; Plazzotta G, 2015, J THEOR BIOL, V368, P67, DOI 10.1016/j.jtbi.2014.12.009; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Register KB, 2015, VET MICROBIOL, V175, P92, DOI 10.1016/j.vetmic.2014.11.002; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P2031, DOI 10.1093/nar/30.9.2031; Sandmeier FC, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2427; Sandmeier FC, 2017, ECOL EVOL, V7, P10616, DOI 10.1002/ece3.3480; Sandmeier FC, 2014, INTEGR COMP BIOL, V54, P387, DOI 10.1093/icb/icu021; Sandmeier FC, 2013, ECOHEALTH, V10, P63, DOI 10.1007/s10393-013-0835-5; Sandmeier FC, 2009, BIOL CONSERV, V142, P1255, DOI 10.1016/j.biocon.2009.02.001; Simecka Jerry W., 1992, P391; Snyder LAS, 2009, MICROB ECOL, V57, P1, DOI 10.1007/s00248-008-9465-9; Tardy L, 2019, P NATL ACAD SCI USA, V116, P16927, DOI 10.1073/pnas.1901556116; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tulman ER, 2012, MICROBIOL-SGM, V158, P2073, DOI 10.1099/mic.0.058560-0; Verstraete K, 2014, TOXINS, V6, P1201, DOI 10.3390/toxins6041201; Weitzman CL, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171003; Weitzman CL, 2018, STAND GENOMIC SCI, V13, DOI 10.1186/s40793-018-0309-z; Weitzman CL, 2017, HERPETOLOGICA, V73, P113, DOI 10.1655/Herpetologica-D-16-00079.1; Wobeser GA., 2013, ESSENTIALS DIS WILD; WOESE CR, 1985, J MOL EVOL, V21, P305, DOI 10.1007/BF02115648; Xiao L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1801-0	53	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0245895	10.1371/journal.pone.0245895	http://dx.doi.org/10.1371/journal.pone.0245895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534823	Green Published, gold			2022-12-26	WOS:000616739700026
J	Varone, E; Decio, A; Chernorudskiy, A; Minoli, L; Brunelli, L; Ioli, F; Piotti, A; Pastorelli, R; Fratelli, M; Gobbi, M; Giavazzi, R; Zito, E				Varone, Ersilia; Decio, Alessandra; Chernorudskiy, Alexander; Minoli, Lucia; Brunelli, Laura; Ioli, Federica; Piotti, Arianna; Pastorelli, Roberta; Fratelli, Maddalena; Gobbi, Marco; Giavazzi, Raffaella; Zito, Ester			The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions	ONCOGENE			English	Article								Solid tumors are often characterized by a hypoxic microenvironment which contributes, through the hypoxia-inducible factor HIF-1, to the invasion-metastasis cascade. Endoplasmic reticulum (ER) stress also leads tumor cells to thrive and spread by inducing a transcriptional and translational program, the Unfolded Protein Response (UPR), aimed at restoring ER homeostasis. We studied ERO1 alpha (henceforth ERO1), a protein disulfide oxidase with the tumor-relevant characteristic of being positively regulated by both ER stress and hypoxia. Analysis of the redox secretome indicated that pro-angiogenic HIF-1 targets, were blunted in ERO1-devoid breast cancer cells under hypoxic conditions. ERO1 deficiency reduced tumor cell migration and lung metastases by impinging on tumor angiogenesis, negatively regulating the upstream ATF4/CHOP branch of the UPR and selectively impeding oxidative folding of angiogenic factors, among which VEGF-A. Thus, ERO1 deficiency acted synergistically with the otherwise feeble curative effects of anti-angiogenic therapy in aggressive breast cancer murine models and it might be exploited to treat cancers with pathological HIF-1-dependent angiogenesis. Furthermore, ERO1 levels are higher in the more aggressive basal breast tumors and correlate inversely with the disease- and metastasis-free interval of breast cancer patients. Thus, taking advantage of our in vitro data on ERO1-regulated gene products we identified a gene set associated with ERO1 expression in basal tumors and related to UPR, hypoxia, and angiogenesis, whose levels might be investigated in patients as a hallmark of tumor aggressiveness and orient those with lower levels toward an effective anti-angiogenic therapy.	[Varone, Ersilia; Decio, Alessandra; Chernorudskiy, Alexander; Brunelli, Laura; Ioli, Federica; Piotti, Arianna; Pastorelli, Roberta; Fratelli, Maddalena; Gobbi, Marco; Giavazzi, Raffaella; Zito, Ester] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy; [Minoli, Lucia] Univ Milan, Dept Vet Med, Mouse & Anim Pathol Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Zito, E (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy.	ester.zito@marionegri.it	Gobbi, Marco/J-2638-2016; Minoli, Lucia/AAB-8777-2022; Varone, Ersilia/ABE-4711-2021; Chernorudskiy, Alexander/ABE-4390-2021; Brunelli, Laura/J-8664-2018; Decio, Alessandra/J-5250-2018	Gobbi, Marco/0000-0003-1014-6225; Minoli, Lucia/0000-0001-8938-4319; Varone, Ersilia/0000-0002-1537-3358; Chernorudskiy, Alexander/0000-0002-8175-5688; Brunelli, Laura/0000-0002-5465-9586; Decio, Alessandra/0000-0002-1845-7063; Piotti, Arianna/0000-0003-3614-8202	AIRC [MFAG 20018, IG 23520]; Cariplo Grant [2017-0896]	AIRC(Fondazione AIRC per la ricerca sul cancro); Cariplo Grant(Fondazione Cariplo)	We are indebted to David Ron, in whose lab some of the reagents were developed, to Enrico Garattini for providing breast tumor cell lines and Nica Borgese for the critical reading of the paper. This study was supported by AIRC MFAG 20018 grant to EZ, Cariplo Grant 2017-0896 to AD and AIRC IG 23520 to RG.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Blais JD, 2010, J BIOL CHEM, V285, P20993, DOI 10.1074/jbc.M110.126599; Canovi M, 2014, SENSORS-BASEL, V14, P10864, DOI 10.3390/s140610864; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chin KT, 2011, FASEB J, V25, P2583, DOI 10.1096/fj.11-184622; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Dey S, 2015, J CLIN INVEST, V125, P2592, DOI 10.1172/JCI78031; Dore-Savard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39460; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mandal K, 2011, ANGEW CHEM INT EDIT, V50, P8029, DOI 10.1002/anie.201103237; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5; Pozzer D, 2019, REDOX BIOL, V20, P354, DOI 10.1016/j.redox.2018.10.017; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sitohy B, 2012, CANCER RES, V72, P1909, DOI 10.1158/0008-5472.CAN-11-3406; Tanaka T, 2016, BRIT J CANCER, V114, P1227, DOI 10.1038/bjc.2016.105; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; VARTANIAN RK, 1994, AM J PATHOL, V144, P1188; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yang SK, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1134-4; Zhang YN, 2019, EBIOMEDICINE, V41, P408, DOI 10.1016/j.ebiom.2019.02.041; Zito E, 2015, FREE RADICAL BIO MED, V83, P299, DOI 10.1016/j.freeradbiomed.2015.01.011; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	45	15	15	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1721	1736		10.1038/s41388-021-01659-y	http://dx.doi.org/10.1038/s41388-021-01659-y		FEB 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33531624	Green Published, hybrid			2022-12-26	WOS:000613991700001
J	Yang, DL; Luo, J; Peng, PH; Li, W; Shi, WB; Jia, LY; He, YM				Yang, Danli; Luo, Ji; Peng, Peihao; Li, Wei; Shi, Wenbo; Jia, Longyu; He, Yongmei			Dynamics of nitrogen and phosphorus accumulation and their stoichiometry along a chronosequence of forest primary succession in the Hailuogou Glacier retreat area, eastern Tibetan Plateau	PLOS ONE			English	Article							ORGANIC-CARBON; ECOSYSTEM DEVELOPMENT; WEATHERING PROCESSES; GONGGA MOUNTAIN; FORELAND; CYCLE; PLANTATIONS; SWITZERLAND; LIMITATION; VEGETATION	As the two limiting nutrients for plants in most terrestrial ecosystems, nitrogen (N) and phosphorus (P) are essential for the development of succession forests. Vegetation N:P stoichiometry is a useful tool for detecting nutrient limitation. In the present work, chronosequence analysis was employed to research N and P accumulation dynamics and their stoichiometry during forest primary succession in a glacier retreat area on the Tibetan Plateau. Our results showed that: (1) total ecosystem N and P pools increased from 97 kg hm(-2) to 7186 kg hm(-2) and 25 kg hm(-2) to 487 kg hm(-2), respectively, with increasing glacier retreat year; (2) the proportion of the organic soil N pool to total ecosystem N sharply increased with increasing glacier retreat year, but the proportion of the organic soil and the vegetation P pools to the total ecosystem P was equivalent after 125 y of recession; (3) the N:P ratio for tree leaves ranged from 10.1 to 14.3, whereas the N:P ratio for total vegetation decreased form 13.3 to 8.4 and remained constant after 35 y of recession, and the N:P ratio for organic soil increased from 0.2 to 23.1 with increasing glacier retreat. These results suggested that organic soil N increased with increasing years of glacier retreat, which may be the main sink for atmospheric N, whereas increased P accumulation in vegetation after 125 y of recession suggested that much of the soil P was transformed into the biomass P pool. As the N:P ratio for vegetation maintained a low level for 35-125 y of recession, we suggested that N might be the main limiting element for plant growth in the development of this ecosystem.	[Yang, Danli; Peng, Peihao; Jia, Longyu] Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China; [Luo, Ji; Li, Wei; He, Yongmei] Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China; [Shi, Wenbo] Chengdu Univ Technol, Tourism & Urban Rural Planning Coll, Chengdu, Sichuan, Peoples R China; [He, Yongmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chengdu University of Technology; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chengdu University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Peng, PH (corresponding author), Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China.	pengpeihao@cdut.edu.cn	SHI, wen/GPW-9531-2022	Yang, Danli/0000-0003-4424-3912	Second Tibetan Plateau Scientific Expedition and Research Program (STEP) [2019QZKK0307]; National Natural Science Foundation of China [41771062]; Key Technical Talents Program of Chinese Academy of Sciences [2016065]	Second Tibetan Plateau Scientific Expedition and Research Program (STEP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technical Talents Program of Chinese Academy of Sciences	This research was financially supported by the Second Tibetan Plateau Scientific Expedition and Research Program (STEP) (Grant No. 2019QZKK0307), the National Natural Science Foundation of China (Grant No. 41771062) and Key Technical Talents Program of Chinese Academy of Sciences(Grant No. 2016065).	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2019, ABI TECHNIK, V39, P84; [Anonymous], 2019, ABI TECHNIK, V39, P84; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Buma B, 2017, ECOLOGY, V98, P1513, DOI 10.1002/ecy.1848; Cassman N.A., 2019, IMPACT NITROGEN FERT; Chang RY, 2018, SOIL BIOL BIOCHEM, V127, P31, DOI 10.1016/j.soilbio.2018.09.006; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Chen G, 2003, RES MICROBIOL, V154, P393, DOI 10.1016/S0923-2508(03)00082-2; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; Di Palo F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182569; Fickert T, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12050191; Filippelli GM, 2008, ELEMENTS, V4, P89, DOI 10.2113/GSELEMENTS.4.2.89; Follmi KB, 2009, GEOCHIM COSMOCHIM AC, V73, P2252, DOI 10.1016/j.gca.2009.01.017; Goransson H, 2016, PLANT SOIL, V404, P251, DOI 10.1007/s11104-016-2821-5; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hooker TD, 2003, ECOL APPL, V13, P299, DOI 10.1890/1051-0761(2003)013[0299:FECANA]2.0.CO;2; Ji Wenjing, 2016, Chinese Journal of Applied and Environmental Biology, V22, P277, DOI 10.3724/SP.J.1145.2015.09001; Jiang YL, 2018, PLANT SOIL, V428, P291, DOI 10.1007/s11104-018-3683-9; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kanakidou M, 2016, J ATMOS SCI, V73, P2039, DOI 10.1175/JAS-D-15-0278.1; Kimmins J P., 2004, FOREST ECOLOGY FDN S, V3rd, DOI [10.1007/s00442-004-1777-y15583941, DOI 10.1007/S00442-004-1777-Y15583941]; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kohls SJ, 2003, PLANT SOIL, V254, P11, DOI 10.1023/A:1024950913234; Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9; Laclau JP, 2010, FOREST ECOL MANAG, V259, P1771, DOI 10.1016/j.foreco.2009.06.010; Laliberte AC, 2008, J BIOGEOGR, V35, P1989, DOI 10.1111/j.1365-2699.2008.01932.x; Luo Ji, 2005, Journal of Beijing Forestry University, V27, P13; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042354; [罗辑 Luo Ji], 2004, [山地学报, Journal of Mountain Science], V22, P421; Mao R, 2010, PLANT SOIL, V332, P277, DOI 10.1007/s11104-010-0292-7; Mavris C, 2010, GEODERMA, V155, P359, DOI 10.1016/j.geoderma.2009.12.019; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; PACHAURI RK, 2014, CLIMATE CHANGE 2007; [庞学勇 Pang Xueyong], 2002, [应用与环境生物学报, Chinese journal of applied and environmental biology], V8, P1; Pellegrini AFA, 2014, ECOLOGY, V95, P342, DOI 10.1890/13-0290.1; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Perez CA, 2016, NEW ZEAL J BOT, V54, P156, DOI 10.1080/0028825X.2016.1143018; Prietzel J, 2013, GEOCHIM COSMOCHIM AC, V108, P154, DOI 10.1016/j.gca.2013.01.029; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Roe GH, 2017, NAT GEOSCI, V10, P95, DOI [10.1038/NGEO2863, 10.1038/ngeo2863]; Sanders CJ, 2014, GEOPHYS RES LETT, V41, P2475, DOI 10.1002/2014GL059789; Schlesinger WH, 2016, BIOGEOCHEMISTRY ANAL; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Schmitz A, 2019, ENVIRON POLLUT, V244, P980, DOI 10.1016/j.envpol.2018.09.101; Sheng WP, 2013, ENVIRON MONIT ASSESS, V185, P833, DOI 10.1007/s10661-012-2594-0; Smits MM, 2012, GEOBIOLOGY, V10, P445, DOI 10.1111/j.1472-4669.2012.00331.x; [宋成军 SONG Cheng-Jun], 2009, [生态学报, Acta Ecologica Sinica], V29, P869; Song XK, 2014, J MOL CATAL B-ENZYM, V100, P49, DOI 10.1016/j.molcatb.2013.11.021; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; Tipper ET, 2012, CHEM GEOL, V312, P80, DOI 10.1016/j.chemgeo.2012.04.002; Tumer J, 2008, FOREST ECOL MANAG, V255, P1701, DOI 10.1016/j.foreco.2007.11.038; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 2003, SCOPE SER, V61, P117; Wang X, 2020, ENVIRON POLLUT, V260, DOI 10.1016/j.envpol.2020.114082; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wongfun N, 2013, GEODERMA, V211, P116, DOI 10.1016/j.geoderma.2013.07.009; Wu YH, 2014, SCI CHINA EARTH SCI, V57, P1860, DOI 10.1007/s11430-013-4741-z; Xu L, 2020, SCI CHINA EARTH SCI, V63, P1475, DOI 10.1007/s11430-019-9600-5; Yang DL, 2015, INT BUS REV, V24, P11, DOI 10.1016/j.ibusrev.2014.05.004; Yang Liu-dong, 2012, Shengtaixue Zazhi, V31, P44; Yang Y, 2014, FOREST ECOL MANAG, V312, P10, DOI 10.1016/j.foreco.2013.10.028; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yates MG, 1992, BIOL NITROGEN FIXATI, P259; Yu GR, 2019, NAT GEOSCI, V12, P424, DOI 10.1038/s41561-019-0352-4; Zhang LX, 2003, ACTA BOT SIN, V45, P1009; Zhou J, 2018, EUR J SOIL SCI, V69, P450, DOI 10.1111/ejss.12536; Zhou J, 2018, PLANT SOIL, V433, P1, DOI 10.1007/s11104-018-3839-7; Zhou J, 2016, GEODERMA, V267, P78, DOI 10.1016/j.geoderma.2015.12.024; Zhou J, 2013, GEODERMA, V195, P251, DOI [10.1016/j.geoderma2012.12.010, 10.1016/j.geoderma.2012.12.010]	75	4	4	18	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246433	10.1371/journal.pone.0246433	http://dx.doi.org/10.1371/journal.pone.0246433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529264	gold, Green Published			2022-12-26	WOS:000616736200048
J	Feinberg, H; Jegouzo, SAF; Lasanajak, Y; Smith, DF; Drickamer, K; Weis, WI; Taylor, ME				Feinberg, Hadar; Jegouzo, Sabine A. F.; Lasanajak, Yi; Smith, David F.; Drickamer, Kurt; Weis, William, I; Taylor, Maureen E.			Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; RECOGNITION DOMAIN; LIGAND-BINDING; DC-SIGN; REPLACEMENT THERAPY; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; SUGAR-BINDING; MECHANISM; OLIGOSACCHARIDES	The human mannose receptor expressed on macrophages and hepatic endothelial cells scavenges released lysosomal enzymes, glycopeptide fragments of collagen, and pathogenic microorganisms and thus reduces damage following tissue injury. The receptor binds mannose, fucose, or N-acetylglucosamine (GlcNAc) residues on these targets. C-type carbohydrate-recognition domain 4 (CRD4) of the receptor contains the site for Ca2+-dependent interaction with sugars. To investigate the details of CRD4 binding, glycan array screening was used to identify oligosaccharide ligands. The strongest signals were for glycans that contain either Man alpha 1-2Man constituents or fucose in various linkages. The mechanisms of binding to monosaccharides and oligosaccharide substructures present in many of these ligands were examined in multiple crystal structures of CRD4. Binding of mannose residues to CRD4 results primarily from interaction of the equatorial 3- and 4-OH groups with a conserved principal Ca2+ common to almost all sugar-binding C-type CRDs. In the Man alpha 1-2Man complex, supplementary interactions with the reducing mannose residue explain the enhanced affinity for this disaccharide. Bound GlcNAc also interacts with the principal Ca2+ through equatorial 3- and 4-OH groups, whereas fucose residues can bind in several orientations, through either the 2- and 3-OH groups or the 3- and 4-OH groups. Secondary contacts with additional sugars in fucose-containing oligosaccharides, such as the Lewis-a trisaccharide, provide enhanced affinity for these glycans. These results explain many of the biologically important interactions of the mannose receptor with both mammalian glycoproteins and microbes such as yeast and suggest additional classes of ligands that have not been previously identified.	[Feinberg, Hadar; Weis, William, I] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Feinberg, Hadar; Weis, William, I] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Jegouzo, Sabine A. F.; Drickamer, Kurt; Taylor, Maureen E.] Imperial Coll London, Dept Life Sci, London, England; [Lasanajak, Yi; Smith, David F.] Emory Univ, Sch Med, Emory Comprehens Glyc Core, Atlanta, GA USA	Stanford University; Stanford University; Imperial College London; Emory University	Weis, WI (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA.; Weis, WI (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.; Taylor, ME (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	bill.weis@stanford.edu; maureen.taylor@imperial.ac.uk	Smith, David/GQQ-8257-2022; Weis, William/G-1437-2011	Feinberg, Hadar/0000-0002-9937-4699; Taylor, Maureen/0000-0001-8300-4987; Jegouzo, Sabine/0000-0001-7768-0102; Weis, William/0000-0002-5583-6150	Biotechnology and Biological Sciences Research Council [BB/P005659/1]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P30GM133894]; Emory University School of Medicine; BBSRC [BB/P005659/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Emory University School of Medicine; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/P005659/1 from the Biotechnology and Biological Sciences Research Council to Maureen E. Taylor and Kurt Drickamer. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS Grant P30GM133894. Glycan array analyses were performed by the Emory Comprehensive Glycomics Core (ECGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Azad A. K., 2014, J CYTOL MOL BIOL, V1, P5; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; BRADY RO, 1994, J INHERIT METAB DIS, V17, P510, DOI 10.1007/BF00711365; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Feinberg H, 2017, J BIOL CHEM, V292, P13402, DOI 10.1074/jbc.M117.799080; Feinberg H, 2013, J BIOL CHEM, V288, P36762, DOI 10.1074/jbc.M113.528000; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hitchen PG, 1998, BIOCHEM J, V333, P601, DOI 10.1042/bj3330601; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Hu ZZ, 2019, J STRUCT BIOL, V208, DOI 10.1016/j.jsb.2019.09.001; Hu ZZ, 2018, STRUCTURE, V26, P60, DOI 10.1016/j.str.2017.11.006; IOBST ST, 1994, J BIOL CHEM, V269, P15505; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang BK, 1998, INFECT IMMUN, V66, P2769, DOI 10.1128/IAI.66.6.2769-2777.1998; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LENNARTZ MR, 1987, BIOCHEM J, V245, P705, DOI 10.1042/bj2450705; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Liu Y, 2001, J MOL BIOL, V305, P481, DOI 10.1006/jmbi.2000.4326; Liu Y, 2017, GLYCOBIOLOGY, V27, P280, DOI 10.1093/glycob/cww118; Lozniewski A, 2003, INFECT IMMUN, V71, P2902, DOI 10.1128/IAI.71.5.2902-2906.2003; Lubow J, 2020, ELIFE, V9, DOI 10.7554/eLife.51035; Monteiro JT, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030059; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; MULLIN NP, 1994, J BIOL CHEM, V269, P28405; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Paracuellos P, 2015, STRUCTURE, V23, P2133, DOI 10.1016/j.str.2015.09.004; Porcaro I, 2003, J LEUKOCYTE BIOL, V74, P206, DOI 10.1189/jlb.1202608; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Takahashi K, 1998, CELL TISSUE RES, V292, P311, DOI 10.1007/s004410051062; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor ME, 1997, GLYCOBIOLOGY, V7, pR5; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	61	22	24	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100368	10.1016/j.jbc.2021.100368	http://dx.doi.org/10.1016/j.jbc.2021.100368			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545173	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400342
J	Bas, J; Sebastian-Galles, N				Bas, Jesus; Sebastian-Galles, Nuria			Infants' representation of social hierarchies in absence of physical dominance	PLOS ONE			English	Article								Social hierarchies are ubiquitous in all human relations since birth, but little is known about how they emerge during infancy. Previous studies have shown that infants can represent hierarchical relationships when they arise from the physical superiority of one agent over the other, but humans have the capacity to allocate social status in others through cues that not necessary entail agents' physical formidability. Here we investigate infants' capacity to recognize the social status of different agents when there are no observable cues of physical dominance. Our results evidence that a first presentation of the agents' social power when obtaining resources is enough to allow infants predict the outputs of their future. Nevertheless, this capacity arises later (at 18 month-olds but not at 15 month-olds) than showed in previous studies, probably due the increased complexity of the inferences needed to make the predictions.	[Bas, Jesus; Sebastian-Galles, Nuria] Univ Pompeu Fabra, Ctr Brain & Cognit CBC, Barcelona, Spain	Pompeu Fabra University	Bas, J (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit CBC, Barcelona, Spain.	jesus.bas@upf.edu		Bas, Jesus/0000-0002-0368-9320	European Community's Seventh Framework Programme (FP7/2007-2013; European Research Council) [323961]; Spanish Ministerio de Ciencia, Innovacion y Universidades / Agencia Estatal de Investigacion [PGC2018-101831-B-I00]; Catalan Government [SGR 2017-268]; Catalan Government (ICREA [Catalan Institution for Research and Advanced Studies] Academia 2018 award); Spanish Ministerio de Economia y Competitividad [BES-2013-063649]	European Community's Seventh Framework Programme (FP7/2007-2013; European Research Council); Spanish Ministerio de Ciencia, Innovacion y Universidades / Agencia Estatal de Investigacion(Spanish Government); Catalan Government; Catalan Government (ICREA [Catalan Institution for Research and Advanced Studies] Academia 2018 award); Spanish Ministerio de Economia y Competitividad(Spanish Government)	This research was supported by grants from the European Community's Seventh Framework Programme (FP7/2007-2013; European Research Council 323961; "Under Control"), Spanish Ministerio de Ciencia, Innovacion y Universidades / Agencia Estatal de Investigacion (PGC2018-101831-B-I00 AEI/FEDER EU), and the Catalan Government (SGR 2017-268 and ICREA [Catalan Institution for Research and Advanced Studies] Academia 2018 award). J.B. received a pre-doctoral fellowship from the Spanish Ministerio de Economia y Competitividad BES-2013-063649.	Bernard S, 2016, J EXP CHILD PSYCHOL, V152, P307, DOI 10.1016/j.jecp.2016.08.007; Brey E, 2015, CHILD DEV, V86, P276, DOI 10.1111/cdev.12334; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Castelain T, 2016, DEVELOPMENTAL SCI, V19, P957, DOI 10.1111/desc.12336; Charafeddine R, 2015, J COGN DEV, V16, P587, DOI 10.1080/15248372.2014.926269; Cheng JT, 2013, J PERS SOC PSYCHOL, V104, P103, DOI 10.1037/a0030398; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Csibra G, 2016, DEV PSYCHOL, V52, P521, DOI 10.1037/dev0000083; de Kwaadsteniet EW, 2010, J EXP SOC PSYCHOL, V46, P515, DOI 10.1016/j.jesp.2010.01.005; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; Enright EA, 2017, COGNITION, V164, P8, DOI 10.1016/j.cognition.2017.03.008; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Fragale AR, 2011, J EXP SOC PSYCHOL, V47, P767, DOI 10.1016/j.jesp.2011.03.006; Gazes RP, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12367; Halevy N, 2011, ORGAN PSYCHOL REV, V1, P32, DOI 10.1177/2041386610380991; Hawley PH, 1999, DEV REV, V19, P97, DOI 10.1006/drev.1998.0470; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Koski JE, 2015, SOC NEUROSCI-UK, V10, P527, DOI 10.1080/17470919.2015.1013223; Lukaszewski AW, 2016, J PERS SOC PSYCHOL, V110, P385, DOI 10.1037/pspi0000042; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Margoni F, 2018, P NATL ACAD SCI USA, V115, pE8835, DOI 10.1073/pnas.1801677115; Mascaro O, 2014, PSYCHOL SCI, V25, P250, DOI 10.1177/0956797613500509; Mascaro O, 2012, P NATL ACAD SCI USA, V109, P6862, DOI 10.1073/pnas.1113194109; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; Over H, 2015, DEVELOPMENTAL SCI, V18, P917, DOI 10.1111/desc.12275; Pietraszewski D, 2015, HUM NATURE-INT BIOS, V26, P44, DOI 10.1007/s12110-015-9220-0; Price ME, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00363; Pun A, 2016, P NATL ACAD SCI USA, V113, P2376, DOI 10.1073/pnas.1514879113; Santamaria-Garcia H, 2014, SOC COGN AFFECT NEUR, V9, P1489, DOI 10.1093/scan/nst133; Smith JE, 2016, TRENDS ECOL EVOL, V31, P54, DOI 10.1016/j.tree.2015.09.013; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0245450	10.1371/journal.pone.0245450	http://dx.doi.org/10.1371/journal.pone.0245450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566835	gold, Green Published			2022-12-26	WOS:000618271700026
J	Hagos, Y; Gugsa, G; Awol, N; Ahmed, M; Tsegaye, Y; Abebe, N; Bsrat, A				Hagos, Yohans; Gugsa, Getachew; Awol, Nesibu; Ahmed, Meselu; Tsegaye, Yisehak; Abebe, Nigus; Bsrat, Abrha			Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia	PLOS ONE			English	Article							FOOD-BORNE PATHOGENS; RETAIL RAW CHICKEN; THERMOPHILIC CAMPYLOBACTER; BROILER-CHICKENS; EMERGING ISSUES; PCR ASSAY; PREVALENCE; RESISTANCE; SPP.; BEEF	Campylobacter jejuni and Campylobacter coli are globally recognized as a major cause of bacterial foodborne gastroenteritis. A cross-sectional study was conducted from October 2015 to May 2016 in Mekelle city to isolate, identify, and estimate the prevalence of C. jejuni and C. coli in raw meat samples and to determine their antibiotic susceptibility pattern. A total of 384 raw meat samples were randomly collected from bovine (n = 210), goat (n = 108), and chicken (n = 66), and isolation and identification of Campylobacter spp. were performed using standard bacteriological techniques and PCR. Antibiotic susceptibility test was performed using disc diffusion method. Of the total 384 raw meat samples, 64 (16.67%) were found positive for Campylobacter spp. The highest prevalence of Campylobacter spp. was found in chicken meat (43.93%) followed by bovine meat (11.90%) and goat meat (9.25%). The most prevalent Campylobacter spp. isolated from meat samples was C. jejuni (81.25%). The overall prevalence of Campylobacter in restaurants, butcher shops, and abattoir was 43.93%, 18.30%, and 9.30%, respectively. 96.8%, 81.25%, 75%, and 71% of the Campylobacter spp. isolates were sensitive to norfloxacin, erythromycin, chloramphenicol, and sulphamethoxazole-trimethoprim, respectively. However, 96.9%, 85.9%, and 50% of the isolates were resistant to ampicillin, amoxicillin, and streptomycin, respectively. Strains that developed multi-drug resistant were 68.7%. The result of this study revealed the occurrence of Campylobacter in bovine, goat, and chicken meats. Hence, there is a chance of acquiring infection via consumption of raw or undercooked meat. Thus, implementation of hygienic practices from a slaughterhouse to the retailers, proper handling and cooking of foods of meat are very important in preventing Campylobacter infection.	[Hagos, Yohans] Shire Agr Tech Vocat & Educ Training Coll, Tigray, Ethiopia; [Gugsa, Getachew; Awol, Nesibu; Ahmed, Meselu] Wollo Univ, Sch Vet Med, Dept Vet Med, Dessie, Ethiopia; [Tsegaye, Yisehak; Abebe, Nigus; Bsrat, Abrha] Mekelle Univ, Coll Vet Sci, Dept Vet Med, Mekelle, Ethiopia	Mekelle University	Gugsa, G (corresponding author), Wollo Univ, Sch Vet Med, Dept Vet Med, Dessie, Ethiopia.	gugsag@yahoo.com	Amede, Getachew Gugsa/AFO-9249-2022; Shumuye, Nigus Abebe/AFS-7035-2022	Amede, Getachew Gugsa/0000-0003-1201-2263; Shumuye, Nigus Abebe/0000-0002-0073-7788; Redda, Yisehak Tsegaye/0000-0003-4535-7735	College of Veterinary Sciences, Mekelle University	College of Veterinary Sciences, Mekelle University	This research work was funded by College of Veterinary Sciences, Mekelle University.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Asrat D, 1999, ETHIOPIAN MED J, V37, P71; Baron E.G.O, 1999, MANUAL CLIN MICROBIO, P716; BLASER MJ, 1983, EPIDEMIOL REV, V5, P157, DOI 10.1093/oxfordjournals.epirev.a036256; BOLTON FJ, 1984, J CLIN MICROBIOL, V19, P169, DOI 10.1128/JCM.19.2.169-171.1984; Bryant C, 2016, INVESTMENT OPPORTUNI; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Cloak OM, 2001, FOOD MICROBIOL, V18, P287, DOI 10.1006/fmic.2001.0400; CSA (Central statistic Authority CSA), 2007, SUMMARY STAT REPORT; Denis M, 1999, LETT APPL MICROBIOL, V29, P406, DOI 10.1046/j.1472-765X.1999.00658.x; EFSA-ECDC European food safety authority and European Centre for disease prevention and control, 2016, EFSA J, V14; Ekin IH, 2006, ACTA VET BRNO, V75, P145, DOI 10.2754/avb200675010145; Elhelberg S, 2005, AME J EPIDEMIOL, V162, P1008; Ertas HB, 2004, INT J FOOD MICROBIOL, V94, P203, DOI 10.1016/S0168-1605(03)00312-X; Fallon R, 2003, LETT APPL MICROBIOL, V36, P277, DOI 10.1046/j.1472-765X.2003.01308.x; Faris G, 2015, IJMIR, V4; Gallay A, 2007, EMERG INFECT DIS, V13, P259, DOI 10.3201/eid1302.060587; Gedlu E, 1996, ANN TROP PAEDIATR, V16, P207, DOI 10.1080/02724936.1996.11747828; Ghafir Y, 2007, INT J FOOD MICROBIOL, V116, P111, DOI 10.1016/j.ijfoodmicro.2006.12.012; Habib I, 2008, APPL ENVIRON MICROB, V74, P5483, DOI 10.1128/AEM.00161-08; Hassanain N. A., 2011, Global Veterinaria, V6, P195; Heredia N, 2018, ANIM NUTR, V4, P250, DOI 10.1016/j.aninu.2018.04.006; Heuvelink AE, 2009, INT J FOOD MICROBIOL, V134, P70, DOI 10.1016/j.ijfoodmicro.2008.12.026; Hong J, 2007, J FOOD PROTECT, V70, P860, DOI 10.4315/0362-028X-70.4.860; Hossein D, 2014, INT ENTERIC PATHOG, V2, pE17087; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Hussain I, 2007, FOOD MICROBIOL, V24, P219, DOI 10.1016/j.fm.2006.06.001; Jorgensen F, 2002, INT J FOOD MICROBIOL, V76, P151, DOI 10.1016/S0168-1605(02)00027-2; Lemma Dadi, 2008, Ethiopian Journal of Health Development, V22, P195; Marinou I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00058; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Mayrhofer S, 2004, INT J FOOD MICROBIOL, V97, P23, DOI 10.1016/j.ijfoodmicro.2004.04.006; Mpalang RKA, 2014, J INFECT DEV COUNTR, V8, P168, DOI 10.3855/jidc.3199; Nachamkin I, 2000, CAMPYLOBACTER, P45; Nonga HE, 2010, TROP ANIM HEALTH PRO, V42, P73, DOI 10.1007/s11250-009-9387-7; Oberhelman RA, 2000, CAMPYLOBACTER, V2nd, P139, DOI 10.1016/s0360-3016(00)00774-4; On SLW, 1996, CLIN MICROBIOL REV, V9, P405, DOI 10.1128/CMR.9.3.405; Pezzotti G, 2003, INT J FOOD MICROBIOL, V82, P281, DOI 10.1016/S0168-1605(02)00314-8; Praakle-Amin K, 2007, INT J FOOD MICROBIOL, V114, P105, DOI 10.1016/j.ijfoodmicro.2006.10.034; Rahimi E., 2010, Global Veterinaria, V4, P504; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P1620; Ricotta EE, 2014, AM J PUBLIC HEALTH, V104, pE108, DOI 10.2105/AJPH.2013.301867; Rosef O, 2008, FOODBORNE PATHOG DIS, V5, P33, DOI 10.1089/fpd.2007.0027; Salihu M. D., 2009, International Journal of Animal and Veterinary Advances, V1, P6; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; Siham A, 2009, SUDAN J VET SCI ANIM, V48, P1; Son I, 2007, INT J FOOD MICROBIOL, V113, P16, DOI 10.1016/j.ijfoodmicro.2006.06.033; Sukhapesna J., 2005, Kasetsart Journal, Natural Sciences, V39, P240; Suzuki H, 2009, J VET MED SCI, V71, P255, DOI 10.1292/jvms.71.255; Tafa B, 2014, INTJ BACTERIOL, V19, P3; Tajada P, 1996, ANTIMICROB AGENTS CH, V40, P1924, DOI 10.1128/AAC.40.8.1924; Tan Y. F., 2009, International Food Research Journal, V16, P31; Taremi M, 2006, INT J FOOD MICROBIOL, V108, P401, DOI 10.1016/j.ijfoodmicro.2005.12.010; Tesfaye Kassa, 2005, Ethiopian Journal of Health Development, V19, P225; Thepault A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00471; Toledo Z, 2018, CIENC RURAL, V48, DOI 10.1590/0103-8478cr20180003; Van Katwyk SR, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002819; Van Looveren M, 2001, J ANTIMICROB CHEMOTH, V48, P235, DOI 10.1093/jac/48.2.235; Vanderline PB, 1998, J FOOD PROTECT, V61, P437, DOI 10.4315/0362-028X-61.4.437; Wesley I., 2009, MICROBIOLOGICALLY SA, P3; WHO. World Health Organization / Department of Communicable Disease Surveillance and Response, 2001, INCR INC HUM CAMP RE; Whyte P, 2004, INT J FOOD MICROBIOL, V95, P111, DOI 10.1016/j.ijfoodmicro.2003.10.018; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280; Winn MDWC, 1998, COLOR ATLAS TXB DIAG, V5th, P322; Woldemariam T, 2009, ETHIOP J HEALTH DEV, V23, P229; Yeshimebet Chanyalew, 2013, Kasetsart Journal, Natural Science, V47, P551; Zanetti F, 1996, INT J FOOD MICROBIOL, V33, P315, DOI 10.1016/0168-1605(96)01166-X; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001	75	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246755	10.1371/journal.pone.0246755	http://dx.doi.org/10.1371/journal.pone.0246755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566816	Green Published, gold			2022-12-26	WOS:000618271700034
J	Daghooghi, M; Borazjani, I				Daghooghi, Mohsen; Borazjani, Iman			A kinematics-based model for the settling of gravity-driven arbitrary-shaped particles on a surface	PLOS ONE			English	Article							DISCRETE-ELEMENT METHOD; PARTICULATE SYSTEMS; NONSPHERICAL PARTICLES; SIMULATION; COLLISION; ALGORITHM; CONTACTS	A discrete model is proposed for settling of an arbitrary-shaped particle onto a flat surface under the gravitational field. In this method, the particle dynamics is calculated such that (a) the particle does not create an overlap with the wall and (b) reaches a realistic equilibrium state, which are not guaranteed in the conventional discrete element methods that add a repulsive force (torque) based on the amount of overlap between the particle and the wall. Instead, upon the detection of collision, the particle's kinematics is modified depending on the type of contact, i.e., point, line, and surface types, by assuming the contact point/line as the instantaneous center/line of rotation for calculating the rigid body dynamics. Two different stability conditions are implemented by comparing the location of the projection of the center of mass on the wall along gravity direction against the contact points to identify the equilibrium (stable) state on the wall for particles with multiple contact points. A variety of simulations are presented, including smooth surface particles (ellipsoids), regular particles with sharp edges (cylinders and pyramids) and irregular-shaped particles, to show that the method can provide the analytically-known equilibrium state.	[Daghooghi, Mohsen] Univ Houston Clear Lake, Coll Sci & Engn, Houston, TX 77058 USA; [Borazjani, Iman] Texas A&M Univ, J Mike Walker 66 Dept Mech Engn, College Stn, TX USA	University of Houston System; University of Houston; University of Houston Clear Lake; Texas A&M University System; Texas A&M University College Station	Daghooghi, M (corresponding author), Univ Houston Clear Lake, Coll Sci & Engn, Houston, TX 77058 USA.	Daghooghi@uhcl.edu	Borazjani, Iman/G-5548-2013	Borazjani, Iman/0000-0001-7940-3168; Daghooghi, Mohsen/0000-0003-0105-488X				Baraff D., 1997, SIGGRAPH COURSE NOTE, P82; Barr A. H., 1981, IEEE Computer Graphics and Applications, V1, P11, DOI 10.1109/MCG.1981.1673799; Borazjani I, 2008, J COMPUT PHYS, V227, P7587, DOI 10.1016/j.jcp.2008.04.028; Cleary PW, 2009, ENG COMPUTATION, V26, P698, DOI 10.1108/02644400910975487; Crowe CT., 2011, MULTIPHASE FLOWS DRO, DOI 10.1201/b11103; CUNDALL PA, 1988, INT J ROCK MECH MIN, V25, P107, DOI 10.1016/0148-9062(88)92293-0; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Daghooghi M, 2018, J FLUID MECH, V839, P663, DOI 10.1017/jfm.2018.65; Daghooghi M, 2015, J FLUID MECH, V781, P506, DOI 10.1017/jfm.2015.504; DAVIS RH, 1986, J FLUID MECH, V163, P479, DOI 10.1017/S0022112086002392; Dong KJ, 2015, CHEM ENG SCI, V126, P500, DOI 10.1016/j.ces.2014.12.059; Girolami L, 2012, GRANUL MATTER, V14, P381, DOI 10.1007/s10035-012-0342-3; Gui N, 2016, ADV POWDER TECHNOL, V27, P154, DOI 10.1016/j.apt.2015.12.002; Haines E., 1994, GRAPHICS GEMS, P24; Hogue C, 1998, ENG COMPUTATION, V15, P374, DOI 10.1108/02644409810208525; Jin F, 2011, POWDER TECHNOL, V212, P134, DOI 10.1016/j.powtec.2011.05.003; Kafui KD, 2002, CHEM ENG SCI, V57, P2395, DOI 10.1016/S0009-2509(02)00140-9; Lin X, 1997, GEOTECHNIQUE, V47, P319, DOI 10.1680/geot.1997.47.2.319; Liu SD, 2014, POWDER TECHNOL, V253, P70, DOI 10.1016/j.powtec.2013.11.001; Lu G, 2012, CHEM ENG SCI, V78, P226, DOI 10.1016/j.ces.2012.05.041; Mando M, 2010, POWDER TECHNOL, V202, P1, DOI 10.1016/j.powtec.2010.05.001; Mohaghegh F, 2019, POWDER TECHNOL, V344, P756, DOI 10.1016/j.powtec.2018.12.062; Moller T., 1997, J GRAPH TOOL, V2, P21, DOI [DOI 10.1080/10867651.1997.10487468, 10.1080/10867651.1997.10487468]; Moreno-Atanasio R, 2010, PARTICUOLOGY, V8, P81, DOI 10.1016/j.partic.2010.01.001; Pediatric Liver Study Group of India, 1999, INDIAN J PEDIAT, V66, pS97; Podlozhnyuk A, 2017, COMPUT PART MECH, V4, P101, DOI 10.1007/s40571-016-0131-6; Teufelsbauer H, 2009, GRANUL MATTER, V11, P209, DOI 10.1007/s10035-009-0142-6; TING JM, 1993, INT J NUMER ANAL MET, V17, P603, DOI 10.1002/nag.1610170902; Tsuji Y., 1991, ADV POWDER TECHNOL, V2, P63, DOI DOI 10.1016/S0921-8831(08)60721-9; Vu-Quoc L, 2000, COMPUT METHOD APPL M, V187, P483, DOI 10.1016/S0045-7825(99)00337-0; Wachs A, 2011, J ENG MATH, V71, P131, DOI 10.1007/s10665-010-9436-2; Wachs A, 2009, COMPUT FLUIDS, V38, P1608, DOI 10.1016/j.compfluid.2009.01.005; Williams J.R., 1992, ENG COMPUTATION, V9, P115, DOI DOI 10.1108/EB023852; WILLIAMS JR, 1995, ENG COMPUTATION, V12, P185, DOI 10.1108/02644409510799550; Wynn EJW, 2009, POWDER TECHNOL, V196, P62, DOI 10.1016/j.powtec.2009.07.004; Zhong WQ, 2016, POWDER TECHNOL, V302, P108, DOI 10.1016/j.powtec.2016.07.010; Zhou ZY, 2011, IND ENG CHEM RES, V50, P9787, DOI 10.1021/ie200862n; Zhu HP, 2007, CHEM ENG SCI, V62, P3378, DOI 10.1016/j.ces.2006.12.089; Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0243716	10.1371/journal.pone.0243716	http://dx.doi.org/10.1371/journal.pone.0243716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561163	Green Published, gold			2022-12-26	WOS:000617533000044
J	Zoleko-Manego, R; Mischlinger, J; Dejon-Agobe, JC; Basra, A; Mackanga, JR; Diop, DA; Adegnika, AA; Agnandji, ST; Lell, B; Kremsner, PG; Matsiegui, PB; Gonzalez, R; Menendez, C; Ramharter, M; Mombo-Ngoma, G				Zoleko-Manego, Rella; Mischlinger, Johannes; Dejon-Agobe, Jean Claude; Basra, Arti; Mackanga, J. Rodolphe; Diop, Daisy Akerey; Adegnika, Ayola Akim; Agnandji, Selidji T.; Lell, Bertrand; Kremsner, Peter G.; Matsiegui, Pierre Blaise; Gonzalez, Raquel; Menendez, Clara; Ramharter, Michael; Mombo-Ngoma, Ghyslain			Birth weight, growth, nutritional status and mortality of infants from Lambarene and Fougamou in Gabon in their first year of life	PLOS ONE			English	Article							MALNUTRITION; COHORT; HEALTH	Background Malnutrition and low birth weight (LBW) are two common causes of morbidity and mortality among children in sub-Saharan Africa. Both malnutrition and LBW affect early childhood development with long term consequences that may vary in their degree depending on the geographical setting. This study evaluates growth, nutritional status and mortality of infants from Lambarene and Fougamou in Gabon from a birth cohort of a malaria in pregnancy clinical trial (NCT00811421). Method A prospective longitudinal birth cohort conducted between 2009 and 2012, included infants that were followed up from birth until their first-year anniversary. The exposure of interest was low birth weight and the outcomes explored were growth represented by weight gain, the nutritional status including stunting, wasting and underweight, and the mortality. Scheduled follow-up visits were at one, nine and 12 months of age. Logistic regression was used to assess the association between low birth weight and growth and nutritional outcomes, and cox regression was used for mortality. Result A total of 907 live-born infants were included in the analysis. The prevalence of LBW was 13% (115). At one month of life, out of 743 infants 10% and 4% presented with stunting and underweight, respectively, while these proportions increased at 12 months of life to 17% and 21%, respectively, out of 530 infants. The proportion of infants with wasting remained constant at 7% throughout the follow-up period. Stunting and underweight were associated with LBW, adjusted odds ratio (aOR): 2.6, 95% confidence interval (95%CI): 1.4-4.9 and aOR: 4.5, 95%CI: 2.5-8.1, respectively. Preterm birth was associated with stunting, aOR: 2.7, 95%CI: 1.2-6.3 and underweight, aOR: 5.4, 95%CI: 1.7-16.1 at one month of life. Infants with LBW were at higher hazard of death during the first year of life, adjusted hazard ratio 4.6, 95%CI: 1.2-17.0. Conclusion Low birthweight infants in Gabon are at higher risks of growth and nutritional deficits and mortality during the first year of life. Tailored interventions aiming at preventing adverse pregnancy outcomes including LBW, early detection and appropriate management of growth, and nutritional deficits in infants are necessary in Gabon.	[Zoleko-Manego, Rella; Dejon-Agobe, Jean Claude; Basra, Arti; Mackanga, J. Rodolphe; Diop, Daisy Akerey; Adegnika, Ayola Akim; Agnandji, Selidji T.; Lell, Bertrand; Kremsner, Peter G.; Ramharter, Michael; Mombo-Ngoma, Ghyslain] Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Zoleko-Manego, Rella; Dejon-Agobe, Jean Claude; Adegnika, Ayola Akim; Agnandji, Selidji T.; Kremsner, Peter G.; Mombo-Ngoma, Ghyslain] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Zoleko-Manego, Rella; Mischlinger, Johannes; Ramharter, Michael; Mombo-Ngoma, Ghyslain] Univ Med Ctr Hamburg Eppendorf, Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany; [Zoleko-Manego, Rella; Mischlinger, Johannes; Ramharter, Michael; Mombo-Ngoma, Ghyslain] Univ Med Ctr Hamburg Eppendorf, Dep Med 1, Hamburg, Germany; [Dejon-Agobe, Jean Claude] Univ Amsterdam, Amsterdam Univ, Ctr Trop Med & Travel Med, Dept Infect Dis,Med Ctr,Div Internal Med,Ctr Trop, Amsterdam, Netherlands; [Adegnika, Ayola Akim; Kremsner, Peter G.] German Ctr Infect Res DZIF, African Partner Inst, CERMEL, Lambarene, Gabon; [Adegnika, Ayola Akim; Kremsner, Peter G.] German Ctr Infect Res DZIF, Partner Site Tubingen, Tubingen, Germany; [Lell, Bertrand] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Matsiegui, Pierre Blaise] Ctr Rech Med Ngounie CRMN, Fougamou, Gabon; [Gonzalez, Raquel; Menendez, Clara] Hosp Clin Univ Barcelona, Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain; [Gonzalez, Raquel; Menendez, Clara] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain; [Gonzalez, Raquel] Cent Univ Catalonia UVic UCC, Fac Med, Barcelona, Spain	Eberhard Karls University of Tubingen; Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Amsterdam; German Center for Infection Research; German Center for Infection Research; Medical University of Vienna; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona	Mombo-Ngoma, G (corresponding author), Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon.; Mombo-Ngoma, G (corresponding author), Univ Tubingen, Inst Tropenmed, Tubingen, Germany.; Mombo-Ngoma, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany.; Mombo-Ngoma, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dep Med 1, Hamburg, Germany.	ghyslain.mombongoma@cermel.org	Mombo-Ngoma, Ghyslain/I-4305-2019; Ramharter, Michael/C-5273-2013	Mombo-Ngoma, Ghyslain/0000-0003-2658-8706; Zoleko Manego, Rella/0000-0001-7425-2794; Ramharter, Michael/0000-0002-9259-1885; Mischlinger, Johannes/0000-0002-2012-6327	European Developing Countries Clinical Trials Partnership (EDCTP) [IP.2007.31080.002]	European Developing Countries Clinical Trials Partnership (EDCTP)	The main (MIPPAD) study was funded by the European Developing Countries Clinical Trials Partnership (EDCTP; IP.2007.31080.002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera L, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0608-9; Akombi BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177338; [Anonymous], WHOS AFR NUTR REP HI; [Anonymous], 2014, DABIQ; [Anonymous], 2017, LEV TRENDS CHILD MOR; [Anonymous], MALN CHILDR; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Barone G, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-28; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Galgamuwa LS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4311-y; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Kabore P, 2004, ARCH PEDIATRIE, V11, P807, DOI 10.1016/j.arcped.2004.03.034; Madhur Borah, 2014, National Journal of Community Medicine, V5, P397; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Motta Maria Eugênia Farias Almeida, 2005, J. Pediatr. (Rio J.), V81, P377, DOI 10.1590/S0021-75572005000600007; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Mwangome M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213523; Ntenda PAM, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0477-8; O'Leary M, 2017, B WORLD HEALTH ORGAN, V95, P574, DOI 10.2471/BLT.16.180273; Padonou G, 2014, ACTA TROP, V135, P1, DOI 10.1016/j.actatropica.2014.03.005; Perez-Escamilla R, 2018, BMJ-BRIT MED J, V361, DOI [10.1136/bmj.k2252, 10.1136/bmj.j2252]; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Ruperez M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001964; Sridhar K., 2002, Indian Journal of Pediatrics, V69, P485, DOI 10.1007/BF02722649; UNICEF, LOW BIRTHW; UNICEF, 2020, CHILDR FOOD NUTR GRO; WHO, STAND FORM LOW BIRTH; WHO, COH STUD LOW BIRTH W; WHO, 2018, GUIDELINES OPTIMAL F; World Health Organization (WHO), STUNT NUTSH	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246694	10.1371/journal.pone.0246694	http://dx.doi.org/10.1371/journal.pone.0246694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561169	Green Published, gold			2022-12-26	WOS:000617533000010
J	Alemanno, F; Houdayer, E; Parma, A; Spina, A; Del Forno, A; Scatolini, A; Angelone, S; Brugliera, L; Tettamanti, A; Beretta, L; Iannaccone, S				Alemanno, Federica; Houdayer, Elise; Parma, Anna; Spina, Alfio; Del Forno, Alessandra; Scatolini, Alessandra; Angelone, Sara; Brugliera, Luigia; Tettamanti, Andrea; Beretta, Luigi; Iannaccone, Sandro			COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience	PLOS ONE			English	Article							RATING SCALE; SURVIVORS; IMPAIRMENT; VALIDITY; OUTCOMES; RISK; MOCA	Introduction COVID-19 complications can include neurological, psychiatric, psychological, and psychosocial impairments. Little is known on the consequences of SARS-COV-2 on cognitive functions of patients in the sub-acute phase of the disease. We aimed to investigate the impact of COVID-19 on cognitive functions of patients admitted to the COVID-19 Rehabilitation Unit of the San Raffaele Hospital (Milan, Italy). Material and methods 87 patients admitted to the COVID-19 Rehabilitation Unit from March 27(th) to June 20(th) 2020 were included. Patients underwent Mini Mental State Evaluation (MMSE), Montreal Cognitive Assessment (MoCA), Hamilton Rating Scale for Depression, and Functional Independence Measure (FIM). Data were divided in 4 groups according to the respiratory assistance in the acute phase: Group1 (orotracheal intubation), Group2 (non-invasive ventilation using Biphasic Positive Airway Pressure), Group3 (Venturi Masks), Group4 (no oxygen therapy). Follow-ups were performed at one month after home-discharge. Results Out of the 87 patients (62 Male, mean age 67.23 +/- 12.89 years), 80% had neuropsychological deficits (MoCA and MMSE) and 40% showed mild-to-moderate depression. Group1 had higher scores than Group3 for visuospatial/executive functions (p = 0.016), naming (p = 0.024), short- and long-term memory (p = 0.010, p = 0.005), abstraction (p = 0.024), and orientation (p = 0.034). Group1 was younger than Groups2 and 3. Cognitive impairments correlated with patients' age. Only 18 patients presented with anosmia. Their data did not differ from the other patients. FIM (<100) did not differ between groups. Patients partly recovered at one-month follow-up and 43% showed signs of post-traumatic stress disorder. Conclusion Patients with severe functional impairments had important cognitive and emotional deficits which might have been influenced by the choice of ventilatory therapy, but mostly appeared to be related to aging, independently of FIM scores. These findings should be integrated for correct neuropsychiatric assistance of COVID-19 patients in the subacute phase of the disease, and show the need for long-term psychological support and treatment of post-COVID-19 patients.	[Alemanno, Federica; Houdayer, Elise; Parma, Anna; Del Forno, Alessandra; Scatolini, Alessandra; Angelone, Sara; Brugliera, Luigia; Tettamanti, Andrea; Iannaccone, Sandro] IRCCS San Raffaele Sci Inst, Dept Rehabil & Funct Recovery, Milan, Italy; [Spina, Alfio] IRCCS San Raffaele Sci Inst, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy; [Beretta, Luigi] IRCCS San Raffaele Sci Inst, Dept Gen Anesthesia & Intens Care, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Houdayer, E (corresponding author), IRCCS San Raffaele Sci Inst, Dept Rehabil & Funct Recovery, Milan, Italy.	houdayer.elise@hsr.it						Al-Janabi OM, 2018, J NEUROIMAGING, V28, P301, DOI 10.1111/jon.12494; Azim D, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8790; Brugliera L, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2714; Brugliera L, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2678; Carda S, 2020, ANN PHYS REHABIL MED, V63, P554, DOI 10.1016/j.rehab.2020.04.001; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Iannaccone S, 2020, ARCH PHYS MED REHAB, V101, P1656, DOI 10.1016/j.apmr.2020.05.015; Inoue S, 2019, ACUTE MED SURG, V6, P233, DOI 10.1002/ams2.415; Inzitari D, 2007, ARCH INTERN MED, V167, P81, DOI 10.1001/archinte.167.1.81; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3981; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Mariotto S, 2020, J NEUROL NEUROSUR PS, V91, P1010, DOI 10.1136/jnnp-2020-323881; Maydych V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00384; Meng XM, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102581; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Murray H, 2020, COGN BEH THER, V13, DOI 10.1017/S1754470X2000015X; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelliot A, 2019, ANN AM THORAC SOC, V16, P731, DOI 10.1513/AnnalsATS.201812-851OC; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Pasqua F, 2009, RESP MED, V103, P471, DOI 10.1016/j.rmed.2008.09.007; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Pfoh ER, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0934-5; Pisani MA, 2003, J AM GERIATR SOC, V51, P689, DOI 10.1034/j.1600-0579.2003.00215.x; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Rawal G, 2017, J TRANSL INTERN MED, V5, P90, DOI 10.1515/jtim-2016-0016; Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z; Varatharaj Aravinthan, 2020, Lancet Psychiatry, V7, P875, DOI 10.1016/S2215-0366(20)30287-X; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946	45	57	63	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246590	10.1371/journal.pone.0246590	http://dx.doi.org/10.1371/journal.pone.0246590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG1VY	33556127	Green Published, gold, Green Submitted			2022-12-26	WOS:000617379900048
J	Chen, BW; Chiu, GW; He, YC; Huang, CY; Huang, HT; Sung, SY; Hsieh, CL; Chang, WC; Hsu, MS; Wei, ZH; Yao, DJ				Chen, Bo-Wei; Chiu, Guo-Wei; He, Yun-Chi; Huang, Chih-Yu; Huang, Hao-Ting; Sung, Shian-Ying; Hsieh, Chia-Ling; Chang, Wei-Chieh; Hsu, Ming-Shinn; Wei, Zung-Hang; Yao, Da-Jeng			Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid	PLOS ONE			English	Article							CONTRAST AGENTS; APOPTOSIS; FIELDS	The use of magnetic nanoparticles (MNPs) magnetized on applying an alternating magnetic field (AMF) to stimulate the thermal characteristics and to induce tumor apoptosis is a currently active area of research in cancer treatment. In previous work, we developed biocompatible and superparamagnetic polystyrene-sulfonic-acid-coated magnetic nanoparticles (PSS-MNPs) as applications for magnetically labeled cell trapping, but without assessment of treatment effects on tumor diseases. In the present work, we examined PSS-MNP-induced magnetic fluid hyperthermia (MFH) on SK-Hep1 hepatocellular carcinoma (HCC) cells for lethal thermal effects with a self-made AMF system; an adjustable AMF frequency generated a variable intensity of magnetic field and induced MNP relaxation. The extracellular and intracellular MFH treatments on a SK-Hep1 cell line were implemented in vitro; the result indicates that the lethal effects were efficient and caused a significantly decreased cell viability of SK-Hep1 cells. As the PSS-MNP concentration decreased, especially in intracellular MFH treatments, the MFH effects on cells, however, largely decreased through heat spreading to the culture medium. On controlling and decreasing the volume of culture medium, the problem of heat spreading was solved. It can be consequently expected that PSS-MNPs would be a prospective agent for intracellular cancer magnetotherapy.	[Chen, Bo-Wei; Wei, Zung-Hang; Yao, Da-Jeng] Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu, Taiwan; [Chiu, Guo-Wei; He, Yun-Chi; Huang, Chih-Yu; Huang, Hao-Ting; Wei, Zung-Hang; Yao, Da-Jeng] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Sung, Shian-Ying; Hsieh, Chia-Ling] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Sung, Shian-Ying; Hsieh, Chia-Ling] Taipei Med Univ, TMU Res Ctr Canc Translat Med, Taipei, Taiwan; [Chang, Wei-Chieh] Chang Bing Show Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan; [Hsu, Ming-Shinn] Min Sheng Hosp, Dept Obstet & Gynecol, Ching Kuo Campus, Taoyuan, Taiwan	National Tsing Hua University; National Tsing Hua University; Taipei Medical University; Taipei Medical University; Chang Bing Show Chwan Memorial Hospital	Yao, DJ (corresponding author), Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu, Taiwan.; Yao, DJ (corresponding author), Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan.	djyao@mx.nthu.edu.tw	Huang, Chih-Yu/AAS-3695-2021	Huang, Chih-Yu/0000-0003-4243-4707	Ministry of Science and Technology (MOST), Taiwan [MOST 105-2628-M-007-002MY3, MOST 104-2221-E-007-015-MY4]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan)	The Ministry of Science and Technology (MOST), Taiwan, provided support for this study in the form of grants (MOST 105-2628-M-007-002MY3 and MOST 104-2221-E-007-015-MY4) awarded to the following authors: BWC; GWC; YCH; CYH; HTH; ZHW; and DJY.	Carter T, 2016, IMMUNOTHERAPY-UK, V8, P941, DOI 10.2217/imt.16.11; Chen BW, 2020, SCI TECHNOL ADV MAT, V21, P471, DOI 10.1080/14686996.2020.1790032; Cheng DF, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-195; Cheng KK, 2015, BIOMATERIALS, V44, P155, DOI 10.1016/j.biomaterials.2014.12.005; Eun JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110744; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Gallo J, 2013, CHEM SOC REV, V42, P7816, DOI 10.1039/c3cs60149h; Gneveckow U, 2004, MED PHYS, V31, P1444, DOI 10.1118/1.1748629; Guardia P, 2012, ACS NANO, V6, P3080, DOI 10.1021/nn2048137; Herea DD, 2018, INT J NANOMED, V13, P5743, DOI 10.2147/IJN.S174853; Hu SH, 2012, ADV MATER, V24, P3627, DOI 10.1002/adma.201201251; Huang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135299; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Hwang ES, 2006, EXP BIOL MED, V231, P322; Jose J, 2020, ENVIRON SCI POLLUT R, V27, P19214, DOI 10.1007/s11356-019-07231-2; Kim DH, 2010, NAT MATER, V9, P165, DOI [10.1038/NMAT2591, 10.1038/nmat2591]; Kobayashi T, 2011, BIOTECHNOL J, V6, P1342, DOI 10.1002/biot.201100045; Latorre M, 2009, P R HEALTH SCI J, V28, P227; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Lee CW, 2018, ONCOL LETT, V15, P559, DOI 10.3892/ol.2017.7320; Leulmi S, 2015, NANOSCALE, V7, P15904, DOI 10.1039/c5nr03518j; Maier-Hauff K, 2011, J NEURO-ONCOL, V103, P317, DOI 10.1007/s11060-010-0389-0; Mansell R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04154-1; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Piazza RD, 2020, MATER RES EXPRESS, V7, DOI 10.1088/2053-1591/ab6700; Sanz B, 2017, BIOMATERIALS, V114, P62, DOI 10.1016/j.biomaterials.2016.11.008; Sengupta S, 2018, J ADV RES, V14, P97, DOI 10.1016/j.jare.2018.06.003; Tai Y, 2018, INT J CLIN EXP PATHO, V11, P2931; Wang HL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014498; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wu K, 2017, AIP ADV, V7, DOI 10.1063/1.4978458; Yagawa Y., 2017, J CANC METASTASIS TR, V3, P218, DOI [DOI 10.20517/2394-4722.2017.35, 10.20517/2394-4722.2017.35]; Zhang EM, 2014, ACS NANO, V8, P3192, DOI 10.1021/nn406302j	33	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245286	10.1371/journal.pone.0245286	http://dx.doi.org/10.1371/journal.pone.0245286			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544751	gold, Green Published			2022-12-26	WOS:000617991900008
J	Seki, T; Kawazoe, Y; Ohe, K				Seki, Tomohisa; Kawazoe, Yoshimasa; Ohe, Kazuhiko			Machine learning-based prediction of in-hospital mortality using admission laboratory data: A retrospective, single-site study using electronic health record data	PLOS ONE			English	Article							ACUTE PHYSIOLOGY SCORE; INTENSIVE-CARE; APACHE; PATIENT; RATES	Risk assessment of in-hospital mortality of patients at the time of hospitalization is necessary for determining the scale of required medical resources for the patient depending on the patient's severity. Because recent machine learning application in the clinical area has been shown to enhance prediction ability, applying this technique to this issue can lead to an accurate prediction model for in-hospital mortality prediction. In this study, we aimed to generate an accurate prediction model of in-hospital mortality using machine learning techniques. Patients 18 years of age or older admitted to the University of Tokyo Hospital between January 1, 2009 and December 26, 2017 were used in this study. The data were divided into a training/validation data set (n = 119,160) and a test data set (n = 33,970) according to the time of admission. The prediction target of the model was the in-hospital mortality within 14 days. To generate the prediction model, 25 variables (age, sex, 21 laboratory test items, length of stay, and mortality) were used to predict in-hospital mortality. Logistic regression, random forests, multilayer perceptron, and gradient boost decision trees were performed to generate the prediction models. To evaluate the prediction capability of the model, the model was tested using a test data set. Mean probabilities obtained from trained models with five-fold cross-validation were used to calculate the area under the receiver operating characteristic (AUROC) curve. In a test stage using the test data set, prediction models of in-hospital mortality within 14 days showed AUROC values of 0.936, 0.942, 0.942, and 0.938 for logistic regression, random forests, multilayer perceptron, and gradient boosting decision trees, respectively. Machine learning-based prediction of short-term in-hospital mortality using admission laboratory data showed outstanding prediction capability and, therefore, has the potential to be useful for the risk assessment of patients at the time of hospitalization.	[Seki, Tomohisa; Kawazoe, Yoshimasa; Ohe, Kazuhiko] Univ Tokyo Hosp, Dept Healthcare Informat Management, Tokyo, Japan; [Kawazoe, Yoshimasa] Univ Tokyo, Grad Sch Med, Artificial Intelligence Healthcare, Tokyo, Japan; [Ohe, Kazuhiko] Univ Tokyo, Grad Sch Social Med, Dept Med Informat & Econ, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Seki, T (corresponding author), Univ Tokyo Hosp, Dept Healthcare Informat Management, Tokyo, Japan.	seki@m.u-tokyo.ac.jp	kawazoe, yoshimasa/GYU-2868-2022	kawazoe, yoshimasa/0000-0002-7277-0827; Seki, Tomohisa/0000-0002-4281-135X	Tokyo Society of Medical Sciences	Tokyo Society of Medical Sciences	This research was supported by the Tokyo Society of Medical Sciences and Grant-in-Aid for Scientific Research (C). There was no additional external funding received for this study.	Asadollahi K, 2011, EMERG MED AUSTRALAS, V23, P354, DOI 10.1111/j.1742-6723.2011.01410.x; Audigier V, 2018, STAT SCI, V33, P160, DOI 10.1214/18-STS646; BATTITI R, 1992, NEURAL COMPUT, V4, P141, DOI 10.1162/neco.1992.4.2.141; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; COX DR, 1958, J R STAT SOC B, V20, P215; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Erez A, 2014, ISR MED ASSOC J, V16, P439; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Froom P, 2006, CLIN CHEM, V52, P325, DOI 10.1373/clinchem.2005.059030; Gunning K, 1999, BRIT MED J, V319, P241, DOI 10.1136/bmj.319.7204.241; Hannan JL, 2012, J PAIN SYMPTOM MANAG, V43, P631, DOI 10.1016/j.jpainsymman.2011.04.009; Kimura M, 2011, METHOD INFORM MED, V50, P131, DOI 10.3414/ME10-01-0015; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Lundberg SM, 2017, ADV NEUR IN, V30; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Pine M, 1997, ANN INTERN MED, V126, P347, DOI 10.7326/0003-4819-126-5-199703010-00002; Pine M, 1998, INT J QUAL HEALTH C, V10, P491, DOI 10.1093/intqhc/10.6.491; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Redfern OC, 2018, RESUSCITATION, V133, P75, DOI 10.1016/j.resuscitation.2018.09.021; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Shameer K, MACHINE LEARNING CAR; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zhang ZH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028101; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246640	10.1371/journal.pone.0246640	http://dx.doi.org/10.1371/journal.pone.0246640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544775	Green Published, gold			2022-12-26	WOS:000617991900053
J	Urban, M; Moran, S				Urban, Matthias; Moran, Steven			Altitude and the distributional typology of language structure: Ejectives and beyond	PLOS ONE			English	Article							R PACKAGE; CLIMATE; EVOLUTION; ENVIRONMENT; AREAS	The first decades of the 21st century have witnessed a renewed interest in the relationship between language structure and the various social and ecological niches in which the languages of the world are used and against the background of which they evolved. In this context, Everett (2013) argued for direct geographical influences on the sound structure of languages. It was observed that ejective consonants, produced with a sudden burst of non-pulmonic air to a salient acoustic effect, tend to occur in high-altitude environments in which these sounds may be adaptive due to a reduced articulatory effort and/or to prevent desiccation. Here, we evaluate this claim and at the same time place it into a broader context. We observe that the distribution of another class of typologically unusual sounds, uvulars, is highly similar to that of ejectives, but that the proposed explanations are not available to account for the similar geographical patterning of uvulars. Hence, we test an alternative explanatory account that would posit indirect rather than direct environmental influences on language structure that are mediated by anthropological factors, in particular the relative sociolinguistic isolation of speech communities at the highest altitudes. Applying Bayesian Logistic Mixed Effects Regression to a large database of phonological inventories of the world's languages, however, we do not find strong support for either a correlation of ejectives or uvulars with high-altitude environments, though the association is somewhat stronger for ejectives than uvulars. A phylogenetic exploration of the development of both classes of sounds in two large language families spoken in widely different environments, Indo-European and Sino-Tibetan, together with a qualitative assessment of the dedicated literature, in contrast, suggests a strong role of language contact rather than environmental factors.	[Urban, Matthias] Univ Tubingen, Ctr Adv Studies Words Bones Genes Tools, Tubingen, Germany; [Moran, Steven] Univ Neuchatel, Inst Biol, Neuchatel, Switzerland	Eberhard Karls University of Tubingen; University of Neuchatel	Urban, M (corresponding author), Univ Tubingen, Ctr Adv Studies Words Bones Genes Tools, Tubingen, Germany.	matthias.urban@uni-tuebingen.de			German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [UR 310-1/1]; Swiss National Science Foundation [PCEFP1_186841]; University of Tubingen's Open Access Publishing Fund	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Tubingen's Open Access Publishing Fund	This study was funded in the form of a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) (Grant No. UR 310-1/1) awarded to MO; the Swiss National Science Foundation (Grant No. PCEFP1_186841) awarded to SM; and funding from the University of Tubingen's Open Access Publishing Fund awarded to all authors.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2009, LINGUISTICS TIBETO B; [Anonymous], 2018, VOX             0919; [Anonymous], 2013, WORLD PHONOTACTICS D; Arbuthnot John, 1751, ESSAY EFFECTS AIR HU; Barrack CM, 2002, INDOGER FORSCH, V107, P76, DOI 10.1515/if-2002-0104; Belyaev BA, 2020, PHYS STATUS SOLIDI-R, V14, DOI 10.1002/pssr.201900467; Benitez-Burraco A, 2018, FRONTIERS PSYCHOL; Benitez-Burraco A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01827; Bentz C, 2018, NAT HUM BEHAV, V2, P816, DOI 10.1038/s41562-018-0457-6; Bentz C, 2013, LANG DYN CHANG, V3, P1, DOI 10.1163/22105832-13030105; Bickel B., 2007, LINGUIST TYPOL, V11, P239, DOI DOI 10.1515/LINGTY.2007.018; Bickel Balthasar., 2015, OXFORD HDB LINGUISTI, V2nd edn., P901; Bickel Balthasar., 2011, LINGUIST TYPOL, V15, P401, DOI [10.1515/lity.2011.027, DOI 10.1515/LITY.2011.027]; Bijankhan M., 2018, OXFORD HDB PERSIAN L, P111; Blevins J, 2017, CAMB HB LANG LINGUIS, P88; Boas Franz, 1911, HDB AM INDIAN LANGUA, V1, P1; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burkner PC, 2018, R PACKAGE VERSION 21; CATFORD JC, 1977, ANNU REV ANTHROPOL, V6, P283, DOI 10.1146/annurev.an.06.100177.001435; Chang W, 2015, LANGUAGE, V91, P194, DOI 10.1353/lan.2015.0005; Chirikba VA, 2008, STUD LANG C, V90, P25; Chirkova K, 2012, LANG LINGUIST-TAIWAN, V13, P133; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Colarusso J., 2014, NW CAUCASIAN LANGUAG; Collins J, 2016, J LANG EVOL, V1, P46, DOI 10.1093/jole/lzv012; Dediu D, 2017, LANG COMMUN, V54, P9, DOI 10.1016/j.langcom.2016.10.002; DRYER MS, 1989, STUD LANG, V13, P257, DOI 10.1075/sl.13.2.03dry; Egenolf JA, 1978, ZENTRALANTIQUARIAT D; Eisen E., 2019, THESIS; Everett C., 2013, THIN AIR RETURN EJEC; Everett C, 2016, J LANG EVOL, V1, P33, DOI 10.1093/jole/lzv004; Everett C, 2016, J LANG EVOL, V1, P83, DOI 10.1093/jole/lzv013; Everett C, 2015, P NATL ACAD SCI USA, V112, P1322, DOI 10.1073/pnas.1417413112; Everett C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065275; Fought JG, 2004, CROSS-CULT RES, V38, P27, DOI 10.1177/1069397103259439; GAMKRELIDZE T, 1973, PHONETICA, V27, P150, DOI 10.1159/000259433; Grossman E, 2020, PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2020), P5316; Hammarstrom H, 2020, P SLTC 2020, P4; Hammarstrom H., 2020, GLOTTOLOG 4 2 1; Hammarstrom H. C., 2013, BLOGPOST DIVERSITY L; Hammarstrom H, 2016, J LANG EVOL, V1, P65, DOI 10.1093/jole/lzv015; Hammarstrom H, 2014, LANG DYN CHANG, V4, P167, DOI 10.1163/22105832-00401001; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hopper PJ, 1973, GLOSSA, V7, P141; Huelsenbeck JP, 2003, SYST BIOL, V52, P131, DOI 10.1080/10635150309342; Jacques G, 2011, DIACHRONICA, V28, P468, DOI 10.1075/dia.28.4.02jac; Jaeger T.F., 2011, LINGUIST TYPOL, V15, P281, DOI [10.1515/lity.2011.021, DOI 10.1515/LITY.2011.021, DOI 10.1075/LA.227.04SZM]; Jeong C, 2014, CURR OPIN GENET DEV, V29, P1, DOI 10.1016/j.gde.2014.06.011; Job M, 2006, CONCISE ENCY LANGUAG, P109; Kirby KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158391; Klimov GA, 1965, KAVKAZSKIE JAZYKI; KORTLANDT F, 1985, FOLIA LINGUIST HIST, V6, P183, DOI 10.1515/flih.1985.6.2.183; Lai M., 2019, COURSE HANDOUTS BAYE; Liljegren H., 2018, J S ASIAN LANGUAGES, V4, P107, DOI [10.1515/jsall-2017-0004, DOI 10.1515/JSALL-2017-0004]; Lindblom B, 2011, PHONOLOGICAL FEATURE, P67; Liu Z., 2010, EXPLORATIONS RENAISS, V4, P165, DOI [10.1163/23526963-90000527, DOI 10.1163/23526963-90000527]; Lupyan G, 2016, TRENDS COGN SCI, V20, P649, DOI 10.1016/j.tics.2016.07.005; Maddieson, 1996, SOUNDS WORLDS LANGUA; Maddieson I., 2013, WORLD ATLAS LANGUAGE; Maddieson I., 1984, PATTERN SOUNDS; Maddieson Ian., 2011, WORLD ATLAS LANGUAGE; Maddieson Ian, 1990, UCLA WORKING PAPERS, V74, P104; Mannheim B, 1982, 5 INT C HIST LING GA, P211; Mannheim Bruce, 1991, LANGUAGE INKA EUROPE; Martinet A, 1952, WORD, V8, P1; Matras Y., 2009, LANGUAGE CONTACT; McNew G, 2018, PROCEEDINGS OF THE ELEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2018), P805; McWhorter John H, 2001, LINGUIST TYPOL, V5, P125; Michaud A., 2017, TONE YONGNING LEXICA; Moran S., 2014, MEASURING GRAMMATICA, P217; Moran Steven, 2019, PHOIBLE 2 0; Moulton WG, 1983, ESSAYS HONOR CF HOCK, P255; Nichols J, 2015, LANGUAGE STRUCTURE E, P261; Nichols Johanna, 2013, SPACE LANGUAGE LINGU, P38; Nichols Johanna, 2003, HDB HIST LINGUISTICS, P283, DOI DOI 10.1002/9780470756393.CH5; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nikolaev D, 2020, PHONOLOGY, V37, P419, DOI 10.1017/S0952675720000226; Nikolaev D, 2018, STUD LANG, V42, P562, DOI 10.1075/sl.17043.nik; Ohala JJ, 2010, HDB PHONETIC SCI, P653; Ong Walter J., 2002, ORALITY LITERACY; Palmer B, 2017, LINGUIST TYPOL, V21, P457, DOI 10.1515/lingty-2017-0011; R Core Team, 2020, R LANG ENV STAT COMP; Regier T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151138; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roberts S., 2013, ALTITUDE EJECTIVES H; Roberts SG, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00166; Sapir E, 1912, AM ANTHROPOL, V14, P226, DOI 10.1525/aa.1912.14.2.02a00020; Team SD, 2018, RSTAN R INT STAN R P; Thomason Sarah G., 2015, ENDANGERED LANGUAGES; Thordarson F., 2009, ENCY IRANICA; THURSTON WR, 1987, PROCESSES CHANGE LAN; Tikkanen B., 2008, P 3 INT HINDU KUSH C, P250; Trudgill P, 2011, SOCIOLINGUISTIC TYPO; Trudgill Peter, 1974, LANGUAGE SOC, V3, P215, DOI [10.1017/S0047404500004358, DOI 10.1017/S0047404500004358]; Tuite K, 1999, LINGUA, V108, P1, DOI 10.1016/S0024-3841(98)00037-0; Urban M, 2018, SPRACHLANDSCHAFTEN R; Urban M., 2012, THESIS; Urban M, 2020, LANG LINGUIST COMPAS, V14, DOI 10.1111/lnc3.12393; Urban M, 2019, LINGUISTICS, V57, P1403, DOI 10.1515/ling-2019-0032; van de Weijer J., 1991, LINGUISTICS NETHERLA, P141; Vasishth S, 2018, J PHONETICS, V71, P147, DOI 10.1016/j.wocn.2018.07.008; Virk SM, 2020, PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2020), P878; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhang MH, 2019, NATURE, V569, P112, DOI 10.1038/s41586-019-1153-z	108	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0245522	10.1371/journal.pone.0245522	http://dx.doi.org/10.1371/journal.pone.0245522			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544750	gold, Green Published			2022-12-26	WOS:000617991900003
J	Bhak, Y; Jeon, Y; Jeon, S; Yoon, C; Kim, M; Blazyte, A; Kim, Y; Kang, Y; Kim, C; Lee, SY; Bae, JW; Kim, W; Kim, YJ; Shim, J; Kim, N; Chun, S; Kim, BC; Kim, BC; Lee, S; Bhak, J; Shin, ES				Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Yoon, Changhan; Kim, Min; Blazyte, Asta; Kim, Yeonkyung; Kang, Younghui; Kim, Changjae; Lee, Sang Yeub; Bae, Jang-Whan; Kim, Weon; Kim, Yeo Jin; Shim, Jungae; Kim, Nayeong; Chun, Sung; Kim, Byoung-Chul; Kim, Byung Chul; Lee, Semin; Bhak, Jong; Shin, Eun-Seok			Polygenic risk score validation using Korean genomes of 265 early-onset acute myocardial infarction patients and 636 healthy controls	PLOS ONE			English	Article							ASSOCIATION; PREDICTION; ACCURACY; TOOL	Background The polygenic risk score (PRS) developed for coronary artery disease (CAD) is known to be effective for classifying patients with CAD and predicting subsequent events. However, the PRS was developed mainly based on the analysis of Caucasian genomes and has not been validated for East Asians. We aimed to evaluate the PRS in the genomes of Korean early-onset AMI patients (n = 265, age <= 50 years) following PCI and controls (n = 636) to examine whether the PRS improves risk prediction beyond conventional risk factors. Results The odds ratio of the PRS was 1.83 (95% confidence interval [CI]: 1.69-1.99) for early-onset AMI patients compared with the controls. For the classification of patients, the area under the curve (AUC) for the combined model with the six conventional risk factors (diabetes mellitus, family history of CAD, hypertension, body mass index, hypercholesterolemia, and current smoking) and PRS was 0.92 (95% CI: 0.90-0.94) while that for the six conventional risk factors was 0.91 (95% CI: 0.85-0.93). Although the AUC for PRS alone was 0.65 (95% CI: 0.61-0.69), adding the PRS to the six conventional risk factors significantly improved the accuracy of the prediction model (P = 0.015). Patients with the upper 50% of PRS showed a higher frequency of repeat revascularization (hazard ratio = 2.19, 95% CI: 1.47-3.26) than the others. Conclusions The PRS using 265 early-onset AMI genomes showed improvement in the identification of patients in the Korean population and showed potential for genomic screening in early life to complement conventional risk prediction.	[Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Yoon, Changhan; Kim, Min; Blazyte, Asta; Kim, Yeonkyung; Kang, Younghui; Kim, Yeo Jin; Shim, Jungae; Kim, Nayeong; Lee, Semin; Bhak, Jong] Ulsan Natl Inst Sci & Technol UNIST, Korean Genom Ctr KOGIC, Ulsan, South Korea; [Bhak, Youngjune; Jeon, Yeonsu; Jeon, Sungwon; Yoon, Changhan; Kim, Min; Blazyte, Asta; Lee, Semin; Bhak, Jong] Ulsan Natl Inst Sci & Technol UNIST, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea; [Kim, Changjae; Kim, Byoung-Chul; Kim, Byung Chul; Bhak, Jong] Clinomics Inc, Ulsan, South Korea; [Lee, Sang Yeub; Bae, Jang-Whan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Cheongju, South Korea; [Kim, Weon] Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Chun, Sung] Boston Childrens Hosp, Div Pulm Med, Boston, MA USA; [Chun, Sung] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Bhak, Jong; Shin, Eun-Seok] Genome Res Fdn, Personal Genom Inst, Ulsan, South Korea; [Shin, Eun-Seok] Ulsan Med Ctr, Dept Internal Med, Div Cardiol, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Chungbuk National University; Kyung Hee University; Kyung Hee University Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bhak, J (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Korean Genom Ctr KOGIC, Ulsan, South Korea.; Bhak, J (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea.; Bhak, J (corresponding author), Clinomics Inc, Ulsan, South Korea.; Bhak, J; Shin, ES (corresponding author), Genome Res Fdn, Personal Genom Inst, Ulsan, South Korea.; Shin, ES (corresponding author), Ulsan Med Ctr, Dept Internal Med, Div Cardiol, Ulsan, South Korea.	jongbhak@genomics.org; sesim1989@gmail.com		Bhak, Youngjune/0000-0002-9273-6984	U-K BRAND Research Fund of UNIST [1.190007.01, 1.200108.01]; Ulsan City Research Fund of UNIST [1.190033.01, 1.200047.01, 2.180016.01]; Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea) [20003641]; Clinomics Inc.; Ministry of Health, Welfare and Family Affairs [18-27, 20-04, 2018-4, 2019-4, 2019-6, 60SA2017002-005]	U-K BRAND Research Fund of UNIST; Ulsan City Research Fund of UNIST; Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Clinomics Inc.; Ministry of Health, Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the U-K BRAND Research Fund (1.190007.01) of UNIST; Research Project Funded by the U-K BRAND Research Fund (1.200108.01) of UNIST; Research Project Funded by Ulsan City Research Fund (1.190033.01) of UNIST; Research Project Funded by Ulsan City Research Fund (1.200047.01) of UNIST; Research Project Funded by Ulsan City Research Fund (2.180016.01) of UNIST. This work was also supported by the Technology Innovation Program (20003641, Development and Dissemination on National Standard Reference Data) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). This work was also supported by internal funding of Clinomics Inc. The funder provided support in the form of salaries for authors C.K., B.K., B.C.K., and J.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We appreciate all participants and Ulsan citizens to support Genome Korea in Ulsan project which provided Korea10K genome information. The biospecimens for this study were provided by Ulsan Medical Center and the Biobanks of Chungbuk National University Hospital (18-27, 20-04), Kyung Hee University Hospital (2018-4, 2019-4, 2019-6), and Ulsan University Hospital (60SA2017002-005) the members of the National Biobank of Korea, which is supported by the Ministry of Health, Welfare and Family Affairs. We thank the Korea Institute of Science and Technology Information (KISTI) provided us the Korea Research Environment Open NETwork (KREONET).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Darst BF, 2017, J ALZHEIMERS DIS, V55, P473, DOI 10.3233/JAD-160195; Duncan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11112-0; Elliott J, 2020, JAMA-J AM MED ASSOC, V323, P636, DOI 10.1001/jama.2019.22241; Gunter R, 2020, KOREAN J FAM MED, V41, P3, DOI 10.4082/kjfm.18.0015; Jeon S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7835; Khera AV, 2019, CIRCULATION, V139, P1593, DOI 10.1161/CIRCULATIONAHA.118.035658; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kim M-S, 2013, PREVALENCE CORONARY, P15545; Levin MG, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002352; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Poplin R., 2018, BIORXIV, DOI DOI 10.1101/201178; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RCore Team, 2020, R LANG ENV STAT COMP; Reisberg S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179238; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shrestha Roman, 2015, Clin Med Rev Vasc Health, V7, P1; Sim DS, 2017, KOREAN CIRC J, V47, P811, DOI 10.4070/kcj.2017.0027; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246538	10.1371/journal.pone.0246538	http://dx.doi.org/10.1371/journal.pone.0246538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539413	Green Published, gold			2022-12-26	WOS:000616960200006
J	Susko, MS; Lazar, AA; Wang, CCJ; Van Loon, K; Feng, M; Hope, TA; Behr, S; Anwar, M				Susko, Matthew S.; Lazar, Ann A.; Wang, Chia-Ching Jackie; Van Loon, Katherine; Feng, Mary; Hope, Tom A.; Behr, Spencer; Anwar, Mekhail			Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTTREATMENT EVALUATION; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; FDG-PET/CT; RADIOTHERAPY; MANAGEMENT; CARCINOMA; IMPACT; CHEMOTHERAPY	Objective Anal cancer is an uncommon malignancy with the primary treatment for localized disease being concurrent radiation and chemotherapy. Pre-treatment PET/CT is useful for target delineation, with minimal exploration of its use in prognostication. In the post-treatment setting there is growing evidence for advanced PET metrics in assessment of treatment response, and early identification of recurrence essential for successful salvage, however this data is limited to small series. Methods Patient with non-metastatic anal cancer from a single institution were retrospectively reviewed for receipt of pre- and post-treatment PET/CTs. PET data was co-registered with radiation therapy planning CT scans for precise longitudinal assessment of advanced PET metrics including SUVmax, metabolic tumor volume (MTV), and total lesion glycolysis (TLG), for assessment with treatment outcomes. Treatment outcomes included local recurrence (LR), progression free survival (PFS), and overall survival (OS), as defined from the completed radiation therapy to the time of the event. Cox proportional hazard modeling with inverse probability weighting (IPW) using the propensity score based on age, BMI, T-stage, and radiation therapy dose were utilized for assessment of these metrics. Results From 2008 to 2017 there were 72 patients who had pre-treatment PET/CT, 61 (85%) had a single follow up PET/CT, and 35 (49%) had two follow up PET/CTs. The median clinical follow-up time was 25 months (IQR: 13-52) with a median imaging follow up time of 16 months (IQR: 7-29). On pre-treatment PET/CT higher MTV2.5 and TLG were significantly associated with higher risk of local recurrence (HR 1.11, 95% CI: 1.06-1.16, p<0.001; and HR 1.12, 95% CI: 1.05-1.19, p<0.001), and worse PFS (HR 1.09, 95% CI: 1.04-1.13, p<0.001; and HR 1.09, 95% CI: 1.03-1.12, p = 0.003) and OS (HR 1.09, 95% CI: 1.04-1.16, p = 0.001; and HR 1.11, 95% CI: 1.04-1.20, p = 0.004). IPW-adjusted pre-treatment PET/CT showed higher MTV2.5 (HR 1.09, 95% CI: 1.02-1.17, p = 0.012) and TLG (HR 1.10, 95% CI: 1.00-1.20, p = 0.048) were significantly associated with worse PFS, and post-treatment MTV2.5 was borderline significant (HR 1.16, 95% CI: 1.00-1.35, p = 0.052). Conclusion Advanced PET metrics, including higher MTV2.5 and TLG, in the pre-treatment and post-treatment setting are significantly associated with elevated rates of local recurrence, and worse PFS and OS. This adds to the growing body of literature that PET/CT for patient with ASCC should be considered for prognostication, and additionally is a useful tool for consideration of early salvage or clinical trial of adjuvant therapies.	[Susko, Matthew S.; Lazar, Ann A.; Feng, Mary; Anwar, Mekhail] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Wang, Chia-Ching Jackie; Van Loon, Katherine] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Wang, Chia-Ching Jackie] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp Med Oncol, San Francisco, CA 94143 USA; [Hope, Tom A.; Behr, Spencer] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Susko, MS (corresponding author), Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA.	matthew.susko@ucsf.edu	Lazar, Ann A/AAX-4057-2021	Susko, Matthew/0000-0002-8522-4585				Ajani JA, 2008, JAMA-J AM MED ASSOC, V299, P1914, DOI 10.1001/jama.299.16.1914; Arnott SJ, 1996, LANCET, V348, P1049; Bannas P, 2011, INT J RADIAT ONCOL, V81, P445, DOI 10.1016/j.ijrobp.2010.05.050; Bartelink H, 1997, J CLIN ONCOL, V15, P2040, DOI 10.1200/JCO.1997.15.5.2040; Bazan JG, 2011, CANCER-AM CANCER SOC, V117, P3342, DOI 10.1002/cncr.25901; Chapet O, 2005, INT J RADIAT ONCOL, V63, P1316, DOI 10.1016/j.ijrobp.2005.05.047; Chung MK, 2009, CLIN CANCER RES, V15, P5861, DOI 10.1158/1078-0432.CCR-08-3290; Cotter SE, 2006, INT J RADIAT ONCOL, V65, P720, DOI 10.1016/j.ijrobp.2006.01.009; DALING JR, 1987, NEW ENGL J MED, V317, P973, DOI 10.1056/NEJM198710153171601; Day FL, 2011, BRIT J CANCER, V105, P498, DOI 10.1038/bjc.2011.274; de Winton E, 2009, BRIT J CANCER, V100, P693, DOI 10.1038/sj.bjc.6604897; Engledow AH, 2011, COLORECTAL DIS, V13, P532, DOI 10.1111/j.1463-1318.2010.02193.x; Gunderson LL, 2012, J CLIN ONCOL, V30, P4344, DOI 10.1200/JCO.2012.43.8085; Hong JLC, 2018, INT J RADIAT ONCOL, V102, P1046, DOI 10.1016/j.ijrobp.2018.04.062; Houard C, 2017, J NUCL MED, V58, P1414, DOI 10.2967/jnumed.116.185280; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Jones MP, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1342-9; Kidd EA, 2010, RADIOTHER ONCOL, V95, P288, DOI 10.1016/j.radonc.2010.02.019; Krengli M, 2009, RADIAT ONCOL, V4, DOI [10.1186/1748-717X-5-10, 10.1186/1748-717X-4-9]; Lee P, 2007, INT J RADIAT ONCOL, V69, P328, DOI 10.1016/j.ijrobp.2007.04.036; Mistrangelo M, 2012, INT J RADIAT ONCOL, V84, P66, DOI 10.1016/j.ijrobp.2011.10.048; Nguyen BT, 2008, RADIOTHER ONCOL, V87, P376, DOI 10.1016/j.radonc.2008.04.003; NIGRO ND, 1983, CANCER, V51, P1826, DOI 10.1002/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sadeghi R, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/9760492; Schwarz JK, 2008, INT J RADIAT ONCOL, V71, P180, DOI 10.1016/j.ijrobp.2007.09.005; Shiels MS, 2012, JNCI-J NATL CANCER I, V104, P1591, DOI 10.1093/jnci/djs371; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Susko M, 2020, ONCOLOGIST, V25, P772, DOI 10.1634/theoncologist.2019-0824; Trautmann TG, 2005, MOL IMAGING BIOL, V7, P309, DOI 10.1007/s11307-005-0003-6; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246535	10.1371/journal.pone.0246535	http://dx.doi.org/10.1371/journal.pone.0246535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539412	gold, Green Published			2022-12-26	WOS:000616960200001
J	Valgeirsdottir, H; Poromaa, IS; Kallak, TK; Vanky, E; Akhter, T; Roos, N; Stephansson, O; Wikstrom, AK				Valgeirsdottir, Heiddis; Poromaa, Inger Sundstrom; Kallak, Theodora Kunovac; Vanky, Eszter; Akhter, Tansim; Roos, Nathalie; Stephansson, Olof; Wikstrom, Anna-Karin			Polycystic ovary syndrome and extremely preterm birth: A nationwide register-based study	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; WOMEN; PREGNANCY; OUTCOMES; RISK; EPIDEMIOLOGY; INFLAMMATION; PREVALENCE; DELIVERY; FEATURES	Introduction Women with polycystic ovary syndrome (PCOS) have increased risk of pregnancy complications, including preterm birth before 37 weeks. However, if this increased risk also includes extremely preterm births (<28 weeks) is unknown. Such information is important to identify women at risk and tailor antenatal care, since child morbidity and mortality become more prevalent with increasing prematurity. Aims To investigate the association between PCOS and extremely preterm birth, and whether onset of PCOS-related preterm birth is predominantly spontaneous or medically indicated. Material and methods This was a nationwide register-based cohort study in Sweden. The study population was all live singleton births registered in the Swedish Medical Birth Register 2005-2014 (n = 1 046 448). Women with and without PCOS were compared by severity of preterm birth [extremely (22+0 to 27+6 weeks), very (28+0 to 31+6 weeks) and moderately (32+0 to 36+6 weeks)] and delivery onset mode (spontaneous or medically indicated). Multinomial logistic regression was performed to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI). Adjustments were made for maternal age, parity, body mass index, smoking, country of birth and year of delivery. Results During the study period, 1.3% of the women giving birth had PCOS diagnosis. They had an overall higher preterm birth rate than women without PCOS (6.7% and 4.8%, respectively). Women with PCOS had increased odds of preterm birth of all severities, with the highest odds for extremely preterm birth (aOR 2.3; 95% CI 1.7-3.0), particularly of spontaneous onset (aOR 2.7; 95% CI 2.0-3.6). Conclusions Women with PCOS had more than a two-fold increased risk of extremely preterm birth with spontaneous onset than women without such diagnosis. This can be important in antenatal risk assessment of preterm birth in women with PCOS. Future research is warranted to investigate the biological mechanisms behind preterm birth in women with PCOS.	[Valgeirsdottir, Heiddis; Poromaa, Inger Sundstrom; Kallak, Theodora Kunovac; Akhter, Tansim; Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Vanky, Eszter] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, Trondheim, Norway; [Vanky, Eszter] Trondheim Reg & Univ Hosp, Dept Obstet & Gynecol, St Olavs Hosp, Trondheim, Norway; [Roos, Nathalie; Stephansson, Olof; Wikstrom, Anna-Karin] Karolinska Inst, Dept Med, Clin Epidemiol Div, Stockholm, Sweden; [Stephansson, Olof] Karolinska Univ Hosp, Dept Womens Hlth, Stockholm, Sweden	Uppsala University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Valgeirsdottir, H (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	heiddis.valgeirsdottir@kbh.uu.se		Kunovac Kallak, Theodora/0000-0002-2112-8674; Roos, Nathalie/0000-0001-9752-2355; Stephansson, Olof/0000-0003-1528-4563	Perinatal Foundation ("Fodelsefonden"), Sweden	Perinatal Foundation ("Fodelsefonden"), Sweden	H.V. was supported by the Perinatal Foundation ("Fodelsefonden"), Sweden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Aus Tariq, 2015, Ceska Gynekol, V80, P279; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bhat G, 2014, REPROD SCI, V21, P340, DOI 10.1177/1933719113497285; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445; Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; Duleba AJ, 2012, FERTIL STERIL, V97, P7, DOI 10.1016/j.fertnstert.2011.11.023; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Ferrero DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162506; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Kallen B., 2003, SWEDISH MED BIRTH RE; Liu MM, 2015, CLIN ENDOCRINOL, V83, P913, DOI 10.1111/cen.12951; Lovvik TS, 2015, BJOG-INT J OBSTET GY, V122, P1295, DOI 10.1111/1471-0528.13339; Lovvik TS, 2019, LANCET DIABETES ENDO, V7, P256, DOI 10.1016/S2213-8587(19)30002-6; Lucaroni F, 2018, J MATERN-FETAL NEO M, V31, P726, DOI 10.1080/14767058.2017.1297404; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Nadeau-Vallee M, 2016, CYTOKINE GROWTH F R, V28, P37, DOI 10.1016/j.cytogfr.2015.11.001; Naver KV, 2014, BJOG-INT J OBSTET GY, V121, P575, DOI 10.1111/1471-0528.12558; Nordstrom L, 2020, HANDLAGGNING NORMAL; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; Palomba S, 2015, HUM REPROD UPDATE, V21, P575, DOI 10.1093/humupd/dmv029; Palomba S, 2014, J CLIN ENDOCR METAB, V99, P2942, DOI 10.1210/jc.2014-1214; Palomba S, 2010, FERTIL STERIL, V94, P1805, DOI 10.1016/j.fertnstert.2009.10.043; Platt MJ, 2014, PUBLIC HEALTH, V128, P399, DOI 10.1016/j.puhe.2014.03.010; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Sterling L, 2016, FERTIL STERIL, V105, P791, DOI 10.1016/j.fertnstert.2015.11.019; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Vogel JP, 2018, BEST PRACT RES CL OB, V52, P3, DOI 10.1016/j.bpobgyn.2018.04.003; Yamamoto M, 2012, J PERINATOL, V32, P770, DOI 10.1038/jp.2011.194; Yildiz BO, 2008, CONT ENDOCRINOL, P333, DOI 10.1007/978-1-59745-108-6_21; Yu HF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004863	37	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246743	10.1371/journal.pone.0246743	http://dx.doi.org/10.1371/journal.pone.0246743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539479	Green Published, gold			2022-12-26	WOS:000616960200079
J	Niela-Vilen, H; Auxier, J; Ekholm, E; Sarhaddi, F; Mehrabadi, MA; Mahmoudzadeh, A; Azimi, I; Liljeberg, P; Rahmani, AM; Axelin, A				Niela-Vilen, Hannakaisa; Auxier, Jennifer; Ekholm, Eeva; Sarhaddi, Fatemeh; Mehrabadi, Milad Asgari; Mahmoudzadeh, Aysan; Azimi, Iman; Liljeberg, Pasi; Rahmani, Amir M.; Axelin, Anna			Pregnant women's daily patterns of well-being before and during the COVID-19 pandemic in Finland: Longitudinal monitoring through smartwatch technology	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; HEALTH; QUALITY; STRESS; LIFE	Background Technology enables the continuous monitoring of personal health parameter data during pregnancy regardless of the disruption of normal daily life patterns. Our research group has established a project investigating the usefulness of an Internet of Things-based system and smartwatch technology for monitoring women during pregnancy to explore variations in stress, physical activity and sleep. The aim of this study was to examine daily patterns of well-being in pregnant women before and during the national stay-at-home restrictions related to the COVID-19 pandemic in Finland. Methods A longitudinal cohort study design was used to monitor pregnant women in their everyday settings. Two cohorts of pregnant women were recruited. In the first wave in January-December 2019, pregnant women with histories of preterm births (gestational weeks 22-36) or late miscarriages (gestational weeks 12-21); and in the second wave between October 2019 and March 2020, pregnant women with histories of full-term births (gestational weeks 37-42) and no pregnancy losses were recruited. The final sample size for this study was 38 pregnant women. The participants continuously used the Samsung Gear Sport smartwatch and their heart rate variability, and physical activity and sleep data were collected. Subjective stress, activity and sleep reports were collected using a smartphone application developed for this study. Data between February 12 to April 8, 2020 were included to cover four-week periods before and during the national stay-at-home restrictions. Hierarchical linear mixed models were exploited to analyze the trends in the outcome variables. Results The pandemic-related restrictions were associated with changes in heart rate variability: the standard deviation of all normal inter-beat intervals (p = 0.034), low-frequency power (p = 0.040) and the low-frequency/high-frequency ratio (p = 0.013) increased compared with the weeks before the restrictions. Women's subjectively evaluated stress levels also increased significantly. Physical activity decreased when the restrictions were set and as pregnancy proceeded. The total sleep time also decreased as pregnancy proceeded, but pandemic-related restrictions were not associated with sleep. Daily rhythms changed in that the participants overall started to sleep later and woke up later. Conclusions The findings showed that Finnish pregnant women coped well with the pandemic-related restrictions and lockdown environment in terms of stress, physical activity and sleep.	[Niela-Vilen, Hannakaisa; Auxier, Jennifer; Axelin, Anna] Univ Turku, Dept Nursing Sci, Turku, Finland; [Ekholm, Eeva; Axelin, Anna] Univ Turku, Turku Univ Hosp, Dept Obstet & Gynaecol, Turku, Finland; [Ekholm, Eeva; Axelin, Anna] Univ Turku, Fac Med, Turku, Finland; [Sarhaddi, Fatemeh; Mahmoudzadeh, Aysan; Azimi, Iman; Liljeberg, Pasi] Univ Turku, Dept Future Technol, Turku, Finland; [Mehrabadi, Milad Asgari; Rahmani, Amir M.] Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA USA; [Rahmani, Amir M.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Rahmani, Amir M.] Univ Calif Irvine, Sch Nursing, Irvine, CA USA	University of Turku; University of Turku; University of Turku; University of Turku; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Niela-Vilen, H (corresponding author), Univ Turku, Dept Nursing Sci, Turku, Finland.	hmniel@utu.fi	azimi, iman/ADF-7907-2022	azimi, iman/0000-0001-5003-299X; Sarhaddi, Fatemeh/0000-0002-5750-5793; Axelin, Anna/0000-0003-2743-3589; rahmani, mohammad/0000-0002-7408-7992; Auxier, Jennifer/0000-0001-9504-2518	Academy of Finland [313448, 313449, 316810, 316811]; U.S. National Science Foundation [CNS-1831918]	Academy of Finland(Academy of Finland); U.S. National Science Foundation(National Science Foundation (NSF))	This research was supported by the Academy of Finland https://www.aka.fi/en/(Awards 313448 (AMR), 313449 (AA), 316810 (AMR), and 316811 (AA)) and U.S. National Science Foundation https://www.nsf.gov/(Award CNS-1831918) (AMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	Agostini F, 2015, MATERN CHILD HLTH J, V19, P1131, DOI 10.1007/s10995-014-1613-x; Azimi I, 2019, FUTURE GENER COMP SY, V96, P297, DOI 10.1016/j.future.2019.02.015; Balserak BI, 2017, PRINCIPLES PRACTICE, VSixth, P1525, DOI 10.1016/j.smrv.2017.09.003; Bolger N, 2013, INTENSIVE LONGITUDIN; Braeken MAKA, 2017, PSYCHOPHYSIOLOGY, V54, P279, DOI 10.1111/psyp.12782; Carolan-Olah M, 2014, MIDWIFERY, V30, P310, DOI 10.1016/j.midw.2013.03.014; Choi A, 2017, PHYSIOL MEAS, V38, P586, DOI 10.1088/1361-6579/aa5efa; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Eichler J, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2328-1; Elgendi Mohamed, 2016, Bioengineering-Basel, V3, P21, DOI 10.3390/bioengineering3040021; Fokkema T, 2017, MED SCI SPORT EXER, V49, P793, DOI 10.1249/MSS.0000000000001146; Georgiou Konstantinos, 2018, Folia Med (Plovdiv), V60, P7, DOI 10.2478/folmed-2018-0012; Grym K, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2187-9; Huizink AC, 2016, ARCH WOMEN MENT HLTH, V19, P125, DOI 10.1007/s00737-015-0531-2; Kim HG, 2018, PSYCHIAT INVEST, V15, P235, DOI 10.30773/pi.2017.08.17; Klinkenberg AV, 2009, ACTA OBSTET GYN SCAN, V88, P77, DOI 10.1080/00016340802566762; Kolu P, 2014, MATERN CHILD HLTH J, V18, P2098, DOI 10.1007/s10995-014-1457-4; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Lagadec N, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2087-4; Mehrabadi MA, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/20465; Moen P, 2011, J HEALTH SOC BEHAV, V52, P404, DOI 10.1177/0022146511418979; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128953; Niela-Vilen H, 2020, J ADV NURS, V76, P243, DOI 10.1111/jan.14223; Official Statistics of Finland, 2020, MAT GRANT; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V2nd ed, DOI [10.2466/pms.2002.94.2.671, DOI 10.2466/PMS.2002.94.2.671]; Rodrigues Paula Borba, 2016, Trends Psychiatry Psychother., V38, P136, DOI 10.1590/2237-6089-2015-0067; Romero R, 2014, AM J OBSTET GYNECOL, V210, P3, DOI 10.1016/j.ajog.2013.11.020; Saarikko J, 2020, JMIR FORM RES, V4, DOI 10.2196/12417; Seabold S., 2010, STATSMODELS ECONOMET, P92, DOI 10.25080/Majora-92bf1922-011.; Sedov ID, 2018, SLEEP MED REV, V38, P168, DOI 10.1016/j.smrv.2017.06.005; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Staneva A, 2015, WOMEN BIRTH, V28, P179, DOI 10.1016/j.wombi.2015.02.003; Teckenberg-Jansson P, 2019, NORD J MUSIC THER, V28, P7, DOI 10.1080/08098131.2018.1546223; van Gent P, 2019, TRANSPORT RES F-TRAF, V66, P368, DOI 10.1016/j.trf.2019.09.015; Zotti ME, 2015, MATERN CHILD HLTH J, V19, P1179, DOI 10.1007/s10995-014-1643-4	35	16	16	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246494	10.1371/journal.pone.0246494	http://dx.doi.org/10.1371/journal.pone.0246494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2OR	33534854	Green Published, gold			2022-12-26	WOS:000616739700006
J	Seipp, R; Zhang, N; Nair, SS; Khamash, H; Sharma, A; Leischow, S; Heilman, R; Keddis, MT				Seipp, Regan; Zhang, Nan; Nair, Sumi Sukumaran; Khamash, Hasan; Sharma, Amit; Leischow, Scott; Heilman, Raymond; Keddis, Mira T.			Patient and allograft outcomes after kidney transplant for the Indigenous patients in the United States	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; RENAL-TRANSPLANTATION; AMERICAN-INDIANS; ETHNIC-DIFFERENCES; NATIVE-AMERICANS; ALASKA NATIVES; DISEASE; INDIVIDUALS; MORTALITY; CANCER	Background The objective is to assess cardiovascular (CV), malignancy, infectious, graft outcomes and tacrolimus levels for the Indigenous patients compared to Whites after kidney transplant (KTx). Methods 165 Indigenous and 165 White patients matched for the KTx year at Mayo Clinic Arizona from 2007-2015 were studied over a median follow-up of 3 years. Propensity score was calculated to account for baseline differences. Results Compared to Whites, Indigenous patients had the following characteristics: younger age, more obesity, diabetes, hypertension, and required dialysis prior to KTx (p<0.01). Indigenous patients had longer hospital stay for KTx, shorter follow-up and lived further from the transplant center (p<0.05). 210 (63.6%) received deceased donor KTx and more Whites received a living donor KTx compared to Indigenous patients (55.2% vs 17.6%, p<0.0001). Post-KTx, there was no difference in the CV event rates. The cumulative incidence of infectious complications was higher among the Indigenous patients (HR 1.81, p = 0.0005, 48.5% vs 38.2%, p = 0.013), with urinary causes as the most common. Malignancy rates were increased among Whites (13.3% vs 3.0%, p = 0.001) with skin cancer being the most common. There was a significant increase in the dose normalized tacrolimus level for the Indigenous patients compared to Whites at 1 months, 3 months, and 1 year post-KTx. After adjustment for the propensity score, there was no statistical difference in infectious or graft outcomes between the two groups but the mean number of emergency room visits and hospitalizations after KTx was significantly higher for Whites compared to Indigenous patients. Conclusions Compared to Whites, Indigenous patients have similar CV events, graft outcomes and infectious complications after accounting for baseline differences.	[Seipp, Regan; Nair, Sumi Sukumaran; Khamash, Hasan; Heilman, Raymond; Keddis, Mira T.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Phoenix, AZ 85054 USA; [Zhang, Nan] Mayo Clin, Sect Biostat, Dept Hlth Sci Res, Phoenix, AZ USA; [Sharma, Amit] Mayo Clin, Div Dermatol, Dept Med, Phoenix, AZ USA; [Leischow, Scott] Mayo Clin, Off Hlth Care Dispar, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Keddis, MT (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Phoenix, AZ 85054 USA.	keddis.mira@mayo.edu	Heilman, Raymond/AAW-5138-2020	nair, sumi/0000-0001-9688-8216; Seipp, Regan/0000-0002-8463-8751	Mayo Clinic Office of Healthcare Disparities Pilot Fund in 2017; Office of Healthcare Disparities Pilot Fund	Mayo Clinic Office of Healthcare Disparities Pilot Fund in 2017; Office of Healthcare Disparities Pilot Fund	M.T.K received intramural funding from the Mayo Clinic Office of Healthcare Disparities Pilot Fund in 2017. The Office of Healthcare Disparities Pilot Fund was in the form of 5% time allocated throughout a calendar year for completion of the study and not in the form of a salary for any of the authors. M.T.K received the 5% time for completion of the study. Members of the Office of Healthcare Disparity at Mayo Clinic Minnesota who awarded this fund did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation or review of the manuscript. Dr. Scott Leischow, coauthor on this manuscript, served as local director of the Office of Health Care Disparity at Mayo Clinic Arizona and did not participate in the application selection for this funding opportunity.	BRAUN WE, 1990, KIDNEY INT, V37, P1363, DOI 10.1038/ki.1990.123; Burrows NR, 2014, AM J PUBLIC HEALTH, V104, pS490, DOI 10.2105/AJPH.2014.301942; Chakkera HA, 2013, TRANSPL P, V45, P137, DOI 10.1016/j.transproceed.2012.10.023; Cho P, 2014, AM J PUBLIC HEALTH, V104, pS496, DOI 10.2105/AJPH.2014.301968; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; Devine PA, 2019, J NEPHROL, V32, P389, DOI 10.1007/s40620-018-0549-4; Devitt J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0726-z; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Golebiewska J, 2011, TRANSPL P, V43, P2985, DOI 10.1016/j.transproceed.2011.07.010; Golebiewska JE, 2014, CLIN TRANSPLANT, V28, P1263, DOI 10.1111/ctr.12465; Grover A, 2011, DRUG METAB DISPOS, V39, P2017, DOI 10.1124/dmd.111.041350; Hall EC, 2013, AM J TRANSPLANT, V13, P714, DOI 10.1111/ajt.12066; Hall YN, 2011, J AM SOC NEPHROL, V22, P743, DOI 10.1681/ASN.2010080819; Ilyas M, 2018, INT J DERMATOL, V57, P406, DOI 10.1111/ijd.13863; Jolly SE, 2011, CLIN J AM SOC NEPHRO, V6, P1858, DOI 10.2215/CJN.00500111; Jolly SE, 2010, AM J KIDNEY DIS, V55, pS15, DOI 10.1053/j.ajkd.2009.09.034; Jolly SE, 2009, AM J NEPHROL, V29, DOI 10.1159/000174857; Jones MA, 2018, NEW ZEAL MED J, V131, P10; Kasiske BL, 1998, TRANSPLANTATION, V66, P209, DOI 10.1097/00007890-199807270-00012; Keddis M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024671; Keddis MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207819; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; Mohamed ME, 2019, AM J TRANSPLANT, V19, P2795, DOI 10.1111/ajt.15385; Narva A, 1996, BLOOD PURIFICAT, V14, P293, DOI 10.1159/000170276; Narva AS, 2002, J NATL MED ASSOC, V94, P738; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Sequist TD, 2004, AM J KIDNEY DIS, V44, P344, DOI 10.1053/j.ajkd.2004.04.039; Smith Mary, 2015, CANNT J, V25, P13; STERLING WA, 1980, TRANSPLANTATION, V29, P165, DOI 10.1097/00007890-198002000-00016; Walker RC, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1115-y	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0244492	10.1371/journal.pone.0244492	http://dx.doi.org/10.1371/journal.pone.0244492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534846	gold, Green Published			2022-12-26	WOS:000616739700038
J	Kazama, T; Hayakawa, K; Kuwahara, VS; Shimotori, K; Imai, A; Komatsu, K				Kazama, Takehiro; Hayakawa, Kazuhide; Kuwahara, Victor S.; Shimotori, Koichi; Imai, Akio; Komatsu, Kazuhiro			Development of photosynthetic carbon fixation model using multi-excitation wavelength fast repetition rate fluorometry in Lake Biwa	PLOS ONE			English	Article							PHYTOPLANKTON PRIMARY PRODUCTION; ELECTRON-TRANSPORT; PRIMARY PRODUCTIVITY; CHLOROPHYLL FLUORESCENCE; ABSORPTION-COEFFICIENTS; LIMITED PHYTOPLANKTON; MARINE-PHYTOPLANKTON; LIGHT-ABSORPTION; ARIAKE BAY; IN-SITU	Direct measurements of gross primary productivity (GPP) in the water column are essential, but can be spatially and temporally restrictive. Fast repetition rate fluorometry (FRRf) is a bio-optical technique based on chlorophyll a (Chl-a) fluorescence that can estimate the electron transport rate (ETRPSII) at photosystem II (PSII) of phytoplankton in real time. However, the derivation of phytoplankton GPP in carbon units from ETRPSII remains challenging because the electron requirement for carbon fixation (CYRILLIC CAPITAL LETTER EFe,C), which is mechanistically 4 mol e(-) mol C-1 or above, can vary depending on multiple factors. In addition, FRRf studies are limited in freshwater lakes where phosphorus limitation and cyanobacterial blooms are common. The goal of the present study is to construct a robust CYRILLIC CAPITAL LETTER EFe,C model for freshwater ecosystems using simultaneous measurements of ETRPSII by FRRf with multi-excitation wavelengths coupled with a traditional carbon fixation rate by the C-13 method. The study was conducted in oligotrophic and mesotrophic parts of Lake Biwa from July 2018 to May 2019. The combination of excitation light at 444, 512 and 633 nm correctly estimated ETRPSII of cyanobacteria. The apparent range of CYRILLIC CAPITAL LETTER EFe,C in the phytoplankton community was 1.1-31.0 mol e(-) mol C-1 during the study period. A generalised linear model showed that the best fit including 12 physicochemical and biological factors explained 67% of the variance in CYRILLIC CAPITAL LETTER EFe,C. Among all factors, water temperature was the most significant, while photosynthetically active radiation intensity was not. This study quantifies the in situ FRRf method in a freshwater ecosystem, discusses core issues in the methodology to calculate CYRILLIC CAPITAL LETTER EFe,C, and assesses the applicability of the method for lake GPP prediction.	[Kazama, Takehiro; Shimotori, Koichi; Imai, Akio] Natl Inst Environm Studies, Lake Biwa Branch Off, Otsu, Shiga, Japan; [Kazama, Takehiro; Shimotori, Koichi; Komatsu, Kazuhiro] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki, Japan; [Hayakawa, Kazuhide] Lake Biwa Environm Res Inst, Otsu, Shiga, Japan; [Kuwahara, Victor S.] Soka Univ, Grad Sch Sci & Engn, Hachioji, Tokyo, Japan	National Institute for Environmental Studies - Japan; Soka University	Kazama, T (corresponding author), Natl Inst Environm Studies, Lake Biwa Branch Off, Otsu, Shiga, Japan.; Kazama, T (corresponding author), Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki, Japan.	kazama.takehiro@nies.go.jp		Kazama, Takehiro/0000-0002-2612-5202; Kuwahara, Victor S./0000-0003-4171-3894	Collaborative Research Fund from Shiga Prefecture entitled "Study on water quality and lake-bottom environment for protection of the soundness of water environment" under the Japanese Grant for Regional Revitalization; Ministry of the Environment, Japan [5-1607]	Collaborative Research Fund from Shiga Prefecture entitled "Study on water quality and lake-bottom environment for protection of the soundness of water environment" under the Japanese Grant for Regional Revitalization; Ministry of the Environment, Japan(Ministry of the Environment, Japan)	TK, KH, KS and AI were supported by the Collaborative Research Fund from Shiga Prefecture entitled "Study on water quality and lake-bottom environment for protection of the soundness of water environment" under the Japanese Grant for Regional Revitalization, and the Environment Research and Technology Development Fund (No. 5-1607) of the Ministry of the Environment, Japan. https://www.kantei.go.jp/jp/singi/tiiki/tiikisaisei/souseikoufukin.html.	Aiba S., 1982, ADV BIOCHEM ENG BIOT, V23, P85, DOI DOI 10.1007/3540116982_3; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2013, FRONT PLANT SCI, DOI DOI 10.3389/FPLS.2013.0000423355843; [Anonymous], [No title captured]; [Anonymous], 2015, MED J ARMED FORCES I, V71, pS221; Aspinwall CL, 2004, PHOTOSYNTH RES, V79, P179, DOI 10.1023/B:PRES.0000015399.43503.95; Barton K., 2022, MULTIMODEL INFERENCE; Belzile C, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003090; Belzile C, 2002, LIMNOL OCEANOGR, V47, P95, DOI 10.4319/lo.2002.47.1.0095; Bender ML, 1987, GLOBAL BIOGEOCHEM CY, V1, P49, DOI 10.1029/GB001i001p00049; Boatman TG, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00319; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Capuzzo E, 2018, GLOBAL CHANGE BIOL, V24, pE352, DOI 10.1111/gcb.13916; Carpenter EJ, 1980, PRIMARY PRODUCTIVITY, P161, DOI [10.1007/978-1-4684-3890-1_9, DOI 10.1007/978-1-4684-3890-1_9]; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Corno G, 2006, J PHYCOL, V42, P51, DOI 10.1111/j.1529-8817.2006.00163.x; Cosgrove J., 2015, J R SOC W AUST, V98, P19; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fernandez-Gonzalez C, 2020, J PHYCOL, V56, P818, DOI 10.1111/jpy.12983; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gorbunov MY, 2021, LIMNOL OCEANOGR, V66, P1, DOI 10.1002/lno.11581; Hagemann M, 2016, J EXP BOT, V67, P2915, DOI 10.1093/jxb/erw178; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hatton IA, 2015, SCIENCE, V349, P1070, DOI 10.1126/science.aac6284; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hirose H, 1969, BOT MAG TOKYO; Hoppe CJM, 2015, NEW PHYTOL, V207, P159, DOI 10.1111/nph.13334; Houliez E, 2017, J MARINE SYST, V169, P40, DOI 10.1016/j.jmarsys.2017.01.007; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Hughes DJ, 2018, LIMNOL OCEANOGR, V63, P1891, DOI 10.1002/lno.10814; Hughes DJ, 2018, ENVIRON SCI TECHNOL, V52, P12039, DOI 10.1021/acs.est.8b03488; Iniguez C, 2020, PLANT J, V101, P897, DOI 10.1111/tpj.14643; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Jones BM, 2017, LIMNOL OCEANOGR-METH, V15, P928, DOI 10.1002/lom3.10213; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Kaiblinger C, 2007, HYDROBIOLOGIA, V578, P29, DOI 10.1007/s10750-006-0430-7; Kaiblinger C, 2006, PHOTOSYNTH RES, V88, P19, DOI 10.1007/s11120-005-9018-8; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kirilovsky D, 2015, PHOTOSYNTH RES, V126, P3, DOI 10.1007/s11120-014-0031-7; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; Kulk G, 2018, LIMNOL OCEANOGR, V63, P2606, DOI 10.1002/lno.10963; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; Longstaff BJ, 2002, PHOTOSYNTH RES, V74, P281, DOI 10.1023/A:1021279627409; Luz B, 2002, LIMNOL OCEANOGR, V47, P33, DOI 10.4319/lo.2002.47.1.0033; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; MEGARD RO, 1984, J PLANKTON RES, V6, P325, DOI 10.1093/plankt/6.2.325; Melrose DC, 2006, MAR ECOL PROG SER, V311, P37, DOI 10.3354/meps311037; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Milligan AJ, 2015, J PLANKTON RES, V37, P692, DOI 10.1093/plankt/fbv051; Miyajima T, 1997, BIOGEOCHEMISTRY, V36, P205, DOI 10.1023/A:1005702707183; Morelle J, 2018, ESTUAR COAST, V41, P1337, DOI 10.1007/s12237-018-0369-8; Napoleon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066423; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; New Energy and Industrial Technology Development Organization (NEDO), 2016, SOL RAD SPECTR DAT; Nishino M., 2012, LAKE BIWA INTERACTIO, P155, DOI 10.1007/978-94-007-1783-1_3; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; OGREN WL, 1984, ANNU REV PLANT PHYS, V35, P415, DOI 10.1146/annurev.pp.35.060184.002215; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Paavel B, 2016, J LIMNOL, V75, P423, DOI 10.4081/jlimnol.2016.1426; Paerl HW, 2016, ENVIRON SCI TECHNOL, V50, P10805, DOI 10.1021/acs.est.6b02575; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; PEETERS J C H, 1978, Hydrobiological Bulletin, V12, P134, DOI 10.1007/BF02260714; Pemberton KL, 2007, CAN J FISH AQUAT SCI, V64, P58, DOI 10.1139/F06-166; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Pringault O, 2007, BIOGEOSCIENCES, V4, P105, DOI 10.5194/bg-4-105-2007; R Development Core Team, 2020, R LANG ENV STAT COMP; Raateoja M, 2004, LIMNOL OCEANOGR, V49, P1006, DOI 10.4319/lo.2004.49.4.1006; Regaudie-de-Gioux A, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00019; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Robinson C, 2014, J MARINE SYST, V139, P299, DOI 10.1016/j.jmarsys.2014.07.016; Robinson C, 2009, AQUAT MICROB ECOL, V54, P13, DOI 10.3354/ame01250; ROHATGI A, 1979, MOL GEN GENET, V169, P59, DOI 10.1007/BF00267545; Rolland A, 2010, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2010023; Ryan-Keogh TJ, 2018, LIMNOL OCEANOGR, V63, P1856, DOI 10.1002/lno.10812; Saroussi SI, 2016, PLANT PHYSIOL, V170, P1975, DOI 10.1104/pp.15.02014; SCHINDLER DW, 1978, LIMNOL OCEANOGR, V23, P478, DOI 10.4319/lo.1978.23.3.0478; Schuback N, 2017, LIMNOL OCEANOGR, V62, P898, DOI 10.1002/lno.10475; Schuback N, 2016, BIOGEOSCIENCES, V13, P1019, DOI 10.5194/bg-13-1019-2016; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; SCHUBERT H, 1989, J PLANKTON RES, V11, P353, DOI 10.1093/plankt/11.2.353; Silsbe GM, 2015, CAN J FISH AQUAT SCI, V72, P651, DOI 10.1139/cjfas-2014-0365; Simis SGH, 2012, PHOTOSYNTH RES, V112, P13, DOI 10.1007/s11120-012-9729-6; SLAWYK G, 1977, LIMNOL OCEANOGR, V22, P925, DOI 10.4319/lo.1977.22.5.0925; Smyth TJ, 2004, J PLANKTON RES, V26, P1337, DOI 10.1093/plankt/fbh124; Sorokin YI, 1999, RADIOISOTOPIC METHOD, P21, DOI [10.1007/978-3-642-59934-7_2, DOI 10.1007/978-3-642-59934-7_2]; Staehr PA, 2004, INT J REMOTE SENS, V25, P5117, DOI 10.1080/01431160410001716932; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strickland J.D., 1972, J FISH RES BOARD CAN; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P608, DOI 10.4319/lo.1999.44.3.0608; Suggett D, 2001, LIMNOL OCEANOGR, V46, P802, DOI 10.4319/lo.2001.46.4.0802; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Terrel MM, 2012, LIMNOLOGY, V13, P237, DOI 10.1007/s10201-012-0372-x; Tripathy SC, 2010, ESTUAR COAST SHELF S, V87, P163, DOI 10.1016/j.ecss.2010.01.006; Uemura Y, 2012, LAKE BIWA INTERACTIO, P3; VENRICK EL, 1977, J EXP MAR BIOL ECOL, V26, P55, DOI 10.1016/0022-0981(77)90080-6; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Wei YQ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01164; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wojtasiewicz B, 2016, J APPL PHYCOL, V28, P2299, DOI 10.1007/s10811-015-0774-3; WYMAN M, 1986, PROC R SOC SER B-BIO, V227, P367, DOI 10.1098/rspb.1986.0027; Yanagi T., 2015, EUTROPHICATION OLIGO, P39, DOI [10.1007/978-94-017-9915-7_3, DOI 10.1007/978-94-017-9915-7_3]; Yellowlees D, 2003, ADV PHOTO RESPIRAT, V14, P437; Ylostalo P, 2014, REMOTE SENS ENVIRON, V148, P190, DOI 10.1016/j.rse.2014.03.023; Zhao Y, 2015, CONT SHELF RES, V102, P33, DOI 10.1016/j.csr.2015.04.014; Zhu Y, 2016, J OCEANOGR, V72, P761, DOI 10.1007/s10872-016-0370-4; Zhu YL, 2017, MAR ECOL PROG SER, V580, P83, DOI 10.3354/meps12310	127	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0238013	10.1371/journal.pone.0238013	http://dx.doi.org/10.1371/journal.pone.0238013			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529253	gold, Green Submitted, Green Published			2022-12-26	WOS:000616736200051
J	Sayinzoga, F; Lundeen, T; Musange, SF; Butrick, E; Nzeyimana, D; Murindahabi, N; Azman-Firdaus, H; Sloan, NL; Benitez, A; Phillips, B; Ghosh, R; Walker, D				Sayinzoga, Felix; Lundeen, Tiffany; Musange, Sabine F.; Butrick, Elizabeth; Nzeyimana, David; Murindahabi, Nathalie; Azman-Firdaus, Hana; Sloan, Nancy L.; Benitez, Alejandra; Phillips, Beth; Ghosh, Rakesh; Walker, Dilys			Assessing the impact of group antenatal care on gestational length in Rwanda: A cluster-randomized trial	PLOS ONE			English	Article							GROUP PRENATAL-CARE; PERINATAL OUTCOMES; MODEL	Background Research on group antenatal care in low- and middle-income contexts suggests high acceptability and preliminary implementation success. Methods We studied the effect of group antenatal care on gestational age at birth among women in Rwanda, hypothesizing that participation would increase mean gestational length. For this unblinded cluster randomized trial, 36 health centers were pair-matched and randomized; half continued individual antenatal care (control), half implemented group antenatal care (intervention). Women who initiated antenatal care between May 2017 and December 2018 were invited to participate, and included in analyses if they presented before 24 weeks gestation, attended at least two visits, and their birth outcome was obtained. We used a generalized estimating equations model for analysis. Findings In total, 4091 women in 18 control clusters and 4752 women in 18 intervention clusters were included in the analysis. On average, women attended three total antenatal care visits. Gestational length was equivalent in the intervention and control groups (39.3 weeks (SD 1.6) and 39.3 weeks (SD 1.5)). There were no significant differences between groups in secondary outcomes except that more women in control sites attended postnatal care visits (40.1% versus 29.7%, p = 0.003) and more women in intervention sites attended at least three total antenatal care visits (80.7% versus 71.7%, p = 0.003). No harms were observed. Interpretation Group antenatal care did not result in a difference in gestational length between groups. This may be due to the low intervention dose. We suggest studies of both the effectiveness and costs of higher doses of group antenatal care among women at higher risk of preterm birth. We observed threats to group care due to facility staff shortages; we recommend studies in which antenatal care providers are exclusively allocated to group antenatal care during visits.	[Sayinzoga, Felix] Rwanda Biomed Ctr, Maternal Child & Community Hlth Div, Kigali, Rwanda; [Lundeen, Tiffany; Butrick, Elizabeth; Azman-Firdaus, Hana; Sloan, Nancy L.; Phillips, Beth; Ghosh, Rakesh; Walker, Dilys] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Musange, Sabine F.; Nzeyimana, David; Murindahabi, Nathalie] Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda; [Benitez, Alejandra] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Walker, Dilys] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	Rwanda Biomedical Center; University of California System; University of California San Francisco; University of Rwanda; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Lundeen, T (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	tiffany.lundeen@gmail.com		Nzeyimana, David/0000-0002-1389-7107	East Africa Preterm Birth initiative - Bill and Melinda Gates Foundation [OPP1107312]	East Africa Preterm Birth initiative - Bill and Melinda Gates Foundation	This trial is supported by the East Africa Preterm Birth initiative, a multi-year, multi-country effort generously funded by the Bill and Melinda Gates Foundation (OPP1107312). The Foundation's website is www.gatesfoundation.org.The funder reviewed the study design but did not have input on analysis or interpretation of results.	Butrick Elizabeth, 2020, Gates Open Res, V4, P7, DOI 10.12688/gatesopenres.13090.1; Catling CJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007622.pub3; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Grenier L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222177; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes G, 2017, STUD CAN MIL HIST, P1; IBM Corp, 2017, REL IBM SPSS STAT VE; Ickovics JR, 2007, OBSTET GYNECOL, V110, P330, DOI 10.1097/01.AOG.0000275284.24298.23; Ickovics JR, 2016, AM J PUBLIC HEALTH, V106, P359, DOI 10.2105/AJPH.2015.302960; Lori JR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1414-5; Lu B, 2011, AM STAT, V65, P21, DOI 10.1198/tast.2011.08294; Lundeen T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219471; Manant A, 2011, J MIDWIFERY WOM HEAL, V56, P94, DOI 10.1111/j.1542-2011.2010.00021.x; Mazzoni SE, 2017, AM J OBSTET GYNECOL, V216, P552, DOI 10.1016/j.ajog.2017.02.006; Musabyimana A, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0750-5; Musange Sabine Furere, 2019, Gates Open Res, V3, P1548, DOI 10.12688/gatesopenres.13053.1; National Institute of Statistics of Rwanda Ministry of Finance and Economic Planning Ministry of Health TDPII, 2016, RWAND DEM HLTH SURV; Nizeyimana Pacifique, 2018, [Journal of the Korean Data And Information Science Sociaty, 한국데이터정보과학회지], V29, P547, DOI 10.7465/jkdi.2018.29.2.547; Patil CL, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1493-3; Patil CL, 2017, INT J GYNECOL OBSTET, V139, P290, DOI 10.1002/ijgo.12324; Press S, 2019, STAT STAT SOFTW REL; R Core Team, 2019, R LANG ENV STAT COMP; Rising SS, 1998, J NURSE-MIDWIFERY, V43, P46, DOI 10.1016/S0091-2182(97)00117-1; Sayinzoga F, 2018, J MIDWIFERY WOM HEAL, V63, P593, DOI 10.1111/jmwh.12871; Thielen K, 2012, J PERINAT EDUC, V21, P209, DOI 10.1891/1058-1243.21.4.209; Villar J, 2014, LANCET; WHO, REC ANT CAR POS PREG	27	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246442	10.1371/journal.pone.0246442	http://dx.doi.org/10.1371/journal.pone.0246442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529256	Green Published, gold			2022-12-26	WOS:000616736200066
J	Velingkaar, N; Mezhnina, V; Poe, A; Kondratov, RV				Velingkaar, Nikkhil; Mezhnina, Volha; Poe, Allan; Kondratov, Roman, V			Two-meal caloric restriction induces 12-hour rhythms and improves glucose homeostasis	FASEB JOURNAL			English	Article						aging; metabolism; diet; circadian rhythms; gene expression; glucose homeostasis; 12&#8208; hour rhythms	PERIPHERAL CIRCADIAN CLOCKS; MTOR SIGNALING PATHWAY; DIETARY RESTRICTION; FOOD-INTAKE; LIFE-SPAN; METABOLISM; LIVER; TIME; GROWTH; MICE	Glucose metabolism is tightly regulated and disrupting glucose homeostasis is a hallmark of many diseases. Caloric restriction (CR), periodic fasting, and circadian rhythms are interlinked with glucose metabolism. Here, we directly investigated if CR depends on periodic fasting and circadian rhythms to improve glucose metabolism. CR was implemented as two-meals per day (2M-CR), provided at 12-hour intervals, and compared with one meal per day CR, mealtime (MT), and ad libitum (AL) feeding. The 2M-CR impacted the circadian rhythms in blood glucose, metabolic signaling, circadian clock, and glucose metabolism gene expression. 2M-CR significantly reduced around the clock blood glucose and improved glucose tolerance. Twenty-four-hour rhythms in mTOR signaling and gene expression observed under AL, MT, and CR, became 12-hour rhythms in 2M-CR. The 12-hour rhythms in behavior, gene expression, and signaling persisted in fasted mice, implicating some internal regulation. The study highlights that the reduction in caloric intake rather than meal frequency and duration of fasting is essential for metabolic reprograming and improvement in glucose metabolism and provides evidence on food-entrained molecular pacemaker, which can be uncoupled from the light-entrained circadian clock and rhythms.	[Velingkaar, Nikkhil; Mezhnina, Volha; Poe, Allan; Kondratov, Roman, V] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Velingkaar, Nikkhil; Mezhnina, Volha; Poe, Allan; Kondratov, Roman, V] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Velingkaar, N; Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.; Velingkaar, N; Kondratov, RV (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	n.velingkaar@vikes.csuohio.edu; r.kondratov@csuohio.edu	Velingkaar, Nikkhil/ABC-8132-2020	Velingkaar, Nikkhil/0000-0003-1571-0833; Mezhnina, Volha/0000-0001-9634-0410	NIA NIH HHS [R01 AG039547] Funding Source: Medline; NIH HHS [S10 OD025252] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Aguilar-Arnal L, 2015, P NATL ACAD SCI USA, V112, P6863, DOI 10.1073/pnas.1411264111; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao R, 2013, NEURON, V79, P712, DOI 10.1016/j.neuron.2013.06.026; Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chavan R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10580; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Greenwell BJ, 2019, CELL REP, V27, P649, DOI 10.1016/j.celrep.2019.03.064; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamming DW, 2011, CELL METAB, V13, P617, DOI 10.1016/j.cmet.2011.05.006; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mukherji A, 2015, P NATL ACAD SCI USA, V112, pE6683, DOI 10.1073/pnas.1519735112; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Patel SA, 2016, FASEB J, V30, P1634, DOI 10.1096/fj.15-282475; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Ray S, 2020, SCIENCE, V367, P800, DOI 10.1126/science.aaw7365; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Solovev I, 2019, BIOGERONTOLOGY, V20, P159, DOI 10.1007/s10522-018-9784-2; Sutton EF, 2018, CELL METAB, V27, P1212, DOI 10.1016/j.cmet.2018.04.010; Taormina G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/308690; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; Tulsian R, 2018, AGING-US, V10, P1640, DOI 10.18632/aging.101498; Ulgherait M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15617-x; Velingkaar N, 2020, AGING CELL, V19, DOI 10.1111/acel.13138; Wu R, 2019, CELL METAB, V29, P653, DOI 10.1016/j.cmet.2018.11.006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	54	1	1	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21342	10.1096/fj.202002470R	http://dx.doi.org/10.1096/fj.202002470R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33543540	hybrid, Green Published			2022-12-26	WOS:000647789600033
J	Hu, Z; Ma, JC; Chen, YC; Tong, WH; Zhu, L; Wang, HH; Cronan, JE				Hu, Zhe; Ma, Jincheng; Chen, Yicai; Tong, Wenhua; Zhu, Lei; Wang, Haihong; Cronan, John E.			Escherichia coli FabG 3-ketoacyl-ACP reductase proteins lacking the assigned catalytic triad residues are active enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-CARRIER PROTEIN; SITE-DIRECTED MUTAGENESIS; MISMATCH-REPAIR; DEHYDROGENASE; CRYSTALLIZATION; BIOSYNTHESIS; COFACTOR; MUTANTS	The FabG 3-ketoacyl-acyl carrier protein (ACP) reductase of Escherichia coli has long been thought to be a classical member of the short-chain alcohol dehydrogenase/reductase (SDR) family. FabG catalyzes the essential 3-ketoacyl-ACP reduction step in the FAS II fatty acid synthesis pathway. Site-directed mutagenesis studies of several other SDR enzymes has identified three highly conserved amino acid residues, Ser, Tyr, and Lys, as the catalytic triad. Structural analyses of E. coli FabG suggested the triad S138-Y151-K155 to form a catalytically competent active site. To test this hypothesis, we constructed a series of E. coli FabG mutants and tested their 3-ketoacyl-ACP reductase activities both in vivo and in vitro. Our data show that plasmid-borne FabG mutants, including the double and triple mutants, restored growth of E. coli and Salmonella enterica fabG temperature-sensitive mutant strains under nonpermissive conditions. In vitro assays demonstrated that all of the purified FabG mutant proteins maintained fatty acid synthetic ability, although the activities of the single mutant proteins were 20% to 50% lower than that of wildtype FabG. The S138A, Y151F, and K155A residue substitutions were confirmed by tandem mass spectral sequencing of peptides that spanned all three residues. We conclude that FabG is not a classical short-chain alcohol dehydrogenase/reductase, suggesting that an alternative mode of 3-ketoacyl-ACP reduction awaits discovery.	[Hu, Zhe; Ma, Jincheng; Chen, Yicai; Tong, Wenhua; Zhu, Lei; Wang, Haihong] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China; [Hu, Zhe; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tong, Wenhua; Zhu, Lei] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China; [Tong, Wenhua] Sichuan Univ Sci & Engn, Coll Bioengn, Yibin 644000, Sichuan, Peoples R China	South China Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Shandong Agricultural University; Sichuan University of Science & Engineering	Wang, HH (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China.; Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.; Cronan, JE (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	wanghh36@scau.edu.cn; jecronan@illinois.edu		Tong, Wenhua/0000-0002-3952-0025; Hu, Zhe/0000-0002-6864-2099	National Natural Science Foundation of China [31671987, 31972232]; NIH [AI15650]; National Institute of Allergy and Infectious Diseases	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Natural Science Foundation of China (Grant numbers: 31671987 and 31972232) and by NIH grant AI15650 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; Cheng JL, 2012, APPL ENVIRON MICROB, V78, P1563, DOI 10.1128/AEM.07335-11; COLS N, 1993, FEBS LETT, V319, P90, DOI 10.1016/0014-5793(93)80043-T; Cronan JE, 2004, CHEM BIOL, V11, P1601, DOI 10.1016/j.chembiol.2004.11.011; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; Fisher M, 2000, ACTA CRYSTALLOGR D, V56, P86, DOI 10.1107/S0907444999013918; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karmodiya K, 2006, FEBS J, V273, P4093, DOI 10.1111/j.1742-4658.2006.05412.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kristan K, 2009, CHEM-BIOL INTERACT, V178, P310, DOI 10.1016/j.cbi.2008.09.030; Lai CY, 2004, J BACTERIOL, V186, P1869, DOI 10.1128/JB.186.6.1869-1878.2004; Mao QL, 2007, ACTA CRYSTALLOGR F, V63, P106, DOI 10.1107/S1744309107000103; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; RADMAN M, 1986, ANNU REV GENET, V20, P523, DOI 10.1146/annurev.ge.20.120186.002515; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Tanabe T, 1998, J BIOCHEM, V124, P634, DOI 10.1093/oxfordjournals.jbchem.a022159; ULRICH AK, 1983, J BACTERIOL, V154, P221, DOI 10.1128/JB.154.1.221-230.1983; Wang HH, 2004, BIOCHEMISTRY-US, V43, P11782, DOI 10.1021/bi0487600; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	34	1	1	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100365	10.1016/j.jbc.2021.100365	http://dx.doi.org/10.1016/j.jbc.2021.100365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545175	gold, Green Published			2022-12-26	WOS:000672866400339
J	Maidment, JHR; Franceschetti, M; Maqbool, A; Saitoh, H; Jantasuriyarat, C; Kamoun, S; Terauchi, R; Banfield, MJ				Maidment, Josephine H. R.; Franceschetti, Marina; Maqbool, Abbas; Saitoh, Hiromasa; Jantasuriyarat, Chatchawan; Kamoun, Sophien; Terauchi, Ryohei; Banfield, Mark J.			Multiple variants of the fungal effector AVR-Pik bind the HMA domain of the rice protein OsHIPP19, providing a foundation to engineer plant defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLAST RESISTANCE GENE; PATHOGEN EFFECTORS; ARMS-RACE; DECOY; IMMUNITY; TARGETS; MODEL	Microbial plant pathogens secrete effector proteins, which manipulate the host to promote infection. Effectors can be recognized by plant intracellular nucleotide-binding leucine-rich repeat (NLR) receptors, initiating an immune response. The AVR-Pik effector from the rice blast fungus Magnaporthe oryzae is recognized by a pair of rice NLR receptors, Pik-1 and Pik-2. Pik-1 contains a noncanonical integrated heavy-metal-associated (HMA) domain, which directly binds AVR-Pik to activate plant defenses. The host targets of AVR-Pik are also HMA-domain-containing proteins, namely heavy-metal-associated isoprenylated plant proteins (HIPPs) and heavy-metal-associated plant proteins (HPPs). Here, we demonstrate that one of these targets interacts with a wider set of AVR-Pik variants compared with the Pik-1 HMA domains. We define the biochemical and structural basis of the interaction between AVR-Pik and OsHIPP19 and compare the interaction to that formed with the HMA domain of Pik-1. Using analytical gel filtration and surface plasmon resonance, we show that multiple AVR-Pik variants, including the stealthy variants AVR-PikC and AVR-PikF, which do not interact with any characterized Pik-1 alleles, bind to OsHIPP19 with nanomolar affinity. The crystal structure of OsHIPP19 in complex with AVR-PikF reveals differences at the interface that underpin high-affinity binding of OsHIPP19-HMA to a wider set of AVR-Pik variants than achieved by the integrated HMA domain of Pik-1. Our results provide a foundation for engineering the HMA domain of Pik-1 to extend binding to currently unrecognized AVR-Pik variants and expand disease resistance in rice to divergent pathogen strains.	[Maidment, Josephine H. R.; Franceschetti, Marina; Maqbool, Abbas; Jantasuriyarat, Chatchawan; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich, Norfolk, England; [Saitoh, Hiromasa] Tokyo Univ Agr, Fac Life Sci, Dept Mol Microbiol, Tokyo, Japan; [Jantasuriyarat, Chatchawan] Kasetsart Univ, Dept Genet, Fac Sci, Natl Res Univ,CASTNAR,NRU KU, Bangkok, Thailand; [Jantasuriyarat, Chatchawan] Kasetsart Univ, Natl Res Univ, CASTNAR, NRU KU,Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand; [Maidment, Josephine H. R.; Maqbool, Abbas; Kamoun, Sophien] Univ East Anglia, Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Div Genom & Breeding, Kitakami, Iwate, Japan; [Terauchi, Ryohei] Kyoto Univ, Grad Sch Agr, Lab Crop Evolut, Kyoto, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Tokyo University of Agriculture; Kasetsart University; Kasetsart University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Iwate Biotechnology Research Center; Kyoto University	Banfield, MJ (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich, Norfolk, England.	mark.banfield@jic.ac.uk	Kamoun, Sophien/B-3529-2009; Banfield, Mark/C-7453-2013; Maqbool, Abbas/ABF-8279-2021; Terauchi, Ryohei/Y-2992-2019; Maqbool, Abbas/G-3191-2016	Kamoun, Sophien/0000-0002-0290-0315; Banfield, Mark/0000-0001-8921-3835; Terauchi, Ryohei/0000-0002-0095-4651; Saitoh, Hiromasa/0000-0002-0124-9276; Maqbool, Abbas/0000-0002-6189-5560; Maidment, Josephine/0000-0002-8229-2718	UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK [BB/M011216/1]; UKRI BBSRC, UK [BB/P012574, BB/M02198X]; European Research Council [ERC] [743165]; John Innes Foundation; JSPS [15H05779, 20H05681]; JSPS/The Royal Society Bilateral Research; BBSRC [BBS/E/J/000PR9795, BB/M022315/1, BBS/E/J/000PR9797, 1654182] Funding Source: UKRI	UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UKRI BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council [ERC](European Research Council (ERC)European Commission); John Innes Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS/The Royal Society Bilateral Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Diamond Light Source (beamline I03) for access to X-ray data collection facilities. We thank Professor David Lawson and Dr Clare Stevenson (JIC X-ray Crystallography/Biophysical Analysis Platform) for help with X-ray data collection and SPR and Andrew Davies and Phil Robinson from JIC Scientific Photography. We also thank Dr Freya Varden for constructive discussions. This work was supported by the UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK [grantBB/M011216/1]; the UKRI BBSRC, UK [grants BB/P012574, BB/M02198X]; the European Research Council [ERC; proposal 743165] the John Innes Foundation; the JSPS [grants 15H05779, 20H05681]; and the JSPS/The Royal Society Bilateral Research for the project "Retooling rice immunity for resistance against rice blast disease" (2018-2019).	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cesari S, 2018, NEW PHYTOL, V219, P17, DOI 10.1111/nph.14877; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chaipanya C, 2017, RICE, V10, DOI 10.1186/s12284-017-0159-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Cowan GH, 2018, PLANT PHYSIOL, V176, P2052, DOI 10.1104/pp.17.01698; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dagdas YF, 2016, ELIFE, V5, DOI 10.7554/eLife.10856; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Abreu-Neto JB, 2013, FEBS J, V280, P1604, DOI 10.1111/febs.12159; de Guillen K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005228; De la Concepcion J. C., 2020, ALLELIC RICE IMMUNE; De la Concepcion JC, 2019, ELIFE, V8, DOI 10.7554/eLife.47713; De la Concepcion JC, 2018, NAT PLANTS, V4, P576, DOI 10.1038/s41477-018-0194-x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Guo LW, 2018, P NATL ACAD SCI USA, V115, P11637, DOI 10.1073/pnas.1810705115; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Khan IU, 2019, ECOTOX ENVIRON SAFE, V175, P8, DOI 10.1016/j.ecoenv.2019.03.040; Khanthong S, 2018, CHIANG MAI J SCI, V45, P2312; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Longya A, 2019, MOL PLANT MICROBE IN, V32, P740, DOI 10.1094/MPMI-09-18-0245-R; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Maqbool A, 2016, J BIOL CHEM, V291, P20270, DOI 10.1074/jbc.M116.744995; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oikawa K., 2020, BLAST PATHOGEN EFFEC; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Ortiz D, 2017, PLANT CELL, V29, P156, DOI 10.1105/tpc.16.00435; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Park CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005529; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Petit-Houdenot Y, 2020, MOL PLANT MICROBE IN, V33, P1032, DOI 10.1094/MPMI-03-20-0052-A; R Core Team, 2020, R LANG ENV STAT COMP; Radakovic ZS, 2018, MOL PLANT PATHOL, V19, P1917, DOI 10.1111/mpp.12668; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Saucet SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7338; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tang MZ, 2017, RICE, V10, DOI 10.1186/s12284-017-0144-7; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang RY, 2016, CURR BIOL, V26, P2399, DOI 10.1016/j.cub.2016.06.072; Wang XY, 2014, RICE - GERMPLASM, GENETICS AND IMPROVEMENT, P195, DOI 10.5772/56824; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wongsaprom C, 2010, FIELD CROP RES, V119, P245, DOI 10.1016/j.fcr.2010.07.013; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Wu WH, 2014, MOL PLANT MICROBE IN, V27, P759, DOI 10.1094/MPMI-02-14-0046-R; Yoshida K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2690-6; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098067; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x	72	15	15	4	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100371	10.1016/j.jbc.2021.100371	http://dx.doi.org/10.1016/j.jbc.2021.100371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548226	Green Published, Green Accepted, gold			2022-12-26	WOS:000672866400345
J	McKinzey, DR; Gomathinayagam, S; Griffin, WC; Klinzing, KN; Jeffries, EP; Rajkovic, A; Trakselis, MA				McKinzey, David R.; Gomathinayagam, Shivasankari; Griffin, Wezley C.; Klinzing, Kathleen N.; Jeffries, Elizabeth P.; Rajkovic, Aleksandar; Trakselis, Michael A.			Motifs of the C-terminal domain of MCM9 direct localization to sites of mitomycin-C damage for RAD51 recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; NUCLEOTIDE EXCISION-REPAIR; DNA MISMATCH REPAIR; CROSS-LINK REPAIR; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; COLORECTAL-CANCER; OVARIAN FAILURE; REPLICATION; PROTEIN	The MCM8/9 complex is implicated in aiding fork progression and facilitating homologous recombination (HR) in response to several DNA damage agents. MCM9 itself is an outlier within the MCM family containing a long C-terminal extension (CTE) comprising 42% of the total length, but with no known functional components and high predicted disorder. In this report, we identify and characterize two unique motifs within the primarily unstructured CTE that are required for localization of MCM8/9 to sites of mitomycin C (MMC)-induced DNA damage. First, an unconventional "bipartite-like" nuclear localization (NLS) motif consisting of two positively charged amino acid stretches separated by a long intervening sequence is required for the nuclear import of both MCM8 and MCM9. Second, a variant of the BRC motif (BRCv) similar to that found in other HR helicases is necessary for localization to sites of MMC damage. The MCM9-BRCv directly interacts with and recruits RAD51 downstream to MMC-induced damage to aid in DNA repair. Patient lymphocytes devoid of functional MCM9 and discrete MCM9 knockout cells have a significantly impaired ability to form RAD51 foci after MMC treatment. Therefore, the disordered CTE in MCM9 is functionally important in promoting MCM8/9 activity and in recruiting downstream interactors; thus, requiring full-length MCM9 for proper DNA repair.	[McKinzey, David R.; Gomathinayagam, Shivasankari; Griffin, Wezley C.; Klinzing, Kathleen N.; Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Jeffries, Elizabeth P.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Rajkovic, Aleksandar] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Rajkovic, Aleksandar] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Rajkovic, Aleksandar] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Baylor University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Trakselis, MA (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.	michael_trakselis@baylor.edu		Gomathinayagam, Shivasankari/0000-0003-2676-2647; Griffin, Wezley/0000-0003-2062-1253; Trakselis, Michael/0000-0001-7054-8475; Klinzing, Kathleen N/0000-0002-3220-4783; McKinzey, David/0000-0003-0845-5352; Rajkovic, Aleksandar/0000-0001-8390-0263	Baylor University; NIH [GM13791]	Baylor University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Baylor University and a NIH R15 (GM13791 to M. A. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlAsiri S, 2015, J CLIN INVEST, V125, P258, DOI 10.1172/JCI78473; ALLEN GC, 1991, J BIOL CHEM, V266, P11610; ALTER BP, 1991, BRIT J HAEMATOL, V77, P410, DOI 10.1111/j.1365-2141.1991.tb08593.x; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; BIZANEK R, 1992, BIOCHEMISTRY-US, V31, P3084, DOI 10.1021/bi00127a008; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Chemes Lucia B, 2012, Methods Mol Biol, V895, P387, DOI 10.1007/978-1-61779-927-3_22; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Crickard JB, 2018, CELL CYCLE, V17, P2520, DOI 10.1080/15384101.2018.1553355; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Desai S, 2017, J CLIN ENDOCR METAB, V102, P576, DOI 10.1210/jc.2016-2565; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026; Fink D, 1996, CANCER RES, V56, P4881; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Furuta T, 2002, CANCER RES, V62, P4899; Gambus A, 2013, CELL CYCLE, V12, P1225, DOI 10.4161/cc.24310; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; Goldberg Y, 2015, CANCER GENET-NY, V208, P621, DOI 10.1016/j.cancergen.2015.10.001; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Griffin WC, 2019, DNA REPAIR, V76, P1, DOI 10.1016/j.dnarep.2019.02.003; Hartford SA, 2011, P NATL ACAD SCI USA, V108, P17702, DOI 10.1073/pnas.1113524108; He DM, 2017, ONCOGENE, V36, P3629, DOI 10.1038/onc.2017.123; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Huselid E, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050498; Hustedt N, 2019, GENE DEV, V33, P1397, DOI 10.1101/gad.329508.119; Iakoucheva LM, 2001, PROTEIN SCI, V10, P560, DOI 10.1110/ps.29401; Islam MN, 2012, J BIOL CHEM, V287, P23808, DOI 10.1074/jbc.M112.375014; Jeffries EP, 2013, GENE, V519, P41, DOI 10.1016/j.gene.2013.01.054; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kato N, 2017, CELL REP, V21, P1375, DOI 10.1016/j.celrep.2017.10.032; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kim KH, 2002, MOL GENET GENOMICS, V268, P287, DOI 10.1007/s00438-002-0758-2; Kim Y, 2019, NUCLEIC ACIDS RES, V47, P1823, DOI 10.1093/nar/gky1244; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Laptenko O, 2016, TRENDS BIOCHEM SCI, V41, P1022, DOI 10.1016/j.tibs.2016.08.011; Lee K. Y., 2015, NAT COMMUN, V6; Lee YJ, 2006, CARCINOGENESIS, V27, P446, DOI 10.1093/carcin/bgi254; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Morii I, 2019, CANCER SCI, V110, P1044, DOI 10.1111/cas.13941; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Natsume T, 2017, GENE DEV, V31, P816, DOI 10.1101/gad.297663.117; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Parker MW, 2019, ELIFE, V8, DOI 10.7554/eLife.48562; Pichierri P, 2002, HUM MOL GENET, V11, P2531, DOI 10.1093/hmg/11.21.2531; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pryor JM, 2014, NUCLEIC ACIDS MOL BI, V30, P85, DOI 10.1007/978-3-642-39796-7_4; Quinet A, 2017, MOL CELL, V68, P830, DOI 10.1016/j.molcel.2017.11.022; Rasband W.S., 1997, IMAGEJ; Rickman K, 2019, J CELL BIOL, V218, P1096, DOI 10.1083/jcb.201809012; Rink SM, 1996, CHEM RES TOXICOL, V9, P382, DOI 10.1021/tx950156q; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Sung CO, 2011, BLOOD, V117, P1291, DOI 10.1182/blood-2010-07-297861; TENG SP, 1989, BIOCHEMISTRY-US, V28, P3901, DOI 10.1021/bi00435a041; Tham KC, 2016, DNA REPAIR, V38, P75, DOI 10.1016/j.dnarep.2015.11.010; Traver S, 2015, MOL CELL, V59, P831, DOI 10.1016/j.molcel.2015.07.010; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Wood-Trageser MA, 2014, AM J HUM GENET, V95, P754, DOI 10.1016/j.ajhg.2014.11.002; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	84	5	5	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100355	10.1016/j.jbc.2021.100355	http://dx.doi.org/10.1016/j.jbc.2021.100355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539926	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400329
J	Mischler, A; Karakis, V; Mahinthakumar, J; Carberry, CK; San Miguel, A; Rager, JE; Fry, RC; Rao, BM				Mischler, Adam; Karakis, Victoria; Mahinthakumar, Jessica; Carberry, Celeste K.; San Miguel, Adriana; Rager, Julia E.; Fry, Rebecca C.; Rao, Balaji M.			Two distinct trophectoderm lineage stem cells from human pluripotent stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO-YAP PATHWAY; TROPHOBLAST DIFFERENTIATION; GENE-EXPRESSION; TEAD4; SPHINGOSINE-1-PHOSPHATE; INHIBITION; FATE; ICM; TE	The trophectoderm layer of the blastocyst-stage embryo is the precursor for all trophoblast cells in the placenta. Human trophoblast stem (TS) cells have emerged as an attractive tool for studies on early trophoblast development. However, the use of TS cell models is constrained by the limited genetic diversity of existing TS cell lines and restrictions on using human fetal tissue or embryos needed to generate additional lines. Here we report the derivation of two distinct stem cell types of the trophectoderm lineage from human pluripotent stem cells. Analogous to villous cytotrophoblasts in vivo, the first is a CDX2(-) stem cell comparable with placenta-derived TS cells-they both exhibit identical expression of key markers, are maintained in culture and differentiate under similar conditions, and share high transcriptome similarity. The second is a CDX2(+) stem cell with distinct cell culture requirements, and differences in gene expression and differentiation, relative to CDX2(-) stem cells. Derivation of TS cells from pluripotent stem cells will significantly enable construction of in vitro models for normal and pathological placental development.	[Mischler, Adam; Karakis, Victoria; Mahinthakumar, Jessica; San Miguel, Adriana; Rao, Balaji M.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Carberry, Celeste K.; Rager, Julia E.; Fry, Rebecca C.] Univ N Carolina, Inst Environm Hlth Solut, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [Rao, Balaji M.] North Carolina State Univ, Golden LEAF Biomfg Training & Educ Ctr BTEC, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Rao, BM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.; Rao, BM (corresponding author), North Carolina State Univ, Golden LEAF Biomfg Training & Educ Ctr BTEC, Raleigh, NC 27695 USA.	bmrao@ncsu.edu	San Miguel, Adriana/C-3937-2017	San Miguel, Adriana/0000-0003-0172-2163	NIH [HD092741, HD093982]; NSF [CBET 1706118]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported by NIH grants HD092741, HD093982 and NSF grant CBET 1706118. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Chi FT, 2020, DEV CELL, V53, P9, DOI 10.1016/j.devcel.2020.02.015; Choi Inchul, 2012, Development, V139, P4623, DOI 10.1242/dev.086645; Cinkornpumin JK, 2020, STEM CELL REP, V15, P198, DOI 10.1016/j.stemcr.2020.06.003; Cornacchia D, 2019, CELL STEM CELL, V25, P120, DOI 10.1016/j.stem.2019.05.001; Dong C, 2020, ELIFE, V9, DOI 10.7554/eLife.52504; Du Toit A, 2019, NAT REV MICROBIOL, V17, P462, DOI 10.1038/s41579-019-0228-z; Gao XF, 2019, NAT CELL BIOL, V21, P687, DOI 10.1038/s41556-019-0333-2; Guo G., 2020, TROPHECTODERM POTENC, DOI [10.1101/2020.02.04.933812, DOI 10.1101/2020.02.04.933812]; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Horii M, 2016, P NATL ACAD SCI USA, V113, pE3882, DOI 10.1073/pnas.1604747113; Hsiao C, 2016, BIOTECHNOL J, V11, P662, DOI 10.1002/biot.201500374; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Klaren WD, 2019, TOXICOL SCI, V167, P157, DOI 10.1093/toxsci/kfy220; Knofler M, 2019, CELL MOL LIFE SCI, V76, P3479, DOI 10.1007/s00018-019-03104-6; Knott JG, 2014, REPRODUCTION, V148, pR121, DOI 10.1530/REP-14-0072; Kono K, 2014, DEV BIOL, V394, P142, DOI 10.1016/j.ydbio.2014.06.023; Li Z, 2018, BIOCHEM BIOPH RES CO, V505, P671, DOI 10.1016/j.bbrc.2018.09.181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Meinhardt G, 2020, P NATL ACAD SCI USA, V117, P13562, DOI 10.1073/pnas.2002630117; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moser G, 2011, PLACENTA, V32, P197, DOI 10.1016/j.placenta.2010.11.008; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohgushi M, 2015, CELL STEM CELL, V17, P448, DOI 10.1016/j.stem.2015.07.009; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.03.023, 10.1016/j.cell.2016.08.009]; Rager JE, 2019, TOXICOL LETT, V305, P40, DOI 10.1016/j.toxlet.2019.01.011; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Roberts RM, 2018, BIOL REPROD, V99, P212, DOI 10.1093/biolre/ioy070; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Saha B, 2020, P NATL ACAD SCI USA, V117, P17864, DOI 10.1073/pnas.2002449117; Sarkar P, 2016, J PROTEOME RES, V15, P2433, DOI 10.1021/acs.jproteome.5b01118; Sarkar P, 2015, J BIOL CHEM, V290, P8834, DOI 10.1074/jbc.M114.620641; Shahbazi MN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17764-7; Sheridan MA, 2019, P NATL ACAD SCI USA, V116, P4336, DOI 10.1073/pnas.1816150116; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Yabe S, 2016, P NATL ACAD SCI USA, V113, pE2598, DOI 10.1073/pnas.1601630113; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	50	18	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100386	10.1016/j.jbc.2021.100386	http://dx.doi.org/10.1016/j.jbc.2021.100386			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556374	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400360
J	Wu, CH; Rismondo, J; Morgan, RML; Shen, Y; Loessner, MJ; Larrouy-Maumus, G; Freemont, PS; Grundling, A				Wu, Chih-Hung; Rismondo, Jeanine; Morgan, Rhodri M. L.; Shen, Yang; Loessner, Martin J.; Larrouy-Maumus, Gerald; Freemont, Paul S.; Grundling, Angelika			Bacillus subtilis YngB contributes to wall teichoic acid glucosylation and glycolipid formation during anaerobic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UGTP MUTANT-CELLS; LIPOTEICHOIC ACID; ESCHERICHIA-COLI; ABNORMAL MORPHOLOGY; BIOSYNTHESIS; EXPRESSION; URIDYLYLTRANSFERASE; GLYCOSYLTRANSFERASE; PYROPHOSPHORYLASE; IDENTIFICATION	UTP-glucose-1-phosphate uridylyltransferases are enzymes that produce UDP-glucose from UTP and glucose-1-phosphate. In Bacillus subtilis 168, UDP-glucose is required for the decoration of wall teichoic acid (WTA) with glucose residues and the formation of glucolipids. The B. subtilis UGPase GtaB is essential for UDP-glucose production under standard aerobic growth conditions, and gtaB mutants display severe growth and morphological defects. However, bioinformatics predictions indicate that two other UTP-glucose-1-phosphate uridylyltransferases are present in B. subtilis. Here, we investigated the function of one of them named YngB. The crystal structure of YngB revealed that the protein has the typical fold and all necessary active site features of a functional UGPase. Furthermore, UGPase activity could be demonstrated in vitro using UTP and glucose-1-phosphate as substrates. Expression of YngB from a synthetic promoter in a B. subtilis gtaB mutant resulted in the reintroduction of glucose residues on WTA and production of glycolipids, demonstrating that the enzyme can function as UGPase in vivo. When WT and mutant B. subtilis strains were grown under anaerobic conditions, YngB-dependent glycolipid production and glucose decorations on WTA could be detected, revealing that YngB is expressed from its native promoter under anaerobic condition. Based on these findings, along with the structure of the operon containing yngB and the transcription factor thought to be required for its expression, we propose that besides WTA, potentially other cell wall components might be decorated with glucose residues during oxygen-limited growth condition.	[Wu, Chih-Hung; Rismondo, Jeanine; Grundling, Angelika] Imperial Coll London, Sect Mol Microbiol, London, England; [Wu, Chih-Hung; Rismondo, Jeanine; Grundling, Angelika] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London, England; [Morgan, Rhodri M. L.] Imperial Coll London, Dept Life Sci, London, England; [Shen, Yang; Loessner, Martin J.] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Larrouy-Maumus, Gerald] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, Dept Life Sci, London, England; [Freemont, Paul S.] Imperial Coll Translat & Innovat Hub, London Biofoundry, White City Campus, London, England; [Freemont, Paul S.] Imperial Coll London, Dept Infect Dis, Sect Struct & Synthet Biol, London, England; [Freemont, Paul S.] Imperial Coll London, UK Dementia Res Inst Ctr Care Res & Technol, London, England	Imperial College London; Imperial College London; Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Imperial College London; Imperial College London; Imperial College London	Grundling, A (corresponding author), Imperial Coll London, Sect Mol Microbiol, London, England.; Grundling, A (corresponding author), Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London, England.; Freemont, PS (corresponding author), Imperial Coll Translat & Innovat Hub, London Biofoundry, White City Campus, London, England.; Freemont, PS (corresponding author), Imperial Coll London, Dept Infect Dis, Sect Struct & Synthet Biol, London, England.; Freemont, PS (corresponding author), Imperial Coll London, UK Dementia Res Inst Ctr Care Res & Technol, London, England.	p.freemont@imperial.ac.uk; a.grundling@imperial.ac.uk	shen, yang/X-2665-2018	shen, yang/0000-0003-4278-1477; Grundling, Angelika/0000-0002-6235-8687; Rismondo, Jeanine/0000-0001-5337-3829	MRC [MR/P011071/1]; German research foundation (DFG) [RI 2920/1]; BBSRC [BB/D524840/1]; Wellcome Trust [202926/Z/16/Z]; MRC [MR/P028225/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German research foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the MRC grant MR/P011071/1 to A. G. and P. S. F. and the German research foundation (DFG) grant RI 2920/1 to J. R. The crystallization facility at Imperial College was funded by the BBSRC (BB/D524840/1) and the Wellcome Trust (202926/Z/16/Z). Datasets were collected at the I03 Beamline at the Diamond Light Source (Harwell Campus, Didcot, UK).	Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; Berbis MA, 2015, CURR MED CHEM, V22, P1687, DOI 10.2174/0929867322666150114151248; Aragao D, 2007, J BACTERIOL, V189, P4520, DOI 10.1128/JB.00277-07; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Benini S, 2017, BBA-PROTEINS PROTEOM, V1865, P1348, DOI 10.1016/j.bbapap.2017.08.015; Bonofiglio L, 2005, CURR MICROBIOL, V51, P217, DOI 10.1007/s00284-005-4466-0; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cools F, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty069; Cress BF, 2014, FEMS MICROBIOL REV, V38, P660, DOI [10.1111/1574-6976.12056, 10.1111/1574-69]; Doerrler WT, 2013, J BACTERIOL, V195, P3, DOI 10.1128/JB.01006-12; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Genevaux P, 1999, ARCH MICROBIOL, V172, P1, DOI 10.1007/s002030050732; Habusha M, 2019, MOL MICROBIOL, V111, P1463, DOI 10.1111/mmi.14231; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hartig E, 2004, J BACTERIOL, V186, P6477, DOI 10.1128/JB.186.19.6477-6484.2004; HORECKER BL, 1966, ANNU REV MICROBIOL, V20, P253, DOI 10.1146/annurev.mi.20.100166.001345; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Kim H, 2010, MOL CELLS, V29, P397, DOI 10.1007/s10059-010-0047-6; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Lahooti M, 1999, MICROBIOL-UK, V145, P3409, DOI 10.1099/00221287-145-12-3409; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarevic V, 2005, APPL ENVIRON MICROB, V71, P39, DOI 10.1128/AEM.71.1.39-45.2005; Luo Yu, 2016, F1000Res, V5, P155, DOI 10.12688/f1000research.8007.1; MANCUSO DJ, 1982, J BACTERIOL, V152, P616; Matsuoka S, 2017, GENES GENET SYST, V92, P217, DOI 10.1266/ggs.17-00017; Matsuoka S, 2016, BIOSCI BIOTECH BIOCH, V80, P2325, DOI 10.1080/09168451.2016.1217147; Matsuoka S, 2011, GENES GENET SYST, V86, P295, DOI 10.1266/ggs.86.295; MAUEL C, 1994, MICROBIOL-UK, V140, P2279, DOI 10.1099/13500872-140-9-2279; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Missiakas D, 2017, ANNU REV MICROBIOL, V71, P79, DOI 10.1146/annurev-micro-090816-093512; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Ogura M, 2010, ARCH MICROBIOL, V192, P569, DOI 10.1007/s00203-010-0586-4; Panta PR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02532; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; POOLEY HM, 1987, J GEN MICROBIOL, V133, P3481; Price KD, 1997, J BACTERIOL, V179, P4959, DOI 10.1128/jb.179.15.4959-4961.1997; Rismondo Jeanine, 2020, Cell Surf, V6, P100038, DOI 10.1016/j.tcsw.2020.100038; Rismondo J, 2018, J BIOL CHEM, V293, P3293, DOI 10.1074/jbc.RA117.001614; Shen Y, 2017, J BIOL CHEM, V292, P17832, DOI 10.1074/jbc.M117.813964; Shuster B, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00321-19; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Sun GF, 1996, J BACTERIOL, V178, P1374, DOI 10.1128/jb.178.5.1374-1385.1996; Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; Thompkins K, 2008, J BACTERIOL, V190, P4489, DOI 10.1128/JB.00414-08; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wagner JK, 2009, MOL MICROBIOL, V73, P963, DOI 10.1111/j.1365-2958.2009.06825.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x; YASBIN RE, 1976, J BACTERIOL, V125, P1120, DOI 10.1128/JB.125.3.1120-1126.1976; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; YOKOYAMA K, 1988, EUR J BIOCHEM, V173, P453, DOI 10.1111/j.1432-1033.1988.tb14020.x; YOUNG FE, 1969, J BACTERIOL, V98, P1087, DOI 10.1128/JB.98.3.1087-1097.1969; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377	64	3	3	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100384	10.1016/j.jbc.2021.100384	http://dx.doi.org/10.1016/j.jbc.2021.100384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556370	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400358
J	Sloman, SJ; Oppenheimer, DM; DeDeo, S				Sloman, Sabina J.; Oppenheimer, Daniel M.; DeDeo, Simon			Can we detect conditioned variation in political speech? two kinds of discussion and types of conversation	PLOS ONE			English	Article							MECHANICAL TURK; LANGUAGE; POLARIZATION; EVOLUTION; IDEOLOGY	Previous work has demonstrated that certain speech patterns vary systematically between sociodemographic groups, so that in some cases the way a person speaks is a valid cue to group membership. Our work addresses whether or not participants use these linguistic cues when assessing a speaker's likely political identity. We use a database of speeches by U.S. Congressional representatives to isolate words that are statistically diagnostic of a speaker's party identity. In a series of four studies, we demonstrate that participants' judgments track variation in word usage between the two parties more often than chance, and that this effect persists even when potentially interfering cues such as the meaning of the word are controlled for. Our results are consistent with a body of literature suggesting that humans' language-related judgments reflect the statistical distributions of our environment.	[Sloman, Sabina J.; Oppenheimer, Daniel M.; DeDeo, Simon] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Sloman, SJ (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	ssloman@andrew.cmu.edu		Sloman, Sabina/0000-0001-7479-4286				Abadi M., 2017, DEMOCRATS REPUBLICAN; Albertson BL, 2015, POLIT BEHAV, V37, P3, DOI 10.1007/s11109-013-9265-x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2008, 1 IMPRESSIONS; [Anonymous], 2017, NY TIMES; Arai M., 2011, CLUSTER ROBUST STAND; Balliet D, 2018, J CONFLICT RESOLUT, V62, P797, DOI 10.1177/0022002716658694; Baugh J, 2003, BLACK LINGUISTICS LA; Bhatia S, 2019, CURR OPIN BEHAV SCI, V29, P31, DOI 10.1016/j.cobeha.2019.01.020; Boyce-Jacino C, 2020, COGNITION, V196, DOI 10.1016/j.cognition.2019.104071; Buhrmester MD, 2018, PERSPECT PSYCHOL SCI, V13, P149, DOI 10.1177/1745691617706516; Burger John D., 2011, P C EMP METH NAT LAN, P1301, DOI DOI 10.1007/S00256-005-0933-8; Calfano BR, 2009, POLIT RES QUART, V62, P329, DOI 10.1177/1065912908319605; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Chmielewski M, 2020, SOC PSYCHOL PERS SCI, V11, P464, DOI 10.1177/1948550619875149; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coombs C. H., 1970, MATH PSYCHOL ELEMENT; Crockett D, 2004, J CONSUM RES, V31, P511, DOI 10.1086/425086; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; DiazCampos M, 2001, ACQUISITION PHONOLOG; Diermeier D, 2012, BRIT J POLIT SCI, V42, P31, DOI 10.1017/S0007123411000160; Firth J.R., 1957, STUDIES LINGUISTIC A, P1; Gautier L., 2017, RPY2 R PYTHON; Geertzen J, 2016, ITAL J LINGUIST, V28, P25; Gentzkow M, 2019, ECONOMETRICA, V87, P1307, DOI 10.3982/ECTA16566; Goldstone RL, 2013, PERCEPTUAL LEARNING; Goldstone RL, 2010, WIRES COGN SCI, V1, P69, DOI 10.1002/wcs.26; Green DM, 1966, SIGNAL DETECTION THE; Griffiths TL, 2007, COGNITIVE SCI, V31, P441, DOI 10.1080/15326900701326576; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hay J, 2018, TOP COGN SCI, V10, P696, DOI 10.1111/tops.12326; Jensen J, 2012, BROOKINGS PAP ECO AC, P1; Jordan K. N., 2017, TRANSL ISS PSYCH SCI, V3, P312; Judd N, 2017, C RECORD PARSER C RE; Kam CLH, 2009, COGNITIVE PSYCHOL, V59, P30, DOI 10.1016/j.cogpsych.2009.01.001; Kilgarriff A, 2006, TEXT SPEECH LANG TEC, V33, P29, DOI 10.1007/1-4020-4809-2_2; Klingenstein S, 2014, P NATL ACAD SCI USA, V111, P9419, DOI 10.1073/pnas.1405984111; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Labov William, 1966, SOCIAL STRATIFICATIO; Labov William, 2010, PRINCIPLES LINGUISTI, V3; Lacatus C, 2021, POLITICS-OXFORD, V41, P3, DOI 10.1177/0263395720935376; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; Luntz F, 2006, NEW AM LEXICON; Mather PA, 2012, J ENGL LINGUIST, V40, P338, DOI 10.1177/0075424211431265; McClelland JL, 1987, PARALLEL DISTRIBUTED, V2; McDonald S, TESTING DISTRIBUTION, P7; Mehl MR, 2003, J PERS SOC PSYCHOL, V84, P857, DOI 10.1037/0022-3514.84.4.857; Mendelberg Tali, 2001, RACE CARD CAMPAIGN S; Mikolov T, 2013, ARXIV13104546CSSTAT; Mikolov T., 2013, P ICLR WORKSH POST S; Miroff N, 2020, TRUMP RAMPS BORDER W; Mollica F, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181393; Murphy C, 2012, J LANG POLIT, V11, P135, DOI 10.1075/jlp.11.1.07mur; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Pinker S., 1999, WORDS RULES; Plotly Technologies Inc. Collaborative data science, COLL DAT SCI; Preoiuc-Pietro D, 2016, P 30 AAAI C ART INT, P8; Preotiuc-Pietro D, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 1, P729, DOI 10.18653/v1/P17-1068; Reali F, 2009, COGNITION, V111, P317, DOI 10.1016/j.cognition.2009.02.012; Rehurek R, 2010, P LREC 2010 WORKSHOP, P45; Richie R, 2020, SIMILARITY JUDGMENT; Robins RH, 1959, T PHILOLOGICAL SOC L, V58, P116, DOI 10.1111/j.1467-968X.1959.tb00301.x; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rudnicka E, 2019, INT J LEXICOGR, V32, P296, DOI 10.1093/ijl/ecz004; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Samara A, 2017, COGNITIVE PSYCHOL, V94, P85, DOI 10.1016/j.cogpsych.2017.02.004; Scala DJ, 2017, ANN AM ACAD POLIT SS, V672, P162, DOI 10.1177/0002716217712696; Shi F, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0079; Sloman SJ, ONE FEE 2 FEES RED F; Smaldino PE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22926-1; Smith K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0051; Smith K, 2010, COGNITION, V116, P444, DOI 10.1016/j.cognition.2010.06.004; Stuart-Smith J, 1999, LEEDS STUDIES ENGLIS; Todorov A., 2012, SAGE HDB SOCIAL COGN, P96, DOI DOI 10.4135/9781446247631.N6; UC Santa Barbara. The American Presidency Project, AM PRESIDENCY PROJEC; Vaux B., CAMBRIDGE ONLINE SUR; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Westfall J., 2016, 5 DIFFERENT COHENS S; William Labov, 2001, PRINCIPLES LINGUISTI, V2; Wonnacott E, 2005, P 29 ANN BOST U C LA, P11	84	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246689	10.1371/journal.pone.0246689	http://dx.doi.org/10.1371/journal.pone.0246689			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571244	Green Published, Green Submitted, gold			2022-12-26	WOS:000618274000102
J	Feyisa, ZT; Woldeamanuel, BT				Feyisa, Zelalem Tadese; Woldeamanuel, Berhanu Teshome			Prevalence and associated risk factors of gastritis among patients visiting Saint Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia	PLOS ONE			English	Article								Background The health of individuals is not only the absence of disease checked medically, but also encompasses social and psychological aspects. Any departure from the state of physiological, psychological, or social well-being was affected by different factors. However, all contributory factors were not equally responsible for affecting disease. This study was undertaken as a search for the relative effects of sociocultural and individual behavioral factors contributing to acute and chronic gastritis patients visiting Saint Paul Hospital Millennium Medical College (SPHMMC). Methods A cross-sectional study was carried out on 364 patients visited SPHMMC in the study. Primary data were collected through an interview schedule tool with an exit approach by validating questions pertaining to sociocultural and individual behavioral factors. The status of gastritis was measured as whether patients had Helicobacter Pylori infection, signs and symptoms indicated gastritis that occurred, and persisted for less than a month, greater than a month, or none of the signs and symptoms. Descriptive statistics, bivariate analysis, and multivariable ordinal logistic regression model were used to identify the predictors of gastritis severity. P-value <= 0.05 was declared as an indicator of statistically significant. Results The prevalence of gastritis in the study area was 78.8%. Specifically, 48.9% and 29.9% had acute and chronic gastritis, respectively. The study found that low income and taking medicinal drugs was slightly significantly contributed to higher gastritis status; however, being younger age was slightly significantly contributed to lower gastritis status. Furthermore, the results indicated that eating spiced foods (Adjusted Odds Ratio (AOR) = 1.508; 95% CI: 1.046, 2.174), lack of physical exercise regularly (AOR = 1.780; 95% CI: 1.001, 3.168), stress (AOR = 2.168; 95% CI: 1.379, 3.4066), and substance use (AOR = 1.478; 95% CI: 1.093, 1.999) were significantly contributed to higher gastritis status. Conclusions The findings suggested that women should take enough rest and sleep well, men refrain from involvement in any risky behaviors, young people and those who earn low income per month should equip with knowledge and understanding on how to practice good health behaviors, eating foods on time, avoiding eating spiced food frequently, doing physical exercise regularly, and taking medicinal drugs according to physician advice are recommended.	[Feyisa, Zelalem Tadese] Salale Univ, Dept Sociol, Fitche, Oromia, Ethiopia; [Woldeamanuel, Berhanu Teshome] Salale Univ, Dept Stat, Fitche, Oromia, Ethiopia		Feyisa, ZT (corresponding author), Salale Univ, Dept Sociol, Fitche, Oromia, Ethiopia.	zetafego@gmail.com		Feyisa, Zelalem Tadese/0000-0003-2391-6364				Agbor Nathan E, 2018, BMC Res Notes, V11, P559, DOI 10.1186/s13104-018-3662-5; Alberts CJ, 2020, HELICOBACTER, V25, DOI 10.1111/hel.12687; Alebie G., 2016, J BACTERIOL MYCOL, V3, P00060; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2013, EPILEPSY BEHAV, V28, pS87; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Banks M, 2019, GUT, V68, P1545, DOI 10.1136/gutjnl-2018-318126; Barkan S E., 2017, INTRO MEDICAL SOCIOL; CDC: Centers for Disease Control and Prevention, 2011, 4 SPEC HLTH BEH CONT; Cecilia R, 2020, GASTRITIS GASTRIC CA; Center for Medicaid and CHIP Services, 2014, STAT MED CHIP INC EL; Ddine LC, 2012, ABCD-ARQ BRAS CIR DI, V25, P96, DOI 10.1590/S0102-67202012000200007; MIRANDA Ariney Costa de, 2019, Arq. Gastroenterol., V56, P264, DOI [10.1590/s0004-2803.201900000-50, 10.1590/S0004-2803.201900000-50]; Demisew G., 2018, AM J THEORETICAL APP, V7, P207, DOI [10.11648/j.ajtas.20180706.12, DOI 10.11648/J.AJTAS.20180706.12]; Hadeel G H, 2019, GENETIC DIVERSITY CA, DOI [10.1101/19007435, DOI 10.1101/19007435]; Hillier S.M., 2015, AGING INDIVIDUAL SOC, V10th; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Ibrahim A, 2017, DIGEST LIVER DIS, V49, P742, DOI 10.1016/j.dld.2017.03.019; Jannathul F., 2016, INDIAN J NAT SCI, V6, P10753; Janzen B, 2012, UNPAID DOMESTIC WORK; Kayacetin S, 2014, TURK J GASTROENTEROL, V25, P233, DOI 10.5152/tjg.2014.7906; Kuykendall S., 2018, ENCY PUBLIC HLTH PRI; Li WQ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5016; Liu Q, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029638; Maeda E, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0833-5; Marginean MO, 2018, J CRIT CARE MED, V4, P143, DOI 10.2478/jccm-2018-0022; Nakvasina M.A., 2016, Vestn. Voronezh. Gos. Univ., Ser.: Khim., Biol., Farm., P67, DOI [DOI 10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]; Niu QB, 2020, GASTROENT RES PRACT, V2020, DOI 10.1155/2020/9342563; Padmavathi G. V., 2013, Scholars Journal of Applied Medical Sciences, V1, P101; Shugufta N., 2018, INT J ADV SCI RES, V3, P43; Sipponen P, 2015, SCAND J GASTROENTERO, V50, P657, DOI 10.3109/00365521.2015.1019918; Sjomina O, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12514; Smith S, 2019, WORLD J GASTROENTERO, V25, P3183, DOI 10.3748/wjg.v25.i25.3183; Toscano EP, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/8454125; WHO, WHO STEP WIS APPR SU; WHO: World Health Organization, 2020, STRAT M SOC DET HLTH; Wirth Hans-Peter, 2016, Inflamm Intest Dis, V1, P113, DOI 10.1159/000446300	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246619	10.1371/journal.pone.0246619	http://dx.doi.org/10.1371/journal.pone.0246619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561152	Green Published, gold			2022-12-26	WOS:000617533000027
J	Kim, SJ; Kwon, OD; Choi, HC; Lee, EJ; Cho, B				Kim, Seung Jae; Kwon, Oh Deog; Choi, Ho Chun; Lee, Eung-Joon; Cho, BeLong			Non-persistence with anti-platelet therapy and long-term mortality after ischemic stroke: A nationwide study	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; RECURRENT STROKE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; MEDICATION ADHERENCE; CLAIMS DATA; RISK; ATTACK; DISCONTINUATION; NONPERSISTENCE	Background We tried to investigate the effect of non-persistence with antiplatelets after ischemic stroke on long-term all-cause mortality (ACM). Methods and findings We selected newly diagnosed ischemic stroke patients aged >= 20years who were newly treated with aspirin or clopidogrel from 2003-2010 Korean National Health Insurance Service-National Sample Cohort, a random sample of 2.2% of total population. Subjects were divided into two pairs of groups according to persistence with antiplatelets at 6 and 12 months: those who discontinued antiplatelets within 6 months (DA6M) and those who continued them for 6 or months or more (CA6M); and those who discontinued antiplatelets within 12 months (DA12M) and those who continued them for 12 months or more (CA12M). Those who died within 6 months among DA6M and those who died within 12 months among DA12M were excluded along with those with medication possession ratio<80% among CA6M and CA12M. Subjects were followed-up until death or December 31, 2013. Among 3,559 total subjects, DA6M were 1,080 and CA6M were 2,479 while, out of 3,628 total patients, DA12M were 1,434 and CA12M were 2,194. The risks of ACM [adjusted hazard ratio (aHR), 2.25; 95% confidence interval (CI), 1.94-2.61], cerebro-cardiovascular disease (CVD) death (aHR, 2.52; 95% CI, 1.96-3.24) and non-CVD death (aHR, 2.11; 95% CI, 1.76-2.64) of DA6M were all significantly increased compared to CA6M. DA12M also had significantly higher risks of ACM (aHR, 1.93; 95% CI, 1.65-2.25), CVD mortality (aHR, 2.13; 95% CI; 1.63-2.77) and non-CVD mortality (aHR, 1.83;95% CI 1.51-2.22) than DA12M but aHRs were lower than that between DA6M and CA6M. The difference rates of ACM, CVD death, and non-CVD death between non-persistent and persistent groups all continuously widened over time but the degree of difference was gradually decreased. Conclusions Maintaining antiplatelets for the first 12 months after ischemic stroke reduces long-term risks of both CVD death and non-CVD death.	[Kim, Seung Jae] Catholic Univ Korea, Coll Med, Dept Family Med, Seoul St Marys Hosp, Seoul, South Korea; [Kwon, Oh Deog] Republ Korea Navy 2nd Fleet Med Corps, Pyeongtaek Si, Gyeonggi Do, South Korea; [Choi, Ho Chun] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul, South Korea; [Choi, Ho Chun] Nuvizen, Palo Alto, CA 94306 USA; [Lee, Eung-Joon] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Cho, BeLong] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, HC (corresponding author), Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul, South Korea.; Choi, HC (corresponding author), Nuvizen, Palo Alto, CA 94306 USA.; Lee, EJ (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.	skyho331@gmail.com; lejoon0824@gmail.com	Cho, Belong/GLU-3443-2022	Cho, Belong/0000-0001-9558-689X; Kim, Seung Jae/0000-0001-8885-7137				Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; Al AlShaikh S, 2016, EUR STROKE J, V1, P65, DOI 10.1177/2396987316647187; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Burke JP, 2010, CURR MED RES OPIN, V26, P1023, DOI 10.1185/03007991003670563; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Bushnell CD, 2011, NEUROLOGY, V77, P1182, DOI 10.1212/WNL.0b013e31822f0423; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Glader EL, 2010, STROKE, V41, P397, DOI 10.1161/STROKEAHA.109.566950; Hackam DG, 2019, STROKE, V50, P773, DOI 10.1161/STROKEAHA.118.023954; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Ho PM, 2010, CIRC-CARDIOVASC QUAL, V3, P261, DOI 10.1161/CIRCOUTCOMES.109.902031; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Iuga AO, 2014, RISK MANAG HEALTHC P, V7, P35, DOI 10.2147/RMHP.S19801; Karve S, 2009, CURR MED RES OPIN, V25, P2303, DOI 10.1185/03007990903126833; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim J, 2018, HYPERTENSION, V72, P391, DOI 10.1161/HYPERTENSIONAHA.118.11139; Kim J, 2017, STROKE, V48, P2723, DOI 10.1161/STROKEAHA.117.018140; Kim YJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0002-y; Kolandaivelu K, 2014, EUR HEART J, V35, P3267, DOI 10.1093/eurheartj/ehu364; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lehmann A, 2014, INT J CLIN PHARM-NET, V36, P55, DOI 10.1007/s11096-013-9865-x; Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20; Nour M, 2011, NEUROTHERAPEUTICS, V8, P330, DOI 10.1007/s13311-011-0046-0; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Soler EP, 2010, CURR CARDIOL REV, V6, P138, DOI 10.2174/157340310791658785; Parker MM, 2015, J AM MED INFORM ASSN, V22, P957, DOI 10.1093/jamia/ocv054; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Rizos T, 2015, STROKE, V46, P1693, DOI 10.1161/STROKEAHA.115.009374; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Sikka Rishi, 2005, Am J Manag Care, V11, P449; Singh RJ, 2018, INT J STROKE, V13, P787, DOI 10.1177/1747493018798526; Sposato LA, 2020, STROKE, V51, P387, DOI 10.1161/STROKEAHA.119.028066; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; VIITANEN M, 1988, EUR NEUROL, V28, P227, DOI 10.1159/000116272; Weimar C, 2013, CEREBROVASC DIS, V35, P538, DOI 10.1159/000351144; World Health Organization, 2006, AN THER CHEM CLASS S; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0244718	10.1371/journal.pone.0244718	http://dx.doi.org/10.1371/journal.pone.0244718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561124	gold, Green Published			2022-12-26	WOS:000617533000028
J	Abou-Arab, O; Beyls, C; Khalipha, A; Guilbart, M; Huette, P; Malaquin, S; Lecat, B; Macq, PY; Roger, PA; Haye, G; Bernasinski, M; Besserve, P; Soriot-Thomas, S; Jounieaux, V; Dupont, H; Mahjoub, Y				Abou-Arab, Osama; Beyls, Christophe; Khalipha, Abdelilah; Guilbart, Mathieu; Huette, Pierre; Malaquin, Stephanie; Lecat, Benoit; Macq, Pierre-Yves; Roger, Pierre Alexandre; Haye, Guillaume; Bernasinski, Michael; Besserve, Patricia; Soriot-Thomas, Sandrine; Jounieaux, Vincent; Dupont, Herve; Mahjoub, Yazine			Microvascular flow alterations in critically ill COVID-19 patients: A prospective study	PLOS ONE			English	Article							FRENCH LEGAL APPROACH; SUBLINGUAL MICROCIRCULATION	Background Data on microcirculatory pattern of COVID-19 critically ill patients are scarce. The objective was to compare sublingual microcirculation parameters of critically ill patients according to the severity of the disease. Methods The study is a single-center prospective study with critically ill COVID-19 patients admitted in ICU. Sublingual microcirculation was assessed by IDF microscopy within 48 hours of ICU admission. Microcirculatory flow index (MFI), proportion of perfused vessel (PPV), total vessel density (TVD), De Backer score (DBS), perfused vessel density (PVD) and heterogeneity index (HI) were assessed. Patients were divided in 2 groups (severe and critical) according to the World health organization definition. Findings From 19(th) of March to 7(th) of April 2020, 43 patients were included. Fourteen patients (33%) were in the severe group and twenty-nine patients (67%) in the critical group. Patients in the critical group were all mechanically ventilated. The critical group had significantly higher values of MFI, DBS and PVD in comparison to severe group (respectively, PaCO2: 49 [44-45] vs 36 [33-37] mmHg; p<0,0001, MFI: 2.8 +/- 0.2 vs 2.5 +/- 0.3; p = 0.001, DBS: 12.7 +/- 2.6 vs 10.8 +/- 2.0 vessels mm(-2); p = 0.033, PVD: 12.5 +/- 3.0 vs 10.1 +/- 2.4 mm.mm(-2); p = 0.020). PPV, HI and TVD were similar between groups Correlation was found between microcirculatory parameters and PaCO2 levels. Conclusion Critical COVID-19 patients under mechanical ventilation seem to have higher red blood cell velocity than severe non-ventilated patients.	[Abou-Arab, Osama; Beyls, Christophe; Khalipha, Abdelilah; Guilbart, Mathieu; Huette, Pierre; Malaquin, Stephanie; Lecat, Benoit; Macq, Pierre-Yves; Roger, Pierre Alexandre; Haye, Guillaume; Bernasinski, Michael; Besserve, Patricia; Dupont, Herve; Mahjoub, Yazine] Amiens Univ Hosp, Dept Anesthesiol & Crit Care Med, Amiens, France; [Soriot-Thomas, Sandrine] Amiens Univ Hosp, Dept Clin Res, Amiens, France; [Jounieaux, Vincent] Amiens Univ Hosp, Dept Pneumol, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Abou-Arab, O (corresponding author), Amiens Univ Hosp, Dept Anesthesiol & Crit Care Med, Amiens, France.	osama.abouarab@gmail.com	Mahjoub, Yazine/AAR-8585-2020; Jounieaux, Vincent/AAH-4474-2020	Jounieaux, Vincent/0000-0003-2131-6429; Abou-Arab, Osama/0000-0003-3766-716X				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Alhazzani Waleed, 2020, Intensive Care Med, V46, P854, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]; Arulkumaran N, 2020, LANCET RESP MED, V8, pE45, DOI 10.1016/S2213-2600(20)30181-8; Carsetti A, 2020, MICROVASC RES, V132, DOI 10.1016/j.mvr.2020.104064; Casey DP, 2012, J PHYSIOL-LONDON, V590, P6321, DOI 10.1113/jphysiol.2012.242396; Damiani E, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00680-w; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2010, INTENS CARE MED, V36, P1813, DOI 10.1007/s00134-010-2005-3; Dubin A, 2009, CRIT CARE, V13, DOI 10.1186/cc7922; Farquhar I, 1996, J SURG RES, V61, P190, DOI 10.1006/jsre.1996.0103; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Hilty MP, 2020, CRIT CARE MED, V48, pE864, DOI 10.1097/CCM.0000000000004491; Ince C, 2018, INTENS CARE MED, V44, P281, DOI 10.1007/s00134-018-5070-7; Jhanji S, 2009, CRIT CARE MED, V37, P1961, DOI 10.1097/CCM.0b013e3181a00a1c; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lang M, 2020, LANCET INFECT DIS, V20, P1365, DOI 10.1016/S1473-3099(20)30367-4; Mahjoub Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02972-w; Massey MJ, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2240-5; Massey MJ, 2013, J CRIT CARE, V28, P913, DOI 10.1016/j.jcrc.2013.06.015; Ospina-Tascon GA, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00651-1; Ottestad W, 2020, BRIT J ANAESTH, V125, pE280, DOI 10.1016/j.bja.2020.04.012; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; ROTHE CF, 1990, AM J PHYSIOL, V259, pH932, DOI 10.1152/ajpheart.1990.259.3.H932; Salgado DR, 2010, CAN J ANESTH, V57, P940, DOI 10.1007/s12630-010-9365-6; Toulouse E, 2020, ANAESTH CRIT CARE PA, V39, P883, DOI 10.1016/j.accpm.2020.10.012; Toulouse E, 2018, ANAESTH CRIT CARE PA, V37, P607, DOI 10.1016/j.accpm.2018.10.013; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246636	10.1371/journal.pone.0246636	http://dx.doi.org/10.1371/journal.pone.0246636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4AY	33556081	gold, Green Published			2022-12-26	WOS:000617531400006
J	Meghdadi, AH; Karic, MS; McConnell, M; Rupp, G; Richard, C; Hamilton, J; Salat, D; Berka, C				Meghdadi, Amir H.; Karic, Marija Stevanovic; McConnell, Marissa; Rupp, Greg; Richard, Christian; Hamilton, Joanne; Salat, David; Berka, Chris			Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; QUANTITATIVE EEG; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RHYTHMS; POWER; SYNCHRONIZATION; COHERENCE; SLEEP; ELECTROENCEPHALOGRAPHY	In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for the detection and assessment of cognitive decline in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Neurophysiological biomarkers of AD derived from EEG and FDG-PET, once characterized and validated, would expand the set of existing diagnostic molecular biomarkers of AD pathology with associated biomarkers of disease progression and neural dysfunction. Since symptoms of AD often begin to appear later in life, successful identification of EEG-based biomarkers must account for age-related neurophysiological changes that occur even in healthy individuals. To this end, we collected EEG data from individuals with AD (n = 26), MCI (n = 53), and cognitively normal healthy controls stratified by age into three groups: 18-40 (n = 129), 40-60 (n = 62) and 60-90 (= 55) years old. For each participant, we computed power spectral density at each channel and spectral coherence between pairs of channels. Compared to age matched controls, in the AD group, we found increases in both spectral power and coherence at the slower frequencies (Delta, Theta). A smaller but significant increase in power of slow frequencies was observed for the MCI group, localized to temporal areas. These effects on slow frequency spectral power opposed that of normal aging observed by a decrease in the power of slow frequencies in our control groups. The AD group showed a significant decrease in the spectral power and coherence in the Alpha band consistent with the same effect in normal aging. However, the MCI group did not show any significant change in the Alpha band. Overall, Theta to Alpha ratio (TAR) provided the largest and most significant differences between the AD group and controls. However, differences in the MCI group remained small and localized. We proposed a novel method to quantify these small differences between Theta and Alpha bands' power using empirically derived distributions of spectral power across the time domain as opposed to averaging power across time. We defined Power Distribution Distance Measure (PDDM) as a distance measure between probability distribution functions (pdf) of Theta and Alpha power. Compared to average TAR, using PDDF enhanced the statistical significance, the effect size, and the spatial distribution of significant effects in the MCI group. We designed classifiers for differentiating individual MCI and AD participants from age-matched controls. The classification performance measured by the area under ROC curve after cross-validation were AUC = 0.85 and AUC = 0.6, for AD and MCI classifiers, respectively. Posterior probability of AD, TAR, and the proposed PDDM measure were all significantly correlated with MMSE score and neuropsychological tests in the AD group.	[Meghdadi, Amir H.; Karic, Marija Stevanovic; McConnell, Marissa; Rupp, Greg; Richard, Christian; Berka, Chris] Adv Brain Monitoring Inc, Carlsbad, CA 92008 USA; [Hamilton, Joanne] Univ Calif San Diego, San Diego, CA 92103 USA; [Hamilton, Joanne] Adv Neurobehav Hlth Southern Calif, San Diego, CA USA; [Salat, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Salat, David] Harvard Med Sch, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Meghdadi, AH (corresponding author), Adv Brain Monitoring Inc, Carlsbad, CA 92008 USA.	amir@b-alert.com		Meghdadi, Amir/0000-0001-7863-6488	National Institute of Health [R44AG050326, R44AG054256]; DARPA [FA865019C68899]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work is supported by National Institute of Health Grant numbers R44AG050326, R44AG054256. Amir H. Meghdadi, Marija Stevanovic Karic, Marissa McConnell, Greg Rupp, Christian Richard, and Chris Berka are employees of Advanced Brain Monitoring. Chris Berka is cofounder and shareholder of Advanced Brain Monitoring. Advanced Brain Monitoring is the manufacturer of the EEG equipment used in this study. The healthy participants in this study were recruited by, and data were collected at Advanced Brain Monitoring. The funder provided support in the form of salaries for AM, MSK, MM, GR, CR and CB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Part of the data used in this work were collected from participants that were initially recruited for a DARPA funded research project separate from the scope of the current manuscript (contract number FA865019C68899). The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of NIH, the DoD, or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2003, J NEURAL TRANSM, V110, P1051, DOI 10.1007/s00702-003-0024-8; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Babiloni C, 2020, NEUROBIOL AGING, V90, P43, DOI 10.1016/j.neurobiolaging.2020.01.012; Babiloni C, 2020, NEUROBIOL AGING, V85, P58, DOI 10.1016/j.neurobiolaging.2019.09.008; Babiloni C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00047; Babiloni C, 2016, INT J PSYCHOPHYSIOL, V103, P88, DOI 10.1016/j.ijpsycho.2015.02.008; Babiloni C, 2016, CLIN NEUROPHYSIOL, V127, P1803, DOI 10.1016/j.clinph.2015.12.007; Babiloni C, 2010, J ALZHEIMERS DIS, V19, P859, DOI 10.3233/JAD-2010-1290; Baker Mary, 2008, Open Neuroimag J, V2, P52, DOI 10.2174/1874440000802010052; Barry RJ, 2017, BIOL PSYCHOL, V129, P293, DOI 10.1016/j.biopsycho.2017.09.010; Benwell CSY, 2020, NEUROBIOL AGING, V85, P83, DOI 10.1016/j.neurobiolaging.2019.10.004; Cassani R, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/5174815; Cook IA, 1996, BEHAV BRAIN RES, V78, P15, DOI 10.1016/0166-4328(95)00214-6; Cummings J, 2019, ALZH DEMENT-TRCI, V5, P272, DOI 10.1016/j.trci.2019.05.008; Dauwels J, 2010, CURR ALZHEIMER RES, V7, P487, DOI 10.2174/156720510792231720; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; den Bakker H, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0214-8; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Espenhahn S, 2017, NEUROIMAGE, V147, P175, DOI 10.1016/j.neuroimage.2016.12.025; Fernandez T, 1993, Int J Neurosci, V68, P255; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fonseca LC, 2011, ARQ NEURO-PSIQUIAT, V69, P875, DOI 10.1590/S0004-282X2011000700005; Fonseca LC, 2011, CLIN EEG NEUROSCI, V42, P185, DOI 10.1177/155005941104200308; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Gallego-Jutgla E, 2015, J ALZHEIMERS DIS, V43, P1175, DOI 10.3233/JAD-140468; Garn H, 2015, CLIN NEUROPHYSIOL, V126, P505, DOI 10.1016/j.clinph.2014.07.005; Garn H, 2014, INT J PSYCHOPHYSIOL, V93, P390, DOI 10.1016/j.ijpsycho.2014.06.003; Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018; Hata M, 2016, CLIN NEUROPHYSIOL, V127, P1269, DOI 10.1016/j.clinph.2015.10.030; Horvath A, 2018, FRONT BIOSCI-LANDMRK, V23, P183, DOI 10.2741/4587; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jackson J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00735; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jalili M, 2017, INFORM SCIENCES, V384, P145, DOI 10.1016/j.ins.2016.08.047; Jelic V, 2000, NEUROBIOL AGING, V21, P533, DOI 10.1016/S0197-4580(00)00153-6; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Knyazeva MG, 2010, NEUROBIOL AGING, V31, P1132, DOI 10.1016/j.neurobiolaging.2008.07.019; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Kondacs A, 1999, CLIN NEUROPHYSIOL, V110, P1708, DOI 10.1016/S1388-2457(99)00122-4; Latif-Hernandez A, 2019, BEHAV BRAIN RES, V364, P431, DOI 10.1016/j.bbr.2017.11.017; Mazaheri A, 2018, NEUROIMAGE-CLIN, V17, P188, DOI 10.1016/j.nicl.2017.10.009; Meghdadi A. H., 2019, IEEE SYST MAN CYB BA; Moretti D., 2014, J BIOMEDICAL SCI ENG, V7, P546; Moretti DV, 2009, CLIN NEUROPHYSIOL, V120, P295, DOI 10.1016/j.clinph.2008.11.012; Moretti Davide V, 2011, Front Psychiatry, V1, P152, DOI 10.3389/fpsyt.2010.00152; Musaeus CS, 2019, J ALZHEIMERS DIS, V68, P947, DOI 10.3233/JAD-181081; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Musiek ES, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.121; Napflin M, 2007, CLIN NEUROPHYSIOL, V118, P2519, DOI 10.1016/j.clinph.2007.07.022; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Pion-Tonachini L, 2019, NEUROIMAGE, V198, P181, DOI 10.1016/j.neuroimage.2019.05.026; Poil SS, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00058; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Roh JH, 2011, CLIN NEUROPHYSIOL, V122, P2169, DOI 10.1016/j.clinph.2011.03.023; Rossini PM, 2006, NEUROSCIENCE, V143, P793, DOI 10.1016/j.neuroscience.2006.08.049; Rossini PM, 2020, CLIN NEUROPHYSIOL, V131, P1287, DOI 10.1016/j.clinph.2020.03.003; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shah D, 2016, ALZHEIMERS DEMENT, V12, P964, DOI 10.1016/j.jalz.2016.03.010; Smailovic U, 2018, NEUROBIOL AGING, V63, P88, DOI 10.1016/j.neurobiolaging.2017.11.005; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stephen TL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50781-1; Stomrud E, 2010, NEUROBIOL AGING, V31, P215, DOI 10.1016/j.neurobiolaging.2008.03.025; SZELIES B, 1994, ELECTROEN CLIN NEURO, V91, P131, DOI 10.1016/0013-4694(94)90034-5; Tenke CE, 2017, PSYCHOPHYSIOLOGY, V54, P34, DOI 10.1111/psyp.12758; Thatcher RW., 2010, J NEUROTHER, V14, P122, DOI [10.1080/10874201003773500, DOI 10.1080/10874201003773500]; Vecchio Fabrizio, 2013, Suppl Clin Neurophysiol, V62, P223; Vlahou EL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05101; Walker MP, 2000, BRIT J PSYCHIAT, V177, P252, DOI 10.1192/bjp.177.3.252; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Wen D, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00054; Ya M, 2015, INT J GERONTOL, V9, P196, DOI 10.1016/j.ijge.2014.07.001	78	28	28	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0244180	10.1371/journal.pone.0244180	http://dx.doi.org/10.1371/journal.pone.0244180			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544703	gold, Green Published			2022-12-26	WOS:000617991900059
J	Calcagno, TM; Zhang, CX; Tian, RX; Ebrahimi, B; Mirsaeidi, M				Calcagno, Tess M.; Zhang, Chongxu; Tian, Runxia; Ebrahimi, Babak; Mirsaeidi, Mehdi			Novel three-dimensional biochip pulmonary sarcoidosis model	PLOS ONE			English	Article							ON-A-CHIP; MYCOBACTERIUM-TUBERCULOSIS; RISK; MORTALITY; ANTIGENS; HEALTH; DUST	Sarcoidosis is a multi-system disorder of granulomatous inflammation which most commonly affects the lungs. Its etiology and pathogenesis are not well defined in part due to the lack of reliable modeling. Here, we present the development of an in vitro three-dimensional lung-on-chip biochip designed to mimic granuloma formation. A lung on chip fluidic macrodevice was developed and added to our previously developed a lung-on-membrane model (LOMM). Granulomas were cultured from blood samples of patients with sarcoidosis and then inserted in the air-lung-interface of the microchip to create a three-dimensional biochip pulmonary sarcoidosis model (3D BSGM). Cytokines were measured after 48 hours. ELISA testing was performed to measure cytokine response difference between LOMM with 3D BSGM. There were statistically significant differences in IL-1ss (P = 0.001953), IL-6 (P = 0.001953), GM-CSF (P = 0.001953), and INF-gamma expressions (P = 0.09375) between two groups. The current model represents the first 3D biochip sarcoidosis model created by adding a microfluidics system to a dual-chambered lung on membrane model and introducing developed sarcoid-granuloma to its air-lung-interface.	[Calcagno, Tess M.] Univ Miami, Dept Med, Miami, FL USA; [Zhang, Chongxu; Tian, Runxia; Mirsaeidi, Mehdi] Univ Miami, Div Pulm & Crit Care, Miami, FL 33136 USA; [Ebrahimi, Babak] Genix Engn, Res & Dev, Irvin, CA USA	University of Miami; University of Miami	Mirsaeidi, M (corresponding author), Univ Miami, Div Pulm & Crit Care, Miami, FL 33136 USA.	msm249@med.miami.edu		Mirsaeidi, Mehdi/0000-0001-5298-8442	Health Resources and Services Administration [234-2005-37011C]; Mallinckrodt Pharmaceuticals [5043]	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Mallinckrodt Pharmaceuticals	This work was supported in part by a Health Resources and Services Administration contract awarded to MM (234-2005-37011C), and Mallinckrodt Pharmaceuticals for research grant support awarded to MM(Grant No. 5043). GenixEngineering provided support for this study in the form of a salary for BE. The specific roles of this author are articulated in the `author contributions' section. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artzy-Schnirman A, 2019, EUR J PHARM BIOPHARM, V144, P11, DOI 10.1016/j.ejpb.2019.09.006; Asmani M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04336-z; Berry SB, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00931; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bielecka MK, 2017, MBIO, V8, DOI 10.1128/mBio.02073-16; Carlisle J, 2007, CLIN EXP IMMUNOL, V150, P460, DOI 10.1111/j.1365-2249.2007.03510.x; Douville NJ, 2011, LAB CHIP, V11, P609, DOI 10.1039/c0lc00251h; Dubaniewicz A, 2006, J CLIN MICROBIOL, V44, P3448, DOI 10.1128/JCM.01433-06; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P45, DOI 10.1016/j.humimm.2012.10.007; EISHI Y, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/935289; Fatimathas L, 2009, GEN PHYSIOL BIOPHYS, V28, pF29; Hu YJ, 2017, CELL TISSUE RES, V367, P651, DOI 10.1007/s00441-016-2526-3; HUANG CT, 1981, EUR J RESPIR DIS, V62, P231; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Huh Dongeun Dan, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS42, DOI 10.1513/AnnalsATS.201410-442MG; Humayun M, 2018, LAB CHIP, V18, P1298, DOI 10.1039/c7lc01357d; KIRSCHENBAUM M, 1961, ARCH DERMATOL, V84, P109, DOI 10.1001/archderm.1961.01580130115018; Konar D, 2016, BIOMED ENG COMPUT BI, V7, P16, DOI 10.4137/BECB.S34252; Korukonda A, 2019, AM J RESP CELL MOL, V60, P717, DOI 10.1165/rcmb.2018-0339LE; Lippmann M, 2015, CRIT REV TOXICOL, V45, P492, DOI 10.3109/10408444.2015.1044601; Llanos O, 2019, MED CLIN N AM, V103, P527, DOI 10.1016/j.mcna.2018.12.011; Locke LW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01719; Maliarik MJ, 1998, AM J RESP CRIT CARE, V158, P1566, DOI 10.1164/ajrccm.158.5.9804123; Mirsaeidi M, 2016, SARCOIDOSIS VASC DIF, V33, P418; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Newman KL, 2012, CURR OPIN ALLERGY CL, V12, P145, DOI 10.1097/ACI.0b013e3283515173; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Schweitzer MD, 2018, ENVIRON RES, V163, P36, DOI 10.1016/j.envres.2018.02.001; Schweitzer MD, 2017, EUR J INTERN MED, V44, pE11, DOI 10.1016/j.ejim.2017.08.006; Shamaei M, 2017, SARCOIDOSIS VASC DIF, V34, P236, DOI 10.36141/svdld.v34i3.5739; Sosa-Hernandez JE, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9100536; Standiford TJ, 2019, AM J RESP CELL MOL, V60, P9, DOI 10.1165/rcmb.2018-0298ED; Swaisgood CM, 2011, AM J RESP CELL MOL, V44, P166, DOI 10.1165/rcmb.2009-0350OC; Ungprasert Patompong, 2019, Mayo Clin Proc Innov Qual Outcomes, V3, P358, DOI 10.1016/j.mayocpiqo.2019.04.006; Walter Fruzsina R, 2020, Curr Protoc Immunol, V130, pe101, DOI 10.1002/cpim.101; Werner JL, 2017, AM J RESP CELL MOL, V56, P121, DOI 10.1165/rcmb.2016-0035OC; Yang XY, 2018, LAB CHIP, V18, P486, DOI 10.1039/c7lc01224a; Zhang CX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64305-9; Zhang CX, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02888; Zhou Y, 2015, CLIN EXP IMMUNOL, V181, P511, DOI 10.1111/cei.12650; 2019, J CROHNS COLITIS S1, V13	42	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245805	10.1371/journal.pone.0245805	http://dx.doi.org/10.1371/journal.pone.0245805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539409	Green Published, gold			2022-12-26	WOS:000616960200093
J	Ramaraju, S; Reichert, S; Wang, Y; Forsyth, R; Taylor, PN				Ramaraju, S.; Reichert, S.; Wang, Y.; Forsyth, R.; Taylor, P. N.			Carbogen inhalation during non-convulsive status epilepticus: A quantitative exploratory analysis of EEG recordings	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; DIOXIDE; CRITERIA; ELECTROENCEPHALOGRAM; MODULATION; SEIZURES; PH	Objective To quantify the effect of inhaled 5% carbon-dioxide/95% oxygen on EEG recordings from patients in non-convulsive status epilepticus (NCSE). Methods Five children of mixed aetiology in NCSE were given high flow of inhaled carbogen (5% carbon dioxide/95% oxygen) using a face mask for maximum 120s. EEG was recorded concurrently in all patients. The effects of inhaled carbogen on patient EEG recordings were investigated using band-power, functional connectivity and graph theory measures. Carbogen effect was quantified by measuring effect size (Cohen's d) between "before", "during" and "after" carbogen delivery states. Results Carbogen's apparent effect on EEG band-power and network metrics across all patients for "before-during" and "before-after" inhalation comparisons was inconsistent across the five patients. Conclusion The changes in different measures suggest a potentially non-homogeneous effect of carbogen on the patients' EEG. Different aetiology and duration of the inhalation may underlie these non-homogeneous effects. Tuning the carbogen parameters (such as ratio between CO2 and O-2, duration of inhalation) on a personalised basis may improve seizure suppression in future.	[Ramaraju, S.; Wang, Y.; Taylor, P. N.] Newcastle Univ, Sch Comp Sci, Interdisciplinary Comp & Complex Biosyst Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Reichert, S.] Offenburg Univ Appl Sci, Dept Elect Engn, Med Engn & Comp Sci, Offenburg, Germany; [Forsyth, R.] Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Hochschule Offenburg; Newcastle University - UK	Ramaraju, S (corresponding author), Newcastle Univ, Sch Comp Sci, Interdisciplinary Comp & Complex Biosyst Grp, Newcastle Upon Tyne, Tyne & Wear, England.	sriharsha.ramaraju@newcastle.ac.uk	Forsyth, Rob/I-9226-2012; Taylor, Peter/E-8927-2011	Forsyth, Rob/0000-0002-5657-4180; Taylor, Peter/0000-0003-2144-9838; Wang, Yujiang/0000-0002-4847-6273; Ramaraju, Sriharsha/0000-0001-5958-0976	Epilepsy Research UK [P1103]; Wellcome Trust [210109/Z/18/Z]	Epilepsy Research UK; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Epilepsy Research UK to Dr R Forsyth(P1103) and Wellcome Trust (210109/Z/18/Z) to Dr P N Taylor.	Abreu R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36976-y; BALESTRINO M, 1988, J PHYSIOL-LONDON, V396, P247, DOI 10.1113/jphysiol.1988.sp016961; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Bloch-Salisbury E, 2000, PSYCHOPHYSIOLOGY, V37, P418, DOI 10.1111/1469-8986.3740418; Brodie MJ, 2011, SEIZURE-EUR J EPILEP, V20, P369, DOI 10.1016/j.seizure.2011.01.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burianova H, 2017, EPILEPSY RES, V137, P45, DOI 10.1016/j.eplepsyres.2017.09.001; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; DAHLBERGPARROW R, 1951, ACTA PHYSIOL SCAND, V23, P55, DOI 10.1111/j.1748-1716.1951.tb00794.x; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Douw L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010839; Dulla CG, 2009, J NEUROPHYSIOL, V102, P1984, DOI 10.1152/jn.90695.2008; Forsyth R, 2016, EUR J PAEDIATR NEURO, V20, P560, DOI 10.1016/j.ejpn.2016.04.001; Galimi R, 2012, MINERVA PEDIATR, V64, P347; Guo L, 2010, J NEUROSCI METH, V193, P156, DOI 10.1016/j.jneumeth.2010.08.030; Hamilton Paul K, 2017, Ulster Med J, V86, P161; Kaplan PW, 2007, EPILEPSIA, V48, P39, DOI 10.1111/j.1528-1167.2007.01345.x; Lee J, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00052; Lennox WG, 1936, ARCH NEURO PSYCHIATR, V36, P1236, DOI 10.1001/archneurpsyc.1936.02260120083006; LOWENSTEIN DH, 1993, NEUROLOGY, V43, P483, DOI 10.1212/WNL.43.3_Part_1.483; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; MEYER JS, 1961, ELECTROEN CLIN NEURO, V13, P762, DOI 10.1016/0013-4694(61)90108-0; MITCHELL WG, 1956, SCIENCE, V123, P223, DOI 10.1126/science.123.3189.223; Pasternack M, 1996, NEUROPHARMACOLOGY, V35, P1279, DOI 10.1016/S0028-3908(96)00075-5; POLLOCK GH, 1949, P SOC EXP BIOL MED, V70, P291; POLLOCK GH, 1949, J NEUROPHYSIOL, V12, P315, DOI 10.1152/jn.1949.12.5.315; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Sutter R, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03593.x; Tolner EA, 2011, EPILEPSIA, V52, P104, DOI 10.1111/j.1528-1167.2010.02731.x; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Tracy JI, 2015, CURR OPIN NEUROL, V28, P158, DOI 10.1097/WCO.0000000000000178; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Walker MC, 2007, INT REV NEUROBIOL, V81, P287, DOI 10.1016/S0074-7742(06)81019-6; WOODBURY DM, 1956, AM J PHYSIOL, V184, P202, DOI 10.1152/ajplegacy.1955.184.1.202; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0240507	10.1371/journal.pone.0240507	http://dx.doi.org/10.1371/journal.pone.0240507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534850	gold, Green Published			2022-12-26	WOS:000616739700016
J	Gao, JL; Weaver, JD; Tuo, JS; Wang, LQ; Siwicki, M; Despres, D; Lizak, M; Schneider, EH; Kovacs, W; Maminishkis, A; Chen, KQ; Yoshimura, T; Wang, JM; Chan, CC; Murphy, PM				Gao, Ji-Liang; Weaver, Joseph D.; Tuo, Jingsheng; Wang, Long Q.; Siwicki, Marie; Despres, Daryl; Lizak, Martin; Schneider, Erich H.; Kovacs, William; Maminishkis, Arvydas; Chen, Keqiang; Yoshimura, Teizo; Wang, Ji Ming; Chan, Chi Chao; Murphy, Philip M.			Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation	FASEB JOURNAL			English	Article						cataract; chemoattractant receptor; eye; formyl peptide; G protein; knockout mouse	FIBER CELL-DIFFERENTIATION; FORMYL PEPTIDE RECEPTORS; LENS EPITHELIUM; HOST-DEFENSE; PROTEINS; GROWTH; PAX6	Cataracts are a common consequence of aging; however, pathogenesis remains poorly understood. Here, we observed that after 3 months of age mice lacking the G protein-coupled leukocyte chemotactic receptor Fpr1 (N-formyl peptide receptor 1) began to develop bilateral posterior subcapsular cataracts that progressed to lens rupture and severe degeneration, without evidence of either systemic or local ocular infection or inflammation. Consistent with this, Fpr1 was detected in both mouse and human lens in primary lens epithelial cells (LECs), the only cell type present in the lens; however, expression was confined to subcapsular LECs located along the anterior hemispheric surface. To maximize translucency, LECs at the equator proliferate and migrate posteriorly, then differentiate into lens fiber cells by nonclassical apoptotic signaling, which results in loss of nuclei and other organelles, including mitochondria which are a rich source of endogenous N-formyl peptides. In this regard, denucleation and posterior migration of LECs were abnormal in lenses from Fpr1(-/-) mice, and direct stimulation of LECs with the prototypic N-formyl peptide agonist fMLF promoted apoptosis. Thus, Fpr1 is repurposed beyond its immunoregulatory role in leukocytes to protect against cataract formation and lens degeneration during aging.	[Gao, Ji-Liang; Weaver, Joseph D.; Wang, Long Q.; Siwicki, Marie; Schneider, Erich H.; Kovacs, William; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Room 11N113, Bethesda, MD 20892 USA; [Tuo, Jingsheng; Chan, Chi Chao] NEI, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Despres, Daryl; Lizak, Martin] NIH, Mouse Imaging Facil, Bldg 10, Bethesda, MD 20892 USA; [Maminishkis, Arvydas] NEI, Sect Epithelial & Retinal Physiol & Dis, NIH, Bethesda, MD 20892 USA; [Chen, Keqiang; Wang, Ji Ming] Natl Canc Inst Frederick, Ctr Canc Res, Lab Canc & Immunometab, Frederick, MD USA; [Yoshimura, Teizo] Okayama Univ, Dept Pathol & Expt Med, Okayama, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Room 11N113, Bethesda, MD 20892 USA.	pmm@nih.gov						Aliancy J.F., 1995, WEBVISION ORG RETINA; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Dahm R, 1999, OPHTHALMIC RES, V31, P163, DOI 10.1159/000055530; de Paulis A, 2009, J IMMUNOL, V183, P3761, DOI 10.4049/jimmunol.0900863; ESHAGHIAN J, 1980, ARCH OPHTHALMOL-CHIC, V98, P134, DOI 10.1001/archopht.1980.01020030136016; Gao JL, 2011, BEHAV GENET, V41, P724, DOI 10.1007/s10519-011-9467-0; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; GREINER JV, 1979, ARCH OPHTHALMOL-CHIC, V97, P135, DOI 10.1001/archopht.1979.01020010069017; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P1874; Lee CM, 2017, CURR OPIN OPHTHALMOL, V28, P98, DOI 10.1097/ICU.0000000000000340; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Martinez G, 2010, INT J BIOCHEM CELL B, V42, P1945, DOI 10.1016/j.biocel.2010.09.012; Minogue PJ, 2017, INVEST OPHTH VIS SCI, V58, P4366, DOI 10.1167/iovs.17-21684; Muta M, 2002, GENES CELLS, V7, P791, DOI 10.1046/j.1365-2443.2002.00560.x; NAKAMURA T, 1995, P NATL ACAD SCI USA, V92, P6142, DOI 10.1073/pnas.92.13.6142; Nicolas-Leveque C, 1999, INVEST OPHTH VIS SCI, V40, P1812; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Reddan JR, 1999, EXP EYE RES, V68, P117, DOI 10.1006/exer.1998.0606; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Schneider EH, 2012, J BIOL CHEM, V287, P40779, DOI 10.1074/jbc.M112.411181; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; STREETEN BW, 1978, ARCH OPHTHALMOL-CHIC, V96, P1653, DOI 10.1001/archopht.1978.03910060279020; Thompson J, 2015, PRIMARY CARE, V42, P409, DOI 10.1016/j.pop.2015.05.012; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Wiley LA, 2011, DIS MODEL MECH, V4, P484, DOI 10.1242/dmm.006593; WORGUL BV, 1976, ARCH OPHTHALMOL-CHIC, V94, P996, DOI 10.1001/archopht.1976.03910030506013; Wormstone IM, 2011, PHILOS T R SOC B, V366, P1190, DOI 10.1098/rstb.2010.0377; Wormstone IM, 2002, EXP EYE RES, V74, P337, DOI 10.1006/exer.2001.1153; Wride MA, 1999, DEV BIOL, V213, P142, DOI 10.1006/dbio.1999.9375; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang MH, 2020, J IMMUNOL, V204, P2464, DOI 10.4049/jimmunol.1900430; Zhang XG, 2011, INVEST OPHTH VIS SCI, V52, P3160, DOI 10.1167/iovs.10-5156	43	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21315	10.1096/fj.202002135R	http://dx.doi.org/10.1096/fj.202002135R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33538366				2022-12-26	WOS:000647789600053
J	Hackl, S; Ng, XW; Lu, DQ; Wohland, T; Becker, CFW				Hackl, Stefanie; Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten; Becker, Christian F. W.			Cytoskeleton-dependent clustering of membrane-bound prion protein on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ANCHORED PROTEINS; PLASMA-MEMBRANE; LIPID RAFTS; COLOCALIZATION; DIFFUSION; MODEL; ORGANIZATION; CONVERSION; PRPSC	Prion diseases are a group of neurodegenerative disorders that infect animals and humans with proteinaceous particles called prions. Prions consist of scrapie prion protein (PrPSc), a misfolded version of the cellular prion protein (PrPC). During disease progression, PrPSc replicates by interacting with PrPC and inducing its conversion to PrPSc. Attachment of PrPC to cellular membranes via a glycosylphosphatidylinositol (GPI) anchor is critical for the conversion of PrPC into PrPSc. However, the mechanisms governing PrPC conversion and replication on the membrane remain largely unclear. Here, a site-selectively modified PrP variant equipped with a fluorescent GPI anchor mimic (PrP-GPI) was employed to directly observe PrP at the cellular membrane in neuronal SH-SY5Y cells. PrP-GPI exhibits a cholesterol-dependent membrane accumulation and a cytoskeleton-dependent mobility. More specifically, inhibition of actin polymerization reduced the diffusion of PrP-GPI indicating protein clustering, which resembles the initial step of PrP aggregation and conversion into its pathogenic isoform. An intact actin cytoskeleton might therefore prevent conversion of PrPC into PrPSc and offer new therapeutic angles.	[Hackl, Stefanie; Becker, Christian F. W.] Univ Vienna, Fac Chem, Inst Biol Chem, Vienna, Austria; [Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten] Natl Univ Singapore NUS, Dept Biol Sci, Singapore, Singapore; [Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten] Natl Univ Singapore NUS, Dept Chem, Singapore, Singapore; [Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten] Natl Univ Singapore NUS, Ctr Bioimaging Sci CBIS, Singapore, Singapore; [Lu, Danqin] East China Normal Univ, Sch Chem & Mol Engn, Shanghai, Peoples R China	University of Vienna; East China Normal University	Becker, CFW (corresponding author), Univ Vienna, Fac Chem, Inst Biol Chem, Vienna, Austria.	christian.becker@univie.ac.at	Becker, Christian F/A-4891-2010	Becker, Christian F/0000-0002-8890-7082	Wien Kultur; Singapore Ministry of Education [R-154-000-B53-114]; Vienna Science and Technology Fund (WWTF) [LS17-008]	Wien Kultur; Singapore Ministry of Education(Ministry of Education, Singapore); Vienna Science and Technology Fund (WWTF)	S. H. is grateful for financial support by Wien Kultur. T. W. received support from the Singapore Ministry of Education (R-154-000-B53-114). C. F. W. B. was funded by the Vienna Science and Technology Fund (WWTF, LS17-008).	Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Aguzzi A, 1998, HAEMOPHILIA, V4, P619, DOI 10.1046/j.1365-2516.1998.440619.x; Araman C, 2017, CHEM SCI, V8, P6626, DOI 10.1039/c7sc02719b; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bag N, 2015, BIOPHYS J, V109, P1925, DOI 10.1016/j.bpj.2015.09.007; Bag N, 2013, CHEM COMMUN, V49, P9155, DOI 10.1039/c3cc44880k; Bag N, 2012, CHEMPHYSCHEM, V13, P2784, DOI 10.1002/cphc.201200032; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Becker CFW, 2008, ANGEW CHEM INT EDIT, V47, P8215, DOI 10.1002/anie.200802161; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chu NK, 2014, J BIOL CHEM, V289, P30144, DOI 10.1074/jbc.M114.587345; Chu NK, 2009, METHOD ENZYMOL, V462, P177, DOI 10.1016/S0076-6879(09)62009-7; Conibear AC, 2018, CHEM SOC REV, V47, P9046, DOI 10.1039/c8cs00573g; Cordelieres F., 2008, IMAGEJ USER DEVELOPE, P174; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de la Serna JB, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00106; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Han Sen, 2008, V459, P145, DOI 10.1007/978-1-59745-234-2_11; Huang S, 2017, BBA-BIOMEMBRANES, V1859, P1483, DOI 10.1016/j.bbamem.2016.12.009; Kapusta P., 2010, ABSOLUTE DIFFUSION C, V1, P1, DOI DOI 10.1209/0295-5075/83/46001; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; Korbel GA, 2001, J AM CHEM SOC, V123, P361, DOI 10.1021/ja0034747; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Metzner C, 2013, MOL BIOTECHNOL, V53, P9, DOI 10.1007/s12033-012-9616-6; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Ng XW, 2016, BIOPHYS J, V111, P418, DOI 10.1016/j.bpj.2016.06.021; Olschewski D, 2007, CHEM BIOL, V14, P994, DOI 10.1016/j.chembiol.2007.08.007; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Rao MD, 2014, CURR OPIN CELL BIOL, V29, P126, DOI 10.1016/j.ceb.2014.05.007; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rigler R., 1992, SPIE LASER SPECTROSC, V1921, P239; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Saha S, 2015, MOL BIOL CELL, V26, P4033, DOI 10.1091/mbc.E15-06-0397; Sang JC, 2019, CHEM SCI, V10, P4588, DOI 10.1039/c8sc05627g; Sang JC, 2018, J AM CHEM SOC, V140, P14789, DOI 10.1021/jacs.8b08311; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sankaran J, 2013, ANAL CHEM, V85, P3948, DOI 10.1021/ac303485t; Sankaran J, 2010, OPT EXPRESS, V18, P25468, DOI 10.1364/OE.18.025468; Sasse J., 2004, CURR PROTOC IMMUNOL; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sun GY, 2015, ANAL CHEM, V87, P4326, DOI 10.1021/acs.analchem.5b00022; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Thompson R. E., 2019, CHEM REV; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; Weissmann Charles, 1994, Trends in Cell Biology, V4, P10, DOI 10.1016/0962-8924(94)90032-9; Widengren J, 2000, J PHYS CHEM A, V104, P6416, DOI 10.1021/jp000059s; Widengren J, 1999, CHEM PHYS, V250, P171, DOI 10.1016/S0301-0104(99)00255-4; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Wohland T, 2001, BIOPHYS J, V80, P2987, DOI 10.1016/S0006-3495(01)76264-9; Yamane T, 2011, BIOCONJUGATE CHEM, V22, P2227, DOI 10.1021/bc200127t; Yu H, 2015, P NATL ACAD SCI USA, V112, P8308, DOI 10.1073/pnas.1419197112; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang LY, 2015, CHEM COMMUN, V51, P7386, DOI 10.1039/c5cc01601k; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	80	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100359	10.1016/j.jbc.2021.100359	http://dx.doi.org/10.1016/j.jbc.2021.100359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539927	gold, Green Published			2022-12-26	WOS:000672866400333
J	Kim, CW; Oh, ET; Park, HJ				Kim, Chan Woo; Oh, Eun-Taex; Park, Heon Joo			A strategy to prevent atherosclerosis via TNF receptor regulation	FASEB JOURNAL			English	Article						atherosclerosis; brusatol; inflammation; TNFR1; TNF&#8208; &#945	ENDOTHELIAL DYSFUNCTION; BRUSATOL; INHIBITION; MECHANISMS; INFLAMMATION; DISEASE; CELLS; CHEMORESISTANCE; DEGRADATION; EXPRESSION	Atherosclerosis is a chronic inflammatory disease of the arterial wall. It has been known that development of atherosclerosis is closely related to activation of tumor necrosis factor alpha (TNF-alpha). The objective of this study was to elucidate the effects of TNF-alpha blockade with brusatol on endothelial activation under pro-atherosclerotic conditions. To this end, we examined the effects of brusatol on TNF-alpha-induced intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in human aortic endothelial cells (HAECs) using western blot and THP-1 adhesion assays. Brusatol induced a decrease in TNF-alpha-induced ICAM-1 and VCAM-1 expression through inhibiting TNFR1 expression, leading to suppression of endothelial inflammation independently of the NRF2 (nuclear factor erythroid 2-related factor 2) pathway. The mechanism underlying brusatol-induced TNF receptor 1 (TNFR1) inhibition was investigated with the aid of protein synthesis, co-immunoprecipitation, and cytokine arrays. Notably, brusatol inhibited TNFR1 protein synthesis and suppressed both the canonical nuclear factor kappa-light-chain-enhancer of activated B cell (NF-kappa B) signaling pathway and TNF-alpha-induced cytokine secretion. We further tested the functional effect of brusatol on atherosclerosis development in vivo using two different atherosclerosis mouse models, specifically, acute partial carotid ligation and conventional chronic high-fat diet-fed mouse models. Administration of brusatol led to significant suppression of atherosclerosis development in both mouse models. Our finding that brusatol prevents atherosclerosis via inhibition of TNFR1 protein synthesis supports the potential of downregulation of cell surface TNFR1 as an effective therapeutic approach to inhibit development of atherosclerosis.	[Kim, Chan Woo; Park, Heon Joo] Inha Univ, Coll Med, Dept Microbiol, Inha Ro 100, Incheon 22212, South Korea; [Kim, Chan Woo] Osong Med Innovat Fdn, Lab Anim Ctr, Dept Preclin Trial, Cheongju, South Korea; [Oh, Eun-Taex; Park, Heon Joo] Inha Univ, Coll Med, Hypoxia Related Dis Res Ctr, Incheon, South Korea; [Oh, Eun-Taex] Inha Univ, Coll Med, Dept Biomed Sci, Incheon, South Korea	Inha University; Osong Medical Innovation Foundation; Inha University; Inha University	Park, HJ (corresponding author), Inha Univ, Coll Med, Dept Microbiol, Inha Ro 100, Incheon 22212, South Korea.	park001@inha.ac.kr			National Research Foundation of Korea (NRF) [NRF-2014R1A5A2009392, NRF-2015M2B2B1068623]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2018R1D1A1B07047058, NRF-2019R1A2C1008142, NRF2020R1A2C2101772]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2014R1A5A2009392 and NRF-2015M2B2B1068623; the Basic Science Research Program through the National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1D1A1B07047058, NRF-2019R1A2C1008142 and NRF2020R1A2C2101772	Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Conti P, 2015, CENT EUR J IMMUNOL, V40, P380, DOI 10.5114/ceji.2015.54603; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; Feingold KR, 1996, J LIPID RES, V37, P223; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; HALL IH, 1983, J PHARM SCI, V72, P1282, DOI 10.1002/jps.2600721111; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harder B, 2017, MOL CARCINOGEN, V56, P1493, DOI 10.1002/mc.22609; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Linden F, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00455; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oh ET, 2017, THERANOSTICS, V7, P3415, DOI 10.7150/thno.20861; Oh ET, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13593; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Olayanju A, 2015, FREE RADICAL BIO MED, V78, P202, DOI 10.1016/j.freeradbiomed.2014.11.003; Raggi P, 2018, ATHEROSCLEROSIS, V276, P98, DOI 10.1016/j.atherosclerosis.2018.07.014; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2014, EUR HEART J, V35, P540, DOI 10.1093/eurheartj/eht398; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Sun XH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070997; Tang WB, 2014, J MED CHEM, V57, P7600, DOI 10.1021/jm5007534; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Vartanian S, 2016, MOL CELL PROTEOMICS, V15, P1220, DOI 10.1074/mcp.M115.055509; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Xanthoulea S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006113; Zhang LS, 2007, ARTERIOSCL THROM VAS, V27, P1087, DOI 10.1161/01.ATV.0000261548.49790.63	41	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21391	10.1096/fj.202000764R	http://dx.doi.org/10.1096/fj.202000764R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565155	Bronze			2022-12-26	WOS:000629576700040
J	Kim, HJ; Kim, E; Lee, H; Jung, JW; Kim, JE; Pack, CG; Lee, JW				Kim, Hye-Jin; Kim, Eunmi; Lee, Haesong; Jung, Jae Woo; Kim, Ji Eon; Pack, Chan-Gi; Lee, Jung Weon			SLAC2B-dependent microtubule acetylation regulates extracellular matrix-mediated intracellular TM4SF5 traffic to the plasma membranes	FASEB JOURNAL			English	Article						cell migration; fibronectin; SLAC2B; tubulin acetylation; vesicle traffic		Transmembrane 4 L six family member 5 (TM4SF5) translocates intracellularly and promotes cell migration, but how subcellular TM4SF5 traffic is regulated to guide cellular migration is unknown. We investigated the influences of the extracellular environment and intracellular signaling on the TM4SF5 traffic with regard to migration directionality. Cell adhesion to fibronectin (FN) but not poly-l-lysine enhanced the traffic velocity and straightness of the TM4SF5(WT) (but not palmitoylation-deficient mutant TM4SF5Pal-) toward the leading edges, depending on tubulin acetylation. Acetylated-microtubules in SLAC2B-positive cells reached mostly the juxtanuclear regions, but reached-out toward the leading edges upon SLAC2B suppression. TM4SF5 expression caused SLAC2B not to be localized at the leading edges. TM4SF5 colocalization with HDAC6 depended on paxillin expression. The trimeric complex consisting of TM4SF5, HDAC6, and SLAC2B might, thus, be enriched at the perinuclear cytosols toward the leading edges. More TM4SF5(WT) translocation to the leading edges was possible when acetylated-microtubules reached the frontal edges following HDAC6 inhibition by paxillin presumably at new cell-FN adhesions, leading to persistent cell migration. Collectively, this study revealed that cell-FN adhesion and microtubule acetylation could control intracellular traffic of TM4SF5 vesicles to the leading edges via coordinated actions of paxillin, SLAC2B, and HDAC6, leading to TM4SF5-dependent cell migration.	[Kim, Hye-Jin; Kim, Eunmi; Lee, Haesong; Kim, Ji Eon; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Pharm, Seoul, South Korea; [Jung, Jae Woo; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Pack, Chan-Gi] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center	Lee, JW (corresponding author), Seoul Natl Univ, Dept Pharm, Coll Pharm, Seoul 08826, South Korea.	jwl@snu.ac.kr		Lee, Jung Weon/0000-0003-2722-8200; Jung, Jae Woo/0000-0001-7178-7400	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2020R1I1A1A01070020, NRF-2018M3A9C8020027, 2020R1A2C3008993]; Tumor Microenvironment GCRC [2011-0030001]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Tumor Microenvironment GCRC	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2020R1I1A1A01070020 to EMK and NRF-2018M3A9C8020027 and 2020R1A2C3008993 to JWL), the Tumor Microenvironment GCRC (2011-0030001) to JWL.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Caswell PT, 2018, TRENDS CELL BIOL, V28, P823, DOI 10.1016/j.tcb.2018.06.003; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Dubois F, 2017, MOL BIOL CELL, V28, P3815, DOI 10.1091/mbc.E17-08-0488; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ibata N, 2020, BIOPHYS J, V119, P2063, DOI 10.1016/j.bpj.2020.09.037; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Jung JW, 2019, CELL METAB, V29, P1306, DOI 10.1016/j.cmet.2019.03.005; Jung O, 2013, BBA-MOL CELL RES, V1833, P629, DOI 10.1016/j.bbamcr.2012.11.026; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102817; Kasai N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20146-1; Kim H-J., 2021, FASEB J, V35, P21369; Kim HJ, 2017, FASEB J, V31, P1461, DOI 10.1096/fj.201600944RR; Kim S, 2018, CANCER LETT, V438, P219, DOI 10.1016/j.canlet.2018.09.009; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Lee D, 2015, HEPATOLOGY, V61, P1978, DOI 10.1002/hep.27721; Lee JW, 2015, INT REV CEL MOL BIO, V319, P141, DOI 10.1016/bs.ircmb.2015.06.004; Lopez-Colome AM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0418-y; McGrath JA, 2012, AM J HUM GENET, V91, P1115, DOI 10.1016/j.ajhg.2012.10.012; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Ryu J, 2021, J PATHOL, V253, P55, DOI 10.1002/path.5548; Scales TME, 2011, CURR OPIN CELL BIOL, V23, P562, DOI 10.1016/j.ceb.2011.05.008; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Ustinova K, 2020, J BIOL CHEM, V295, P2614, DOI 10.1074/jbc.RA119.011243; Watanabe S, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202006010; Wloga D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102207; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100	40	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21369	10.1096/fj.202002138RR	http://dx.doi.org/10.1096/fj.202002138RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33554392				2022-12-26	WOS:000629576700037
J	Lu, AP; Guo, P; Pan, HY; Tseng, C; Sinha, KM; Yang, F; Scibetta, A; Cui, Y; Huard, M; Zhong, L; Ravuri, S; Huard, J				Lu, Aiping; Guo, Ping; Pan, Haiying; Tseng, Chieh; Sinha, Krishna M.; Yang, Fan; Scibetta, Alex; Cui, Yan; Huard, Matthieu; Zhong, Ling; Ravuri, Sudheer; Huard, Johnny			Enhancement of myogenic potential of muscle progenitor cells and muscle healing during pregnancy	FASEB JOURNAL			English	Article						circulating factors; heterochronic parabiosis; myogenic differentiation; skeletal muscle injury	SKELETAL-MUSCLE; STEM-CELLS; SATELLITE-CELL; REGENERATIVE CAPACITY; CLINICAL-IMPLICATIONS; GROWTH-HORMONE; TISSUE-REPAIR; FETAL CELLS; ACTIVATION; IMPROVE	The decline of muscle regenerative potential with age has been attributed to a diminished responsiveness of muscle progenitor cells (MPCs). Heterochronic parabiosis has been used as a model to study the effects of aging on stem cells and their niches. These studies have demonstrated that, by exposing old mice to a young systemic environment, aged progenitor cells can be rejuvenated. One interesting idea is that pregnancy represents a unique biological model of a naturally shared circulatory system between developing and mature organisms. To test this hypothesis, we evaluated the muscle regeneration potential of pregnant mice using a cardiotoxin (CTX) injury mouse model. Our results indicate that the pregnant mice demonstrate accelerated muscle healing compared to nonpregnant control mice following muscle injury based on improved muscle histology, superior muscle regeneration, and a reduction in inflammation and necrosis. Additionally, we found that MPCs isolated from pregnant mice display a significant improvement of myogenic differentiation capacity in vitro and muscle regeneration in vivo when compared to the MPCs from nonpregnant mice. Furthermore, MPCs from nonpregnant mice display enhanced myogenic capacity when cultured in the presence of serum obtained from pregnant mice. Our proteomics data from these studies provides potential therapeutic targets to enhance the myogenic potential of progenitor cells and muscle repair.	[Lu, Aiping; Guo, Ping; Scibetta, Alex; Huard, Matthieu; Ravuri, Sudheer] Steadman Philippon Res Inst, Vail, CO USA; [Pan, Haiying; Tseng, Chieh; Sinha, Krishna M.; Cui, Yan; Zhong, Ling; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Houston, TX 77030 USA; [Yang, Fan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Traumat Surg, Wuhan, Peoples R China	Steadman Philippon Research Institute; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology	Lu, AP; Huard, J (corresponding author), Steadman Philippon Res Inst SPRI, Ctr Regenerat Sports Med, Vail, CO 81657 USA.	alu@sprivail.org; jhuard@sprivail.org			National Institutes of Health (NIH) [R21 AR073509-01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS broken vertical bar National Institutes of Health (NIH), Grant/Award Number: R21 AR073509-01	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beiner J M, 2001, J Am Acad Orthop Surg, V9, P227; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Bernardi H, 2011, AM J PHYSIOL-CELL PH, V300, pC1122, DOI 10.1152/ajpcell.00214.2010; Best T M, 2000, Phys Med Rehabil Clin N Am, V11, P251; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; Chan WFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045592; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2012, CELL CYCLE, V11, P2260, DOI 10.4161/cc.20437; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Delos D, 2013, SPORTS HEALTH, V5, P346, DOI 10.1177/1941738113480934; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dohar JE, 1998, ARCH OTOLARYNGOL, V124, P25, DOI 10.1001/archotol.124.1.25; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FLORINI JR, 1993, ADV EXP MED BIOL, V343, P319; Fu X, 2015, CELL MOL LIFE SCI, V72, P1663, DOI 10.1007/s00018-014-1819-5; Garrett WE, 1996, AM J SPORT MED, V24, pS2, DOI 10.1177/036354659602406S02; GARRETT WE, 1984, J HAND SURG-AM, V9A, P683, DOI 10.1016/S0363-5023(84)80014-3; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gielchinsky Y, 2010, GENE DEV, V24, P543, DOI 10.1101/gad.563110; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Huard J, 2015, CELLS TISSUES ORGANS, V202, P227, DOI 10.1159/000443926; JARVINEN MJ, 1993, SPORTS MED, V15, P78; Jeanty C, 2014, CURR OPIN PEDIATR, V26, P377, DOI 10.1097/MOP.0000000000000087; Jones AE, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0038-6; Kara RJ, 2012, CIRC RES, V110, P82, DOI 10.1161/CIRCRESAHA.111.249037; Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2; Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Kong WY, 2008, EXP CELL RES, V314, P1529, DOI 10.1016/j.yexcr.2008.01.022; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Lapaire O, 2007, J MATERN-FETAL NEO M, V20, P1, DOI 10.1080/14767050601144834; Laumonier Thomas, 2016, J Exp Orthop, V3, P15, DOI 10.1186/s40634-016-0051-7; Lavasani M, 2006, HUM GENE THER, V17, P180, DOI 10.1089/hum.2006.17.180; Lavasani Mitra, 2013, Methods Mol Biol, V976, P53, DOI 10.1007/978-1-62703-317-6_5; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; Li Y, 2005, ANN NY ACAD SCI, V1041, P395, DOI 10.1196/annals.1282.060; Li Y, 2005, PHYSICIAN SPORTSMED, V33, P44, DOI 10.3810/psm.2005.05.91; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lippert T. H., 1996, Clinical and Experimental Obstetrics and Gynecology, V23, P65; Lu AP, 2012, MOL THER, V20, P661, DOI 10.1038/mt.2011.261; MAGRI KA, 1991, ADV EXP MED BIOL, V293, P57; Mahmood Uzma, 2014, Chimerism, V5, P40; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mansurov N, 2018, J TISSUE ENG REGEN M, V12, pE1164, DOI 10.1002/term.2451; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Michaeli TF, 2015, AGING CELL, V14, P698, DOI 10.1111/acel.12286; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mu XD, 2015, HUM MOL GENET, V24, P2923, DOI 10.1093/hmg/ddv055; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Murphy MM, 2014, STEM CELL REP, V3, P475, DOI 10.1016/j.stemcr.2014.06.019; Murphy T, 2015, AGEING RES REV, V19, P53, DOI 10.1016/j.arr.2014.11.004; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nassar D, 2012, FASEB J, V26, P149, DOI 10.1096/fj.11-180695; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Nijagal A, 2013, SEMIN PEDIATR SURG, V22, P62, DOI 10.1053/j.sempedsurg.2012.10.011; Ota S, 2011, AM J SPORT MED, V39, P1912, DOI 10.1177/0363546511415239; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rudolf A, 2016, CELL REP, V15, P1277, DOI 10.1016/j.celrep.2016.04.022; Semsarian C, 1999, BIOCHEM J, V339, P443, DOI 10.1042/0264-6021:3390443; Seppanen EJ, 2012, STEM CELLS DEV, V21, P2809, DOI 10.1089/scd.2012.0047; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Tamaki T, 2008, STEM CELLS DEV, V17, P653, DOI 10.1089/scd.2008.0070; Tiidus PM, 2003, EXERC SPORT SCI REV, V31, P40, DOI 10.1097/00003677-200301000-00008; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Velders M, 2013, SPORTS MED, V43, P1089, DOI 10.1007/s40279-013-0081-6; Vella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029226; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780; Yamakawa H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051830; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zeng XX, 2010, STEM CELLS DEV, V19, P1819, DOI 10.1089/scd.2010.0046; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zhou Y, 2017, TISSUE ENG PART C-ME, V23, P1012, DOI [10.1089/ten.tec.2017.0216, 10.1089/ten.TEC.2017.0216]; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008	103	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21378	10.1096/fj.202001914R	http://dx.doi.org/10.1096/fj.202001914R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565161	Bronze			2022-12-26	WOS:000629576700024
J	Song, TT; Guan, X; Wang, X; Qu, SS; Zhang, SW; Hui, WT; Men, LH; Chen, X				Song, Tongtong; Guan, Xin; Wang, Xuan; Qu, Shanshan; Zhang, Siwei; Hui, Wenting; Men, Lihui; Chen, Xia			Dynamic modulation of gut microbiota improves post-myocardial infarct tissue repair in rats via butyric acid-mediated histone deacetylase inhibition	FASEB JOURNAL			English	Article						butyric acid; HDAC; microbiome; myocardial infarction	MYOCARDIAL-INFARCTION; INTESTINAL MICROBIOTA; FIBROBLASTS	The complex and dynamic population of gut microbiota exerts a marked influence on the host during homeostasis and disease. Imbalance of gut microbiota metabolites may lead to cardiac dysfunction in patients with heart failure, which is related to myocardial infarction(MI) severity. However, the role of gut microbiota in the repair process after MI has rarely been reported. To explore the role of gut microbiota in MI repair and its underlying mechanism, we mixed antibiotics in drinking water to interfere with gut microbiota in rats. Hematoxylin and eosin staining, Sirius red staining, western blotting, and immunohistochemistry were used to detect tissue repair and fibrosis. We found that the expressions of alpha-smooth muscle actin, collagen, and histone deacetylase (HDAC) activities were significantly increased. We detected gut microbiota at different time points after MI using 16S ribosomal RNA sequencing and detected that Prevotellaceae, Clostridiaceae, and Lachnospiraceae were significantly altered among the butyric acid producers. We administered sodium butyrate via drinking water and discovered that sodium butyrate reduced HDAC activities and adverse repair. Therefore, we speculated that gut microbiota influences the acetylation level and tissue repair process after MI by affecting butyric acid production.	[Song, Tongtong; Guan, Xin; Wang, Xuan; Qu, Shanshan; Zhang, Siwei; Hui, Wenting; Men, Lihui; Chen, Xia] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China	Jilin University	Chen, X (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China.	TongtongSong2018@163.com; chenxjluedu@163.com	chen, xia/GXM-5435-2022		National Natural Science Foundation of China (NSFC) [81570253]; Health and Family Planning Commission of Jilin Province [2015Z040]; Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department) [20180101168JC]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Jilin Province; Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570253; Health and Family Planning Commission of Jilin Province, Grant/Award Number: 2015Z040; Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department), Grant/Award Number: 20180101168JC	Ahmadmehrabi S, 2017, CURR OPIN CARDIOL, V32, P761, DOI 10.1097/HCO.0000000000000445; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ascher S, 2018, EUR J IMMUNOL, V48, P564, DOI 10.1002/eji.201646879; Bultman SJ, 2018, NAT MICROBIOL, V3, P1332, DOI 10.1038/s41564-018-0299-z; Cahill TJ, 2017, NAT REV DRUG DISCOV, V16, P699, DOI 10.1038/nrd.2017.106; Chistiakov DA, 2016, EXP MOL PATHOL, V101, P231, DOI 10.1016/j.yexmp.2016.09.002; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Esquivel-Elizondo S, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00051-17; Fernandes MR, 2017, MICROB DRUG RESIST, V23, P56, DOI 10.1089/mdr.2015.0320; Harada N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23001; Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002; Heiss CN, 2018, J INNATE IMMUN, V10, P163, DOI 10.1159/000481519; Janssen AWF, 2015, FASEB J, V29, P3111, DOI 10.1096/fj.14-269514; Jia QJ, 2019, J CELL MOL MED, V23, P2314, DOI 10.1111/jcmm.14164; Jneid H, 2017, J AM COLL CARDIOL, V70, P2048, DOI 10.1016/j.jacc.2017.06.032; Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698; Kiouptsi K, 2019, BIOL OPEN, V8, DOI 10.1242/bio.038851; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Lau K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080859; Li ZP, 2015, MICROB ECOL, V69, P307, DOI 10.1007/s00248-014-0497-z; Lippi G, 2017, SEMIN THROMB HEMOST, V43, P609, DOI 10.1055/s-0036-1597903; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Miller PE, 2019, AM J CARDIOL, V124, P1140, DOI 10.1016/j.amjcard.2019.06.029; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nural-Guvener H, 2015, INT J MOL SCI, V16, P11482, DOI 10.3390/ijms160511482; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Song TT, 2021, FASEB J, V35, DOI 10.1096/fj.201903129RRR; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Talmor-Barkan Y, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0014; Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510; Ueki T, 2014, MBIO, V5, DOI 10.1128/mBio.01636-14; Vahed SZ, 2018, PHARMACOL RES, V129, P308, DOI 10.1016/j.phrs.2017.11.008; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Lam V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160840; Yang T, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13256; Yuille S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201073; Zabell Allyson, 2017, Curr Treat Options Cardiovasc Med, V19, P27, DOI 10.1007/s11936-017-0528-4	44	9	9	11	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21385	10.1096/fj.201903129RRR	http://dx.doi.org/10.1096/fj.201903129RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33565193	Bronze			2022-12-26	WOS:000629576700006
J	Ziogas, A; Sajib, MS; Lim, JH; Alves, TC; Das, A; Witt, A; Hagag, E; Androulaki, N; Grossklaus, S; Gerlach, M; Noll, T; Grinenko, T; Mirtschink, P; Hajishengallis, G; Chavakis, T; Mikelis, CM; Sprott, D				Ziogas, Athanasios; Sajib, Md Sanaullah; Lim, Jong-Hyung; Alves, Tiago C.; Das, Anupam; Witt, Anke; Hagag, Eman; Androulaki, Nikolais; Grossklaus, Sylvia; Gerlach, Michael; Noll, Thomas; Grinenko, Tatyana; Mirtschink, Peter; Hajishengallis, George; Chavakis, Triantafyllos; Mikelis, Constantinos M.; Sprott, David			Glycolysis is integral to histamine-induced endothelial hyperpermeability	FASEB JOURNAL			English	Article								Histamine-induced vascular leakage is a core process of allergic pathologies, including anaphylaxis. Here, we show that glycolysis is integral to histamine-induced endothelial barrier disruption and hyperpermeability. Histamine rapidly enhanced glycolysis in endothelial cells via a pathway that involved histamine receptor 1 and phospholipase C beta signaling. Consistently, partial inhibition of glycolysis with 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) prevented histamine-induced hyperpermeability in human microvascular endothelial cells, by abolishing the histamine-induced actomyosin contraction, focal adherens junction formation, and endothelial barrier disruption. Pharmacologic blockade of glycolysis with 3PO in mice reduced histamine-induced vascular hyperpermeability, prevented vascular leakage in passive cutaneous anaphylaxis and protected from systemic anaphylaxis. In conclusion, we elucidated the role of glycolysis in histamine-induced disruption of endothelial barrier integrity. Our data thereby point to endothelial glycolysis as a novel therapeutic target for human pathologies related to excessive vascular leakage, such as systemic anaphylaxis.	[Ziogas, Athanasios; Alves, Tiago C.; Witt, Anke; Hagag, Eman; Androulaki, Nikolais; Grossklaus, Sylvia; Grinenko, Tatyana; Mirtschink, Peter; Chavakis, Triantafyllos; Sprott, David] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany; [Ziogas, Athanasios; Alves, Tiago C.; Witt, Anke; Hagag, Eman; Androulaki, Nikolais; Grossklaus, Sylvia; Grinenko, Tatyana; Mirtschink, Peter; Chavakis, Triantafyllos; Sprott, David] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany; [Sajib, Md Sanaullah; Mikelis, Constantinos M.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA; [Lim, Jong-Hyung; Hajishengallis, George] Univ Penn, Penn Dent Med, Lab Innate Immun & Inflammat, Dept Basic & Translat Sci, Philadelphia, PA 19104 USA; [Das, Anupam; Noll, Thomas] Tech Univ Dresden, Dept Physiol, Fac Med Carl Gustav Carus, Dresden, Germany; [Gerlach, Michael] Tech Univ Dresden, Fac Med Carl Gustav Carus, Core Facil Cellular Imaging CFCI, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Pennsylvania; Technische Universitat Dresden; Technische Universitat Dresden	Sprott, D (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany.; Sprott, D (corresponding author), Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany.; Mikelis, CM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA.	Constantinos.Mikelis@ttuhsc.edu; David.Sprott@uniklinikum-dresden.de	Mikelis, Constantinos/AGF-9423-2022	Sajib, Md Sanaullah/0000-0002-8182-1681; Gerlach, Michael/0000-0002-6831-751X	Deutsche Forschungsgemeinschaft [TR-SFB 127]; NIH/NIDCR [DE026152]; TTUHSC Office of Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); TTUHSC Office of Research	Deutsche Forschungsgemeinschaft, Grant/Award Number: TR-SFB 127; NIH/NIDCR, Grant/Award Number: DE026152; TTUHSC Office of Research	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Cao YP, 2019, P NATL ACAD SCI USA, V116, P13394, DOI 10.1073/pnas.1821401116; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; De Bisschop MB, 2012, CURR OPIN CRIT CARE, V18, P308, DOI 10.1097/MCC.0b013e3283557a63; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Diaz-Coranguez M, 2017, VISION RES, V139, P123, DOI 10.1016/j.visres.2017.05.009; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Kim B, 2018, J CLIN INVEST, V128, P4543, DOI 10.1172/JCI120912; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Lamprecht DA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12393; Lu CM, 2010, P NATL ACAD SCI USA, V107, P18967, DOI 10.1073/pnas.1008816107; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mesquida M, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.5.32; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Noll T, 1999, J EXP MED, V189, P1373, DOI 10.1084/jem.189.9.1373; Ogola B, 2018, AM J PHYSIOL-CELL PH, V314, pC554, DOI 10.1152/ajpcell.00152.2017; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Park-Windhol C, 2016, ANNU REV PATHOL-MECH, V11, P251, DOI 10.1146/annurev-pathol-012615-044506; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rautava S, 2005, J ALLERGY CLIN IMMUN, V116, P31, DOI 10.1016/j.jaci.2005.02.010; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Rice CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07505-2; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Tomita Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041188; Turner PJ, 2017, J ALLER CL IMM-PRACT, V5, P1169, DOI 10.1016/j.jaip.2017.06.031; Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang LN, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104292; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; WHITE MV, 1990, J ALLERGY CLIN IMMUN, V86, P599, DOI 10.1016/S0091-6749(05)80223-4; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yarbro JR, 2019, MECH AGEING DEV, V183, DOI 10.1016/j.mad.2019.111146; Ziogas A., 2021, FASEB J, V35; Ziogas A, 2020, J IMMUNOL, V204, P1214, DOI 10.4049/jimmunol.1900746	52	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21425	10.1096/fj.202001634R	http://dx.doi.org/10.1096/fj.202001634R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33566443	hybrid, Green Accepted			2022-12-26	WOS:000629576700051
J	Cassmann, ED; Mammadova, N; Moore, SJ; Benestad, S; Greenlee, JJ				Cassmann, Eric D.; Mammadova, Najiba; Moore, S. Jo; Benestad, Sylvie; Greenlee, Justin J.			Transmission of the atypical/Nor98 scrapie agent to Suffolk sheep with VRQ/ARQ, ARQ/ARQ, and ARQ/ARR genotypes	PLOS ONE			English	Article								Scrapie is a transmissible spongiform encephalopathy that occurs in sheep. Atypical/Nor98 scrapie occurs in sheep that tend to be resistant to classical scrapie and it is thought to occur spontaneously. The purpose of this study was to test the transmission of the Atypical/Nor98 scrapie agent in three genotypes of Suffolk sheep and characterize the distribution of misfolded prion protein (PrPSc). Ten sheep were intracranially inoculated with brain homogenate from a sheep with Atypical/Nor98 scrapie. All sheep with the ARQ/ARQ and ARQ/ARR genotypes developed Atypical/Nor98 scrapie confirmed by immunohistochemistry, and one sheep with the VRQ/ARQ genotype had detectable PrPSc consistent with Atypical/Nor98 scrapie at the experimental endpoint of 8 years. Sheep with mild early accumulations of PrPSc in the cerebellum had concomitant retinal PrPSc. Accordingly, large amounts of retinal PrPSc were identified in clinically affected sheep and sheep with dense accumulations of PrPSc in the cerebellum.	[Cassmann, Eric D.; Mammadova, Najiba; Moore, S. Jo; Greenlee, Justin J.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Benestad, Sylvie] Norwegian Vet Inst, Oslo, Norway	United States Department of Agriculture (USDA); Norwegian Veterinary Institute	Greenlee, JJ (corresponding author), ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	justin.greenlee@usda.gov		Cassmann, Eric/0000-0002-7130-2650; Greenlee, Justin/0000-0003-2202-3054	ORAU under DOE [DESC0014664]	ORAU under DOE	This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agricultural Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, or the preparation of the manuscript. The findings and conclusions in this publication are those of the author(s) and should not be construed to represent any official USDA or U.S. Government determination or policy. This research was supported in part by appointments (N. Mammadova and S. Jo Moore) to the Agricultural Research Service (ARS) Research Participation Program administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). ORISE is managed by ORAU under DOE contract number DESC0014664. All opinions expressed in this paper are the author's and do not necessarily reflect the policies and views of USDA, ARS, DOE, or ORAU/ORISE.	Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Cassmann ED, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00430; Cassmann ED, 2019, VET PATHOL, V56, P409, DOI 10.1177/0300985818817066; Cook RW, 2016, AUST VET J, V94, P452, DOI 10.1111/avj.12529; Dagleish MP, 2008, VET REC, V162, P518, DOI 10.1136/vr.162.16.518; GOLDMANN W, 1990, P NATL ACAD SCI USA, V87, P2476, DOI 10.1073/pnas.87.7.2476; Greenlee JJ, 2019, VET PATHOL, V56, P6, DOI 10.1177/0300985818794247; Greenlee JJ, 2016, RES VET SCI, V105, P188, DOI 10.1016/j.rvsc.2016.02.016; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hunter N, 1997, VET REC, V141, P137, DOI 10.1136/vr.141.6.137; Huor A, 2019, P NATL ACAD SCI USA, V116, P26853, DOI 10.1073/pnas.1915737116; Kittelberger R, 2010, J VET DIAGN INVEST, V22, P863, DOI 10.1177/104063871002200604; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Matsuura Y, 2019, J VET MED SCI, V81, P986, DOI 10.1292/jvms.18-0710; Mayhew J., 2008, LARGE ANIMAL NEUROLO, V2; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; O'Rourke KI, 1998, J CLIN MICROBIOL, V36, P1750; Okada H, 2016, J VET MED SCI, V78, P1619, DOI 10.1292/jvms.16-0259; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Simmons HA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-8; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Simmons MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117063; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; Simmons MM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-14; Spraker TR, 2002, J VET DIAGN INVEST, V14, P3, DOI 10.1177/104063870201400102; Tongue SC, 2006, VET REC, V158, P43, DOI 10.1136/vr.158.2.43; van Keulen LJM, 2002, APMIS, V110, P23, DOI 10.1034/j.1600-0463.2002.100104.x	32	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246503	10.1371/journal.pone.0246503	http://dx.doi.org/10.1371/journal.pone.0246503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571246	gold, Green Published			2022-12-26	WOS:000620071100005
J	Sabry, M; Mostafa, S; Rashed, L; Abdelgwad, M; Kamar, S; Estaphan, S				Sabry, Maha; Mostafa, Seham; Rashed, Laila; Abdelgwad, Marwa; Kamar, Samaa; Estaphan, Suzanne			Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats	PLOS ONE			English	Article							OXIDIZED LOW-DENSITY; C-REACTIVE PROTEIN; MATRIX METALLOPROTEINASES; BONE TURNOVER; ANIMAL-MODEL; VASCULAR CALCIFICATION; LIPOPROTEIN; CARVEDILOL; MMP-9; OBESITY	Background Cardiovascular diseases (CVD) represent one of the major sequelae of obesity. On the other hand, the relationship between bone diseases and obesity remains unclear. An increasing number of biological and epidemiological studies suggest the presence of a link between atherosclerosis and osteoporosis, however, the precise molecular pathways underlying this close association remain poorly understood. The present work thus aimed to study Matrix Metalloproteinase 9 (MMP-9), as a proposed link between atherosclerosis and osteoporosis in high fat diet fed rats. Methods and findings 40 rats were randomly divided into 4 groups: control, untreated atherosclerosis group, atherosclerotic rats treated with carvedilol (10mg/kg/d) and atherosclerotic rats treated with alendronate sodium (10mg/kg/d). After 8 weeks, blood samples were collected for estimation of Lipid profile (Total cholesterol, HDL, TGs), inflammatory markers (IL-6, TNF-alpha, CRP and NO) and Bone turnover markers (BTMs) (Alkaline phosphatase, osteocalcin and pyridinoline). Rats were then euthanized and the aortas and tibias were dissected for histological examination and estimation of MMP-9, N-terminal propeptide of type I procollagen (PINP), C-terminal telopeptide of type I collagen (CTX) and NF-kB expression. Induction of atherosclerosis via high fat diet and chronic stress induced a significant increase in BTMs, inflammatory markers and resulted in a state of dyslipidaemia. MMP-9 has also shown to be significantly increased in the untreated atherosclerosis rats and showed a significant correlation with all measured parameters. Interestingly, Carvedilol and bisphosphonate had almost equal effects restoring the measured parameters back to normal, partially or completely. Conclusion MMP-9 is a pivotal molecule that impact the atherogenic environment of the vessel wall. A strong cross talk exists between MMP-9, cytokine production and macrophage function. It also plays an important regulatory role in osteoclastogenesis. So, it may be a key molecule in charge for coupling CVD and bone diseases in high fat diet fed rats. Therefore, we suggest MMP-9 as a worthy molecule to be targeted pharmacologically in order to control both conditions simultaneously. Further studies are needed to support, to invest and to translate this hypothesis into clinical studies and guidelines.	[Sabry, Maha; Mostafa, Seham; Estaphan, Suzanne] Cairo Univ, Fac Med, Physiol Dept, Giza, Egypt; [Rashed, Laila; Abdelgwad, Marwa] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Giza, Egypt; [Kamar, Samaa] Cairo Univ, Fac Med, Histol Dept, Giza, Egypt; [Estaphan, Suzanne] Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Australian National University	Estaphan, S (corresponding author), Cairo Univ, Fac Med, Physiol Dept, Giza, Egypt.; Estaphan, S (corresponding author), Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia.	suzanne.estaphan@anu.edu.au	ESTAPHAN, Suzanne/N-6377-2017	ESTAPHAN, Suzanne/0000-0003-2369-4052; kamar, Samaa/0000-0002-9040-584X				Alexander JP, 2001, INVEST OPHTH VIS SCI, V42, P2831; ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; Ardans JA, 2002, J LEUKOCYTE BIOL, V71, P1012; Azevedo A, 2018, CURR PHARM DESIGN, V24, P1801, DOI 10.2174/1381612824666180604112925; BACHORIK PS, 1980, J LIPID RES, V21, P608; Berg RM, 2015, CALCIFIED TISSUE INT, V97, P40, DOI 10.1007/s00223-015-0008-3; Boshra V, 2013, CURR DRUG THER, V8, P164, DOI 10.2174/15748855113086660010; BUCOLO G, 1973, CLIN CHEM, V19, P476; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Carbone S, 2019, VASC HEALTH RISK MAN, V15, P89, DOI 10.2147/VHRM.S168946; Cavusoglu E, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.029; Chen-Scarabelli C, 2012, AM J CARDIOVASC DRUG, V12, P391, DOI 10.2165/11636090-000000000-00000; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066391; de Paula FJA, 2010, ARQ BRAS ENDOCRINOL, V54, P150, DOI 10.1590/S0004-27302010000200010; DiNicolantonio JJ, 2012, EXPERT REV CARDIOVAS, V10, P13, DOI [10.1586/erc.11.166, 10.1586/ERC.11.166]; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Elefteriou F, 2014, CALCIFIED TISSUE INT, V94, P140, DOI 10.1007/s00223-013-9752-4; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Ezhov M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040129; Fakhry M, 2017, BBA-MOL BASIS DIS, V1863, P643, DOI 10.1016/j.bbadis.2016.12.003; Ferron M, 2010, BIOCHEM BIOPH RES CO, V397, P691, DOI 10.1016/j.bbrc.2010.06.008; Freise C, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0362-8; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Giaze TR, 2018, TROP J PHARM RES, V17, P611, DOI 10.4314/tjpr.v17i4.7; GIRI JG, 1994, J IMMUNOL, V153, P5802; Gluba-Brzozka A, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0191-x; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Gu PY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/563919; Hajsadeghi S, 2011, J SAUDI HEART ASSOC, V23, P143, DOI 10.1016/j.jsha.2011.03.001; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Herzog CJ, 2009, NEUROSCIENCE, V159, P982, DOI 10.1016/j.neuroscience.2009.01.059; HOSHINO H, 1995, ATHEROSCLEROSIS, V112, P39, DOI 10.1016/0021-9150(94)05395-Y; Idelevich A, 2011, ARTERIOSCL THROM VAS, V31, pE55, DOI 10.1161/ATVBAHA.111.230904; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kim DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122646; Kim K, 2016, GENE DEV, V30, P208, DOI 10.1101/gad.268714.115; Kinra P, 2013, TROP BIOMED, V30, P645; Kmiec Z., 2016, CYTOBIOLOGIE, V54, P58; Konstantino Y, 2009, BIOMARKERS, V14, P118, DOI 10.1080/13547500902765140; Lacy M, 2019, PHARMACOL THERAPEUT, V193, P50, DOI 10.1016/j.pharmthera.2018.08.012; Lau AC, 2009, CLIN EXP IMMUNOL, V157, P300, DOI 10.1111/j.1365-2249.2009.03949.x; Lu M, 2006, ANGLE ORTHOD, V76, P598; Mallavia B, 2013, AM J PATHOL, V182, P1910, DOI 10.1016/j.ajpath.2013.01.022; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Nanni S, 2007, TRANSL RES, V149, P137, DOI 10.1016/j.trsl.2006.09.001; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Pennisi P, 2004, OSTEOPOROSIS INT, V15, P389, DOI 10.1007/s00198-003-1550-9; Pizzino G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00558; Pytlik M, 2004, POL J PHARMACOL, V56, P571; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Saratzis A, 2014, HEART, V100, P916, DOI 10.1136/heartjnl-2013-305130; Shetty Sahana, 2016, Indian J Endocrinol Metab, V20, P846; Sigala F, 2010, J CELL MOL MED, V14, P2273, DOI 10.1111/j.1582-4934.2010.01082.x; Silvello D, 2014, BIOMARKERS, V19, P49, DOI 10.3109/1354750X.2013.866165; Singh U, 2008, J LIPID RES, V49, P1015, DOI 10.1194/jlr.M700535-JLR200; Soltesz P, 2007, THROMB HAEMOSTASIS, V98, P413, DOI 10.1160/TH06-10-0561; Stojanovic OL, 2011, ARCH MED SCI, V7, P179, DOI 10.5114/aoms.2011.22066; Suvarna K.S., 2018, BANCROFTS THEORY PRA; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Vergnaud P, 1997, J CLIN ENDOCR METAB, V82, P719, DOI 10.1210/jc.82.3.719; Wagsater D, 2011, INT J MOL MED, V28, P247, DOI 10.3892/ijmm.2011.693; Wu TC, 2007, FREE RADICAL BIO MED, V43, P1508, DOI 10.1016/j.freeradbiomed.2007.08.010; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zheng XF, 2018, EXP THER MED, V16, P1807, DOI 10.3892/etm.2018.6356	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0244650	10.1371/journal.pone.0244650	http://dx.doi.org/10.1371/journal.pone.0244650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571214	Green Published, gold			2022-12-26	WOS:000618274000098
J	Zhang, H; Zhang, LQ; Yang, CC; Li, J; Tian, XY; Li, DN; Cui, J; Cai, JP				Zhang, He; Zhang, Li-Qun; Yang, Cheng-Cheng; Li, Jin; Tian, Xin-Yuan; Li, Dan-Ni; Cui, Ju; Cai, Jian-Ping			The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; CCND1 AMPLIFICATION; ADP-RIBOSYLATION; HUMAN LUNG; ERK; CHEMORESISTANCE; INHIBITOR; MK-4827; CELLS	NUDIX hydrolase type 5 (NUDT5) is a kind of ADP-ribose pyrophosphatase and nucleotide metabolizing enzyme in cell metabolism. Previous studies have shown NUDT5 expression affected chromosome remodeling, involved in cell adhesion, cancer stem cell maintenance and epithelial to mesenchyme transition in breast cancer cells. Nevertheless, the role of NUDT5 in breast cancer progression and prognosis has not yet been systematically studied. This study explored the association of NUDT5 with the tumor development and poor prognosis in patients with breast cancer. Our results show that the levels of NUDT5 were upregulated in breast cancer cell lines and breast tumor tissues, and the expression of NUDT5 in breast tumor tissues increased significantly when compared with adjacent non-tumorous tissues by immunohistochemical staining of tissue microarrays. Breast cancer patients with high NUDT5 expression had a worse prognosis than those with low expression of NUDT5. In addition, the knockdown of NUDT5 suppressed breast cancer cell lines proliferation, migration and invasion, and dramatically inhibited the AKT phosphorylation at Thr308 and expression of Cyclin D1. The opposite effects were observed in vitro following NUDT5 rescue. Our findings indicated that the high expression of NUDT5 is probably involved in the poor prognosis of breast cancer via the activation of the AKT / Cyclin D pathways, which could be a prognostic factor and potential target in the diagnosis and treatment of breast cancer.	[Zhang, He; Cai, Jian-Ping] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China; [Zhang, He; Cai, Jian-Ping] Chinese Acad Med Sci, Beijing, Peoples R China; [Zhang, He; Zhang, Li-Qun; Yang, Cheng-Cheng; Li, Jin; Tian, Xin-Yuan; Li, Dan-Ni; Cui, Ju; Cai, Jian-Ping] Beijing Hosp, Natl Ctr Gerontol, Beijing Inst Geriatr, Key Lab Geriatr,Natl Hlth Commiss, Beijing, Peoples R China; [Zhang, He; Yang, Cheng-Cheng; Li, Jin; Tian, Xin-Yuan; Li, Dan-Ni; Cui, Ju; Cai, Jian-Ping] Chinese Acad Med Sci, Inst Geriatr Med, Beijing, Peoples R China; [Yang, Cheng-Cheng] Wenzhou Med Coll, Dept Pharm, Wenzhou, Zhejiang, Peoples R China; [Tian, Xin-Yuan; Li, Dan-Ni] Peking Univ, Beijing Hosp, Sch Clin Med 5, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Wenzhou Medical University; Beijing Hospital; Peking University	Cai, JP (corresponding author), Peking Union Med Coll, Grad Sch, Beijing, Peoples R China.; Cai, JP (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.; Cai, JP (corresponding author), Beijing Hosp, Natl Ctr Gerontol, Beijing Inst Geriatr, Key Lab Geriatr,Natl Hlth Commiss, Beijing, Peoples R China.; Cai, JP (corresponding author), Chinese Acad Med Sci, Inst Geriatr Med, Beijing, Peoples R China.	caijp61@vip.sina.com		Cai, Jian-Ping/0000-0003-2793-9221	CAMS Innovation Fund for Medical Sciences [2018-I2M-1-002]; National Key R&D Program of China [2018YFC2000300]	CAMS Innovation Fund for Medical Sciences; National Key R&D Program of China	This work was supported by the CAMS Innovation Fund for Medical Sciences (No. 2018-I2M-1-002), National Key R&D Program of China (2018YFC2000300).; We are grateful to the members of the Institute of Geriatrics of the Ministry of Health for their assistance and advice. This work was supported by the CAMS Innovation Fund for Medical Sciences (No. 2018-I2M-1-002) and the National Key R&D Program of China (2018YFC2000300).	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bridges KA, 2014, ONCOTARGET, V5, P5076, DOI 10.18632/oncotarget.2083; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Carreras-Puigvert J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01642-w; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dizdar O, 2015, EXPERT OPIN PHARMACO, V16, P2751, DOI 10.1517/14656566.2015.1100168; Elsheikh S, 2008, BREAST CANCER RES TR, V109, P325, DOI 10.1007/s10549-007-9659-8; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Frizzell KM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2451; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Hayakawa J, 2000, CANCER RES, V60, P5988; Hori M, 2010, FREE RADICAL BIO MED, V48, P1197, DOI 10.1016/j.freeradbiomed.2010.02.002; Ishibashi T, 2003, EMBO REP, V4, P479, DOI 10.1038/sj.embor.embor838; Ito R, 2011, J BIOCHEM, V149, P731, DOI 10.1093/jb/mvr028; JUST I, 1994, EUR J BIOCHEM, V221, P1047, DOI 10.1111/j.1432-1033.1994.tb18823.x; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Legare S, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0897-3; Li J, 2017, ONCOTARGET, V8, P105714, DOI 10.18632/oncotarget.22393; Li YL, 2017, J CELL BIOCHEM, V118, P4498, DOI 10.1002/jcb.26107; Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305; Luo KT, 2017, EMBO J, V36, P1434, DOI 10.15252/embj.201695669; MCDONALD LJ, 1994, MOL CELL BIOCHEM, V138, P221, DOI 10.1007/BF00928465; McGuire S, 2016, ADV NUTR, V7, P418, DOI 10.3945/an.116.012211; Miao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41942; Padala RR, 2017, MOL BIOSYST, V13, P830, DOI 10.1039/c6mb00786d; Page BDG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02293-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pickup KE, 2019, CANCERS, V11, DOI 10.3390/cancers11091337; Pirkmaier A, 2003, ONCOGENE, V22, P4425, DOI 10.1038/sj.onc.1206488; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sisay Mekonnen, 2017, Gynecol Oncol Res Pract, V4, P18, DOI 10.1186/s40661-017-0055-8; Sun YS, 2017, INT J BIOL SCI, V13, P1387, DOI 10.7150/ijbs.21635; Sunada S, 2018, CANC SCI; Tompa R, 2018, CANCER DISCOV, V8, P256, DOI 10.1158/2159-8290.CD-NB2018-008; UEDA K, 1979, J BIOL CHEM, V254, P679; Wang L, 2012, INVEST NEW DRUG, V30, P2113, DOI 10.1007/s10637-011-9770-x; Wright RHG, 2016, SCIENCE, V352, P1221, DOI 10.1126/science.aad9335; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zhang LQ, 2013, FREE RADICAL RES, V47, P511, DOI 10.3109/10715762.2013.795221; Zhang LQ, 2012, MOL CELL BIOCHEM, V363, P377, DOI 10.1007/s11010-011-1190-x	47	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0245876	10.1371/journal.pone.0245876	http://dx.doi.org/10.1371/journal.pone.0245876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571243	Green Published, gold			2022-12-26	WOS:000618274000103
J	Jian, H; Liu, GX; He, BY				Jian Huang; Liu Guixiong; He, Binyuan			Fast semantic segmentation method for machine vision inspection based on a fewer-parameters atrous convolution neural network	PLOS ONE			English	Article							OBJECT DETECTION	Owing to the recent development in deep learning, machine vision has been widely used in intelligent manufacturing equipment in multiple fields, including precision-manufacturing production lines and online product-quality inspection. This study aims at online Machine Vision Inspection, focusing on the method of online semantic segmentation under complex backgrounds. First, the fewer-parameters optimization of the atrous convolution architecture is studied. Atrous spatial pyramid pooling (ASPP) and residual network (ResNet) are selected as the basic architectures of. seg and. main, respectively, which indicate that the improved proportion of the participating input image feature is beneficial for improving the accuracy of feature extraction during the change of the number and dimension of feature maps. Second, this study proposes five modified ResNet residual building blocks, with the main path having a 3 x 3 convolution layer, 2 x 2 skip path, and pooling layer with l(s) = 2, which can improve the use of image features. Finally, the simulation experiments show that our modified structure can significantly decrease segmentation time T-seg from 719 to 296 ms (decreased by 58.8%), with only a slight decrease in the intersection-over-union from 86.7% to 86.6%. The applicability of the proposed machine vision method was verified through the segmentation recognition of the China Yuan (CNY) for the 2019 version. Compared with the conventional method, the proposed model of semantic segmentation visual detection effectively reduces the detection time while ensuring the detection accuracy and has a significant effect of fewer-parameters optimization. This slows for the possibility of neural network detection on mobile terminals.	[Jian Huang; Liu Guixiong; He, Binyuan] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Liu, GX (corresponding author), South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China.	megxliu@scut.edu.cn			Key-Area Research and Development Program of Guangdong Province, China [2019B010154003]; Guangzhou Science and Technology Plan Project [201802030006]	Key-Area Research and Development Program of Guangdong Province, China; Guangzhou Science and Technology Plan Project	This work was supported in part by the Key-Area Research and Development Program of Guangdong Province, China under Grant 2019B010154003, and in part by the Guangzhou Science and Technology Plan Project under Grant 201802030006.	Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Carreira J, 2012, LECT NOTES COMPUT SC, V7578, P430, DOI 10.1007/978-3-642-33786-4_32; Chen L. C., 2014, 14127062 ARXIV; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Cordts M, 2016, PROC CVPR IEEE, P3213, DOI 10.1109/CVPR.2016.350; Dong J, 2014, LECT NOTES COMPUT SC, V8693, P299, DOI 10.1007/978-3-319-10602-1_20; Everingham M, 2015, INT J COMPUT VISION, V111, P98, DOI 10.1007/s11263-014-0733-5; Guo J, 2020, J MACH LEARN RES, V21; Guo YM, 2016, NEUROCOMPUTING, V187, P27, DOI 10.1016/j.neucom.2015.09.116; Hariharan B, 2014, LECT NOTES COMPUT SC, V8695, P297, DOI 10.1007/978-3-319-10584-0_20; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang J, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/6903130; Huang J, 2016, FRONT MECH ENG-PRC, V11, P311, DOI 10.1007/s11465-016-0376-z; Lafferty John, 2001, P INT C MACH LEARN, P282; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu GX, 2019, LASER J, V40, P10; Lu QS, 2017, IEEE ACCESS, V5, P24023, DOI 10.1109/ACCESS.2017.2770178; Nowozin S, 2014, PROC CVPR IEEE, P548, DOI 10.1109/CVPR.2014.77; Perez L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030335; Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI 10.1109/TPAMI.2016.2572683; Wu JF, 2019, CHINA MEASUREMENT TE, V45, P01; Yadollahpour P, 2013, PROC CVPR IEEE, P1923, DOI 10.1109/CVPR.2013.251; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Yu F., 2015, ARXIV PREPRINT ARXIV, DOI DOI 10.1006/JMBI.1990.9999; Yu JM, 2018, INT CONF CONTR AUTO, P378, DOI 10.1109/ICCAIS.2018.8570503; Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660	28	0	0	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246093	10.1371/journal.pone.0246093	http://dx.doi.org/10.1371/journal.pone.0246093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566844	Green Published, gold			2022-12-26	WOS:000618271700014
J	Lee, J; Kim, HS; Jo, HY; Kwon, MJ				Lee, Jeonggil; Kim, Han-Suk; Jo, Ho Young; Kwon, Man Jae			Revisiting soil bacterial counting methods: Optimal soil storage and pretreatment methods and comparison of culture-dependent and -independent methods	PLOS ONE			English	Article								Although a number of different methods have been used to quantify soil bacteria, identifying the optimal method(s) for soil bacterial abundance is still in question. No single method exists for undertaking an absolute microbial count using culture-dependent methods (CDMs) or even culture-independent methods (CIMs). This study investigated soil storage and pretreatment methods for optimal bacterial counts. Appropriate storage temperature (4 degrees C) and optimal pretreatment methods (sonication time for 3 min and centrifugation at 1400 g) were necessary to preserve bacterial cell viability and eliminate interference from soil particles. To better estimate soil bacterial numbers under various cellular state and respiration, this study also evaluated three CDMs (i.e., colony forming unit, spotting, and most probable number (MPN) and three CIMs (i.e., flow cytometry (FCM), epifluorescence microscopy (EM) count, and DNA quantitation). Each counting method was tested using 72 soil samples collected from a local arable farm site at three different depths (i.e., 10-20, 90-100, and 180-190 cm). Among all CDMs, MPN was found to be rapid, simple, and reliable. However, the number of bacteria quantified by MPN was 1-2 orders lower than that quantified by CIMs, likely due to the inability of MPN to count anaerobic bacteria. The DNA quantitation method appeared to overestimate soil bacterial numbers, which may be attributed to DNA from dead bacteria and free DNA in the soil matrix. FCM was found to be ineffective in counting soil bacteria as it was difficult to separate the bacterial cells from the soil particles. Dyes used in FCM stained the bacterial DNA and clay particles. The EM count was deemed a highly effective method as it provided information on soil mineral particles, live bacteria, and dead bacteria; however, it was a time-consuming and labor-intensive process. Combining both types of methods was considered the best approach to acquire better information on the characteristics of indigenous soil microorganisms (aerobic versus anaerobic, live versus dead).	[Lee, Jeonggil; Kwon, Man Jae] Korea Univ, KU KIST Green Sch, Seoul, South Korea; [Kim, Han-Suk; Jo, Ho Young; Kwon, Man Jae] Korea Univ, Dept Earth & Environm Sci, Seoul, South Korea	Korea University; Korea University	Kwon, MJ (corresponding author), Korea Univ, KU KIST Green Sch, Seoul, South Korea.; Kwon, MJ (corresponding author), Korea Univ, Dept Earth & Environm Sci, Seoul, South Korea.	manjaekwon@korea.ac.kr		Kim, Han-Suk/0000-0003-1588-7428	Korea Environment Industry & Technology Institute through Subsurface Environment Management Project - Korea Ministry of Environment [2018002440002]	Korea Environment Industry & Technology Institute through Subsurface Environment Management Project - Korea Ministry of Environment	This work was supported by the Korea Environment Industry & Technology Institute through Subsurface Environment Management Project, funded by Korea Ministry of Environment (grant number 2018002440002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzazou T, 2015, ENVIRON SCI POLLUT R, V22, P11446, DOI 10.1007/s11356-015-4372-3; Alessi H, 2019, ANAL GEOMICROBIOLOGY; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Barcenas-Moreno G, 2009, GLOBAL CHANGE BIOL, V15, P2950, DOI 10.1111/j.1365-2486.2009.01882.x; Buesing N, 2002, AQUAT MICROB ECOL, V27, P29, DOI 10.3354/ame027029; Carini P, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.242; Christensen H, 1999, APPL ENVIRON MICROB, V65, P1753; Curd EE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2079; Daniell TJ, 2012, J MICROBIOL METH, V91, P38, DOI 10.1016/j.mimet.2012.07.010; DIGERONIMO MJ, 1978, MICROBIAL ECOL, V4, P263, DOI 10.1007/BF02015082; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Ekelund F, 2001, SOIL BIOL BIOCHEM, V33, P475, DOI 10.1016/S0038-0717(00)00188-7; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Epelde L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu007; Frossard A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00903; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gilbert B, 1998, FEMS MICROBIOL ECOL, V25, P117, DOI 10.1016/S0168-6496(97)00088-3; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Haines JR, 1996, J IND MICROBIOL, V16, P36, DOI 10.1007/BF01569919; Hielm S, 1996, INT J FOOD MICROBIOL, V31, P357, DOI 10.1016/0168-1605(96)00984-1; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Huang J, 2014, APPL ENVIRON MICROB, V80, P29, DOI 10.1128/AEM.02335-13; ISHIZAWA S., 1957, Soil and Plant Food, V3, P85; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Khalili B, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00435-19; Korea Ministry of Environment, 2018, SMART SEM RES CTR AN; Lawlor K, 2000, FEMS MICROBIOL ECOL, V33, P129, DOI 10.1111/j.1574-6941.2000.tb00735.x; Lennon JT, 2018, MBIO, V9, DOI 10.1128/mBio.00637-18; Liu Z, 2017, J ENVIRON MANAGE, V191, P268, DOI 10.1016/j.jenvman.2017.01.022; Muthukrishnan T, 2017, J MAR SCI ENG, V5, DOI 10.3390/jmse5010004; Nagler M, 2018, APPL MICROBIOL BIOT, V102, P6343, DOI 10.1007/s00253-018-9120-4; OLSEN RA, 1987, MICROB ECOL, V13, P59, DOI 10.1007/BF02014963; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Portillo MC, 2013, APPL ENVIRON MICROB, V79, P7610, DOI 10.1128/AEM.02710-13; Qin SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058691; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Rodrigues JLM, 2002, J MICROBIOL METH, V51, P181, DOI 10.1016/S0167-7012(02)00067-2; Rosenberg M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42906-3; Rousk J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00103; Steen AD, 2019, ISME J, V13, P3126, DOI 10.1038/s41396-019-0484-y; TORSVIK VL, 1978, SOIL BIOL BIOCHEM, V10, P7, DOI 10.1016/0038-0717(78)90003-2; Trolldenier G., 1973, "Modern Methods in the Study of Microbial Ecology". Bulletins from the Ecological Research Committee, Sweden, V17, P53; TUZIMURA K., 1961, Soil and Plant Food, V7, P61; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wagner AO, 2012, BIOMASS BIOENERG, V45, P311, DOI 10.1016/j.biombioe.2012.06.015; Williamson KE, 2013, BIOL FERT SOILS, V49, P857, DOI 10.1007/s00374-013-0780-z; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhang ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05260-w	48	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246142	10.1371/journal.pone.0246142	http://dx.doi.org/10.1371/journal.pone.0246142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4UN	33566842	Green Published, gold			2022-12-26	WOS:000618271700024
J	Midorikawa, H; Aiba, M; Lebowitz, A; Taguchi, T; Shiratori, Y; Ogawa, T; Takahashi, A; Takahashi, S; Nemoto, K; Arai, T; Tachikawa, H				Midorikawa, Haruhiko; Aiba, Miyuki; Lebowitz, Adam; Taguchi, Takaya; Shiratori, Yuki; Ogawa, Takafumi; Takahashi, Asumi; Takahashi, Sho; Nemoto, Kiyotaka; Arai, Tetsuaki; Tachikawa, Hirokazu			Confirming validity of The Fear of COVID-19 Scale in Japanese with a nationwide largescale sample	PLOS ONE			English	Article							EVENT SCALE; CRITERIA; VERSION; IMPACT	Assessing fear and anxiety regarding COVID-19 viral infection is essential for investigating mental health during this epidemic. We have developed and validated a Japanese-language version of The Fear of COVID-19 Scale (FCV-19S) based on a large, nationwide residential sample (n = 6,750) recruited through news and social media responding to an online version of the questionnaire. Data was collected from August 4-25, 2020. Results correlated with K6, GAD-7 and IES-R psychological scales, and T-tests and analysis of variance identified associated factors. All indices indicated the two-factor model emotional fear reactions and symptomatic expressions of fear a better fit for our data than a single-factor model in Confirmatory Factor Analysis (chi(2) = 164.16, p<0.001, CFI 0.991, TLI = 0.985, RMSEA = 0.043). Socio-demographic factors identified as disaster vulnerabilities such as female sex, sexual minority, elderly, unemployment, and present psychiatric history associated with higher scores. However, respondent or family member experience of infection risk, or work/school interference from confinement, had greatest impact. Results suggest necessity of mental health support during this pandemic similar to other disasters.	[Midorikawa, Haruhiko; Ogawa, Takafumi; Takahashi, Asumi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Majors Clin Sci, Tsukuba, Ibaraki, Japan; [Aiba, Miyuki] Toyo Gakuen Univ, Fac Human Sci, Bunkyo Ku, Tokyo, Japan; [Lebowitz, Adam] Jichi Med Univ, Gen Studies Dept, Shimotsuke, Tochigi, Japan; [Taguchi, Takaya; Takahashi, Sho; Tachikawa, Hirokazu] Univ Tsukuba, Fac Med, Dept Disaster & Community Psychiat, Div Clin Med, Tsukuba, Ibaraki, Japan; [Shiratori, Yuki] Tsukuba Univ Hlth Ctr, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Nemoto, Kiyotaka; Arai, Tetsuaki] Univ Tsukuba, Fac Med, Dept Psychiat, Tsukuba, Ibaraki, Japan	University of Tsukuba; Jichi Medical University; University of Tsukuba; University of Tsukuba	Tachikawa, H (corresponding author), Univ Tsukuba, Fac Med, Dept Disaster & Community Psychiat, Div Clin Med, Tsukuba, Ibaraki, Japan.	tachikawa@md.tsukuba.ac.jp	Miyuki, Aiba/AHE-7344-2022; Lebowitz, Adam/O-8539-2019; Midorikawa, Haruhiko/GMW-9510-2022; Nemoto, Kiyotaka/C-4987-2013	Lebowitz, Adam/0000-0003-1761-7464; Nemoto, Kiyotaka/0000-0001-8623-9829; Takahashi, Asumi/0000-0003-3076-889X				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Alyami M, 2021, INT J MENT HEALTH AD, V19, P2219, DOI 10.1007/s11469-020-00316-x; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bergman YS, 2020, INT PSYCHOGERIATR, V32, P1371, DOI 10.1017/S1041610220001258; Bitan DT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113100; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Chang KC, 2020, J FORMOS MED ASSOC, V119, P1772, DOI 10.1016/j.jfma.2020.07.032; Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590; de Freitas LD, 2020, PSYCHIAT CLIN NEUROS, V74, P99, DOI 10.1111/pcn.12947; Doshi D, 2021, INT J MENT HEALTH AD, V19, P2383, DOI 10.1007/s11469-020-00332-x; Elemo AS, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00448-0; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Hao FY, 2020, BRAIN BEHAV IMMUN, V87, P100, DOI 10.1016/j.bbi.2020.04.069; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huarcaya-Victoria J, 2022, INT J MENT HEALTH AD, V20, P249, DOI 10.1007/s11469-020-00354-5; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lotfi M, 2020, CLIN CHIM ACTA, V508, P254, DOI 10.1016/j.cca.2020.05.044; Mahmood QK, 2022, INT J MENT HEALTH AD, V20, P426, DOI 10.1007/s11469-020-00371-4; Mamun MA, 2020, BRAIN BEHAV IMMUN, V87, P163, DOI 10.1016/j.bbi.2020.05.028; Martinez-Lorca M, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113350; Masuyama A, 2022, INT J MENT HEALTH AD, V20, P387, DOI 10.1007/s11469-020-00368-z; Meng H, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.112983; Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2; Muramatsu K, 2009, PANMINERVA MED 20 WO; NHK, 2020, COVID 19 SPEC SIT; Nomura S, 2021, TRENDS SUICIDE JAPAN, V295, DOI DOI 10.1016/J.PSYCHRES.2020.113622; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Perz CA, 2022, INT J MENT HEALTH AD, V20, P273, DOI 10.1007/s11469-020-00356-3; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Public Health England, 2020, MENTAL HLTH COVID 19; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Reznik A, 2021, INT J MENT HEALTH AD, V19, P1903, DOI 10.1007/s11469-020-00283-3; Rohde C, 2020, ACTA NEUROPSYCHIATR, V32, P274, DOI 10.1017/neu.2020.24; Sakib N, 2022, INT J MENT HEALTH AD, V20, P2623, DOI 10.1007/s11469-020-00289-x; Salerno JP, 2020, PUBLIC HEALTH REP, V135, P721, DOI 10.1177/0033354920954511; Satici B, 2021, INT J MENT HEALTH AD, V19, P1980, DOI 10.1007/s11469-020-00294-0; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Somasundaram DJ, 2006, J CLIN PSYCHIAT, V67, P64; Soraci P, 2022, INT J MENT HEALTH AD, V20, P1913, DOI 10.1007/s11469-020-00277-1; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; SurveyMonkey, SURVEYMONKEY USER MA; Torous John, 2020, JMIR Ment Health, V7, pe18848, DOI 10.2196/18848; Tsipropoulou V, 2021, INT J MENT HEALTH AD, V19, P2279, DOI 10.1007/s11469-020-00319-8; Valentine SE, 2018, CLIN PSYCHOL REV, V66, P24, DOI 10.1016/j.cpr.2018.03.003; Valenzuela B, 2020, PREPRINT; Wakashima K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241958; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Weiss Daniel S., 1997, P399; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Winter T, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00342-9; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Yamamoto T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249382	66	35	35	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246840	10.1371/journal.pone.0246840	http://dx.doi.org/10.1371/journal.pone.0246840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	33566868	Green Published, gold			2022-12-26	WOS:000618271700054
J	Oliveira, MXS; Palma, ASV; Reis, BR; Franco, CSR; Marconi, APS; Shiozaki, FA; Reis, LG; Salles, MSV; Netto, AS				X. S. Oliveira, Mauricio; Palma, Andre S. V.; Reis, Barbara R.; Franco, Camila S. R.; Marconi, Alessandra P. S.; Shiozaki, Fabiana A.; G. Reis, Leriana; Salles, Marcia S. V.; Netto, Arlindo S.			Inclusion of soybean and linseed oils in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human diet	PLOS ONE			English	Article							LIPID EXTRACTION; LINOLEIC-ACID; CHOLESTEROL; SUPPLEMENTATION; OMEGA-3-FATTY-ACIDS; METAANALYSIS; CONCENTRATE; METABOLISM; TOXICITY; FLAXSEED	Fluid milk and its derivatives are important dietary ingredients that contribute to daily nutrient intake of the modern Homo sapiens. To produce milk that is healthier for human consumption, the present study evaluated the effect of adding soybean oil and linseed oil in the diet of lactating cows. The fatty acid profile of milk, milk composition, and the blood parameters of cows were evaluated. Eighteen Holstein cows were distributed in a replicated Latin square design and distributed according to the following treatments: 1) Control (CC): traditional dairy cow diet, without addition of oil; 2) Soybean oil (SO): 2.5% addition of soybean oil to the traditional diet, as a source of omega-6; 3) Linseed oil (LO): 2.5% addition of linseed oil in the diet as a source of omega-3. Milk production was not affected, but oil supplementation decreased feed intake by 1.93 kg/cow/day. The milk fat percentage was significantly lower when cows were supplemented with vegetable oil (3.37, 2.75 and 2.89% for CC, SO and LO, respectively). However, both soybean and linseed oils decreased the concentration of saturated fatty acids (66.89, 56.52 and 56.60 g/100g for CC, SO and LO respectively), increased the amount of unsaturated fatty acids in milk (33.05, 43.39, and 43.35 g/100g for CC, SO and LO respectively) and decreased the ratio between saturated/unsaturated fatty acids (2.12, 1.34, and 1.36 for CC, SO and LO respectively). Furthermore, SO and LO increased significantly the concentration of monounsaturated fatty acids (29.58, 39.55 and 39.47 g/100g for CC, SO and LO respectively), though it did not significantly alter the level of polyunsaturated fatty acids in milk fat (3.57, 3.93 and 3.98 g/100g for CC, SO and LO respectively). Supplementation with LO enhanced the concentration of omega-3 fatty acids on milk (0.32, 0.36, and 1.02 for CC, SO and LO respectively). Blood variables aspartate aminotransferase, gamma glutamyl transferase, urea, albumin, creatinine and total proteins were not altered. On the other hand, total cholesterol, HDL and LDL were greater in the group supplemented with vegetable oils. Supplementation with vegetable oils reduced the dry matter intake of cows, the fat content of milk, and improved saturated/unsaturated fatty acid ratio of milk fat. Compared to the SO treatment, animals fed LO produced milk with greater content of omega-3, and a more desirable omega-6/omega-3 ratio on a human nutrition perspective. Thus, the inclusion of SO and LO in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human consumption.	[X. S. Oliveira, Mauricio; Palma, Andre S. V.; Reis, Barbara R.; Franco, Camila S. R.; Marconi, Alessandra P. S.; Shiozaki, Fabiana A.; G. Reis, Leriana; Netto, Arlindo S.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Pirassununga, SP, Brazil; [Salles, Marcia S. V.] Anim Sci Inst, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Netto, AS (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Pirassununga, SP, Brazil.	saranetto@usp.br	Salles, Márcia/AIE-9694-2022; Reis, Leriana Garcia/X-5786-2019; Netto, Arlindo SN saran/E-4978-2012; Salles, Márcia S.V./K-4022-2013	Reis, Leriana Garcia/0000-0001-9581-9235; Netto, Arlindo SN saran/0000-0003-0170-8134; Salles, Márcia S.V./0000-0001-6343-0647	Sao Paulo Research Foundation (FAPESP) Sao Paulo, Brazil [2015/193938, 2016/23735-4, 2016/23797-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Sao Paulo Research Foundation (FAPESP) Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Sao Paulo Research Foundation (FAPESP) Sao Paulo, Brazil, research funding (FAPESP Process 2015/193938); two scholarships (FAPESP Processes 2016/23735-4 and 2016/23797-0), and one master's scholarship - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), for Mauricio X. S. Oliveira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MS, 2000, J DAIRY SCI, V83, P1598, DOI 10.3168/jds.S0022-0302(00)75030-2; Annunziata A., 2009, 113 EAAE SEMINAR A R, DOI [10.22004/ag.econ.57661, DOI 10.22004/AG.ECON.57661]; [Anonymous], 2018, CIRCULATION, V137, pe29; [Anonymous], ENT GUID 8 2 US GUID, P502; AOAC International, OFFICIAL METHODS ANA, V19th; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Bartsch H, 1999, CARCINOGENESIS, V20, P2209, DOI 10.1093/carcin/20.12.2209; Bauman DE, 2011, ANNU REV NUTR, V31, P299, DOI 10.1146/annurev.nutr.012809.104648; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; Baumann E, 2016, J DAIRY SCI, V99, P6311, DOI 10.3168/jds.2015-10746; Bentley Intruments, 1998, BENTL CHEMSP 150 US; Bentley Intruments, 1995, BENTL SOM 300 OP MAN; Bentley Intruments, 1995, BENTL 2000 OP MAN; Bernard L, EXPRESSION NUTR REGU, P34; Broughton KS, 1997, AM J CLIN NUTR, V65, P1011, DOI 10.1093/ajcn/65.4.1011; BROWN WH, 1962, J DAIRY SCI, V45, P191, DOI 10.3168/jds.S0022-0302(62)89364-3; Calder PC, 2003, BRAZ J MED BIOL RES, V36, P433, DOI 10.1590/S0100-879X2003000400004; Caroprese M, 2010, J DAIRY SCI, V93, P2580, DOI 10.3168/jds.2008-2003; Chang CL, 2013, CURR OPIN LIPIDOL, V24, P345, DOI 10.1097/MOL.0b013e3283616364; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Cortes C, 2011, ANIM FEED SCI TECH, V169, P270, DOI 10.1016/j.anifeedsci.2011.06.016; Council N.R., 2001, NUTR REQ DAIR CATTL, V7th ed., DOI [10.17226/9825, DOI 10.17226/9825]; de Caterina R, 2006, HEART INT, V2, P141, DOI 10.4081/hi.2006.141; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Fievez V, 2012, ANIM FEED SCI TECH, V172, P51, DOI 10.1016/j.anifeedsci.2011.12.008; Freitas JB, 2010, REV NUTR, V23, P269, DOI 10.1590/S1415-52732010000200010; Griinari JM, 2000, J NUTR, V130, P2285, DOI 10.1093/jn/130.9.2285; GRUMMER RR, 1991, J DAIRY SCI, V74, P3244, DOI 10.3168/jds.S0022-0302(91)78510-X; GRUNDY SM, 1994, AM J CLIN NUTR, V60, p986S, DOI 10.1093/ajcn/60.6.986S; Hall MB, 1999, J SCI FOOD AGR, V79, P2079, DOI 10.1002/(SICI)1097-0010(199912)79:15&lt;2079::AID-JSFA502&gt;3.0.CO;2-Z; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Haug A, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-25; HOPKINS PN, 1992, AM J CLIN NUTR, V55, P1060, DOI 10.1093/ajcn/55.6.1060; Kalscheur KF, 1997, J DAIRY SCI, V80, P2115, DOI 10.3168/jds.S0022-0302(97)76157-5; Kaur N, 2014, J FOOD SCI TECH MYS, V51, P2289, DOI 10.1007/s13197-012-0677-0; KEENEY M, 1962, J AM OIL CHEM SOC, V39, P198, DOI 10.1007/BF02635818; KELLENS MJ, 1986, BIOTECHNOL BIOENG, V28, P1268, DOI 10.1002/bit.260280820; Kennelly JJ, 1996, ANIM FEED SCI TECH, V60, P137, DOI 10.1016/0377-8401(96)00973-X; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, P1009; Thanh LP, 2015, ASIAN AUSTRAL J ANIM, V28, P796, DOI 10.5713/ajas.14.0810; Loor JJ, 2005, J DAIRY SCI, V88, P726, DOI 10.3168/jds.S0022-0302(05)72736-3; Lubary M, 2011, EUR FOOD RES TECHNOL, V232, P1, DOI 10.1007/s00217-010-1387-3; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Martin Clayton Antunes, 2006, Rev. Nutr., V19, P761, DOI 10.1590/S1415-52732006000600011; Maynard LJ, 2003, REV AGR ECON, V25, P316, DOI 10.1111/1467-9353.00141; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Nelson D.L., 2008, PRINCIPLES BIOCH; Palmquist DL, 2017, J DAIRY SCI, V100, P10061, DOI 10.3168/jds.2017-12924; PALMQUIST DL, 1978, J DAIRY SCI, V61, P561, DOI 10.3168/jds.S0022-0302(78)94410-7; Palmquist Donald L, 2005, Adv Food Nutr Res, V50, P179, DOI 10.1016/S1043-4526(05)50006-8; Paul M., AMAZON COM BOOKS; Pires J.A.A., 2008, R. Bras. Zootec., V37, P287; Rego OA, 2005, ANIM RES, V54, P17, DOI 10.1051/animres:2005002; Rodriguez-Ruiz J, 1998, BIOTECHNOL TECH, V12, P689, DOI 10.1023/A:1008812904017; RUSSELL JB, 1992, J ANIM SCI, V70, P3551, DOI 10.2527/1992.70113551x; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Saldanha T., 2004, Ciencia e Tecnologia de Alimentos, V24, P109, DOI 10.1590/S0101-20612004000100020; Salles MSV, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020481; Santos-Silva J, 2002, LIVEST PROD SCI, V77, P187, DOI 10.1016/S0301-6226(02)00059-3; Shingfield KJ, 2008, ADV EXP MED BIOL, V606, P3, DOI 10.1007/978-0-387-74087-4_1; Simopoulos A.P., 2016, EVOLUTIONARY THINKIN, P119, DOI DOI 10.1007/978-3-319-29716-3_9; Simopoulos AP, 2002, ASIA PAC J CLIN NUTR, V11, pS163, DOI 10.1046/j.1440-6047.11.s.6.5.x; Simopoulos AP, 2004, FOOD REV INT, V20, P77, DOI 10.1081/FRI-120028831; Statista, 2019, US FLUID MILK PROD C; Statista, 2018, MILK CAP CONS CAN; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; Welter KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151876; WHO, 2020, FATS FATT AC HUM NUT	69	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2021	16	2							e0246357	10.1371/journal.pone.0246357	http://dx.doi.org/10.1371/journal.pone.0246357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4BO	33561133	gold, Green Published			2022-12-26	WOS:000617533000040
J	Rojo, I; Anadon, JD; Garcia-Charton, JA				Rojo, Irene; Anadon, Jose Daniel; Garcia-Charton, Jose Antonio			Exceptionally high but still growing predatory reef fish biomass after 23 years of protection in a Marine Protected Area	PLOS ONE			English	Article							RESERVES; SIZE; RECOVERY; TRAJECTORIES; COMMUNITIES; POPULATIONS; EXTINCTION; MANAGEMENT; ABUNDANCE; BENEFITS	Marine Protected Areas (MPAs) help replenish fish assemblages, though different trophic levels may show diverse recovery patterns. Long-term protection is required to achieve total recovery but poaching events may prevent the achievement of full carrying capacity. Here, we have analysed the effect of long-term protection on the entire reef fish community and the different trophic levels in the Cabo de Palos-Islas Hormigas MPA (SE Spain; SW Mediterranean Sea) in order to assess their recovery patterns after 23 years of protection. We compared the values for carrying capacity obtained with the maximum values achieved at regional scale, and we assessed the effect of a reduction in the surveillance over a few years, during which poaching events increased, on the recovery patterns. We found that, overall, biomass of fishes increased with time while density diminished. In particular, piscivorous and macro-invertivore fish increased while the other trophic groups remained constant or declined, suggesting top-down processes. For the entire study period, those trophic groups were approaching carrying capacity; however, when accounting only for the period in which enforcement was high and constant, they grew exponentially, indicating that full carrying capacity may have not been achieved yet. When compared to other Mediterranean MPAs, the Cabo de Palos-Islas Hormigas MPA showed values for biomass that were disproportionately higher, suggesting that local factors, such as habitat structure and associated oceanographic processes, may be responsible for the dynamics found. Our results help to understand the potential trajectories of fish assemblages over a consolidated MPA and highlight empirically how the reduction of surveillance in a period may change the recovery patterns.	[Rojo, Irene; Garcia-Charton, Jose Antonio] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Anadon, Jose Daniel] CSIC, Inst Pirenaico Ecol, Zaragoza, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Rojo, I (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	ire.rojo@gmail.com	Moreno, Irene Rojo/R-9803-2019; Garcia-Charton, Jose Antonio/E-2793-2010	Garcia-Charton, Jose Antonio/0000-0002-5973-9913; Rojo, Irene/0000-0002-9007-3101	EU; REDEMED [MINECO CGL2013-49039-R]; ABHACO2DE [19516/PI/14]; Spanish MINECO FPI contract	EU(European Commission); REDEMED; ABHACO2DE; Spanish MINECO FPI contract	This work is part of the research projects "Scientific Monitoring of the Cabo de Palos - Islas Hormigas marine reserve (1996-2018)" (Regional Fisheries and Aquaculture Service - Autonomous Community of Murcia, with funds from EU, notably the European Maritime and Fisheries Fund -EMFF), REDEMED (MINECO CGL2013-49039-R) and ABHACO2DE (Fundacion Seneca 19516/PI/14). IR is funded by a Spanish MINECO FPI contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANG ENV STAT COMP; Astruch P, 2018, SCI REPORTS PORT CRO; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barneche DR, 2014, ECOL LETT, V17, P1067, DOI 10.1111/ele.12309; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beaudreau AH, 2011, MAR BIOL, V158, P471, DOI 10.1007/s00227-010-1574-6; Bell J.D., 1983, Tethys, V11, P1; BIANCHI G, 1992, MAR ECOL PROG SER, V85, P25, DOI 10.3354/meps085025; Boaden AE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00292.1; Bradley D, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43131; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Calvin JC, 1999, CARTOGRAFIA BIONOMIC; Chapman EJ, 2018, GLOB ECOL CONSERV, V13, DOI 10.1016/j.gecco.2017.e00365; Cheng BS, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2617; Cinner J, 2006, ECOL SOC, V11; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cohen PJ, 2013, GLOBAL ENVIRON CHANG, V23, P1702, DOI 10.1016/j.gloenvcha.2013.08.010; Coll J, 2013, ICES J MAR SCI, V70, P578, DOI 10.1093/icesjms/fst025; Edgar GJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177216; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Esparza O., 2010, THESIS; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Friedlander AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174787; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R, 2017, WORLD WIDE WEB ELECT; Funes M, 2018, FOOD WEBS, V16; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Garcia-Charton JA, 2018, UNIVERSIDAD MURCIA; GARCIA-RUBIES A, 1990, Scientia Marina, V54, P317; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Giakoumi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08850-w; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Goetze JS, 2011, CORAL REEFS, V30, P507, DOI 10.1007/s00338-011-0732-8; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Hackradt CM, 2012, THESIS U MURCIA MURC; Halpern BS, 2003, ECOL APPL, V13, pS117; HARMELIN JG, 1987, MAR ECOL-P S Z N I, V8, P263, DOI 10.1111/j.1439-0485.1987.tb00188.x; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Harmelin-Vivien M, 2015, GLOB ECOL CONSERV, V3, P279, DOI 10.1016/j.gecco.2014.12.005; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; Hatton IA, 2015, SCIENCE, V349, P1070, DOI 10.1126/science.aac6284; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Henderson PA, 2010, P ROY SOC B-BIOL SCI, V277, P1561, DOI 10.1098/rspb.2009.2189; Hogg K, 2021, MAR POLICY, V127, DOI 10.1016/j.marpol.2017.10.035; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; MACPHERSON E, 1991, MAR ECOL PROG SER, V71, P103, DOI 10.3354/meps071103; Marra S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146391; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154585; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; Mellin C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10491; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Morey G, 2003, FISH RES, V62, P89, DOI 10.1016/S0165-7836(02)00250-3; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perez-Ruzafa A, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.0245; Prato G, 2014, MAR ECOL PROG SER, V512, P71, DOI 10.3354/meps10988; Rincon-Diaz MP, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2433; Rojo I, 2019, MAR ENVIRON RES, V149, P100, DOI 10.1016/j.marenvres.2019.06.005; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Sahyoun R, 2013, J MAR BIOL ASSOC UK, V93, P425, DOI 10.1017/S0025315412000975; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sbragaglia V, 2018, ICES J MAR SCI, V75, P1779, DOI 10.1093/icesjms/fsy059; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Tyler EHM, 2009, BIOL CONSERV, V142, P652, DOI 10.1016/j.biocon.2008.11.017; Hackradt CW, 2020, HYDROBIOLOGIA, V847, P757, DOI 10.1007/s10750-019-04135-7; Hackradt CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098206; Williams JJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2456	80	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0246335	10.1371/journal.pone.0246335	http://dx.doi.org/10.1371/journal.pone.0246335			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556064	Green Published, gold			2022-12-26	WOS:000617379900016
J	Woo, MT; Davids, K; Chow, JY; Jaakkola, T				Woo, Mei Teng; Davids, Keith; Chow, Jia Yi; Jaakkola, Timo			Acute effects of wearing compression knee-length socks on ankle joint position sense in community-dwelling older adults	PLOS ONE			English	Article							POSTURAL CONTROL; PROPRIOCEPTION; PERFORMANCE; STABILITY; RISK; FOOT; AGE; INFORMATION; HEALTHY; STANCE	Functional proprioceptive information is required to allow an individual to interact with the environment effectively for everyday activities such as locomotion and object manipulation. Specifically, research suggests that application of compression garments could improve proprioceptive regulation of action by enhancing sensorimotor system noise in individuals of different ages and capacities. However, limited research has been conducted with samples of elderly people thus far. This study aimed to examine acute effects of wearing knee-length socks (KLS) of various compression levels on ankle joint position sense in community-dwelling, older adults. A total of 26 participants (12 male and 14 female), aged between 65 and 84 years, were randomly recruited from local senior activity centres in Singapore. A repeated-measures design was used to determine effects on joint position awareness of three different treatments-wearing clinical compression socks (20-30 mmHg); wearing non-clinical compression socks (< 20 mmHg); wearing normal socks, and one control condition (barefoot). Participants were required to use the dominant foot to indicate 8 levels of steepness (2.5 degrees, 5 degrees, 7.5 degrees, 10 degrees, 12.5 degrees, 15 degrees, 17.5 degrees, and 20 degrees), while standing on a modified slope box, in a plantar flexion position. Findings showed that wearing clinical compression KLS significantly reduced the mean absolute errors compared to the barefoot condition. However, there were no significant differences observed between other KLS and barefoot conditions. Among the KLS of various compression levels, results suggested that only wearing clinical compression KLS (20-30 mmHg) improved the precision of estimation of ankle joint plantar flexion movement, by reducing absolute performance errors in elderly people. It is concluded that wearing clinical compression KLS could potentially provide an affordable strategy to ameliorate negative effects of ageing on the proprioception system to enhance balance and postural control in community-dwelling individuals.	[Woo, Mei Teng; Jaakkola, Timo] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Woo, Mei Teng] Republ Polytech, Sch Sports Hlth & Leisure, Singapore, Singapore; [Davids, Keith] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield, S Yorkshire, England; [Chow, Jia Yi] Nanyang Technol Univ, Natl Inst Educ, Phys Educ & Sports Sci, Singapore, Singapore	University of Jyvaskyla; Sheffield Hallam University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Woo, MT (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.; Woo, MT (corresponding author), Republ Polytech, Sch Sports Hlth & Leisure, Singapore, Singapore.	woo_mei_teng@rp.edu.sg	Woo, Mei Teng/AFF-5711-2022	Jaakkola, Timo/0000-0003-1227-2460	National Institute of education (NIE) Academic Research Fund [(ACRF) x RI 8/13 CJY]	National Institute of education (NIE) Academic Research Fund	National Institute of education (NIE) Academic Research Fund [grant numbers (ACRF) x RI 8/13 CJY].	Barss TS, 2018, J NEUROPHYSIOL, V120, P186, DOI 10.1152/jn.00581.2017; Birmingham TB, 2001, MED SCI SPORT EXER, V33, P1253, DOI 10.1097/00005768-200108000-00002; Born DP, 2013, INT J SPORT PHYSIOL, V8, P4, DOI 10.1123/ijspp.8.1.4; Davids K, 2004, BRIT J SPORT MED, V38, P601, DOI 10.1136/bjsm.2003.007427; Doan BK, 2003, J SPORT SCI, V21, P601, DOI 10.1080/0264041031000101971; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Field A, 2013, DISCOVERING STAT USI; Ghai S, 2018, GAIT POSTURE, V60, P258, DOI 10.1016/j.gaitpost.2016.08.008; Ghai S, 2017, PHYS THER SPORT, V25, P65, DOI 10.1016/j.ptsp.2016.05.006; Gilman S, 2002, J NEUROL NEUROSUR PS, V73, P473, DOI 10.1136/jnnp.73.5.473; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Hasan H, 2016, HUM MOVEMENT SCI, V48, P102, DOI 10.1016/j.humov.2016.04.008; Herrington Lee, 2005, Res Sports Med, V13, P37, DOI 10.1080/15438620590922077; Hijmans JM, 2009, GAIT POSTURE, V29, P322, DOI 10.1016/j.gaitpost.2008.10.051; Ko SU, 2015, AGE AGEING, V44, P485, DOI 10.1093/ageing/afv005; Long Z, 2017, J SCI MED SPORT, V20, P236, DOI 10.1016/j.jsams.2016.08.024; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Lowrey CR, 2010, NEUROSCI LETT, V485, P6, DOI 10.1016/j.neulet.2010.08.033; Miralles I, 2010, FOOT ANKLE INT, V31, P1099, DOI 10.3113/FAI.2010.1099; Orth D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060349; Qiu F, 2012, GAIT POSTURE, V35, P630, DOI 10.1016/j.gaitpost.2011.12.013; Ribeiro F, 2007, EUR REV AGING PHYS A, V4, P71, DOI 10.1007/s11556-007-0026-x; Robbins S, 1995, BRIT J SPORT MED, V29, P242, DOI 10.1136/bjsm.29.4.242; ROBBINS S, 1995, AGE AGEING, V24, P67, DOI 10.1093/ageing/24.1.67; Robbins S, 1997, CRIT REV PHYS REHABI, V9, P53; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Simoneau GG, 1997, J ATHL TRAINING, V32, P141; Siong KH, 2016, GERIATR GERONTOL INT, V16, P259, DOI 10.1111/ggi.12463; Suetterlin KJ, 2014, AGE AGEING, V43, P313, DOI 10.1093/ageing/aft174; Thelen DG, 1998, J GERONTOL A-BIOL, V53, pM33, DOI 10.1093/gerona/53A.1.M33; Van Tiggelen D, 2008, CLIN J SPORT MED, V18, P259, DOI 10.1097/JSM.0b013e31816d78c1; Waddington G, 2003, BRIT J SPORT MED, V37, P170, DOI 10.1136/bjsm.37.2.170; Woo MT, 2014, PROCEDIA ENGINEER, V72, P162, DOI 10.1016/j.proeng.2014.06.028; Woo MT, 2018, GAIT POSTURE, V66, P63, DOI 10.1016/j.gaitpost.2018.08.011; Woo MT, 2017, GERIATR ORTHOP SURG, V8, P256, DOI 10.1177/2151458517745989; Woo MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174522; Wu GKH, 2001, AM J SPORT MED, V29, P641, DOI 10.1177/03635465010290051801; You SH, 2005, ARCH PHYS MED REHAB, V86, P346, DOI 10.1016/j.apmr.2004.01.035; You SH, 2004, J ORTHOP SPORT PHYS, V34, P449, DOI 10.2519/jospt.2004.34.8.449	39	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2021	16	2							e0245979	10.1371/journal.pone.0245979	http://dx.doi.org/10.1371/journal.pone.0245979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG1VY	33556067	Green Published, gold, Green Accepted			2022-12-26	WOS:000617379900025
J	Millan, MGD; de la Torre, MGMV; Rojas, RH				Genoveva Dancausa Millan, Ma; Genoveva Millan Vazquez de la Torre, Ma; Hernandez Rojas, Ricardo			Analysis of the demand for gastronomic tourism in Andalusia (Spain)	PLOS ONE			English	Article							CULINARY TOURISM; FOOD; MOTIVATION; EXPERIENCES; HERITAGE	In recent years, gastronomy has become a fundamental motivation to travel. Learning how to prepare gastronomic dishes and about the raw materials that compose them has attracted increasing numbers of tourists. In Andalusia (region of southern Spain), there are many quality products endorsed by Protected Designations of Origin, around which gastronomic routes have been created, some visited often (e.g., wine) and others remaining unknown (e.g., ham and oil). This study analyses the profile of gastronomic tourists in Andalusia to understand their motivations and estimates the demand for gastronomic tourism using seasonal autoregressive integrated moving average (SARIMA) models. The results obtained indicate that the gastronomic tourist in Andalusia is very satisfied with the places he/she visits and the gastronomy he/she savours. However, the demand for this tourist sector is very low and heterogeneous; while wine tourism is well established, tourism focusing on certain products, such as olive oil or ham, is practically non-existent. To obtain a homogeneous demand, synergies or pairings should be created between food products, e.g., wine-ham, oil-ham, etc., to attract a greater number of tourists and distinguish Andalusia as a gastronomic holiday destination.	[Genoveva Dancausa Millan, Ma] Cordoba Univ, Dept Stat, Cordoba, Spain; [Genoveva Millan Vazquez de la Torre, Ma] Univ Loyola Andalucia, Dept Quantitat Methods, Seville, Spain; [Hernandez Rojas, Ricardo] Cordoba Univ, Dept Agr Econ, Cordoba, Spain	Universidad Loyola Andalucia	de la Torre, MGMV (corresponding author), Univ Loyola Andalucia, Dept Quantitat Methods, Seville, Spain.; Rojas, RH (corresponding author), Cordoba Univ, Dept Agr Econ, Cordoba, Spain.	gmillan@uloyola.es; ricardo.hernandez@uco.es	Dancausa, Genoveva/AFO-3016-2022; Millan Vazquez de la Torre/G-2231-2015	Dancausa, Genoveva/0000-0002-2733-6570; Hernandez Rojas, Ricardo David/0000-0002-3055-2151; Millan Vazquez de la Torre/0000-0002-6635-4456				Ab Karim S, 2010, J HOSP MARKET MANAG, V19, P531, DOI 10.1080/19368623.2010.493064; Abramson J., 2017, CONT FR CIVILIZ, V42, P259, DOI [10.3828/cfc.2017.17, DOI 10.3828/CFC.2017.17]; Abril M., 2019, J TOUR HERIT RES, V2, P436; Agrawal J, 1999, INT J RES MARK, V16, P255, DOI 10.1016/S0167-8116(99)00017-8; Troncoso CA, 2019, INVESTIG TUR, P169, DOI 10.14198/INTURI2019.18.08; [Anonymous], 2020, J ADDICT MED, V14, P1, DOI 10.1097/ADM.0000000000000633; [Anonymous], 2003, ICCP, V16, P13; [Anonymous], 2020, COMMUN BIOL, V3, P1; [Anonymous], 2004, FILM INT, V10, P37; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; [Anonymous], 2015, RIV STORICA ITAL, V6, P1, DOI DOI 10.3389/fpls.2015.00951; Aramendia G.Z., 2020, J BUS ECON STAT, V11, P22; Armesto X., 2004, CUADERNOS GEOGRAFICO, V34, P83; Armesto-Lopez X. A., 2004, CUAD GEOGR, V34, P83, DOI [DOI 10.30827/CUADGEO.V34I1.1821, 10.30827/cuadgeo.v34i1.1821]; Barrera E., 2008, SCI GASTRONOMICHE U, V3, P1; Barrera E., 2003, MANUAL TURISMO RURAL, P1; Barrera E., 2006, TURISMO RURAL NUEVA, P1; Batu Ali, 2018, Journal of Ethnic Foods, V5, P76; Bene Z., 2018, MANAG STUD, V6, P367; Bessiere J, 2013, J SCI FOOD AGR, V93, P3420, DOI 10.1002/jsfa.6284; Biaogowska A., 2014, SCI REV PHYS CULT, V4, P14; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Briganda JP, 2016, INT J GASTRON FOOD S, V3, P12, DOI 10.1016/j.ijgfs.2016.03.001; Bukharov I, 2018, WORLDW HOSP TOUR THE, V10, P449, DOI [10.1108/whatt-03-2018-0019, 10.1108/WHATT-03-2018-0019]; Castano Blanco J. M., 2003, Estudios Turisticos, P5; Ceretta C. C., 2012, Estudios y Perspectivas en Turismo, V21, P1558; Chang W., 2011, EVENT MANAGE, V15, P13, DOI DOI 10.3727/152599511X12990855575024; Chien-Ho Wang, 2019, Sustainability, V11, DOI 10.3390/su11030744; Chiodo E, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229388; Clemente Ricolfe J. S., 2008, PASOS: Revista de Turismo y Patrimonio Cultural, V6, P189; Cottrill EE, 2017, INT FORUM ALLERGY RH, V7, P154, DOI 10.1002/alr.21851; COVID-19 Prevention and Control Expert Group Chinese Preventive Medicine Association, 2020, CHIN J VIRAL DIS, V12, P1, DOI [10.16505/j.2095-0136.2020.0015, DOI 10.16505/J.2095-0136.2020.0015]; De Falco S., 2018, CITY CULTURE SOC, V14, P1, DOI [10.1016/j.ccs.2018.03.002, DOI 10.1016/J.CCS.2018.03.002]; de Pouplana J. R., 2020, TECNOHOTEL REV PROFE, P30; DEVESA M., 2010, REV ELECT MOTIVACION, VXIII, P169; Feo F. P., 2014, CUADERNOS DE TURISMO, V33, P31; Folgado-Fernandez J.A., 2014, REV TUR DESENVOLV, V21, P341, DOI [10.20344/amp.12927, DOI 10.20344/AMP.12927]; Gluchowski A, 2019, FOODS, V8, DOI 10.3390/foods8080323; Gomez B., 2002, ACT 11 C GEOGR RUR, V1, P139; Gujarati D., 2003, ECONOMETRIA; Ortega BH, 2006, UNIVERSIA BUS REV, P54; Hernández Rojas Ricardo D, 2018, Estud. perspect. tur., V27, P413; Ivic P., 2017, Journal of Hygienic Engineering and Design, V18, P45; Julien-David D, 2020, NUTRI H ASP TRAD ETH, P109, DOI 10.1016/B978-0-12-813171-8.00007-X; Khanna R., 2017, Journal of Gastronomy and Tourism, V2, P163, DOI 10.3727/216929717x14870140201071; Kiatkawsin K, 2019, INT J HOSP MANAG, V82, P209, DOI 10.1016/j.ijhm.2019.04.024; Kim S., 2016, FOOD TOURISM REGIONA, P151; Leaf healthcare, 2015, CISC VIS NETW IND GL, P1; Lin C.J., 2011, INT J BUS ADM, V2, P14, DOI [10.5430/ijba.v2n2p14, DOI 10.5430/IJBA.V2N2P14]; Llano Fabián Andrés, 2017, Cuad. Geogr. Rev. Colomb. Geogr., V26, P295, DOI 10.15446/rcdg.v26n2.59280; Lopez M., 1996, DENOMINACIONES ORIGE, V1st, P1; Lopez-Guzman T, 2017, BRIT FOOD J, V119, P267, DOI 10.1108/BFJ-06-2016-0246; Lopez-Guzman T, 2012, PASOS, V10, P575, DOI 10.25145/j.pasos.2012.10.072; Perez-Llorens JL, 2019, INT J GASTRON FOOD S, V17, DOI 10.1016/j.ijgfs.2019.100170; Macias U., 2003, RED JUDERIAS ESPANA; Mak AHN, 2018, ROUT STUD GASTRO FOO, P60; Marquez A. M., 2001, REV ESTUDIOS COOPERA, V74, P123; Martins Uiara Maria Oliveira, 2011, Estud. perspect. tur., V20, P404; Mascarenhas Tramontin Rúbia Gisele, 2010, Estud. perspect. tur., V19, P776; Melendez ST, 2017, TOUR ANAL, V22, P261, DOI 10.3727/108354217X14888192562564; Metaxas T, 2016, J DEV ENTREP, V21, DOI 10.1142/S1084946716500187; Mgonja JT, 2017, J SUSTAIN TOUR, V25, P796, DOI 10.1080/09669582.2016.1250768; de la Torre MGV, 2017, TOUR MANAG PERSPECT, V21, P100, DOI 10.1016/j.tmp.2016.12.003; Minta S., 2015, POLJOPRIVREDA SUMARS, V61, P51, DOI 10.17707/AgricultForest.61.1.06; Mohanty P.P., 2020, INT J TOUR HOSP ASIA, V3, P15, DOI [DOI 10.32535/IJTHAP.V3I1.721, 10.32535/ijthap.v3i1.721]; Moreno-Rojas R, 2020, INT J GASTRON FOOD S, V20, DOI 10.1016/j.ijgfs.2020.100201; Motoyama M, 2016, MEAT SCI, V120, P10, DOI 10.1016/j.meatsci.2016.04.026; Mouritsen O. G, 2018, FRONT COMM SCI ENV C, V3, P38, DOI DOI 10.3389/FCOMM.2018.00038; Niedbala G, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135344; Obrenovic D., 2019, TURISTICKO POSLOVANJ, V24, P15; Oktay S, 2018, INT J GASTRON FOOD S, V12, P6, DOI 10.1016/j.ijgfs.2018.03.003; Oliveira Simão, 2011, Estud. perspect. tur., V20, P738; Orgaz Aguera F., 2015, ARA J, V5, P43; Peistikou M., 2019, STRATEG INNOV MARK T, P1039; Richards G., 2012, FOOD TOURISM EXPERIE, P13; Rodriguez-Fernandez M. M., 2017, REV ESPACIOS, V38, P24; Sainz de la Maza A., 2005, CLIO REV HIST, V39, P82; Schluter RG, 2008, PASOS, V6, P249, DOI 10.25145/j.pasos.2008.06.019; Shin JungYoung [Shin J. Y. T. ], 2018, Edible insects in sustainable food systems, P147; Sohn Jeong-Min, 2016, Culinary Science & Hospitality Research, V22, P135; Song H, 2008, TOURISM MANAGE, V29, P203, DOI 10.1016/j.tourman.2007.07.016; Suman S, 2016, INT J AGRIC STAT SCI, V12, P109; Toktassynova Z., 2017, International Journal of Contemporary Tourism Research, V1, P29; Torre Genoveva Millán Vázquez De La, 2012, TMStudies, P78; Torres E., 2003, CULTURA PLATO, P306; Torres-Onate F, 2019, ADV SCI TECHNOL INN, P109, DOI 10.1007/978-3-030-10804-5_11; Tovar R., 2007, COCINA COSTUMBRES JU; de la Torre GMV, 2016, TOUR HOSP MANAG-CROA, V22, P173, DOI 10.20867/thm.22.2.7; Villalobos P. A. C., 2020, J TOURISM HERITAGE R, V3, P311; Wang C., 2019, ROUTLEDGE HDB GASTRO, P395; Widjaja D. C., 2018, THESIS; Yanting X., 2016, REV JAPANESE GASTRON, V80, P1036; Yu CE, 2019, TOURISM MANAGE, V75, P257, DOI 10.1016/j.tourman.2019.05.011; Zhang HM, 2018, J DESTIN MARK MANAGE, V8, P326, DOI 10.1016/j.jdmm.2017.06.004; Zur A, 2020, EDUC SCI, V10, DOI 10.3390/educsci10030062	95	8	8	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0246377	10.1371/journal.pone.0246377	http://dx.doi.org/10.1371/journal.pone.0246377			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH0TZ	33544734	Green Published, gold			2022-12-26	WOS:000617991900011
J	Medina-Salguero, AX; Cornejo-Franco, JF; Grinstead, S; Mowery, J; Mollov, D; Quito-Avila, DF				Medina-Salguero, Andres X.; Cornejo-Franco, Juan F.; Grinstead, Sam; Mowery, Joseph; Mollov, Dimitre; Quito-Avila, Diego F.			Genetic characterization of a mild isolate of papaya ringspot virus type-P (PRSV-P) and assessment of its cross-protection potential under greenhouse and field conditions	PLOS ONE			English	Article							COAT PROTEIN; MOSAIC-VIRUS; MOLECULAR EPIDEMIOLOGY; ZUCCHINI-SQUASH; AMINO-ACID; POTYVIRUS; SEQUENCE; TRANSMISSIBILITY; RECOMBINATION; VARIABILITY	A mild isolate of Papaya ringspot virus type-P, abbreviated as PRSV-mild, from Ecuador was sequenced and characterized. The most distinguishing symptom induced by PRSV-mild was gray powder-like leaf patches radiating from secondary veins. In greenhouse experiments, PRSV-mild did not confer durable protection against a severe isolate of the virus (PRSV-sev), obtained from the same field. Furthermore, isolate specific detection in mixed-infected plants showed that PRSV-sev becomes dominant in infections, rendering PRSV-mild undetectable at 90-120 days post superinfection. Virus testing using isolate-specific primers detected PRSV-mild in two out of five surveyed provinces, with 10% and 48% of incidence in Santo Domingo and Los Rios, respectively. Comparative genomics showed that PRSV-mild lacks two amino acids from the coat protein region, whereas amino acid determinants for asymptomatic phenotypes were not identified. Recombination events were not predicted in the genomes of the Ecuadorean isolates. Phylogenetic analyses placed both PRSV-mild and PRSV-sev in a clade that includes an additional PRSV isolate from Ecuador and others from South America.	[Medina-Salguero, Andres X.; Cornejo-Franco, Juan F.; Quito-Avila, Diego F.] Escuela Super Politecn Litoral, Ctr Invest Biotecnol Ecuador, ESPOL, Guayaquil, Guayas, Ecuador; [Grinstead, Sam; Mollov, Dimitre] USDA ARS, Natl Germplasm Resources Lab, Beltsville, MD USA; [Mowery, Joseph] USDA ARS, Electron & Confocal Microscopy Unit, Beltsville, MD USA; [Quito-Avila, Diego F.] Escuela Super Politecn Litoral, Fac Ciencias Vida, ESPOL, Guayaquil, Guayas, Ecuador	Escuela Superior Politecnica del Litoral; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Escuela Superior Politecnica del Litoral	Quito-Avila, DF (corresponding author), Escuela Super Politecn Litoral, Ctr Invest Biotecnol Ecuador, ESPOL, Guayaquil, Guayas, Ecuador.; Quito-Avila, DF (corresponding author), Escuela Super Politecn Litoral, Fac Ciencias Vida, ESPOL, Guayaquil, Guayas, Ecuador.	dquito@espol.edu.ec		Mollov, Dimitre/0000-0002-4750-6194; Grinstead, Samuel/0000-0002-1708-8235; Mowery, Joseph/0000-0001-7128-1397	Ecuadorean University Network (REDU), through ESPOL [PREDU-2016-001]	Ecuadorean University Network (REDU), through ESPOL	This work was funded partially by the Ecuadorean University Network (REDU) project PREDU-2016-001, through ESPOL.	Adams I., 2016, CURRENT RES TOPICS P, P323, DOI DOI 10.1007/978-3-319-32919-2_14; Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; [Anonymous], 2018, MICROSC MICROANAL; ATREYA PL, 1991, P NATL ACAD SCI USA, V88, P7887, DOI 10.1073/pnas.88.17.7887; Babu K. S., 2018, Indian Phytopathology, V71, P611, DOI 10.1007/s42360-018-0097-9; Bateson MF, 2002, J GEN VIROL, V83, P2575, DOI 10.1099/0022-1317-83-10-2575; Blanc S, 1998, J GEN VIROL, V79, P3119, DOI 10.1099/0022-1317-79-12-3119; Chen KC, 2008, MOL PLANT MICROBE IN, V21, P1046, DOI 10.1094/MPMI-21-8-1046; Chiang CH, 2007, EUR J PLANT PATHOL, V118, P333, DOI 10.1007/s10658-007-9130-z; Cornejo-Franco JF, 2020, EUR J PLANT PATHOL, V157, P961, DOI 10.1007/s10658-020-02037-2; Desbiez C, 2020, PAPAYA RINGSPOT VIRU; Desbiez C, 2010, ARCH VIROL, V155, P397, DOI 10.1007/s00705-009-0569-4; FermIn G, 2010, CP TRANSGENIC NONTRA; Gal-On A, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P261, DOI 10.1007/1-4020-3780-5_12; Gal-On A, 2000, PHYTOPATHOLOGY, V90, P467, DOI 10.1094/PHYTO.2000.90.5.467; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Hull R., 2009, CURR PROTOC MICROBIO, V13, p16B.6.1, DOI [10.1002/9780471729259.mc16b06s13, DOI 10.1002/9780471729259.MC16B06S13]; JENSEN DD, 1949, PHYTOPATHOLOGY, V39, P212; Kalleshwaraswamy CM, 2008, PHYTOPATHOLOGY, V98, P541, DOI 10.1094/PHYTO-98-5-0541; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laney AG, 2012, EUR J PLANT PATHOL, V134, P227, DOI 10.1007/s10658-012-9985-5; Lopez-Moya JJ, 1999, J GEN VIROL, V80, P3281, DOI 10.1099/0022-1317-80-12-3281; Maina S, 2019, PLANT DIS, V103, P737, DOI 10.1094/PDIS-07-18-1136-RE; Mangrauthia S, 2008, BIOCHEM GENET, V46, P835, DOI 10.1007/s10528-008-9198-y; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martins DD, 2016, CROP PROT, V90, P191, DOI 10.1016/j.cropro.2016.08.030; Mishra Ritesh, 2019, VirusDisease, V30, P261, DOI 10.1007/s13337-019-00512-x; Nigam D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01439; Castillo XAO, 2011, VIRUS RES, V159, P132, DOI 10.1016/j.virusres.2011.04.011; Perring TM, 1995, CROP PROT, V14, P601, DOI 10.1016/0261-2194(95)00030-5; Quito-Avila DF, 2015, EUR J PLANT PATHOL, V143, P199, DOI 10.1007/s10658-015-0675-y; Rezende JAM, 1998, PLANT DIS, V82, P171, DOI 10.1094/PDIS.1998.82.2.171; Romay G, 2014, ARCH VIROL, V159, P277, DOI 10.1007/s00705-013-1798-0; Freitas DMS, 2008, SCI AGR, V65, P183, DOI 10.1590/S0103-90162008000200012; Silva-Rosales L, 2000, ARCH VIROL, V145, P835, DOI 10.1007/s007050050676; Tatineni S, 2016, J VIROL, V90, P10886, DOI 10.1128/JVI.01697-16; Tripathi S, 2008, MOL PLANT PATHOL, V9, P269, DOI 10.1111/J.1364-3703.2008.00467.X; Wang HL, 1987, PLANT DIS, P7; Yeh S.D., 1984, PHYTOPATHOLOGY, P6; YEH SD, 1992, J GEN VIROL, V73, P2531, DOI 10.1099/0022-1317-73-10-2531	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2021	16	2							e0241652	10.1371/journal.pone.0241652	http://dx.doi.org/10.1371/journal.pone.0241652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH0TZ	33544737	Green Submitted, gold, Green Published			2022-12-26	WOS:000617991900023
J	Lin, I; Edison, B; Mantri, S; Albert, S; Daeschler, M; Kopil, C; Marras, C; Chahine, LM				Lin, Iris; Edison, Briana; Mantri, Sneha; Albert, Steven; Daeschler, Margaret; Kopil, Catherine; Marras, Connie; Chahine, Lana M.			Triggers and alleviating factors for fatigue in Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; HIGH-INTENSITY EXERCISE; RANDOMIZED CLINICAL-TRIAL; NONMOTOR SYMPTOMS; PHYSICAL-ACTIVITY; SLEEP; PEOPLE; MOTOR; IMPACT; FLUCTUATIONS	Background Fatigue is common in Parkinson's Disease, but few effective treatments are available for it. Exploring triggers and alleviating factors, including effects of exercise, could inform development of management strategies for Parkinson's Disease fatigue. Objectives To examine triggers and alleviating factors for fatigue reported by individuals with Parkinson's Disease, including perceived effect of exercise. Methods A sample of individuals with self-reported Parkinson's Disease participating in the study Fox Insight were administered an online survey. The survey included the Parkinson's Fatigue Scale, the Physical Activity Scale for the Elderly, and multiple-choice questions about triggers and alleviating factors for fatigue. Results Among the sample of 1,029 individuals with Parkinson's disease, mean (standard deviation (SD)) age was 67.4 (9.3) years, 44.0% were female. Parkinson's Fatigue Scale score ranged from 16-80, mean (SD) 48.8 (16.2). Poor sleep (62.1%) and physical exertion (45.1%) were frequently reported triggers for fatigue. Coping strategies including sitting quietly (58.1%), laying down with or without napping, and exercise (20%). Physical Activity Scale for the Elderly scores were higher in those who reported that exercise alleviated their fatigue (49.7%) compared to those who reported it worsened their fatigue (18.9%) (mean (SD) score 158.5 (88.8) vs 119.8 (66.6) respectively; p<0.001). Conclusions Several behavioral and environmental triggers and alleviating strategies for fatigue are reported by individuals with Parkinson's disease. Many feel that exercise alleviates fatigue, though the relationship between exercise and fatigue in Parkinson's Disease appears complex. This exploratory study may inform future development of treatments or coping strategies for Parkinson's disease fatigue.	[Lin, Iris; Edison, Briana; Chahine, Lana M.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Mantri, Sneha] Duke Univ, Dept Neurol, Durham, NC USA; [Albert, Steven] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Daeschler, Margaret] Columbia Univ, Sch Social Work, New York, NY USA; [Kopil, Catherine] Michael J Fox Fdn Parkinsons Res, New York, NY USA; [Marras, Connie] Univ Toronto, Dept Neurol, Toronto, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; University of Toronto	Chahine, LM (corresponding author), Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA.	lchahine2018@gmail.com		Albert, Steven/0000-0001-6786-9956; Chahine, Lana/0000-0003-2521-7196	Michael J Fox Foundation (MJFF)	Michael J Fox Foundation (MJFF)	This study was funded by the Michael J Fox Foundation (MJFF). MJFF also provided support in the form of salary for authors CM, LMC, and SM, and provided consultant fees for author SM. Cerevel Therapeutics provided support in the form of salary for author SM and Deep Brain Innovations LLC provided consultant fees for author SM. Authors CK and MD are or were previously employed by the MJFF, the sponsor of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afshari M, 2017, J PARKINSON DIS, V7, P703, DOI 10.3233/JPD-171173; Ahlskog JE, 2011, NEUROLOGY, V77, P288, DOI 10.1212/WNL.0b013e318225ab66; Alves G, 2004, NEUROLOGY, V63, P1908, DOI 10.1212/01.WNL.0000144277.06917.CC; Amara AW, 2019, PARKINSONISM RELAT D, V61, P118, DOI 10.1016/j.parkreldis.2018.11.006; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Black Christopher D, 2005, Dyn Med, V4, P3, DOI 10.1186/1476-5918-4-3; Boccabella A, 2017, J CLIN SLEEP MED, V13, P685, DOI 10.5664/jcsm.6584; Brown RG, 2005, PARKINSONISM RELAT D, V11, P49, DOI 10.1016/j.parkreldis.2004.07.007; Bryant MS, 2012, EUR NEUROL, V67, P326, DOI 10.1159/000335877; Chou KL, 2016, PARKINSONISM RELAT D, V23, P45, DOI 10.1016/j.parkreldis.2015.11.029; Corcos DM, 2013, MOVEMENT DISORD, V28, P1230, DOI 10.1002/mds.25380; Cramp F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub3; Dashtipour K, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/586378; de Paula FR, 2006, MOVEMENT DISORD, V21, P1073, DOI 10.1002/mds.20763; Elbers R, 2009, MOVEMENT DISORD, V24, P1512, DOI 10.1002/mds.22664; Elbers RG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010925.pub2; Ellis T, 2013, PHYS THER, V93, P628, DOI 10.2522/ptj.20120279; Factor SA, 2016, NEUROLOGY, V86, P2278, DOI 10.1212/WNL.0000000000002670; Fisher BE, 2008, ARCH PHYS MED REHAB, V89, P1221, DOI 10.1016/j.apmr.2008.01.013; Franke C, 2017, INT REV NEUROBIOL, V134, P947, DOI [10.1016/bs.im.2017.05.021, 10.1016/bs.irn.2017.05.021]; Franssen M, 2014, MOVEMENT DISORD, V29, P1675, DOI 10.1002/mds.26030; Friedman JH, 2007, MOVEMENT DISORD, V22, P297, DOI 10.1002/mds.21240; Friedman JH, 2010, MOVEMENT DISORD, V25, P805, DOI 10.1002/mds.22989; Fu R, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0056-2; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Grace J, 2007, PARKINSONISM RELAT D, V13, P443, DOI 10.1016/j.parkreldis.2006.09.001; Herlofson K, 2012, EUR J NEUROL, V19, P963, DOI 10.1111/j.1468-1331.2012.03663.x; Herlofson K, 2017, J NEUROL SCI, V374, P38, DOI 10.1016/j.jns.2016.12.061; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Hogl B, 2010, MOVEMENT DISORD, V25, P2704, DOI 10.1002/mds.23190; Karlsen K, 1999, MOVEMENT DISORD, V14, P237, DOI 10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.3.CO;2-O; Kelly NA, 2014, J APPL PHYSIOL, V116, P582, DOI 10.1152/japplphysiol.01277.2013; Kluger BM, 2016, MOVEMENT DISORD, V31, P625, DOI 10.1002/mds.26511; Landers MR, 2019, J NEUROL PHYS THER, V43, P12, DOI 10.1097/NPT.0000000000000249; Larun L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub4; Lindholm B, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-19; Lopez C, 2011, J PSYCHOSOM RES, V70, P328, DOI 10.1016/j.jpsychores.2010.11.010; Lou JS, 2001, MOVEMENT DISORD, V16, P190, DOI 10.1002/mds.1042; Low DA, 2014, PARKINSONISM RELAT D, V20, P549, DOI 10.1016/j.parkreldis.2014.02.006; Mantri S, 2020, J PARKINSONS DIS; Mantri S, 2018, J PARKINSON DIS, V8, P107, DOI 10.3233/JPD-171218; Marinus J, 2003, SLEEP, V26, P1049, DOI 10.1093/sleep/26.8.1049; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Moore CG, 2013, CONTEMP CLIN TRIALS, V36, P90, DOI 10.1016/j.cct.2013.06.002; Muller B, 2013, PARKINSONISM RELAT D, V19, P1027, DOI 10.1016/j.parkreldis.2013.07.010; Nijs J, 2008, J REHABIL MED, V40, P241, DOI 10.2340/16501977-0185; Olivola E, 2018, NEUROL SCI, V39, P2169, DOI 10.1007/s10072-018-3569-x; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Postuma RB, 2017, NEUROLOGY, V89, P310, DOI [10.1212/WNL.0000000000004568, 10.1212/WNL.0000000000004163]; Rafferty MR, 2017, J PARKINSON DIS, V7, P193, DOI 10.3233/JPD-160912; Ramdharry GM, 2012, NEUROMUSCULAR DISORD, V22, pS208, DOI 10.1016/j.nmd.2012.10.016; Reynolds GO, 2016, MOVEMENT DISORD, V31, P23, DOI 10.1002/mds.26484; Ridgel AL, 2009, NEUROREHAB NEURAL RE, V23, P600, DOI 10.1177/1545968308328726; Schifitto G, 2008, NEUROLOGY, V71, P481, DOI 10.1212/01.wnl.0000324862.29733.69; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shulman LM, 2013, JAMA NEUROL, V70, P183, DOI 10.1001/jamaneurol.2013.646; Skorvanek M, 2013, J NEUROL, V260, P1554, DOI 10.1007/s00415-012-6828-4; Smolensky L, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0401-2; Solla P, 2014, J NEUROL, V261, P382, DOI 10.1007/s00415-013-7207-5; Storch A, 2013, NEUROLOGY, V80, P800, DOI 10.1212/WNL.0b013e318285c0ed; Swinn L, 2003, MOVEMENT DISORD, V18, P1459, DOI 10.1002/mds.10586; Tessitore A, 2016, MOVEMENT DISORD, V31, P1497, DOI 10.1002/mds.26650; van der Kolk NM, 2013, MOVEMENT DISORD, V28, P1587, DOI 10.1002/mds.25658; van Dijk JP, 2013, EUR NEUROL, V70, P201, DOI 10.1159/000351779; van Gilst MM, 2012, J PARKINSON DIS, V2, P167, DOI 10.3233/JPD-2012-12087; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Winward C, 2012, MOVEMENT DISORD, V27, P143, DOI 10.1002/mds.23966; Witjas T, 2002, NEUROLOGY, V59, P408, DOI 10.1212/WNL.59.3.408; Yeung EYH, 2014, MOV DISORD CLIN PRAC, V1, P307, DOI 10.1002/mdc3.12063	72	5	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245285	10.1371/journal.pone.0245285	http://dx.doi.org/10.1371/journal.pone.0245285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0ZY	33540422	gold, Green Published			2022-12-26	WOS:000617317500006
J	McCarthy, GC; Morgan, SC; Martiniuk, JT; Newman, BL; McCann, SE; Measday, V; Durall, DM				McCarthy, Garrett C.; Morgan, Sydney C.; Martiniuk, Jonathan T.; Newman, Brianne L.; McCann, Stephanie E.; Measday, Vivien; Durall, Daniel M.			An indigenous Saccharomyces uvarum population with high genetic diversity dominates uninoculated Chardonnay fermentations at a Canadian winery	PLOS ONE			English	Article							BAYANUS VAR. UVARUM; SPONTANEOUS ALCOHOLIC FERMENTATION; FUNGAL ENDOPHYTIC COMMUNITIES; INTERNAL TRANSCRIBED SPACER; SULFUR-DIOXIDE ADDITION; YEAST POPULATIONS; ENOLOGICAL PROPERTIES; MICROBIAL DIVERSITY; CEREVISIAE STRAINS; GRAPE BERRIES	Saccharomyces cerevisiae is the primary yeast species responsible for most fermentations in winemaking. However, other yeasts, including Saccharomyces uvarum, have occasionally been found conducting commercial fermentations around the world. S. uvarum is typically associated with white wine fermentations in cool-climate wine regions, and has been identified as the dominant yeast in fermentations from France, Hungary, northern Italy, and, recently, Canada. However, little is known about how the origin and genetic diversity of the Canadian S. uvarum population relates to strains from other parts of the world. In this study, a highly diverse S. uvarum population was found dominating uninoculated commercial fermentations of Chardonnay grapes sourced from two different vineyards. Most of the strains identified were found to be genetically distinct from S. uvarum strains isolated globally. Of the 106 strains of S. uvarum identified in this study, four played a dominant role in the fermentations, with some strains predominating in the fermentations from one vineyard over the other. Furthermore, two of these dominant strains were previously identified as dominant strains in uninoculated Chardonnay fermentations at the same winery two years earlier, suggesting the presence of a winery-resident population of indigenous S. uvarum. This research provides valuable insight into the diversity and persistence of non-commercial S. uvarum strains in North America, and a stepping stone for future work into the enological potential of an alternative Saccharomyces yeast species.	[McCarthy, Garrett C.; Morgan, Sydney C.; Newman, Brianne L.; McCann, Stephanie E.; Durall, Daniel M.] Univ British Columbia, Irfigving K Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada; [Martiniuk, Jonathan T.; Measday, Vivien] Univ British Columbia, Fac Land & Food Syst, Wine Res Ctr, Vancouver, BC, Canada; [Morgan, Sydney C.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA	University of British Columbia; University of British Columbia; University of California System; University of California San Diego	Morgan, SC (corresponding author), Univ British Columbia, Irfigving K Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada.; Morgan, SC (corresponding author), Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.	scmorgan@health.ucsd.edu		Morgan, Sydney/0000-0002-8152-1320	Natural Sciences and Engineerig Research Council of Canada (NSERC) [RGPIN-2016-04261]; NSERC Collaborative Research and Development Grant [CRDPJ 514045-17]	Natural Sciences and Engineerig Research Council of Canada (NSERC); NSERC Collaborative Research and Development Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineerig Research Council of Canada (NSERC) Discovery Grant (RGPIN-2016-04261) to V.M., and an NSERC Collaborative Research and Development Grant (CRDPJ 514045-17) to D.M.D. and V.M.	Albertin W, 2017, APPL MICROBIOL BIOT, V101, P7603, DOI 10.1007/s00253-017-8492-1; Almeida P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5044; Alonso-del-Real J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00150; Alsammar H, 2020, FEMS YEAST RES, V20, DOI 10.1093/femsyr/foaa013; Amerine M.F., 1983, WINES THEIR SENSORY; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; [Anonymous], **DATA OBJECT**; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Blanco P, 2012, J APPL MICROBIOL, V112, P936, DOI 10.1111/j.1365-2672.2012.05278.x; Blanco P, 2011, J IND MICROBIOL BIOT, V38, P235, DOI 10.1007/s10295-010-0818-2; Bokulich NA, 2015, AM J ENOL VITICULT, V66, P73, DOI 10.5344/ajev.2014.14096; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bolyen E, 2019, NAT BIOTECHNOL, V7, DOI [10.1038/nbt0119-730605161, DOI 10.1038/NBT0119-730605161]; Borneman AR, 2015, GENETICS, V199, P281, DOI 10.1534/genetics.114.173633; Brewer MT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-268; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Capozzi V, 2015, MICROBIOL RES, V181, P75, DOI 10.1016/j.micres.2015.10.005; Castaneda LE, 2018, PEERJ, V6, DOI 10.7717/peerj.5715; CASTELLARI L, 1994, VITIS, V33, P49; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; Clavijo A, 2011, ANTON LEEUW INT J G, V99, P727, DOI 10.1007/s10482-010-9514-5; Combina M, 2005, INT J FOOD MICROBIOL, V99, P237, DOI 10.1016/j.ijfoodmicro.2004.08.017; Constanti M, 1997, AM J ENOL VITICULT, V48, P339; Coton E, 2006, INT J FOOD MICROBIOL, V108, P130, DOI 10.1016/j.ijfoodmicro.2005.10.016; Csoma H, 2010, INT J FOOD MICROBIOL, V140, P239, DOI 10.1016/j.ijfoodmicro.2010.03.024; Deed RC, 2017, J AGR FOOD CHEM, V65, P8902, DOI 10.1021/acs.jafc.7b03229; Dellaglio F, 2003, ANN MICROBIOL, V53, P411; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; Rodriguez ME, 2014, FEMS YEAST RES, V14, P948, DOI 10.1111/1567-1364.12183; FEIBELMAN T, 1994, MYCOL RES, V98, P614, DOI 10.1016/S0953-7562(09)80407-3; Fernandez-Espinar MT, 2001, INT J FOOD MICROBIOL, V70, P1, DOI 10.1016/S0168-1605(01)00502-5; Freire L, 2017, INT J FOOD MICROBIOL, V241, P181, DOI 10.1016/j.ijfoodmicro.2016.10.027; Gadoury DM, 2007, PHYTOPATHOLOGY, V97, P1356, DOI 10.1094/PHYTO-97-10-1356; Gamero A, 2013, J APPL MICROBIOL, V114, P1405, DOI 10.1111/jam.12126; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021014; Gayevskiy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085196; Gayevskiy V, 2012, ISME J, V6, P1281, DOI 10.1038/ismej.2011.195; Gonzalez V, 2011, FUNGAL DIVERS, V47, P29, DOI 10.1007/s13225-010-0073-x; Granchi L, 2002, FEMS YEAST RES, V2, P403, DOI 10.1111/j.1567-1364.2002.tb00110.x; Grangeteau C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00268; Houck L., 1971, AGR RES SERV; Inoue T, 2013, TOXINS, V5, P1219, DOI 10.3390/toxins5071219; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2020, ANAL MULTILOCUS GENO; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kecskemeti E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160852; Knight S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14233; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Le Jeune C, 2007, FEMS YEAST RES, V7, P540, DOI 10.1111/j.1567-1364.2007.00207.x; Le Jeune C, 2006, FOOD MICROBIOL, V23, P709, DOI 10.1016/j.fm.2006.02.007; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Lorion CM, 2009, FRESHWATER BIOL, V54, P165, DOI 10.1111/j.1365-2427.2008.02092.x; Magyar I, 2011, FOOD MICROBIOL, V28, P94, DOI 10.1016/j.fm.2010.08.011; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martini M, 2009, PLANT DIS, V93, P993, DOI 10.1094/PDIS-93-10-0993; Martiniuk JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160259; Masneuf-Pomarede I, 2007, SYST APPL MICROBIOL, V30, P75, DOI 10.1016/j.syapm.2006.02.006; Masneuf-Pomarede I, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow002; Mateo R, 2007, INT J FOOD MICROBIOL, V119, P79, DOI 10.1016/j.ijfoodmicro.2007.07.029; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Morgan SC, 2019, FEMS YEAST RES, V19, DOI 10.1093/femsyr/foz049; Morgan SC, 2019, INT J FOOD MICROBIOL, V290, P1, DOI 10.1016/j.ijfoodmicro.2018.09.020; Morgan SC, 2017, INT J FOOD MICROBIOL, V244, P96, DOI 10.1016/j.ijfoodmicro.2016.12.025; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Naumov GI, 2002, APPL MICROBIOL BIOT, V59, P727, DOI 10.1007/s00253-002-1077-6; Naumov GI, 2001, INT J FOOD MICROBIOL, V65, P163, DOI 10.1016/S0168-1605(00)00515-8; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Ocon E, 2010, EUR FOOD RES TECHNOL, V230, P885, DOI 10.1007/s00217-010-1233-7; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Pateraki C, 2014, EUR FOOD RES TECHNOL, V239, P1067, DOI 10.1007/s00217-014-2303-z; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Martin F, 2014, INT J FOOD MICROBIOL, V190, P44, DOI 10.1016/j.ijfoodmicro.2014.08.020; Petruzzi L, 2014, APPL MICROBIOL BIOT, V98, P6555, DOI 10.1007/s00253-014-5814-4; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rainieri S, 1999, FEMS MICROBIOL LETT, V177, P177, DOI 10.1111/j.1574-6968.1999.tb13729.x; Varanda CMR, 2016, FUNGAL BIOL-UK, V120, P1525, DOI 10.1016/j.funbio.2016.08.002; Rodriguez ME, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fow109; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sabate J, 1998, LETT APPL MICROBIOL, V26, P452, DOI 10.1046/j.1472-765X.1998.00369.x; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Santamaria P, 2005, INT J FOOD MICROBIOL, V103, P49, DOI 10.1016/j.ijfoodmicro.2004.11.024; Santamaria P, 2008, EUR FOOD RES TECHNOL, V227, P1563, DOI 10.1007/s00217-008-0855-5; Scholl CM, 2016, AUST J GRAPE WINE R, V22, P384, DOI 10.1111/ajgw.12221; SCHUTZ M, 1995, AM J ENOL VITICULT, V46, P175; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Setati ME, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01358; Sipiczki M, 2001, ANTON LEEUW INT J G, V79, P97, DOI 10.1023/A:1010249408975; Soleas GJ, 2001, J AGR FOOD CHEM, V49, P2733, DOI 10.1021/jf0100651; Stefanini I, 2016, MICROB BIOTECHNOL, V9, P195, DOI 10.1111/1751-7915.12337; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Sturm J, 2006, J APPL MICROBIOL, V101, P1241, DOI 10.1111/j.1365-2672.2006.03034.x; Suarez-Lepe JA, 2012, TRENDS FOOD SCI TECH, V23, P39, DOI 10.1016/j.tifs.2011.08.005; Takahashi M, 2014, J BIOSCI BIOENG, V117, P569, DOI 10.1016/j.jbiosc.2013.10.012; Tosi E, 2009, J APPL MICROBIOL, V107, P210, DOI 10.1111/j.1365-2672.2009.04196.x; Valero E, 2007, FEMS YEAST RES, V7, P317, DOI 10.1111/j.1567-1364.2006.00161.x; Valles BS, 2007, FOOD MICROBIOL, V24, P25, DOI 10.1016/j.fm.2006.04.001; Varela C, 2017, YEAST, V34, P111, DOI 10.1002/yea.3219; Viana F, 2008, FOOD MICROBIOL, V25, P778, DOI 10.1016/j.fm.2008.04.015; Wei F, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00334, 10.3389/fmicb.2016.00502]; Zhang HY, 2015, FOOD MICROBIOL, V46, P92, DOI 10.1016/j.fm.2014.07.016; Zott K, 2010, FOOD MICROBIOL, V27, P559, DOI 10.1016/j.fm.2010.01.006; Zott K, 2008, INT J FOOD MICROBIOL, V125, P197, DOI 10.1016/j.ijfoodmicro.2008.04.001	114	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0225615	10.1371/journal.pone.0225615	http://dx.doi.org/10.1371/journal.pone.0225615			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	33539404	Green Published, gold, Green Submitted			2022-12-26	WOS:000616960200035
J	Carvalho, MA; Bejjani, L; Francisco, RPV; Patino, EG; Vivanti, A; Batista, FS; Zugaib, M; Mercier, FJ; Bernardes, LS; Benachi, A				Carvalho, Mariana A.; Bejjani, Lina; Francisco, Rossana P., V; Patino, Elizabeth G.; Vivanti, Alexandre; Batista, Fernanda S.; Zugaib, Marcelo; Mercier, Frederic J.; Bernardes, Lisandra S.; Benachi, Alexandra			Outcomes following medical termination versus prolonged pregnancy in women with severe preeclampsia before 26 weeks	PLOS ONE			English	Article							GESTATION; BIRTH	Objective To compare maternal complications and describe neonatal outcomes in women with severe preeclampsia at <= 26(+0) weeks in two countries with different management policies: expectant management (Brazil) versus termination of pregnancy (France). Methods We conducted a retrospective comparative study by reviewing the medical records of women with severe preeclampsia at <= 26(+0) weeks, from January 2010 to June 2018, in two centers: Hospital das Clinicas da Faculdade de Medicina, in Sao Paulo, Brazil (where medical abortion is forbidden in this indication) and Hopital Antoine-Beclere, Clamart, France (where medical termination is accepted). We collected information on maternal characteristics, laboratory tests, maternal complications and fetal and newborn characteristics. We used Student's t-test and the Mann-Whitney U nonparametric test to compare quantitative variables, and Chi-square test or Fisher's exact test to evaluate the associations between the qualitative variables. Results There was no between-group difference in maternal complications during hospitalization (p = 0.846). In Brazil, the rate of cesarean section was 66.7%, and 20% of patients had vertical incision. The rate of spontaneous fetal death was 35.6% and among the live-born infants 26.6% were discharged from hospital. In France, one patient had a cesarean section with vertical incision. Conclusion When comparing termination of pregnancy to expectant management in severe preeclampsia before 26 weeks, maternal complications were equivalent but maternal reproductive future might have been compromised in 20% of cases due to a higher risk of uterine rupture in subsequent pregnancies for patients having classic cesarean (vertical incision). 26.6% of children survived the neonatal period when pregnancy was pursued, however we lack information on their long-term follow-up.	[Carvalho, Mariana A.; Francisco, Rossana P., V; Patino, Elizabeth G.; Batista, Fernanda S.; Zugaib, Marcelo; Bernardes, Lisandra S.] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo, Brazil; [Bejjani, Lina; Vivanti, Alexandre; Benachi, Alexandra] Hop Antoine Beclere, Assistance Publ Hop Paris AP HP, Obstet & Gynecol Dept, Clamart, France; [Vivanti, Alexandre; Mercier, Frederic J.; Benachi, Alexandra] Univ Paris Saclay, Le Kremlin Bicetre, France; [Mercier, Frederic J.] Hop Antoine Beclere, Assistance Publ Hop Paris AP HP, Dept Anesthesia, Clamart, France	Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Bernardes, LS (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Sao Paulo, Brazil.	lisbernardes@yahoo.com	Vivanti, Alexandre/AAN-1693-2020; Francisco, Rossana PV/C-5648-2012; Azevedo Carvalho, Mariana/F-2693-2016; Spadotto Baptista, Fernanda/P-9785-2018	Vivanti, Alexandre/0000-0002-4921-0047; Francisco, Rossana PV/0000-0002-9981-8069; Azevedo Carvalho, Mariana/0000-0001-7193-4917; Spadotto Baptista, Fernanda/0000-0002-5251-2556	DGOS (Direction generale de l'offre de soins du ministere des solidarites et de la sante)	DGOS (Direction generale de l'offre de soins du ministere des solidarites et de la sante)	LB A grant to finance the cooperation program was allocated by the DGOS (Direction generale de l'offre de soins du ministere des solidarites et de la sante) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzuaga BH, 2019, CURR OPIN PEDIATR, V31, P182, DOI 10.1097/MOP.0000000000000731; Belghiti J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.062; Bombrys AE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.086; Budden A, 2006, AUST NZ J OBSTET GYN, V46, P407, DOI 10.1111/j.1479-828X.2006.00626.x; Easterling T, 2019, LANCET, V394, P1011, DOI 10.1016/S0140-6736(19)31282-6; Guillen U, 2019, J PEDIATR-US, V209, P52, DOI 10.1016/j.jpeds.2019.02.023; Haddad B, 2004, AM J OBSTET GYNECOL, V190, P1590, DOI 10.1016/j.ajog.2004.03.050; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; INSERM et DRESS, 2017, ENQ NAT PER RAPP 201; Jenkins SM, 2002, AM J OBSTET GYNECOL, V186, P790, DOI 10.1067/mob.2002.122290; Kukora SK, 2018, SEMIN FETAL NEONAT M, V23, P17, DOI 10.1016/j.siny.2017.09.003; Lecarpentier E, 2016, PRESSE MED, V45, P638, DOI 10.1016/j.lpm.2016.04.017; Marrs CC, 2016, AM J PERINAT, V33, P569, DOI 10.1055/s-0035-1569989; Mayrink J, 2018, ScientificWorldJournal, V2018, P6268276, DOI 10.1155/2018/6268276; Morsing E, 2011, PEDIATRICS, V127, pE874, DOI 10.1542/peds.2010-1821; Mounier-Vehier C, 2017, FUND CLIN PHARMACOL, V31, P83, DOI 10.1111/fcp.12254; Ploteau S, 2008, MISES JOUR GYNECOLOG; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sabol B, 2015, CLIN OBSTET GYNECOL, V58, P309, DOI 10.1097/GRF.0000000000000101; Soudee S, 2014, NEONATOLOGY, V106, P304, DOI 10.1159/000360842; van Oostwaard MF, 2017, BJOG-INT J OBSTET GY, V124, P1440, DOI 10.1111/1471-0528.14512; WHO, 2011, REC PREV TREATM PREE	22	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2021	16	2							e0246392	10.1371/journal.pone.0246392	http://dx.doi.org/10.1371/journal.pone.0246392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2OR	33534858	Green Published, gold			2022-12-26	WOS:000616739700045
